PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Herman, L; Legois, B; Todeschini, AL; Veitia, RA				Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.			Genomic exploration of the targets of FOXL2 and ESR2 unveils their implication in cell migration, invasion, and adhesion	FASEB JOURNAL			English	Article						cell movement; ESR2; forkhead box protein L2; gene expression regulation; granulosa cell		FOXL2 and ESR2 are key transcriptional regulators in ovarian granulosa cells. To explore their transcriptional roles and their interplay, we have depleted Foxl2 and Esr2 in mouse primary granulosa cells to assess their ability to bind their targets and/or to modulate gene expression and cellular functions. We show that FOXL2 is involved in a large number of regulatory actions essential for the maintenance of granulosa cell fate. A parallel ChIP-seq analysis showed that FOXL2 mainly binds to sites located in intergenic regions quite far from its targets. A bioinformatic analysis demonstrated that FOXL2-activated genes were enriched in peaks associated with the H3K27ac mark, whereas FOXL2-repressed genes were not, suggesting that FOXL2 can activate transcription through binding to enhancer sites. We also identified about 500 deregulated genes upon Esr2 silencing, of which one third are also targets of FOXL2. We provide evidence showing that both factors modulate, through a coherent feed-forward loop, a number of common targets. Many of the FOXL2/ESR2 targets are involved in cell motility and, consistently, granulosa cells depleted for either Foxl2 or Esr2 exhibit decreased migration, invasion and adhesion. This effect is paralleled by the depletion of their target Phactr1, involved in actin cytoskeleton dynamics. Our analysis expands the number of direct and indirect transcriptional targets of both FOXL2 and ESR2, which deserve investigation in the context of adult-type granulosa cell tumors whose molecular diagnostic hallmark is the presence of the C134W FOXL2 pathogenic variant.	[Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris, Fac Sci, Paris, France; [Herman, Laetitia; Legois, Berangere; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris, CNRS, Inst Jacques Monod, Paris, France; [Veitia, Reiner A.] Univ Paris Saclay, Commissariat Energie Atom, Inst Biol F Jacob, Fontenay Aux Roses, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Todeschini, AL (corresponding author), Univ Paris, CNRS UMR7592, Inst Jacques Monod, Reiner Veitia Team Oncol Mol & Pathol Ovariennes, 15 Rue Helene Brion, F-75205 Paris, France.	anne-laure.todeschini@ijm.fr		Legois, Berangere/0000-0002-3610-7593	Universite Paris Diderot; Agence National pour la Recherche, Sexmaintain projet	Universite Paris Diderot; Agence National pour la Recherche, Sexmaintain projet(French National Research Agency (ANR))	This study was supported by Universite Paris Diderot (LH, BL, ALT, RAV), and the Agence National pour la Recherche, Sexmaintain projet (LH, BL, ALT, RAV).	Anttonen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085545; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Benayoun BA, 2013, ONCOGENE, V32, P2739, DOI 10.1038/onc.2012.298; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Carles A, 2020, CANCER RES, V80, P3480, DOI 10.1158/0008-5472.CAN-20-0104; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dipietromaria A, 2009, HUM MOL GENET, V18, P3324, DOI 10.1093/hmg/ddp273; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dutertre M, 2001, ENDOCRINOLOGY, V142, P4040, DOI 10.1210/en.142.9.4040; Garcia-Moreno SA, 2019, DEV BIOL, V446, P168, DOI 10.1016/j.ydbio.2018.12.023; Georges A, 2014, ELIFE, V3, DOI 10.7554/eLife.04207; Grossman H, 2015, FASEB J, V29, P3206, DOI 10.1096/fj.14-269449; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Jin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15748-1; Jing Y, 2019, MED SCI MONITOR, V25, P1291, DOI 10.12659/MSM.912586; Kakourou G, 2013, FERTIL STERIL, V99, P803, DOI 10.1016/j.fertnstert.2012.10.036; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khristi V, 2018, MOL CELL ENDOCRINOL, V474, P214, DOI 10.1016/j.mce.2018.03.012; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim JH, 2014, J REPROD DEVELOP, V60, P14, DOI 10.1262/jrd.2013-090; L'Hote D, 2012, HUM MOL GENET, V21, P3264, DOI 10.1093/hmg/dds170; Liu CY, 2019, BIOL REPROD, V100, P1057, DOI 10.1093/biolre/ioy246; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234795; Mouilleron S, 2012, STRUCTURE, V20, P1960, DOI 10.1016/j.str.2012.08.031; Nicol B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13060-1; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rolaki A, 2007, AM J PATHOL, V170, P1561, DOI 10.2353/ajpath.2007.060926; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Szabo Q, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1668; Todeschini AL, 2011, HUM MOL GENET, V20, P3376, DOI 10.1093/hmg/ddr244; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	44	1	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21355	10.1096/fj.202002444R	http://dx.doi.org/10.1096/fj.202002444R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749886				2022-12-26	WOS:000635216100002
J	Takla, A; Savulescu, J; Kappes, A; Wilkinson, DJC				Takla, Antony; Savulescu, Julian; Kappes, Andreas; Wilkinson, Dominic J. C.			British laypeople's attitudes towards gradual sedation, sedation to unconsciousness and euthanasia at the end of life	PLOS ONE			English	Article							TERMINAL SEDATION; PALLIATIVE SEDATION; LAST-RESORT; UNTIL DEATH; OPTIONS; OPIOIDS; CARE	Background Many patients at the end of life require analgesia to relieve pain. Additionally, up to 1/5 of patients in the UK receive sedation for refractory symptoms at the end of life. The use of sedation in end-of-life care (EOLC) remains controversial. While gradual sedation to alleviate intractable suffering is generally accepted, there is more opposition towards deliberate and rapid sedation to unconsciousness (so-called "terminal anaesthesia", TA). However, the general public's views about sedation in EOLC are not known. We sought to investigate the general public's views to inform policy and practice in the UK. Methods We performed two anonymous online surveys of members of the UK public, sampled to be representative for key demographic characteristics (n = 509). Participants were given a scenario of a hypothetical terminally ill patient with one week of life left. We sought views on the acceptability of providing titrated analgesia, gradual sedation, terminal anaesthesia, and euthanasia. We asked participants about the intentions of doctors, what risks of sedation would be acceptable, and the equivalence of terminal anaesthesia and euthanasia. Findings Of the 509 total participants, 84% and 72% indicated that it is permissible to offer titrated analgesia and gradual sedation (respectively); 75% believed it is ethical to offer TA. Eighty-eight percent of participants indicated that they would like to have the option of TA available in their EOLC (compared with 79% for euthanasia); 64% indicated that they would potentially wish for TA at the end of life (52% for euthanasia). Two-thirds indicated that doctors should be allowed to make a dying patient completely unconscious. More than 50% of participants believed that TA and euthanasia were non-equivalent; a third believed they were. Interpretation These novel findings demonstrate substantial support from the UK general public for the use of sedation and TA in EOLC. More discussion is needed about the range of options that should be offered for dying patients.	[Takla, Antony] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Takla, Antony; Savulescu, Julian; Wilkinson, Dominic J. C.] Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford, England; [Savulescu, Julian; Wilkinson, Dominic J. C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Kappes, Andreas] City Univ London, Sch Arts & Social Sci, Dept Psychol, London, England; [Wilkinson, Dominic J. C.] John Radcliffe Hosp, Oxford, England	Monash University; University of Oxford; Murdoch Children's Research Institute; City University London; University of Oxford	Wilkinson, DJC (corresponding author), Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford, England.; Wilkinson, DJC (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Wilkinson, DJC (corresponding author), John Radcliffe Hosp, Oxford, England.	dominic.wilkinson@philosophy.ox.ac.uk		Takla, Antony/0000-0001-6138-5184	Wellcome Trust [WT203132, WT104848]; Uehiro Centre for Practical Ethics, Oxford	Wellcome Trust(Wellcome Trust); Uehiro Centre for Practical Ethics, Oxford	The authors were supported by grants from the Wellcome Trust WT203132 (Julian Savulescu, Dominic Wilkinson) WT104848 (Julian Savulescu). Funding for this project was through the Uehiro Centre for Practical Ethics, Oxford.	Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Cherny NI, 2009, PALLIATIVE MED, V23, P581, DOI 10.1177/0269216309107024; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fohr S A, 1998, J Palliat Med, V1, P315, DOI 10.1089/jpm.1998.1.315; Huber S, 2012, RELIGIONS, V3, P710, DOI 10.3390/rel3030710; Kaldjian LC, 2004, J MED ETHICS, V30, P499, DOI 10.1136/jme.2003.004895; Kirby D, 2008, PERSPECT SEX REPRO H, V40, P34, DOI 10.1363/4003408; Lipuma SH, 2013, J MED PHILOS, V38, P190, DOI 10.1093/jmp/jht005; Lundstrom S, 2005, J PAIN SYMPTOM MANAG, V30, P570, DOI 10.1016/j.jpainsymman.2005.05.017; Mazoyer J, 2017, SUPPORT CARE CANCER, V25, P2723, DOI 10.1007/s00520-017-3682-z; Mazoyer J, 2016, J MED ETHICS, V42, P627, DOI 10.1136/medethics-2016-103456; Mercadante S, 1999, CANCER-AM CANCER SOC, V85, P1849, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1849::AID-CNCR27>3.0.CO;2-6; Miele E, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015615; Morita T, 2002, J CLIN ONCOL, V20, P758, DOI 10.1200/JCO.2002.20.3.758; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; National Institute of Health and Care Excellence, CAR DYING AD LAST DA; Office for National Statistics, 2019, POPULATION ESTIMATES; Office for National Statistics, EXPL REL ENGL WAL FE; Office for National Statistics, 2011, POP ENGL WAL; Putman MS, 2013, J PAIN SYMPTOM MANAG, V46, P326, DOI 10.1016/j.jpainsymman.2012.09.007; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 2009, ANN INTERN MED, V151, P421, DOI 10.7326/0003-4819-151-6-200909150-00007; Raho JA, 2015, J MED PHILOS, V40, P529, DOI 10.1093/jmp/jhv018; Raus K., 2014, OXFORD HDB ETHICS EN, P1, DOI [10.1093/oxfordhb/9780199974412.001.0001/oxfordhb-9780199974412, DOI 10.1093/OXFORDHB/9780199974412.001.0001/OXFORDHB-9780199974412]; Reid Thomas T., 2010, Pain Management, V1, P31; Rietjens JAC, 2005, SOC SCI MED, V61, P1723, DOI 10.1016/j.socscimed.2005.03.024; Rys S, 2012, J BIOETHIC INQ, V9, P171, DOI 10.1007/s11673-012-9369-8; Savulescu J, 2014, J MED ETHICS, V40, P110, DOI 10.1136/medethics-2013-101379; Seale C, 2010, J PAIN SYMPTOM MANAG, V39, P44, DOI 10.1016/j.jpainsymman.2009.06.007; Simon Alfred, 2007, BMC Palliat Care, V6, P4, DOI 10.1186/1472-684X-6-4; Sulmasy DP, 2018, THEOR MED BIOETH, V39, P233, DOI 10.1007/s11017-018-9459-7; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Takla A, 2021, BIOETHICS, V35, P284, DOI 10.1111/bioe.12838; Twycross Robert, 2019, Palliat Care, V12, p1178224218823511, DOI 10.1177/1178224218823511; Verkerk M, 2007, J PAIN SYMPTOM MANAG, V34, P666, DOI 10.1016/j.jpainsymman.2007.01.005	37	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0247193	10.1371/journal.pone.0247193	http://dx.doi.org/10.1371/journal.pone.0247193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770083	Green Accepted, Green Published, gold			2022-12-26	WOS:000634833500036
J	Azuma, K; Nojiri, T; Kawashima, M; Hanai, A; Ayaki, M; Tsubota, K				Azuma, Koichiro; Nojiri, Tetsuya; Kawashima, Motoko; Hanai, Akiyoshi; Ayaki, Masahiko; Tsubota, Kazuo		TRF Japan Study Grp	Possible favorable lifestyle changes owing to the coronavirus disease 2019 (COVID-19) pandemic among middle-aged Japanese women: An ancillary survey of the TRF-Japan study using the original "Taberhythm" smartphone app	PLOS ONE			English	Article							IMPACT	Coronavirus disease 2019 (COVID-19) has had a global effect on people's lifestyles. Many people have become physically inactive and developed irregular eating patterns, which leads to unhealthier lifestyles and aggravation of lifestyle-related diseases; these in turn increase the severity of COVID-19. Prior to the COVID-19 pandemic, we developed a smartphone application called "Taberhythm" to investigate eating patterns, physical activity, and subjective feelings of happiness. We aimed to compare lifestyle data before and during the first phase of the COVID-19 pandemic to objectively assess lifestyle changes during quarantine. A total of 464 smartphone users (346 women, 35 +/- 12 years old, body mass index [BMI] 23.4 +/- 4.5) participated in Period A (January 7 to April 28, 2019) and 622 smartphone users (533 women, 32 +/- 11 years old, BMI 23.3 +/- 4.0) participated in Period B (January 6 to April 26, 2020). Compared with Period A, there was a sharp decline in physical activity during Period B (4642 +/- 3513 vs. 3814 +/- 3529 steps/day, p<0.001), especially during the final 9 weeks in both periods (4907 <plus/minus> 3908 vs. 3528 +/- 3397 steps/day, p<0.001); however, there were large variations in physical activity among participants. We found a surprising trend during Period B toward increased happiness among women aged 30-50 years, the group most affected by stay-at-home policies that led to working from home and school closure. Moreover, daily eating duration declined in this population. Additionally, there was a positive association of happiness with steps per day in Period B (<rho> = 0.38, p = 0.02). Despite the many negative effects of the COVID-19 pandemic, subjective feelings of happiness among middle-aged Japanese women tended to increase, which indicates that some favorable lifestyle changes that could be adopted during quarantine in the ongoing COVID-19 pandemic.	[Azuma, Koichiro] Nerima Gen Hosp, Dept Med, Tokyo, Japan; [Azuma, Koichiro] Tokyo Healthcare Fdn, Inst Healthcare Qual Improvement, Publ Interest Inc Fdn, Tokyo, Japan; [Azuma, Koichiro] Keio Univ, Inst Integrated Sports Med, Sch Med, Tokyo, Japan; [Nojiri, Tetsuya; Hanai, Akiyoshi] Oishi Kenko Inc, Tokyo, Japan; [Kawashima, Motoko; Ayaki, Masahiko; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University	Azuma, K (corresponding author), Nerima Gen Hosp, Dept Med, Tokyo, Japan.; Azuma, K (corresponding author), Tokyo Healthcare Fdn, Inst Healthcare Qual Improvement, Publ Interest Inc Fdn, Tokyo, Japan.; Azuma, K (corresponding author), Keio Univ, Inst Integrated Sports Med, Sch Med, Tokyo, Japan.	azumakx@keio.jp			Keio University School of Medicine Departmental Teaching and Research Allowance	Keio University School of Medicine Departmental Teaching and Research Allowance	This study was supported by a grant from Keio University School of Medicine Departmental Teaching and Research Allowance (KT). Oishi Kenko Incorporated developed the smartphone app and covered all expenses of developing the app, as well as the costs of processing and analyzing the data. The CEO and an employee of Oishi Kenko Incorporated had central roles in the conceptualization of the study (TN) and in the collection and analysis of data (AH). TN has received directors' compensation from this company. AH has received a salary as a full-time employee of Oishi Kenko Incorporated.	Ammar A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176237; Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583; Bigalke JA, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00333-4; Casagrande M, 2020, SLEEP MED, V75, P12, DOI 10.1016/j.sleep.2020.05.011; Chopra S, 2020, DIABETES METAB SYND, V14, P2021, DOI 10.1016/j.dsx.2020.09.034; Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5; Forte G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061802; Hamer Mark, 2020, medRxiv, DOI 10.1101/2020.05.09.20096438; Kawashima M, 2018, J OCCUP HEALTH, V60, P281, DOI 10.1539/joh.2017-0191-OA; Kawashima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123299; Malkawi SH, 2021, MATERN CHILD HLTH J, V25, P695, DOI 10.1007/s10995-020-03034-x; Malta DC, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.1590/S1679-49742020000400026, 10.1590/s1679-49742020000400026]; Maugeri G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04315; Meyer J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186469; Mukhtar S, 2020, INT J SOC PSYCHIATR, V66, P512, DOI 10.1177/0020764020925835; Ong JL, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa179; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Poelman Maartje P, 2021, Appetite, V157, P105002, DOI 10.1016/j.appet.2020.105002; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Roitblat Y, 2021, SLEEP MED, V77, P177, DOI 10.1016/j.sleep.2020.09.003; Sinha M, 2020, J PUBLIC HEALTH RES, V9, P239, DOI 10.4081/jphr.2020.1826; Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065; Sun SX, 2020, J MED INTERNET RES, V22, DOI 10.2196/19992; Vegesna A, 2017, TELEMED E-HEALTH, V23, P3, DOI 10.1089/tmj.2016.0051; Werneck AO, 2021, TRANSL BEHAV MED, V11, P323, DOI 10.1093/tbm/ibaa095; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381	26	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248935	10.1371/journal.pone.0248935	http://dx.doi.org/10.1371/journal.pone.0248935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765024	Green Published, gold			2022-12-26	WOS:000634832800031
J	Gao, B; Wang, LR; Santella, AJ; Zhuang, GH; Huang, RZ; Xu, BY; Liu, YJ; Xiao, SY; Wang, SF				Gao, Bei; Wang, Lirong; Santella, Anthony J.; Zhuang, Guihua; Huang, Ruizhe; Xu, Boya; Liu, Yujiao; Xiao, Shuya; Wang, Shifan			HIV testing behaviors and willingness to receive oral rapid HIV testing among dental patients in Xi'an, China	PLOS ONE			English	Article								Introduction HIV testing is an important strategy for controlling and ultimately ending the global pandemic. Oral rapid HIV testing (ORHT) is an evidence-based strategy and the evidence-based shows is favored over traditional blood tests in many key populations. The dental setting has been found to be a trusted, convenient, and yet untapped venue to conduct ORHT. This study assessed the HIV testing behaviors and willingness to receive ORHT among dental patients in Xi'an, China. Methods A cross-sectional survey of dental patients from Xi'an was conducted from August to September 2017. Dental patients were recruited using a stratified cluster sampling. A 44-item survey was used to measure HIV/AIDS knowledge, HIV testing behaviors, and willingness to receive ORHT. Results Nine hundred and nine dental patients completed the survey with a mean HIV/AIDS knowledge score of 10.7/15 (SD 2.8). Eighty-four participants (9.2%) had previously received an HIV test. Participants would have a high rate of HIV testing if they had higher monthly income (OR = 1.982, 95% CI: 1.251-3.140) and a higher HIV/AIDS knowledge score (OR = 1.137, 95% CI: 1.032-1.252). Five hundred and eighty-two participants (64.0%) were willing to receive ORHT before a dental treatment, 198 (21.8%) were not sure, and 129 (14.2%) were unwilling. Logistic regression showed that age (OR = 0.970, 95% CI: 0.959-0.982), HIV/AIDS knowledge score (OR = 1.087, 95% CI: 1.031-1.145), previous HIV test (OR = 2.057, 95% CI: 1.136-3.723), having advanced HIV testing knowledge (OR = 1.570, 95% CI: 1.158-2.128), and having advanced ORHT knowledge (OR = 2.074, 95%: CI 1.469-2.928) were the factors affecting the willingness to receive ORHT. Conclusions The majority of dental patients had not previously received an HIV test, although many were receptive to being tested in the dental setting. The dental setting as a venue to screen people for HIV needs further exploration, particularly because many people do not associate dentistry with chairside screenings. Increasing awareness of ORHT and reducing testing price can further improve the patient's willingness to receive ORHT.	[Gao, Bei] Xi An Jiao Tong Univ, Stomatol Hosp, Hlth Sci Ctr, Dept Orthodont, Xian, Shaanxi, Peoples R China; [Wang, Lirong; Zhuang, Guihua; Liu, Yujiao; Xiao, Shuya; Wang, Shifan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China; [Santella, Anthony J.] Hofstra Univ, Sch Hlth Profess & Human Serv, Dept Hlth Profess, Hempstead, NY 11550 USA; [Huang, Ruizhe] Xi An Jiao Tong Univ, Stomatol Hosp, Hlth Sci Ctr, Dept Prevent Dent, Xian, Shaanxi, Peoples R China; [Xu, Boya] Xi An Jiao Tong Univ, Stomatol Hosp, Hlth Sci Ctr, Dept Oral Implantol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Hofstra University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, LR (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China.	wanglr@mail.xjtu.edu.cn	gao, bei/HGV-2277-2022		National T&S Major Project of China [2018ZX10721202]	National T&S Major Project of China	We would like to thank the National T&S Major Project of China (grant no. 2018ZX10721202) for supporting us. The sponsors were not involved in the study design; collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	[Anonymous], 2018, PROGR AIDS PREVENTIO; [Anonymous], 2004, RAP HIV TEST KIT; [Anonymous], 2014, 90 90 90 AMBITIOUS T; Batey DS, 2012, AIDS RES HUM RETROV, V28, P352, DOI 10.1089/aid.2011.0074; Baumann Katherine Ellen, 2018, J Int Assoc Provid AIDS Care, V17, p2325957417752258, DOI 10.1177/2325957417752258; Belete W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210866; Bradley ELP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196323; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Chung R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231638; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P1300, DOI 10.15585/mmwr.mm6647e1; Davide Susan H, 2017, J Dent Hyg, V91, P41; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; Groenewegen H, 2019, J INFECTION, V78, P171, DOI 10.1016/j.jinf.2018.11.008; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Jin Xia, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P323; Kassim S, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0870-x; Li M, 2005, CHEM RES CHINESE U, V21, P114; Li SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014601; Lopez-Quintero C, 2016, AIDS CARE, V28, P137, DOI 10.1080/09540121.2015.1071769; Ngaihte PC., 2015, INT J DEV RES, V5, P5975; Pakfetrat Atessa, 2015, Iran J Otorhinolaryngol, V27, P43; Parish CL, 2018, AIDS CARE, V30, P347, DOI 10.1080/09540121.2017.1367087; Park JC, 2011, J PERIODONTAL IMPLAN, V41, P3, DOI [10.5051/jpis.2011.41.1.3, 10.5051/jpis.2010.40.1.3]; Pollack HA, 2014, AM J PUBLIC HEALTH, V104, P872, DOI 10.2105/AJPH.2013.301700; Pollack HA, 2010, AM J PUBLIC HEALTH, V100, P88, DOI 10.2105/AJPH.2008.157230; Ranganathan K, 2019, PERIODONTOL 2000, V80, P177, DOI 10.1111/prd.12274; Santella A., 2015, J DENT RES, V94, P3907; Santella AJ, 2016, AUST DENT J, V61, P270, DOI 10.1111/adj.12371; Santella AJ, 2016, BRIT DENT J, V220, P229, DOI 10.1038/sj.bdj.2016.172; Tang HL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3158-x; UNAIDS, 2020, GLOB HIV AIDS STAT 2; van Wijk PTL, 2012, COMMUNITY DENT ORAL, V40, P567, DOI 10.1111/j.1600-0528.2012.00702.x; Wang LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119274; Wang W., 2018, MILITARY MED RES, V121, DOI [DOI 10.1016/S1473-3099(20)30134-1, DOI 10.1186/S40779-020-0233-6]; Wilton J, 2019, HIV MED, V20, P110, DOI 10.1111/hiv.12686; Xu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064652; Xun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080594; Ye Z, 2018, AIDS CARE, V30, P793, DOI 10.1080/09540121.2017.1417534; Zachary D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-183; Zhang C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061990	45	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248585	10.1371/journal.pone.0248585	http://dx.doi.org/10.1371/journal.pone.0248585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765025	gold, Green Published			2022-12-26	WOS:000634832800106
J	Habyarimana, E; Baloch, FS				Habyarimana, Ephrem; Baloch, Faheem S.			Machine learning models based on remote and proximal sensing as potential methods for in-season biomass yields prediction in commercial sorghum fields	PLOS ONE			English	Article							TIME-SERIES; SATELLITE; WHEAT; CROP; BICOLOR; L.; REFLECTANCE; AGRICULTURE; PRODUCTS; IMAGERY	Crop yield monitoring demonstrated the potential to improve agricultural productivity through improved crop breeding, farm management and commodity planning. Remote and proximal sensing offer the possibility to cut crop monitoring costs traditionally associated with surveys and censuses. Fraction of absorbed photosynthetically active radiation (fAPAR), chlorophyll concentration (CI) and normalized difference vegetation (NDVI) indices were used in crop monitoring, but their comparative performances in sorghum monitoring is lacking. This work aimed therefore at closing this gap by evaluating the performance of machine learning modelling of in-season sorghum biomass yields based on Sentinel-2-derived fAPAR and simpler high-throughput optical handheld meters-derived NDVI and CI calculated from sorghum plants reflectance. Bayesian ridge regression showed good cross-validated performance, and high reliability (R-2 = 35%) and low bias (mean absolute prediction error, MAPE = 0.4%) during the validation step. Hand-held optical meter-derived CI and Sentinel-2-derived fAPAR showed comparable effects on machine learning performance, but CI outperformed NDVI and was therefore considered as a good alternative to Sentinel-2's fAPAR. The best times to sample the vegetation indices were the months of June (second half) and July. The results obtained in this work will serve several purposes including improvements in plant breeding, farming management and sorghum biomass yield forecasting at extension services and policy making levels.	[Habyarimana, Ephrem] CREA Res Ctr Cereal & Ind Crops, Bologna, Italy; [Baloch, Faheem S.] Sivas Univ Sci & Technol, Fac Agr Sci & Technol, Sivas, Turkey		Habyarimana, E (corresponding author), CREA Res Ctr Cereal & Ind Crops, Bologna, Italy.	ephrem.habyarimana@crea.gov.it	Baloch, Faheem Shehzad/ABG-8788-2020	Baloch, Faheem Shehzad/0000-0002-7470-0080; Habyarimana, Ephrem/0000-0003-2731-2744	European Union [732064]; Ministero delle Politiche Agricole, Alimentari, Forestali e del Turismo (Rome, Italy) through the project Risorse GeneticheVegetali (RGV/FAO) 2017-2019; Belgium (FWO); France (INRA); Germany (BLE); Italy (MIPAAF); Latvia (IZM); Norway (RCN); Portugal (FCT); Spain (AEI); ERA-NET ERAHDHL [696295]	European Union(European Commission); Ministero delle Politiche Agricole, Alimentari, Forestali e del Turismo (Rome, Italy) through the project Risorse GeneticheVegetali (RGV/FAO) 2017-2019; Belgium (FWO)(FWO); France (INRA); Germany (BLE); Italy (MIPAAF); Latvia (IZM)(Latvian Ministry of Education and Science); Norway (RCN); Portugal (FCT); Spain (AEI); ERA-NET ERAHDHL	This research was funded by the European Union, grant number 732064 (H2020-ICT-2016-1-innovation action through the project Data-driven Bioeconomy (www.databio.eu), the Ministero delle Politiche Agricole, Alimentari, Forestali e del Turismo (Rome, Italy) through the project Risorse GeneticheVegetali (RGV/FAO) 2017-2019, and the The project SYSTEMIC "an integrated approach to the challenge of sustainable food systems: adaptive and mitigatory strategies to address climate change and malnutrition", Knowledge hub on Nutrition and Food Security, has received funding from national research funding parties in Belgium (FWO), France (INRA), Germany (BLE), Italy (MIPAAF), Latvia (IZM), Norway (RCN), Portugal (FCT), and Spain (AEI) in a joint action of JPI HDHL, JPI-OCEANS and FACCEJPI launched in 2019 under the ERA-NET ERAHDHL (no 696295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	Afonso S, 2018, J PLANT NUTR, V41, P261, DOI 10.1080/01904167.2017.1385798; Atzberger C, 2011, INT J DIGIT EARTH, V4, P365, DOI 10.1080/17538947.2010.505664; Baret F, 2013, REMOTE SENS ENVIRON, V137, P299, DOI 10.1016/j.rse.2012.12.027; BARNETT TL, 1982, REMOTE SENS ENVIRON, V12, P509, DOI 10.1016/0034-4257(82)90025-6; Bausch WC, 1996, T ASAE, V39, P1869, DOI 10.13031/2013.27665; BENEDETTI R, 1993, REMOTE SENS ENVIRON, V45, P311, DOI 10.1016/0034-4257(93)90113-C; Benor D, 1987, 13336 WORLD BANK, P1; Breiman L, 1997, 486 U CAL; Davenport JR, 2005, HORTTECHNOLOGY, V15, P31, DOI 10.21273/HORTTECH.15.1.0031; De Keukelaere L, 2018, EUR J REMOTE SENS, V51, P525, DOI 10.1080/22797254.2018.1457937; Diouf AA, 2015, REMOTE SENS-BASEL, V7, P9122, DOI 10.3390/rs70709122; Duveiller G, 2013, REMOTE SENS-BASEL, V5, P1091, DOI 10.3390/rs5031091; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; El Bassam N, 2010, HDB BIOENERGY CROPS; Gallego J, 2012, J AUTOMAT INFORM SCI, V44, P67, DOI 10.1615/JAutomatInfScien.v44.i5.70; Gao F, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10091489; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd ed.; Gonfalonieri A, 2019, 5 WAYS DEAL LACK DAT; Habyarimana Ephrem, 2019, Software Technology: Methods and Tools. 51st International Conference, TOOLS 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11771), P227, DOI 10.1007/978-3-030-29852-4_19; Habyarimana E, 2004, IND CROP PROD, V20, P23, DOI 10.1016/j.indcrop.2003.12.019; Habyarimana E, 2004, IND CROP PROD, V20, P3, DOI 10.1016/j.indcrop.2003.12.020; Habyarimana E., 2016, Australian Journal of Crop Science, V10, P127; Habyarimana E, 2010, MAYDICA, V55, P187; Habyarimana E, 2002, MAYDICA, V47, P303; Habyarimana E, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110841; Habyarimana E, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9040203; Habyarimana E, 2018, BIOMASS BIOENERG, V111, P187, DOI 10.1016/j.biombioe.2017.03.004; Hastie T., 2009, UNSUPERVISED LEARNIN; HATFIELD JL, 1983, REMOTE SENS ENVIRON, V13, P301, DOI 10.1016/0034-4257(83)90032-9; Hoogenboom G, 2004, FIELD CROP RES, V90, P145, DOI 10.1016/j.fcr.2004.07.014; Hughes MP, 2017, ANIM NUTR, V3, P67, DOI 10.1016/j.aninu.2016.10.002; IDSO SB, 1978, REMOTE SENS ENVIRON, V7, P273, DOI 10.1016/0034-4257(78)90038-X; Jacquemoud S., 2009, PROSPECT SAIL MODELS, DOI [10.7863/jum.2009.28.3.389, DOI 10.7863/JUM.2009.28.3.389]; Johnson DM, 2016, INT J APPL EARTH OBS, V52, P65, DOI 10.1016/j.jag.2016.05.010; Jones JW, 2001, AGR SYST, V70, P421, DOI 10.1016/S0308-521X(01)00054-3; Kayad A, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11232873; Kogan F, 2013, J AUTOMAT INFORM SCI, V45, P68, DOI 10.1615/JAutomatInfScien.v45.i6.70; Kogan F, 2013, INT J APPL EARTH OBS, V23, P192, DOI 10.1016/j.jag.2013.01.002; Kowalik W, 2014, INT J APPL EARTH OBS, V32, P228, DOI 10.1016/j.jag.2014.03.011; Kross A, 2015, INT J APPL EARTH OBS, V34, P235, DOI 10.1016/j.jag.2014.08.002; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kussul NN, 2010, J AUTOMAT INFORM SCI, V42, P32, DOI 10.1615/JAutomatInfScien.v42.i12.40; Kussul N, 2011, NATO SCI PEACE SECUR, P19, DOI 10.1007/978-90-481-9618-0_3; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Macallister AM, 2018, INVESTIGATING USE BA; Maestrini B, 2018, FIELD CROP RES, V219, P106, DOI 10.1016/j.fcr.2018.01.028; Mas JF, 2008, INT J REMOTE SENS, V29, P617, DOI 10.1080/01431160701352154; Meuwissen THE, 2001, GENETICS, V157, P1819; Murdock L., 2004, COMP USE CHLOROPHYLL, P4; Osborne SL, 2002, AGRON J, V94, P1215, DOI 10.2134/agronj2002.1215; Panda SS, 2010, REMOTE SENS-BASEL, V2, P673, DOI 10.3390/rs2030673; Pavlovic A, 2006, B ENVIRON CONTAM TOX, V77, P763, DOI 10.1007/s00128-006-1129-1; Peters AJ, 2003, CLIMATIC CHANGE, V60, P175, DOI 10.1023/A:1026081615868; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Pu R, 2017, T&F SER REMOTE SENS, P1, DOI 10.1201/9781315120607; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman MM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10121866; Russell S. J., 2010, ARTIF INTELL, V3rd; Schellberg J, 2008, EUR J AGRON, V29, P59, DOI 10.1016/j.eja.2008.05.005; Schwalbert RA, 2018, BIOSYST ENG, V171, P179, DOI 10.1016/j.biosystemseng.2018.04.020; Shafian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196605; SHIBAYAMA M, 1986, JPN J CROP SCI, V55, P53, DOI 10.1626/jcs.55.53; Skakun S, 2016, GEOMAT NAT HAZ RISK, V7, P901, DOI 10.1080/19475705.2015.1016555; Skakun S, 2014, INT GEOSCI REMOTE SE, P5091, DOI 10.1109/IGARSS.2014.6947642; Stefaniak TR, 2012, CROP SCI, V52, P1949, DOI 10.2135/cropsci2011.10.0534; Sudbrink DL, 2003, FLA ENTOMOL, V86, P290, DOI 10.1653/0015-4040(2003)086[0290:EORSTI]2.0.CO;2; TUCKER CJ, 1980, PHOTOGRAMM ENG REM S, V46, P657; Turhan H, 2008, AFR J BIOTECHNOL, V7, P750; Vabalas A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224365; Vuolo F, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8110938; Vuolo F, 2015, AGR WATER MANAGE, V147, P82, DOI 10.1016/j.agwat.2014.08.004; WALKER GK, 1979, AGRON J, V71, P967, DOI 10.2134/agronj1979.00021962007100060019x; Wang X, 2017, HEREDITY, V118, P302, DOI 10.1038/hdy.2016.87; Weiss M, 2016, ATBD S2TOOLBOX LEVEL, V53; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Xie QY, 2018, IEEE J-STARS, V11, P1482, DOI 10.1109/JSTARS.2018.2813281; Yadav S, 2020, PHYSIOL MOL BIOL PLA, V26, P195, DOI 10.1007/s12298-019-00751-8; Yuan HH, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040309	79	3	3	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249136	10.1371/journal.pone.0249136	http://dx.doi.org/10.1371/journal.pone.0249136			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765103	gold, Green Published			2022-12-26	WOS:000634832800025
J	Wright, L; Steptoe, A; Fancourt, D				Wright, Liam; Steptoe, Andrew; Fancourt, Daisy			Are adversities and worries during the COVID-19 pandemic related to sleep quality? Longitudinal analyses of 46,000 UK adults	PLOS ONE			English	Article							PSYCHOMETRIC EVALUATION; SOCIOECONOMIC-STATUS; DOMESTIC VIOLENCE; EMOTIONAL BRAIN; SOCIAL SUPPORT; HEALTH; DEPRESSION; STRESS; METAANALYSIS; DISTURBANCE	Background There are concerns that both the experience of adversities during the COVID-19 pandemic and worries about experiencing adversities will have substantial and lasting effects on mental health. One pathway through which both experience of and worries about adversity may impact health is through effects on sleep. Methods We used data from 46,284 UK adults in the COVID-19 Social Study assessed weekly from 01/04/2020-12/05/2020 to study the association between adversities and sleep quality. We studied six categories of adversity including both worries and experiences of: illness with COVID-19, financial difficulty, loss of paid work, difficulties acquiring medication, difficulties accessing food, and threats to personal safety. We used random-effect within-between models to account for all time-invariant confounders. Results Both the total number of adversity experiences and total number of adversity worries were associated with lower quality sleep. Each additional experience was associated with a 1.16 (95% CI = 1.10, 1.22) times higher odds of poor quality sleep while each additional worry was associated with a 1.20 (95% CI = 1.17, 1.22) times higher odds of poor quality sleep. When considering specific experiences and worries, all worries and experiences were significantly related to poorer quality sleep except experiences relating to employment and finances. Having a larger social network offered some buffering effects on associations but there was limited further evidence of moderation by other social or psychiatric factors. Conclusion Poor sleep may be a mechanism by which COVID-19 adversities are affecting mental health. This highlights the importance of interventions that support adaptive coping strategies during the pandemic.	[Wright, Liam; Steptoe, Andrew; Fancourt, Daisy] UCL, Dept Behav Sci & Hlth, London, England; [Wright, Liam] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London; University of London; University College London	Wright, L (corresponding author), UCL, Dept Behav Sci & Hlth, London, England.; Wright, L (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	liam.wright.17@ucl.ac.uk		Wright, Liam/0000-0002-6347-5121	Nuffield Foundation [WEL/FR-000022583]; MARCH Mental Health Network - Cross-Disciplinary Mental Health Network Plus initiative; UK Research and Innovation [ES/S002588/1]; Wellcome Trust [221400/Z/20/Z, 205407/Z/16/Z]; Economic and Social Research Council through the UCL; East London Doctoral Training Partnership [ES/P000592/1]; HealthWise Wales, the Health and Car Research Wales initiative; Bloomsbury	Nuffield Foundation; MARCH Mental Health Network - Cross-Disciplinary Mental Health Network Plus initiative; UK Research and Innovation(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council through the UCL; East London Doctoral Training Partnership; HealthWise Wales, the Health and Car Research Wales initiative; Bloomsbury	The Covid-19 Social Study was funded by the Nuffield Foundation [WEL/FR-000022583], but the views expressed are those of the authors and not necessarily the Foundation (https://www.nuffieldfoundation.org/).The study was also supported by the MARCH Mental Health Network (https://www.marchnetwork.org/) funded by the Cross-Disciplinary Mental Health Network Plus initiative supported by UK Research and Innovation [ES/S002588/1] (https://www.ukri.org/), and by the Wellcome Trust [221400/Z/20/Z] (https://wellcome.org/).DF was funded by the Wellcome Trust [205407/Z/16/Z]. LW is funded by the Economic and Social Research Council (https://esrc.ukri.org/) through the UCL, Bloomsbury and East London Doctoral Training Partnership [ES/P000592/1] (https://ubel-dtp.ac.uk/).The study was also supported by HealthWise Wales, the Health and Car Research Wales initiative, which is led by Cardiff University in collaboration with SAIL, Swansea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All researchers listed as authors are independent from the funders and all final decisions about the research were taken by the investigators and were unrestricted.	Aguiar M, 2013, AM ECON REV, V103, P1664, DOI 10.1257/aer.103.5.1664; Allison PD, 2009, FIXED EFFECT REGRESS; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET, V395, P1089, DOI 10.1016/S0140-6736(20)30757-1; [Anonymous], 2018, OVERVIEW UK POPULATI; [Anonymous], 2020, COVID 19 VIOLENCE WO; Barrech A, 2016, SCAND J WORK ENV HEA, V42, P170, DOI 10.5271/sjweh.3546; Bell A., 2019, QUAL QUANT, V53, P1051, DOI [10.1007/s11135-018-0802-x, DOI 10.1007/S11135-018-0802-X]; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chen E, 2013, ANNU REV CLIN PSYCHO, V9, P723, DOI 10.1146/annurev-clinpsy-050212-185634; Chung RYN, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1329; Clark AE, 2015, RES ECON INEQUAL, V23, P1, DOI 10.1108/S1049-258520150000023001; Cutler DM, 2015, SOC SCI MED, V127, P63, DOI 10.1016/j.socscimed.2014.07.056; Cutler DM., 2016, EC CONDITIONS MORTAL; de Grey RGK, 2018, HEALTH PSYCHOL, V37, P787, DOI [10.1037/hea0000628.supp, 10.1037/hea0000628]; De Lange AH, 2009, J SLEEP RES, V18, P374, DOI 10.1111/j.1365-2869.2009.00735.x; Desclaux A, 2017, SOC SCI MED, V178, P38, DOI 10.1016/j.socscimed.2017.02.009; El-Sheikh M, 2015, BEHAV SLEEP MED, V13, P506, DOI 10.1080/15402002.2014.940110; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Feldner MT, 2006, J COGN PSYCHOTHER, V20, P201, DOI 10.1891/088983906780639808; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Goldstein AN, 2014, ANNU REV CLIN PSYCHO, V10, P679, DOI 10.1146/annurev-clinpsy-032813-153716; Grey I, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113452; Hartmann JA, 2015, J CLIN PSYCHIAT, V76, pE768, DOI 10.4088/JCP.14m09066; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Humphreys C, 2009, CHILD FAM SOC WORK, V14, P6, DOI 10.1111/j.1365-2206.2008.00575.x; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Kelly WE, 2002, J GENET PSYCHOL, V163, P296, DOI 10.1080/00221320209598685; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kubzansky Laura D., 1997, CIRCULATION, V95, P818, DOI [10.1161/01.cir.95.4.818, DOI 10.1161/01.CIR.95.4.818]; Li DJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124479; Madrid-Valero JJ, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz229; Masterson T, 2020, PANDEMIC INEQUALITY; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; Mihashi M, 2009, HEALTH PSYCHOL, V28, P91, DOI 10.1037/a0013674; Nordin M, 2008, J HEALTH PSYCHOL, V13, P55, DOI 10.1177/1359105307084312; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036; Pow J, 2017, J OCCUP HEALTH PSYCH, V22, P71, DOI 10.1037/a0040107; Prather AA, 2013, PSYCHOSOM MED, V75, P350, DOI 10.1097/PSY.0b013e31828ef15b; R Core Team, 2020, R LANG ENV STAT COMP; Rief W, 2012, J PSYCHOSOM RES, V72, P318, DOI 10.1016/j.jpsychores.2011.11.017; Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0; Snyder E, 2018, J CLIN SLEEP MED, V14, P1849, DOI 10.5664/jcsm.7478; StataCorp, 2019, STAT REL 16 STAT SOF; Sullivan D, 2009, Q J ECON, V124, P1265, DOI 10.1162/qjec.2009.124.3.1265; Szabo M, 2011, ANXIETY STRESS COPIN, V24, P91, DOI 10.1080/10615801003653430; Talamini LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062480; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Uchino BN, 2018, PRINCIPLES CONCEPTS, P341, DOI [10.1007/978-0-387-93826-4_12, DOI 10.1007/978-0-387-93826-4_12]; Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Wanberg C, 2012, PERS PSYCHOL, V65, P887, DOI 10.1111/peps.12005; Wanberg CR, 2012, ACAD MANAGE J, V55, P261, DOI 10.5465/amj.2010.0157; Wilken JA, 2017, PREHOSP DISASTER MED, V32, P673, DOI [10.1017/S1049023X17006720, 10.1017/s1049023x17006720]; Wright L., 2021, J EPIDEMIOL COMMUN H, DOI [10.1136/jech-2020-215598, DOI 10.1136/JECH-2020-215598]; Wright L, 2020, J EPIDEMIOL COMMUN H, V74, P683, DOI 10.1136/jech-2020-214475; Xue ZP, 2020, SLEEP MED, V70, P112, DOI 10.1016/j.sleep.2020.04.014; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zorn JV, 2017, PSYCHONEUROENDOCRINO, V77, P25, DOI 10.1016/j.psyneuen.2016.11.036	69	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248919	10.1371/journal.pone.0248919	http://dx.doi.org/10.1371/journal.pone.0248919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765097	Green Published, gold, Green Submitted			2022-12-26	WOS:000634832800087
J	Guven, S; Friedmann, N				Guven, Selcuk; Friedmann, Naama			Vowel dyslexia in Turkish: A window to the complex structure of the sublexical route	PLOS ONE			English	Article							DEVELOPMENTAL SURFACE DYSLEXIA; PHONOLOGICAL OUTPUT BUFFER; LETTER POSITION DYSLEXIA; MORPHOLOGICAL DECOMPOSITION; CHILDREN; DISORDERS; MODEL; PERFORMANCE; DYSGRAPHIA; PATTERNS	We report on developmental vowel dyslexia, a type of dyslexia that selectively affects the reading aloud of vowel letters. We identified this dyslexia in 55 Turkish-readers aged 9-10, and made an in-depth multiple-case analysis of the reading of 17 participants whose vowel dyslexia was relatively selective. These participants made significantly more vowel errors (vowel substitution, omission, migration, and addition) than age-matched controls, and significantly more errors in vowel letters than in consonants. Vowel harmony, a pivotal property of Turkish phonology, was intact and the majority of their vowel errors yielded harmonic responses. The transparent character of Turkish orthography indicates that vowel dyslexia is not related to ambiguity in vowel conversion. The dyslexia did not result from a deficit in the phonological-output stage, as the participants did not make vowel errors in nonword repetition or in repeating words they had read with a vowel error. The locus of the deficit was not in the orthographic-visual-analyzer either, as their same-different decision on words differing in vowels was intact, and so was their written-word comprehension. They made significantly more errors on nonwords than on words, indicating that their deficit was in vowel processing in the sublexical route. Given that their single-vowels conversion was intact, and that they showed an effect of the number of vowels, we conclude that their deficit is in a vowel-specific buffer in the sublexical route. They did not make vowel errors within suffixes, indicating that suffixes are converted as wholes in a separate sublexical sub-route. These results have theoretical implications for the dual-route model: they indicate that the sublexical route converts vowels and consonants separately, that the sublexical route includes a vowel buffer, and a separate morphological conversion route. The results also indicate that types of dyslexia can be detected in transparent languages given detailed error-analysis and dyslexia-relevant stimuli.	[Guven, Selcuk] Anadolu Univ, Dept Speech & Language Therapy, Eskisehir, Turkey; [Friedmann, Naama] Tel Aviv Univ, Language & Brain Lab, Tel Aviv, Israel; [Guven, Selcuk] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada	Anadolu University; Tel Aviv University; Universite de Montreal	Friedmann, N (corresponding author), Tel Aviv Univ, Language & Brain Lab, Tel Aviv, Israel.	naamafr@tauex.tau.ac.il	Güven, Selçuk/AAM-6863-2021	Güven, Selçuk/0000-0002-2023-7852	Anadolu University [1503E142]; Branco-Weiss Chair for Child Development and Education	Anadolu University(Anadolu University); Branco-Weiss Chair for Child Development and Education	This research was supported by Anadolu University Grant No 1503E142 to the author SG; and by the Branco-Weiss Chair for Child Development and Education to NF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksan Y., 2016, FREQUENCY DICT TURKI; Aksu-Koc A., 1985, CROSS LINGUISTIC STU, V1, P839, DOI [https://doi.org/10.4324/9781315802541, DOI 10.4324/9781315802541]; Angelelli P, 2010, COGN NEUROPSYCHOL, V27, P305, DOI 10.1080/02643294.2010.543539; ARDILA A, 1991, BRAIN LANG, V41, P437, DOI 10.1016/0093-934X(91)90165-W; Babayigit S, 2010, READ WRIT, V23, P539, DOI 10.1007/s11145-009-9173-y; Barca L, 2006, BRAIN LANG, V98, P347, DOI 10.1016/j.bandl.2006.05.001; BERENT I, 1995, PSYCHOL REV, V102, P146, DOI 10.1037/0033-295X.102.1.146; Brizzolara D, 2006, COGN BEHAV NEUROL, V19, P141, DOI 10.1097/01.wnn.0000213902.59827.19; CARAMAZZA A, 1990, COGNITION, V37, P243, DOI 10.1016/0010-0277(90)90047-N; Castles A, 2004, COGNITION, V91, P77, DOI 10.1016/S0010-0277(03)00164-1; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Castles A, 1996, COGN NEUROPSYCHOL, V13, P25, DOI 10.1080/026432996382051; Castles A, 2014, MIND LANG, V29, P270, DOI 10.1111/mila.12050; Castles A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0407; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; COLTHEART M, 1981, VISIBLE LANG, V15, P245; Coltheart M., 2012, HDB NEUROPSYCHOLOGY, P892, DOI DOI 10.1002/9781118432501.CH43; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Danelli L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01328; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Dotan D, 2015, CORTEX, V63, P317, DOI 10.1016/j.cortex.2014.08.014; Dulay KM, 2015, COGN NEUROPSYCHOL, V32, P29, DOI 10.1080/02643294.2014.984602; Egan J., 2004, READING WRITING INTE, V17, P567, DOI [10.1023/B:READ.0000044433.30864.23, DOI 10.1023/B:READ.0000044433.30864.23]; Ellis A. W., 2013, HUMAN COGNITIVE NEUR; Erden G., 2002, ILK RETIM OKULLARINA; Ergul C., 2012, KURAM UYGULAMADA EGI, V12, P2033; Friedmann N, 2001, COGNITIVE NEUROPSYCH, V18, P673, DOI 10.1080/02643290143000051; Friedmann N., 2018, HDB COMMUNICATION DI, P721, DOI [10.1515/9781614514909.?752, DOI 10.1515/9781614514909.?752, 10.1515/9781614514909-036, DOI 10.1515/9781614514909-036]; Friedmann N., 2017, LANGUAGE BRAIN, V12, P1; Friedmann N., 2014, HDB ARABIC LITERACY, V9, P119; Friedmann N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00143; Friedmann N, 2014, J RES READ, V37, P297, DOI 10.1111/j.1467-9817.2011.01525.x; Friedmann N, 2012, BEHAV NEUROL, V25, P193, DOI [10.3233/BEN-2012-119004, 10.1155/2012/296974]; Friedmann N, 2010, CORTEX, V46, P982, DOI 10.1016/j.cortex.2009.08.007; Goswami U, 2002, ANN DYSLEXIA, V52, P141; Gries ST., 2019, 10 LECT CORPUS LINGU; Gries Stefan T., 2008, INT J CORPUS LINGUIS, V13, P403, DOI DOI 10.1075/IJCL.13.4.02GRI; Guven Selcuk, 2019, Front Psychol, V10, P2401, DOI 10.3389/fpsyg.2019.02401; Gvion A, 2010, NEUROPSYCHOLOGIA, V48, P1935, DOI 10.1016/j.neuropsychologia.2010.03.014; Haluts N, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22060662; Hanley J.R., 2017, CURR DEV DISORD REP, V4, P101, DOI [https://doi.org/10.1007/s40474-017-0125-y, DOI 10.1007/S40474-017-0125-Y]; Hohenberger A., 2016, ACQUISITION TURKISH, V20, P29; Jackson N. E., 2013, ROUTES READING SUCCE; Joanisse MF, 2000, J EXP CHILD PSYCHOL, V77, P30, DOI 10.1006/jecp.1999.2553; JOB R, 1984, Q J EXP PSYCHOL-A, V36, P435, DOI 10.1080/14640748408402171; Job R., 1984, DYSLEXIA GLOBAL ISSU, P133; Judica A, 2002, NEUROPSYCHOL REHABIL, V12, P177, DOI 10.1080/09602010244000002; Katz L., 1992, ADV PSYCHOL, V94, P67, DOI [10.1016/S0166-4115(08)62789-2, DOI 10.1016/S0166-4115(08)62789-2]; Khentov-Kraus L, 2018, COGN NEUROPSYCHOL, V35, P223, DOI 10.1080/02643294.2018.1457517; Kinoshita S, 2009, J EXP PSYCHOL LEARN, V35, P1, DOI 10.1037/a0014277; Kohnen S, 2012, NEUROPSYCHOLOGIA, V50, P3681, DOI 10.1016/j.neuropsychologia.2012.07.016; Larsen L, 2020, EARLY CHILD RES Q, V51, P379, DOI 10.1016/j.ecresq.2019.12.001; Leikin M, 2006, J PSYCHOLINGUIST RES, V35, P471, DOI 10.1007/s10936-006-9025-8; Marinelli CV, 2009, READ WRIT, V22, P333, DOI 10.1007/s11145-008-9118-x; Marshall J.C., 1984, DYSLEXIA GLOBAL ISSU, P45; MARSHALL JC, 1973, J PSYCHOLINGUIST RES, V2, P175, DOI 10.1007/BF01067101; Marshall JC, 1998, NEW ENGL J MED, V338, P1852; Marshall JC., 1984, DYSLEXIA GLOBAL ISSU, P211; Masterson J., 1985, SURFACE DYSLEXIA NEU, P215; McCloskey M, 2000, J MEM LANG, V43, P157, DOI 10.1006/jmla.2000.2724; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Oney B, 1997, APPL PSYCHOLINGUIST, V18, P1, DOI 10.1017/S014271640000984X; Ozmen RG, 2005, E ITIM BILIM, V30; Pagliuca G, 2008, LANG COGNITIVE PROC, V23, P422, DOI 10.1080/01690960701626036; Petrashchuk O, 2014, P NATL AVIATION U, V3, P109; Raman I, 2005, BEHAV NEUROL, V16, P59, DOI 10.1155/2005/568540; Raman I, 2005, ANN DYSLEXIA, V55, P79, DOI 10.1007/s11881-005-0005-8; Raman I, 2011, BRIT J PSYCHOL, V102, P328, DOI 10.1348/000712610X522572; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Ripamonti E, 2014, BRAIN LANG, V134, P44, DOI 10.1016/j.bandl.2014.04.001; Sak H, 2008, LECT NOTES ARTIF INT, V5221, P417; Schmalz X, 2015, PSYCHON B REV, V22, P1614, DOI 10.3758/s13423-015-0835-2; Shallice T, 1988, NEUROPSYCHOLOGY MENT, DOI [10.1093/brain/111.2.323, DOI 10.1093/BRAIN/111.2.323]; SHANWEILER D, 1995, PSYCHOL SCI, V6, P149, DOI 10.1111/j.1467-9280.1995.tb00324.x; Snowling M., 1998, CHILD PSYCHOL PSYCHI, V3, P4, DOI [10.1111/1475-3588.00201, DOI 10.1017/S1360641797001366, DOI 10.1111/1475-3588.00201]; Sotiropoulos A, 2017, COGNITION, V168, P205, DOI 10.1016/j.cognition.2017.06.024; Sternberg T., 2007, LANGUAGE BRAIN, V6, P91; Tainturier MJ, 2004, NEUROCASE, V10, P122, DOI 10.1080/13554790490497238; Tomasino B, 2015, CORTEX, V73, P112, DOI 10.1016/j.cortex.2015.08.010; Topbas S, 2014, CLIN LINGUIST PHONET, V28, P602, DOI 10.3109/02699206.2014.927003; Traficante D, 2017, AC APH 55 ANN M 5 7, P119; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; Wimmer H, 2001, DYSLEXIA, FLUENCY, AND THE BRAIN, P93; Zoccolotti P, 1999, APPL PSYCHOLINGUIST, V20, P191, DOI 10.1017/S0142716499002027	84	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0249016	10.1371/journal.pone.0249016	http://dx.doi.org/10.1371/journal.pone.0249016			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760863	gold, Green Published			2022-12-26	WOS:000633030400033
J	Teasdale, CA; Geller, A; Shongwe, S; Mafukidze, A; Choy, M; Magaula, B; Yuengling, K; King, K; De Gusmao, EP; Ryan, C; Ao, T; Callahan, T; Modi, S; Abrams, EJ				Teasdale, Chloe A.; Geller, Amanda; Shongwe, Siphesihle; Mafukidze, Arnold; Choy, Michelle; Magaula, Bhekinkhosi; Yuengling, Katharine; King, Katherine; De Gusmao, Eduarda Pimentel; Ryan, Caroline; Ao, Trong; Callahan, Tegan; Modi, Surbhi; Abrams, Elaine J.			Patient feedback surveys among pregnant women in Eswatini to improve antenatal care retention	PLOS ONE			English	Article								Background Uptake and retention in antenatal care (ANC) is critical for preventing adverse pregnancy outcomes for both mothers and infants. Methods We implemented a rapid quality improvement project to improve ANC retention at seven health facilities in Eswatini (October-December 2017). All pregnant women attending ANC visits were eligible to participate in anonymous tablet-based audio assisted computer self-interview (ACASI) surveys. The 24-question survey asked about women's interactions with health facility staff (HFS) (nurses, mentor mothers, receptionists and lab workers) with a three-level symbolic response options (agree/happy, neutral, disagree/sad). Women were asked to self-report HIV status. Survey results were shared with HFS at monthly quality improvement sessions. Chi-square tests were used to assess differences in responses between months one and three, and between HIV-positive and negative women. Routine medical record data were used to compare retention among pregnant women newly enrolled in ANC two periods, January-February 2017 ('pre-period') and January-February 2018 ('post-period') at two of the participating health facilities. Proportions of women retained at 3 and 6 months were compared using Cochran-Mantel-Haenszel and Wilcoxon tests. Results A total of 1,483 surveys were completed by pregnant women attending ANC, of whom 508 (34.3%) self-reported to be HIV-positive. The only significant change in responses from month one to three was whether nurses listened with agreement increasing from 88.3% to 94.8% (p<0.01). Overall, WLHIV had significantly higher proportions of reported satisfaction with HFS interactions compared to HIV-negative women. A total of 680 pregnant women were included in the retention analysis; 454 (66.8%) HIV-negative and 226 (33.2%) WLHIV. In the pre- and post-periods, 59.4% and 64.6%, respectively, attended at least four ANC visits (p = 0.16). The proportion of women retained at six months increased from 60.9% in the pre-period to 72.7% in the post-period (p = 0.03). For HIV-negative women, pre- and post-period six-month retention significantly increased from 56.6% to 71.6% (p = 0.02); however, the increase in WLHIV retained at six months from 70.7% (pre-period) to 75.0% (post-period) was not statistically significant (p = 0.64). Conclusion The type of rapid quality improvement intervention we implemented may be useful in improving patient-provider relationships although whether it can improve retention remains unclear.	[Teasdale, Chloe A.] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Teasdale, Chloe A.; Shongwe, Siphesihle; Mafukidze, Arnold; Choy, Michelle; Magaula, Bhekinkhosi; Yuengling, Katharine; De Gusmao, Eduarda Pimentel; Abrams, Elaine J.] ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Teasdale, Chloe A.; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Geller, Amanda; Callahan, Tegan; Modi, Surbhi] US Ctr Dis Control & Prevent, Atlanta, GA USA; [King, Katherine] NYC Dept Hlth & Mental Hyg, NYC Hlth Training Clin Operat & Tech Assistance P, New York, NY USA; [Ryan, Caroline; Ao, Trong] US Ctr Dis Control & Prevent, Mbabane, Eswatini; [Abrams, Elaine J.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA	City University of New York (CUNY) System; Columbia University; Centers for Disease Control & Prevention - USA; Columbia University	Teasdale, CA (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Teasdale, CA (corresponding author), ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.; Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	chloe.teasdale@sph.cuny.edu			ICAP at Columbia University; US Centers for Disease Control and Prevention [U2GGH00994]; Columbia University	ICAP at Columbia University; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Columbia University	Yes, the authors listed from ICAP at Columbia University received funding from the US Centers for Disease Control and Prevention (U2GGH00994) to complete the work described in the paper. All funding was received by Columbia University (no individual funding).	Abuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123606; Alli F, 2013, J COMMUN HEALTH, V38, P150, DOI 10.1007/s10900-012-9595-3; [Anonymous], 2008, PATIENT SAFETY QUALI; Asefa A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-57; Ataguba JEO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204822; Austin A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S1; Barry OM, 2012, AIDS CARE, V24, P680, DOI 10.1080/09540121.2011.630369; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Downe S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0466-y; Duysburgh E, 2016, TROP MED INT HEALTH, V21, P70, DOI 10.1111/tmi.12627; Kearns AD, 2016, BJOG-INT J OBSTET GY, V123, P540, DOI 10.1111/1471-0528.13818; Kim YM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-345; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Kruk ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160764; Kruk ME, 2018, HEALTH POLICY PLANN, V33, pE26, DOI 10.1093/heapol/czu079; Mannava P, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0117-9; Okafor II, 2015, INT J GYNECOL OBSTET, V128, P110, DOI 10.1016/j.ijgo.2014.08.015; Organization WH, 2015, GUID START ANT THER; Oyeledun B, 2017, JAIDS-J ACQ IMM DEF, V75, pS156, DOI [10.1097/QAI.0000000000001363, 10.1097/qai.0000000000001363]; Rawlins BJ, 2013, MIDWIFERY, V29, P53, DOI 10.1016/j.midw.2011.10.005; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; UNAIDS, ESW UNAIDS COUNT DAT; UNICEF, ESW KEY DEM IND 2018; Vo BN, 2012, AIDS CARE, V24, P1442, DOI 10.1080/09540121.2011.652357; World Health Organization, 2018, WHO REC ANT CAR POS; Yabo AN., 2015, AM J NURSING SCI, V4, P57	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248685	10.1371/journal.pone.0248685	http://dx.doi.org/10.1371/journal.pone.0248685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760864	Green Published, gold			2022-12-26	WOS:000633030400023
J	Huo, FC; Zhu, ZM; Zhu, WT; Du, QY; Liang, J; Mou, J				Huo, Fu-Chun; Zhu, Zhi-Man; Zhu, Wen-Tao; Du, Qiu-Ying; Liang, Jia; Mou, Jie			METTL3-mediated m(6)A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2	ONCOGENE			English	Article								N6-methyladenosine (m(6)A) RNA methylation is profoundly involved in epigenetic regulation, especially for carcinogenesis and tumor progression. Mounting evidence suggests that methyltransferase METTL3 regulates malignant behaviors of gastric cancer (GC). However, the clinical significance and biological implication of SPHK2 and its related m(6)A modification in GC remain unclear. In this study, quantitative real-time PCR (qRT-PCR), western blot and immunohistochemistry were utilized to detect the expression profiles and prognostic significance of SPHK2 in GC. Here, we showed that increased SPHK2 was signified a poor prognosis of GC patients. Phosphorylation and ubiquitination assays were used to investigate the possible mechanisms of SPHK2-mediated KLF2 expression. SPHK2 can promote the phosphorylation of KLF2, which triggers the ubiquitination and degradation of KLF2 protein in GC. Methylated RNA immunoprecipitation (MeRIP) was performed to uncover the m(6)A modification of SPHK2 mRNA. METTL3 promotes translation of SPHK2 mRNA via an m(6)A-YTHDF1-dependent manner. Functionally, SPHK2 facilitates GC cell proliferation, migration and invasion by inhibiting KLF2 expression. SPHK2/KLF2 regulates the cell proliferation, migration, and invasion induced by METTL3 in GC. Overall, our findings reveal that METTL3-mediated m(6)A modification of SPHK2 contributes to GC progression, which extends the understanding of the importance m(6)A methylation in GC and represents a potential target for GC therapy.	[Huo, Fu-Chun; Zhu, Wen-Tao; Du, Qiu-Ying; Liang, Jia; Mou, Jie] Xuzhou Med Univ, Dept Pathol, Xuzhou, Jiangsu, Peoples R China; [Zhu, Zhi-Man] Jiangsu Coll Nursing, Dept Basic Med, Huaian, Peoples R China; [Mou, Jie] Xuzhou Med Univ, Jiangsu Key Lab New Drug & Clin Pharm, Xuzhou, Jiangsu, Peoples R China; [Mou, Jie] Xuzhou Med Univ, Sch Pharm, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Mou, J (corresponding author), Xuzhou Med Univ, Dept Pathol, Xuzhou, Jiangsu, Peoples R China.; Mou, J (corresponding author), Xuzhou Med Univ, Jiangsu Key Lab New Drug & Clin Pharm, Xuzhou, Jiangsu, Peoples R China.; Mou, J (corresponding author), Xuzhou Med Univ, Sch Pharm, Xuzhou, Jiangsu, Peoples R China.	mou.jie@xzhmu.edu.cn						Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Bialkowska AB, 2017, DEVELOPMENT, V144, P737, DOI 10.1242/dev.145441; Bornschein J, 2014, FRONT BIOSCI-LANDMRK, V19, P312, DOI 10.2741/4210; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Chen Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1671-5; Chu JH, 2014, BIOMED PHARMACOTHER, V68, P1089, DOI 10.1016/j.biopha.2014.10.001; Costamagna G, 2012, ANN ITAL CHIR, V83, P183; Dong JL, 2018, BIOMED PHARMACOTHER, V105, P922, DOI 10.1016/j.biopha.2018.06.052; Hasanifard L, 2019, J CELL PHYSIOL, V234, P8162, DOI 10.1002/jcp.27612; He HB, 2019, BIOCHEM BIOPH RES CO, V517, P581, DOI 10.1016/j.bbrc.2019.07.058; Huo FC, 2019, CELL DEATH DIFFER, V26, P994, DOI 10.1038/s41418-018-0178-4; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Kao SH, 2017, ONCOGENE, V36, P5916, DOI 10.1038/onc.2017.302; Li XB, 2018, CANCER GENE THER, V25, P58, DOI 10.1038/s41417-017-0007-9; Lian YF, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0333-9; Liang JY, 2018, J CONTROL RELEASE, V286, P348, DOI 10.1016/j.jconrel.2018.07.039; Lin S, 2019, OPEN MED-WARSAW, V14, P25, DOI 10.1515/med-2019-0005; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Liu H, 2016, LIFE SCI, V151, P23, DOI 10.1016/j.lfs.2016.02.098; Liu W, 2016, TUMOR BIOL, V37, P6331, DOI 10.1007/s13277-015-4480-1; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marfe G, 2015, MINI-REV MED CHEM, V15, P300, DOI 10.2174/1389557515666150227105415; Matsubara J, 2011, ONCOLOGY-BASEL, V81, P291, DOI 10.1159/000334462; Pham DH, 2014, ONCOGENE, V33, P5559, DOI 10.1038/onc.2013.502; Qiu WW, 2016, ONCOTARGET, V7, P39907, DOI 10.18632/oncotarget.9530; Rane MJ, 2019, EBIOMEDICINE, V40, P743, DOI 10.1016/j.ebiom.2019.01.021; Shi WN, 2017, ONCOTARGET, V8, P39605, DOI 10.18632/oncotarget.17174; Shimada H, 2014, GASTRIC CANCER, V17, P26, DOI 10.1007/s10120-013-0259-5; Sun E, 2016, TUMOR BIOL, V37, P473, DOI 10.1007/s13277-015-3818-z; Wang BS, 2018, AM J MENS HEALTH, V13, DOI 10.1177/1557988318816907; Wang L, 2019, EUR REV MED PHARMACO, V23, P201, DOI [10.26355/eurrev_201908_18648, 10.26355/eurrev_201908_1864d]; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang QQ, 2019, AM J TRANSL RES, V11, P4895; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wei J, 2016, WORLD J GASTROENTERO, V22, P7478, DOI 10.3748/wjg.v22.i33.7478; Xiao GQ, 2018, ONCOL RES, V26, P1183, DOI 10.3727/096504018X15151495109394; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Xue KC, 2017, EUR REV MED PHARMACO, V21, P3794; Xun C, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0205-y; Yang DD, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00115; Yuan XH, 2020, EUR REV MED PHARMACO, V24, P673, DOI 10.26355/eurrev_202001_20044; Yue B, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1065-4; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033	45	27	27	3	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2968	2981		10.1038/s41388-021-01753-1	http://dx.doi.org/10.1038/s41388-021-01753-1		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33758320				2022-12-26	WOS:000631804500001
J	Hofer, CK; Garcia, PDW; Heim, C; Ganter, MT				Hofer, Christoph Karl; Garcia, Pedro David Wendel; Heim, Christof; Ganter, Michael Thomas			Analysis of anaesthesia services to calculate national need and supply of anaesthetics in Switzerland during the COVID-19 pandemic	PLOS ONE			English	Article							REGIONAL ANESTHESIA; FRANCE	Background In Switzerland, details of current anaesthesia practice are unknown. However, they are urgently needed to manage anaesthesia drug supply in times of drug shortages due to the pandemic. Methods We surveyed all Swiss anaesthesia institutions in April 2020 to determine their annual anaesthesia activity. Together with a detailed analysis on anaesthetic drug use of a large, representative Swiss anaesthesia index institution, calculations and projections for the annual need of anaesthetics in Switzerland were made. Only those drugs have been analysed that are either being used very frequently or that have been classified critical with regard to their supply by the pharmacy of the index institution or the Swiss Federal Office of Public Health. Results The response rate to our questionnaire was 98%. Out of the present 188 Swiss anaesthesia institutions, 185 responded. In Switzerland, the annual number of anaesthesias was 1'071'054 (12'445 per 100'000 inhabitants) with a mean anaesthesia time of 2.03 hours. Teaching hospitals (n = 54) performed more than half (n = 572'231) and non-teaching hospitals (n = 103) provided almost half of all anaesthesias (n = 412'531). Thereby, private hospitals conducted a total of 290'690 anaesthesias. Finally, office-based anaesthesia institutions with mainly outpatients (n = 31) administered 86'292 anaesthesias. Regarding type of anaesthesia provided, two thirds were general anaesthesias (42% total intravenous, 17% inhalation, 8% combined), 20% regional and 12% monitored anaesthesia care. Projecting for example the annual need for propofol in anaesthesia, Switzerland requires 48'573 L of propofol 1% which corresponds to 5'644 L propofol 1% per 100'000 inhabitants every year. Conclusions To actively manage anaesthesia drug supply in the context of the current pandemic, it is mandatory to have a detailed understanding of the number and types of anaesthesias provided. On this basis, the Swiss annual consumption of anaesthetics could be projected and the replenishment organized.	[Hofer, Christoph Karl] Schulthess Clin, Anaesthesiol, Zurich, Switzerland; [Hofer, Christoph Karl; Heim, Christof; Ganter, Michael Thomas] Comm Data & Qual Management, Swiss Soc Anaesthesiol & Resuscitat SSAR, Bern, Switzerland; [Garcia, Pedro David Wendel; Ganter, Michael Thomas] Kantonsspital Winterthur, Inst Anaesthesiol, Winterthur, Switzerland	Schulthess Clinic	Ganter, MT (corresponding author), Comm Data & Qual Management, Swiss Soc Anaesthesiol & Resuscitat SSAR, Bern, Switzerland.; Ganter, MT (corresponding author), Kantonsspital Winterthur, Inst Anaesthesiol, Winterthur, Switzerland.	mt.ganter@gmail.com	Wendel Garcia, Pedro David/AAU-4579-2021	Wendel Garcia, Pedro David/0000-0001-7775-3279				Ammar MA, 2021, J INTENSIVE CARE MED, V36, P157, DOI 10.1177/0885066620951426; Au Yong Phui Sze Angie, 2020, SN Compr Clin Med, V2, P871, DOI 10.1007/s42399-020-00345-6; Bauer M, 2020, ANASTH INTENSIVMED, V61, P516, DOI 10.19224/ai2020.516; Clergue F, 1999, ANESTHESIOLOGY, V91, P1509, DOI 10.1097/00000542-199911000-00045; Clergue Francois, 2002, Best Pract Res Clin Anaesthesiol, V16, P459, DOI 10.1053/bean.2002.0226; Cozowicz C, 2015, BRIT J ANAESTH, V115, P57, DOI 10.1093/bja/aev381; Dadure C, 2015, ANAESTH CRIT CARE PA, V34, P191, DOI 10.1016/j.accpm.2014.12.003; Haller G., 2020, SAEZ, V101, P1358; Holmer H, 2019, BRIT J SURG, V106, pE138, DOI 10.1002/bjs.11061; Hubner M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241331; Kempthorne P, 2017, ANESTH ANALG, V125, P981, DOI 10.1213/ANE.0000000000002258; Lefrant JY, 2020, ANAESTH CRIT CARE PA, V39, P709, DOI 10.1016/j.accpm.2020.09.007; Mallhi TH, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.561924; Marie A, 2015, ANAESTH CRIT CARE PA, V34, P199, DOI 10.1016/j.accpm.2015.04.002; R Core Team, 2021, R LANGUAGE ENV STAT; Siow WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02971-x; Sites BD, 2010, REGION ANESTH PAIN M, V35, pS74, DOI 10.1097/AAP.0b013e3181d34ff5; Sury MRJ, 2014, BRIT J ANAESTH, V113, P575, DOI 10.1093/bja/aeu292; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248997	10.1371/journal.pone.0248997	http://dx.doi.org/10.1371/journal.pone.0248997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740018	gold, Green Published, Green Accepted			2022-12-26	WOS:000631030200014
J	Tolossa, T; Wakuma, B; Besho, M; Mulisa, D; Fekadu, G; Bayisa, L; Tsegaye, R				Tolossa, Tadesse; Wakuma, Bizuneh; Besho, Merga; Mulisa, Diriba; Fekadu, Ginenus; Bayisa, Lami; Tsegaye, Reta			HIV serostatus disclosure and associated factors among HIV positive pregnant and lactating women at Nekemte public health facilities, western Ethiopia	PLOS ONE			English	Article								Background Disclosure of Human Immune Virus (HIV) serostatus by pregnant and lactating women is crucial for the successful prevention of mother to child transmission of HIV/AIDS. However, little has been studied regarding the prevalence and factors associated with HIV status disclosure among HIV positive pregnant and lactating women in Ethiopia. Methods An institution-based cross-sectional study was conducted in the Nekemte Public Health facilities among 380 pregnant and lactating women enrolled in universal antiretroviral therapy (ART) treatment from January 2015-December, 2019. The data were collected by using a checklist, developed from Prevention of Mother to Child Transmission (PMTCT) logbook, ART intake forms, and medical cards of the patients. Epidata version 3.2 was used for data entry, and then the data were exported to STATA version 14 for further analysis. The binary logistic regression model was employed to determine factors associated with the disclosure status among HIV positive pregnant and lactating women. Adjusted Odds Ratio (AOR) with 95% confidence intervals was computed and statistical significance was declared when it is significant at a 5% level (p-value < 0.05). Results A total of 380 women have participated in the study. Two hundred seventy-six (73.4%) of women had disclosed their HIV status to at least one individual. The study found living in urban (OR = 1.83, 95% CI: 1.04, 3.20), married women (OR = 4.16, 95% CI: 1.87, 9.24), higher educational status (OR = 2.35, 95% CI: 1.31, 5.51), positive HIV status of partner (OR = 2.35, 95%CI: 1.17, 4.70), and being multipara (OR = 4.94, 95% CI: 2.29, 10.66) were independent determinants of HIV status disclosure. Conclusions HIV status disclosure among pregnant and lactating women in the study area was sub-optimal. Empowering women through education, encouraging partners for HIV testing, and enhancing active male involvement in HIV treatment and control programs should get due attention.	[Tolossa, Tadesse] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Wakuma, Bizuneh; Besho, Merga; Mulisa, Diriba; Bayisa, Lami; Tsegaye, Reta] Wollega Univ, Sch Nursing & Midwifery, Inst Hlth Sci, Nekemte, Ethiopia; [Fekadu, Ginenus] Wollega Univ, Sch Pharm, Inst Hlth Sci, Nekemte, Ethiopia		Tolossa, T (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	yadanotolasa@gmail.com	Fekadu, Ginenus/AAH-1203-2019	Fekadu, Ginenus/0000-0002-4926-0685; Tolasa, Tadesse/0000-0002-7936-9024				Alemayehu D., 2014, INT J INFECT CONTROL, V10, P10, DOI [10.3396/IJICv10i4.028.14, DOI 10.3396/IJICV10I4.028.14]; Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Aloyce Z, 2021, AIDS CARE, V33, P1009, DOI 10.1080/09540121.2020.1799921; Belay GM, 2019, AIDS RES TREAT, V2019, DOI 10.1155/2019/3862098; Brittain K, 2018, AIDS BEHAV, V22, P3933, DOI 10.1007/s10461-018-2263-6; Damian DJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211921; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Diemer SCH, 2018, SANTE PUBLIQUE, V30, P397, DOI 10.3917/spub.183.0397; Elenga N., 2012, PREDICTIVE FACTORS H; Federal Ministry of Health (FMoH),, 2017, COMP BAS NAT COMPR P; Gari T., 2010, E AFRICAN J PUBLIC H, V7; Idele P, 2017, AIDS BEHAV, V21, pS23, DOI 10.1007/s10461-016-1670-9; Kassahun G, 2018, HLTH SCI J, V12; Kennedy Caitlin E, 2015, AIDS, V29 Suppl 1, pS7, DOI 10.1097/QAD.0000000000000671; Mashora M.C., 2020, MULTIINSTITUTIONAL C, DOI [10.11604/pamj.2020.37.58.23062, DOI 10.11604/PAMJ.2020.37.58.23062]; Mekonnen FA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8097-y; Meseret Y., 2019, OBSTET GYNECOL INT J, V10, P317, DOI [10.15406/ogij.2019.10.00460, DOI 10.15406/OGIJ.2019.10.00460]; Mwanga J.A., 2012, HIV SERO STATUS DISC; Naigino R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0367-5; Ngonzi J, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.200.12541; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Tam M, 2015, AIDS CARE, V27, P436, DOI 10.1080/09540121.2014.997662; Zea MC, 2005, AIDS BEHAV, V9, P15, DOI 10.1007/s10461-005-1678-z	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248278	10.1371/journal.pone.0248278	http://dx.doi.org/10.1371/journal.pone.0248278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33739992	Green Published, gold			2022-12-26	WOS:000631030200009
J	Weyhe, D; Obonyo, D; Uslar, VN; Stricker, I; Tannapfel, A				Weyhe, Dirk; Obonyo, Dennis; Uslar, Verena Nicole; Stricker, Ingo; Tannapfel, Andrea			Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; R1 RESECTION; PANCREATICODUODENECTOMY; HEAD; IMPACT; CLEARANCE; CHEMORADIOTHERAPY; CLASSIFICATION; MESOPANCREAS	Factors for overall survival after pancreatic ductal adenocarcinoma (PDAC) seem to be nodal status, chemotherapy administration, UICC staging, and resection margin. However, there is no consensus on the definition for tumor free resection margin. Therefore, univariate OS as well as multivariate long-term survival using cancer center data was analyzed with regards to two different resection margin definitions. Ninety-five patients met inclusion criteria (pancreatic head PDAC, R0/R1, no 30 days mortality). OS was analyzed in univariate analysis with respect to R-status, CRM (circumferential resection margin; positive: <= 1mm; negative: >1mm), nodal status, and chemotherapy administration. Long-term survival >36 months was modelled using multivariate logistic regression instead of Cox regression because the distribution function of the dependent data violated the requirements for the application of this test. Significant differences in OS were found regarding the R status (Median OS and 95%CI for R0: 29.8 months, 22.3-37.4; R1: 15.9 months, 9.2-22.7; p = 0.005), nodal status (pN0 = 34.7, 10.4-59.0; pN1 = 17.1, 11.5-22.8; p = 0.003), and chemotherapy (with CTx: 26.7, 20.4-33.0; without CTx: 9.7, 5.2-14.1; p < .001). OS according to CRM status differed on a clinically relevant level by about 12 months (CRM positive: 17.2 months, 11.5-23.0; CRM negative: 29.8 months, 18.6-41.1; p = 0.126). A multivariate model containing chemotherapy, nodal status, and CRM explained long-term survival (p = 0.008; correct prediction >70%). Chemotherapy, nodal status and resection margin according to UICC R status are univariate factors for OS after PDAC. In contrast, long-term survival seems to depend on wider resection margins than those used in UICC R classification. Therefore, standardized histopathological reporting (including resection margin size) should be agreed upon.	[Weyhe, Dirk; Obonyo, Dennis; Uslar, Verena Nicole] Carl von Ossietzky Univ Oldenburg, Pius Hosp, Univ Hosp Visceral Surg, Oldenburg, Germany; [Stricker, Ingo; Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Carl von Ossietzky Universitat Oldenburg; Pius-Hospital Oldenburg; Ruhr University Bochum	Uslar, VN (corresponding author), Carl von Ossietzky Univ Oldenburg, Pius Hosp, Univ Hosp Visceral Surg, Oldenburg, Germany.	verena.uslar@uol.de						ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Albores-Saavedra J, 1999, AM J CLIN PATHOL, V111, P304; Alexakis N, 2004, BRIT J SURG, V91, P1410, DOI 10.1002/bjs.4794; Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131; Bouassida M, 2013, INT J SURG, V11, P834, DOI 10.1016/j.ijsu.2013.08.009; Campbell F, 2010, ROYAL COLL PATHOLOGI; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; Chang DK, 2009, J CLIN ONCOL, V27, P2855, DOI 10.1200/JCO.2008.20.5104; Gomez-Mateo MD, 2014, WORLD J GASTRO ONCOL, V6, P351, DOI 10.4251/wjgo.v6.i9.351; Demir IE, 2018, ANN SURG, V268, P1058, DOI 10.1097/SLA.0000000000002345; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Fatima J, 2010, ARCH SURG-CHICAGO, V145, P167, DOI 10.1001/archsurg.2009.282; Gebauer F, 2015, WORLD J SURG, V39, P493, DOI 10.1007/s00268-014-2808-4; Gockel Ines, 2007, World J Surg Oncol, V5, P44; Groot VP, 2018, ANN SURG, V267, P936, DOI 10.1097/SLA.0000000000002234; Henne-Bruns D, 2000, WORLD J SURG, V24, P595, DOI 10.1007/s002689910089; Jamieson NB, 2013, J GASTROINTEST SURG, V17, P511, DOI 10.1007/s11605-012-2131-z; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Kawabata Y, 2012, EJSO-EUR J SURG ONC, V38, P574, DOI 10.1016/j.ejso.2012.04.007; KAYAHARA M, 1993, CANCER, V72, P2118, DOI 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4; Khalifa Mahmoud A, 2007, HPB (Oxford), V9, P146, DOI 10.1080/13651820701278273; Khalifa MA, 2009, VIRCHOWS ARCH, V454, P125, DOI 10.1007/s00428-008-0711-9; Kleeff J, 2007, ANN SURG, V245, P566, DOI 10.1097/01.sla.0000245845.06772.7d; Kurahara H, 2007, WORLD J SURG, V31, P483, DOI 10.1007/s00268-006-0463-0; Lewis R, 2013, HPB, V15, P49, DOI 10.1111/j.1477-2574.2012.00571.x; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; McDowell BD, 2015, ANN SURG, V261, P740, DOI 10.1097/SLA.0000000000000796; Menon KV, 2009, HPB, V11, P18, DOI 10.1111/j.1477-2574.2008.00013.x; Michalski CW, 2007, BRIT J SURG, V94, P265, DOI 10.1002/bjs.5716; Murakami Y, 2010, J AM COLL SURGEONS, V211, P196, DOI 10.1016/j.jamcollsurg.2010.03.037; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2001, ANN SURG, V234, P758, DOI 10.1097/00000658-200112000-00007; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Peparini N, 2013, EJSO-EUR J SURG ONC, V39, P1303, DOI 10.1016/j.ejso.2013.10.012; Petrou A, 2016, J BUON, V21, P874; Rau BM, 2012, SURGERY, V152, pS103, DOI 10.1016/j.surg.2012.05.015; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Richter A, 2003, WORLD J SURG, V27, P324, DOI 10.1007/s00268-002-6659-z; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Strobel O, 2017, ANN SURG, V265, P565, DOI 10.1097/SLA.0000000000001731; Tummers WS, 2019, BRIT J SURG, V106, P1055, DOI 10.1002/bjs.11115; Verbeke CS, 2008, HISTOPATHOLOGY, V52, P787, DOI 10.1111/j.1365-2559.2007.02935.x; Verbeke CS, 2006, BRIT J SURG, V93, P1232, DOI 10.1002/bjs.5397; Verbeke CS, 2011, HISTOPATHOLOGY, V59, P1111, DOI 10.1111/j.1365-2559.2011.04056.x; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Wittekind C, 2009, CANCER-AM CANCER SOC, V115, P3483, DOI 10.1002/cncr.24320; Zuo HD, 2012, WORLD J RADIOL, V4, P13, DOI 10.4329/wjr.v4.i1.13	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248633	10.1371/journal.pone.0248633	http://dx.doi.org/10.1371/journal.pone.0248633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735191	Green Published, gold			2022-12-26	WOS:000631029700070
J	Siefert, P; Buling, N; Grunewald, B				Siefert, Paul; Buling, Nastasya; Gruenewald, Bernd			Honey bee behaviours within the hive: Insights from long-term video analysis	PLOS ONE			English	Article								The combined behaviours of individuals within insect societies determine the survival and development of the colony. For the western honey bee (Apis mellifera), individual behaviours include nest building, foraging, storing and ripening food, nursing the brood, temperature regulation, hygiene and defence. However, the various behaviours inside the colony, especially within the cells, are hidden from sight, and until recently, were primarily described through texts and line drawings, which lack the dynamics of moving images. In this study, we provide a comprehensive source of online video material that offers a view of honey bee behaviour within comb cells, thereby providing a new mode of observation for the scientific community and the general public. We analysed long-term video recordings from longitudinally truncated cells, which allowed us to see sideways into the cells in the middle of a colony. Our qualitative study provides insight into worker behaviours, including the use of wax scales and existing nest material to remodel combs, storing pollen and nectar in cells, brood care and thermoregulation, and hygienic practices, such as cannibalism, grooming and surface cleaning. We reveal unique processes that have not been previously published, such as the rare mouth-to-mouth feeding by nurses to larvae as well as thermoregulation within cells containing the developing brood. With our unique video method, we are able to bring the processes of a fully functioning social insect colony into classrooms and homes, facilitating ecological awareness in modern times. We provide new details and images that will help scientists test their hypotheses on social behaviours. In addition, we encourage the non-commercial use of our material to educate beekeepers, the media and the public and, in turn, call attention to the general decline of insect biomass and diversity.	[Siefert, Paul; Buling, Nastasya; Gruenewald, Bernd] Goethe Univ, Inst Bienenkunde, Polytech Gesell Frankfurt am Main, Frankfurt, Germany	Goethe University Frankfurt	Siefert, P (corresponding author), Goethe Univ, Inst Bienenkunde, Polytech Gesell Frankfurt am Main, Frankfurt, Germany.	siefert@bio.uni-frankfurt.de	Grünewald, Bernd/G-2060-2012	Siefert, Paul/0000-0003-3732-4466	European Union and Land Hessen (Germany)	European Union and Land Hessen (Germany)	We thank the European Union and Land Hessen (Germany) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonsus EC, 1932, J ECON ENTOMOL, V25, P815, DOI 10.1093/jee/25.4.815; [Anonymous], 1877, DIFFERENT FORMS FLOW; BOZIC J, 1995, APIDOLOGIE, V26, P141, DOI 10.1051/apido:19950207; BROUWERS EVM, 1987, J APICULT RES, V26, P11, DOI 10.1080/00218839.1987.11100729; BUCHLER R, 1992, EXP APPL ACAROL, V16, P313, DOI 10.1007/BF01218573; BUDEL A, 1948, Z VERGL PHYSIOL, V31, P249; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; Casteel D. B., 1912, U S Department of Agriculture Bureau of Entomology Bulletin, VNo. 121; Casteel DB., 1912, CIRC US BUR ENTOMOL, V161, P1; de Reaumur RAF, 1742, MEMOIRES SERVIR HIST, V6; Du PRAW E. J., 1961, TRANS AMER MICROSC SOC, V80, P185, DOI 10.2307/3223908; ESCH H, 1991, NATURWISSENSCHAFTEN, V78, P325, DOI 10.1007/BF01221422; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; FREE J. B., 1963, EMTOMOL EXP APPL, V6, P234; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Haydak M. H., 1945, AMER BEE JOUR, V85, P316; HEINRICH B, 1994, AM SCI, V82, P164; Holldobler B., 1990, ANTS, DOI [10.1007/BF01021020, DOI 10.1007/BF01021020]; Huber Francois, 1806, NEW OBSERVATIONS NAT; JAY SC, 1964, CAN ENTOMOL, V96, P784, DOI 10.4039/Ent96784-5; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; KOENIGER N, 1978, APIDOLOGIE, V9, P305, DOI 10.1051/apido:19780404; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; Land BB, 2004, ETHOLOGY, V110, P1, DOI 10.1046/j.1439-0310.2003.00947.x; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LINDAUER M., 1955, BEE WORLD, V36, P62; Lindauer M., 1967, COMMUNICATION SOCIAL; McAfee A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24054-2; MICHENER CD, 1969, ANNU REV ENTOMOL, V14, P299, DOI 10.1146/annurev.en.14.010169.001503; MOOSBECKHOFER R, 1992, APIDOLOGIE, V23, P523, DOI 10.1051/apido:19920604; Nelson J. A, 1924, GROWTH FEEDING HONEY; Park OW, 1923, AM BEE J, V63, P553; Park W, 1925, J ECON ENTOMOL, V18, P405, DOI 10.1093/jee/18.2.405; Pettis JS, 1998, APIDOLOGIE, V29, P241, DOI 10.1051/apido:19980304; Praagh J. P. van, 1975, Apidologie, V6, P283, DOI 10.1051/apido:19750305; ROSCH G. A., 1930, ZEITSCHR WISSENSCH BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V12, P1, DOI 10.1007/BF00339476; Rosch G.A, 1925, Z VERGL PHYSIOL, V2, P571; Rosch GA., 1927, J COMP PHYSL NEUROET, V6, P264; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; SHUEL R. W., 1959, CANADIAN JOUR ZOOL, V37, P803, DOI 10.1139/z59-081; Siefert P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65425-y; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1987, BIOSCIENCE, V37, P395, DOI 10.2307/1310562; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; von Frisch K., 1967, DANCE LANGUAGE ORIEN; von Frisch K, 1965, TANZSPRACHE ORIENTIE; von Frisch K., 1922, HDB BIOL ARBEITSMETH; Woyke J., 1963, Journal of Apicultural Research London, V2, P73	50	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247323	10.1371/journal.pone.0247323	http://dx.doi.org/10.1371/journal.pone.0247323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730051	gold, Green Published			2022-12-26	WOS:000630345000053
J	Parvathaneni, S; Li, ZG; Sacks, DB				Parvathaneni, Swetha; Li, Zhigang; Sacks, David B.			Calmodulin influences MAPK signaling by binding KSR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IQGAP1 INTEGRATES CA2+/CALMODULIN; REGULATED KINASE PATHWAY; TARGET RECOGNITION; ACTIVATION; SCAFFOLD; RAS; CALCIUM; PROTEINS; TRANSLOCATION; INHIBITOR	The mitogen-activated protein kinase (MAPK) cascade is a fundamental signaling pathway that regulates cell fate decisions in response to external stimuli. Several scaffold proteins bind directly to kinase components of this pathway and regulate their activation by growth factors. One of the best studied MAPK scaffolds is kinase suppressor of Ras1 (KSR1), which is induced by epidermal growth factor (EGF) to translocate to the plasma membrane where it activates extracellular signal-regulated kinase (ERK). While Ca2+ has been shown to modulate MAPK signaling, the molecular mechanisms by which this occurs are incompletely understood. Here we tested the hypothesis that Ca2+ alters MAPK activity at least in part via KSR1. Using several approaches, including fusion proteins, immunoprecipitation, confocal microscopy, and a cell-permeable chemical inhibitor, we investigated the functional interaction between KSR1 and calmodulin. In vitro analysis with pure proteins reveals that calmodulin binds directly to KSR1. Moreover, endogenous calmodulin and KSR1 co-immunoprecipitate from mammalian cell lysates. Importantly, Ca2+ is required for the association between calmodulin and KSR1, both in vitro and in cells. The cell-permeable calmodulin antagonist CGS9343B significantly reduced activation of ERK by EGF in mouse embryo fibroblasts that overexpress KSR1, but not in control cells. Moreover, CGS9343B impaired the ability of EGF to induce KSR1 translocation to the plasma membrane and to stimulate formation of KSR1-ERK and KSR1-pERK (phosphorylated ERK) complexes in cells. Collectively, our data identify a previously unrecognized mechanism by which the scaffold protein KSR1 couples Ca2+ and calmodulin signaling to the MAPK cascade.	[Parvathaneni, Swetha; Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is dedicated to the memory of Jay M. McDonald; mentor, colleague, and friend. We are grateful to Robert LewisY (University of Nebraska Medical Center) for generously donating the KSR1+/+ and KSR1-/-mouse embryonic fibroblasts and to Piero Crespo (Instituto de Biomedicina y Biotecnologia de Cantabria, Spain) for the gift of His-tagged KSR1. We thank Michael Kruhlak, Andy Tran, and Langston Lim (Experimental Immunology Branch, National Institutes of Health) for expert assistance with confocal microscopy. The study was supported by the Intramural Research Program of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Garcia-Palmero I, 2012, FEBS LETT, V586, P1533, DOI 10.1016/j.febslet.2012.04.017; Gorisse L, 2018, BIOCHEM J, V475, P3073, DOI 10.1042/BCJ20180594; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Koveal D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003289; Kyosseva SV, 2016, OPHTHALMOL EYE DIS, V8, P23, DOI 10.4137/OED.S32200; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZG, 2000, BIOCHEMISTRY-US, V39, P5089, DOI 10.1021/bi992623z; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; MEDEMA JP, 1994, MOL CELL BIOL, V14, P7078, DOI 10.1128/MCB.14.11.7078; Miningou N, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2020.109541; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nagao M, 2020, DIABETES, V69, P1193, DOI 10.2337/db19-0944; Neilsen BK, 2017, EXPERT OPIN THER TAR, V21, P499, DOI 10.1080/14728222.2017.1311325; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roberson MS, 2005, MOL ENDOCRINOL, V19, P2412, DOI 10.1210/me.2005-0094; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Tajan M, 2018, ENDOCR REV, V39, P676, DOI 10.1210/er.2017-00232; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; Villalobo A, 2018, BBA-MOL CELL RES, V1865, P507, DOI 10.1016/j.bbamcr.2017.12.004; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Yang CM, 2000, MOL ENDOCRINOL, V14, P317, DOI 10.1210/me.14.2.317; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	63	3	3	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100577	10.1016/j.jbc.2021.100577	http://dx.doi.org/10.1016/j.jbc.2021.100577			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766558	Green Published, gold			2022-12-26	WOS:000672866400550
J	Brito, FMJD; Butcher, A; Pisconti, A; Poulet, B; Prior, A; Charlesworth, G; Sperinck, C; di Mase, MS; Liu, K; Bou-Gharios, G; van 't Hof, RJ; Daroszewska, A				Johnson de Sousa Brito, Francesca Manuela; Butcher, Andrew; Pisconti, Addolorata; Poulet, Blandine; Prior, Amanda; Charlesworth, Gemma; Sperinck, Catherine; Scotto di Mase, Michele; Liu, Ke; Bou-Gharios, George; Jurgen van 't Hof, Robert; Daroszewska, Anna			Syndecan-3 enhances anabolic bone formation through WNT signaling	FASEB JOURNAL			English	Article						bone; frizzled; osteoblast; Syndecan&#8208; 3; WNT		Osteoporosis is the most common age-related metabolic bone disorder, which is characterized by low bone mass and deterioration in bone architecture, with a propensity to fragility fractures. The best treatment for osteoporosis relies on stimulation of osteoblasts to form new bone and restore bone structure, however, anabolic therapeutics are few and their use is time restricted. Here, we report that Syndecan-3 increases new bone formation through enhancement of WNT signaling in osteoblasts. Young adult Sdc3(-/-) mice have low bone volume, reduced bone formation, increased bone marrow adipose tissue, increased bone fragility, and a blunted anabolic bone formation response to mechanical loading. This premature osteoporosis-like phenotype of Sdc3(-/-) mice is due to delayed osteoblast maturation and impaired osteoblast function, with contributing increased osteoclast-mediated bone resorption. Indeed, overexpressing Sdc3 in osteoblasts using the Col1a1 promoter rescues the low bone volume phenotype of the Sdc3(-/-) mice, and also increases bone volume in WT mice. Mechanistically, SDC3 enhances canonical WNT signaling in osteoblasts through stabilization of Frizzled 1, making SDC3 an attractive target for novel bone anabolic drug development.	[Johnson de Sousa Brito, Francesca Manuela; Butcher, Andrew; Poulet, Blandine; Prior, Amanda; Charlesworth, Gemma; Sperinck, Catherine; Scotto di Mase, Michele; Liu, Ke; Bou-Gharios, George; Jurgen van 't Hof, Robert; Daroszewska, Anna] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal & Ageing Sci, Dept Musculoskeletal Biol,Inst Life Course & Med, Liverpool, Merseyside, England; [Pisconti, Addolorata] Univ Liverpool, Dept Biochem, IIB, Liverpool, Merseyside, England; [Pisconti, Addolorata] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Daroszewska, Anna] Liverpool Univ Hosp NHS Fdn Trust, Dept Clin Biochem & Metab Med, Liverpool, Merseyside, England; [Daroszewska, Anna] Liverpool Univ Hosp NHS Fdn Trust, Dept Rheumatol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	van 't Hof, RJ; Daroszewska, A (corresponding author), Univ Liverpool, Inst Life Course & Med Sci, Dept Musculoskeletal & Ageing Sci, 6 West Derby St, Liverpool L7 8TX, Merseyside, England.	r.vanthof@liverpool.ac.uk; a.daroszewska@liverpool.ac.uk		Pisconti, Addolorata/0000-0002-9631-8720; Daroszewska, Anna/0000-0002-6692-6610; Johnson de Sousa Brito, Francesca/0000-0001-9376-0487	Medical Research Council [MR/R002819/1]; Institute of Ageing and Chronic Disease, University of Liverpool, UK	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Ageing and Chronic Disease, University of Liverpool, UK	This project was financially supported by the Medical Research Council (grant MR/R002819/1) and funding from the Institute of Ageing and Chronic Disease, University of Liverpool, UK. We would like to thank Andy Houghton and Euan Owen, Institute of Life Course and Medical Sciences (formerly Institute of Ageing and Chronic Disease), University of Liverpool, for their help with animal work.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Afratis NA, 2017, FEBS J, V284, P27, DOI 10.1111/febs.13940; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bhat V, 2016, STEM CELLS DEV, V25, P522, DOI 10.1089/scd.2015.0315; Canalis E, 2018, EUR J ENDOCRINOL, V178, pR33, DOI 10.1530/EJE-17-0920; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Eastell R, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.69, 10.1038/nrdp.2016.70]; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Ghali O, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0056-6; GOULD SE, 1995, DEV BIOL, V168, P438, DOI 10.1006/dbio.1995.1093; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Idris AI, 2009, ENDOCRINOLOGY, V150, P5, DOI 10.1210/en.2008-0998; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Imai S, 2009, BONE, V44, P785, DOI 10.1016/j.bone.2009.01.004; Itzstein C, 2012, METHODS MOL BIOL, V816, P177, DOI 10.1007/978-1-61779-415-5_12; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kaksonen M, 2002, MOL CELL NEUROSCI, V21, P158, DOI 10.1006/mcne.2002.1167; Katoh M, 2007, INT J MOL MED, V19, P529; Kim JM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1167-8; Koyama E, 1996, J ORTHOPAED RES, V14, P403, DOI 10.1002/jor.1100140310; KOYAMA E, 1995, DEV DYNAM, V203, P152, DOI 10.1002/aja.1002030204; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Lehoczky JA, 2018, NATURE, V557, P495, DOI 10.1038/d41586-018-04820-y; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mansouri R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.287; Newton PT, 2019, NATURE, V567, P234, DOI 10.1038/s41586-019-0989-6; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Pacifici M, 2005, J BONE MINER METAB, V23, P191, DOI 10.1007/s00774-004-0584-1; Pataki CA, 2015, J HISTOCHEM CYTOCHEM, V63, P465, DOI 10.1369/0022155415586961; Pisconti A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0104-8; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; RAULO E, 1994, J BIOL CHEM, V269, P12999; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Shimazu A, 1996, EXP CELL RES, V229, P126, DOI 10.1006/excr.1996.0350; Shimo T, 2004, DEV DYNAM, V229, P607, DOI 10.1002/dvdy.20009; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Simmons GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098861; Szenker-Ravi E, 2018, NATURE, V557, P564, DOI 10.1038/s41586-018-0118-y; Taipaleenmaki H, 2011, EXP CELL RES, V317, P745, DOI 10.1016/j.yexcr.2010.12.015; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; van't Hof RJ, 2012, METHODS MOL BIOL, V816, P461, DOI 10.1007/978-1-61779-415-5_27; Varanasi SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010692; Wang XD, 2018, JBMR PLUS, V2, P164, DOI 10.1002/jbm4.10030; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Wuelling M, 2019, NATURE, V567, P178, DOI 10.1038/d41586-019-00527-w; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019	61	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21246	10.1096/fj.202002024R	http://dx.doi.org/10.1096/fj.202002024R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769615	Green Published, hybrid			2022-12-26	WOS:000635216100022
J	Ohsawa, I; Kawano, F				Ohsawa, Ikumi; Kawano, Fuminori			Chronic exercise training activates histone turnover in mouse skeletal muscle fibers	FASEB JOURNAL			English	Article						exercise training; H2B&#8208; GFP; histone modification; myonucleus; skeletal muscle	PGC-1-ALPHA MESSENGER-RNA; METHYLATION; DYNAMICS; EXCHANGE	Epigenetic regulation of skeletal muscle adaptation to exercise is a recent topic for which there is limited information. This study investigated whether exercise training activates histone turnover in the skeletal muscle fibers of mice. Experiments using a tetracycline-inducible H2B-GFP expression model demonstrated that 4 weeks of running training, but not 2 weeks of training, significantly promoted the incorporation of H2B-GFP into nucleosomes and the dissociation of histone H3.3 at both transcriptionally upregulated and nonresponsive loci. Muscle-specific PGC-1 alpha-b-overexpressing mice crossed with H2B-GFP mice showed a slight increase in H2B-GFP incorporation at transcriptionally active loci, but not in the dissociation of H3.3 from nucleosomes. Gene expression responses to a single bout of running were significantly enhanced in 4-week trained mice when compared with those in 2-week trained mice. The most drastic increase in the gene response was found in the expression of Hspa1a and Hspa1b, in which the magnitude of upregulation in response to running was significantly enhanced from 8-fold in 2 week trained mice to 97- and 121-fold in 4 week trained mice, respectively. It was also found that the HSP70 level increased during the training period. In a myonuclear immunohistochemical analysis of chromatin remodelers, we further found that the level of SPT16, an H2A-H2B-specific chaperone, was upregulated after running training. These results revealed that 4 weeks of running training activated histone turnover in skeletal muscle fibers. They also suggested that histone turnover led to loosening of the nucleosomes and enhanced gene responses to exercise.	[Ohsawa, Ikumi; Kawano, Fuminori] Matsumoto Univ, Grad Sch Hlth Sci, 2095-1 Niimura, Matsumoto, Nagano 3901295, Japan		Kawano, F (corresponding author), Matsumoto Univ, Grad Sch Hlth Sci, 2095-1 Niimura, Matsumoto, Nagano 3901295, Japan.	kawano@t.matsu.ac.jp		Kawano, Fuminori/0000-0002-3714-0360	MEXT | Japan Society for the Promotion of Science (JSPS) [19K22824]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16H03263; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 19K22824	ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Barone R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19781; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Boonsanay V, 2016, CELL STEM CELL, V18, P229, DOI 10.1016/j.stem.2015.11.002; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Goh Q, 2019, ELIFE, V8, DOI 10.7554/eLife.44876; Hsieh FK, 2013, P NATL ACAD SCI USA, V110, P7654, DOI 10.1073/pnas.1222198110; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Jamai A, 2007, MOL CELL, V25, P345, DOI 10.1016/j.molcel.2007.01.019; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawano F, 2015, J APPL PHYSIOL, V119, P1042, DOI 10.1152/japplphysiol.00289.2015; Koya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077788; Lim C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231321; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Nakamura K, 2017, J APPL PHYSIOL, V123, P902, DOI 10.1152/japplphysiol.00289.2017; Ohsawa I, 2018, J APPL PHYSIOL, V125, P1097, DOI 10.1152/japplphysiol.00074.2018; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Seaborne RA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20287-3; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Svensson JP, 2015, GENOME RES, V25, P872, DOI 10.1101/gr.188870.114; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Turner DC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40787-0; Tvardovskiy A, 2017, NUCLEIC ACIDS RES, V45, P9272, DOI 10.1093/nar/gkx696; Valenzuela N, 2017, J CELL SCI, V130, P2551, DOI 10.1242/jcs.200642; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wenderski W, 2016, BIOESSAYS, V38, P410, DOI 10.1002/bies.201500171; White Z, 2017, SKELET MUSCLE, V7, DOI [10.1186/s13395-017-0120-3, 10.1186/s13395-016-0117-3]; Winje IM, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13034; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Zhou JJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12996	39	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21453	10.1096/fj.202002027RR	http://dx.doi.org/10.1096/fj.202002027RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749947				2022-12-26	WOS:000635216100075
J	Barker, S; Harding, SV; Gray, D; Richards, MI; Atkins, HS; Harmer, NJ				Barker, Sam; Harding, Sarah V.; Gray, David; Richards, Mark I.; Atkins, Helen S.; Harmer, Nicholas J.			Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species	PLOS ONE			English	Article								Burkholderia pseudomallei is a soil-dwelling organism present throughout the tropics. It is the causative agent of melioidosis, a disease that is believed to kill 89,000 people per year. It is naturally resistant to many antibiotics, requiring at least two weeks of intravenous treatment with ceftazidime, imipenem or meropenem followed by 6 months of orally delivered co-trimoxazole. This places a large treatment burden on the predominantly middle-income nations where the majority of disease occurs. We have established a high-throughput assay for compounds that could be used as a co-therapy to potentiate the effect of ceftazidime, using the related non-pathogenic bacterium Burkholderia thailandensis as a surrogate. Optimization of the assay gave a Z' factor of 0.68. We screened a library of 61,250 compounds and identified 29 compounds with a pIC(50) (-log(10)(IC50)) greater than five. Detailed investigation allowed us to down select to six "best in class" compounds, which included the licensed drug chloroxine. Co-treatment of B. thailandensis with ceftazidime and chloroxine reduced culturable cell numbers by two orders of magnitude over 48 hours, compared to treatment with ceftazidime alone. Hit expansion around chloroxine was performed using commercially available compounds. Minor modifications to the structure abolished activity, suggesting that chloroxine likely acts against a specific target. Finally, an initial study demonstrates the utility of chloroxine to act as a co-therapy to potentiate the effect of ceftazidime against B. pseudomallei. This approach successfully identified potential co-therapies for a recalcitrant Gram-negative bacterial species. Our assay could be used more widely to aid in chemotherapy to treat infections caused by these bacteria.	[Barker, Sam; Atkins, Helen S.; Harmer, Nicholas J.] Univ Exeter, Dept Biosci, Coll Life & Environm Sci, Exeter, Devon, England; [Harding, Sarah V.; Richards, Mark I.; Atkins, Helen S.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Gray, David] Univ Dundee, Drug Discovery Unit, Dundee, Scotland; [Harmer, Nicholas J.] Living Syst Inst, Exeter, Devon, England; [Barker, Sam] Midatech Pharma Plc, Cardiff, Wales	University of Exeter; Defence Science & Technology Laboratory; University of Dundee	Harmer, NJ (corresponding author), Univ Exeter, Dept Biosci, Coll Life & Environm Sci, Exeter, Devon, England.; Harmer, NJ (corresponding author), Living Syst Inst, Exeter, Devon, England.	N.J.Harmer@exeter.ac.uk	Gray, David W/F-6674-2011; Harmer, Nicholas/AAJ-2596-2020	Gray, David W/0000-0001-9512-3828; Harmer, Nicholas/0000-0002-4073-0505	Dstl [Dstlx-1000060221]	Dstl	The authors note that author SB was employed by Phoremost Ltd and Midatech Plc after completing his work on this manuscript, but before the final manuscript was completed. These companies provided his salary but did not have any influence on the text or data of the manuscript, or the decision to publish. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors declare no other competing interests. This work was funded by grant Dstlx-1000060221 from Dstl to NJH.	Abraham Y, 2014, J BIOMOL SCREEN, V19, P628, DOI 10.1177/1087057114524987; Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Bennett J.E., 2019, MANDELL DOUGLAS BENN, V9th ed.; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Caglic D, 2014, J MED CHEM, V57, P669, DOI 10.1021/jm4012164; Carroll KC, 2019, MANUAL CLIN MICROBIO; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2013, AM J TROP MED HYG, V88, P411, DOI 10.4269/ajtmh.12-0555; Chetchotisakd P, 2014, LANCET, V383, P807, DOI 10.1016/S0140-6736(13)61951-0; Currie BJ, 2016, NATURE, V529, P290, DOI 10.1038/529290a; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Dutta Subarna, 2017, BMC Res Notes, V10, P299, DOI 10.1186/s13104-017-2626-5; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Feng J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.53; Gassiep I, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00006-19; Gilbert IH, 2013, J MED CHEM, V56, P7719, DOI 10.1021/jm400362b; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Harris P, 2011, INT J ANTIMICROB AG, V37, P547, DOI 10.1016/j.ijantimicag.2011.02.001; Harwood C.R.CSM., 1990, CHEM DEFINED GROWTH, V1990; Hatcher Christopher L, 2015, Curr Trop Med Rep, V2, P62; Hemsley CM, 2014, ANTIMICROB AGENTS CH, V58, P5775, DOI 10.1128/AAC.02793-14; Jones-Carson J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003079; Khosravi Yalda, 2014, ScientificWorldJournal, V2014, P132971, DOI 10.1155/2014/132971; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Lall Namrita, 2013, Int J Microbiol, V2013, P420601, DOI 10.1155/2013/420601; Lee JH, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0297-6; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; McLeod C, 2015, CLIN INFECT DIS, V60, P21, DOI 10.1093/cid/ciu733; Niu HX, 2015, ANTIBIOTICS-BASEL, V4, P179, DOI 10.3390/antibiotics4020179; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P4398, DOI 10.1128/AAC.00372-13; PEARSON RD, 1980, ANTIMICROB AGENTS CH, V18, P699, DOI 10.1128/AAC.18.5.699; Pitman MC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003586; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Ross BN, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00210; Sanford JP., SANFORD GUIDE ANTIMI; Sarovich DS, 2014, J CLIN MICROBIOL, V52, P650, DOI 10.1128/JCM.02239-13; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TAYLOR PC, 1983, ANTIMICROB AGENTS CH, V23, P142, DOI 10.1128/AAC.23.1.142; Titball RW, 2017, VACCINE, V35, P5981, DOI 10.1016/j.vaccine.2017.03.022; Vlieghe E, 2011, EMERG INFECT DIS, V17, P1289, DOI 10.3201/eid1707.101069; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Willcocks SJ, 2016, CURR OPIN MICROBIOL, V29, P94, DOI 10.1016/j.mib.2015.11.007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248119	10.1371/journal.pone.0248119	http://dx.doi.org/10.1371/journal.pone.0248119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764972	Green Published, gold			2022-12-26	WOS:000634832800055
J	Reinhardt, J; Bengler, K				Reinhardt, Jakob; Bengler, Klaus			Design of a hesitant movement gesture for mobile robots	PLOS ONE			English	Article								In previous experiments, a back-off movement was introduced as a motion strategy of robots to facilitate the order of passage at bottlenecks in human-robot spatial interaction. In this article we take a closer look at the appropriate application of motion parameters that make the backward movement legible. Related works in distance perception, size-speed illusions, and viewpoint-based legibility considerations suggest a relationship between the size of the robot and the observer's perspective on the expected execution of this movement. We performed a participant experiment (N = 50) in a virtual reality environment where participants adjusted the minimum required back-off length and preferred back-off speed as a result of the robot size, and the viewpoint of the back-off movement. We target a model-based approach on how appropriate back-off design translates to different sized robots and observer's viewpoints. Thus, we allow the application of back-off in a variety of autonomous moving systems. The results show a significant correlation between the increasingly expected back-off lengths with increasing robot size, but only weak effects of the viewpoint on the requirements of this movement. An exploratory analysis suggests that execution time might be a promising parameter to consider for the design of legible motion.	[Reinhardt, Jakob; Bengler, Klaus] Tech Univ Munich, Chair Ergon, Dept Mech Engn, Munich, Bavaria, Germany	Technical University of Munich	Reinhardt, J (corresponding author), Tech Univ Munich, Chair Ergon, Dept Mech Engn, Munich, Bavaria, Germany.	jakob.reinhardt@tum.de						Ackermann C, 2019, TRANSPORT RES F-TRAF, V62, P757, DOI 10.1016/j.trf.2019.03.006; Armbruster C, 2008, CYBERPSYCHOL BEHAV, V11, P9, DOI 10.1089/cpb.2007.9935; Beggiato M, 2017, AUTOMOTIVEUI 2017: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON AUTOMOTIVE USER INTERFACES AND INTERACTIVE VEHICULAR APPLICATIONS, P50, DOI 10.1145/3122986.3122995; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Carstengerdes N., 2005, THESIS U TRIER; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Clark HE, 2016, ACCIDENT ANAL PREV, V86, P146, DOI 10.1016/j.aap.2015.10.028; Clark HE, 2013, ACCIDENT ANAL PREV, V55, P226, DOI 10.1016/j.aap.2013.02.037; CUTTING JE, 1995, PSYCHOL REV, V102, P627, DOI 10.1037/0033-295X.102.4.627; DeLucia P.R., 2004, ADV PSYCHOL, P243, DOI DOI 10.1016/S0166-4115(04)80013-X; DeLucia PR, 1999, PERCEPT PSYCHOPHYS, V61, P1168, DOI 10.3758/BF03207621; Dragan AD, 2013, ACMIEEE INT CONF HUM, P301, DOI 10.1109/HRI.2013.6483603; Durgin F. H., 2005, ACM T APPL PERCEPT, V2, P234, DOI [10.1145/1077399.1077403, DOI 10.1145/1077399.1077403]; Fuest T, 2018, IEEE INT C INTELL TR, P3596, DOI 10.1109/ITSC.2018.8569486; Gibson JJ, 1950, PERCEPTION VISUAL WO; Groeger J. A, 2000, UNDERSTING DRIVIN; HALL ET, 1968, CURR ANTHROPOL, V9, P83, DOI 10.1086/200975; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Kelly JW, 2017, ACM T APPL PERCEPT, V15, DOI 10.1145/3106155; Knight H, 2014, IEEE ROMAN, P267, DOI 10.1109/ROMAN.2014.6926264; Lasseter J., 1987, ACM SIGGRAPH COMPUTE, P35, DOI DOI 10.1145/37402.37407; Lauckner M, 2014, IEEE ROMAN, P780, DOI 10.1109/ROMAN.2014.6926348; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LEIBOWITZ HW, 1985, AM SCI, V73, P558; Lichtenthaler C, 2013, ACMIEEE INT CONF HUM, P181, DOI 10.1109/HRI.2013.6483561; Manser MP, 2007, ACCIDENT ANAL PREV, V39, P69, DOI 10.1016/j.aap.2006.06.005; Maruhn P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224651; Moon A, 2013, J HUM-ROBOT INTERACT, V2, P18, DOI 10.5898/JHRI.2.3.Moon; Nikolaidis S, 2016, ACMIEEE INT CONF HUM, P271, DOI 10.1109/HRI.2016.7451762; Petzoldt T, 2016, ACCIDENT ANAL PREV, V95, P132, DOI 10.1016/j.aap.2016.07.010; Piwek L, 2014, COGNITION, V130, P271, DOI 10.1016/j.cognition.2013.11.001; Reinhardt J, ACM T HUM-ROBOT INTE; Reinhardt J, 2017, IEEE SYS MAN CYBERN, P1493; Sanders Elizabeth B.-N, 2008, CoDesign, V4, P5, DOI 10.1080/15710880701875068; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Schmidtler J, 2018, ACM T APPL PERCEPT, V15, DOI 10.1145/3182176; Smeets JBJ, 1996, PERCEPTION, V25, P583, DOI 10.1068/p250583; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; Verbeke G., 1997, LINEAR MIXED MODELS, P63, DOI [10.1007/978-1-4612-2294-1, DOI 10.1007/978-1-4612-2294-1]; Watson M.R., 2012, ENCY HUMAN BEHAV, V2nd, P690; Zimmermann R, 2017, AUTOMOTIVEUI 2017: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON AUTOMOTIVE USER INTERFACES AND INTERACTIVE VEHICULAR APPLICATIONS, P58, DOI 10.1145/3122986.3122988	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249081	10.1371/journal.pone.0249081	http://dx.doi.org/10.1371/journal.pone.0249081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765032	Green Published, gold			2022-12-26	WOS:000634832800016
J	Zeng, R; Zhang, JP; Cai, K; Gao, WC; Pan, WJ; Jiang, CY; Zhang, PY; Wu, BW; Wang, CH; Jin, XY; Li, DC				Zeng, R.; Zhang, J. P.; Cai, K.; Gao, W. C.; Pan, W. J.; Jiang, C. Y.; Zhang, P. Y.; Wu, B. W.; Wang, C. H.; Jin, X. Y.; Li, D. C.			How similar is "similar," or what is the best measure of soil spectral and physiochemical similarity?	PLOS ONE			English	Article								Spectral similarity indices were used to select similar soil samples from a spectral library and improve the predictive accuracy of target samples. There are many similarity indices available, and precisely how to select the optimum index has become a critical question. Five similarity indices were evaluated: Spectral angle mapper (SAM), Euclidean distance (ED), Mahalanobis distance (MD), SAM_pca and ED_pca in the space of principal components applied to a global soil spectral library. The accordance between spectral and compositional similarity was used to select the optimum index. Then the optimum index was evaluated if it can maintain the greatest predictive accuracy when selecting similar samples from a spectral library for the prediction of a target sample using a partial least squares regression (PLSR) model. The evaluated physiochemical properties were: soil organic carbon, pH, cation exchange capacity (CEC), clay, silt, and sand content. SAM and SAM_pca selected samples were closer in composition compared to the target samples. Based on similar samples selected using these two indices, PLSR models achieved the highest predictive accuracy for all soil properties, save for CEC. This validates the hypothesis that the accordance information between spectral and compositional similarity can help select the appropriate similarity index when selecting similar samples from a spectral library for prediction.	[Zeng, R.; Zhang, J. P.; Zhang, P. Y.; Wu, B. W.; Wang, C. H.; Jin, X. Y.] Nanjing Univ Informat Sci & Technol, Sch Geog Sci, Nanjing, Peoples R China; [Cai, K.; Gao, W. C.] Upland Flue Cured Tobacco Qual & Ecol Key Lab Chi, Guiyang, Peoples R China; [Cai, K.] Southwest Univ, Coll Resources & Environm, Chongqing, Peoples R China; [Pan, W. J.; Jiang, C. Y.] China Natl Tobacco Corp Guizhou Prov Co, Guiyang, Peoples R China; [Li, D. C.] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Peoples R China	Nanjing University of Information Science & Technology; Southwest University - China; China National Tobacco Corporation; Chinese Academy of Sciences; Institute of Soil Science, CAS	Li, DC (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Peoples R China.	dcli@issas.ac.cn			China Tobacco Corporation Guizhou Provincial Company Science and Technology Project [201910]; Key deployment projects of Chinese Academy of Sciences [KGFZD-135-19-10]; National Key Research and Development Program of China [2017YFB0503903]; National College Students Innovation and Entrepreneurship Training Program [201910300005Z]; Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology	China Tobacco Corporation Guizhou Provincial Company Science and Technology Project; Key deployment projects of Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Research and Development Program of China; National College Students Innovation and Entrepreneurship Training Program; Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology	This research was funded by China Tobacco Corporation Guizhou Provincial Company Science and Technology Project (201910, awarded to DCL and KC), Key deployment projects of Chinese Academy of Sciences (KGFZD-135-19-10, awarded to RZ), National Key Research and Development Program of China (No.2017YFC0803807), National College Students Innovation and Entrepreneurship Training Program (201910300005Z, awarded to JPZ) and National Key Research and Development Program of China (2017YFB0503903). CN was supported by The Startup Foundation for Introducing Talent of Nanjing University of Information Science and Technology.	Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Goge F, 2014, GEODERMA, V213, P1, DOI 10.1016/j.geoderma.2013.07.016; Guerrero C, 2016, SOIL TILL RES, V155, P501, DOI 10.1016/j.still.2015.07.008; Han GZ, 2012, SOIL SCI, V177, P158, DOI 10.1097/SS.0b013e31823fd493; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; ICRAF ISRIC., 2004, GLOBALLY DISTRIBUTED; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N; McBratney AB, 2006, GEODERMA, V136, P272, DOI 10.1016/j.geoderma.2006.03.051; Qin YH, 2019, INFRARED PHYS TECHN, V100, P57, DOI 10.1016/j.infrared.2019.05.006; Ramirez-Lopez L, 2013, GEODERMA, V199, P43, DOI 10.1016/j.geoderma.2012.08.035; Rossel RAV, 2016, EARTH-SCI REV, V155, P198, DOI 10.1016/j.earscirev.2016.01.012; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shi Z, 2015, EUR J SOIL SCI, V66, P679, DOI 10.1111/ejss.12272; Shi Z, 2014, SCI CHINA EARTH SCI, V57, P1671, DOI 10.1007/s11430-013-4808-x; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Wetterlind Johanna, 2013, Methods Mol Biol, V953, P95, DOI 10.1007/978-1-62703-152-3_6; Woods B, 2014, FORENSIC SCI INT, V245, P187, DOI 10.1016/j.forsciint.2014.08.009; Xu CC, 2017, CATENA, V158, P350, DOI 10.1016/j.catena.2017.07.014; Zeng R, 2016, SOIL SCI, V181, P13, DOI 10.1097/SS.0000000000000132	22	3	3	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0247028	10.1371/journal.pone.0247028	http://dx.doi.org/10.1371/journal.pone.0247028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765035	gold, Green Published			2022-12-26	WOS:000634832800067
J	Moreno, T; Monterde, B; Gonzalez-Silva, L; Betancor-Fernandez, I; Revilla, C; Agraz-Doblas, A; Freire, J; Isidro, P; Quevedo, L; Blanco, R; Montes-Moreno, S; Cereceda, L; Astudillo, A; Casar, B; Crespo, P; Torres, CM; Scaffidi, P; Gomez-Roman, J; Salido, E; Varela, I				Moreno, Thaidy; Monterde, Beatriz; Gonzalez-Silva, Laura; Betancor-Fernandez, Isabel; Revilla, Carlos; Agraz-Doblas, Antonio; Freire, Javier; Isidro, Pablo; Quevedo, Laura; Blanco, Rosa; Montes-Moreno, Santiago; Cereceda, Laura; Astudillo, Aurora; Casar, Berta; Crespo, Piero; Morales Torres, Cristina; Scaffidi, Paola; Gomez-Roman, Javier; Salido, Eduardo; Varela, Ignacio			ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer	ONCOGENE			English	Article								The survival rate in lung cancer remains stubbornly low and there is an urgent need for the identification of new therapeutic targets. In the last decade, several members of the SWI/SNF chromatin remodeling complexes have been described altered in different tumor types. Nevertheless, the precise mechanisms of their impact on cancer progression, as well as the application of this knowledge to cancer patient management are largely unknown. In this study, we performed targeted sequencing of a cohort of lung cancer patients on genes involved in chromatin structure. In addition, we studied at the protein level the expression of these genes in cancer samples and performed functional experiments to identify the molecular mechanisms linking alterations of chromatin remodeling genes and tumor development. Remarkably, we found that 20% of lung cancer patients show ARID2 protein loss, partially explained by the presence of ARID2 mutations. In addition, we showed that ARID2 deficiency provokes profound chromatin structural changes altering cell transcriptional programs, which bolsters the proliferative and metastatic potential of the cells both in vitro and in vivo. Moreover, we demonstrated that ARID2 deficiency impairs DNA repair, enhancing the sensitivity of the cells to DNA-damaging agents. Our findings support that ARID2 is a bona fide tumor suppressor gene in lung cancer that may be exploited therapeutically.	[Moreno, Thaidy; Monterde, Beatriz; Gonzalez-Silva, Laura; Revilla, Carlos; Agraz-Doblas, Antonio; Quevedo, Laura; Blanco, Rosa; Casar, Berta; Crespo, Piero; Varela, Ignacio] Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, Santander, Spain; [Betancor-Fernandez, Isabel; Salido, Eduardo] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Dept Patol, Tenerife, Spain; [Freire, Javier; Montes-Moreno, Santiago; Cereceda, Laura; Gomez-Roman, Javier] HUMV IDIVAL, Serv Anat Patol & Biobanco Valdecilla, Santander, Spain; [Isidro, Pablo; Astudillo, Aurora] Hosp Univ Cent Asturias, Biobanco Principado Asturias BBPA, Oviedo, Spain; [Casar, Berta; Crespo, Piero] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Morales Torres, Cristina; Scaffidi, Paola] Francis Crick Inst, Canc Epigenet Lab, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Marques de Valdecilla (HUMV); Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Francis Crick Institute	Varela, I (corresponding author), Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, Santander, Spain.	ignacio.varela@unican.es	Montes-Moreno, Santiago/E-7008-2011; Scaffidi, Paola/GRS-9019-2022; José Javier, Gómez-Román/AAC-8156-2021; Astudillo, Aurora/AAA-5487-2022; Crespo, Piero/M-3273-2014; Varela, Ignacio/G-1699-2016	Montes-Moreno, Santiago/0000-0002-3565-8262; Scaffidi, Paola/0000-0002-3642-4193; José Javier, Gómez-Román/0000-0002-2849-9435; Astudillo, Aurora/0000-0001-8947-8809; Crespo, Piero/0000-0003-2825-7783; Quevedo, Laura/0000-0001-8902-5818; Moreno Rodriguez, Thaidy/0000-0003-3588-3889; CERECEDA, LAURA/0000-0002-0106-1898; Gonzalez-Silva, Laura/0000-0001-8625-1473; Varela, Ignacio/0000-0002-0969-506X	Spanish Ministerio de Economia y Competitividad (MINECO) [SAF2012-31627, SAF2016-76758-R]; Fundacion Ramon Areces grant; European Research Council [ERC2014-StG637904]; Ayudas para la formacion de profesorado universitario (FPU, Ministerio de Educacion y Formacion Profesional, Spain); MINECO/FEDER, UE [SAF-2015-63638R]; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC); Asociacion Espanola Contra el Cancer (AECC) [GCB141423113]; Retos Jovenes Investigadores grant (AEI/FEDER, UE) [SAF-2015-73364-JIN]; Fundacion Francisco Cobos; Francis Crick Institute; Cancer Research UK [FC001152]; UK Medical Research Council [FC001152]; Servicio de Salud del Principado de Asturias; Fundacion Bancaria Cajastur; Wellcome Trust [FC001152]; Instituto de Salud Carlos III; Programa Ramon y Cajal (MINECO, Spain); Ayudas para la contratacion de investigadores predoctorales (MINECO, Spain)	Spanish Ministerio de Economia y Competitividad (MINECO); Fundacion Ramon Areces grant; European Research Council(European Research Council (ERC)European Commission); Ayudas para la formacion de profesorado universitario (FPU, Ministerio de Educacion y Formacion Profesional, Spain)(German Research Foundation (DFG)); MINECO/FEDER, UE; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC); Asociacion Espanola Contra el Cancer (AECC); Retos Jovenes Investigadores grant (AEI/FEDER, UE); Fundacion Francisco Cobos; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Servicio de Salud del Principado de Asturias; Fundacion Bancaria Cajastur; Wellcome Trust(Wellcome TrustEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Programa Ramon y Cajal (MINECO, Spain); Ayudas para la contratacion de investigadores predoctorales (MINECO, Spain)	IV is supported by SAF2012-31627 and SAF2016-76758-R grants from the Spanish Ministerio de Economia y Competitividad (MINECO), by a Fundacion Ramon Areces grant and by ERC2014-StG637904 grant from the European Research Council. IV has been awardee of the Programa Ramon y Cajal (MINECO, Spain). TM has been awardee of the Ayudas para la contratacion de investigadores predoctorales (MINECO, Spain). BM is awardee of the Ayudas para la formacion de profesorado universitario (FPU, Ministerio de Educacion y Formacion Profesional, Spain). PC laboratory is supported by grant SAF-2015-63638R (MINECO/FEDER, UE); by Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) and by Asociacion Espanola Contra el Cancer (AECC), grant GCB141423113. BC has been supported by a Retos Jovenes Investigadores grant SAF-2015-73364-JIN (AEI/FEDER, UE) and a grant from Fundacion Francisco Cobos. PS is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001152) and the UK Medical Research Council (FC001152). HUCA/IUOPA is jointly financed by Servicio de Salud del Principado de Asturias, Instituto de Salud Carlos III, and Fundacion Bancaria Cajastur. This research was funded in part by the Wellcome Trust [FC001152].	Alver BH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14648; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Flowers S, 2010, CANCER RES, V70, P8282, DOI 10.1158/0008-5472.CAN-10-2205; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gelsomino F, 2014, CANCERS, V6, P2100, DOI 10.3390/cancers6042100; Giacobbe A, 2016, ONCOGENE, V35, P1602, DOI 10.1038/onc.2015.230; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kayser G, 2015, BRIT J CANCER, V112, P866, DOI 10.1038/bjc.2015.2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lauand C, 2015, BRAZ J MED BIOL RES, V48, P382, DOI 10.1590/1414-431X20144262; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Manceau G, 2013, INT J CANCER, V132, P2217, DOI 10.1002/ijc.27900; Martinez N, 2014, LEUKEMIA, V28, P1334, DOI 10.1038/leu.2013.365; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mularoni L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0994-0; Nakayama RT, 2017, NAT GENET, V49, P1613, DOI 10.1038/ng.3958; Niimi A, 2012, NUCLEIC ACIDS RES, V40, P7393, DOI 10.1093/nar/gks453; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ray A, 2009, MOL CELL BIOL, V29, P6206, DOI 10.1128/MCB.00503-09; Reisman DN, 2003, CANCER RES, V63, P560; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor MD, 2018, CLIN EXP METASTAS, V35, P15, DOI 10.1007/s10585-017-9869-3; Tordella L, 2016, GENE DEV, V30, P2187, DOI 10.1101/gad.286112.116; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	9	9	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2923	2935		10.1038/s41388-021-01748-y	http://dx.doi.org/10.1038/s41388-021-01748-y		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742126	Green Accepted			2022-12-26	WOS:000630655600001
J	Liu, YY; Yao, LS; Ci, Y; Cao, XM; Zhao, MH; Li, Y; Zhang, XL				Liu, Yingying; Yao, Lisi; Ci, Ying; Cao, Xiaomei; Zhao, Minghui; Li, Ying; Zhang, XiaoLong			Genetic differentiation of geographic populations of Rattus tanezumi based on the mitochondrial Cytb gene	PLOS ONE			English	Article							CYTOCHROME-B GENE; PHYLOGENETIC-RELATIONSHIPS; DISPERSAL; EVOLUTION; POLYMORPHISM; DIVERSITY; BARRIERS; CHINA; BIRDS	Rattus tanezumi is a common domestic rat and host of the bubonic plague pathogen in China and Southeast Asia (SEA). The origin, genetic differentiation and dispersal of R. tanezumi have received increasing attention from researchers. The population genetics of R. tanezumi based on its mitochondrial cytochrome b gene have been studied to explain the origin, relationships and dispersal of populations. In this study, we captured a total of 229 rats; morphological and molecular biological identification cytochrome oxidase subunit I (COI) confirmed 131 R. tanezumi individuals collected from 6 provincial areas, and their Cytb gene sequences were analyzed. The results showed that the population in Mohan (MH), Yunnan, had the highest genetic diversity, while that in Ningde (ND), Fujian, had the lowest. Tajima's D statistic for all populations was negative and nonsignificant, indicating the possible expansion of R. tanezumi populations. Low gene flow occurred between the Zhangmu (ZM) R. tanezumi population and other populations, and the genetic differentiation among them was high. Furthermore, our analyses revealed the ZM lineage was the oldest lineage among the groups and diverged similar to 1.06 Mya, followed by the Luoyang (LY) lineages (similar to 0.51 Mya) and Yunnan lineage (similar to 0.33 Mya). In southeastern Yunnan, the Jinshuihe (JSH) and MH populations were more closely related to the populations in southeastern China (Fuzhou (FZ), ND, Quanzhou (QZ), Nanchang (NC)) and inland areas (Chongqing (CQ), LY) than to those in other areas of Yunnan (Jiegao (JG) and Qingshuihe (QSH)), indicating that R. tanezumi may have spread from southeastern Yunnan to the interior of China. In summary, R. tanezumi may have originated in ZM and adjacent areas, spread to Yunnan, and then spread from the southeast of Yunnan inland or directly eastward from ZM to inland China.	[Liu, Yingying; Yao, Lisi; Ci, Ying; Cao, Xiaomei; Li, Ying; Zhang, XiaoLong] Chinese Acad Inspect & Quarantine, Inst Hlth Inspect & Quarantine, Beijing, Peoples R China; [Zhao, Minghui] Jiangxi Int Travel Hlth Care Ctr, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Inspection & Quarantine	Zhang, XL (corresponding author), Chinese Acad Inspect & Quarantine, Inst Hlth Inspect & Quarantine, Beijing, Peoples R China.	Zhzhsh2001@126.com	LIU, YING/GZL-7252-2022	Liu, Yingying/0000-0001-8359-2125	 [2017ZX10303404-003-003];  [2017ZX10303404-003-004];  [2019YJ060]	; ; 	This work is supported by the establishment of a mitochondrial genome-based abnormal movement monitoring technology for Rattus tanezumi (2017ZX10303404-003-003), the field application of vector population abnormal movement monitoring technology based on mitochondrial genome (2017ZX10303404-003-004) and the real-time monitoring of rodents around the Winter Olympics venues and comprehensive control technology research and application (2019YJ060).	Agorreta A, 2013, MOL PHYLOGENET EVOL, V66, P80, DOI 10.1016/j.ympev.2012.09.010; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnett S., 2001, THEIR IMPACT US OUR; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; [边琳鹤 Bian Linhe], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P33; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Corbet G.B., 1992, P1; Deng C., 2014, GENETIC DIVERSITY EL; Dinnis RE, 2014, TICKS TICK-BORNE DIS, V5, P152, DOI 10.1016/j.ttbdis.2013.10.001; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Guo S, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0714-3; HACKETT SJ, 1995, MOL PHYLOGENET EVOL, V4, P350, DOI 10.1006/mpev.1995.1030; Hall Robert, 1998, P99; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HAY JM, 1995, MOL BIOL EVOL, V12, P928; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jiang HH, 2014, VET PARASITOL, V203, P318, DOI 10.1016/j.vetpar.2014.04.016; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lack JB, 2012, MOL ECOL, V21, P3545, DOI 10.1111/j.1365-294X.2012.05620.x; Ladoukakis ED, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0060-4; [李继变 LI Ji-bian], 2009, [复旦学报. 自然科学版, Journal of Fudan University. Natural Sciences], V48, P680; Li R, 2009, J ZOOL, V277, P309, DOI 10.1111/j.1469-7998.2008.00543.x; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Lu Jiqi, 1996, Acta Theriologica Sinica, V16, P119; Ma Ying, 2011, Chinese Journal of Zoology, V46, P126; Marshall Jr J.T., 1977, MAMMALS THAILAND, P396; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; MEYER A, 1990, J MOL EVOL, V31, P359, DOI 10.1007/BF02106050; MEYER A, 1994, TRENDS ECOL EVOL, V9, P278, DOI 10.1016/0169-5347(94)90028-0; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Miller RW, 2008, PHILIPPINE RATS ECOL, P25; Mora MS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-9; Morando M, 2013, MOL PHYLOGENET EVOL, V66, P694, DOI 10.1016/j.ympev.2012.10.019; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; NEI M, 1978, GENETICS, V89, P583; Pages M, 2013, MOL ECOL, V22, P1019, DOI 10.1111/mec.12149; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wenzel MA, 2012, CONSERV GENET, V13, P1213, DOI 10.1007/s10592-012-0366-6; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; Wu C, 2016, B WORLD HEALTH ORGAN, V94, P167, DOI 10.2471/BLT.15.160929; Yi Jinxin, 2019, Fisheries Science (Liaoning), V38, P716; Yu HY, 2019, T NONFERR METAL SOC, V29, P2331, DOI 10.1016/S1003-6326(19)65139-3; Zhang Li-Xun, 2005, Acta Zoologica Sinica, V51, P1044; Zhou R., 2014, CLASSIFICATION PHYLO; Zou B., 1992, PLANT PROT Q, V3, P51	63	1	1	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248102	10.1371/journal.pone.0248102	http://dx.doi.org/10.1371/journal.pone.0248102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735257	gold, Green Published			2022-12-26	WOS:000631029700118
J	Monteschio, JD; Junior, FMD; da Silva, ALA; das Chagas, RA; Fernandes, T; Leonardo, AP; Kaneko, IN; Pinto, LAD; Guerrero, A; de Melo, AA; Ferraz, VP; Fagundes, GM; Muir, JP				Monteschio, Jessica de Oliveira; de Vargas Junior, Fernando Miranda; Alves da Silva, Adrielly Lais; das Chagas, Renata Alves; Fernandes, Tatiane; Leonardo, Ariadne Patricia; Kaneko, Isabelle Naemi; de Moraes Pinto, Laura Adriane; Guerrero, Ana; de Melo Filho, Antonio Alves; Ferraz, Vany Perpetua; Fagundes, Gisele Maria; Muir, James Pierre			Effect of copaiba essential oil (Copaifera officinalis L.) as a natural preservative on the oxidation and shelf life of sheep burgers	PLOS ONE			English	Article								We evaluated the effects of the inclusion of copaiba (Copaifera officinalis L.) essential oil at 0.05 and 0.1% as a possible replacement of synthetic additive butylated hydroxytoluene (BHT) in sheep burgers during 14 days of storage in a refrigerated display case (4 degrees C). During the shelf life days, analyzes of antioxidant activity, lipid oxidation, pH, color, cooking loss, texture and consumer acceptability were carried out on refrigerated burgers. The addition of copaiba essential oil showed an antioxidant effect in sheep burgers (P > 0.05), reducing lipid oxidation. Copaiba essential oil added at 0.05% showed the highest antioxidant activity, decreased cooking losses and delaying discoloration (loss of redness) during storage; it further improved, the tenderness of sheep burgers (P < 0.05). The treatments had no effect (P > 0.05) on consumer acceptability. Copaiba essential oil is a promising natural antioxidant to increase the shelf life of meat products, as well as being a viable solution to replace synthetic antioxidant BHT, thereby promoting the fresh-like quality appeal of sheep burgers.	[Monteschio, Jessica de Oliveira; Fagundes, Gisele Maria] Univ Fed Roraima, Dept Anim Sci, Boa Vista, Roraima, Brazil; [de Vargas Junior, Fernando Miranda; Alves da Silva, Adrielly Lais; das Chagas, Renata Alves; Fernandes, Tatiane; Leonardo, Ariadne Patricia] Fed Univ Grande Dourados, Dept Agr Sci, Dourados, MS, Brazil; [Kaneko, Isabelle Naemi] Univ Fed Paraiba, Dept Anim Sci, Areia, Paraiba, Brazil; [de Moraes Pinto, Laura Adriane] Univ Fed Parana, Dept Anim Sci, Palotina, Parana, Brazil; [Guerrero, Ana] CEU Univ, Dept Prod & Sanidad Anim, Fac Vet, Univ Cardenal Herrera CEU, Valencia, Spain; [de Melo Filho, Antonio Alves] Univ Fed Roraima, Dept Chem, Boa Vista, Roraima, Brazil; [Ferraz, Vany Perpetua] Univ Fed Minas Gerais, Dept Chem, Belo Horizonte, MG, Brazil; [Muir, James Pierre] Tarleton State Univ, Dept Soil & Crop Sci, Stephenville, TX USA	Universidade Federal de Roraima; Universidade Federal da Grande Dourados; Universidade Federal da Paraiba; Universidade Federal do Parana; Universidad CEU Cardenal Herrera; Universidade Federal de Roraima; Universidade Federal de Minas Gerais; Texas A&M University System; Tarleton State University	Monteschio, JD (corresponding author), Univ Fed Roraima, Dept Anim Sci, Boa Vista, Roraima, Brazil.	jessica.monteschio@ufrr.br	Fagundes, Gisele/AGQ-9432-2022; Fagundes, Gisele/GLS-6895-2022; Guerrero Barrado, Ana/A-7272-2017; Miranda de Vargas Junior, Fernando/D-1496-2018; Monteschio, jessica/D-6498-2018	Fagundes, Gisele/0000-0001-9304-6160; Guerrero Barrado, Ana/0000-0001-6420-6364; Miranda de Vargas Junior, Fernando/0000-0002-3050-7107; Fernandes, Tatiane/0000-0002-9825-5735; Monteschio, jessica/0000-0003-1331-3260				Al-Shabib NA, 2017, J MOL LIQ, V230, P557, DOI 10.1016/j.molliq.2017.01.066; Amiri E, 2019, MEAT SCI, V153, P66, DOI 10.1016/j.meatsci.2019.03.004; [Anonymous], 2001, REV NACL CARNE; Kempinski EMBC, 2017, LWT-FOOD SCI TECHNOL, V84, P579, DOI 10.1016/j.lwt.2017.06.016; Bernardes WA, 2010, Z NATURFORSCH C, V65, P588; Brochini Claudia B., 2007, Rev. bras. farmacogn., V17, P266, DOI 10.1590/S0102-695X2007000200022; Carocho M, 2014, COMPR REV FOOD SCI F, V13, P377, DOI 10.1111/1541-4337.12065; de Carvalho FAL, 2019, FOOD RES INT, V125, DOI 10.1016/j.foodres.2019.108554; Fachinello MR, 2018, J FOOD PROCESS PRES, V42, DOI 10.1111/jfpp.13780; Faustman C, 2010, MEAT SCI, V86, P86, DOI 10.1016/j.meatsci.2010.04.025; FDA  HHS, 2015, CODE FEDERAL REGULAT; Fernandes RPP, 2017, FOOD CHEM, V233, P101, DOI 10.1016/j.foodchem.2017.04.100; Fernandes RPP, 2016, FOOD CONTROL, V63, P65, DOI 10.1016/j.foodcont.2015.11.027; Fidyt K, 2016, CANCER MED-US, V5, P3007, DOI 10.1002/cam4.816; Furia T.E., 2018, REGULATORY STATUS DI; Galucio CD, 2016, QUIM NOVA, V39, P795, DOI 10.5935/0100-4042.20160096; Ghaderi-Ghahfarokhi M, 2017, INT J BIOL MACROMOL, V102, P19, DOI 10.1016/j.ijbiomac.2017.04.002; Harris SE, 2001, J ANIM SCI, V79, P666; Li WD, 2009, CENT EUR J BIOL, V4, P499, DOI 10.2478/s11535-009-0041-1; Mancini S, 2015, MEAT SCI, V110, P93, DOI 10.1016/j.meatsci.2015.07.005; Mizi L, 2019, INNOV FOOD SCI EMERG, V51, P32, DOI 10.1016/j.ifset.2018.04.010; Mohamed HMH, 2012, LWT-FOOD SCI TECHNOL, V45, P79, DOI 10.1016/j.lwt.2011.07.031; Monteschio JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191668; Monteschio JDO, 2017, MEAT SCI, V130, P50, DOI 10.1016/j.meatsci.2017.04.002; Forell SCP, 2010, MEAT SCI, V86, P364, DOI 10.1016/j.meatsci.2010.05.015; Pouzo LB, 2016, MEAT SCI, V111, P1, DOI 10.1016/j.meatsci.2015.07.026; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rivaroli DC, 2016, MEAT SCI, V121, P278, DOI 10.1016/j.meatsci.2016.06.017; Rowe LJ, 2004, J ANIM SCI, V82, P3254; dos Santos JFS, 2018, FOOD CHEM, V261, P233, DOI 10.1016/j.foodchem.2018.04.015; Shahidi F, 2010, CHEM SOC REV, V39, P4067, DOI 10.1039/b922183m; Shan B, 2009, J SCI FOOD AGR, V89, P1879, DOI 10.1002/jsfa.3667; Sharafati-Chaleshtori R, 2015, J AGR SCI TECH-IRAN, V17, P817; Sharafati-Chaleshtori R, 2014, ITAL J FOOD SCI, V26, P427; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Souza FN, 2011, VET IMMUNOL IMMUNOP, V143, P162, DOI 10.1016/j.vetimm.2011.05.028; Taghvaei M, 2015, J FOOD SCI TECH MYS, V52, P1272, DOI 10.1007/s13197-013-1080-1; Teixeira E. M. B., 2013, Nutrire - Revista da Sociedade Brasileira de Alimentacao e Nutricao, V38, P220, DOI 10.4322/nutrire.2013.021; Urasaki Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082851; Urasaki Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072259; Viuda-Martos M, 2010, MEAT SCI, V85, P568, DOI 10.1016/j.meatsci.2010.03.007; Wang HF, 2010, J FOOD DRUG ANAL, V18, P24	42	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248499	10.1371/journal.pone.0248499	http://dx.doi.org/10.1371/journal.pone.0248499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735251	Green Published, gold			2022-12-26	WOS:000631029700047
J	Cheng, YH; Chiang, EPI; Syu, JN; Chao, CY; Lin, HY; Lin, CC; Yang, MD; Tsai, SY; Tang, FY				Cheng, Yen-Huang; Chiang, En-Pei Isabel; Syu, Jia-Ning; Chao, Che-Yi; Lin, Hung-Yu; Lin, Cheng-Chieh; Yang, Mei-Due; Tsai, Shu-Yao; Tang, Feng-Yao			Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NECROSIS-FACTOR-ALPHA; VITAMIN-D ANALOGS; UP-REGULATION; DOWN-REGULATION; 13-CIS-RETINOIC ACID; INFLAMMATION; RADIOTHERAPY; GEMCITABINE; COMBINATION	Human pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer type with a very high mortality rate. Inflammatory cytokine such as tumor necrosis factor- alpha (TNF-alpha) plays a pivotal role in the progression of PDAC. Recently, suppression of cell invasion by preventive agents has received considerable attention in the prevention of metastatic tumors. Several clinical studies suggested that natural forms or analogues of fat-soluble vitamins such as vitamin A and vitamin D can work as anti-cancer agents to inhibit the development of cancer. In this study, our results demonstrated that co-treatment of 13-cis retinoic acid (13-cis RA) and 1,25-dihydroxyvitamin D3 (1,25-VD3) significantly inhibited TNF-alpha mediated cell invasion in PDAC in vitro. Cotreatment of 13-cis RA and 1,25-VD3 also inhibited TNF-alpha mediated expression of matrix metalloproteinase-9 (MMP-9) protein through blocking c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappa B) signaling pathways. Our results demonstrated that treatment of TNF-alpha lead to a decreased expression of tissue inhibitor of metalloproteinase- 3 (TIMP-3) protein and an induction of MMP-9 protein and cell invasion through an upregulation of microRNA-221 (miR-221) in human PDAC cells. Moreover, treatment of SP600125 (a specific inhibitor of JNK pathway) or cotreatment of 13-cis RA and 1,25-VD3 significantly induced a decreased expression of miR-221 and an increased expression of TIMP-3 protein. These results suggest that 13-cis RA and 1,25-VD3 significantly suppress TNF-alpha mediated cell invasion and therefore potentially act as preventive agents against PDAC.	[Cheng, Yen-Huang] Show Chwan Mem Hosp, Dept Emergency Med, Changhua, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung, Taiwan; [Chiang, En-Pei Isabel] Natl Chung Hsing Univ, Innovat & Dev Ctr Sustainable Agr IDCSA, Taichung, Taiwan; [Syu, Jia-Ning; Tang, Feng-Yao] China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan; [Chao, Che-Yi; Tsai, Shu-Yao] Asia Univ, Dept Food Nutr & Hlth Biotechnol, Taichung, Taiwan; [Chao, Che-Yi] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Hung-Yu] Show Chwan Mem Hosp, Res Assistant Ctr, Changhua, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Yang, Mei-Due] China Med Univ Hosp, Dept Surg, Taichung, Taiwan	Show Chwan Memorial Hospital; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Show Chwan Memorial Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Tang, FY (corresponding author), China Med Univ, Dept Nutr, Biomed Sci Lab, Taichung, Taiwan.	vincenttang@mail.cmu.edu.tw	Chiang, EnPei/K-1694-2013	Chiang, EnPei/0000-0002-0158-0962; Lin, Hung-Yu/0000-0002-9035-5408	Ministry of Science and Technology (MOST), Taiwan [MOST-104-2320-B-039-041-MY3, 107-2320-B-039-008-MY3, 103-2811-B-039-009, 105-2811-B-039-005, 105-2811-B-039-031, 106-2811-B-039-002, 106-2811-B-039-016, MOST 107-2320-B-005-003 -MY3, 107-2621-M-005-008 -MY3, 108-2321-B005-004]; China Medical University (CMU) [CMU102-ASIA-23, CMU103ASIA-20, CMU103-S-46, CMU104-S-32]; Show Chwan Memorial Hospital [SRD-109047, SRD-109048]; Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHUIDCSA	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University (CMU)(China Medical University); Show Chwan Memorial Hospital; Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHUIDCSA	This research project is supported by the grant of Ministry of Science and Technology (MOST), Taiwan, under the agreements MOST-104-2320-B-039-041-MY3,107-2320-B-039-008-MY3, 103-2811-B-039-009, 105-2811-B-039-005,105-2811-B-039-031, 106-2811-B-039-002, 106-2811-B-039-016, MOST 107-2320-B-005-003 -MY3, 107-2621-M-005-008 -MY3, 108-2321-B005-004, China Medical University (CMU) grant under agreements CMU102-ASIA-23, CMU103ASIA-20, CMU103-S-46, CMU104-S-32, Show Chwan Memorial Hospital grant under agreements SRD-109047, SRD-109048 and as well as in part by the Ministry of Education (MOE) Taiwan under the Higher Education Sprout Project at NCHUIDCSA. Any results, conclusions, or implication described in this publication are from the author(s) of this manuscript and do not necessarily reflect the view of the MOST, MOE, Asia University, Show Chwan Memorial Hospital and CMU.	Adissu HA, 2015, PROSTATE, V75, P1831, DOI 10.1002/pros.23056; Alizadeh F, 2014, INT IMMUNOPHARMACOL, V18, P43, DOI 10.1016/j.intimp.2013.10.027; Altieri B, 2017, CRIT REV FOOD SCI, V57, P3472, DOI 10.1080/10408398.2015.1136922; Awasthi N, 2019, J CELL MOL MED, V23, P3878, DOI 10.1111/jcmm.14242; Bleul T, 2015, MOL CARCINOGEN, V54, P870, DOI 10.1002/mc.22158; Blogowski W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097613; Bramhall SR, 1997, J PATHOL, V182, P347, DOI 10.1002/(SICI)1096-9896(199707)182:3<347::AID-PATH848>3.0.CO;2-J; Cabal-Hierro L, 2014, CELL SIGNAL, V26, P2658, DOI 10.1016/j.cellsig.2014.08.011; Chronopoulos A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12630; Cooks T, 2014, MOL CELL, V56, P611, DOI 10.1016/j.molcel.2014.11.018; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; Dougan SK, 2017, CANCER J, V23, P321, DOI 10.1097/PPO.0000000000000288; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gracia-Marco L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020416; Guan J, 2014, CANCER LETT, V345, P132, DOI 10.1016/j.canlet.2013.12.006; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Innocenti F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202272; Kondo J, 2008, INT J MOL MED, V22, P645, DOI 10.3892/ijmm_00000067; Kunte M, 2018, CELL J, V20, P211, DOI 10.22074/cellj.2018.5277; Leelawat K, 2005, CANCER LETT, V224, P303, DOI 10.1016/j.canlet.2004.10.016; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Li F, 2018, ARTIF CELL NANOMED B, V46, P482, DOI 10.1080/21691401.2017.1315429; Liu SL, 2018, CELL PHYSIOL BIOCHEM, V47, P567, DOI 10.1159/000489990; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Michael A, 2007, CLIN ONCOL-UK, V19, P150, DOI 10.1016/j.clon.2006.11.008; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Park TK, 1998, EUR J GYNAECOL ONCOL, V19, P35; Pettersson F, 2000, BRIT J CANCER, V83, P239; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Selland LG, 2018, MECH DEVELOP, V150, P28, DOI 10.1016/j.mod.2018.02.005; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Van Loon K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju185; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Wang K, 2019, AM J PHYSIOL-GASTR L, V316, pG632, DOI 10.1152/ajpgi.00344.2018; Wang KW, 2015, HISTOPATHOLOGY, V67, P386, DOI 10.1111/his.12663; Xu QH, 2015, ONCOTARGET, V6, P14153, DOI 10.18632/oncotarget.3686; Yu L, 2014, ONCOL REP, V31, P321, DOI 10.3892/or.2013.2841; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; Zhou X, 2018, GENE, V673, P181, DOI 10.1016/j.gene.2018.06.037; Zhu Y, 2016, ONCOTARGET, V7, P5327, DOI 10.18632/oncotarget.6633; Zugmaier G, 1996, BRIT J CANCER, V73, P1341, DOI 10.1038/bjc.1996.256	45	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247550	10.1371/journal.pone.0247550	http://dx.doi.org/10.1371/journal.pone.0247550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730072	Green Published, gold			2022-12-26	WOS:000630345000028
J	Maheshwari, Y; Selvaraj, V; Godfrey, K; Hajeri, S; Yokomi, R				Maheshwari, Yogita; Selvaraj, Vijayanandraj; Godfrey, Kristine; Hajeri, Subhas; Yokomi, Raymond			Multiplex detection of "Candidatus Liberibacter asiaticus" and Spiroplasma citri by qPCR and droplet digital PCR	PLOS ONE			English	Article								"Candidatus Liberibacter asiaticus" (CLas) and Spiroplasma citri are phloem-limited bacteria that infect citrus and are transmitted by insect vectors. S. citri causes citrus stubborn disease (CSD) and is vectored by the beet leafhopper in California. CLas is associated with the devastating citrus disease, Huanglongbing (HLB), and is vectored by the Asian citrus psyllid. CLas is a regulatory pathogen spreading in citrus on residential properties in southern California and is an imminent threat to spread to commercial citrus plantings. CSD is endemic in California and has symptoms in citrus that can be easily confused with HLB. Therefore, the objective of this study was to develop a multiplex qPCR and duplex droplet digital PCR (ddPCR) assay for simultaneous detection of CLas and S. citri to be used where both pathogens can co-exist. The multiplex qPCR assay was designed to detect multicopy genes of CLas-RNR (5 copies) and S. citri-SPV1 ORF1 (13 copies), respectively, and citrus cytochrome oxidase (COX) as internal positive control. Absolute quantitation of these pathogens was achieved by duplex ddPCR as a supplement for marginal qPCR results. Duplex ddPCR allowed higher sensitivity than qPCR for detection of CLas and S. citri. ddPCR showed higher tolerance to inhibitors and yielded highly reproducible results. The multiplex qPCR assay has the benefit of testing both pathogens at reduced cost and can serve to augment the official regulatory protocol for CLas detection in California. Moreover, the ddPCR provided unambiguous absolute detection of CLas and S. citri at very low concentrations without any standards for pathogen titer.	[Maheshwari, Yogita; Selvaraj, Vijayanandraj; Yokomi, Raymond] ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA 93648 USA; [Godfrey, Kristine] Univ Calif Davis, Contained Res Facil, Davis, CA 95616 USA; [Hajeri, Subhas] Cent Calif Tristeza Eradicat Agcy, Citrus Pest Detect Program, Tulare, CA USA; [Maheshwari, Yogita] CSIR, Plant Virus Lab, Inst Himalayan Bioresource Technol, Palampur, Himachal Prades, India; [Selvaraj, Vijayanandraj] CSIR, Plant Mol Virol Lab, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India	United States Department of Agriculture (USDA); University of California System; University of California Davis; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Selvaraj, V; Yokomi, R (corresponding author), ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA 93648 USA.; Selvaraj, V (corresponding author), CSIR, Plant Mol Virol Lab, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India.	Vijayanandraj@hotmail.com; ray.yokomi@usda.gov	Hajeri, Subhas/E-8180-2018	Hajeri, Subhas/0000-0002-5993-118X; selvaraj, vijayanandraj/0000-0002-0544-3009; Yokomi, Raymond/0000-0002-5658-2279	United States Department of Agriculture, Agricultural Research Service, Base Project; Citrus Research Board [RY 5300-191]; California citrus Nursery Board [RY Yok-18]; United States Department of Agriculture, Agricultural Research Service, Base Project [RY 203422000-013-10D]	United States Department of Agriculture, Agricultural Research Service, Base Project; Citrus Research Board; California citrus Nursery Board; United States Department of Agriculture, Agricultural Research Service, Base Project	RY 5300-191 Citrus Research Board RY Yok-18 California citrus Nursery Board RY 203422000-013-10D United States Department of Agriculture, Agricultural Research Service, Base Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkar-Purushothama CR, 2010, J PLANT DIS PROTECT, V117, P241, DOI 10.1007/BF03356367; Bove JM, 1988, P C INT ORG CITR VIR, P295; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; LIU HY, 1983, PHYTOPATHOLOGY, V73, P585, DOI 10.1094/Phyto-73-585; Loconsole G, 2013, MOL CELL PROBE, V27, P221, DOI 10.1016/j.mcp.2013.07.003; Maheshwari Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184751; Osman F., 2017, CITROGRAPH, V8, P64; Osman F, 2017, J VIROL METHODS, V245, P40, DOI 10.1016/j.jviromet.2017.03.007; Pagliaccia D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02041; Roy A, 2005, J VIROL METHODS, V129, P47, DOI 10.1016/j.jviromet.2005.05.008; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; Saponari M, 2019, METHODS MOL BIOL, V2015, P67, DOI 10.1007/978-1-4939-9558-5_6; Saponari M, 2013, J VIROL METHODS, V193, P478, DOI 10.1016/j.jviromet.2013.07.002; Sauer AV, 2015, PLANT DIS, V99, P1125, DOI 10.1094/PDIS-09-14-0926-RE; Selvaraj V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197184; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Wang XF, 2015, PLANT DIS, V99, P149, DOI 10.1094/PDIS-06-14-0572-RE; Yokomi R.K., 2019, CURR AGR RES, V8, P1, DOI [10.12944/CARJ.8.1.01, DOI 10.12944/CARJ.8.1.01]; Yokomi RK, 2008, PLANT DIS, V92, P253, DOI 10.1094/PDIS-92-2-0253; Yokomi RK., 2011, P 18 C INT ORG CITR; Zheng Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep39020; Zhong X, 2018, J INTEGR AGR, V17, P483, DOI 10.1016/S2095-3119(17)61815-X	24	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0242392	10.1371/journal.pone.0242392	http://dx.doi.org/10.1371/journal.pone.0242392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730040	Green Submitted, gold, Green Published			2022-12-26	WOS:000630345000043
J	He, HY; Luo, HW; Liu, L; Shangguan, YF; Xie, XK; Wen, YX; Wang, H; Chen, LB				He, Hangyuan; Luo, Hanwen; Liu, Liang; Shangguan, Yangfan; Xie, Xingkui; Wen, Yinxian; Wang, Hui; Chen, Liaobin			Prenatal caffeine exposure caused H-type blood vessel-related long bone dysplasia via miR375/CTGF signaling	FASEB JOURNAL			English	Article						bone dysplasia; connective tissue growth factor; H&#8208; type blood vessel; microRNA375; prenatal caffeine exposure	GROWTH-FACTOR CTGF/CCN2; LATE-STAGE; ANGIOGENESIS; TISSUE; EXPRESSION; DIFFERENTIATION; OSTEOGENESIS; OSTEOPOROSIS; MICRORNAS; MECHANISM	Caffeine has developmental toxicity. Prenatal caffeine exposure (PCE) caused intrauterine growth retardation (IUGR) and multiple organ dysplasia. This study intended to explore the effect and mechanism of PCE on long bone development in female fetal rats. In vivo, the PCE group pregnant rats were given different concentrations of caffeine during the gestational Day 9-20. The mRNA expression of osteogenesis-related genes were significantly reduced in PCE group. In the PCE group (120 mg/kg center dot d), the length and primary center of fetal femur were shorter, and accompanied by H-type blood vessel abundance reducing. Meanwhile, connective tissue growth factor (CTGF) expression decreased in the growth plate of the PCE group (120 mg/kg center dot d). In contrast, the miR375 expression increased. In vitro, caffeine decreased CTGF and increased miR375 expression in fetal growth plate chondrocytes. After co-culture with caffeine-treated chondrocytes, the tube formation ability for the H-type endothelial cells was decreased. Furthermore, CTGF overexpression or miR375 inhibitor reversed caffeine-induced reduction of tube formation ability, and miR375 inhibitor reversed caffeine-induced CTGF expression inhibition. In summary, PCE decreased the expression of CTGF by miR375, ultimately resulting in H-type blood vessel-related long bone dysplasia.	[He, Hangyuan; Liu, Liang; Shangguan, Yangfan; Xie, Xingkui; Wen, Yinxian; Wang, Hui; Chen, Liaobin] Wuhan Univ, Dept Joint Surg & Sports Med, Zhongnan Hosp, Wuhan, Peoples R China; [Luo, Hanwen; Wen, Yinxian] Guangxi Med Univ, Affiliated Hosp 4, Dept Orthoped Surg, Liuzhou, Peoples R China; [Shangguan, Yangfan; Xie, Xingkui; Wang, Hui; Chen, Liaobin] Hubei Prov Key Lab Dev Originated Dis, Wuhan, Peoples R China; [Wang, Hui] Wuhan Univ, Dept Pharmacol, Basic Med Sch, Wuhan, Peoples R China	Wuhan University; Guangxi Medical University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Dept Joint Surg & Sports Med, Zhongnan Hosp, Wuhan, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Dept Pharmacol, Med Sch, Wuhan, Peoples R China.	wanghui19@whu.edu.cn; lbchen@whu.edu.cn						Alam KJ, 2017, INT J CANCER, V141, P1614, DOI 10.1002/ijc.30861; Available N., 2003, ED HLTH ABINGDON, V16, P2; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Berglundh S, 2021, EUR J NUTR, V60, P791, DOI 10.1007/s00394-020-02280-7; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Chen LW, 2018, EXP THER MED, V15, P4318, DOI 10.3892/etm.2018.5952; Cheung WH, 2001, CANCER LETT, V163, P25, DOI 10.1016/S0304-3835(00)00653-4; Choi S, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800254; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Gillette R, 2017, HORM BEHAV, V87, P8, DOI 10.1016/j.yhbeh.2016.10.011; Gkiatas Ioannis, 2015, Am J Orthop (Belle Mead NJ), V44, P61; He Z, 2019, TOXICOL LETT, V302, P7, DOI 10.1016/j.toxlet.2018.12.001; Herberth G, 2014, J ALLERGY CLIN IMMUN, V133, P543, DOI 10.1016/j.jaci.2013.06.036; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Kuczkowski K M, 2003, Med J Malaysia, V58, P147; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee SH, 2018, MOL REPROD DEV, V85, P336, DOI 10.1002/mrd.22969; Lei NB, 2019, EUR REV MED PHARMACO, V23, P11043, DOI 10.26355/eurrev_201912_19812; Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3; Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002; Li QX, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104555; Lun WJ, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0575-2; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Ma LM, 2013, J GENET GENOMICS, V40, P143, DOI 10.1016/j.jgg.2013.03.002; Mehta RR, 2011, ANGIOGENESIS, V14, P355, DOI 10.1007/s10456-011-9220-6; Melton LJ, 2001, CALCIFIED TISSUE INT, V69, P179, DOI 10.1007/s00223-001-1043-9; Modzelewska D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2215-9; Mu SZ, 2016, MOL CELL BIOCHEM, V416, P99, DOI 10.1007/s11010-016-2699-9; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; Ojeda NB, 2014, ACTA PHYSIOL, V210, P307, DOI 10.1111/apha.12206; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddi HV, 2013, CANCER GENE THER, V20, P267, DOI 10.1038/cgt.2013.16; Sakai N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05624-2; Shangguan YF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.546; Sun T., 2017, PLOS ONE, V12, P171; Wang FQ, 2012, ENVIRON SCI TECHNOL, V46, P6822, DOI 10.1021/es3008547; Wang L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.36; Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007; Wu ZX, 2020, FOOD CHEM TOXICOL, V136, DOI 10.1016/j.fct.2019.111083; Xiao H, 2020, BRIT J PHARMACOL, V177, P4683, DOI 10.1111/bph.15225; Xiao H, 2019, FASEB J, V33, P12972, DOI 10.1096/fj.201901145RR; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yamaai T, 2005, J BONE MINER METAB, V23, P280, DOI 10.1007/s00774-004-0600-5; Zhang W, 2012, CELL BIOCHEM FUNCT, V30, P297, DOI 10.1002/cbf.2801; Zhou JZ, 2014, INT J MOL MED, V33, P1250, DOI 10.3892/ijmm.2014.1691	51	1	1	11	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21370	10.1096/fj.202002230R	http://dx.doi.org/10.1096/fj.202002230R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33734471				2022-12-26	WOS:000647789600086
J	Lima, CA; da Silva, BEB; Hora, EC; Lima, MS; Brito, EDC; Santos, MD; da Silva, AM; Nunes, MAP; Brito, HLD; Lima, MMM				Lima, Carlos Anselmo; Barreto da Silva, Brenda Evelin; Hora, Evania Curvelo; Lima, Marcela Sampaio; Costa Brito, Erika de Abreu; Santos, Marceli de Oliveira; da Silva, Angela Maria; Prado Nunes, Marco Antonio; de Farias Brito, Hugo Leite; Macedo Lima, Marcia Maria			Trends in prostate cancer incidence and mortality to monitor control policies in a northeastern Brazilian state	PLOS ONE			English	Article							GEOGRAPHIC REGIONS; TIME TRENDS; PART I; SURVIVAL; MEN; PREVALENCE; PATTERNS; HISTORY; RACE	Prostate cancer differently affects different regions of the world, displaying higher rates in more developed areas. After the implementation of prostate-specific antigen (PSA) testing, several studies described rising rates globally, but it is possible that indolent lesions are being detected given the lack of changes in mortality data. The Brazilian government recommends against PSA screening in the male population regardless of age, but the Urology Society issued a report recommending that screening should start at 50 years old for certain men and for those aged >= 75 years with a life expectancy exceeding 10 years. In this study, we examined the incidence and mortality rates of invasive prostate cancer over time in the Sergipe state of Brazil. The databases of the Aracaju Cancer Registry and Mortality Information System were used to calculate age-standardized rates for all prostate tumors (International Classification of Diseases 10th edition: C61 and D07.5) in the following age ranges: 20-44, 45-54, and >= 65 years. We identified 3595 cases of cancer, 30 glandular intraepithelial high-grade lesions, and 3269 deaths. Using the Joinpoint Regression Program, we found that the incidence of prostate cancer dramatically increased over time until the mid-2000s for all age groups, after which the rates declined. Prostate cancer mortality rates increased until 2005, followed by a non-significant annual percent change of 22.0 in 2001-2005 and a stable rate thereafter. We noticed that the increases and decreases of the incidence rates of prostate cancer were associated with the screening recommendations. Meanwhile, the increased mortality rates did not appear to be associated with decreased PSA testing; instead, they were linked to the effects of age and improvements in identification of the cause of death. Thus, we do not believe a PSA screening program would benefit the population of this study.	[Lima, Carlos Anselmo] Aracaju Canc Registry, Aracaju, Sergipe, Brazil; [Lima, Carlos Anselmo; Barreto da Silva, Brenda Evelin; Hora, Evania Curvelo; Lima, Marcela Sampaio; Costa Brito, Erika de Abreu; da Silva, Angela Maria; Prado Nunes, Marco Antonio; de Farias Brito, Hugo Leite] Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil; [Lima, Carlos Anselmo; da Silva, Angela Maria; Prado Nunes, Marco Antonio; Macedo Lima, Marcia Maria] Programa Posgrad Profiss Gestao & Inovacao Tecnol, Aracaju, Sergipe, Brazil; [Lima, Carlos Anselmo; Lima, Marcela Sampaio; Costa Brito, Erika de Abreu; da Silva, Angela Maria; Prado Nunes, Marco Antonio; de Farias Brito, Hugo Leite; Macedo Lima, Marcia Maria] Univ Fed Sergipe, Univ Hosp, EBSERH, Aracaju, Sergipe, Brazil; [Santos, Marceli de Oliveira] Brazilian Natl Canc Inst, CONPREV, Rio De Janeiro, RJ, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; National Cancer Institute (Inca)	Lima, CA (corresponding author), Aracaju Canc Registry, Aracaju, Sergipe, Brazil.; Lima, CA (corresponding author), Univ Fed Sergipe, Hlth Sci Grad Program, Aracaju, Sergipe, Brazil.; Lima, CA (corresponding author), Programa Posgrad Profiss Gestao & Inovacao Tecnol, Aracaju, Sergipe, Brazil.; Lima, CA (corresponding author), Univ Fed Sergipe, Univ Hosp, EBSERH, Aracaju, Sergipe, Brazil.	carlos.a.lima@ufs.br	Nunes, Marco/E-2187-2014; Lima, Carlos Anselmo/A-4225-2013	Nunes, Marco/0000-0001-5244-5843; Lima, Carlos Anselmo/0000-0003-4269-7320	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe FAPITEC/SE	Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe FAPITEC/SE	CAL received a Research Development Grant from the Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe FAPITEC/SE.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Altwein J, 1997, UROLOGY, V49, P66, DOI 10.1016/S0090-4295(99)80325-2; Berg AO, 2002, ANN INTERN MED, V137, P915, DOI 10.7326/0003-4819-137-11-200212030-00013; Bhatt NR, 2017, CENT EUR J UROL, V70, P143, DOI 10.5173/ceju.2017.1361; Bryant RJ, 2008, EUR UROL, V53, P37, DOI 10.1016/j.eururo.2007.08.034; Canadian Cancer Statistics Advisory Committee, 2018, CAN CANC STAT 2018; Culp MB, 2020, EUR UROL, V77, P38, DOI 10.1016/j.eururo.2019.08.005; Dasgupta P, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00238; Doll R, 1966, CANC INCIDENCE 5 COU; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Faria EF, 2010, UROLOGY, V76, P1052, DOI 10.1016/j.urology.2010.02.044; Araujo FAGD, 2019, INT BRAZ J UROL, V45, P478, DOI [10.1590/s1677-5538.ibju.2018.0179, 10.1590/S1677-5538.IBJU.2018.0179]; Gordetsky JB, 2017, AM J SURG PATHOL, V41, P101, DOI 10.1097/PAS.0000000000000723; Gray PJ, 2017, EUR UROL, V71, P729, DOI 10.1016/j.eururo.2016.08.047; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1901, DOI 10.1001/jama.2018.3710; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Instituto Brasileiro de Geografia e Estatistica, ESTADO MATO GRO; Instituto Nacional De Cancer, 2013, RASTR CANC PROST; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; LeBlanc AG, 2019, HEALTH REP, V30, P12, DOI 10.25318/82-003-x201900400002-eng; Loffeler S, 2018, SCAND J UROL, V52, P122, DOI 10.1080/21681805.2017.1421260; Loveman M, 2012, ETHNIC RACIAL STUD, V35, P1466, DOI 10.1080/01419870.2011.607503; Mahal BA, 2019, JAMA-J AM MED ASSOC, V321, P704, DOI 10.1001/jama.2018.19941; Conceicao MBM, 2014, CAD SAUDE PUBLICA, V30, P559, DOI 10.1590/0102-311X00005813; Braga SFM, 2017, CANCER EPIDEMIOL, V50, P53, DOI 10.1016/j.canep.2017.07.016; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nguyen-Nielsen M, 2019, CANCER EPIDEMIOL, V59, P249, DOI 10.1016/j.canep.2019.02.017; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Quinn M, 2002, BJU INT, V90, P174, DOI 10.1046/j.1464-410X.2002.02823.x; Sierra MS, 2016, CANCER EPIDEMIOL, V44, pS131, DOI 10.1016/j.canep.2016.06.010; Taitt HE, 2018, AM J MENS HEALTH, V12, P1807, DOI 10.1177/1557988318798279; Teoh JYC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221775; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249009	10.1371/journal.pone.0249009	http://dx.doi.org/10.1371/journal.pone.0249009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765051	Green Published, gold			2022-12-26	WOS:000634832800001
J	Tao, FZ; Xing, X; Wu, JN; Jiang, RL				Tao, Fuzheng; Xing, Xi; Wu, Jiannong; Jiang, Ronglin			Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice	PLOS ONE			English	Article								Nutritional support using exclusive enteral nutrition (EEN) has been studied as primary therapy for the management of liver diseases, Crohn's disease, and cancers. EEN can also increase the number of beneficial microbiotas in the gut, improve bile acid and lipid metabolism, and decrease the number of harmful dietary micro-particles, possibly by influencing disease occurrence and increasing immunity. This study investigated the effects of EEN-n-3 polyunsaturated fatty acids (3PUFAs) (EEN-3PUFAs) on the gut microbiome, intestinal barrier, and lipid or bile acid metabolism in mice. Metagenomic sequencing technology was used to analyze the effects of EEN-3PUFAs on the composition of gut microbiome signatures. The contents of short-chain fatty acids (SCFAs) and bile acids in the feces and liver of the mice were assayed by gas chromatography and ultra-high-pressure liquid chromatography/high-resolution tandem mass spectrometry, respectively. The levels of lipopolysaccharide (LPS) and D-lactic acid in the blood were used to assess intestinal permeability. The results indicated that EEN-3PUFAs could improve the composition of gut microbiome signatures and increase the abundance of Barnesiella and Lactobacillus (genus), Porphyromonadaceae, and Bacteroidia (species), and Bacteroidetes (phylum) after EEN-3PUFAs initiation. In addition, EEN-3PUFAs induced the formation of SCFAs (mainly including acetic acid, propionic acid, and butyric acid) and increased the intestinal wall compared to the control group. In conclusion, EEN-3PUFAs modulate the alterations in gut microbiome signatures, enhanced intestinal barrier, and regulated the fatty acid composition and lipid metabolism shifts and the putative mechanisms underlying these effects.	[Tao, Fuzheng] Taizhou Hosp Integrated Tradit Chinese & Western, Intens Care Unit, Taizhou, Zhejiang, Peoples R China; [Xing, Xi; Wu, Jiannong; Jiang, Ronglin] Zhejiang Univ Tradit Chinese Med, Hosp Affiliated 1, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University	Jiang, RL (corresponding author), Zhejiang Univ Tradit Chinese Med, Hosp Affiliated 1, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China.	jiangronglin@126.com			National Natural Science Foundation of China [81774070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81774070).	Abadi ATB, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00026; Adamji M, 2019, INTEST RES, V17, P171, DOI 10.5217/ir.2018.00079; Aldaba-Muruato LR, 2012, BBA-GEN SUBJECTS, V1820, P65, DOI 10.1016/j.bbagen.2011.09.018; Alexander JW, 1998, NUTRITION, V14, P627, DOI 10.1016/S0899-9007(98)00004-5; Arnold Isabelle C, 2016, Inflamm Intest Dis, V1, P102, DOI 10.1159/000445985; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barandouzi ZA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00541; Bauer G, 2001, MED HYPOTHESES, V57, P252, DOI 10.1054/mehy.2000.1285; Baumgart DC, 2002, CURR OPIN CLIN NUTR, V5, P685, DOI 10.1097/00075197-200211000-00012; Baxter NT, 2019, MBIO, V10, DOI [10.1128/mbio.02566-18, 10.1128/mBio.02566-18]; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Biedermann L, 2015, EUR J PEDIATR, V174, P151, DOI 10.1007/s00431-014-2476-2; Blaut Michael, 2012, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-24716-3_11; Bravo D, 2018, WORLD J GASTROENTERO, V24, P3071, DOI 10.3748/wjg.v24.i28.3071; Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485; Cai JS, 2014, J MEMBRANE BIOL, V247, P1067, DOI 10.1007/s00232-014-9715-3; Chaplin A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111651; Chen Chien-Chang, 2005, Adv Pediatr, V52, P77, DOI 10.1016/j.yapd.2005.03.001; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Colombo C, 2000, DIGEST LIVER DIS, V32, P152, DOI 10.1016/S1590-8658(00)80403-X; Day A, 2020, JGH OPEN, V4, P260, DOI 10.1002/jgh3.12256; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Enomoto N, 2004, J GASTROENTEROL, V39, P1175, DOI 10.1007/s00535-004-1468-9; Flock MR, 2013, NUTR REV, V71, P692, DOI 10.1111/nure.12071; Forbes A, 2017, CLIN NUTR, V36, P321, DOI 10.1016/j.clnu.2016.12.027; Gaby AR, 2009, ALTERN MED REV, V14, P258; Ghazalpour A, 2016, CURR OPIN LIPIDOL, V27, P141, DOI 10.1097/MOL.0000000000000278; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004; HINCHEY EJ, 1972, CAN MED ASSOC J, V107, P184; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hurley Bryan P, 2004, Curr Gastroenterol Rep, V6, P355, DOI 10.1007/s11894-004-0050-1; Ikemoto S, 1997, AM J PHYSIOL-ENDOC M, V273, pE37, DOI 10.1152/ajpendo.1997.273.1.E37; Inagaki A, 2005, J NUTR SCI VITAMINOL, V51, P156, DOI 10.3177/jnsv.51.156; Jakava-Vijanen M, 2007, VET MICROBIOL, V124, P264, DOI 10.1016/j.vetmic.2007.04.029; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kammermeier J, 2016, ARCH DIS CHILD, V101, P475, DOI 10.1136/archdischild-2014-307217; Kawamura T, 2009, DIGEST DIS SCI, V54, P238, DOI 10.1007/s10620-008-0348-1; Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835; King CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206484; Lanzini A, 2000, ALIMENT PHARM THERAP, V14, P58, DOI 10.1046/j.1365-2036.2000.014s2058.x; Lei ChunLong, 2012, Chinese Journal of Animal Nutrition, V24, P416; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Ma CX, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/8495913; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matziouridou C, 2016, MOL NUTR FOOD RES, V60, P1150, DOI 10.1002/mnfr.201500738; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; MURRAY MJ, 1993, J SURG RES, V54, P507, DOI 10.1006/jsre.1993.1078; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Pacht ER, 2003, CRIT CARE MED, V31, P491, DOI 10.1097/01.CCM.0000049952.96496.3E; Pandak William M, 2019, Liver Res, V3, P88, DOI 10.1016/j.livres.2019.05.001; Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64; Pitcher MCL, 1996, GUT, V39, P1, DOI 10.1136/gut.39.1.1; Pohanka M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3419034; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Ross BD, 2019, NATURE, V575, P224, DOI 10.1038/s41586-019-1708-z; Scaioli E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122619; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Stoma I, 2021, CLIN INFECT DIS, V73, DOI 10.1093/cid/ciaa068; Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Tsuchida T, 2012, METABOLISM, V61, P944, DOI 10.1016/j.metabol.2011.10.023; VOITK AJ, 1975, BRIT J CLIN PRACT, V29, P55; Wall CL, 2013, WORLD J GASTROENTERO, V19, P7652, DOI 10.3748/wjg.v19.i43.7652; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022	78	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248482	10.1371/journal.pone.0248482	http://dx.doi.org/10.1371/journal.pone.0248482			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764993	gold, Green Published			2022-12-26	WOS:000634832800084
J	Valach, AC; Kasak, K; Hemes, KS; Anthony, TL; Dronova, I; Taddeo, S; Silver, WL; Szutu, D; Verfaillie, J; Baldocchi, DD				Valach, Alex C.; Kasak, Kuno; Hemes, Kyle S.; Anthony, Tyler L.; Dronova, Iryna; Taddeo, Sophie; Silver, Whendee L.; Szutu, Daphne; Verfaillie, Joseph; Baldocchi, Dennis D.			Productive wetlands restored for carbon sequestration quickly become net CO2 sinks with site-level factors driving uptake variability	PLOS ONE			English	Article							FRESH-WATER WETLAND; LAND-USE CHANGE; ENVIRONMENTAL-CONDITIONS; METHANE PRODUCTION; TYPHA-LATIFOLIA; DIOXIDE FLUXES; RESTORATION; VEGETATION; SOIL; AZOLLA	Inundated wetlands can potentially sequester substantial amounts of soil carbon (C) over the long-term because of slow decomposition and high primary productivity, particularly in climates with long growing seasons. Restoring such wetlands may provide one of several effective negative emission technologies to remove atmospheric CO2 and mitigate climate change. However, there remains considerable uncertainty whether these heterogeneous ecotones are consistent net C sinks and to what degree restoration and management methods affect C sequestration. Since wetland C dynamics are largely driven by climate, it is difficult to draw comparisons across regions. With many restored wetlands having different functional outcomes, we need to better understand the importance of site-specific conditions and how they change over time. We report on 21 site-years of C fluxes using eddy covariance measurements from five restored fresh to brackish wetlands in a Mediterranean climate. The wetlands ranged from 3 to 23 years after restoration and showed that several factors related to restoration methods and site conditions altered the magnitude of C sequestration by affecting vegetation cover and structure. Vegetation established within two years of re-flooding but followed different trajectories depending on design aspects, such as bathymetry-determined water levels, planting methods, and soil nutrients. A minimum of 55% vegetation cover was needed to become a net C sink, which most wetlands achieved once vegetation was established. Established wetlands had a high C sequestration efficiency (i.e. the ratio of net to gross ecosystem productivity) comparable to upland ecosystems but varied between years undergoing boom-bust growth cycles and C uptake strength was susceptible to disturbance events. We highlight the large C sequestration potential of productive inundated marshes, aided by restoration design and management targeted to maximise vegetation extent and minimise disturbance. These findings have important implications for wetland restoration, policy, and management practitioners.	[Valach, Alex C.; Kasak, Kuno; Hemes, Kyle S.; Anthony, Tyler L.; Dronova, Iryna; Silver, Whendee L.; Szutu, Daphne; Verfaillie, Joseph; Baldocchi, Dennis D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA; [Kasak, Kuno] Univ Tartu, Inst Ecol & Earth Sci, Dept Geog, Tartu, Estonia; [Hemes, Kyle S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Taddeo, Sophie] Univ Calif Berkeley, Dept Landscape Architecture & Environm Planning, Berkeley, CA 94720 USA; [Valach, Alex C.] Agroscope, Agroecol & Environm Div, Zurich, Switzerland; [Taddeo, Sophie] Chicago Bot Garden, Negaunee Inst Plant Conservat Sci & Act, Chicago, IL USA	University of California System; University of California Berkeley; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Stanford University; University of California System; University of California Berkeley; Swiss Federal Research Station Agroscope	Valach, AC (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Ecosyst Sci Div, Berkeley, CA 94720 USA.; Valach, AC (corresponding author), Agroscope, Agroecol & Environm Div, Zurich, Switzerland.	a.c.valach@gmail.com	Baldocchi, Dennis/A-1625-2009; Kasak, Kuno/F-6063-2017	Baldocchi, Dennis/0000-0003-3496-4919; Kasak, Kuno/0000-0002-0810-2154; Valach, Alex/0000-0003-4782-5766; Silver, Whendee/0000-0003-0372-8745; Anthony, Tyler/0000-0001-8235-6980	California Department of Water Resources from the California Department of Fish and Wildlife; United States Department of Agriculture (NIFA) [2011-67003-30371]; U.S. Department of Energy's Office of Science (AmeriFlux) [7079856]; Delta Science Program [R/SF-52]; Estonian Research Council [PSG631]; Baltic-American Freedom Foundation Research Scholar program; California Sea Grant Delta Science Fellowship [R/SF-70, R/SF-71, R/SF-89, 2271, 5298]; McIntire Stennis grant [CA-B-ECO-7673-MS]; National Science Foundation [1948997, 1948994, 1948857]	California Department of Water Resources from the California Department of Fish and Wildlife; United States Department of Agriculture (NIFA)(United States Department of Agriculture (USDA)); U.S. Department of Energy's Office of Science (AmeriFlux)(United States Department of Energy (DOE)); Delta Science Program; Estonian Research Council(Estonian Research Council); Baltic-American Freedom Foundation Research Scholar program; California Sea Grant Delta Science Fellowship; McIntire Stennis grant; National Science Foundation(National Science Foundation (NSF))	This work was supported in the form of funding by the California Department of Water Resources through a contract from the California Department of Fish and Wildlife and the United States Department of Agriculture (NIFA grant #2011-67003-30371) awarded to DDB. Funding for the AmeriFlux core sites was provided by the U.S. Department of Energy's Office of Science (AmeriFlux contract #7079856) and the aerial images and footprint mapping was funded by the Delta Science Program grant #R/SF-52 awarded to DDB and KSH. KK was supported by the Estonian Research Council grant No. PSG631 and by the Baltic-American Freedom Foundation Research Scholar program. KSH, ST and TLA were supported by the California Sea Grant Delta Science Fellowship (programs R/SF-70, R/SF-71 and R/SF-89 and grant no. 2271 and 5298). McIntire Stennis grant CA-B-ECO-7673-MS awarded to WLS partially supported this work. This work uses data and processing services provided by the OpenTopography Facility with support from the National Science Foundation under NSF Award Numbers 1948997, 1948994 & 1948857.	Abbott KM, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2828; Altor AE, 2008, WETLANDS, V28, P423, DOI 10.1672/07-98.1; Anderson FE, 2016, J GEOPHYS RES-BIOGEO, V121, P777, DOI 10.1002/2015JG003083; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Baldocchi D, 2012, AGR FOREST METEOROL, V153, P177, DOI 10.1016/j.agrformet.2011.04.013; Bates M.E., 2013, SAN FRANC ESTUARY WA, V11, P1, DOI [DOI 10.15447/SFEWS.2013V11ISS1ART1, https://doi.org/10.15447/sfews.2013v11iss1art1]; Berkowitz JF, 2013, ECOL INDIC, V34, P600, DOI 10.1016/j.ecolind.2013.06.025; Bharati K, 2000, AGR ECOSYST ENVIRON, V79, P73, DOI 10.1016/S0167-8809(99)00148-6; Bouchard V, 2007, ECOLOGY, V88, P2903, DOI 10.1890/06-1144.1; Brouwer P, 2016, BIOENERG RES, V9, P369, DOI 10.1007/s12155-015-9665-3; Byrd KB, 2014, REMOTE SENS ENVIRON, V149, P166, DOI 10.1016/j.rse.2014.04.003; Callaway J. C., 2011, SAN FRANCISCO ESTUAR, V9, P1; Cardon ZG, 2002, OECOLOGIA, V133, P215, DOI 10.1007/s00442-002-1045-y; Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P52, DOI 10.1016/j.envsoft.2011.09.008; Chamberlain SD, 2020, ECOSYSTEMS, V23, P675, DOI 10.1007/s10021-019-00430-5; Childers DL, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.576936; Chu HS, 2018, GEOPHYS RES LETT, V45, P9275, DOI 10.1029/2018GL079306; Delta Stewardship Council, 2013, DELTA PLAN; Delta Vision Blue Ribbon Task Force, 2008, DELTA VISION STRATEG; Detto M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004693; Deverel S., 2010, SF EST WAT SCI, V6; Drexler J., 2019, BLUE CARBON PRIMER; Dronova I, 2021, AGR FOREST METEOROL, V296, DOI 10.1016/j.agrformet.2020.108215; Dronova I, 2016, WETLANDS, V36, P705, DOI 10.1007/s13157-016-0780-5; Duman T, 2018, ECOL ENG, V114, P16, DOI 10.1016/j.ecoleng.2017.08.031; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Eichelmann E, 2018, AGR FOREST METEOROL, V256, P179, DOI 10.1016/j.agrformet.2018.03.007; Emilson EJS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04236-2; Esri Inc, 2020, ARCMAP V10; Essl F, 2018, WIRES CLIM CHANGE, V9, DOI 10.1002/wcc.486; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Flechard CR, 2020, BIOGEOSCIENCES, V17, P1621, DOI 10.5194/bg-17-1621-2020; Frolking S, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000091; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Gunther A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15499-z; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hemes KS, 2019, AGR FOREST METEOROL, V268, P202, DOI 10.1016/j.agrformet.2019.01.017; Hemes KS, 2018, J GEOPHYS RES-BIOGEO, V123, P2072, DOI 10.1029/2018JG004494; Hemes KS, 2018, GEOPHYS RES LETT, V45, P6081, DOI 10.1029/2018GL077747; Hong MG, 2017, J PLANT BIOL, V60, P241, DOI 10.1007/s12374-016-0572-8; Hopfensperger KN, 2009, J VEG SCI, V20, P767, DOI 10.1111/j.1654-1103.2009.01083.x; Howard J., 2014, COASTAL BLUE CARBON; Hsieh CI, 2000, ADV WATER RESOUR, V23, P765, DOI 10.1016/S0309-1708(99)00042-1; Humpenoder F, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abae2a; Iguchi H, 2019, J BIOSCI BIOENG, V128, P450, DOI 10.1016/j.jbiosc.2019.04.009; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Keenan TF, 2019, NAT ECOL EVOL, V3, P407, DOI 10.1038/s41559-019-0809-2; Kimmerer WJ., 2005, SF EST WAT SCI, V3; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kljun N, 2015, GEOSCI MODEL DEV, V8, P3695, DOI 10.5194/gmd-8-3695-2015; Knox SH, 2016, J GEOPHYS RES-BIOGEO, V121, P978, DOI 10.1002/2015JG003247; Knox SH, 2015, GLOBAL CHANGE BIOL, V21, P750, DOI 10.1111/gcb.12745; Kochy M, 2015, SOIL-GERMANY, V1, P351, DOI 10.5194/soil-1-351-2015; Kollah B, 2016, ENVIRON SCI POLLUT R, V23, P4358, DOI 10.1007/s11356-015-5857-9; Krauss KW, 2018, GLOBAL BIOGEOCHEM CY, V32, P817, DOI 10.1029/2018GB005897; Lamb D., 2014, ECOL PROCESS, V3, P1, DOI DOI 10.1186/2192-1709-3-8; Langley JA, 2012, WETLANDS, V32, P571, DOI 10.1007/s13157-012-0292-x; Lee JS, 2003, BIOTECHNOL BIOPROC E, V8, P354, DOI 10.1007/BF02949279; Li XF, 2020, BIOGEOSCIENCES, V17, P3409, DOI 10.5194/bg-17-3409-2020; Loganathan P., 2012, P INT FOR ENB S; Lu WZ, 2017, GLOBAL CHANGE BIOL, V23, P1180, DOI 10.1111/gcb.13424; Lund J.R., 2008, COMPARING FUTURES SA; Luoma Samuel N., 2015, San Francisco Estuary & Watershed Science, V13, P7; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Macreadie PI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069244; Matthes JH, 2014, J GEOPHYS RES-BIOGEO, V119, P1322, DOI 10.1002/2014JG002642; Matthews JW, 2009, ECOL APPL, V19, P2093, DOI 10.1890/08-1371.1; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Miller R., 2008, SAN FRANC ESTUARYWAT, V6, DOI [10.15447/sfews.2008v6iss3art1, DOI 10.15447/SFEWS.2008V6ISS3ART1]; Miller RL., 2011, RIVER DELTAS TYPES S; Miller RL, 2010, WETL ECOL MANAG, V18, P1, DOI 10.1007/s11273-009-9143-9; Mitsch WJ, 2018, ECOL ENG, V114, P1, DOI 10.1016/j.ecoleng.2017.12.027; Mitsch WJ, 2013, LANDSCAPE ECOL, V28, P583, DOI 10.1007/s10980-012-9758-8; Mitsch WJ, 2005, ECOL ENG, V25, P510, DOI 10.1016/j.ecoleng.2005.04.014; Mitsch WJ, 1996, ECOL APPL, V6, P77, DOI 10.2307/2269554; Mitsch WJ., 2015, WETLANDS, V5, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mohedano RA, 2019, SCI TOTAL ENVIRON, V691, P1043, DOI 10.1016/j.scitotenv.2019.07.169; Moomaw WR, 2018, WETLANDS, V38, P183, DOI 10.1007/s13157-018-1023-8; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; Mount J., 2005, SAN FRANC ESTUARY WA, V3, DOI 10.15447/sfews.2005v3iss1art7; Naeeni STO., 2011, P 2011 WORLD ENBV; Negandhi K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40763-8; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Newman S, 1996, ECOL APPL, V6, P774, DOI 10.2307/2269482; Nichols JE, 2019, NAT GEOSCI, V12, P917, DOI 10.1038/s41561-019-0454-z; Ogle D. H., 2018, FSA FISHERIES STOCK; Pennypacker S, 2016, BOUND-LAY METEOROL, V158, P165, DOI 10.1007/s10546-015-0090-0; Petrescu AMR, 2015, P NATL ACAD SCI USA, V112, P4594, DOI 10.1073/pnas.1416267112; Piao SL, 2020, GLOBAL CHANGE BIOL, V26, P300, DOI 10.1111/gcb.14884; Prasanna R, 2002, MICROBIOL RES, V157, P1, DOI 10.1078/0944-5013-00124; Pugh CA, 2018, BIOGEOCHEMISTRY, V137, P15, DOI 10.1007/s10533-017-0414-x; RAUPACH MR, 1994, BOUND-LAY METEOROL, V71, P211, DOI 10.1007/BF00709229; Rogers K, 2019, NATURE, V567, P91, DOI 10.1038/s41586-019-0951-7; Rothman E, 2007, WETLANDS, V27, P1134, DOI 10.1672/0277-5212(2007)27[1134:ROCPBM]2.0.CO;2; Sahoo D., 2012, PHYKOS, V42, P32; San Francisco Estuary Institute-Aquatic Science Center, 2014, REPORT SFEI ASCS RES, V729; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; Schafer KVR, 2019, AGR FOREST METEOROL, V275, P223, DOI 10.1016/j.agrformet.2019.05.026; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schile LM, 2013, REMOTE SENS LETT, V4, P542, DOI 10.1080/2150704X.2013.766372; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Sloey TM, 2015, RESTOR ECOL, V23, P430, DOI 10.1111/rec.12212; Speelman EN, 2009, GEOBIOLOGY, V7, P155, DOI 10.1111/j.1472-4669.2009.00195.x; Sturtevant C, 2016, J GEOPHYS RES-BIOGEO, V121, P188, DOI 10.1002/2015JG003054; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Svengsouk LJ, 2001, AM MIDL NAT, V145, P309, DOI 10.1674/0003-0031(2001)145[0309:DOMOTL]2.0.CO;2; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Taddeo S, 2018, ECOL INDIC, V94, P454, DOI 10.1016/j.ecolind.2018.07.010; Taillardat P, 2020, INTERFACE FOCUS, V10, DOI 10.1098/rsfs.2019.0129; Team RStudio, 2019, RSTUDIO INT DEV R; Tuovinen JP, 2019, BIOGEOSCIENCES, V16, P255, DOI 10.5194/bg-16-255-2019; Valach AC., WETLAND CARBON ENV M; Villa JA, 2018, ECOL ENG, V114, P115, DOI 10.1016/j.ecoleng.2017.06.037; Wickham H., 2019, DPLYR GRAMMAR DATA M, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Windham-Myers L., 2019, BLUE CARBON PRIMER, DOI [10.1002/etc.4535, DOI 10.1002/ETC.4535]; Windham-Myers L, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaae74	118	15	15	8	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248398	10.1371/journal.pone.0248398	http://dx.doi.org/10.1371/journal.pone.0248398			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765085	Green Published, gold			2022-12-26	WOS:000634832800002
J	Watanabe, K; Nakayama, M; Yamamoto, T; Yamada, G; Sato, H; Miyazaki, M; Ito, S				Watanabe, Kimio; Nakayama, Masaaki; Yamamoto, Tae; Yamada, Gen; Sato, Hiroshi; Miyazaki, Mariko; Ito, Sadayoshi			Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study	PLOS ONE			English	Article								Background Hyperuricemia is highly prevalent in chronic kidney disease (CKD) patients, but the evidence for a relationship between uric acid (UA) and clinical outcomes in CKD patients is limited and inconsistent. We hypothesized that UA has a different impact on clinical outcomes according to the underlying disease causing CKD. Methods This study prospectively investigated the associations between UA and renal and non-renal outcomes according to the underlying disease causing CKD in 2,797 Japanese patients under the care of nephrologists. The patients were categorized into four groups: primary renal disease (n = 1306), hypertensive nephropathy (n = 467), diabetic nephropathy (n = 275), and other nephropathy (n = 749). The renal outcome was defined as end-stage renal disease (ESRD), and the non-renal outcome was defined as a composite endpoint of cardiovascular events (CVEs) and all-cause mortality. Results During a median 4.8-year follow-up, 359 (12.8%) patients reached the renal outcome, and 260 (9.3%) reached the non-renal outcome. In the all-patient analysis, hyperuricemia was not associated with the risks for renal and non-renal outcomes, but in primary renal disease (PRD) and hypertensive renal disease (HTN) patients, hyperuricemia was significantly associated with non-renal outcomes. Per 1 mg/dl higher UA level, multivariable adjusted hazard ratio was 1.248 (95% CI: 1.003 to 1.553) for PRD, and 1.250 (1.035 to 1.510) for HTN. Allopurinol did not reduce the risks for renal and non-renal outcomes, both in all patients and in the subgroup analysis. Conclusions The effect of hyperuricemia on clinical outcomes in CKD patients varies according to the underlying disease causing CKD. Hyperuricemia is an independent risk factor for non-renal outcomes in primary renal disease and hypertensive renal disease patients. Allopurinol did not decrease the risks for renal and non-renal outcomes.	[Watanabe, Kimio; Nakayama, Masaaki] St Lukes Int Hosp, Div Kidney Ctr, Tokyo, Japan; [Nakayama, Masaaki] Tohoku Univ Hosp, Res Div Chron Kidney Dis & Dialysis Treatment, Sendai, Miyagi, Japan; [Yamamoto, Tae] Sendai City Hosp, Div Kidney Ctr, Sendai, Miyagi, Japan; [Yamada, Gen] Osaki Citizen Hosp, Div Nephrol & Endocrinol, Osaki, Japan; [Sato, Hiroshi] JR Sendai Hosp, Div Internal Med, Sendai, Miyagi, Japan; [Miyazaki, Mariko] Tohoku Univ Hosp, Div Blood Purificat, Sendai, Miyagi, Japan; [Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ, Div Nephrol Hypertens & Endocrinol, Sendai, Miyagi, Japan; [Ito, Sadayoshi] Katta Gen Publ Hosp, Shiroishi, Japan	St. Luke's International Hospital; Tohoku University; Tohoku University; Tohoku University	Watanabe, K (corresponding author), St Lukes Int Hosp, Div Kidney Ctr, Tokyo, Japan.	spyh63x9@gmail.com		Watanabe, Kimio/0000-0002-8773-0967				Badve SV, 2020, NEW ENGL J MED, V382, P2504, DOI 10.1056/NEJMoa1915833; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Doria A, 2020, NEW ENGL J MED, V382, P2493, DOI 10.1056/NEJMoa1916624; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Fleeman N, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18400; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Iseki K, 2013, HYPERTENS RES, V36, P650, DOI 10.1038/hr.2013.11; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Jing JJ, 2015, NEPHROL DIAL TRANSPL, V30, P613, DOI 10.1093/ndt/gfu352; Johnson RJ, 2018, AM J KIDNEY DIS, V71, P851, DOI 10.1053/j.ajkd.2017.12.009; Kimura K, 2018, AM J KIDNEY DIS, V72, P798, DOI 10.1053/j.ajkd.2018.06.028; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liu WC, 2012, CLIN J AM SOC NEPHRO, V7, P541, DOI 10.2215/CJN.09420911; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Meier-Kriesche HU, 2009, CLIN J AM SOC NEPHRO, V4, P1655, DOI 10.2215/CJN.02700409; Nacak H, 2015, NEPHROL DIAL TRANSPL, V30, P2039, DOI 10.1093/ndt/gfv225; Nakagawa T, 2020, J AM SOC NEPHROL, V31, P898, DOI 10.1681/ASN.2019101015; Ohno I, 2001, NEPHRON, V87, P333, DOI 10.1159/000045939; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Terawaki H, 2013, CLIN EXP NEPHROL, V17, P549, DOI 10.1007/s10157-012-0742-z	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249240	10.1371/journal.pone.0249240	http://dx.doi.org/10.1371/journal.pone.0249240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765101	Green Published, gold			2022-12-26	WOS:000634832800020
J	Fujimaki, T; Wako, M; Koyama, K; Furuya, N; Shinohara, R; Otawa, S; Kobayashi, A; Horiuchi, S; Kushima, M; Yamagata, Z; Haro, H				Fujimaki, Taro; Wako, Masanori; Koyama, Kensuke; Furuya, Naoto; Shinohara, Ryoji; Otawa, Sanae; Kobayashi, Anna; Horiuchi, Sayaka; Kushima, Megumi; Yamagata, Zentaro; Haro, Hirotaka		Japan Environm Children's Study Gr	Prevalence of floating toe and its relationship with static postural stability in children: The Yamanashi adjunct study of the Japan Environment and Children's Study (JECS-Y)	PLOS ONE			English	Article								Floating toe (FT) is a frequently seen condition in which a toe is inadequately in contact with the ground. Although toes play an important role in stabilizing standing posture and walking, many aspects of the effects of FT on the body remain unclear. To our knowledge, there have been no reports about the relationship between FT and postural stability, especially in children. This study aimed to clarify the prevalence of FT and its relationship with static postural stability in children. Of the 400 children aged 8 years who participated in our cohort study, 396, who were examined for static postural stability, were included in this study. Postural stability and FT were assessed using a foot pressure plate. The sway path length of the center of pressure and the area of the ellipse defined as the size of the area marked by the center of pressure, were measured as an evaluation of static postural stability. We calculated the "floating toe score (FT score: small FT score indicates insufficient ground contact of the toes)" using the image of the plantar footprint obtained at the postural stability measurement. The rate of FT was elevated at more than 90%, and the FT score in the eyes-closed condition was significantly higher than that in the eyes-open condition in both sexes. The FT score significantly correlated with the center of pressure path and area. Our results suggest that ground contact of the toes is not directly related to static postural stability in children, but it may function to stabilize the body when the condition becomes unstable, such as when the eyes are closed.	[Fujimaki, Taro; Wako, Masanori; Koyama, Kensuke; Furuya, Naoto; Haro, Hirotaka] Univ Yamanashi, Fac Med, Dept Orthopaed Surg, Chuo, Yamanashi, Japan; [Shinohara, Ryoji; Otawa, Sanae; Kobayashi, Anna; Horiuchi, Sayaka; Kushima, Megumi; Yamagata, Zentaro] Univ Yamanashi, Ctr Birth Cohort Studies, Interdisciplinary Grad Sch Med, Chuo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Wako, M (corresponding author), Univ Yamanashi, Fac Med, Dept Orthopaed Surg, Chuo, Yamanashi, Japan.	wako@yamanashi.ac.jp	Wako, Masanori/ABS-9520-2022					Angin S, 2013, EKLEM HAST CERRAHISI, V24, P144, DOI 10.5606/ehc.2013.32; Araki T, 2015, J PHYS THER SCI, V27, P3158, DOI 10.1589/jpts.27.3159; de Sa CDC, 2018, BRAZ J PHYS THER, V22, P70, DOI 10.1016/j.bjpt.2017.10.006; Chou SW, 2009, J ORTHOP RES, V27, P549, DOI 10.1002/jor.20661; Cote KP, 2005, J ATHL TRAINING, V40, P41; Fukuyama K, 2011, J PHYS THER SCI, V23, P33, DOI 10.1589/jpts.23.33; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Hofstaetter SG, 2005, J BONE JOINT SURG BR, V87B, P1507, DOI 10.1302/0301-620X.87B11.16590; HUGHES J, 1990, J BONE JOINT SURG BR, V72, P245, DOI 10.1302/0301-620X.72B2.2312564; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Lambrinudi C, 1932, Postgrad Med J, V8, P459; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Migues A, 2004, FOOT ANKLE INT, V25, P609, DOI 10.1177/107110070402500902; Perez HR, 2008, J FOOT ANKLE SURG, V47, P520, DOI 10.1053/j.jfas.2008.08.005; Plandowska M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227119; Saito Ryuta, 2019, J Phys Ther Sci, V31, P344, DOI 10.1589/jpts.31.344; Smith AW, 2012, J HUM KINET, V33, P25, DOI 10.2478/v10078-012-0041-5; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Tasaka Seishiro, 2016, J Phys Ther Sci, V28, P2322, DOI 10.1589/jpts.28.2322; Trnka HJ, 2001, FOOT ANKLE INT, V22, P47, DOI 10.1177/107110070102200107	20	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0246010	10.1371/journal.pone.0246010	http://dx.doi.org/10.1371/journal.pone.0246010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760833	gold, Green Published, Green Submitted			2022-12-26	WOS:000633030400006
J	Li, XW; Xu, ST; Neupane, A; Abdoulmoumine, N; DeBruyn, JM; Walker, FR; Jagadamma, S				Li, Xiuwen; Xu, Sutie; Neupane, Avishesh; Abdoulmoumine, Nourredine; DeBruyn, Jennifer M.; Walker, Forbes R.; Jagadamma, Sindhu			Co-application of biochar and nitrogen fertilizer reduced nitrogen losses from soil	PLOS ONE			English	Article							NET N MINERALIZATION; N2O EMISSIONS; AMMONIA MONOOXYGENASE; UREA; NITRIFICATION; ARCHAEA; TEMPERATURE; ADSORPTION; HYDROLYSIS; GRASSLAND	Combined application of biochar and nitrogen (N) fertilizer has the potential to reduce N losses from soil. However, the effectiveness of biochar amendment on N management can vary with biochar types with different physical and chemical properties. This study aimed to assess the effect of two types of hardwood biochar with different ash contents and cation exchange capacity (CEC) on soil N mineralization and nitrous oxide (N2O) production when applied alone and in combination with N fertilizer. Soil samples collected from a temperate pasture system were amended with two types of biochar (B1 and B2), urea, and urea plus biochar, and incubated for 60 days along with soil control (without biochar or urea addition). Soil nitrate N, ammonium N, ammonia-oxidizing bacteria amoA gene transcripts, and N2O production were measured during the experiment. Compared to control, addition of B1 (higher CEC and lower ash content) alone decreased nitrate N concentration by 21% to 45% during the incubation period while the addition of B2 (lower CEC and higher ash content) alone increased the nitrate N concentration during the first 10 days. Biochar B1 also reduced the abundance of amoA transcripts by 71% after 60 days. Compared to B1 + urea, B2 + urea resulted in a significantly greater initial increase in soil ammonium and nitrate N concentrations. However, B2 + urea had a significantly lower 60-day cumulative N2O emission compared to B1 + urea. Overall, when applied with urea, the biochar with higher CEC reduced ammonification and nitrification rates, while biochar with higher ash content reduced N N2O production. Our study demonstrated that biochar has the potential to enhance N retention in soil and reduce N2O emission when it is applied with urea, but the specific effects of the added biochar depend on its physical and chemical properties.	[Li, Xiuwen; Xu, Sutie; Neupane, Avishesh; Abdoulmoumine, Nourredine; DeBruyn, Jennifer M.; Walker, Forbes R.; Jagadamma, Sindhu] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Jagadamma, S (corresponding author), Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA.	sjagada1@utk.edu	Jagadamma, Sindhu/F-7168-2012; DeBruyn, Jennifer/A-8813-2010	Jagadamma, Sindhu/0000-0003-4831-3308; DeBruyn, Jennifer/0000-0002-2993-4144; Neupane, Avishesh/0000-0003-4401-2161; Walker, Forbes/0000-0003-2715-3990	USDA [TEN00509]; Maxwell/Jean Springer Assistantship fund	USDA(United States Department of Agriculture (USDA)); Maxwell/Jean Springer Assistantship fund	I, Sindhu Jagadamma, on behalf of all the authors, declare the following financial support for conducting this study. 1. USDA Hatch Grant TEN00509, funded the salary of Dr. Sindhu Jagadamma 2. Maxwell/Jean Springer Assistantship funded the tuition and stipend of Ms. Xiuwen Li.	Adelman IR, 2009, ENVIRON TOXICOL CHEM, V28, P2216, DOI 10.1897/08-619.1; [Anonymous], 2013, INDIAN J SCI TECHNOL; ANTHONISEN AC, 1976, J WATER POLLUT CON F, V48, P835; ASTM, 2007, STANDARD TEST METHOD; Baiga R, 2017, SOIL USE MANAGE, V33, P54, DOI 10.1111/sum.12328; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Cao H, 2019, APPL SOIL ECOL, V135, P25, DOI 10.1016/j.apsoil.2018.11.002; Clough TJ, 2013, AGRONOMY-BASEL, V3, P275, DOI 10.3390/agronomy3020275; Daebeler A, 2014, ISME J, V8, P2397, DOI 10.1038/ismej.2014.81; Denecke M, 2003, BIOPROC BIOSYST ENG, V25, P249, DOI 10.1007/s00449-002-0303-z; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Egan G, 2018, SOIL BIOL BIOCHEM, V118, P97, DOI 10.1016/j.soilbio.2017.12.005; Fiorentino N, 2019, SOIL BIOL BIOCHEM, V131, P166, DOI 10.1016/j.soilbio.2019.01.005; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; Grutzmacher P, 2018, SCI TOTAL ENVIRON, V625, P1459, DOI 10.1016/j.scitotenv.2017.12.196; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Harter J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39574; Harter J, 2014, ISME J, V8, P660, DOI 10.1038/ismej.2013.160; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P10641, DOI 10.1021/es302971d; Hommes NG, 1998, J BACTERIOL, V180, P3353, DOI 10.1128/JB.180.13.3353-3359.1998; Hu XL, 2018, ENVIRON SCI POLLUT R, V25, P19932, DOI 10.1007/s11356-018-2198-5; IFA, 2019, SHORT TERM FERT OUTL; Kumar Umesh, 2007, Archives of Agronomy and Soil Science, V53, P173, DOI 10.1080/03650340601138818; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu ZQ, 2017, BIORESOURCES, V12, P6024, DOI 10.15376/biores.12.3.6024-6039; Lu L, 2012, ISME J, V6, P1978, DOI 10.1038/ismej.2012.45; Luo XX, 2016, GEODERMA, V282, P120, DOI 10.1016/j.geoderma.2016.07.015; Mandal S, 2016, CHEMOSPHERE, V142, P120, DOI 10.1016/j.chemosphere.2015.04.086; Martin SL, 2015, BIOMASS BIOENERG, V79, P39, DOI 10.1016/j.biombioe.2015.04.030; Maynard DG, 1993, SOIL SAMPLING METHOD, P25; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mukherjee A, 2014, SOLID EARTH, V5, P693, DOI 10.5194/se-5-693-2014; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Mukome FND, 2013, J AGR FOOD CHEM, V61, P2196, DOI 10.1021/jf3049142; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; NOAA, 2019, CLIM GLANC COUNT MAP; Obia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138781; Ouyang Y, 2017, SOIL BIOL BIOCHEM, V113, P161, DOI 10.1016/j.soilbio.2017.06.010; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Quin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16773; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Romano N, 2007, AQUACULTURE, V266, P246, DOI 10.1016/j.aquaculture.2007.01.035; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Saha BK, 2017, SCI TOTAL ENVIRON, V601, P1496, DOI 10.1016/j.scitotenv.2017.05.270; Savoy HJ., 2007, SO REGION COOPERATIV, V190D; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; Staley C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00634; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Tambone F, 2017, J PLANT NUTR SOIL SC, V180, P355, DOI 10.1002/jpln.201600241; The Fertilizer Institute, 2017, WHAT AR 4RS; Nguyen TTN, 2017, GEODERMA, V288, P79, DOI 10.1016/j.geoderma.2016.11.004; Thomazini A, 2015, AGR ECOSYST ENVIRON, V207, P183, DOI 10.1016/j.agee.2015.04.012; Timilsena YP, 2015, J SCI FOOD AGR, V95, P1131, DOI 10.1002/jsfa.6812; Tong DL, 2012, J ENVIRON SCI, V24, P682, DOI 10.1016/S1001-0742(11)60832-2; Wang B, 2015, CHEMOSPHERE, V138, P120, DOI 10.1016/j.chemosphere.2015.05.062; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Wang ZY, 2017, EUR J SOIL SCI, V68, P559, DOI 10.1111/ejss.12436; Yang F, 2015, ENVIRON SCI POLLUT R, V22, P9184, DOI 10.1007/s11356-014-4067-1; Zhang J, 2015, BIORESOURCE TECHNOL, V176, P288, DOI 10.1016/j.biortech.2014.11.011; Zhao HH, 2018, WATER SCI TECHNOL, V77, P548, DOI 10.2166/wst.2017.568	65	3	3	10	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248100	10.1371/journal.pone.0248100	http://dx.doi.org/10.1371/journal.pone.0248100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760843	Green Published, gold			2022-12-26	WOS:000633030400067
J	Neelon, B; Mutiso, F; Mueller, NT; Pearce, JL; Benjamin-Neelon, SE				Neelon, Brian; Mutiso, Fedelis; Mueller, Noel T.; Pearce, John L.; Benjamin-Neelon, Sara E.			Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States	PLOS ONE			English	Article							POPULATIONS; DISPARITIES	Background Socially vulnerable communities may be at higher risk for COVID-19 outbreaks in the US. However, no prior studies examined temporal trends and differential effects of social vulnerability on COVID-19 incidence and death rates. Therefore, we examined temporal trends among counties with high and low social vulnerability to quantify disparities in trends over time. Methods We conducted a longitudinal analysis examining COVID-19 incidence and death rates from March 15 to December 31, 2020, for each US county using data from USAFacts. We classified counties using the Social Vulnerability Index (SVI), a percentile-based measure from the Centers for Disease Control and Prevention, with higher values indicating more vulnerability. Using a Bayesian hierarchical negative binomial model, we estimated daily risk ratios (RRs) comparing counties in the first (lower) and fourth (upper) SVI quartiles, adjusting for rurality, percentage in poor or fair health, percentage female, percentage of smokers, county average daily fine particulate matter (PM2.5), percentage of primary care physicians per 100,000 residents, daily temperature and precipitation, and proportion tested for COVID-19. Results At the outset of the pandemic, the most vulnerable counties had, on average, fewer cases per 100,000 than least vulnerable SVI quartile. However, on March 28, we observed a crossover effect in which the most vulnerable counties experienced higher COVID-19 incidence rates compared to the least vulnerable counties (RR = 1.05, 95% PI: 0.98, 1.12). Vulnerable counties had higher death rates starting on May 21 (RR = 1.08, 95% PI: 1.00,1.16). However, by October, this trend reversed and the most vulnerable counties had lower death rates compared to least vulnerable counties. Conclusions The impact of COVID-19 is not static but can migrate from less vulnerable counties to more vulnerable counties and back again over time.	[Neelon, Brian; Mutiso, Fedelis] Med Univ South Carolina, Dept Publ Hlth Sci, Div Biostat, Charleston, SC 29425 USA; [Neelon, Brian] Ralph H Johnson VA Med Ctr, Charleston Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA; [Mueller, Noel T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mueller, Noel T.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Pearce, John L.] Med Univ South Carolina, Dept Publ Hlth Sci, Div Environm Hlth, Charleston, SC 29425 USA; [Benjamin-Neelon, Sara E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Medical University of South Carolina; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Neelon, B (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Div Biostat, Charleston, SC 29425 USA.; Neelon, B (corresponding author), Ralph H Johnson VA Med Ctr, Charleston Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA.	neelon@musc.edu			National Heart, Lung, And Blood Institute of the National Institutes of Health [K01HL141589]	National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Mueller was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K01HL141589 (PI: Mueller). Dr. Neelon is a parttime employee of the Department of Veterans Affairs. The content of this article does not represent the views of the Department of Veterans Affairs or the U.S. government. The article represents the views of the authors and not those of the VA or Health Services Research and Development.	[Anonymous], 2018, TECHNOLOGY NIOSA; [Anonymous], 2020, CDC COVID DATA TRACK; Bibbins-Domingo K, 2020, ANN INTERN MED, V173, P233, DOI 10.7326/M20-2247; Bureau USC, 2019, NAT POP TOT COMP CHA; Centers for Disease Control and Prevention, 2019, COUNT POP EST, DOI [10-2019/counties/asrh/, DOI 10-2019/COUNTIES/ASRH]; Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry/ Geospatial Research A and Services Program, SOCIAL VULNERABILITY; Changeux JP, 2020, CR BIOL, V343, P33, DOI 10.5802/crbiol.8; Chiu Weihsueh A, 2020, Res Sq, DOI 10.21203/rs.3.rs-40364/v1; Dadaneh SZ, 2018, BIOINFORMATICS, V34, P3349, DOI 10.1093/bioinformatics/bty330; Davidson PM, 2020, J CLIN NURS, V29, P2758, DOI 10.1111/jocn.15297; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Edwards JK, 2021, AM J EPIDEMIOL, V190, P17, DOI 10.1093/aje/kwaa159; Fallon A, 2020, QJM-INT J MED, V113, P391, DOI 10.1093/qjmed/hcaa136; Farsalinos K, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320935765; Flanagan BE, 2018, J ENVIRON HEALTH, V80, P34; Gil RM, 2020, J INFECT DIS, V222, P1592, DOI 10.1093/infdis/jiaa474; Grundy EJ, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/124788; Guest JL, 2020, JMIR PUBLIC HLTH SUR, V6, P4, DOI 10.2196/19043; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Information NCfE, 2020, NAT OC ATM ADM; Johns Hopkins University CfSSaE, 2020, FAQ COVID 19 US CAS; Johns Hopkins University CfSSaE, 2020, COVID 19 CAS COUNTS; Jonathan WP., 2012, FULLY BAYESIAN INFER, P1898; Karaye IM, 2020, AM J PREV MED, V59, P317, DOI 10.1016/j.amepre.2020.06.006; Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297; Khazanchi R, 2020, J GEN INTERN MED, V35, P2784, DOI 10.1007/s11606-020-05882-3; Kim SJ, 2020, HEALTH EDUC BEHAV, V47, P509, DOI 10.1177/1090198120929677; Kinner SA, 2020, LANCET PUBLIC HEALTH, V5, pE188, DOI 10.1016/S2468-2667(20)30058-X; Kneib T, 2011, J R STAT SOC C-APPL, V60, P51, DOI 10.1111/j.1467-9876.2010.00723.x; Ku BS, 2020, J GEN INTERN MED, V35, P3404, DOI 10.1007/s11606-020-06130-4; Kuy S, 2020, ACAD MED, V95, pE2, DOI 10.1097/ACM.0000000000003571; Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0; Lieberman-Cribbin W, 2020, AM J PREV MED, V59, P326, DOI 10.1016/j.amepre.2020.06.005; Lithander FE, 2020, AGE AGEING, V49, P501, DOI 10.1093/ageing/afaa093; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Nayak Aditi, 2020, medRxiv, DOI 10.1101/2020.04.10.20060962; Ndugga N., 2021, EARLY STATE VACCINAT; Neelon B, 2019, BAYESIAN ANAL, V14, P829, DOI [10.1214/18-ba1132, 10.1214/18-BA1132]; Neelon B, 2017, BIOMETRICS, V73, P185, DOI 10.1111/biom.12558; Neelon B, 2016, STAT METHODS MED RES, V25, P2558, DOI 10.1177/0962280214527079; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Robert Wood Johnson Foundation, 2020, COUNT HLTH RANK COUN; Rodriguez-Diaz CE, 2020, ANN EPIDEMIOL, V52, P46, DOI 10.1016/j.annepidem.2020.07.007; Rodriguez-Lonebear D, 2020, J PUBLIC HEALTH MAN, V26, P371, DOI 10.1097/PHH.0000000000001206; Salisbury-Afshar EM, 2020, AM J PREV MED, V58, P892, DOI 10.1016/j.amepre.2020.04.002; Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215; Survey USG, 2020, MAPP REM SENS GEOSP; Thakur N, 2020, AM J RESP CRIT CARE, V202, P943, DOI 10.1164/rccm.202005-1523PP; Thebault RBT A., 2020, WASH POST; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; United States Census Bureau, 2019, STAT POP TOT 2010 20; USA Facts, 2020, US COR CAS DEATHS; Wang CY, 2022, INT J ENVIRON HEAL R, V32, P1147, DOI 10.1080/09603123.2020.1847258; Wu Xiao, 2020, medRxiv, DOI 10.1101/2020.04.05.20054502; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	56	22	22	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248702	10.1371/journal.pone.0248702	http://dx.doi.org/10.1371/journal.pone.0248702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760849	gold, Green Submitted, Green Published			2022-12-26	WOS:000633030400058
J	Galatas, B; Nhantumbo, H; Soares, R; Djive, H; Murato, I; Simone, W; Macete, E; Rabinovich, NR; Alonso, P; Candrinho, B; Saute, F; Aide, P; Munguambe, K				Galatas, Beatriz; Nhantumbo, Hoticha; Soares, Rodolfo; Djive, Helder; Murato, Ilda; Simone, Wilson; Macete, Eusebio; Rabinovich, N. Regina; Alonso, Pedro; Candrinho, Baltazar; Saute, Francisco; Aide, Pedro; Munguambe, Khatia			Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: A mixed methods study	PLOS ONE			English	Article							MALARIA ELIMINATION; PERCEPTIONS	Background This study aimed to capture the acceptability prior to, during and after the implementation of the first year of MDA rounds conducted under the Magude project, a malaria elimination project in southern Mozambique. Methods This was a mixed-methods study, consisting of focus group discussions (FGDs) prior to the implementation of MDA rounds (September 2015), non-participant observations (NPOs) conducted during the MDA rounds (November 2015 -beginning of February 2016), and semi-structured interviews (SSIs) after the second round (end of February 2016). Community leaders, women in reproductive age, general members of the community, traditional healers and health professionals were recruited to capture the opinions of all representing key members of the community. A generic outline of nodes and codes was designed to analyze FGDs and SSI separately. Qualitative and quantitative NPO information was analyzed following a content analysis approach. Findings 222 participants took part in the FGDs (n = 154), and SSIs (n = 68); and 318 household visits during the MDA underwent NPOs. The community engagement campaign emerged throughout the study stages as a crucial factor for the acceptability of MDAs. Acceptability was also fostered by the community's general will to cooperate in any government-led activity that would reduce malaria burden, the appropriate behavior and knowledge of field workers, or the fact that the intervention was available free of charge to all. Absenteeism of heads of households was identified as the main barrier for the success of the campaign. The most commonly reported factors that negatively affected acceptability were the fear of adverse events, rumors of deaths, being unable to drink alcohol while taking DHAp, or the fear to take DHAp while in anti-retroviral treatment. Pregnancy testing and malaria testing were generally well accepted by the community. Conclusion Magude's community generally accepted the first and second antimalarial MDA rounds, and the procedures associated to the intervention. Future implementation of antimalarial MDAs in southern Mozambique should focus on locally adapted strategies that engage the community to minimize absenteeism and refusals to the intervention.	[Galatas, Beatriz; Nhantumbo, Hoticha; Djive, Helder; Murato, Ilda; Simone, Wilson; Macete, Eusebio; Alonso, Pedro; Saute, Francisco; Aide, Pedro; Munguambe, Khatia] Ctr Invest Saude Manhica, Maputo, Mozambique; [Galatas, Beatriz; Rabinovich, N. Regina; Alonso, Pedro] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain; [Soares, Rodolfo] Ctr Int Studies CEI IUL, Lisbon, Portugal; [Macete, Eusebio] Minist Hlth, Natl Directorate Hlth, Maputo, Mozambique; [Rabinovich, N. Regina] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Candrinho, Baltazar] Minist Hlth, Natl Malaria Control Programme NMCP, Maputo, Mozambique; [Aide, Pedro] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Munguambe, Khatia] Univ Eduardo Mondlane UEM, Fac Med, Maputo, Mozambique	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Harvard University; Harvard T.H. Chan School of Public Health; Eduardo Mondlane University	Galatas, B (corresponding author), Ctr Invest Saude Manhica, Maputo, Mozambique.; Galatas, B (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.	beatriz.galatas@isglobal.org	Galatas, Beatriz/AAP-4362-2020		Bill and Melinda Gates Foundation; Obra Social "la Caixa" Partnership for the Elimination of Malaria in Southern Mozambique [OPP1115265]; community of the District of Magude; Government of Mozambique; Spanish Agency for International Development Cooperation (AECID)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Obra Social "la Caixa" Partnership for the Elimination of Malaria in Southern Mozambique; community of the District of Magude; Government of Mozambique; Spanish Agency for International Development Cooperation (AECID)(Spanish Government)	Funding was provided by the Bill and Melinda Gates Foundation and Obra Social "la Caixa" Partnership for the Elimination of Malaria in Southern Mozambique (OPP1115265).; The authors would like to thank the community of the District of Magude for participating in this study, and all those who have supported in the implementation of this study directly or indirectly. We would also like to acknowledge the Administrative and District Health Authorities of Magude and the National Malaria Control Program for their collaboration in the implementation of the Magude Project. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development Cooperation (AECID).	Aide P, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2832-9; Arroz JAH, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051006360, 10.1590/S1518-8787.2017051006360]; Daniels RF, 2020, AM J TROP MED HYG, V103, P66, DOI 10.4269/ajtmh.19-0666; De Martin S, 2001, TROP MED INT HEALTH, V6, P442, DOI 10.1046/j.1365-3156.2001.00723.x; Deng CS, 2018, CLIN INFECT DIS, V67, P1670, DOI 10.1093/cid/ciy364; Eisele TP, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2906-8; Galatas B, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003227; Galatas B, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033985; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Guise A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3185-7; Jaiteh F, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2672-7; Kajeechiwa L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1528-7; Kisoka WJ, 2016, J BIOSOC SCI, V48, P94, DOI 10.1017/S0021932015000024; Magaia T., 2012, ACTA HORTIC, V223; National Malaria Control Program (NMCP) Ministerio da Saude (MISAU), 2017, PLANO ESTRAT GICO MA; Ndima SD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0063-x; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Njomo DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083413; Pell C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1854-4; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Portugaliza HP, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2867-y; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Nguyen TN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1662-2; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Wanzira H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2624-7; WHO, 2017, MASS DRUG ADM FALC M; World Health Organization, 2015, GLOBAL MALARIA PROGR	29	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249080	10.1371/journal.pone.0249080	http://dx.doi.org/10.1371/journal.pone.0249080			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755685	gold, Green Published			2022-12-26	WOS:000632916600013
J	Muwawa, EM; Obieze, CC; Makonde, HM; Jefwa, JM; Kahindi, JHP; Khasa, DP				Muwawa, Edith M.; Obieze, Chinedu C.; Makonde, Huxley M.; Jefwa, Joyce M.; Kahindi, James H. P.; Khasa, Damase P.			16S rRNA gene amplicon-based metagenomic analysis of bacterial communities in the rhizospheres of selected mangrove species from Mida Creek and Gazi Bay, Kenya	PLOS ONE			English	Article							SP-NOV.; MICROBIAL COMMUNITY; EMENDED DESCRIPTION; DIVERSITY; SEDIMENT; NITROGEN; SOIL; FOREST; VEGETATION; RESOLUTION	Prokaryotic communities play key roles in biogeochemical transformation and cycling of nutrients in the productive mangrove ecosystem. In this study, the vertical distribution of rhizosphere bacteria was evaluated by profiling the bacterial diversity and community structure in the rhizospheres of four mangrove species (Sonneratia alba, Rhizophora mucronata, Ceriops tagal and Avicennia marina) from Mida Creek and Gazi Bay, Kenya, using DNA-metabarcoding. Alpha diversity was not significantly different between sites, but, significantly higher in the rhizospheres of S. alba and R. mucronata in Gazi Bay than in Mida Creek. Chemical parameters of the mangrove sediments significantly correlated inversely with alpha diversity metrics. The bacterial community structure was significantly differentiated by geographical location, mangrove species and sampling depth, however, differences in mangrove species and sediment chemical parameters explained more the variation in bacterial community structure. Proteobacteria (mainly Deltaproteobacteria and Gammaproteobacteria) was the dominant phylum while the families Desulfobacteraceae, Pirellulaceae and Syntrophobacteraceae were dominant in both study sites and across all mangrove species. Constrained redundancy analysis indicated that calcium, potassium, magnesium, electrical conductivity, pH, nitrogen, sodium, carbon and salinity contributed significantly to the species-environment relationship. Predicted functional profiling using PICRUSt2 revealed that pathways for sulfur and carbon metabolism were significantly enriched in Gazi Bay than Mida Creek. Overall, the results indicate that bacterial community composition and their potential function are influenced by mangrove species and a fluctuating influx of nutrients in the mangrove ecosystems of Gazi Bay and Mida Creek.	[Muwawa, Edith M.; Jefwa, Joyce M.; Kahindi, James H. P.] Pwani Univ, Dept Biol Sci, Kilifi, Kenya; [Muwawa, Edith M.; Khasa, Damase P.] Laval Univ, Ctr Forest Res, Quebec City, PQ, Canada; [Muwawa, Edith M.; Khasa, Damase P.] Laval Univ, Inst Syst & Integrat Biol, Quebec City, PQ, Canada; [Obieze, Chinedu C.] Univ Port Harcourt, Africa Ctr Excellence Oilfield Chem Res, Choba, Nigeria; [Makonde, Huxley M.] Tech Univ Mombasa, Dept Pure & Appl Sci, Mombasa, Kenya; [Jefwa, Joyce M.] Natl Museums Kenya, Nairobi, Kenya	Pwani University; Laval University; Laval University; University of Port Harcourt; Technical University of Mombasa	Muwawa, EM (corresponding author), Pwani Univ, Dept Biol Sci, Kilifi, Kenya.; Muwawa, EM (corresponding author), Laval Univ, Ctr Forest Res, Quebec City, PQ, Canada.; Muwawa, EM (corresponding author), Laval Univ, Inst Syst & Integrat Biol, Quebec City, PQ, Canada.	edithmuwawa@yahoo.com	Obieze, Chinedu/GPX-2790-2022	Muwawa, Edith/0000-0002-2404-3764; Obieze, Chinedu/0000-0002-1381-0948	Queen Elizabeth II Jubilee Scholarship; NSERC; International Foundation for Science [A/5719-1]; Centre for Forest Research and Institute for Systems and Integrative Biology of Laval University, Canada; Pwani University	Queen Elizabeth II Jubilee Scholarship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); International Foundation for Science(International Foundation for Science); Centre for Forest Research and Institute for Systems and Integrative Biology of Laval University, Canada; Pwani University	This research was funded by the Queen Elizabeth II Jubilee Scholarship to EMM and NSERC discovery grant to DPK and the International Foundation for Science (Ref No.: IFS Grant A/5719-1) to HMM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The NACOSTI, NEMA, KWS and KEPHIS are acknowledged for approving the research study and providing permits that facilitated field studies and shipment of samples to Canada. We also acknowledge the Centre for Forest Research and Institute for Systems and Integrative Biology of Laval University, Canada and Pwani University for support during the project.	Alemayehu F., 2014, OPEN J FOR, V04, P398, DOI [http://dx.doi.org/10.4236/ojf.2014.44045, DOI 10.4236/OJF.2014.44045]; Alfaro-Espinoza G, 2014, INT J SYST EVOL MICR, V64, P3988, DOI 10.1099/ijs.0.067462-0; Alvarenga DO, 2015, BIODIVERS CONSERV, V24, P799, DOI 10.1007/s10531-015-0871-2; Alzubaidy H, 2016, GENE, V576, P626, DOI 10.1016/j.gene.2015.10.032; AMACHER MC, 1986, COMMUN SOIL SCI PLAN, V17, P1019, DOI 10.1080/00103628609367771; Andersen KS., 2018, AMPVIS2 AN R PACKAGE; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Azman AS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00856; Baker BJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0077-6; Barbera P, 2019, SYST BIOL, V68, P365, DOI 10.1093/sysbio/syy054; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Czech L., 2019, GENESIS GAPPA LIB TO; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; de Mendiburu F., 2020, R PACKAGE VERSION, DOI DOI 10.1890/08-1823.1; Dekas AE, 2014, ENVIRON MICROBIOL, V16, P3012, DOI 10.1111/1462-2920.12247; Dhal PK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221543; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Geldenhuys C, 2016, S AFR J BOT, V107, P137, DOI 10.1016/j.sajb.2016.04.013; Ghosh A, 2018, ENVIRON SCI POLLUT R, V25, P5722, DOI 10.1007/s11356-017-0852-y; Gomes NCM, 2014, ESTUAR COAST SHELF S, V139, P40, DOI 10.1016/j.ecss.2013.12.022; Gwada P, 2001, S AFR J BOT, V67, P443, DOI 10.1016/S0254-6299(15)31162-5; Hoffmann L, 1999, EUR J PHYCOL, V34, P371; Imchen M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09254-6; Inagaki F, 2003, INT J SYST EVOL MICR, V53, P1801, DOI 10.1099/ijs.0.02682-0; Jacoby R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01617; Jayadev A, 2015, ACTIVITY SCREENING M, V3, P202; Jenoh EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154849; KALRA YP, 1995, J AOAC INT, V78, P310; Khramenkov SV, 2013, MICROBIOLOGY+, V82, P628, DOI 10.1134/S002626171305007X; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kruger C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00719; Lang'at JKS., 2008, VARIABILITY MANGROVE; Lin XL, 2019, MICROB ECOL, V78, P57, DOI 10.1007/s00248-018-1261-6; Liu M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44788-x; Louca S, 2018, BIOINFORMATICS, V34, P1053, DOI 10.1093/bioinformatics/btx701; Matthijs S., 1999, Mangroves and Salt Marshes, V3, P243, DOI 10.1023/A:1009971023277; Mendes LW, 2018, ANTON LEEUW INT J G, V111, P101, DOI 10.1007/s10482-017-0931-6; Mohamed MOS, 2009, WETL ECOL MANAG, V17, P243, DOI 10.1007/s11273-008-9104-8; Nathan VK, 2020, REG STUD MAR SCI, V35, DOI 10.1016/j.rsma.2020.101184; Nonoh J, 2018, OPEN MICROBIOLOGY J, V12, P354; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Owuor MA, 2019, OCEAN COAST MANAGE, V175, P172, DOI 10.1016/j.ocecoaman.2019.03.027; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Purahong W, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120585; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rampadarath S, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2442-7; Rath KM, 2019, ISME J, V13, P836, DOI 10.1038/s41396-018-0313-8; Ristova PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169906; Rogers KL, 2020, LIMNOL OCEANOGR LETT, V5, P18, DOI 10.1002/lol2.10136; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sengupta S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0495-4; Sharma A, 2017, INDIAN J MICROBIOL, V57, P23, DOI 10.1007/s12088-016-0629-x; Slomp CP., 2019, METAGENOMIC ANAL REV; Somanathan H., 2004, OECOLOGIA, V15, P413; Sonmez S, 2008, GEODERMA, V144, P361, DOI 10.1016/j.geoderma.2007.12.005; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Trevathan-Tackett SM, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135806; Veitch DP, 2019, ALZHEIMERS DEMENT, V15, P106, DOI 10.1016/j.jalz.2018.08.005; Wang M, 2018, ESTUAR COAST SHELF S, V207, P283, DOI 10.1016/j.ecss.2018.04.021; Watanabe M, 2017, INT J SYST EVOL MICR, V67, P2994, DOI 10.1099/ijsem.0.002062; Wu P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164082; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yang J, 2013, ESTUAR COAST SHELF S, V134, P11, DOI 10.1016/j.ecss.2013.09.017; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yin XJ, 2019, APPL SOIL ECOL, V143, P80, DOI 10.1016/j.apsoil.2019.05.027; Yin YC, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2020.137385; Zhang CJ, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00442-19; Zhang XY, 2018, SCI TOTAL ENVIRON, V633, P518, DOI 10.1016/j.scitotenv.2018.03.158; Zhang X, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579018; Zhao HX, 2019, J MICROBIOL, V57, P575, DOI 10.1007/s12275-019-8679-5; Zhu P, 2018, APPL SOIL ECOL, V130, P159, DOI 10.1016/j.apsoil.2018.06.003	74	10	10	15	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248485	10.1371/journal.pone.0248485	http://dx.doi.org/10.1371/journal.pone.0248485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755699	Green Published, gold			2022-12-26	WOS:000632916600020
J	Paranjape, N; Staples, LL; Stradwick, CY; Ray, HG; Saldanha, IJ				Paranjape, Neha; Staples, Lauren L.; Stradwick, Christina Y.; Ray, Herman Gene; Saldanha, Ian J.			Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19	PLOS ONE			English	Article								Background Identifying factors that can predict severe disease in patients needing hospitalization for COVID-19 is crucial for early recognition of patients at greatest risk. Objective (1) Identify factors predicting intensive care unit (ICU) transfer and (2) develop a simple calculator for clinicians managing patients hospitalized with COVID-19. Methods A total of 2,685 patients with laboratory-confirmed COVID-19 admitted to a large metropolitan health system in Georgia, USA between March and July 2020 were included in the study. Seventy-five percent of patients were included in the training dataset (admitted March 1 to July 10). Through multivariable logistic regression, we developed a prediction model (probability score) for ICU transfer. Then, we validated the model by estimating its performance accuracy (area under the curve [AUC]) using data from the remaining 25% of patients (admitted July 11 to July 31). Results We included 2,014 and 671 patients in the training and validation datasets, respectively. Diabetes mellitus, coronary artery disease, chronic kidney disease, serum C-reactive protein, and serum lactate dehydrogenase were identified as significant risk factors for ICU transfer, and a prediction model was developed. The AUC was 0.752 for the training dataset and 0.769 for the validation dataset. We developed a free, web-based calculator to facilitate use of the prediction model (https://icucovid19.shinyapps.io/ICUCOVID19/). Conclusion Our validated, simple, and accessible prediction model and web-based calculator for ICU transfer may be useful in assisting healthcare providers in identifying hospitalized patients with COVID-19 who are at high risk for clinical deterioration. Triage of such patients for early aggressive treatment can impact clinical outcomes for this potentially deadly disease.	[Paranjape, Neha] Wellstar Med Grp, Dept Infect Dis, Marietta, GA 30060 USA; [Staples, Lauren L.; Stradwick, Christina Y.; Ray, Herman Gene] Kennesaw State Univ, Analyt & Data Sci Inst, Marietta, GA USA; [Saldanha, Ian J.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Ctr Evidence Synth Hlth, Providence, RI 02912 USA; [Saldanha, Ian J.] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA	University System of Georgia; Kennesaw State University; Brown University; Brown University	Paranjape, N (corresponding author), Wellstar Med Grp, Dept Infect Dis, Marietta, GA 30060 USA.	neha.paranjape@wellstar.org		Stradwick, Christina/0000-0002-1141-3148				Castro VM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.23934; CDC, COVID DAT TRACK; Centers for Disease Control and Prevention, 2020, EVIDENCE USED UPDATE; Centers for Disease Control and Prevention, 2020, COVID 19 HOSP DEATH, DOI [10.1007/s10903-020-01111-5, DOI 10.1007/S10903-020-01111-5]; Ciceri F, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108509; Collins Gary S., 2015, ANN INTERN MED; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Henry BM, 2020, AM J EMERG MED, V38, P1722, DOI 10.1016/j.ajem.2020.05.073; Hu H, 2020, ACAD EMERG MED, V27, P461, DOI 10.1111/acem.13992; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kiss Szabolcs, 2020, OBES REV; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Sahu BR, 2020, CLIN CHIM ACTA, V509, P91, DOI 10.1016/j.cca.2020.06.013; Wellstar, 2019, COMMUNITY HLTH NEEDS; Zhang C, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00318; Zhao ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236618; Zhenga Zhaohai., 2020, J INFECTION; Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248891	10.1371/journal.pone.0248891	http://dx.doi.org/10.1371/journal.pone.0248891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740030	gold, Green Published, Green Submitted			2022-12-26	WOS:000631030200040
J	Lima, LL; Atman, APF				Lima, L. L.; Atman, A. P. F.			Impact of mobility restriction in COVID-19 superspreading events using agent-based model	PLOS ONE			English	Article							TRANSMISSION	COVID-19 pandemic is an immediate major public health concern. The search for the understanding of the disease spreading made scientists around the world turn their attention to epidemiological studies. An interesting approach in epidemiological modeling nowadays is to use agent-based models, which allow to consider a heterogeneous population and to evaluate the role of superspreaders in this population. In this work, we implemented an agent-based model using probabilistic cellular automata to simulate SIR (Susceptible-Infected-Recovered) dynamics using COVID-19 infection parameters. Differently to the usual studies, we did not define the superspreaders individuals a priori, we only left the agents to execute a random walk along the sites. When two or more agents share the same site, there is a probability to spread the infection if one of them is infected. To evaluate the spreading, we built the transmission network and measured the degree distribution, betweenness, and closeness centrality. The results displayed for different levels of mobility restriction show that the degree reduces as the mobility reduces, but there is an increase of betweenness and closeness for some network nodes. We identified the superspreaders at the end of the simulation, showing the emerging behavior of the model since these individuals were not initially defined. Simulations also showed that the superspreaders are responsible for most of the infection propagation and the impact of personal protective equipment in the spreading of the infection. We believe that this study can bring important insights for the analysis of the disease dynamics and the role of superspreaders, contributing to the understanding of how to manage mobility during a highly infectious pandemic as COVID-19.	[Lima, L. L.; Atman, A. P. F.] Ctr Fed Educ Tecnol Minas Gerais CEFET MG, Programa Posgrad Modelagem Matemat & Computat, Belo Horizonte, MG, Brazil; [Atman, A. P. F.] Ctr Fed Educ Tecnol Minas Gerais CEFET MG, Dept Fis, Belo Horizonte, MG, Brazil; [Atman, A. P. F.] Natl Inst Sci & Technol Complex Syst CEFET MG, Belo Horizonte, MG, Brazil		Lima, LL (corresponding author), Ctr Fed Educ Tecnol Minas Gerais CEFET MG, Programa Posgrad Modelagem Matemat & Computat, Belo Horizonte, MG, Brazil.	larissalopeslima@yahoo.com.br	Atman, Allbens/A-2752-2008	Atman, Allbens/0000-0002-7614-2721				Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Althouse BM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000897; Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Bauch CT, 2005, EPIDEMIOLOGY, V16, P791, DOI 10.1097/01.ede.0000181633.80269.4c; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Bifolchi N, 2013, SPAT SPATIO-TEMPORAL, V6, P59, DOI 10.1016/j.sste.2013.07.001; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Choi S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020011; Chun BC, 2016, INFECT CHEMOTHER, V48, P147, DOI 10.3947/ic.2016.48.2.147; Dodd RY, 2020, TRANSFUS MED REV, V34, P73, DOI 10.1016/j.tmrv.2020.02.004; Duan W, 2013, IEEE INTELL SYST, V28, P18, DOI 10.1109/MIS.2013.29; Fujie R, 2007, PHYSICA A, V374, P843, DOI 10.1016/j.physa.2006.08.050; Garske T, 2008, J THEOR BIOL, V253, P228, DOI 10.1016/j.jtbi.2008.02.038; Hlremath P, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102088; Kim Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112369; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Mkhatshwa T., 2011, IAENG INT J APPL MAT, V41, P82; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; WHO, 2020, RISK ASSESSMENT MANA; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601; Yan P, 2019, QUANTITATIVE METHODS	33	15	15	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248708	10.1371/journal.pone.0248708	http://dx.doi.org/10.1371/journal.pone.0248708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735290	Green Published, gold			2022-12-26	WOS:000631029700056
J	Mandel, DR; Irwin, D				Mandel, David R.; Irwin, Daniel			On measuring agreement with numerically bounded linguistic probability schemes: A re-analysis of data from Wintle, Fraser, Wills, Nicholson, and Fidler (2019)	PLOS ONE			English	Article							UNCERTAINTY; ACCURACY	Across a wide range of domains, experts make probabilistic judgments under conditions of uncertainty to support decision-making. These judgments are often conveyed using linguistic expressions (e.g., x is likely). Seeking to foster shared understanding of these expressions between senders and receivers, the US intelligence community implemented a communication standard that prescribes a set of probability terms and assigns each term an equivalent numerical probability range. In an earlier PLOS ONE article, [1] tested whether access to the standard improves shared understanding and also explored the efficacy of various enhanced presentation formats. Notably, they found that embedding numeric equivalents in text (e.g., x is likely [55-80%]) substantially outperformed the status-quo approach in terms of the percentage overlap between participants' interpretations of linguistic probabilities (defined in terms of the numeric range equivalents they provided for each term) and the numeric ranges in the standard. These results have important prescriptive implications, yet Wintle et al.'s percentage overlap measure of agreement may be viewed as unfairly punitive because it penalizes individuals for being more precise than the stipulated guidelines even when the individuals' interpretations fall perfectly within the stipulated ranges. Arguably, subjects' within-range precision is a positive attribute and should not be penalized in scoring interpretive agreement. Accordingly, in the present article, we reanalyzed Wintle et al.'s data using an alternative measure of percentage overlap that does not penalize in-range precision. Using the alternative measure, we find that percentage overlap is substantially elevated across conditions. More importantly, however, the effects of presentation format and probability level are highly consistent with the original study. By removing the ambiguity caused by Wintle et al.'s unduly punitive measure of agreement, these findings buttress Wintle et al.'s original claim that the methods currently used by intelligence organizations are ineffective at coordinating the meaning of uncertainty expressions between intelligence producers and intelligence consumers. Future studies examining agreement between senders and receivers are also encouraged to reflect carefully on the most appropriate measures of agreement to employ in their experiments and to explicate the bases for their methodological choices.	[Mandel, David R.] Toronto Res Ctr, Def Res & Dev Canada, Intelligence Influence & Collaborat Sect, Toronto, ON, Canada; [Irwin, Daniel] Dept Natl Def, Toronto, ON, Canada	Defence Research & Development Canada	Mandel, DR (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Intelligence Influence & Collaborat Sect, Toronto, ON, Canada.	drmandel66@gmail.com		Mandel, David/0000-0003-1036-2286	Canadian Safety and Security Program [CSSP-2018-TI-2394]	Canadian Safety and Security Program	DRM: CSSP-2018-TI-2394. Canadian Safety and Security Program. https://www.canada.ca/en/defence-research-development/programs/public-safety-and-security.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes A, 2016, INTELL NATL SECUR, V31, P327, DOI 10.1080/02684527.2014.994955; Benjamin DM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00403; Budescu David V., 2014, Nature Climate Change, V4, P508, DOI 10.1038/nclimate2194; Budescu DV, 2012, CLIMATIC CHANGE, V113, P181, DOI 10.1007/s10584-011-0330-3; Budescu DV, 2009, PSYCHOL SCI, V20, P299, DOI 10.1111/j.1467-9280.2009.02284.x; Burgman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022998; Dhami MK, 2021, AM PSYCHOL, V76, P549, DOI 10.1037/amp0000637; Dhami MK, 2015, PERSPECT PSYCHOL SCI, V10, P753, DOI 10.1177/1745691615598511; Friedman J. A., 2019, WAR CHANCE ASSESSING; Ho EH, 2015, BEHAV SCI POLICY, V1, P43, DOI DOI 10.1353/BSP.2015.0015; Irwin D, 2020, ASSESSMENT COMMUNICA, P319; Lewis SC, 2019, EARTHS FUTURE, V7, P1020, DOI 10.1029/2019EF001273; Mandel DR, 2021, EARTHS FUTURE, V9, DOI 10.1029/2020EF001526; Mandel DR, 2021, INT J INTELL COUNTER, V34, P558, DOI 10.1080/08850607.2020.1809056; Mandel DR, 2020, INTELL NATL SECUR, V35, P438, DOI 10.1080/02684527.2020.1723830; Mandel DR, 2018, J BEHAV DECIS MAKING, V31, P127, DOI 10.1002/bdm.2055; Mandel DR, 2014, P NATL ACAD SCI USA, V111, P10984, DOI 10.1073/pnas.1406138111; Mandel DR., JUDGM DECIS MAK; Mastrandrea MD, 2011, CLIMATIC CHANGE, V108, P675, DOI 10.1007/s10584-011-0178-6; Morgan MG, 1998, HUM ECOL RISK ASSESS, V4, P25, DOI 10.1080/10807039.1998.11009680; Moxey A, 2003, J GEN INTERN MED, V18, P948, DOI 10.1046/j.1525-1497.2003.20928.x; MURPHY AH, 1984, J AM STAT ASSOC, V79, P489, DOI 10.2307/2288395; Tetlock P. E., 2015, SUPERFORECASTING; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; UK House of Commons Foreign Affairs Committee, 2003, 9 REP FOR AFF COMM S; UK Intelligence and Security Committee, 2003, IR WEAP MASS DESTR I; US Central Intelligence Agency, 1983, REP STUD INT JUDG P; US Congressional Select Committee on Intelligence, 2004, REP US INT COMM PREW; US Office of the Director of National Intelligence, 2015, INT COMM DIR ICD 203; Webster RK, 2017, DRUG SAFETY, V40, P743, DOI 10.1007/s40264-017-0542-1; Wintle BC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213522; YANIV I, 1995, J EXP PSYCHOL GEN, V124, P424, DOI 10.1037/0096-3445.124.4.424; Yaniv I, 1997, J BEHAV DECIS MAKING, V10, P21, DOI 10.1002/(SICI)1099-0771(199703)10:1<21::AID-BDM243>3.0.CO;2-G	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248424	10.1371/journal.pone.0248424	http://dx.doi.org/10.1371/journal.pone.0248424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735197	Green Submitted, gold, Green Published			2022-12-26	WOS:000631029700058
J	Nilsson, K; Skoog, E; Jones, V; Sandelin, LL; Bjorling, C; Fridenstrom, E; Edvinsson, M; Martensson, A; Olsen, B				Nilsson, Kenneth; Skoog, Elisabet; Jones, Viktor; Labbe Sandelin, Lisa; Bjorling, Christina; Fridenstrom, Ester; Edvinsson, Marie; Martensson, Andreas; Olsen, Bjorn			A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure	PLOS ONE			English	Article							QUALITY-OF-LIFE; LYME-DISEASE; AUTOANTIBODIES; RESPONSES; ASSAY; TIME	Background Persistent symptoms attributed to presumed tick-bite exposure constitute an unresolved medical controversy. We evaluated whether Swedish adults who met the criteria for post-treatment Lyme disease syndrome (PTLDS) exhibited characteristics distinguishable from adults who did not, but who displayed similar symptoms and disease course after suspected previous tick-bite infection (TBI). Methods and findings During 2015-2018, 255 patients-referred to the Centre for Vector-borne Infections, Uppsala University Hospital, Sweden with symptoms lasting longer than six months-were recruited. Of this group, 224 completed the study. Each patient was examined by an infectious disease specialist and, besides a full medical history, underwent a panel of blood and cerebrospinal fluid laboratory tests including hematological, biochemical, microbiological and immunological analyses, and the RAND-36 scale to measure quality of life. For analysis purposes, patients were divided into five subgroups, of which one represented PTLDS. According to serological results indicating TBI and documented/ reported objective signs of Lyme disease, 85 (38%) patients fulfilled the criteria for PTLDS and were compared with the other 139 (62%) serologically classified patients. In the PTLDS group, erythema chronicum migrans (ECM) was documented/reported in 86% of patients, previous neuroborreliosis in 15%, and acrodermatitis chronica atroficans (ACA) in 3.5%. However, there were no significant differences regarding symptoms, laboratory results or disease course between patients with PTLDS and those without laboratory evidence of Borrelia exposition. Most reported symptoms were fatigue-related (70%), musculoskeletal (79%), neurological (82%) and neurocognitive (57%). Tick bites were recalled by 74%. The RAND-36 score was significantly below that of the general Swedish population. Signs of immunological/inflammatory reactivity with myositis antibodies were detected in 20% of patients, fibrinogen levels were moderately increased in 21% and elevated rheumatoid factor in 6%. Conclusions The PTLDS group did not differ exclusively in any respect from the other subgroups, which either lacked previously documented/reported evidence of borreliosis or even lacked detectable serological signs of exposure to Lyme disease. The results suggest that symptoms often categorized as Chronic-Lyme-Disease (CLD) in the general debate, cannot be uniquely linked to Lyme disease. However, approximately 20% of the total group of patients showed signs of autoimmunity. Further studies are needed to elucidate the underlying causes and mechanisms of PTLDS and there is reason to consider a multifactorial approach.	[Nilsson, Kenneth; Skoog, Elisabet; Jones, Viktor; Labbe Sandelin, Lisa; Bjorling, Christina; Fridenstrom, Ester; Edvinsson, Marie; Olsen, Bjorn] Uppsala Univ, Sect Infect Dis, Dept Med Sci, Uppsala, Sweden; [Nilsson, Kenneth] Uppsala Univ, Sect Clin Microbiol, Dept Med Sci, Uppsala, Sweden; [Nilsson, Kenneth; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Zoonosis Sci Ctr, Uppsala, Sweden; [Labbe Sandelin, Lisa] Kalmar Cty Hosp, Dept Communicable Dis & Dis Control, Kalmar, Sweden; [Martensson, Andreas] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlt, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Nilsson, K (corresponding author), Uppsala Univ, Sect Infect Dis, Dept Med Sci, Uppsala, Sweden.; Nilsson, K (corresponding author), Uppsala Univ, Sect Clin Microbiol, Dept Med Sci, Uppsala, Sweden.; Nilsson, K (corresponding author), Uppsala Univ, Dept Med Sci, Zoonosis Sci Ctr, Uppsala, Sweden.	kenneth.nilsson@medsci.uu.se		Nilsson, Kenneth/0000-0002-0093-5725	Uppsala County Council [41403, 42309, 1040311]	Uppsala County Council	This work was supported by Uppsala County Council, project grant 41403, 42309, 1040311, held by BO, KN and AM respectively The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Ali A, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-79; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ASCH ES, 1994, J RHEUMATOL, V21, P454; Beaman MH, 2016, INTERN MED J, V46, P1370, DOI 10.1111/imj.13278; Benjamini Y, 2001, ANN STAT, V29, P1165; Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425; Bujak DI, 1996, J RHEUMATOL, V23, P1392; Bundell C, 2016, PATHOLOGY, V48, P363, DOI 10.1016/j.pathol.2016.03.012; DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Grankvist A, 2015, EMERG INFECT DIS, V21, P1462, DOI 10.3201/eid2108.150060; Halperin JJ, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.10.008; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Horowitz RI, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6040129; Kannian P, 2007, ARTHRITIS RHEUM-US, V56, P4216, DOI 10.1002/art.23135; Karbowiak Grzegorz, 2018, Annals of Parasitology, V64, P151, DOI 10.17420/ap6403.147; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Larsson U, 2007, RESP MED, V101, P1291, DOI 10.1016/j.rmed.2006.10.014; Lindblom A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166653; Ljostad U, 2012, EUR J NEUROL, V19, P1128, DOI 10.1111/j.1468-1331.2012.03691.x; Maloney EL, 2016, J INFUS MURS, V39, P369, DOI 10.1097/NAN.0000000000000195; Mayne PJ, 2015, INT J GEN MED, V8, P15, DOI 10.2147/IJGM.S75825; Melia MT, 2016, NEW ENGL J MED, V374, P1277, DOI 10.1056/NEJMe1502350; Nemeth J, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14353; Oliveira CR, 2015, CURR OPIN PEDIATR, V27, P100, DOI 10.1097/MOP.0000000000000167; Rebman AW, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00224; Rebman AW, 2017, QUAL HEALTH RES, V27, P534, DOI 10.1177/1049732315619380; Regier Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2042-7; Roelofs K, 2007, CLIN PSYCHOL REV, V27, P798, DOI 10.1016/j.cpr.2007.07.004; Ronnelid J, 2009, AUTOIMMUN REV, V9, P58, DOI 10.1016/j.autrev.2009.03.005; SATOH M, 1995, BRIT J RHEUMATOL, V34, P915; Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Steere AC, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.90; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003	42	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247384	10.1371/journal.pone.0247384	http://dx.doi.org/10.1371/journal.pone.0247384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735220	gold, Green Published			2022-12-26	WOS:000631029700069
J	Ameke, S; Asare, P; Aboagye, SY; Otchere, ID; Osei-Wusu, S; Yeboah-Manu, D; Asante-Poku, A				Ameke, Selassie; Asare, Prince; Aboagye, Samuel Yaw; Otchere, Isaac Darko; Osei-Wusu, Stephen; Yeboah-Manu, Dorothy; Asante-Poku, Adwoa			Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana	PLOS ONE			English	Article								Context Available molecular epidemiological data from recent studies suggest significant genetic variation between the different lineages of Mycobacterium tuberculosis complex (MTBC) and the MTBC lineages might have adapted to different human populations. Aim This study sought to determine the population structure of clinical MTBC isolates from the Volta Region of Ghana. Methods The MTBC isolates obtained from collected sputum samples were identified by PCR detecting of IS6110 and genotyped using spoligotyping. Non-tuberculous mycobacterial isolates were characterized by amplification of the heat shock protein 65 (hsp65) gene and sequencing. The drug susceptibility profiles of the MTBCs determined using GenoType MTBDRplus. Results One hundred and seventeen (117, 93.6%) out of 125 mycobacterial positive isolates were characterized as members of the MTBC of which M. tuberculosis sensu stricto (MTBss) and M. africanum (MAF) were respectively 94 (80.3%) and 23 (19.7%). In all, 39 distinct spoligotype patterns were obtained; 26 for MTBss and 13 for MAF lineages. Spoligotyping identified 89 (76%) Lineage 4, 16 (13.6%) Lineage 5, 7 (6.0%) Lineage 6, 3 (2.6%) Lineage 2, 1(0.9%) Lineage 3 and 1 (0.9%) Lineage 1. Among the Lineage 4 isolates, 62/89 (69.7%) belonged to Cameroon sub-lineage, 13 (14.7%) Ghana, 8 (9.0%) Haarlem, 2 (2.2%) LAM, 1 (1.1%) Uganda I, 1 (1.1%) X and the remaining two (2.2%) were orphan. Significant localization of MAF was found within the Ho municipality (n = 13, 29.5%) compared to the more cosmopolitan Ketu-South/Aflao (n = 3, 8.3%) (p-value = 0.017). Eight (8) non-tuberculous mycobacteria were characterized as M. abscessus (7) and M. fortuitum (1). Conclusion We confirmed the importance of M. africanum lineages as a cause of TB in the Volta region of Ghana.	[Ameke, Selassie; Asare, Prince; Aboagye, Samuel Yaw; Otchere, Isaac Darko; Osei-Wusu, Stephen; Yeboah-Manu, Dorothy; Asante-Poku, Adwoa] Univ Ghana, Noguchi Mem Inst Med Res NMIMR, Bacteriol Dept, Accra, Ghana; [Ameke, Selassie; Yeboah-Manu, Dorothy; Asante-Poku, Adwoa] Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Accra, Ghana	University of Ghana; University of Ghana	Asante-Poku, A (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res NMIMR, Bacteriol Dept, Accra, Ghana.; Asante-Poku, A (corresponding author), Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Accra, Ghana.	aasante-poku@noguchi.ug.edu.gh	Otchere, Isaac Darko/ABV-4511-2022; Aboagye, Samuel Yaw/GNP-5291-2022	Otchere, Isaac Darko/0000-0001-8982-9488; Aboagye, Samuel Yaw/0000-0001-7702-982X	WACCBIP Postdoctoral Fellowship funds from a DELTAS Africa grant [DEL-15-007]; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107755/Z/15/Z, 097134/Z/11/Z]; UK government	WACCBIP Postdoctoral Fellowship funds from a DELTAS Africa grant; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported by WACCBIP Postdoctoral Fellowship funds to A.A.P from a DELTAS Africa grant (DEL-15-007: Awandare). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (107755/Z/15/Z: Awandare) and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. SM was supported by Wellcome Trust intermediate fellowship grant 097134/Z/11/Z to Dorothy Yeboah-Manu.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; [Anonymous], 2019, WHO GLOBAL TUBERCULO; Asante-Poku A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1725-6; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Degasperi Bertoletti Ariane Christine, 2011, Revista do Instituto Adolfo Lutz, V70, P622; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000; Government of Ghana, 2010, GHAN DEM HLTH SURV; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Homolka S, 2010, INT J MED MICROBIOL, V300, P489, DOI 10.1016/j.ijmm.2010.04.019; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; Otchere ID, 2016, TUBERCULOSIS, V99, P147, DOI 10.1016/j.tube.2016.05.014; Otchere ID, 2017, INT J MYCOBACT, V6, P70, DOI 10.4103/2212-5531.201895; Ouassa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045363; Riccardi G, 2014, J ANTIBIOT, V67, P655, DOI 10.1038/ja.2014.109; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Sharma SK, 2019, INDIAN J MED RES, V150, P458, DOI 10.4103/ijmr.IJMR_194_19; Sinha P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1450-1; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Thumamo BP, 2012, INFECT GENET EVOL, V12, P671, DOI 10.1016/j.meegid.2011.08.011; Vilcheze C, 2014, MICROBIOL SPECTR, V2; Yeboah-Manu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161892; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0238898	10.1371/journal.pone.0238898	http://dx.doi.org/10.1371/journal.pone.0238898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730036	gold, Green Published			2022-12-26	WOS:000630345000059
J	Schmidt-Posthaus, H; Schneider, E; Scholzel, N; Hirschi, R; Stelzer, M; Peter, A				Schmidt-Posthaus, Heike; Schneider, Ernst; Schoelzel, Nils; Hirschi, Regula; Stelzer, Moritz; Peter, Armin			The role of migration barriers for dispersion of Proliferative Kidney Disease-Balance between disease emergence and habitat connectivity	PLOS ONE			English	Article								Natural and uninterrupted water courses are important for biodiversity and fish population stability. Nowadays, many streams and rivers are obstructed by artificial migration barriers, often preventing the migration of fish. On the other hand, distribution of pathogens by migrating fishes is still a point of concern. Pathogen transport and transmission is a driving force in the dynamics of many infectious diseases. The aim of the study was to investigate the possible consequences of the removal of an artificial migration barrier for the upstream transport of Tetracapsuloides bryosalmonae, the causative agent of Proliferative Kidney Disease (PKD) in brown trout, by migrating fish. To test this question, a river system was selected with a migration barrier separating a PKD positive river from a PKD negative tributary. After removal of the barrier, PKD prevalence and pathology was examined during five years after elimination of the barrier. In the tributary, no PKD was recorded at any time of the survey. By means of unidirectional PIT (passive integrated transponder)-tagging, we confirmed upstream migration of adult brown trout into the tributary during the cold season, presumably for spawning. By eDNA, we confirmed presence of T. bryoalmonae and Fredericella sp., the definitive host, DNA in water from the PKD positive river stretch, but not in the PKD negative tributary. Our study illustrates the importance of the connectivity of streams for habitat maintenance. Although migration of brown trout from a PKD-positive river into a PKD-negative tributary, mainly for spawning, was confirmed, upstream spreading of PKD was not observed.	[Schmidt-Posthaus, Heike; Hirschi, Regula; Stelzer, Moritz] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Dept Infect Dis & Pathobiol, Bern, Switzerland; [Schoelzel, Nils; Peter, Armin] FishConsulting GmbH, Olten, Switzerland	University of Bern	Schmidt-Posthaus, H (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Dept Infect Dis & Pathobiol, Bern, Switzerland.	heike.schmidt@vetsuisse.unibe.ch		Schmidt-Posthaus, Heike/0000-0003-2628-4454; Stelzer, Moritz/0000-0001-6686-4651				Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Anderson CL, 1999, BULL EUR ASSN FISH P, V19, P94; Bagliniere JL, 2002, PROD ANIM, V15, P319; Bailey C, 2018, PEERJ, V6, DOI 10.7717/peerj.5956; Bailey C, 2017, FISH SHELLFISH IMMUN, V63, P424, DOI 10.1016/j.fsi.2017.02.039; Bettge K, 2009, PARASITOLOGY, V136, P615, DOI 10.1017/S0031182009005800; Bettge K, 2009, DIS AQUAT ORGAN, V83, P67, DOI 10.3354/dao01989; Bundesamt fr Umwelt BAFU, 2017, GEW SSER AUFWERTEN F; Burkhardt-Holm P, 2005, ENVIRON SCI TECHNOL, V39, p441A, DOI 10.1021/es053375z; Canning EU, 2000, J EUKARYOT MICROBIOL, V47, P456, DOI 10.1111/j.1550-7408.2000.tb00075.x; Carraro L, 2017, P NATL ACAD SCI USA, V114, P11992, DOI 10.1073/pnas.1713691114; Dash M, 2014, DIS AQUAT ORGAN, V109, P139, DOI 10.3354/dao02731; Feist S.W., 2004, TROUT NEWS, V38, P17; FEIST SW, 1993, FISH RES, V17, P51, DOI 10.1016/0165-7836(93)90006-S; Feist SW, 2001, DIS AQUAT ORGAN, V45, P61, DOI 10.3354/dao045061; Freeman MC, 2001, ECOL APPL, V11, P179, DOI 10.1890/1051-0761(2001)011[0179:FAHEOJ]2.0.CO;2; Froese R., 2016, FISHBASE WORLD WIDE; Gay M, 2001, DIS AQUAT ORGAN, V46, P31, DOI 10.3354/dao046031; Gorgoglione B, 2016, DIS AQUAT ORGAN, V119, P117, DOI 10.3354/dao02993; Grabner DS, 2008, DIS AQUAT ORGAN, V79, P133, DOI 10.3354/dao01894; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Hedrick R. P., 1993, Annual Review of Fish Diseases, V3, P277, DOI 10.1016/0959-8030(93)90039-E; Hedrick RP, 2004, PARASITOL RES, V92, P81, DOI 10.1007/s00436-003-0986-3; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Junge C, 2014, AQUAT CONSERV, V24, P297, DOI 10.1002/aqc.2391; Kent ML, 1998, J AQUAT ANIM HEALTH, V10, P12, DOI 10.1577/1548-8667(1998)010&lt;0012:RDSAOI&gt;2.0.CO;2; Kristmundsson A, 2010, B EUR ASSOC FISH PAT, V30, P35; Longshaw M, 1999, BULL EUR ASSN FISH P, V19, P146; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miya M, 2016, JOVE-J VIS EXP, DOI 10.3791/54741; Morris DJ, 2006, PARASITOLOGY, V133, P701, DOI 10.1017/S003118200600093X; Morris DC, 2002, J FISH DIS, V25, P483, DOI 10.1046/j.1365-2761.2002.00398.x; Nesnidal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054576; Okamura B, 2001, J PARASITOL, V87, P379, DOI 10.1645/0022-3395(2001)087[0379:POOARS]2.0.CO;2; Okamura B, 2002, J FISH DIS, V25, P469, DOI 10.1046/j.1365-2761.2002.00376.x; Okamura B, 2011, FRESHWATER BIOL, V56, P735, DOI 10.1111/j.1365-2427.2010.02465.x; OKL K, 2003, HYDROBIOLOGIA, V501, P179; Palikova M, 2017, VET PARASITOL, V238, P5, DOI 10.1016/j.vetpar.2017.03.003; Ricker WE., 1970, IBP HDB, V3; Ros A., 2018, AUF AUF, P40; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Schick RS, 2007, J APPL ECOL, V44, P1116, DOI 10.1111/j.1365-2664.2007.01383.x; Schmidt-Posthaus H, 2015, DIS AQUAT ORGAN, V114, P139, DOI 10.3354/dao02855; Shao XJ, 2019, SCI TOTAL ENVIRON, V689, P21, DOI 10.1016/j.scitotenv.2019.06.340; Skovgaard A, 2012, DIS AQUAT ORGAN, V101, P33, DOI 10.3354/dao02502; Soliman H, 2018, DIS AQUAT ORGAN, V127, P151, DOI 10.3354/dao03200; Strepparava N, 2018, PARASITOLOGY, V145, P281, DOI 10.1017/S0031182017001482; Tops S, 2006, DIS AQUAT ORGAN, V70, P227, DOI 10.3354/dao070227; Tops S, 2004, DIS AQUAT ORGAN, V60, P109, DOI 10.3354/dao060109; Venditti David A., 2000, North American Journal of Fisheries Management, V20, P41, DOI 10.1577/1548-8675(2000)020<0041:MBAFDO>2.0.CO;2; Wahli T, 2002, J FISH DIS, V25, P491, DOI 10.1046/j.1365-2761.2002.00401.x; Waldner K, 2020, ECOL FRESHW FISH, V29, P465, DOI 10.1111/eff.12528; White A, 2000, OIKOS, V89, P137, DOI 10.1034/j.1600-0706.2000.890115.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247482	10.1371/journal.pone.0247482	http://dx.doi.org/10.1371/journal.pone.0247482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730108	Green Published, gold			2022-12-26	WOS:000630345000057
J	Harper, CB; Blumrich, EM; Cousin, MA				Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.			Synaptophysin controls synaptobrevin-II retrieval via a cryptic C-terminal interaction site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; COMPLEX; TRAFFICKING; ENDOCYTOSIS; DYNAMIN; PHOSPHORYLATION; SYNAPTOTAGMIN; MECHANISM; KINETICS; INFLUX	The accurate retrieval of synaptic vesicle (SV) proteins during endocytosis is essential for the maintenance of neuro-transmission. Synaptophysin (Syp) and synaptobrevin-II (SybII) are the most abundant proteins on SVs. Neurons lacking Syp display defects in the activity-dependent retrieval of SybII and a general slowing of SV endocytosis. To determine the role of the cytoplasmic C terminus of Syp in the control of these two events, we performed molecular replacement studies in primary cultures of Syp knockout neurons using genetically encoded reporters of SV cargo trafficking at physiological temperatures. Under these conditions, we discovered, 1) no slowing in SV endocytosis in Syp knockout neurons, and 2) a continued defect in SybII retrieval in knockout neurons expressing a form of Syp lacking its C terminus. Sequential truncations of the Syp C-terminus revealed a cryptic interaction site for the SNARE motif of SybII that was concealed in the full-length form. This suggests that a conformational change within the Syp C terminus is key to permitting SybII binding and thus its accurate retrieval. Furthermore, this study reveals that the sole presynaptic role of Syp is the control of SybII retrieval, since no defect in SV endocytosis kinetics was observed at physiological temperatures.	[Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.] Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh EH8 9XD, Midlothian, Scotland; [Harper, Callista B.; Blumrich, Eva-Maria; Cousin, Michael A.] Univ Edinburgh, Muir Maxwell Epilepsy Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Cousin, Michael A.] Univ Edinburgh, Simons Initiat Developing Brain, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Cousin, MA (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Edinburgh EH8 9XD, Midlothian, Scotland.; Cousin, MA (corresponding author), Univ Edinburgh, Muir Maxwell Epilepsy Ctr, Edinburgh EH8 9XD, Midlothian, Scotland.; Cousin, MA (corresponding author), Univ Edinburgh, Simons Initiat Developing Brain, Edinburgh EH8 9XD, Midlothian, Scotland.	M.Cousin@ed.ac.uk		Cousin, Michael/0000-0002-1762-160X	Biotechnology and Biological Sciences Research Council [BB/L019329/1]; Wellcome Trust [204954/Z/16/Z]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust)	Work funded by the Biotechnology and Biological Sciences Research Council (BB/L019329/1) and The Wellcome Trust (204954/Z/16/Z).	Adams DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13659; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Becher A, 1999, J NEUROSCI, V19, P1922; Bonanomi D, 2007, BIOCHEM J, V404, P525, DOI 10.1042/BJ20061907; Brunger AT, 2018, ANNU REV BIOPHYS, V47, P469, DOI 10.1146/annurev-biophys-070816-034117; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Egashira Y, 2015, J NEUROSCI, V35, P3701, DOI 10.1523/JNEUROSCI.4160-14.2015; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; Felkl M, 2008, NEUROSCIENCE, V156, P344, DOI 10.1016/j.neuroscience.2008.07.033; Gordon SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149457; Gordon Sarah L, 2016, Front Synaptic Neurosci, V8, P1, DOI 10.3389/fnsyn.2016.00001; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harper CB, 2017, NEUROBIOL DIS, V108, P298, DOI 10.1016/j.nbd.2017.08.021; Hinz B, 2001, EUR J CELL BIOL, V80, P615, DOI 10.1078/0171-9335-00196; Horikawa HPM, 2002, MOL CELL NEUROSCI, V21, P454, DOI 10.1006/mcne.2002.1191; Japel M, 2020, CELL REP, V30, P409, DOI 10.1016/j.celrep.2019.12.035; Kaempf N, 2015, P NATL ACAD SCI USA, V112, P7297, DOI 10.1073/pnas.1501627112; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; Khvotchev MV, 2004, BIOCHEMISTRY-US, V43, P15037, DOI 10.1021/bi048290+; Kokotos AC, 2019, J NEUROCHEM, V151, P28, DOI 10.1111/jnc.14797; Kononenko NL, 2013, P NATL ACAD SCI USA, V110, pE526, DOI 10.1073/pnas.1218432110; Koo SJ, 2015, NEURON, V88, P330, DOI 10.1016/j.neuron.2015.08.034; Koo SJ, 2011, P NATL ACAD SCI USA, V108, P13540, DOI 10.1073/pnas.1107067108; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Mitter D, 2003, J NEUROCHEM, V84, P35, DOI 10.1046/j.1471-4159.2003.01258.x; Rajappa R, 2016, CELL REP, V14, P1369, DOI 10.1016/j.celrep.2016.01.031; Reisinger C, 2004, J NEUROCHEM, V90, P1, DOI 10.1111/j.1471-4159.2004.02472.x; Rizo J, 2018, PROTEIN SCI, V27, P1364, DOI 10.1002/pro.3445; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Treppmann P, 2011, J NEUROCHEM, V117, P757, DOI 10.1111/j.1471-4159.2011.07247.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010; Yelamanchili SV, 2005, EUR J CELL BIOL, V84, P467, DOI 10.1016/j.ejcb.2004.11.007; Zhang N, 2015, J NEUROSCI, V35, P2492, DOI 10.1523/JNEUROSCI.4248-14.2015	48	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100266	10.1016/j.jbc.2021.100266	http://dx.doi.org/10.1016/j.jbc.2021.100266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33769286	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400242
J	Oliveira, E; Parikh, A; Lopez-Ruiz, A; Carrilo, M; Goldberg, J; Cearras, M; Fernainy, K; Andersen, S; Mercado, L; Guan, J; Zafar, H; Louzon, P; Carr, A; Baloch, N; Pratley, R; Silverstry, S; Hsu, V; Sniffen, J; Herrera, V; Finkler, N				Oliveira, Eduardo; Parikh, Amay; Lopez-Ruiz, Arnaldo; Carrilo, Maria; Goldberg, Joshua; Cearras, Martin; Fernainy, Khaled; Andersen, Sonja; Mercado, Luis; Guan, Jian; Zafar, Hammad; Louzon, Patricia; Carr, Amy; Baloch, Natasha; Pratley, Richard; Silverstry, Scott; Hsu, Vincent; Sniffen, Jason; Herrera, Victor; Finkler, Neil			ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida	PLOS ONE			English	Article								Background Observational studies have consistently described poor clinical outcomes and increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who require mechanical ventilation (MV). Our study describes the clinical characteristics and outcomes of patients with severe COVID-19 admitted to ICU in the largest health care system in the state of Florida, United States. Methods Retrospective cohort study of patients admitted to ICU due to severe COVID-19 in AdventHealth health system in Orlando, Florida from March 11(th) until May 18th, 2020. Patients were characterized based on demographics, baseline comorbidities, severity of illness, medical management including experimental therapies, laboratory markers and ventilator parameters. Major clinical outcomes analyzed at the end of the study period were: hospital and ICU length of stay, MV-related mortality and overall hospital mortality of ICU patients. Results Out of total of 1283 patients with COVID-19, 131 (10.2%) met criteria for ICU admission (median age: 61 years [interquartile range (IQR), 49.5-71.5]; 35.1% female). Common comorbidities were hypertension (84; 64.1%), and diabetes (54; 41.2%). Of the 131 ICU patients, 109 (83.2%) required MV and 9 (6.9%) received ECMO. Lower positive end expiratory pressure (PEEP) were observed in survivors [9.2 (7.7-10.4)] vs non-survivors [10 (9.1-12.9] p = 0.004]. Compared to non-survivors, survivors had a longer MV length of stay (LOS) [14 (IQR 8-22) vs 8.5 (IQR 5-10.8) p< 0.001], Hospital LOS [21 (IQR 13-31) vs 10 (7-1) p< 0.001] and ICU LOS [14 (IQR 7-24) vs 9.5 (IQR 6-11), p < 0.001]. The overall hospital mortality and MV-related mortality were 19.8% and 23.8% respectively. After exclusion of hospitalized patients, the hospital and MV-related mortality rates were 21.6% and 26.5% respectively. Conclusions Our study demonstrates an important improvement in mortality of patients with severe COVID-19 who required ICU admission and MV in comparison to previous observational reports and emphasizes the importance of standard of care measures in the management of COVID-19.	[Oliveira, Eduardo; Parikh, Amay; Lopez-Ruiz, Arnaldo; Carrilo, Maria; Goldberg, Joshua; Cearras, Martin; Fernainy, Khaled; Andersen, Sonja; Baloch, Natasha] AdventHlth Orlando, Div Crit Care, AdventHlth Med Grp, Orlando, FL 32803 USA; [Mercado, Luis; Guan, Jian; Zafar, Hammad] AdventHlth Orlando, Internal Med Residency Program, Orlando, FL USA; [Louzon, Patricia; Carr, Amy] AdventHlth Orlando, Dept Pharm, Orlando, FL USA; [Pratley, Richard] AdventHlth Orlando, Res Inst, Orlando, FL USA; [Silverstry, Scott] AdventHlth Orlando, Transplant Inst, Orlando, FL USA; [Hsu, Vincent; Sniffen, Jason; Herrera, Victor] AdventHlth Orlando, Div Infect Dis, Orlando, FL USA; [Finkler, Neil] AdventHlth Orlando, Cent Florida Div, Orlando, FL USA	Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando	Oliveira, E (corresponding author), AdventHlth Orlando, Div Crit Care, AdventHlth Med Grp, Orlando, FL 32803 USA.	Eduardo.Oliveira.md@adventhealth.com	Carr, Amy/GQY-8956-2022	Carr, Amy/0000-0002-5197-7132; Oliveira, Eduardo/0000-0002-2565-7709				Antwi-Amoabeng D, 2020, J MED VIROL, V92, P2516, DOI 10.1002/jmv.26038; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Cavalcanti AB, 2017, JAMA-J AM MED ASSOC, V318, P1335, DOI 10.1001/jama.2017.14171; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chang JC, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619887437; Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9; Deng LS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.03.002; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Henry BM, 2020, J CRIT CARE, V58, P27, DOI 10.1016/j.jcrc.2020.03.011; Henry BM, 2020, LANCET RESP MED, V8, pE24, DOI 10.1016/S2213-2600(20)30119-3; Herrera V., 2020, NEJM CATALYST INNOVA, V1, DOI [10.1056/CAT.20.0087, DOI 10.1056/CAT.20.0087]; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Levy MM, 2018, INTENS CARE MED, V44, P925, DOI 10.1007/s00134-018-5085-0; Lewnard JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1923; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; Maatman TK, 2020, CRIT CARE MED, V48, pE783, DOI 10.1097/CCM.0000000000004466; Maca J, 2017, RESP CARE, V62, P113, DOI 10.4187/respcare.04716; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Quah P, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03006-1; Rahmanzade R, 2020, ANESTH ANALG, V131, pE114, DOI 10.1213/ANE.0000000000004943; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5; Villar J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1456-4; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	37	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249038	10.1371/journal.pone.0249038	http://dx.doi.org/10.1371/journal.pone.0249038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765049	Green Published, Green Submitted, gold			2022-12-26	WOS:000634832800112
J	Park, SJ; Choi, H; Kim, JH; Kim, CS				Park, Sung Joon; Choi, Hyunsu; Kim, Ji Heon; Kim, Choung-Soo			Antifibrotic effects of eupatilin on TGF-beta 1-treated human vocal fold fibroblasts	PLOS ONE			English	Article								Vocal fold scarring is a major cause of dysphonia. Vocal fold fibroblasts (VFFs) and the TGF-beta signaling pathway play important roles in scar formation. Eupatilin, a chromone derivative of the Artemisia species, is a traditional folk remedy for wound healing. However, until recently, few studies investigated the therapeutic effects of eupatilin. We investigated the antifibrogenic effects of eupatilin on TGF-beta 1-treated human vocal fold fibroblasts (hVFFs). The optimal concentration of eupatilin was determined by a cell viability assay. Western blotting was used to measure the expression of alpha-smooth muscle actin during myofibroblast differentiation, fibronectin (FN), collagen type I (Col I), and collagen type III (Col III) extracellular matrix proteins, and Smad2, Smad3, and p38 in the fibrotic pathway. Measurements were made before and after eupatilin treatment. Eupatilin at 100 nM was shown to be safe for use in hVFFs. TGF-beta 1 induced hVFFs to proliferate and differentiate into myofibroblasts and increased Col III and FN synthesis in a time- and dose-dependent manner. Eupatilin suppressed TGF-beta 1-induced hVFF proliferation and differentiation into myofibroblasts through the Smad and p38 signaling pathways. Furthermore, eupatilin inhibited TGF-beta 1-induced FN, Col I, and Col III synthesis in hVFFs. Our in vitro findings show that eupatilin effectively suppressed TGF-beta 1-induced fibrotic changes in hVFFs via the Smad and p38 signaling pathways. Thus, eupatilin may be considered a novel therapeutic agent for the treatment of vocal fold fibrosis.	[Park, Sung Joon; Kim, Choung-Soo] Catholic Univ Korea, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Park, Sung Joon] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Choi, Hyunsu] Daejeon St Marys Hosp, Clin Res Inst, Daejeon, South Korea; [Kim, Ji Heon; Kim, Choung-Soo] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea; [Park, Sung Joon] Yeouido St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Choi, Hyunsu; Kim, Ji Heon; Kim, Choung-Soo] Daejeon St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kim, CS (corresponding author), Catholic Univ Korea, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.; Kim, CS (corresponding author), Catholic Univ Korea, Daejeon St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea.; Kim, CS (corresponding author), Daejeon St Marys Hosp, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea.	drchoung@catholic.ac.kr		Kim, Choung Soo/0000-0002-9551-9571	National Research Foundation of Korea (NRF) - Korea government Ministry of Science and ICT (MSIT) [2020R1G1A1004280]; Catholic University of Korea Daejeon St. Mary's Hospital [CMCDJ-P-2019-003]; E.N.T. Fund of the Catholic University of Korea [5-2020-B0001-00260]	National Research Foundation of Korea (NRF) - Korea government Ministry of Science and ICT (MSIT); Catholic University of Korea Daejeon St. Mary's Hospital; E.N.T. Fund of the Catholic University of Korea	This study was supported by The National Research Foundation of Korea (NRF) (https://www.nrf.re.kr/index) in the form of a grant funded by the Korea government Ministry of Science and ICT (MSIT) and awarded to CSK (2020R1G1A1004280), The Catholic University of Korea Daejeon St. Mary's Hospital (https://www.cmcdj.or.kr/) in the form of a Clinical Research Institute Grant awarded to CSK (CMCDJ-P-2019-003), and The E.N.T. Fund of the Catholic University of Korea in the form of a grant made in the program year of 2020 and awarded to CSK (5-2020-B0001-00260).	Bartlett RS, 2019, J BIOMECH, V83, P227, DOI 10.1016/j.jbiomech.2018.11.050; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Branski RC, 2016, LARYNGOSCOPE, V126, P1151, DOI 10.1002/lary.25673; Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; Chen JT, 2018, J FORMOS MED ASSOC, V117, P1115, DOI 10.1016/j.jfma.2017.12.014; Herman AP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/475152; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE308, DOI 10.1002/lary.26648; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE35, DOI 10.1002/lary.26121; Hu XP, 2018, ONCOL LETT, V15, P4867, DOI 10.3892/ol.2018.7926; Jiang WN, 2010, INT J MOL MED, V26, P571, DOI 10.3892/ijmm_00000501; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Katholnig K, 2013, J IMMUNOL, V190, P1519, DOI 10.4049/jimmunol.1202683; Kim HS, 2019, EBIOMEDICINE, V39, P484, DOI 10.1016/j.ebiom.2018.12.017; Lee SH, 2019, TUBERC RESPIR DIS, V82, P42, DOI 10.4046/trd.2017.0111; Leyva-Lopez N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060921; Lichtman MK, 2016, WOUND REPAIR REGEN, V24, P215, DOI 10.1111/wrr.12398; Liu HY, 2019, MED SCI MONITOR, V25, P8289, DOI 10.12659/MSM.917406; Liu HZ, 2016, EXP THER MED, V11, P998, DOI 10.3892/etm.2016.2969; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Ohno T, 2009, OTOLARYNG HEAD NECK, V140, P757, DOI 10.1016/j.otohns.2008.12.065; Page TH, 2010, ARTHRITIS RHEUM-US, V62, P3221, DOI 10.1002/art.27631; Paul BC, 2014, LARYNGOSCOPE, V124, P2327, DOI 10.1002/lary.24723; Rousseau B, 2008, ANN OTO RHINOL LARYN, V117, P598, DOI 10.1177/000348940811700809; Singh RK, 2018, HUM EXP TOXICOL, V37, P521, DOI 10.1177/0960327117715901; Song EH, 2018, PHYTOMEDICINE, V42, P1, DOI 10.1016/j.phymed.2017.08.027; Thibeault SL, 2008, OTOLARYNG HEAD NECK, V139, P816, DOI 10.1016/j.otohns.2008.09.009; Vallee A, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0362-3; Xiao YT, 2017, CELL PHYSIOL BIOCHEM, V41, P623, DOI 10.1159/000457933; Zhou K, 2018, PHYTOMEDICINE, V46, P46, DOI 10.1016/j.phymed.2018.04.033	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249041	10.1371/journal.pone.0249041	http://dx.doi.org/10.1371/journal.pone.0249041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765087	Green Published, gold			2022-12-26	WOS:000634832800069
J	Bradfield, Z; Wynter, K; Hauck, Y; Vasilevski, V; Kuliukas, L; Wilson, AN; Szabo, RA; Homer, CSE; Sweet, L				Bradfield, Zoe; Wynter, Karen; Hauck, Yvonne; Vasilevski, Vidanka; Kuliukas, Lesley; Wilson, Alyce N.; Szabo, Rebecca A.; Homer, Caroline S. E.; Sweet, Linda			Experiences of receiving and providing maternity care during the COVID-19 pandemic in Australia: A five-cohort cross-sectional comparison	PLOS ONE			English	Article							IMPACT	Introduction The global COVID-19 pandemic has radically changed the way health care is delivered in many countries around the world. Evidence on the experience of those receiving or providing maternity care is important to guide practice through this challenging time. Methods A cross-sectional study was conducted in Australia. Five key stakeholder cohorts were included to explore and compare the experiences of those receiving or providing care during the COVID-19 pandemic. Women, their partners, midwives, medical practitioners and midwifery students who had received or provided maternity care from March 2020 onwards in Australia were recruited via social media and invited to participate in an online survey released between 13(th) May and 24(th) June 2020; a total of 3701 completed responses were received. Findings While anxiety related to COVID-19 was high among all five cohorts, there were statistically significant differences between the responses from each cohort for most survey items. Women were more likely to indicate concern about their own and family's health and safety in relation to COVID-19 whereas midwives, doctors and midwifery students were more likely to be concerned about occupational exposure to COVID-19 through working in a health setting than those receiving care through attending these environments. Midwifery students and women's partners were more likely to respond that they felt isolated because of the changes to the way care was provided. Despite concerns about care received or provided not meeting expectations, most respondents were satisfied with the quality of care provided, although midwives and midwifery students were less likely to agree. Conclusion This paper provides a unique exploration and comparison of experiences of receiving and providing maternity care during the COVID-19 pandemic in Australia. Findings are useful to support further service changes and future service redesign. New evidence provided offers unique insight into key stakeholders' experiences of the rapid changes to health services.	[Bradfield, Zoe; Hauck, Yvonne; Kuliukas, Lesley] Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Bradfield, Zoe; Hauck, Yvonne] King Edward Mem Hosp, Dept Nursing Midwifery Educ & Res, Subiaco, WA, Australia; [Wynter, Karen; Vasilevski, Vidanka; Sweet, Linda] Deakin Univ, Sch Nursing & Midwifery, Geelong, Vic, Australia; [Wynter, Karen; Vasilevski, Vidanka; Sweet, Linda] Ctr Qual & Patient Safety Res, Western Hlth Partnership, Burwood, Vic, Australia; [Wilson, Alyce N.; Homer, Caroline S. E.] Burnet Inst, Maternal Child & Adolescent Hlth Program, Melbourne, Vic, Australia; [Szabo, Rebecca A.] Univ Melbourne, Dept Med Educ, Melbourne, Vic, Australia; [Szabo, Rebecca A.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	Curtin University; King Edward Memorial Hospital; University of Western Australia; Deakin University; Burnet Institute; University of Melbourne; University of Melbourne	Bradfield, Z (corresponding author), Curtin Univ, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.; Bradfield, Z (corresponding author), King Edward Mem Hosp, Dept Nursing Midwifery Educ & Res, Subiaco, WA, Australia.	zoe.bradfield@curtin.edu.au	Vasilevski, Vidanka/AEO-7913-2022	Szabo, Rebecca/0000-0002-7426-0978; Wynter, Karen/0000-0003-4620-7691; Bradfield, Zoe/0000-0002-1013-0461; Vasilevski, Vidanka/0000-0002-2772-811X	Curtin University, Faculty of Health Sciences	Curtin University, Faculty of Health Sciences	Curtin University, Faculty of Health Sciences provided funding for the article processing charges associated with this manuscript. The Faculty and the University had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABS, 2019, BIRTHS AUSTR 2018 CA; ACM, 2020, WOM EXP MAT CAR HEIG; AHPRA, 2020, 2019 9 ANN REP OUR N; AIHW, 2018, PER NAT MIN DAT SET; ANMAC, 2020, CONT CAR EXP COVID 1; [Anonymous], 2020, ANN COVID 19 OUTBR P; Bletzer KV, 2015, J EDUC EVAL HEALTH P, V12, DOI 10.3352/jeehp.2015.12.12; Coxon K, 2020, MIDWIFERY, V88, DOI 10.1016/j.midw.2020.102779; DOH Health CoADo, 2020, AUSTR HLTH SECT EM R; Fernandez R, 2020, INT J NURS STUD, V111, DOI 10.1016/j.ijnurstu.2020.103637; Finset A, 2020, PATIENT EDUC COUNS, V103, P873, DOI 10.1016/j.pec.2020.03.027; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Health Q, 2020, QUEENSLAND CLIN GUID; Heimerl F, 2014, P ANN HICSS, P1833, DOI 10.1109/HICSS.2014.231; HRIC, 2020, HUM RIGHTS VIOL PREG; Jeffery T, 2015, J PERINAT EDUC, V24, P181, DOI 10.1891/1058-1243.24.3.181; Lista G, 2020, EARLY HUM DEV, V144, DOI 10.1016/j.earlhumdev.2020.105048; Megalokonomous M, 2020, FAMILIES EXPECTING B; Midwifery Accreditation Council: ANMAC, 2014, MIDW ACCR STAND; Pallangyo E, 2020, MIDWIFERY, V89, DOI 10.1016/j.midw.2020.102775; Pascuzzi L., 2020, AUSTR MIDWIFERY NEWS, V2; Psychology Board of Australia, 2020, REG PROGR; Renfrew MJ, 2020, MIDWIFERY, V88, DOI 10.1016/j.midw.2020.102759; Semaan A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002967; Sheikh A, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010370; Shields L., 2016, NURSING MIDWIFERY RE, V5th; Sogut S, 2021, PERSPECT PSYCHIATR C, V57, P246, DOI 10.1111/ppc.12555; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Taskforce NC-CE, 2020, CAR PEOPL COVID 19 L; Torda A, 2020, INTERN MED J, V50, P1150, DOI 10.1111/imj.14882; Vogel J.P., 2020, RAPID REV MATERNAL H; WHO, 2018, RESPECTFUL MATERNITY; Wilson AN, 2021, WOMEN BIRTH, V34, P206, DOI 10.1016/j.wombi.2020.03.011; World Health Organization, 2020, ARCH WHO TIM COVID 1; Wu WZ, 2020, J MED VIROL, V92, P1962, DOI 10.1002/jmv.25914	35	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248488	10.1371/journal.pone.0248488	http://dx.doi.org/10.1371/journal.pone.0248488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760851	Green Published, gold, Green Submitted			2022-12-26	WOS:000633030400030
J	James, A; Plank, MJ; Hendy, S; Binny, RN; Lustig, A; Steyn, N				James, Alex; Plank, Michael J.; Hendy, Shaun; Binny, Rachelle N.; Lustig, Audrey; Steyn, Nic			Model-free estimation of COVID-19 transmission dynamics from a complete outbreak	PLOS ONE			English	Article								New Zealand had 1499 cases of COVID-19 before eliminating transmission of the virus. Extensive contract tracing during the outbreak has resulted in a dataset of epidemiologically linked cases. This data contains useful information about the transmission dynamics of the virus, its dependence on factors such as age, and its response to different control measures. We use Monte-Carlo network construction techniques to provide an estimate of the number of secondary cases for every individual infected during the outbreak. We then apply standard statistical techniques to quantify differences between groups of individuals. Children under 10 years old are significantly under-represented in the case data. Children infected fewer people on average and had a lower probability of transmitting the disease in comparison to adults and the elderly. Imported cases infected fewer people on average and also had a lower probability of transmitting than domestically acquired cases. Superspreading is a significant contributor to the epidemic dynamics, with 20% of cases among adults responsible for 65-85% of transmission. Subclinical cases infected fewer individuals than clinical cases. After controlling for outliers serial intervals were approximated with a normal distribution (mu = 4.4 days, sigma = 4.7 days). Border controls and strong social distancing measures, particularly when targeted at superspreading, play a significant role in reducing the spread of COVID-19.	[James, Alex; Plank, Michael J.] Univ Canterbury, Sch Maths & Stats, Christchurch, New Zealand; [James, Alex; Plank, Michael J.; Hendy, Shaun; Binny, Rachelle N.; Lustig, Audrey; Steyn, Nic] Te Punaha Matatini, Auckland, New Zealand; [Hendy, Shaun; Steyn, Nic] Univ Auckland, Dept Phys, Auckland, New Zealand; [Binny, Rachelle N.; Lustig, Audrey] Manaaki Whenua, Lincoln, New Zealand	University of Canterbury; University of Auckland; Landcare Research - New Zealand	James, A (corresponding author), Univ Canterbury, Sch Maths & Stats, Christchurch, New Zealand.; James, A (corresponding author), Te Punaha Matatini, Auckland, New Zealand.	alex.james@canterbury.ac.nz	Hendy, Shaun/A-9776-2008	Hendy, Shaun/0000-0003-3468-6517; Steyn, Nicholas/0000-0001-8904-2941; Lustig, Audrey/0000-0002-0869-3847	MIBIE, New Zealand; Te Punaha Matatini, the NZ Centre of Research Excellence in Complex Systems	MIBIE, New Zealand; Te Punaha Matatini, the NZ Centre of Research Excellence in Complex Systems	All authors received funding for this work from MIBIE, New Zealand and Te Punaha Matatini, the NZ Centre of Research Excellence in Complex Systems. These funders did not play any role in the study.	Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; [Anonymous], 2020, TRANSMISSION INTERVA; Binny R. N., 2020, EFFECT ALERT LEVEL 4; Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mei S, 2020, Lancet Infect Dis, V20, P911; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	20	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0238800	10.1371/journal.pone.0238800	http://dx.doi.org/10.1371/journal.pone.0238800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760817	gold, Green Submitted, Green Published			2022-12-26	WOS:000633030400037
J	Chaim, CH; Santana, GL; Albertin, PD; Silveira, CM; Siu, ER; Viana, MC; Pang, WY; Andrade, LH				Chaim, Carolina Hanna; Santana, Geilson Lima; de Vries Albertin, Paula; Silveira, Camila Magalhaes; Siu, Erica Rosanna; Viana, Maria Carmen; Pang, Wang Yuan; Andrade, Laura Helena			Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area	PLOS ONE			English	Article							MENTAL-HEALTH-SURVEY; NATIONAL EPIDEMIOLOGIC SURVEY; SUBSTANCE-USE DISORDERS; DSM-IV; NEGATIVE EMOTIONALITY; DEPENDENT PATIENTS; COMORBIDITY; PREVALENCE; TRAITS; POPULATION	Introduction Alcohol Use Disorders are frequently comorbid with personality disorders. However, the heterogeneity of the prevalence estimates is high, and most data come from high income countries. Our aim is to estimate the prevalence and association between alcohol use outcomes and the three DSM-5 clusters of personality disorders in a representative sample of the Sao Paulo Metropolitan Area. Materials and methods A representative household sample of 2,942 adults was interviewed using the WHO Composite International Diagnostic Interview and the International Personality Disorder Examination Screening Questionnaire. Lifetime PD diagnoses were multiply imputed, and AUD diagnoses were obtained using DSM-5 criteria. We conducted cross-tabulations and logistic regression to estimate the associations between AUDs and PDs. Results and discussion Our study did not find significant associations of PDs with heavy drinking patterns or mild AUD. Cluster B PD respondents tended to show the highest conditional prevalence estimates of most alcohol use patterns and AUD, including its severity subtypes. When alcohol outcomes were regressed on all PD Clusters simultaneously, with adjustment for sex and age, only cluster B was significantly associated with past-year alcohol use (OR 3.0), regular drinking (OR 3.2), and AUDs (OR 8.5), especially moderate and severe cases of alcohol use disorders (OR 9.7 and 16.6, respectively). These associations between Cluster B PDs and these alcohol outcomes were shown to be independent of other PD Clusters and individuals ' sex and age. Conclusion The main finding of our study is that AUDs are highly comorbid with PDs. The presence of Cluster B PDs significantly increases the odds of alcohol consumption and disorders and of more severe forms of AUDs. Considering the local context of poor treatment provision, more specific prevention and intervention strategies should be directed to this population.	[Chaim, Carolina Hanna; Santana, Geilson Lima; de Vries Albertin, Paula; Silveira, Camila Magalhaes; Siu, Erica Rosanna; Pang, Wang Yuan; Andrade, Laura Helena] Univ Sao Paulo, Med Sch, Inst & Dept Psychiat LIM 23, Sect Psychiat Epidemiol, Sao Paulo, SP, Brazil; [Viana, Maria Carmen] Univ Fed Espirito Santo, Dept Social Med, Vitoria, ES, Brazil	Universidade de Sao Paulo; Universidade Federal do Espirito Santo	Chaim, CH (corresponding author), Univ Sao Paulo, Med Sch, Inst & Dept Psychiat LIM 23, Sect Psychiat Epidemiol, Sao Paulo, SP, Brazil.	carolina.hanna@usp.br	Wang, Yuan-Pang/A-4863-2008; Santana, Geilson/GLU-9777-2022; Siu, Erica/J-9116-2012	Wang, Yuan-Pang/0000-0001-7076-8312; Santana, Geilson/0000-0002-6611-1702; Chaim, Carolina/0000-0001-8227-0423; de Vries Albertin, Paula/0000-0002-6752-033X; Siu, Erica/0000-0001-7492-7579; Magalhaes Silveira, Camila/0000-0002-1598-4896	State of Sao Paulo Research Foundation, Brazil (FAPESP) [03/00204-3]; Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria-FACITEC) [002/2003]; Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; BristolMyers Squibb; Shire; Coordination for the Improvement of Higher Education Personnel-Program of Academic Excellence (CAPES-PROEX), Ministry of Education, Brazil; Brazilian Council for Scientific and Technological Development(CNPq) [307784/2016-9]; State of Sao Paulo Research Foundation (FAPESP; Project Saude mental, migracao e Sao Paulo MegacityM3SP) [16/50307-3]	State of Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria-FACITEC); Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly and Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); BristolMyers Squibb(Bristol-Myers Squibb); Shire; Coordination for the Improvement of Higher Education Personnel-Program of Academic Excellence (CAPES-PROEX), Ministry of Education, Brazil; Brazilian Council for Scientific and Technological Development(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (FAPESP; Project Saude mental, migracao e Sao Paulo MegacityM3SP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Sao Paulo Megacity Mental Health Survey was funded by the State of Sao Paulo Research Foundation, Brazil (FAPESP Grant 03/00204-3, URL: http://www.fapesp.br/materia/176/projeto-tematico/projeto-tematico.htm).Instrument development was supported by the Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria-FACITEC 002/2003). The sub-project on violence and trauma was supported by the Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil. The Sao Paulo Megacity Mental Health Survey is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The main coordination center activities, at Harvard University, were supported by the United States National Institutes of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly and Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, BristolMyers Squibb, and Shire. Geilson Lima Santana received a scholarship and travel expenses funding to present these results in international symposia from Coordination for the Improvement of Higher Education Personnel-Program of Academic Excellence (CAPES-PROEX), Ministry of Education, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Laura Helena Andrade is supported by the Brazilian Council for Scientific and Technological Development(CNPq Grant #307784/2016-9) and the State of Sao Paulo Research Foundation (FAPESP; Project Saude mental, migracao e Sao Paulo MegacityM3SP; Grant #16/50307-3).	American Psychiatric Association , 2013, DIAGN STAT MAN MENT, V5th, P991; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; [Anonymous], 1999, PARS PSYCHOL ASSESSM; Bartoli F, 2015, ADDICT BEHAV, V41, P46, DOI 10.1016/j.addbeh.2014.09.029; Belcher AM, 2014, TRENDS COGN SCI, V18, P211, DOI 10.1016/j.tics.2014.01.010; Bjorkenstam E, 2017, EUR J EPIDEMIOL, V32, P721, DOI 10.1007/s10654-017-0264-9; Bowden-Jones O, 2004, ADDICTION, V99, P1306, DOI 10.1111/j.1360-0443.2004.00813.x; Carter RR, 2012, ALCOHOL TREAT Q, V30, P163, DOI 10.1080/07347324.2012.663286; Casadio P, 2014, SUBST ABUS-RES TREAT, V8, P17, DOI 10.4137/SART.S13764; Castaldelli-Maia JM, 2014, DRUG ALCOHOL DEPEN, V136, P92, DOI 10.1016/j.drugalcdep.2013.12.012; Dom G, 2006, ALCOHOL CLIN EXP RES, V30, P1670, DOI 10.1111/j.1530-0277.2006.00202.x; Few LR, 2014, ADDICTION, V109, P2118, DOI 10.1111/add.12690; Girotto E, 2014, OCCUP ENVIRON MED, V71, P71, DOI 10.1136/oemed-2013-101452; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94, 10.1016/S0140-6736(18)31310-2]; Guy N, 2018, PERSONAL MENT HEALTH, V12, P216, DOI 10.1002/pmh.1415; Harel O, 2018, AM J EPIDEMIOL, V187, P576, DOI 10.1093/aje/kwx349; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Helle AC, 2020, ALCOHOL CLIN EXP RES, V44, P632, DOI 10.1111/acer.14284; Huang YQ, 2009, BRIT J PSYCHIAT, V195, P46, DOI 10.1192/bjp.bp.108.058552; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2000, CENSO DEMOGR FICO PO; James LM, 2007, ADDICT BEHAV, V32, P714, DOI 10.1016/j.addbeh.2006.06.012; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kotov R, 2017, J ABNORM PSYCHOL, V126, P454, DOI 10.1037/abn0000258; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lenzenweger MF, 1997, ARCH GEN PSYCHIAT, V54, P345; Lenzenweger MF, 1999, ARCH GEN PSYCHIAT, V56, P1009, DOI 10.1001/archpsyc.56.11.1009; Lopez-Quintero C, 2011, ADDICTION, V106, P657, DOI 10.1111/j.1360-0443.2010.03194.x; LORANGER AW, 1994, ARCH GEN PSYCHIAT, V51, P215; Martin CS, 2011, PSYCHOL MED, V41, P2008, DOI 10.1017/S0033291711000717; McAdams DP, 2010, ANNU REV PSYCHOL, V61, P517, DOI 10.1146/annurev.psych.093008.100507; Newton-Howes G, 2018, CURR OPIN PSYCHIATR, V31, P50, DOI 10.1097/YCO.0000000000000375; Nichols LR, 2019, ADDICT BEHAV, V89, P178, DOI [10.1016/j.addbeh.2018.10, 10.1016/j.addbeh.2018.10.004]; Oberleitner LMS, 2015, CHILD MALTREATMENT, V20, P301, DOI 10.1177/1077559515591270; Paiva CEP., 2009, ENGENHARIA, V596, P511; Perez-Rodriguez MM, 2018, PSYCHIAT CLIN N AM, V41, P633, DOI 10.1016/j.psc.2018.07.012; Rhemtulla M, 2012, J COGN DEV, V13, P425, DOI 10.1080/15248372.2012.717340; Roncero C, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00019; Rubin DB, 2004, MULTIPLE IMPUTATION; Ruocco AC, 2013, BIOL PSYCHIAT, V73, P153, DOI 10.1016/j.biopsych.2012.07.014; Santana GL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195581; Shah R, 2018, PSYCHIAT CLIN N AM, V41, P583, DOI 10.1016/j.psc.2018.07.009; Sharp C, 2018, PSYCHIAT CLIN N AM, V41, P669, DOI 10.1016/j.psc.2018.07.004; Silveira CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108355; Silveira CM, 2011, ALCOHOL ALCOHOLISM, V46, P324, DOI 10.1093/alcalc/agr007; Silvia PJ, 2014, BEHAV RES METHODS, V46, P41, DOI 10.3758/s13428-013-0353-y; StataCorp, 2017, STATA STAT SOFTWARE; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; Trull TJ, 2004, EXP CLIN PSYCHOPHARM, V12, P65, DOI 10.1037/1064-1297.12.1.65; Tuithof M, 2012, DRUG ALCOHOL DEPEN, V123, P115, DOI 10.1016/j.drugalcdep.2011.10.030; Turner S, 2018, DEPRESS ANXIETY, V35, P851, DOI 10.1002/da.22771; Tyrer P, 2011, LANCET, V377, P1814, DOI 10.1016/S0140-6736(10)61926-5; United Nations Department of Economic and Social Affairs Population Division, 2006, WORLD URB PROSP 2005, P106; Verheul R, 2001, EUR PSYCHIAT, V16, P274, DOI 10.1016/S0924-9338(01)00578-8; Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016; Winsper C, 2020, BRIT J PSYCHIAT, V216, P69, DOI 10.1192/bjp.2019.166; World Health Organization Harvard University., WORLD MENTAL HLTH SU	60	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248403	10.1371/journal.pone.0248403	http://dx.doi.org/10.1371/journal.pone.0248403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755679	gold, Green Published			2022-12-26	WOS:000632916600023
J	Kashaf, MS; Wolle, MA; Munoz, BE; Mkocha, H; Funga, N; Gracewello, C; West, SK				Kashaf, Michael Saheb; Wolle, Meraf A.; Munoz, Beatriz E.; Mkocha, Harran; Funga, Nicodemus; Gracewello, Catherine; West, Sheila K.			Patient perceived barriers to surgical follow-up: Study of 6-month post-operative trichiasis surgery follow-up in Tanzania	PLOS ONE			English	Article								Background Post-surgical follow-up is a challenge in low- and middle-income countries. Understanding barriers to trachomatous trichiasis (TT) surgical follow-up can inform program improvements. In this study, patient perceived barriers and enabling factors to follow-up after TT surgery are identified. Methods A longitudinal study was carried out in a community-based cohort of persons who received TT surgery in Bahi district, Tanzania. Questionnaires were administered before TT surgery and again after the scheduled 6-month follow-up. Those who did not return were examined at their homes. Results At baseline, 852 participants were enrolled. Of these, 633 (74%) returned at 6 months and 128 (15%) did not and were interviewed at home. Prior to surgery, attenders were more likely to report familiarity with a community health worker (CHW) (22% vs. 14%; p = 0.01) and less likely to state that time constraints are a potential reason for failure to follow-up (66% vs. 74%; p = .04). At follow-up, non-attenders were more likely to endorse barriers pertaining to knowledge about the need for follow-up, lack of transportation, and satisfaction with surgery. There was no difference in post-operative TT between attenders and non-attenders (23% vs. 18% respectively; p = 0.25). Conclusions The outcome of surgery was not a barrier to follow-up. However, better integration of CHWs into their communities and work at coordinating post-surgical care may improve follow-up rates. Moreover, provision of transportation and implementation of effective reminder systems may address patient-perceived barriers to improve follow-up.	[Kashaf, Michael Saheb; Wolle, Meraf A.; Munoz, Beatriz E.; West, Sheila K.] Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA; [Mkocha, Harran; Funga, Nicodemus; Gracewello, Catherine] Kongwa Trachoma Project, Kongwa, Tanzania	Johns Hopkins University; Johns Hopkins Medicine	West, SK (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21218 USA.	shwest@jhmi.edu			El Maghraby Chair of Ophthalmology at the Wilmer Eye Institute	El Maghraby Chair of Ophthalmology at the Wilmer Eye Institute	Funds provided by the El Maghraby Chair of Ophthalmology at the Wilmer Eye Institute.	Bergen N, 2020, QUAL HEALTH RES, V30, P783, DOI 10.1177/1049732319889354; Bickley RJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005211; Bowman RJC, 2000, TROP MED INT HEALTH, V5, P528, DOI 10.1046/j.1365-3156.2000.00605.x; Chakraborty J., 2013, CROSS CULTURAL DESIG; Chu KM, 2011, WORLD J SURG, V35, P1169, DOI 10.1007/s00268-011-1084-9; Goldman W., 2017, POSTTRICHIASIS SURG; Gupta V, 2013, OPHTHAL EPIDEMIOL, V20, P40, DOI 10.3109/09286586.2012.741278; Habtamu E, 2018, LANCET GLOB HEALTH, V6, pE579, DOI 10.1016/S2214-109X(18)30111-6; Habtamu E, 2016, LANCET GLOB HEALTH, V4, pE175, DOI 10.1016/S2214-109X(15)00299-5; Habte D, 2008, OPHTHAL EPIDEMIOL, V15, P328, DOI 10.1080/09286580801974897; Huang GF, 2012, OPHTHAL EPIDEMIOL, V19, P67, DOI 10.3109/09286586.2011.628777; Jo MS, 2000, PSYCHOL MARKET, V17, P137, DOI 10.1002/(SICI)1520-6793(200002)17:2<137::AID-MAR5>3.0.CO;2-V; McQueen KK., 2009, BURDEN SURG DIS STRA; Merbs S., 2013, TRICHIASIS SURG TRAC; Mwangi G, 2021, BRIT J OPHTHALMOL, V105, P904, DOI 10.1136/bjophthalmol-2019-315777; Ologunde R, 2013, LANCET GLOB HEALTH, V1, pE132, DOI 10.1016/S2214-109X(13)70061-5; Rajak SN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002392; Rajak SN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001766; REACHER MH, 1992, ARCH OPHTHALMOL-CHIC, V110, P667, DOI 10.1001/archopht.1992.01080170089030; Schein M, 2010, WORLD J SURG, V34, P471, DOI 10.1007/s00268-009-0385-8; Ssemanda EN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001576; Statistics NBo, 2013, 2012 POPULATION HOUS; Steyn E, 2019, BRIT J SURG, V106, pE17, DOI 10.1002/bjs.11028; West ES, 2005, INVEST OPHTH VIS SCI, V46, P447, DOI 10.1167/iovs.04-0600; West S, 2007, OPHTHAL EPIDEMIOL, V14, P273, DOI 10.1080/09286580701410323; Wolle MA, 2019, EXPERT REV ANTI-INFE, V17, P189, DOI 10.1080/14787210.2019.1577136	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0247994	10.1371/journal.pone.0247994	http://dx.doi.org/10.1371/journal.pone.0247994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739975	Green Published, gold			2022-12-26	WOS:000631030200029
J	Quaas, MF; Meya, JN; Schenk, H; Bos, B; Drupp, MA; Requate, T				Quaas, Martin F.; Meya, Jasper N.; Schenk, Hanna; Bos, Bjorn; Drupp, Moritz A.; Requate, Till			The social cost of contacts: Theory and evidence for the first wave of the COVID-19 pandemic in Germany	PLOS ONE			English	Article								Building on the epidemiological SIR model, we present an economic model with heterogeneous individuals deriving utility from social contacts creating infection risks. Focusing on social distancing of individuals susceptible to an infection we theoretically characterize the gap between private and social cost of contacts. Our main contribution is to quantify this gap by calibrating the model with unique survey data from Germany on social distancing and impure altruism from the beginning of the COVID-19 pandemic. The optimal policy is to drastically reduce contacts at the beginning to almost eradicate the epidemic and keep them at levels that contain the pandemic at a low prevalence level. We find that also in laissez faire, private protection efforts by forward-looking, risk averse individuals would have stabilized the epidemic, but at a much higher prevalence of infection than optimal. Altruistic motives increase individual protection efforts, but a substantial gap to the social optimum remains.	[Quaas, Martin F.; Meya, Jasper N.; Schenk, Hanna] Univ Leipzig, Dept Econ, Leipzig, Germany; [Quaas, Martin F.; Meya, Jasper N.; Schenk, Hanna] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Bos, Bjorn; Drupp, Moritz A.] Univ Hamburg, Dept Econ, Hamburg, Germany; [Drupp, Moritz A.] CESifo, Munich, Germany; [Requate, Till] Univ Kiel, Dept Econ, Kiel, Germany; [Quaas, Martin F.] German Ctr Integrat Biodivers Res iDiv, Biodivers Econ Grp, Leipzig, Germany	Leipzig University; University of Hamburg; Ifo Institut; University of Kiel	Quaas, MF (corresponding author), Univ Leipzig, Dept Econ, Leipzig, Germany.; Quaas, MF (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.; Quaas, MF (corresponding author), German Ctr Integrat Biodivers Res iDiv, Biodivers Econ Grp, Leipzig, Germany.	martin.quaas@idiv.de	Quaas, Martin/C-4220-2012	Quaas, Martin/0000-0003-0812-8829; Bos, Bjorn/0000-0003-0242-474X	German Federal Ministry of Education and Research (BMBF) [01LC1826E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded in the form of a grant by the German Federal Ministry of Education and Research (BMBF) (Grant No. 01LC1826E) awarded to MD.	Adler MD, 2021, J HEALTH ECON, V75, DOI 10.1016/j.jhealeco.2020.102412; Alfaro L., 2020, SOCIAL INTERACTIONS, P27134; ANDREONI J, 1988, J PUBLIC ECON, V35, P57, DOI 10.1016/0047-2727(88)90061-8; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Andreoni J, 2007, J PUBLIC ECON, V91, P1731, DOI 10.1016/j.jpubeco.2007.06.002; [Anonymous], MEASURING VOLUNTARY, DOI [10.1101/2020.05.01.20087874v1, DOI 10.1101/2020.05.01.20087874V1]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Arefin MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72971-y; Argente D., IN PRESS; Avery C, 2020, J ECON PERSPECT, V34, P79, DOI 10.1257/jep.34.4.79; Barrett S, 2007, ENVIRON DEV ECON, V12, P627, DOI 10.1017/S1355770X07003816; Barrett S, 2003, J EUR ECON ASSOC, V1, P591, DOI 10.1162/154247603322391224; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Bayham J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0814; Bethune Zachary A., 2020, NBER WORKING PAPER S, P27009; Bodenstein M., 2020, SOCIAL DISTANCING SU, P2020; Bos B, 2020, ENVIRON RESOUR ECON, V76, P1117, DOI 10.1007/s10640-020-00477-2; Bramoulle Y, 2009, J EUR ECON ASSOC, V7, P1042, DOI 10.1162/JEEA.2009.7.5.1042; Brotherhood L., 2020, EC MODEL COVID 19 EP, P14695; Byrd RH, 2006, NONCONVEX OPTIM, V83, P35; Byrd RH, 1999, SIAM J OPTIMIZ, V9, P877, DOI 10.1137/S1052623497325107; Chernozhukov V., 2021, IN PRESS; Chudik A., 2020, VOLUNTARY MANDATORY, P8243; Coibion O., 2020, COST COVID 19 CRISIS, P27141; Dasaratha K., 2020, VIRUS DYNAMICS BEHAV; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Drupp MA, 2018, AM ECON J-ECON POLIC, V10, P109, DOI 10.1257/pol.20160240; Fadinger H., 2020, COVID EC, P107, DOI [DOI 10.3886/E124902V2, DOI 10.1016/J.JVB.2020.103435]; Falk A, 2018, Q J ECON, V133, P1645, DOI 10.1093/qje/qjy013; Farboodi M., 2020, INTERNAL EXTERNAL EF, P27059; Fenichel EP, 2013, J HEALTH ECON, V32, P440, DOI 10.1016/j.jhealeco.2013.01.002; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Garriga C, HCEO WORKING PAPER S; Gerlagh R, 2020, CLOSED FORM SOLUTION; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Gersovitz M, 2011, ANNU REV RESOUR ECON, V3, P277, DOI 10.1146/annurev-resource-083110-120052; Goeree JK, 2002, J PUBLIC ECON, V83, P255, DOI 10.1016/S0047-2727(00)00160-2; Gollier C, 2020, J PUBLIC ECON THEORY, V22, P1746, DOI 10.1111/jpet.12486; Gonzalez-Eiras M., 2020, OPTIMAL LOCKDOWN EPI, P8240; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Greenwood J, 2019, ECONOMETRICA, V87, P1081, DOI 10.3982/ECTA11530; Grimm V., 2020, EXTENSIONS SEIR MODE; Guerrieri Veronica, 2020, MACROECONOMIC IMPLIC; Harsanyi JC, 1955, J POLIT ECON, V63, P309, DOI 10.1086/257678; Jones CJ., 2020, OPTIMAL MITIGATION P, P26984; Kabir KMA, 2020, J THEOR BIOL, V503, DOI 10.1016/j.jtbi.2020.110399; Kabir KMA, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2019.0484; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Malekian, 2020, 27483 NBER; McBride M, 2006, J PUBLIC ECON, V90, P1181, DOI 10.1016/j.jpubeco.2005.09.012; Morin BR, 2013, NAT RESOUR MODEL, V26, P505, DOI 10.1111/nrm.12011; MORTENSEN DT, 1994, REV ECON STUD, V61, P397, DOI 10.2307/2297896; Ottoni-Wilhelm M, 2017, AM ECON REV, V107, P3617, DOI 10.1257/aer.20141222; Pindyck RS., 2020, COVID 19 WELFARE EFF, P27121; Quaas MF, 2008, ECOL ECON, V65, P397, DOI 10.1016/j.ecolecon.2007.07.004; Quaas MF, 2019, MAR RESOUR ECON, V34, P291, DOI 10.1086/705905; Rachel L., 2020, ANAL MODEL COVID 19; Robert Koch Institut, 2020, DAILY SIT REP; Roemer JE, 1996, THEORIES DISTRIBUTIV; Rowthorn BR., 2012, OPTIMAL CONTROL INFE, P8925; Tahvonen I, 2018, J ENVIRON ECON MANAG, V92, P659, DOI 10.1016/j.jeem.2017.08.011; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Toxvaerd F., 2020, EQUILIBRIUM SOCIAL D, P2021; Trabandt M., 2020, MACROECONOMICS EPIDE, P26882	69	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248288	10.1371/journal.pone.0248288	http://dx.doi.org/10.1371/journal.pone.0248288			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740007	gold, Green Published			2022-12-26	WOS:000631030200023
J	Song, D; Lan, JQ; Chen, YQ; Liu, AY; Wu, Q; Zhao, CC; Feng, YD; Wang, J; Luo, XL; Cao, ZX; Cao, XN; Hu, JB; Wang, GH				Song, Da; Lan, Jingqin; Chen, Yaqi; Liu, Anyi; Wu, Qi; Zhao, Chongchong; Feng, Yongdong; Wang, Jing; Luo, Xuelai; Cao, Zhixin; Cao, Xiaonian; Hu, Junbo; Wang, Guihua			NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein	ONCOGENE			English	Article								Tumor angiogenesis plays vital roles in tumorigenesis and development; regulatory mechanism of angiogenesis is still not been fully elucidated. NSD2, a histone methyltransferase catalyzing di-methylation of histone H3 at lysine 36, has been proved a critical molecule in proliferation, metastasis, and tumorigenesis. But its role in tumor angiogenesis remains unknown. Here we demonstrated that NSD2 promoted tumor angiogenesis in vitro and in vivo. Furthermore, we confirmed that the angiogenic function of NSD2 was mediated by STAT3. Momentously, we found that NSD2 promoted the methylation and activation of STAT3. In addition, mass spectrometry and site-directed mutagenesis assays revealed that NSD2 methylated STAT3 at lysine 163 (K163). Meanwhile, K to R mutant at K163 of STAT3 attenuated the activation and angiogenic function of STAT3. Taken together, we conclude that methylation of STAT3 catalyzed by NSD2 promotes the activation of STAT3 pathway and enhances the ability of tumor angiogenesis. Our findings investigate a NSD2-dependent methylation-phosphorylation regulation pattern of STAT3 and reveal that NSD2/STAT3/VEGFA axis might be a potential target for tumor therapy.	[Song, Da; Lan, Jingqin; Chen, Yaqi; Liu, Anyi; Wu, Qi; Feng, Yongdong; Luo, Xuelai; Cao, Zhixin; Cao, Xiaonian; Hu, Junbo; Wang, Guihua] Huazhong Univ Sci & Technol, Tongji Hosp, GI Canc Res Inst, Wuhan, Peoples R China; [Lan, Jingqin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thyroid & Breast Surg, Wuhan, Peoples R China; [Zhao, Chongchong] Tsinghua Univ, Technol Ctr Prot Sci, Prot Facil, Beijing, Peoples R China; [Wang, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan, Peoples R China; [Cao, Xiaonian] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Tsinghua University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, JB; Wang, GH (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, GI Canc Res Inst, Wuhan, Peoples R China.	jbhu@tjh.tjmu.edu.cn; ghwang@tjh.tjmu.edu.cn	Wang, Guihua/AAX-3130-2021		NSFC [81773113, 81922053, 81702264, 81974432, 81874186]	NSFC(National Natural Science Foundation of China (NSFC))	We are grateful to the members in Guihua Wang's lab and Junbo Hu's lab for the critical inputs and suggestions. This work is supported by NSFC (No. 81773113 GW, No. 81922053 GW, No.81702264 XC, No. 81974432 GW, and No. 81874186 JH).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Aytes A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07511-4; Bharadwaj U, 2020, PHARMACOL REV, V72, P486, DOI 10.1124/pr.119.018440; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Canavese M, 2017, INT J CANCER, V140, P2183, DOI 10.1002/ijc.30567; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Cheong CM, 2020, CANCER LETT, V475, P99, DOI 10.1016/j.canlet.2020.01.040; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dasgupta M, 2015, P NATL ACAD SCI USA, V112, P3985, DOI 10.1073/pnas.1503152112; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Foltz SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16434-y; Guo JP, 2019, NAT CELL BIOL, V21, P226, DOI 10.1038/s41556-018-0261-6; Haibe Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00221; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1347-1; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hou ZL, 2020, CANCER LETT, V487, P63, DOI 10.1016/j.canlet.2020.05.029; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lhoumaud P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12811-4; Luo J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09784-9; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Park JW, 2018, ONCOGENE, V37, P6212, DOI 10.1038/s41388-018-0393-y; Saltz LB, 2016, LANCET ONCOL, V17, P1469, DOI 10.1016/S1470-2045(16)30213-3; Smeets D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06567-6; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stubbs MC, 2019, CLIN CANCER RES, V25, P300, DOI 10.1158/1078-0432.CCR-18-0098; Swaroop A, 2019, ONCOGENE, V38, P671, DOI 10.1038/s41388-018-0474-y; Wang GH, 2019, NAT CELL BIOL, V21, P214, DOI 10.1038/s41556-018-0266-1; Wang JJ, 2019, ACTA PHARMACOL SIN, V40, P1067, DOI 10.1038/s41401-018-0199-z; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Xie ZG, 2019, LEUKEMIA, V33, P739, DOI 10.1038/s41375-018-0300-0; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang JF, 2019, CANCER DISCOV, V9, P1306, DOI 10.1158/2159-8290.CD-18-0083; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4	45	4	4	4	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2952	2967		10.1038/s41388-021-01747-z	http://dx.doi.org/10.1038/s41388-021-01747-z		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742125				2022-12-26	WOS:000630655600003
J	Eroume, K; Vasilevich, A; Vermeulen, S; de Boer, J; Carlier, A				Eroume, K.; Vasilevich, A.; Vermeulen, S.; de Boer, J.; Carlier, A.			On the influence of cell shape on dynamic reaction-diffusion polarization patterns	PLOS ONE			English	Article							POLARITY; MODELS; ACTIVATION; MIGRATION; GTPASES; RAC1	The distribution of signaling molecules following mechanical or chemical stimulation of a cell defines cell polarization, with regions of high active Cdc42 at the front and low active Cdc42 at the rear. As reaction-diffusion phenomena between signaling molecules, such as Rho GTPases, define the gradient dynamics, we hypothesize that the cell shape influences the maintenance of the "front-to-back" cell polarization patterns. We investigated the influence of cell shape on the Cdc42 patterns using an established computational polarization model. Our simulation results showed that not only cell shape but also Cdc42 and Rho-related (in)activation parameter values affected the distribution of active Cdc42. Despite an initial Cdc42 gradient, the in silico results showed that the maximal Cdc42 concentration shifts in the opposite direction, a phenomenon we propose to call "reverse polarization". Additional in silico analyses indicated that "reverse polarization" only occurred in a particular parameter value space that resulted in a balance between inactivation and activation of Rho GTPases. Future work should focus on a mathematical description of the underpinnings of reverse polarization, in combination with experimental validation using, for example, dedicated FRET-probes to spatiotemporally track Rho GTPase patterns in migrating cells. In summary, the findings of this study enhance our understanding of the role of cell shape in intracellular signaling.	[Eroume, K.; Vermeulen, S.; Carlier, A.] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Netherlands; [Vasilevich, A.; Vermeulen, S.; de Boer, J.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Eindhoven University of Technology	Carlier, A (corresponding author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Maastricht, Netherlands.	a.carlier@maastrichtuniversity.nl		Carlier, Aurelie/0000-0002-2305-5667; de Boer, Jan/0000-0001-9188-9324	Dutch province of Limburg [FCL67723]; Dutch Science Foundation (NWO) [15075]; European Union [676338]	Dutch province of Limburg; Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	AC and JDB kindly acknowledge the Dutch province of Limburg in the LINK (FCL67723) ("Limburg INvesteert in haar Kenniseconomie") knowledge economy project. AC acknowledges a VENI grant (number 15075) from the Dutch Science Foundation (NWO). SV is supported by the European Union's Horizon 2020 Programme (H2020-MSCA-ITN-2015; Grant agreement 676338). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergmann F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218328; Bolado-Carrancio A, 2020, ELIFE, V9, DOI 10.7554/eLife.58165; Brasch ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211408; Cao YS, 2019, ELIFE, V8, DOI 10.7554/eLife.48478; Chalut KJ, 2016, DEV CELL, V38, P571, DOI 10.1016/j.devcel.2016.09.011; Chiou JG, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006095; Cusseddu D, 2019, J THEOR BIOL, V481, P119, DOI 10.1016/j.jtbi.2018.09.008; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; de Beco S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07286-8; Edelstein-Keshet L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0003; Feng SL, 2018, BIOMECH MODEL MECHAN, V17, P1611, DOI 10.1007/s10237-018-1047-2; Fink A, AREA GEOMETRY DEPEND; Fritz Rafael Dominik, 2016, F1000Res, V5, DOI 10.12688/f1000research.7370.1; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Giese W, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066014; Goedhart Joachim, 2019, Small GTPases, V10, P178, DOI 10.1080/21541248.2017.1302551; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Goryachev AB, 2006, PLOS COMPUT BIOL, V2, P1511, DOI 10.1371/journal.pcbi.0020172; Goryachev AB, 2017, MOL BIOL CELL, V28, P370, DOI 10.1091/mbc.E16-10-0739; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Holmes WR, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/4/046001; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Knoch F, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/4/046002; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Liu Y, SPOTS STRIPS SPIRAL; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; Maree AFM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002402; Martin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21901; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Narang A, 2001, ANN BIOMED ENG, V29, P677, DOI 10.1114/1.1385805; O'Neill PR, 2016, MOL BIOL CELL, V27, P1442, DOI 10.1091/mbc.E15-12-0832; Otsuji M, 2007, PLOS COMPUT BIOL, V3, P1040, DOI 10.1371/journal.pcbi.0030108; Pandya P, 2017, MOL ONCOL, V11, P5, DOI 10.1002/1878-0261.12019; Park J, 2017, P NATL ACAD SCI USA, V114, pE5750, DOI 10.1073/pnas.1700054114; Spill F, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/3/036008; Subramanian KK, 2004, J THEOR BIOL, V231, P49, DOI 10.1016/j.jtbi.2004.05.024; Walther GR, 2012, B MATH BIOL, V74, P2570, DOI 10.1007/s11538-012-9766-5; Warner H, 2019, CURR OPIN CELL BIOL, V56, P64, DOI 10.1016/j.ceb.2018.09.003; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Zheng ZZ, 2011, MATH BIOSCI ENG, V8, P1135, DOI 10.3934/mbe.2011.8.1135	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248293	10.1371/journal.pone.0248293	http://dx.doi.org/10.1371/journal.pone.0248293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735291	Green Published, gold			2022-12-26	WOS:000631029700111
J	Jensen, SA; Atwa, O; Handford, PA				Jensen, Sacha A.; Atwa, Ondine; Handford, Penny A.			Assembly assay identifies a critical region of human fibrillin-1 required for 10-12 nm diameter microfibril biogenesis	PLOS ONE			English	Article							NEONATAL MARFAN-SYNDROME; FACTOR-LIKE DOMAINS; SYNDROME MUTATIONS; MISSENSE MUTATION; INTEGRIN BINDING; FBN1 MUTATIONS; CELL-ADHESION; CDNA-CLONES; GENE; CALCIUM	The human FBN1 gene encodes fibrillin-1 (FBN1); the main component of the 10-12 nm diameter extracellular matrix microfibrils. Marfan syndrome (MFS) is a common inherited connective tissue disorder, caused by FBN1 mutations. It features a wide spectrum of disease severity, from mild cases to the lethal neonatal form (nMFS), that is yet to be explained at the molecular level. Mutations associated with nMFS generally affect a region of FBN1 between domains TB3-cbEGF18-the "neonatal region". To gain insight into the process of fibril assembly and increase our understanding of the mechanisms determining disease severity in MFS, we compared the secretion and assembly properties of FBN1 variants containing nMFS-associated substitutions with variants associated with milder, classical MFS (cMFS). In the majority of cases, both nMFS- and cMFS-associated neonatal region variants were secreted at levels comparable to wild type. Microfibril incorporation by the nMFS variants was greatly reduced or absent compared to the cMFS forms, however, suggesting that nMFS substitutions disrupt a previously undefined site of microfibril assembly. Additional analysis of a domain deletion variant caused by exon skipping also indicates that register in the neonatal region is likely to be critical for assembly. These data demonstrate for the first time new requirements for microfibril biogenesis and identify at least two distinct molecular mechanisms associated with disease substitutions in the TB3-cbEGF18 region; incorporation of mutant FBN1 into microfibrils changing their integral properties (cMFS) or the blocking of wild type FBN1 assembly by mutant molecules that prevents late-stage lateral assembly (nMFS).	[Jensen, Sacha A.; Atwa, Ondine; Handford, Penny A.] Univ Oxford, Dept Biochem, Oxford, England; [Jensen, Sacha A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Atwa, Ondine] Broad Inst, Cardiovasc Dis Initiat, Cambridge, MA USA; [Atwa, Ondine] Broad Inst, Precis Cardiol Lab, Cambridge, MA USA	University of Oxford; James Cook University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jensen, SA; Handford, PA (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.; Jensen, SA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	sacha.jensen@jcu.edu.au; penny.handford@bioch.ox.ac.uk			Arthritis Research UK [20785]; MRC [MR/M009831/1]	Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SAJ and PAH gratefully acknowledge support from Arthritis Research UK (www.versusarthritis.org; project grant no. 20785) and the MRC (https://mrc.ukri.org; grant number MR/M009831/1).	Ades LC, 2006, AM J MED GENET A, V140A, P1047, DOI 10.1002/ajmg.a.31202; Arbustini Eloisa, 2005, Hum Mutat, V26, P494, DOI 10.1002/humu.9377; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Baldwin AK, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.9; Barnett CP, 2010, AM J MED GENET A, V152A, P2409, DOI 10.1002/ajmg.a.33406; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bresters D, 1999, ACTA PAEDIATR, V88, P98; Buoni S, 2004, ANN HUM GENET, V68, P633, DOI 10.1046/j.1529-8817.2004.00113.x; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Cain SA, 2008, J BIOL CHEM, V283, P27017, DOI 10.1074/jbc.M803373200; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; Chandra A, 2012, INVEST OPHTH VIS SCI, V53, P4889, DOI 10.1167/iovs.12-9874; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Del Cid JS, 2019, J BIOL CHEM, V294, P18232, DOI 10.1074/jbc.RA119.011109; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X; FRANCKE U, 1995, AM J HUM GENET, V56, P1287; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Jensen SA, 2005, J BIOL CHEM, V280, P14076, DOI 10.1074/jbc.M412832200; Jensen SA, 2015, HUM MOL GENET, V24, P4454, DOI 10.1093/hmg/ddv181; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P10155, DOI 10.1073/pnas.1401697111; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; Kettle S, 2000, INT J BIOCHEM CELL B, V32, P201, DOI 10.1016/S1357-2725(99)00120-X; Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Liu WO, 1997, GENET TEST, V1, P237, DOI 10.1089/gte.1997.1.237; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; Lonnqvist L, 1996, GENOMICS, V36, P468, DOI 10.1006/geno.1996.0492; Lu YH, 2005, J MOL BIOL, V349, P73, DOI 10.1016/j.jmb.2005.03.066; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Matyas G, 2007, HUM GENET, V122, P23, DOI 10.1007/s00439-007-0371-x; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Peng Q, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0598-6; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Piha-Gossack A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033560; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Reyes-Hernandez OD, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0935-9; Robertson I, 2011, BIOCHEM J, V433, P263, DOI 10.1042/BJ20101320; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Stheneur C, 2009, EUR J HUM GENET, V17, P1121, DOI 10.1038/ejhg.2009.36; Tekin M, 2007, AM J MED GENET A, V143A, P875, DOI 10.1002/ajmg.a.31660; Tiecke F, 2001, EUR J HUM GENET, V9, P13, DOI 10.1038/sj.ejhg.5200582; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Tjeldhorn L, 2006, GENET TEST, V10, P258, DOI 10.1089/gte.2006.258-264; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wang M, 1997, HUM MUTAT, V9, P359, DOI 10.1002/(SICI)1098-1004(1997)9:4<359::AID-HUMU10>3.0.CO;2-1; Wang MC, 2009, J MOL BIOL, V388, P168, DOI 10.1016/j.jmb.2009.02.062; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Whiteman P, 2003, HUM MOL GENET, V12, P727, DOI 10.1093/hmg/ddg081; Whiteman P, 2007, HUM MOL GENET, V16, P907, DOI 10.1093/hmg/ddm035; Whiteman P, 2013, J BIOL CHEM, V288, P7305, DOI 10.1074/jbc.M112.428854; Yadin DA, 2014, BIOMOL NMR ASSIGN, V8, P75, DOI 10.1007/s12104-012-9456-0; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	73	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248532	10.1371/journal.pone.0248532	http://dx.doi.org/10.1371/journal.pone.0248532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735269	Green Published, gold, Green Accepted			2022-12-26	WOS:000631029700049
J	Koizumi, R; Kusama, Y; Muraki, Y; Ishikane, M; Yamasaki, D; Tanabe, M; Ohmagari, N				Koizumi, Ryuji; Kusama, Yoshiki; Muraki, Yuichi; Ishikane, Masahiro; Yamasaki, Daisuke; Tanabe, Masaki; Ohmagari, Norio			Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance	PLOS ONE			English	Article								Purpose Regional-level measures can complement national antimicrobial stewardship programs. In Japan, sub-prefectural regions called secondary medical areas (SMAs) provide general inpatient care within their borders, and regional antimicrobial stewardship measures are frequently implemented at this level. There is therefore a need to conduct antimicrobial use (AMU) surveillance at this level to ascertain antimicrobial consumption. However, AMU estimates are generally standardized to residence-based nighttime populations, which do not account for population mobility across regional borders. We examined the impact of population in/outflow on SMA-level AMU estimates by comparing the differences between standardization using daytime and nighttime populations. Methods We obtained AMU information from the National Database of Health Insurance Claims and Specific Health Checkups of Japan. AMU was quantified at the prefectural and SMA levels using the number of defined daily doses (DDDs) divided by (a) 1,000 nighttime population per day or (b) 1,000 daytime population per day. We identified and characterized the discrepancies between the two types of estimates at the prefectural and SMA levels. Results The national AMU was 17.21 DDDs per 1,000 population per day. The mean (95% confidence interval) prefectural-level DDDs per 1,000 nighttime and daytime population per day were 17.27 (14.10, 20.44) and 17.41 (14.30, 20.53), respectively. The mean (95% confidence interval) SMA-level DDDs per 1,000 nighttime and daytime population per day were 16.12 (9.84, 22.41) and 16.41 (10.57, 22.26), respectively. The nighttime population-standardized estimates were generally higher than the daytime population-standardized estimates in urban areas, but lower in the adjacent suburbs. Large differences were observed in the main metropolitan hubs in eastern and western Japan. Conclusion Regional-level AMU estimates, especially of smaller regions such as SMAs, are susceptible to the use of different populations for standardization. This finding indicates that AMU standardization based on population values is not suitable for AMU estimates in small regions.	[Koizumi, Ryuji; Kusama, Yoshiki; Ishikane, Masahiro; Ohmagari, Norio] Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan; [Kusama, Yoshiki; Ohmagari, Norio] Tohoku Univ, Sch Med, Dept Emerging & Reemerging Infect Dis, Sendai, Miyagi, Japan; [Muraki, Yuichi] Kyoto Pharmaceut Univ, Dept Clin Pharmacoepidemiol, Kyoto, Japan; [Ishikane, Masahiro; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Yamasaki, Daisuke; Tanabe, Masaki] Mie Univ Hosp, Dept Infect Control & Prevent, Tsu, Mie, Japan	National Center for Global Health & Medicine - Japan; Tohoku University; Kyoto Pharmaceutical University; National Center for Global Health & Medicine - Japan; Mie University	Kusama, Y (corresponding author), Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan.; Kusama, Y (corresponding author), Tohoku Univ, Sch Med, Dept Emerging & Reemerging Infect Dis, Sendai, Miyagi, Japan.	stone.bagle@gmail.com	Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970	Ministry of Health, Labor and Welfare (MHLW) research grant of Japan [20HA2003]	Ministry of Health, Labor and Welfare (MHLW) research grant of Japan	This work was supported by the Ministry of Health, Labor and Welfare (MHLW) research grant of Japan (20HA2003).	Avedissian SN, 2018, J ANTIMICROB CHEMOTH, V73, P2876, DOI 10.1093/jac/dky275; Benic MS, 2018, J ANTIMICROB CHEMOTH, V73, P50, DOI 10.1093/jac/dky118; Joint Programming Initiative on Antimicrobial Resistance, 2016, NATL ACTION PLAN ANT; Kusama Y, 2019, JPN J INFECT DIS, V72, P326, DOI 10.7883/yoken.JJID.2018.417; Kuster SP, 2008, INFECTION, V36, P549, DOI 10.1007/s15010-008-7462-z; Matsuda S., 2014, ASIAN PAC J DIS MANA, V6, P55, DOI [10.7223/apjdm.6.55, DOI 10.7223/apjdm.6.55]; Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA; Park YM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030908; Qi W, 2015, J GEOGR SCI, V25, P756, DOI 10.1007/s11442-015-1200-0; WHO, WHO METH GLOB PROGR; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2019 ATC DDD IND 2019; Yu KC, 2018, CLIN INFECT DIS, V67, P1677, DOI 10.1093/cid/ciy354	13	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248338	10.1371/journal.pone.0248338	http://dx.doi.org/10.1371/journal.pone.0248338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735299	Green Published, gold			2022-12-26	WOS:000631029700101
J	Anwari, V; Ng, WCK; Hondjeu, ARM; Xiao, ZX; Afenu, E; Trac, J; Kazlovich, K; Hiansen, J; Mashari, A				Anwari, Vahid; Ng, William C. K.; Mbadjeu Hondjeu, Arnaud Romeo; Xiao, Zixuan; Afenu, Edem; Trac, Jessica; Kazlovich, Kate; Hiansen, Joshua; Mashari, Azad			Development, manufacturing, and preliminary validation of a reusable half-face respirator during the COVID-19 pandemic	PLOS ONE			English	Article								Introduction The COVID-19 pandemic has led to widespread shortages of N95 respirators and other personal protective equipment (PPE). An effective, reusable, locally-manufactured respirator can mitigate this problem. We describe the development, manufacture, and preliminary testing of an open-hardware-licensed device, the "simple silicone mask" (SSM). Methods A multidisciplinary team developed a reusable silicone half facepiece respirator over 9 prototype iterations. The manufacturing process consisted of 3D printing and silicone casting. Prototypes were assessed for comfort and breathability. Filtration was assessed by user seal checks and quantitative fit-testing according to CSA Z94.4-18. Results The respirator originally included a cartridge for holding filter material; this was modified to connect to standard heat-moisture exchange (HME) filters (N95 or greater) after the cartridge showed poor filtration performance due to flow acceleration around the filter edges, which was exacerbated by high filter resistance. All 8 HME-based iterations provided an adequate seal by user seal checks and achieved a pass rate of 87.5% (N = 8) on quantitative testing, with all failures occurring in the first iteration. The overall median fit-factor was 1662 (100 = pass). Estimated unit cost for a production run of 1000 using distributed manufacturing techniques is CAD $15 in materials and 20 minutes of labor. Conclusion Small-scale manufacturing of an effective, reusable N95 respirator during a pandemic is feasible and cost-effective. Required quantities of reusables are more predictable and less vulnerable to supply chain disruption than disposables. With further evaluation, such devices may be an alternative to disposable respirators during public health emergencies. The respirator described above is an investigational device and requires further evaluation and regulatory requirements before clinical deployment. The authors and affiliates do not endorse the use of this device at present.	[Anwari, Vahid] Univ Hlth Network, Toronto Gen Hosp, Joint Dept Med Imaging, Toronto, ON, Canada; [Anwari, Vahid; Kazlovich, Kate; Hiansen, Joshua; Mashari, Azad] Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Pain Management, Lynn & Arnold Irwin Adv Perioperat Imaging Lab, Toronto, ON, Canada; [Ng, William C. K.; Mashari, Azad] Univ Toronto, Dept Anesthesiol & Pain Med, Toronto, ON, Canada; [Ng, William C. K.; Mbadjeu Hondjeu, Arnaud Romeo; Mashari, Azad] Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Pain Management, Toronto, ON, Canada; [Ng, William C. K.] Hosp Sick Children, Dept Anaesthesia & Pain Management, Toronto, ON, Canada; [Xiao, Zixuan] Univ Alberta, Fac Med, Edmonton, AB, Canada; [Afenu, Edem] Univ Toronto, Sch Biomed Engn, Toronto, ON, Canada; [Afenu, Edem; Trac, Jessica] Univ Toronto, Fac Med, Toronto, ON, Canada; [Kazlovich, Kate] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Toronto; University of Toronto; University of Toronto	Ng, WCK (corresponding author), Univ Toronto, Dept Anesthesiol & Pain Med, Toronto, ON, Canada.; Ng, WCK (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Pain Management, Toronto, ON, Canada.; Ng, WCK (corresponding author), Hosp Sick Children, Dept Anaesthesia & Pain Management, Toronto, ON, Canada.	DrWilliam.Ng@mail.utoro.ca	Mashari, Azad/S-3096-2018; Ng, William C. K./D-7460-2015	Mashari, Azad/0000-0002-8403-1271; Ng, William C. K./0000-0002-0183-8951; Afenu, Edem Andy/0000-0002-2778-869X; Anwari, Vahid/0000-0001-5104-2276; Xiao, Maggie/0000-0002-7534-6079; Mbadjeu hondjeu, Arnaud romeo/0000-0001-6470-4574				3M, 2013, 3M TM REUS RESP; Ahmed Jubair, 2020, Medical Devices & Sensors, V3, P221; Alenezi H, 2021, BIO-DES MANUF, V4, P1, DOI 10.1007/s42242-020-00097-1; [Anonymous], 2020, SMOOTH ON TM SMOOTH; Brosseau L., 2009, N95 RESPIRATORS SURG; Centers for Disease Control and Prevention, 2020, DEC REUS FILT FAC RE; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; GREENE VW, 1986, INFECT CONT HOSP EP, V7, P508, DOI 10.1017/S0195941700065140; Hines SE, 2019, AM J INFECT CONTROL, V47, P648, DOI 10.1016/j.ajic.2018.11.021; Ibrahim AMS, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000298; Intersurgical Canada, 2019, AIR GUARD TM CLEAR P; Keles O, 2017, RAPID PROTOTYPING J, V23, P320, DOI 10.1108/RPJ-09-2015-0122; National Institute for Occupational Health and Safety, 2015, HOSP RESP PROT PROGR, DOI [10.26616/NIOSHPUB2015117, DOI 10.26616/NIOSHPUB2015117]; National Institute for Occupational Safety and Health : National Personal Protective Technology Laboratory, 2019, DET PART FILT EFF LE; Ng WCK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242304; Occupational Safety and Health Administration, 2004, 1910 OCC SAF HLTH AD; Patel A, 2017, HEALTH SECUR, V15, P244, DOI 10.1089/hs.2016.0129; Purchas DB., 2002, HDB FILTER MEDIA, P453, DOI [10.1016/B978-185617375-9/50012-2, DOI 10.1016/B978-185617375-9/50012-2]; Ramirez JA., 2015, EVALUATION PARTICLE, DOI [10.17077/etd.wfvehzie, DOI 10.17077/ETD.WFVEHZIE]; Shahrubudin N, 2019, PROCEDIA MANUF, V35, P1286, DOI 10.1016/j.promfg.2019.06.089; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Standards Council of Canada, 2018, CAN CSA Z94 4 18 SEL; Tcharkhtchi A, 2021, BIOACT MATER, V6, P106, DOI 10.1016/j.bioactmat.2020.08.002; US Gov, 2004, CODE FEDERAL REGULAT; USA Medical and Surgical Supplies, 2020, 3M 1860 SURG MASK; Walsh M, 2020, GLOBE MAIL; Wizner K, 2016, WORKPLACE HEALTH SAF, V64, P359, DOI 10.1177/2165079916657108	28	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247575	10.1371/journal.pone.0247575	http://dx.doi.org/10.1371/journal.pone.0247575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730106	Green Published, gold			2022-12-26	WOS:000630345000074
J	Szilagyi, A; Bodor, A; Tolvai, N; Kovacs, KL; Bodai, L; Wirth, R; Bagi, Z; Szepesi, A; Marko, V; Kakuk, B; Bounedjoum, N; Rakhely, G				Szilagyi, Arpad; Bodor, Attila; Tolvai, Norbert; Kovacs, Kornel L.; Bodai, Laszlo; Wirth, Roland; Bagi, Zoltan; Szepesi, Agnes; Marko, Viktoria; Kakuk, Balazs; Bounedjoum, Naila; Rakhely, Gabor			A comparative analysis of biogas production from tomato bio-waste in mesophilic batch and continuous anaerobic digestion systems	PLOS ONE			English	Article							DAIRY MANURE; CO-DIGESTION; BY-PRODUCTS; FOOD WASTE; SP-NOV; COMMUNITIES; PERFORMANCE; BIOMETHANE; DIVERSITY; SUBSTRATE	Annually, agricultural activity produces an enormous amount of plant biomass by-product. Many studies have reported the biomethane potential of agro-industrial wastes, but only a few studies have investigated applying the substrates in both batch and continuous mode. Tomato is one of the most popular vegetables globally; its processing releases a substantial amount of by-product, such as stems and leaves. This study examined the BMP of tomato plant (Solanum lycopersicum Mill. L. cv. Alfred) waste. A comparative test revealed that the BMPs of corn stover, tomato waste,and their combination were approximately the same, around 280 mL methane/g Volatile Solid. In contrast, the relative biogas production decreased in the presence of tomato waste in a continuous mesophilic anaerobic digestion system; the daily biogas productions were 860 +/- 80, 290 +/- 50, and 570 +/- 70 mL biogas/gVolatile Solid/day in the case of corn stover, tomato waste, and their mixture, respectively. The methane content of biogas was around 46-48%. The fermentation parameters of the continuous AD experiments were optimal in all cases; thus, TW might have an inhibitory effect on the microbial community. Tomato plant materials contain e.g. flavonoids, glycoalkaloids (such as tomatine and tomatidine), etc. known as antimicrobial and antifungal agents. The negative effect of tomatine on the biogas yield was confirmed in batch fermentation experiments. Metagenomic analysis revealed that the tomato plant waste caused significant rearrangements in the microbial communities in the continuously operated reactors. The results demonstrated that tomato waste could be a good mono-substrate in batch fermentations or a co-substrate with corn stover in a proper ratio in continuous anaerobic fermentations for biogas production. These results also point to the importance of running long-term continuous fermentations to test the suitability of a novel biomass substrate for industrial biogas production.	[Szilagyi, Arpad; Bodor, Attila; Tolvai, Norbert; Kovacs, Kornel L.; Wirth, Roland; Bagi, Zoltan; Marko, Viktoria; Kakuk, Balazs; Bounedjoum, Naila; Rakhely, Gabor] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Bodor, Attila; Rakhely, Gabor] Univ Szeged, Inst Environm Sci, Szeged, Hungary; [Bodor, Attila; Kovacs, Kornel L.; Rakhely, Gabor] Biol Res Ctr, Inst Biophys, Szeged, Hungary; [Kovacs, Kornel L.] Univ Szeged, Dept Oral Biol & Expt Dent Res, Szeged, Hungary; [Bodai, Laszlo] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Szepesi, Agnes] Univ Szeged, Dept Plant Biol, Szeged, Hungary	Szeged University; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Szeged University; Szeged University	Rakhely, G (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.; Rakhely, G (corresponding author), Univ Szeged, Inst Environm Sci, Szeged, Hungary.; Rakhely, G (corresponding author), Biol Res Ctr, Inst Biophys, Szeged, Hungary.	rakhely.gabor@brc.hu	Bodai, Laszlo/A-9764-2012; Szepesi, Agnes/AAK-8966-2020; Szilágyi, Árpád/M-9511-2018; Wirth, Roland/L-8886-2018	Bodai, Laszlo/0000-0001-8411-626X; Szepesi, Agnes/0000-0003-3043-4857; Szilágyi, Árpád/0000-0002-3276-1934; Kakuk, Balazs/0000-0002-4314-5707; Wirth, Roland/0000-0002-2383-2323	Hungarian National Research, Development and Innovation Fund [EFOP-3.6.2-16-201700010]; Hungarian NRDIO under the PD16 funding scheme [PD121085]; National Talent Program [NTP-NFTO-19-B-0087]	Hungarian National Research, Development and Innovation Fund; Hungarian NRDIO under the PD16 funding scheme(National Research, Development & Innovation Office (NRDIO) - Hungary); National Talent Program	This study has been supported in part by the Hungarian National Research, Development and Innovation Fund projects EFOP-3.6.2-16-201700010. R. Wreceived support from the Hungarian NRDIO funded projects PD121085 financed under the PD16 funding scheme. For A.SZ. the financial support of National Talent Program (NTP-NFTO-19-B-0087) is gratefully appreciated.	Abe K, 2012, J GEN APPL MICROBIOL, V58, P405, DOI 10.2323/jgam.58.405; Achinas Spyridon, 2016, Resource-Efficient Technologies, V2, P143, DOI 10.1016/j.reffit.2016.08.001; Costa OYA, 2015, J IND MICROBIOL BIOT, V42, P73, DOI 10.1007/s10295-014-1533-1; Atem AD, 2010, INT J HYDROGEN ENERG, V35, P6048, DOI 10.1016/j.ijhydene.2009.12.075; Bagi Z, 2017, ANAEROBE, V46, P13, DOI 10.1016/j.anaerobe.2017.03.001; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Brochier-Armanet C, 2012, ISME J, V6, P227, DOI [10.1038/ismej.2011.145, 10.1038/ismej.2012.110]; Budiyono Manthia F, 2018, MATEC WEB C, DOI [10.1051/matecconf/201815603053, DOI 10.1051/MATECCONF/201815603053]; Buettner C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49313-8; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Cook LE, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00581-18; Deressa L., 2015, ENV ECOLOGY RES, V3, P65, DOI [10.13189/eer.2015.030303, DOI 10.13189/EER.2015.030303]; Detman A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1106-z; Deublein D., 2010, BIOGAS WASTE RENEWAB, P55, DOI [10.1002/9783527632794.ch7, DOI 10.1002/9783527632794.CH7]; Food and Agriculture Organization of the United Nations (FAO), 2018, FAOSTAT AGR LAND AR; Gharechahi J, 2015, SYST APPL MICROBIOL, V38, P67, DOI 10.1016/j.syapm.2014.09.004; Goering H., 1970, AGR HDB, V379, P1; HILLS DJ, 1979, AGR WASTES, V1, P267, DOI 10.1016/0141-4607(79)90011-8; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holliger C, 2016, WATER SCI TECHNOL, V74, P2515, DOI 10.2166/wst.2016.336; Kakuk B, 2017, ANAEROBE, V46, P78, DOI 10.1016/j.anaerobe.2017.05.015; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Kassab Z, 2020, CELLULOSE, V27, P4287, DOI 10.1007/s10570-020-03097-7; Kassambara A., 2018, GGPUBR GGPLOT2 BASED; Kassambara A., 2017, EXTRACT VISUALIZE RE; Kim W, 2010, BIORESOURCE TECHNOL, V101, pS17, DOI 10.1016/j.biortech.2009.03.029; Koeck DE, 2014, J BIOTECHNOL, V188, P136, DOI 10.1016/j.jbiotec.2014.08.024; Kovacs KL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/482653; Kulcu R, 2014, POL J ENVIRON STUD, V23, P1341; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li PF, 2019, ENERGIES, V12, DOI 10.3390/en12010026; Li YY, 2018, BIORESOURCE TECHNOL, V270, P103, DOI 10.1016/j.biortech.2018.08.061; Li YY, 2018, WASTE MANAGE, V73, P130, DOI 10.1016/j.wasman.2017.11.041; Liu CQ, 2019, BIORESOURCE TECHNOL, V291, DOI 10.1016/j.biortech.2019.121877; Liu Y, 2019, BIORESOURCE TECHNOL, V287, DOI 10.1016/j.biortech.2019.121339; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luengo Elisa, 2014, Front Nutr, V1, P12, DOI 10.3389/fnut.2014.00012; Manas P, 2018, INT J ENVIRON SCI TE, V15, P273, DOI 10.1007/s13762-017-1386-z; Martinez M, 2017, ACTA HORTIC, V1159, P151, DOI 10.17660/ActaHortic.2017.1159.23; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Minot S. S., 2015, ONE CODEX SENSITIVE, DOI [10.1101/027607, DOI 10.1101/027607]; Mitchell G, 2011, ANTIMICROB AGENTS CH, V55, P1937, DOI 10.1128/AAC.01468-10; Nugroho A, 2020, AIP CONF PROC, V2197, DOI 10.1063/1.5140902; Pane C, 2015, CHEM BIOL TECHNOL AG, V2, DOI 10.1186/s40538-014-0026-9; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Silva-Beltran NP, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/284071; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; R Core Team, 2021, R LANGUAGE ENV STAT; Raud M., 2015, Agronomy Research, V13, P405; Rettenmaier R, 2019, SYST APPL MICROBIOL, V42, P481, DOI 10.1016/j.syapm.2019.05.002; Rui JP, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0339-3; Saev M B, 2009, J U CHEM TECHNOLOGY, V44, P55; Saghouri M, 2018, J MATER CYCLES WASTE, V20, P561, DOI 10.1007/s10163-017-0622-4; Schieber A, 2001, TRENDS FOOD SCI TECH, V12, P401, DOI 10.1016/S0924-2244(02)00012-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnurer A, 2009, MICROBIOLOGICAL HDB; Tapadia-Maheshwari S, 2019, BIORESOURCE TECHNOL, V289, DOI 10.1016/j.biortech.2019.121639; Torres-Leon C, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00052; Ulusoy Y, 2009, AFR J AGR RES, V4, P996; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097265; Weiss S, 2010, WATER RES, V44, P1970, DOI 10.1016/j.watres.2009.11.048; Westerholm M., 2019, MICROBIAL RESPONSES, DOI [DOI 10.5772/INTECHOPEN.82815, 10.5772/intechopen.82815]; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Zamanzadeh M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15784-w; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9	67	3	3	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248654	10.1371/journal.pone.0248654	http://dx.doi.org/10.1371/journal.pone.0248654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730081	gold, Green Accepted, Green Published			2022-12-26	WOS:000630345000054
J	Ayuso, M; Irwin, R; Walsh, C; Van Cruchten, S; Van Ginneken, C				Ayuso, Miriam; Irwin, Rachelle; Walsh, Colum; Van Cruchten, Steven; Van Ginneken, Chris			Low birth weight female piglets show altered intestinal development, gene expression, and epigenetic changes at key developmental loci	FASEB JOURNAL			English	Article						gene expression; gene methylation; intestinal development; LBW; piglet	INTRAUTERINE GROWTH RESTRICTION; DNA METHYLATION; MESSENGER-RNA; ALKALINE-PHOSPHATASE; NEONATAL PIGLETS; BARRIER FUNCTION; GUT DEVELOPMENT; MODEL; MORPHOLOGY; IMMUNITY	Intestinal development is compromised in low birth weight (LBW) pigs, negatively impacting their growth, health, and resilience. We investigated the molecular mechanisms of the altered intestinal maturation observed in neonatal and juvenile LBW female piglets by comparing the changes in intestinal morphology, gene expression, and methylation in LBW versus normal birth weight (NBW) female piglets. A total of 16 LBW/NBW sibling pairs were sacrificed at 0 hours, 8 hours, 10 days, and 8 weeks of age. The gastrointestinal tract was weighed, measured, and the small intestine was sampled for histomorphology, gene expression, and methylation analyses. Impaired intestinal development, with shorter villi and shallower crypts, was observed in LBW female piglets. The expression of intestinal development markers (ALPI and OLFM) rapidly peaked after birth in NBW but not in LBW female piglets. The lower expression of genes involved in nutrient digestion (ANPEP and SI) and barrier function (OCLN and CLDN4) in LBW, together with their delayed development of intestinal villi and crypts could help to explain the compromised health and growth potential of LBW female piglets. The changes in methylation observed in LBW in key regulators of intestinal development (OLFM4 and FZD5) suggest long-term effects of BW on intestinal gene expression, development, and function. Accordingly, experimental demethylation induced in IPEC-J2 cells led to increased expression of intestinal genes (MGA, DPP4, and GLUT2). Overall, we have identified the alterations in transcription or epigenetic marking at a number of genes critical to intestinal development, which may contribute to both the short- and long-term failure of LBW female piglets to thrive.	[Ayuso, Miriam; Van Cruchten, Steven; Van Ginneken, Chris] Univ Antwerp, Dept Vet Sci, Comparat Perinatal Dev, Antwerp, Belgium; [Irwin, Rachelle; Walsh, Colum] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland	University of Antwerp; Ulster University	Ayuso, M (corresponding author), Univ Antwerp, Dept Vet Sci, Campus CDE U016,Univ Pl 1, B-2610 Antwerp, Belgium.	Miriam.AyusoHernando@uantwerpen.be	ayuso, miriam/GPX-8386-2022	ayuso, miriam/0000-0001-6045-394X; Van Ginneken, Chris/0000-0002-1622-9120	University of Antwerp Bijzonder Onderzoeksfonds (BOF) [34479]; STSM under the COST Action "Sharing Advances on Large Animal Models (SALAAM)" [BM1308]	University of Antwerp Bijzonder Onderzoeksfonds (BOF); STSM under the COST Action "Sharing Advances on Large Animal Models (SALAAM)"	This research was funded by the special research fund of the University of Antwerp Bijzonder Onderzoeksfonds (BOF) under grant no 34479. The research stay abroad that allowed MA to perform gene expression and methylation analyses in the lab of CW was funded by an STSM under the COST Action BM1308 "Sharing Advances on Large Animal Models (SALAAM)."	Ashworth CJ, 2001, J REP FER S, P233; Ayuso M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197263; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Biesterveld BE, 2015, J SURG RES, V196, P235, DOI 10.1016/j.jss.2015.02.030; Buddington RK, 2012, J ANIM SCI, V90, P290, DOI 10.2527/jas.54604; Burrin DG, 2000, AM J CLIN NUTR, V71, P1603; Butler JE, 2013, IMMUNOLOGY, V138, P134, DOI 10.1111/imm.12018; Che LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157314; Cui XL, 2003, BBA-BIOMEMBRANES, V1612, P178, DOI 10.1016/S0005-2736(03)00129-9; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Gao F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-716; GODA T, 1985, J PEDIATR GASTR NUTR, V4, P998, DOI 10.1097/00005176-198512000-00024; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; Gonzalez-Bulnes A, 2016, THERIOGENOLOGY, V86, P110, DOI 10.1016/j.theriogenology.2016.03.024; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Gunadi, 2014, J PEDIATR SURG, V49, P1614, DOI 10.1016/j.jpedsurg.2014.04.011; Hamard A, 2010, J NUTR BIOCHEM, V21, P914, DOI 10.1016/j.jnutbio.2009.07.004; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hoch M, 1996, MECH DEVELOP, V58, P3, DOI 10.1016/S0925-4773(96)00541-2; Hu Y, 2018, MOL GENET GENOMICS, V293, P807, DOI 10.1007/s00438-018-1422-9; Huygelen V, 2014, J ANIM SCI, V92, P3398, DOI 10.2527/jas.2014-7742; Irwin RE, 2014, GENOMICS, V104, P383, DOI 10.1016/j.ygeno.2014.08.013; Ivanova E, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00857-x; Jorgensen BG, 2019, J NEUROGASTROENTEROL, V25, P377, DOI 10.5056/jnm19077; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Lackeyram D, 2010, J NUTR, V140, P461, DOI 10.3945/jn.109.117267; Leedham SJ, 2005, J CELL MOL MED, V9, P11, DOI 10.1111/j.1582-4934.2005.tb00333.x; Lengyel J A, 1998, Cell Res, V8, P273; Lickert H, 2001, MECH DEVELOP, V105, P181, DOI 10.1016/S0925-4773(01)00390-2; Liu X, 2020, SIGNAL IMAGE VIDEO P, V14, P1227, DOI 10.1007/s11760-020-01644-0; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Niinikoski H, 2004, J NUTR, V134, P1467, DOI 10.1093/jn/134.6.1467; Ovilo C, 2014, BRIT J NUTR, V111, P735, DOI 10.1017/S0007114513002948; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Rasmussen SO, 2016, AM J PHYSIOL-GASTR L, V311, pG480, DOI 10.1152/ajpgi.00139.2016; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rutledge CE., 2014, DEVELOPMENT, V141, p1313; Rutledge CE, 2014, DEVELOPMENT, V141, P1313, DOI 10.1242/dev.104646; Sangild PT, 2007, AM J PHYSIOL-REG I, V293, pR2179, DOI 10.1152/ajpregu.00395.2007; Sarr O., BIORXIV; SCHREIBER RA, 1988, ANN ALLERGY, V61, P3; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Stoy A.C.F., 2013, ISRN GENOMICS, V2013, P1, DOI [10.1155/2013/980651, DOI 10.1155/2013/980651]; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Tsukahara T, 2013, ANIM SCI J, V84, P54, DOI 10.1111/j.1740-0929.2012.01039.x; Umar Shahid, 2010, Curr Gastroenterol Rep, V12, P340, DOI 10.1007/s11894-010-0130-3; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Vanden Hole C, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02510; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergauwen H, 2015, IMPACT FOOD BIOACTIV, P125, DOI DOI 10.1007/978-3-319-16104-4_12; Vergauwen H, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5040041; Vergauwen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120485; Wadley GD, 2013, PHYSIOL GENOMICS, V45, P99, DOI 10.1152/physiolgenomics.00095.2012; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Xu S, 2015, J APPL MICROBIOL, V119, P225, DOI 10.1111/jam.12833; Yang H, 2009, ANN NY ACAD SCI, V1165, P338, DOI 10.1111/j.1749-6632.2009.04026.x; Yeruva L, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0456-x; Zhang H, 2018, POULTRY SCI, V97, P628, DOI 10.3382/ps/pex328	68	4	4	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21522	10.1096/fj.202002587R	http://dx.doi.org/10.1096/fj.202002587R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734504	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000635216100021
J	Ilic, N; Tao, YL; Boutros-Suleiman, S; Kadali, VN; Emanuelli, A; Levy-Cohen, G; Blank, M				Ilic, Natasa; Tao, Yulei; Boutros-Suleiman, Sandy; Kadali, Venkata Narasimha; Emanuelli, Andrea; Levy-Cohen, Gal; Blank, Michael			SMURF2-mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells	FASEB JOURNAL			English	Article						interactome; PARP1; PARylation; SMURF2; ubiquitinome	PROTEOME-WIDE IDENTIFICATION; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; ADP-RIBOSYLATION; ASSOCIATION; DOMAINS	Poly(ADP-ribose) polymerase 1 (PARP1) is a key molecular stress sensor and response mediator implicated in multiple cellular functions in health and diseases. Despite its importance and intrinsic involvement in pivotal molecular and cellular processes, including DNA repair, transcription regulation, chromatin organization, and cell death, the regulatory mechanisms of PARP1 are poorly understood. In this study, we show that SMURF2, a HECT-type E3 ubiquitin ligase and suggested tumor suppressor, physically interacts with PARP1 in different cellular settings, directly ubiquitinates it in vitro and stimulates its PARylation activity in cells, the phenomenon that required SMURF2 E3 ubiquitin ligase function. Intriguingly, in the cellular environment SMURF2 was found to regulate the dynamic exchange of ubiquitin moieties on PARP1, mostly decreasing its monoubiquitination. Through the set of systematic mass spectrometry analyses conducted on SMURF2-modified cells, we identified on PARP1 18 lysine residues (out of 126 present in PARP1) as sites which ubiquitination was considerably affected by SMURF2. Subsequent site-directed mutagenesis coupled with in cellula ubiquitination and PARylation assays unveiled K222 as a critical site enabling a cross talk between SMURF2-modulated monoubiquitination of PARP1 and its activity, and pointed to K498, S507, and a KTR triad (K498/K521/K524) as the main auto-PARylation sites affected by SMURF2. The results also uncovered that SMURF2 controls PARP1 interactome, influencing its functions and expression in a context-dependent manner. Taken together, these findings suggest that SMURF2-mediated ubiquitin signaling plays an essential role in PARP1 regulation, beyond the regulation of its protein expression.	[Ilic, Natasa; Tao, Yulei; Boutros-Suleiman, Sandy; Kadali, Venkata Narasimha; Emanuelli, Andrea; Levy-Cohen, Gal; Blank, Michael] Bar Ilan Univ, Lab Mol & Cellular Canc Biol, Azrieli Fac Med, IL-1311502 Safed, Israel; [Emanuelli, Andrea] Univ Bordeaux, Lab Angiogenese & Microenvironm Canc LAMC ACML, Inserm U1029, Campus Talence Allee Geoffroy St Hilaire, F-33615 Pessac, France	Bar Ilan University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Blank, M (corresponding author), Bar Ilan Univ, Lab Mol & Cellular Canc Biol, Azrieli Fac Med, IL-1311502 Safed, Israel.	michael.blank@biu.ac.il	Emanuelli, Andrea/AAJ-8175-2020; Kadali, Venkata Narasimha/AGR-3560-2022; Ilic, Natasa/AAR-2491-2021	Kadali, Venkata Narasimha/0000-0003-2041-7092; Ilic, Natasa/0000-0001-5987-2805; Boutros-Suleiman, Sandy/0000-0003-4216-0371	Israel Science Foundation [422/20]; Marie-Curie FP-7 CIG [612816]	Israel Science Foundation(Israel Science Foundation); Marie-Curie FP-7 CIG	Israel Science Foundation, Grant/Award Number: #422/20; Marie-Curie FP-7 CIG, Grant/Award Number: #612816	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Alemasova EE, 2019, NUCLEIC ACIDS RES, V47, P3811, DOI 10.1093/nar/gkz120; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; Borroni AP, 2018, AGING CELL, V17, DOI 10.1111/acel.12732; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Ciccarone F, 2017, SEMIN CELL DEV BIOL, V63, P123, DOI 10.1016/j.semcdb.2016.11.010; Dawicki-McKenna JM, 2015, MOL CELL, V60, P755, DOI 10.1016/j.molcel.2015.10.013; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Emanuelli A, 2019, CANCERS, V11, DOI 10.3390/cancers11040556; Emanuelli A, 2017, CANCER RES, V77, P4217, DOI 10.1158/0008-5472.CAN-16-2828; Franzese E, 2019, CANCER TREAT REV, V73, P1, DOI 10.1016/j.ctrv.2018.12.002; Fu L, 2020, SEMIN CANCER BIOL, V67, P102, DOI 10.1016/j.semcancer.2019.12.023; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hottiger MO, 2015, ANNU REV BIOCHEM, V84, P227, DOI 10.1146/annurev-biochem-060614-034506; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kashima L, 2012, J BIOL CHEM, V287, P12975, DOI 10.1074/jbc.M111.321828; Kim JJ, 2018, MOL CELLS, V41, P799, DOI 10.14348/molcells.2018.0078; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Langelier MF, 2011, METHODS MOL BIOL, V780, P209, DOI 10.1007/978-1-61779-270-0_13; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Levy-Cohen G, 2015, ANAL BIOCHEM, V484, P37, DOI 10.1016/j.ab.2015.04.040; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Ayyathan DM, 2020, ONCOGENE, V39, P3396, DOI 10.1038/s41388-020-1226-3; Martello R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12917; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Qian H, 2020, J CELL MOL MED, V24, P4600, DOI 10.1111/jcmm.15121; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; Sun CY, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5148; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Zhang NJ, 2020, CELL DEATH DIFFER, V27, P2605, DOI 10.1038/s41418-020-0523-2; Zhang Y, 2017, ONCOTARGET, V8, P94505, DOI 10.18632/oncotarget.21784; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	47	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21436	10.1096/fj.202001759R	http://dx.doi.org/10.1096/fj.202001759R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734501				2022-12-26	WOS:000635216100070
J	Devine, A; Vahanian, A; Sawadogo, B; Zan, S; Bocoum, FY; Kelly, H; Gilham, C; Nagot, N; Ong, JJ; Legood, R; Meda, N; Miners, A; Mayaud, P				Devine, Angela; Vahanian, Alice; Sawadogo, Bernard; Zan, Souleymane; Bocoum, Fadima Yaya; Kelly, Helen; Gilham, Clare; Nagot, Nicolas; Ong, Jason J.; Legood, Rosa; Meda, Nicolas; Miners, Alec; Mayaud, Philippe		HARP Consortium	Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; INTRAEPITHELIAL NEOPLASIA; ACETIC-ACID; PERFORMANCE; PREVENTION; LESIONS	Introduction This study estimated the costs and incremental cost per case detected of screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+) in women living with HIV (WLHIV) attending HIV clinics in Burkina Faso. Methods The direct healthcare provider costs of screening tests (visual inspection with acetic acid (VIA), VIA combined visual inspection with Lugol's iodine (VIA/VILI), cytology and a rapid HPV DNA test (careHPV)) and confirmatory tests (colposcopy, directed biopsy and systematic four-quadrant (4Q) biopsy) were collected alongside the HPV in Africa Research Partnership (HARP) study. A model was developed for a hypothetical cohort of 1000 WLHIV using data on CIN2+ prevalence and the sensitivity of the screening tests. Costs are reported in USD (2019). Results The study enrolled 554 WLHIV with median age 36 years (inter-quartile range, 31-41) and CIN2+ prevalence of 5.8%. The average cost per screening test ranged from US$3.2 for VIA to US$24.8 for cytology. Compared to VIA alone, the incremental cost per CIN2+ case detected was US$48 for VIA/VILI and US$814 for careHPV. Despite higher costs, careHPV was more sensitive for CIN2+ cases detected compared to VIA/VILI (97% and 56%, respectively). The cost of colposcopy was US$6.6 per person while directed biopsy was US$33.0 and 4Q biopsy was US$48.0. Conclusion Depending on the willingness to pay for the detection of a case of cervical cancer, decision makers in Burkina Faso can consider a variety of cervical cancer screening strategies for WLHIV. While careHPV is more costly, it has the potential to be cost-effective depending on the willingness to pay threshold. Future research should explore the lifetime costs and benefits of cervical cancer screening to enable comparisons with interventions for other diseases.	[Devine, Angela] Charles Darwin Univ, Global & Trop Hlth Div, Menzies Sch Hlth Res, Darwin, NT, Australia; [Devine, Angela] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Vahanian, Alice; Kelly, Helen; Gilham, Clare; Ong, Jason J.; Legood, Rosa; Miners, Alec; Mayaud, Philippe] London Sch Hyg & Trop Med, London, England; [Sawadogo, Bernard; Meda, Nicolas] Univ Ouagadougou, Ctr Rech Int Sante, Ouagadougou, Burkina Faso; [Zan, Souleymane] Ctr Hosp Univ Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Bocoum, Fadima Yaya] Inst Rech Sci Sante, Ouagadougou, Burkina Faso; [Nagot, Nicolas] Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, Etab Francais Sang, Montpellier, France; [Ong, Jason J.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	Charles Darwin University; Menzies School of Health Research; University of Melbourne; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Monash University	Devine, A (corresponding author), Charles Darwin Univ, Global & Trop Hlth Div, Menzies Sch Hlth Res, Darwin, NT, Australia.; Devine, A (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	angela.devine@menzies.edu.au	Devine, Angela/A-6295-2012; Legood, Rosa/GQZ-9121-2022	Devine, Angela/0000-0002-3321-8706; Legood, Rosa/0000-0003-2761-5227; Ong, Jason/0000-0001-5784-7403; MAYAUD, Philippe/0000-0001-5730-947X; Nagot, Nicolas/0000-0002-3493-2821	European Commission (EC) 7th Framework Programme [HEALTH-2010-F2-265396]	European Commission (EC) 7th Framework Programme	The research leading to these results has received funding from the European Commission (EC) 7th Framework Programme under grant agreement No. HEALTH-2010-F2-265396 (https://ec.europa.eu/research/fp7) awarded to PM. The funder did not contribute in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HARP STUDY INVESTIGA; Assemblee Nationale-Republique du Burkina Faso, 2012, LOI N 041 2010AN LOI; Bansil P, 2015, J LOW GENIT TRACT DI, V19, P215, DOI 10.1097/LGT.0000000000000090; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campos NG, 2018, JAIDS-J ACQ IMM DEF, V79, P195, DOI [10.1097/QAI.0000000000001778, 10.1097/qai.0000000000001778]; Canfell K, 2019, PAPILLOMAVIRUS RES, V8, DOI 10.1016/j.pvr.2019.100184; Castle PE, 2012, VACCINE, V30, pF117, DOI 10.1016/j.vaccine.2012.05.071; Centers for Disease Control and Prevention, 1992, MMWR, V41 RR-17; Chung MH, 2013, AIDS, V27, P2909, DOI 10.1097/01.aids.0000432472.92120.1b; Compaore S, 2016, J CANCER EDUC, V31, P760, DOI 10.1007/s13187-015-0898-9; Denny L, 2008, REPROD HEALTH MATTER, V16, P18, DOI 10.1016/S0968-8080(08)32397-0; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Denslow SA, 2014, INT J STD AIDS, V25, P163, DOI 10.1177/0956462413491735; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Domgue JF, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00048; Doutre S, 2018, J CLIN PATHOL, V71, P40, DOI 10.1136/jclinpath-2017-204512; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Fokom-Domgue J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3084; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hu LM, 2019, JNCI-J NATL CANCER I, V111, P923, DOI 10.1093/jnci/djy225; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Kelly H, 2018, LANCET HIV, V5, pE45, DOI 10.1016/S2352-3018(17)30149-2; Kelly H, 2017, SEX TRANSM INFECT, V93, pS36, DOI 10.1136/sextrans-2016-053070; Kelly HA, 2017, AIDS, V31, P273, DOI 10.1097/QAD.0000000000001301; Koliopoulos G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008587.pub2; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Legood R, 2005, INT J CANCER, V117, P981, DOI 10.1002/ijc.21220; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Lince-Deroche N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141969; Mezei AK, 2017, INT J CANCER, V141, P437, DOI 10.1002/ijc.30695; Muwonge R, 2007, J MED SCREEN, V14, P144, DOI 10.1258/096914107782066158; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OANDA, 2012, CURR CONV HIST EXCH; President du Burkina Faso, 1992, COD TRAV DECR 92 379; Quentin W, 2011, TROP MED INT HEALTH, V16, P379, DOI 10.1111/j.1365-3156.2010.02722.x; Sawadogo B, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.175.3866; Segondy M, 2016, BRIT J CANCER, V115, P425, DOI 10.1038/bjc.2016.207; Shi JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-123; The World Bank, 2020, GDP DEFLATOR BASE YE; UNAIDS, HIV PREVALENCE 2015; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Vodicka EL, 2017, INT J GYNECOL OBSTET, V136, P220, DOI 10.1002/ijgo.12025; WHO, 2003, WHO GUIDE COST EFFEC; World Health Organization, 2013, GUID SCREEN TREATM P; Yeates K, 2020, JCO GLOB ONCOL, V6, P1114, DOI 10.1200/GO.20.00124	46	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248832	10.1371/journal.pone.0248832	http://dx.doi.org/10.1371/journal.pone.0248832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765011	Green Published, Green Accepted, gold			2022-12-26	WOS:000634832800010
J	Jeliazkov, JR; Frick, R; Zhou, J; Gray, JJ				Jeliazkov, Jeliazko R.; Frick, Rahel; Zhou, Jing; Gray, Jeffrey J.			Robustification of RosettaAntibody and Rosetta SnugDock	PLOS ONE			English	Article								In recent years, the observed antibody sequence space has grown exponentially due to advances in high-throughput sequencing of immune receptors. The rise in sequences has not been mirrored by a rise in structures, as experimental structure determination techniques have remained low-throughput. Computational modeling, however, has the potential to close the sequence-structure gap. To achieve this goal, computational methods must be robust, fast, easy to use, and accurate. Here we report on the latest advances made in RosettaAntibody and Rosetta SnugDock-methods for antibody structure prediction and antibody-antigen docking. We simplified the user interface, expanded and automated the template database, generalized the kinematics of antibody-antigen docking (which enabled modeling of single-domain antibodies) and incorporated new loop modeling techniques. To evaluate the effects of our updates on modeling accuracy, we developed rigorous tests under a new scientific benchmarking framework within Rosetta. Benchmarking revealed that more structurally similar templates could be identified in the updated database and that SnugDock broadened its applicability without losing accuracy. However, there are further advances to be made, including increasing the accuracy and speed of CDR-H3 loop modeling, before computational approaches can accurately model any antibody.	[Jeliazkov, Jeliazko R.; Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Frick, Rahel; Zhou, Jing; Gray, Jeffrey J.] Johns Hopkins Univ, Chem & Biomol Engn, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gray, JJ (corresponding author), Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA.; Gray, JJ (corresponding author), Johns Hopkins Univ, Chem & Biomol Engn, Baltimore, MD 21218 USA.; Gray, JJ (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Gray, JJ (corresponding author), Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA.	jgray@jhu.edu	Gray, Jeffrey/B-5682-2008	Gray, Jeffrey/0000-0001-6380-2324; Frick, Rahel/0000-0002-3469-5686; Jeliazkov, Jeliazko/0000-0003-4249-1955	National Institutes of Health - NIGMS [F31-GM123616, T32-GM008403]; NIGMS [R01-GM078221]	National Institutes of Health - NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (https://www.nih.gov/).JRJ was funded by NIGMS grants F31-GM123616 and T32-GM008403. JRJ, RF, JZ, and JJG were funded by NIGMS grant R01-GM078221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Almagro JC, 2014, PROTEINS, V82, P1553, DOI 10.1002/prot.24567; Ambrosetti F, 2020, STRUCTURE, V28, P119, DOI 10.1016/j.str.2019.10.011; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Dunbar J, 2014, NUCLEIC ACIDS RES, V42, pD1140, DOI 10.1093/nar/gkt1043; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Guest JD, 2020, EXPANDED BENCHMARK A; Hua CK, 2017, ELIFE, V6, DOI 10.7554/eLife.29023; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kaas Q, 2004, NUCLEIC ACIDS RES, V32, pD208, DOI 10.1093/nar/gkh042; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Krawczyk K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01698; Leem J, 2016, MABS-AUSTIN, V8, P1259, DOI 10.1080/19420862.2016.1205773; Lepore R, 2017, NUCLEIC ACIDS RES, V45, pW17, DOI 10.1093/nar/gkx334; Long XY, 2019, PEERJ, V7, DOI 10.7717/peerj.6179; Marze NA, 2018, BIOINFORMATICS, V34, P3461, DOI 10.1093/bioinformatics/bty355; Marze NA, 2016, PROTEIN ENG DES SEL, V29, P409, DOI 10.1093/protein/gzw013; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Parsons J, 2005, J COMPUT CHEM, V26, P1063, DOI 10.1002/jcc.20237; Ramirez-Aportela E, 2016, BIOINFORMATICS, V32, P2386, DOI 10.1093/bioinformatics/btw141; Lopez-Blanco JR, 2019, BIOINFORMATICS, V35, P3013, DOI 10.1093/bioinformatics/btz026; Regep C, 2017, PROTEINS, V85, P1311, DOI 10.1002/prot.25291; Roy Burman SS, 2019, PROTEINS, DOI [DOI 10.1002/PROT.25855, 10.1002/prot.25855]; Rudolph MJ, 2017, J BIOL CHEM, V292, P872, DOI 10.1074/jbc.M116.758102; Ruffolo JA., 2020, GEOMETRIC POTENTIALS, DOI [10.1101/2020.02.09.940254, DOI 10.1101/2020.02.09.940254]; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weitzner BD, 2017, NAT PROTOC, V12, P401, DOI 10.1038/nprot.2016.180; Weitzner BD, 2017, J IMMUNOL, V198, P505, DOI 10.4049/jimmunol.1601137; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Wong WK, 2019, BIOINFORMATICS, V35, P1774, DOI 10.1093/bioinformatics/bty877	38	9	9	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0234282	10.1371/journal.pone.0234282	http://dx.doi.org/10.1371/journal.pone.0234282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764990	gold, Green Submitted, Green Published			2022-12-26	WOS:000634832800021
J	Dixon, BE; Wools-Kaloustian, KK; Fadel, WF; Duszynski, TJ; Yiannoutsos, C; Halverson, PK; Menachemi, N				Dixon, Brian E.; Wools-Kaloustian, Kara K.; Fadel, William F.; Duszynski, Thomas J.; Yiannoutsos, Constantin; Halverson, Paul K.; Menachemi, Nir			Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study	PLOS ONE			English	Article								Background Prior studies examining symptoms of COVID-19 are primarily descriptive and measured among hospitalized individuals. Understanding symptoms of SARS-CoV-2 infection in pre-clinical, community-based populations may improve clinical screening, particularly during flu season. We sought to identify key symptoms and symptom combinations in a community-based population using robust methods. Methods We pooled community-based cohorts of individuals aged 12 and older screened for SARS-CoV-2 infection in April and June 2020 for a statewide prevalence study. Main outcome was SARS-CoV-2 positivity. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for individual symptoms as well as symptom combinations. We further employed multivariable logistic regression and exploratory factor analysis (EFA) to examine symptoms and combinations associated with SARS-CoV-2 infection. Results Among 8214 individuals screened, 368 individuals (4.5%) were RT-PCR positive for SARS-CoV-2. Although two-thirds of symptoms were highly specific (>90.0%), most symptoms individually possessed a PPV <50.0%. The individual symptoms most greatly associated with SARS-CoV-2 positivity were fever (OR = 5.34, p<0.001), anosmia (OR = 4.08, p<0.001), ageusia (OR = 2.38, p = 0.006), and cough (OR = 2.86, p<0.001). Results from EFA identified two primary symptom clusters most associated with SARS-CoV-2 infection: (1) ageusia, anosmia, and fever; and (2) shortness of breath, cough, and chest pain. Moreover, being non-white (13.6% vs. 2.3%, p<0.001), Hispanic (27.9% vs. 2.5%, p<0.001), or living in an Urban area (5.4% vs. 3.8%, p<0.001) was associated with infection. Conclusions Symptoms can help distinguish SARS-CoV-2 infection from other respiratory viruses, especially in community or urgent care settings where rapid testing may be limited. Symptoms should further be structured in clinical documentation to support identification of new cases and mitigation of disease spread by public health. These symptoms, derived from asymptomatic as well as mildly infected individuals, can also inform vaccine and therapeutic clinical trials.	[Dixon, Brian E.; Duszynski, Thomas J.] IU Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46202 USA; [Dixon, Brian E.; Menachemi, Nir] Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN 46202 USA; [Wools-Kaloustian, Kara K.] IU Sch Med, Dept Med, Indianapolis, IN USA; [Wools-Kaloustian, Kara K.] Indiana Univ, Ctr Global Hlth, Indianapolis, IN 46204 USA; [Fadel, William F.; Yiannoutsos, Constantin] IU Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN USA; [Halverson, Paul K.; Menachemi, Nir] IU Fairbanks Sch Publ Hlth, Dept Hlth Policy & Management, Indianapolis, IN USA; [Halverson, Paul K.] IU Sch Med, Dept Family Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Dixon, BE (corresponding author), IU Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46202 USA.; Dixon, BE (corresponding author), Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN 46202 USA.	bedixon@regenstrief.org	Dixon, Brian E/A-9494-2013	Dixon, Brian E/0000-0002-1121-0607; Menachemi, Nir/0000-0002-3411-2700; Duszynski, Thomas/0000-0003-1860-2774	Indiana Department of Health; U.S. National Library of Medicine [T15LM012502]; U.S. Centers for Disease Control and Prevention [U18DP006500]	Indiana Department of Health; U.S. National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Indiana Department of Health to the Fairbanks School of Public Health (PI -NM) as a component of its efforts to examine seroprevalence of the state population for COVID-19. The funder played a role in data collection, but it did not play a role in study design, analysis, or preparation of the manuscript. Dr. Dixon receives funding from the U.S. National Library of Medicine (T15LM012502) to train public health informatics researchers as well as the U.S. Centers for Disease Control and Prevention (U18DP006500) and the Indiana Department of Health to support disease surveillance research.	Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Centers for Disease Control and Prevention [Internet, 2020, SYMPT COR; Centers for Disease Control and Prevention US, 2020, COVID 19 RAC ETHN MI; Chow EJ, 2020, JAMA-J AM MED ASSOC, V323, P2087, DOI 10.1001/jama.2020.6637; Coletta MA., 2020, PUBLIC HLTH INFORM I, P269; Denis F, 2020, J MED INTERNET RES, V22, DOI 10.2196/19855; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Kim GU, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.04.040; Menachemi N, 2021, INDIANA STATEWIDE SA; Menachemi N, 2020, MMWR-MORBID MORTAL W, V69, P960, DOI 10.15585/mmwr.mm6929e1; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Ming LC, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19796; National Center for Immunization and Respiratory Diseases Division of Viral Diseases, 2020, HLTH EQ CONS RAC ETH; Pascarella G, 2020, J INTERN MED, V288, P192, DOI 10.1111/joim.13091; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Skerman HM, 2009, RES NURS HEALTH, V32, P345, DOI 10.1002/nur.20323; Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665; Tong JY, 2020, OTOLARYNG HEAD NECK, V163, P3, DOI 10.1177/0194599820926473; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Yamamoto K, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19902; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	22	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0241875	10.1371/journal.pone.0241875	http://dx.doi.org/10.1371/journal.pone.0241875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760821	Green Published, gold, Green Submitted			2022-12-26	WOS:000633030400066
J	Fils, PEL; Cholley, P; Gbaguidi-Haore, H; Hocquet, D; Sauget, M; Bertrand, X				Fils, Pierre Edwige L.; Cholley, Pascal; Gbaguidi-Haore, Houssein; Hocquet, Didier; Sauget, Marlene; Bertrand, Xavier			ESBL-producing Klebsiella pneumoniae in a University hospital: Molecular features, diffusion of epidemic clones and evaluation of cross-transmission	PLOS ONE			English	Article							CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CHANGING EPIDEMIOLOGY; OUTBREAK; DISSEMINATION; COLONIZATION; PREVALENCE; EMERGENCE; EXPANSION; ST147; GENE	The worldwide spread of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL-Kp) is a significant threat. Specifically, various pandemic clones of ESBL-Kp are involved in hospital outbreaks and caused serious infections. In that context, we assessed the phenotypic and molecular features of a collection of ESBL-Kp isolates in a French university hospital and evaluated the occurrence of potential cross-transmissions. Over a 2-year period (2017-2018), 204 non-duplicate isolates of ESBL-Kp were isolated from clinical (n = 118, 57.8%) or screening (n = 86, 42.2%) sample cultures. These isolates were predominantly resistant to cotrimoxazole (88.8%) and ofloxacin (82.8%) but remained susceptible to imipenem (99.3%) and amikacin (93.8%). CTX-M-15 was the most frequent ESBL identified (83.6%). Multilocus sequence typing and pulse-field gel electrophoresis analysis showed an important genetic variability with 41 sequence types (ST) and 50 pulsotypes identified, and the over representation of the international epidemic clones ST307 and ST405. An epidemiological link attesting probable cross-transmission has been identified for 16 patients clustered in 4 groups during the study period. In conclusion, we showed here the dissemination of pandemic clones of ESBL-Kp in our hospital on a background of clonal diversity.	[Fils, Pierre Edwige L.; Cholley, Pascal; Gbaguidi-Haore, Houssein; Hocquet, Didier; Sauget, Marlene; Bertrand, Xavier] Ctr Hosp Univ, Hyg Hosp, Besancon, France; [Cholley, Pascal; Gbaguidi-Haore, Houssein; Hocquet, Didier; Sauget, Marlene; Bertrand, Xavier] Univ Bourgogne Franche Comte, UMR CNRS Chronoenvironm 6249, Besancon, France; [Hocquet, Didier; Sauget, Marlene] Ctr Hosp Reg Univ, Ctr Ressources Biol Filiere Microbiol Besancon, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Sauget, M (corresponding author), Ctr Hosp Univ, Hyg Hosp, Besancon, France.; Sauget, M (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS Chronoenvironm 6249, Besancon, France.; Sauget, M (corresponding author), Ctr Hosp Reg Univ, Ctr Ressources Biol Filiere Microbiol Besancon, Besancon, France.	msauget@chu-besancon.fr	Bertrand, Xavier/AAL-3809-2021	Bertrand, Xavier/0000-0002-8028-1396; Sauget, Marlene/0000-0003-4734-1075; Hocquet, Didier/0000-0002-4192-7238	University of Franche-Comte'moniae</it> in a University hospital: Molecular features, diffusion of epidemic clones and evaluation of cross-transmission	University of Franche-Comte'moniae</it> in a University hospital: Molecular features, diffusion of epidemic clones and evaluation of cross-transmission	This work was supported by a grant from the University of Franche-Comte ' to P.E.L.F.	Becker L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00322; Bonura C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132936; Boo NY, 2005, J HOSP INFECT, V61, P68, DOI 10.1016/j.jhin.2005.01.025; Bowers JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133727; Brechet C, 2014, CLIN INFECT DIS, V58, P1658, DOI 10.1093/cid/ciu190; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Calbo E, 2015, FUTURE MICROBIOL, V10, P1063, DOI [10.2217/fmb.15.22, 10.2217/FMB.15.22]; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Damjanova I, 2008, J ANTIMICROB CHEMOTH, V62, P978, DOI 10.1093/jac/dkn287; Del Franco M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0597-z; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dong N, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000149; Elhani D, 2011, ANN BIOL CLIN-PARIS, V69, P523, DOI 10.1684/abc.2011.0610; EUCAST, 2017, EUCAST GUIDELINES DE; European Centre for Disease Prevention and Control, ECDC ANN EP REP 2017; Geraci DM, 2015, CLIN MICROBIOL INFEC, V21, pE15, DOI 10.1016/j.cmi.2014.08.022; Gharout-Sait A, 2014, J MED MICROBIOL, V63, P1316, DOI 10.1099/jmm.0.073767-0; Glupczynski Y, 2012, INT J ANTIMICROB AG, V39, P168, DOI 10.1016/j.ijantimicag.2011.10.005; Gupta Archana, 2003, J Perinatol, V23, P439, DOI 10.1038/sj.jp.7210973; Hendrik TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140754; Jasper RT, 2015, FUTURE MICROBIOL, V10, P819, DOI 10.2217/FMB.15.16; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Liapis E, 2014, CLIN MICROBIOL INFEC, V20, pO1121, DOI 10.1111/1469-0691.12727; Liu HH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00335; Long SW, 2017, MBIO, V8, DOI [10.1128/mBio.00489-17, 10.1128/mbio.00489-17]; Machuca J, 2016, J ANTIMICROB CHEMOTH, V71, P2353, DOI 10.1093/jac/dkw137; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Novovic K, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02550-16; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Palacios-Baena ZR, 2016, J INFECTION, V72, P152, DOI 10.1016/j.jinf.2015.10.008; Park DJ, 2015, MICROB DRUG RESIST, V21, P622, DOI 10.1089/mdr.2015.0001; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rodrigues C, 2014, INT J MED MICROBIOL, V304, P1100, DOI 10.1016/j.ijmm.2014.08.003; Ruiz-Garbajosa P, 2016, J ANTIMICROB CHEMOTH, V71, P348, DOI 10.1093/jac/dkv355; Sante publique France, 2019, ENQU TE NATIONALE PR; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing, 731 EDEF; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wyres KL, 2019, J ANTIMICROB CHEMOTH, V74, P577, DOI 10.1093/jac/dky492; Xercavins M, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-019-0661-9; Zhou K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01250	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247875	10.1371/journal.pone.0247875	http://dx.doi.org/10.1371/journal.pone.0247875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760834	Green Published, gold			2022-12-26	WOS:000633030400029
J	Mremi, A; Yahaya, JJ; Nyindo, M; Mollel, E				Mremi, Alex; Yahaya, James J.; Nyindo, Mramba; Mollel, Edson			Transfusion-Transmitted Infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: A study of blood donors between 2017 and 2019	PLOS ONE			English	Article								Background Blood transfusion saves many people every year that would otherwise have died. The present study aimed to provide an update and insightful information regarding prevalence of the common Transfusion-Transmitted Infections (TTIs) and associated factors among blood donors in Tanzania. Methods This was a cross-sectional study involving retrospectively collected data of blood donors from the Tanzania Northern Zone Blood Transfusion Center between 2017 and 2019. Descriptive statistics were performed to describe characteristics of the blood donors. Univariable and multivariable logistic regression analyses were performed to determine association between prevalence of TTIs and socio-demographic factors. P-value Results A total of 101, 616 blood donors were included in the present study of which 85,053(83.7%) were males while 16,563 (16.3%) were females. Of all participants, the majority 45,400 (44.7%) were aged between 18 and 25 years; 79,582 (78.3%) were voluntary non-remunerated donors while 22,034 (21.7%) were replacement donors. The vast majority of them 99,626 (98%) were first time blood donors while 1990 (2%) were multiple donors. The overall prevalence of TTIs was 10.1% (10,226 out of 101,616) of which the leading was HBV accounting for 5.1% (5,264 out of 101,616). Being a replacement donor was associated with all the four types of TTIs: HIV (AOR = 1.22, 95% CI = 1.10-1.35), HBV (AOR = 1.35, 95% CI = 1.27-1.44), HCV (AOR = 1.28, 95% CI = 1.12-1.46), and syphilis (AOR = 1.33, 95% CI = 1.20-1.48). Conclusions Our study has demonstrated that Tanzania has relatively high prevalence of TTIs compared to some countries in Sub-Saharan Africa. HBV infection seems to be the most common infection among blood donors and replacement blood donors are at a higher risk of harboring the commonest TTIs among blood donors.	[Mremi, Alex] Kilimanjaro Christian Med Ctr KCMC, Dept Pathol, Moshi, Tanzania; [Mremi, Alex; Nyindo, Mramba] Kilimanjaro Christian Med Univ Coll KCMUCO, Fac Med, Moshi, Tanzania; [Yahaya, James J.] Univ Dodoma, Sch Med & Dent, Dept Histopathol & Morbid Anat, Dodoma, Tanzania; [Mollel, Edson] Northern Zone Blood Transfus Ctr NZBTC, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Mremi, A (corresponding author), Kilimanjaro Christian Med Ctr KCMC, Dept Pathol, Moshi, Tanzania.; Mremi, A (corresponding author), Kilimanjaro Christian Med Univ Coll KCMUCO, Fac Med, Moshi, Tanzania.	alex.mremi@kcmuco.ac.tz	Yahaya, James/AAY-5619-2021	Mremi, Alex/0000-0001-7226-0168				Bartonjo G, 2019, PAN AFR MED J, V34, DOI 10.11604/pamj.2019.34.31.17885; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Ifland L, 2018, TRANSFUSION, V58, P105, DOI 10.1111/trf.14374; Kawambwa RH, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8294-8; Kimani D, 2011, VOX SANG, V100, P212, DOI 10.1111/j.1423-0410.2010.01376.x; Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x; Loua A., 2017, J BLOOD TRANSFUS, V2017, DOI [10.1155/2017/1970479, DOI 10.1155/2017/1970479]; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Mohamed Z, 2019, J VIRAL HEPATITIS, V26, P750, DOI 10.1111/jvh.13073; Mosley JW, 2005, HEPATOLOGY, V42, P86, DOI 10.1002/hep.20742; Okoroiwu HU, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5555-x; Perez P, 2001, TRANSFUSION, V41, P862, DOI 10.1046/j.1537-2995.2001.41070862.x; Ross RS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-72; Sachdev S, 2015, INDIAN J HEMATOL BLO, V31, P378, DOI 10.1007/s12288-014-0460-7; Seighali F, 2015, BLOOD TRANSFUS-ITALY, V13, P583, DOI 10.2450/2015.0035-15; Shao ER, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3376-2; Shaz BH, 2011, J NATL MED ASSOC, V103, P351, DOI 10.1016/S0027-9684(15)30316-3; Siraj N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3174-x; Slot E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151038; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Valerian DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206487	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0249061	10.1371/journal.pone.0249061	http://dx.doi.org/10.1371/journal.pone.0249061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760870	gold, Green Published			2022-12-26	WOS:000633030400052
J	Masojc, M; Kim, JY; Krupa-Kurzynowska, J; Sohn, YK; Ehlert, M; Michalec, G; Cendrowska, M; Andrieux, E; Armitage, SJ; Szmit, M; Dreczko, E; Kim, JC; Kim, JS; Lee, GS; Moska, P; Jadain, MA				Masojc, Miroslaw; Kim, Ju Yong; Krupa-Kurzynowska, Joanna; Sohn, Young Kwan; Ehlert, Maciej; Michalec, Grzegorz; Cendrowska, Marzena; Andrieux, Eric; Armitage, Simon J.; Szmit, Marcin; Dreczko, Ewa; Kim, Jin Cheul; Kim, Ji Sung; Lee, Gwang-Soo; Moska, Piotr; Jadain, Modather Abdalla			The oldest Homo erectus buried lithic horizon from the Eastern Saharan Africa. EDAR 7-an Acheulean assemblage with Kombewa method from the Eastern Desert, Sudan	PLOS ONE			English	Article							JINMIUM ROCK SHELTER; MIDDLE PLEISTOCENE; HOMININ DISPERSALS; NORTHERN AUSTRALIA; MULTIPLE GRAINS; WEAR ANALYSIS; STONE TOOLS; SITE 8-B-11; SAI ISLAND; QUARTZ	Although essential for reconstructing hominin behaviour during the Early Palaeolithic, only a handful of Acheulean sites have been dated in the Eastern Sahara region. This is due to the scarcity of sites for this time period and the lack of datable material. However, recent excavations in the Atbara region (Sudan) have provided unique opportunities to analyse and date Acheulean stone tools. We report here on EDAR 7, part of a cluster of Acheulean and Middle Stone Age (MSA) sites that were recently discovered in the Eastern Desert Atbara River (EDAR) region, located in the Eastern Desert (Sudan) far from the Nile valley. At EDAR 7, a 3.5 metre sedimentary sequence was excavated, allowing an Acheulean assemblage to be investigated using a combination of sedimentology, stone tool studies and optically stimulated luminescence dating (OSL). The site has delivered a complete Acheulean knapping chaine operatoire, providing new information about the Saharan Acheulean. The EDAR 7 site is interpreted as a remnant of a campsite based on the co-occurrence of two reduction modes: one geared towards the production of Large Cutting Tools (LCTs), and the other based on the flaking of small debitage and production of flake tools. Particularly notable in the EDAR 7 assemblage is the abundance of cleavers, most of which display evidence of flake production. Implementation of giant Kombewa flakes was also observed. A geometric morphometric analysis of hand-axes was conducted to verify a possible Late Acheulean assemblage standardisation in the Nubian Sahara. In addition, the analysis of micro-traces and wear on the artefacts has provided information on the use history of the Acheulean stone tools. Sediment analyses and OSL dating show that the EDAR 7 sequence contains the oldest Acheulean encampment remains in the Eastern Sahara, dated to the MIS 11 or earlier. This confirms that Homo erectus occupied the EDAR region during Middle Pleistocene humid periods, and demonstrates that habitable corridors existed between the Ethiopian Highlands, the Nile and the Red Sea coast, allowing population dispersals across the continent and out of it.	[Masojc, Miroslaw; Ehlert, Maciej; Michalec, Grzegorz; Cendrowska, Marzena; Dreczko, Ewa] Univ Wroclaw, Inst Archaeol, Wroclaw, Poland; [Kim, Ju Yong; Kim, Jin Cheul; Kim, Ji Sung; Lee, Gwang-Soo] Korea Inst Geosci & Mineral Resources KIGAM, Daejeon, South Korea; [Krupa-Kurzynowska, Joanna] Wroclaw Univ Sci & Technol, Fac Geoengn Min & Geol, Wroclaw, Poland; [Sohn, Young Kwan] Gyeongsang Natl Univ GNU, Dept Geol, Jinju, South Korea; [Sohn, Young Kwan] Gyeongsang Natl Univ GNU, Res Inst Nat Sci, Jinju, South Korea; [Ehlert, Maciej; Cendrowska, Marzena] Archeolodzy Org Fdn, Wroclaw, Poland; [Andrieux, Eric; Armitage, Simon J.] Royal Holloway Univ London, Dept Geog, London, England; [Andrieux, Eric] Univ Durham, Dept Archaeol, Durham, England; [Armitage, Simon J.] Univ Bergen, SFF Ctr Early Sapiens Behav SapienCE, Bergen, Norway; [Szmit, Marcin] Gdansk Archaeol Museum, Gdansk, Poland; [Moska, Piotr] Silesian Tech Univ, Inst Phys, Div Geochronol & Isotope Res Environm, Gliwice, Poland; [Jadain, Modather Abdalla] Al Neelain Univ, Dept Archaeol, Khartoum, Sudan	University of Wroclaw; Korea Institute of Geoscience & Mineral Resources (KIGAM); Wroclaw University of Science & Technology; Gyeongsang National University; Gyeongsang National University; University of London; Royal Holloway University London; Durham University; University of Bergen; Silesian University of Technology	Masojc, M (corresponding author), Univ Wroclaw, Inst Archaeol, Wroclaw, Poland.	miroslaw.masojc@uwr.edu.pl	Krupa-Kurzynowska, Joanna/P-3467-2018; Michalec, Grzegorz/AAH-5904-2021; Sohn, Young Kwan/AAA-1393-2022; Armitage, Simon J/K-7471-2015	Michalec, Grzegorz/0000-0002-5794-5334; Sohn, Young Kwan/0000-0002-1811-0545; Armitage, Simon J/0000-0003-1480-9188; Masojc, Miroslaw/0000-0001-7779-5014; Cendrowska, Marzena/0000-0002-6140-555X	National Science Centre, Poland [NCN 2015/19/B/HS3/03562]; Korea Institute of Geoscience and Mineral Resources [GP2017-013]; Research Institute of Natural Science of the Gyeonsang National University, Korea; Al Neelain University, Khartoum, Sudan	National Science Centre, Poland(National Science Centre, Poland); Korea Institute of Geoscience and Mineral Resources; Research Institute of Natural Science of the Gyeonsang National University, Korea; Al Neelain University, Khartoum, Sudan	This project is funded by the National Science Centre, Poland, a government agency supervised by the Ministry of Science and Higher Education (NCN 2015/19/B/HS3/03562 http://sudan.archeo.uni.wroc.pl).The research is supported by the Korea Institute of Geoscience and Mineral Resources (GP2017-013) and the Research Institute of Natural Science of the Gyeonsang National University, Korea and Al Neelain University, Khartoum, Sudan. OSL measurements were conducted by the OSL laboratory of the Korean Institute of Geosciences and Mineral Resources (KIGAM) and Gliwice Absolute Dating Method Centre (GADAM) and further analysed at Royal Holloway University of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate E, 2010, PALAEOGEOGR PALAEOCL, V292, P12, DOI 10.1016/j.palaeo.2010.03.022; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Arkell AJ, 1949, OLD STONE AGE ANGLOE; Preysler JB, 2018, QUATERNARY SCI REV, V190, P123, DOI 10.1016/j.quascirev.2018.04.015; Bakry A, 2020, J AFR ARCHAEOL, V18, P229, DOI 10.1163/21915784-20200010; Bell WT, 1979, ANCIENT TL, V8, P2; Berruti GLF, 2016, J LITHIC STUD, V3, DOI 10.2218/jls.v3i2.1400; Beshkani A, 2017, ARAB ARCHAEOL EPIGR, V28, P125, DOI 10.1111/aae.12101; Beyin A, 2019, J FIELD ARCHAEOL, V44, P147, DOI 10.1080/00934690.2019.1580099; Bluszcz A., 1993, EGYPT LAST INTERGLAC, P224; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bordes F, 1961, TYPOLOGIE PAL OLITHI; Carlson RL, 2015, KHOR ABU ANGA MAGEND; Caton-Thompson G., 1952, KHARGA OASIS PREHIST; Chaix L., 2000, RECENT RES STONE AGE, P33; Chavaillon J., 1966, COMPTES RENDUS S ANC, V63, P65; Chmielewski W., 1968, PREHISTORY NUBIA, P110; Chmielewski W., 1987, PRZEGLAD ARCHEOLOGIC, V34, P5; Churcher CS, 1999, PALAEOGEOGR PALAEOCL, V154, P301, DOI 10.1016/S0031-0182(99)00104-2; Clark JD., 1992, NEW LIGHT NE AFRICAN, P17; Clark JGD, 2001, KALAMBO FALLS VOL, VIII; Clark JGD, 1969, WORLD PREHISTORY; Conte IC, 2015, MAN ARCHAEOL METH, P59, DOI 10.1007/978-3-319-08257-8_5; Clemente-Conte I., 2009, NONFLINT RAW MAT USE, V1939, P93; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; de la Torre I, 2018, J HUM EVOL, V120, P329, DOI 10.1016/j.jhevol.2018.01.003; Derndarsky M, 2001, J ARCHAEOL SCI, V28, P1149, DOI 10.1006/jasc.2000.0646; Dibble HL, 1999, LITHIC TECHNOL, V24, P38, DOI DOI 10.1080/01977261.1999.11720944; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Durcan JA, 2015, QUAT GEOCHRONOL, V28, P54, DOI 10.1016/j.quageo.2015.03.012; Emberling G, 2020, OXFORD HDB ANCIENT N, P81; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Gallotti R, 2014, QUATERN INT, V343, P17, DOI 10.1016/j.quaint.2014.04.039; Gallotti R, 2010, AFR ARCHAEOL REV, V27, P291, DOI 10.1007/s10437-010-9083-z; Garcea E.A.A., 2020, PREHISTORY SUDAN; Garcia-Medrano P, 2020, J PALEOLITH ARCHAEOL, V3, P756, DOI 10.1007/s41982-020-00054-5; Garcia-Medrano P, 2020, J LITHIC STUD, V7, DOI 10.2218/jls.4327; Gilbert William Henry, 2016, Paleoanthropology, P58; Goren-Inbar N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0353; GorenInbar N, 2018, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-3-319-74051-5; Guerin G, 2011, ANCIENT TL, V29, P5; Guerin G, 2012, RADIAT MEAS, V47, P778, DOI 10.1016/j.radmeas.2012.04.004; Haynes C.V., 1997, GEOARCHAEOLOGY, V12, P819, DOI [10.1002/(SICI)1520-6548(199712)12:83.0.CO;2-8, DOI 10.1002/(SICI)1520-6548(199712)12:83.0.CO;2-8]; Herman ChF, 2006, ARCH O NIL, V16, P41060; Hill CL, 2017, J AFR EARTH SCI, V136, P201, DOI 10.1016/j.jafrearsci.2017.02.031; Hill CL, 2009, CATENA, V78, P250, DOI 10.1016/j.catena.2009.02.003; Hill CL, 2001, GEOARCHAEOLOGY, V16, P65, DOI 10.1002/1520-6548(200101)16:1<65::AID-GEA6>3.0.CO;2-Q; Hong D., 1998, LUMINESCENCE STIMULA; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Kindermann K., 2013, ANTIQUITY PROJECT GA, V87; Kleindienst M. R., 1962, ACT 4 C PAN PREH ET, P81; Knutsson H, 2015, J ARCHAEOL SCI-REP, V2, P517, DOI 10.1016/j.jasrep.2015.04.008; Knutsson K, 1988, PATTERNS TOOL USE SC; Knutsson K., 1990, SILEX SA GEN SE LOUT, V17, P607; Kobusiewicz M., 2018, DESERT NILE PREHISTO, P483; Lane P, 2013, OXFORD HDB AFRICAN A, P307; Lazuen T, 2011, TRABAJOS PREHIST, V68, P237, DOI 10.3989/tp.2011.11068; Leakey MD., 1975, AUSTRALOPITHECINES, P477, DOI [10.1515/9783110878837.477, DOI 10.1515/9783110878837.477]; Leipus M., 2014, ESTADO ACTUAL INVEST, V5, DOI [10.3390/ma7085427, DOI 10.3390/MA7085427]; Lemorini C, 2014, J HUM EVOL, V72, P10, DOI 10.1016/j.jhevol.2014.03.002; Lepiongeon A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188824; Liu J., 2016, DOCUMENTA PRAEHISTOR, V43, P507, DOI 10.4312/dp.43.27; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2007, J ARCHAEOL SCI, V34, P1434, DOI 10.1016/j.jas.2006.11.001; Lycett SJ, 2016, QUATERN INT, V411, P386, DOI 10.1016/j.quaint.2015.08.021; Madsen B., 2004, EURASIAN PREHISTORY, V2, P3; Masojc M., STUDIES AFRICAN ARCH, V16; Masojc M, 2010, 1 NOTE DISCOVERY STR, V21, P63; Masojc M, 2019, J HUM EVOL, V130, P141, DOI 10.1016/j.jhevol.2019.01.004; Masojc M, 2017, J ARCHAEOL SCI-REP, V16, P391, DOI 10.1016/j.jasrep.2017.10.026; MasojE M., 2020, ARCHAEOL POL, V58, P39, DOI [10.23858/APa58.2020.003, DOI 10.23858/APA58.2020.003]; McNabb J, 2017, J ARCHAEOL SCI-REP, V13, P403, DOI 10.1016/j.jasrep.2017.04.010; Mendez-Quintas E, 2019, J ARCHAEOL SCI, V108, DOI 10.1016/j.jas.2019.104975; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Noll M., 2003, MULTIPLE APPROACHES, P31; Olle A, 2016, QUATERN INT, V424, P154, DOI 10.1016/j.quaint.2016.02.005; Owen AWE, 1938, MAN, V38, P203; Pedergnana A, 2017, QUATERN INT, V427, P35, DOI 10.1016/j.quaint.2016.01.053; Pelegrin J, 1990, ARCHAEOLOGICAL REV C, V9, P116; PETRAGLIA MD, 1994, J ANTHROPOL ARCHAEOL, V13, P228, DOI 10.1006/jaar.1994.1014; Pillai KCS, 2014, MULTIVARIATE ANAL VA; Piperno M., 2004, STUDIES EARLY PALEOL, P545; PRESCOTT JR, 1988, NUCL TRACKS RAD MEAS, V14, P223; Raynal J-P., 2004, STUDIES EARLY PALEOL, P137; Roberts RG, 1999, ARCHAEOMETRY, V41, P365, DOI 10.1111/j.1475-4754.1999.tb00988.x; Rots V, 2006, J ARCHAEOL SCI, V33, P360, DOI 10.1016/j.jas.2005.08.002; Scerri EML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35242-5; Schild R., 2010, S E MEDITERRANEAN PE, P89; Schild R., 2009, UNDERSTANDING, P315; Schild R., 1977, PREHISTORY DAKHLA OA; Schild R., 1981, PREHISTORY EGYPTIAN; Schild R., 2005, MITEKUFAT HAEVEN J I, P117; Schmidt C, 2015, J ARCHAEOL SCI, V63, P94, DOI 10.1016/j.jas.2015.08.016; Schwarcz H., 1993, EGYPT LAST INTERGLAC, P17; Serwatka K., 2014, LITHICS J LITHIC STU, V35, P18; Sharon G., 2007, ACHEULIAN LARGE FLAK; Sharon G., 2004, EURASIAN PREHISTORY, V2, P53; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Shipton C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200497; Spinapolice EE, 2018, J AFR ARCHAEOL, V16, P193, DOI 10.1163/21915784-20180010; Stemp WJ, 2013, SCANNING, V35, P28, DOI 10.1002/sca.21032; Taipale N, 2012, MICROVS MACROMICROWE; Torres C, 2020, J PALEOLITH ARCHAEOL, V3, P889, DOI 10.1007/s41982-020-00063-4; Usai D., 2019, HDB ANCIENT NUBIA, P155; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; VANPEER P, 1991, J ANTHROPOL ARCHAEOL, V10, P107, DOI 10.1016/0278-4165(91)90017-R; Venditti F, 2016, QUATERN INT, V424, P143, DOI 10.1016/j.quaint.2015.07.046; Vermeersch P.M., 2000, PALAEOLITHIC LIVING; Vermeersch P.M., 2000, PALAEOLITHIC LIVING, P57; Vermeersch PM., 1992, NEW LIGHT NE AFRICAN, P99, DOI [10.1055/s-2006-961539, DOI 10.1055/S-2006-961539]; Vroomans JM, 2004, FARMING, V3, P1; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035804; WENDORF F, 1987, J FIELD ARCHAEOL, V14, P43, DOI 10.1179/jfa.1987.14.1.43; Wendorf F, 1968, PREHISTORY NUBIA, DOI [10.1126/science.162.3857.1032, DOI 10.1126/SCIENCE.162.3857.1032]; Wendorf F., 1992, NEW LIGHT NE AFRICAN, P39; Wendorf F., 1993, EGYPT LAST INTERGLAC; Wendorf F, 1965, CONTRIBUTIONS PREHIS; Wendorf F, 1994, LATE QUATERNARY CHRO, P147; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918; WYNN T, 1990, AM ANTHROPOL, V92, P73, DOI 10.1525/aa.1990.92.1.02a00050	123	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248279	10.1371/journal.pone.0248279	http://dx.doi.org/10.1371/journal.pone.0248279			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755675	Green Published, Green Accepted, gold			2022-12-26	WOS:000632916600010
J	Yau, CWH; Lenguerrand, E; Morris, S; Draycott, T; Pizzo, E				Yau, Christopher Wai Hung; Lenguerrand, Erik; Morris, Steve; Draycott, Tim; Pizzo, Elena			A model-based cost-utility analysis of multi-professional simulation training in obstetric emergencies	PLOS ONE			English	Article							ECONOMIC-EVALUATION; SHOULDER DYSTOCIA; INFORMAL CARE; IMPACT; INCLUSION; ILLNESS	Objective To determine the cost-utility of a multi-professional simulation training programme for obstetric emergencies-Practical Obstetric Multi-Professional Training (PROMPT)-with a particular focus on its impact on permanent obstetric brachial plexus injuries (OBPIs). Design A model-based cost-utility analysis. Setting Maternity units in England. Population Simulated cohorts of individuals affected by permanent OBPIs. Methods A decision tree model was developed to estimate the cost-utility of adopting annual, PROMPT training (scenario 1a) or standalone shoulder dystocia training (scenario 1b) in all maternity units in England compared to current practice, where only a proportion of English units use the training programme (scenario 2). The time horizon was 30 years and the analysis was conducted from an English National Health Service (NHS) and Personal Social Services perspective. A probabilistic sensitivity analysis was performed to account for uncertainties in the model parameters. Main outcome measures Outcomes for the entire simulated period included the following: total costs for PROMPT or shoulder dystocia training (including costs of OBPIs), number of OBPIs averted, number of affected adult/parental/dyadic quality adjusted life years (QALYs) gained and the incremental cost per QALY gained. Results Nationwide PROMPT or shoulder dystocia training conferred significant savings (in excess of 1 pound billion ($1.5 billion)) compared to current practice, resulting in cost-savings of at least 1 pound million ($1.5 million) per any type of QALY gained. The probabilistic sensitivity analysis demonstrated similar findings. Conclusion In this model, national implementation of multi-professional simulation training for obstetric emergencies (or standalone shoulder dystocia training) in England appeared to both be cost-saving when evaluating their impact on permanent OBPIs.	[Yau, Christopher Wai Hung; Lenguerrand, Erik] Univ Bristol, Translat Hlth Sci, Bristol, Avon, England; [Yau, Christopher Wai Hung; Draycott, Tim] Southmead Hosp, Bristol, Avon, England; [Morris, Steve] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Pizzo, Elena] UCL, Dept Appl Hlth Res, London, England	University of Bristol; Southmead Hospital; University of Cambridge; University of London; University College London	Pizzo, E (corresponding author), UCL, Dept Appl Hlth Res, London, England.	e.pizzo@ucl.ac.uk		Lenguerrand, Erik/0000-0002-0371-731X; Pizzo, Elena/0000-0003-0790-7505	The Erb's Palsy Group; National Institute for Health Research (NIHR) Applied Research Collaboration North Thames (ARC North Thames) at Barts Health NHS Trust	The Erb's Palsy Group; National Institute for Health Research (NIHR) Applied Research Collaboration North Thames (ARC North Thames) at Barts Health NHS Trust	The Erb's Palsy Group (www.erbspalsygroup.co.uk) funded and supported this study (awarded to CWHY). EP was funded by the National Institute for Health Research (NIHR) Applied Research Collaboration North Thames (ARC North Thames) at Barts Health NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi H, 2011, PHARMACOECONOMICS, V29, P1015, DOI 10.2165/11593940-000000000-00000; [Anonymous], 2016, NATL MATERNITY REV B; Banke-Thomas A, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1586-z; Barsuk JH, 2017, ACTA OBSTET GYN SCAN, V96, P1273, DOI 10.1111/aogs.13187; Bergh AM, 2015, BEST PRACT RES CL OB, V29, P1017, DOI 10.1016/j.bpobgyn.2015.03.015; Bergh AM, 2015, BEST PRACT RES CL OB, V29, P1028, DOI 10.1016/j.bpobgyn.2015.03.017; Chappell LC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2812; Chauhan SP, 2014, SEMIN PERINATOL, V38, P210, DOI 10.1053/j.semperi.2014.04.007; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crofts JF, 2016, BJOG-INT J OBSTET GY, V123, P111, DOI 10.1111/1471-0528.13302; Crofts JF, 2015, B WORLD HEALTH ORGAN, V93, P347, DOI 10.2471/BLT.14.145532; Davidson T, 2010, APPL HEALTH ECON HEA, V8, P25, DOI 10.2165/11313910-000000000-00000; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Draycott TJ, 2015, BEST PRACT RES CL OB, V29, P1067, DOI 10.1016/j.bpobgyn.2015.07.003; Evans-Jones G, 2003, ARCH DIS CHILD-FETAL, V88, P185, DOI 10.1136/fn.88.3.F185; Gardner AK, 2016, SURGERY, V160, P546, DOI 10.1016/j.surg.2016.03.028; Goodrich K, 2012, VALUE HEALTH, V15, P975, DOI 10.1016/j.jval.2012.05.009; GOV.UK, IMPR SAF MAT CAR NHS; GOV.UK, LORD CHANC ANN NEW D; Herbst MA, 2005, AM J OBSTET GYNECOL, V193, P1035, DOI 10.1016/j.ajog.2005.06.030; Hospital Episode Statistics Analysis Health and Social Care Information Centre, 2015, HOSP EP STAT NHS MAT; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; International Monetary Fund, WORLD EC OUTLOOK DAT; Koch BA., 2011, MED LIABILITY EUROPE, P165; Krol M, 2015, PHARMACOECONOMICS, V33, P123, DOI 10.1007/s40273-014-0218-y; Ledger S., 2018, MIND GAP INVESTIGATI; Liberati EG, 2019, SOC SCI MED, V223, P64, DOI 10.1016/j.socscimed.2019.01.035; MacKenzie IZ, 2007, OBSTET GYNECOL, V110, P1059, DOI 10.1097/01.AOG.0000287615.35425.5c; Manasyan A, 2011, PEDIATRICS, V127, pE1176, DOI 10.1542/peds.2010-2158; Maternity Safety Programme Team Department of Health, 2016, SAF MAT CAR NEXT STE; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; NHS Digital, PROV LEV AN 2015 201; NHS Litigation Authority, 2012, 10 YEARS MAT CLAIMS; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Office for National Statistics, INFL PRIC IND; RCOG, 2012, SHOULD DYST GREEN TO; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Shoushtarian M, 2014, BJOG-INT J OBSTET GY, V121, P1710, DOI 10.1111/1471-0528.12767; Siassakos D, 2009, BJOG-INT J OBSTET GY, V116, P1028, DOI 10.1111/j.1471-0528.2009.02178.x; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; van de Ven J, 2017, EUR J OBSTET GYN R B, V216, P130, DOI 10.1016/j.ejogrb.2017.07.027; Weiner CP, 2016, J PERINATOL, V36, P19, DOI 10.1038/jp.2015.136; Winter C, 2017, PROMPT COURSE MANUAL; Wittenberg E, 2013, PHARMACOECONOMICS, V31, P489, DOI 10.1007/s40273-013-0040-y; Wittenberg E, 2013, MED DECIS MAKING, V33, P235, DOI 10.1177/0272989X12464434; Yau CWH, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1039-z; Yau CWH, 2016, ACTA OBSTET GYN SCAN, V95, P1111, DOI 10.1111/aogs.12956; Yentis S, 2014, SAVING LIVES IMPROVI, pp65; Zendejas B, 2013, SURGERY, V153, P160, DOI 10.1016/j.surg.2012.06.025	50	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249031	10.1371/journal.pone.0249031	http://dx.doi.org/10.1371/journal.pone.0249031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755716	Green Published, gold			2022-12-26	WOS:000632916600050
J	Heffernan, C; Paulsen, C; Asadi, L; Egedahl, ML; Rowe, BH; Barrie, J; Long, R				Heffernan, Courtney; Paulsen, Catherine; Asadi, Leyla; Egedahl, Mary-Lou; Rowe, Brian H.; Barrie, James; Long, Richard			Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DECISION INSTRUMENT; CLASSIC SYMPTOMS; RECOMMENDATIONS; VALIDITY	Objectives To determine: i) the emergency department (ED) utilization history of pulmonary tuberculosis (PTB) patients, and ii) the potential individual and public health consequences of a missed diagnosis of PTB in this setting. Design Retrospective observational cohort study. Participants Patients with PTB aged >16 years diagnosed between April 1, 2010 and December 31, 2016 in the Province of Alberta, Canada. Methods We identified valid new cases of PTB from a provincial registry and linked them to ED attendees in administrative databases. Visits are considered 'PTB', pulmonary 'other', and non-pulmonary based on the most responsible discharge diagnosis. Individual consequences of a missed diagnosis included health system delay and PTB-related death; public health consequences included nosocomial ED exposure time and secondary cases. Results Of 711 PTB patients, 378 (53%) made 845 ED visits in the six months immediately preceding the date of diagnosis. The most responsible ED discharge diagnosis was PTB in 92 (10.9%), pulmonary 'other' in 273 (32%) and non-pulmonary in 480 (56.8%). ED attendees had a median (IQR) health system delay of 27 (7,180) days and, compared to non-ED attendees were more likely to die a TB-related death 5.9% vs 1.2%, p = 0.001. Emergency attendees generated 3812 hours of ED nosocomial exposure time, and 31 secondary cases (60.8% of all secondary cases reported). Mycobacterium tuberculosis isolates from ED-attendees were more likely than non-attendees to be clustered-i.e., have an identical DNA fingerprint with another isolate (27% vs. 21%, p = 0.037). Conclusions ED utilization by PTB patients, and related consequences, are substantial. EDs are a potential resource for earlier PTB diagnosis.	[Heffernan, Courtney; Paulsen, Catherine; Asadi, Leyla; Egedahl, Mary-Lou; Long, Richard] Univ Alberta, Dept Med, TB Program Evaluat & Res Unit, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Rowe, Brian H.; Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Barrie, James] Univ Alberta, Dept Radiol & Diagnost Imaging, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Heffernan, C (corresponding author), Univ Alberta, Dept Med, TB Program Evaluat & Res Unit, Edmonton, AB, Canada.	cheffern@ualberta.ca	Paulsen, Catherine/AAP-4665-2021; Heffernan, Courtney/G-5296-2016	Heffernan, Courtney/0000-0003-1241-7201	Alberta Lung Association/Respiratory Health Strategic Clinical Health Network Studentship [SFR1218]; University of Alberta Pulmonary Research Group award; Canadian Institutes of Health Research (CIHR; Ottawa, ON) [SOP 168483]	Alberta Lung Association/Respiratory Health Strategic Clinical Health Network Studentship; University of Alberta Pulmonary Research Group award; Canadian Institutes of Health Research (CIHR; Ottawa, ON)(Canadian Institutes of Health Research (CIHR))	This work received financial support in the following forms: An Alberta Lung Association/Respiratory Health Strategic Clinical Health Network Studentship (SFR1218), and University of Alberta Pulmonary Research Group award provided financial support to CH for her studies, of which this work represents one part. BR's research is supported by a Scientific Director Grant (SOP 168483) from the Canadian Institutes of Health Research (CIHR; Ottawa, ON).	[Anonymous], 2014, 2013 14 ALBERTA HLTH; [Anonymous], 2017, CANADA COMPARES RESU; [Anonymous], 2005, MMWR RECOMM REP, V54; [Anonymous], 2017, 2016 17 ALBERTA HLTH; Appleton SC, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2016-000154; Cohen R, 1996, CHEST, V109, P420, DOI 10.1378/chest.109.2.420; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; Geyer BC, 2013, J EMERG MED, V45, P658, DOI 10.1016/j.jemermed.2013.05.002; Heffernan C, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2019-000521; Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x; Lau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154032; Long R, 2002, INT J TUBERC LUNG D, V6, P332; Long R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212706; Miller Aaron C, 2015, Open Forum Infect Dis, V2, pofv171, DOI 10.1093/ofid/ofv171; Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027; Redd JT, 1997, AM J PUBLIC HEALTH, V87, P1543, DOI 10.2105/AJPH.87.9.1543; Sokolove PE, 2000, ANN EMERG MED, V35, P327, DOI 10.1016/S0196-0644(00)70050-3; Sokolove PE, 2000, ACAD EMERG MED, V7, P1056, DOI 10.1111/j.1553-2712.2000.tb02100.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; The Canadian Tuberculosis Standards, 2013, CAN TUB STAND, V7th; Vachon J, 2018, Can Commun Dis Rep, V44, P75; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248493	10.1371/journal.pone.0248493	http://dx.doi.org/10.1371/journal.pone.0248493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750959	Green Published, gold			2022-12-26	WOS:000631967100020
J	Arani, HZ; Manshadi, GD; Atashi, HA; Nejad, AR; Ghorani, SM; Abolghasemi, S; Bahrani, M; Khaledian, H; Savodji, PB; Hoseinian, M; Bejandi, AK; Abolghasemi, S				Arani, Hamid Zaferani; Manshadi, Giti Dehghan; Atashi, Hesam Adin; Nejad, Aida Rezaei; Ghorani, Seyyed Mojtaba; Abolghasemi, Soheila; Bahrani, Maryam; Khaledian, Homayoon; Savodji, Pantea Bozorg; Hoseinian, Mohammad; Bejandi, Atefe Kazemzade; Abolghasemi, Shahla			Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study	PLOS ONE			English	Article								During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world. Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing. The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated. The patients were divided into severe cases (n = 82) and non-severe cases (n = 110). Demographic and clinical characteristics were compared between the two study clusters. The mean age was 54.6 +/- 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%). The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity. Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data. As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions. Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg.	[Arani, Hamid Zaferani; Atashi, Hesam Adin; Ghorani, Seyyed Mojtaba; Khaledian, Homayoon; Savodji, Pantea Bozorg; Hoseinian, Mohammad; Bejandi, Atefe Kazemzade] Islamic Azad Univ, Tehran Med Sci, Young Researchers & Elite Club, Tehran, Iran; [Manshadi, Giti Dehghan] Islamic Azad Univ, Dept Anesthesiol & Crit Care, Tehran Med Sci, Tehran, Iran; [Nejad, Aida Rezaei] Univ Tehran Med Sci, Stem Cell & Regenerat Med Ctr Excellence, Tehran, Iran; [Abolghasemi, Soheila] Islamic Azad Univ, Dept Infect Dis, Tehran Med Sci, Tehran, Iran; [Bahrani, Maryam] Islamic Azad Univ, Fac Med, Dept Emergency Med, Tehran Med Sci, Tehran, Iran; [Abolghasemi, Shahla] Islamic Azad Univ, Tehran Med Sci, Tehran, Iran	Islamic Azad University; Islamic Azad University; Tehran University of Medical Sciences; Islamic Azad University; Islamic Azad University; Islamic Azad University	Abolghasemi, S (corresponding author), Islamic Azad Univ, Tehran Med Sci, Tehran, Iran.	Sh.abolghasemi@iautmc.ac.ir	abolghasemi, soheila/AAV-3986-2021; Atashi, Hesam Adin/ABA-1400-2021; manshadi, giti dehghan/AAO-4122-2021	Atashi, Hesam Adin/0000-0003-3558-204X; Ghorani, Seyyed Mojtaba/0000-0002-1683-1816; rezaei nejad, aida/0000-0001-7737-7824				Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Education MoHaM, 2020, 300000 IRANIANS INFE; Guillen E, 2020, AM J TRANSPLANT, V20, P1875, DOI 10.1111/ajt.15874; Hou C, 2020, J MED VIROL, V92, P841, DOI 10.1002/jmv.25827; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Koff WC, 2020, NEW ENGL J MED, V383, P804, DOI 10.1056/NEJMp2006761; Kou Z-Q., 2020, J INFECT DIS; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089; Li CY, 2020, EMERG INFECT DIS, V26, P1626, DOI 10.3201/eid2607.200718; Li GQ., 2013, CHIN J INTEGR MED, V33; Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Little P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1185; McIntosh JJ, 2020, AM J PERINAT, V37, P809, DOI 10.1055/s-0040-1709684; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Nikpouraghdam M, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104378; Organization WH, 2016, MIDDLE E RESP SYNDRO; Shoenfeld Y, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102538; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Takian A, 2020, LANCET, V395, P1035, DOI 10.1016/S0140-6736(20)30668-1; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; WHO, REMARKS DR MICHAEL R; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Y., 2020, CELL DISCOV, V6, P1, DOI [10.1038/s41421-020-0153-3, DOI 10.1038/s41421-020-0153-3]	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0246314	10.1371/journal.pone.0246314	http://dx.doi.org/10.1371/journal.pone.0246314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739987	gold, Green Published			2022-12-26	WOS:000631030200035
J	Gebremedhin, HT; Mezgebo, HM; Geberhiwot, GT; Gebru, TT; Tesfamichael, YA; Ygzaw, HB; Baraki, MF; Woledemariam, GT; Gebru, TH; Tadese, HT; Kindeya, GG; Azale, T				Gebremedhin, Haftom Tesfay; Mezgebo, Hagos Mehari; Geberhiwot, Gessessew Teklebrhan; Gebru, Tesfay Tsegay; Tesfamichael, Yowhans Ashebir; Ygzaw, Hailu Belay; Baraki, Mulu Ftwi; Woledemariam, Guesh Teklu; Gebru, Tsegu Hailu; Tadese, Haileslassie Tesfay; Kindeya, Gebreslassie Gebreegziabhier; Azale, Telake			Erectile dysfunction and its associated factors among the male population in Adigrat Town, Tigrai Region, Ethiopia: A cross-sectional study	PLOS ONE			English	Article								Background Erectile dysfunction is one of the common sexual dysfunctions, but it is generally misunderstood as it is not a condition that threatens life. It affects an individual's physical as well as psychosocial health and has a significant impact on sufferers and their families' quality of life. No data are suggesting the prevalence of erectile dysfunction at the population level in Ethiopia. This research aimed to assess the prevalence and associated factors of erectile dysfunction among the male population. Methods We employed a community based cross-sectional study among 802 study participants. A two-stage random sampling method was used for enrolling study participants. Including the International Index of Erectile Function Questionnaire-5 (IIEF-5) for erectile dysfunction, data were collected using pretested and a structured questionnaire administered by an interviewer. Binary logistic regression was performed to identify factors associated with erectile dysfunction. Result Out of the total of 802 individuals, 25.4%(95% CI:(22.4, 28.3%)) (n = 204) reported erectile dysfunction. The mean age of the participants was 34.3 +/- 9.6 years. Age of 40years and above [AOR = 10.74, 95% CI: (7.07, 16.35)], physical inactivity [AOR = 3.62, 95% CI: (2.40, 5.45)], depression [AOR = 4.01, 95% CI: (2.22, 7.21)], poor quality of life [AOR = 1.59, 95% CI: (1.07, 2.36)] were significantly associated with erectile dysfunction. Conclusions In this study, the prevalence of erectile dysfunction was high. Therefore, it is recommended that erectile dysfunction treatment be integrated into the health care system that focuses on educating and inspiring people on healthy eating, physical activity, and behavior enhancing wellbeing.	[Gebremedhin, Haftom Tesfay; Mezgebo, Hagos Mehari; Geberhiwot, Gessessew Teklebrhan; Ygzaw, Hailu Belay] Adigrat Univ, Coll Med & Hlth Sci, Dept Psychiat, Adigrat, Ethiopia; [Gebru, Tesfay Tsegay; Tesfamichael, Yowhans Ashebir; Woledemariam, Guesh Teklu; Gebru, Tsegu Hailu; Tadese, Haileslassie Tesfay] Adigrat Univ, Coll Med & Hlth Sci, Dept Nursing, Adigrat, Ethiopia; [Baraki, Mulu Ftwi] Adigrat Univ, Coll Med & Hlth Sci, Dept Midwifery, Adigrat, Ethiopia; [Kindeya, Gebreslassie Gebreegziabhier] Aksum Univ, Coll Hlth Sci, Dept Psychiat, Aksum, Ethiopia; [Azale, Telake] Univ Gondar, Coll Med & Hlth Sci, Dept Psychiat, Gondar, Ethiopia	University of Gondar	Gebremedhin, HT (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Psychiat, Adigrat, Ethiopia.	haftomtesfay30@gmail.com						Abolfotouh M., 2001, EFFECT ERECTILE DYSF; Agency C.S., 2013, POPULATION PROJECTIO; Akkus E, 2002, EUR UROL, V41, P298, DOI 10.1016/S0302-2838(02)00027-1; Althof SE, 2002, UROLOGY, V59, P803, DOI 10.1016/S0090-4295(02)01606-0; Ansong KS, 2000, ANN EPIDEMIOL, V10, P293, DOI 10.1016/S1047-2797(00)00050-8; Ariba AJ, 2007, S AFR FAM PRACT, V49, P16, DOI 10.1080/20786204.2007.10873632; Bai Q, 2004, ASIAN J ANDROL, V6, P343; Berrada S, 2003, INT J IMPOT RES, V15, pS3, DOI 10.1038/sj.ijir.3900968; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Burchardt M, 2001, INT J IMPOT RES, V13, P276, DOI 10.1038/sj.ijir.3900725; Burnett AL, 2006, J SEX MED, V3, P578, DOI 10.1111/j.1743-6109.2006.00270.x; Cheng JYW, 2007, INT J IMPOT RES, V19, P229, DOI 10.1038/sj.ijir.3901517; Chew KK, 2008, J SEX MED, V5, P60, DOI 10.1111/j.1743-6109.2007.00548.x; Chirita V, 2016, B INTEGRATIVE PSYCHI, V22, P119; Cho BL, 2003, INT J IMPOT RES, V15, P323, DOI 10.1038/sj.ijir.3901022; Corona G, 2004, INT J IMPOT RES, V16, P395, DOI 10.1038/sj.ijir.3901225; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; JONLER M, 1995, BRIT J UROL, V75, P651, DOI 10.1111/j.1464-410X.1995.tb07426.x; Martin-Morales A, 2001, J UROLOGY, V166, P569, DOI 10.1016/S0022-5347(05)65986-1; Moreira ED, 2002, INT J IMPOT RES, V14, pS3, DOI 10.1038/sj.ijir.3900892; Moreira ED, 2001, UROLOGY, V58, P583, DOI 10.1016/S0090-4295(01)01274-2; Moreira Júnior Edson Duarte, 2002, Sao Paulo Med. J., V120, P49; Nassar OH, 2014, EURASIAN J MED, V46, P69, DOI 10.5152/eajm.2014.18; Nicolosi A, 2003, INT J IMPOT RES, V15, P253, DOI 10.1038/sj.ijir.3901010; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Nosarev AV, 2015, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00073; Oladiji F, 2013, INT J IMPOT RES, V25, P18, DOI 10.1038/ijir.2012.28; Organization W.H, 1998, PROGR MENT HLTH WHOQ; Organization WH., 1996, WHOQOL BREF INTRO AD; Oyelade BO, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.124.8660; Pallangyo P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0249-2; Phillips RL, 2000, AM FAM PHYSICIAN, V62, P782; Prins J, 2002, INT J IMPOT RES, V14, P422, DOI 10.1038/sj.ijir.3900905; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Safarinejad MR, 2003, INT J IMPOT RES, V15, P246, DOI 10.1038/sj.ijir.3901024; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; Seyam RM, 2003, INT J IMPOT RES, V15, P237, DOI 10.1038/sj.ijir.3901000; Shiri R, 2007, J UROLOGY, V177, P669, DOI 10.1016/j.juro.2006.09.030; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Tan J. K., 2003, SMJ Singapore Medical Journal, V44, P020; Vo TT, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00094	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0242335	10.1371/journal.pone.0242335	http://dx.doi.org/10.1371/journal.pone.0242335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740010	gold, Green Published			2022-12-26	WOS:000631030200013
J	Aycrigg, JL; Wells, AG; Garton, EO; Magipane, B; Liston, GE; Prugh, LR; Rachlow, JL				Aycrigg, Jocelyn L.; Wells, Adam G.; Garton, Edward. O.; Magipane, Buck; Liston, Glen E.; Prugh, Laura R.; Rachlow, Janet L.			Habitat selection by Dall's sheep is influenced by multiple factors including direct and indirect climate effects	PLOS ONE			English	Article							OVIS-DALLI; ENERGY EXPENDITURES; SYNOPTIC MODEL; HOME-RANGE; SPACE USE; ALPINE; SNOW; VARIABILITY; RESILIENCE; LOCOMOTION	Arctic and boreal environments are changing rapidly, which could decouple behavioral and demographic traits of animals from the resource pulses that have shaped their evolution. Dall's sheep (Ovis dalli dalli) in northwestern regions of the USA and Canada, survive long, severe winters and reproduce during summers with short growing seasons. We sought to understand the vulnerability of Dall's sheep to a changing climate in Lake Clark National Park and Preserve, Alaska, USA. We developed ecological hypotheses about nutritional needs, security from predators, energetic costs of movement, and thermal shelter to describe habitat selection during winter, spring, and summer and evaluated habitat and climate variables that reflected these hypotheses. We used the synoptic model of animal space use to estimate parameters of habitat selection by individual females and calculated likelihoods for ecological hypotheses within seasonal models. Our results showed that seasonal habitat selection was influenced by multiple ecological requirements simultaneously. Across all seasons, sheep selected steep rugged areas near escape terrain for security from predators. During winter and spring, sheep selected habitats with increased forage and security, moderated thermal conditions, and lowered energetic costs of movement. During summer, nutritional needs and security influenced habitat selection. Climate directly influenced habitat selection during the spring lambing period when sheep selected areas with lower snow depths, less snow cover, and higher air temperatures. Indirectly, climate is linked to the expansion of shrub/scrub vegetation, which was significantly avoided in all seasons. Dall's sheep balance resource selection to meet multiple needs across seasons and such behaviors are finely tuned to patterns of phenology and climate. Direct and indirect effects of a changing climate may reduce their ability to balance their needs and lead to continued population declines. However, several management approaches could promote resiliency of alpine habitats that support Dall's sheep populations.	[Aycrigg, Jocelyn L.; Wells, Adam G.; Garton, Edward. O.; Rachlow, Janet L.] Univ Idaho, Coll Nat Resources, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Magipane, Buck] Natl Pk Serv, Lake Clark Natl Pk & Preserve, Anchorage, AK USA; [Liston, Glen E.] Colorado State Univ, Cooperat Inst Res Atmosphere, Ft Collins, CO 80523 USA; [Prugh, Laura R.] Univ Washington, Coll Environm, Seattle, WA 98195 USA	Idaho; University of Idaho; United States Department of the Interior; Colorado State University; University of Washington; University of Washington Seattle	Aycrigg, JL (corresponding author), Univ Idaho, Coll Nat Resources, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	aycrigg@uidaho.edu	Aycrigg, Jocelyn/AAA-5719-2020	Aycrigg, Jocelyn/0000-0002-6511-7985; Wells, Adam/0000-0001-9675-4963	Arctic Boreal Vulnerability Experiment (ABoVE), a NASA Terrestrial Ecology campaign [NNX15AU21A]; USDOI National Park Service [H8W07110001]	Arctic Boreal Vulnerability Experiment (ABoVE), a NASA Terrestrial Ecology campaign; USDOI National Park Service	This research was conducted as part of the Arctic Boreal Vulnerability Experiment (ABoVE), a NASA Terrestrial Ecology campaign (award NNX15AU21A to LRP; url: above.nasa.gov). Additional support was provided to JLA, AGW, JLR, and EOG through Cooperative Agreement #H8W07110001 with the USDOI National Park Service (url: www.nps.gov).The National Park Service collected the GPS data for Dall's sheep at Lake Clark National Park and Preserve. The funders have no role in study design, data analysis, decision to published or preparation of the manuscript.	Alaska Department of Fish and Game, 2014, ADFGDWCWMR20143, P44; [Anonymous], 2017, NAT MAP; Bertram MR., 2018, DISTRIBUTION MOVEMEN; Bleich VC, 1997, WILDLIFE MONOGR, P1; Bliss L. C., 1971, ANNU REV ECOL SYST, V2, P405, DOI [10.1146/annurev.es.02.110171.002201, DOI 10.1146/ANNUREV.ES.02.110171.002201]; BON R, 1995, J ZOOL, V235, P43, DOI 10.1111/j.1469-7998.1995.tb05126.x; BOWYER R T, 1992, Mammalian Species, P1, DOI 10.2307/3504164; Bowyer R.T., 2000, ECOLOGY MANAGAMENT L, P491; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Chapin FS, 2006, AMBIO, V35, P198, DOI 10.1579/0044-7447(2006)35[198:BRAATM]2.0.CO;2; Cooper EJ, 2014, ANNU REV ECOL EVOL S, V45, P271, DOI 10.1146/annurev-ecolsys-120213-091620; Corti P, 2002, CAN J ZOOL, V80, P2108, DOI [10.1139/z02-207, 10.1139/Z02-207]; Cosgrove CL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244787; DAILEY TV, 1989, CAN J ZOOL, V67, P2368, DOI 10.1139/z89-335; Davidson SC, 2020, SCIENCE, V370, P712, DOI 10.1126/science.abb7080; Davison T, 2018, SURVEY DALLS SHEEP N; Dertien JS, 2017, J WILDLIFE MANAGE, V81, P1457, DOI 10.1002/jwmg.21308; Dial RJ, 2016, GLOBAL CHANGE BIOL, V22, P1841, DOI 10.1111/gcb.13207; Dye DG, 2002, HYDROL PROCESS, V16, P3065, DOI 10.1002/hyp.1089; Festa-Bianchet M., 2008, MOUNTAIN GOATS ECOLO; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Geist V., 1971, MOUNTAIN SHEEP STUDY; Gilbert SL, 2017, J MAMMAL, V98, P246, DOI 10.1093/jmammal/gyw167; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; Jageman HR, 2018, J RAPTOR RES, V52, P349, DOI 10.3356/JRR-17-21.1; Jenkerson C., 2010, EMODIS USER FRIENDLY DATA SOURCE, DOI [10.1086/653498, DOI 10.1086/653498]; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Juhasz CC, 2020, J ANIM ECOL, V89, P704, DOI 10.1111/1365-2656.13104; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Koizumi CL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215519; Koizumi CL., 2011, TRC1101 YUK FISH WIL, P56; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Liston GE, 2002, GLOBAL CHANGE BIOL, V8, P17, DOI 10.1046/j.1354-1013.2001.00416.x; Liston GE, 2006, J HYDROMETEOROL, V7, P1259, DOI 10.1175/JHM548.1; Liston GE, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015913; Mahoney PJ, 2018, ECOL APPL, V28, P1715, DOI 10.1002/eap.1773; Mangipane B, 2010, 17 BIENN S N WILD SH, P17; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martin KM, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P239; McBean G, 2005, ARCTIC CLIMATE IMPAC, P21; McCune B, 2018, MYCOSPHERE, V9, P859, DOI 10.5943/mycosphere/9/4/10; Merkle JA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0456; Myers-Smith IH, 2018, J ECOL, V106, P547, DOI 10.1111/1365-2745.12817; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; NETTE T, 1984, CAN FIELD NAT, V98, P252; Nichols L, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P23; Nuttall M., 2005, ARCTIC CLIMATE IMPAC, P649; Overland J, 2019, POLAR SCI, V21, P6, DOI 10.1016/j.polar.2018.11.008; OVERLAND JE, 2018, ARCTIC REPORT CARD 2, P5; Pan CG, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac9d3; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Potter C, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12101546; Prugh LR, 2015, OIKOS, V124, P1241, DOI 10.1111/oik.02017; Putkonen J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016326; Rachlow JL, 1998, J ZOOL, V245, P457, DOI 10.1111/j.1469-7998.1998.tb00120.x; RACHLOW JL, 1994, J MAMMAL, V75, P328, DOI 10.2307/1382551; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; Rattenbury K., 2017, ALASKA PARK SCI, P67; Rattenbury K., 2016, ALASKA DALL SHEEP WO; Rattenbury KL., 2017, ALASKA PARK SCI, V16, P67; Rattenbury KL, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2513; Rich P.M., 1994, AM SOC PHOTOGRAMM RE; Roffler GH, 2017, J MAMMAL, V98, P94, DOI 10.1093/jmammal/gyw135; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; SEIP DR, 1985, J WILDLIFE MANAGE, V49, P397, DOI 10.2307/3801541; Semenchuk PR, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/125006; Sivy KJ, 2018, CAN J ZOOL, V96, P1170, DOI 10.1139/cjz-2017-0259; Smith K., 2020, HABITAT SELECTION DA; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Swanson DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138387; Terskaia A, 2020, ECOGRAPHY, V43, P769, DOI 10.1111/ecog.05015; Van de Kerk M, 2020, J WILDLIFE MANAGE, V84, P1127, DOI 10.1002/jwmg.21873; van de Kerk M, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aace64; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Verbyla D, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9111157; Walker ABD, 2007, ECOSCIENCE, V14, P55, DOI 10.2980/1195-6860(2007)14[55:HSBFSS]2.0.CO;2; Walker ABD, 2006, CAN J ZOOL, V84, P1187, DOI 10.1139/Z06-109; Watson S, 1986, P 5 BIENN S N AM WIL; Wells AG, 2014, ECOL MODEL, V273, P242, DOI 10.1016/j.ecolmodel.2013.11.008; Western Regional Climate Center (WRCC), 2020, RAWS US CLIM ARCH GR; Zhu J., 2013, MODIS NDVI PRODUCTS	87	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248763	10.1371/journal.pone.0248763	http://dx.doi.org/10.1371/journal.pone.0248763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735234	Green Published, gold			2022-12-26	WOS:000631029700094
J	Bai, AD; Irfan, N; Main, C; El-Helou, P; Mertz, D				Bai, Anthony D.; Irfan, Neal; Main, Cheryl; El-Helou, Philippe; Mertz, Dominik			Local audit of empiric antibiotic therapy in bacteremia: A retrospective cohort study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; MORTALITY; REASSESSMENT; CARRIAGE	Background It is unclear if a local audit would be useful in providing guidance on how to improve local practice of empiric antibiotic therapy. We performed an audit of antibiotic therapy in bacteremia to evaluate the proportion and risk factors for inadequate empiric antibiotic coverage. Methods This retrospective cohort study included patients with positive blood cultures across 3 hospitals in Hamilton, Ontario, Canada during October of 2019. Antibiotic therapy was considered empiric if it was administered within 24 hours after blood culture collection. Adequate coverage was defined as when the isolate from blood culture was tested to be susceptible to the empiric antibiotic. A multivariable logistic regression model was used to predict inadequate empiric coverage. Diagnostic accuracy of a clinical pathway based on patient risk factors was compared to clinician's decision in predicting which bacteria to empirically cover. Results Of 201 bacteremia cases, empiric coverage was inadequate in 56 (27.9%) cases. Risk factors for inadequate empiric coverage included unknown source at initiation of antibiotic therapy (adjusted odds ratio (aOR) of 2.76 95% CI 1.27-6.01, P = 0.010) and prior antibiotic therapy within 90 days (aOR of 2.46 95% CI 1.30-4.74, P = 0.006). A clinical pathway that considered community-associated infection as low risk for Pseudomonas was better at ruling out Pseudomonas bacteremia with a negative likelihood ratio of 0.17 (95% CI 0.03-1.10) compared to clinician's decision with negative likelihood ratio of 0.34 (95% CI 0.10-1.22). Conclusions An audit of antibiotic therapy in bacteremia is feasible and may provide useful feedback on how to locally improve empiric antibiotic therapy.	[Bai, Anthony D.; El-Helou, Philippe; Mertz, Dominik] McMaster Univ, Div Infect Dis, Hamilton, ON, Canada; [Irfan, Neal] McMaster Univ, Div Med, Hamilton, ON, Canada; [Main, Cheryl] McMaster Univ, Div Med Microbiol, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Bai, AD (corresponding author), McMaster Univ, Div Infect Dis, Hamilton, ON, Canada.	anthony.bai@medportal.ca		Mertz, Dominik/0000-0003-4337-1613; Bai, Anthony/0000-0003-0448-9934				Adam HJ, 2011, DIAGN MICR INFEC DIS, V69, P307, DOI 10.1016/j.diagmicrobio.2010.10.026; Al-Hasan MN, 2013, CLIN MICROBIOL INFEC, V19, P948, DOI 10.1111/1469-0691.12085; Al-Hasan MN, 2008, AM J MED, V121, P702, DOI 10.1016/j.amjmed.2008.03.029; Al-Rawahi GN, 2008, J CLIN MICROBIOL, V46, P477, DOI 10.1128/JCM.01596-07; Carrara E, 2018, INT J ANTIMICROB AG, V51, P548, DOI 10.1016/j.ijantimicag.2017.12.013; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gilbert D.N., 2019, SANFORD GUIDE ANTIMI; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Harris PNA, 2018, JAMA-J AM MED ASSOC, V320, P984, DOI 10.1001/jama.2018.12163; Kadri SS, 2021, LANCET INFECT DIS, V21, P241, DOI 10.1016/S1473-3099(20)30477-1; Kanamaru A, 2004, CLIN INFECT DIS, V39, pS7, DOI 10.1086/383042; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lambregts MMC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208819; Lesprit P, 2010, J ANTIMICROB CHEMOTH, V65, P789, DOI 10.1093/jac/dkq018; MacFadden DR, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.03.029; MacFadden DR, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.01780-18, 10.1128/JCM.01780-18]; MacFadden DR, 2013, CAN MED ASSOC J, V185, pE725, DOI 10.1503/cmaj.130364; Mahar P, 2010, BURNS, V36, P1228, DOI 10.1016/j.burns.2010.05.009; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Ortega M, 2007, EUR J CLIN MICROBIOL, V26, P453, DOI 10.1007/s10096-007-0304-6; Pulcini C, 2008, J ANTIMICROB CHEMOTH, V61, P1384, DOI 10.1093/jac/dkn113; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; Savage RD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154944; Schechner V, 2009, CLIN INFECT DIS, V48, P580, DOI 10.1086/596709; Yeoh LY, 2014, HEMODIAL INT, V18, P142, DOI 10.1111/hdi.12061	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248817	10.1371/journal.pone.0248817	http://dx.doi.org/10.1371/journal.pone.0248817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735326	gold, Green Published			2022-12-26	WOS:000631029700038
J	Ji, Z; Tinti, M; Ferguson, MAJ				Ji, Zhe; Tinti, Michele; Ferguson, Michael A. J.			Proteomic identification of the UDP-GlcNAc: PI alpha 1-6 GlcNAc-transferase subunits of the glycosylphosphatidylinositol biosynthetic pathway of Trypanosoma brucei	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; GPI-ANCHORED PROTEINS; STRUCTURAL-CHARACTERIZATION; MEMBRANE ANCHOR; HUMAN ARV1; YEAST; FORMS; COMPLEMENTATION; TRANSAMIDASE; EXPRESSION	The first step of glycosylphosphatidylinositol (GPI) anchor biosynthesis in all eukaryotes is the addition of N-acetylglucosamine (GlcNAc) to phosphatidylinositol (PI) which is catalysed by a UDP-GlcNAc: PI alpha 1-6 GlcNAc-transferase, also known as GPI GnT. This enzyme has been shown to be a complex of seven subunits in mammalian cells and a similar complex of six homologous subunits has been postulated in yeast. Homologs of these mammalian and yeast subunits were identified in the Trypanosoma brucei predicted protein database. The putative catalytic subunit of the T. brucei complex, TbGPI3, was epitope tagged with three consecutive c-Myc sequences at its C-terminus. Immunoprecipitation of TbGPI3-3Myc followed by native polyacrylamide gel electrophoresis and anti-Myc Western blot showed that it is present in a similar to 240 kDa complex. Label-free quantitative proteomics were performed to compare anti-Myc pull-downs from lysates of TbGPI-3Myc expressing and wild type cell lines. TbGPI3-3Myc was the most highly enriched protein in the TbGPI3-3Myc lysate pull-down and the expected partner proteins TbGPI15, TbGPI19, TbGPI2, TbGPI1 and TbERI1 were also identified with significant enrichment. Our proteomics data also suggest that an Arv1-like protein (TbArv1) is a subunit of the T. brucei complex. Yeast and mammalian Arv1 have been previously implicated in GPI biosynthesis, but here we present the first experimental evidence for physical association of Arv1 with GPI biosynthetic machinery. A putative E2-ligase has also been tentatively identified as part of the T. brucei UDP-GlcNAc: PI alpha 1-6 GlcNAc-transferase complex.	[Ji, Zhe; Tinti, Michele; Ferguson, Michael A. J.] Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee, Scotland	University of Dundee	Ferguson, MAJ (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Dundee, Scotland.	majferguson@dundee.ac.uk		Ferguson, Michael/0000-0003-1321-8714	China Scholarship Council [201706310166]; Wellcome Investigator Award [101842/Z13/Z]	China Scholarship Council(China Scholarship Council); Wellcome Investigator Award	Z.J. China Scholarship Council PhD scholarship (201706310166), https://www.csc.edu.cn/M.A.J.F.Wellcome Investigator Award (101842/Z13/Z), https://wellcome.org/.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Casas-SuYnchez A., 2018, CRYSTAL STRUCTURE LO; Chang TH, 2002, J BIOL CHEM, V277, P50176, DOI 10.1074/jbc.M208374200; Davids M, 2020, MOL GENET METAB, V130, P49, DOI 10.1016/j.ymgme.2020.02.005; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Ferguson MAJ., 2009, GLYCOSYLPHOSPHATIDYL, P137; Georgiev AG, 2013, TRAFFIC, V14, P912, DOI 10.1111/tra.12082; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hong YC, 2006, FEBS LETT, V580, P603, DOI 10.1016/j.febslet.2005.12.075; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Ikeda A, 2016, YEAST, V33, P37, DOI 10.1002/yea.3138; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Lane-Serff H, 2014, ELIFE, V3, DOI 10.7554/eLife.05553; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Macleod OJS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15125-y; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MazhariTabrizi R, 1996, BIOCHEM J, V316, P853, DOI 10.1042/bj3160853; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2007, MOL BIOCHEM PARASIT, V151, P220, DOI 10.1016/j.molbiopara.2006.11.001; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; MENON AK, 1990, J BIOL CHEM, V265, P9033; Nagamune K, 2003, P NATL ACAD SCI USA, V100, P10682, DOI 10.1073/pnas.1833260100; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Okai H, 2020, FEBS LETT, V594, P2431, DOI 10.1002/1873-3468.13843; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Segel R, 2020, NEUROGENETICS, V21, P259, DOI 10.1007/s10048-020-00615-4; Sobering AK, 2004, CELL, V117, P637, DOI 10.1016/j.cell.2004.05.003; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; Tinti M., 2019, WELLCOME OPEN RES, V4, P1, DOI [10.12688/wellcomeopenres.14976.2 31245630, DOI 10.12688/WELLCOMEOPENRES.14976.231245630]; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Treumann A., 2010, GLYCOANALYSIS PROTOC, P213; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; VIDUGIRIENE J, 1994, J CELL BIOL, V127, P333, DOI 10.1083/jcb.127.2.333; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	48	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0244699	10.1371/journal.pone.0244699	http://dx.doi.org/10.1371/journal.pone.0244699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735232	Green Published, Green Submitted, gold			2022-12-26	WOS:000631029700037
J	Nowakowska, J; Gazda, A; Tomski, A; Szwagrzyk, J				Nowakowska, Joanna; Gazda, Anna; Tomski, Andrzej; Szwagrzyk, Jerzy			Drainage ditches enhance forest succession in a raised bog but do not affect the spatial pattern of tree encroachment	PLOS ONE			English	Article							SCOTS PINE; BLACK SPRUCE; PEATLAND; DYNAMICS; CLIMATE; MIRES; SYLVESTRIS; GROWTH; CONSERVATION; REGENERATION	The study was conducted in the raised bog Kusowo (Baltic region, West Pomerania, Poland). Along a transect line crossing two open mires affected by forest succession we analysed tree age distribution. One of those mires had been drained in the past years and still retained some open ditches, while the other one was located far from the ditches. Every 10 meters along the transect line one tree was drilled at the root collar in order to determine its age. We also conducted phytosociological analyses and short-term water level measurements in the sample plots. We expected faster tree encroachment in the undisturbed part of the open mire. The results showed, that there were no significant differences in water table level and in soil moisture indicator values between the formerly drained and undisturbed open mire. There were also no statistically significant differences in tree encroachment between the disturbed and undisturbed mires. Location and the age distribution of the trees suggest that changes in the tree growth conditions cannot be directly explained by the general decreasing of water level in the bog, although periods following drainage works were associated with more numerous establishment of young trees, in the drained part of the bog as well as in the part not directly affected by drainage ditches.	[Nowakowska, Joanna; Gazda, Anna; Szwagrzyk, Jerzy] Agr Univ Krakow, Dept Forest Biodivers, Krakow, Poland; [Tomski, Andrzej] Univ Silesia Katowice, Inst Math, Katowice, Poland	Agricultural University Krakow; University of Silesia in Katowice	Gazda, A (corresponding author), Agr Univ Krakow, Dept Forest Biodivers, Krakow, Poland.	rlgazda@cyf-kr.edu.pl	Gazda, Anna/B-7566-2011	Gazda, Anna/0000-0001-9806-1159; Tomski, Andrzej/0000-0001-6944-0600	Polish National Science Agency (NCN) [2011/01/N/NZ9/04502]; Ministry of Science and Higher Education of the Republic of Poland [SUB/040011-D019/2020]	Polish National Science Agency (NCN); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	JN, JS -The project was funded by Polish National Science Agency (NCN) research grant No 2011/01/N/NZ9/04502 https://www.ncn.gov.pl/? language=en AG The Ministry of Science and Higher Education of the Republic of Poland for the statutory activities of the Forestry Faculty of the University of Agriculture in Krakow (SUB/040011-D019/2020) https://www.gov.pl/web/science.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1990, J ECOL, V78, P1049, DOI 10.2307/2260951; [Anonymous], 2020, BIULETYN STATYSTYCZN; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Bragazza L, 2006, P NATL ACAD SCI USA, V103, P19386, DOI 10.1073/pnas.0606629104; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G; Brumelis G, 2009, SILVA FENN, V43, P767, DOI 10.14214/sf.172; Cedro A, 2008, BALT FOR, V14, P26; Cedro A, 2016, FORESTS, V7, DOI 10.3390/f7090202; Cedro A, 2011, DENDROCHRONOLOGIA, V29, P211, DOI 10.1016/j.dendro.2010.12.004; Choi WJ, 2007, ECOLOGY, V88, P443, DOI 10.1890/0012-9658(2007)88[443:DATGAC]2.0.CO;2; Chojnacki T., 2003, Prace Instytutu Badawczego Lesnictwa, Seria A, P31; Czerepko J., 2011, I BADAW LESNICTWA; Dudova L, 2010, PRESLIA, V82, P223; Dyderski MK, 2016, SCI TOTAL ENVIRON, V562, P648, DOI 10.1016/j.scitotenv.2016.04.102; Eckstein J, 2009, DENDROCHRONOLOGIA, V27, P129, DOI 10.1016/j.dendro.2009.06.007; Ellenberg H., 2001, SCR GEOBOT, V18, P211; Frelechoux F, 2000, FOLIA GEOBOT, V35, P273, DOI 10.1007/BF02803119; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Grzybowski M, 2020, J NAT CONSERV, V53, DOI 10.1016/j.jnc.2019.125778; Gunnarson BE, 1999, GEOGR ANN A, V81A, P421, DOI 10.1111/j.0435-3676.1999.00071.x; Gunnarsson U, 1998, WETLANDS, V18, P133, DOI 10.1007/BF03161450; Gunnarsson U., 2000, ACTA U UPS COMPR SUM, V561, P25; Gunnarsson U, 2007, J VEG SCI, V18, P595, DOI 10.1111/j.1654-1103.2007.tb02573.x; Heijmans MMPD, 2013, GLOBAL CHANGE BIOL, V19, P2240, DOI 10.1111/gcb.12202; Kleinen T, 2012, BIOGEOSCIENCES, V9, P235, DOI 10.5194/bg-9-235-2012; Kloss M., 2008, TORFOWISKA GOR WYZYN; Laiho R, 2004, SOIL BIOL BIOCHEM, V36, P1095, DOI 10.1016/j.soilbio.2004.02.020; Lamentowicz M, 2008, PALAEOGEOGR PALAEOCL, V265, P93, DOI 10.1016/j.palaeo.2008.04.023; Langanke T, 2007, LANDSCAPE URBAN PLAN, V79, P160, DOI 10.1016/j.landurbplan.2006.02.006; Lavoie C, 2001, ECOSCIENCE, V8, P247, DOI 10.1080/11956860.2001.11682651; Leifeld J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03406-6; Macdonald SE, 1999, J ECOL, V87, P404, DOI 10.1046/j.1365-2745.1999.00370.x; Magnan G, 2019, BOREAS, V48, P131, DOI 10.1111/bor.12345; Obidzinski A, 2009, HOLOCENE, V19, P229, DOI 10.1177/0959683608100567; OHLSON M, 1991, OIKOS, V61, P369, DOI 10.2307/3545244; OHLSON M, 1995, PLANT SOIL, V172, P235, DOI 10.1007/BF00011326; Ohlson M, 2001, OIKOS, V94, P425, DOI 10.1034/j.1600-0706.2001.940305.x; Paivanen J., 1973, ACTA FOR FENN, V129, DOI [10.14214/aff.7563, DOI 10.14214/AFF.7563]; Pellerin S, 2003, J ECOL, V91, P1008, DOI 10.1046/j.1365-2745.2003.00834.x; Ratcliffe JL, 2017, SCI TOTAL ENVIRON, V607, P816, DOI 10.1016/j.scitotenv.2017.06.276; Roy V, 1999, CAN J FOREST RES, V29, P563, DOI 10.1139/cjfr-29-5-563; Sakari Sarkkola., 2006, STAND STRUCTURAL DYN, DOI [10.14214/df.29, DOI 10.14214/DF.29]; Socha J, 2012, FOREST ECOL MANAG, V274, P172, DOI 10.1016/j.foreco.2012.02.032; Sundstrom E., 1992, OX417; Tahvanainen T, 2011, J ECOL, V99, P404, DOI 10.1111/j.1365-2745.2010.01778.x; Tsiripidis I., 2017, EUROPEAN RED LIST HA, DOI [10.2779/091372, DOI 10.2779/091372]; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1	48	2	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247760	10.1371/journal.pone.0247760	http://dx.doi.org/10.1371/journal.pone.0247760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735308	Green Published, gold			2022-12-26	WOS:000631029700103
J	Zloch, M; Pomastowski, P; Peer, M; Sparbier, K; Kostrzewa, M; Buszewski, B				Zloch, Michal; Pomastowski, Pawel; Peer, Markus; Sparbier, Katrin; Kostrzewa, Markus; Buszewski, Boguslaw			Study on carbapenemase-producing bacteria by matrix-assisted laser desorption/ionization approach	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MALDI-TOF MS; FLIGHT MASS-SPECTROMETRY; RAPID DETECTION; PSEUDOMONAS-AERUGINOSA; ACINETOBACTER-BAUMANNII; ENTEROBACTERIACEAE; RESISTANCE; ASSAY	The development of new techniques for the detection of carbapenemase activity is of great importance since the increased incident of resistance against carbapenems represents a serious threat to global public health. In this context, the matrix-assisted laser desorption/ionization approach already demonstrated to be a reliable tool for rapid carbapenemase detection. As a newly developed test, there is still a lack of in-depth analysis of its robustness and possible wider application. The main goal of this study was to evaluate the potential for using the design MBT STAR-Carba assay as the pre-characterization method for Enterobacterales and P. aeruginosa strains in terms of the produced classes of carbapenemases using modified procedure parameters-various suspension densities and incubation times. Moreover, its usefulness for the in-depth analysis and characterization of metallo-beta-lactamases (MBL) was tested by applying inhibition assays. In this study, the designed assay proved to be a sensitive tool for the detection of carbapenemase hydrolytic activity, which can be successfully used to partially classify the class of carbapenemase present. Additionally, the use of defined high concentration suspensions would allow to shorten the incubation time to 1 minute for certain strains. Considering that the assay was also suitable to investigate the effect of different inhibitors on the MBL activity, it demonstrates far higher discriminatory potential than only a rapid routine carbapenemase detection tool and could be used as a susceptibility assay.	[Zloch, Michal; Pomastowski, Pawel; Buszewski, Boguslaw] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Peer, Markus; Sparbier, Katrin; Kostrzewa, Markus] Bruker Daltonik GmbH, Bremen, Germany; [Buszewski, Boguslaw] Nicolaus Copernicus Univ, Chair Environm Chem & Bioanalyt, Fac Chem, Torun, Poland	Nicolaus Copernicus University; Bruker Corporation; Bruker Daltonik GmbH; Nicolaus Copernicus University	Zloch, M (corresponding author), Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland.	michal.zloch@umk.pl	Zloch, Michal/D-3655-2018	Zloch, Michal/0000-0001-6169-3099; Buszewski, Boguslaw/0000-0002-5482-7500	National Science Centre, Poland [2018/28/C/ST4/00434]	National Science Centre, Poland(National Science Centre, Poland)	This research was supported by a grant from the National Science Centre, Poland to MZ (SONATINA 2 project No. 2018/28/C/ST4/00434). Bruker Daltonik GmbH (Germany) provided support in the form of salaries for authors MP, KS, and MK. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Alvarez-Buylla A, 2013, J CLIN MICROBIOL, V51, P1589, DOI 10.1128/JCM.00181-13; Anantharajah A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01413; Bakthavatchalam YD, 2016, J GLOB INFECT DIS, V8, P41, DOI 10.4103/0974-777X.176149; Bernabeu S, 2017, J ANTIMICROB CHEMOTH, V72, P1646, DOI 10.1093/jac/dkx061; Braud A, 2010, ENV MICROBIOL REP, V2, P419, DOI 10.1111/j.1758-2229.2009.00126.x; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Bush K, 2019, NAT REV MICROBIOL, V17, P295, DOI 10.1038/s41579-019-0159-8; Bush K, 2013, J GLOB ANTIMICROB RE, V1, P7, DOI 10.1016/j.jgar.2013.01.005; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carvalhaes CG, 2014, J ANTIMICROB CHEMOTH, V69, P2132, DOI 10.1093/jac/dku094; Carvalhaes CG, 2013, J CLIN MICROBIOL, V51, P287, DOI 10.1128/JCM.02365-12; Chong PM, 2015, J MICROBIOL METH, V111, P21, DOI 10.1016/j.mimet.2015.01.024; Choquet M, 2018, EUR J CLIN MICROBIOL, V37, P149, DOI 10.1007/s10096-017-3115-4; Cordovana M, 2020, MICROB DRUG RESIST, V26, P1298, DOI 10.1089/mdr.2019.0466; Cordovana M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02854; Dortet L, 2018, J ANTIMICROB CHEMOTH, V73, P2352, DOI 10.1093/jac/dky209; Findlay J, 2015, J ANTIMICROB CHEMOTH, V70, P1338, DOI 10.1093/jac/dku571; Gazin M, 2012, J CLIN MICROBIOL, V50, P1140, DOI 10.1128/JCM.06852-11; Ghebremedhin B, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0120-x; Girlich D, 2013, DIAGN MICR INFEC DIS, V77, P200, DOI 10.1016/j.diagmicrobio.2013.08.002; Hoyos-Mallecot Y, 2014, LETT APPL MICROBIOL, V58, P325, DOI 10.1111/lam.12203; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Johansson A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-89; Knox J, 2017, DIAGN MICR INFEC DIS, V87, P258, DOI 10.1016/j.diagmicrobio.2016.11.018; Lambert PA, 2002, J ROY SOC MED, V95, P22; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Miltgen G, 2018, J MICROBIOL METH, V145, P66, DOI 10.1016/j.mimet.2017.12.011; Monteferrante CG, 2016, J ANTIMICROB CHEMOTH, V71, P2856, DOI 10.1093/jac/dkw208; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Oviano M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00328; Oviano M, 2017, J ANTIMICROB CHEMOTH, V72, P2259, DOI 10.1093/jac/dkx127; Oviano M, 2017, DIAGN MICR INFEC DIS, V87, P129, DOI 10.1016/j.diagmicrobio.2016.10.016; Oviano M, 2016, J CLIN MICROBIOL, V54, P754, DOI 10.1128/JCM.02496-15; Pachori P, 2019, GENES DIS, V6, P109, DOI 10.1016/j.gendis.2019.04.001; Pierce VM, 2017, J CLIN MICROBIOL, V55, P2321, DOI 10.1128/JCM.00193-17; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Rodriguez-Sanchez B, 2019, EUROSURVEILLANCE, V24, P72, DOI 10.2807/1560-7917.ES.2019.24.4.1800193; Sanguinetti M, 2016, EXPERT REV PROTEOMIC, V13, P965, DOI 10.1080/14789450.2016.1231578; Sparbier K, 2012, J CLIN MICROBIOL, V50, P927, DOI 10.1128/JCM.05737-11; Tamma PD, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01140-18, 10.1128/jcm.01140-18]; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Zhou ML, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00395-18, 10.1128/jcm.00395-18]	44	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247369	10.1371/journal.pone.0247369	http://dx.doi.org/10.1371/journal.pone.0247369			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735168	gold, Green Published			2022-12-26	WOS:000631029700107
J	Salgado, BAB; Fabbri, S; Dickenson, A; Hasan, MI; Walsh, JL				Salgado, Breno A. B.; Fabbri, Stefania; Dickenson, Aaron; Hasan, Mohammad, I; Walsh, James L.			Surface barrier discharges for Escherichia coli biofilm inactivation: Modes of action and the importance of UV radiation	PLOS ONE			English	Article								Cold plasma generated in air at atmospheric pressure is an extremely effective antimicrobial agent, with proven efficacy against clinically relevant bacterial biofilms. The specific mode of bacterial inactivation is highly dependent upon the configuration of the plasma source used. In this study, the mode of microbial inactivation of a surface barrier discharge was investigated against Escherichia coli biofilms grown on polypropylene coupons. Different modes of exposure were considered and it was demonstrated that the long-lived reactive species created by the plasma are not solely responsible for the observed microbial inactivation. It was observed that a synergistic interaction occurs between the plasma generated long-lived reactive species and ultraviolet (UV) photons, acting to increase the antimicrobial efficacy of the approach by an order of magnitude. It is suggested that plasma generated UV is an important component for microbial inactivation when using a surface barrier discharge; however, it is not through the conventional pathway of direct DNA damage, rather through the synergistic interaction between liquid in the biofilm matrix and long-lived chemical species created by the discharge.	[Salgado, Breno A. B.; Fabbri, Stefania; Dickenson, Aaron; Hasan, Mohammad, I; Walsh, James L.] Univ Liverpool, Ctr Plasma Microbiol, Dept Elect Engn & Elect, Liverpool, Merseyside, England	University of Liverpool	Walsh, JL (corresponding author), Univ Liverpool, Ctr Plasma Microbiol, Dept Elect Engn & Elect, Liverpool, Merseyside, England.	J.L.Walsh@liverpool.ac.uk		Hasan, Mohammad/0000-0001-6993-933X; Walsh, James/0000-0002-6318-0892; Fabbri, Stefania/0000-0002-7381-4086; Dickenson, Aaron/0000-0003-4721-7138	UK Engineering and Physical Sciences Research Council [EP/S025790/1, EP/N021347/1, EP/R041849/1, EP/T000104/1]	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JW: The UK Engineering and Physical Sciences Research Council, grants: EP/S025790/1, EP/N021347/1, EP/R041849/1. MH: The UK Engineering and Physical Sciences Research Council, grant: EP/T000104/1. https://epsrc.ukri.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawareek MY, 2012, FEMS IMMUNOL MED MIC, V65, P381, DOI 10.1111/j.1574-695X.2012.00942.x; Arora DP, 2015, BIOCHEMISTRY-US, V54, P3717, DOI 10.1021/bi501476n; Bang CS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-65; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; Boudam MK, 2006, J PHYS D APPL PHYS, V39, P3494, DOI 10.1088/0022-3727/39/16/S07; Brandenburg R, 2017, PLASMA SOURCES SCI T, V26, DOI 10.1088/1361-6595/aa6426; Brun P, 2018, J APPL MICROBIOL, V125, P398, DOI 10.1111/jam.13780; Dezest M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173618; Dickenson A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14117-1; Dickenson A, 2018, PHYS CHEM CHEM PHYS, V20, P28499, DOI 10.1039/c8cp05762a; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Edengeiser E, 2015, J BIOPHOTONICS, V8, P918, DOI 10.1002/jbio.201400123; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Han L, 2016, APPL ENVIRON MICROB, V82, P450, DOI 10.1128/AEM.02660-15; Hasan MI, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4979178; Hasan MI, 2016, J APPL PHYS, V119, DOI 10.1063/1.4952574; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Jeon J, 2014, PLASMA PROCESS POLYM, V11, P426, DOI 10.1002/ppap.201300173; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Lackmann JW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0591; Lai ACK, 2018, J HAZARD MATER, V358, P389, DOI 10.1016/j.jhazmat.2018.07.003; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Li YF, 2012, PLASMA PROCESS POLYM, V9, P585, DOI 10.1002/ppap.201100090; Lis KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197773; Liu DX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23737; Lu H, 2014, J APPL MICROBIOL, V116, P784, DOI 10.1111/jam.12426; McKenzie K, 2016, MICROBIOL-SGM, V162, P1680, DOI 10.1099/mic.0.000350; Miyamoto K, 2016, ARCH BIOCHEM BIOPHYS, V605, P95, DOI 10.1016/j.abb.2016.03.023; Modic M, 2017, INT J ANTIMICROB AG, V49, P375, DOI 10.1016/j.ijantimicag.2016.11.022; Ni Y, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/35/355203; Olatunde OO, 2019, J FOOD SAFETY, V39, DOI 10.1111/jfs.12705; Park S, 2019, CHEM ENG J, V378, DOI 10.1016/j.cej.2019.122163; Patange A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02841; Prasad P, 2017, FOOD RES INT, V102, P402, DOI 10.1016/j.foodres.2017.09.030; Sakiyama Y, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/425201; Schneider S, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/29/295201; Shimizu T, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103028; Smet C, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01539; Soler-Arango J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216817; Sun Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23040975; Taglioli M, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/6/06LT01; Tanaka H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50136-w; Thana P., SURF COAT TECHNOL, V2020, DOI [10.1016/j.heliyon.2019.e02455, DOI 10.1016/J.HELIYON.2019.E02455]; Theinkom F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223925; Vumma R, 2016, J ANTIBIOT, V69, P183, DOI 10.1038/ja.2015.112; Wang LY, 2010, J APPL MICROBIOL, V108, P851, DOI 10.1111/j.1365-2672.2009.04483.x; Waskow A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03164; Winter T, 2011, PROTEOMICS, V11, P3518, DOI 10.1002/pmic.201000637; Yang Y, 2020, CLIN ORAL INVEST, V24, P1465, DOI 10.1007/s00784-019-03179-2; Ziuzina D., 2014, PLASMA MED, V4, P137, DOI [DOI 10.1615/PLASMAMED.2014011996, 10.1615/PlasmaMed.2014011996]; Ziuzina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138209	52	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247589	10.1371/journal.pone.0247589	http://dx.doi.org/10.1371/journal.pone.0247589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730103	gold, Green Published			2022-12-26	WOS:000630345000011
J	Duarte, M; Viegas, A; Alves, VD; Prates, JAM; Ferreira, LMA; Najmudin, S; Cabrita, EJ; Carvalho, AL; Fontes, CMGA; Bule, P				Duarte, Marlene; Viegas, Aldino; Alves, Victor D.; Prates, Jose A. M.; Ferreira, Luis M. A.; Najmudin, Shabir; Cabrita, Eurico J.; Carvalho, Ana Luisa; Fontes, Carlos M. G. A.; Bule, Pedro			A dual cohesin-dockerin complex binding mode in Bacteroides cellulosolvens contributes to the size and complexity of its cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE ATTACHMENT; X-RAY CHARACTERIZATION; CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; SCAFFOLDIN; SPECIFICITIES; MODULE; CRYSTALLIZATION; OVEREXPRESSION; CALCIUM	The Cellulosome is an intricate macromolecular protein complex that centralizes the cellulolytic efforts of many anaerobic microorganisms through the promotion of enzyme synergy and protein stability. The assembly of numerous carbohydrate processing enzymes into a macromolecular multiprotein structure results from the interaction of enzyme-borne dockerin modules with repeated cohesin modules present in noncatalytic scaffold proteins, termed scaffoldins. Cohesin-dockerin (Coh-Doc) modules are typically classified into different types, depending on structural conformation and cellulosome role. Thus, type I Coh-Doc complexes are usually responsible for enzyme integration into the cellulosome, while type II Coh-Doc complexes tether the cellulosome to the bacterial wall. In contrast to other known cellulosomes, cohesin types from Bacteroides cellulosolvens, a cellulosome-producing bacterium capable of utilizing cellulose and cellobiose as carbon sources, are reversed for all scaffoldins, i.e., the type II cohesins are located on the enzyme-integrating primary scaffoldin, whereas the type I cohesins are located on the anchoring scaffoldins. It has been previously shown that type I B. cellulosolvens interactions possess a dual-binding mode that adds flexibility to scaffoldin assembly. Herein, we report the structural mechanism of enzyme recruitment into B. cellulosolvens cellulosome and the identification of the molecular determinants of its type II cohesin-dockerin interactions. The results indicate that, unlike other type II complexes, these possess a dual-binding mode of interaction, akin to type I complexes. Therefore, the plasticity of dual-binding mode interactions seems to play a pivotal role in the assembly of B. cellulosolvens cellulosome, which is consistent with its unmatched complexity and size.	[Duarte, Marlene; Alves, Victor D.; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Bule, Pedro] Univ Lisbon, Polo Univ Alto da Ajuda, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, Lisbon, Portugal; [Viegas, Aldino; Cabrita, Eurico J.; Carvalho, Ana Luisa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO, Caparica, Portugal; [Najmudin, Shabir] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Fontes, Carlos M. G. A.] NZYTech Genes & Enzymes, Res & Dev, Lisbon, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa; University of London; King's College London	Bule, P (corresponding author), Univ Lisbon, Polo Univ Alto da Ajuda, Fac Vet Med, CIISA Ctr Interdisciplinary Res Anim Hlth, Ave Univ Tecn, Lisbon, Portugal.; Carvalho, AL (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO, Caparica, Portugal.	almc@fct.unl.pt; pedrobule@fmv.ulisboa.pt	Prates, José A M/K-9934-2013; Viegas, Aldino/A-1889-2011; Bule, Pedro/W-6838-2019; Cabrita, Eurico/E-8053-2011; Carvalho, Ana Luisa/G-5638-2011	Prates, José A M/0000-0003-1032-5987; Viegas, Aldino/0000-0003-1733-136X; Bule, Pedro/0000-0003-2531-9926; Cabrita, Eurico/0000-0002-0720-2751; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Duarte Santos, Marlene/0000-0001-5634-699X; Carvalho, Ana Luisa/0000-0002-3824-0240	Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA) [UIDB/00276/2020]; Portuguese Foundation for Science and Technology (FCT-MCTES) through Applied Molecular Biosciences Unit (UCIBIO) [UIDB/04378/2020]; FCT-MCTES [SFRH/BD/35992/2007, SFRH/BD/146965/2019]; Portuguese Foundation for Science and Technology (FCT-MCTES) [RECI/BBB-BEP/0124/2012]; Fundação para a Ciência e a Tecnologia [UIDB/04378/2020, SFRH/BD/35992/2007, SFRH/BD/146965/2019, RECI/BBB-BEP/0124/2012] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA); Portuguese Foundation for Science and Technology (FCT-MCTES) through Applied Molecular Biosciences Unit (UCIBIO); FCT-MCTES(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT-MCTES)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by the Portuguese Foundation for Science and Technology (FCT-MCTES) through the Centro de Investigacao Interdisciplinar em Sanidade Animal (CIISA) grant UIDB/00276/2020, the Applied Molecular Biosciences Unit (UCIBIO) grant UIDB/04378/2020, and through the National Project grant RECI/BBB-BEP/0124/2012. M. D. is supported by a PhD studentship (SFRH/BD/146965/2019) from FCT-MCTES. A. V. was supported by a PhD studentship (SFRH/BD/35992/2007) FCT-MCTES.	Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Adams JJ, 2005, BIOCHEMISTRY-US, V44, P2173, DOI 10.1021/bi048039u; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bras JLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38292; Bule P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25171-8; Bule P, 2018, J BIOL CHEM, V293, P4201, DOI 10.1074/jbc.RA117.001241; Bule P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00919-w; Bule P, 2016, J BIOL CHEM, V291, P26658, DOI 10.1074/jbc.M116.761643; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1061, DOI 10.1107/S2053230X14012667; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2011, ACTA CRYSTALLOGR D, V67, P233, DOI 10.1107/S0907444911007578; Dassa B, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01022-15; Ding S.-Y., 2000, SCAFFOLDIN BACTEROID; Ding SY, 2000, J BACTERIOL, V182, P4915, DOI 10.1128/JB.182.17.4915-4925.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; GIULIANO C, 1984, APPL ENVIRON MICROB, V48, P446, DOI 10.1128/AEM.48.2.446-448.1984; GIULIANO C, 1985, BIOTECHNOL BIOENG, V27, P980, DOI 10.1002/bit.260270708; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Israeli-Ruimy V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42355; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noach I, 2005, J MOL BIOL, V348, P1, DOI 10.1016/j.jmb.2005.02.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Vera AM, 2021, STRUCTURE, V29, P587, DOI 10.1016/j.str.2021.01.006; Yaniv O, 2011, ACTA CRYSTALLOGR D, V67, P506, DOI 10.1107/S0907444911011322; Yao XZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd7182; Zhao GS, 2006, BIOSCI BIOTECH BIOCH, V70, P1636, DOI 10.1271/bbb.50699; Zhivin O, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0898-6	38	2	3	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100552	10.1016/j.jbc.2021.100552	http://dx.doi.org/10.1016/j.jbc.2021.100552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744293	Green Published, gold			2022-12-26	WOS:000672866400525
J	Min, KB; Hwang, W; Lee, KM; Kim, JB; Yoon, SS				Min, Kyung Bae; Hwang, Wontae; Lee, Kang-Mu; Kim, June Beom; Yoon, Sang Sun			Chemical inhibitors of the conserved bacterial transcriptional regulator DksA1 suppressed quorum sensing-mediated virulence of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA PROMOTERS; PPGPP; POLYMERASE; MODULATION; MECHANISMS; EXPRESSION; INITIATION; INSIGHTS; ROLES	Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen whose virulence is dependent on quorum sensing (QS). DksA1, an RNA polymerase-binding transcriptional regulator, plays a role in determining a number of phenotypes, including QS-mediated virulence. We therefore envisioned that DksA1 inhibitors may help to control P. aeruginosa infection. Here, we screened a library of 6970 chemical compounds and identified two compounds (henceforth termed Dkstatins) that specifically suppressed DksA1 activity. Treatment with these two compounds also substantially decreased the production of elastase and pyocyanin, dominant virulence determinants of P. aeruginosa, and protected murine hosts from lethal infection from a prototype strain of P. aeruginosa, PAO1. The Dkstatins also suppressed production of homoserine lactone (HSL)-based autoinducers that activate P. aeruginosa QS. The level of 3-oxo-C12-HSL produced by Dkstatin-treated wildtype PAO1 closely resembled that of the Delta dksA1 mutant. RNA-Seq analysis showed that transcription levels of QS- and virulence-associated genes were markedly reduced in Dkstatin-treated PAO1 cells, indicating that Dkstatin-mediated suppression occurs at the transcriptional level. Importantly, Dkstatins increased the antibiotic susceptibilities of PAO1, particularly to protein synthesis inhibitors, such as tobramycin and tetracycline. Co-immunoprecipitation assays demonstrated that these Dkstatins interfered with DksA1 binding to the beta subunit of RNA polymerase, pointing to a potential mechanism of action. Collectively, our results illustrate that inhibition of P. aeruginosa QS may be achieved via DksA1 inhibitors and that Dkstatins may serve as potential lead compounds to control infection.	[Min, Kyung Bae; Hwang, Wontae; Lee, Kang-Mu; Kim, June Beom; Yoon, Sang Sun] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Min, Kyung Bae; Hwang, Wontae; Kim, June Beom; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea.; Yoon, SS (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	sangsun_yoon@yuhs.ac		LEE, Kang-Mu/0000-0001-7414-5921; Yoon, Sang Sun/0000-0003-2979-365X	National Research Foundation (NRF) of Korea [2017M3A9F3041233, 2019R1A6A1A03032869]; Korea Health Technology R&D Project - Ministry of Health Welfare, Korea [HI14C1324]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [918003041SB010]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project - Ministry of Health Welfare, Korea; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of KoreaInstitute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea)	This work was supported by grants from the National Research Foundation (NRF) of Korea, (2017M3A9F3041233, 2019R1A6A1A03032869). This research was also supported by a grant from the Korea Health Technology R&D Project, funded by the Ministry of Health & Welfare, Korea (HI14C1324). This work was also supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Agricultural Microbiome R&D Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (918003041SB010).	Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Azriel S, 2016, INFECT IMMUN, V84, P375, DOI 10.1128/IAI.01135-15; Berger R, 2011, CHEM SOC REV, V40, P3496, DOI 10.1039/c0cs00221f; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cloutier JF, 2001, J MOL BIOL, V313, P539, DOI 10.1006/jmbi.2001.4997; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Doniselli N, 2015, NUCLEIC ACIDS RES, V43, P5249, DOI 10.1093/nar/gkv391; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; Fan XJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01950; Filloux A, 2014, METHODS MOL BIOL, V1149, pV; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Gray MJ, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00664-18; Guendouze A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00227; Henard CA, 2010, J BIOL CHEM, V285, P36785, DOI 10.1074/jbc.M110.160960; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Ikeda H, 2006, CHEM PHARM BULL, V54, P731, DOI 10.1248/cpb.54.731; Jiang Q, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2015978; Kim HY, 2018, J BIOL CHEM, V293, P5679, DOI [10.1074/jbc.RA117.000383, 10.1074/jbc.ra117.000383]; Kim JS, 2018, P NATL ACAD SCI USA, V115, pE11780, DOI 10.1073/pnas.1813572115; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; Lee K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw104; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Min KB, 2020, J BIOL CHEM, V295, P3851, DOI 10.1074/jbc.RA119.011692; Moradali MF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00039; Nathwani D, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-32; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Parshin A, 2015, P NATL ACAD SCI USA, V112, pE6862, DOI 10.1073/pnas.1521365112; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; Ross W, 2016, MOL CELL, V62, P811, DOI 10.1016/j.molcel.2016.04.029; Scoffone VC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081838; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Valentini M, 2018, CURR OPIN MICROBIOL, V41, P15, DOI 10.1016/j.mib.2017.11.006; Yang YX, 2012, J MICROBIOL, V50, P987, DOI 10.1007/s12275-012-2149-7; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	48	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100576	10.1016/j.jbc.2021.100576	http://dx.doi.org/10.1016/j.jbc.2021.100576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757766	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400549
J	Buisseret, B; Guillemot-Legris, O; Ben Kouidar, Y; Paquot, A; Muccioli, GG; Alhouayek, M				Buisseret, Baptiste; Guillemot-Legris, Owein; Ben Kouidar, Youssef; Paquot, Adrien; Muccioli, Giulio G.; Alhouayek, Mireille			Effects of R-flurbiprofen and the oxygenated metabolites of endocannabinoids in inflammatory pain mice models	FASEB JOURNAL			English	Article						analgesia; capsaicin; eicosanoid; lipid mediator; prostanoid; PGD(2)&#8208; G		Pain is one of the cardinal signs accompanying inflammation. The prostaglandins (PGs), synthetized from arachidonic acid by cyclooxygenase (COX)-2, are major bioactive lipids implicated in inflammation and pain. However, COX-2 is also able to metabolize other lipids, including the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide (AEA), to give glycerol ester (PG-G) and ethanolamide (PG-EA) derivatives of the PGs. Consequently, COX-2 can be considered as a hub not only controlling PG synthesis, but also PG-G and PG-EA synthesis. As they were more recently characterized, these endocannabinoid metabolites are less studied in nociception compared to PGs. Interestingly R-profens, previously considered as inactive enantiomers of nonsteroidal anti-inflammatory drugs (NSAIDs), are substrate-selective COX inhibitors. Indeed, R-flurbiprofen can selectively block PG-G and PG-EA production, without affecting PG synthesis from COX-2. Therefore, we compared the effect of R-flurbiprofen and S-flurbiprofen in models of inflammatory pain triggered by local administration of lipopolysaccharides (LPS) and carrageenan in mice. Remarkably, the effects of flurbiprofen enantiomers on mechanical hyperalgesia seem to depend on (i) the inflammatory stimuli, (ii) the route of administration, and (iii) the timing of administration. We also assessed the effect of administration of the PG-Gs, PG-EAs, and PGs on LPS-induced mechanical hyperalgesia. Our data support the interest of studying the nonhydrolytic endocannabinoid metabolism in the context of inflammatory pain.	[Buisseret, Baptiste; Guillemot-Legris, Owein; Ben Kouidar, Youssef; Paquot, Adrien; Muccioli, Giulio G.; Alhouayek, Mireille] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG; Alhouayek, M (corresponding author), Univ Catholique Louvain UCL, Louvain Drug Res Inst LDRI, Bioanal & Pharmacol Bioact Lipids Res Grp BPBL, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be; mireille.alhouayek@uclouvain.be	Alhouayek, Mireille/R-5058-2018	Alhouayek, Mireille/0000-0002-9193-0718; Guillemot-Legris, Owein/0000-0003-3738-3423; Muccioli, Giulio/0000-0002-1600-9259	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Alhouayek M, 2018, FASEB J, V32, P5000, DOI 10.1096/fj.201701205R; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; ANSEL JC, 1993, J IMMUNOL, V150, P4478; Ates M, 2003, EUR J NEUROSCI, V17, P597, DOI 10.1046/j.1460-9568.2003.02470.x; Ayoub SS, 2010, METHODS MOL BIOL, V644, P117, DOI 10.1007/978-1-59745-364-6_9; Bang SS, 2018, J CLIN INVEST, V128, P3568, DOI 10.1172/JCI99888; Bennett DL, 2019, PHYSIOL REV, V99, P1079, DOI 10.1152/physrev.00052.2017; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Booker L, 2012, BRIT J PHARMACOL, V165, P2485, DOI 10.1111/j.1476-5381.2011.01445.x; Bottemanne P, 2019, FASEB J, V33, P7635, DOI 10.1096/fj.201802259R; Buisseret B, 2019, TRENDS MOL MED, V25, P882, DOI 10.1016/j.molmed.2019.04.009; Buisseret B, 2019, BBA-MOL CELL BIOL L, V1864, P609, DOI 10.1016/j.bbalip.2019.01.009; Buritova J, 1998, BRIT J PHARMACOL, V125, P87, DOI 10.1038/sj.bjp.0702053; Calil IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090013; CATANZARO PJ, 1971, AM J PATHOL, V64, P387; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Clapper JR, 2018, J PHARMACOL EXP THER, V367, P494, DOI 10.1124/jpet.118.252296; de Bruin N, 2018, CHIRALITY, V30, P632, DOI 10.1002/chir.22826; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Donvito G, 2018, NEUROPSYCHOPHARMACOL, V43, P52, DOI 10.1038/npp.2017.204; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Edwards SR, 2007, CLIN EXP PHARMACOL P, V34, P414, DOI 10.1111/j.1440-1681.2007.04581.x; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; JAMALI F, 1988, J PHARM SCI, V77, P666, DOI 10.1002/jps.2600770805; KALGUTKAR AS, 1994, BIOCHEMISTRY-US, V33, P8625, DOI 10.1021/bi00195a002; Khasabova IA, 2019, BLOOD, V133, P1989, DOI 10.1182/blood-2018-11-884346; Kim SG, 2003, CELL MOL NEUROBIOL, V23, P401, DOI 10.1023/A:1023696806609; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Leipold DD, 2004, CHIRALITY, V16, P379, DOI 10.1002/chir.20053; Matsuda M, 2019, J ANESTH, V33, P131, DOI 10.1007/s00540-018-2579-4; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Myers MJ, 2019, MOL IMMUNOL, V109, P38, DOI 10.1016/j.molimm.2019.02.020; NEUGEBAUER V, 1995, J PHARMACOL EXP THER, V275, P618; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Piomelli D, 2014, J NEUROSCI, V34, P15184, DOI 10.1523/JNEUROSCI.3475-14.2014; Rose TM, 2014, BIOORG MED CHEM LETT, V24, P5695, DOI 10.1016/j.bmcl.2014.10.064; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; Sala A, 2018, BIOCHEM PHARMACOL, V158, P161, DOI 10.1016/j.bcp.2018.10.007; Sasso O, 2015, PHARMACOL RES, V97, P7, DOI 10.1016/j.phrs.2015.04.001; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Watanabe M, 2015, NEUROREPORT, V26, P173, DOI 10.1097/WNR.0000000000000322; Woodhams SG, 2017, NEUROPHARMACOLOGY, V124, P105, DOI 10.1016/j.neuropharm.2017.06.015; Woodhams SG, 2015, HANDB EXP PHARMACOL, V227, P119, DOI 10.1007/978-3-662-46450-2_7; Yang F, 2017, PROTEIN CELL, V8, P169, DOI 10.1007/s13238-016-0353-7	54	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21411	10.1096/fj.202002468R	http://dx.doi.org/10.1096/fj.202002468R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749884				2022-12-26	WOS:000635216100035
J	Farzi, A; Ip, CK; Reed, F; Enriquez, R; Zenz, G; Durdevic, M; Zhang, L; Holzer, P; Herzog, H				Farzi, Aitak; Ip, Chi Kin; Reed, Felicia; Enriquez, Ronaldo; Zenz, Geraldine; Durdevic, Marija; Zhang, Lei; Holzer, Peter; Herzog, Herbert			Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet	FASEB JOURNAL			English	Article						food intake; gut hormones; intestinal barrier; intestinal microbiota; obesity		Peptide YY (PYY), produced by endocrine L cells in the gut, is known for its critical role in regulating gastrointestinal functions as well as satiety. However, how these processes are integrated with maintaining a healthy gut microbiome composition is unknown. Here, we show that lack of PYY in mice leads to distinct changes in gut microbiome composition that are diet-dependent. While under chow diet only slight differences in gut microbiome composition could be observed, high-fat diet (HFD) aggravated these differences. Specifically an increased abundance of the Bacteroidetes phylum with a corresponding decrease of the Firmicutes/Bacteroidetes ratio could be detected in Pyy-knockout (KO) mice in response to HFD. Detailed analysis of the Bacteroidetes phylum further revealed that the Alistipes genus belonging to the Rikenellaceae family, the Parabacteroides belonging to the Tannerellaceae family, as well as Muribaculum were increased in Pyy-KO mice. In order to investigate whether these changes are associated with changed markers of gut barrier and immunity, we analyzed the colonic expression of various pro-inflammatory cytokines, as well as tight junction proteins and mucin 2, and identified increased mRNA expression of the tight junction proteins Cldn2 and Ocel1 in Pyy-KO mice, while pro-inflammatory cytokine expression was not significantly altered. Together these results highlight a critical gene-environment interaction between diet and the gut microbiome and its impact on homeostasis of the intestinal epithelium under conditions of reduced PYY signaling which is commonly seen under obese conditions.	[Farzi, Aitak; Ip, Chi Kin; Reed, Felicia; Enriquez, Ronaldo; Zhang, Lei; Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Farzi, Aitak; Zenz, Geraldine; Holzer, Peter] Med Univ Graz, Otto Loewi Res Ctr, Div Pharmacol, Univ Pl 4, A-8010 Graz, Austria; [Ip, Chi Kin; Zhang, Lei; Herzog, Herbert] Univ NSW, Fac Med, Sydney, NSW, Australia; [Durdevic, Marija] Med Univ Graz, Ctr Med Res, Graz, Austria; [Durdevic, Marija] Med Univ Graz, Diagnost & Res Inst Pathol, Graz, Austria; [Durdevic, Marija] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Medical University of Graz; University of New South Wales Sydney; Medical University of Graz; Medical University of Graz; Medical University of Graz	Herzog, H (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Neurosci Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.; Farzi, A (corresponding author), Med Univ Graz, Otto Loewi Res Ctr, Div Pharmacol, Univ Pl 4, A-8010 Graz, Austria.	aitak.farzi@medunigraz.at; h.herzog@garvan.org.au	Holzer, Peter/F-7578-2011	Holzer, Peter/0000-0002-5754-395X; Zhang, Lei/0000-0002-3927-8881; , Herbert/0000-0002-1713-1029; IP, CHI KIN/0000-0002-0464-4706; Zenz, Geraldine/0000-0003-3611-8724; Farzi, Aitak/0000-0001-9606-3871	Austrian Science Fund (FWF) [J-3814]; Department of Health | National Health and Medical Research Council (NHMRC) [1124723, 118775]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Austrian Science Fund (FWF), Grant/Award Number: J-3814; Department of Health | National Health and Medical Research Council (NHMRC), Grant/Award Number: 1124723 and 118775	Adam CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140392; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Al Mushref M, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.11.01; Allaire JM, 2018, AM J PHYSIOL-GASTR L, V314, pG360, DOI 10.1152/ajpgi.00181.2017; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Brennan IM, 2011, INT J OBESITY, V35, P448, DOI 10.1038/ijo.2010.153; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung YW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227886; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Cox HM, 2007, PEPTIDES, V28, P345, DOI 10.1016/j.peptides.2006.07.023; Cox HM, 2007, AUTON NEUROSCI-BASIC, V133, P76, DOI 10.1016/j.autneu.2006.10.005; Cox HM, 2010, CELL METAB, V11, P532, DOI 10.1016/j.cmet.2010.04.014; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Fernandes SP, 2020, J PEDIATR ENDOCR MET, V33, P873, DOI 10.1515/jpem-2020-0033; Forbes SC, 2014, NEUROGASTROENT MOTIL, V26, P1605, DOI 10.1111/nmo.12428; Ip CK, 2019, CELL METAB, V30, P111, DOI 10.1016/j.cmet.2019.04.001; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Kang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42658; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; Kuo WT, 2019, GASTROENTEROLOGY, V157, P1323, DOI 10.1053/j.gastro.2019.07.058; L'Huillier C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061348; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Lean MEJ, 2016, INT J OBESITY, V40, P622, DOI 10.1038/ijo.2015.220; Leon-Coria A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007466; Liu DL, 2017, RSC ADV, V7, P48136, DOI 10.1039/c7ra07651g; Marion S, 2020, J LIPID RES, V61, P1450, DOI [10.1194/jlr.RA120001021, 10.1194/jlr.RA120001021.]; Nagpal R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02897; Parker BJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00906; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Robertson SJ, 2019, CELL REP, V27, P1910, DOI 10.1016/j.celrep.2019.04.023; Rodriguez-Pineiro AM, 2015, GUT MICROBES, V6, P326, DOI 10.1080/19490976.2015.1086057; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shobar RM, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.54; Smith BJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1494-7; Souli A, 1997, PEPTIDES, V18, P551, DOI 10.1016/S0196-9781(97)00069-7; Svane MS, 2016, INT J OBESITY, V40, P1699, DOI 10.1038/ijo.2016.121; Trivedi PG, 2001, PEPTIDES, V22, P395, DOI 10.1016/S0196-9781(01)00349-7; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Webb CR, 2018, INFLAMM BOWEL DIS, V24, P361, DOI 10.1093/ibd/izx014; Ye LH, 2019, ELIFE, V8, DOI 10.7554/eLife.48479; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x	51	4	4	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21435	10.1096/fj.202002215R	http://dx.doi.org/10.1096/fj.202002215R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749879	Green Published			2022-12-26	WOS:000635216100071
J	Johnson, KE; Stoddard, M; Nolan, RP; White, DE; Hochberg, NS; Chakravarty, A				Johnson, Kaitlyn E.; Stoddard, Madison; Nolan, Ryan P.; White, Douglas E.; Hochberg, Natasha S.; Chakravarty, Arijit			In the long shadow of our best intentions: Model-based assessment of the consequences of school reopening during the COVID-19 pandemic	PLOS ONE			English	Article							ASYMPTOMATIC TRANSMISSION; SARS-COV-2; CHILDREN	As the world grapples with the ongoing COVID-19 pandemic, a particularly thorny set of questions surrounds the reopening of primary and secondary (K-12) schools. The benefits of in-person learning are numerous, in terms of education quality, mental health, emotional well-being, equity and access to food and shelter. Early reports suggested that children might have reduced susceptibility to COVID-19, and children have been shown to experience fewer complications than older adults. Over the past few months, our understanding of COVID-19 has been further shaped by emerging data, and it is now understood that children are as susceptible to infection as adults and have a similar viral load during infection, even if asymptomatic. Based on this updated understanding of the disease, we have used epidemiological modeling to explore the feasibility and consequences of school reopening in the face of differing rates of COVID-19 prevalence and transmission. We focused our analysis on the United States, but the results are applicable to other countries as well. We demonstrate the potential for a large discrepancy between detected cases and true infections in schools due to the combination of high asymptomatic rates in children coupled with delays in seeking testing and receiving results from diagnostic tests. Our findings indicate that, regardless of the initial prevalence of the disease, and in the absence of robust surveillance testing and contact-tracing, most schools in the United States can expect to remain open for 20-60 days without the emergence of sizeable disease clusters. At this point, even if schools choose to close after outbreaks occur, COVID-19 cases will be seeded from these school clusters and amplified into the community. Thus, our findings suggest that the debate between the risks to student safety and benefits of in-person learning frames a false dual choice. Reopening schools without surveillance testing and contact tracing measures in place will lead to spread within the schools and within the communities that eventually forces a return to remote learning and leaves a trail of infection in its wake.	[Johnson, Kaitlyn E.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Johnson, Kaitlyn E.; Stoddard, Madison; Chakravarty, Arijit] Fractal Therapeut, Cambridge, MA 02139 USA; [Nolan, Ryan P.] Halozyme Therapeut, San Diego, CA USA; [Hochberg, Natasha S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hochberg, Natasha S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of Texas System; University of Texas Austin; Halozyme; Boston University; Boston University	Johnson, KE (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Johnson, KE; Chakravarty, A (corresponding author), Fractal Therapeut, Cambridge, MA 02139 USA.	k.john@utexas.edu; arijit@fractaltx.com		Johnson, Kaitlyn/0000-0001-8011-0012; Chakravarty, Arijit/0000-0003-1338-5432; Hochberg, Natasha/0000-0002-5449-9973				Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Alagoz Oguzhan, 2020, medRxiv, DOI 10.1101/2020.06.07.20124859; American Academy of Pediatrics, 2020, CRIT UPDAT COVID 19, V2019, P1; [Anonymous], 2020, MMWR-MORBID MORTAL W, V69, P422; Auxier B., 2020, PEW RES CTR, P1; B.Wilder, 2020, medRxiv, DOI 10.1101/2020.06.22.20136309; Bae SH, 2020, EMERG INFECT DIS, V26, P2705, DOI 10.3201/eid2611.203353; Basu S., 2020, GOING NUMBERS LEARNI; Baum M., 2020, STATE NATION 50 STAT; Berger D. W., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26901; Bi Q, 2020, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099(20)30287-5; Bielecki M., 2020, CLIN INFECT DIS; Brown NE, 2020, EMERG INFECT DIS, V26, P2263, DOI 10.3201/eid2609.201802; Chakravarty A., 2020, KINETIC ANAL NEW ENZ; Chen M, 2020, J INFECT PUBLIC HEAL, V13, P883, DOI 10.1016/j.jiph.2020.05.018; Cohen J, 2020, SCIENCE, V368, P564, DOI 10.1126/science.368.6491.564; Couzin-Frankel J., 2020, SCIENCE JUL; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; DeBiasi RL, 2021, JAMA PEDIATR, V175, P16, DOI 10.1001/jamapediatrics.2020.3996; Dimeglio C, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104451; Dong Y., 2020, PEDIATRICS, V145; Errett Nicole A, 2020, J Emerg Manag, V18, P7, DOI 10.5055/jem.2020.0446; Fitzpatrick BR, 2020, EDUC RESEARCHER, V49, P161, DOI 10.3102/0013189X20909814; Fontanet A, 2020, CLUSTER COVID 19 NO, DOI [10.1101/2020.04.18.20071134, DOI 10.1101/2020.04.18.20071134]; Gavin C., 2020, BOSTON GLOBE; Gentile C., 2020, FALMOUTH ENTERP 0814; Giordano G., 2020, NAT MED; Goldman E, 2020, LANCET INFECT DIS, V20, P892, DOI 10.1016/S1473-3099(20)30561-2; Goldstein E, 2021, J INFECT DIS, V223, P362, DOI [10.1093/infdis/jiaa691, 10.1101/2020.07.19.20157362]; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651; Jayaweera M, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109819; Jing Q.-L., 2020, HOUSEHOLD SECONDARY, V32611; Johnston C., 2020, CNN HEAL; Jones T.C., 2020, MEDRXIV; Keeling, 2008, MODELING INFECT DIS; Kevat A, 2020, J PAEDIATR CHILD H, V56, P657, DOI 10.1111/jpc.14876; Kinoshita R, 2020, INT J INFECT DIS; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Lachmann M., 2020, PULMONARY CARDIAC PA; Larosa E, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.49.2001911; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; May R.M., 1991, INFECT DIS HUMANS; Mizumoto K., 2020, AGE SPECIFICITY CASE, P0; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Munro APS, 2020, ARCH DIS CHILD, V105, P618, DOI 10.1136/archdischild-2020-319474; NASEM (National Academies of Sciences Engineering and Medicine), 2020, VISION NSF EARTH SCI, P144, DOI [DOI 10.17226/25761, 10.17226/25761]; National Association of School Nurses, 2020, NASN SAF RET SCH STA; News Kyodo., 2020, KYODO NEWS; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; ONS, 2020, OFF NATL STAT STAT B, P1; Paganini M, 2020, DISASTER MED PUBLIC, V14, P541, DOI 10.1017/dmp.2020.57; Price C., 2020, CATAL TODAY; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Qureshi Z., 2020, WHAT IS EVIDENCE SUP; Redden Elizabeth, 2020, INSIDE HIGHER ED; Richard Fausset, 2020, NEW YORK TIMES; Russell T.W., 2020, EFFECT INT TRAVEL RE, DOI [10.1016/S2468-2667%2820%2930263-2, DOI 10.1016/S2468-2667%2820%2930263-2]; Shapiro E., 2020, CHILD VACCINATIONS P; Sheets C., 2020, ALABAMA 0904; Snyder S., 2020, EXPERT INSIGHTS; Sola AM, 2021, JAMA PEDIATR, V175, P212, DOI 10.1001/jamapediatrics.2020.4460; Song XY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20495; Springer S, 2020, DIALOGUES HUM GEOGR, V10, P112, DOI 10.1177/2043820620931277; Stein-Zamir C., 2020, EURO SURVEILL, V25, P1; Systrom K., 2020, RTLIVE; Szablewski CM, 2020, MMWR-MORBID MORTAL W, V69, P1023, DOI 10.15585/mmwr.mm6931e1; Taipale J., 2020, POPULATION SCALE TES; The University of Texas Modeling Consortium, 2020, EXP NUMB COVID 19 CA; Tutman P., 2020, CLICK DETROIT 0914; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; WHO, 2020, TRANSM SARS COV 2 IM; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Jiaquan, 2020, NCHS Data Brief, P1; Yonker LM, 2020, J PEDIATR-US, V227, P45, DOI 10.1016/j.jpeds.2020.08.037; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhu Y., 2020, BRIEFINGS BIOINF; Zweig D., 2020, WIRED	84	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248509	10.1371/journal.pone.0248509	http://dx.doi.org/10.1371/journal.pone.0248509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765026	gold, Green Submitted, Green Published			2022-12-26	WOS:000634832800104
J	Lin, HC; Huang, KT; Lin, HL; Uang, YS; Ho, Y; Keller, JJ; Wang, LH				Lin, Hsiu-Chen; Huang, Kuan-Tzu; Lin, Hsiu-Li; Uang, Yow-Sheng; Ho, Yi; Keller, Joseph Jordan; Wang, Li-Hsuan			Use of gastric acid-suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study	PLOS ONE			English	Article								Background Prescriptions for gastric acid-suppressive agents, including proton-pump inhibitors (PPIs) and histamine type-2 receptor antagonists (H2RAs), are rising. However, little data exist regarding their association with dementia in the Asian population. The objective of this study was thus to investigate the impact of the use of PPIs and H2RAs on the risk of dementia in an Asian population with upper gastrointestinal disease (UGID). Methods We conducted a population-based retrospective cohort study with a 10-year follow-up using data from 2000 to 2015 derived from Taiwan's Longitudinal Health Insurance Database. We included 6711 patients with UGID receiving gastric acid-suppressive agents, 6711 patients with UGID not receiving agents, and 6711 patients without UGID or treatment thereof, all at least 20 years of age. Groups were matched for age, sex, and index date. The association between gastric acid-suppressive agent use and dementia was analyzed using a Cox proportional hazards regression model adjusted for potential confounders. Results The adjusted hazard ratio (aHR) of dementia for patients with UGID receiving gastric acid-suppressive agents compared with patients with UGID without gastric acid-suppressive agents was 1.470 (95% confidence interval [CI] 1.267-1.705, p < 0.001). Both PPIs and H2RAs increase the risk of dementia (PPIs: aHR 1.886 [95% CI 1.377-2.582], p < 0.001; H2RAs: aHR 1.357 [95% CI 1.098-1.678], p < 0.01), with PPIs exhibiting significantly greater risk (aHR 1.456 [95% CI 1.022-2.075], p < 0.05). Conclusions Our results demonstrate an increased risk of dementia in patients with UGID receiving gastric acid-suppressive agents, including PPIs and H2RAs, and the use of PPIs was associated with a significantly greater risk than H2RA use.	[Lin, Hsiu-Chen] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Lin, Hsiu-Chen] Taipei Med Univ Hosp, Dept Clin Pathol, Taipei, Taiwan; [Huang, Kuan-Tzu; Uang, Yow-Sheng; Ho, Yi; Wang, Li-Hsuan] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Huang, Kuan-Tzu] Taipei Vet Gen Hosp, Dept Pharm, Div Clin Pharm, Taipei, Taiwan; [Lin, Hsiu-Li] Gen Cathay Hosp, Dept Neurol, New Taipei, Taiwan; [Keller, Joseph Jordan] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Wang, Li-Hsuan] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Veterans General Hospital; Cathay General Hospital; University System of Ohio; Ohio State University; Taipei Medical University; Taipei Medical University Hospital	Wang, LH (corresponding author), Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan.; Wang, LH (corresponding author), Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan.	shiuan@tmu.edu.tw	Wang, Li-Hsuan/AAU-3257-2021	Li-Hsuan, Wang/0000-0001-8047-5310				Badiola N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058837; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Boustani M, 2007, J AM GERIATR SOC, V55, P1248, DOI 10.1111/j.1532-5415.2007.01270.x; Cai XY, 2013, ALZHEIMERS DEMENT, V9, P377, DOI 10.1016/j.jalz.2012.02.005; Haenisch B, 2015, EUR ARCH PSY CLIN N, V265, P419, DOI 10.1007/s00406-014-0554-0; Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861; Jessen F, 2010, EUR ARCH PSY CLIN N, V260, pS111, DOI 10.1007/s00406-010-0156-4; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Makunts T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53622-3; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Prince M., WORLD ALZHEIMER REPO; STARR JM, 1994, DRUG SAFETY, V11, P310, DOI 10.2165/00002018-199411050-00003; Tai SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171006; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249050	10.1371/journal.pone.0249050	http://dx.doi.org/10.1371/journal.pone.0249050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765029	Green Published, gold			2022-12-26	WOS:000634832800083
J	Hallum, LE; Cloherty, SL				Hallum, Luke E.; Cloherty, Shaun L.			Liquid-Crystal Display (LCD) of achromatic, mean-modulated flicker in clinical assessment and experimental studies of visual systems	PLOS ONE			English	Article								Achromatic, mean-modulated flicker-wherein luminance increments and decrements of equal magnitude are applied, over time, to a test field-is commonly used in both clinical assessment of vision and experimental studies of visual systems. However, presenting flicker on computer-controlled displays is problematic; displays typically introduce luminance artifacts at high flicker frequency or contrast, potentially interfering with the validity of findings. Here, we present a battery of tests used to weigh the relative merits of two displays for presenting achromatic, mean-modulated flicker. These tests revealed marked differences between a new high-performance liquid-crystal display (LCD; EIZO ColorEdge CG247X) and a new consumer-grade LCD (Dell U2415b), despite displays' vendor-supplied specifications being almost identical. We measured displayed luminance using a spot meter and a linearized photodiode. We derived several measures, including spatial uniformity, the effect of viewing angle, response times, Fourier amplitude spectra, and cycle-averaged luminance. We presented paired luminance pulses to quantify the displays' nonlinear dynamics. The CG247X showed relatively good spatial uniformity (e.g., at moderate luminance, standard deviation 2.8% versus U2415b's 5.3%). Fourier transformation of nominally static test patches revealed spectra free of artifacts, with the exception of a frame response. The CG247X's rise and fall times depended on both the luminance from which, and to which, it responded, as is to be generally expected from LCDs. Despite this nonlinear behaviour, we were able to define a contrast and frequency range wherein the CG247X appeared largely artifact-free; the relationship between nominal luminance and displayed luminance was accurately modelled using a causal, linear time-invariant system. This range included contrasts up to 80%, and flicker frequencies up to 30 Hz. This battery of tests should prove useful to others conducting clinical assessment of vision and experimental studies of visual systems.	[Hallum, Luke E.] Univ Auckland, Dept Mech Engn, Auckland, New Zealand; [Cloherty, Shaun L.] RMIT Univ, Sch Engn, Melbourne, Vic, Australia	University of Auckland; Royal Melbourne Institute of Technology (RMIT)	Hallum, LE (corresponding author), Univ Auckland, Dept Mech Engn, Auckland, New Zealand.	l.hallum@auckland.ac.nz		Cloherty, Shaun/0000-0002-7679-1764	University of Auckland Faculty of Engineering Research Development Fund	University of Auckland Faculty of Engineering Research Development Fund	This work was partly supported by the University of Auckland Faculty of Engineering Research Development Fund.	Alferink F, ELECT MEASUREMENTS; Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Baseler HA, 1997, VISION RES, V37, P675, DOI 10.1016/S0042-6989(96)00209-X; Brainard D. H., 2002, DISPLAY CHARACTERIZA, P172; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cristaldi DJ., 2009, LIQUID CRYSTAL DISPL; DELAN.H, 1961, J OPT SOC AM, V51, P415, DOI 10.1364/JOSA.51.000415; Elze T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044048; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FARRELL JE, 1987, P SID, V28, P449; FARRELL JE, 1986, BEHAV INFORM TECHNOL, V5, P349, DOI 10.1080/01449298608914528; Garcia-Perez MA, 2001, SPATIAL VISION, V14, P201, DOI 10.1163/156856801300202931; Gassler G., 2015, HDB VISUAL DISPLAY T; Ghodrati M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00303; HUNG G, 1977, MATH BIOSCI, V37, P135, DOI 10.1016/0025-5564(77)90091-8; Kleiner M, 2007, PERCEPTION, V36, P14; Krantz JH, 2000, BEHAV RES METH INS C, V32, P221, DOI 10.3758/BF03207787; LaFontaine D, 2006, ELECTRON WORLD, V112, P15; Lagroix HEP, 2012, ATTEN PERCEPT PSYCHO, V74, P1033, DOI 10.3758/s13414-012-0281-4; Lamparter J, 2012, INVEST OPHTH VIS SCI, V53, P7553, DOI 10.1167/iovs.12-10892; Lee SW, 2006, J SOC INF DISPLAY, V14, P387, DOI 10.1889/1.2196515; Matsumoto CS, 2014, J VISION, V14, DOI 10.1167/14.9.2; McCartney RI, 2003, SOC INF DISPL S, V34, P1350; METHA AB, 1993, BEHAV RES METH INSTR, V25, P371, DOI 10.3758/BF03204528; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Pelli DG, 1997, SPATIAL VISION, V10, P443, DOI 10.1163/156856897X00375; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Quaid PT, 2005, VISION RES, V45, P1075, DOI 10.1016/j.visres.2004.10.013; RAMACHANDRAN VS, 1991, B PSYCHONOMIC SOC, V29, P391; Sandberg A, 1968, Brain Res, V11, P194, DOI 10.1016/0006-8993(68)90081-4; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P148, DOI 10.3758/BF03209939; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wall M, 1995, PERIMETRY UPDATE 199; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Watson AB, 2010, J SOC INF DISPLAY, V18, P179, DOI 10.1889/JSID18.2.179; Williams PE, 2004, J NEUROSCI, V24, P8278, DOI 10.1523/JNEUROSCI.2716-04.2004; WOLLMAN DE, 1995, J NEUROSCI METH, V60, P107, DOI 10.1016/0165-0270(94)00226-7; Zele AJ, 2005, J NEUROSCI METH, V141, P1, DOI 10.1016/j.jneumeth.2004.05.005; Zhang GL, 2018, BEHAV RES METHODS, V50, P1496, DOI 10.3758/s13428-018-1018-7	39	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248180	10.1371/journal.pone.0248180	http://dx.doi.org/10.1371/journal.pone.0248180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760857	Green Submitted, Green Published, gold			2022-12-26	WOS:000633030400073
J	Irwin, NAT; Twynstra, CS; Mathur, V; Keeling, PJ				Irwin, Nicholas A. T.; Twynstra, Chantelle S.; Mathur, Varsha; Keeling, Patrick J.			The molecular phylogeny of Chionaster nivalis reveals a novel order of psychrophilic and globally distributed Tremellomycetes (Fungi, Basidiomycota)	PLOS ONE			English	Article							SNOW ALGAE; COMMUNITIES; DIVERSITY; SUCCESS; REGION; ICE	Snow and ice present challenging substrates for cellular growth, yet microbial snow communities not only exist, but are diverse and ecologically impactful. These communities are dominated by green algae, but additional organisms, such as fungi, are also abundant and may be important for nutrient cycling, syntrophic interactions, and community structure in general. However, little is known about these non-algal community members, including their taxonomic affiliations. An example of this is Chionaster nivalis, a unicellular fungus that is morphologically enigmatic and frequently observed in snow communities globally. Despite being described over one hundred years ago, the phylogeny and higher-level taxonomic classifications of C. nivalis remain unknown. Here, we isolated and sequenced the internal transcribed spacer (ITS) and the D1-D2 region of the large subunit ribosomal RNA gene of C. nivalis, providing a molecular barcode for future studies. Phylogenetic analyses using the ITS and D1-D2 region revealed that C. nivalis is part of a novel lineage in the class Tremellomycetes (Basidiomycota, Agaricomycotina) for which a new order Chionasterales ord. nov. (MB838717) and family Chionasteraceae fam. nov. (MB838718) are proposed. Comparisons between C. nivalis and sequences generated from environmental surveys revealed that the Chionasterales are globally distributed and probably psychrophilic, as they appear to be limited to the high alpine and arctic regions. These results highlight the unexplored diversity that exists within these extreme habitats and emphasize the utility of single-cell approaches in characterizing these complex algal-dominated communities.	[Irwin, Nicholas A. T.; Twynstra, Chantelle S.; Mathur, Varsha; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Irwin, Nicholas A. T.] Univ Oxford, Merton Coll, Oxford, England	University of British Columbia; University of Oxford	Irwin, NAT (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Irwin, NAT (corresponding author), Univ Oxford, Merton Coll, Oxford, England.	nickatirwin@gmail.com		Irwin, Nicholas/0000-0002-2904-8214	Gordon and Betty Moore Foundation; NSERC Canadian Graduate Scholarship; Junior Research Fellowship from Merton College, Oxford; Science Undergraduate Research Experience award by Dean of Science, University of British Columbia; University Graduate Fellowship from the University of British Columbia	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Junior Research Fellowship from Merton College, Oxford; Science Undergraduate Research Experience award by Dean of Science, University of British Columbia; University Graduate Fellowship from the University of British Columbia	This work was supported by an Investigator Grant from the Gordon and Betty Moore Foundation awarded to P. J. K. (https://doi.org/10.37807/GBMF9201).N.A.T.I.was supported by an NSERC Canadian Graduate Scholarship and a Junior Research Fellowship from Merton College, Oxford. C. S. T. was supported by a Science Undergraduate Research Experience award provided by the Dean of Science, University of British Columbia, and V. M. was supported by a University Graduate Fellowship from the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerlocher Felix, 2007, Fungal Biology Reviews, V21, P19, DOI 10.1016/j.fbr.2007.02.003; Baschien C, 2013, FUNGAL BIOL-UK, V117, P660, DOI 10.1016/j.funbio.2013.07.004; Belliveau MJR, 2005, MYCOL RES, V109, P1407, DOI 10.1017/S0953756205004119; Boetius A, 2015, NAT REV MICROBIOL, V13, P677, DOI 10.1038/nrmicro3522; Bohlin K, 1893, BOT NOTISER, V43, P42; Bormann KJ, 2018, NAT CLIM CHANGE, V8, P923, DOI 10.1038/s41558-018-0318-3; Brown SP, 2019, MICROB ECOL, V77, P946, DOI 10.1007/s00248-019-01357-z; Brown SP, 2015, ARCT ANTARCT ALP RES, V47, P729, DOI 10.1657/AAAR0014-071; Buzzini P., 2017, YEASTS NATURAL ECOSY, P331, DOI DOI 10.1007/978-3-319-62683-3_11; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cepak V, 2016, NOVA HEDWIGIA, V103, P457, DOI 10.1127/nova_hedwigia/2016/0365; Cornut J, 2019, MYCOLOGIA, V111, P177, DOI 10.1080/00275514.2018.1528129; Dang CK, 2007, MYCOLOGIA, V99, P24, DOI 10.3852/mycologia.99.1.24; Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189; Davey MP, 2019, NEW PHYTOL, V222, P1242, DOI 10.1111/nph.15701; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Duarte S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045289; Freeman KR, 2009, P NATL ACAD SCI USA, V106, P18315, DOI 10.1073/pnas.0907303106; Ganey GQ, 2017, NAT GEOSCI, V10, P754, DOI 10.1038/NGEO3027; GARRIC RK, 1965, AM J BOT, V52, P1, DOI 10.2307/2439968; Hamilton TL, 2017, GEOBIOLOGY, V15, P280, DOI 10.1111/gbi.12219; Hanzelova M, 2018, BIOLOGIA, V73, P1177, DOI 10.2478/s11756-018-0136-0; Heeger F, 2018, MOL ECOL RESOUR, V18, P1500, DOI 10.1111/1755-0998.12937; Hisakawa N, 2015, PEERJ, V3, DOI 10.7717/peerj.1491; Hoham RW, 2020, J PHYCOL, V56, P264, DOI 10.1111/jpy.12952; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearns SG, 2008, FUNGAL ECOL, V1, P13, DOI 10.1016/j.funeco.2007.07.001; KOL E, 1974, Annales Historico-Naturales Musei Nationalis Hungarici, V66, P59; Kol E., 1935, VERHANDLUNGEN INT VE, V7, P475, DOI [10.1080/03680770.1935.11898576, DOI 10.1080/03680770.1935.11898576]; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Li AH, 2020, STUD MYCOL, P17, DOI 10.1016/j.simyco.2020.01.002; LIGHT J J, 1968, British Phycological Bulletin, V3, P471; Liu XZ, 2015, STUD MYCOL, P85, DOI 10.1016/j.simyco.2015.12.001; Lukavsky J, 2009, NOVA HEDWIGIA, V88, P97, DOI 10.1127/0029-5035/2009/0088-0097; Luo W, 2020, POLAR BIOL, V43, P1391, DOI 10.1007/s00300-020-02716-0; Lutz S, 2017, ENVIRON MICROBIOL, V19, P551, DOI 10.1111/1462-2920.13494; Lutz S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11968; MARCHANT HJ, 1982, PHYCOLOGIA, V21, P178, DOI 10.2216/i0031-8884-21-2-178.1; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Qiao M, 2018, MYCOKEYS, P1, DOI 10.3897/mycokeys.40.23828; Rambaut A., 2012, FIGTREE GRAPHICAL VI; Remias D, 2005, EUR J PHYCOL, V40, P259, DOI 10.1080/09670260500202148; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt SK, 2012, FUNGAL ECOL, V5, P443, DOI 10.1016/j.funeco.2011.10.005; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Segawa T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05521-w; Taylor WR, 1922, RHODORA, V24, P101, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Terashima M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01481; Uetake J, 2006, ANN GLACIOL-SER, V43, P70, DOI 10.3189/172756406781811925; Wille N., 1903, NYTT MAG NATURVIDENS, V41, P97; Yakimovich KM, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01721; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	56	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247594	10.1371/journal.pone.0247594	http://dx.doi.org/10.1371/journal.pone.0247594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760841	Green Published, gold			2022-12-26	WOS:000633030400026
J	van Tol, HM; Armbrust, EV				van Tol, Helena M.; Armbrust, E. Virginia			Genome-scale metabolic model of the diatom Thalassiosira pseudonana highlights the importance of nitrogen and sulfur metabolism in redox balance	PLOS ONE			English	Article								Diatoms are unicellular photosynthetic algae known to secrete organic matter that fuels secondary production in the ocean, though our knowledge of how their physiology impacts the composition of dissolved organic matter remains limited. Like all photosynthetic organisms, their use of light for energy and reducing power creates the challenge of avoiding cellular damage. To better understand the interplay between redox balance and organic matter secretion, we reconstructed a genome-scale metabolic model of Thalassiosira pseudonana strain CCMP 1335, a model for diatom molecular biology and physiology, with a 60-year history of studies. The model simulates the metabolic activities of 1,432 genes via a network of 2,792 metabolites produced through 6,079 reactions distributed across six subcellular compartments. Growth was simulated under different steady-state light conditions (5-200 mu mol photons m(-2) s(-1)) and in a batch culture progressing from exponential growth to nitrate-limitation and nitrogen-starvation. We used the model to examine the dissipation of reductants generated through light-dependent processes and found that when available, nitrate assimilation is an important means of dissipating reductants in the plastid; under nitrate-limiting conditions, sulfate assimilation plays a similar role. The use of either nitrate or sulfate uptake to balance redox reactions leads to the secretion of distinct organic nitrogen and sulfur compounds. Such compounds can be accessed by bacteria in the surface ocean. The model of the diatom Thalassiosira pseudonana provides a mechanistic explanation for the production of ecologically and climatologically relevant compounds that may serve as the basis for intricate, cross-kingdom microbial networks. Diatom metabolism has an important influence on global biogeochemistry; metabolic models of marine microorganisms link genes to ecosystems and may be key to integrating molecular data with models of ocean biogeochemistry.	[van Tol, Helena M.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [van Tol, Helena M.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA	University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	van Tol, HM; Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.; van Tol, HM (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	vantol2@llnl.gov; armbrust@uw.edu		Armbrust, Virginia/0000-0001-7865-5101	Gordon and Betty Moore Foundation [GBMF3776]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by Gordon and Betty Moore Foundation grant GBMF3776 awarded to E.V.A (https://www.moore.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMIRAAL W, 1986, J EXP MAR BIOL ECOL, V98, P241, DOI 10.1016/0022-0981(86)90216-9; Ahmad A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8091396; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; ALLEN JF, 1975, NATURE, V256, P599, DOI 10.1038/256599a0; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Baird ME, 2018, ECOL MODEL, V386, P20, DOI 10.1016/j.ecolmodel.2018.07.013; Bender SJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00003; Bertrand EM, 2015, P NATL ACAD SCI USA, V112, P9938, DOI 10.1073/pnas.1501615112; Broddrick JT, 2019, NEW PHYTOL, V222, P1364, DOI 10.1111/nph.15685; Broddrick JT, 2016, P NATL ACAD SCI USA, V113, pE8344, DOI 10.1073/pnas.1613446113; Brown MR, 1996, J PHYCOL, V32, P64, DOI 10.1111/j.0022-3646.1996.00064.x; Bucciarelli E, 2003, LIMNOL OCEANOGR, V48, P2256, DOI 10.4319/lo.2003.48.6.2256; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cermeno P, 2013, J PLANKTON RES, V35, P12, DOI 10.1093/plankt/fbs073; CHALKER BE, 1983, J EXP MAR BIOL ECOL, V73, P37, DOI 10.1016/0022-0981(83)90004-7; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; CHISHOLM SW, 1981, J EXP MAR BIOL ECOL, V51, P107, DOI 10.1016/0022-0981(81)90123-4; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cruz S, 2011, J EXP BOT, V62, P509, DOI 10.1093/jxb/erq284; Dahlgren B., 2018, J OPEN SOURCE SOFTW, V3, P565, DOI [10.21105/joss.00565, DOI 10.21105/JOSS.00565]; Danger M, 2007, FUNCT ECOL, V21, P202, DOI 10.1111/j.1365-2435.2006.01222.x; Davis A, 2017, PROTIST, V168, P134, DOI 10.1016/j.protis.2016.10.005; Devred E, 2013, REMOTE SENS-BASEL, V5, P6812, DOI 10.3390/rs5126812; Diaz JM, 2019, ENVIRON MICROBIOL, V21, P2415, DOI 10.1111/1462-2920.14630; Downing JA, 1997, BIOGEOCHEMISTRY, V37, P237, DOI 10.1023/A:1005712322036; Durham BP, 2019, NAT MICROBIOL, V4, P1706, DOI 10.1038/s41564-019-0507-5; Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Dyhrman ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033768; Dyhrman ST, 2009, NAT GEOSCI, V2, P696, DOI 10.1038/NGEO639; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Elbourne LDH, 2017, NUCLEIC ACIDS RES, V45, pD320, DOI 10.1093/nar/gkw1068; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emerson S, 2008, CHEMICAL OCEANOGRAPHY AND THE MARINE CARBON CYCLE, P3, DOI 10.1017/CBO9780511793202.002; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finkel ZV, 2006, LIMNOL OCEANOGR, V51, P2690, DOI 10.4319/lo.2006.51.6.2690; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Fisher NL, 2016, PHOTOSYNTH RES, V129, P183, DOI 10.1007/s11120-016-0282-6; Fritzemeier CJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005494; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; GEIDER RJ, 1985, J PHYCOL, V21, P609; Gonzalez NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025316; Granum E, 2002, MAR ECOL PROG SER, V242, P83, DOI 10.3354/meps242083; Grouneva I, 2016, J PROTEOME RES, V15, P1649, DOI 10.1021/acs.jproteome.6b00124; Gruber A, 2015, PLANT J, V81, P519, DOI 10.1111/tpj.12734; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; Hartleb D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005036; Heal KR, 2017, P NATL ACAD SCI USA, V114, P364, DOI 10.1073/pnas.1608462114; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Heureux AMC, 2017, J EXP BOT, V68, P3959, DOI 10.1093/jxb/erx179; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Hunter JE, 2015, PHYTOPLANKTON LIPIDO; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; Jallet D, 2016, ALGAL RES, V18, P51, DOI 10.1016/j.algal.2016.05.014; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; Kliphuis AMJ, 2012, J APPL PHYCOL, V24, P253, DOI 10.1007/s10811-011-9674-3; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; La Vars SM, 2013, ANAL BIOANAL CHEM, V405, P3359, DOI 10.1007/s00216-013-6746-z; Lau WWY, 2006, ENVIRON MICROBIOL, V8, P1688, DOI 10.1111/j.1462-2920.2006.01092.x; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Levering J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155038; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liefer JD, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00763; Liefer JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195705; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; Lomas MW, 2000, J PLANKTON RES, V22, P2351, DOI 10.1093/plankt/22.12.2351; Longnecker K, 2015, MAR CHEM, V168, P114, DOI 10.1016/j.marchem.2014.11.003; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Noecker C, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00579-19; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Parker K., 2013, METABOLIC NETWORK CO; Parker MS, 2005, J PHYCOL, V41, P1142, DOI 10.1111/j.1529-8817.2005.00139.x; Parker MS, 2004, J PHYCOL, V40, P557, DOI 10.1111/j.1529-8817.2004.03184.x; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PLATT T, 1980, J MAR RES, V38, P687; Price NM, 2005, LIMNOL OCEANOGR, V50, P1159, DOI 10.4319/lo.2005.50.4.1159; Rosenwasser S, 2014, P NATL ACAD SCI USA, V111, P2740, DOI 10.1073/pnas.1319773111; Samukawa M, 2014, PHOTOSYNTH RES, V121, P235, DOI 10.1007/s11120-014-9967-x; Sanudo-Wilhelmy SA, 2014, ANNU REV MAR SCI, V6, P339, DOI 10.1146/annurev-marine-120710-100912; Sarmento H, 2012, ENVIRON MICROBIOL, V14, P2348, DOI 10.1111/j.1462-2920.2012.02787.x; Schober AF, 2019, PLANT CELL PHYSIOL, V60, P1811, DOI 10.1093/pcp/pcz097; Shang F., 2011, THALASSIOSIRA PSEUDO; Shuler M, 2002, BIOPROCESS ENG, P209; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Sobrino C, 2008, LIMNOL OCEANOGR, V53, P494, DOI 10.4319/lo.2008.53.2.0494; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Stramski D, 2002, LIMNOL OCEANOGR, V47, P392, DOI 10.4319/lo.2002.47.2.0392; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thamatrakoln K, 2008, PLANT PHYSIOL, V146, P1397, DOI 10.1104/pp.107.107094; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; TURPIN DH, 1988, CAN J BOT, V66, P2083, DOI 10.1139/b88-286; Valenzuela JJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04742-3; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vedalankar P, 2019, PROTOPLASMA, V256, P293, DOI 10.1007/s00709-018-1317-y; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; Yin KD, 1998, J EXP MAR BIOL ECOL, V228, P151, DOI 10.1016/S0022-0981(98)00025-2; Young JN, 2017, J EXP BOT, V68, P3751, DOI 10.1093/jxb/erx130; Young JN, 2016, J EXP BOT, V67, P3445, DOI 10.1093/jxb/erw163; Yu ET, 2009, J APPL PHYCOL, V21, P669, DOI 10.1007/s10811-008-9400-y; ZLOTNIK I, 1989, LIMNOL OCEANOGR, V34, P831, DOI 10.4319/lo.1989.34.5.0831	126	8	8	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0241960	10.1371/journal.pone.0241960	http://dx.doi.org/10.1371/journal.pone.0241960			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760840	Green Submitted, gold, Green Published			2022-12-26	WOS:000633030400014
J	Okawa, K; Inoue, T; Asaoka, R; Azuma, K; Obata, R; Arasaki, R; Ikeda, S; Ito, A; Maruyama-Inoue, M; Yanagi, Y; Kadonosono, K				Okawa, Kazuyoshi; Inoue, Tatsuya; Asaoka, Ryo; Azuma, Keiko; Obata, Ryo; Arasaki, Rei; Ikeda, Shouko; Ito, Arisa; Maruyama-Inoue, Maiko; Yanagi, Yasuo; Kadonosono, Kazuaki			Correlation between choroidal structure and smoking in eyes with central serous chorioretinopathy	PLOS ONE			English	Article								Purpose A smoking habit can cause various health problems encompassing retinal diseases including central serous chorioretinopathy (CSC). The aim of the current study was to investigate the effect of smoking on the choroidal structure in patients with CSC. Methods The choroidal vascular index (CVI) was calculated using the binarized OCT images. Baseline parameters (age, refractive error [SE], subfoveal choroidal thickness [SFCT] and CVI) were compared between smokers and non-smokers using Wilcoxon rank sum test. Moreover, the associations between SFCT and the baseline parameters were analyzed using a multivariate linear regression followed by the AICc model selection. Results Among 75 CSC patients, 45 patients were smokers and 30 patients were non-smokers. No significant differences in age and SE were seen between the smoking group and the non-smoking group. A significant difference in the SFCT was seen between two groups (382.0 +/- 68.2 mu m in the smoking group vs. 339.3 +/- 52.3 mu m in the non-smoking group, p = 0.0038), while no significant difference was observed in the CVI (p = 0.32). The optimal model for SFCT included the variables of age, SE and past history of smoking among the baseline parameters. Additionally, increased pack years was associated with increased SFCT. Conclusion Cigarette smoking was associated with an increased SFCT in patients with CSC. Thicker choroid in smoking CSC patients may be an important modulator of the disease.	[Okawa, Kazuyoshi; Inoue, Tatsuya; Arasaki, Rei; Ikeda, Shouko; Ito, Arisa; Maruyama-Inoue, Maiko; Yanagi, Yasuo; Kadonosono, Kazuaki] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan; [Asaoka, Ryo; Azuma, Keiko; Obata, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Asaoka, Ryo] Seirei Hamamatsu Gen Hosp, Dept Ophthalmol, Shizuoka, Japan; [Asaoka, Ryo] Seirei Christopher Univ, Shizuoka, Japan	Yokohama City University; University of Tokyo	Inoue, T (corresponding author), Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan.	inouet-tky@umin.ac.jp	Yanagi, Yasuo/AAA-5441-2022					Agrawal R, 2016, RETINA-J RET VIT DIS, V36, P1646, DOI 10.1097/IAE.0000000000001040; Agrawal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21090; Azuma K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212055; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BURNS DM, 1991, CLIN CHEST MED, V12, P631; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Ersoz MG, 2019, BRIT J OPHTHALMOL, V103, P725, DOI 10.1136/bjophthalmol-2018-312431; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Hanumunthadu D, 2019, J OPHTHAL VIS RES, V14, P164, DOI 10.4103/jovr.jovr_152_17; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Kang NH, 2013, EYE, V27, P387, DOI 10.1038/eye.2012.273; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; Kim YK, 2015, AM J OPHTHALMOL, V160, P72, DOI 10.1016/j.ajo.2015.04.011; Liegl R, 2014, OPHTHALMOLOGICA, V232, P65, DOI 10.1159/000360014; Liu B, 2019, CLIN EXP OPHTHALMOL, V47, P631, DOI 10.1111/ceo.13467; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; PICCOLINO FC, 1994, RETINA-J RET VIT DIS, V14, P231, DOI 10.1097/00006982-199414030-00008; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Turkcu FM, 2014, CUTAN OCUL TOXICOL, V33, P115, DOI 10.3109/15569527.2013.810633; Wei X, 2019, INVEST OPHTH VIS SCI, V60, P1316, DOI 10.1167/iovs.18-25764	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249073	10.1371/journal.pone.0249073	http://dx.doi.org/10.1371/journal.pone.0249073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755707	Green Published, Green Submitted, gold			2022-12-26	WOS:000632916600046
J	Salom-Perez, R; Corrales-Gutierrez, D; Araya-Gamboa, D; Espinoza-Munoz, D; Finegan, B; Petracca, LS				Salom-Perez, Roberto; Corrales-Gutierrez, Daniel; Araya-Gamboa, Daniela; Espinoza-Munoz, Deiver; Finegan, Bryan; Petracca, Lisanne S.			Forest cover mediates large and medium-sized mammal occurrence in a critical link of the Mesoamerican Biological Corridor	PLOS ONE			English	Article							JAGUAR PANTHERA-ONCA; SPECIES RICHNESS; SEED DISPERSAL; FOOD-HABITS; CONSERVATION; OCCUPANCY; PUMAS; INFRASTRUCTURE; BIODIVERSITY; CONCOLOR	Connectivity of natural areas through biological corridors is essential for ecosystem resilience and biodiversity conservation. However, robust assessments of biodiversity in corridor areas are often hindered by logistical constraints and the statistical challenges of modeling data from multiple species. Herein, we used a hierarchical community occupancy model in a Bayesian framework to evaluate the status of medium and large-sized mammals in a critical link of the Mesoamerican Biological Corridor (MBC) in Costa Rica. We used camera traps deployed from 2013-2017 to detect 18 medium (1-15 kg) and 6 large (>15 kg) mammal species in a portion of two Jaguar Conservation Units (JCUs) and the Corridor linking them. Camera traps operated for 16,904 trap nights across 209 stations, covering an area of 880 km(2). Forest cover was the most important driver of medium and large-sized mammal habitat use, with forest specialists such as jaguars (Panthera onca) and pumas (Puma concolor) strongly associated with high forest cover, while habitat generalists such as coyotes (Canis latrans) and raccoons (Procyon lotor) were associated with low forest cover. Medium and large-sized mammal species richness was lower in the Corridor area ((x ) over bar = 9.78 +/- 1.84) than in the portions evaluated of the two JCUs = 11.50 +/- 1.52). Puma and jaguar habitat use probabilities were strongly correlated with large prey species richness (jaguar, r= 0.59, p<0.001; puma, r= 0.72, p<0.001), and correlated to a lesser extent with medium prey species richness (jaguar, r= 0.36, p = 0.003; puma, r= 0.23, p = 0.064). Low estimated jaguar habitat use probability in one JCU (Central Volcanic Cordillera: (x) over bar = 0.15 +/- 0.11) suggests that this is not the jaguar stronghold previously assumed. In addition, the western half of the Corridor has low richness of large mammals, making it necessary to take urgent actions to secure habitat connectivity for mammal populations.	[Salom-Perez, Roberto; Corrales-Gutierrez, Daniel; Araya-Gamboa, Daniela; Espinoza-Munoz, Deiver] Panthera, New York, NY 10018 USA; [Salom-Perez, Roberto] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83843 USA; [Salom-Perez, Roberto; Finegan, Bryan] CATIE Ctr Agron Trop Invest & Ensenanza, Turrialba, Costa Rica; [Petracca, Lisanne S.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Idaho; University of Idaho; University of Washington; University of Washington Seattle	Salom-Perez, R (corresponding author), Panthera, New York, NY 10018 USA.; Salom-Perez, R (corresponding author), Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83843 USA.; Salom-Perez, R (corresponding author), CATIE Ctr Agron Trop Invest & Ensenanza, Turrialba, Costa Rica.	rsalom@panthera.org		Petracca, Lisanne/0000-0003-2460-1292	Interamerican Development Bank [CID/CCR/823/2013]; Small Cats Action Fund [06-2016]; Kaplan Graduate Awards Program [06-2017]	Interamerican Development Bank; Small Cats Action Fund; Kaplan Graduate Awards Program	RSP received support from Interamerican Development Bank (#CID/CCR/823/2013) https://www.iadb.org/, Small Cats Action Fund (#06-2016) https://www.panthera.org/grants-and-fellowships, and Kaplan Graduate Awards Program (#06-2017) https://www.panthera.org/grants-and-fellowships.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RLTS.T3745A103893556.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T3745A103893556.EN]; [Anonymous], IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-1.RLTS.T41686A45216638.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T41686A45216638.EN]; [Anonymous], IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2011-2.RLTS.T41777A10562361.en, DOI 10.2305/IUCN.UK.2011-2.RLTS.T41777A10562361.EN]; [Anonymous], 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016, DOI 10.2305/IUCN.UK.2016]; [Anonymous], IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2014-1.RLTS.T6290A47440785.en, DOI 10.2305/IUCN.UK.2014-1.RLTS.T6290A47440785.EN]; Ara M., 1994, ACTA ZOOLOGICA MEX, P11; Artavia Adolfo, 2015, Brenesia, V83-84, P37; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carrillo E., 2000, ECOLOGY CONSERVATION; Ceballos Gerardo, 2002, P403; Chinchilla FA, 1997, REV BIOL TROP, V45, P1223; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Didan K., 2015, MOD13Q1 MODIS TERRA, P6, DOI DOI 10.5067/MODIS/MOD13Q1.006; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2009, ECOL SOC, V14; Ferretti F, 2020, MAMMAL REV, V50, P291, DOI 10.1111/mam.12197; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Figel JJ, 2018, REV BIOL TROP, V66, P1741, DOI 10.15517/rbt.v66i4.32544; Food and Agriculture Organization, 2020, Global Forest Resources Assessment (FRA) 2020: main report, DOI 10.4060/ca9825en; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hebblewhite M, 2014, BIOL CONSERV, V178, P50, DOI 10.1016/j.biocon.2014.07.013; IEG (Independent Evaluation Group), 2011, MES BIOL CORR REG PR; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jedrzejewski W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194719; Kellner Ken, 2019, CRAN; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; MA, 2005, ECOSYSTEMS HUMAN WEL; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI., 2018, RPRESENCE R INTERFAC, P2; Meyer NFV, 2020, CONSERV BIOL, V34, P207, DOI 10.1111/cobi.13384; Miller Brian, 2001, Endangered Species Update, V18, P202; Miller K, 2001, DEFINING COMMON GROU, P55; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Nielsen C.K., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.EN]; Nunez R, 2000, J ZOOL, V252, P373, DOI 10.1111/j.1469-7998.2000.tb00632.x; ORTIZMALAVASI E, 2009, ATLAS DIGITAL COSTA; Paolucci LN, 2019, BIOTROPICA, V51, P245, DOI 10.1111/btp.12627; Petracca LS, 2020, ANIM CONSERV, V23, P420, DOI 10.1111/acv.12555; Petracca LS, 2018, J APPL ECOL, V55, P723, DOI 10.1111/1365-2664.12972; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Queheillalt DM, 2002, WILDLIFE SOC B, V30, P756; Quigley H., 2017, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2017-3.RLTS.T15953A50658693.en; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reid F., 2009, FIELD GUIDE MAMMALS, V2nd; Rich LN, 2016, J APPL ECOL, V53, P1225, DOI 10.1111/1365-2664.12650; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Saetersdal M, 2011, J APPL ECOL, V48, P1236, DOI 10.1111/j.1365-2664.2011.02027.x; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Sandom C, 2013, ECOLOGY, V94, P1112, DOI 10.1890/12-1342.1; Santos F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213671; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Silman MR, 2003, ECOLOGY, V84, P431, DOI 10.1890/0012-9658(2003)084[0431:PROADR]2.0.CO;2; SINAC, 2018, EST CONS JAG PANTH O; SMYTHE N, 1986, ANNU REV ECOL SYST, V17, P169; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Sunquist ME, 2002, WILD CATS WORLD; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Torres A, 2016, P NATL ACAD SCI USA, V113, P8472, DOI 10.1073/pnas.1522488113; WHO and SCBD, 2015, CONNECTING GLOBAL PR, P364, DOI [10.13140/rg.2.1.3679.6565, DOI 10.13140/RG.2.1.3679.6565]; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162377; Zeller KA., 2013, MOL POPULATION GENET, P629; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	87	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249072	10.1371/journal.pone.0249072	http://dx.doi.org/10.1371/journal.pone.0249072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755706	gold, Green Published			2022-12-26	WOS:000632916600047
J	Siripanthong, S; Techasen, A; Nantasenamat, C; Malik, AA; Sithithaworn, P; Leelayuwat, C; Jumnainsong, A				Siripanthong, Sitthinon; Techasen, Anchalee; Nantasenamat, Chanin; Malik, Aijaz Ahmad; Sithithaworn, Paiboon; Leelayuwat, Chanvit; Jumnainsong, Amonrat			Production and characterization of antibody against Opisthorchis viverrini via phage display and molecular simulation	PLOS ONE			English	Article								In this study, a key issue to be addressed is the safe disposal of hybridoma instability. Hybridoma technology was used to produce anti-O. viverrini monoclonal antibody. Previous studies have shown that antibody production via antibody phage display can sustain the hybridoma technique. This paper presents the utility of antibody phage display technology for producing the phage displayed KKU505 Fab fragment and using experiments in concomitant with molecular simulation for characterization. The phage displayed KKU505 Fab fragment and characterization were successfully carried out. The KKU505 hybridoma cell line producing anti-O. viverrini antibody predicted to bind to myosin was used to synthesize cDNA so as to amplify the heavy chain and the light chain sequences. The KKU505 displayed phage was constructed and characterized by a molecular modeling in which the KKU505 Fab fragment and -O. viverrini myosin head were docked computationally and it is assumed that the Fab fragment was specific to -O. viverrini on the basis of mass spectrometry and Western blot. This complex interaction was confirmed by molecular simulation. Furthermore, the KKU505 displayed phage was validated using indirect enzyme-linked immunosorbent assays (ELISA) and immunohistochemistry. It is worthy to note that ELISA and immunohistochemistry results confirmed that the Fab fragment was specific to the -O. viverrini antigen. Results indicated that the approach presented herein can generate anti-O. viverrini antibody via the phage display technology. This study integrates the use of phage display technology together with molecular simulation for further development of monoclonal antibody production. Furthermore, the presented work has profound implications for antibody production, particularly by solving the problem of hybridoma stability issues.	[Siripanthong, Sitthinon] Khon Kaen Univ, Grad Sch, Khon Kaen, Thailand; [Techasen, Anchalee; Sithithaworn, Paiboon] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Inst, Khon Kaen, Thailand; [Techasen, Anchalee] Khon Kaen Univ, Dept Clin Microbiol, Fac Associated Med Sci, Khon Kaen, Thailand; [Nantasenamat, Chanin; Malik, Aijaz Ahmad] Mahidol Univ, Ctr Data Min & Biomed Informat, Fac Med Technol, Bangkok, Thailand; [Sithithaworn, Paiboon] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen, Thailand; [Leelayuwat, Chanvit; Jumnainsong, Amonrat] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen, Thailand; [Leelayuwat, Chanvit; Jumnainsong, Amonrat] Khon Kaen Univ, Dept Clin Immunol & Transfus Sci, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Jumnainsong, A (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev, Med Diagnost Labs, Khon Kaen, Thailand.; Jumnainsong, A (corresponding author), Khon Kaen Univ, Dept Clin Immunol & Transfus Sci, Khon Kaen, Thailand.	amonrat@kku.ac.th	Nantasenamat, Chanin/AAD-1032-2019	Nantasenamat, Chanin/0000-0003-1040-663X; Leelayuwat, Chanvit/0000-0002-2770-7415	MSc scholarship from the centre for research and development of medical diagnostic laboratories, Liver fluke and cholangiocarcinoma research center; Graduate School, Khon Kaen University, Thailand; Center of Excellence on Medical Biotechnology (CEMB), Thailand; S&T Postgraduate Education and Research Development Office (PERDO), Thailand; Office of Higher Education Commission (OHEC), Thailand	MSc scholarship from the centre for research and development of medical diagnostic laboratories, Liver fluke and cholangiocarcinoma research center; Graduate School, Khon Kaen University, Thailand; Center of Excellence on Medical Biotechnology (CEMB), Thailand; S&T Postgraduate Education and Research Development Office (PERDO), Thailand; Office of Higher Education Commission (OHEC), Thailand(Office of Higher Education Commission (OHEC))	This research has been funded by the MSc scholarship from the centre for research and development of medical diagnostic laboratories, Liver fluke and cholangiocarcinoma research center, and the Graduate School, Khon Kaen University, Thailand. CN is grateful for financial support by the Center of Excellence on Medical Biotechnology (CEMB), the S&T Postgraduate Education and Research Development Office (PERDO) and the Office of Higher Education Commission (OHEC), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh M, 2019, INT J GEN MED, V12, P13, DOI 10.2147/IJGM.S186854; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; Baker Nathan A, 2003, Methods Biochem Anal, V44, P427; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Blechacz B, 2017, GUT LIVER, V11, P13, DOI 10.5009/gnl15568; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carmen Sara, 2002, Briefings in Functional Genomics & Proteomics, V1, P189, DOI 10.1093/bfgp/1.2.189; CASTILLO FJ, 1994, DEV BIOL STAND, V83, P55; Charoensuk L, 2019, ACTA TROP, V191, P13, DOI 10.1016/j.actatropica.2018.12.018; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Fernandez-Quintero ML, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01319-z; Fernandez-Quintero ML, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1744328; Fernandez-Quintero ML, 2019, MABS-AUSTIN, V11, P1077, DOI 10.1080/19420862.2019.1618676; Finlay WJJ, 2017, METHODS MOL BIOL, V1485, P85, DOI 10.1007/978-1-4939-6412-3_6; Frank M, 2003, J MOL MODEL, V9, P308, DOI 10.1007/s00894-003-0144-y; Frei JC, 2016, METHOD ENZYMOL, V580, P45, DOI 10.1016/bs.mie.2016.05.005; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521; Hnasko RM, 2015, METHODS MOL BIOL, V1318, P15, DOI 10.1007/978-1-4939-2742-5_2; Nguyen HH, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10010028; Johansen MV, 2015, ACTA TROP, V141, P161, DOI 10.1016/j.actatropica.2013.07.006; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Kaewpitoon Natthawut, 2015, Asian Pac J Cancer Prev, V16, P6825; Kamsa-ard Siriporn, 2018, Asian Pac J Cancer Prev, V19, P605; KESSLER N, 1993, IN VITRO CELL DEV-AN, V29A, P203; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Laha T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-189; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Lousa D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28099; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Mihalache F, 2010, J GASTROINTEST LIVER, V19, P285; Nantasenamat C, 2015, EXPERT OPIN DRUG DIS, V10, P321, DOI 10.1517/17460441.2015.1016497; Phumyen A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/597647; Pomes A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02067; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saeed AFUH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00495; Shafaghati L, 2017, B MATH BIOL, V79, P2450, DOI 10.1007/s11538-017-0336-8; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sripa B, 2000, INT J PARASITOL, V30, P735, DOI 10.1016/S0020-7519(00)00054-0; Tan YY, 2016, BIOTECHNOL J, V11, P732, DOI 10.1002/biot.201500458; Thompson J, 1996, J MOL BIOL, V256, P77, DOI 10.1006/jmbi.1996.0069; Tomita M, 2011, IMMUNOTHERAPY-UK, V3, P371, DOI 10.2217/IMT.11.4; Treeprasertsuk S, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-016-0565-6; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wongratanacheewin S, 2003, ACTA TROP, V88, P195, DOI 10.1016/j.actatropica.2003.02.002; Worasith C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004157; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248887	10.1371/journal.pone.0248887	http://dx.doi.org/10.1371/journal.pone.0248887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755687	Green Published, gold			2022-12-26	WOS:000632916600024
J	Teshale, AB; Tesema, GA				Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn			Timely initiation of breastfeeding and associated factors among mothers having children less than two years of age in sub-Saharan Africa: A multilevel analysis using recent Demographic and Health Surveys data	PLOS ONE			English	Article							DETERMINANTS; ETHIOPIA; INFANTS; DELIVERY; PREVALENCE; PREGNANCY; NORTHWEST; BIRTH; ZONE; MILK	Background Despite the significant advantages of timely initiation of breastfeeding (TIBF), many countries particularly low- and middle-income countries have failed to initiate breastfeeding on time for their newborns. Optimal breastfeeding is one of the key components of the SDG that may help to achieve reduction of under-five mortality to 25 deaths per 1000 live births. Objective To assess the pooled prevalence and associated factors of timely initiation of breastfeeding among mothers having children less than two years of age in sub-Saharan Africa. Methods We used pooled data from the 35 sub-Saharan Africa (SSA) Demographic and Health Surveys (DHS). We used a total weighted sample of 101,815 women who ever breastfeed and who had living children under 2 years of age. We conducted the multilevel logistic regression and variables with p<0.05, in the multivariable analysis, were declared significantly associated with TIBF. Results The pooled prevalence of TIBF in SSA was 58.3% [95%CI; 58.0-58.6%] with huge variation between countries, ranging from 24% in Chad to 86% in Burundi. Both individual and community level variables were associated with TIBF. Among individual-level factors; being older-aged mothers, having primary education, being from wealthier households, exposure to mass media, being multiparous, intended pregnancy, delivery at a health facility, vaginal delivery, single birth, and average size of the child at birth were associated with higher odds of TIBF. Of community-level factors, rural place of residence, higher community level of ANC utilization, and health facility delivery were associated with higher odds of TIBF. Conclusion In this study, the prevalence of TIBF in SSA was low. Both individual and community-level factors were associated with TIBF. The authors recommend interventions at both individual and community levels to increase ANC utilization as well as health facility delivery that are crucial for advertising optimal breastfeeding practices such as TIBF.	[Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Adhikari M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0021-6; Alebel A, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0133-x; Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Batal M, 2006, PUBLIC HEALTH NUTR, V9, P313, DOI 10.1079/PHN2006860; Bee M, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0141-5; Belachew A, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-018-0196-3; Berde AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0818-y; Biks GA, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0055-4; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Chen C, 2018, J HUM LACT, V34, P526, DOI 10.1177/0890334417741434; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Dankwah E, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0753-2; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DiGirolamo AM, 2001, BIRTH-ISS PERINAT C, V28, P94, DOI 10.1046/j.1523-536X.2001.00094.x; Dorgham LS., 2014, LIFE SCI J, V11, P1; Edmond KM, 2007, AM J CLIN NUTR, V86, P1126, DOI 10.1093/ajcn/86.4.1126; Ekubay M, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0146-0; El-Gilany A. -H., 2012, Eastern Mediterranean Health Journal, V18, P250; Exavery A, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0052-7; Gebremeskel SG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4718-x; Goldman AS, 2000, J NUTR, V130, p426S, DOI 10.1093/jn/130.2.426S; Haider R, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-21; Hanif HM, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-15; Issaka AI, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014145; Jiang H, 2014, JAMA PEDIATR, V168, P471, DOI 10.1001/jamapediatrics.2014.58; Kim BY, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-016-0094-5; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S2; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; McKinn Shannon, 2019, Health Lit Res Pract, V3, pe31, DOI 10.3928/24748307-20190102-01; Mekonen L, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0160-2; Mihrshahi S, 2010, FOOD NUTR BULL, V31, P295, DOI 10.1177/156482651003100220; Miller BC, 2001, DEV REV, V21, P1, DOI 10.1006/drev.2000.0513; Mukora-Mutseyekwa Fadzai, 2019, Matern Health Neonatol Perinatol, V5, P2, DOI 10.1186/s40748-018-0097-x; Ndirangu MN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1811-4; Ng SK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-460; Organization WH, 2018, MARK BREAST MILK SUB; Organization WH, 2017, REACH EV NEWB NAT 20; Organization WH, 2004, GUID PRINC FEED INF; Orun E, 2010, TURKISH J PEDIATR, V52, P10; Patel A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S10; Patel A, 2013, J HUM LACT, V29, P572, DOI 10.1177/0890334412474718; Regan J, 2013, BREASTFEED MED, V8, P181, DOI 10.1089/bfm.2012.0049; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; The DHS Program, 2015, SAMPL WEIGHT DHS DAT; Tilahun G, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0086-5; UNICEF, 2015, STATE WORLDS CHILDRE; UNICEF, 2018, PROGR EV CHILD SDG E; Victor R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001529; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760; Vinje KH, 2017, PUBLIC HEALTH NUTR, V20, P1333, DOI 10.1017/S1368980016003591; Walters CN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7877-8; WHO, 2012, 10 FACTS BREASTF; WHO, 2012, BREASTF EARL IN; Yahya WB., 2013, CHILD DEV RES, V2013, P1; Yaya S, 2018, INT HEALTH, V10, P310, DOI 10.1093/inthealth/ihx073	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248976	10.1371/journal.pone.0248976	http://dx.doi.org/10.1371/journal.pone.0248976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755702	Green Published, gold			2022-12-26	WOS:000632916600030
J	Dias, S; Adam, S; Abrahams, Y; Rheeder, P; Pheiffer, C				Dias, Stephanie; Adam, Sumaiya; Abrahams, Yoonus; Rheeder, Paul; Pheiffer, Carmen			Adiponectin DNA methylation in South African women with gestational diabetes mellitus: Effects of HIV infection	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; CORD BLOOD; PERIPHERAL-BLOOD; MATERNAL SMOKING; RISK; PREGNANCY; OBESITY; GENOME; HYPOMETHYLATION	DNA methylation is increasingly recognized as a potential biomarker of metabolic disease. However, there is limited information on the impact of human immunodeficiency virus (HIV) infection on the candidacy of DNA methylation to serve as molecular biomarkers. This study investigated the effect of HIV infection on DNA methylation patterns in the peripheral blood of South African women with (n = 95) or without (n = 191) gestational diabetes mellitus (GDM). DNA methylation levels at eight CpG sites in the adiponectin gene (ADIPOQ) promoter were measured using bisulfite conversion and pyrosequencing. Differences between HIV negative ((-)) and positive ((+)) women were observed. In HIV- women, methylation at CpG -3400 was lower in GDM(+) women compared to those with normoglycemia (8.5-fold; p = 0.004), and was associated with higher fasting glucose (beta-co-efficient = 0.973; p = 0.006) and lower adiponectin (beta-co-efficient = -0.057; p = 0.014) concentrations. These associations were not observed in HIV+ women. In silico analysis showed that Transcription Factor AP2-alpha is able to bind to the altered CpG site, suggesting that CpG -3400 may play a functional role in the regulation of ADIPOQ expression. Our findings show that DNA methylation differs by HIV status, suggesting that HIV infection needs to be taken into consideration in studies exploring DNA methylation as a biomarker of GDM in high HIV prevalence settings.	[Dias, Stephanie; Abrahams, Yoonus; Pheiffer, Carmen] South African Med Res Council, Biomed Res & Innovat Platform BRIP, Cape Town, South Africa; [Dias, Stephanie; Adam, Sumaiya] Univ Pretoria, Dept Obstet & Gynecol, Pretoria, South Africa; [Abrahams, Yoonus; Pheiffer, Carmen] Stellenbosch Univ, Fac Hlth Sci, Div Med Physiol, Cape Town, South Africa; [Rheeder, Paul] Univ Pretoria, Fac Hlth Sci, Dept Internal Med, Pretoria, South Africa	South African Medical Research Council; University of Pretoria; Stellenbosch University; University of Pretoria	Pheiffer, C (corresponding author), South African Med Res Council, Biomed Res & Innovat Platform BRIP, Cape Town, South Africa.; Pheiffer, C (corresponding author), Stellenbosch Univ, Fac Hlth Sci, Div Med Physiol, Cape Town, South Africa.	carmen.pheiffer@mrc.ac.za	dias, stephanie/ABD-9740-2021	Dias, Stephanie/0000-0003-3008-4279; Pheiffer, Carmen/0000-0002-0707-1552; Rheeder, Paul/0000-0002-1573-4985	National Research Foundation, South Africa [99391]; South African Medical Research Council	National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Research Foundation, South Africa (Unique Grant no. 99391) (SD), and the South African Medical Research Council (CP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2017, SAMJ S AFR MED J, V107, P523, DOI [10.7196/samj.2017.v107i6.12043, 10.7196/SAMJ.2017.v107i6.12043]; Adam S, 2018, BIOMARKERS, V23, P386, DOI 10.1080/1354750X.2018.1432690; Agbozo F, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2017-000493; Bakhtiarizadeh MR, 2014, GENES GENOM, V36, P105, DOI 10.1007/s13258-013-0145-x; Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bouchard L, 2012, DIABETES, V61, P1272, DOI 10.2337/db11-1160; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Caminos JE, 2005, J CLIN ENDOCR METAB, V90, P4276, DOI 10.1210/jc.2004-0930; Catalano PM, 2006, DIABETOLOGIA, V49, P1677, DOI 10.1007/s00125-006-0264-x; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Christensen Brock C., 2011, Frontiers in Genetics, V2, P84, DOI 10.3389/fgene.2011.00084; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Dahlman I, 2015, INT J OBESITY, V39, P910, DOI 10.1038/ijo.2015.31; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390; Dias S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235828; Dias Stephanie, 2018, Int J Mol Sci, V19, DOI 10.3390/ijms19102926; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Dye CK, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0694-1; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Enquobahrie DA, 2015, REPROD SCI, V22, P904, DOI 10.1177/1933719115570903; Fakruddin M., 2012, AM J BIOCH BIOTECHNO, V8, P14, DOI [10.3844/ajbbsp.2012.14.20, DOI 10.3844/AJBBSP.2012.14.20]; Fuke T, 2010, INT J OBESITY, V34, P670, DOI 10.1038/ijo.2009.295; Garcia-Cardona MC, 2014, INT J OBESITY, V38, P1457, DOI 10.1038/ijo.2014.30; Ghadge AA, 2018, CYTOKINE GROWTH F R, V39, P151, DOI 10.1016/j.cytogfr.2018.01.004; Grabe N., ALIBABA2; Guelfi KJ, 2017, METABOLISM, V75, P54, DOI 10.1016/j.metabol.2017.08.003; HARBERS K, 1981, P NATL ACAD SCI-BIOL, V78, P7609, DOI 10.1073/pnas.78.12.7609; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS173, DOI [10.1016/S0020-7292(15)30007-2, 10.1016/S0020-7292(15)30033-3]; Houshmand-Oeregaard A, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0338-2; International Diabetes Federation, 2017, IDF DIAB ACR GLOB; Joint United Nations, 2018, UNAIDS DATA 2018; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kang J, 2017, DIABETES RES CLIN PR, V132, P127, DOI 10.1016/j.diabres.2017.07.034; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Landon MB, 2015, DIABETES CARE, V38, P445, DOI 10.2337/dc14-2159; Li L, 2012, J EPIDEMIOL, V22, P384, DOI 10.2188/jea.JE20120003; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Marsit CJ, 2015, EPIGENETICS-US, V10, P708, DOI 10.1080/15592294.2015.1060389; Mart?n Reina J., 2017, J TOXINS, V4, P7, DOI DOI 10.13188/2328-1723.1000019; Matta-Coelho C, 2019, ENDOCRINE, V63, P507, DOI 10.1007/s12020-018-1760-8; Meek CL, 2015, DIABETOLOGIA, V58, P2003, DOI 10.1007/s00125-015-3647-z; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miailhe G, 2015, EUR J OBSTET GYN R B, V191, P95, DOI 10.1016/j.ejogrb.2015.05.003; Mitanchez D, 2015, BEST PRACT RES CL OB, V29, P256, DOI 10.1016/j.bpobgyn.2014.08.004; Miyake K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23772-x; Mohammadi Tanin, 2017, Clin Nutr Res, V6, P267, DOI 10.7762/cnr.2017.6.4.267; Mohibullah N, 1999, NUCLEIC ACIDS RES, V27, P2760, DOI 10.1093/nar/27.13.2760; National Department of Health South Africa, 2015, NAT CONS GUID PREV M; Nelson KN, 2017, AIDS, V31, P571, DOI 10.1097/QAD.0000000000001360; Nigam A, 2019, BJOG-INT J OBSTET GY, V126, P27, DOI 10.1111/1471-0528.15849; Nogues P, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0612-6; Nordquist N, 2009, OBESITY, V17, P1762, DOI 10.1038/oby.2009.83; Ott R, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0567-z; Pajvani Utpal B, 2003, Curr Diab Rep, V3, P207, DOI 10.1007/s11892-003-0065-2; Pauwels S, 2017, EPIGENETICS-US, V12, P1, DOI 10.1080/15592294.2016.1257450; Pheiffer C, 2019, MOL DIAGN THER, V23, P499, DOI 10.1007/s40291-019-00404-2; Pheiffer C, 2016, CLIN BIOCHEM, V49, P433, DOI 10.1016/j.clinbiochem.2015.11.021; Pion M, 2013, AIDS, V27, P2019, DOI 10.1097/QAD.0b013e32836253fd; Ranheim T, 2004, ACTA OBSTET GYN SCAN, V83, P341, DOI 10.1111/j.0001-6349.2004.00413.x; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Retnakaran R, 2010, DIABETOLOGIA, V53, P268, DOI 10.1007/s00125-009-1600-8; Sheridan RM, 2012, HUM PATHOL, V43, P1866, DOI 10.1016/j.humpath.2012.01.011; Su SY, 2014, TWIN RES HUM GENET, V17, P183, DOI 10.1017/thg.2014.22; Wang GH, 2018, NUCLEIC ACIDS RES, V46, pD146, DOI 10.1093/nar/gkx1096; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Willmer T, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00744; Worda C, 2004, AM J OBSTET GYNECOL, V191, P2120, DOI 10.1016/j.ajog.2004.04.038; Wu P, 2018, EPIGENETICS-US, V13, P122, DOI 10.1080/15592294.2016.1166321; Zainolabidin N, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00281; Zhang BC, 2012, CLIN ENDOCRINOL, V77, P370, DOI 10.1111/j.1365-2265.2011.04260.x; Zhang CL, 2016, DIABETOLOGIA, V59, P1385, DOI 10.1007/s00125-016-3979-3; Zhang XY, 2016, EPIGENETICS-US, V11, P750, DOI 10.1080/15592294.2016.1221569; Zhao P, 2016, DIABETOLOGIA, V59, P2339, DOI 10.1007/s00125-016-4062-9	80	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248694	10.1371/journal.pone.0248694	http://dx.doi.org/10.1371/journal.pone.0248694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750967	Green Published, gold			2022-12-26	WOS:000631967100014
J	Iavicoli, S; Boccuni, F; Buresti, G; Gagliardi, D; Persechino, B; Valenti, A; Rondinone, BM				Iavicoli, Sergio; Boccuni, Fabio; Buresti, Giuliana; Gagliardi, Diana; Persechino, Benedetta; Valenti, Antonio; Rondinone, Bruna Maria			Risk assessment at work and prevention strategies on COVID-19 in Italy	PLOS ONE			English	Article							STATES	The COVID-19 pandemic has spread worldwide, with considerable public health and socio-economic impacts that are seriously affecting health and safety of workers, as well as their employment stability. Italy was the first of many other western countries to implement extended containment measures. Health workers and others employed in essential sectors have continued their activity, reporting high infection rate with many fatalities. The epidemiological trend highlighted the importance of work as a substantial factor to consider both when implementing strategies aimed at containing the pandemic and shaping the lockdown mitigation strategy required for sustained economic recovery. To support the decision-making process, we have developed a strategy to predict the risk of infection by SARS-CoV-2 in the workplace based on the analysis of the working process and proximity between employees; risk of infection connected to the type of activity; involvement of third parties in the working processes and risk of social aggregation. We applied this approach to outline a risk index for each economic activity sector, with different levels of detail, also considering the impact on mobility of the working population. This method was implemented into the national epidemiological surveillance model in order to estimate the impact of re-activation of specific activities on the reproduction number. It has also been adopted by the national scientific committee set up by the Italian Government for action-oriented policy advice on the COVID-19 emergency in the post lockdown phase. This approach may play a key role for public health if associated with measures for risk mitigation in enterprises through strategies of business process re-engineering. Furthermore, it will make a contribution to reconsidering the organization of work, including also innovation and fostering the integration with the national occupational safety and health (OSH) system.	[Iavicoli, Sergio; Boccuni, Fabio; Buresti, Giuliana; Gagliardi, Diana; Persechino, Benedetta; Valenti, Antonio; Rondinone, Bruna Maria] INAIL, Dept Occupat & Environm Med, Epidemiol & Hyg, Rome, Italy		Boccuni, F (corresponding author), INAIL, Dept Occupat & Environm Med, Epidemiol & Hyg, Rome, Italy.	f.boccuni@inail.it		Gagliardi, DIana/0000-0003-0236-3385; BOCCUNI, FABIO/0000-0002-4976-631X				Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972; Barbieri T., 2020, 46 INAPP WP; Chirico F, 2020, INFECT CONT HOSP EP, V41, P1117, DOI 10.1017/ice.2020.148; Dyal JW, 2020, MMWR-MORBID MORTAL W, V69, P557, DOI 10.15585/mmwr.mm6918e3; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Ente Italiano di Normazione (UNI), 1995, IMP AER FIN BEN GEN, V10339, P1995; EU-OSHA, 1996, GUID RISK ASS WORK; European Agency for Safety and Health at Work (EU-OSHA), 2020, COVID 19 EU OSHA GUI; Felice C, 2020, J COMMUN HEALTH, V45, P675, DOI 10.1007/s10900-020-00845-5; Huang YY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01429-6; INAIL, 2014, IND NAZ SAL SIC LAV; Italian National Institute of Statistics (ISTAT), 2009, CLASS ATT EC ATECO 2; Italian National Institute of Statistics (ISTAT), 2020, MEM SCRITT I NAZ STA; Italian Workers' Compensation Authority (INAIL), 2020, IND NAZ SAL SIC LAV; Italian Workers' Compensation Authority (INAIL), 2020, DOC TECN POSS RIM MI; Italian Workers' Compensation Authority (INAIL), 2020, I DAT DEN COVID 19 3; Koh D, 2020, OCCUP MED-OXFORD, V70, P3, DOI 10.1093/occmed/kqaa036; Mosites E, 2020, MMWR-MORBID MORTAL W, V69, P521, DOI 10.15585/mmwr.mm6917e1; National Fire Protection Association (NFPA), 2018, 101 NFPA; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; 't Mannetje A, 2003, INT J EPIDEMIOL, V32, P419, DOI 10.1093/ije/dyg080; US Department of Labor, 2019, O NET 24 2 DAT; Wallace M, 2020, MMWR-MORBID MORTAL W, V69, P587, DOI 10.15585/mmwr.mm6919e1; WHO, 2020, COVID 19 STRAT UPD; WHO, 2020, 82 WHO; World Health Organization, 2020, CONS PUBL HLTH SOC M; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117	27	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248874	10.1371/journal.pone.0248874	http://dx.doi.org/10.1371/journal.pone.0248874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740016	Green Published, gold			2022-12-26	WOS:000631030200015
J	Smith, GC; Budgey, R				Smith, Graham C.; Budgey, Richard			Simulating the next steps in badger control for bovine tuberculosis in England	PLOS ONE			English	Article							MELES-MELES; VACCINATION; MODEL	Industry-led culling of badgers has occurred in England to reduce the incidence of bovine tuberculosis in cattle for a number of years. Badger vaccination is also possible, and a move away from culling was "highly desirable" in a recent report to the UK government. Here we used an established simulation model to examine badger control option in a post-cull environment in England. These options included no control, various intermittent culling, badger vaccination and use of a vaccine combined with fertility control. The initial simulated cull led to a dramatic reduction in the number of infected badgers present, which increased slowly if there was no further badger management. All three approaches led to a further reduction in the number of infected badgers, with little to choose between the strategies. We do note that of the management strategies only vaccination on its own leads to a recovery of the badger population, but also an increase in the number of badgers that need to be vaccinated. We conclude that vaccination post-cull, appears to be particularly effective, compared to vaccination when the host population is at carrying capacity.	[Smith, Graham C.; Budgey, Richard] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England	Animal & Plant Health Agency UK	Smith, GC (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	graham.smith@apha.gov.uk	Smith, Graham/J-2593-2013	Smith, Graham/0000-0002-9897-6794	Defra (Department for Environment and Rural Affairs)	Defra (Department for Environment and Rural Affairs)	This work was funded by Defra (Department for Environment and Rural Affairs) as a request to investigate the topic. They played no role in study design, analysis or drafting the paper.	[Anonymous], 2012, VET REC, V171, P361, DOI 10.1136/vr.e6782; [Anonymous], 2012, VET REC, V171, P285, DOI 10.1136/vr.e6219; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; Brunton LA, 2017, ECOL EVOL, V7, P7213, DOI 10.1002/ece3.3254; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Cowan D, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-019-1296-0; Defra, 2017, SUMMARY BADGER CONTR; Defra, 2016, SUMMARY BADGER CONTR; Defra, 2020, SUMMARY 2019 BADGER; Defra, 2018, SUMMARY BADGER CONTR; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Downs SH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49957-6; Godfray C., 2018, BOVINE TB STRATEGY R; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Smith GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167206; Smith GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039250; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x	21	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248426	10.1371/journal.pone.0248426	http://dx.doi.org/10.1371/journal.pone.0248426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735292	gold, Green Published			2022-12-26	WOS:000631029700054
J	Rzucidlo-Hymczak, A; Hymczak, H; Kedziora, A; Kapelak, B; Drwila, R; Plicner, D				Rzucidlo-Hymczak, Anna; Hymczak, Hubert; Kedziora, Anna; Kapelak, Boguslaw; Drwila, Rafal; Plicner, Dariusz			Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery	PLOS ONE			English	Article								Background It is unclear whether acid-base balance disturbances during the perioperative period may impact Clostridium difficile infection (CDI), which is the third most common major infection following cardiac surgery. We hypothesized that perioperative acid-base abnormalities including lactate disturbances may predict the probability of incidence of CDI in patients after cardiac procedures. Methods Of the 12,235 analyzed patients following cardiac surgery, 143 (1.2%) developed CDI. The control group included 200 consecutive patients without diarrhea, who underwent cardiac procedure within the same period of observation. Pre-, intra and post-operative levels of blood gases, as well as lactate and glucose concentrations were determined. Postoperatively, arterial blood was drawn four times: immediately after surgery and successively; 4, 8 and 12 h following the procedure. Results Baseline pH was lower and PaO2 was higher in CDI patients (p < 0.001 and p = 0.001, respectively). Additionally, these patients had greater base deficiency at each of the analyzed time points (p < 0.001, p = 0.004, p = 0.012, p = 0.001, p = 0.016 and p = 0.001, respectively). Severe hyperlactatemia was also more common in CDI patients; during the cardiac procedure, 4 h and 12 h after surgery (p = 0.027, p = 0.004 and p = 0.001, respectively). Multivariate logistic regression analysis revealed that independent risk factors for CDI following cardiac surgery were as follows: intraoperative severe hyperlactatemia (OR 2.387, 95% CI 1.155-4.933, p = 0.019), decreased lactate clearance between values immediately and 12 h after procedure (OR 0.996, 95% CI 0.994-0.999, p = 0.013), increased age (OR 1.045, 95% CI 1.020-1.070, p < 0.001), emergent surgery (OR 2.755, 95% CI 1.565-4.848, p < 0.001) and use of antibiotics other than periprocedural prophylaxis (OR 2.778, 95% CI 1.690-4.565, p < 0.001). Conclusion This study is the first to show that perioperative hyperlactatemia and decreased lactate clearance may be predictors for occurrence of CDI after cardiac surgery.	[Rzucidlo-Hymczak, Anna] John Paul 2 Hosp, Dept Pediat Infect Dis & Pediat Hepatol, Krakow, Poland; [Hymczak, Hubert] John Paul 2 Hosp, Dept Anesthesiol & Intens Care, Krakow, Poland; [Kedziora, Anna; Kapelak, Boguslaw] John Paul 2 Hosp, Dept Cardiovasc Surg & Transplantat, Krakow, Poland; [Drwila, Rafal] Jagiellonian Univ, Med Coll, Krakow, Poland; [Plicner, Dariusz] Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Unit Expt Cardiol & Cardiac Surg, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Andrzej Frycz Modrzewski Krakow University	Plicner, D (corresponding author), Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Unit Expt Cardiol & Cardiac Surg, Krakow, Poland.	plicner.dariusz@gmail.com		Hymczak, Hubert/0000-0003-2345-9108; Rzucidlo-Hymczak, Anna/0000-0002-4312-0665; Plicner, Dariusz/0000-0002-3687-512X; Kedziora, Anna/0000-0003-1716-9374	science found on John Paul II Hospital, Krakow, Poland [FN1/2021]	science found on John Paul II Hospital, Krakow, Poland	This article was supported by science found on John Paul II Hospital, Krakow, Poland (no. FN1/2021 to D.P.).	Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Ben-Hamouda Nawfel, 2013, Rev Med Suisse, V9, P2335; Borgmann S, 2008, Euro Surveill, V13; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Crabtree T, 2007, ANN THORAC SURG, V83, P1396, DOI 10.1016/j.athoracsur.2006.10.067; Czepiel J, 2019, EUR J CLIN MICROBIOL, V38, P1211, DOI 10.1007/s10096-019-03539-6; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Foucher CD, LACTIC ACIDOSIS INTE; Furuya-Kanamori L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1258-4; Furuya-Kanamori L, 2015, INFECT CONT HOSP EP, V36, P132, DOI 10.1017/ice.2014.39; Gelijns AC, 2014, J AM COLL CARDIOL, V64, P372, DOI 10.1016/j.jacc.2014.04.052; Hajjar LA, 2013, J THORAC CARDIOV SUR, V146, P455, DOI 10.1016/j.jtcvs.2013.02.003; Kamboj M, 2019, EMERG INFECT DIS, V25, P1683, DOI 10.3201/eid2509.181142; Kintu-Luwaga R, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-44; Kirkwood KA, 2018, J THORAC CARDIOV SUR, V155, P670, DOI 10.1016/j.jtcvs.2017.09.089; Lange H, 1997, Lakartidningen, V94, P1893; Lemaire A, 2015, SURG INFECT, V16, P24, DOI 10.1089/sur.2013.097; Maillet JM, 2003, CHEST, V123, P1361, DOI 10.1378/chest.123.5.1361; Marty P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-3; Minton Jonathon, 2017, J Extra Corpor Technol, V49, P7; Ong GKB, 2017, AM J SURG, V213, P565, DOI 10.1016/j.amjsurg.2016.10.035; Ranucci M, 2006, CRIT CARE, V10, DOI 10.1186/cc5113; Rzucidlo-Hymczak A, 2020, PEERJ, V8, DOI 10.7717/peerj.9972; Sartelli M, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0228-3; Sousa-Uva M, 2018, EUR J CARDIO-THORAC, V53, P5, DOI 10.1093/ejcts/ezx314; Suljagic V, 2020, LIBYAN J MED, V15, DOI 10.1080/19932820.2019.1708639; Sun DQ, 2018, EUR J GASTROEN HEPAT, V30, P1361, DOI 10.1097/MEG.0000000000001189; Soto LU, 2016, MED CLIN-BARCELONA, V147, P543, DOI 10.1016/j.medcli.2016.09.026; Yarushina Y N, 2019, Ter Arkh, V91, P20, DOI 10.26442/00403660.2019.11.000337; Zante B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205309	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248512	10.1371/journal.pone.0248512	http://dx.doi.org/10.1371/journal.pone.0248512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730090	Green Published, gold			2022-12-26	WOS:000630345000009
J	Dias, HG; Resck, MEB; Caldas, GC; Resck, AF; da Silva, NV; dos Santos, AMV; Sousa, TD; Ogrzewalska, MH; Siqueira, MM; Pauvolid-Correa, A; dos Santos, FB				Dias, Helver Goncalves; Barreto Resck, Maria Eduarda; Caldas, Gabriela Cardoso; Resck, Alessandro Fioretti; da Silva, Natalia Valente; Vieira dos Santos, Aline Marcele; Sousa, Thiago das Chagas; Ogrzewalska, Maria Halina; Siqueira, Marilda Mendonca; Pauvolid-Correa, Alex; dos Santos, Flavia Barreto			Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil	PLOS ONE			English	Article							CORONAVIRUS; OUTBREAK	The epidemic of coronavirus disease 2019 (COVID-19), caused by a novel Betacoronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a public health emergency worldwide. Few reports indicate that owned pets from households with at least one human resident that was diagnosed with COVID-19 can be infected by SARS-CoV-2. However, the exposure to SARS-CoV-2 of pets from households with no COVID-19 cases or stray animals remains less assessed. Using real-time reverse transcriptase polymerase chain reaction (RT-PCR) and plaque reduction neutralization test (PRNT90), we investigated the infection and previous exposure of dogs and cats to SARS-CoV-2 during the ongoing COVID-19 epidemic in Rio de Janeiro, Brazil. From June to August 2020, 96 animals were sampled, including 49 cats (40 owned and 9 stray) and 47 dogs (42 owned and 5 stray). Regarding owned pets, 75.6% (62/82) belonged to households with no COVID-19 cases. Samples included serum, and rectal and oropharyngeal swabs. All swabs were negative for SARS-CoV-2 RNA, but serum samples of a stray cat and a stray dog presented neutralizing antibodies for SARS-CoV-2, with PRNT90 titer of 80 and 40, respectively. Serological data presented here suggest that not only owned pets from households with COVID19 cases, but also stray animals are being exposed to SARS-CoV-2 during the COVID-19 pandemic.	[Dias, Helver Goncalves; dos Santos, Flavia Barreto] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil; [Barreto Resck, Maria Eduarda] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil; [Caldas, Gabriela Cardoso] Fiocruz MS, Inst Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, Brazil; [Resck, Alessandro Fioretti] Clin Vet Anim Help, Rio De Janeiro, Brazil; [da Silva, Natalia Valente; Vieira dos Santos, Aline Marcele; Sousa, Thiago das Chagas; Ogrzewalska, Maria Halina; Siqueira, Marilda Mendonca; Pauvolid-Correa, Alex] Fiocruz MS, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil; [Pauvolid-Correa, Alex] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station	dos Santos, FB (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.	flaviab@ioc.fiocruz.br	Ogrzewalska, Maria/AAR-7145-2021; Pauvolid-Corrêa, Alex/D-3643-2017; dos Santos, Flavia Barreto/AAI-8292-2021; Pauvolid-Correa, Alex/AGF-6881-2022; Ogrzewalska, Maria/J-8700-2013	Ogrzewalska, Maria/0000-0002-9207-743X; Pauvolid-Corrêa, Alex/0000-0002-6924-157X; dos Santos, Flavia Barreto/0000-0002-1309-5366; Pauvolid-Correa, Alex/0000-0002-6924-157X; Ogrzewalska, Maria/0000-0002-9207-743X; Vieira dos Santos, Aline Marcele/0000-0002-6873-8357; Dias, Helver/0000-0001-5181-7078	Coordenacao de Aperfeicoamento de Nivel Superior - Brasil (CAPES); Fundacao Oswaldo Cruz (Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302462/2018-0]	Coordenacao de Aperfeicoamento de Nivel Superior - Brasil (CAPES); Fundacao Oswaldo Cruz (Fiocruz); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Coordenacao de Aperfeicoamento de Nivel Superior - Brasil (CAPES), Fundacao Oswaldo Cruz (Fiocruz) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number 302462/2018-0 to FBS and to MAMTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao JS, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.142645; Algaissi A, 2020, METHODS MOL BIOL, V2099, P107, DOI 10.1007/978-1-0716-0211-9_9; [Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; Barrs VR, 2020, EMERG INFECT DIS, V26, P3071, DOI [10.3201/eid2612.202786, 10.3201/eid2612.202786.]; Bonilla-Aldana DK, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100147; Bosco-Lauth AM, 2020, P NATL ACAD SCI USA, V117, P26382, DOI 10.1073/pnas.2013102117; Castro TX, 2015, VET J, V206, P115, DOI 10.1016/j.tvjl.2015.06.014; Castro TX, 2013, CAN VET J, V54, P885; CDC, 2020, PREP VIR TRANSP MED; Farnia P, 2020, BIOMED BIOTECH RES J, V4, P49, DOI 10.4103/bbrj.bbrj_130_20; Gaudreault NN, 2020, EMERG MICROBES INFEC, V9, P2322, DOI 10.1080/22221751.2020.1833687; Halfmann PJ, 2020, NEW ENGL J MED, V383, P592, DOI 10.1056/NEJMc2013400; Hamer Sarah A, 2020, bioRxiv, DOI 10.1101/2020.12.08.416339; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Instituto Pet Brasil, 2019, PAIS TEM 39 MILH AN; Kiyonga AN, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040396; Leroy EM, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100133; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Medardo M., 2020, EVIDENCE EXPOSURE SA; Ministerio da Saude do Brasil, 2020, PAIN CAS DOENC PEL C; Newman A, 2020, MMWR-MORBID MORTAL W, V69, P710, DOI 10.15585/mmwr.mm6923e3; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Oliveira FR., 2015, ACTA VET BRAS, V9, P296; Oreshkova N, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.23.2001005; Prado T, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200196; Ren LL, 2020, CHINESE MED J-PEKING, V133, P1015, DOI 10.1097/CM9.0000000000000722; Ruiz-Arrondo I, 2021, TRANSBOUND EMERG DIS, V68, P973, DOI 10.1111/tbed.13803; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sailleau C, 2020, TRANSBOUND EMERG DIS, V67, P2324, DOI 10.1111/tbed.13659; Secretaria Estadual de Saude do Rio de Janeiro, 2020, PAIN COR COVID 19; Segales J, 2020, P NATL ACAD SCI USA, V117, P24790, DOI 10.1073/pnas.2010817117; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Shuai L., 2021, NATL SCI REV, V8, pNWAA291, DOI [10.1093/nsr/nwaa291, DOI 10.1093/NSR/NWAA291]; Sit THC, 2020, NATURE, V586, P776, DOI 10.1038/s41586-020-2334-5; United States Department of Agriculture, 2020, CONF CAS SARS COV 2; USDA, 2020, USDA STAT CONF COVID; Wong SJ, 2020, J INFECT DIS; World Health Organization, 2020, POPULATION BASED AGE; Zhang Q, 2020, EMERG MICROBES INFEC, V9, P2013, DOI 10.1080/22221751.2020.1817796; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	40	16	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248578	10.1371/journal.pone.0248578	http://dx.doi.org/10.1371/journal.pone.0248578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765012	Green Published, gold			2022-12-26	WOS:000634832800096
J	Morais, C; Rajandram, R; Blakeney, JS; Iyer, A; Suen, JY; Johnson, DW; Gobe, GC; Fairlie, DP; Vesey, DA				Morais, Christudas; Rajandram, Retnagowri; Blakeney, Jade S.; Iyer, Abishek; Suen, Jacky Y.; Johnson, David W.; Gobe, Glenda C.; Fairlie, David P.; Vesey, David A.			Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines	PLOS ONE			English	Article								Expression of the protease sensing receptor, protease activated receptor-2 (PAR2), is elevated in a variety of cancers and has been promoted as a potential therapeutic target. With the development of potent antagonists for this receptor, we hypothesised that they could be used to treat renal cell carcinoma (RCC). The expression of PAR2 was, therefore, examined in human RCC tissues and selected RCC cell lines. Histologically confirmed cases of RCC, together with paired non-involved kidney tissue, were used to produce a tissue microarray (TMA) and to extract total tissue RNA. Immunohistochemistry and qPCR were then used to assess PAR2 expression. In culture, RCC cell lines versus primary human kidney tubular epithelial cells (HTEC) were used to assess PAR2 expression by qPCR, immunocytochemistry and an intracellular calcium mobilization assay. The TMA revealed an 85% decrease in PAR2 expression in tumour tissue compared with normal kidney tissue. Likewise, qPCR showed a striking reduction in PAR2 mRNA in RCC compared with normal kidney. All RCC cell lines showed lower levels of PAR2 expression than HTEC. In conclusion, we found that PAR2 was reduced in RCC compared with normal kidney and is unlikely to be a target of interest in the treatment of this type of cancer.	[Morais, Christudas; Johnson, David W.; Gobe, Glenda C.; Vesey, David A.] Univ Queensland, Translat Res Inst, Ctr Kidney Dis Res, Brisbane, Qld, Australia; [Morais, Christudas] Princess Alexandra Hosp, Dept Urol, Brisbane, Qld, Australia; [Rajandram, Retnagowri] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Blakeney, Jade S.; Iyer, Abishek; Suen, Jacky Y.; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Ctr Inflammat & Dis Res, Brisbane, Qld, Australia; [Johnson, David W.; Vesey, David A.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia	University of Queensland; Universiti Malaya; University of Queensland	Vesey, DA (corresponding author), Univ Queensland, Translat Res Inst, Ctr Kidney Dis Res, Brisbane, Qld, Australia.; Vesey, DA (corresponding author), Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia.	david.vesey@health.qld.gov.au	Rajandram, Retnagowri/E-1245-2012; Rajandram, Retnagowri/O-6135-2019; Suen, Jacky/G-4077-2015; Johnson, David/F-2897-2011; Vesey, David/C-2253-2011	Rajandram, Retnagowri/0000-0001-5247-2817; Rajandram, Retnagowri/0000-0001-5247-2817; Suen, Jacky/0000-0002-0309-2524; Johnson, David/0000-0001-5491-3460; Vesey, David/0000-0002-2856-6650	National Health and Medical Research Council (NHMRC) of Australia [1083131, 1084083, 1143601, 1117017]; Australian Research Council Centre of Excellence in Advanced Molecular Imaging [CE140100011]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Advanced Molecular Imaging(Australian Research Council)	This research was supported by the National Health and Medical Research Council (NHMRC) of Australia grants (1083131 awarded to DAV, GCG, JYS; 1084083, 1143601 to AI & DPF, Senior Principal Research Fellowship 1117017 to DPF) and by infrastructure support through the Australian Research Council Centre of Excellence in Advanced Molecular Imaging (CE140100011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Arakaki AKS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071886; Asaduzzaman M, 2018, ALLERGY, V73, P416, DOI 10.1111/all.13313; Barry GD, 2006, CURR MED CHEM, V13, P243, DOI 10.2174/092986706775476070; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Chang JH, 2010, DIS COLON RECTUM, V53, P1202, DOI 10.1007/DCR.0b013e3181d536f6; Cho E, 2011, HEMATOL ONCOL CLIN N, V25, P651, DOI 10.1016/j.hoc.2011.04.002; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Fujimoto D, 2006, J SURG ONCOL, V93, P139, DOI 10.1002/jso.20420; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Han N, 2011, ONCOL LETT, V2, P599, DOI 10.3892/ol.2011.291; Han YJ, 2019, CLIN EXP PHARMACOL P, V46, P456, DOI 10.1111/1440-1681.13077; Ikeda O, 2003, INT J ONCOL, V22, P295; Jahan I, 2007, ANN ONCOL, V18, P1506, DOI 10.1093/annonc/mdm190; Jiang YH, 2018, J PHARMACOL EXP THER, V364, P246, DOI 10.1124/jpet.117.245027; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Koshkin VS, 2016, EXPERT OPIN PHARMACO, V17, P1225, DOI 10.1080/14656566.2016.1182987; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Lohman RJ, 2012, J PHARMACOL EXP THER, V340, P256, DOI 10.1124/jpet.111.187062; Martin CE, 2019, CANCER METAST REV, V38, P357, DOI 10.1007/s10555-019-09811-7; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mitschke J, 2019, CANCER METAST REV, V38, P431, DOI 10.1007/s10555-019-09808-2; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Ng KL, 2018, PATHOLOGY, V50, P504, DOI 10.1016/j.pathol.2018.01.007; Pulz LH, 2017, VET COMP ONCOL, V15, P669, DOI 10.1111/vco.12223; Sevenich L, 2014, GENE DEV, V28, P2331, DOI 10.1101/gad.250647.114; Shi XL, 2004, MOL CANCER RES, V2, P395; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Suen JY, 2012, BRIT J PHARMACOL, V165, P1413, DOI 10.1111/j.1476-5381.2011.01610.x; Sun ZX, 2015, EXP MOL PATHOL, V98, P382, DOI 10.1016/j.yexmp.2015.03.018; Ungefroren H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112494; Vesey DA, 2005, KIDNEY INT, V67, P1315, DOI 10.1111/j.1523-1755.2005.00209.x; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; Vesey DA, 2007, NEPHROLOGY, V12, P36, DOI 10.1111/j.1440-1797.2006.00746.x; Vesey DA, 2013, AM J PHYSIOL-RENAL, V304, pF737, DOI 10.1152/ajprenal.00540.2012; Wojtukiewicz MZ, 2015, CANCER METAST REV, V34, P775, DOI 10.1007/s10555-015-9599-4; Yau MK, 2016, ACS MED CHEM LETT, V7, P1179, DOI 10.1021/acsmedchemlett.6b00306; Yau MK, 2013, J MED CHEM, V56, P7477, DOI 10.1021/jm400638v; Zhang XT, 2013, EXP MOL PATHOL, V94, P91, DOI 10.1016/j.yexmp.2012.08.005; Zuo K, 2019, CANCER METAST REV, V38, P507, DOI 10.1007/s10555-019-09802-8	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248983	10.1371/journal.pone.0248983	http://dx.doi.org/10.1371/journal.pone.0248983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765016	gold, Green Published			2022-12-26	WOS:000634832800111
J	Luo, K; Jiao, YY				Luo, Ke; Jiao, Yingying			Automatic fault detection of sensors in leather cutting control system under GWO-SVM algorithm	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; DIAGNOSIS; MODEL; DECOMPOSITION; RESONANCE; FAILURE; ENTROPY; ENERGY; TOOLS; LASER	The purposes are to meet the individual needs of leather production, improve the efficiency of leather cutting, and increase the product's competitiveness. According to the existing problems in current leather cutting systems, a Fault Diagnosis (FD) method combining Convolutional Neural Network (CNN) and the Support Vector Machine (SVM) of Gray Wolf Optimizer (GWO) is proposed. This method first converts the original signal into a scale spectrogram and then selects the pre-trained CNN model, AlexNet, to extract the signal scale spectrogram's features. Next, the Principal Component Analysis (PCA) reduces the obtained feature's dimensionality. Finally, the normalized data are input into GWO's SVM classifier to diagnose the bearing's faults. Results demonstrate that the proposed model has higher cutting accuracy than the latest fault detection models. After model optimization, when c is 25 and g is 0.2, the model accuracy can reach 99.24%, an increase of 66.96% compared with traditional fault detection models. The research results can provide ideas and practical references for improving leather cutting enterprises' process flow.	[Luo, Ke; Jiao, Yingying] Shandong Jianzhu Univ, Sch Informat & Elect Engn, Jinan, Shandong, Peoples R China	Shandong Jianzhu University	Luo, K (corresponding author), Shandong Jianzhu Univ, Sch Informat & Elect Engn, Jinan, Shandong, Peoples R China.	11279@sdjzu.edu.cn						Almomani O, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12061046; Brigham K, 2020, WIND ENERGY, V23, P1135, DOI 10.1002/we.2478; Cho S, 2018, RENEW ENERG, V120, P306, DOI 10.1016/j.renene.2017.12.102; De Martini D, 2020, IEEE-ASME T MECH, V25, P2197, DOI 10.1109/TMECH.2020.3011005; Deng W, 2018, IEEE ACCESS, V6, P35042, DOI 10.1109/ACCESS.2018.2834540; Diallo D., 2020, ELECT SYSTEMS 1 DIAG, P121; Dong ZL, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21060621; Ellefsen AL, 2019, IEEE ACCESS, V7, P16101, DOI 10.1109/ACCESS.2019.2895394; Fu W., 2019, COMPLEXITY, V2019, P2023; Fu WL, 2019, COMPLEXITY, DOI 10.1155/2019/3264969; Gupta S, 2019, SWARM EVOL COMPUT, V44, P101, DOI 10.1016/j.swevo.2018.01.001; Hsu CY, 2021, J INTELL MANUF, V32, P823, DOI 10.1007/s10845-020-01591-0; Huang HS, 2019, SYST SCI CONTROL ENG, V7, P289, DOI 10.1080/21642583.2019.1650673; Huang HK, 2020, IEEE COMMUN MAG, V58, P40, DOI 10.1109/MCOM.001.1900283; Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063; Jang DW, 2018, INT J FATIGUE, V114, P57, DOI 10.1016/j.ijfatigue.2018.05.004; Lang L., 2017, ELECT POWER AUTOMATI, P5; Lee S, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010048; Li B, 2020, IEEE ACCESS, V8, P173865, DOI 10.1109/ACCESS.2020.3025714; LI Q., 2017, J QINGDAO U ENG TECH, P20; Li Y, 2016, INT J ADV MANUF TECH, V82, P2157, DOI 10.1007/s00170-015-7544-x; Ellefsen AL, 2020, IEEE T INSTRUM MEAS, V69, P8216, DOI 10.1109/TIM.2020.2994012; Lu SL, 2019, MECH SYST SIGNAL PR, V116, P230, DOI 10.1016/j.ymssp.2018.06.032; Lu ZY, 2019, INT J ADV MANUF TECH, V104, P1953, DOI 10.1007/s00170-019-03919-4; Ma J, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814017751446; Mehra Bhanu, 2016, J Lab Physicians, V8, P36, DOI 10.4103/0974-2727.176239; Metawa N, 2017, EXPERT SYST APPL, V80, P75, DOI 10.1016/j.eswa.2017.03.021; Mitra B, 2018, IET RENEW POWER GEN, V12, P1563, DOI 10.1049/iet-rpg.2018.5274; Moktadir MA, 2020, J CLEAN PROD, V251, DOI 10.1016/j.jclepro.2019.119737; Nasiri S, 2017, ENG FAIL ANAL, V81, P270, DOI 10.1016/j.engfailanal.2017.07.011; Nayak R, 2016, FASH TEXT, V3, DOI 10.1186/s40691-016-0057-x; Okaro IA, 2019, ADDIT MANUF, V27, P42, DOI 10.1016/j.addma.2019.01.006; Qu YZ, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7050515; Shah SJ, 2020, CIRCULATION, V141, P1001, DOI 10.1161/CIRCULATIONAHA.119.041886; slusarczyk B., 2019, ENG MANAGEMENT PRODU, V11, P52, DOI [10.2478/emj-2019-0011, DOI 10.2478/EMJ-2019-0011]; Srikanth K, 2018, COMPUT ELECTR ENG, V70, P243, DOI 10.1016/j.compeleceng.2017.07.023; Tun H.M., 2017, BAHRIA U J INFORM CO, V10, P1; Wang DS, 2018, SOFT COMPUT, V22, P387, DOI 10.1007/s00500-016-2474-6; Wang JJ, 2019, INT J PROD RES, V57, P3920, DOI 10.1080/00207543.2018.1552032; Wang YX, 2018, COMPUT ELECTRON AGR, V151, P249, DOI 10.1016/j.compag.2018.06.027; Xu GN, 2018, TECHNOL FORECAST SOC, V136, P208, DOI 10.1016/j.techfore.2017.06.030; Xu TL, 2017, J INTELL FUZZY SYST, V32, P2061, DOI 10.3233/JIFS-161676; YAN B.-k., 2016, INSTRUMENT TECHNIQUE, P22; Yan XA, 2018, NEUROCOMPUTING, V313, P47, DOI 10.1016/j.neucom.2018.05.002; Yilmaz A, 2019, ELECTR POW SYST RES, V177, DOI 10.1016/j.epsr.2019.105984; Yuan Y, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081949; Zhang CG, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22070739; Zhou LR, 2016, J CLEAN PROD, V112, P3721, DOI 10.1016/j.jclepro.2015.05.093; Zhu KH, 2019, T I MEAS CONTROL, V41, P4013, DOI 10.1177/0142331219844555	49	1	1	9	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248515	10.1371/journal.pone.0248515	http://dx.doi.org/10.1371/journal.pone.0248515			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760850	gold, Green Published			2022-12-26	WOS:000633030400003
J	Markert, L; Holdmann, J; Klinger, C; Kaufmann, M; Schork, K; Turewicz, M; Eisenacher, M; Savelsbergh, A				Markert, Lukas; Holdmann, Jonas; Klinger, Claudia; Kaufmann, Michael; Schork, Karin; Turewicz, Michael; Eisenacher, Martin; Savelsbergh, Andreas			Small RNAs as biomarkers to differentiate benign and malign prostate diseases: An alternative for transrectal punch biopsy of the prostate?	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CANCER; MICRORNAS; BIOGENESIS; EXPRESSION; MECHANISM; CLUSTER; MYC	Prostate cancer (PCa) is the most common cancer and the third most frequent cause of male cancer death in Germany. MicroRNAs (miRNA) appear to be involved in the development and progression of PCa. A diagnostic differentiation from benign prostate hyperplasia (BPH) is often only possible through transrectal punch biopsy. This procedure is described as painful and carries risks. It was investigated whether urinary miRNAs can be used as biomarkers to differentiate the prostate diseases above. Therefore urine samples from urological patients with BPH (25) or PCa (28) were analysed using Next-Generation Sequencing to detect the expression profile of total and exosomal miRNA/piRNA. 79 miRNAs and 5 piwi-interacting RNAs (piRNAs) were significantly differentially expressed (adjusted p-value < 0.05 and log2-Fc > 1 or < -1). Of these, 6 miRNAs and 2 piRNAs could be statistically validated (AUC on test cohort > = 0.7). In addition, machine-learning algorithms were used to identify a panel of 22 additional miRNAs, whose interaction makes it possible to differentiate the groups as well. There are promising individual candidates for potential use as biomarkers in prostate cancer. The innovative approach of applying machine learning methods to this kind of data could lead to further small RNAs coming into scientific focus, which have so far been neglected.	[Markert, Lukas; Holdmann, Jonas; Klinger, Claudia; Kaufmann, Michael; Savelsbergh, Andreas] Witten Herdecke Univ, Div Funct Genom, Chair Biochem & Mol Med, Witten, Germany; [Klinger, Claudia; Kaufmann, Michael; Savelsbergh, Andreas] Witten Herdecke Univ, Ctr Biomed Educ & Res ZBAF, Witten, Germany; [Schork, Karin; Turewicz, Michael; Eisenacher, Martin] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Schork, Karin; Turewicz, Michael; Eisenacher, Martin] Ruhr Univ, Ctr Prot Diagnost ProDi, Med Proteome Anal, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Markert, L (corresponding author), Witten Herdecke Univ, Div Funct Genom, Chair Biochem & Mol Med, Witten, Germany.	lukas.markert@uni-wh.de	Markert, Lukas/GLT-2562-2022; Schork, Karin/AAU-9708-2021	Markert, Lukas/0000-0002-1739-3619; Schork, Karin/0000-0003-3756-4347; Turewicz, Michael/0000-0003-0737-1114	Paul-Kuth-Foundation, Wuppertal, Germany [AZ310]; German Federal Ministry of Education and Research [FKZ 031 A 534A]; PURE project of Northrhine-Westphalia; VALIBIO project of Northrhine-Westphalia	Paul-Kuth-Foundation, Wuppertal, Germany; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); PURE project of Northrhine-Westphalia; VALIBIO project of Northrhine-Westphalia	LM, JH, AS, CK, MK and AS were funded by the Paul-Kuth-Foundation, Wuppertal, Germany, for this study with 43.175(sic). (AZ310, https://www.im.nrw/paul-kuth-stiftung) The funding institution did not have any influence on the setting, implementation, analysis, evaluation and publication of the study. The work of KS, MT and ME was supported by de.NBI (FKZ 031 A 534A), a project of the German Federal Ministry of Education and Research. The funding of ME relates to PURE and VALIBIO, projects of Northrhine-Westphalia. (https://www.denbi.de).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell KJL, 2015, INT J CANCER, V137, P1749, DOI 10.1002/ijc.29538; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Braunhut Beth L, 2018, Surg Pathol Clin, V11, P759, DOI 10.1016/j.path.2018.07.003; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Coordes A, 2014, LARYNGO RHINO OTOL, V93, P201, DOI 10.1055/s-0033-1363960; Feng JL, 2014, J CELL MOL MED, V18, P2125, DOI 10.1111/jcmm.12398; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Ganten D., 2013, MOLEKULARMEDIZINISCH; Gat Y, 2008, ANDROLOGIA, V40, P273, DOI 10.1111/j.1439-0272.2008.00883.x; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hu JS, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0183-8; Huang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080707; Jahn JL, 2015, INT J CANCER, V137, P2795, DOI 10.1002/ijc.29408; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar B, 2016, ASIAN J ANDROL, V18, P559, DOI 10.4103/1008-682X.177839; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Leitlinienprogramm_Onkologie (Deutsche Krebsgesellschaft D.K. AWMF), 2019, INT LEITL QUAL S3 FR, P52; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39001; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Maugeri-Sacca M, 2012, CANCER J, V18, P253, DOI 10.1097/PPO.0b013e318258b5b6; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Panigrahi Gati K, 2018, Oncotarget, V9, P13894, DOI 10.18632/oncotarget.24532; Peng WZ, 2014, INT J MOL SCI, V15, P4031, DOI 10.3390/ijms15034031; RCore Team, 2020, R LANG ENV STAT COMP; Robert-Koch-Institut, 2016, BERICHT ZUM KREBSGES, P40; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; Turewicz M, 2017, J BIOTECHNOL, V261, P116, DOI 10.1016/j.jbiotec.2017.06.005; Utaijaratrasmi P, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0760-x; Verdoodt B, 2013, INT J ONCOL, V43, P307, DOI 10.3892/ijo.2013.1915; Wang JJ, 2019, NUCLEIC ACIDS RES, V47, pD175, DOI 10.1093/nar/gky1043; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Wu W, 2017, MICRORNA CANC METHOD, P222; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Zhang XJ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-46; Zhi TL, 2017, ONCOTARGET, V8, P96239, DOI 10.18632/oncotarget.21996	48	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247930	10.1371/journal.pone.0247930	http://dx.doi.org/10.1371/journal.pone.0247930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760831	gold, Green Published			2022-12-26	WOS:000633030400070
J	Zhang, J; Zhang, SQ; Shi, Q; Allen, TD; You, FM; Yang, D				Zhang, Jing; Zhang, Shenqiu; Shi, Qiong; Allen, Thaddeus D.; You, Fengming; Yang, Dun			A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil	PLOS ONE			English	Article							INHIBITION; CANCER; APOPTOSIS; PROMOTES; TUMORS; H1152; TRANSFORMATION; TUMORIGENESIS; INACTIVATION; PHENOTYPE	A synthetic lethal effect arises when a cancer-associated change introduces a unique vulnerability to cancer cells that makes them unusually susceptible to a drug's inhibitory activity. The synthetic lethal approach is attractive because it enables targeting of cancers harboring specific genomic or epigenomic alterations, the products of which may have proven refractory to direct targeting. An example is cancer driven by overexpression of MYC. Here, we conducted a high-content screen for compounds that are synthetic lethal to elevated MYC using a small-molecule library to identify compounds that are closely related to, or are themselves, regulatory-approved drugs. The screen identified dimethylfasudil, a potent and reversible inhibitor of Rho-associated kinases, ROCK1 and ROCK2. Close analogs of dimethylfasudil are used clinically to treat neurologic and cardiovascular disorders. The synthetic lethal interaction was conserved in rodent and human cell lines and could be observed with activation of either MYC or its paralog MYCN. The synthetic lethality seems specific to MYC overexpressing cells as it could not be substituted by a variety of oncogenic manipulations and synthetic lethality was diminished by RNAi-mediated depletion of MYC in human cancer cell lines. Collectively, these data support investigation of the use of dimethylfasudil as a drug that is synthetic lethal for malignancies that specifically overexpress MYC.	[Zhang, Jing; Zhang, Shenqiu; Shi, Qiong; Allen, Thaddeus D.; Yang, Dun] Anticanc Biosci, Chengdu, Peoples R China; [Zhang, Jing; Zhang, Shenqiu; Shi, Qiong; Allen, Thaddeus D.; Yang, Dun] J Michael Bishop Inst Canc Res, Chengdu, Peoples R China; [You, Fengming; Yang, Dun] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine	Allen, TD; Yang, D (corresponding author), Anticanc Biosci, Chengdu, Peoples R China.; Allen, TD; Yang, D (corresponding author), J Michael Bishop Inst Canc Res, Chengdu, Peoples R China.; Yang, D (corresponding author), Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China.	thaddeus.allen@mbicr.org; dun.yang@mbicr.org		Zhang, Shenqiu/0000-0003-2105-2435; Zhang, Jing/0000-0001-6708-4630; Allen, Thaddeus/0000-0002-4268-3394	Anticancer Bioscience, Ltd. (ACB); ACB	Anticancer Bioscience, Ltd. (ACB); ACB	This work was carried out at the private research institute, MBICR (http://www.mbicr.org/), with funding through the commercial company, Anticancer Bioscience, Ltd. (ACB) (https://www.anticancerbio.com/).J.Z., S.Z., Q.S., T.D.A. and D. Y. are jointly employed by the MBICR and ACB and are paid salary derived from ACB funding. Along with F.Y., individuals mentioned above collectively contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript. T.D.A. is also affiliated with Tradewind BioScience (TWB). TWB did not contribute funding to this research and holds not commercial interest.	Breitenlechner C, 2003, STRUCTURE, V11, P1595, DOI 10.1016/j.str.2003.11.002; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eunju O, 2012, BIOSCI BIOTECH BIOCH, V76, P172, DOI 10.1271/bbb.110468; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Ghazizadeh Z, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00129-y; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Hann SR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014399; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Kumper S, 2016, ELIFE, V5, DOI 10.7554/eLife.12203; Liao WR, 2007, CARCINOGENESIS, V28, P1867, DOI 10.1093/carcin/bgm092; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Loirand G, 2015, PHARMACOL REV, V67, P1074, DOI 10.1124/pr.115.010595; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Wang HL, 2013, NEUROPHARMACOLOGY, V70, P1, DOI 10.1016/j.neuropharm.2013.01.006; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhang J, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112112	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248355	10.1371/journal.pone.0248355	http://dx.doi.org/10.1371/journal.pone.0248355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760847	gold, Green Published, Green Submitted			2022-12-26	WOS:000633030400007
J	Nyandiko, WM; Kiptoon, P; Lubuya, FA				Nyandiko, Winstone Mokaya; Kiptoon, Paul; Lubuya, Florence Ajaya			Neonatal hypothermia and adherence to World Health Organisation thermal care guidelines among newborns at Moi Teaching and Referral Hospital, Kenya	PLOS ONE			English	Article							ADMISSION HYPOTHERMIA; PRETERM INFANTS; RISK-FACTORS; PREVALENCE; MORTALITY	Neonatal hypothermia is a great concern with near epidemic levels globally. In Kenya, its prevalence is as high as 87% with limited local data on the associated factors such as adherence to warm chain guidelines as recommended by the World Health Organisation (WHO) is limited. This study aimed to determine the prevalence of hypothermia and level of adherence to the WHO thermal care guidelines among newborns admitted at Moi Teaching and Referral Hospital (MTRH). It adopted a prospective study design of following up neonates for the first 24 hours of admission to the MTRH newborn unit. Thermometry, interview of mothers and observation of thermal care practices was done. Descriptive and inferential statistical techniques were adopted. Specifically, Pearson's chi-square test of associations between predictors of neonatal hypothermia and management outcomes was conducted with their corresponding risk estimates at 95% confidence interval. Among the 372 participants, 64.5% (n = 240) were born at MTRH, 47.6% (177) were preterm and 53.2% (198) had birth weights below 2500 grams. Admission hypothermia was noted among 73.7% (274) and 13% (49) died on the first day of admission. Only 7.8% (29) newborns accessed optimal thermal care. Prematurity, day one mortality and adherence to the warm chain were significantly (p<0.001) associated with admission hypothermia. Inappropriate thermal appliance, inadequate clothing and late breastfeeding significantly increased the risk of neonatal hypothermia. Absence of admission hypothermia increased the likelihood of neonatal survival more than twenty-fold (AOR = 20.91, 95% CI: 2.15-153.62). Three out four neonates enrolled had admission hypothermia which was significantly associated with prematurity, lack of adherence to warm chain and increased risk of neonatal mortality on the first day of life. There was low adherence to the WHO thermal care guidelines. This should be optimized among preterm neonates to improve likelihood of survival.	[Nyandiko, Winstone Mokaya; Kiptoon, Paul; Lubuya, Florence Ajaya] Moi Univ, Coll Hlth Sci, Dept Child Hlth & Paediat, Eldoret, Kenya; [Nyandiko, Winstone Mokaya] Acad Model Providing Access Healthcare, Eldoret, Kenya	Moi University	Lubuya, FA (corresponding author), Moi Univ, Coll Hlth Sci, Dept Child Hlth & Paediat, Eldoret, Kenya.	flubuya@gmail.com		Lubuya, Florence/0000-0001-6341-7100	Moi Teaching and Referral Hospital's administration and pediatrics department	Moi Teaching and Referral Hospital's administration and pediatrics department	The authors would like to thank the mothers and the neonates who participated in this study. Secondly, this study could not have happened without the approval and support of Moi Teaching and Referral Hospital's administration and pediatrics department.	Asekun-Olarinmoye EO., 2010, W AFR J MED, V29, P19, DOI [10.4314/wajm.v29i1.56183, DOI 10.4314/WAJM.V29I1.56183]; Babaei G., 2007, INCIDENCE RISK FACTO; BATTISTI O, 1981, ARCH DIS CHILD, V56, P775, DOI 10.1136/adc.56.10.775; Bayih WA, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1632-2; Boo NY, 2013, J TROP PEDIATRICS, V59, P447, DOI 10.1093/tropej/fmt051; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Byaruhanga R, 2005, J TROP PEDIATRICS, V51, P212, DOI 10.1093/tropej/fmh098; Demissie BW, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1238-0; Ebrahim E., 2015, GEN MED OPEN ACCESS, P2015; GARCIAMUNOZ F, 2014, AN PEDIATR, P144; Hatada K, 2002, PURE APPL CHEM, V74, P915, DOI 10.1351/pac200274060915; Kambarami RA, 2003, ANN TROP PAEDIATR, V23, P55, DOI 10.1179/000349803125002931; Khanal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089950; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lunze K, 2012, J PERINATOL, V32, P317, DOI 10.1038/jp.2012.11; Lunze K., 2014, PREVENTION MANAGEMEN, DOI [10.1371/journal.pone.0092006, DOI 10.1371/JOURNAL.PONE.0092006]; Lunze K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-24; Mank A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164817; Marete I K, 2011, East Afr Med J, V88, P18; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Mullany LC, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-43; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P71, DOI 10.1001/archpediatrics.2009.239; O'Brien EA, 2019, J MATERN-FETAL NEO M, V32, P2763, DOI 10.1080/14767058.2018.1446076; Ogunlesi TA, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-40; Ogunlesi TA, 2009, J PERINAT MED, V37, P180, DOI 10.1515/JPM.2009.014; Onalo R, 2013, NIGER J CLIN PRACT, V16, P129, DOI 10.4103/1119-3077.110120; Reta MA., 2019, NEONATAL HYPOTHERMIA; Silveira SMD, 2003, J TROP PEDIATRICS, V49, P115, DOI 10.1093/tropej/49.2.115; Vilinsky Sheridan A., 2014, BR J MIDWIFERY, V22, P557, DOI [10.12968/bjom.2014.22.8.557, DOI 10.12968/BJOM.2014.22.8.557]; WHO, WHORHTMSM972 THERM P; Wilson E, 2016, J PEDIATR-US, V175, P61, DOI 10.1016/j.jpeds.2016.04.016	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248838	10.1371/journal.pone.0248838	http://dx.doi.org/10.1371/journal.pone.0248838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755686	Green Submitted, Green Published, gold			2022-12-26	WOS:000632916600004
J	Oktaria, V; Danchin, M; Triasih, R; Soenarto, Y; Bines, JE; Ponsonby, AL; Clarke, MW; Graham, SM				Oktaria, Vicka; Danchin, Margaret; Triasih, Rina; Soenarto, Yati; Bines, Julie E.; Ponsonby, Anne-Louise; Clarke, Michael W.; Graham, Stephen M.			The incidence of acute respiratory infection in Indonesian infants and association with vitamin D deficiency	PLOS ONE			English	Article							25-HYDROXYVITAMIN D LEVELS; D SUPPLEMENTATION; TRACT INFECTIONS; LOMBOK ISLAND; RISK-FACTORS; CHILDREN; PNEUMONIA; CHILDHOOD; EPIDEMIOLOGY; ETIOLOGY	Background Vitamin D deficiency has been associated with acute respiratory infection (ARI) in early life, but this has not been evaluated in Indonesia. We aimed to determine the incidence of ARI in Indonesian infants, and to evaluate the association with vitamin D deficiency. Methods From 23 December 2015 to 31 December 2017, we conducted a community-based prospective cohort study in Yogyakarta province. We enrolled 422 pregnant women and followed their infants from birth until 12 months of age for ARI episodes. Vitamin D status was measured at birth and at age six months. We performed Cox proportional hazard regression analysis to evaluate the association between vitamin D deficiency and pneumonia incidence. Results At study completion, 95% (400/422) of infants retained with a total of 412 child years of observation (CYO). The incidence of all ARI and of WHO-defined pneumonia was 3.89 (95% CI 3.70-4.08) and 0.25 (95% CI 0.21-0.30) episodes per CYO respectively. Vitamin D deficiency at birth was common (90%, 308/344) and associated with more frequent episodes of ARI non-pneumonia (adjusted odds ratio 4.48, 95% CI:1.04-19.34). Vitamin D status at birth or six months was not associated with subsequent pneumonia incidence, but greater maternal sun exposure during pregnancy was associated with a trend to less frequent ARI and pneumonia in infants. Conclusion ARI, pneumonia, and vitamin D deficiency at birth were common in Indonesian infants. Minimising vitamin D deficiency at birth such as by supplementation of mothers or safe sun exposure during pregnancy has the potential to reduce ARI incidence in infants in this setting.	[Oktaria, Vicka; Danchin, Margaret; Bines, Julie E.; Ponsonby, Anne-Louise; Graham, Stephen M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia; [Oktaria, Vicka; Triasih, Rina; Soenarto, Yati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Child Hlth Dept, Yogyakarta, Indonesia; [Clarke, Michael W.] Univ Western Australia, Metabol Australia, Ctr Microscopy Characterisat & Anal, Perth, WA, Australia; [Clarke, Michael W.] Univ Western Australia, Fac Hlth & Med Sci, Sch Biomed Sci, Perth, WA, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Gadjah Mada University; University of Western Australia; University of Western Australia	Oktaria, V (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia.; Oktaria, V (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Child Hlth Dept, Yogyakarta, Indonesia.	vicka.oktaria@ugm.ac.id	Oktaria, Vicka/GLV-5552-2022	Oktaria, Vicka/0000-0002-3556-3028; Clarke, Michael/0000-0002-9639-5670; Triasih, Rina/0000-0002-6907-3422; Bines, Julie/0000-0002-5452-6601	Murdoch Children's Research Institute; Schlumberger foundation faculty; Indonesia Endowment Fund for Education (LPDP) Ministry of Finance [20130822080370]; David Bickart Clinician Research Fellowship from the University of Melbourne; Australia-Indonesia Centre (AIC) [01HSP1MELDancUGM003]; Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy	Murdoch Children's Research Institute; Schlumberger foundation faculty(Schlumberger); Indonesia Endowment Fund for Education (LPDP) Ministry of Finance(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); David Bickart Clinician Research Fellowship from the University of Melbourne; Australia-Indonesia Centre (AIC); Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	This study was supported by Murdoch Children's Research Institute in the form of funding awarded to SMG, Schlumberger foundation faculty for the future in the form of funding awarded to VO, Indonesia Endowment Fund for Education (LPDP) Ministry of Finance in the form of a grant awarded to VO (20130822080370), the David Bickart Clinician Research Fellowship from the University of Melbourne awarded to MD, Australia-Indonesia Centre (AIC) in the form of a grant awarded to MD and YS (01HSP1MELDancUGM003), and infrastructure funding from the Western Australian State Government, in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy awarded to MWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AMS, 2016, EPIDEMIOL INFECT, V144, P3494, DOI 10.1017/S0950268816001771; Anders KL, 2015, PEDIATR INFECT DIS J, V34, P361, DOI 10.1097/INF.0000000000000643; ANONYMOUS, 2018, LANCET GLOB HEALTH, V6, pE1253, DOI DOI 10.1016/S2214-109X(18)30495-9; Ariyawatkul K, 2018, EUR J PEDIATR, V177, P1541, DOI 10.1007/s00431-018-3210-2; Bhutta ZA, 2017, J PEDIATR-US, V186, P210; Bolland MJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j456; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Clarke MW, 2013, METABOLOMICS, V9, P1031, DOI 10.1007/s11306-013-0518-9; Das RR, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011597.pub2; Dunne E.M., 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0195098; Felton SJ, 2016, BRIT J DERMATOL, V175, P1320, DOI 10.1111/bjd.14863; Gessner BD, 1998, PEDIATR INFECT DIS J, V17, pS179, DOI 10.1097/00006454-199809001-00018; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Goodman D, 2019, LANCET RESP MED, V7, P1068, DOI 10.1016/S2213-2600(19)30249-8; Gupta P, 2016, INDIAN PEDIATR, V53, P967, DOI 10.1007/s13312-016-0970-5; Haider N, 2010, J PAK MED ASSOC, V60, P729; Haugen J, 2017, PEDIATR RES, V82, P986, DOI 10.1038/pr.2017.71; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Kimball S, 2011, J CLIN ENDOCR METAB, V96, P2826, DOI 10.1210/jc.2011-0325; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Lind T, 2003, AM J CLIN NUTR, V77, P883, DOI 10.1093/ajcn/77.4.883; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Luczynska A, 2014, EUR J EPIDEMIOL, V29, P585, DOI 10.1007/s10654-014-9918-z; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; Mogire RM, 2020, LANCET GLOB HEALTH, V8, pE134, DOI 10.1016/S2214-109X(19)30457-7; Mohamed WAW, 2013, J TROP PEDIATRICS, V59, P29, DOI 10.1093/tropej/fms042; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Oktaria V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239603; Poh BK, 2016, ASIA PAC J CLIN NUTR, V25, P538, DOI 10.6133/apjcn.092015.02; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2013, J GLOB HEALTH, V3, DOI [10.7189/jogh.03.010101, 10.7189/jogh.03.010401]; Sandjaja S, 2013, BRIT J NUTR, V110, pS11, DOI 10.1017/S0007114513002109; Saraf R, 2016, MATERN CHILD NUTR, V12, P647, DOI 10.1111/mcn.12210; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Shibata T, 2014, INT J ENV RES PUB HE, V11, P12190, DOI 10.3390/ijerph111212190; Simoes EAF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P483; Sudfeld CR, 2017, J PEDIATR GASTR NUTR, V65, P467, DOI 10.1097/MPG.0000000000001658; Sutanto A, 2002, AM J TROP MED HYG, V66, P175, DOI 10.4269/ajtmh.2002.66.175; Telcian AG, 2017, ANTIVIR RES, V137, P93, DOI 10.1016/j.antiviral.2016.11.004; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization, VIT D SUPPL RESP INF; Yakoob MY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008824.pub2; Zisi D, 2019, HORM-INT J ENDOCRINO, V18, P353, DOI 10.1007/s42000-019-00155-z	50	12	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248722	10.1371/journal.pone.0248722	http://dx.doi.org/10.1371/journal.pone.0248722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755666	Green Published, gold			2022-12-26	WOS:000632916600022
J	Walton, DM; Elliott, JM; Lee, J; Fakhereddin, M; Seo, W				Walton, David M.; Elliott, James M.; Lee, Joshua; Fakhereddin, Mohamad; Seo, Wonjin			Identification of clinically-useful cut scores of the Traumatic Injuries Distress Scale (TIDS) for predicting rate of recovery following musculoskeletal trauma	PLOS ONE			English	Article								Objective The Traumatic Injuries Distress Scale (TIDS) is a 12-item self-report tool intended for prognostic risk phenotyping in people with acute musculoskeletal (MSK) trauma. The initial validation study showed good associations with outcomes 12 weeks later in a cohort of 72 acutely injured patients from one region in Canada. This study aims to provide further clinical utility through identification of meaningful cut scores in a larger, mixed geography sample, and expands the prediction window from 12 to 52 weeks. Methods Data were drawn from databanks in London, Canada and Chicago, United States. Participants were recruited within 3 weeks of non-catastrophic MSK trauma and followed for 12 months. Using outcomes trajectories, the TIDS underwent linear regression-based analysis to predict 52-week outcomes, and area under the receiver operating characteristic curves to identify discriminative accuracy and meaningful cut scores. Results N = 224 participants with acute trauma were followed and both %Interference and Pain Severity were captured at intake and 3 follow-ups to establish curvilinear recovery trajectories. The TIDS explained significant variance in both the interference and severity outcomes after controlling for sex, region of injury, and baseline scores. ROC analysis revealed significant discriminative accuracy for predicting both the trajectories and the distal outcomes over 52 weeks. The TIDS was more accurate for identifying the low-risk than high-risk patients. Conclusion The TIDS is a useful tool for 'ruling out' high risk of poor outcome in a mixed sample of participants from two different countries. Impact statement The TIDS will be a useful tool for clinicians to predict the rate of recovery by displaying meaningful cut-scores for their patients after an acute musculoskeletal injury. This could lead to reduced burden of care for low risk patients and more informed treatment options for higher risk patients.	[Walton, David M.; Lee, Joshua; Fakhereddin, Mohamad; Seo, Wonjin] Western Univ, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada; [Elliott, James M.] Univ Sydney, Northern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Elliott, James M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia	Western University (University of Western Ontario); University of Sydney; University of Sydney	Fakhereddin, M (corresponding author), Western Univ, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada.	mfakere@uwo.ca		Elliott, James/0000-0002-8890-6012	Canadian Pain Society; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research Strategy for Patient Oriented Research (SPOR) program; National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research	Canadian Pain Society; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research Strategy for Patient Oriented Research (SPOR) program(Canadian Institutes of Health Research (CIHR)); National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	DMW is supported by the Canadian Pain Society, the Ontario Ministry of Research and Innovation, and the Canadian Institutes of Health Research Strategy for Patient Oriented Research (SPOR) program. JME is supported by National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton DE, 2001, ARTHRIT RHEUM-ARTHR, V45, P270, DOI 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.0.CO;2-T; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS87, DOI 10.1016/j.jmpt.2008.11.013; Chen Y, 2018, PAIN, V159, P252, DOI 10.1097/j.pain.0000000000001097; Cote P, 2011, SPINE, V36, pS275, DOI 10.1097/BRS.0b013e3182388d32; Downie AS, 2016, PAIN, V157, P225, DOI 10.1097/j.pain.0000000000000351; Evans R, 2014, EUR SPINE J, V23, P888, DOI 10.1007/s00586-013-3149-y; George SZ, 2018, J ORTHOP SPORT PHYS, V48, P460, DOI 10.2519/jospt.2018.7811; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hill JC, 2010, EUR J PAIN, V14, P83, DOI 10.1016/j.ejpain.2009.01.003; Kelly J, 2017, MUSCULOSKEL SCI PRAC, V27, P155, DOI 10.1016/j.math.2016.10.066; Krebs EE, 2010, MED CARE, V48, P1007, DOI 10.1097/MLR.0b013e3181eaf835; Lee JY, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03621-7; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lentz TA, 2016, J ORTHOP SPORT PHYS, V46, P327, DOI 10.2519/jospt.2016.6487; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Panken G, 2016, SCAND J WORK ENV HEA, V42, P520, DOI 10.5271/sjweh.3584; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Sarrami P, 2017, J ORTHOP TRAUMATOL, V18, P9, DOI 10.1007/s10195-016-0431-x; Scott IC, 2020, SEMIN ARTHRITIS RHEU, V50, P813, DOI 10.1016/j.semarthrit.2020.06.022; Setchell J, 2018, PHYSIOTHER CAN, V70, P301, DOI 10.3138/ptc.70.4.gee; Sterling M, 2019, BRIT J SPORT MED, V53, P1240, DOI 10.1136/bjsports-2018-100139; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Van Son MAC, 2017, QUAL LIFE RES, V26, P3251, DOI 10.1007/s11136-017-1670-x; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Walton DM, 2016, J ORTHOP SPORT PHYS, V46, P920, DOI 10.2519/jospt.2016.6594; Walton David M, 2013, Open Orthop J, V7, P420, DOI 10.2174/1874325001307010420; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248745	10.1371/journal.pone.0248745	http://dx.doi.org/10.1371/journal.pone.0248745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755664	Green Published, gold			2022-12-26	WOS:000632916600041
J	Wang, IJ; Bae, BK; Cho, YM; Cho, SJ; Yeom, SR; Lee, SB; Chun, M; Kim, H; Kim, HH; Lee, SM; Huh, U; Moon, SY				Wang, Il-Jae; Bae, Byung-Kwan; Cho, Young Mo; Cho, Suck Ju; Yeom, Seok-Ran; Lee, Sang-Bong; Chun, Mose; Kim, Hyerim; Kim, Hyung-Hoi; Lee, Sun Min; Huh, Up; Moon, Soo Young			Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients	PLOS ONE			English	Article								Background The effect of alcohol on the outcome and fibrinolysis phenotype in trauma patients remains unclear. Hence, we performed this study to determine whether alcohol is a risk factor for mortality and fibrinolysis shutdown in trauma patients. Materials and methods A total of 686 patients who presented to our trauma center and underwent rotational thromboelastometry were included in the study. The primary outcome was in-hospital mortality. Logistic regression analysis was performed to determine whether alcohol was an independent risk factor for in-hospital mortality and fibrinolysis shutdown. Results The rate of in-hospital mortality was 13.8% and blood alcohol was detected in 27.7% of the patients among our study population. The patients in the alcohol-positive group had higher mortality rate, higher clotting time, and lower maximum lysis, more fibrinolysis shutdown, and hyperfibrinolysis than those in the alcohol-negative group. In logistic regression analysis, blood alcohol was independently associated with in-hospital mortality (odds ratio [OR] 2.578; 95% confidence interval [CI], 1.550-4.288) and fibrinolysis shutdown (OR 1.883 [95% CI, 1.286-2.758]). Within the fibrinolysis shutdown group, blood alcohol was an independent predictor of mortality (OR 2.168 [95% CI, 1.030-4.562]). Conclusions Alcohol is an independent risk factor for mortality and fibrinolysis shutdown in trauma patients. Further, alcohol is an independent risk factor for mortality among patients who experienced fibrinolysis shutdown.	[Wang, Il-Jae; Bae, Byung-Kwan; Cho, Young Mo; Cho, Suck Ju; Yeom, Seok-Ran] Pusan Natl Univ Hosp, Dept Emergency Med, Busan, South Korea; [Wang, Il-Jae; Kim, Hyerim; Kim, Hyung-Hoi; Moon, Soo Young] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Cho, Suck Ju; Yeom, Seok-Ran] Pusan Natl Univ, Dept Emergency Med, Sch Med, Yangsan, South Korea; [Lee, Sang-Bong] Pusan Natl Univ Hosp, Dept Trauma Surg, Busan, South Korea; [Chun, Mose] Pusan Natl Univ, Dept Emergency Med, Yangsan Hosp, Pusan, South Korea; [Kim, Hyerim; Kim, Hyung-Hoi; Moon, Soo Young] Pusan Natl Univ Hosp, Dept Lab Med, Busan, South Korea; [Lee, Sun Min] Pusan Natl Univ, Dept Lab Med, Yangsan Hosp, Yangsan, South Korea; [Huh, Up] Pusan Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Moon, SY (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.; Moon, SY (corresponding author), Pusan Natl Univ Hosp, Dept Lab Med, Busan, South Korea.	symoon9@gmail.com		Yeom, Seokran/0000-0002-1000-9637	Pusan National University	Pusan National University(Pusan National University)	This work was supported by a 2-year Research Grant from Pusan National University. No specific other funder is to be disclosed.	Bilello J, 2011, WORLD J SURG, V35, P2149, DOI 10.1007/s00268-011-1191-7; BLOMQVIST S, 1987, J TRAUMA, V27, P40, DOI 10.1097/00005373-198701000-00007; Cantle PM, 2017, CRIT CARE CLIN, V33, P71, DOI 10.1016/j.ccc.2016.08.002; Cohen MJ, 2017, CRIT CARE CLIN, V33, P101, DOI 10.1016/j.ccc.2016.08.003; Cook MR, 2015, INJURY, V46, P131, DOI 10.1016/j.injury.2014.09.017; Davis JW, 1997, J TRAUMA, V43, P507, DOI 10.1097/00005373-199709000-00020; Eismann H, 2020, KOREAN J ANESTHESIOL, V73, P334, DOI 10.4097/kja.20071; Engstrom M, 2006, BLOOD COAGUL FIBRIN, V17, P661, DOI 10.1097/MBC.0b013e32801010b7; Gall LS, 2017, SEMIN THROMB HEMOST, V43, P224, DOI 10.1055/s-0036-1598001; Gomez-Builes JC, 2018, ANESTH ANALG, V127, P840, DOI 10.1213/ANE.0000000000003341; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Howard BM, 2018, J TRAUMA ACUTE CARE, V84, P97, DOI 10.1097/TA.0000000000001716; Jung K, 2016, YONSEI MED J, V57, P728, DOI 10.3349/ymj.2016.57.3.728; Kushimoto S, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0196-6; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Moore EE, 2005, J TRAUMA, V59, pS53, DOI 10.1097/01.ta.0000174868.13616.67; Moore HB, 2019, ANESTH ANALG, V129, P762, DOI 10.1213/ANE.0000000000004234; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Rao AJ, 2018, WORLD NEUROSURG, V112, pE216, DOI 10.1016/j.wneu.2018.01.025; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; Stettler GR, 2021, EUR J TRAUMA EMERG S, V47, P1827, DOI 10.1007/s00068-020-01328-x; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Walsh M, 2017, SEMIN THROMB HEMOST, V43, P200, DOI 10.1055/s-0036-1597900; Wirtz MR, 2017, SEMIN THROMB HEMOST, V43, P375, DOI 10.1055/s-0037-1598057	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248810	10.1371/journal.pone.0248810	http://dx.doi.org/10.1371/journal.pone.0248810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755680	gold, Green Published			2022-12-26	WOS:000632916600035
J	Zabel, P; Kaluzny, JJ; Zabel, K; Kaluzna, M; Lamkowski, A; Jaworski, D; Makowski, J; Gebska-Toloczko, M; Kucharski, R				Zabel, Przemyslaw; Kaluzny, Jakub J.; Zabel, Katarzyna; Kaluzna, Martyna; Lamkowski, Aleksander; Jaworski, Damian; Makowski, Jaroslaw; Gebska-Toloczko, Martyna; Kucharski, Robert			Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma	PLOS ONE			English	Article							NERVE-FIBER LAYER; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA; NEURODEGENERATIVE DISEASES; OCT ANGIOGRAPHY; GANGLION-CELLS; MOUSE MODEL; DEGENERATION; DEMENTIA; ASSOCIATION	Purpose Assessment and a direct comparison of retinal vessel density with the thickness of inner retinal layer (IRL) and outer retinal layer (ORL) in the same regions of the macula in subjects with Alzheimer's disease (AD) and primary open-angle glaucoma (POAG). Methods We analyzed data from 48 eyes of healthy control (HC) participants, 71 eyes with POAG, and 49 eyes of AD patients. Ophthalmic examination included optical coherence tomography (OCT) imaging to measure IRL and ORL thickness and OCT angiography (OCTA) in the same region for the imaging of vessel density in the superficial vascular plexus (SVP) and deep vascular plexus (DVP) of the retina. A direct comparison of vessel density and retinal layers thickness, which different dynamic ranges, was obtained by normalizing values as percentage losses. Results Patients with AD presented significantly greater losses of vascular density in the DVP and ORL thickness compared to POAG (p <0.001), but percentage losses of vessel density in SVP and IRL thickness were considerable in POAG compared to AD eyes (p<0.001). Positive associations among presence of AD were observed primarily in outer retina where a 1% decrease of ORL thickness was associated with about 24-29% increase in odds of the presence of AD. According to OCTA measurements, a 1% decrease of vessel density in DVP was positively associated with a 4-9% increase in odds of the presence of AD. In POAG positive associations among presence of disease were observed only in inner retina where 1% loss of IRL thickness and a 1% loss of vessel density in the SVP were positively associated with a 13-23% increase in risk of presence of the disease. Conclusions Analysis of ORL thickness and vessel density in DVP could potentially improve diagnostic capabilities and may provide a valuable approach for predicting of AD.	[Zabel, Przemyslaw; Kaluzny, Jakub J.; Zabel, Katarzyna; Gebska-Toloczko, Martyna] Nicolaus Copernicus Univ, Coll Med, Dept Sensory Organ Studies, Bydgoszcz, Poland; [Zabel, Przemyslaw; Kaluzny, Jakub J.; Zabel, Katarzyna; Kaluzna, Martyna; Lamkowski, Aleksander; Jaworski, Damian; Makowski, Jaroslaw] Oftalmika Eye Hosp, Bydgoszcz, Poland; [Zabel, Przemyslaw; Zabel, Katarzyna] Nicolaus Copernicus Univ, Coll Med, Dept Ophthalmol, Bydgoszcz, Poland; [Kucharski, Robert] Sue Ryder Home Leading Pallmed Ltd, Ctr Psychoneurol Elderly, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Zabel, P (corresponding author), Nicolaus Copernicus Univ, Coll Med, Dept Sensory Organ Studies, Bydgoszcz, Poland.; Zabel, P (corresponding author), Oftalmika Eye Hosp, Bydgoszcz, Poland.; Zabel, P (corresponding author), Nicolaus Copernicus Univ, Coll Med, Dept Ophthalmol, Bydgoszcz, Poland.	przemo.zab@gmail.com		Zabel, Przemyslaw/0000-0002-5219-9811; Kaluzny, Jakub/0000-0003-1908-2141; Jaworski, Damian/0000-0003-3842-1241; Zabel, Katarzyna/0000-0003-2701-4309				Asanad S, 2019, INVEST OPHTH VIS SCI, V60, P1491, DOI 10.1167/iovs.18-25966; Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bulut M, 2018, BRIT J OPHTHALMOL, V102, P233, DOI 10.1136/bjophthalmol-2017-310476; Camino A, 2016, BIOMED OPT EXPRESS, V7, P3905, DOI 10.1364/BOE.7.003905; Cantor LB, 2014, 2014 2015 BASIC CLIN, P40; Chan VTT, 2019, OPHTHALMOLOGY, V126, P497, DOI 10.1016/j.ophtha.2018.08.009; Chen HSL, 2017, INVEST OPHTH VIS SCI, V58, P3637, DOI 10.1167/iovs.17-21846; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Chua J, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00724-0; Criscuolo C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233975; Criscuolo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00053; Cunha LP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153830; Damiani D, 2012, J COMP NEUROL, V520, P1406, DOI 10.1002/cne.22802; den Haan Jurre, 2017, Alzheimers Dement (Amst), V6, P162, DOI 10.1016/j.dadm.2016.12.014; Diniz A, 2017, JAMA OPHTHALMOL, V135, P734, DOI 10.1001/jamaophthalmol.2017.1279; Dorr A, 2012, BRAIN, V135, P3039, DOI 10.1093/brain/aws243; Feke GT, 2014, AM J OPHTHALMOL, V158, P105, DOI 10.1016/j.ajo.2014.03.015; Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Grewal DS, 2018, OSLI RETINA, V49, P440, DOI 10.3928/23258160-20180601-09; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Hou HY, 2019, AM J OPHTHALMOL, V199, P120, DOI 10.1016/j.ajo.2018.11.012; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P1411, DOI 10.1001/jamaophthalmol.2016.4272; Ito Y, 2020, OPHTHALMOLOGY, V127, P107, DOI 10.1016/j.ophtha.2019.05.021; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jiang H, 2018, J NEURO-OPHTHALMOL, V38, P292, DOI 10.1097/WNO.0000000000000580; Jones-Odeh E, 2015, EYE, V29, P1270, DOI 10.1038/eye.2015.158; Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150; Khan TK, 2015, J ALZHEIMERS DIS, V46, P817, DOI 10.3233/JAD-150238; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Lahme L, 2018, J ALZHEIMERS DIS, V66, P1745, DOI 10.3233/JAD-180738; Lee JC, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0250-2; Lee V, 2012, NEUROBIOL AGING, V33, P2382, DOI 10.1016/j.neurobiolaging.2011.12.002; Lommatzsch C, 2018, INT J OPHTHALMOL-CHI, V11, P835, DOI 10.18240/ijo.2018.05.20; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Moreno-Ramos T, 2013, J ALZHEIMERS DIS, V34, P659, DOI 10.3233/JAD-121975; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nielsen RB, 2017, ALZHEIMERS DEMENT, V13, P1143, DOI 10.1016/j.jalz.2017.02.007; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; SADUN AA, 1987, AM J OPHTHALMOL, V104, P113, DOI 10.1016/0002-9394(87)90001-8; Salobrar-Garcia E, 2020, J PERS MED, V10, DOI 10.3390/jpm10040231; Shin JY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80892-z; Siesky B, 2009, SURV OPHTHALMOL, V54, P33, DOI 10.1016/j.survophthal.2008.06.002; Takusagawa HL, 2017, OPHTHALMOLOGY, V124, P1589, DOI 10.1016/j.ophtha.2017.06.002; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Tolboom N, 2009, J NUCL MED, V50, P191, DOI 10.2967/jnumed.108.056499; Touloumis A, 2015, J STAT SOFTW, V64, P1; TRICK GL, 1995, NEUROLOGY, V45, P68, DOI 10.1212/WNL.45.1.68; Uchida A, 2018, INVEST OPHTH VIS SCI, V59, P2768, DOI 10.1167/iovs.17-23240; Wang L, 2018, EYE VISION, V5, DOI 10.1186/s40662-018-0104-3; Williams PA, 2013, NEUROBIOL AGING, V34, P1799, DOI 10.1016/j.neurobiolaging.2013.01.006; Yan YB, 2021, J ALZHEIMERS DIS, V79, P1307, DOI 10.3233/JAD-200971; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yoon SP, 2019, OSLI RETINA, V50, P709, DOI 10.3928/23258160-20191031-06; Zabel P, 2019, MED SCI MONITOR, V25, P1001, DOI 10.12659/MSM.914889; Zhang CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160549; Zhang YS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214685	65	7	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248284	10.1371/journal.pone.0248284	http://dx.doi.org/10.1371/journal.pone.0248284			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739997	gold, Green Published, Green Submitted			2022-12-26	WOS:000631030200031
J	Grundy, Q; Mazzarello, S; Brennenstuhl, S; Karanges, EA				Grundy, Quinn; Mazzarello, Sasha; Brennenstuhl, Sarah; Karanges, Emily A.			A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers	PLOS ONE			English	Article							INDUSTRY PAYMENTS; PRESCRIPTION; PAIN	Background Educational activities for physicians sponsored by opioid manufacturers are implicated in the over- and mis-prescribing of opioids. However, the implications of promotion to nurses are poorly understood. Nurses play a key role in assessing pain, addressing the determinants of pain, and administering opioid medications. We sought to understand the nature and content of pain-related educational events sponsored by opioid manufacturers and to compare events targeting physicians and nurses. Methods We conducted a cross sectional, descriptive analysis of pharmaceutical company reports detailing 116,845 sponsored educational events attended by health professionals from 2011 to 2015 in Australia. We included events that were sponsored by manufacturers of prescription opioid analgesics and were pain related. We compared event characteristics across three attendee groups: (a) physicians only; (b) at least one nurse in attendance; and (c) nurses only. We coded the unstructured data using iteratively generated keywords for variables related to location, format, and content focus. Results We identified 3,411 pain-related events sponsored by 3 companies: bioCSL/CSL (n = 15), Janssen (n = 134); and Mundipharma (n = 3,262). Pain-related events were most often multidisciplinary, including at least one nurse (1,964/3,411; 58%); 38% (1,281/3,411) included physicians only, and 5% (166/3,411) nurses only. The majority of events were held in clinical settings (61%) and 43% took the form of a journal club. Chronic pain was the most common event topic (26%) followed by cancer pain and palliative care (18%), and then generic or unspecified references to pain (15%); nearly a third (32%) of event descriptions contained insufficient information to determine the content focus. Nurse-only events were less frequently held in clinical settings (32%; p < .001) and more frequently were product launches (17%; p < .001) and a significantly larger proportion focused on cancer or palliative care (33%; p < .001), generic pain topics (27%; p < .001), and geriatrics (25%; p < .001) than physician-only or multidisciplinary events. Discussion Opioid promotion via sponsored educational events extends beyond physicians to multidisciplinary teams and specifically, nurses. Despite lack of evidence that opioids improve outcomes for long-term chronic non-cancer pain, hundreds of sponsored educational events focused on chronic pain. Regulators should consider the validity of distinguishing between pharmaceutical companies' "promotional" and "non-promotional" activities.	[Grundy, Quinn; Mazzarello, Sasha; Brennenstuhl, Sarah] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Grundy, Quinn; Karanges, Emily A.] Univ Sydney, Sydney Pharm Sch, Fac Med & Hlth, Sydney, NSW, Australia; [Karanges, Emily A.] Univ Melbourne, Ctr Youth Mental Hlth, Fac Med Dent & Hlth, Melbourne, Vic, Australia; [Karanges, Emily A.] Orygen, Melbourne, Vic, Australia	University of Toronto; University of Sydney; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health	Grundy, Q (corresponding author), Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada.; Grundy, Q (corresponding author), Univ Sydney, Sydney Pharm Sch, Fac Med & Hlth, Sydney, NSW, Australia.	quinn.grundy@utoronto.ca			Connaught New Researcher Award from the University of Toronto	Connaught New Researcher Award from the University of Toronto	This study was funded by a Connaught New Researcher Award from the University of Toronto to QG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Nurses Association, 2018, OP EP EV NURS; ANA Center for Ethics and Human Rights, 2018, ETH RESP MAN PAIN SU; [Anonymous], 2019, NEW YORK TIMES 0826; [Anonymous], 2020, CONTR SUBST ACT VIOL; Asamoah-Boaheng M, 2021, AM J PREV MED, V60, pE15, DOI 10.1016/j.amepre.2020.07.012; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Blanch B, 2014, BRIT J CLIN PHARMACO, V78, P1159, DOI 10.1111/bcp.12446; Bureau of Labor Statistics, 2016, OCC EMPL STAT; CMS, 2021, NEWL ADD COV REC; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Fabbri A, 2018, INT J HEALTH POLICY, V7, P504, DOI 10.15171/ijhpm.2018.20; Fabbri A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016701; Gelineau K., 2019, AUSTR FINES SACKLER; Glover S., LA TIMES 1218, V18, P2016; Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217; Grundy Q, 2016, JAMA INTERN MED, V176, P1718, DOI 10.1001/jamainternmed.2016.5276; Grundy Q, 2016, ANN INTERN MED, V164, P733, DOI 10.7326/M15-2522; Grundy Q, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001561; Hadland SE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6007; Hadland SE, 2018, JAMA INTERN MED, V178, P861, DOI 10.1001/jamainternmed.2018.1999; Hadland SE, 2017, AM J PUBLIC HEALTH, V107, P1493, DOI 10.2105/AJPH.2017.303982; Health Canada, 2019, RESTR MARK ADV OP OT; Health Canada, 2019, DISTINCTION PROMOTIO; Hoffman J., 2019, NEW YORK TIMES, V21, P2019; Holliday SM, 2017, PAIN, V158, P278, DOI 10.1097/j.pain.0000000000000755; Jutel A, 2010, INT NURS REV, V57, P92, DOI 10.1111/j.1466-7657.2009.00749.x; Karanges EA, 2019, JAMA INTERN MED, V179, P1430, DOI 10.1001/jamainternmed.2019.1371; Karanges EA, 2018, PHARMACOEPIDEM DR S, V27, P504, DOI 10.1002/pds.4369; Karanges EA, 2016, BRIT J CLIN PHARMACO, V82, P255, DOI 10.1111/bcp.12937; Mangan D., 2017, CNBC, V28, P2017; McCracken LM, 2012, J PAIN, V13, P32, DOI 10.1016/j.jpain.2011.09.007; Medicines Australia, 2019, COD COND; Mogilenko DA, 2012, FASEB J, V26, P2019, DOI 10.1096/fj.11-193946; Moynihan, 2005, SELLING SICKNESS WOR; Mundipharma Pty Ltd, PAN AC EA PAIN ADVOC; Parker L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024928; Persaud N, 2014, J MED ETHICS, V40, P414, DOI 10.1136/medethics-2013-101343; Pew Prescription Project, 2013, PERSUADING PRESCRIBE; Robertson J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000128; Schaffer AL, 2019, PHARMACOEPIDEM DR S, V28, P97, DOI 10.1002/pds.4683; Sismondo S, 2013, J LAW MED ETHICS, V41, P635, DOI 10.1111/jlme.12073; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; The Pharmaceutical Benefits Scheme (PBS), 2020, NURS PRACT PBS PRESC; Thomas, 2015, NEW YORK TIMES; Welfare AIoHa, 2018, OPIOID HARM AUSTR CO; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248238	10.1371/journal.pone.0248238	http://dx.doi.org/10.1371/journal.pone.0248238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735203	Green Published, gold			2022-12-26	WOS:000631029700071
J	Larkin, BP; Saad, S; Glastras, SJ; Nguyen, LT; Hou, M; Chen, H; Wang, R; Pollock, CA				Larkin, Benjamin P.; Saad, Sonia; Glastras, Sarah J.; Nguyen, Long T.; Hou, Miao; Chen, Hui; Wang, Rosy; Pollock, Carol A.			Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet	PLOS ONE			English	Article							KIDNEY-DISEASE; FIBROBLAST ACTIVATION; OXIDATIVE STRESS; DNA METHYLATION; PROGRESSION; HYPERMETHYLATION; PROTEINURIA; EPIGENETICS; OBESITY; HEALTH	Background Maternal high fat diet (HFD) promotes chronic kidney disease (CKD) in offspring. This is in accordance with the theory of fetal programming, which suggests adverse conditions occurring in utero predispose offspring to chronic conditions later in life. DNA methylation has been proposed as a key mechanism by which fetal programming occurs and is implicated in CKD progression. DNA demethylating drugs may interrupt the fetal programming of CKD by maternal obesity. Hydralazine, an antihypertensive agent, demethylates DNA at low doses which do not reduce blood pressure. We used a mouse model of maternal obesity to determine whether gestational administration of low-dose hydralazine to mothers can prevent CKD in offspring. Methods C57BL/6 dams received HFD or chow from 6 weeks prior to mating and were administered subcutaneous hydralazine (5mg/kg) or saline thrice weekly during gestation. Male offspring were weaned to chow and were sacrificed at either postnatal week 9 or week 32. Biometric and metabolic parameters, renal global DNA methylation, renal structural and functional changes and markers of fibrosis, oxidative stress and inflammation were measured in offspring at weeks 9 and 32. Results In week 9 offspring, maternal HFD consumption did not significantly alter anthropometric or metabolic parameters, or renal global DNA methylation. Week 32 offspring had increased renal global DNA methylation, together with albuminuria, glomerulosclerosis, renal fibrosis and oxidative stress. Administration of low-dose hydralazine to obese mothers during gestation reduced renal global DNA methylation and renal fibrotic markers in week 32 offspring. Conclusion Gestational hydralazine reduced renal global DNA methylation in offspring of obese mothers and attenuated maternal obesity-induced renal fibrosis. These data support the use of low-dose hydralazine as a demethylating agent to prevent CKD arising in offspring due to maternal HFD consumption.	[Larkin, Benjamin P.; Saad, Sonia; Glastras, Sarah J.; Nguyen, Long T.; Wang, Rosy; Pollock, Carol A.] Univ Sydney, Kolling Inst Med Res, Renal Res Lab, Sydney, NSW, Australia; [Saad, Sonia; Chen, Hui] Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia; [Glastras, Sarah J.] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, Sydney, NSW, Australia; [Hou, Miao] Soochow Univ, Dept Cardiol, Childrens Hosp, Suzhou, Jiangsu, Peoples R China	University of Sydney; Kolling Institute of Medical Research; University of Technology Sydney; Royal North Shore Hospital; Soochow University - China	Saad, S (corresponding author), Univ Sydney, Kolling Inst Med Res, Renal Res Lab, Sydney, NSW, Australia.; Saad, S (corresponding author), Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia.	sonia.saad@sydney.edu.au	Glastras, Sarah J./AAL-2541-2020; Chen, Hui/D-2005-2014	Glastras, Sarah J./0000-0002-9317-1348; Nguyen, Long/0000-0002-0630-4959; Saad, Sonia/0000-0001-8067-8046; Larkin, Benjamin/0000-0002-7278-1112; Chen, Hui/0000-0001-6883-3752	Royal Australasian College of Physicians; Diabetes Australia Research Trust (DART); Rebecca L. Cooper Medical Research Foundation	Royal Australasian College of Physicians(General Electric); Diabetes Australia Research Trust (DART); Rebecca L. Cooper Medical Research Foundation	B.P.L. is the recipient of a Jacquot Research Entry Scholarship in Nephrology from the Royal Australasian College of Physicians. This study was partly funded by grants from the Diabetes Australia Research Trust (DART) and the Rebecca L. Cooper Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Alfaradhi Maria Z., 2011, Frontiers in Genetics, V2, P27, DOI 10.3389/fgene.2011.00027; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Chen H, 2014, DIABETOLOGIA, V57, P614, DOI 10.1007/s00125-013-3132-5; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Cheong JN, 2016, ENDOCRINOLOGY, V157, P4104, DOI 10.1210/en.2016-1335; Cheong JN, 2016, J PHYSIOL-LONDON, V594, P4727, DOI 10.1113/JP271745; Cutfield WS, 2007, PEDIATR RES, V61, p68R, DOI 10.1203/pdr.0b013e318045764c; Daiber A, 2005, AM J CARDIOL, V96, p25I, DOI 10.1016/j.amjcard.2005.07.030; Dotsch J, 2012, PEDIATR NEPHROL, V27, P513, DOI 10.1007/s00467-011-1781-5; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Frijhoff J, 2015, ANTIOXID REDOX SIGN, V23, P1144, DOI 10.1089/ars.2015.6317; Glastras SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180050; Glastras SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172644; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27769; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Glastras SJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0032-3; Hayashi K, 2015, ARCH IMMUNOL THER EX, V63, P193, DOI 10.1007/s00005-014-0326-6; Heerspink HJL, 2015, CLIN J AM SOC NEPHRO, V10, P1079, DOI 10.2215/CJN.11511114; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kandler MR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004934.pub4; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Larkin BP, 2018, FASEB J, V32, P5215, DOI 10.1096/fj.201800205R; Neugarten J, 2013, ADV CHRONIC KIDNEY D, V20, P390, DOI 10.1053/j.ackd.2013.05.004; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Nomura Y, 2014, REPROD SCI, V21, P131, DOI 10.1177/1933719113492206; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Ratliff BB, 2016, ANTIOXID REDOX SIGN, V25, P119, DOI 10.1089/ars.2016.6665; Rodriguez-Gonzalez GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209; Segura-Pacheco B, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-32; Sookoian S, 2013, PEDIATR RES, V73, P531, DOI 10.1038/pr.2013.2; Stangenberg S, 2015, AM J PHYSIOL-RENAL, V308, pF1189, DOI 10.1152/ajprenal.00638.2014; Tain YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020381; Tampe B, 2017, KIDNEY INT, V91, P157, DOI 10.1016/j.kint.2016.07.042; Tampe B, 2015, EBIOMEDICINE, V2, P19, DOI 10.1016/j.ebiom.2014.11.005; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Zambrano P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-44; Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a; Zeisberg EM, 2013, J PATHOL, V229, P264, DOI 10.1002/path.4120; Zeisberg MA, 2016, J CLIN EPIGENETICS, V2	44	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248854	10.1371/journal.pone.0248854	http://dx.doi.org/10.1371/journal.pone.0248854			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735324	gold, Green Published			2022-12-26	WOS:000631029700108
J	Mercado-Salas, NF; Khodami, S; Arbizu, PM				Mercado-Salas, Nancy F.; Khodami, Sahar; Martinez Arbizu, Pedro			Copepods and ostracods associated with bromeliads in the Yucatan Peninsula, Mexico	PLOS ONE			English	Article							SPECIES IDENTIFICATION; TROPICAL FOREST; DNA; CRUSTACEA; PHYTOTELMATA; DISPERSAL; EVOLUTION; CONSERVATION; PHYLOGENY; DIVERSITY	A substantial fraction of the freshwater available in the Neotropical forests is enclosed within the rosettes of bromeliads that form small aquatic islands within a terrestrial landscape. These aquatic oases provide shelter, water, nutrients and resting of aggregation sites for several aquatic organisms, among them crustaceans. However, in comparison with the multitude of studies on open aquatic systems, our knowledge on crustaceans inhabiting semi-terrestrial habitats and phytotelmata is limited and their presence in such environments is poorly understood. The present study was carried out in two natural protected areas of the Yucatan Peninsula aiming to understand the diversity and dispersal strategies of crustaceans living in bromeliads. Sediment and water contained in four species of bromeliads have been collected in order to understand the diversity and dispersal strategies of crustaceans living in such habitats. From a total of 238 bromeliads surveyed, 55% were colonized by crustaceans. Sixteen copepod, three ostracod and one branchiopod species were recorded during this study, however only seven species are considered as true bromeliad inhabitants. Different degrees of association between crustaceans and bromeliad species were assessed with an indicator species analysis, where significant associations were found for all crustaceans. We found significant differences between bromeliad species and reserves and their associated fauna. In order to analyze the genetic diversity of this fauna, we sequenced several individuals of each species with two genetic markers (18S rRNA and COI mtDNA). Bayesian analyses and the Generalized Mixed Yule Coalescent method (GMYC), delimited 7 well supported species. A comparison of the dispersal strategies used by different species, including passive dispersal, phoretic behavior and active dispersal, is included. This study stresses the need of studying meiofauna of phytotelms, which could be used as an indicator of local diversity in Neotropical forests.	[Mercado-Salas, Nancy F.; Khodami, Sahar; Martinez Arbizu, Pedro] German Ctr Marine Biodivers Res, Senckenberg Meer Wilhelmshaven, Wilhelmshaven, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN)	Mercado-Salas, NF (corresponding author), German Ctr Marine Biodivers Res, Senckenberg Meer Wilhelmshaven, Wilhelmshaven, Germany.	nancy.mercado.salas@uni-hamburg.de		Mercado-Salas, Nancy F./0000-0001-8303-3585	National Council of Science and Technology (CONACyT-Mexico) [234894, 265817]; 2015 Edward & Phyllis Reed Fellowship for Copepod Research (Smithsonian National Museum of Natural History); OCEANUS A.C.	National Council of Science and Technology (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 2015 Edward & Phyllis Reed Fellowship for Copepod Research (Smithsonian National Museum of Natural History); OCEANUS A.C.	This research was supported by the National Council of Science and Technology (CONACyT-Mexico) through International Postdoctoral Fellowship for the Consolidation of Research Groups (Grants: 234894 and 265817 to NFMS). Sampling Campaigns were founded by OCEANUS A.C. and the 2015 Edward & Phyllis Reed Fellowship for Copepod Research (Smithsonian National Museum of Natural History) both granted to NFMS.	Alcocer J, 2010, HYDROBIOLOGIA, V644, P15, DOI 10.1007/s10750-010-0211-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araujo Alan P., 2019, Herpetology Notes, V12, P531; Balke M, 2008, P NATL ACAD SCI USA, V105, P6356, DOI 10.1073/pnas.0710368105; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brouard O, 2012, FRESHWATER BIOL, V57, P815, DOI 10.1111/j.1365-2427.2012.02749.x; Cheng Fangping, 2013, Advances in Polar Science, V24, P119, DOI 10.3724/SP.J.1085.2013.00119; CONANP, 2019, MEX COM NAC AR NAT P; Corgosinho PHC, 2017, ZOOTAXA, V4238, P499, DOI 10.11646/zootaxa.4238.4.2; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; de Paula AT, 2017, BIOTA NEOTROP, V17, DOI [10.1590/1676-0611-BN-2016-0188, 10.1590/1676-0611-bn-2016-0188]; Dejean A, 1997, J NAT HIST, V31, P1313, DOI 10.1080/00222939700770741; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Espejo-Serna Adolfo, 2004, Selbyana, V25, P33; Espejo-Serna A, 2018, BOT SCI, V96, P533, DOI 10.17129/botsci.1918; Espejo-Serna A, 2012, BOT SCI, V90, P385, DOI 10.17129/botsci.471; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; García Gil Gerardo, 2002, Invest. Geog, P7; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Givnish TJ, 2004, INT J PLANT SCI, V165, pS35, DOI 10.1086/421067; HAMBY RK, 1988, PLANT SYST EVOL, V160, P29, DOI 10.1007/BF00936707; Henaut Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114592; Hernandez-Baz F, 2011, REV MEX BIODIVERS, V82, P1034; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Jocque M, 2010, HYDROBIOLOGIA, V649, P293, DOI 10.1007/s10750-010-0272-1; Jocque M, 2013, J CRUSTACEAN BIOL, V33, P451, DOI 10.1163/1937240X-00002161; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Ladino G, 2019, ECOL EVOL, V9, P7360, DOI 10.1002/ece3.5296; Little TJ, 1996, FRESHWATER BIOL, V36, P327, DOI 10.1046/j.1365-2427.1996.00094.x; Lopez LCS, 2005, HYDROBIOLOGIA, V549, P15, DOI 10.1007/s10750-005-1701-4; Lopez LCS, 1999, BIOTROPICA, V31, P705, DOI 10.1111/j.1744-7429.1999.tb00421.x; Lopez Luiz Carlos Serramo, 2001, Selbyana, V22, P219; Martinez Arbizu P., 2019, CEDIA MULT THC ASS P; Mercado-Salas NF, 2013, AQUAT CONSERV, V23, P939, DOI 10.1002/aqc.2350; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mondragon Chaparro DM., 2011, FAMILIA BROMELIACEAE, V1st ed; Mondragon-Chaparro DM., 2011, NATURALEZA DESARROLL, V4, P13; Neretina AN, 2019, ZOOTAXA, V4567, P347, DOI 10.11646/zootaxa.4567.2.7; Oksanen J., 2019, PACKAGEVEGAN; Ospina-Bautista F., 2008, REV COLOMB ENTOMOL, V32, P224; Perez L, 2011, HYDROBIOLOGIA, V661, P407, DOI 10.1007/s10750-010-0552-9; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ramirez M. Ivon M., 1999, Harvard Papers in Botany, V4, P185; Reid JW, 1996, INVERTEBR BIOL, V115, P305, DOI 10.2307/3227020; Reid JW, 2001, HYDROBIOLOGIA, V453, P201, DOI 10.1023/A:1013148808110; Sabagh LT, 2014, NATURWISSENSCHAFTEN, V101, P493, DOI 10.1007/s00114-014-1178-y; Schmitter-Soto JJ, 2002, HYDROBIOLOGIA, V467, P215, DOI 10.1023/A:1014923217206; Suarez-Morales E, 2010, ZOOSYSTEMA, V32, P393, DOI 10.5252/z2010n3a2; TAJIMA F, 1989, GENETICS, V123, P585; Teixeira Ana Paula, 2018, Acta Scientiarum Biological Sciences, V40, pe40994, DOI 10.4025/actascibiolsci.v40i1.40994; Wiackowski K, 2017, HYDROBIOLOGIA, V790, P13, DOI 10.1007/s10750-016-2941-1; Zanella CM, 2012, GENET MOL BIOL, V35, P1020, DOI 10.1590/S1415-47572012000600017; Zotz G, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0069-9; Zytynska SE, 2012, OECOLOGIA, V170, P467, DOI 10.1007/s00442-012-2310-3	58	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248863	10.1371/journal.pone.0248863	http://dx.doi.org/10.1371/journal.pone.0248863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735283	Green Published, gold			2022-12-26	WOS:000631029700124
J	Wang, JL; Westveld, AH; Welsh, AH; Parker, M; Loong, B				Wang, Jiali; Westveld, Anton H.; Welsh, A. H.; Parker, Melissa; Loong, Bronwyn			Analysis of survey on menstrual disorder among teenagers using Gaussian copula model with graphical lasso prior	PLOS ONE			English	Article							REGRESSION; SELECTION; ENDOMETRIOSIS; DIAGNOSIS	A high prevalence of menstrual disturbance has been reported among teenage girls, and research shows that there are delays in diagnosis of endometriosis among young girls. Using data from the Menstrual Disorder of Teenagers Survey (administered in 2005 and 2016), we propose a Gaussian copula model with graphical lasso prior to identify cohort differences in menstrual characteristics and to predict endometriosis. The model includes random effects to account for clustering by school, and we use the extended rank likelihood copula model to handle variables of mixed-type. The graphical lasso prior shrinks the elements in the precision matrix of a Gaussian distribution to encourage a sparse graphical structure, where the level of shrinkage is adaptable based on the strength of the conditional associations among questions in the survey. Applying our proposed model to the menstrual disorder data set, we found that menstrual disturbance was more pronouncedly reported over a decade, and we found some empirical differences between those girls with higher risk of developing endometriosis and the general population.	[Wang, Jiali; Westveld, Anton H.; Welsh, A. H.; Loong, Bronwyn] Australian Natl Univ, Coll Business & Econom, Res Sch Finance Actuarial Studies & Stat, Canberra, ACT, Australia; [Parker, Melissa] Centenary Hosp Women & Children, Canberra Endometriosis Ctr, ACT Hlth, Canberra, ACT, Australia	Australian National University	Wang, JL (corresponding author), Australian Natl Univ, Coll Business & Econom, Res Sch Finance Actuarial Studies & Stat, Canberra, ACT, Australia.	wangjiali0320@gmail.com						Agarwal A, 2009, J PEDIATR ADOL GYNEC, V22, P365, DOI 10.1016/j.jpag.2009.02.005; ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; [Anonymous], 2013, TEXTS STAT SCI SERIE; Arruda MS, 2003, HUM REPROD, V18, P756, DOI 10.1093/humrep/deg136; Cakir M, 2007, PEDIATR INT, V49, P938, DOI 10.1111/j.1442-200X.2007.02489.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DESANCTIS V, 2017, ACTA BIOMED, V87, P233; Dmowski WP, 1997, FERTIL STERIL, V67, P238, DOI 10.1016/S0015-0282(97)81904-8; Esen I, 2016, J CLIN RES PEDIATR E, V8, P192, DOI 10.4274/jcrpe.2026; Fan JQ, 2009, ANN APPL STAT, V3, P521, DOI 10.1214/08-AOAS215; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; GENEST C, 1995, BIOMETRIKA, V82, P543, DOI 10.2307/2337532; Hoff PD, 2007, ANN APPL STAT, V1, P265, DOI 10.1214/07-AOAS107; Kyung M, 2010, BAYESIAN ANAL, V5, P369, DOI 10.1214/10-BA607; Lenkoski A, 2011, J COMPUT GRAPH STAT, V20, P140, DOI 10.1198/jcgs.2010.08181; Marlin B. M., 2009, P 25 C UNC ART INT, P383; Mohammadi A, 2015, BAYESIAN ANAL, V10, P109, DOI 10.1214/14-BA889; Mohammadi A, 2015, ARXIV PREPRINT ARXIV; Mohammadi A, 2017, J R STAT SOC C-APPL, V66, P629, DOI 10.1111/rssc.12171; Nelsen R. B., 2007, INTRO COPULAS; Overton C, 1997, BRIT J OBSTET GYNAEC, V104, P1351, DOI 10.1111/j.1471-0528.1997.tb11003.x; Parker MA, 2010, BJOG-INT J OBSTET GY, V117, P185, DOI 10.1111/j.1471-0528.2009.02407.x; RUE H., 2005, GAUSSIAN MARKOV RAND; Suvitie PA, 2016, J PEDIATR ADOL GYNEC, V29, P97, DOI 10.1016/j.jpag.2015.07.001; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang H, 2012, BAYESIAN ANAL, V7, P867, DOI 10.1214/12-BA729; Westveld A, 2017, ARXIV PREPRINT ARXIV; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Yuan M, 2007, BIOMETRIKA, V94, P19, DOI 10.1093/biomet/asm018	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248340	10.1371/journal.pone.0248340	http://dx.doi.org/10.1371/journal.pone.0248340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735289	Green Published, gold			2022-12-26	WOS:000631029700126
J	Wiebel-Herboth, CB; Kruger, M; Wollstadt, P				Wiebel-Herboth, Christiane B.; Krueger, Matti; Wollstadt, Patricia			Measuring inter- and intra-individual differences in visual scan patterns in a driving simulator experiment using active information storage	PLOS ONE			English	Article							GAZE ENTROPY; EYE-MOVEMENTS; SIGNALS; VISION; TOOL	Scan pattern analysis has been discussed as a promising tool in the context of real-time gaze-based applications. In particular, information-theoretic measures of scan path predictability, such as the gaze transition entropy (GTE), have been proposed for detecting relevant changes in user state or task demand. These measures model scan patterns as first-order Markov chains, assuming that only the location of the previous fixation is predictive of the next fixation in time. However, this assumption may not be sufficient in general, as recent research has shown that scan patterns may also exhibit more long-range temporal correlations. Thus, we here evaluate the active information storage (AIS) as a novel information-theoretic approach to quantifying scan path predictability in a dynamic task. In contrast to the GTE, the AIS provides means to statistically test and account for temporal correlations in scan path data beyond the previous last fixation. We compare AIS to GTE in a driving simulator experiment, in which participants drove in a highway scenario, where trials were defined based on an experimental manipulation that encouraged the driver to start an overtaking maneuver. Two levels of difficulty were realized by varying the time left to complete the task. We found that individual observers indeed showed temporal correlations beyond a single past fixation and that the length of the correlation varied between observers. No effect of task difficulty was observed on scan path predictability for either AIS or GTE, but we found a significant increase in predictability during overtaking. Importantly, for participants for which the first-order Markov chain assumption did not hold, this was only shown using AIS but not GTE. We conclude that accounting for longer time horizons in scan paths in a personalized fashion is beneficial for interpreting gaze pattern in dynamic tasks.	[Wiebel-Herboth, Christiane B.; Krueger, Matti; Wollstadt, Patricia] Honda Res Inst Europe, Offenbach, Germany	Honda Motor Company	Wiebel-Herboth, CB (corresponding author), Honda Res Inst Europe, Offenbach, Germany.	christiane.wiebel@honda-ri.de		Wollstadt, Patricia/0000-0002-7105-5207				Allsop J, 2014, J APPL RES MEM COGN, V3, P63, DOI 10.1016/j.jarmac.2014.04.010; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beer RD, 2015, COGNITIVE SCI, V39, P1, DOI 10.1111/cogs.12142; Besag J, 2013, BIOMETRICS, V69, P488, DOI 10.1111/biom.12009; Bouma G., 2009, P GSCL; Chanijani SSM, 2016, P 2016 ACM INT JOINT, P159; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Chen PY, 2020, TUNN UNDERGR SP TECH, V99, DOI 10.1016/j.tust.2020.103362; Coutrot A, 2018, BEHAV RES METHODS, V50, P362, DOI 10.3758/s13428-017-0876-8; Crosato E, 2018, SWARM INTELL-US, V12, P283, DOI 10.1007/s11721-018-0157-x; Crutchfield JP, 2003, CHAOS, V13, P25, DOI 10.1063/1.1530990; Di Stasi LL, 2016, SURG ENDOSC, V30, P5034, DOI 10.1007/s00464-016-4851-8; Diaz-Piedra C, 2019, APPL ERGON, V77, P92, DOI 10.1016/j.apergo.2019.01.012; Diaz-Piedra C, 2017, UROLOGY, V107, P26, DOI 10.1016/j.urology.2017.06.030; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; Fahrmeir L., 2007, REGRESSION; Fano RM., 1961, TRANSMISSION INFORM; Gilland J., 2008, P HUM FACTORS ERGON, V3, P1883, DOI DOI 10.1037/E578302012-012; Gomez C, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00009; Gwizdka J., 2018, P 2018 ACM S EYE TRA, P94; Hayes TR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196654; Hayes TR, 2017, J VISION, V17, DOI 10.1167/17.5.23; Hayes TR, 2011, J VISION, V11, DOI 10.1167/11.10.10; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hooge Ignace, 2013, Front Psychol, V4, P996, DOI 10.3389/fpsyg.2013.00996; Hoppe D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37536-0; Hu JF, 2018, COGN NEURODYNAMICS, V12, P431, DOI 10.1007/s11571-018-9485-1; Jin LS, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/432634; Kassner M, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P1151, DOI 10.1145/2638728.2641695; Keller F., 2015, P 27 INT C SCI STAT, V1, P1; Krejtz K., 2014, P S EYE TRACKING RES, P159, DOI DOI 10.1145/2578153.2578176; Krejtz K, 2015, ACM T APPL PERCEPT, V13, DOI 10.1145/2834121; Kruger M., 2018, PROC ADJUNCT PROC 10, P164, DOI [DOI 10.1145/3239092.3265961, 10.1145/3239092.3265961]; Kruger M, 2020, P AUGM HUM INT C, P1; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lizier J.T., 2012, MULTIVARIATE CONSTRU; Lizier J.T., 2008, P 11 INT C SIM SYNTH, P366; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Lizier JT, 2014, UNDERST COMPLEX SYST, P161, DOI 10.1007/978-3-642-54474-3_7; Lizier JT, 2012, THEOR BIOSCI, V131, P193, DOI 10.1007/s12064-011-0145-9; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lizier JT., 2012, LOCAL INFORM DYNAMIC; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; MacKay D. J. C., 2005, INFORM THEORY INFERE; Miller G., 1955, INFORM THEORY PSYCHO, P95; Novelli L, 2019, NETW NEUROSCI, V3, P827, DOI 10.1162/netn_a_00092; Obst O, 2013, ARXIV PREPRINT ARXIV; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Raptis GE., 2017, UMAP 2017, P164; Satterthwaite FE, 1941, PSYCHOMETRIKA, V6, P309, DOI 10.1007/BF02288586; Schor P., 2018, P 3 WORKSHOP EYE TRA, P1; Sendhoff B, 2020, 2020 IEEE INT C HUM, P1; Shiferaw B, 2019, NEUROSCI BIOBEHAV R, V96, P353, DOI 10.1016/j.neubiorev.2018.12.007; Shiferaw BA, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.06.021; Shiferaw BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20588-7; Strayer DL, 2017, HEART RATE DETECTION; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; van Dijk H, 2011, INT J AVIAT PSYCHOL, V21, P343, DOI 10.1080/10508414.2011.606747; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Victor TW, 2005, TRANSPORT RES F-TRAF, V8, P167, DOI 10.1016/j.trf.2005.04.014; Wang XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040084; Wibral M, 2014, 2014 8TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO), P131, DOI 10.1109/ESGCO.2014.6847554; Wibral M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00001; Wiebel-Herboth Christiane B., 2020, UMAP '20 Adjunct: Adjunct Publication of the 28th ACM Conference on User Modeling, Adaptation and Personalization, P35, DOI 10.1145/3386392.3397595; Wollstadt P, 2020, ARXIV PREPRINT ARXIV; Wollstadt P., 2019, J OPEN SOURCE SOFTW, V4, P1081, DOI [10.21105/joss.01081, DOI 10.21105/JOSS.01081]	73	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248166	10.1371/journal.pone.0248166	http://dx.doi.org/10.1371/journal.pone.0248166			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735199	Green Published, gold			2022-12-26	WOS:000631029700027
J	Li, F; Yin, C; Ma, ZW; Yang, KL; Sun, LJ; Duan, C; Wang, T; Hussein, A; Wang, LN; Zhu, XT; Gao, P; Xi, QY; Zhang, YL; Shu, G; Wang, SB; Jiang, QY				Li, Fan; Yin, Cong; Ma, Zewei; Yang, Kelin; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan			PHD3 mediates denervation skeletal muscle atrophy through Nf-kappa B signal pathway	FASEB JOURNAL			English	Article						Inflammation; NF&#8208; kB; PHD3; protein turnover; skeletal muscle	PROMOTES NEOVASCULARIZATION; SATELLITE CELLS; MURINE MODEL; HYPOXIA; INHIBITION; HIF; EXPRESSION; PROTEIN; HYPERTROPHY; DYSFUNCTION	Skeletal muscle is the largest organ of the body, the development of skeletal muscle is very important for the health of the animal body. Prolyl hydroxylases (PHDs) are the classical regulator of the hypoxia inducible factor (HIF) signal pathway, many researchers found that PHDs are involved in the muscle fiber type transformation, muscle regeneration, and myocyte differentiation. However, whether PHDs can impact the protein turnover of skeletal muscle is poorly understood. In this study, we constructed denervated muscle atrophy mouse model and found PHD3 was highly expressed in the atrophic muscles and there was a significant correlation between the expression level of PHD3 and skeletal muscle weight which was distinct from PHD1 and PHD2. Then, the similar results were getting from the different weight muscles of normal mice. To further verify the relationship between PHD3 and skeletal muscle protein turnover, we established a PHD3 interference model by injecting PHD3 sgRNA virus into tibialis anterior muscle (TA) muscle of MCK-Cre-cas9 mice and transfecting PHD3 shRNA lentivirus into primary satellite cells. It was found that the Knock-out of PHD3 in vivo led to a significant increase in muscle weight and muscle fiber area (P < .05). Besides, the activity of protein synthesis signal pathway increased significantly, while the protein degradation pathway was inhibited evidently (P < .05). In vitro, the results of 5-ethynyl-2 '-deoxyuridine (EdU) and tetramethylrhodamine ethyl ester (TMRE) fluorescence detection showed that PHD3 interference could lead to a decrease in cell proliferation and an increase of cell apoptosis. After the differentiation of satellite cells, the production of puromycin in the interference group was higher than that in the control group, and the content of 3-methylhistidine in the interference group was lower than that in the control group (P < .05) which is consistent with the change of protein turnover signal pathway in the cell. Mechanistically, there is an interaction between PHD3, NF-kappa B, and IKB alpha which was detected by immunoprecipitation. With the interfering of PHD3, the expression of the inflammatory signal pathway also significantly decreased (P < .05). These results suggest that PHD3 may affect protein turnover in muscle tissue by mediating inflammatory signal pathway. Finally, we knocked out PHD3 in denervated muscle atrophy mice and LPS-induced myotubes atrophy model. Then, we found that the decrease of PHD3 protein level could alleviate the muscle weight and muscle fiber reduction induced by denervation in mice. Meanwhile, the protein level of the inflammatory signal pathway and the content of 3-methylhistidine in denervated atrophic muscle were also significantly reduced (P < .05). In vitro, PHD3 knock-out could alleviate the decrease of myotube diameter induced by LPS, and the expression of protein synthesis pathway was also significantly increased (P < .05). On the contrary, the expression level of protein degradation and inflammatory signal pathway was significantly decreased (P < .05). Through these series of studies, we found that the increased expression of PHD3 in denervated muscle might be an important regulator in inducing muscle atrophy, and this process is likely to be mediated by the inflammatory NF-kappa B signal pathway.	[Li, Fan; Yin, Cong; Ma, Zewei; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Li, Fan; Yin, Cong; Ma, Zewei; Sun, Lijuan; Duan, Chen; Wang, Tao; Hussein, Abdelaziz; Wang, Lina; Zhu, Xiaotong; Gao, Ping; Xi, Qianyun; Zhang, Yongliang; Shu, Gang; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Coll Anim Sci, Guangzhou 510642, Peoples R China; [Yang, Kelin] Foshan Univ, Sch Life Sci & Engn, Guangdong Prov Key Lab Anim Mol Design & Precise, Foshan, Peoples R China	South China Agricultural University; South China Agricultural University; Foshan University	Wang, SB; Jiang, QY (corresponding author), South China Agr Univ, Guangdong Lab Lingnan Modern Agr, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou 510642, Peoples R China.; Wang, SB; Jiang, QY (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Regulat, Coll Anim Sci, Guangzhou 510642, Peoples R China.	songbowang@scau.edu.cn; qyjiang@scau.edu.cn		Hussein, Abdelaziz/0000-0002-4620-8080	Major Program of the National Natural Science Foundation of China [31790411, 31972636]; Local Innovative and Research Teams Project of Guangdong Province [2019BT02N630]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Local Innovative and Research Teams Project of Guangdong Province	This work was supported by the Major Program of the National Natural Science Foundation of China (Grant No. 31790411 to Q.Y.J, 31972636 to S.B.W). Local Innovative and Research Teams Project of Guangdong Province (Grant No. 2019BT02N630 to G.S.)	Aglan A, 2017, J MOL MED, V95, P257, DOI 10.1007/s00109-016-1503-3; Agrawal A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204283; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Amicarelli F, 1999, BBA-MOL BASIS DIS, V1453, P105, DOI 10.1016/S0925-4439(98)00088-X; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Baghdadi MB, 2018, DEV BIOL, V433, P200, DOI 10.1016/j.ydbio.2017.07.026; Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Batt JAE, 2013, JOVE-J VIS EXP, DOI 10.3791/50657; Beneke A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.375; Billin AN, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0179-5; BILMAZES C, 1978, METABOLISM, V27, P525, DOI 10.1016/0026-0495(78)90018-5; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Borisov AB, 2000, ANAT REC, V258, P292; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Buford TW, 2010, J GERONTOL A-BIOL, V65, P532, DOI 10.1093/gerona/glp196; Cai XC, 2018, FASEB J, V32, P488, DOI 10.1096/fj.201700670R; Cao RY, 2018, ADV EXP MED BIOL, V1088, P605, DOI 10.1007/978-981-13-1435-3_29; Chen R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7097580; Darby IA, 2016, CELL TISSUE RES, V365, P553, DOI 10.1007/s00441-016-2461-3; de Theije CC, 2013, AM J PHYSIOL-LUNG C, V305, pL82, DOI 10.1152/ajplung.00354.2012; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Dutt V, 2015, PHARMACOL RES, V99, P86, DOI 10.1016/j.phrs.2015.05.010; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Flandin P, 2005, FEBS LETT, V579, P3411, DOI 10.1016/j.febslet.2005.04.084; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Freeman RS, 2003, MOL CELLS, V16, P1; Fry C.S., 2016, PHYS REP, V4, DOI DOI 10.14814/PHY2.13014; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hoffmann C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029793; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kuprash DV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1237, DOI 10.1134/S0006297916110018; Lang F, 2017, DIS MODEL MECH, V10, P881, DOI 10.1242/dmm.028910; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Lee D, 2015, J BIOL CHEM, V290, P30269, DOI 10.1074/jbc.M115.685164; Li LF, 2016, TRANSL RES, V173, P131, DOI 10.1016/j.trsl.2016.03.011; Liu HM, 2019, AM J PHYSIOL-CELL PH, V316, pC456, DOI 10.1152/ajpcell.00441.2018; Loeffler JP, 2016, BRAIN PATHOL, V26, P227, DOI 10.1111/bpa.12350; MacDonald EM, 2014, DIS MODEL MECH, V7, P471, DOI 10.1242/dmm.014126; MacLauchlan SC, 2018, MATRIX BIOL, V65, P45, DOI 10.1016/j.matbio.2017.07.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin NRW, 2017, J CELL BIOCHEM, V118, P2599, DOI 10.1002/jcb.25982; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Musaro A, 2017, METHODS MOL BIOL, V1553, P155, DOI 10.1007/978-1-4939-6756-8_12; Nakagawa K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5695217; Norrby Marlene, 2012, J Mol Signal, V7, P7, DOI 10.1186/1750-2187-7-7; Okamoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03980-7; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Paudyal A, 2018, EXP GERONTOL, V106, P165, DOI 10.1016/j.exger.2018.03.008; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Place TL, 2013, HYPOXIA, V1, P13, DOI 10.2147/HP.S50091; Rishi MT, 2015, MICROVASC RES, V97, P181, DOI 10.1016/j.mvr.2014.10.009; Romanick M, 2013, BBA-MOL BASIS DIS, V1832, P1410, DOI 10.1016/j.bbadis.2013.03.011; Ross LF., 2019, NEOREVIEWS, V20, P437; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scalabrin M, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101294; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Settelmeier S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233261; Shen H, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155124; Shin J, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0079-5; Shiotani A, 2001, GENE THER, V8, P1043, DOI 10.1038/sj.gt.3301486; Sinha I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00153; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Slot IGM, 2014, CELL SIGNAL, V26, P1837, DOI 10.1016/j.cellsig.2014.04.016; Spendiff S, 2016, J PHYSIOL-LONDON, V594, P7361, DOI 10.1113/JP272487; Takeda K, 2014, AM J PATHOL, V184, P686, DOI 10.1016/j.ajpath.2013.11.032; Tang HB, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004809; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273; Wilkinson DJ, 2018, AGEING RES REV, V47, P123, DOI 10.1016/j.arr.2018.07.005; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yang J, 2018, ADV EXP MED BIOL, V1088, P329, DOI 10.1007/978-981-13-1435-3_15; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Yoon HJ, 2020, CELL METAB, V32, P215, DOI 10.1016/j.cmet.2020.06.017; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43935; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	94	2	4	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21444	10.1096/fj.202002049R	http://dx.doi.org/10.1096/fj.202002049R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749901				2022-12-26	WOS:000635216100065
J	Holm, S; Holm, T; Martinsen, OG				Holm, Sverre; Holm, Thomas; Martinsen, Orjan Grottem			Simple circuit equivalents for the constant phase element	PLOS ONE			English	Article							IMPEDANCE	The constant phase element (CPE) is a capacitive element with a frequency-independent negative phase between current and voltage which interpolates between a capacitor and a resistor. It is used extensively to model the complexity of the physics in e.g. the bioimpedance and electrochemistry fields. There is also a similar element with a positive phase angle, and both the capacitive and inductive CPEs are members of the family of fractional circuit elements or fractance. The physical meaning of the CPE is only partially understood and many consider it an idealized circuit element. The goal here is to provide alternative equivalent circuits, which may give rise to better interpretations of the fractance. Both the capacitive and the inductive CPEs can be interpreted in the time-domain, where the impulse and step responses are temporal power laws. Here we show that the current impulse responses of the capacitive CPE is the same as that of a simple time-varying series RL-circuit where the inductor's value increases linearly with time. Similarly, the voltage response of the inductive CPE corresponds to that of a simple parallel RC circuit where the capacitor's value increases linearly with time. We use the Micro-Cap circuit simulation program, which can handle time-varying circuits, for independent verification. The simulation corresponds exactly to the expected response from the proposed equivalents within 0.1% error. The realization with time-varying components correlates with known time-varying properties in applications, and may lead to a better understanding of the link between CPE and applications.	[Holm, Sverre; Martinsen, Orjan Grottem] Univ Oslo, Dept Phys, Oslo, Norway; [Holm, Thomas] Inst Energy Technol, Kjeller, Norway; [Martinsen, Orjan Grottem] Oslo Univ Hosp, Dept Clin & Biomed Engn, Oslo, Norway	University of Oslo; Institute for Energy Technology (IFE); University of Oslo	Holm, S (corresponding author), Univ Oslo, Dept Phys, Oslo, Norway.	Sverre.Holm@fys.uio.no	Martinsen, Orjan G/M-4459-2014	Martinsen, Orjan G/0000-0003-1632-4352; Holm, Thomas/0000-0002-8987-0808; Holm, Sverre/0000-0002-2273-705X				Abdelouahab MS, 2014, INT J BIFURCAT CHAOS, V24, DOI 10.1142/S0218127414300237; Allagui A, 2017, ELECTROCHIM ACTA, V258, P1081, DOI 10.1016/j.electacta.2017.11.161; Allagui A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38568; Biolkova V., 2007, P EL DEV SYS IMAPS C, V2007, P39; BRUG GJ, 1984, J ELECTROANAL CHEM, V176, P275, DOI 10.1016/s0022-0728(84)80324-1; Buckingham MJ, 2000, J ACOUST SOC AM, V108, P2796, DOI 10.1121/1.1322018; Chen WK., 2018, CIRCUITS FILTERS HDB; Chhabra RP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P3, DOI 10.1007/978-1-4419-6494-6_1; Cole K. S., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P110; Cole KS, 1928, J GEN PHYSIOL, V12, P29, DOI 10.1085/jgp.12.1.29; Di Ventra M, 2009, P IEEE, V97, P1717, DOI 10.1109/JPROC.2009.2021077; Fouda ME, 2020, AEU-INT J ELECTRON C, V117, DOI 10.1016/j.aeue.2020.153104; Gharbi O, 2020, ELECTROCHIM ACTA, V343, DOI 10.1016/j.electacta.2020.136109; Hirschorn B, 2010, J ELECTROCHEM SOC, V157, pC452, DOI 10.1149/1.3499564; Hirschorn B, 2010, ELECTROCHIM ACTA, V55, P6218, DOI 10.1016/j.electacta.2009.10.065; Holm S., 2019, WAVES POWER LAW ATTE; Holm Sverre, 2020, J Electr Bioimpedance, V11, P101, DOI 10.2478/joeb-2020-0015; Hsu CH, 2001, CORROSION, V57, P747, DOI 10.5006/1.3280607; Johnsen GK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031916; JONSCHER AK, 1977, NATURE, V267, P673, DOI 10.1038/267673a0; Kalvoy H, 2009, PHYSIOL MEAS, V30, P129, DOI 10.1088/0967-3334/30/2/002; Lasia A, 1999, MOD ASPECT ELECTROC, P143; Lee CH, 2018, COMMUN PHYS-UK, V1, DOI 10.1038/s42005-018-0035-2; Martinsen O. G., 2015, BIOIMPEDANCE BIOELEC; Martinsen OG, 1997, MED BIOL ENG COMPUT, V35, P172, DOI 10.1007/BF02530033; Orazem M. E., 2008, ELECTROCHEMICAL SOC; Pabst O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34059-6; Pandey V, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032606; Radwan AG, 2012, INT J CIRC THEOR APP, V40, P533, DOI 10.1002/cta.760; Sharma T, 2019, ELECTROCHIM ACTA, V317, P528, DOI 10.1016/j.electacta.2019.05.119; WESTERLUND S, 1994, IEEE T DIELECT EL IN, V1, P826, DOI 10.1109/94.326654; WESTERLUND S, 1991, PHYS SCRIPTA, V43, P174, DOI 10.1088/0031-8949/43/2/011; YAMAMOTO T, 1981, MED BIOL ENG COMPUT, V19, P302, DOI 10.1007/BF02442549; Yang X, 2020, INT J NONLIN MECH, V119, DOI 10.1016/j.ijnonlinmec.2019.103372; Zhang L, 2018, RENEW SUST ENERG REV, V81, P1868, DOI 10.1016/j.rser.2017.05.283; Zubair M., 2012, FRACTIONAL FIELDS WA	36	10	10	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248786	10.1371/journal.pone.0248786	http://dx.doi.org/10.1371/journal.pone.0248786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770096	Green Published, gold, Green Submitted			2022-12-26	WOS:000634833500057
J	Lee, IH; Kim, DH; Park, JS; Jeun, SS; Hong, YK; Kim, SW				Lee, Il Hwan; Kim, Do Hyun; Park, Jae-Sung; Jeun, Sin-Soo; Hong, Yong-Kil; Kim, Sung Won			Cerebrospinal fluid leakage repair of various grades developing during endoscopic transnasal transsphenoidal surgery	PLOS ONE			English	Article								Objectives We describe the strategy used to repair intraoperative leaks of various grades and define factors for preventing postoperative cerebrospinal fluid leakage (CSF) after surgery via the endoscopic endonasal transsphenoidal approach (EETA). Study design Retrospective chart review at a tertiary referral center. Methods Patients who underwent surgery via EETA from January 2009 to May 2020 were retrospectively reviewed. Intraoperative CSF leakage was graded 0-3 in terms of the dural defect size; various repairs were used depending on the grade. Results A total of 777 patients underwent 869 operations via EETA; 609 (70.1%) experienced no intraoperative CSF leakage (grade 0) but 260 (29.9%) did. Leakage was of grade 1 in 135 cases (15.5%), grade 2 in 83 (9.6%), and grade 3 in 42 (4.8%). In 260 patients with intraoperative CSF leakage, a buttress was wedged into the sellar defect site in 178 cases (68.5%) and a pedicled flap was placed in 105 cases (40.4%). Autologous fat (108 cases, 41.5%) and a synthetic dural substitute (91 cases, 35%) were used to fill the dead space of the sellar resection cavity. Postoperative CSF leakage developed in 21 patients: 6 of grade 1, 7 of grade 2, and 8 of grade 3. Buttress placement significantly decreased postoperative leakage in grade 1 patients (p = 0.041). In patients of perioperative leakage grades 2 and 3, postoperative CSF leakage was significantly reduced only when both fat and a buttress were applied (p = 0.042 and p = 0.043, respectively). Conclusion A buttress prevented postoperative CSF leakage in grade 1 patients; both fat and buttress were required by patients with intraoperative leakage of grades 2 and 3.	[Lee, Il Hwan; Kim, Do Hyun; Kim, Sung Won] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Jae-Sung; Jeun, Sin-Soo; Hong, Yong-Kil] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr	Kim, Do Hyun/AAA-2792-2021	Kim, Do Hyun/0000-0002-9248-5572				BENGTSON BP, 1993, AM J SURG, V166, P326, DOI 10.1016/S0002-9610(05)80325-3; Bohoun CA, 2019, WORLD NEUROSURG, V127, pE896, DOI 10.1016/j.wneu.2019.03.293; Cappabianca P, 2002, MINIM INVAS NEUROSUR, V45, P193, DOI 10.1055/s-2002-36197; Castelnuovo P, 2006, RHINOLOGY, V44, P2; Cavallo LM, 2014, J NEUROSURG, V121, P100, DOI 10.3171/2014.3.JNS131521; Chin CJ, 2010, J OTOLARYNGOL-HEAD N, V39, P594, DOI 10.2310/7070.2010.090212; Chivukula S, 2013, J NEUROSURG-PEDIATR, V11, P227, DOI 10.3171/2012.10.PEDS12160; Conger A, 2019, J NEUROSURG, V130, P861, DOI 10.3171/2017.11.JNS172141; Eckardt A, 2003, J CRANIO MAXILL SURG, V31, P197, DOI 10.1016/S1010-5182(03)00039-8; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; Fraser S, 2018, J NEUROSURG, V128, P1066, DOI 10.3171/2016.12.JNS1694; Ganly I, 2005, HEAD NECK-J SCI SPEC, V27, P445, DOI 10.1002/hed.20166; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4; Horridge M, 2013, BRIT J NEUROSURG, V27, P739, DOI 10.3109/02688697.2013.795525; Ivan ME, 2015, J CLIN NEUROSCI, V22, P48, DOI 10.1016/j.jocn.2014.08.009; Jeffcoate WJ, 2004, DIABETES-METAB RES, V20, pS78, DOI 10.1002/dmrr.476; Jeon CM, 2017, J CLIN NEUROSCI, V45, P227, DOI 10.1016/j.jocn.2017.07.012; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; Keshavarzi S, 2013, WOUNDS, V25, P160; Khouri RK, 1998, PLAST RECONSTR SURG, V102, P711, DOI 10.1097/00006534-199809030-00015; Kim BY, 2013, LARYNGOSCOPE, V123, P2605, DOI 10.1002/lary.24098; Kim BY, 2017, J CRANIOFAC SURG, V28, P468, DOI 10.1097/SCS.0000000000003393; Kong DS, 2011, ACTA NEUROCHIR, V153, P807, DOI 10.1007/s00701-011-0941-5; Koutourousiou M, 2013, J NEUROSURG, V119, P1194, DOI 10.3171/2013.6.JNS122259; Kshettry VR, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.9.FOCUS16292; Marin J, 1999, EXP GERONTOL, V34, P503, DOI 10.1016/S0531-5565(99)00029-7; Nicolai P, 2008, AM J RHINOL, V22, P308, DOI 10.2500/ajr.2008.22.3170; Park JH, 2015, J KOREAN NEUROSURG S, V58, P36, DOI 10.3340/jkns.2015.58.1.36; Wang YY, 2011, ACTA NEUROCHIR, V153, P815, DOI 10.1007/s00701-010-0862-8; Yannoutsos A, 2014, J HYPERTENS, V32, P216, DOI 10.1097/HJH.0000000000000021; Yoon TM, 2008, ACTA OTO-LARYNGOL, V128, P785, DOI 10.1080/00016480701730752; Zanation AM, 2011, OTOLARYNG CLIN N AM, V44, P1201, DOI 10.1016/j.otc.2011.06.016; Zanation AM, 2009, AM J RHINOL ALLERGY, V23, P518, DOI 10.2500/ajra.2009.23.3378	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248229	10.1371/journal.pone.0248229	http://dx.doi.org/10.1371/journal.pone.0248229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770089	Green Published, gold			2022-12-26	WOS:000634833500052
J	Bollmann, A; Hohenstein, S; Pellissier, V; Stengler, K; Reichardt, P; Ritz, JP; Thiele, H; Borger, MA; Hindricks, G; Meier-Hellmann, A; Kuhlen, R				Bollmann, Andreas; Hohenstein, Sven; Pellissier, Vincent; Stengler, Katharina; Reichardt, Peter; Ritz, Joerg-Peter; Thiele, Holger; Borger, Michael A.; Hindricks, Gerhard; Meier-Hellmann, Andreas; Kuhlen, Ralf			Utilization of in- and outpatient hospital care in Germany during the Covid-19 pandemic insights from the German-wide Helios hospital network	PLOS ONE			English	Article								Background During the early phase of the Covid-19 pandemic, reductions of hospital admissions with a focus on emergencies have been observed for several medical and surgical conditions, while trend data during later stages of the pandemic are scarce. Consequently, this study aims to provide up-to-date hospitalization trends for several conditions including cardiovascular, psychiatry, oncology and surgery cases in both the in- and outpatient setting. Methods and findings Using claims data of 86 Helios hospitals in Germany, consecutive cases with an in- or outpatient hospital admission between March 13, 2020 (the begin of the "protection" stage of the German pandemic plan) and December 10, 2020 (end of study period) were analyzed and compared to a corresponding period covering the same weeks in 2019. Cause-specific hospitalizations were defined based on the primary discharge diagnosis according to International Statistical Classification of Diseases and Related Health Problems (ICD-10) or German procedure classification codes for cardiovascular, oncology, psychiatry and surgery cases. Cumulative hospitalization deficit was computed as the difference between the expected and observed cumulative admission number for every week in the study period, expressed as a percentage of the cumulative expected number. The expected admission number was defined as the weekly average during the control period. A total of 1,493,915 hospital admissions (723,364 during the study and 770,551 during the control period) were included. At the end of the study period, total cumulative hospitalization deficit was -10% [95% confidence interval -10; -10] for cardiovascular and -9% [-10; -9] for surgical cases, higher than -4% [-4; -3] in psychiatry and 4% [4; 4] in oncology cases. The utilization of inpatient care and subsequent hospitalization deficit was similar in trend with some variation in magnitude between cardiovascular (-12% [-13; -12]), psychiatry (-18% [-19; -17]), oncology (-7% [-8; -7]) and surgery cases (-11% [-11; -11]). Similarly, cardiovascular and surgical outpatient cases had a deficit of -5% [-6; -5] and -3% [-4; -3], respectively. This was in contrast to psychiatry (2% [1; 2]) and oncology cases (21% [20; 21]) that had a surplus in the outpatient sector. While in-hospital mortality, was higher during the Covid-19 pandemic in cardiovascular (3.9 vs. 3.5%, OR 1.10 [95% CI 1.06-1.15], P<0.01) and in oncology cases (4.5 vs. 4.3%, OR 1.06 [95% CI 1.01-1.11], P<0.01), it was similar in surgical (0.9 vs. 0.8%, OR 1.06 [95% CI 1.00-1.13], P = 0.07) and in psychiatry cases (0.4 vs. 0.5%, OR 1.01 [95% CI 0.78-1.31], P<0.95). Conclusions There have been varying changes in care pathways and in-hospital mortality in different disciplines during the Covid-19 pandemic in Germany. Despite all the inherent and well-known limitations of claims data use, this data may be used for health care surveillance as the pandemic continues worldwide. While this study provides an up-to-date analysis of utilization of hospital care in the largest German hospital network, short- and long-term consequences are unknown and deserve further studies.	[Bollmann, Andreas; Hohenstein, Sven; Pellissier, Vincent; Thiele, Holger; Borger, Michael A.; Hindricks, Gerhard] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany; [Bollmann, Andreas; Hohenstein, Sven; Pellissier, Vincent; Thiele, Holger; Borger, Michael A.; Hindricks, Gerhard] Leipzig Heart Inst, Leipzig, Germany; [Stengler, Katharina] Helios Pk Hosp, Dept Psychiat Psychotherapy & Psychosomat, Leipzig, Germany; [Reichardt, Peter] Helios Hosp Berlin Buch, Oncol Ctr Berlin Buch, Berlin, Germany; [Reichardt, Peter] Berlin Canc Inst, Berlin, Germany; [Ritz, Joerg-Peter] Helios Hosp Schwerin, Dept Surg, Schwerin, Germany; [Meier-Hellmann, Andreas] Helios Kliniken, Berlin, Germany; [Kuhlen, Ralf] Helios Hlth, Berlin, Germany	Heart Center Leipzig GMBH; Leipzig University; Heart Center Leipzig GMBH; Helios Kliniken	Bollmann, A (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany.; Bollmann, A (corresponding author), Leipzig Heart Inst, Leipzig, Germany.	andreas.bollmann@helios-gesundheit.de	Borger, Michael/AAX-1514-2020	Borger, Michael/0000-0003-1046-1364; Hohenstein, Sven/0000-0002-9708-1593; Bollmann, Andreas/0000-0002-5441-3906				Anderson TS, 2020, J GEN INTERN MED, V35, P3129, DOI 10.1007/s11606-020-06027-2; Baum A, 2020, JAMA-J AM MED ASSOC, V324, P96, DOI 10.1001/jama.2020.9972; Bollmann A, 2020, EUR HEART J QUAL CAR, DOI [10.1093/ehjqcco/qcaa071, DOI 10.1093/EHJQCCO/QCAA071]; Bollmann A, 2020, EUR HEART J-QUAL CAR, V6, P221, DOI 10.1093/ehjqcco/qcaa049; Cozad M, 2019, AM J PUBLIC HEALTH, V109, P1584, DOI 10.2105/AJPH.2019.305317; Gluckman TJ, 2020, JAMA CARDIOL, V5, P1419, DOI 10.1001/jamacardio.2020.3629; Konig S, 2020, EUR J HEART FAIL, V22, P2190, DOI 10.1002/ejhf.2044; Konig S, 2018, EUR HEART J, V39, P3947, DOI 10.1093/eurheartj/ehy528; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0; Oseran AS, 2020, AM J MANAG CARE, V26, P327, DOI 10.37765/ajmc.2020.43837; Singh S, 2020, RESUSCITATION, V156, P164, DOI 10.1016/j.resuscitation.2020.08.133; Stang A, 2020, J INFECTION, V81, P797, DOI 10.1016/j.jinf.2020.09.012; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	14	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249251	10.1371/journal.pone.0249251	http://dx.doi.org/10.1371/journal.pone.0249251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765096	gold, Green Published			2022-12-26	WOS:000634832800030
J	Chu, J				Chu, Jeffrey			A statistical analysis of the novel coronavirus (COVID-19) in Italy and Spain	PLOS ONE			English	Article							TRANSMISSION; MODEL; CHINA	The novel coronavirus (COVID-19) that was first reported at the end of 2019 has impacted almost every aspect of life as we know it. This paper focuses on the incidence of the disease in Italy and Spain-two of the first and most affected European countries. Using two simple mathematical epidemiological models-the Susceptible-Infectious-Recovered model and the log-linear regression model, we model the daily and cumulative incidence of COVID-19 in the two countries during the early stage of the outbreak, and compute estimates for basic measures of the infectiousness of the disease including the basic reproduction number, growth rate, and doubling time. Estimates of the basic reproduction number were found to be larger than 1 in both countries, with values being between 2 and 3 for Italy, and 2.5 and 4 for Spain. Estimates were also computed for the more dynamic effective reproduction number, which showed that since the first cases were confirmed in the respective countries the severity has generally been decreasing. The predictive ability of the log-linear regression model was found to give a better fit and simple estimates of the daily incidence for both countries were computed.	[Chu, Jeffrey] Renmin Univ China, Sch Stat, Beijing, Peoples R China	Renmin University of China	Chu, J (corresponding author), Renmin Univ China, Sch Stat, Beijing, Peoples R China.	jeffrey.jchu@gmail.com						Alboaneen D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124568; [Anonymous], 2020, REUTERS; Arora P, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110017; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Bastos S.B., 2020, ARXIV200314288V2; Berenguer J, 2020, CLIN MICROBIOL INFEC, V26, P1525, DOI 10.1016/j.cmi.2020.07.024; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; Buonomo B, 2008, MATH BIOSCI, V216, P9, DOI 10.1016/j.mbs.2008.07.011; Calafiore GC, 2020, ANNU REV CONTROL, V50, P361, DOI 10.1016/j.arcontrol.2020.10.005; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Caruso D, 2020, RADIOLOGY, V296, pE79, DOI 10.1148/radiol.2020201237; Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), 2020, CORONAVIRUS COVID 19; Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817; Cori A., 2019, EPIESTIM ESTIMATE TI; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Correia AM, 2011, SPRINGER PROC MATH, V2, P247, DOI 10.1007/978-3-642-14788-3_19; d'Onofrio A, 2005, APPL MATH LETT, V18, P729, DOI 10.1016/j.aml.2004.05.012; Deng Y., ESTIMATION TIME VARY; Dottori M, 2015, PHYSICA A, V434, P25, DOI 10.1016/j.physa.2015.04.007; Du ZC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179623; Eurostat, 2019, POPULATION DEMOGRAPH; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Forster PM, 2020, NAT CLIM CHANGE, V10, P913, DOI 10.1038/s41558-020-0883-0; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Garba SM, 2020, MATH BIOSCI, V328, DOI 10.1016/j.mbs.2020.108441; Ghysels E, 2016, J ECONOMETRICS, V193, P294, DOI 10.1016/j.jeconom.2016.04.008; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; GitHub, 2020, PCM DPCCOVID 19 COVI; GitHub, 2020, DATASETSCOVID 19 MAS; Godefroy R., 2020, ESTIMATING COVID 19; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Jombart T., 2019, EPITRIX SMALL HELPER; Jombart T., 2018, PROJECTIONS PROJECT; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kuzin V, 2011, INT J FORECASTING, V27, P529, DOI 10.1016/j.ijforecast.2010.02.006; Li Jing, 2011, Comput Math Methods Med, V2011, P527610, DOI 10.1155/2011/527610; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Lu ZH, 2002, MATH COMPUT MODEL, V36, P1039, DOI 10.1016/S0895-7177(02)00257-1; McAlinn K, 2020, J AM STAT ASSOC, V115, P1092, DOI 10.1080/01621459.2019.1660171; McAlinn K, 2019, J ECONOMETRICS, V210, P155, DOI 10.1016/j.jeconom.2018.11.010; McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P55, DOI 10.1016/j.nonrwa.2008.10.014; McKinsey & Company, 2020, COVID 19 IMPLICATION; Mei S, 2020, Lancet Infect Dis, V20, P911; Ministerio de Sanidad Consumo y Bienestar Social, ENFERMEDAD NUEVO COR; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884; Ogundokun RO, 2020, INFECT DIS MODEL, V5, P543, DOI 10.1016/j.idm.2020.08.003; Omori R, 2020, INT J INFECT DIS, V96, P673, DOI 10.1016/j.ijid.2020.04.080; Osthus D, 2017, ANN APPL STAT, V11, P202, DOI 10.1214/16-AOAS1000; Palmieri L, 2020, J GERONTOL A-BIOL, V75, P1796, DOI 10.1093/gerona/glaa146; Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007; Park H, 2020, ENVIRON RESOUR ECON, V76, P665, DOI 10.1007/s10640-020-00439-8; Pham H, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8050655; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Qi C., 2020, ARXIV200401575V1; R Development Core Team, 2020, R LANGUAGE ENV STAT; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Roques L., 2020, ARXIV200310720V3; Sarkar K, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110049; Satsuma J, 2004, PHYSICA A, V336, P369, DOI 10.1016/j.physa.2003.12.035; Schumacher J, 2020, incidence: Compute, Handle, Plot and Model Incidence of Dated Events; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; Soreide K, 2020, BRIT J SURG, V107, P1250, DOI 10.1002/bjs.11670; Stolerman LM, 2015, SIAM J APPL MATH, V75, P2581, DOI 10.1137/140996148; Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6; Stubinger J, 2020, ALGORITHMS, V13, DOI 10.3390/a13040095; Stubinger J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020099; Stubinger J, 2019, QUANT FINANC, V19, P921, DOI 10.1080/14697688.2018.1537503; Taboe HB, 2020, MATH BIOSCI, V328, DOI 10.1016/j.mbs.2020.108431; Takele R, 2020, INFECT DIS MODEL, V5, P598, DOI 10.1016/j.idm.2020.08.005; The World Health Organization, 2020, IMMUNITY PASSPORTS C; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Towers S, 2011, J THEOR BIOL, V289, P259, DOI 10.1016/j.jtbi.2011.08.011; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang PP, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110058; Worldometer, 2020, WORLDOMETER REAL TIM; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Wu J, 2020, NEUROCOMPUTING, V395, P78, DOI 10.1016/j.neucom.2020.02.017; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xu R, 2009, NONLINEAR ANAL-REAL, V10, P3175, DOI 10.1016/j.nonrwa.2008.10.013; Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050; Zakary O., 2016, INT J COMPUTER APPL, V133, DOI [10.5120/ijca2016908030, DOI 10.5120/IJCA2016908030]; Zaman G, 2008, BIOSYSTEMS, V93, P240, DOI 10.1016/j.biosystems.2008.05.004; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhao ZB, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138959; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	91	21	21	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249037	10.1371/journal.pone.0249037	http://dx.doi.org/10.1371/journal.pone.0249037			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765088	gold, Green Published			2022-12-26	WOS:000634832800107
J	Walters, KJ; Lopez, RG				Walters, Kellie J.; Lopez, Roberto G.			Modeling growth and development of hydroponically grown dill, parsley, and watercress in response to photosynthetic daily light integral and mean daily temperature	PLOS ONE			English	Article								In controlled environments, crop models that incorporate environmental factors can be developed to optimize growth and development as well as conduct cost and/or resource use benefit analyses. The overall objective of this study was to model growth and development of dill 'Bouquet' (Anethum graveolens), parsley 'Giant of Italy' (Petroselinum crispum), and watercress (Nasturtium officinale) in response to photosynthetic daily light integral (DLI) and mean daily temperature (MDT). Plants were grown hydroponically in five greenhouse compartments with MDTs ranging from 9.7 to 27.2 degrees C under 0%, 30%, or 50% shade cloth to create DLIs ranging from 6.2 to 16.9 mol.m(2).d(1). MDT and DLI interacted to influence dill fresh mass and height, and watercress maximum quantum yield of dark adapted leaves (F-v/F-m), height, and branch number while only MDT affected dill leaf number and watercress fresh mass and branch length. Besides dry matter concentration (DMC), parsley was influenced by MDT and not DLI. Increasing MDT from approximate to 10 to 22.4 degrees C (parsley) or 27.2 degrees C (dill and watercress), linearly or near-linearly increased fresh mass. For dill, increasing DLI decreased fresh mass when MDT was low (9.7 to 13.9 degrees C) and increased fresh mass when MDT was high (18.4 to 27.2 degrees C). DMC of dill, parsley, and watercress increased as MDT decreased or DLI increased, indicating a higher proportion of plant fresh mass is water at higher MDTs or lower DLIs. With these data we have created growth and development models for culinary herbs to aid in predicting responses to DLI and MDT.	[Walters, Kellie J.; Lopez, Roberto G.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Walters, Kellie J.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA	Michigan State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Walters, KJ (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.; Walters, KJ (corresponding author), Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA.	waltersk@utk.edu		Walters, Kellie/0000-0002-7171-2000	Michigan State University AgBioResearch [GREEEN GR19-019]; United States Department of Agriculture National Institute of Food and Agriculture [MICL024772]; Fred C. Gloeckner Foundation, Inc.	Michigan State University AgBioResearch; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Fred C. Gloeckner Foundation, Inc.	R.G.L. and K.J.W. Project GREEEN GR19-019 Michigan State University AgBioResearch https://www.canr.msu.edu/research/R.G.L.Hatch project MICL024772 United States Department of Agriculture National Institute of Food and Agriculture https://nifa.usda.gov/program/hatch-act-1887-multistate-research-fund R.G.L. and K.J.W. The Fred C. Gloeckner Foundation, Inc. http://www.gloecknerfoundation.org/fundingp.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 1997, ANN BOT-LONDON, V80, P107, DOI 10.1006/anbo.1997.0411; Adams SR, 1997, ANN BOT-LONDON, V79, P219, DOI 10.1006/anbo.1996.0347; [Anonymous], U.S. Department of Agriculture (USDA)-National Agriculture Statistics Service. 2014 U.S. Census of Horticulture Specialties; [Anonymous], Both, A.J. & Faust, J.E. Light transmission. in Light Management in Controlled Environments (eds Lopez, R.G, & Runkle, E.S.) Meister Media Worldwide, Willoughby OH. (2017).; [Anonymous], U.S. Agency for International Development -Acceso. The U.S. market for fresh herbs. Market Brief #20. <; Beaman AR, 2009, HORTSCIENCE, V44, P64, DOI 10.21273/HORTSCI.44.1.64; BEINHART G, 1962, PLANT PHYSIOL, V37, P709, DOI 10.1104/pp.37.6.709; Blanchard MG, 2011, SCI HORTIC-AMSTERDAM, V129, P313, DOI 10.1016/j.scienta.2011.03.044; Chang XM, 2005, J HORTIC SCI BIOTECH, V80, P593, DOI 10.1080/14620316.2005.11511983; CHERMNYKH L N, 1987, Biotronics, V16, P1; COCKSHULL KE, 1992, J HORTIC SCI, V67, P11, DOI 10.1080/00221589.1992.11516215; Currey CJ, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9070389; Currey CJ, 2012, HORTSCIENCE, V47, P25, DOI 10.21273/HORTSCI.47.1.25; DEKONING ANM, 1990, SCI HORTIC-AMSTERDAM, V45, P117, DOI 10.1016/0304-4238(90)90074-O; DEKONING ANM, 1988, J HORTIC SCI, V63, P465, DOI 10.1080/14620316.1988.11515880; Dou HJ, 2018, HORTSCIENCE, V53, P496, DOI [10.21273/hortsci12785-17, 10.21273/HORTSCI12785-17]; Engelen-Eigles G, 2006, J AGR FOOD CHEM, V54, P328, DOI 10.1021/jf051857o; ENOCH HZ, 1977, J EXP BOT, V28, P84, DOI 10.1093/jxb/28.1.84; Fausey BA, 2005, HORTSCIENCE, V40, P114, DOI 10.21273/HORTSCI.40.1.114; Faust JE, 2018, HORTSCIENCE, V53, P1250, DOI 10.21273/HORTSCI13144-18; Faust JE, 2005, HORTSCIENCE, V40, P645, DOI 10.21273/HORTSCI.40.3.645; FAUST JE, 1994, J AM SOC HORTIC SCI, V119, P727, DOI 10.21273/JASHS.119.4.72; Fraszczak B., 2009, Vegetable Crops Research Bulletin, V71, P59, DOI 10.2478/v10032-009-0027-6; Gent MPN, 2014, HORTSCIENCE, V49, P173, DOI 10.21273/HORTSCI.49.2.173; HOWARD HW, 1952, J ECOL, V40, P228, DOI 10.2307/2258032; Hurd R.G, 1983, ACTA HORT, V148, P547; KARLSSON MG, 1991, SCI HORTIC-AMSTERDAM, V45, P323, DOI 10.1016/0304-4238(91)90078-D; Korner O, 2003, J HORTIC SCI BIOTECH, V78, P335; Litvin-Zabal A.G, QUANTIFYING EFFECTS; Liu WD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35384; Moccaldi LA, 2007, J AM SOC HORTIC SCI, V132, P283, DOI 10.21273/JASHS.132.3.283; Morgan A, 2016, HORTSCIENCE, V51, pS219; Oh W, 2015, HORTIC ENVIRON BIOTE, V56, P762, DOI 10.1007/s13580-015-1124-8; Pramuk LA, 2005, J AM SOC HORTIC SCI, V130, P813, DOI 10.21273/JASHS.130.6.813; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; TAYLOR AO, 1971, PLANT PHYSIOL, V47, P713, DOI 10.1104/pp.47.5.713; Walters KJ, 2020, HORTSCIENCE, V55, P758, DOI 10.21273/HORTSCI14901-20; Walters KJ, 2019, HORTSCIENCE, V54, P1915, DOI 10.21273/HORTSCI12976-18	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248662	10.1371/journal.pone.0248662	http://dx.doi.org/10.1371/journal.pone.0248662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765084	gold, Green Published			2022-12-26	WOS:000634832800045
J	Frasca, D; Reidy, L; Cray, C; Diaz, A; Romero, M; Kahl, K; Blomberg, BB				Frasca, Daniela; Reidy, Lisa; Cray, Carolyn; Diaz, Alain; Romero, Maria; Kahl, Kristin; Blomberg, Bonnie B.			Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients	PLOS ONE			English	Article							BODY-MASS INDEX; B-CELLS; ADIPOSE-TISSUE; INFLAMMATION; LEPTIN; SECRETION; INFECTION; EXPANSION; RESPONSES; FERRITIN	SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-2), cause of COVID-19 (Coronavirus Disease of 2019), represents a significant risk to people living with pre-existing conditions associated with exacerbated inflammatory responses and consequent dysfunctional immunity. In this paper, we have evaluated the influence of obesity, a condition associated with chronic systemic inflammation, on the secretion of SARS-CoV-2-specific IgG antibodies in the blood of COVID-19 patients. Our hypothesis is that obesity is associated with reduced amounts of specific IgG antibodies. Results have confirmed our hypothesis and have shown that SARS-CoV-2 IgG antibodies are negatively associated with Body Mass Index (BMI) in COVID-19 obese patients, as expected based on the known influence of obesity on humoral immunity. Antibodies in COVID-19 obese patients are also negatively associated with serum levels of pro-inflammatory and metabolic markers of inflammaging and pulmonary inflammation, such as SAA (serum amyloid A protein), CRP (C-reactive protein), and ferritin, but positively associated with NEFA (nonesterified fatty acids). These results altogether could help to identify an inflammatory signature with strong predictive value for immune dysfunction. Inflammatory markers identified may subsequently be targeted to improve humoral immunity in individuals with obesity and in individuals with other chronic inflammatory conditions.	[Frasca, Daniela; Diaz, Alain; Romero, Maria; Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Frasca, Daniela; Blomberg, Bonnie B.] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA; [Reidy, Lisa; Cray, Carolyn; Kahl, Kristin] Univ Miami, Dept Pathol & Lab Med, Miller Sch Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Frasca, D (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.; Frasca, D (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL 33136 USA.; Reidy, L (corresponding author), Univ Miami, Dept Pathol & Lab Med, Miller Sch Med, Miami, FL 33136 USA.	dfrasca@med.miami.edu; lreidy@med.miami.edu			NIH [AG32576, AG059719, AG023717]; University of Miami Department of Pathology AMP; Laboratory Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami Department of Pathology AMP; Laboratory Medicine	NIH awards AG32576 (DF/BBB), AG059719 (DF), AG023717(BBB/DF) and the University of Miami Department of Pathology & Laboratory Medicine.	Adlowitz DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128269; Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Apovian CM, 2012, CIRCULATION, V125, P1178, DOI 10.1161/CIRCULATIONAHA.111.022541; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; BALLOU SP, 1992, CYTOKINE, V4, P361, DOI 10.1016/1043-4666(92)90079-7; Casadevall A, 2020, J CLIN INVEST, V130, P1545, DOI 10.1172/JCI138003; Casas R, 2014, ENDOCR METAB IMMUNE, V14, P245, DOI 10.2174/1871530314666140922153350; Cheng L, 2020, INFECTION, V48, P715, DOI 10.1007/s15010-020-01468-7; Chiappetta S, 2020, INT J OBESITY, V44, P1790, DOI 10.1038/s41366-020-0597-4; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Cui GH, 2021, J GENE MED, V23, DOI 10.1002/jgm.3297; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franssen FME, 2008, THORAX, V63, P1110, DOI 10.1136/thx.2007.086827; Frasca D, 2020, ANNU REV CELL DEV BI, V36, P551, DOI 10.1146/annurev-cellbio-011620-034148; Frasca D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00392; Frasca D, 2020, CELL IMMUNOL, V348, DOI 10.1016/j.cellimm.2019.103994; Frasca D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219545; Frasca D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197472; Frasca D, 2017, EXP GERONTOL, V87, P113, DOI 10.1016/j.exger.2016.12.001; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Frasca D, 2014, EXP GERONTOL, V54, P116, DOI 10.1016/j.exger.2014.01.004; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; George MD, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-015-0550-z; Golinski ML, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00032; Gomez-Pastora J, 2020, CLIN CHIM ACTA, V509, P249, DOI 10.1016/j.cca.2020.06.033; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Gupta S, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-3; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Khurana S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101140; Kruglikov IL, 2020, OBESITY, V28, P1187, DOI 10.1002/oby.22856; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Langhi DM, 2020, HEMATOL TRANSF CELL, V42, P113, DOI 10.1016/j.htct.2020.04.003; Li H, 2020, J INFECTION, V80, P646, DOI 10.1016/j.jinf.2020.03.035; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370; Manson JJ, 2020, LANCET RHEUMATOL, V2, pE594, DOI 10.1016/S2665-9913(20)30275-7; Martorana A, 2014, IMMUNOL LETT, V162, P303, DOI 10.1016/j.imlet.2014.06.003; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Montecucco F, 2008, J LEUKOCYTE BIOL, V84, P1109, DOI 10.1189/jlb.0208123; Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344; Murugan A T, 2008, Chron Respir Dis, V5, P233, DOI 10.1177/1479972308096978; Nevalainen T, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0159-6; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Shea D, 2013, INT J OBESITY, V37, P1510, DOI 10.1038/ijo.2013.16; Oysyannikova IG, 2014, VACCINE, V32, P881, DOI 10.1016/j.vaccine.2013.12.009; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ritter A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165793; Rottoli M, 2020, EUR J ENDOCRINOL, V183, P389, DOI 10.1530/EJE-20-0541; Ruscitti P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69031-w; Saadoun D, 2013, ARTHRITIS RHEUM-US, V65, P1085, DOI 10.1002/art.37828; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Setty AR, 2007, ARCH INTERN MED, V167, P1670, DOI 10.1001/archinte.167.15.1670; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Sun L, 2014, EUR J IMMUNOL, V44, P2153, DOI 10.1002/eji.201344310; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Toelzer C, 2020, SCIENCE, V370, P725, DOI 10.1126/science.abd3255; van der Voort PHJ, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04696; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	79	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0245424	10.1371/journal.pone.0245424	http://dx.doi.org/10.1371/journal.pone.0245424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760825	gold, Green Published			2022-12-26	WOS:000633030400039
J	Haendiges, J; Jinneman, K; Gonzalez-Escalona, N				Haendiges, Julie; Jinneman, Karen; Gonzalez-Escalona, Narjol			Choice of library preparation affects sequence quality, genome assembly, and precise in silico prediction of virulence genes in shiga toxin-producing Escherichia coli	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; OUTBREAK	Whole genome sequencing (WGS) provides essential public health information and is used worldwide for pathogen surveillance, epidemiology, and source tracking. Foodborne pathogens are often sequenced using rapid library preparation chemistries based on transposon technology; however, this method may miss random segments of genomes that can be important for accurate downstream analyses. As new technologies become available, it may become possible to achieve better overall coverage. Here we compare the sequence quality obtained using libraries prepared from the Nextera XT and Nextera DNA Prep (Illumina, San Diego, CA) chemistries for 31 Shiga toxin-producing Escherichia coli (STEC) O121:H19 strains, which had been isolated from flour during a 2016 outbreak. The Nextera DNA Prep gave superior performance metrics including sequence quality, assembly quality, uniformity of genome coverage, and virulence gene identification, among other metrics. Comprehensive detection of virulence genes is essential for making educated assessments of STECs virulence potential. The phylogenetic SNP analysis did not show any differences in the variants detected by either library preparation method which allows isolates prepared from either library method to be analysed together. Our comprehensive comparison of these chemistries should assist researchers wishing to improve their sequencing workflow for STECs and other genomic risk assessments.	[Haendiges, Julie; Gonzalez-Escalona, Narjol] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Jinneman, Karen] US FDA, Off Regulatory Affairs, Bothell, WA USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Haendiges, J; Gonzalez-Escalona, N (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	Julie.Haendiges@fda.hhs.gov; narjol.gonzalez-escalona@fda.hhs.gov		Haendiges, Julie/0000-0003-0109-9711; Gonzalez-Escalona, Narjol/0000-0003-4568-0022	FDA Foods Science and Research Intramural Program	FDA Foods Science and Research Intramural Program	This work was supported by the FDA Foods Science and Research Intramural Program.	Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Bruinsma S, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5096-9; Crowe SJ, 2017, NEW ENGL J MED, V377, P2036, DOI [10.1056/NEJMoa1615910, 10.1056/nejmoa1615910]; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Frank C, 2011, EUROSURVEILLANCE, V16, P2; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gargis AS, 2016, J CLIN MICROBIOL, V54, P2857, DOI 10.1128/JCM.00949-16; Garmendia J, 2005, J CLIN MICROBIOL, V43, P5715, DOI 10.1128/JCM.43.11.5715-5720.2005; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gonzalez-Escalona N., 2019, MICROBIOL RESOUR ANN, V8; Gonzalez-Escalona N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220494; Gonzalez-Escalona N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214620; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kozyreva VK, 2017, J CLIN MICROBIOL, V55, P2502, DOI 10.1128/JCM.00361-17; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Ooka T, 2009, GENOME RES, V19, P1809, DOI 10.1101/gr.089615.108; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seth-Smith HMB, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00241; Stamatakis Alexandros, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi0614s51; Tozzoli R, 2005, J CLIN MICROBIOL, V43, P4052, DOI 10.1128/JCM.43.8.4052-4056.2005; Tyler AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148676; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0242294	10.1371/journal.pone.0242294	http://dx.doi.org/10.1371/journal.pone.0242294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33761524	Green Published, gold			2022-12-26	WOS:000633030400004
J	Nique, AM; Coronado-Marquina, F; Rico, JAM; Mendoza, MPG; Rojas-Serrano, N; Simas, PVM; Sanchez, CC; Drexler, JF				Nique, Adolfo Marcelo; Coronado-Marquina, Fiorella; Rico, Jairo Andres Mendez; Mendoza, Maria Paquita Garcia; Rojas-Serrano, Nancy; Simas, Paulo Vitor Marques; Sanchez, Cesar Cabezas; Drexler, Jan Felix			A faster and less costly alternative for RNA extraction of SARS-CoV-2 using proteinase k treatment followed by thermal shock	PLOS ONE			English	Article								One of the biggest challenges during the pandemic has been obtaining and maintaining critical material to conduct the increasing demand for molecular tests. Sometimes, the lack of suppliers and the global shortage of these reagents, a consequence of the high demand, make it difficult to detect and diagnose patients with suspected SARS-CoV-2 infection, negatively impacting the control of virus spread. Many alternatives have enabled the continuous processing of samples and have presented a decrease in time and cost. These measures thus allow broad testing of the population and should be ideal for controlling the disease. In this sense, we compared the SARS-CoV-2 molecular detection effectiveness by Real time RT-PCR using two different protocols for RNA extraction. The experiments were conducted in the National Institute of Health (INS) from Peru. We compared Ct values average (experimental triplicate) results from two different targets, a viral and internal control. All samples were extracted in parallel using a commercial kit and our alternative protocol-samples submitted to proteinase K treatment (3 mu g/mu L, 56 degrees C for 10 minutes) followed by thermal shock (98 degrees C for 5 minutes followed by 4 degrees C for 2 minutes); the agreement between results was 100% in the samples tested. In addition, we compared the COVID-19 positivity between six epidemiological weeks: the initial two in that the Real time RT-PCR reactions were conducted using RNA extracted by commercial kit, followed by two other using RNA obtained by our kit-free method, and the last two using kit once again; they did not differ significantly. We concluded that our in-house method is an easy, fast, and cost-effective alternative method for extracting RNA and conducing molecular diagnosis of COVID-19.	[Nique, Adolfo Marcelo; Coronado-Marquina, Fiorella; Mendoza, Maria Paquita Garcia; Rojas-Serrano, Nancy; Simas, Paulo Vitor Marques; Sanchez, Cesar Cabezas] Natl Inst Hlth INS, Inst Nacl Salud INS, Lima, Peru; [Rico, Jairo Andres Mendez] Pan Amer Hlth Org PAHO, Washington, DC USA; [Simas, Paulo Vitor Marques] Univ San Marcos, Fac Vet Med, Univ Nacl Mayor San Marcos UNMSM, Lima, Peru; [Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany	Instituto Nacional de Salud - Peru; Pan American Health Organization; Universidad Nacional Mayor de San Marcos; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nique, AM (corresponding author), Natl Inst Hlth INS, Inst Nacl Salud INS, Lima, Peru.	adolfo.marcelo.n@gmail.com	Drexler, Jan Felix/GMW-5098-2022	Drexler, Jan Felix/0000-0002-3509-0232; Simas, Paulo Vitor Marques/0000-0003-2241-6915; CABEZAS, CESAR/0000-0001-5120-0713	Nacional Institute of Health (NIH); Ministry of Health from Peru	Nacional Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health from Peru	This study was supported by Nacional Institute of Health (NIH), state Institution associated whit Ministry of Health from Peru. We thank the Pan American Health Organization (PAHO) for providing primers, probes and referential controls and the initial protocol for RNA extraction using thermal shock.	Bruce EA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000896; cdc.gov, INTERIM GUIDELINES C; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Fraczek MG., 2020, CURR PROTOC MICROBIO; Hessling M, 2020, GMS HYG INFECT CONTR, V15, DOI 10.3205/dgkh000351; Kriegova E, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080605; La Rosa G., 2020, SCI TOTAL ENVIRON, V736, DOI [10.1016/j.scitotenv.2020.139652, DOI 10.1016/j.scitotenv.2020.139652]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Merindol N, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104423; Michel D, 2020, J VIROL METHODS, V286, DOI 10.1016/j.jviromet.2020.113965; Sawilowsky S., 2002, J MODERN APPL STAT M, V1, P461, DOI DOI 10.22237/JMASM/1036109940; Smyrlaki I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18611-5; Wang J, 2020, INT J INFECT DIS, V94, P103, DOI 10.1016/j.ijid.2020.04.024; who.int, WHO GUIDELINES COLLE; who.int [Internet]. World Health Organization, EMERGENCY CORONAVIRU; wma.net, WMA DECLARATION HELS; Wozniak A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73616-w	18	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248885	10.1371/journal.pone.0248885	http://dx.doi.org/10.1371/journal.pone.0248885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760876	Green Published, gold			2022-12-26	WOS:000633030400034
J	Hill, SV; Johnson, J; Rahman, F; Dauria, EF; Mugavero, M; Matthews, LT; Simpson, T; Elopre, L				Hill, Samantha, V; Johnson, Jarvis; Rahman, Fazlur; Dauria, Emily F.; Mugavero, Michael; Matthews, Lynn T.; Simpson, Tina; Elopre, Latesha			Exploring adults as support persons for improved pre-exposure prophylaxis for HIV use among select adolescents and young adults in the Deep South	PLOS ONE			English	Article								Purpose Pre-exposure prophylaxis for HIV (PrEP) is an effective yet underutilized biomedical tool for adolescents and young adults' (AYA) HIV prevention due to barriers such as PrEP adherence. We assessed HIV prevention knowledge, attitudes and beliefs from adults who self-identified as a primary support person to an AYA. Methods We surveyed AYA primary support persons at an academic hospital. Univariate and multivariate regression analyses were completed to identify factors associated with the belief AYAs engaging in HIV-associated behaviors should use PrEP and willingness to support AYAs on PrEP. Results 200 primary support persons completed the survey. Participants were predominately female (77%) and black (56%). Nearly all primary support persons believed AYAs engaging in HIV-associated behaviors should take PrEP (94%) and 98% would support an AYA taking PrEP via transportation to appointments, assistance with refilling prescriptions, medication reminders, or encouragement. Conclusions Primary support persons are willing to support AYAs using PrEP.	[Hill, Samantha, V; Simpson, Tina] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35294 USA; [Johnson, Jarvis] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Rahman, Fazlur] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Dauria, Emily F.] Univ Calif San Francisco, Div Infant Child & Adolescent Psychiat, San Francisco, CA 94143 USA; [Mugavero, Michael; Matthews, Lynn T.; Elopre, Latesha] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Hill, SV (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35294 USA.	shill@peds.uab.eu	; Dauria, Emily/AEU-8168-2022	Hill, Samantha/0000-0002-4103-9329; Dauria, Emily/0000-0003-4706-7782	University of Alabama at Birmingham (UAB) Department of Pediatrics Dixon Fellowship	University of Alabama at Birmingham (UAB) Department of Pediatrics Dixon Fellowship	Funded studies Recipient: SVH Funder: University of Alabama at Birmingham (UAB) Department of Pediatrics Dixon Fellowship Award URL: https://www.uab.edu/medicine/peds/newsevents/department-news/1880-2018-dixon-fellows-announced The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSVu, LOC DAT AL; Allen E, 2017, CURR OPIN PEDIATR, V29, P399, DOI 10.1097/MOP.0000000000000512; Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Behavior Health. and Education Health, THEORY RES PRACTICE; Bouris A, 2017, AIDS BEHAV, V21, P3618, DOI 10.1007/s10461-017-1954-8; Centers for Disease Control and Prevention, HIV US DEP AR; Centers for Disease Control and Prevention, HIV YOUTH; Dashiff C, 2008, J ADV NURS, V62, P140, DOI 10.1111/j.1365-2648.2007.04549.x; Denison JA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19358; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Dittus P, 2004, J CHILD FAM STUD, V13, P5, DOI DOI 10.1023/B:JCFS.0000010487.46007.08; Fletcher FE, 2018, J EMPIR RES HUM RES, V13, P173, DOI 10.1177/1556264618755919; Goethals ER, 2017, J PEDIATR PSYCHOL, V42, P922, DOI 10.1093/jpepsy/jsx053; Grieb SM, 2018, AIDS PATIENT CARE ST, V32, P208, DOI 10.1089/apc.2018.0012; Guilamo-Ramos V, 2011, J ADOLESCENT HEALTH, V48, P159, DOI 10.1016/j.jadohealth.2010.06.007; Hart-Cooper GD, 2018, J ADOLESCENT HEALTH, V63, P242, DOI 10.1016/j.jadohealth.2018.03.016; Hill SV., 2019, SEX T DIS 2019; HIV.gov, WHAT IS END HIV EP P; Hosek SG, 2017, JAMA PEDIATR, V171, P1063, DOI 10.1001/jamapediatrics.2017.2007; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Marhefka SL, 2006, AIDS PATIENT CARE ST, V20, P429, DOI 10.1089/apc.2006.20.429; Naar-King S, 2009, J PEDIATR PSYCHOL, V34, P187, DOI 10.1093/jpepsy/jsn065; Rice WS, 2019, AIDS BEHAV, V23, P2966, DOI 10.1007/s10461-019-02591-9; Sawicki GS, 2015, PEDIATR PULM, V50, P127, DOI 10.1002/ppul.23017; Schuster MA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39609.657581.25; Shah M, 2019, AIDS PATIENT CARE ST, V33, P425, DOI 10.1089/apc.2019.0109; Sterrett EM, 2011, AM J COMMUN PSYCHOL, V48, P284, DOI 10.1007/s10464-011-9429-y; Sutton MY, 2011, PUBLIC HEALTH REP, V126, P653, DOI 10.1177/003335491112600507; Thoma BC, 2018, JAIDS-J ACQ IMM DEF, V79, P453, DOI 10.1097/QAI.0000000000001837; US Public Health Service, PREEXP PROPH PREV HI; Williams PL, 2006, PEDIATRICS, V118, pE1745, DOI 10.1542/peds.2006-0493	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248858	10.1371/journal.pone.0248858	http://dx.doi.org/10.1371/journal.pone.0248858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740005	Green Published, gold			2022-12-26	WOS:000631030200034
J	Han, FL; Zhao, Q; Liu, J				Han, Fenglu; Zhao, Qi; Liu, Jun			Preliminary bone histological analysis of Lystrosaurus (Therapsida: Dicynodontia) from the Lower Triassic of North China, and its implication for lifestyle and environments after the end-Permian extinction	PLOS ONE			English	Article							OXYGEN-ISOTOPE EVIDENCE; KAROO-BASIN; MASS EXTINCTION; AQUATIC HABITS; GROWTH; BOUNDARY; MICROANATOMY; ANOMODONTIA; PHYSIOLOGY; AMNIOTES	Lystrosaurus represents one of the most successful dicynodonts, a survivor of the end-Permian mass extinction that remained abundant in the Early Triassic, but many aspects of its paleobiology are still controversial. The bone histology of Lystrosaurus species from South Africa and India has provided important information on their growth strategy and lifestyle, but until recently no data was available on the bone histology of Lystrosaurus from China. Here, we report on the bone microstructure of seven Lystrosaurus individuals from the Lower Triassic of Xinjiang, providing the first such data for the Chinese Lystrosaurus species. Our samples indicate that the microstructure of Lystrosaurus limb bones from China is characterized by fibrolamellar bone tissue similar to those from South Africa and India. Three ontogenetic stages were identified: juvenile, early subadult, and late subadult based on lines of arrested growth (LAGs) and bone tissue changes. Bone histology supports a rapid growth strategy for Lystrosaurus during early ontogeny. Unlike Early Triassic Lystrosaurus from South Africa, lines of arrested growth are common in our specimens, suggesting that many individuals of Chinese Lystrosaurus had reached the subadult stage and were interrupted in growth. The differences in bone histology between Lystrosaurus from South Africa and China may indicate different environmental conditions in these two regions.	[Han, Fenglu] China Univ Geosci Wuhan, Sch Earth Sci, Wuhan, Peoples R China; [Zhao, Qi; Liu, Jun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Liu, Jun] CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China; [Liu, Jun] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Han, FL (corresponding author), China Univ Geosci Wuhan, Sch Earth Sci, Wuhan, Peoples R China.; Liu, J (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; Liu, J (corresponding author), CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China.; Liu, J (corresponding author), Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China.	hanfl@cug.edu.cn; liujun@ivpp.ac.cn		, Fenglu/0000-0003-3399-4008; Liu, Jun/0000-0003-2205-9671	Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]; National Natural Science Foundation of China [41530104, 41661134047]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Strategic Priority Research Program of Chinese Academy of Sciences (XDB26000000) to JL, the National Natural Science Foundation of China (www.nsfc.gov.cn; 41530104, 41661134047) to FH and JL respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Bernardi M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2331; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Botha J, 2007, LETHAIA, V40, P125, DOI 10.1111/j.1502-3931.2007.00011.x; Botha J, 2020, PEERJ, V8, DOI 10.7717/peerj.10408; Botha J, 2020, PALAEOGEOGR PALAEOCL, V540, DOI 10.1016/j.palaeo.2019.109467; Botha-Brink J, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1365080; Botha-Brink J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24053; Botha-Brink J, 2010, ZOOL J LINN SOC-LOND, V160, P341, DOI 10.1111/j.1096-3642.2009.00601.x; Camp J, 2011, J VERTEBR PALEONTOL, V31, P82; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Chinsamy A., 1993, Palaeontologia Africana, V30, P97; Chinsamy-Turan A., 2012, FORERUNNERS MAMMALS, P65; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chu DL, 2015, PALAEOGEOGR PALAEOCL, V435, P38, DOI 10.1016/j.palaeo.2015.06.003; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; Colbert E.H., 1982, Geobios Memoire Special (Lyon), P375; COSGRIFF JW, 1982, J PALEONTOL, V56, P371; Donath K., 2003, HDB HISTOLOGY METHOD, P243, DOI 10.1007/978-1-59259-417-7_16; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Francillon-Vieillot H., 1990, P471; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Gastaldo RA, 2020, J SEDIMENT RES, V90, P609, DOI 10.2110/jsr.2020.32; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Green JL, 2010, PALAEONTOLOGY, V53, P347, DOI 10.1111/j.1475-4983.2010.00944.x; Hasiotis Stephen T., 2004, Ichnos, V11, P103, DOI 10.1080/10420940490428760; Hassler A, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0197; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Huttenlocker AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087553; King G.M., 1991, Historical Biology, V4, P323; King G.M., 1991, Historical Biology, V4, P285; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Li Jinling, 1988, Vertebrata Palasiatica, V26, P241; Li Y.A., 2003, GEOL REV, V49, P525; Liu DD, 2019, INT GEOL REV, V61, P1016, DOI 10.1080/00206814.2018.1490932; Liu Jun, 2002, Vertebrata Palasiatica, V40, P267; MacLeod KG, 2017, GEOLOGY, V45, P483, DOI 10.1130/G38957.1; MAXWELL WD, 1992, PALAEONTOLOGY, V35, P571; Modesto SP, 2010, PALAIOS, V25, P274, DOI 10.2110/palo.2009.p09-077r; Ozkurt Sakir, 2005, Turkish Journal of Zoology, V29, P91; Ray S, 2005, PALAEONTOLOGY, V48, P1169, DOI 10.1111/j.1475-4983.2005.00513.x; Ray S, 2009, J BIOSCIENCES, V34, P661, DOI 10.1007/s12038-009-0055-x; Ray S., 2012, FORERUNNERS MAMMALS, P121; Retallack GJ, 2013, GONDWANA RES, V24, P90, DOI 10.1016/j.gr.2012.03.003; Rey K, 2020, PALAEOGEOGR PALAEOCL, V556, DOI 10.1016/j.palaeo.2020.109882; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002; Song Haijun, 2016, Earth Science (Wuhan), V41, P901; Stanley SM, 2016, P NATL ACAD SCI USA, V113, pE6325, DOI 10.1073/pnas.1613094113; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Tabor NJ, 2017, J VERTEBR PALEONTOL, V37, P240, DOI 10.1080/02724634.2017.1415211; Talanda M, 2011, PALAIOS, V26, P99, DOI 10.2110/palo.2010.p10-024r; Thomas SG, 2011, PALAEOGEOGR PALAEOCL, V308, P41, DOI 10.1016/j.palaeo.2010.10.037; Torsvik T.H., 2016, EARTH HIST PALAEOGEO; WALL WP, 1983, J PALEONTOL, V57, P197; Wan ML, 2019, REV PALAEOBOT PALYNO, V267, P62, DOI 10.1016/j.revpalbo.2019.05.005; Whitney MR, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01207-6; Yang W, 2010, GLOBAL PLANET CHANGE, V73, P15, DOI 10.1016/j.gloplacha.2010.03.008; YOUNG C. C., 1935, BULL GEOL SOC CHINA, V14, P483	62	5	5	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248681	10.1371/journal.pone.0248681	http://dx.doi.org/10.1371/journal.pone.0248681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735263	Green Published, gold			2022-12-26	WOS:000631029700033
J	Kretz, L; Koll, K; Seele-Dilbat, C; van der Plas, F; Weigelt, A; Wirth, C				Kretz, Lena; Koll, Katinka; Seele-Dilbat, Carolin; van der Plas, Fons; Weigelt, Alexandra; Wirth, Christian			Plant structural diversity alters sediment retention on and underneath herbaceous vegetation in a flume experiment	PLOS ONE			English	Article							SUSPENDED SEDIMENT; RIVER RESTORATION; SPECIES-DIVERSITY; FLOW RESISTANCE; FINE SEDIMENT; SOIL-EROSION; LAND-USE; DEPOSITION; PRODUCTIVITY; TRANSPORT	Sediment retention is a key ecosystem function provided by floodplains to filter sediments and nutrients from the river water during floods. Floodplain vegetation is an important driver of fine sediment retention. We aim to understand which structural properties of the vegetation are most important for capturing sediments. In a hydraulic flume experiment, we investigated this by disentangling sedimentation on and underneath 96 vegetation patches (40 cm x 60 cm). We planted two grass and two herb species in each patch and conducted a full-factorial manipulation of 1) vegetation density, 2) vegetation height, 3) structural diversity (small-tall vs tall-tall species combinations) and 4) leaf pubescence (based on trait information). We inundated the vegetation patches for 21 h in a flume with silt- and clay-rich water and subsequently measured the amount of accumulated sediment on the vegetation and on a fleece as ground underneath it. We quantified the sediment by washing it off the biomass and off the fleece, drying the sediment and weighting it. Our results showed that all manipulated vegetation properties combined (vegetation density and height, and the interaction of structural diversity and leaf pubescence) explained sedimentation on the vegetation (total R-2 = 0.34). The sedimentation underneath the vegetation was explained by the structural diversity and the leaf pubescence (total R-2 = 0.11). We further found that vegetation biomass positively affected the sedimentation on and underneath the vegetation. These findings are crucial for floodplain management strategies with the aim to increase sediment retention. Based on our findings, we can identify management strategies and target plant communities that are able to maximize a floodplain's ability to capture sediments.	[Kretz, Lena; Seele-Dilbat, Carolin; van der Plas, Fons; Weigelt, Alexandra; Wirth, Christian] Univ Leipzig, Life Sci Systemat Bot & Funct Biodivers, Leipzig, Germany; [Kretz, Lena; Seele-Dilbat, Carolin] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Koll, Katinka] Tech Univ Carolo Wilhelmina Braunschweig, Leichtweiss Inst Hydraul Engn & Water Resources, Braunschweig, Germany; [van der Plas, Fons] Wageningen Univ, Plant Ecol & Nat Conservat, Wageningen, Netherlands; [Weigelt, Alexandra; Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Wirth, Christian] Max Planck Inst Biogeochem, Jena, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Braunschweig University of Technology; Wageningen University & Research; Max Planck Society	Kretz, L (corresponding author), Univ Leipzig, Life Sci Systemat Bot & Funct Biodivers, Leipzig, Germany.; Kretz, L (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	lena.kretz@uni-leipzig.de	Kretz, Lena/AAA-3302-2022; van der Plas, Fons/A-2242-2017	Kretz, Lena/0000-0002-8040-4421; van der Plas, Fons/0000-0003-4680-543X; Koll, Katinka/0000-0003-3026-4085	German Federal Ministry of Education and Research (BMBF); German Federal Agency for Nature Conservation (BfN) [01LC1322E]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Agency for Nature Conservation (BfN)	C.W. received funding from the German Federal Ministry of Education and Research (BMBF) and the German Federal Agency for Nature Conservation (BfN) for the project: Wilde Mulde Revitalization of a wild river landscape in Central Germany (Funding label: 01LC1322E).	Albayrak I, 2014, AQUAT SCI, V76, P269, DOI 10.1007/s00027-013-0335-2; Albayrak I, 2012, AQUAT SCI, V74, P267, DOI 10.1007/s00027-011-0220-9; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asselman NEM, 2003, HYDROL PROCESS, V17, P3225, DOI 10.1002/hyp.1384; Aureliano AF, 2018, NATIVA, V6, P389, DOI 10.31413/nativa.v6i4.5405; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berendse F, 2015, ECOSYSTEMS, V18, P881, DOI 10.1007/s10021-015-9869-6; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Borin M, 2005, AGR ECOSYST ENVIRON, V105, P101, DOI 10.1016/j.agee.2004.05.011; Bouwman AF, 2013, BIOGEOSCIENCES, V10, P1, DOI 10.5194/bg-10-1-2013; Bracken LJ, 2015, EARTH SURF PROC LAND, V40, P177, DOI 10.1002/esp.3635; Brown C, 2019, J VEG SCI, V30, P789, DOI 10.1111/jvs.12785; Camporeale C, 2013, REV GEOPHYS, V51, P379, DOI 10.1002/rog.20014; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Corenblit D, 2011, EARTH-SCI REV, V106, P307, DOI 10.1016/j.earscirev.2011.03.002; Corenblit D, 2009, EARTH SURF PROC LAND, V34, P1790, DOI 10.1002/esp.1876; Corenblit D, 2009, GLOBAL ECOL BIOGEOGR, V18, P507, DOI 10.1111/j.1466-8238.2009.00461.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Elliott AH, 2000, J HYDRAUL ENG-ASCE, V126, P570, DOI 10.1061/(ASCE)0733-9429(2000)126:8(570); Erktan A, 2013, PLANT SOIL, V370, P653, DOI 10.1007/s11104-013-1738-5; FathiMaghadam M, 1997, J HYDRAUL ENG, V123, P51, DOI 10.1061/(ASCE)0733-9429(1997)123:1(51); FENNESSY MS, 1994, ECOL ENG, V3, P409; Findlay S, 2006, ECOSYSTEMS, V9, P84, DOI 10.1007/s10021-004-0053-7; Fox J., 2019, R COMPANION APPL REG, VThird; Green JC, 2005, RIVER RES APPL, V21, P671, DOI 10.1002/rra.854; Green JC, 2005, HYDROL PROCESS, V19, P1245, DOI 10.1002/hyp.5564; Grizzetti B, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003085; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; Habersack H, 2016, SCI TOTAL ENVIRON, V543, P828, DOI 10.1016/j.scitotenv.2015.10.123; Hancock PJ, 2002, ENVIRON MANAGE, V29, P763, DOI 10.1007/s00267-001-0064-5; HOGG ID, 1991, AUST J MAR FRESH RES, V42, P507; Horn R., 2007, HYDROECOLOGY ECOHYDR, P269; Hunter HM, 2008, J HYDROL, V356, P131, DOI 10.1016/j.jhydrol.2008.04.003; Jones JI, 2012, RIVER RES APPL, V28, P1006, DOI 10.1002/rra.1486; Kervroedan L, 2019, PLANT SOIL, V441, P511, DOI 10.1007/s11104-019-04142-6; Kleiss BA, 1996, WETLANDS, V16, P321, DOI 10.1007/BF03161323; Kretz L, 2020, OECOLOGIA, V193, P535, DOI 10.1007/s00442-020-04664-2; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Luhar M, 2008, ENVIRON FLUID MECH, V8, P423, DOI 10.1007/s10652-008-9080-9; Marion A, 2014, J HYDRAUL RES, V52, P744, DOI 10.1080/00221686.2014.968887; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Miler O, 2012, AQUAT SCI, V74, P31, DOI 10.1007/s00027-011-0188-5; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nepf HM, 2012, J HYDRAUL RES, V50, P262, DOI 10.1080/00221686.2012.696559; Ortiz AC, 2013, J GEOPHYS RES-EARTH, V118, P2585, DOI 10.1002/2013JF002858; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Paul M, 2016, COAST ENG, V117, P70, DOI 10.1016/j.coastaleng.2016.07.004; Pearce RA, 1998, J RANGE MANAGE, V51, P309, DOI 10.2307/4003416; Proulx R, 2014, J PLANT ECOL, V7, P518, DOI 10.1093/jpe/rtt065; Quilbe R, 2006, J HYDROL, V326, P295, DOI 10.1016/j.jhydrol.2005.11.008; Roscher C, 2016, J PLANT ECOL, V9, P792, DOI 10.1093/jpe/rtw013; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Sand-Jensen K, 1998, FRESHWATER BIOL, V39, P663, DOI 10.1046/j.1365-2427.1998.00316.x; Schulze IM, 2009, ECOL STUD-ANAL SYNTH, V208, P155, DOI 10.1007/978-3-642-00340-0_10; Sharma P, 2004, J HYDROL, V289, P190, DOI 10.1016/j.jhydrol.2003.11.023; Smith SMC, 2011, GEOPHYS MONOGR SER, V194, P293, DOI 10.1029/2011GM001085; Steiger J, 2005, RIVER RES APPL, V21, P719, DOI 10.1002/rra.879; Steiger J, 2003, GEOMORPHOLOGY, V49, P1, DOI 10.1016/S0169-555X(02)00144-7; Sukhodolov AN, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011805; Sukhodolova TA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011804; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; Taylor KG, 2008, SUS MANAGE SEDIMENT, V4, P83; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; VanDijk PM, 1996, HYDROL PROCESS, V10, P1069, DOI 10.1002/(SICI)1099-1085(199608)10:8&lt;1069::AID-HYP412&gt;3.0.CO;2-4; Vastila K, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001058; Vastila K, 2018, J SOIL SEDIMENT, V18, P3114, DOI 10.1007/s11368-017-1776-3; Vastila K, 2013, J HYDROL, V492, P49, DOI 10.1016/j.jhydrol.2013.04.015; Venables WN., 2002, MODERN APPL STAT S 4; Venterink HO, 2006, APPL VEG SCI, V9, P163; Walling DE, 2003, APPL GEOCHEM, V18, P195, DOI 10.1016/S0883-2927(02)00121-X; WEDDING JB, 1975, ENVIRON SCI TECHNOL, V9, P151, DOI 10.1021/es60100a004; Weiner J, 2010, ANNU REV ECOL EVOL S, V41, P173, DOI 10.1146/annurev-ecolsys-102209-144642	75	3	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248320	10.1371/journal.pone.0248320	http://dx.doi.org/10.1371/journal.pone.0248320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735182	Green Published, gold			2022-12-26	WOS:000631029700026
J	Ladak, Z; Garcia, E; Yoon, J; Landry, T; Armstrong, EA; Yager, JY; Persad, S				Ladak, Zeenat; Garcia, Elizabeth; Yoon, Jenny; Landry, Takaaki; Armstrong, Edward A.; Yager, Jerome Y.; Persad, Sujata			Sulforaphane (SFA) protects neuronal cells from oxygen & glucose deprivation (OGD)	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; GESTATIONAL-AGE INFANTS; NEURAL CREST CELLS; ACTIVATION; LIPOPOLYSACCHARIDE; MITOCHONDRIA; INHIBITION; ASTROCYTES; INDUCTION; APOPTOSIS	Background Perinatal brain injury results in neurodevelopmental disabilities (neuroDDs) that include cerebral palsy, autism, attention deficit disorder, epilepsy, learning disabilities and others. Commonly, injury occurs when placental circulation, that is responsible for transporting nutrients and oxygen to the fetus, is compromised. Placental insufficiency (PI) is a reduced supply of blood and oxygen to the fetus and results in a hypoxic-ischemic (HI) environment. A significant HI state in-utero leads to perinatal compromise, characterized by fetal growth restriction and brain injury. Given that over 80% of perinatal brain injuries that result in neuroDDs occur during gestation, prior to birth, preventive approaches are needed to reduce or eliminate the potential for injury and subsequent neuroDDs. Sulforaphane (SFA) derived from cruciferous vegetables such as broccoli sprouts (BrSps) is a phase-II enzyme inducer that acts via cytoplasmic Nrf2 to enhance the production of anti-oxidants in the brain through the glutathione pathway. We have previously shown a profound in vivo neuro-protective effect of BrSps/SFA as a dietary supplement in pregnant rat models of both PI and fetal inflammation. Strong evidence also points to a role for SFA as treatment for various cancers. Paradoxically, then SFA has the ability to enhance cell survival, and with conditions of cancer, enhance cell death. Given our findings of the benefit of SFA/Broccoli Sprouts as a dietary supplement during pregnancy, with improvement to the fetus, it is important to determine the beneficial and toxic dosing range of SFA. We therefore explored, in vitro, the dosing range of SFA for neuronal and glial protection and toxicity in normal and oxygen/glucose deprived (OGD) cell cultures. Methods OGD simulates, in vitro, the condition experienced by the fetal brain due to PI. We developed a cell culture model of primary cortical neuronal, astrocyte and combined brain cell co-cultures from newborn rodent brains. The cultures were exposed to an OGD environment for various durations of time to determine the LD50 (duration of OGD required for 50% cell death). Using the LD50 as the time point, we evaluated the efficacy of varying doses of SFA for neuroprotective and neurotoxicity effects. Control cultures were exposed to normal media without OGD, and cytotoxicity of varying doses of SFA was also evaluated. Immunofluorescence (IF) and Western blot analysis of cell specific markers were used for culture characterization, and quantification of LD50. Efficacy and toxicity effect of SFA was assessed by IF/high content microscopy and by AlamarBlue viability assay, respectively. Results We determined the LD50 to be 2 hours for neurons, 8 hours for astrocytes, and 10 hours for co-cultures. The protective effect of SFA was noticeable at 2.5 mu M and 5 mu M for neurons, although it was not significant. There was a significant protective effect of SFA at 2.5 mu M (p<0.05) for astrocytes and co-cultures. Significant toxicity ranges were also confirmed in OGD cultures as >= 100 mu M (p<0.05) for astrocytes, >= 50 mu M (p<0.01) for co-cultures, but not toxic in neurons; and toxic in control cultures as >= 100 mu M (p<0.01) for neurons, and >= 50 mu M (p<0.01) for astrocytes and co-cultures. One Way ANOVA and Dunnett's Multiple Comparison Test were used for statistical analysis. Conclusions Our results indicate that cell death shows a trend to reduction in neuronal and astrocyte cultures, and is significantly reduced in co-cultures treated with low doses of SFA exposed to OGD. Doses of SFA that were 10 times higher were toxic, not only under conditions of OGD, but in normal control cultures as well. The findings suggest that: 1. SFA shows promise as a preventative agent for fetal ischemic brain injury, and 2. Because the fetus is a rapidly growing organism with profound cell multiplication, dosing parameters must be established to insure safety within efficacious ranges. This study will influence the development of innovative therapies for the prevention of childhood neuroDD.	[Ladak, Zeenat; Garcia, Elizabeth; Yoon, Jenny; Landry, Takaaki; Armstrong, Edward A.; Yager, Jerome Y.; Persad, Sujata] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta	Yager, JY; Persad, S (corresponding author), Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada.	jyager@ualberta.ca; sujata.persad@ualberta.ca		Ladak, Zeenat/0000-0001-8904-3186	Women & Children's Health Research Institute (WCHRI); ALVA Foundation	Women & Children's Health Research Institute (WCHRI); ALVA Foundation	This study was funded by a grant from the Women & Children's Health Research Institute (WCHRI) to SP and JYY, and the ALVA Foundation to JYY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barateiro A, 2016, CURR PHARM DESIGN, V22, P656, DOI 10.2174/1381612822666151204000636; Brandenburg LO, 2010, INFLAMM RES, V59, P443, DOI 10.1007/s00011-009-0116-5; Chen X, 2013, BRIT J PHARMACOL, V169, P437, DOI 10.1111/bph.12133; Chen X, 2018, CELL PHYSIOL BIOCHEM, V50, P1201, DOI 10.1159/000494547; Cho JH, 2014, EUR J PHARMACOL, V741, P247, DOI 10.1016/j.ejphar.2014.08.007; Danilov CA, 2009, GLIA, V57, P645, DOI 10.1002/glia.20793; Fahey JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140963; Greco T, 2010, J BIOENERG BIOMEMBR, V42, P491, DOI 10.1007/s10863-010-9312-9; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Han JM, 2007, J PHARMACOL EXP THER, V321, P249, DOI 10.1124/jpet.106.110866; Iizumi T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0564-0; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Juurlink BHJ, 1999, NEUROTOX RES, V1, P119, DOI 10.1007/BF03033276; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Koning G, 2018, INT J DEV NEUROSCI, V70, P56, DOI 10.1016/j.ijdevneu.2018.01.002; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Ladak Z., 2020, NUTRACEUTICALS BRAIN; Lee JH, 2014, NEUROSCIENCE, V278, P31, DOI 10.1016/j.neuroscience.2014.07.072; Li B, 2017, PROG NEUROBIOL, V159, P50, DOI 10.1016/j.pneurobio.2017.10.006; Li B, 2015, INT J MOL MED, V36, P53, DOI 10.3892/ijmm.2015.2199; Li YH, 2019, BBA-MOL BASIS DIS, V1865, P2586, DOI 10.1016/j.bbadis.2019.07.002; Luque-Fernandez MA, 2015, EUR J EPIDEMIOL, V30, P331, DOI 10.1007/s10654-015-9993-9; Nguyen AT, 2016, BEHAV BRAIN RES, V307, P239, DOI 10.1016/j.bbr.2016.03.017; Niu Z, 2015, PLACENTA, V36, P876, DOI 10.1016/j.placenta.2015.05.005; Pal S, 2016, MINI-REV MED CHEM, V16, P980, DOI 10.2174/1389557516666151120115027; Parra-Saavedra M, 2014, PLACENTA, V35, P269, DOI 10.1016/j.placenta.2014.01.010; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; Savchev S, 2013, ULTRASOUND OBST GYN, V42, P201, DOI 10.1002/uog.12391; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Shaw OEF, 2019, PHARMACOL RES, V139, P228, DOI 10.1016/j.phrs.2018.08.022; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sukhanova IA, 2019, INT J DEV NEUROSCI, V78, P7, DOI 10.1016/j.ijdevneu.2019.06.007; Thomi G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080855; Wang LP, 2015, ONCOTARGET, V6, P25917, DOI 10.18632/oncotarget.4542; Wang XL, 2012, J NEUROTRAUM, V29, P936, DOI 10.1089/neu.2011.1922; Wang XY, 2007, ANN NEUROL, V61, P263, DOI 10.1002/ana.21066; Yang F, 2018, LIFE SCI, V213, P149, DOI 10.1016/j.lfs.2018.10.034; Yuan FQ, 2018, EXP NEUROL, V300, P60, DOI 10.1016/j.expneurol.2017.10.020; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248777	10.1371/journal.pone.0248777	http://dx.doi.org/10.1371/journal.pone.0248777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735260	gold, Green Published			2022-12-26	WOS:000631029700045
J	Somma, F; Stoia, V; D'Angelo, R; Fiore, F				Somma, Francesco; Stoia, Vincenzo; D'Angelo, Roberto; Fiore, Francesco			Imaging-guided radiofrequency ablation of osteoid osteoma in typical and atypical sites: Long term follow up	PLOS ONE			English	Article							THERMAL ABLATION; LASER-ABLATION	Purpose To assess efficacy and safety of imaging-guided radiofrequency ablation (RFA) of Osteoid Osteoma (OO) in both typical and atypical sites. Methods and materials Between January 2014 and March 2019, 102 consecutive percutaneous RFA were performed and retrospectively reviewed. The procedures were performed using a RFA bipolar ablation system (Covidien, exposed tip of 0.7-1cm), under Computed Tomography (CT) guidance or using a navigation system (Masmec) under CT and Cone Beam CT (CBCT) guidance. Patients were followed up over 24 months. Clinical success and recurrences were considered on the base of established criteria. In patients with clinical failure and/or imaging evidence of relapse, retreatment was considered. Results Administered power per-procedure was <= 8 W (mean temperature, 90 degrees C). The pre-procedure average value of visual analog scale (VAS) was 8.33+/-0.91. Primary and secondary success rate 96.08% (98/102) and100% (102/102), respectively. No major complication was described. Technical success was proved in every patient by CT scan acquisition after needle positioning. Relapse and tumour location were significantly correlated (p-value = 0.0165). The mean dose-length product was 751.55 mGycm2. Advanced bone healing was noted in 68 lesions after 1y-follow up and in 86 lesions after 2y-follow up. Conclusion Imaging-guided percutaneous RFA is a highly effective technique for OO, both in typical and atypical sites. CT or CBCT guidance, navigation systems and operator experience grant the technical success, which is the most crucial parameter affecting outcome.	[Somma, Francesco; Stoia, Vincenzo; D'Angelo, Roberto; Fiore, Francesco] Ist Nazl Tumori IRCCS Fdn G Pascale, Radiol Interventist, Naples, Italy	IRCCS Fondazione Pascale	Somma, F (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Radiol Interventist, Naples, Italy.	fra1585@hotmail.it	Somma, Francesco/AAA-9462-2021; , vincenzo/AAY-6364-2021	, vincenzo/0000-0002-8919-861X; Somma, Francesco/0000-0002-8193-3050				ADAM G, 1995, ROFO FORTSCHR RONTG, V162, P232, DOI 10.1055/s-2007-1015871; Bhure U, 2019, EUR J NUCL MED MOL I, V46, P1019, DOI 10.1007/s00259-018-4181-2; Bing F, 2019, INT J HYPERTHER, V35, P471, DOI 10.1080/02656736.2018.1508758; BLOEM JL, 1993, RADIOL CLIN N AM, V31, P261; Chai JW, 2010, RADIOGRAPHICS, V30, P737, DOI 10.1148/rg.303095120; Ciftdemir Mert, 2015, Eur J Orthop Surg Traumatol, V25, P17, DOI 10.1007/s00590-013-1291-1; Davies M, 2002, SKELETAL RADIOL, V31, P559, DOI 10.1007/s00256-002-0546-4; El-Mowafi H, 2015, ACTA ORTHOP BELG, V81, P47; Gangi A, 1997, RADIOLOGY, V203, P843, DOI 10.1148/radiology.203.3.9169714; Gebauer B, 2013, ROFO-FORTSCHR RONTG, V185, P959, DOI 10.1055/s-0033-1350347; HELMS CA, 1987, CLIN ORTHOP RELAT R, P167; Koch G, 2018, SEMIN INTERVENT RAD, V35, P324, DOI 10.1055/s-0038-1673640; Kulkarni Suyash S, 2017, Indian J Radiol Imaging, V27, P318, DOI 10.4103/ijri.IJRI_30_17; Lindner NJ, 2001, J BONE JOINT SURG BR, V83B, P391, DOI 10.1302/0301-620X.83B3.11679; Lindner NJ, 1997, Z ORTHOP GRENZGEB, V135, P522, DOI 10.1055/s-2008-1039739; Maurer MH, 2012, EUR J RADIOL, V81, pE1002, DOI 10.1016/j.ejrad.2012.07.010; Motamedi D, 2009, RADIOGRAPHICS, V29, P2127, DOI 10.1148/rg.297095081; Niazi GE, 2021, ACAD RADIOL, V28, P68, DOI 10.1016/j.acra.2020.01.028; O'Connell JX, 1998, MODERN PATHOL, V11, P175; Pinto CH, 2002, AM J ROENTGENOL, V179, P1633, DOI 10.2214/ajr.179.6.1791633; Rehnitz C, 2012, EUR J RADIOL, V81, P3426, DOI 10.1016/j.ejrad.2012.04.037; Rimondi E, 2012, EUR RADIOL, V22, P181, DOI 10.1007/s00330-011-2240-1; Rosenthal DI, 2003, RADIOLOGY, V229, P171, DOI 10.1148/radiol.2291021053; ROSENTHAL DI, 1992, RADIOLOGY, V183, P29, DOI 10.1148/radiology.183.1.1549690; Rosenthal DI, 1998, J BONE JOINT SURG AM, V80A, P815, DOI 10.2106/00004623-199806000-00005; Rybak LD, 2010, AM J ROENTGENOL, V195, pW293, DOI 10.2214/AJR.10.4192; Seemann RJ, 2020, ROFO-FORTSCHR RONTG, V192, P335, DOI 10.1055/a-1012-2143; Skjeldal S, 2000, ACTA ORTHOP SCAND, V71, P637, DOI 10.1080/000164700317362307; Somma F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216935; Somma F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129573; Streitparth F, 2009, CARDIOVASC INTER RAD, V32, P320, DOI 10.1007/s00270-008-9447-9; Tsoumakidou G, 2016, CARDIOVASC INTER RAD, V39, P1229, DOI 10.1007/s00270-016-1402-6; Vanderschueren GM, 2009, SPINE, V34, P901, DOI 10.1097/BRS.0b013e3181995d39; Vanderschueren GM, 2002, RADIOLOGY, V224, P82, DOI 10.1148/radiol.2241011135; Woertler K, 2001, J VASC INTERV RADIOL, V12, P717, DOI 10.1016/S1051-0443(07)61443-2; Zieglgansberger W., 2005, GRUNDLAGENSPEZIELLES, P17	36	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248589	10.1371/journal.pone.0248589	http://dx.doi.org/10.1371/journal.pone.0248589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735214	gold, Green Published			2022-12-26	WOS:000631029700120
J	Tempski, P; Arantes-Costa, FM; Kobayasi, R; Siqueira, MAM; Torsani, MB; Amaro, BQRC; Nascimento, MEFM; Siqueira, SL; Santos, IS; Martins, MA				Tempski, Patricia; Arantes-Costa, Fernanda M.; Kobayasi, Renata; Siqueira, Marina A. M.; Torsani, Matheus B.; Amaro, Bianca Q. R. C.; Nascimento, Maria Eduarda F. M.; Siqueira, Saulo L.; Santos, Itamar S.; Martins, Milton A.			Medical students' perceptions and motivations during the COVID-19 pandemic	PLOS ONE			English	Article							GENDER-DIFFERENCES; VOLUNTEERS; QUALITY	Background There has been a rapid increase in the number of cases of COVID-19 in Latin America, Africa, Asia and many countries that have an insufficient number of physicians and other health care personnel, and the need for the inclusion of medical students on health teams is a very important issue. It has been recommended that medical students work as volunteers, undergo appropriate training, not undertake any activity beyond their level of competence, and receive continuous supervision and adequate personal protective equipment. However, the motivation of medical students must be evaluated to make volunteering a more evidence-based initiative. The aim of our study was to evaluate the motivation of medical students to be part of health teams to aid in the COVID-19 pandemic. Methods and findings We developed a questionnaire specifically to evaluate medical students' perceptions about participating in the care of patients with suspected infection with coronavirus during the COVID-19 pandemic. The questionnaire had two parts: a) one part with questions on individual characteristics, year in medical school and geographic location of the medical school and b) a second part with twenty-eight statements assessed on a 5-point Likert scale (totally agree, agree, neither agree nor disagree, disagree and totally disagree). To develop the questionnaire, we performed consensus meetings with a group of faculty and medical students. The questionnaire was sent to student organizations of 257 medical schools in Brazil and answered by 10,433 students. We used multinomial logistic regression models to analyze the data. Statements associated with greater odds ratios for participation of medical students in the COVID-19 pandemic were related to a sense of purpose or duty ("It is the duty of the medical student to put himself or herself at the service of the population in the pandemic"), altruism ("I am willing to take risks by participating in practice in the context of the pandemic"), and perception of good performance and professional identity ("I will be a better health professional for having experienced the pandemic"). Males were more prone than females to believe that only interns should participate in the care of patients with COVID-19 (odds ratio 1.36 [coefficient interval 95%:1.24-1.49]) and that all students should participate (OR 1.68 [CI:1.4-1.91]). Conclusions Medical students are more motivated by a sense of purpose or duty, altruism, perception of good performance and values of professionalism than by their interest in learning. These results have implications for the development of volunteering programs and the design of health force policies in the present pandemic and in future health emergencies.	[Tempski, Patricia; Arantes-Costa, Fernanda M.; Kobayasi, Renata; Siqueira, Marina A. M.; Torsani, Matheus B.; Siqueira, Saulo L.; Santos, Itamar S.; Martins, Milton A.] Univ Sao Paulo, Fac Med, Ctr Desenvolvimento Educ Med, Sao Paulo, Brazil; [Tempski, Patricia; Arantes-Costa, Fernanda M.; Kobayasi, Renata; Siqueira, Marina A. M.; Torsani, Matheus B.; Siqueira, Saulo L.; Santos, Itamar S.; Martins, Milton A.] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil; [Amaro, Bianca Q. R. C.] Univ Fed Roraima, Ctr Desenvolvimento Educ Med, Boa Vista, Parana, Brazil; [Amaro, Bianca Q. R. C.] Univ Fed Roraima, Dept Clin Med, Boa Vista, Parana, Brazil; [Nascimento, Maria Eduarda F. M.] Univ Pernambuco, Ctr Desenvolvimento Educ Med, Recife, PE, Brazil; [Nascimento, Maria Eduarda F. M.] Univ Pernambuco, Dept Clin Med, Recife, PE, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Roraima; Universidade Federal de Roraima; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE)	Martins, MA (corresponding author), Univ Sao Paulo, Fac Med, Ctr Desenvolvimento Educ Med, Sao Paulo, Brazil.; Martins, MA (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, Brazil.	mmartins@usp.br	Santos, Itamar/K-7055-2012	Santos, Itamar/0000-0003-3212-8466				[Anonymous], ESCOLAS MED BRASIL; [Anonymous], MINIST RIO SA DE BRA; Clary EG, 1998, J PERS SOC PSYCHOL, V74, P1516, DOI 10.1037/0022-3514.74.6.1516; edical Schools Council of United Kingdom, STAT EXP MED STUD VO; El-Sadr WM, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2008193; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Gallagher TH, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005234; Gerull KM, 2019, AM J SURG, V217, P306, DOI 10.1016/j.amjsurg.2018.09.029; Glynn JR, 2020, LANCET INFECT DIS, DOI [10.1016/S1473-3099%2820%2930311-X, DOI 10.1016/S1473-3099%2820%2930311-X]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guntert ST, 2016, J SOC PSYCHOL, V156, P310, DOI 10.1080/00224545.2015.1135864; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hill MR, 2018, MED EDUC ONLINE, V23, DOI 10.1080/10872981.2018.1530558; Kobayasi R, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1378-9; Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281; Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227; Ruiz-Cantero MT, 2007, J EPIDEMIOL COMMUN H, V61, P46, DOI 10.1136/jech.2007.062034; Soled D, 2020, ACAD MED, V95, P1384, DOI 10.1097/ACM.0000000000003401; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Whelan A, INTERIM GUIDANCE MED; Whelan A., 2020, GUIDANCE MED STUDENT; World Health Organization, COR DIS 2019 COVID 1	22	25	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248627	10.1371/journal.pone.0248627	http://dx.doi.org/10.1371/journal.pone.0248627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730091	gold, Green Published			2022-12-26	WOS:000630345000061
J	Rehling, D; Zhang, SM; Jemth, AS; Koolmeister, T; Throup, A; Wallner, O; Scaletti, E; Moriyama, T; Nishii, R; Davies, J; Desroses, M; Rudd, SG; Scobie, M; Homan, E; Berglund, UW; Yang, JJ; Helleday, T; Stenmark, P				Rehling, Daniel; Zhang, Si Min; Jemth, Ann-Sofie; Koolmeister, Tobias; Throup, Adam; Wallner, Olov; Scaletti, Emma; Moriyama, Takaya; Nishii, Rina; Davies, Jonathan; Desroses, Matthieu; Rudd, Sean G.; Scobie, Martin; Homan, Evert; Berglund, Ulrika Warpman; Yang, Jun J.; Helleday, Thomas; Stenmark, Pal			Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR; METHYLTRANSFERASE; 6-MERCAPTOPURINE; THERAPY; 6-THIOGUANINE; AZATHIOPRINE; INTOLERANCE	The enzyme NUDT15 efficiently hydrolyzes the active metabolites of thiopurine drugs, which are routinely used for treating cancer and inflammatory diseases. Loss-of-function variants in NUDT15 are strongly associated with thiopurine intolerance, such as leukopenia, and preemptive NUDT15 genotyping has been clinically implemented to personalize thiopurine dosing. However, understanding the molecular consequences of these variants has been difficult, as no structural information was available for NUDT15 proteins encoded by clinically actionable pharmacogenetic variants because of their inherent instability. Recently, the small molecule NUDT15 inhibitor TH1760 has been shown to sensitize cells to thiopurines, through enhanced accumulation of 6-thio-guanine in DNA. Building upon this, we herein report the development of the potent and specific NUDT15 inhibitor, TH7755. TH7755 demonstrates a greatly improved cellular target engagement and 6-thioguanine potentiation compared with TH1760, while showing no cytotoxicity on its own. This potent inhibitor also stabilized NUDT15, enabling analysis by X-ray crystallography. We have determined high-resolution structures of the clinically relevant NUDT15 variants Arg139Cys, Arg139His, Val18Ile, and V18_V19insGlyVal. These structures provide clear insights into the structural basis for the thiopurine intolerance phenotype observed in patients carrying these pharmacogenetic variants. These findings will aid in predicting the effects of new NUDT15 sequence variations yet to be discovered in the clinic.	[Rehling, Daniel; Scaletti, Emma; Davies, Jonathan; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Zhang, Si Min; Jemth, Ann-Sofie; Koolmeister, Tobias; Throup, Adam; Wallner, Olov; Desroses, Matthieu; Rudd, Sean G.; Scobie, Martin; Homan, Evert; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden; [Scaletti, Emma; Davies, Jonathan; Stenmark, Pal] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Moriyama, Takaya; Nishii, Rina; Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA; [Helleday, Thomas] Univ Sheffield, Weston Pk Canc Ctr, Dept Oncol & Metab, Sheffield, S Yorkshire, England	Stockholm University; Karolinska Institutet; Lund University; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Sheffield	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Helleday, T (corresponding author), Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.; Helleday, T (corresponding author), Univ Sheffield, Weston Pk Canc Ctr, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	thomas.helleday@scilifelab.se; stenmark@dbb.su.se	Rudd, Sean/AAC-3150-2019; Nishii, Rina/AAC-4177-2022	Rudd, Sean/0000-0002-4368-3855; Scaletti, Emma Rose/0000-0002-8741-8981; Rehling, Daniel/0000-0002-8627-3469; Jemth, Ann-Sofie/0000-0002-7550-1833; Davies, Jonathan/0000-0002-4986-8594; Homan, Evert/0000-0002-9057-1848; Zhang, Si Min/0000-0001-7763-603X	Swedish Research Council [2018-03406, 2018-02114, 2015-00162]; European Research Council [TAROX-695376]; Swedish Cancer Society [201287 PjF, CAN2018/0658, 19-0056-JI]; Knut and Alice Wallenberg Foundation [KAW2014.0273]; Swedish Children's Cancer Foundation [PR2018-0095, PR2019-0014]; Swedish Pain Relief Foundation [SSF/01-05]; Crafoord Foundation; Torsten and Ragnar Soderberg Foundation; Felix Mindus contribution to Leukemia Research [2019-02004, 2020-02573]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Children's Cancer Foundation; Swedish Pain Relief Foundation; Crafoord Foundation; Torsten and Ragnar Soderberg Foundation; Felix Mindus contribution to Leukemia Research	This project was supported by the Swedish Research Council (P. S. 2018-03406, T. H. 2015-00162, S. G. R. 2018-02114), the European Research Council (TAROX-695376, T. H.), Swedish Cancer Society (201287 PjF, P. S.; CAN2018/0658, T. H.; 19-0056-JI, S. G. R). The Knut and Alice Wallenberg Foundation (KAW2014.0273, T. H.; P. S.), the Swedish Children's Cancer Foundation (PR2018-0095, T. H.; PR2019-0014, S. G. R.), the Swedish Pain Relief Foundation (SSF/01-05, T. H.), the Crafoord Foundation (P. S.), the Torsten and Ragnar Soderberg Foundation (T. H.), and the Felix Mindus contribution to Leukemia Research (2019-02004 and 2020-02573, S. M. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beilsten-Edmands J, 2020, ACTA CRYSTALLOGR D, V76, P385, DOI 10.1107/S2059798320003198; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bradford K, 2011, WORLD J GASTROENTERO, V17, P4166, DOI 10.3748/wjg.v17.i37.4166; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fotoohi AK, 2010, BIOCHEM PHARMACOL, V79, P1211, DOI 10.1016/j.bcp.2010.01.006; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gardiner SJ, 2008, CLIN GASTROENTEROL H, V6, P654, DOI 10.1016/j.cgh.2008.02.032; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; Li GM, 1999, ONCOL RES, V11, P393; LING YH, 1991, MOL PHARMACOL, V40, P508; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Moriyama T, 2016, NAT GENET, V48, P367, DOI 10.1038/ng.3508; NELSON JA, 1975, CANCER RES, V35, P2872; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Regueiro M, 2002, J CLIN GASTROENTEROL, V35, P240, DOI 10.1097/00004836-200209000-00008; Relling MV, 2019, CLIN PHARMACOL THER, V105, P1095, DOI 10.1002/cpt.1304; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Schmiegelow K, 2014, J PEDIAT HEMATOL ONC, V36, P503, DOI 10.1097/MPH.0000000000000206; Suiter CC, 2020, P NATL ACAD SCI USA, V117, P5394, DOI 10.1073/pnas.1915680117; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Valerie NCK, 2016, CANCER RES, V76, P5501, DOI 10.1158/0008-5472.CAN-16-0584; WARREN DJ, 1995, CANCER RES, V55, P1670; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JJ, 2015, J CLIN ONCOL, V33, P1235, DOI 10.1200/JCO.2014.59.4671; Yang SK, 2014, NAT GENET, V46, P1017, DOI 10.1038/ng.3060; Zhang RS, 2019, DRUG DELIV, V26, P328, DOI 10.1080/10717544.2019.1582730; Zhang SM, 2020, NAT CHEM BIOL, V16, P1120, DOI 10.1038/s41589-020-0592-z	35	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100568	10.1016/j.jbc.2021.100568	http://dx.doi.org/10.1016/j.jbc.2021.100568			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753169	Green Accepted, gold, Green Published			2022-12-26	WOS:000672866400541
J	Bottemanne, P; Paquot, A; Ameraoui, H; Guillemot-Legris, O; Alhouayek, M; Muccioli, GG				Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Guillemot-Legris, Owein; Alhouayek, Mireille; Muccioli, Giulio G.			25-Hydroxycholesterol metabolism is altered by lung inflammation, and its local administration modulates lung inflammation in mice	FASEB JOURNAL			English	Article						25&#8208; HC; ARDS; cholesterol&#8208; 25&#8208; hydroxylase; corticosteroid; leukotrienes; pneumonia		Inflammation is a critical component of many lung diseases including asthma and acute lung injury (ALI). Using high-performance liquid chromatography-mass spectrometry, we quantified the levels of oxysterols in two different murine models of lung diseases. These are lipid mediators derived from cholesterol and known to modulate immunity and inflammation. Interestingly, 25-hydroxycholesterol (25-OHC) was the only oxysterol with altered levels during lung inflammation, and its levels were differently affected according to the model. Therefore, we sought to assess how this oxysterol would affect lung inflammatory responses. In a model of lipopolysaccharide (LPS)-induced acute lung inflammation, 25-OHC levels were increased, and most of the hallmarks of the model (eg, leukocyte recruitment, mRNA expression, and secretion of inflammatory cytokines) were decreased following its intratracheal administration. We also found that, when administered in the lung, 25-OHC is metabolized locally into 25-hydroxycholesterol-3-sulfate and 7 alpha,25-dihydroxycholesterol. Their administration in the lungs did not recapitulate all the effects of 25-OHC. Conversely, in a model of allergic asthma induced by intranasal administration of house dust mites (HDM), 25-OHC levels were decreased, and when intranasally administered, this oxysterol worsened the hallmarks of the model (eg, leukocyte recruitment, tissue remodeling [epithelium thickening and peribranchial fibrosis], and cytokine expression) and induced changes in leukotriene levels. Ex vivo, we found that 25-OHC decreases LPS-induced primary alveolar macrophage activation while having no effect on neutrophil activation. Its sulfated metabolite, 25-hydroxycholesterol-3-sulfate, decreased neutrophil, but not macrophage activation. Taken together, our data support a differential role of 25-OHC in ALI and allergic inflammation models.	[Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Guillemot-Legris, Owein; Alhouayek, Mireille; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Ave E Mounier,72 B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	; Alhouayek, Mireille/R-5058-2018	Muccioli, Giulio/0000-0002-1600-9259; Alhouayek, Mireille/0000-0002-9193-0718; Paquot, Adrien/0000-0002-4784-3510; Guillemot-Legris, Owein/0000-0003-3738-3423	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain	Fonds De La Recherche Scientifique - FNRS (FNRS); Universite catholique de Louvain	Alhouayek M, 2017, BBA-MOL CELL BIOL L, V1862, P474, DOI 10.1016/j.bbalip.2017.01.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alm AS, 2010, RESP PHYSIOL NEUROBI, V171, P157, DOI 10.1016/j.resp.2010.02.009; Asti C, 2000, PULM PHARMACOL THER, V13, P61, DOI 10.1006/pupt.2000.0231; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Birrell MA, 2008, J IMMUNOL, V181, P4265, DOI 10.4049/jimmunol.181.6.4265; Bleecker ER, 2018, CHEST, V154, P982, DOI 10.1016/j.chest.2018.08.1022; Bottemanne P, 2019, FASEB J, V33, P7635, DOI 10.1096/fj.201802259R; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Chen JX, 2015, INT IMMUNOPHARMACOL, V25, P43, DOI 10.1016/j.intimp.2015.01.013; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Claar D, 2015, EXPERT REV RESP MED, V9, P55, DOI 10.1586/17476348.2015.992783; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Ganeshan K, 2013, J IMMUNOL, V190, P5731, DOI 10.4049/jimmunol.1203362; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Guillemot-Legris O, 2019, J CROHNS COLITIS, V13, P218, DOI 10.1093/ecco-jcc/jjy157; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hu X, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4652695; Ichikawa T, 2013, EXP CELL RES, V319, P1176, DOI 10.1016/j.yexcr.2013.02.014; Jia J, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708349; Koarai A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-63; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li N, 2010, P NATL ACAD SCI USA, V107, P3734, DOI 10.1073/pnas.0911377107; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Madenspacher JH, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137189; Makinde T, 2007, IMMUNOL CELL BIOL, V85, P348, DOI 10.1038/sj.icb.7100044; Mutemberezi V, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1114-8; Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Ning YX, 2017, METABOLISM, V71, P83, DOI 10.1016/j.metabol.2016.12.007; Ninomiya Y, 2007, J STEROID BIOCHEM, V103, P44, DOI 10.1016/j.jsbmb.2006.07.009; Ouyang W, 2018, J CELL MOL MED, V22, P5494, DOI 10.1111/jcmm.13820; Panini SR, 2001, J LIPID RES, V42, P1678; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Perucha E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08332-9; Pokharel SM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09453-x; Ragaller Maximillian, 2010, J Emerg Trauma Shock, V3, P43, DOI 10.4103/0974-2700.58663; Raselli T, 2019, J CROHNS COLITIS, V13, P1186, DOI 10.1093/ecco-jcc/jjz039; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Shen ZJ, 2017, AM J RESP CRIT CARE, V195, P1576, DOI [10.1164/rccm.201608-1580OC, 10.1164/rccm.201608-1580oc]; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092668; Smet M, 2016, IMMUN INFLAMM DIS, V4, P350, DOI 10.1002/iid3.118; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Verheijden KAT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02419; Verheijden KAT, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0171-0; Vigne S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01184; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao ZM, 2016, AM J PATHOL, V186, P2614, DOI 10.1016/j.ajpath.2016.06.018; Zou XL, 2018, THER CLIN RISK MANAG, V14, P1627, DOI 10.2147/TCRM.S172262; Zu SL, 2020, CELL RES, V30, P1043, DOI 10.1038/s41422-020-00398-1	64	9	10	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21514	10.1096/fj.202002555R	http://dx.doi.org/10.1096/fj.202002555R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734509				2022-12-26	WOS:000635216100032
J	Matthews, LT; Greener, L; Khidir, H; Psaros, C; Harrison, A; Mosery, FN; Mathenjwa, M; O'Neil, K; Milford, C; Safren, SA; Bangsberg, DR; Smit, JA				Matthews, Lynn T.; Greener, Letitia; Khidir, Hazar; Psaros, Christina; Harrison, Abigail; Mosery, F. Nzwakie; Mathenjwa, Mxolisi; O'Neil, Kasey; Milford, Cecilia; Safren, Steven A.; Bangsberg, David R.; Smit, Jennifer A.			"It really proves to us that we are still valuable": Qualitative research to inform a safer conception intervention for men living with HIV in South Africa	PLOS ONE			English	Article							RECEIVING ANTIRETROVIRAL THERAPY; SERO-DISCORDANT COUPLES; RISK BEHAVIOR; WOMEN; PREVENTION; PREGNANCY; CARE; SERVICES; CHILDREN; IMPLEMENTATION	Objective Many men living with HIV want to have children. Opportunities to reduce periconception HIV transmission include antiretroviral therapy as prevention, pre-exposure prophylaxis, limiting condomless sex to peak fertility, and sperm processing. Whether men have knowledge of or want to adopt these strategies remains unknown. Methods We conducted focus group discussions (FGDs) with men accessing HIV care in South Africa in 2014 to inform a safer conception intervention for men. Eligible men were 25-45 years old, living with HIV, not yet accessing treatment, and wanting to have a child with an HIV-negative or unknown serostatus female partner (referred to as the "desired pregnancy partner"). FGDs explored motivations for having a healthy baby, feasibility of a clinic-based safer conception intervention, and acceptability of safer conception strategies. Data were analyzed using thematic analysis. Results Twelve participants from three FGDs had a median age of 37 (range 23-45) years, reported a median of 2 (range 1-4) sexual partners, and 1 (range 1-3) desired pregnancy partner(s). A third (N = 4) had disclosed HIV-serostatus to the pregnancy partner. Emergent themes included opportunities for and challenges to engaging men in safer conception services. Opportunities included enthusiasm for a clinic-based safer conception intervention and acceptance of some safer conception strategies. Challenges included poor understanding of safer conception strategies, unfamiliarity with risk reduction [versus "safe" (condoms) and "unsafe" (condomless) sex], mixed acceptability of safer conception strategies, and concerns about disclosing HIV-serostatus to a partner. Conclusions Men living with HIV expressed interest in safer conception and willingness to attend clinic programs. Imprecise prevention counseling messages make it difficult for men to conceptualize risk reduction. Effective safer conception programs should embrace clear language, e.g. undetectable = untransmittable (U = U), and support multiple approaches to serostatus disclosure to pregnancy partners.	[Matthews, Lynn T.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Matthews, Lynn T.; O'Neil, Kasey] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Matthews, Lynn T.; O'Neil, Kasey] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Greener, Letitia; Mosery, F. Nzwakie; Mathenjwa, Mxolisi; Milford, Cecilia; Smit, Jennifer A.] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, MRU MatCH, Durban, South Africa; [Greener, Letitia] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst Wits RHI, Fac Hlth Sci, Johannesburg, South Africa; [Khidir, Hazar] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Combined Residency Program Emergency Med, Boston, MA 02115 USA; [Psaros, Christina] Massachusetts Gen Hosp, Dept Psychiat, Behav Med, Boston, MA 02114 USA; [Harrison, Abigail] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Safren, Steven A.] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Bangsberg, David R.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Witwatersrand; University of Witwatersrand; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Brown University; University of Miami; Oregon Health & Science University; Portland State University	Matthews, LT (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.; Matthews, LT (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.; Matthews, LT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	lynnmatthews@uabmc.edu			National Institutes of Health (NIH) [MH100948, MH095655, MH096651, MH087227, MH094214]; Harvard CFAR P30 [AI060354]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard CFAR P30	This work was supported by National Institutes of Health (NIH, https://urldefense.proofpoint.com/v2/url?u=http-3A__www.nih.gov&d=DwIGaQ&c=o3PTkfaYAd6No7SurnLt5qpge1aKYwPQyBFS7c8AA0&r= gogn30blU2aosnJjpi727b9K-qufLi2BKLsFiLaeo_ U&m=86VO_njWvYfHhG1S2zTCw2keBxdMZiKedjcrviJsKo&s= 4cB5P8jmZRi23kr3nk3zngI9MgCA2hQ_ fGdAPBnYJps&e=) awards R34 (MH100948) (LTM), K23 (MH095655) (LTM), K23 (MH096651) (CP), K24 (MH087227) (DRB), K24 (MH094214) (SS), as well as the Harvard CFAR P30 (AI060354) (LTM). This work does not necessarily reflect the opinions of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyeye AO, 2018, LANCET, V392, P2334, DOI 10.1016/S0140-6736(18)32994-5; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Ayieko J, 2019, JAIDS-J ACQ IMM DEF, V80, P414, DOI [10.1097/QAI.0000000000001939, 10.1097/qai.0000000000001939]; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Beyeza-Kashesya J, 2009, AFR HEALTH SCI, V9, P2; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Calabrese SK, 2019, LANCET HIV, V6, pE211, DOI 10.1016/S2352-3018(19)30030-X; Card KG, 2018, JAIDS-J ACQ IMM DEF, V77, P8, DOI 10.1097/QAI.0000000000001557; Carter A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20039; Crankshaw TL, 2016, SOC SCI MED, V166, P169, DOI 10.1016/j.socscimed.2016.08.020; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Davies NECG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21271; Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Fransen-dos Santos R, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21749; Gosset A, 2019, JAIDS-J ACQ IMM DEF, V80, P375, DOI [10.1097/QAI.0000000000001938, 10.1097/qai.0000000000001938]; Grimsrud A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25526; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Heffron R, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25261; Heffron R, 2015, J INT AIDS SOC, V18, P44, DOI 10.7448/IAS.18.6.20272; Huerga H, 2016, JAIDS-J ACQ IMM DEF, V73, P411, DOI 10.1097/QAI.0000000000001081; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Kaida A, 2019, JAIDS-J ACQ IMM DEF, V81, P497, DOI 10.1097/QAI.0000000000002053; Kharsany ABM, 2010, HIV MED, V11, P661, DOI 10.1111/j.1468-1293.2010.00838.x; Khidir H, 2018, AIDS BEHAV, V22, P1725, DOI 10.1007/s10461-017-1719-4; Kilembe W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1959-z; Makusha T, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25510; Matthews LT, 2015, AIDS BEHAV, V19, P2291, DOI 10.1007/s10461-015-1050-x; Matthews L T, 2012, Infect Dis Obstet Gynecol, V2012, P146348, DOI 10.1155/2012/146348; Matthews LT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027227; Matthews LT, 2018, AIDS BEHAV, V22, P1713, DOI 10.1007/s10461-017-1777-7; Matthews LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183131; Matthews LT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4195762; Matthews LT, 2014, JAIDS-J ACQ IMM DEF, V67, pS210, DOI 10.1097/QAI.0000000000000374; Matthews LT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-843; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Mindry DL, 2015, AIDS CARE, V27, P25, DOI 10.1080/09540121.2014.951311; Mindry D, 2017, AIDS BEHAV, V21, P2488, DOI 10.1007/s10461-017-1816-4; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; National Department of Health SA, 2010, CLIN GUID MAN HIV AI; Osler M, 2018, CLIN INFECT DIS, V66, pS118, DOI 10.1093/cid/cix1140; Otte Christian, 2011, Dialogues Clin Neurosci, V13, P413; Pettifor A, 2010, AIDS BEHAV, V14, P913, DOI 10.1007/s10461-008-9462-5; Psaros C, 2016, AIDS; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rodriguez Violeta J, 2017, J Int Assoc Provid AIDS Care, V16, P133, DOI 10.1177/2325957415612127; Saleem HT, 2019, AIDS CARE, V31, P908, DOI 10.1080/09540121.2019.1576844; Schwartz SR, 2019, LANCET HIV, V6, pE438, DOI 10.1016/S2352-3018(19)30144-4; Schwartz SR, 2016, INT J STD AIDS, V27, P984, DOI 10.1177/0956462415604091; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Shapiro AE, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25514; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Siegel K, 2018, AIDS BEHAV, V22, P1736, DOI 10.1007/s10461-017-1864-9; Taylor TN, 2013, CULT HEALTH SEX, V15, P1101, DOI 10.1080/13691058.2013.809147; Thomson KA., 2018, J INFECT DIS; UNAIDS, 2015, MEN BOYS AIDS REFR C; Vandormael A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13473-y; Villar-Loubet OM, 2013, CULT HEALTH SEX, V15, P253, DOI 10.1080/13691058.2012.716166; Weber S, 2015, 10 INT C HIV TREATM; World_Health_Organization :_ Department_of_Gender WaH, 2010, POL APPR ENG MEN BOY	68	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0240990	10.1371/journal.pone.0240990	http://dx.doi.org/10.1371/journal.pone.0240990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765001	Green Published, gold			2022-12-26	WOS:000634832800068
J	Furno, A; El Faouzi, NE; Sharma, R; Zimeo, E				Furno, Angelo; El Faouzi, Nour-Eddin; Sharma, Rajesh; Zimeo, Eugenio			Graph-based ahead monitoring of vulnerabilities in large dynamic transportation networks	PLOS ONE			English	Article							URBAN TRAFFIC-FLOW; BETWEENNESS CENTRALITY; COMPUTATION	Betweenness Centrality (BC) has proven to be a fundamental metric in many domains to identify the components (nodes) of a system modelled as a graph that are mostly traversed by information flows thus being critical to the proper functioning of the system itself. In the transportation domain, the metric has been mainly adopted to discover topological bottlenecks of the physical infrastructure composed of roads or railways. The adoption of this metric to study the evolution of transportation networks that take into account also the dynamic conditions of traffic is in its infancy mainly due to the high computation time needed to compute BC in large dynamic graphs. This paper explores the adoption of dynamic BC, i.e., BC computed on dynamic large-scale graphs, modeling road networks and the related vehicular traffic, and proposes the adoption of a fast algorithm for ahead monitoring of transportation networks by computing approximated BC values under time constraints. The experimental analysis proves that, with a bounded and tolerable approximation, the algorithm computes BC on very large dynamically weighted graphs in a significantly shorter time if compared with exact computation. Moreover, since the proposed algorithm can be tuned for an ideal trade-off between performance and accuracy, our solution paves the way to quasi real-time monitoring of highly dynamic networks providing anticipated information about possible congested or vulnerable areas. Such knowledge can be exploited by travel assistance services or intelligent traffic control systems to perform informed re-routing and therefore enhance network resilience in smart cities.	[Furno, Angelo; El Faouzi, Nour-Eddin] Univ Lyon, Univ Gustave Eiffel, ENTPE, LICIT UMR T9401, Lyon, France; [Sharma, Rajesh] Univ Tartu, Inst Comp Sci, Tartu, Estonia; [Zimeo, Eugenio] Univ Sannio, Dept Engn, Benevento, Italy	Universite Gustave-Eiffel; University of Tartu; University of Sannio	Furno, A (corresponding author), Univ Lyon, Univ Gustave Eiffel, ENTPE, LICIT UMR T9401, Lyon, France.; Zimeo, E (corresponding author), Univ Sannio, Dept Engn, Benevento, Italy.	angelo.furno@univ-eiffel.fr; eugenio.zimeo@unisannio.it	Furno, Angelo/Y-3756-2019	Furno, Angelo/0000-0001-9658-9179	French ANR research project PROMENADE [ANR-18-CE22-0008]; GAUSS project (MIUR,PRIN 2015) [2015KWREMX]; EU; French National Agency of Research; Italian CINI "Smart Cities and Communities" National Lab; SAI project	French ANR research project PROMENADE(French National Research Agency (ANR)); GAUSS project (MIUR,PRIN 2015); EU(European Commission); French National Agency of Research(French National Research Agency (ANR)); Italian CINI "Smart Cities and Communities" National Lab; SAI project	This work has been supported by the French ANR research project PROMENADE (grant number ANR-18-CE22-0008), the GAUSS project (MIUR, PRIN 2015, Contract 2015KWREMX) and the EU H2020 SoBigData++ project.; The authors would like to thank Lorenzo Goglia for his support in the comparative evaluation of W2C-Fast-BC with the BADIOS framework, as well as Loic Bonnetain and Elise Henry for their support in the analysis of the correlation between TTBC and traffics dynamics. The authors also acknowledge the French National Agency of Research, the Italian CINI "Smart Cities and Communities" National Lab and the SAI project for supporting this work.	Abadi A, 2015, IEEE T INTELL TRANSP, V16, P653, DOI 10.1109/TITS.2014.2337238; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Bader DA, 2007, LECT NOTES COMPUT SC, V4863, P124; Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4; Batista SFA, 2018, J ADV TRANSPORT, DOI 10.1155/2018/9876598; Berche B, 2009, EUR PHYS J B, V71, P125, DOI 10.1140/epjb/e2009-00291-3; Bergamini E, 2016, INTERNET MATH, V12, P281, DOI 10.1080/15427951.2016.1177802; Bilotta S, 2020, FUTURE GENER COMP SY; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borassi Michele, 2019, Journal of Experimental Algorithmics, V24, DOI 10.1145/3284359; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandes U, 2007, INT J BIFURCAT CHAOS, V17, P2303, DOI 10.1142/S0218127407018403; Castiello A, 2018, IEEE INT CONF BIG DA, P4006, DOI 10.1109/BigData.2018.8622091; Chehreghani M.H., 2018, PAC AS C KNOWL DISC, P752; Chehreghani MH, 2018, IEEE INT CONF BIG DA, P2114, DOI 10.1109/BigData.2018.8622452; Cheng YY, 2015, LECT NOTES SOC NETW, P23, DOI 10.1007/978-3-319-19003-7_2; Crucitti P, 2006, CHAOS, V16, DOI 10.1063/1.2150162; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; Daniel C, 2019, IEEE INT CONF BIG DA, P603, DOI 10.1109/BigData47090.2019.9006576; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Furno A., 2018, INT C COMPL NETW THE, P52; Furno A., 2017, COMPLEX NETWORKS, P65; Furno A., 2017, FAST COMPUTATION BET; Furno A, 2017, IEEE INT CONF BIG DA, P1289; Ganin AA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701079; Gao S, 2013, ENVIRON PLANN B, V40, P135, DOI 10.1068/b38141; Gauthier P, 2018, TRANSPORT RES REC, V2672, P54, DOI 10.1177/0361198118792115; Geisberger R, 2008, SIAM PROC S, P90; Guo K, 2021, IEEE T INTELL TRANSP, V22, P1138, DOI 10.1109/TITS.2019.2963722; Hayashi T, 2015, PROC VLDB ENDOW, V9, P48; Henry E., 2019, 2019 6 INT C MOD TEC, P1; Holme P, 2003, ADV COMPLEX SYST, V6, P163, DOI 10.1142/S0219525903000803; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; Jayasinghe A., 2015, INT J TRAFFIC TRANSP, V5, P134, DOI [10.7708/ijtte.2015.5(2).05, DOI 10.7708/IJTTE.2015.5(2).05]; KAO WW, 1991, VNIS 91 : VEHICLE NAVIGATION & INFORMATION SYSTEMS CONFERENCE PROCEEDINGS, PTS 1 AND 2, P635; Karypis G, 1998, J PARALLEL DISTR COM, V48, P96, DOI 10.1006/jpdc.1997.1404; King D., 2016, TRANSPORT RES REC; Kourtellis N, 2015, IEEE T KNOWL DATA EN, V27, P2494, DOI 10.1109/TKDE.2015.2419666; LaSalle D, 2016, PROC INT CONF PARAL, P236, DOI 10.1109/ICPP.2016.34; Leung IX., 2011, ARXIV PREPRINT ARXIV, P1; Li YH, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2230; Liu WY, 2019, J ADV TRANSPORT, DOI 10.1155/2019/9024745; Mahmassani HS, 2009, 12 WORLD C INT TRANS, P5022; Mallick T, 2019, ARXIV PREPRINT ARXIV; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ohara K, 2016, LECT NOTES ARTIF INT, V9956, P376, DOI 10.1007/978-3-319-46307-0_24; Pentl A, 2011, SECURING TRANSP SYST, P1; Perez A., 2015, DIRECTED LOUVAIN MAX; Ren YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6347; Riondato M, 2016, DATA MIN KNOWL DISC, V30, P438, DOI 10.1007/s10618-015-0423-0; Sariyuce A.E., 2013, P 2013 SIAM INT C DA, P686, DOI DOI 10.1137/1.9781611972832.76; Sariyuce AE, 2017, ACM T KNOWL DISCOV D, V11, DOI 10.1145/3022668; Sotera, DGA GRAPHX GRAPHX AL; Suppa P, 2015, IEEE INT CONGR BIG, P47, DOI 10.1109/BigDataCongress.2015.17; van Essen M, 2016, TRANSPORT REV, V36, P527, DOI 10.1080/01441647.2015.1125399; Wang HJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046105; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Winter, 2009, 12 AGILE INT C GEOGR; Zhang YY, 2011, TRANSPORT RES REC, P16, DOI 10.3141/2256-03; Zhao SM, 2017, PHYSICA A, V478, P143, DOI 10.1016/j.physa.2017.02.069	63	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248764	10.1371/journal.pone.0248764	http://dx.doi.org/10.1371/journal.pone.0248764			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760878	Green Published, gold			2022-12-26	WOS:000633030400035
J	Devkota, HR; Sijali, TR; Bogati, R; Ahmad, M; Shakya, KL; Adhikary, P				Devkota, Hridaya Raj; Sijali, Tula Ram; Bogati, Ramji; Ahmad, Meraj; Shakya, Karuna Laxmi; Adhikary, Pratik			The impact of COVID-19 on mental health outcomes among hospital fever clinic attendants across Nepal: A cross-sectional study	PLOS ONE			English	Article								Background The COVID-19 pandemic has been creating a panic and distressing situations among the entire population globally including Nepal. No study has been conducted assessing the psychological impact of this pandemic on the general public in Nepal. The objective of this study is to assess the mental health status during COVID-19 outbreak and explore the potential influencing factors among the population attending the hospital fever clinics with COVID-19 symptoms. Methods A cross-sectional survey was conducted between May-June, 2020 with a sample of 645 participants aged 18 and above in 26 hospitals across Nepal. Telephone interviews were conducted using a semi-structured questionnaire along with a validated psychometric tool, the Depression, Anxiety and Stress (DASS-21) scale. The metrics and scores of symptoms and their severity were created and analyzed. Multivariate logistic regression was used to determine the association of potential covariates with outcome variables. Results The prevalence of anxiety, depression and stress were 14%, 7% and 5% respectively. In reference to Karnali, participants from Bagmati province reported higher level of anxiety (OR 3.44, 95% CI 1.31-9.06), while stress (OR 4.27, 95% CI 1.09-18.32) and depressive symptoms (OR 3.11, 95% CI 1.05-9.23) observed higher among the participants in Province 1. Women were more at risk of anxiety (OR 3.41, 95% CI 1.83-6.36) than men. Similarly, people currently living in rented houses reported more stress (OR 2.97, 95% CI 1.05-8.43) and those living far from family reported higher rates of depressive symptoms (OR 3.44, 95% CI 1.03-11.46). Conclusion The study identified increased prevalence of stress, anxiety and depressive symptoms during the initial stage of COVID-19 pandemic in Nepal. Considering the findings, there is urgent need to develop and implement appropriate community-based mental health programs targeting individuals who have had COVID-19 symptoms and who are prone to develop adverse mental health outcomes.	[Devkota, Hridaya Raj; Sijali, Tula Ram; Bogati, Ramji] Community Support Assoc Nepal COSAN, Kathmandu, Nepal; [Ahmad, Meraj] Manipal Coll Med Sci, Pokhara, Nepal; [Shakya, Karuna Laxmi] Pokhara Univ, Cent Inst Sci & Technol CIST Coll, Pokhara, Nepal; [Adhikary, Pratik] UC Berkeley, Inst Social & Environm Res, ISER N, Bharatpur, Nepal		Devkota, HR (corresponding author), Community Support Assoc Nepal COSAN, Kathmandu, Nepal.	hridaya.devkota.10@ucl.ac.uk		Devkota, Hridaya Raj/0000-0002-2892-5836	Association of Nepal (COSAN)	Association of Nepal (COSAN)	The authors acknowledge the support and contribution of Community Support Association of Nepal (COSAN) and the colleagues who offered organizational facilities and staff time for this research. In addition, the authors wish to acknowledge the support provided by the hospitals and the data collectors-Shital Shrestha, Bhumika Sunuwar, Nabin Basnet, Asmita KC, Aayush Shrestha, Jeshika Shahi, Radhika Khadka, Dikshya Sharma, Sashi Bam, Ajay Poudel, Rakshya Adhikari, Aahana Sapkota, Prativa Pandey, Bibhushi Bhattarai, Saleena Shrestha, Aagya Dahal, Aaradhana Rayamajhi, Prashabdhi Shakya, Nisha Adhikari, Sapna Chaudhari, Deepa Ghimire and Nirmala Koju. The authors are grateful to those who participated in the study and shared their views and personal experiences.	[Anonymous], 2020, HIMALAYAN TIMES; [Anonymous], 2020, KATHMANDU POST; Asmundson GJG, 2020, J ANXIETY DISORD, V70, DOI 10.1016/j.janxdis.2020.102196; Choi EPH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103740; Devkota HR, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.589372; Devkota HR, 2020, WOMENS HEALTH, V16, DOI 10.1177/1745506519895175; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Gill P, 2020, DIPLOMAT; GoN/MoHP, 2020, SITREP 43; GoN/MoHP, 2020, SITREP 1; Government of Nepal Ministry of Health and Population, 2020, HLTH SECT RESP COVID; Gu J, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1867, DOI 10.1177/1010539512443699; Koenig HG, 2006, AGING MENT HEALTH, V10, P1, DOI 10.1080/13607860500308132; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Leary AO, 2018, FEAR CULTURE CONTEXT, V2014, P1; Lee EH, 2019, ASIAN NURS RES, V13, P30, DOI 10.1016/j.anr.2018.11.006; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lumley M, 2018, J CROSS CULT PSYCHOL, V49, P1269, DOI 10.1177/0022022118786458; Maunder RG, 2009, GEN HOSP PSYCHIAT, V31, P316, DOI 10.1016/j.genhosppsych.2009.04.004; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Novick G, 2008, RES NURS HEALTH, V31, P391, DOI 10.1002/nur.20259; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rehman U, 2021, COMMUNITY MENT HLT J, V57, P42, DOI 10.1007/s10597-020-00664-x; Tonsing KN, 2014, ASIAN J PSYCHIATR, V8, P63, DOI 10.1016/j.ajp.2013.11.001; Tsai J, 2020, LANCET PUBLIC HEALTH, V5, pE186, DOI 10.1016/S2468-2667(20)30053-0; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; WHO, 2017, DEPR OTH COMM MENT D; World Health Organization, 2021, COVID 19 WORLD WORK; World Health Organization, 2019, MENTAL DISORDER KEY; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248684	10.1371/journal.pone.0248684	http://dx.doi.org/10.1371/journal.pone.0248684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750955	Green Published, gold			2022-12-26	WOS:000631967100025
J	Ghosh, S; Pattanshetty, SM; Mallya, SD; Pandey, D; Guddattu, V; Kamath, VG; Kabekkodu, SP; Satyamoorthy, K; Shetty, RS				Ghosh, Supriti; Pattanshetty, Sanjay M.; Mallya, Sneha D.; Pandey, Deeksha; Guddattu, Vasudeva; Kamath, Veena G.; Kabekkodu, Shama Prasada; Satyamoorthy, Kapaettu; Shetty, Ranjitha S.			Cervical cytology and associated factors among tribal women of Karnataka, India	PLOS ONE			English	Article								Background Reproductive well-being is a crucial element of women's health. Due to the asymptomatic nature of gynaecological morbidities, women rarely seek medical advice in the initial period leading to delayed diagnosis and poor prognosis of subsequent disease. The present study aimed to explore the cervical cytology and its associated risk factors among women from tribal communities of the southern part of coastal Karnataka, India. Methods Papanicolaou (Pap) smear test was performed among 1140 women from three tribal populations, to detect cervical lesions, infections and reactive changes. A semi-structured questionnaire was administered to collect data on socio-demographic and reproductive characteristics of the study population. Results The most predominant gynaecological complaint among the participants was severe lower back ache (77.6%), followed by white discharge per vagina (29.0%) and menstrual irregularities (25.9%). Of the 1140 women screened, 12.4% showed cervical microbial infections, 23.6% were reported to have reactive changes, and 0.2% had epithelial cell abnormalities in the cervix. Cervical microbial infections were found to be associated with younger age group, low socio-economic status and younger age at sexual debut. Conclusion Most of the symptoms suggestive of gynaecological morbidities reported in this study are preventable or treatable. Strengthening ongoing cervical cancer screening programme and implementation of health education programmes among tribal population would be the right policy approach to prevent, detect and treat these symptoms at an early stage and to achieve acceptable health outcomes among tribal women.	[Ghosh, Supriti; Kabekkodu, Shama Prasada; Satyamoorthy, Kapaettu] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Cell & Mol Biol, Manipal, Karnataka, India; [Pattanshetty, Sanjay M.] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Dept Hlth Policy, Manipal, Karnataka, India; [Mallya, Sneha D.; Kamath, Veena G.; Shetty, Ranjitha S.] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Community Med, Manipal, Karnataka, India; [Pandey, Deeksha] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Obstet & Gynaecol, Manipal, Karnataka, India; [Guddattu, Vasudeva] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Dept Data Sci, Manipal, Karnataka, India; [Shetty, Ranjitha S.] Manipal Acad Higher Educ, Kasturba Med Coll, Ctr Indigenous Populat, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Shetty, RS (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Dept Community Med, Manipal, Karnataka, India.; Shetty, RS (corresponding author), Manipal Acad Higher Educ, Kasturba Med Coll, Ctr Indigenous Populat, Manipal, Karnataka, India.	ranjitha.shetty@manipal.edu	Kabekkodu, Shama Prasada/AAD-2947-2021	Kabekkodu, Shama Prasada/0000-0002-4158-3893; Ghosh, Supriti/0000-0001-9875-0720; Satyamoorthy, Kapaettu/0000-0002-2368-5490	Indian Council of Medical Research (ICMR), New Delhi, India [TRIBAL/70/2013-ECD-II]; Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship, Department of Science and Technology, Government of India [IF150647]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship, Department of Science and Technology, Government of India	This work was supported by the Indian Council of Medical Research (ICMR), New Delhi, India, grant number TRIBAL/70/2013-ECD-II (http://icmrextramural.in/ICMR/) provided to RSS. SG was supported by Innovation in Science Pursuit for Inspired Research (INSPIRE) fellowship, Department of Science and Technology, Government of India (IF150647) -http://www.inspire-dst.gov.in/.	Abraham A, 2014, INDAN J COMMUNITY HE, V26, P230; Agrawal PK, 2010, ASIAN ETHN, V11, P61, DOI 10.1080/14631360903506778; Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; [Anonymous], CENS 2011; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Apgar BS, 2003, AM FAM PHYSICIAN, V68, P1992; Arora BB., 2014, J SEX TRANSM DIS, V2014, P1; Atilgan R, 2012, INDIAN J PATHOL MICR, V55, P52, DOI 10.4103/0377-4929.94856; Babu A., 2016, INT J COMMUNITY MED, V3, P3430; Bhalla P, 2007, INDIAN J MED RES, V125, P167; Bir T, 2014, INT J DEV RES, V4, P2540; Castle PE, 2010, BJOG-INT J OBSTET GY, V117, P1067, DOI 10.1111/j.1471-0528.2010.02650.x; Dahiya N, 2019, TZU CHI MED J, V31, P240, DOI 10.4103/tcmj.tcmj_145_18; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Garcia PJ, 2004, B WORLD HEALTH ORGAN, V82, P483; Geetha P., 2015, Studies of Tribes and Tribals, V13, P73; Ghosh S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219173; Inamdar ISPDM, 2013, IOSR J DENT MED SCI, V7, P5; Kambo IP, 2003, INDIAN J COMMUNITY M, V28, P67; Kielmann K, 2003, J HEALTH PSYCHOL, V8, P525, DOI 10.1177/13591053030085005; Kulkarni PR, 2013, ASIAN PAC J CANCER P, V14, P5101, DOI 10.7314/APJCP.2013.14.9.5101; Marconi C, 2015, INT J GYNECOL OBSTET, V131, P137, DOI 10.1016/j.ijgo.2015.05.016; Marrazzo JM, 2006, J INFECT DIS, V193, P617, DOI 10.1086/500149; Mathur M, 2017, INT J REPROD CONTRAC, V6, P5330; Nagarkar Aarti, 2015, Indian J Sex Transm Dis AIDS, V36, P18, DOI 10.4103/0253-7184.156690; Nandini Bhattacharyya, 2020, Journal of the Anthropological Survey of India, V69, P124, DOI 10.1177/2277436X20927252; Nayani ZS, 2015, J EVOL MED DENT SCI-, V4, P9236, DOI 10.14260/jemds/2015/1341; Nayir Tufan, 2015, Asian Pac J Cancer Prev, V16, P6909; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P33; Parvez R., 2016, INT J CURR MICROBIOL, V5, P28; Poornima S., 2013, Al Ameen Journal of Medical Sciences, V6, P226; Sachan PL, 2018, ASIA-PAC J ONCOL NUR, V5, P337, DOI 10.4103/apjon.apjon_15_18; Sengul D, 2014, ASIAN PAC J CANCER P, V15, P2069, DOI 10.7314/APJCP.2014.15.5.2069; Tehrani FR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-863; Vaghela B. K., 2014, International Journal of Biomedical and Advance Research, V5, P47; Vasuki S., 2014, ASIA PACIFIC J RES, V1, P68; Verma A, 2017, MIDDLE EAST FERTIL S, V22, P39, DOI 10.1016/j.mefs.2016.09.002; von Glehn Mateus de Paula, 2017, J Family Med Prim Care, V6, P88, DOI 10.4103/2249-4863.214982; World Heatlh Organization, 1990, MEAS REPR MORB REP T; Zhang XJ, 2009, EUR J OBSTET GYN R B, V147, P187, DOI 10.1016/j.ejogrb.2009.08.017; Zurayk H, 1993, Health Transit Rev, V3, P17	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248963	10.1371/journal.pone.0248963	http://dx.doi.org/10.1371/journal.pone.0248963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740008	gold, Green Published			2022-12-26	WOS:000631030200027
J	Koyama, K; Tanaka, M; Cho, BH; Yoshikawa, Y; Koseki, S				Koyama, Kento; Tanaka, Marin; Cho, Byeong-Hyo; Yoshikawa, Yusaku; Koseki, Shige			Predicting sensory evaluation of spinach freshness using machine learning model and digital images	PLOS ONE			English	Article							CONSUMER PERCEPTION; NETWORK; CLASSIFICATION; STORAGE	The visual perception of freshness is an important factor considered by consumers in the purchase of fruits and vegetables. However, panel testing when evaluating food products is time consuming and expensive. Herein, the ability of an image processing-based, nondestructive technique to classify spinach freshness was evaluated. Images of spinach leaves were taken using a smartphone camera after different storage periods. Twelve sensory panels ranked spinach freshness into one of four levels using these images. The rounded value of the average from all twelve panel evaluations was set as the true label. The spinach image was removed from the background, and then converted into a gray scale and CIE-Lab color space (L*a*b*) and Hue, Saturation and Value (HSV). The mean value, minimum value, and standard deviation of each component of color in spinach leaf were extracted as color features. Local features were extracted using the bag-of-words of key points from Oriented FAST (Features from Accelerated Segment Test) and Rotated BRIEF (Binary Robust Independent Elementary Features). The feature combinations selected from the spinach images were used to train machine learning models to recognize freshness levels. Correlation analysis between the extracted features and the sensory evaluation score showed a positive correlation (0.5 < r < 0.6) for four color features, and a negative correlation (-0.6 < r < -0.5) for six clusters in the local features. The support vector machine classifier and artificial neural network algorithm successfully classified spinach samples with overall accuracy 70% in four-class, 77% in three-class and 84% in two-class, which was similar to that of the individual panel evaluations. Our findings indicate that a model using support vector machine classifiers and artificial neural networks has the potential to replace freshness evaluations currently performed by non-trained panels.	[Koyama, Kento; Tanaka, Marin; Cho, Byeong-Hyo; Yoshikawa, Yusaku; Koseki, Shige] Hokkaido Univ, Grad Sch Agr Sci, Sapporo, Hokkaido, Japan	Hokkaido University	Koyama, K (corresponding author), Hokkaido Univ, Grad Sch Agr Sci, Sapporo, Hokkaido, Japan.	kento.koyama@frontier.hokudai.ac.jp	Koseki, Shige/J-8317-2012	Koseki, Shige/0000-0001-7046-5354; Koyama, Kento/0000-0003-1521-2981				Angerosa F, 1996, J SCI FOOD AGR, V72, P323, DOI 10.1002/(SICI)1097-0010(199611)72:3<323::AID-JSFA662>3.0.CO;2-A; Arce-Lopera C, 2013, FOOD QUAL PREFER, V27, P202, DOI 10.1016/j.foodqual.2012.03.005; Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Bhargava A., 2018, FRUITS VEGETABLES QU, DOI [10.1016/j. jksuci.2018.06.002., 10.1016/j.jksuci.2018.06.002]; Boccorh RK, 2002, FOOD QUAL PREFER, V13, P117, DOI 10.1016/S0950-3293(01)00072-6; Calonder M, 2010, LECT NOTES COMPUT SC, V6314, P778, DOI 10.1007/978-3-642-15561-1_56; Carvalho NB, 2013, FOOD SCI TECH-BRAZIL, V33, P722, DOI 10.1590/S0101-20612013000400018; Cavallo DP, 2018, J FOOD ENG, V223, P46, DOI 10.1016/j.jfoodeng.2017.11.042; Cohen J, 1977, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cortez P, 2009, DECIS SUPPORT SYST, V47, P547, DOI 10.1016/j.dss.2009.05.016; Cubero S, 2011, FOOD BIOPROCESS TECH, V4, P487, DOI 10.1007/s11947-010-0411-8; Dowlati M, 2013, J FOOD ENG, V119, P277, DOI 10.1016/j.jfoodeng.2013.05.023; El-Bendary N, 2015, EXPERT SYST APPL, V42, P1892, DOI 10.1016/j.eswa.2014.09.057; Ferentinos KP, 2018, COMPUT ELECTRON AGR, V145, P311, DOI 10.1016/j.compag.2018.01.009; Frewer LJ., 2013, FOOD PEOPLE SOC; Gimenez A, 2012, FOOD RES INT, V49, P311, DOI 10.1016/j.foodres.2012.07.008; Glorot X., 2011, P 14 INT C ART INT S, P315, DOI DOI 10.1177/1753193410395357; Hameed K, 2018, IMAGE VISION COMPUT, V80, P24, DOI 10.1016/j.imavis.2018.09.016; Harris C., 1988, P ALVEY VIS C, p23.1; Heenan SP, 2009, FOOD QUAL PREFER, V20, P380, DOI 10.1016/j.foodqual.2009.02.008; Hu J, 2020, FISH RES, V221, DOI 10.1016/j.fishres.2019.105376; Huang XY, 2019, J FOOD SAFETY, V39, DOI 10.1111/jfs.12708; Hurst PL, 1998, FOOD CHEM, V61, P381, DOI 10.1016/S0308-8146(97)00031-9; Jung YJ, 2012, POSTHARVEST BIOL TEC, V73, P115, DOI 10.1016/j.postharvbio.2012.06.005; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kumar C, 2015, 2015 INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND SIGNAL PROCESSING (ICCSP), P1743, DOI 10.1109/ICCSP.2015.7322820; Lappalainen R, 1998, FOOD QUAL PREFER, V9, P467, DOI 10.1016/S0950-3293(98)00018-4; Lawless H. T., 2010, SENSORY EVALUATION F; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Liu XC, 2015, LWT-FOOD SCI TECHNOL, V60, P142, DOI 10.1016/j.lwt.2014.09.030; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mahendra O, 2018, 2018 INTERNATIONAL CONFERENCE ON COMPUTER, CONTROL, INFORMATICS AND ITS APPLICATIONS (IC3INA), P7, DOI 10.1109/IC3INA.2018.8629534; Navotas I. C., 2018, J ENG APPL SCI, V13, P4912; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pathare PB, 2013, FOOD BIOPROCESS TECH, V6, P36, DOI 10.1007/s11947-012-0867-9; Peneau S, 2007, POSTHARVEST BIOL TEC, V45, P20, DOI 10.1016/j.postharvbio.2007.02.001; Peneau S, 2006, FOOD QUAL PREFER, V17, P9, DOI 10.1016/j.foodqual.2005.05.002; Peneau S, 2006, THESIS SWITZERLAND; Pydipati R, 2006, COMPUT ELECTRON AGR, V52, P49, DOI 10.1016/j.compag.2006.01.004; Quevedo RA, 2010, FOOD BIOPROCESS TECH, V3, P637, DOI 10.1007/s11947-008-0106-6; Ragaert P, 2004, FOOD QUAL PREFER, V15, P259, DOI 10.1016/S0950-3293(03)00066-1; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Rublee E, 2011, IEEE I CONF COMP VIS, P2564, DOI 10.1109/ICCV.2011.6126544; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; Sanaeifar A, 2016, TALANTA, V148, P54, DOI 10.1016/j.talanta.2015.10.073; Sanahuja S, 2018, J FOOD ENG, V226, P53, DOI 10.1016/j.jfoodeng.2017.12.013; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Sun DW, 2016, COMPUTER VISION TECHNOLOGY FOR FOOD QUALITY EVALUATION, 2ND EDITION, P1, DOI 10.1016/C2014-0-01718-2; TOIVONEN PMA, 1992, HORTSCIENCE, V27, P1014, DOI 10.21273/HORTSCI.27.9.1014; Wada Y, 2007, APPETITE, V49, P183, DOI 10.1016/j.appet.2007.01.009; Wandel M, 1997, FOOD QUAL PREFER, V8, P19, DOI 10.1016/S0950-3293(96)00004-3; YAMANE A, 1994, J AGR FOOD CHEM, V42, P1010, DOI 10.1021/jf00040a033; Yang Y, 2016, KNOWL-BASED SYST, V94, P105, DOI 10.1016/j.knosys.2015.11.012	54	11	11	13	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248769	10.1371/journal.pone.0248769	http://dx.doi.org/10.1371/journal.pone.0248769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739969	gold, Green Published			2022-12-26	WOS:000631030200018
J	Thompson, K; Nahmias, E; Fani, N; Kvaran, T; Turner, J; Tone, E				Thompson, Khalil; Nahmias, Eddy; Fani, Negar; Kvaran, Trevor; Turner, Jessica; Tone, Erin			The Prisoner's Dilemma paradigm provides a neurobiological framework for the social decision cascade	PLOS ONE			English	Article								To function during social interactions, we must be able to consider and coordinate our actions with other people's perspectives. This process unfolds from decision-making, to anticipation of that decision's consequences, to feedback about those consequences, in what can be described as a "cascade" of three phases. The iterated Prisoner's Dilemma (iPD) task, an economic-exchange game used to illustrate how people achieve stable cooperation over repeated interactions, provides a framework for examining this "social decision cascade". In the present study, we examined neural activity associated with the three phases of the cascade, which can be isolated during iPD game rounds. While undergoing functional magnetic resonance imaging (fMRI), 31 adult participants made a) decisions about whether to cooperate with a co-player for a monetary reward, b) anticipated the co-player's decision, and then c) learned the co-player's decision. Across all three phases, participants recruited the temporoparietal junction (TPJ) and the dorsomedial prefrontal cortex (dmPFC), regions implicated in numerous facets of social reasoning such as perspective-taking and the judgement of intentions. Additionally, a common distributed neural network underlies both decision-making and feedback appraisal; however, differences were identified in the magnitude of recruitment between both phases. Furthermore, there was limited evidence that anticipation following the decision to defect evoked a neural signature that is distinct from the signature of anticipation following the decision to cooperate. This study is the first to delineate the neural substrates of the entire social decision cascade in the context of the iPD game.	[Thompson, Khalil; Nahmias, Eddy; Kvaran, Trevor; Turner, Jessica; Tone, Erin] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Fani, Negar] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Emory University	Thompson, K (corresponding author), Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA.	kthompson70@gsu.edu	Fani, Negar/AAW-1445-2021	Fani, Negar/0000-0002-7720-252X; Thompson, Khalil/0000-0001-5346-8123	National Science Foundation Graduate Research Fellowship [DGE-1550139]; GSU Brains & Behavior seed grant; GSU/GA Tech Center for Advanced Brain Imaging grant; National Institute of Health [NIH-5R01MH121246]; 2CI Fellowship for Neuroimaging from GSU	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); GSU Brains & Behavior seed grant; GSU/GA Tech Center for Advanced Brain Imaging grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2CI Fellowship for Neuroimaging from GSU	This work was supported by: a National Science Foundation Graduate Research Fellowship DGE-1550139] to K. Thompson, a GSU Brains & Behavior seed grant to E. Tone & E. Nahmias, the GSU/GA Tech Center for Advanced Brain Imaging grant to E. Tone & J. Turner, a National Institute of Health grant to J. Turner [NIH-5R01MH121246], as well as a 2CI Fellowship for Neuroimaging from GSU awarded to K. Thompson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://nsf.gov/https://www.nih.gov/https://neuroscience.gsu.edu/brains-behavior/http://www.cabiatl.com/CABI/.	[Anonymous], [No title captured]; Arefin MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72971-y; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Bitsch F, 2018, HUM BRAIN MAPP, V39, P3072, DOI 10.1002/hbm.24061; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Botvinick MM, 2009, PSYCHOL RES-PSYCH FO, V73, P835, DOI 10.1007/s00426-008-0197-8; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Caceda R, 2015, BEHAV BRAIN RES, V292, P478, DOI 10.1016/j.bbr.2015.07.008; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Chase HW, 2015, COGN AFFECT BEHAV NE, V15, P435, DOI 10.3758/s13415-015-0338-7; Cohen MX, 2007, SOC COGN AFFECT NEUR, V2, P20, DOI 10.1093/scan/nsl021; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DeSalvo MN, 2014, BRAIN BEHAV, V4, P877, DOI 10.1002/brb3.286; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E., 2006, HDB EC GIVING ALTRUI, P615, DOI [DOI 10.1016/S1574-0714(06)01008-6, 10.1016/S1574-0714(06)01008-6]; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Gonzalez-Castillo J, 2018, NEUROIMAGE, V180, P526, DOI 10.1016/j.neuroimage.2017.08.006; Greco JA, 2016, NEUROPSYCHOPHARMACOL, V41, P320, DOI 10.1038/npp.2015.255; Grupe DW, 2013, CEREB CORTEX, V23, P1874, DOI 10.1093/cercor/bhs175; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Haber SN, 2014, NEURON, V83, P1019, DOI 10.1016/j.neuron.2014.08.031; Heberlein KA, 2004, MAGN RESON MED, V51, P212, DOI 10.1002/mrm.10680; Ito H, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181085; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Lambert B, 2017, SOC COGN AFFECT NEUR, V12, P609, DOI 10.1093/scan/nsw170; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Levan A, 2016, BRAIN IMAGING BEHAV, V10, P1090, DOI 10.1007/s11682-015-9472-7; Liljeholm M, 2012, TRENDS COGN SCI, V16, P467, DOI 10.1016/j.tics.2012.07.007; Loitfelder M, 2015, BRAIN CONNECT, V5, P312, DOI 10.1089/brain.2014.0334; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180; Mathews Z, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01443; McClure-Tone EB, 2011, DEV NEUROPSYCHOL, V36, P453, DOI 10.1080/87565641.2010.549876; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Miller FG, 2008, KENNEDY INST ETHIC J, V18, P235, DOI 10.1353/ken.0.0196; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Patel RS, 2006, HUM BRAIN MAPP, V27, P267, DOI 10.1002/hbm.20182; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Schurz M., 2020, PSYCHOL B; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schurz M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00712; Shankman SA, 2014, NEUROREPORT, V25, P596, DOI 10.1097/WNR.0000000000000144; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Smoski MJ, 2009, J AFFECT DISORDERS, V118, P69, DOI 10.1016/j.jad.2009.01.034; Sun P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160503; Suzuki S, 2011, SOC COGN AFFECT NEUR, V6, P338, DOI 10.1093/scan/nsq042; Tanimoto J, 2018, EV ECON SOC COMP SCI, V17, P1, DOI 10.1007/978-981-13-2769-8; Tanimoto J, 2007, BIOSYSTEMS, V90, P105, DOI 10.1016/j.biosystems.2006.07.005; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Walter M, 2008, MAGN RESON MATER PHY, V21, P103, DOI 10.1007/s10334-007-0103-1; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Watanabe T, 2014, P NATL ACAD SCI USA, V111, P3990, DOI 10.1073/pnas.1318570111; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	74	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248006	10.1371/journal.pone.0248006	http://dx.doi.org/10.1371/journal.pone.0248006			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735226	gold, Green Published			2022-12-26	WOS:000631029700091
J	Bouche, L; Kamel, R; Tamareille, S; Garcia, G; Villedieu, C; Pillot, B; Gueguen, N; Chehaitly, A; de la Barca, JMC; Beaumont, J; Baetz, D; Ovize, M; Sesaki, H; Henrion, D; Reynier, P; Lenaers, G; Prunier, F; Mirebeau-Prunier, D				Bouche, Laura; Kamel, Rima; Tamareille, Sophie; Garcia, Gabriel; Villedieu, Camille; Pillot, Bruno; Gueguen, Naig; Chehaitly, Ahmad; de la Barca, Juan Manuel Chao; Beaumont, Justine; Baetz, Delphine; Ovize, Michel; Sesaki, Hiromi; Henrion, Daniel; Reynier, Pascal; Lenaers, Guy; Prunier, Fabrice; Mirebeau-Prunier, Delphine			DRP1 haploinsufficiency attenuates cardiac ischemia/reperfusion injuries	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; MITOCHONDRIAL FISSION; REPERFUSION INJURY; DISEASE; FUSION; HEART; AUTOPHAGY	Mitochondrial dynamics is a possible modulator of myocardial ischemia/reperfusion injuries (IRI). We previously reported that mice partially deficient in the fusion protein OPA1 exhibited higher IRI. Therefore, we investigated whether deficiency in the fission protein DRP1 encoded by Dnm1l gene would affect IRI in Dnm1l(+/-) mouse. After baseline characterization of the Dnm1l(+/-) mice heart, using echocardiography, electron microscopy, and oxygraphy, 3-month-old Dnm1l(+/-) and wild type (WT) mice were exposed to myocardial ischemia/reperfusion (I/R). The ischemic area-at-risk (AAR) and area of necrosis (AN) were delimited, and the infarct size was expressed by AN/AAR. Proteins involved in mitochondrial dynamics and autophagy were analyzed before and after I/R. Mitochondrial permeability transition pore (mPTP) opening sensitivity was assessed after I/R. Heart weight and left ventricular function were not significantly different in 3-, 6- and 12-month-old Dnm1l(+/-) mice than in WT. The cardiac DRP1 protein expression levels were 60% lower, whereas mitochondrial area and lipid degradation were significantly higher in Dnm1l(+/-) mice than in WT, though mitochondrial respiratory parameters and mPTP opening did not significantly differ. Following I/R, the infarct size was significantly smaller in Dnm1l(+/-) mice than in WT (34.6 +/- 3.1% vs. 44.5 +/- 3.3%, respectively; p<0.05) and the autophagic markers, LC3 II and P62 were significantly increased compared to baseline condition in Dnm1l(+/-) mice only. Altogether, data indicates that increasing fusion by means of Dnm1l deficiency was associated with protection against IRI, without alteration in cardiac or mitochondrial functions at basal conditions. This protection mechanism due to DRP1 haploinsufficiency increases the expression of autophagic markers.	[Bouche, Laura; Kamel, Rima; Tamareille, Sophie; Garcia, Gabriel; Gueguen, Naig; Chehaitly, Ahmad; de la Barca, Juan Manuel Chao; Beaumont, Justine; Henrion, Daniel; Reynier, Pascal; Lenaers, Guy; Prunier, Fabrice; Mirebeau-Prunier, Delphine] Univ Angers, CNRS UMR 6015 INSERM U1083, Inst MITOVASC, Angers, France; [Garcia, Gabriel; Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France; [Villedieu, Camille; Pillot, Bruno; Baetz, Delphine; Ovize, Michel] Univ Claude Bernard Lyon 1, Univ Lyon, CarMeN Lab, INSERM, Bron, France; [Gueguen, Naig; de la Barca, Juan Manuel Chao; Reynier, Pascal; Mirebeau-Prunier, Delphine] CHU Angers, Dept Biochim & Genet, Angers, France; [Ovize, Michel] Hosp Civils Lyon, Serv Explorat Fonct Cardiovasc, Hop Louis Pradel, Lyon, France; [Ovize, Michel] Hosp Civils Lyon, CIC Lyons, Hop Louis Pradel, Lyon, France; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Hunterian 111, Baltimore, MD USA	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Lyon; CHU Lyon; Johns Hopkins University	Prunier, F (corresponding author), Univ Angers, CNRS UMR 6015 INSERM U1083, Inst MITOVASC, Angers, France.; Prunier, F (corresponding author), CHU Angers, Serv Cardiol, Angers, France.	FaPrunier@chu-angers.fr	Carmen, Team3/Y-7384-2019; Pillot, Bruno/D-5448-2015; Garcia, Gabriel/GWZ-5540-2022; Tamareille, Sophie/K-1770-2015; Henrion, Daniel/J-8141-2015	Carmen, Team3/0000-0002-3614-0924; Pillot, Bruno/0000-0002-1499-3299; Tamareille, Sophie/0000-0001-8563-6558; Reynier, Pascal/0000-0003-0802-4608; Henrion, Daniel/0000-0003-1094-0285; CHEHAITLY, Ahmad/0000-0002-5864-4429; Lab, Carmen/0000-0002-5935-3236				Bochaton T, 2015, J MOL CELL CARDIOL, V84, P61, DOI 10.1016/j.yjmcc.2015.03.017; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; Cadete VJJ, 2019, BBA-MOL BASIS DIS, V1865, P782, DOI 10.1016/j.bbadis.2018.11.018; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; de la Barca JMC, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-21116; Din S, 2013, P NATL ACAD SCI USA, V110, P5969, DOI 10.1073/pnas.1213294110; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066; McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Sebastian D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wilding JR, 2006, J PHYSIOL-LONDON, V575, P191, DOI 10.1113/jphysiol.2006.114116; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang HL, 2017, CARDIOVASC RES, V113, P160, DOI 10.1093/cvr/cvw212; Zhao T, 2012, J BIOL CHEM, V287, P23615, DOI 10.1074/jbc.M112.379164	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248554	10.1371/journal.pone.0248554	http://dx.doi.org/10.1371/journal.pone.0248554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765018	gold, Green Published			2022-12-26	WOS:000634832800012
J	Chueh, AC; Advani, G; Foroutan, M; Smith, J; Ng, N; Nandurkar, H; Lio, DS; Zhu, HJ; Chong, YP; Verkade, H; Fujita, DJ; Bjorge, J; Basheer, F; Lim, JP; Luk, I; Dhillon, A; Sakthianandeswaren, A; Mouradov, D; Sieber, O; Hollande, F; Mariadason, JM; Cheng, HC				Chueh, Anderly C.; Advani, Gahana; Foroutan, Momeneh; Smith, Jai; Ng, Nadia; Nandurkar, Harshal; Lio, Daisy S.; Zhu, Hong-Jian; Chong, Yuh-Ping; Verkade, Heather; Fujita, Donald J.; Bjorge, Jeffrey; Basheer, Faiza; Lim, Jet Phey; Luk, Ian; Dhillon, Amardeep; Sakthianandeswaren, Anuratha; Mouradov, Dmitri; Sieber, Oliver; Hollande, Frederic; Mariadason, John M.; Cheng, Heung-Chin			CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation	ONCOGENE			English	Article							PROTEIN-TYROSINE KINASE; SRC-FAMILY; C-SRC; HUMAN COLON; PHOSPHATASE-ACTIVITY; DNA METHYLATION; CELLS; EXPRESSION; ACTIVATION; CLONING	Hyperactivation of SRC-family protein kinases (SFKs) contributes to the initiation and progression of human colorectal cancer (CRC). Since oncogenic mutations of SFK genes are rare in human CRC, we investigated if SFK hyperactivation is linked to dysregulation of their upstream inhibitors, C-terminal SRC kinase (CSK) and its homolog CSK-homologous kinase (CHK/MATK). We demonstrate that expression of CHK/MATK but not CSK was significantly downregulated in CRC cell lines and primary tumours compared to normal colonic tissue. Investigation of the mechanism by which CHK/MATK expression is down-regulated in CRC cells uncovered hypermethylation of the CHK/MATK promoter in CRC cell lines and primary tumours. Promoter methylation of CHK/MATK was also observed in several other tumour types. Consistent with epigenetic silencing of CHK/MATK, genetic deletion or pharmacological inhibition of DNA methyltransferases increased CHK/MATK mRNA expression in CHK/MATK-methylated colon cancer cell lines. SFKs were hyperactivated in CHK/MATK-methylated CRC cells despite expressing enzymatically active CSK, suggesting loss of CHK/MATK contributes to SFK hyperactivation. Re-expression of CHK/MATK in CRC cell lines led to reduction in SFK activity via a non-catalytic mechanism, a reduction in anchorage-independent growth, cell proliferation and migration in vitro, and a reduction in tumour growth and metastasis in a zebrafish embryo xenotransplantation model in vivo, collectively identifying CHK/MATK as a novel putative tumour suppressor gene in CRC. Furthermore, our discovery that CHK/MATK hypermethylation occurs in the majority of tumours warrants its further investigation as a diagnostic marker of CRC.	[Chueh, Anderly C.; Luk, Ian; Mariadason, John M.] Austin Hosp, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Chueh, Anderly C.; Sakthianandeswaren, Anuratha; Mouradov, Dmitri; Sieber, Oliver] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Chueh, Anderly C.; Sakthianandeswaren, Anuratha; Mouradov, Dmitri; Sieber, Oliver] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Chueh, Anderly C.; Mariadason, John M.] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia; [Chueh, Anderly C.; Sieber, Oliver] Monash Univ, Biomedicine Discovery Inst, Canc Program, Clayton, Vic, Australia; [Chueh, Anderly C.; Sieber, Oliver] Monash Univ, Biomedicine Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Advani, Gahana; Ng, Nadia; Lio, Daisy S.; Verkade, Heather; Cheng, Heung-Chin] Univ Melbourne, Bio21 Inst, Dept Biochem & Pharmacol, Parkville, Vic, Australia; [Foroutan, Momeneh; Smith, Jai; Hollande, Frederic] Univ Melbourne, Dept Clin Pathol, Victorian Comprehens Canc Ctr, Parkville, Vic, Australia; [Foroutan, Momeneh; Smith, Jai; Hollande, Frederic] Univ Melbourne, Victorian Comprehens Canc Ctr, Ctr Canc Res, Parkville, Vic, Australia; [Nandurkar, Harshal] Monash Univ, Australian Ctr Blood Dis, Prahran, Vic, Australia; [Zhu, Hong-Jian; Sieber, Oliver] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia; [Chong, Yuh-Ping] RMIT Univ, Sch Hlth & Biomed Sci, Discipline Lab Med, Bundoora, Vic, Australia; [Fujita, Donald J.; Bjorge, Jeffrey] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Basheer, Faiza; Lim, Jet Phey; Dhillon, Amardeep] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, Sch Med, Geelong, Vic, Australia; [Mariadason, John M.] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Walter & Eliza Hall Institute; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); University of Calgary; Deakin University; La Trobe University	Chueh, AC (corresponding author), Austin Hosp, Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia.; Chueh, AC (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Chueh, AC (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Chueh, AC (corresponding author), Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia.; Chueh, AC (corresponding author), Monash Univ, Biomedicine Discovery Inst, Canc Program, Clayton, Vic, Australia.; Chueh, AC (corresponding author), Monash Univ, Biomedicine Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Cheng, HC (corresponding author), Univ Melbourne, Bio21 Inst, Dept Biochem & Pharmacol, Parkville, Vic, Australia.	Anderly.Chueh@monash.edu; heung@unimelb.edu.au	Chüeh, Anderly C/AFC-2076-2022; Sieber, Oliver/ABA-9211-2021; Nandurkar, Harshal/AAO-7443-2020; BASHEER, FAIZA/GPF-8188-2022; Basheer, Faiza/AAW-5083-2021; Hollande, Frederic/GLS-4120-2022; Chueh, Anderly/AAF-9375-2022	Chüeh, Anderly C/0000-0003-1140-5516; Sieber, Oliver/0000-0001-9480-0786; BASHEER, FAIZA/0000-0003-4850-2205; Basheer, Faiza/0000-0003-4850-2205; Hollande, Frederic/0000-0002-7046-8392; Smith, Jai/0000-0003-4997-6189; Chong, Yuh Ping/0000-0002-9596-3242; Narwani, Gahana/0000-0003-3129-6249; Dhillon, Amardeep/0000-0002-6065-663X; Zhu, Hong-Jian/0000-0002-1478-995X; Mouradov, Dmitri/0000-0001-8149-816X; Foroutan, Momeneh/0000-0002-1440-0457	NHMRC [GNT1136119, 628727, 1050486]; Australian Brain Foundation [1141906]; NHMRC Senior Research fellowship [GNT1046092]; Tour de Cure Foundation, Australia; National Health and Medical Research Council of Australia [1164081]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Brain Foundation; NHMRC Senior Research fellowship(National Health and Medical Research Council (NHMRC) of Australia); Tour de Cure Foundation, Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	O. Sieber is a NHMRC Senior Research Fellow (GNT1136119); grant support to H.-J. Zhu: NHMRC project grant #628727, grant support to H.-C. Cheng: NHMRC project grant # 1050486 and Australian Brain Foundation, grant support to A. Dhillon: NHMRC project grants #1141906. J. Mariadason was supported by a NHMRC Senior Research fellowship (GNT1046092). F. Hollande received grants from the Tour de Cure Foundation, Australia (Senior Project grant) and the National Health and Medical Research Council of Australia (Grant #1164081).	Advani G, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0186-x; [Anonymous], 2014, JAMA, V312, P2566, DOI 10.1001/jama.2014.15746; AVRAHAM S, 1995, J BIOL CHEM, V270, P1833, DOI 10.1074/jbc.270.4.1833; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Boczek EE, 2019, J BIOL CHEM, V294, P13186, DOI 10.1074/jbc.RA119.008199; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Carethers JM, 2020, ANNU REV MED, V71, P59, DOI 10.1146/annurev-med-103018-123125; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; Constancio-Lund SS, 2009, MOL CARCINOGEN, V48, P156, DOI 10.1002/mc.20466; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Cordero JB, 2014, EMBO J, V33, P1474, DOI 10.1002/embj.201387454; Druliner BR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21525-4; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hesson LB, 2016, MOL CANCER RES, V14, P1217, DOI 10.1158/1541-7786.MCR-16-0175; Hoekstra E, 2016, ONCOTARGET, V7, P21922, DOI 10.18632/oncotarget.7829; Huang WY, 2015, NUCLEIC ACIDS RES, V43, pD856, DOI 10.1093/nar/gku1151; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jones RJ, 2002, BRIT J CANCER, V87, P1128, DOI 10.1038/sj.bjc.6600594; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; Kong XQ, 2019, CANCER CELL, V35, P633, DOI 10.1016/j.ccell.2019.03.003; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Luebeck GE, 2019, CANCER RES, V79, P495, DOI 10.1158/0008-5472.CAN-18-1682; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; MCVICAR DW, 1994, ONCOGENE, V9, P2037; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; PARK JS, 1993, ONCOGENE, V8, P2627; Poh AR, 2017, CANCER CELL, V31, P563, DOI 10.1016/j.ccell.2017.03.006; PURCHIO AF, 1983, MOL CELL BIOL, V3, P1589, DOI 10.1128/MCB.3.9.1589; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schneider C, 2019, NAT REV IMMUNOL, V19, P584, DOI 10.1038/s41577-019-0176-x; Scott A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177210; Shah NH, 2018, CRIT REV BIOCHEM MOL, V53, P535, DOI 10.1080/10409238.2018.1495173; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sirvent A, 2012, AM J CANCER RES, V2, P357; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Welman A, 2006, NEOPLASIA, V8, P905, DOI 10.1593/neo.06475; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yan KS, 2017, CELL STEM CELL, V21, P78, DOI 10.1016/j.stem.2017.06.014; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhu S, 2008, ONCOGENE, V27, P2027, DOI 10.1038/sj.onc.1210838; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	52	4	4	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3015	3029		10.1038/s41388-021-01755-z	http://dx.doi.org/10.1038/s41388-021-01755-z		MAR 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33767439				2022-12-26	WOS:000632824700001
J	Sheriff, O; Alemayehu, K; Haile, A				Sheriff, Oumer; Alemayehu, Kefyalew; Haile, Aynalem			Phenotypic ranking experiments in identifying breeding objective traits of smallholder farmers in northwestern Ethiopia	PLOS ONE			English	Article								We executed two live animal ranking experiments, own-flock and group-animal ranking, to identify the breeding objectives of Arab and Oromo goat keepers in northwestern Ethiopia as a preliminary step towards designing sustainable breeding programs for two goat populations. In the own-flock ranking experiment, a total of 147 households, out of which 46 were Arab and 101 were Oromo goat keepers that live in semi-arid and sub-humid agroecologies respectively, were visited at their homesteads and were asked to choose their first best, second best, third best and the most inferior does from their own flock. The reasons of ranking and life history of the does (age, previous production and reproduction information) were inquired and recorded; live body weight and some linear body measurements were taken. In the group-animal ranking experiment, 12 breeding does and 12 breeding bucks from Arab goats and the same number of animals from Oromo goats were randomly selected. Life history of selected does and bucks (age, birth type, libido and temperament) were inquired from the owners. The selected animals were randomly grouped into four in Arab goats (three animals per group) and the same was applied in Oromo goats. Twelve farmers for Arab goats and the same number of farmers for Oromo goats who have not known the experimental animals were invited to do the ranking. Each person ranked the three animals in each group as 1(st), 2(nd) and 3(rd), giving reasons of ranking. After a first round of ranking, s/he was then provided with the history of each individual animal and asked whether s/he would consider re-ranking them. This procedure was continued eight times until a person covered all groups of does and bucks. It was found out that in own-flock ranking experiment, keepers focus on productive, reproductive and behavioral traits (such as body size, mothering ability, twinning rate, kidding interval and temperament) while in group-animal ranking experiment, there was a general tendency to focus on observable physical traits like coat color, body size and body conformation. Simultaneous use of both own-flock and group-animal ranking experiments is advisable to identify breeding objective traits in production systems where record keeping is absent.	[Sheriff, Oumer] Assosa Univ, Dept Anim Sci, Assosa, Ethiopia; [Sheriff, Oumer; Alemayehu, Kefyalew] Bahir Dar Univ, Dept Anim Prod & Technol, Bahir Dar, Ethiopia; [Sheriff, Oumer; Alemayehu, Kefyalew] Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia; [Haile, Aynalem] Int Ctr Agr Res Dry Areas ICARDA, Resilient Agr Livelihood Syst Program RALSP, Addis Ababa, Ethiopia	Bahir Dar University; Bahir Dar University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA)	Sheriff, O (corresponding author), Assosa Univ, Dept Anim Sci, Assosa, Ethiopia.; Sheriff, O (corresponding author), Bahir Dar Univ, Dept Anim Prod & Technol, Bahir Dar, Ethiopia.; Sheriff, O (corresponding author), Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia.	soumer74@yahoo.com			Biotechnology research institute of Bahir Dar University [1/4449/1.11.10]	Biotechnology research institute of Bahir Dar University	The research is funded by Biotechnology research institute of Bahir Dar University 1/4449/1.11.10 (BRI-BDU). The recipient of the fund is the corresponding author (Oumer Sheriff). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz S., 2013, Animal Genetic Resources, V53, P69, DOI 10.1017/S2078633613000088; Abegaz S., 2014, DESIGN COMMUNITY BAS; Abraham H, 2018, TROP ANIM HEALTH PRO, V50, P1887, DOI 10.1007/s11250-018-1640-5; Berhe G., 2010, MINISTRY AGR RURAL D; Bett RC, 2009, TROP ANIM HEALTH PRO, V41, P307, DOI 10.1007/s11250-008-9191-9; Central Statistical Agency (CSA), STAT B, V583; Central Statistical Agency (CSA), REPORT LIVESTOCK LIV, VII, P587; Central Statistical Agency (CSA), STAT B, V585; Duguma G, 2011, ANIMAL, V5, P1984, DOI 10.1017/S1751731111001029; FAO, 2012, PHENOTYPIC CHARACTER; Food and Agricultural Organization (FAO), 2004, LIVESTOCK SECTOR BRI; Gardner DS, 2007, REPRODUCTION, V133, P297, DOI 10.1530/REP-06-0042; Gebreyesus G., 2013, LIVESTOCK RES RURAL, V25; Getnet A, 2005, ETHIOPIAN J ANIMAL P, V5, P13; Gizaw S, 2010, LIVEST SCI, V128, P67, DOI 10.1016/j.livsci.2009.10.016; Haile A, 2011, ICARDA TOOLS GUIDELI; Jaitner J, 2001, SMALL RUMINANT RES, V40, P101, DOI 10.1016/S0921-4488(00)00221-2; Kosgey IS, 2008, SMALL RUMINANT RES, V77, P11, DOI 10.1016/j.smallrumres.2008.02.005; Kugonza DR., 2014, LIVESTOCK RES RURAL, V26; Legese G., 2014, ICARDAILRI PROJECT R; Mirkena T., THESIS U NATURAL RES; Ndumu DB, 2008, LIVEST SCI, V113, P234, DOI 10.1016/j.livsci.2007.04.004; Oumer S., 2021, E AFRICAN J AGR FORE; R Core Team, 2020, R LANG ENV STAT COMP; Sheriff O, 2020, TROP ANIM HEALTH PRO, V52, P1467, DOI 10.1007/s11250-019-02150-3; Solomon AK., 2014, ILRI PROJECT REPORT; Temesgen J., 2019, PARTIAL FULFILLMENT; Wurzinger M, 2011, SMALL RUMINANT RES, V98, P170, DOI 10.1016/j.smallrumres.2011.03.035	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248779	10.1371/journal.pone.0248779	http://dx.doi.org/10.1371/journal.pone.0248779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765002	Green Published, gold			2022-12-26	WOS:000634832800034
J	Subussa, BW; Eshetu, T; Degefa, T; Ali, MM				Subussa, Bereket Wake; Eshetu, Teferi; Degefa, Teshome; Ali, Musa Mohammed			Asymptomatic Plasmodium infection and associated factors among pregnant women in the Merti district, Oromia, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; MALARIA; FALCIPARUM; ANEMIA; REVEALS	Background Asymptomatic Plasmodium infection (API) that occurs during pregnancy increases the risk of stillbirths, abortion, premature delivery, and low birth weight. API also hinders the control and prevention of malaria as infected hosts serve as silent reservoirs for transmission of Plasmodium species in the community. Objective The aim of this study was to determine the prevalence of API and associated factors among pregnant women. This community-based cross-sectional study was conducted at Merti district, Oromia, Ethiopia among 364 pregnant women from March to September 2018. Methods Sociodemographic and obstetrics features were collected using a structured questionnaire. About 2ml of blood was collected from participants to detect Plasmodium species, gametocyte carriage rate, parasite density, and anemia. Results The prevalence of API among pregnant women was 3.6%. The proportion of Plasmodium falciparum and Plasmodium vivax was 6(46.2%) and 7(53.8%) respectively. Out of 13 Plasmodium species identified, Gametocyte carriage rate was 4(30.7%). The geometric mean density of the asexual stage of the parasites was 994.7(interquartile [IQR], 320 to 2200) parasites/ul. The geometric mean gametocyte density was 303.3 (interquartile range [IQR], 160 to 600). The proportion of anemia among Plasmodium-infected participants was 12(92.3%). Previous infection by Plasmodium species (AOR = 5.42; 95% CI: 1.19-29.03, p = 0.047), lack of insecticide-treated bed net use (AOR = 6.52; 95% CI: 1.17-36.44, p = 0.032), and living close to stagnant water (AOR = 4.18; 95% CI (1.12-17.36, p = 0.049) were significantly associated with API. Anemia was significantly higher among Plasmodium-infected than non-infected pregnant women (x(2) = 27.62, p <0.001). Conclusion In the current study, a relatively high prevalence of API was detected among pregnant women. Identifying API in the community is important to prevent the unwanted outcomes of Plasmodium infection and its transmission.	[Subussa, Bereket Wake] Arsi Univ, Dept Med Lab Sci, Coll Hlth Sci, Assella, Ethiopia; [Eshetu, Teferi; Degefa, Teshome] Jimma Univ, Sch Med Lab Sci, Coll Hlth Sci, Jimma, Ethiopia; [Ali, Musa Mohammed] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia	Jimma University; Hawassa University	Ali, MM (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia.	ysnmss@yahoo.com	Ali, Musa/AAO-1172-2021	Ali, Musa/0000-0001-7786-3400; Degefa, Teshome/0000-0002-3518-2372				Adam I, 2005, T ROY SOC TROP MED H, V99, P739, DOI 10.1016/j.trstmh.2005.02.008; Akiyama T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1548-3; Antelman G, 2000, J NUTR, V130, P1950, DOI 10.1093/jn/130.8.1950; Arango EM, 2013, AM J TROP MED HYG, V89, P178, DOI 10.4269/ajtmh.12-0669; Bin Mohanna M. A., 2007, Eastern Mediterranean Health Journal, V13, P35; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Carmona-Fonseca J, 2017, J VECTOR DIS, V54, P201, DOI 10.4103/0972-9062.217610; Chala B., 2011, J PARASITOL VECTOR B, V3, P52; Correa G, 2017, CONFL HEALTH, V11, DOI 10.1186/s13031-017-0113-1; CSA, 2016, POPULATION HOUSING C; Cutts JC, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1467-6; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; Degefa T.L., 2016, HUM PARASIT DIS, V8, P17; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Emiasegen SE, 2017, MALARIA WORLD J, V15, P25; FMoH, 2016, ETHIOPIA NATL MALARI; Francine N, 2016, ACTA TROP, V153, P111, DOI 10.1016/j.actatropica.2015.10.009; Gajida AU, 2010, ANN AFR MED, V9, P188, DOI 10.4103/1596-3519.68352; Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098442; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Larocque R, 2005, AM J TROP MED HYG, V73, P783, DOI 10.4269/ajtmh.2005.73.783; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Matangila JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-132; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-244; Nega Desalegn, 2015, BMC Res Notes, V8, P110, DOI 10.1186/s13104-015-1081-4; Nega D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123630; Nzobo BJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1009-4; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Offei BE, THESIS U GHANA; Ogbu GI., 2015, CIRCULATION, V2, P34; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Sohail M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/740512; Suárez-Mutis Martha C., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P159, DOI 10.1590/S0036-46652007000300005; Tegegne Yalewayker, 2019, J Parasitol Res, V2019, P8396091, DOI 10.1155/2019/8396091; Twohig KA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007140; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-218; Yalew Aregawi, 2016, BMC Res Notes, V9, P483	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248074	10.1371/journal.pone.0248074	http://dx.doi.org/10.1371/journal.pone.0248074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765017	Green Published, gold			2022-12-26	WOS:000634832800070
J	Calderon-Villalon, J; Ramirez-Garcia, G; Fernandez-Ruiz, J; Sangri-Gil, F; Campos-Romo, A; Galvez, V				Calderon-Villalon, Jesus; Ramirez-Garcia, Gabriel; Fernandez-Ruiz, Juan; Sangri-Gil, Fernanda; Campos-Romo, Aurelio; Galvez, Victor			Planning deficits in Huntington's disease: A brain structural correlation by voxel-based morphometry	PLOS ONE			English	Article								Introduction Early Huntington's disease (HD) patients begin to show planning deficits even before motor alterations start to manifest. Generally, planning ability is associated with the functioning of anterior brain areas such as the medial prefrontal cortex. However, early HD neuropathology involves significant atrophy in the occipital and parietal cortex, suggesting that more posterior regions could also be involved in these planning deficits. Objective To identify brain regions associated with planning deficits in HD patients at an early clinical stage. Materials and methods Twenty-two HD-subjects genetically confirmed with incipient clinical manifestation and twenty healthy subjects were recruited. All participants underwent MRI T1 image acquisition as well as testing in the Stockings of Cambridge (SOC) task to measure planning ability. First, group comparison of SOC measures were performed. Then, correlation voxel-based morphometry analyses were done between gray matter degeneration and SOC performance in the HD group. Results Accuracy and efficiency planning scores correlated with gray matter density in right lingual gyrus, middle temporal gyrus, anterior cingulate gyrus, and paracingulate gyrus. Conclusions Our results suggest that planning deficits exhibited by early HD-subjects are related to occipital and temporal cortical degeneration in addition to the frontal areas deterioration.	[Calderon-Villalon, Jesus; Sangri-Gil, Fernanda; Galvez, Victor] Univ Panamer, Lab Neurociencias Cognit & Desarrollo, Escuela Psicol, Mexico City, DF, Mexico; [Ramirez-Garcia, Gabriel; Fernandez-Ruiz, Juan] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Lab Neuropsicol, Mexico City, DF, Mexico; [Fernandez-Ruiz, Juan] Univ Veracruzana, Inst Neuroetol, Mexico City, DF, Mexico; [Campos-Romo, Aurelio; Galvez, Victor] Univ Nacl Autonoma Mexico, Fac Med, Inst Nacl Neurol & Neurocirugia MVS, Mexico City, DF, Mexico	Universidad Panamericana - Ciudad de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Veracruzana; Universidad Nacional Autonoma de Mexico	Galvez, V (corresponding author), Univ Panamer, Lab Neurociencias Cognit & Desarrollo, Escuela Psicol, Mexico City, DF, Mexico.; Galvez, V (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Inst Nacl Neurol & Neurocirugia MVS, Mexico City, DF, Mexico.	vnalvez@up.edu.mx	Fernandez-Ruiz, Juan/B-6154-2012; Gálvez Zúñiga, Victor Hugo/AFR-5821-2022	Fernandez-Ruiz, Juan/0000-0002-4038-0904; Gálvez Zúñiga, Victor Hugo/0000-0002-6075-9620	CONACYT [220871, A1-S-10669, 574022/403010]; PAPIIT-UNAM [IN220019]; FCS-Universidad Panamericana	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); FCS-Universidad Panamericana	This study was supported in part by CONACYT grant No. 220871 and No. A1-S-10669, PAPIIT-UNAM grant No. IN220019 to JFR, and CONACYT fellowship No. 574022/403010 to GRG. V. Ga ' lvez received a grant "Fondo semilla 2019" from FCS-Universidad Panamericana.	Bartley JE, 2018, NEUROSCI BIOBEHAV R, V92, P318, DOI 10.1016/j.neubiorev.2018.06.009; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; Cazalis F, 2003, EUR J NEUROSCI, V17, P2219, DOI 10.1046/j.1460-9568.2003.02633.x; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Coppen EM, 2018, BEHAV BRAIN RES, V351, P63, DOI 10.1016/j.bbr.2018.05.019; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Deng YJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00333; Dravida S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00537; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Johnson EB, 2021, BIOL PSYCHIAT, V89, P807, DOI 10.1016/j.biopsych.2020.11.009; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Mimenza-Alvarado AJ., 2017, ASOCIACION COLOMBIAN, V47, P237, DOI [10.1016/j.rcp.2017.05.003, DOI 10.1016/J.RCP.2017.05.003]; Morkl S, 2016, EUR ARCH PSY CLIN N, V266, P663, DOI 10.1007/s00406-016-0707-4; Newman SD, 2009, BRAIN RES, V1286, P123, DOI 10.1016/j.brainres.2009.06.031; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Poudel GR, 2015, NEUROBIOL DIS, V74, P406, DOI 10.1016/j.nbd.2014.12.009; Ramirez-Garcia G, 2020, EUR J NEUROSCI, V51, P1827, DOI 10.1111/ejn.14617; Schall U, 2003, NEUROIMAGE, V20, P1154, DOI 10.1016/S1053-8119(03)00338-0; Schobel SA, 2017, NEUROLOGY, V89, P2495, DOI 10.1212/WNL.0000000000004743; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHOULSON I, 1979, NEUROLOGY, V29, P1, DOI 10.1212/WNL.29.1.1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Torgersen J., 2012, J BEHAV BRAIN SCI, V02, P108, DOI [10.4236/jbbs.2012.21013, DOI 10.4236/JBBS.2012.21013]; Unschuld PG, 2013, CORTEX, V49, P2661, DOI 10.1016/j.cortex.2013.05.015; Vriend C, 2020, BRAIN STRUCT FUNCT, V225, P365, DOI 10.1007/s00429-019-02004-6; Watkins LHA, 2000, NEUROPSYCHOLOGIA, V38, P1112, DOI 10.1016/S0028-3932(00)00028-2; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0249144	10.1371/journal.pone.0249144	http://dx.doi.org/10.1371/journal.pone.0249144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760890	Green Published, gold			2022-12-26	WOS:000633030400044
J	Cury, VF; Antoniazzi, LQ; de Oliveira, PHK; Borelli, WV; da Cunha, SV; Frison, GC; Moretto, EE; Seligman, R				Cury, Vinicius Ferraz; Antoniazzi, Lucas Quadros; de Oliveira, Paulo Henrique Kranz; Borelli, Wyllians Vendramini; da Cunha, Sainan Voss; Frison, Guilherme Cristianetti; Moretto, Enrico Emerim; Seligman, Renato			Developing the Pneumonia-Optimized Ratio for Community-acquired pneumonia: An easy, inexpensive and accurate prognostic biomarker	PLOS ONE			English	Article							NEUTROPHIL; HOSPITALIZATION; MORTALITY; SEPSIS; ADULTS	Introduction Community-acquired pneumonia (CAP) is still a major public health problem. Prognostic scores at admission in tertiary services may improve early identification of severity and better allocation of resources, ultimately improving survival. Herein, we aimed at evaluating prognostic biomarkers of CAP and a Pneumonia-Optimized Ratio was created to improve prognostic performance. Methods In this retrospective study, all patients with suspected Community-acquired pneumonia aged 18 or older admitted to a public hospital from January 2019 to February 2020 were included in this study. Blood testing and clinical information at admission were collected, and the primary outcome was overall survival. CURB-65 scores and prognostic biomarkers were measured, namely Neutrophil-to-Lymphocyte Cell Ratio (NLCR), Platelet to Lymphocyte ratio (PLR), Monocyte to Lymphocyte Ratio (MLR). A Pneumonia-Optimized Ratio (POR) score was created by selecting the biomarker with larger accuracy (NLCR) and multiplying it by the patients' CURB-65 score. Multivariate regression model was performed and ROC curves were created for each biomarker. Results Our sample consisted of 646 individuals (median 66 years [IQR, 18-103], 53.9% females) with complete blood testing at the time of admission. Patients scored 0-1 (323, 50%), 2 (187, 28.9%), or 3 or above (122, 18.9%) in the CURB-65, and 65 (10%) presented the primary outcome of death. POR exhibited the highest Area Under Curve (AUC) in the ROC analysis (AUC = 0.753), when compared with NLCR (AUC = 0.706), PLR (AUC = 0.630) and MLR (AUC = 0.627). POR and NLCR presented increased crude mortality rate in the fourth quartile in comparison with the first quartile, and the fourth quartile of NLCR had more days of hospitalization than the first quartile (11.06 +/- 15.96 vs. 7.02 +/- 8.39, p = 0.012). Conclusion The Pneumonia-Optimized Ratio in patients with CAP showed good prognostic performance of mortality at the admission of a tertiary service. The NLCR may also be used as an estimation of days of hospitalization. Prognostic biomarkers may provide important guidance to resource allocation in resource-limited settings.	[Cury, Vinicius Ferraz; Antoniazzi, Lucas Quadros; de Oliveira, Paulo Henrique Kranz; da Cunha, Sainan Voss; Frison, Guilherme Cristianetti; Moretto, Enrico Emerim; Seligman, Renato] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Borelli, Wyllians Vendramini] Hosp Clin Porto Alegre, Neurol Serv, Porto Alegre, RS, Brazil; [Seligman, Renato] Hosp Clin Porto Alegre, Internal Med Serv, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Seligman, R (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.; Seligman, R (corresponding author), Hosp Clin Porto Alegre, Internal Med Serv, Porto Alegre, RS, Brazil.	reseligman@hcpa.edu.br	Borelli, Wyllians Vendramini/F-5585-2016	Borelli, Wyllians Vendramini/0000-0001-9282-0601; Emerim Moretto, Enrico/0000-0001-8713-0710; Cristianetti Frison, Guilherme/0000-0001-6172-0843; Kranz de Oliveira, Paulo Henrique/0000-0003-3132-8036; Cury, Vinicius/0000-0002-7070-8341				Nunes SEA, 2017, EINSTEIN-SAO PAULO, V15, P212, DOI [10.1590/s1679-45082017gs3855, 10.1590/S1679-45082017GS3855]; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Correa R de A., 2009, J BRAS PNEUMOL, V35, P574, DOI [10.1590/s1806-37132009000600011, DOI 10.1590/S1806-37132009000600011]; Correa RD, 2018, J BRAS PNEUMOL, V44, P405, DOI [10.1590/S1806-37562018000000130, 10.1590/s1806-37562018000000130]; Curbeloa J, 2019, ARCH BRONCONEUMOL, V55, P472, DOI 10.1016/j.arbres.2019.02.005; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Escadafal C, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7030044; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ge YL, 2019, CLIN LAB, V65, P839, DOI 10.7754/Clin.Lab.2018.181042; Gomes M, 2018, J BRAS PNEUMOL, V44, P254, DOI [10.1590/S1806-37562018000040002, 10.1590/s1806-37562018000040002]; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Musher DM, 2017, CLIN INFECT DIS, V65, P1736, DOI 10.1093/cid/cix549; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Regunath H, 2020, STATPEARLS; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Salciccioli JD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0731-6; Shimoyama Y, 2018, ACTA MED OKAYAMA, V72, P591, DOI 10.18926/AMO/56377; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Wunderink RG, 2004, INFECT DIS CLIN N AM, V18, P743, DOI 10.1016/j.idc.2004.07.004; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang H, 2019, CLIN LAB, V65, P1867, DOI 10.7754/Clin.Lab.2019.190226	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248897	10.1371/journal.pone.0248897	http://dx.doi.org/10.1371/journal.pone.0248897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755711	Green Published, gold			2022-12-26	WOS:000632916600034
J	Ramos, EDF; Rosa, UA; Ribeiro, GD; Villanova, F; Milagres, FAD; Brustulin, R; Morais, VD; Araujo, ELL; Pandey, RP; Raj, VS; Sabino, EC; Deng, XT; Delwart, E; Luchs, A; Leal, E; da Costa, AC				Foro Ramos, Endrya do Socorro; Rosa, Ulisses Alves; Ribeiro, Geovani de Oliveira; Villanova, Fabiola; de Padua Milagres, Flavio Augusto; Brustulin, Rafael; Morais, Vanessa dos Santos; Lima Araujo, Emerson Luiz; Pandey, Ramendra Pati; Raj, V. Samuel; Sabino, Ester Cerdeira; Deng, Xutao; Delwart, Eric; Luchs, Adriana; Leal, Elcio; da Costa, Antonio Charlys			Multiple clades of Husavirus in South America revealed by next generation sequencing	PLOS ONE			English	Article								Husavirus (HuV) is an unclassified virus of the order Picornavirales that has already been identified worldwide in various locations. The genetic, epidemiological, and pathogenic characteristics are, however, little understood. In children with acute gastroenteritis, this study used next-generation sequencing to recognize unknown sources of viruses. In particular, 251 fecal samples obtained from individuals were sequenced in southern, northeastern, and northern Brazil. all samples were also analyzed using culture methods and parasitological tests to classify other enteric pathogens such as bacteria, parasites, and viruses. 1.9% of the samples tested positive for HuV, for a total of 5 positive children, with a mean age of 2 year, with three males and two females. Detailed molecular characterization of full genomes showed that Brazilian HuVs' nucleotide divergence is less than 11%. The genetic gap between Brazilian sequences and the closest HuV reported previously, on the other hand, is 18%. The study showed that Brazilian sequences are closely related to the HuV defined in Viet Nam in 2013, further characterization based on phylogenetics. At least two divergent clades of HuV in South America were also seen in the phylogenetic study.	[Foro Ramos, Endrya do Socorro; Rosa, Ulisses Alves; Ribeiro, Geovani de Oliveira; Villanova, Fabiola; Leal, Elcio] Univ Fed Para, Inst Ciencias Biol, Lab Divers Viral, Belem, Para, Brazil; [de Padua Milagres, Flavio Augusto; Brustulin, Rafael] Secretary Hlth Tocantins, Tocantins, Brazil; [de Padua Milagres, Flavio Augusto; Brustulin, Rafael] Publ Hlth Lab Tocantins State LACEN TO, Tocantins, Brazil; [Morais, Vanessa dos Santos; Sabino, Ester Cerdeira; da Costa, Antonio Charlys] Univ Sao Paulo, Fac Med, Inst Med Trop, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil; [Lima Araujo, Emerson Luiz] Minist Hlth CGLAB DAEVS SVS MS, Dept Hlth Surveillance, Gen Coordinat Publ Hlth Labs Strateg Articulat, Brasilia, DF, Brazil; [Pandey, Ramendra Pati; Raj, V. Samuel] SRM Univ, Delhi NCR, Ctr Drug Design Discovery & Dev C4D, Sonepat, Haryana, India; [Deng, Xutao; Delwart, Eric] Vitalant Res Inst, San Francisco, CA USA; [Deng, Xutao; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA; [Luchs, Adriana] Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; SRM University Haryana; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Instituto Adolfo Lutz	Leal, E (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Divers Viral, Belem, Para, Brazil.; da Costa, AC (corresponding author), Univ Sao Paulo, Fac Med, Inst Med Trop, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.	charlysbr@yahoo.com.br; elcioleal@gmail.com	Sabino, Ester C/F-7750-2010; Leal, Elcio/M-5275-2019; da-Costa, Antonio Charlys/G-1548-2010; MORAIS, VANESSA DOS SANTOS/ABE-1941-2021	Sabino, Ester C/0000-0003-2623-5126; Leal, Elcio/0000-0003-3463-0492; da-Costa, Antonio Charlys/0000-0001-5516-5177; MORAIS, VANESSA DOS SANTOS/0000-0002-3813-3154; Milagres, Flavio/0000-0002-6889-8772; Ramos, Endrya/0000-0001-5229-896X; Ribeiro, Geovani de Oliveira/0000-0002-8832-7803	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP [2017/00021-9]; Conselho Nacional de Pesquisa/CNPq [302677/2019-4]; CNPq [400450/2016-0]; FAPESP [2015/12944-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	ACC has a scholarship provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (2017/00021-9), EL has a scholarship provided by the Conselho Nacional de Pesquisa/CNPq (302677/2019-4) and AL is supported by CNPq (400450/2016-0) and FAPESP (2015/12944-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202054; Aoki H, 2019, ARCH VIROL, V164, P2147, DOI 10.1007/s00705-019-04289-8; Chung HC, 2020, RES VET SCI, V128, P286, DOI 10.1016/j.rvsc.2019.11.007; Coy SR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090487; da Costa AC, 2019, VIRUS GENES, V55, P332, DOI 10.1007/s11262-019-01648-0; Costa AC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100520; da Costa AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30214-1; da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Duraisamy R, 2018, VIRUS GENES, V54, P256, DOI 10.1007/s11262-018-1543-6; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Han ZZ, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12090995; Hause BM, 2016, J GEN VIROL, V97, P1362, DOI 10.1099/jgv.0.000461; Hause BM, 2015, VIRUS GENES, V51, P144, DOI 10.1007/s11262-015-1215-8; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Leal E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060488; Lecuit M, 2013, TRENDS MICROBIOL, V21, P510, DOI 10.1016/j.tim.2013.07.001; Luchs A, 2018, VIRUS GENES, V54, P470, DOI 10.1007/s11262-018-1557-0; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Munnink BBO, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex022; Munnink BBO, 2015, J GEN VIROL, V96, P3440, DOI 10.1099/jgv.0.000279; Nora-Krukle Z, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110639; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reuter G, 2015, ARCH VIROL, V160, P565, DOI 10.1007/s00705-014-2304-z; Ribeiro GD, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010016; Rosa UA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55216-5; Sano K, 2016, ARCH VIROL, V161, P3541, DOI 10.1007/s00705-016-3048-8; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Siqueira JD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06502-9; Tahmasebi R, 2020, J GEN VIROL, V101, P1280, DOI 10.1099/jgv.0.001500; Tahmasebi R, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050508; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911; Zhang W, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0308-0	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248486	10.1371/journal.pone.0248486	http://dx.doi.org/10.1371/journal.pone.0248486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755700	gold, Green Published			2022-12-26	WOS:000632916600017
J	Assem, AS; Tegegne, MM; Fekadu, SA; Hejtmancik, JF				Assem, Abel Sinshaw; Tegegne, Mebratu Mulusew; Fekadu, Sofonias Addis; Hejtmancik, James Fielding			Prevalence and associated factors of myopia among school children in Bahir Dar city, Northwest Ethiopia, 2019	PLOS ONE			English	Article								Background Myopia is the leading cause of correctable visual impairment and preventable blindness worldwide. Genetic and environmental factors contribute to the development of myopia. Myopia is appearing with greater prevalence in young children. Objective This study aimed to assess the prevalence and associated factors of myopia among school children in Bahir Dar city, Northwest Ethiopia, 2019. Methods and materials A school-based cross-sectional study was conducted among school children of 6 to 18 years of age in Bahir Dar city from October to November 2019. A pretested interviewer-administered structured questionnaire was used to collect data among 634 participants using a multi-stage sampling technique from primary and secondary schools. Cycloplegic refraction was performed by optometrists for each student with 1% cyclopentolate eye drop, and subjective refraction was carried out to determine the final prescription of the students. Myopia was defined as spherical equivalent refractive error of >= 0.5 diopter in either eye. Data were entered into Epi Info version 7 and exported to Statistical Package for Social Sciences version 23 for analysis. Tables, frequency, and mean were used for descriptive statistics. Bivariable and multivariable logistic regression analyses were done to identify risk factors of myopia. Odds ratio with 95% confidence level was determined and variables with p-value of < 0.05 were considered as statistically significant. Results Among a total of 601 study participants, 51 (8.49%) were myopic. Age group of 10-13 years (AOR = 6.54: 95% CI = 5.56-10.86), 14-18 years (AOR = 6.32: 95% CI = 5.32-9.69), 2-4 hour per day mobile exposure (AOR = 3.69: 95% CI = 1.63-8.38), > 4 hour per day mobile exposure (AOR = 11.6: 95% CI = 4.41-30.42), near working distance of < 33 centimeter (AOR = 6.89: 95% CI = 2.71-17.56) and outdoor activity (AOR = 3.94: 95% CI = 1.87-8.31) were significantly associated with myopia. Conclusions The prevalence of myopia was high among school children in Bahir Dar city. Older age, longer duration of mobile exposure, shorter near working distance were the risk factors for the development of myopia whereas having outdoor activity was the protective factor.	[Assem, Abel Sinshaw; Tegegne, Mebratu Mulusew; Fekadu, Sofonias Addis; Hejtmancik, James Fielding] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Optometry, Gondar, Ethiopia	University of Gondar	Assem, AS (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Optometry, Gondar, Ethiopia.	abelsinshaw@gmail.com						Al Bahhawi T, 2018, OPEN OPHTHALMOL J, V12, P264, DOI 10.2174/1874364101812010264; Bar Dayan Y, 2005, INVEST OPHTH VIS SCI, V46, P2760, DOI 10.1167/iovs.04-0260; Belete GT, 2017, CLIN OPTOM, V9, P11, DOI 10.2147/OPTO.S120485; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Hashim SE, 2008, ANN ACAD MED SINGAP, V37, P940; Khader Y. S., 2006, Eastern Mediterranean Health Journal, V12, P434; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Lin LLK, 2001, J FORMOS MED ASSOC, V100, P684; Misganaw C., 2014, INT J MED HLTH SCI R, V1, P92; Pan CW, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0808-0; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Rudnicka AR, 2016, BRIT J OPHTHALMOL, V100, P882, DOI 10.1136/bjophthalmol-2015-307724; Samir KC, 2010, DEMOGR RES, V22, P383, DOI 10.4054/DemRes.2010.22.15; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Saxena R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117349; Sewunet SA, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-95; Singh NK, 2019, OPTOMETRY VISION SCI, V96, P200, DOI 10.1097/OPX.0000000000001344; Sun JT, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/9781987; Theophanous C, 2018, CLIN OPHTHALMOL, V12, P1581, DOI 10.2147/OPTH.S164641; Tibebu K., 2000, ETHIOP J HEALTH DEV, P117; Tideman JWL, 2016, EUR J EPIDEMIOL, V31, P491, DOI 10.1007/s10654-016-0128-8; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; Wang JY, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-019-1281-0; Wedner SH, 2002, BRIT J OPHTHALMOL, V86, P1200, DOI 10.1136/bjo.86.11.1200; World Health Organization, 2013, WHO LIB CAT DATA, V96, P22; Wu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120764; Yekta A, 2010, CLIN EXP OPHTHALMOL, V38, P242, DOI 10.1111/j.1442-9071.2010.02247.x	32	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248936	10.1371/journal.pone.0248936	http://dx.doi.org/10.1371/journal.pone.0248936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750986	Green Published, gold			2022-12-26	WOS:000631967100006
J	Fukuhara-Makiyama, N; Hayashida, M; Kobayashi, M; Sagara, I; Ogawa, S; Maeda, M; Shirabe, S				Fukuhara-Makiyama, Nozomi; Hayashida, Masaki; Kobayashi, Masakazu; Sagara, Ikuko; Ogawa, Sayaka; Maeda, Mayumi; Shirabe, Susumu			Personality traits and BMI trends over three years in Japanese university students	PLOS ONE			English	Article							BODY-MASS INDEX; HEALTH-RISK BEHAVIORS; PHYSICAL-ACTIVITY; WEIGHT; OBESITY; TEMPERAMENT; NEUROTICISM; TRANSITION; MORTALITY; CHARACTER	In Europe and America, associations between personality traits and body-mass index (BMI) have been reported. However, in Japan, the association between personality traits and BMI (i.e., thinness and obesity) has not been well studied. In this study, we investigated the relationship between Temperament and Character Inventory (TCI) personality traits and changes in BMI status among Japanese students during their university attendance. We measured the height and weight of 5,340 students in a Japanese university during annual medical checkups and calculated their BMI. The students' personality traits were measured using the short Japanese version of the TCI at university admission. The participants were divided into seven groups based on how BMI changed from the first year to the fourth year at university. In men, compared to the group that maintained normal BMI status (N = 2,189) over time (i.e., the control group), the group that maintained thinness status (N = 226) were lower in Reward Dependence, and the group whose status improved from thinness to normal (N = 117) were higher in Harm Avoidance. In women, compared with the control group (N = 1,510), the group that maintained thinness status (N = 302) was lower in Novelty Seeking, and the group whose status worsened from normal to thinness (N = 127) was higher in Harm Avoidance. Weak associations were found between thinness and TCI personality traits among Japanese university students. Further elaboration of the relationship between obesity or thinness and personality traits may help to provide effective preventive interventions in these areas.	[Fukuhara-Makiyama, Nozomi; Hayashida, Masaki; Kobayashi, Masakazu; Shirabe, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Unit Prevent Med, Nagasaki, Japan; [Fukuhara-Makiyama, Nozomi; Hayashida, Masaki; Kobayashi, Masakazu; Sagara, Ikuko; Ogawa, Sayaka; Maeda, Mayumi; Shirabe, Susumu] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki, Japan	Nagasaki University; Nagasaki University	Kobayashi, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Prevent Med, Nagasaki, Japan.; Kobayashi, M (corresponding author), Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki, Japan.	masakazu-f328@nagasaki-u.ac.jp		fu yuan, shi mei/0000-0001-7871-9996				Aparicio-Martinez P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214177; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Boyd H, 2017, BODY IMAGE, V21, P90, DOI 10.1016/j.bodyim.2017.03.003; Bray SR, 2004, J AM COLL HEALTH, V52, P181, DOI 10.3200/JACH.52.4.181-188; Butler SM, 2004, AM J HEALTH BEHAV, V28, P24, DOI 10.5993/AJHB.28.1.3; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x; DeBate RD, 2001, ADOLESCENCE, V36, P819; Fassino S, 2002, COMPR PSYCHIAT, V43, P431, DOI 10.1053/comp.2002.35906; Fernandez-Aranda F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104534; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; Gerlach G, 2015, OBES REV, V16, P32, DOI 10.1111/obr.12235; Graham EK, 2017, J RES PERS, V70, P174, DOI 10.1016/j.jrp.2017.07.005; Hill WD, 2020, MOL PSYCHIATR, V25, P3034, DOI 10.1038/s41380-019-0387-3; Hintsanen M, 2012, J PSYCHOSOM RES, V73, P391, DOI 10.1016/j.jpsychores.2012.08.012; Iwasa H, 2008, AM J GERIAT PSYCHIAT, V16, P399, DOI 10.1097/JGP.0b013e3181662ac9; Japan society for the study of obesity, 2016, GUIDELINES MANAGEMEN, V1st; Kakizaki M, 2008, J PSYCHOSOM RES, V64, P71, DOI 10.1016/j.jpsychores.2007.07.008; Keller S, 2008, PREV MED, V46, P189, DOI 10.1016/j.ypmed.2007.09.008; Kvalem Ingela Lundin, 2006, Body Image, V3, P263; Kwan MY, 2012, AM J PREV MED, V42, P14, DOI 10.1016/j.amepre.2011.08.026; McCreary DR, 2000, J AM COLL HEALTH, V48, P297, DOI 10.1080/07448480009596271; Murnen SK, 2003, SEX ROLES, V49, P427, DOI 10.1023/A:1025868320206; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Ohara K, 2014, EAT WEIGHT DISORD-ST, V19, P461, DOI 10.1007/s40519-014-0130-7; Otonari J, 2012, QUAL LIFE RES, V21, P1847, DOI 10.1007/s11136-011-0098-y; Pike KM, 2004, CULT MED PSYCHIAT, V28, P493, DOI 10.1007/s11013-004-1066-6; Pope H.G., 2000, ADONIS COMPLEX SECRE; Racette SB, 2005, J AM COLL HEALTH, V53, P245, DOI 10.3200/JACH.53.6.245-251; Raudenbush B, 2003, J SPORT EXERCISE PSY, V25, P161, DOI 10.1123/jsep.25.2.161; Shim U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090516; Silliman K., 2004, CALIF J HLTH PROMOT, V2, P10, DOI [DOI 10.32398/cjhp.v2i2.1729, 10.32398/cjhp.v2i2.1729, DOI 10.32398/CJHP.V2I2.1729]; Special Committee on Preparation of White Paper on Student Health, 2018, 2015 WHIT PAP STUD H; Sullivan S, 2007, INT J OBESITY, V31, P669, DOI 10.1038/sj.ijo.0803464; Sutin AR, 2016, PSYCHOL HEALTH, V31, P259, DOI 10.1080/08870446.2015.1082561; Sutin AR, 2015, J RES PERS, V58, P137, DOI 10.1016/j.jrp.2015.07.006; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Suzuki A, 2009, J NERV MENT DIS, V197, P199, DOI 10.1097/NMD.0b013e3181999465; Tokunaga M., 2002, J HEALTH SCI, V24, P57; Turiano NA, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.268; Uragami R., 2015, JPN J EDUC PSYCHOL, V63, P309; van Rensburg CJ, 2013, HEALTH SA GESONDHEID, V18, DOI 10.4102/hsag.v18i1.735; Vandereycken W, 2008, EUR EAT DISORD REV, V16, P109, DOI 10.1002/erv.857; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Weston SJ, 2018, J RES PERS, V73, P27, DOI 10.1016/j.jrp.2017.10.005; World Health Organization, GLOB HLTH OBS GHO DA; Yamaguchi A., 2008, JPN J PERS, V16, P324; Yasuno F, 2001, NEUROSCI LETT, V300, P59, DOI 10.1016/S0304-3940(01)01552-X; Yoshiike N., 2018, J JPN SOC STUDY OBES, V24, P16	50	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248833	10.1371/journal.pone.0248833	http://dx.doi.org/10.1371/journal.pone.0248833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RB2TH	33750962	Green Published, gold			2022-12-26	WOS:000631967100002
J	Mammone, M; Ferrier-Pages, C; Lavorano, S; Rizzo, L; Piraino, S; Rossi, S				Mammone, Marta; Ferrier-Pages, Christine; Lavorano, Silvia; Rizzo, Lucia; Piraino, Stefano; Rossi, Sergio			High photosynthetic plasticity may reinforce invasiveness of upside-down zooxanthellate jellyfish in Mediterranean coastal waters	PLOS ONE			English	Article							CASSIOPEA SP; LIGHT; RESPIRATION; BLOOMS; CARBON; ACCLIMATION; SCYPHOZOA; PHOTOPHYSIOLOGY; PHOTOPROTECTION; PRODUCTIVITY	Ecological profiling of non-native species is essential to predict their dispersal and invasiveness potential across different areas of the world. Cassiopea is a monophyletic taxonomic group of scyphozoan mixotrophic jellyfish including C. andromeda, a recent colonizer of sheltered, shallow-water habitats of the Mediterranean Sea, such as harbors and other light-limited, eutrophic coastal habitats. To assess the ecophysiological plasticity of Cassiopea jellyfish and their potential to spread across the Mare Nostrum by secondary introductions, we investigated rapid photosynthetic responses of jellyfish to irradiance transitions-from reduced to increased irradiance conditions (as paradigm of transition from harbors to coastal, meso/oligotrophic habitats). Laboratory incubation experiments were carried out to compare oxygen fluxes and photobiological variables in Cassiopea sp. immature specimens pre-acclimated to low irradiance (PAR = 200 mu mol photons m(-2) s(-1)) and specimens rapidly exposed to higher irradiance levels (PAR = 500 mu mol photons m(-2) s(-1)). Comparable photosynthetic potential and high photosynthetic rates were measured at both irradiance values, as also shown by the rapid light curves. No significant differences were observed in terms of symbiont abundance between control and treated specimens. However, jellyfish kept at the low irradiance showed a higher content in chlorophyll a and c (0.76 +/- 0.51SD vs 0.46 +/- 0.13SD mg g(-1) AFDW) and a higher Ci (amount of chlorophyll per cell) compared to jellyfish exposed to higher irradiance levels. The ratio between gross photosynthesis and respiration (P:R) was >1, indicating a significant input from the autotrophic metabolism. Cassiopea sp. specimens showed high photosynthetic performances, at both low and high irradiance, demonstrating high potential to adapt to sudden changes in light exposure. Such photosynthetic plasticity, combined with Cassiopea eurythermal tolerance and mixotrophic behavior, jointly suggest the upside-down jellyfish as a potentially successful invader in the scenario of a warming Mediterranean Sea.	[Mammone, Marta; Piraino, Stefano; Rossi, Sergio] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Ferrier-Pages, Christine] Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco; [Lavorano, Silvia] Acquario Genova, Genoa, Italy; [Rizzo, Lucia] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy; [Piraino, Stefano; Rossi, Sergio] Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy; [Rossi, Sergio] Univ Fed Ceara, Labomar, Fortaleza, Ceara, Brazil	University of Salento; Stazione Zoologica Anton Dohrn di Napoli; CoNISMa; Universidade Federal do Ceara	Mammone, M; Piraino, S; Rossi, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy.; Piraino, S; Rossi, S (corresponding author), Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy.; Rossi, S (corresponding author), Univ Fed Ceara, Labomar, Fortaleza, Ceara, Brazil.	marta.mammone@unisalento.it; stefano.piraino@unisalento.it; sergio.rossi@unisalento.it	Rizzo, Lucia/AAZ-7575-2021; Piraino, Stefano/J-5234-2012	Rizzo, Lucia/0000-0002-0893-0582; Piraino, Stefano/0000-0002-8752-9390	project "PULMO" from the European Commission Marie Sklodowska-Curie individual Fellowships (H2020-MSCA-IF-2015) [708698]; Marie Curie International Outgoing Fellowship project ANIMAL FOREST HEALTH [327845]; P-SPHERE (COFUND Marie Curie) [665919]	project "PULMO" from the European Commission Marie Sklodowska-Curie individual Fellowships (H2020-MSCA-IF-2015); Marie Curie International Outgoing Fellowship project ANIMAL FOREST HEALTH; P-SPHERE (COFUND Marie Curie)	This work was supported by the project "PULMO" funded from the European Commission Marie Sklodowska-Curie individual Fellowships (H2020-MSCA-IF-2015) under grant agreement No. 708698. SR wants to thank the Marie Curie International Outgoing Fellowship project ANIMAL FOREST HEALTH (Grant Agreement Number 327845) and the P-SPHERE (COFUND Marie Curie, Grant Agreement Number 665919).	Al-jbour SM, 2017, J SEA RES, V128, P92, DOI 10.1016/j.seares.2017.08.006; Beer S, 1998, MAR ECOL PROG SER, V174, P293, DOI 10.3354/meps174293; Bernhardt JR, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0454; Bianchi C. N., 2012, LIFE MEDITERRANEAN S, P1; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F., 2016, EXPLAINING OCEAN WAR, P213, DOI DOI 10.2305/IUCN.CH.2016.08.EN; Bosch-Belmar M, 2020, REV FISH SCI AQUAC, V29, P242, DOI 10.1080/23308249.2020.1806201; CATES N, 1975, J EXP MAR BIOL ECOL, V18, P55, DOI 10.1016/0022-0981(75)90016-7; CIESM, 2001, CIESM WORKSHOP SERIE, V14; Cillari T, 2018, CAH BIOL MAR, V59, P193, DOI 10.21411/CBM.A.1037AA; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Dawson MN, 2009, HYDROBIOLOGIA, V616, P193, DOI 10.1007/s10750-008-9591-x; Deidun A, 2018, BIOINVASIONS REC, V7, P399, DOI 10.3391/bir.2018.7.4.07; Ding JF, 2011, FOOD HYDROCOLLOID, V25, P1350, DOI 10.1016/j.foodhyd.2010.12.013; Djeghri N, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3581-6; EDMUNDS PJ, 1988, CORAL REEFS, V7, P7, DOI 10.1007/BF00301975; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES, DOI [10.1515/9781400849727, DOI 10.1515/9781400849727]; Falkowski PG., 1997, AQUATIC PHOTOSYNTHES, P375; Ferrier-Pages C, 2015, PHOTOSYNTH RES, V123, P95, DOI 10.1007/s11120-014-0042-4; Ferrier-Pages C, 2011, LIMNOL OCEANOGR, V56, P1429, DOI 10.4319/lo.2011.56.4.1429; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Figueroa FL, 2003, PHOTOSYNTH RES, V75, P259, DOI 10.1023/A:1023936313544; Forcioli D, 2011, MAR ECOL PROG SER, V439, P57, DOI 10.3354/meps09314; Freeman CJ, 2017, MAR ECOL PROG SER, V571, P245, DOI 10.3354/meps12138; Freeman CJ, 2016, MAR ECOL PROG SER, V544, P281, DOI 10.3354/meps11605; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; GALIL B S, 1990, Zoologische Mededelingen (Leiden), V64, P95; Galil B.S., 2015, LIMNOL OCEANOGR B, V24, P41, DOI DOI 10.1002/LOB.10036; Galil BS, 2015, BIOL INVASIONS, V17, P973, DOI 10.1007/s10530-014-0778-y; GARCIA JR, 1993, J EXP MAR BIOL ECOL, V173, P71, DOI 10.1016/0022-0981(93)90208-6; Gordoa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074721; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jantzen C, 2010, MAR ECOL PROG SER, V411, P117, DOI 10.3354/meps08623; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Karydis M, 2012, ENVIRON MONIT ASSESS, V184, P4931, DOI 10.1007/s10661-011-2313-2; KIKINGER R, 1992, MAR ECOL-P S Z N I, V13, P333, DOI 10.1111/j.1439-0485.1992.tb00359.x; KREMER P, 1990, LIMNOL OCEANOGR, V35, P609, DOI 10.4319/lo.1990.35.3.0609; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Leone A, 2015, MAR DRUGS, V13, P4654, DOI 10.3390/md13084654; Lucas CH, 2009, J MAR BIOL ASSOC UK, V89, P77, DOI 10.1017/S0025315408002804; Maas O, 1903, SIBOGA EXPED, V11, P1; Maggio T, 2019, J MAR BIOL ASSOC UK, V99, P1765, DOI 10.1017/S0025315419000924; MCCLOSKEY LR, 1994, MAR BIOL, V119, P13, DOI 10.1007/BF00350101; Milisenda G, 2018, ESTUAR COAST SHELF S, V201, P29, DOI 10.1016/j.ecss.2016.01.002; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Morandini A.C, 2019, WORLD ATLAS JELLYFIS; Mortillaro JM, 2009, J EXP MAR BIOL ECOL, V378, P22, DOI 10.1016/j.jembe.2009.07.003; MUSCATINE L, 1986, MAR ECOL PROG SER, V32, P279, DOI 10.3354/meps032279; Ohdera AH, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00035; Ozgur Elif, 2008, Aquatic Invasions, V3, P423, DOI 10.3391/ai.2008.3.4.9; Petrou K, 2011, MAR BIOL, V158, P1029, DOI 10.1007/s00227-011-1628-4; Petrou K, 2011, J PHYCOL, V47, P77, DOI 10.1111/j.1529-8817.2010.00944.x; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; POR F D, 1990, Bulletin de l'Institut Oceanographique (Monaco), P1; Pupier CA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54209-8; Purcell J.E., 2001, JELLYFISH BLOOM ECOL, DOI [10.1007/978-94-010-0722-1, DOI 10.1007/978-94-010-0722-1]; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; RIESSELMANN S, 1992, PLANT PHYSIOL, V100, P1840, DOI 10.1104/pp.100.4.1840; Roberty S, 2014, NEW PHYTOL, V204, P81, DOI 10.1111/nph.12903; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rossi S, 2016, MARINE ANIMAL FOREST, P887, DOI DOI 10.1007/978-3-319-17001-5; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Schembri Patrick J., 2010, Marine Biodiversity Records, V3, pe6; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; Selosse MA, 2017, ECOL LETT, V20, P246, DOI 10.1111/ele.12714; SFRISO A, 1994, ENVIRON TECHNOL, V15, P1, DOI 10.1080/09593339409385399; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPANIER E, 1989, ISR J ZOOL, V36, P55; Stabili L, 2019, MAR DRUGS, V17, DOI 10.3390/md17010017; Terlizzi A, 2000, BIOFOULING, V15, P327, DOI 10.1080/08927010009386322; The J, 2020, MAR ENVIRON RES, V162, DOI 10.1016/j.marenvres.2020.105161; Tilves U, 2018, MAR ECOL PROG SER, V591, P101, DOI 10.3354/meps12332; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Verde EA, 1998, MAR ECOL PROG SER, V168, P147, DOI 10.3354/meps168147; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Welsh DT, 2009, HYDROBIOLOGIA, V635, P351, DOI 10.1007/s10750-009-9928-0; Zenetos A, 2011, MEDITERR MAR SCI, V12, P95, DOI 10.12681/mms.55	92	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248814	10.1371/journal.pone.0248814	http://dx.doi.org/10.1371/journal.pone.0248814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739995	gold, Green Published			2022-12-26	WOS:000631030200033
J	Kim, SH; Lee, J; Oh, I; Oh, Y; Sim, CS; Bang, JH; Park, J; Kim, Y				Kim, Suk Hwan; Lee, Jiho; Oh, Inbo; Oh, Yeonsuh; Sim, Chang Sun; Bang, Jin-Hee; Park, Jungsun; Kim, Yangho			Allergic rhinitis is associated with atmospheric SO2: Follow-up study of children from elementary schools in Ulsan, Korea	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; DUST-MITE; PRESCHOOL-CHILDREN; RESPIRATORY HEALTH; ATOPIC ECZEMA; RISK-FACTORS; HOUSE-DUST; PREVALENCE; EXPOSURE; ASTHMA	Objectives The purpose of this study was to examine the association of allergic rhinitis with air pollutant concentrations using the follow-up data of elementary school children in Ulsan, Korea. Methods All students of four elementary schools in Ulsan, South Korea were surveyed at two-year intervals. The survey used data collected five times, over a nine-year period from June 2009 to April 2018. The questionnaire used in the survey was a modified version of the ISAAC (International society of asthma and allergy of children) questionnaire. A skin prick test (SPT) was performed with 24 standard antigens. To estimate the levels of exposure to outdoor air pollution, the concentrations of sulfur dioxide (SO2), nitrogen dioxide (NO2), ozone (O-3), carbon monoxide (CO), and particulate matter 10 mu m or less in diameter (PM10) were used. As a dependent variable, a history of allergic rhinitis diagnosed by a doctor during the last 1-year was considered. Logistic regression analysis was used to select variables suitable for the statistical model. The selected variables were then used to assess their association with the dependent variable using the generalized estimation equation. Results Among environmental factors, SO2 was associated with a high risk and PM10 was associated with a low risk of allergic rhinitis. The risk of allergic rhinitis from living in a house built within the last year was high, and the risk from living in a multi-family house or apartment was higher than that from living in a segregated house. History of allergic diseases in the family was a high-risk factor for allergic rhinitis. There was a relationship between a history of bronchiolitis at less than 2 years of age and a high risk of allergic rhinitis. Boys were at a higher risk than girls. Conclusion From the follow-up data of elementary school students in Ulsan, Korea, the concentration of SO2, which is an indicator of the degree of industrialization, was related to the prevalence of allergic rhinitis. Among all the risk factors, history of allergic disease in the parents was the most important factor, and the study reconfirmed the results of the previous studies.	[Kim, Suk Hwan] POSCO, POSCO Hlth Ctr, Pohang, South Korea; [Lee, Jiho; Oh, Yeonsuh; Sim, Chang Sun; Kim, Yangho] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea; [Oh, Inbo; Bang, Jin-Hee] Univ Ulsan, Coll Med, Environm Hlth Ctr, Ulsan, South Korea; [Park, Jungsun] Catholic Univ Daegu, Dept Occupat Hlth, Gyongsan, South Korea	POSCO; University of Ulsan; Ulsan University Hospital; University of Ulsan; Catholic University of Daegu	Kim, Y (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea.	yanghokm@ulsan.ac.kr		Kim, Yangho/0000-0002-6462-0829	Environmental Health Center - Ministry of Environment, Republic of Korea KY	Environmental Health Center - Ministry of Environment, Republic of Korea KY(Ministry of Environment (ME), Republic of Korea)	This research was supported by the Environmental Health Center funded by the Ministry of Environment, Republic of Korea KY received this fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsowaidi S, 2010, INT ARCH ALLERGY IMM, V153, P274, DOI 10.1159/000314368; Anderson HR, 2010, OCCUP ENVIRON MED, V67, P293, DOI 10.1136/oem.2009.048785; Bae HS, 2017, HUM EXP TOXICOL, V36, P451, DOI 10.1177/0960327116665673; Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636; Byun DW, 1999, EPA600R99030 NERL; Cabrera M, 2019, J INVEST ALLERG CLIN, V29, P371, DOI 10.18176/jiaci.0368; Cai YT, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02127-2015; Cesaroni G, 2008, OCCUP ENVIRON MED, V65, P683, DOI 10.1136/oem.2007.037846; Chen G, 2014, SCI TOTAL ENVIRON, V485, P563, DOI 10.1016/j.scitotenv.2014.03.107; Chen S M, 2019, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V33, P402, DOI 10.13201/j.issn.1001-1781.2019.05.005; Chinratanapisit S, 2019, ASIAN PAC J ALLERGY, V37, P232, DOI 10.12932/AP-120618-0337; Chung HY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030268; CLARKE CW, 1979, CLIN ALLERGY, V9, P147, DOI 10.1111/j.1365-2222.1979.tb01535.x; de Marco R, 2002, CLIN EXP ALLERGY, V32, P1405, DOI 10.1046/j.1365-2745.2002.01466.x; Deng QH, 2016, RESP MED, V121, P67, DOI 10.1016/j.rmed.2016.10.016; DEVALIA JL, 1994, RESP MED, V88, P241, DOI 10.1016/0954-6111(94)90052-3; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; Diepgen TL, 1996, J INVEST DERMATOL, V106, P977, DOI 10.1111/1523-1747.ep12338475; Directive C., 1996, OFFICIAL J L, V296, P11; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Engvall K, 2000, INDOOR AIR, V10, P101; Engvall K, 2010, INT ARCH OCC ENV HEA, V83, P85, DOI 10.1007/s00420-009-0447-0; Erwin EA, 2007, J ALLERGY CLIN IMMUN, V119, P359, DOI 10.1016/j.jaci.2006.12.648; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Gent JF, 2009, ENVIRON HEALTH PERSP, V117, P1168, DOI 10.1289/ehp.0800335; Gonzalez-Barcala FJ, 2013, PUBLIC HEALTH, V127, P275, DOI 10.1016/j.puhe.2012.12.028; Hahm MI, 2014, ALLERGY, V69, P479, DOI 10.1111/all.12355; Hamilton LA, 2018, J MED MICROBIOL, V67, P1491, DOI 10.1099/jmm.0.000822; HULETT AC, 1979, ANN ALLERGY, V42, P160; Huss-Marp J, 2006, CLIN EXP ALLERGY, V36, P338, DOI 10.1111/j.1365-2222.2006.02448.x; Hwang BF, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-23; Hwang SH, 2013, ALLERGY ASTHMA RESPI, V1, P321, DOI 10.4168/aard.2013.1.4.321; Izadi N, 2018, ANN ALLERG ASTHMA IM, V120, P542, DOI 10.1016/j.anai.2018.02.022; Jacquemin B, 2009, EPIDEMIOLOGY, V20, P119, DOI 10.1097/EDE.0b013e3181886e76; Ji-Ho Lee, 2017, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V43, P478; Jung YG, 2010, AM J RHINOL ALLERGY, V24, P226, DOI 10.2500/ajra.2010.24.3459; Kang IG, 2015, INT J ENV RES PUB HE, V12, P735, DOI 10.3390/ijerph120100735; Kang SY, 2018, ASIA PAC ALLERGY, V8, DOI 10.5415/apallergy.2018.8.e8; Kim HH, 2013, ENVIRON SCI POLLUT R, V20, P4831, DOI 10.1007/s11356-012-1358-2; Kim HH, 2016, YONSEI MED J, V57, P698, DOI 10.3349/ymj.2016.57.3.698; Kim J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121220; Kishi Reiko, 2018, Nihon Eiseigaku Zasshi, V73, P116, DOI 10.1265/jjh.73.116; Korea Meteorological Administration, 2011, CLIM NORM KOR 1981 2; Kramer U, 2000, EPIDEMIOLOGY, V11, P64, DOI 10.1097/00001648-200001000-00014; Lee DaeGyun, 2011, Asian Journal of Atmospheric Environment, V5, P278; Lee JH, 2012, TOX RESEARCH, V28, P103, DOI 10.5487/TR.2012.28.2.103; Lee KS, 2018, ALLERGY ASTHMA RESPI, V6, pS58, DOI 10.4168/aard.2018.6.S1.S58; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Liu MM, 2013, J EPIDEMIOL, V23, P280, DOI 10.2188/jea.JE20120175; Liu W, 2016, ENVIRON INT, V92-93, P284, DOI 10.1016/j.envint.2016.04.019; Lu C, 2013, CHINESE SCI BULL, V58, P4252, DOI 10.1007/s11434-013-5725-2; Ministry of Environment, 2018, ANN REP AIR QUAL KOR; Ministry of Environment, 2012, ANN REP AIR QUAL KOR; MIYAMOTO T, 1974, J ALLERGY CLIN IMMUN, V53, P9, DOI 10.1016/0091-6749(74)90094-3; Moya J, 2004, PEDIATRICS, V113, P996; National Institute of Environmental Research, 2010, RES HAZ AIR POLL HAP; Ni J, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1594-4; Norlen U., 1993, P INDOOR AIR, V93, P743; Oh I-B., 2012, J ENVIRON HEALTH SCI, V38, P472; Oh I, 2021, ATMOS ENVIRON, V244, DOI 10.1016/j.atmosenv.2020.117907; Oh I, 2015, J KOREAN SOC ATMOS E, V31, P181, DOI 10.5572/KOSAE.2015.31.2.181; Pawankar R, 2013, WAO WHITE BOOK ALLER; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Peat JK, 1999, J ALLERGY CLIN IMMUN, V103, P1, DOI 10.1016/S0091-6749(99)70517-8; Peroni DG, 2008, BRIT J DERMATOL, V158, P539, DOI 10.1111/j.1365-2133.2007.08344.x; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Rohr AC, 2014, AIR QUAL ATMOS HLTH, V7, P239, DOI 10.1007/s11869-013-0230-y; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P26, DOI 10.1007/s12199-008-0052-y; Schwartz J, 2004, PEDIATRICS, V113, P1037; Shima M, 2002, ARCH ENVIRON HEALTH, V57, P529, DOI 10.1080/00039890209602084; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; SMITH JM, 1969, BRIT MED J, V2, P723, DOI 10.1136/bmj.2.5659.723; Tatar EC, 2012, AM J RHINOL ALLERGY, V26, pE37, DOI 10.2500/ajra.2012.26.3750; Timin B, 2010, NATO SCI PEACE SEC B, P175; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wang IJ, 2016, INT J HYG ENVIR HEAL, V219, P66, DOI 10.1016/j.ijheh.2015.09.001; Wang J, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141734; Wang XD, 2016, ALLERGY, V71, P1170, DOI 10.1111/all.12874; Wise SK, 2018, INT FORUM ALLERGY RH, V8, P85, DOI 10.1002/alr.22070; Yang N, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072569; Young Kim Hye, 2009, [Allergy Asthma & Respiratory Diseases, 알레르기 천식 호흡기질환], V19, P106; Zou QY, 2018, INT J PEDIATR OTORHI, V112, P82, DOI 10.1016/j.ijporl.2018.06.039; 남승연, 2005, [Allergy Asthma & Respiratory Diseases, 알레르기 천식 호흡기질환], V15, P439	83	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248624	10.1371/journal.pone.0248624	http://dx.doi.org/10.1371/journal.pone.0248624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735252	Green Published, gold			2022-12-26	WOS:000631029700114
J	Kim, D; Kim, V; McCarty, KD; Guengerich, FP				Kim, Donghak; Kim, Vitchan; McCarty, Kevin D.; Guengerich, F. Peter			Tight binding of cytochrome b(5) to cytochrome P450 17A1 is a critical feature of stimulation of C21 steroid lyase activity and androgen synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED 17,20-LYASE DEFICIENCY; PROSTATE-CANCER; ABIRATERONE ACETATE; ESCHERICHIA-COLI; CATIONIC CHARGES; P450C17; CYP17; CASTRATION; BIOSYNTHESIS; PHOSPHORYLATION	It has been recognized for >50 years that cytochrome b(5) (b(5)) stimulates some cytochrome P450 (P450)-catalyzed oxidations, but the basis of this function is still not understood well. The strongest stimulation of catalytic activity by b(5) is in the P450 17A1 lyase reaction, an essential step in androgen synthesis from 21-carbon (C21) steroids, making this an excellent model system to interrogate b(5) function. One of the issues in studying b(5)-P450 interactions has been the limited solution assay methods. We constructed a fluorescently labeled variant of human b5 that can be used in titrations. The labeled b(5) bound to WT P450 17A1 with a K-d of 2.5 nM and rapid kinetics, on the order of 1 s(-1). Only weak binding was observed with the clinical P450 17A1 variants E305G, R347H, and R358Q; these mutants are deficient in lyase activity, which has been hypothesized to be due to attenuated b5 binding. K-d values were not affected by the presence of P450 17A1 substrates. A peptide containing the P450 17A1 Arg-347/Arg-358 region attenuated Alexa 488-T70C-b(5) fluorescence at higher concentrations. The addition of NADPH-P450 reductase (POR) to an Alexa 488-T70C-b(5):P450 17A1 complex resulted in a concentration-dependent partial restoration of b(5) fluorescence, indicative of a ternary P450:b(5):POR complex, which was also supported by gel filtration experiments. Overall, these results are interpreted in the context of a dynamic and tight P450 17A1:b5 complex that also binds POR to form a catalytically competent ternary complex, and variants that disrupt this interaction have low catalytic activity.	[Kim, Donghak; McCarty, Kevin D.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Kim, Donghak; Kim, Vitchan] Konkuk Univ, Dept Biol Sci, Seoul, South Korea	Vanderbilt University; Konkuk University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 GM118122]; Konkuk University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Konkuk University	This study was supported by the National Institutes of Health grant R01 GM118122 (F. P. G.). This work constitutes part of a Konkuk University research support program for its faculty on sabbatical leave in 2020 (D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertolle ME, 2019, CHEM RES TOXICOL, V32, P484, DOI 10.1021/acs.chemrestox.8b00353; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Bhatt MR, 2017, J STEROID BIOCHEM, V170, P2, DOI 10.1016/j.jsbmb.2016.02.033; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; Burris-Hiday SD, 2021, MOL CELL ENDOCRINOL, V528, DOI 10.1016/j.mce.2021.111261; Child SA, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108596; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Duggal R, 2018, FEBS LETT, V592, P2282, DOI 10.1002/1873-3468.13153; Duggal R, 2016, BIOCHEM BIOPH RES CO, V477, P202, DOI 10.1016/j.bbrc.2016.06.043; Ershov PV, 2019, J STEROID BIOCHEM, V187, P124, DOI 10.1016/j.jsbmb.2018.11.009; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gonzalez E, 2018, J BIOL CHEM, V293, P541, DOI 10.1074/jbc.RA117.000504; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2018, CHEM REV, V118, P6573, DOI 10.1021/acs.chemrev.8b00031; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUO ZY, 1994, ARCH BIOCHEM BIOPHYS, V312, P436, DOI 10.1006/abbi.1994.1330; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Holien JK, 2017, CURR PROTEIN PEPT SC, V18, P515, DOI 10.2174/1389203717666161220142957; Huggins C, 1940, J UROLOGY, V43, P705, DOI 10.1016/S0022-5347(17)71453-X; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Krug SJ, 2013, J STEROID BIOCHEM, V134, P75, DOI 10.1016/j.jsbmb.2012.10.019; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lee-Robichaud P, 1999, BIOCHEM J, V342, P309, DOI 10.1042/0264-6021:3420309; Lee-Robichaud P, 1998, BIOCHEM J, V332, P293, DOI 10.1042/bj3320293; Lim YR, 2017, BIOMOL THER, V25, P171, DOI 10.4062/biomolther.2016.182; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Mendieta MAEPB, 2008, J MED CHEM, V51, P5009, DOI 10.1021/jm800355c; OMURA T, 1964, J BIOL CHEM, V239, P2370; ONODA M, 1982, BIOCHEM BIOPH RES CO, V108, P454, DOI 10.1016/0006-291X(82)90850-6; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Park HG, 2017, J MICROBIOL BIOTECHN, V27, P983, DOI 10.4014/jmb.1701.01028; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Saad F, 2015, LANCET ONCOL, V16, P338, DOI 10.1016/S1470-2045(15)70027-6; SANDHU P, 1993, ARCH BIOCHEM BIOPHYS, V306, P443, DOI 10.1006/abbi.1993.1536; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Scott LJ, 2017, DRUGS, V77, P1565, DOI 10.1007/s40265-017-0799-9; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; Simonov AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141252; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; STAYTON PS, 1989, BIOCHEMISTRY-US, V28, P8201, DOI 10.1021/bi00446a035; STAYTON PS, 1988, J BIOL CHEM, V263, P13544; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Storbeck KH, 2012, J STEROID BIOCHEM, V132, P311, DOI 10.1016/j.jsbmb.2012.07.006; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Wang CX, 2017, J BIOL CHEM, V292, P10767, DOI 10.1074/jbc.M117.792465; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Wrobel TM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144868; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Yang LPH, 2011, DRUGS, V71, P2067, DOI 10.2165/11208080-000000000-00000; Yang WH, 2005, J BIOL CHEM, V280, P10196, DOI 10.1074/jbc.M411886200; Yin LN, 2014, NAT REV UROL, V11, P32, DOI 10.1038/nrurol.2013.274; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	76	7	7	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100571	10.1016/j.jbc.2021.100571	http://dx.doi.org/10.1016/j.jbc.2021.100571			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753170	gold, Green Published			2022-12-26	WOS:000672866400544
J	Vasam, G; Nadeau, R; Cadete, VJJ; Lavallee-Adam, M; Menzies, KJ; Burelle, Y				Vasam, Goutham; Nadeau, Rachel; Cadete, Virgilio J. J.; Lavallee-Adam, Mathieu; Menzies, Keir J.; Burelle, Yan			Proteomics characterization of mitochondrial-derived vesicles under oxidative stress	FASEB JOURNAL			English	Article						hyper&#8208; reactive cysteine residues; mitochondrial stress; mitochondrial&#8208; derived vesicle proteome; mitochondrial quality control; mitochondrial iron transport	MEMBRANE-VESICLES; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-PRODUCTION; HUMAN THIOREDOXIN-1; INACTIVATION; PEROXIREDOXIN; TRANSPORT; OXYGEN; SITES; RATES	Mitochondria share attributes of vesicular transport with their bacterial ancestors given their ability to form mitochondrial-derived vesicles (MDVs). MDVs are involved in mitochondrial quality control and their formation is enhanced with stress and may, therefore, play a potential role in mitochondrial-cellular communication. However, MDV proteomic cargo has remained mostly undefined. In this study, we strategically used an in vitro MDV budding/reconstitution assay on cardiac mitochondria, followed by graded oxidative stress, to identify and characterize the MDV proteome. Our results confirmed previously identified cardiac MDV markers, while also revealing a complete map of the MDV proteome, paving the way to a better understanding of the role of MDVs. The oxidative stress vulnerability of proteins directed the cargo loading of MDVs, which was enhanced by antimycin A (Ant-A). Among OXPHOS complexes, complexes III and V were found to be Ant-A-sensitive. Proteins from metabolic pathways such as the TCA cycle and fatty acid metabolism, along with Fe-S cluster, antioxidant response proteins, and autophagy were also found to be Ant-A sensitive. Intriguingly, proteins containing hyper-reactive cysteine residues, metabolic redox switches, including professional redox enzymes and those that mediate iron metabolism, were found to be components of MDV cargo with Ant-A sensitivity. Last, we revealed a possible contribution of MDVs to the formation of extracellular vesicles, which may indicate mitochondrial stress. In conclusion, our study provides an MDV proteomics signature that delineates MDV cargo selectivity and hints at the potential for MDVs and their novel protein cargo to serve as vital biomarkers during mitochondrial stress and related pathologies.	[Vasam, Goutham; Burelle, Yan] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Fac Hlth Sci, Ottawa, ON, Canada; [Nadeau, Rachel; Lavallee-Adam, Mathieu; Menzies, Keir J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Nadeau, Rachel; Lavallee-Adam, Mathieu] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Cadete, Virgilio J. J.; Burelle, Yan] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON, Canada; [Cadete, Virgilio J. J.] Ottawa Hosp Res Inst, Sinclair Ctr Regenerat Med, Ottawa, ON, Canada; [Menzies, Keir J.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Burelle, Y (corresponding author), Univ Ottawa, Univ Res Chair Integrat Mitochondrial Biol, Interdisciplinary Sch Hlth Sci, Fac Hlth Sci, RGN Bldg,451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	yburell2@uottawa.ca		Vasam, Goutham/0000-0003-1733-3189; Menzies, Keir J/0000-0002-1873-8500; Lavallee-Adam, Mathieu/0000-0003-2124-3872	Canadian Institutes of Health Research [MOP 136999, MOP 159455]; Natural Sciences and Engineering Research Council of Canada [RGPIN 2016-09932, RGPIN 2018-06838, DGECR 2018-00012]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Canadian Institutes of Health Research, Grant/Award Number: MOP 136999 and MOP 159455; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: RGPIN 2016-09932, RGPIN 2018-06838 and DGECR 2018-00012	Asara JM, 2008, PROTEOMICS, V8, P994, DOI 10.1002/pmic.200700426; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Cadete VJJ, 2019, BBA-MOL BASIS DIS, V1865, P782, DOI 10.1016/j.bbadis.2018.11.018; Cadete VJJ, 2016, J PHYSIOL-LONDON, V594, P5343, DOI 10.1113/JP272703; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Cheow ESH, 2016, MOL CELL PROTEOMICS, V15, P2628, DOI 10.1074/mcp.M115.055731; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Colletti M, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600430; Cosme J, 2017, J PROTEOME RES, V16, P2836, DOI 10.1021/acs.jproteome.7b00144; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Du YT, 2013, J BIOL CHEM, V288, P32241, DOI 10.1074/jbc.M113.495150; Gangoda L, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600370; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Ibrahim WH, 2013, FREE RADICAL BIO MED, V65, P143, DOI 10.1016/j.freeradbiomed.2013.06.026; Jang SC, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1635420; Jeannin P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23505-0; Jiang RL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017478; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; Kuang MY, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9225-5; Kucera Mike, 2016, F1000Res, V5, P1717; Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Matheoud D, 2016, CELL, V166, P314, DOI 10.1016/j.cell.2016.05.039; McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Merico D, 2011, METHODS MOL BIOL, V781, P257, DOI 10.1007/978-1-61779-276-2_12; Nanadikar MS, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101152; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Riemer J, 2015, BIOL CHEM, V396, P465, DOI 10.1515/hsz-2014-0293; Smith AC, 2016, NUCLEIC ACIDS RES, V44, pD1258, DOI 10.1093/nar/gkv1001; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	57	13	13	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21278	10.1096/fj.202002151R	http://dx.doi.org/10.1096/fj.202002151R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769614	Green Published			2022-12-26	WOS:000635216100051
J	Wang, XS; Feng, M; Xiao, TF; Guo, BS; Liu, DY; Liu, CL; Pei, JP; Liu, QF; Xiao, Y; Rosin-Arbesfeld, R; Shi, Y; Zhou, Y; Yang, MX; Feng, YX; Jiang, YZ; Shao, ZM; Yu, K; Zhu, D				Wang, Xiaoshuang; Feng, Mei; Xiao, Tengfei; Guo, Baosen; Liu, Danyang; Liu, Chenglong; Pei, Jinpeng; Liu, Qiaofeng; Xiao, Yi; Rosin-Arbesfeld, Rina; Shi, Ying; Zhou, Yang; Yang, Mengxuan; Feng, Yu-Xiong; Jiang, Yizhou; Shao, Zhimin; Yu, Ker; Zhu, Di			BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer	ONCOGENE			English	Article								Treatment of patients with triple-negative breast cancer (TNBC) has been challenging due to a lack of well-defined molecular targets. The Wnt/beta-catenin pathway is known to be activated in many TNBC patients and BCL9 and BCL9L are important transcriptional co-activators of beta-catenin, but whether inhibition of BCL9/BCL9L can suppress TNBC growth and the underlying mechanism are not fully understood. Here we demonstrate that the expression of BCL9 and BCL9L is directly correlated with malignancy in TNBC patient tumors and that BCL9 and BCL9L promote tumor cell growth, cell migration and metastasis in TNBC models. Mechanistically, we found that BCL9/BCL9L promotes tumorigenicity through both the Wnt and TGF-beta pathways. Besides, BCL9/BCL9L expression inversely correlates with CD8(+) T cell infiltration in TNBC and BCL9/BCL9L inhibits the infiltration of CD8(+) T cells in the tumor microenvironment. hsBCL9(CT)-24, an inhibitor of BCL9/beta-catenin peptides, promotes intratumoral infiltration of cytotoxic T cells, reducing regulatory T cells (Treg) and increasing dendritic cells (DCs). Inhibition of BCL9/BCL9L and TGF-beta suppresses activity of Treg. TGF-beta signaling increases tumor infiltration of cytotoxic CD8(+) T cells. In accordance, genetic or pharmacological inhibition of BCL9/BCL9L synergizes with PD-1/L1 antibodies to inhibit tumor growth. In summary, these results suggest that targeting BCL9/BCL9L has a direct anti-tumor effect and also unleashes an anti-cancer immune response through inhibition of both Wnt and TGF-beta signaling, suggesting a viable therapeutic approach for TNBC treatment.	[Wang, Xiaoshuang; Feng, Mei; Liu, Chenglong; Pei, Jinpeng; Liu, Qiaofeng; Shi, Ying; Zhou, Yang; Yu, Ker; Zhu, Di] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Xiao, Tengfei] XBH Biotech, Shanghai, Peoples R China; [Guo, Baosen] Shenzhen Digital Life Inst, Shenzhen, Guangdong, Peoples R China; [Liu, Danyang] Fudan Univ, Obstet & Gynecol Hosp, Shanghai, Peoples R China; [Xiao, Yi; Jiang, Yizhou; Shao, Zhimin] Fudan Univ, Dept Surg Breast Canc, Shanghai Canc Ctr, Shanghai, Peoples R China; [Rosin-Arbesfeld, Rina] Tel Aviv Univ, Dept Microbiol & Immunol, Sackler Fac Med, Tel Aviv, Israel; [Yang, Mengxuan; Feng, Yu-Xiong] Zhejiang Univ, Sch Med, Inst Translat Med, Affiliated Hosp 1, Hangzhou, Peoples R China; [Zhu, Di] Fudan Univ, Fudan Affiliated Zhongshan Hosp, Minhang Branch, Shanghai, Peoples R China; [Zhu, Di] Fudan Univ, Key Lab Smart Drug Delivery, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Tel Aviv University; Sackler Faculty of Medicine; Zhejiang University; Fudan University; Fudan University	Yu, K; Zhu, D (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.; Zhu, D (corresponding author), Fudan Univ, Fudan Affiliated Zhongshan Hosp, Minhang Branch, Shanghai, Peoples R China.; Zhu, D (corresponding author), Fudan Univ, Key Lab Smart Drug Delivery, Shanghai, Peoples R China.	keryu@fudan.edu.cn; zhudi@fudan.edu.cn		Wang, Xiaoshaung/0000-0002-0725-9440; Liu, Chenglong/0000-0002-1657-6683	projects on the National Natural Science Foundation of China [81373442]; National Science and Technology Major Project of China [2018ZX09711002-008]; National Basic Research Program (973 Program) of China [2013CB932500]; Science and Technology Commission of Shanghai [18ZR1403900, 18JC1413800]; National Natural Science Foundation of China [81872895]; project on joint translational research in the School of Pharmacy and Minhang Hospital [RO-MY201712]	projects on the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; National Basic Research Program (973 Program) of China(National Basic Research Program of China); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project on joint translational research in the School of Pharmacy and Minhang Hospital	The current study was supported by projects on the National Natural Science Foundation of China (81373442) (KY), National Science and Technology Major Project of China (2018ZX09711002-008) (KY), the National Basic Research Program (973 Program) of China (2013CB932500) (KY), the Science and Technology Commission of Shanghai (18ZR1403900, 18JC1413800) (DZ), the National Natural Science Foundation of China (81872895) (DZ), and the project on joint translational research in the School of Pharmacy and Minhang Hospital (RO-MY201712) (DZ).	Adachi S, 2004, CANCER RES, V64, P8496, DOI 10.1158/0008-5472.CAN-04-2254; Ahmadzadeh M, 2005, J IMMUNOL, V174, P5215, DOI 10.4049/jimmunol.174.9.5215; [Anonymous], 2019, CANCER DISCOV, V9; Augustin I, 2016, STEM CELL RES, V17, P607, DOI 10.1016/j.scr.2016.10.010; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Bishai WR, 2019, P AACR SPEC C TUM IM; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Elsarraj HS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0630-z; Feng M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau5240; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fu CM, 2015, P NATL ACAD SCI USA, V112, P2823, DOI 10.1073/pnas.1414167112; Galluzzi L, 2019, TRENDS CELL BIOL, V29, P44, DOI 10.1016/j.tcb.2018.08.005; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Gay DM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08586-3; Golovina TN, 2010, CANCER J, V16, P342, DOI 10.1097/PPO.0b013e3181eb336d; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; He Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-1002-1; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ovcaricek T, 2011, RADIOL ONCOL, V45, P46, DOI 10.2478/v10019-010-0054-4; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pohl SG, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.14; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Salgado R, 2015, JAMA ONCOL, V1, P448, DOI 10.1001/jamaoncol.2015.0830; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Spranger S, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0089-6; Takada K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003808; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Xu YH, 2015, ONCOL REP, V34, P747, DOI 10.3892/or.2015.4056; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zatula N, 2014, ONCOTARGET, V5, P6770, DOI 10.18632/oncotarget.2252	50	7	7	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2982	2997		10.1038/s41388-021-01756-y	http://dx.doi.org/10.1038/s41388-021-01756-y		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33767438				2022-12-26	WOS:000632824700002
J	Karman, J; Wang, J; Bodea, C; Cao, S; Levesque, MC				Karman, Jozsef; Wang, Jing; Bodea, Corneliu; Cao, Sherry; Levesque, Marc C.			Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms	PLOS ONE			English	Article								Idiopathic pulmonary fibrosis is a progressive and debilitating lung disease with large unmet medical need and few treatment options. We describe an analysis connecting single cell gene expression with bulk gene expression-based subsetting of patient cohorts to identify IPF patient subsets with different underlying pathogenesis and cellular changes. We reproduced earlier findings indicating the existence of two major subsets in IPF and showed that these subsets display different alterations in cellular composition of the lung. We developed classifiers based on the cellular changes in disease to distinguish subsets. Specifically, we showed that one subset of IPF patients had significant increases in gene signature scores for myeloid cells versus a second subset that had significantly increased gene signature scores for ciliated epithelial cells, suggesting a differential pathogenesis among IPF subsets. Ligand-receptor analyses suggested there was a monocyte-macrophage chemoattractant axis (including potentially CCL2-CCR2 and CCL17-CCR4) among the myeloid-enriched IPF subset and a ciliated epithelium-derived chemokine axis (e.g. CCL15) among the ciliated epithelium-enriched IPF subset. We also found that these IPF subsets had differential expression of pirfenidone-responsive genes suggesting that our findings may provide an approach to identify patients with differential responses to pirfenidone and other drugs. We believe this work is an important step towards targeted therapies and biomarkers of response.	[Karman, Jozsef; Wang, Jing; Bodea, Corneliu; Cao, Sherry; Levesque, Marc C.] AbbVie, Cambridge Res Ctr, Cambridge, MA 02139 USA	AbbVie	Karman, J (corresponding author), AbbVie, Cambridge Res Ctr, Cambridge, MA 02139 USA.	jozsef.karman@abbvie.com			AbbVie	AbbVie(AbbVie)	All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication. The funder provided support in the form of salaries for authors (JK, JW, CB, SC, MCL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Allen RJ, 2020, AM J RESP CRIT CARE, V201, P564, DOI 10.1164/rccm.201905-1017OC; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Azuma A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-143; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barkauskas CE, 2014, AM J PHYSIOL-CELL PH, V306, pC987, DOI 10.1152/ajpcell.00321.2013; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Celada LJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar8356; Cha SI, 2012, HISTOPATHOLOGY, V61, P98, DOI 10.1111/j.1365-2559.2012.04197.x; Donahoe M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127771; Fingerlin TE, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0377-2; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Florez-Sampedro L, 2018, REGENERATION, V5, P3, DOI 10.1002/reg2.97; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Heukels P, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1195-7; Huang Y, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0142-8; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Jedroszka D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188842; Joshi N, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00646-2019; Kazanietz MG, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00471; Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341; Kim S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2170-4; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Kwapiszewska G, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00564-2018; Lambert I, 2020, PLANT METHODS, V16, DOI 10.1186/s13007-020-00611-7; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lewis M, 2021, SEMIN CELL DEV BIOL, V110, P51, DOI 10.1016/j.semcdb.2020.04.007; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mathai SK, 2019, THORAX, V74, P1131, DOI 10.1136/thoraxjnl-2018-212430; McDonough JE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131597; Morse C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02441-2018; Peljto AL, 2013, JAMA-J AM MED ASSOC, V309, P2232, DOI 10.1001/jama.2013.5827; Peng XY, 2016, FASEB J, V30, P4056, DOI 10.1096/fj.201600373R; Raghu G, 2011, EUR RESPIR J, V37, P743, DOI 10.1183/09031936.00017711; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Reidel B, 2018, AM J RESP CRIT CARE, V197, P492, DOI 10.1164/rccm.201708-1590OC; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Richeldi L, 2020, LANCET RESP MED, V8, P25, DOI 10.1016/S2213-2600(19)30262-0; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiller HB, 2017, AM J RESP CRIT CARE, V196, P1298, DOI 10.1164/rccm.201611-2263OC; Scott MKD, 2019, LANCET RESP MED, V7, P497, DOI 10.1016/S2213-2600(18)30508-3; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207; Shamseldin HE, 2020, GENET MED, V22, P1051, DOI 10.1038/s41436-020-0761-1; Sivakumar P, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00117-2019; Solomon JJ, 2020, CHEST, V157, P1513, DOI 10.1016/j.chest.2019.12.005; Tan JN, 2016, AM J RESP CRIT CARE, V194, P1392, DOI 10.1164/rccm.201509-1865OC; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5; Tyler SR, 2019, CELL REP, V26, P1951, DOI 10.1016/j.celrep.2019.01.063; Tzouvelekis A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/654354; Vallania F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07242-6; Welsh KG, 2017, CHEST, V152, P771, DOI 10.1016/j.chest.2017.07.001; Whitsett JA, 2018, ANN AM THORAC SOC, V15, pS143, DOI 10.1513/AnnalsATS.201802-128AW; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xue JM, 2013, J IMMUNOL, V191, P2089, DOI 10.4049/jimmunol.1203476; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu GY, 2018, NAT MED, V24, P39, DOI 10.1038/nm.4447; Zhang L, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0864-2; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	69	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248889	10.1371/journal.pone.0248889	http://dx.doi.org/10.1371/journal.pone.0248889			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755690	gold, Green Published			2022-12-26	WOS:000632916600015
J	Alabyad, D; Rangaraju, S; Liu, M; Imran, R; Kempton, CL; Sharifpour, M; Auld, SC; Gaddh, M; Sniecinski, R; Maier, CL; Guarner, J; Duncan, A; Nahab, F				Alabyad, Darwish; Rangaraju, Srikant; Liu, Michael; Imran, Rajeel; Kempton, Christine L.; Sharifpour, Milad; Auld, Sara C.; Gaddh, Manila; Sniecinski, Roman; Maier, Cheryl L.; Guarner, Jeannette; Duncan, Alexander; Nahab, Fadi			Validation of an admission coagulation panel for risk stratification of COVID-19 patients	PLOS ONE			English	Article								Background There is limited data on the markers of coagulation and hemostatic activation (MOCHA) profile in Coronavirus disease 2019 (COVID-19) and its ability to identify COVID-19 patients at risk for thrombotic events and other complications. Methods Hospitalized patients with confirmed SARS-COV-2 from four Atlanta hospitals were included in this observational cohort study and underwent admission testing of MOCHA parameters (plasma d-dimer, prothrombin fragment 1.2, thrombin-antithrombin complex, fibrin monomer). Clinical outcomes included deep vein thrombosis, pulmonary embolism, myocardial infarction, ischemic stroke, access line thrombosis, ICU admission, intubation and mortality. Main results Of 276 patients (mean age 59 +/- 6.4 years, 47% female, 62% African American), 45 (16%) had a thrombotic endpoint. Each MOCHA parameter was independently associated with a thrombotic event (p<0.05) and >= 2 abnormalities was associated with thrombotic endpoints (OR 3.3, 95% CI 1.2-8.8) as were admission D-dimer >= 2000 ng/mL (OR 3.1, 95% CI 1.5-6.6) and >= 3000 ng/mL (OR 3.6, 95% CI 1.6-7.9). However, only >= 2 MOCHA abnormalities were associated with ICU admission (OR 3.0, 95% CI 1.7-5.2) and intubation (OR 3.2, 95% CI 1.6-6.4). MOCHA and D-dimer cutoffs were not associated with mortality. MOCHA with <2 abnormalities (26% of the cohort) had 89% sensitivity and 93% negative predictive value for a thrombotic endpoint. Conclusions An admission MOCHA profile is useful to risk-stratify COVID-19 patients for thrombotic complications and more effective than isolated d-dimer for predicting risk of ICU admission and intubation.	[Alabyad, Darwish] Morehouse Sch Med, Atlanta, GA 30310 USA; [Rangaraju, Srikant; Liu, Michael; Imran, Rajeel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Kempton, Christine L.; Gaddh, Manila] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Sharifpour, Milad] Emory Univ, Sch Med, Dept Anesthesiol, Div Crit Care Med, Atlanta, GA 30322 USA; [Auld, Sara C.] Emory Univ, Div Pulm Allergy Crit Care & Sleep Med, Dept Med, Emory Crit Care Ctr,Sch Med, Atlanta, GA USA; [Auld, Sara C.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA USA; [Sniecinski, Roman] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Maier, Cheryl L.; Guarner, Jeannette; Duncan, Alexander] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nahab, Fadi] Emory Univ, Dept Neurol & Pediat, Atlanta, GA 30322 USA	Morehouse School of Medicine; Emory University; Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University	Nahab, F (corresponding author), Emory Univ, Dept Neurol & Pediat, Atlanta, GA 30322 USA.	fnahab@emory.edu	Guarner, Jeannette/B-8273-2013	Guarner, Jeannette/0000-0001-5610-3541; Liu, Michael/0000-0002-4438-1285; Sniecinski, Roman/0000-0003-4766-3314; Alabyad, Darwish/0000-0002-4585-6334				Ahmed S, 2020, CLIN RHEUMATOL, V39, P2529, DOI 10.1007/s10067-020-05275-1; Al-Samkari H., 2020, AM J HEMATOL, P1; Artifoni M, 2020, J THROMB THROMBOLYS, V50, P211, DOI 10.1007/s11239-020-02146-z; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Dati F, 1998, SEMIN THROMB HEMOST, V24, P443, DOI 10.1055/s-2007-996037; Ellis D, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013830; Iba T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03077-0; Karsy M, 2020, WORLD NEUROSURG, V133, pE774, DOI 10.1016/j.wneu.2019.09.160; Liu M., 2020, STROKE, V51, pA27; Moosavi M, 2021, AM J CLIN PATHOL, V155, P498, DOI [10.1093/AJCP/AQAA266, 10.1093/ajcp/aqaa266]; Nahab F, 2020, NEUROLOGY, V94, pE1892, DOI 10.1212/WNL.0000000000009365; Sakka M, 2020, J Med Vasc, V45, P268, DOI 10.1016/j.jdmv.2020.05.003; Shi A, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.03.003; Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929; Yao YM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00466-z	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248230	10.1371/journal.pone.0248230	http://dx.doi.org/10.1371/journal.pone.0248230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740793	Green Published, gold			2022-12-26	WOS:000631030200016
J	Kajitani, Y; Hatayama, M				Kajitani, Yoshio; Hatayama, Michinori			Explaining the effective reproduction number of COVID-19 through mobility and enterprise statistics: Evidence from the first wave in Japan	PLOS ONE			English	Article								This study uses mobility statistics combined with business census data for the eight Japanese prefectures with the highest coronavirus disease-2019 (COVID-19) infection rates to study the effect of mobility reductions on the effective reproduction number (i.e., the average number of secondary cases caused by one infected person). Mobility statistics are a relatively new data source created by compiling smartphone location data; they can be effectively used for understanding pandemics if integrated with epidemiological findings and other economic data sets. Based on data for the first wave of infections in Japan, we found that reductions targeting the hospitality industry were slightly more effective than restrictions on general business activities. Specifically, we found that to hold back the pandemic (that is, to reduce the effective reproduction number to one or less for all days), a 20%-35% reduction in weekly mobility is required, depending on the region. A lesser goal, 80% of days with one or less observed transmission, can be achieved with a 6%-30% reduction in weekly mobility. These are the results if other potential causes of spread are ignored; for a fuller picture, more careful observations, expanded data sets, and advanced statistical modeling are needed.	[Kajitani, Yoshio] Kagawa Univ, Dept Engn & Design, Fac Engn & Design, Takamatsu, Kagawa, Japan; [Hatayama, Michinori] Kyoto Univ, Disaster Prevent Res Inst, Res Ctr Disaster Reduct Syst, Uji, Kyoto, Japan	Kagawa University; Kyoto University	Kajitani, Y (corresponding author), Kagawa Univ, Dept Engn & Design, Fac Engn & Design, Takamatsu, Kagawa, Japan.	kajtiani.yoshio@kagawa-u.ac.jp	KAJITANI, YOSHIO/W-2338-2019	KAJITANI, YOSHIO/0000-0003-3110-7436				Arimura Mikiharu, 2020, Transp Res Interdiscip Perspect, V7, P100212, DOI 10.1016/j.trip.2020.100212; Cabinet Office Japan, 2020, Q EST GDP; Carteni A, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.104999; Carteni A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140489; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Engle S., 2020, STAYING HOME MOBILIT, DOI [10.2139/ssrn.3565703, DOI 10.2139/SSRN.3565703]; Glaeser EL, 2020, W27519 NBER; google.com, COMM MOB REP; Jiang P, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123673; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee HC, 2020, INT J INFECT DIS, V96, P399, DOI 10.1016/j.ijid.2020.05.031; Luo YJ, 2021, INT J NEUROSCI, V131, P170, DOI 10.1080/00207454.2020.1734598; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Ministry of Health Labor and Welfare (MHLW), COR DIS 2019 COVID 1; Ministry of Internal Affairs and Communications (MIC), 2014, EC CENS BUS FRAM; Ministry of Internal Affairs and Communications (MIC), CONTR SHAR COMM SERV; Nishiura H, 2020, INT J INFECT DIS 202, DOI [10.1101/2020.02.03.20019497, DOI 10.1101/2020.02.03.20019497]; NTT Docomo, MOB SPAT STAT; Tokyo Metropolitan government, 2018, DAYT POP TOK; Yabe T., 2020, ARXIV200509423	21	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247186	10.1371/journal.pone.0247186	http://dx.doi.org/10.1371/journal.pone.0247186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735174	Green Submitted, Green Published, gold			2022-12-26	WOS:000631029700012
J	Thiel, CL; Park, S; Musicus, AA; Agins, J; Gan, J; Held, J; Horrocks, A; Bragg, MA				Thiel, Cassandra L.; Park, SiWoon; Musicus, Aviva A.; Agins, Jenna; Gan, Jocelyn; Held, Jeffrey; Horrocks, Amy; Bragg, Marie A.			Waste generation and carbon emissions of a hospital kitchen in the US: Potential for waste diversion and carbon reductions	PLOS ONE			English	Article								This study measured the total quantity and composition of waste generated in a large, New York City (NYC) hospital kitchen over a one-day period to assess the impact of potential waste diversion strategies in potential weight of waste diverted from landfill and reduction in greenhouse gas (GHG) emissions. During the one-day audit, the hospital kitchen generated 1515.15 kg (1.7 US tons) of solid waste daily or 0.23 kg of total waste per meal served. Extrapolating to all meals served in 2019, the hospital kitchen generates over 442,067 kg (487 US tons) of waste and emits approximately 294,466 kg of CO(2)e annually from waste disposal. Most of this waste (85%, 376,247 kg or 415 US tons annually) is currently sent to landfill. With feasible changes, including increased recycling and moderate composting, this hospital could reduce landfilled waste by 205,245 kg (226 US tons, or 55% reduction) and reduce GHG emissions by 189,025 kg CO(2)e (64% reduction). Given NYC's ambitious waste and GHG emission reduction targets outlined in its OneNYC strategic plan, studies analyzing composition, emissions, and waste diversion potential of large institutions can be valuable in achieving city sustainability goals.	[Thiel, Cassandra L.; Park, SiWoon; Bragg, Marie A.] NYU, Dept Populat Hlth, Grossman Sch Med, New York, NY 10003 USA; [Thiel, Cassandra L.] NYU, Dept Civil & Urban Engn, Tandon Sch Engn, New York, NY 10003 USA; [Musicus, Aviva A.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Agins, Jenna; Gan, Jocelyn; Held, Jeffrey; Horrocks, Amy] NYU Langone Hlth, New York, NY USA; [Bragg, Marie A.] NYU, Dept Nutr, Sch Global Publ Hlth, New York, NY USA	New York University; New York University; New York University Tandon School of Engineering; Harvard University; Harvard T.H. Chan School of Public Health; NYU Langone Medical Center; New York University	Thiel, CL (corresponding author), NYU, Dept Populat Hlth, Grossman Sch Med, New York, NY 10003 USA.; Thiel, CL (corresponding author), NYU, Dept Civil & Urban Engn, Tandon Sch Engn, New York, NY 10003 USA.	cassandra.thiel@nyulangone.org		Bragg, Marie/0000-0002-6858-7173; Thiel, Cassandra/0000-0002-1875-886X; Park, Siwoon/0000-0002-6322-4824	NIH Early Independence Award [5DP5OD021373-05]; NIH [2T32CA057711-27]	NIH Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support was provided by an NIH Early Independence Award (5DP5OD021373-05) for MB (https://commonfund.nih.gov/earlyindependence).AAM is supported by NIH grant number 2T32CA057711-27. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, INT J HEALTHC MANAG; Basier J., 1996, J AM DIET ASSOC, V96, pA45; Blondin SA, 2017, AM J PUBLIC HEALTH, V107, P590, DOI 10.2105/AJPH.2016.303647; Blondin SA, 2015, PUBLIC HEALTH NUTR, V18, P1565, DOI 10.1017/S1368980014002948; City of New York, 2020, NEW YORK CITYS GREEN; Dupertuis YM, 2003, CLIN NUTR, V22, P115, DOI 10.1054/clnu.2002.0623; EPA.gov US EPA, 2020, OOD MAT SPEC DAT; Freedman MR, 2010, J HUNGER ENVIRON NUT, V5, P370, DOI 10.1080/19320248.2010.504109; Goldsmith CD, 2012, J AIR WASTE MANAGE, V62, P183, DOI 10.1080/10473289.2011.639480; Hong W., 1995, FOODSERV RES INT, V8, P115, DOI [10.1111/j.1745-4506.1995.tb00081.x, DOI 10.1111/J.1745-4506.1995.TB00081.X]; Hoover D, 2017, ESTIMATING QUANTITIE; Howard J, 2016, MOD HEALTHCARE; Huang E., 2011, Journal of Foodservice Business Research, V14, P241, DOI 10.1080/15378020.2011.594386; ICF International, 2019, DOC GREENH GAS EM EN; McCaffree J, 2009, J AM DIET ASSOC, V109, P205, DOI 10.1016/j.jada.2008.11.038; McLymont V, 2003, J NURS CARE QUAL, V18, P27, DOI 10.1097/00001786-200301000-00005; Mirosa M, 2016, BRIT FOOD J, V118, P2326, DOI 10.1108/BFJ-12-2015-0460; Montague J., 2014, AUSTIN J NUTR FOOD S, V2; New York City Department of Sanitation, 2018, PUBL RUL NEW YORK CI; New York State, 2019, FOOD DON FOOD SCRAPS; New York State Department of Health New York State, 2020, HLTH FAC CERT INF; NYC Mayor's Office of Sustainability, 2020, ZER WAST CHALL; O'Connor M., 2018, PRACTICE GREENHEALTH; Ofei KT, 2015, APPETITE, V91, P157, DOI 10.1016/j.appet.2015.04.043; Peregrin T, 2011, J AM DIET ASSOC, V111, P1286, DOI 10.1016/j.jada.2011.07.017; Practice Greenhealth, 2019, PRACT GREENH 2019 SU; Redling A., 2018, RECYC TODAY; Sonnino R, 2011, FOOD POLICY, V36, P823, DOI 10.1016/j.foodpol.2011.09.003; Strotmann C, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081409; US EPA, 2020, BEN LANDF GAS EN PRO; US EPA, 2012, EPA430R12006 US EPA; US EPA, 2020, GREENH GAS EQ CALC 2; Watters CA, 2003, J AM DIET ASSOC, V103, P1347, DOI 10.1016/S0002-8223(03)01077-0; Williams P., 2011, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V6, pe235; Wilson ED, 2011, CAN J DIET PRACT RES, V72, P117, DOI 10.3148/72.3.2011.117; Wilson ED, 2011, CAN J DIET PRACT RES, V72, P43, DOI 10.3148/72.1.2011.43	36	3	3	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247616	10.1371/journal.pone.0247616	http://dx.doi.org/10.1371/journal.pone.0247616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730046	gold, Green Published			2022-12-26	WOS:000630345000067
J	Massari, M; Nicoll, CR; Mattevi, A				Massari, Marta; Nicoll, Callum R.; Mattevi, Andrea			A lonely electron blocks incoming pairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRANSFERRING FLAVOPROTEIN	Electron bifurcation exploits high energetic states to drive unfavorable single electron reactions and determining the overall mechanism governing these electron transfers represents an arduous task. Using extensive stopped-flow spectroscopy and kinetic simulations, Sucharitakul et al. now explore the bifurcation mechanism of the electron transfer flavoprotein EtfAB from the anaerobic gut bacterium Acidaminococcus fermentans. Strikingly, they illustrated that catalysis is orchestrated by a negatively charged radical, alpha-FAD, that inhibits further reductions and features an atypical inverted kinetic isotope effect. These results provide additional insight behind electron transfers that are prevalent within multienzyme governed reactions.	[Massari, Marta; Nicoll, Callum R.; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy	University of Pavia	Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy.	andrea.mattevi@unipv.it	; Mattevi, Andrea/K-5464-2012	Massari, Marta/0000-0002-7731-7626; Nicoll, Callum/0000-0002-2122-9387; Mattevi, Andrea/0000-0002-9523-7128				Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Sucharitakul J., 2021, J BIOL CHEM, V296	8	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100294	10.1016/j.jbc.2021.100294	http://dx.doi.org/10.1016/j.jbc.2021.100294			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33755021	gold, Green Published			2022-12-26	WOS:000672866400268
J	Li, HY; Zhuang, P; Zhang, Y; Shou, QY; Lu, YH; Wang, GF; Qiu, JN; Wang, J; He, LL; Chen, JN; Jiao, JJ				Li, Haoyu; Zhuang, Pan; Zhang, Yu; Shou, Qiyang; Lu, Yanhua; Wang, Guangfa; Qiu, Jieni; Wang, Jun; He, Lilin; Chen, Jingnan; Jiao, Jingjing			Mixed conjugated linoleic acid sex-dependently reverses high-fat diet-induced insulin resistance via the gut-adipose axis	FASEB JOURNAL			English	Article						conjugated linoleic acid; gut&#8208; adipose axis; insulin resistance; obesity; sexual dimorphism	BODY-FAT; MICROBIOTA; TISSUE; OBESE; INFLAMMATION; BROWN; SUPPLEMENTATION; WHITE; OVERWEIGHT; EXPRESSION	Conjugated linoleic acid (CLA) may prevent the development of obesity and metabolic disorders. However, the effects of CLA on inflammation and glucose metabolism are controversial. The underlying mechanisms governing the gut microbiota and sexual dimorphisms have also not been elucidated. The present study assessed the effect of CLA on glucose and lipid metabolism in established obesity and examined the mechanism of action based on gut microbiota. Four-week-old C57BL/6J mice were fed a high-fat diet (HFD) for 10 weeks to induce obesity. The diet-induced obese (DIO) mice were fed an HFD supplemented with mixed CLA (50% cis-9, trans-11 isomer and 50% trans-10, cis-12 isomers, 0.2% wt/wt) for 15 weeks. CLA supplementation remarkably reversed body weight in both sexes. CLA favored anti-inflammatory microbiota in male mice, mediating increased short-chain fatty acids and decreased lipopolysaccharide (LPS) production, which alleviated global inflammation and improved insulin sensitivity via inhibition of the TLR4-NF-kappa B pathway in adipose tissue. CLA promoted the growth of hydrogen sulfide-producing Desulfovibrio and the release of LPS in female mice, which aggravated adipose inflammation and insulin resistance. Although CLA impaired glucose metabolism in females, brown adipose tissue was significantly activated with browning of white adipose tissue in both sexes, which led to enhanced energy expenditure. Fecal transplantation from CLA-treated mice to DIO mice mimicked the sex-dependent phenotype. In conclusion, CLA decreased body weight and increased energy expenditure but sex-dependently modulated insulin resistance via the gut-adipose axis.	[Li, Haoyu; Zhuang, Pan; Zhang, Yu; Wang, Jun; He, Lilin; Chen, Jingnan] Zhejiang Key Lab Agrofood Proc, Natl Engn Lab Intelligent Food Technol & Equipmen, Hangzhou, Peoples R China; [Li, Haoyu; Zhuang, Pan; Zhang, Yu; Wang, Jun; He, Lilin; Chen, Jingnan] Zhejiang Univ, Fuli Inst Food Sci, Coll Biosyst Engn & Food Sci, Hangzhou, Peoples R China; [Shou, Qiyang] Zhejiang Chinese Med Univ, Inst Comparat Med, Expt Anim Res Ctr, Hangzhou, Peoples R China; [Lu, Yanhua] Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou, Peoples R China; [Wang, Guangfa] Zhejiang Univ, Dept PET Ctr, Affiliated First Hosp, Sch Med, Hangzhou, Peoples R China; [Qiu, Jieni; Jiao, Jingjing] Zhejiang Univ, Dept Nutr, Sch Publ Hlth, Affiliated Second Hosp,Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University; Hangzhou Normal University; Zhejiang University; Zhejiang University	Jiao, JJ (corresponding author), Zhejiang Univ, Dept Nutr, Sch Publ Hlth, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jingjingjiao@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LR18C200001]; National Natural Science Foundation of China (NSFC) [81773419]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LR18C200001; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81773419	Bettini S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00548; Bezan PN, 2018, EXP CLIN ENDOCR DIAB, V126, P379, DOI 10.1055/s-0043-118348; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carvalho BM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/986734; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; Chen SC, 2012, NUTRITION, V28, P559, DOI 10.1016/j.nut.2011.09.008; den Hartigh LJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020370; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Garibay-Nieto N, 2017, J CLIN ENDOCR METAB, V102, P132, DOI 10.1210/jc.2016-2701; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Halade GV, 2010, J NUTR BIOCHEM, V21, P332, DOI 10.1016/j.jnutbio.2009.01.006; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jang H, 2020, CLIN NUTR, V39, P765, DOI 10.1016/j.clnu.2019.03.032; Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450; Jin CY, 2016, CHEMOSPHERE, V160, P349, DOI 10.1016/j.chemosphere.2016.06.105; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kim BS, 2014, J ETHNOPHARMACOL, V152, P532, DOI 10.1016/j.jep.2014.01.038; Kim JH, 2016, ANNU REV FOOD SCI T, V7, P221, DOI 10.1146/annurev-food-041715-033028; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015; Lam YY, 2015, OBESITY, V23, P1429, DOI 10.1002/oby.21122; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; O'Reilly ME, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900599; Onakpoya Igho J, 2012, Eur J Nutr, V51, P127, DOI 10.1007/s00394-011-0253-9; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Ribeiro AS, 2016, INT J SPORT NUTR EXE, V26, P135, DOI 10.1123/ijsnem.2015-0236; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rodriguez-Alcala LM, 2007, J DAIRY SCI, V90, P2083, DOI 10.3168/jds.2006-693; Roura-Guiberna A, 2019, CELL SIGNAL, V53, P281, DOI 10.1016/j.cellsig.2018.10.013; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Sahuri-Arisoylu M, 2016, INT J OBESITY, V40, P955, DOI 10.1038/ijo.2016.23; Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398; Sharifnia T, 2015, AM J PHYSIOL-GASTR L, V309, pG270, DOI 10.1152/ajpgi.00304.2014; Shen W, 2015, J NUTR BIOCHEM, V26, P616, DOI 10.1016/j.jnutbio.2014.12.016; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wang XK, 2012, JOVE-J VIS EXP, DOI 10.3791/4060; Wei ZS, 2015, FEBS LETT, V589, P165, DOI 10.1016/j.febslet.2014.11.042; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399; Yamasaki M, 1999, BIOSCI BIOTECH BIOCH, V63, P1104, DOI 10.1271/bbb.63.1104; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhou XR, 2008, GROWTH HORM IGF RES, V18, P361, DOI 10.1016/j.ghir.2008.01.001; Zhuang P, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900946; Zhuang P, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800448; Zhuang P, 2017, BBA-MOL BASIS DIS, V1863, P2715, DOI 10.1016/j.bbadis.2017.07.003	65	3	3	6	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21466	10.1096/fj.202002161RR	http://dx.doi.org/10.1096/fj.202002161RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734496				2022-12-26	WOS:000635216100092
J	Sekulovski, N; Whorton, AE; Shi, MX; Hayashi, K; MacLean, JA				Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II			Insulin signaling is an essential regulator of endometrial proliferation and implantation in mice	FASEB JOURNAL			English	Article						endometrial proliferation; implantations; insulin signaling; knockout mice; uterus		Insulin signaling is critical for the development of preovulatory follicles and progression through the antral stage. Using a conditional knockout model that escapes this blockage, we recently described the role of insulin signaling in granulosa cells during the periovulatory window in mice lacking Insr and Igf1r driven by Pgr-Cre. These mice were infertile, exhibiting defects in ovulation, luteinization, steroidogenesis, and early embryo development. Herein, we demonstrate that while these mice exhibit normal uterine receptivity, uterine cell proliferation and decidualization are compromised resulting in complete absence of embryo implantation in uteri lacking both receptors. While the histological organization of double knockout mice appeared normal, the thickness of their endometrium was significantly reduced. This was supported by the reduced proliferation of both epithelial and stromal cells during the preimplantation stages of pregnancy. Expression and localization of the main drivers of uterine proliferation, ESR1 and PGR, was normal in knockouts, suggesting that insulin signaling acts downstream of these two receptors. While AKT/PI3K signaling was unaffected by insulin receptor ablation, activation of p44/42 MAPK was significantly reduced in both single and double knockout uteri at 3.5 dpc. Overall, we conclude that both INSR and IGF1R are necessary for optimal endometrial proliferation and implantation.	[Sekulovski, Nikola; Whorton, Allison E.; Shi, Mingxin; Hayashi, Kanako; MacLean, James A., II] Southern Illinois Sch Med, Dept Physiol, Carbondale, IL USA; [Hayashi, Kanako; MacLean, James A., II] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [MacLean, James A., II] Washington State Univ, Coll Vet Med, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA	Washington State University; Washington State University	MacLean, JA (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, POB 647520, Pullman, WA 99164 USA.	james.maclean@wsu.edu		MacLean, James/0000-0003-3061-150X; Whorton, Allison/0000-0003-2983-401X; Hayashi, Kanako/0000-0002-5028-799X	Research Seed Grant from the Southern Illinois University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD093802]	Research Seed Grant from the Southern Illinois University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported by a Research Seed Grant from the Southern Illinois University School of Medicine and by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD093802.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Ardon O, 2014, MOLEC GENET METAB RE, V1, P71, DOI 10.1016/j.ymgmr.2013.12.006; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Dai CW, 2016, AM J TRANSL RES, V8, P3329; DeSouza MM, 1999, J REPROD IMMUNOL, V45, P127, DOI 10.1016/S0165-0378(99)00046-7; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Escobar-Morreale HF, 2016, DIABETES CARE, V39, P639, DOI 10.2337/dc15-2577; Fukui Y, 2019, REPROD MED BIOL, V18, P234, DOI 10.1002/rmb2.12280; GIUDICE LC, 1994, J CLIN ENDOCR METAB, V79, P1284, DOI 10.1210/jc.79.5.1284; Gomez-Hernandez A, 2013, ENDOCRINOLOGY, V154, P2352, DOI 10.1210/en.2012-2161; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2017, ENDOCRINOLOGY, V158, P2427, DOI 10.1210/en.2017-00349; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Huang Y, 2018, DIABETES RES CLIN PR, V140, P351, DOI 10.1016/j.diabres.2018.05.033; Johansson GS, 2006, AM J PHYSIOL-ENDOC M, V291, pE1124, DOI 10.1152/ajpendo.00565.2005; Kalantari H, 2018, REPROD BIOMED ONLINE, V36, P210, DOI 10.1016/j.rbmo.2017.10.115; KAPUR S, 1992, BIOL REPROD, V46, P208, DOI 10.1095/biolreprod46.2.208; Kirkwood A, 2018, PEDIATR ANESTH, V28, P23, DOI 10.1111/pan.13273; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Li ML, 2016, J BIOL REG HOMEOS AG, V30, P1059; Lindberg ME, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109462; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKWOOD CJ, 1993, J CLIN ENDOCR METAB, V76, P231, DOI 10.1210/jc.76.1.231; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Majchrzak-Baczmanska D, 2016, GINEKOL POL, V87, P598, DOI 10.5603/GP.2016.0052; Matsumoto H, 2008, MOL HUM REPROD, V14, P485, DOI 10.1093/molehr/gan038; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Neff AM, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqz021; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Richards RG, 1998, J BIOL CHEM, V273, P11962, DOI 10.1074/jbc.273.19.11962; RUTANEN EM, 1991, J CLIN ENDOCR METAB, V72, P27, DOI 10.1210/jcem-72-1-27; Satin LS, 2015, MOL ASPECTS MED, V42, P61, DOI 10.1016/j.mam.2015.01.003; Sato T, 2002, ENDOCRINOLOGY, V143, P2673, DOI 10.1210/en.143.7.2673; Schaefer-Graf U, 2018, DIABETOLOGIA, V61, P1012, DOI 10.1007/s00125-018-4545-y; Sekulovski N, 2020, FASEB J, V34, P2376, DOI 10.1096/fj.201901791R; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thong EP, 2020, LANCET DIABETES ENDO, V8, P134, DOI 10.1016/S2213-8587(19)30345-6; US Department of Health and Human Services Centers for Disease Control and Prevention, 2020, NAT DIAB STAT REP; Welborn JP, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124834; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Whitworth KW, 2011, DIABETOLOGIA, V54, P516, DOI 10.1007/s00125-010-2003-6; Winuthayanon W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07728-1; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	61	5	5	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21440	10.1096/fj.202002448R	http://dx.doi.org/10.1096/fj.202002448R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749878	Green Accepted			2022-12-26	WOS:000635216100069
J	Al Marri, MG; Al-Ghouti, MA; Shunmugasamy, VC; Zouari, N				Al Marri, Moza Ghorab; Al-Ghouti, Mohammad A.; Shunmugasamy, Vasanth C.; Zouari, Nabil			Date pits based nanomaterials for thermal insulation applications-Towards energy efficient buildings in Qatar	PLOS ONE			English	Article							FLY-ASH CEMENT; PHYSICAL-PROPERTIES; WALL MATERIALS; CONDUCTIVITY; PERFORMANCE; NANOPARTICLES; NANOGRAPHITE; GRAPHITE; BEHAVIOR; FILLER	Air-conditioning systems make the most significant part of energy consumption in the residential sector. There is no denying that it is essential to produce a comfortable indoor thermal environment for residents in a building. The actual goal is to achieve thermal comfort level without putting too much cost on the ecological system by trying to conserve the amount of energy consumed. An effective way to help achieve such a goal is by incorporating thermal insulation in buildings. Thermal insulations help reduce thermal energy gained during the implementation of a desired thermal comfort level. This study aims to use an environmentally friendly nanoparticle of date pits to create thermal insulations that can be used in buildings. Different ratios of the nanoparticle of the date pits and sand composite were investigated. Fourier transform infrared spectroscopy and scanning electron microscopy were used to characterize the new materials. The material with nanoparticles of date pits and 50% by-volume epoxy provided good thermal insulation with thermal conductivity of 0.26 W/mK that could be used in the existing buildings. This has the potential to reduce the overall energy consumption by 4,494 kWh and thereby reduce CO2 emissions of a 570 m(2) house by 1.8 tons annually. In conclusion, the future of using nanoparticles of date pits in construction is bright and promising due to their promising results.	[Al Marri, Moza Ghorab; Al-Ghouti, Mohammad A.; Zouari, Nabil] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar; [Shunmugasamy, Vasanth C.] Texas A&M Univ, Mech Engn Program, Doha, Qatar	Qatar University; Qatar Foundation (QF); Texas A&M University Qatar	Al-Ghouti, MA (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar.	mohammad.alghouti@qu.edu.qa		Zouari, Nabil/0000-0003-4652-1656; Al-Ghouti, Mohammad/0000-0002-9943-1091	Qatar National Library	Qatar National Library(Qatar National Research Fund (QNRF))	The publication of this article was funded by the Qatar National Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Jdayil B, 2019, INT J POLYM SCI, V2019, DOI 10.1155/2019/1697627; Abu-Jdayil B, 2016, CONSTR BUILD MATER, V105, P472, DOI 10.1016/j.conbuildmat.2015.12.180; Agoudjil B, 2011, ENERG BUILDINGS, V43, P491, DOI 10.1016/j.enbuild.2010.10.014; Al-Ghouti MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51594-y; Al-Ghouti MA, 2017, CHEM ENG J, V308, P463, DOI 10.1016/j.cej.2016.09.091; Al-Ghouti MA, 2013, J ENVIRON MANAGE, V130, P80, DOI 10.1016/j.jenvman.2013.08.045; Al-Ghouti MA, 2010, J HAZARD MATER, V176, P510, DOI 10.1016/j.jhazmat.2009.11.059; Al-Kuwari MG, 2016, J SPORT MED PHYS FIT, V56, P275; Alabdulkarem A, 2018, CONSTR BUILD MATER, V187, P185, DOI 10.1016/j.conbuildmat.2018.07.213; AlMarri M., 2019, QSPACE INSTITUTIONAL; Alzubaidi S., 2012, 2012 IEEE International Power Engineering and Optimization Conference, P291, DOI 10.1109/PEOCO.2012.6230877; Ashraf MA, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2624-0; Boudenne A, 2005, COMPOS PART A-APPL S, V36, P1545, DOI 10.1016/j.compositesa.2005.02.005; Bozsaky D, 2016, SLOVAK J CIV ENG, V24, P17, DOI 10.1515/sjce-2016-0003; Chen L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170523; Nguyen DM, 2018, CONSTR BUILD MATER, V186, P686, DOI 10.1016/j.conbuildmat.2018.07.153; Dickinson E, 2015, J COLLOID INTERF SCI, V449, P38, DOI 10.1016/j.jcis.2014.09.080; Elvin G., 2007, 2007 NSTI NAN C TRAD, V4, P683; Eremin DB, 2017, COORDIN CHEM REV, V346, P2, DOI 10.1016/j.ccr.2016.12.021; Frormann L, 2008, J APPL POLYM SCI, V107, P2695, DOI 10.1002/app.27349; Gammampila R, 2010, APPL NANOMATERIALS S; Griffiths P. R., 2010, HDB VIBRATIONAL SPEC; Guiheneuf V, 2017, SOL ENERGY, V157, P477, DOI 10.1016/j.solener.2017.08.044; GUSTAFSSON SE, 1991, REV SCI INSTRUM, V62, P797, DOI 10.1063/1.1142087; Han YX, 2020, COMPOS SCI TECHNOL, V187, DOI 10.1016/j.compscitech.2019.107944; Hassan I, 2017, AGROCHIMICA, V61, P75, DOI 10.12871/0021857201716; Hellstrom P, 2014, CELLULOSE, V21, P1489, DOI 10.1007/s10570-014-0243-1; Henniges U, 2012, BIOMACROMOLECULES, V13, P4171, DOI 10.1021/bm3014457; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Jannat N, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12124892; Jelle BP, 2012, J MATER SCI, V47, P6475, DOI 10.1007/s10853-012-6349-7; Jusner P, 2021, CARBOHYD POLYM, V252, DOI 10.1016/j.carbpol.2020.117196; Kamilaris A, 2014, RENEW SUST ENERG REV, V34, P536, DOI 10.1016/j.rser.2014.03.037; Kharseh M, 2015, ENERG BUILDINGS, V88, P409, DOI 10.1016/j.enbuild.2014.12.019; Kirgiz MS, 2018, COMPOS PART B-ENG, V154, P423, DOI 10.1016/j.compositesb.2018.09.012; Kirgiz MS, 2015, COMPOS PART B-ENG, V82, P59, DOI 10.1016/j.compositesb.2015.08.003; Kirgiz MS, 2016, MECH MATER, V92, P223, DOI 10.1016/j.mechmat.2015.09.013; Kirgiz MS, 2014, ZKG INT, V67, P42; Koval S, 2018, J ENVIRON MANAGE, V223, P196, DOI 10.1016/j.jenvman.2018.06.038; Lee S, 2015, ENERG BUILDINGS, V99, P67, DOI 10.1016/j.enbuild.2015.03.058; Long LS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24181; Maheswari CU, 2012, BIOMASS BIOENERG, V46, P555, DOI 10.1016/j.biombioe.2012.06.039; Mechri ML, 2017, J AFR EARTH SCI, V125, P18, DOI 10.1016/j.jafrearsci.2016.10.007; Meier A., 2013, ECEEE 2013 SUMMER ST, P41; Mihiretie BM, 2017, INT J HEAT MASS TRAN, V115, P216, DOI 10.1016/j.ijheatmasstransfer.2017.08.036; Muhamad II, 2019, WOODH PUB S COMPOS S, P149, DOI 10.1016/B978-0-08-102290-0.00008-8; Mujeebu MA, 2016, APPL ENERG, V173, P141, DOI 10.1016/j.apenergy.2016.04.014; Muratov DS, 2014, J ALLOY COMPD, V586, pS451, DOI 10.1016/j.jallcom.2012.11.142; Newbury DE, 2013, SCANNING, V35, P141, DOI 10.1002/sca.21041; Nurul MS, 2013, J THERMOPLAST COMPOS, V26, P627, DOI 10.1177/0892705711427345; Olar R., 2011, SECTIA CONSTRUCTII A, V57, P109; Panchal P, 2019, NANOSCALE ADV, V1, P2612, DOI 10.1039/c9na00265k; Patti A., 2020, POLYPROPYLENE POLYME; Petit T, 2018, DIAM RELAT MATER, V89, P52, DOI 10.1016/j.diamond.2018.08.005; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Qatar General Electricity & water Corporation, 2020, KAHRAMAA WATER ELECT; Rahman SM, 2017, ENVIRON PROG SUSTAIN, V36, P1208, DOI 10.1002/ep.12558; Raut AN, 2018, APPL THERM ENG, V136, P309, DOI 10.1016/j.applthermaleng.2018.03.017; Sato K, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10030448; Scalisi F, 2009, NANOTECHNOLOGY IN CONSTRUCTION 3, PROCEEDINGS, P351, DOI 10.1007/978-3-642-00980-8_47; Shoubi MV, 2015, AIN SHAMS ENG J, V6, P41, DOI 10.1016/j.asej.2014.09.006; Stanil P., 2013, J NANOTECHNOL, V8, P18; Stolle A, 2011, CHEM SOC REV, V40, P2317, DOI 10.1039/c0cs00195c; Uetani K, 2017, SCI TECHNOL ADV MAT, V18, P877, DOI 10.1080/14686996.2017.1390692; Velazquez-Marti B, 2018, RENEW ENERG, V126, P954, DOI 10.1016/j.renene.2018.04.021; Wang S, 2016, PROG POLYM SCI, V53, P169, DOI 10.1016/j.progpolymsci.2015.07.003; Wang T, 2018, CONSTR BUILD MATER, V190, P1163, DOI 10.1016/j.conbuildmat.2018.09.131; Wu K, 2016, COMPOS SCI TECHNOL, V130, P28, DOI 10.1016/j.compscitech.2016.04.034; Xie YJ, 2010, COMPOS PART A-APPL S, V41, P806, DOI 10.1016/j.compositesa.2010.03.005; Yan GX, 2018, J MANUF PROCESS, V32, P763, DOI 10.1016/j.jmapro.2018.04.004; Yew MC, 2018, PROG ORG COAT, V124, P33, DOI 10.1016/j.porgcoat.2018.07.022; Yousaf M., 2018, 2017 INT C OPT INSTR; Yu Z, 2011, ENERG BUILDINGS, V43, P1409, DOI 10.1016/j.enbuild.2011.02.002	73	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0247608	10.1371/journal.pone.0247608	http://dx.doi.org/10.1371/journal.pone.0247608			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770082	gold, Green Published			2022-12-26	WOS:000634833500038
J	Zuckerman, NS; Bucris, E; Drori, Y; Erster, O; Sofer, D; Pando, R; Mendelson, E; Mor, O; Mandelboim, M				Zuckerman, Neta S.; Bucris, Efrat; Drori, Yaron; Erster, Oran; Sofer, Danit; Pando, Rakefet; Mendelson, Ella; Mor, Orna; Mandelboim, Michal			Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel	PLOS ONE			English	Article								Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) which causes corona virus disease (COVID-19) was first identified in Wuhan, China in December 2019 and has since led to a global pandemic. Importations of SARS-CoV-2 to Israel in late February from multiple countries initiated a rapid outbreak across the country. In this study, SARS-CoV-2 whole genomes were sequenced from 59 imported samples with a recorded country of importation and 101 early circulating samples in February to mid-March 2020 and analyzed to infer clades and mutational patterns with additional sequences identified Israel available in public databases. Recorded importations in February to mid-March, mostly from Europe, led to multiple transmissions in all districts in Israel. Although all SARS-CoV-2 defined clades were imported, clade 20C became the dominating clade in the circulating samples. Identification of novel, frequently altered mutated positions correlating with clade-defining positions provide data for surveillance of this evolving pandemic and spread of specific clades of this virus. SARS-CoV-2 continues to spread and mutate in Israel and across the globe. With economy and travel resuming, surveillance of clades and accumulating mutations is crucial for understanding its evolution and spread patterns and may aid in decision making concerning public health issues.	[Zuckerman, Neta S.; Bucris, Efrat; Drori, Yaron; Erster, Oran; Sofer, Danit; Pando, Rakefet; Mendelson, Ella; Mor, Orna; Mandelboim, Michal] Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Ramat Gan, Israel; [Drori, Yaron; Mendelson, Ella; Mor, Orna; Mandelboim, Michal] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Pando, Rakefet] Chaim Sheba Med Ctr, Israel Ctr Dis Control, Israel Minist Hlth, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Zuckerman, NS (corresponding author), Chaim Sheba Med Ctr, Cent Virol Lab, Minist Hlth, Ramat Gan, Israel.	Neta.Zuckerman@sheba.health.gov.il		Zuckerman, Neta/0000-0001-6074-2100				Alm E, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.32.2001410; Atchley WR, 1999, J MOL EVOL, V48, P501, DOI 10.1007/PL00006494; Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Delphine C., 2007, STRUCTURAL APPROACHE, P207; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li H., 2013, ALIGNING SEQUENCE RE; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Toyoshima Y, 2020, J HUM GENET, V65, P1075, DOI 10.1038/s10038-020-0808-9; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	22	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0243265	10.1371/journal.pone.0243265	http://dx.doi.org/10.1371/journal.pone.0243265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770098	gold, Green Published			2022-12-26	WOS:000634833500006
J	Ruderman, MA; Kim, B; Stolzmann, K; Connolly, S; Miller, CJ; Bauer, MS				Ruderman, Michael A.; Kim, Bo; Stolzmann, Kelly; Connolly, Samantha; Miller, Christopher J.; Bauer, Mark S.			Time course and heterogeneity of treatment effect of the collaborative chronic care model on psychiatric hospitalization rates: A survival analysis using routinely collected electronic medical records	PLOS ONE			English	Article							DEPRESSION; MANAGEMENT	Background Health systems are undergoing widespread adoption of the collaborative chronic care model (CCM). Care structured around the CCM may reduce costly psychiatric hospitalizations. Little is known, however, about the time course or heterogeneity of treatment effects (HTE) for CCM on psychiatric hospitalization. Rationale Assessment of CCM implementation support on psychiatric hospitalization might be more efficient if the timing were informed by an expected time course. Further, understanding HTE could help determine who should be referred for intervention. Objectives (i) Estimate the trajectory of CCM effect on psychiatric hospitalization rates. (ii) Explore HTE for CCM across demographic and clinical characteristics. Methods Data from a stepped wedge CCM implementation trial were reanalyzed using 5 570 patients in CCM treatment and 46 443 patients receiving usual care. Time-to-event data was constructed from routine medical records. Effect trajectory of CCM on psychiatric hospitalization was simulated from an extended Cox model over one year of implementation support. Covariate risk contributions were estimated from subset stratified Cox models without using simulation. Ratios of hazard ratios (RHR) allowed comparison by trial arm for HTE analysis, also without simulation. No standard Cox proportional hazards models were used for either estimating the time-course or heterogeneity of treatment effect. Results The effect of CCM implementation support increased most rapidly immediately after implementation start and grew more gradually throughout the rest of the study. On the final study day, psychiatric hospitalization rates in the treatment arm were 17% to 49% times lower than controls, with adjustment for all model covariates (HR 0.66; 95% CI 0.51-0.83). Our analysis of HTE favored usual care for those with a history of prior psychiatric hospitalization (RHR 4.92; 95% CI 3.15-7.7) but favored CCM for those with depression (RHR 0.61; 95% CI: 0.41-0.91). Having a single medical diagnosis, compared to having none, favored CCM (RHR 0.52; 95% CI 0.31-0.86). Conclusion Reduction of psychiatric hospitalization is evident immediately after start of CCM implementation support, but assessments may be better timed once the effect size begins to stabilize, which may be as early as six months. HTE findings for CCM can guide future research on utility of CCM in specific populations.	[Ruderman, Michael A.; Kim, Bo; Stolzmann, Kelly; Connolly, Samantha; Miller, Christopher J.; Bauer, Mark S.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA; [Ruderman, Michael A.; Kim, Bo; Connolly, Samantha; Miller, Christopher J.; Bauer, Mark S.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Ruderman, Michael A.] San Francisco VA Med Ctr, Div Mental Hlth Serv, San Francisco, CA 94121 USA; [Ruderman, Michael A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Ruderman, MA (corresponding author), VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA.; Ruderman, MA (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Ruderman, MA (corresponding author), San Francisco VA Med Ctr, Div Mental Hlth Serv, San Francisco, CA 94121 USA.; Ruderman, MA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mikeruderman@gmail.com	Ruderman, Michael/GWC-2211-2022; Miller, Christopher/ABC-5892-2021	Kim, Bo/0000-0001-7730-1627; Ruderman, Michael/0000-0003-1169-3597	United States Department of Veterans Affairs, Office of Mental Health and Suicide Research via Quality Enhancement Research Initiative [QUE-15-289, CIN-13-403]; Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL 1TR002541]; Harvard University	United States Department of Veterans Affairs, Office of Mental Health and Suicide Research via Quality Enhancement Research Initiative(US Department of Veterans Affairs); Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award); Harvard University	BK, KS, SC, CJM, MAR, and MSB acknowledge financial support from the United States Department of Veterans Affairs, Office of Mental Health and Suicide Research via grants through their Quality Enhancement Research Initiative, grants QUE-15-289 and CIN-13-403 (url: https://www.research.va.gov/).This funder was a partner in designing and conducting the primary trial on which the current study is based. This funder had no role in the analysis, decision to publish, or preparation of the manuscript for the current study. MAR acknowledges receiving statistical consultation financially supported by the Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health (url: https://catalyst.harvard.edu/services/biostatsconsult/).This funder had no role in study design, data collection, and analysis (beyond initial consultation), decision to publish, or preparation of the manuscript. MAR received salary support from the Harvard South Shore Psychiatry Residency Training Program (url: https://www.harvardsouthshore.org/research.html).This funder had no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript for the current study.	[Anonymous], 2013, BEST CARE LOWER COST, P13444, DOI [10.17226/13444, DOI 10.17226/13444]; Atkins D, 2017, ANNU REV PUBL HEALTH, V38, P467, DOI 10.1146/annurev-publhealth-031816-044255; Barthel FMS, 2006, STATA J, V6, P348, DOI 10.1177/1536867X0600600304; Bauer MS, 2019, MED CARE, V57, pS221, DOI 10.1097/MLR.0000000000001145; Bauer MS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0230; Bauer MS, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0385-7; Belsher BE, 2018, J GEN INTERN MED, V33, P1124, DOI 10.1007/s11606-018-4451-5; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Davey C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0838-3; Eibner Christine, 2016, Rand Health Q, V5, P13; Gandrud C, 2015, J STAT SOFTW, V65, P1; Garrison GM, 2016, J AM BOARD FAM MED, V29, P10, DOI 10.3122/jabfm.2016.01.150128; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Grud C, 2015, SIMPH R PACKAGE SHOW; Henderson NC, 2020, BIOSTATISTICS, V21, P50, DOI 10.1093/biostatistics/kxy028; Kim B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030696; Kirchner JE, 2014, J GEN INTERN MED, V29, pS904, DOI 10.1007/s11606-014-3027-2; Lew RA, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0893-3; Long JS, 2021, SOCIOL METHOD RES, V50, P1284, DOI 10.1177/0049124118799374; Longman JM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1137-0; Miller CJ, 2013, MED CARE, V51, P922, DOI 10.1097/MLR.0b013e3182a3e4c4; Shen CY, 2016, J BIOPHARM STAT, V26, P507, DOI 10.1080/10543406.2015.1052480; Therneau TM, 2020, **DATA OBJECT**; US Department of Veterans Affairs, VA HLTH EC RES CTR M; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Voort TYG, 2015, BRIT J PSYCHIAT, V206, P393, DOI 10.1192/bjp.bp.114.152520; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Willke RJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-185; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616; Young PL., 2010, VALUE HLTH CARE ACCO	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249007	10.1371/journal.pone.0249007	http://dx.doi.org/10.1371/journal.pone.0249007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765038	gold, Green Published			2022-12-26	WOS:000634832800009
J	Yen, YH; Cheng, YF; Wang, JH; Lin, CC; Chen, CH; Wang, CC				Yen, Yi-Hao; Cheng, Yu-Fan; Wang, Jing-Houng; Lin, Chih-Che; Chen, Chien-Hung; Wang, Chih-Chi			Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; AMERICAN ASSOCIATION; MANAGEMENT; CIRRHOSIS; TRANSPLANTATION; RECOMMENDATIONS; PROGNOSIS; DIAGNOSIS; RESECTION; SURVIVAL	Background and aims The Barcelona Clinic Liver Cancer (BCLC) staging system is the most widely applied staging system for hepatocellular carcinoma (HCC) and is recommended for treatment allocation and prognostic prediction. The BCLC guidelines were modified in 2018 to indicate that Child-Pugh A without any ascites is essential for all stages except stage D. This study sought to provide a description of patients with HCC treated at a high-volume liver surgery center in Taiwan where referral is not needed and all treatment modalities are available and reimbursed by the National Health Insurance program. As such, certain variables that could modulate treatment decisions in clinical practice, including financial constraints, the availability of treatment procedures, and the expertise of the hospital, could be excluded. The study further sought to evaluate the adherence to the modified BCLC guidelines. Methods This was a retrospective study with prospectively collected data. 1801 consecutive patients with de novo HCC were enrolled through our institution from 2011-2017. Results There were 302 patients with stage 0, 783 with stage A, 242 with stage B, 358 with stage C, and 116 with stage D HCC. Treatment adhering to the modified BCLC guidelines recommendations was provided to 259 (85.8%) stage 0 patients, 606 (77.4%) stage A patients, 120 (49.6%) stage B patients, 93 (26.0%) stage C patients, and 83 (71.6%) stage D patients. Conclusions We reported treatment adhering to the modified BCLC guidelines at a high-volume liver surgery center in Taiwan. We found that non-adherence to the modified BCLC staging system was common in treating stage B and C patients.	[Yen, Yi-Hao; Wang, Jing-Houng; Chen, Chien-Hung] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Yen, Yi-Hao; Wang, Jing-Houng; Chen, Chien-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Ctr, Dept Diagnost Radiol,Coll Med, Kaohsiung, Taiwan; [Lin, Chih-Che; Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Liver Transplantat Ctr, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Yen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan.; Yen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	cassellyen@yahoo.com.tw			Kaohsiung Chang Gung Memorial Hospital, Taiwan [CMRPG8J1281]	Kaohsiung Chang Gung Memorial Hospital, Taiwan	This study was supported by Grant CMRPG8J1281 from the Kaohsiung Chang Gung Memorial Hospital, Taiwan. Grant Recipient is YiHao Yen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."There was no additional external funding received for this study.	Borzio M, 2013, FUTURE ONCOL, V9, P283, DOI [10.2217/FON.12.183, 10.2217/fon.12.183]; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cauchy F, 2013, BRIT J SURG, V100, P113, DOI 10.1002/bjs.8963; Cholongitas E, 2005, ALIMENT PHARM THERAP, V22, P1079, DOI 10.1111/j.1365-2036.2005.02691.x; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Edge SB, 2010, AM JOINT COMMITTEE C, P175; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Fomer A, 2014, NAT REV CLIN ONCOL, V11, P525, DOI 10.1038/nrclinonc.2014.122; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Gawrieh S, 2019, ALIMENT PHARM THER, V50, P809, DOI 10.1111/apt.15464; Giannini EG, 2018, HEPATOLOGY, V67, P1784, DOI 10.1002/hep.29668; Guarino M, 2018, J GASTROEN HEPATOL, V33, P1123, DOI 10.1111/jgh.14013; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Ikai Iwao, 2003, Surg Oncol Clin N Am, V12, P65, DOI 10.1016/S1055-3207(02)00082-0; Kudo M, 2015, LIVER CANCER, V4, P39, DOI 10.1159/000367727; Labgaa I, 2019, HEPATOLOGY, V69, P923, DOI 10.1002/hep.30338; Lin CC, 2016, HEPATOL SURG NUTR, V5, P415, DOI 10.21037/hbsn.2016.08.02; Liu YW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230897; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Sangiovanni A, 2018, LIVER INT, V38, P1624, DOI 10.1111/liv.13888; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Varela M, 2010, MED CLIN-BARCELONA, V134, P569, DOI 10.1016/j.medcli.2009.10.042; Vigano L, 2015, J HEPATOL, V63, P93, DOI 10.1016/j.jhep.2015.01.024; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Vitale A, 2015, J HEPATOL, V62, P617, DOI 10.1016/j.jhep.2014.10.037; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yen YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230005	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249194	10.1371/journal.pone.0249194	http://dx.doi.org/10.1371/journal.pone.0249194			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765059	gold, Green Published			2022-12-26	WOS:000634832800051
J	Adenan, NNH; Ariffin, MRK; Yunos, F; Sapar, SH; Asbullah, MA				Adenan, Nurul Nur Hanisah; Ariffin, Muhammad Rezal Kamel; Yunos, Faridah; Sapar, Siti Hasana; Asbullah, Muhammad Asyraf			Analytical cryptanalysis upon N = p(2)q utilizing Jochemsz-May strategy	PLOS ONE			English	Article								This paper presents a cryptanalytic approach on the variants of the RSA which utilizes the modulus N= p(2)q where p and p are balanced large primes. Suppose e is an element of Z(+) satisfying gcd (e, phi(N)) = 1 where phi(N) = p(p- 1)(q- 1) and d< N-delta be its multiplicative inverse. From ed - k phi(N) = 1, by utilizing the extended strategy of Jochemsz and May, our attack works when the primes share a known amount of Least Significant Bits(LSBs). This is achievable since we obtain the small roots of our specially constructed integer polynomial which leads to the factorization of N. More specifically we show that N can be factored when the bound delta < 11/9 - 2/9 root 4 + 18 gamma. Our attack enhances the bound of some former attacks upon N= p(2)q.	[Adenan, Nurul Nur Hanisah; Ariffin, Muhammad Rezal Kamel; Sapar, Siti Hasana; Asbullah, Muhammad Asyraf] Univ Putra Malaysia, Inst Math Res, Serdang, Selangor, Malaysia; [Ariffin, Muhammad Rezal Kamel; Yunos, Faridah; Sapar, Siti Hasana; Asbullah, Muhammad Asyraf] Univ Putra Malaysia, Fac Sci, Dept Math, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Ariffin, MRK (corresponding author), Univ Putra Malaysia, Inst Math Res, Serdang, Selangor, Malaysia.; Ariffin, MRK (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Math, Serdang, Selangor, Malaysia.	rezal@upm.edu.my		Adenan, Nurul Nur Hanisah/0000-0002-5957-1524	Ministry of Higher Education Malaysia [FRGS/2/2013/SG04/UPM/02/2]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	The research was supported by Ministry of Higher Education Malaysia with Fundamental Research Grant Scheme (FRGS/2/2013/SG04/UPM/02/2).	Ariffin MRK, 2013, MALAYS J MATH SCI, V7, P19; Asbullah MA, 2015, J PHYS CONF SER, V622, DOI 10.1088/1742-6596/622/1/012019; Asbullah MA, 2016, MALAYS J MATH SCI, V10, P1; Boneh D, 1998, LECT NOTES COMPUT SC, V1514, P25; Boneh D, 2000, IEEE T INFORM THEORY, V46, P1339, DOI 10.1109/18.850673; Boneh D., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P326; Coppersmith D, 1997, J CRYPTOL, V10, P233, DOI 10.1007/s001459900030; Hinek MJ, 2010, CRYPTANALYSIS RSA IT, P155; Howgrave-Graham N, 1997, LECT NOTES COMPUT SC, V1355, P131, DOI 10.1007/BFb0024458; Jochemsz E, 2006, LECT NOTES COMPUT SC, V4284, P267; LENSTRA AK, 1982, MATH ANN, V261, P515, DOI 10.1007/BF01457454; Lu Y, 2015, LECT NOTES COMPUT SC, V9452, P189, DOI 10.1007/978-3-662-48797-6_9; May A, 2004, LECT NOTES COMPUT SC, V2947, P218; Nitaj Abderrahmane, 2013, Progress in Cryptology - AFRICACRYPT 2013. 6th International Conference on Crytology in Africa. Proceedings, P297, DOI 10.1007/978-3-642-38553-7_17; Nitaj A, 2014, LECT NOTES COMPUT SC, V8469, P178; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI [10.1145/359340.359342, 10.1145/357980.358017]; Sarkar S, 2014, DESIGN CODE CRYPTOGR, V73, P383, DOI 10.1007/s10623-014-9928-6; Sun HM, 2008, LECT NOTES COMPUT SC, V5339, P49; Takagi T, 2004, IEICE T FUND ELECTR, VE87A, P94; WIENER MJ, 1990, IEEE T INFORM THEORY, V36, P553, DOI 10.1109/18.54902; Zhao YD, 2007, LECT NOTES COMPUT SC, V4779, P221	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248888	10.1371/journal.pone.0248888	http://dx.doi.org/10.1371/journal.pone.0248888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760865	gold, Green Published			2022-12-26	WOS:000633030400019
J	Bryson, JM; Patterson, K; Berrang-Ford, L; Lwasa, S; Namanya, DB; Twesigomwe, S; Kesande, C; Ford, JD; Harper, SL				Bryson, Julia M.; Patterson, Kaitlin; Berrang-Ford, Lea; Lwasa, Shuaib; Namanya, Didacus B.; Twesigomwe, Sabastian; Kesande, Charity; Ford, James D.; Harper, Sherilee L.		Indigenous Hlth Adaptation Climate	Seasonality, climate change, and food security during pregnancy among indigenous and non-indigenous women in rural Uganda: Implications for maternal-infant health	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; KANUNGU DISTRICT; CHILD UNDERNUTRITION; NUTRITIONAL-STATUS; CHANGE IMPACTS; VULNERABILITY; INSECURITY; BATWA; MOTHERS; ASSOCIATION	Background Climate change is expected to decrease food security globally. Many Indigenous communities have heightened sensitivity to climate change and food insecurity for multifactorial reasons including close relationships with the local environment and socioeconomic inequities which increase exposures and challenge adaptation to climate change. Pregnant women have additional sensitivity to food insecurity, as antenatal undernutrition is linked with poor maternal-infant health. This study examined pathways through which climate change influenced food security during pregnancy among Indigenous and non-Indigenous women in rural Uganda. Specific objectives were to characterize: 1) sensitivities to climate-associated declines in food security for pregnant Indigenous women; 2) women's perceptions of climate impacts on food security during pregnancy; and 3) changes in food security and maternal-infant health over time, as observed by women. Methods Using a community-based research approach, we conducted eight focus group discussions-four in Indigenous Batwa communities and four in non-Indigenous communities-in Kanungu District, Uganda, on the subject of climate and food security during pregnancy. Thirty-six women with >= 1 pregnancy participated. Data were analysed using a constant comparative method and thematic analysis. Results Women indicated that food insecurity was common during pregnancy and had a bidirectional relationship with antenatal health issues. Food security was thought to be decreasing due to weather changes including extended droughts and unpredictable seasons harming agriculture. Women linked food insecurity with declines in maternal-infant health over time, despite improved antenatal healthcare. While all communities described food security struggles, the challenges Indigenous women identified and described were more severe. Conclusions Programs promoting women's adaptive capacity to climate change are required to improve food security for pregnant women and maternal-infant health. These interventions are particularly needed in Indigenous communities, which often face underlying health inequities. However, resiliency among mothers was strong and, with supports, they can reduce food security challenges in a changing climate.	[Bryson, Julia M.; Patterson, Kaitlin; Harper, Sherilee L.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Bryson, Julia M.] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Berrang-Ford, Lea; Ford, James D.] Univ Leeds, Priestley Int Ctr Climate, Leeds, W Yorkshire, England; [Lwasa, Shuaib] Makerere Univ, Dept Geog Geoinformat & Climat Sci, Kampala, Uganda; [Namanya, Didacus B.] Ugandan Minist Hlth, Dept Community Hlth, Kampala, Uganda; [Twesigomwe, Sabastian; Kesande, Charity] Batwa Dev Program, Buhoma, Uganda; [Harper, Sherilee L.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Guelph; McMaster University; University of Leeds; Makerere University; University of Alberta	Bryson, JM; Patterson, K; Harper, SL (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON, Canada.; Bryson, JM (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada.; Harper, SL (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	brysonj@mcmaster.ca; kpatte08@uoguelph.ca; sherilee.harper@ualberta.ca	Lwasa, Shuaib/G-3723-2014; Ford, James/A-4284-2013; Harper, Sherilee/L-4996-2013	Lwasa, Shuaib/0000-0003-4312-2836; Ford, James/0000-0002-2066-3456; Patterson, Kaitlin/0000-0002-3444-0472; Harper, Sherilee/0000-0001-7298-8765	University of Guelph; Frederick Banting Doctoral Graduate Scholarship (Canadian Institutes of Health Research); International Development Research Centre doctoral research award; Canadian Institutes of Health Research	University of Guelph; Frederick Banting Doctoral Graduate Scholarship (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); International Development Research Centre doctoral research award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was provided by a University of Guelph (www.uoguelph.ca) Summerlee travel scholarship awarded to JMB; a Frederick Banting Doctoral Graduate Scholarship (Canadian Institutes of Health Research, cihr-irsc. gc.ca), an International Development Research Centre (www.idrc.ca) doctoral research award, and a University of Guelph (www.uoguelph.ca) Summerlee research grant awarded to KP; and a Canadian Institutes of Health Research (cihr-irsc. gc.ca) grant awarded to SLH, LBF, SL, DBN, JDF and the IHACC Research Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenle AA, 2017, ECOL ECON, V141, P190, DOI 10.1016/j.ecolecon.2017.06.004; Anyah RO, 2012, INT J CLIMATOL, V32, P347, DOI 10.1002/joc.2270; Becquey E, 2012, BRIT J NUTR, V107, P1860, DOI 10.1017/S0007114511005071; Berrang-Ford L, 2012, SOC SCI MED, V75, P1067, DOI 10.1016/j.socscimed.2012.04.016; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blakstad MM, 2020, LANCET PLANET HEALTH, V4, pE547, DOI 10.1016/S2542-5196(20)30246-1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bunce A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/123003; Clark S, 2015, EPIDEMIOL INFECT, V143, P2287, DOI 10.1017/S0950268814003124; Cooper PJM, 2008, AGR ECOSYST ENVIRON, V126, P24, DOI 10.1016/j.agee.2008.01.007; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Dewing S, 2013, J AFFECT DISORDERS, V150, P460, DOI 10.1016/j.jad.2013.04.040; Donnelly B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1299-1; Epule TE, 2017, LAND USE POLICY, V65, P154, DOI 10.1016/j.landusepol.2017.04.013; FAO, 2008, INTR BAS CONC FOOD S; FAO, 2018, COUNTRY GENDER ASSES; FAO, 2016, STAT FOOD SEC NUTR W; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Ford JD, 2006, GLOBAL ENVIRON CHANG, V16, P145, DOI 10.1016/j.gloenvcha.2005.11.007; Ford JD, 2018, GLOBAL ENVIRON CHANG, V49, P129, DOI 10.1016/j.gloenvcha.2018.02.006; Ford JD, 2012, AM J PUBLIC HEALTH, V102, P1260, DOI 10.2105/AJPH.2012.300752; Ford JD, 2010, GLOBAL ENVIRON CHANG, V20, P668, DOI 10.1016/j.gloenvcha.2010.05.003; Ford JD, 2009, REG ENVIRON CHANGE, V9, P83, DOI 10.1007/s10113-008-0060-x; Grace K, 2017, POPUL ENVIRON, V38, P369, DOI 10.1007/s11111-016-0268-5; Guyot M, 2006, INT J CIRCUMPOL HEAL, V65, P403, DOI 10.3402/ijch.v65i5.18135; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hirvonen K, 2016, PUBLIC HEALTH NUTR, V19, P1723, DOI 10.1017/S1368980015003237; Hlimi T, 2015, HEALTH PLACE, V31, P180, DOI 10.1016/j.healthplace.2014.12.003; Hofmeijer I, 2013, MITIG ADAPT STRAT GL, V18, P957, DOI 10.1007/s11027-012-9402-6; International Food Policy Research Institute, 2016, GLOBAL NUTR REPORT 2; Isiugo-Abanihe U.C., 2002, AFRICAN POPULATION S, V17, P61; Jebena MG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0699-5; Jones AD, 2017, AM J PREV MED, V53, P264, DOI 10.1016/j.amepre.2017.04.008; Jones R, 2014, HEALTH HUM RIGHTS, V16, P54; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kuehn L, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080853; Labbe J, 2016, MITIG ADAPT STRAT GL, V21, P931, DOI 10.1007/s11027-015-9635-2; Lake Victoria Basin Commission, 2018, LAKE VICTORIA BASIN; Laraia BA, 2010, J AM DIET ASSOC, V110, P692, DOI 10.1016/j.jada.2010.02.014; Levy BS, 2015, ANN GLOB HEALTH, V81, P310, DOI 10.1016/j.aogh.2015.08.008; MacVicar S, 2017, SOC SCI MED, V187, P39, DOI 10.1016/j.socscimed.2017.06.021; Magrath J., 2008, OXFAM POLICY PRACT A, V8, P96; Mason JB, 2012, FOOD NUTR BULL, V33, pS104, DOI 10.1177/15648265120332S107; Mosha I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-523; Mozurkewich EL, 2000, OBSTET GYNECOL, V95, P623, DOI 10.1016/S0029-7844(99)00598-0; Muller C, 2014, GLOBAL CHANGE BIOL, V20, P2505, DOI 10.1111/gcb.12586; Namanya D.B., 2013, THESIS INT HLTH SCI; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Park CY, 2014, J ACAD NUTR DIET, V114, P1967, DOI 10.1016/j.jand.2014.04.025; Patterson K, 2017, PUBLIC HEALTH NUTR, V20, P1, DOI 10.1017/S1368980016002494; Peterman A, 2013, STUD FAMILY PLANN, V44, P411, DOI 10.1111/j.1728-4465.2013.00367.x; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Riang'a RM, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0130-0; Roba KT, 2015, NUTRITION, V31, P1213, DOI 10.1016/j.nut.2015.03.007; Rylander C, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.19538; Salam RA, 2013, EXPERT REV OBSTET GY, V8, P559; Satyal P, 2021, CLIM DEV, V13, P529, DOI 10.1080/17565529.2020.1824888; Sauer J, 2018, SOC SCI MED, V217, P55, DOI 10.1016/j.socscimed.2018.09.027; Sherman M, 2015, NAT HAZARDS, V77, P2049, DOI 10.1007/s11069-015-1690-1; Smithson J., 2000, INT J SOC RES METHOD, V3, P103, DOI [10.1080/136455700405172, DOI 10.1080/136455700405172]; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; Ssentongo P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21427-5; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Thompson H. E., 2010, Sustainability, V2, P2719, DOI 10.3390/su2082719; Uganda Bureau of Statistics, 2014, NATL POPULATION HOUS; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; Vouking MZ, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.349.5090; Wallerstein NB, 2006, HEALTH PROMOT PRACT, V7, P312, DOI 10.1177/1524839906289376; Watson PE, 2007, EUR J CLIN NUTR, V61, P1271, DOI 10.1038/sj.ejcn.1602644; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Zaninka P., 2001, IMPACT FOREST NATURE	77	2	2	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247198	10.1371/journal.pone.0247198	http://dx.doi.org/10.1371/journal.pone.0247198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760848	Green Published, gold			2022-12-26	WOS:000633030400027
J	Lin, SY; Chen, CM; Huang, BS; Lai, YC; Pan, KT; Lin, SM; Chu, SY; Tseng, JH				Lin, Shen-Yen; Chen, Chien-Ming; Huang, Bing-Shen; Lai, Ying-Chieh; Pan, Kuang-Tse; Lin, Shi-Ming; Chu, Sung-Yu; Tseng, Jeng-Hwei			A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness	PLOS ONE			English	Article							RADIATION-THERAPY; MANAGEMENT; RADIOTHERAPY; OUTCOMES	Purpose To demonstrate the feasibility of magnetic resonance imaging (MRI) for early prediction of proton beam therapy (PBT) effectiveness in hepatocellular carcinoma (HCC). Methods Clinical data of the HCC patients without regional lymph node involvement or distant metastasis who received PBT at this institution between 2014 and 2017 were reviewed. A total of 43 patients were included. Tumor regression pattern after PBT were examined on the basis of follow-up duration. The variables were compared between patients with and without early tumor regression (ETR). Results The median follow-up duration was 40 months (range, 9-62 months). The cumulative overall survival rate at 6 months, 1 years and 5 years was 100%, 88.4%, 63.4%, respectively. Child-Pugh class A, local tumor control (LTC), complete response (CR), and ETR were significantly associated with overall survival (p < 0.05 each). Of 43 patients, 25 patients (58.1%) reached CR in the PBT-irradiated region. Twelve patients (27.9%) had a partial response and 3 patients (7.0%) had a stationary disease. Three patients (7.0%) developed in-field progression. The LTC rate at 5 years was 93.0%. Of the 25 patients who achieved a CR in the PBT-irradiated region, the median time to CR was 5 months (range, 1-19 months). Twenty-two patients (51.2%) showed ETR of the HCC, while 21 patients (48.8%) showed non-ETR. A significant association was observed between ETR and CR of the HCC after PBT (p < 0.001). Conclusion The post-PBT MRI follow-up at 3 months is helpful for monitoring therapeutic response. ETR of the HCC predicted a higher rate of CR and was associated with overall survival, which provides more accurate clinical management.	[Lin, Shen-Yen; Chen, Chien-Ming; Lai, Ying-Chieh; Pan, Kuang-Tse; Chu, Sung-Yu; Tseng, Jeng-Hwei] Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Lin, Shen-Yen; Chen, Chien-Ming; Huang, Bing-Shen; Lai, Ying-Chieh; Pan, Kuang-Tse; Lin, Shi-Ming; Chu, Sung-Yu; Tseng, Jeng-Hwei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Bing-Shen] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Lin, Shi-Ming] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tseng, JH (corresponding author), Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Taoyuan, Taiwan.; Tseng, JH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	cgmhradiologygi@gmail.com		Chen, Chien-Ming/0000-0001-7829-1504; Chu, Sung-Yu/0000-0002-2258-4129				Alongi F, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01510-w; Apisarnthanarax S, 2018, SEMIN RADIAT ONCOL, V28, P309, DOI 10.1016/j.semradonc.2018.06.008; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bush DA, 2016, INT J RADIAT ONCOL, V95, P477, DOI 10.1016/j.ijrobp.2016.02.027; Chadha AS, 2019, RADIOTHER ONCOL, V133, P54, DOI 10.1016/j.radonc.2018.10.041; Chuong M, 2020, J GASTROINTEST ONCOL, V11, P157, DOI 10.21037/jgo.2019.04.02; Corradini S, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1308-y; Dionisi F, 2014, RADIOTHER ONCOL, V111, P1, DOI 10.1016/j.radonc.2014.02.001; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukuda K, 2017, CANCER SCI, V108, P497, DOI 10.1111/cas.13145; Gandhi SJ, 2015, PRACT RADIAT ONCOL, V5, P209, DOI 10.1016/j.prro.2015.01.004; Han KH, 2011, ONCOLOGY-BASEL, V81, P158, DOI 10.1159/000333280; Hata M, 2006, STRAHLENTHER ONKOL, V182, P713, DOI 10.1007/s00066-006-1564-2; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Hung SP, 2020, AM J CLIN ONCOL-CANC, V43, P180, DOI 10.1097/COC.0000000000000646; Hussein RS, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0690-1; Jarnagin WR, 2010, ANN SURG ONCOL, V17, P1226, DOI 10.1245/s10434-010-0978-3; Kawashima M, 2005, J CLIN ONCOL, V23, P1839, DOI 10.1200/JCO.2005.00.620; Kim J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.85; Kim TH, 2018, ONCOTARGET, V9, P4034, DOI 10.18632/oncotarget.23428; Kolthammer JA, 2011, EUR J NUCL MED MOL I, V38, P1248, DOI 10.1007/s00259-011-1743-y; Lee CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203854; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Llovet JM, 2020, J HEPATOL, V72, P288, DOI 10.1016/j.jhep.2019.09.026; Lu RC, 2019, WORLD J GASTROENTERO, V25, P4682, DOI 10.3748/wjg.v25.i32.4682; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Oldrini G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176118; Park JW, 2019, KOREAN J RADIOL, V20, P1042, DOI 10.3348/kjr.2019.0140; Sanford NN, 2019, INT J RADIAT ONCOL, V105, P64, DOI 10.1016/j.ijrobp.2019.01.076; Wang XC, 2008, MED DOSIM, V33, P259, DOI 10.1016/j.meddos.2007.04.008; Yaghmai V, 2013, AM J ROENTGENOL, V201, P80, DOI 10.2214/AJR.13.10706; Yu JI, 2018, RADIAT ONCOL J, V36, P25, DOI 10.3857/roj.2017.00409; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249003	10.1371/journal.pone.0249003	http://dx.doi.org/10.1371/journal.pone.0249003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755701	Green Published, gold			2022-12-26	WOS:000632916600007
J	Westmoreland, FM; Kusuma, P; Bugbee, B				Westmoreland, F. Mitchell; Kusuma, Paul; Bugbee, Bruce			Cannabis lighting: Decreasing blue photon fraction increases yield but efficacy is more important for cost effective production of cannabinoids	PLOS ONE			English	Article								LED technology facilitates a range of spectral quality, which can be used to optimize photosynthesis, plant shape and secondary metabolism. We conducted three studies to investigate the effect of blue photon fraction on yield and quality of medical hemp. Conditions were varied among studies to evaluate potential interactions with environment, but all environmental conditions other than the blue photon fraction were maintained constant among the five-chambers in each study. The photosynthetic photon flux density (PPFD, 400 to 700 nm) was rigorously maintained at the set point among treatments in each study by raising the fixtures. The lowest fraction of blue photons was 4% from HPS, and increased to 9.8, 10.4, 16, and 20% from LEDs. There was a consistent, linear, 12% decrease in yield in each study as the fraction of blue photons increased from 4 to 20%. Dry flower yield ranged from 500 to 750 g m(-2). This resulted in a photon conversion efficacy of 0.22 to 0.36 grams dry flower mass yield per mole of photons. Yield was higher at a PPFD of 900 than at 750 mu mol m(-2) s(-1). There was no effect of spectral quality on CBD or THC concentration. CBD and THC were 8% and 0.3% at harvest in trials one and two, and 12% and 0.5% in trial three. The CBD/THC ratio was about 25 to 1 in all treatments and studies. The efficacy of the fixtures ranged from 1.7 (HPS) to 2.5 mu mol per joule (white+red LED). Yield under the white+red LED fixture (10.4% blue) was 4.6% lower than the HPS on a per unit area basis, but was 27% higher on a per dollar of electricity basis. These findings suggest that fixture efficacy and initial cost of the fixture are more important for return on investment than spectral distribution at high photon flux.	[Westmoreland, F. Mitchell; Kusuma, Paul; Bugbee, Bruce] Utah State Univ, Crop Physiol Lab, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Westmoreland, FM (corresponding author), Utah State Univ, Crop Physiol Lab, Logan, UT 84322 USA.	mitchell.westmoreland@usu.edu		Westmoreland, Fredrick/0000-0001-6806-1748	Utah Agricultural Research Station; Acuity Brands Lighting Inc.	Utah Agricultural Research Station; Acuity Brands Lighting Inc.	This research was funded by the Utah Agricultural Research Station with help from Acuity Brands Lighting Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; [Anonymous], 2020, TECHNICAL MEMORANDUM; [Anonymous], DATABASE HORTICULTUR; [Anonymous], 2019, FED REG; [Anonymous], 1957, ENV CONTROL PLANT GR; Backer R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00495; BARNES C, 1993, HORTSCIENCE, V28, P1197, DOI 10.21273/HORTSCI.28.12.1197; Bazzaz F. A., 1975, Biochemical Systematics and Ecology, V3, P15, DOI 10.1016/0305-1978(75)90036-8; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bilodeau SE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00296; Campbell B. J., 2019, Agrosystems, Geosciences & Environment, V2, DOI 10.2134/age2018.11.0057; Carvalho A, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox037; Chandra Suman, 2008, Physiol Mol Biol Plants, V14, P299, DOI 10.1007/s12298-008-0027-x; Chandra S, 2017, EPILEPSY BEHAV, V70, P302, DOI 10.1016/j.yebeh.2016.11.029; Chandra Suman, 2011, Physiology and Molecular Biology of Plants, V17, P297, DOI 10.1007/s12298-011-0068-4; Cope KR, 2014, PHOTOCHEM PHOTOBIOL, V90, P574, DOI 10.1111/php.12233; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; CROMBIE WML, 1977, PHYTOCHEMISTRY, V16, P1369, DOI 10.1016/S0031-9422(00)88784-1; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; FAIRBAIRN JW, 1974, J PHARM PHARMACOL, V26, P413, DOI 10.1111/j.2042-7158.1974.tb09306.x; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hanus LO, 2016, NAT PROD REP, V33, P1357, DOI 10.1039/c6np00074f; Hernandez E, 2020, HORTICULTURAE, V6, DOI 10.3390/horticulturae6010007; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Kang WH, 2016, HORTIC ENVIRON BIOTE, V57, P573, DOI 10.1007/s13580-016-0093-x; Kinross AD, 2020, J CHROMATOGR A, V1627, DOI 10.1016/j.chroma.2020.461414; Kusuma P, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-0283-7; Legris M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13045-0; Magagnini Gianmaria, 2018, Med Cannabis Cannabinoids, V1, P19, DOI 10.1159/000489030; Mahlberg P. G., 2004, Journal of Industrial Hemp, V9, P15, DOI 10.1300/J237v09n01_04; MAHLBERG PG, 1983, BOT GAZ, V144, P43, DOI 10.1086/337342; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; MCCREE KJ, 1972, AGR METEOROL, V10, P443, DOI 10.1016/0002-1571(72)90045-3; MECHOULA.R, 1965, J AM CHEM SOC, V87, P3273, DOI 10.1021/ja01092a065; Meng QW, 2019, SCI HORTIC-AMSTERDAM, V255, P269, DOI 10.1016/j.scienta.2019.05.030; Mills E, 2012, ENERG POLICY, V46, P58, DOI 10.1016/j.enpol.2012.03.023; Monje O, 1998, PLANT CELL ENVIRON, V21, P315, DOI 10.1046/j.1365-3040.1998.00284.x; Namdar D, 2019, IND CROP PROD, V132, P177, DOI 10.1016/j.indcrop.2019.02.016; Nelson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138930; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Ouzounis T, 2015, HORTSCIENCE, V50, P1128, DOI 10.21273/HORTSCI.50.8.1128; Pacifico D, 2008, EUPHYTICA, V160, P231, DOI 10.1007/s10681-007-9543-y; Park Y, 2018, ENVIRON EXP BOT, V155, P206, DOI 10.1016/j.envexpbot.2018.06.033; Park YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202386; Park Y, 2017, ENVIRON EXP BOT, V136, P41, DOI 10.1016/j.envexpbot.2016.12.013; Potter DJ, 2014, DRUG TEST ANAL, V6, P31, DOI 10.1002/dta.1531; SAGER JC, 1988, T ASAE, V31, P1882; Schluttenhofer C, 2017, TRENDS PLANT SCI, V22, P917, DOI 10.1016/j.tplants.2017.08.004; SHOYAMA Y, 1975, PHYTOCHEMISTRY, V14, P2189, DOI 10.1016/S0031-9422(00)91096-3; Snowden MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163121; Son KH, 2015, HORTIC ENVIRON BIOTE, V56, P639, DOI 10.1007/s13580-015-1064-3; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Thoma F, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00497; Unkovich M, 2010, ADV AGRON, V105, P173, DOI 10.1016/S0065-2113(10)05005-4; VALLE JR, 1978, B NARCOTICS, V30, P67; van Iersel MW, 2000, J AM SOC HORTIC SCI, V125, P86, DOI 10.21273/JASHS.125.1.86; Vanhove W, 2011, FORENSIC SCI INT, V212, P158, DOI 10.1016/j.forsciint.2011.06.006; Wallace C, 2016, ACTA HORTIC, V1134, P435, DOI 10.17660/ActaHortic.2016.1134.55; Wang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00250; Wei M, 2019, LIGHTING RES TECHNOL, V51, P858, DOI 10.1177/1477153519825997; Zager JJ, 2019, PLANT PHYSIOL, V180, P1877, DOI 10.1104/pp.18.01506; Zhen SY, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.581156; Zhen SY, 2020, PLANT CELL ENVIRON, V43, P1259, DOI 10.1111/pce.13730; Zhen S, 2017, J PLANT PHYSIOL, V209, P115, DOI 10.1016/j.jplph.2016.12.004	65	15	15	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248988	10.1371/journal.pone.0248988	http://dx.doi.org/10.1371/journal.pone.0248988			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755709	Green Published, gold			2022-12-26	WOS:000632916600042
J	de Amorim, AN; Deardon, R; Saini, V				de Amorim, Arthur Novaes; Deardon, Rob; Saini, Vineet			A stacked ensemble method for forecasting influenza-like illness visit volumes at emergency departments	PLOS ONE			English	Article							SEASONAL INFLUENZA; PREDICTION; EPIDEMICS	Accurate and reliable short-term forecasts of influenza-like illness (ILI) visit volumes at emergency departments can improve staffing and resource allocation decisions within hospitals. In this paper, we developed a stacked ensemble model that averages the predictions from various competing methodologies in the current frontier for ILI-related forecasts. We also constructed a back-of-the-envelope prediction interval for the stacked ensemble, which provides a conservative characterization of the uncertainty in the stacked ensemble predictions. We assessed the accuracy and reliability of our model with 1 to 4 weeks ahead forecast targets using real-time hospital-level data on weekly ILI visit volumes during the 2012-2018 flu seasons in the Alberta Children's Hospital, located in Calgary, Alberta, Canada. Our results suggest the forecasting performance of the stacked ensemble meets or exceeds the performance of the individual models over all forecast targets.	[de Amorim, Arthur Novaes] Univ Calgary, Dept Econ, Calgary, AB, Canada; [Deardon, Rob] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada; [Deardon, Rob] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Saini, Vineet] Alberta Hlth Serv, Prov Populat & Publ Hlth, Res & Innovat, Calgary, AB, Canada; [Saini, Vineet] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Saini, Vineet] Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	de Amorim, AN (corresponding author), Univ Calgary, Dept Econ, Calgary, AB, Canada.	arthur.novaesdeamori@ucalgary.ca		Novaes de Amorim, Arthur/0000-0002-2685-0068				[Anonymous], 2008, MODEL SELECTION MODE; Arnold T.B., 2020, GENLASSO PATH ALGORI; Breiman L., 2001, MACH LEARN, V45, P5; Brooks LC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004382; Claeskens G, 2016, INT J FORECASTING, V32, P754, DOI 10.1016/j.ijforecast.2015.12.005; Dormann CF, 2018, ECOL MONOGR, V88, P485, DOI 10.1002/ecm.1309; Farrow D, 2016, THESIS; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Hyndman R. J., 2007, AUTOMATIC TIME SERIE; Kandula S, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0174; Kim S, 2016, INT J FORECASTING, V32, P669, DOI 10.1016/j.ijforecast.2015.12.003; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Menec V., 2001, IMPACT INFLUENZA LIK; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; O'Hara-Wild M, 2020, FORECASTING FUNCTION; Ray EL, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005910; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Ward MA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7521-7; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Yang W, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005201	22	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0241725	10.1371/journal.pone.0241725	http://dx.doi.org/10.1371/journal.pone.0241725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750974	Green Published, gold, Green Submitted			2022-12-26	WOS:000631967100030
J	Baz, H; Ichihara, K; Selim, M; Awad, A; Aglan, S; Ramadan, D; Hassab, A; Mansour, L; Elgaddar, O				Baz, Heba; Ichihara, Kiyoshi; Selim, May; Awad, Ahmed; Aglan, Sarah; Ramadan, Dalia; Hassab, Amina; Mansour, Lamia; Elgaddar, Ola			Establishment of reference intervals of clinical chemistry analytes for the adult population in Egypt	PLOS ONE			English	Article								Background This is the first Egyptian nationwide study for derivation of reference intervals (RIs) for 34 major chemistry analytes. It was conducted as a part of the global initiative by the IFCC Committee on Reference Intervals and Decision Limits (C-RIDL) for establishing country-specific RIs based on a harmonized protocol. Methods 691 apparently healthy volunteers aged >= 18 years were recruited from multiple regions in Egypt. Serum specimens were analyzed in two centers. The harmonization and standardization of test results were achieved by measuring value-assigned serum panel provided by C-RIDL. The RIs were calculated by parametric method. Sources of variation of reference values (RVs) were evaluated by multiple regression analysis. The need for partitioning by sex, age, and region was judged primarily by standard deviation ratio (SDR). Results Gender-specific RIs were required for six analytes including total bilirubin (TBil), aspartate and alanine aminotransferase (AST, ALT). Seven analytes required age-partitioning including glucose and low-density lipoprotein cholesterol (LDL-C). Regional differences were observed between northern and southern Egypt for direct bilirubin, glucose, and high-density-lipoprotein cholesterol (HDL-C) with all their RVs lower in southern Egypt. Compared with other collaborating countries, the features of Egyptian RVs were lower HDL-C and TBil and higher TG and C-reactive protein. In addition, BMI showed weak association with most of nutritional markers. These features were shared with two other Middle Eastern countries: Saudi Arabia and Turkey. Conclusion The standardized RIs established by this study can be used as common Egyptian RI, except for a few analytes that showed regional differences. Despite high prevalence of obesity among Egyptians, their RVs of nutritional markers are less sensitive to increased BMI, compared to other collaborating countries.	[Baz, Heba; Selim, May; Ramadan, Dalia; Mansour, Lamia] Cairo Univ, Chem Pathol Dept, Cairo, Egypt; [Ichihara, Kiyoshi] Yamaguchi Univ, Fac Hlth Sci, Dept Clin Lab Sci, Grad Sch Med, Ube, Yamaguchi, Japan; [Awad, Ahmed; Aglan, Sarah; Elgaddar, Ola] Alexandria Univ, Med Res Inst, Chem Pathol Dept, Alexandria, Egypt; [Hassab, Amina] Alexandria Univ, Clin Pathol Dept, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Yamaguchi University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Ichihara, K (corresponding author), Yamaguchi Univ, Fac Hlth Sci, Dept Clin Lab Sci, Grad Sch Med, Ube, Yamaguchi, Japan.	ichihara@yamaguchi-u.ac.jp	Baz, Heba/ABE-5281-2020	Baz, Heba/0000-0002-5764-3459; Elgaddar, Ola/0000-0002-7156-1441	Cairo University research fund; Japan Society for the Promotion of Science (JSPS) [16H02771]	Cairo University research fund(Cairo University); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The part of the study that took place at Cairo University has been funded by a Cairo University research fund awarded to HB and MS. The part fulfilled in Alexandria university as well as all the immunoturbidimetric assays of the whole study were funded by the Japan Society for the Promotion of Science (JSPS), Scientific Research Fund number (16H02771: 2016-2019) awarded to KI. None of the authors received any salaries from any commercial body, neither were there any sponsorship of any sort.	Al-Ghamdi HS, 2007, J PERIODONTOL, V78, P1043, DOI 10.1902/jop.2007.060431; Alberti G, 2005, EUR HEART J SUPPL, V7, pD3, DOI 10.1093/eurheartj/sui021; Borai A, 2016, CLIN CHEM LAB MED, V54, P843, DOI 10.1515/cclm-2015-0490; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fraser CG, 2001, BIOL VARIATION PRINC; Ibrahim MM, 2013, EGYPT HEART J, V65, P79, DOI 10.1016/j.ehj.2012.08.005; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; Ichihara K, 2017, CLIN CHIM ACTA, V467, P70, DOI 10.1016/j.cca.2016.09.016; Ichihara K, 2017, CLIN CHIM ACTA, V467, P83, DOI 10.1016/j.cca.2016.09.015; Ichihara K, 2014, CLIN CHIM ACTA, V432, P108, DOI 10.1016/j.cca.2014.01.025; Ichihara K, 2013, CLIN CHEM LAB MED, V51, P1443, DOI 10.1515/cclm-2012-0422; Ichihara K, 2010, CLIN CHEM LAB MED, V48, P1537, DOI 10.1515/CCLM.2010.319; Koh KK, 2005, J AM COLL CARDIOL, V46, P1978, DOI 10.1016/j.jacc.2005.06.082; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Ozarda Y, 2014, CLIN CHEM LAB MED, V52, P1823, DOI 10.1515/cclm-2014-0228; Ozarda Y, 2013, CLIN CHEM LAB MED, V51, P1027, DOI 10.1515/cclm-2013-0249; Prajapati Ketankumar Jayantilal, 2016, J Oral Maxillofac Pathol, V20, P219, DOI 10.4103/0973-029X.185919; Shah SAV, 2018, CLIN CHEM LAB MED, V56, P2093, DOI 10.1515/cclm-2018-0152; Shamai L, 2011, OBES SURG, V21, P42, DOI 10.1007/s11695-010-0170-7; Shimizu Y, 2017, CLIN CHIM ACTA, V472, P131, DOI 10.1016/j.cca.2017.07.022; Tarbiah N, 2019, BASIC CLIN PHARMACOL, V125, P474, DOI 10.1111/bcpt.13278; Xia LY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002915	22	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0236772	10.1371/journal.pone.0236772	http://dx.doi.org/10.1371/journal.pone.0236772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740794	gold, Green Published, Green Submitted			2022-12-26	WOS:000631030200017
J	Huang, JW; Kuo, CH; Kuo, HC; Shih, JY; Tsai, TW; Chang, LC				Huang, Jhih-Wei; Kuo, Ching-Hua; Kuo, Han-Chun; Shih, Jin-Yuan; Tsai, Teng-Wen; Chang, Lin-Chau			Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel	PLOS ONE			English	Article								Peripheral neuropathy (PN) is a dose-limiting, painful adverse reaction associated with the use of paclitaxel. This common side effect was often partially attributed to the solvent used for solubilization of the highly hydrophobic drug substance. Therefore, the development of alternative formulations thrived, which included that of Abraxane(R) containing nanoparticle albumin-bound paclitaxel (nab-paclitaxel). However, studies demonstrated inconsistent conclusions regarding the mitigation of PN in comparison with the traditional formulation. The mass spectrometry-based cell metabolomics approach was used in the present study to explore the potentially associated mechanisms. Although no significant difference in the effects on cell viability was observed, fold changes in carnitine, several acylcarnitines and long-chain fatty acid(s) were significantly different between treatment groups in differentiated and undifferentiated SH-SY5Y cells. The most prominent difference observed was the significant increase of octanoylcarnitine in cells treated with solvent-based paclitaxel, which was found to be associated with significant decrease of medium-chain acyl-CoA dehydrogenase (MCAD). The findings suggested the potential role of altered fatty acid oxidation in the different neurotoxicity patterns observed, which may be a possible target for therapeutic interventions worth further investigation.	[Huang, Jhih-Wei; Kuo, Ching-Hua; Tsai, Teng-Wen; Chang, Lin-Chau] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Zhongzheng Dist, Taiwan; [Kuo, Ching-Hua; Kuo, Han-Chun] Natl Taiwan Univ, Ctr Genom, Metabol Core Lab, Taipei, Zhongzheng Dist, Taiwan; [Kuo, Ching-Hua; Kuo, Han-Chun] Natl Taiwan Univ, Ctr Precis Med, Metabol Core Lab, Taipei, Zhongzheng Dist, Taiwan; [Shih, Jin-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Zhongzheng Dist, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, LC (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Zhongzheng Dist, Taiwan.	linchauchang@ntu.edu.tw		SHIH, JIN-YUAN/0000-0002-2854-5067; Chang, Lin-Chau/0000-0001-7441-9355	Ministry of Science and Technology, Taiwan; MOST [108-2320-B002-012-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); MOST	This work was supported by the Ministry of Science and Technology, Taiwan (Grant No. MOST 108-2320-B002-012-MY2) (https://www.most.gov.tw/?l=de). The principal investigator who received the grant is LCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakogeorgos M, 2017, EXPERT REV ANTICANC, V17, P1045, DOI 10.1080/14737140.2017.1374856; Bernabeu E, 2017, INT J PHARMACEUT, V526, P474, DOI 10.1016/j.ijpharm.2017.05.016; Blair HA, 2015, DRUGS, V75, P2017, DOI 10.1007/s40265-015-0484-9; Chao HC, 2017, ANAL CHIM ACTA, V971, P68, DOI 10.1016/j.aca.2017.03.033; Chen GY, 2015, ANAL CHEM, V87, P9731, DOI 10.1021/acs.analchem.5b01869; Chen NH, 2014, J CLIN PHARMACOL, V54, P1097, DOI 10.1002/jcph.304; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; Di Stefano G, 2019, J PAIN RES, V12, P1341, DOI 10.2147/JPR.S190231; Dinicola S, 2018, EUR REV MED PHARMACO, V22, P4739, DOI 10.26355/eurrev_201807_15534; Duggett NA, 2016, NEUROSCIENCE, V333, P13, DOI 10.1016/j.neuroscience.2016.06.050; Halama A, 2014, ARCH BIOCHEM BIOPHYS, V564, P100, DOI 10.1016/j.abb.2014.09.002; Herrera DA, 2019, EXPERT OPIN PHARMACO, V20, P95, DOI 10.1080/14656566.2018.1546290; Ho CH, 2015, PROSTATE, V75, P1454, DOI 10.1002/pros.23033; Hsu HW, 2008, PEDIATRICS, V121, pE1108, DOI 10.1542/peds.2007-1993; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Kamei D, 2018, NEPHROLOGY, V23, P737, DOI 10.1111/nep.13079; Kidd JF, 2002, J BIOL CHEM, V277, P6504, DOI 10.1074/jbc.M106802200; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Krishna A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1154; Kudlowitz D, 2013, CLIN CANCER RES, V19, P4570, DOI 10.1158/1078-0432.CCR-13-0572; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Ma JC, 2018, CANCER-AM CANCER SOC, V124, P2289, DOI 10.1002/cncr.31248; Naganuma M, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119836011; Sun YH, 2018, BREAST CANCER RES TR, V171, P657, DOI 10.1007/s10549-018-4862-3; Tein I, 2013, HAND CLINIC, V113, P1675, DOI 10.1016/B978-0-444-59565-2.00035-6; Untch M, 2016, LANCET ONCOL, V17, P345, DOI 10.1016/S1470-2045(15)00542-2; Voigt W, 2005, METH MOLEC MED, V110, P39; Wang R, 2019, MOL MED REP, V19, P743, DOI 10.3892/mmr.2018.9647; Wang ZX, 2016, NEUROMUSCULAR DISORD, V26, P170, DOI 10.1016/j.nmd.2015.12.002; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Zang XW, 2019, J CONTROL RELEASE, V303, P109, DOI 10.1016/j.jconrel.2019.04.013	33	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248942	10.1371/journal.pone.0248942	http://dx.doi.org/10.1371/journal.pone.0248942			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740022	Green Published, gold			2022-12-26	WOS:000631030200049
J	Hutchinson, SA; Websdale, A; Cioccoloni, G; Roberg-Larsen, H; Lianto, P; Kim, B; Rose, A; Soteriou, C; Pramanik, A; Wastall, LM; Williams, BJ; Henn, MA; Chen, JJ; Ma, LQ; Moore, JB; Nelson, E; Hughes, TA; Thorne, JL				Hutchinson, Samantha A.; Websdale, Alex; Cioccoloni, Giorgia; Roberg-Larsen, Hanne; Lianto, Priscilia; Kim, Baek; Rose, Ailsa; Soteriou, Chrysa; Pramanik, Arindam; Wastall, Laura M.; Williams, Bethany J.; Henn, Madeline A.; Chen, Joy J.; Ma, Liqian; Moore, J. Bernadette; Nelson, Erik; Hughes, Thomas A.; Thorne, James L.			Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer	ONCOGENE			English	Article								Triple negative breast cancer (TNBC) is challenging to treat successfully because targeted therapies do not exist. Instead, systemic therapy is typically restricted to cytotoxic chemotherapy, which fails more often in patients with elevated circulating cholesterol. Liver x receptors are ligand-dependent transcription factors that are homeostatic regulators of cholesterol, and are linked to regulation of broad-affinity xenobiotic transporter activity in non-tumor tissues. We show that LXR ligands confer chemotherapy resistance in TNBC cell lines and xenografts, and that LXRalpha is necessary and sufficient to mediate this resistance. Furthermore, in TNBC patients who had cancer recurrences, LXRalpha and ligands were independent markers of poor prognosis and correlated with P-glycoprotein expression. However, in patients who survived their disease, LXRalpha signaling and P-glycoprotein were decoupled. These data reveal a novel chemotherapy resistance mechanism in this poor prognosis subtype of breast cancer. We conclude that systemic chemotherapy failure in some TNBC patients is caused by co-opting the LXRalpha:P-glycoprotein axis, a pathway highly targetable by therapies that are already used for prevention and treatment of other diseases.	[Hutchinson, Samantha A.; Websdale, Alex; Cioccoloni, Giorgia; Lianto, Priscilia; Soteriou, Chrysa; Moore, J. Bernadette; Thorne, James L.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England; [Hutchinson, Samantha A.] Inst Canc Res, London, England; [Roberg-Larsen, Hanne] Univ Oslo, Dept Chem, Oslo, Norway; [Kim, Baek; Wastall, Laura M.; Williams, Bethany J.] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Rose, Ailsa; Pramanik, Arindam; Hughes, Thomas A.] Univ Leeds, Sch Med, Leeds, W Yorkshire, England; [Henn, Madeline A.; Chen, Joy J.; Ma, Liqian; Nelson, Erik] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Nelson, Erik] Univ Illinois, Canc Ctr Illinois, Urbana, IL USA; [Nelson, Erik] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Nelson, Erik] Univ Illinois, Canc Ctr, Chicago, IL USA; [Nelson, Erik] Univ Illinois, Carl R Woese Inst Genom Biol, Anticanc Discovery Pets People Theme, Urbana, IL USA; [Hughes, Thomas A.; Thorne, James L.] Univ Leeds, Fac Med & Hlth, Leeds Breast Canc Res Grp, Leeds, W Yorkshire, England	University of Leeds; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oslo; University of Leeds; University of Leeds; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Leeds	Thorne, JL (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.; Hughes, TA (corresponding author), Univ Leeds, Sch Med, Leeds, W Yorkshire, England.; Hughes, TA; Thorne, JL (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds Breast Canc Res Grp, Leeds, W Yorkshire, England.	t.hughes@leeds.ac.uk; j.l.thorne@leeds.ac.uk	Pramanik, Arindam/AAD-1192-2019; Hughes, Thomas A/O-8031-2015; Nelson, Erik/B-5158-2013	Pramanik, Arindam/0000-0002-5827-6267; Hughes, Thomas A/0000-0003-1169-3386; Chen, Joy/0000-0002-3703-4787; Soteriou, Chrysa/0000-0002-2808-1215; Moore, J Bernadette/0000-0003-4750-1550; Ma, Liqian/0000-0002-0264-9263; Nelson, Erik/0000-0002-8887-1905; Hutchinson, Samantha/0000-0003-4780-2441; Kim, Baek/0000-0001-9759-7533	Breast Cancer Action [3T57/9R17-02]; Breast Cancer UK [PO-180309]; University of Leeds School of Food Science and Nutrition; British Endocrine Society; National Cancer Institute of the National Institutes of Health [R01CA234025]; School of Food Science and Nutrition; Leeds Doctoral Scholarships	Breast Cancer Action; Breast Cancer UK; University of Leeds School of Food Science and Nutrition; British Endocrine Society; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); School of Food Science and Nutrition; Leeds Doctoral Scholarships	GC was supported by a grant funding from Breast Cancer Action (3T57/9R17-02). The human metabolite data collection and analysis, immunohistochemistry, and antibody validation performed by AW was supported by a grant from Breast Cancer UK (PO-180309) and by the University of Leeds School of Food Science and Nutrition. The British Endocrine Society provided an equipment award (NOV2016) allowing the development of the high throughput chemotherapy efflux assay. SAH, CS, and PL were supported with Leeds Doctoral Scholarships and School of Food Science and Nutrition consumables support. ERN was supported by the National Cancer Institute of the National Institutes of Health (R01CA234025).	Baek AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00910-z; Bagegni NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222358; Bauriaud-Mallet M, 2019, J STEROID BIOCHEM, V192, DOI 10.1016/j.jsbmb.2019.105390; Brennan SF, 2017, CRIT REV FOOD SCI, V57, P1999, DOI 10.1080/10408398.2012.724481; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; CLARE K, 1995, ATHEROSCLEROSIS, V118, P67, DOI 10.1016/0021-9150(95)05594-M; Dalenc F, 2017, J STEROID BIOCHEM, V169, P210, DOI 10.1016/j.jsbmb.2016.06.010; Das S, 2013, J BIOL CHEM, V288, P11824, DOI 10.1074/jbc.M112.432302; De Cicco P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071514; Dias IHK, 2018, REDOX BIOL, V16, P139, DOI 10.1016/j.redox.2018.02.014; dos Santos CR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-132; Eccles SA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3493; ElAli A, 2012, BRAIN PATHOL, V22, P175, DOI 10.1111/j.1750-3639.2011.00517.x; Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399; Guillemot-Legris O, 2016, SCI REP-UK, V6, DOI 10.1038/srep19694; Hutchinson SA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112618; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang L, 2019, J ONCOL, V2019, DOI 10.1155/2019/7479518; Kim B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1625-y; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liu BL, 2017, BREAST CANCER RES TR, V164, P1, DOI 10.1007/s10549-017-4246-0; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; Poirot M, 2018, BIOCHEM PHARMACOL, V153, P75, DOI 10.1016/j.bcp.2018.01.046; Saint-Pol J, 2013, BRAIN RES, V1517, P1, DOI 10.1016/j.brainres.2013.04.008; Shahoei SH, 2019, ENDOCRINOLOGY, V160, P1573, DOI 10.1210/en.2019-00025; Sozen E, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8520746; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tavazoie MF, 2018, CELL, V172, P825, DOI 10.1016/j.cell.2017.12.026; Thorne JL, 2020, P NUTR SOC, V79, P367, DOI 10.1017/S0029665120000099; Thorne JL, 2018, BBA-GENE REGUL MECH, V1861, P996, DOI 10.1016/j.bbagrm.2018.08.005; Toledo E, 2015, JAMA INTERN MED, V175, P1752, DOI 10.1001/jamainternmed.2015.4838; Wouters E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01811; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006; Xia LY, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01907-7; Yang MY, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8030167	37	12	12	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2872	2883		10.1038/s41388-021-01720-w	http://dx.doi.org/10.1038/s41388-021-01720-w		MAR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742124	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000630675000004
J	Wang, YH; Chan, YT; Hung, TH; Hung, JT; Kuo, MW; Wang, SH; Huang, YL; Lin, YJ; Chen, SC; Yu, JC; Wu, JC; Yu, J; Yu, AL				Wang, Ya-Hui; Chan, Yu-Tzu; Hung, Tsai-Hsien; Hung, Jung-Tung; Kuo, Ming-Wei; Wang, Sheng-Hung; Huang, Yenlin; Lin, Yu-Ju; Chen, Shin-Cheh; Yu, Jyh-Cherng; Wu, Jen-Chine; Yu, John; Yu, Alice L.			Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation	ONCOGENE			English	Article								Cancer stem cells (CSC) play a pivotal role in cancer metastasis and resistance to therapy. Previously, we compared the phosphoproteomes of breast cancer stem cells (BCSCs) enriched subpopulation and non-BCSCs sorted from breast cancer patient-derived xenograft (PDX), and identified a function unknown protein, transmembrane and coiled-coil domain family 3 (TMCC3) to be a potential enrichment marker for BCSCs. We demonstrated greater expression of TMCC3 in BCSCs than non-BCSCs and higher expression of TMCC3 in metastatic lymph nodes and lungs than in primary tumor of breast cancer PDXs. TMCC3 silencing suppressed mammosphere formation, ALDH activity and cell migration in vitro, along with reduced tumorigenicity and metastasis in vivo. Mechanistically, we found that AKT activation was reduced by TMCC3 silencing, but enhanced by TMCC3 overexpression. We further demonstrated that TMCC3 interacted directly with AKT through its 1-153 a.a. domain by cell-free biochemical assay in vitro and co-immunoprecipitation and interaction domain mapping assays in vivo. Based on domain truncation studies, we showed that the AKT-interacting domain of TMCC3 was essential for TMCC3-induced AKT activation, self-renewal, and metastasis. Clinically, TMCC3 mRNA expression in 202 breast cancer specimens as determined by qRT-PCR assay showed that higher TMCC3 expression correlated with poorer clinical outcome of breast cancer, including early-stage breast cancer. Multivariable analysis identified TMCC3 expression as an independent risk factor for survival. These findings suggest that TMCC3 is crucial for maintenance of BCSCs features through AKT regulation, and TMCC3 expression has independent prognostic significance in breast cancer. Thus, TMCC3 may serve as a new target for therapy directed against CSCs.	[Wang, Ya-Hui; Chan, Yu-Tzu; Hung, Tsai-Hsien; Hung, Jung-Tung; Kuo, Ming-Wei; Wang, Sheng-Hung; Lin, Yu-Ju; Wu, Jen-Chine; Yu, John; Yu, Alice L.] Chang Gung Mem Hosp Linkou, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Huang, Yenlin] Chang Gung Mem Hosp Linkou, Dept Anat Pathol, Taoyuan, Taiwan; [Huang, Yenlin; Yu, John; Yu, Alice L.] Chang Gung Univ, Taoyuan, Taiwan; [Chen, Shin-Cheh] Chang Gung Mem Hosp Linkou, Gen Surg Dept, Taoyuan, Taiwan; [Yu, Jyh-Cherng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Yu, Alice L.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Defense Medical Center; Tri-Service General Hospital; University of California System; University of California San Diego	Yu, J; Yu, AL (corresponding author), Chang Gung Mem Hosp Linkou, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan.; Yu, J; Yu, AL (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Yu, AL (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.	johnyu@gate.sinica.edu.tw; alyu@ucsd.edu		yu, alice/0000-0003-2444-0505; Yu, John/0000-0002-3237-4272; Hung, Jung-Tung/0000-0001-7161-1915	Ministry of Science and Technology in Taiwan [MOST106-3114-B-182A-001, MOST106-2811-B-182A-017, MOST107-2321-B-182A-005, MOST107-2811-B182A-504, MOST108-2321-B-182A-004, MOST 108-2811-B-182A-505, MOST109-2321-B-182A-005, MOST109-2811-B-182A-501]; Taiwan Biosignature for Breast Cancer [BP004]; Chang Gung Medical Foundation [OMRPG3C0011-16, CMRPG3F0973, CMRPG3G1531-1533]; Chang Gung Postdoctoral Fellowship	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Biosignature for Breast Cancer; Chang Gung Medical Foundation; Chang Gung Postdoctoral Fellowship	This study was supported by grants to ALY from the Ministry of Science and Technology in Taiwan (MOST106-3114-B-182A-001, MOST106-2811-B-182A-017, MOST107-2321-B-182A-005, MOST107-2811-B182A-504, MOST108-2321-B-182A-004, MOST 108-2811-B-182A-505, MOST109-2321-B-182A-005, MOST109-2811-B-182A-501), Taiwan Biosignature for Breast Cancer (BP004), and Chang Gung Medical Foundation (OMRPG3C0011-16). Grant from Chang Gung Medical Foundation (CMRPG3F0973 to JY; CMRPG3G1531-1533 to JTH) and Chang Gung Postdoctoral Fellowship Award to YHW.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ayob AZ, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0426-4; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bose S, 2006, MODERN PATHOL, V19, P238, DOI 10.1038/modpathol.3800525; Bozorgi A, 2015, J BREAST CANCER, V18, P303, DOI 10.4048/jbc.2015.18.4.303; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Chan YT, 2020, INT J CANCER, V146, P1674, DOI 10.1002/ijc.32588; Chang WW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3423; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Clark DW, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.82; Cochrane CR, 2015, CANCERS, V7, P1554, DOI 10.3390/cancers7030851; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Desai A, 2019, STEM CELL TRANSL MED, V8, P75, DOI 10.1002/sctm.18-0123; DESOUSA E, 2016, CANCERS, V8, P60, DOI DOI 10.3390/cancers8070060; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hopkins PCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055810; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Hoyer MJ, 2018, CELL, V175, P254, DOI 10.1016/j.cell.2018.08.030; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jain MV, 2015, CELL CYCLE, V14, P2109, DOI 10.1080/15384101.2015.1041692; Johnston HE, 2018, MOL CELL PROTEOMICS, V17, P776, DOI 10.1074/mcp.RA117.000539; Kahn M, 2018, PROG MOL BIOL TRANSL, V153, P209, DOI 10.1016/bs.pmbts.2017.11.007; Kaltschmidt C, 2019, CANCERS, V11, DOI 10.3390/cancers11050655; Kim LC, 2017, ONCOGENE, V36, P2191, DOI 10.1038/onc.2016.363; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Kume H, 2014, MOL CELL PROTEOMICS, V13, P1471, DOI 10.1074/mcp.M113.037093; Kuo MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004980; Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lombardo Y, 2015, JOVE-J VIS EXP, DOI 10.3791/52671; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Matsui WH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004765; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Prossomariti A, 2020, CELL MOL GASTROENTER, V10, P491, DOI 10.1016/j.jcmgh.2020.04.007; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saadin K, 2013, EXPERT REV MOL DIAGN, V13, P49, DOI [10.1586/erm.12.117, 10.1586/ERM.12.117]; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shorning BY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124507; Sohn WJ, 2016, BMB REP, V49, P629, DOI 10.5483/BMBRep.2016.49.11.151; Swiatkowski P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01826-w; Vieira AF, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00248; Wang T, 2016, CANCER BIOL THER, V17, P698, DOI 10.1080/15384047.2016.1190488; Wang W, 2019, J CLIN INVEST, V129, P1015, DOI 10.1172/JCI97712; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Wisesa S, 2019, BIOCHEM J, V476, P3241, DOI 10.1042/BCJ20190359; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yeo HL, 2019, INT J CANCER, V144, P1996, DOI 10.1002/ijc.31891; Yin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024080; Yudushkin I, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020067; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085206	53	0	0	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2858	2871		10.1038/s41388-021-01729-1	http://dx.doi.org/10.1038/s41388-021-01729-1		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742122	hybrid, Green Published			2022-12-26	WOS:000630675000002
J	Berdugo-Cely, JA; Martinez-Moncayo, C; Lagos-Burbano, TC				Berdugo-Cely, Jhon A.; Martinez-Moncayo, Carolina; Lagos-Burbano, Tulio Cesar			Genetic analysis of a potato (Solanum tuberosum L.) breeding collection for southern Colombia using Single Nucleotide Polymorphism (SNP) markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; R PACKAGE; DIVERSITY; VARIETIES; CLUSTERS; NUMBER; ARRAY	Detailed knowledge on genetic parameters such as diversity, structure, and linkage disequilibrium (LD) and identification of duplicates in a germplasm bank and/or breeding collection are essential to conservation and breeding strategies in any crop. Therefore, the potato genetic breeding collection at the Universidad de Narino in Colombia, which is made up of diploid and tetraploid genotypes in two of the more diverse genebanks in the world, was analyzed with 8303 single nucleotide polymorphisms (SNP) from SolCAP version 1. In total, 144 genotypes from this collection were analyzed identifying an 57.2% of the polymorphic markers that allowed establishing two and three subpopulations that differentiated the diploid genotypes from the tetraploids. These subpopulations had high levels of heterozygosity and linkage disequilibrium. The diversity levels were higher in the tetraploid genotypes, while the LD levels were higher in the diploid genotypes. For the tetraploids, the genotypes from Peru had greater diversity and lower linkage disequilibrium than those from Colombia, which had slightly lower diversity and higher degrees of LD. The genetic analysis identified, adjusted and/or selected diploid and tetraploid genotypes under the following characteristics: 1) errors in classification associated with the level of ploidy; 2) presence of duplicates; and 3) genotypes with broad genetic distances and potential use in controlled hybridization processes. These analyses suggested that the potato genetic breeding collection at the Universidad de Narino has a genetic base with a potential use in breeding programs for this crop in the Department of Narino, in southern Colombia.	[Berdugo-Cely, Jhon A.] Corp Colombiana Invest Agr AGROSAVIA, Ctr Invest Turipana, Monteria, Cerete, Colombia; [Martinez-Moncayo, Carolina] Univ Narino, Grp Invest Prod Frutales Andinos, Pasto, Colombia; [Lagos-Burbano, Tulio Cesar] Univ Narino, Fac Ciencias Agr, Pasto, Narino, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA	Berdugo-Cely, JA (corresponding author), Corp Colombiana Invest Agr AGROSAVIA, Ctr Invest Turipana, Monteria, Cerete, Colombia.	jberdugo@agrosavia.co		LAGOS BURBANO, TULIO CESAR/0000-0001-9222-4674; Berdugo-Cely, Jhon A./0000-0002-2675-0462; Martinez-Moncayo, Carolina/0000-0001-5336-1510	Gobernacion de Narino through the Fondo de Ciencia, Tecnologia e Innovacion del Sistema General de Regalias [2014000100022]; Universidad de Narino [480-15]; AGROSAVIA [480-15]	Gobernacion de Narino through the Fondo de Ciencia, Tecnologia e Innovacion del Sistema General de Regalias; Universidad de Narino; AGROSAVIA	The resources for the development of this research were provided by the Ministerio de Ciencia y Tecnologia de Colombia (Minciencias) and the Gobernacion de Narino through the Fondo de Ciencia, Tecnologia e Innovacion del Sistema General de Regalias, with the approval of the project "Improvement technological and productive of the potato system in the Department of Narino", identified with code BPIN No. 2014000100022. The execution of this project was carried out between the Universidad de Narino and AGROSAVIA through the macro agreement 480-15. The hours spent by researcher Jhon A. Berdugo-Cely MSc. for the development of this study were provided by AGROSAVIA through Variable Transfer (TV) 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronet, ESTAD STICAS HOME; [Anonymous], 2020, **DATA OBJECT**; [Anonymous], 2020, CADENA PAPA; [Anonymous], CULTIVATED POTATO GE; [Anonymous], R R PROJECT STAT COM; [Anonymous], ACCESSIONS GRIN GLOB; [Anonymous], MEJORANDO PRODUCTIVI; Bamberg J, 2020, AM J POTATO RES, V97, P547, DOI 10.1007/s12230-020-09802-3; Berdugo-Cely J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173039; Bernal AM., 2006, AGRONOM A COLOMBIANA, P226; Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996; Charrad M, 2014, J STAT SOFTW, V61, P1; Madronera IC, 2013, TEMAS AGRAR, V18, P50, DOI 10.21897/rta.v18i2.716; Deperi SI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194398; Devaux A, 2014, POTATO RES, V57, P185, DOI 10.1007/s11540-014-9265-1; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellis D, 2018, GENOME, V61, P523, DOI 10.1139/gen-2017-0201; Endelman JB, 2017, AM J POTATO RES, V94, P184, DOI 10.1007/s12230-016-9556-y; Esnault F, 2016, POTATO RES, V59, P329, DOI 10.1007/s11540-016-9332-x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Fulladolsa AC, 2015, AM J POTATO RES, V92, P444, DOI 10.1007/s12230-015-9431-2; Gabriel Julio, 2016, Rev. colomb. biotecnol, V18, P17, DOI 10.15446/rev.colomb.biote.v18n1.57712; Ghislain M, 2006, THEOR APPL GENET, V113, P1515, DOI 10.1007/s00122-006-0399-7; de Albuquerque HYG, 2019, SCI AGR, V76, P328, DOI [10.1590/1678-992X-2017-0389, 10.1590/1678-992x-2017-0389]; Govindaraj M, 2015, GENET RES INT, V2015, DOI 10.1155/2015/431487; Hackett CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063939; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hardigan MA, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.06.0025; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Hosaka K, 2020, AM J POTATO RES, V97, P127, DOI 10.1007/s12230-020-09762-8; Igarashi T, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-018-0917-8; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Juyo D, 2015, CROP SCI, V55, P760, DOI 10.2135/cropsci2014.07.0524; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kolech SA, 2016, AM J POTATO RES, V93, P609, DOI 10.1007/s12230-016-9543-3; Lee C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S73; Lindqvist-Kreuze H, 2014, PHYTOPATHOLOGY, V104, P624, DOI 10.1094/PHYTO-10-13-0270-R; Loda B, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.12.0128; Massa AN, 2015, G3-GENES GENOM GENET, V5, P2357, DOI 10.1534/g3.115.019646; Mosquera T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156254; Navarro C, 2010, REV CIENC AGRIC, V27, P27; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pritchard JK, 2000, GENETICS, V155, P945; Remon-Gamboa Y.K., 2018, DIVERSIDAD GEN TICA, V25, P259; Sharma SK, 2018, G3-GENES GENOM GENET, V8, P3185, DOI 10.1534/g3.118.200377; Spooner DM, 2010, AM J BOT, V97, P2049, DOI 10.3732/ajb.1000277; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; Tillault AS, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.140; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Vos PG, 2017, THEOR APPL GENET, V130, P123, DOI 10.1007/s00122-016-2798-8; Vos PG, 2015, THEOR APPL GENET, V128, P2387, DOI 10.1007/s00122-015-2593-y; Wang Y, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00139; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zaheer K, 2016, CRIT REV FOOD SCI, V56, P711, DOI 10.1080/10408398.2012.724479	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248787	10.1371/journal.pone.0248787	http://dx.doi.org/10.1371/journal.pone.0248787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735184	Green Published, gold			2022-12-26	WOS:000631029700059
J	de Souza, FSH; Hojo-Souza, NS; Batista, BD; da Silva, CM; Guidoni, DL				de Souza, Fernanda Sumika Hojo; Hojo-Souza, Natalia Satchiko; Batista, Ben Deivide de Oliveira; da Silva, Cristiano Maciel; Guidoni, Daniel Ludovico			On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019; AGE	Background Brazil became the epicenter of the COVID-19 epidemic in a brief period of a few months after the first officially registered case. The knowledge of the epidemiological/clinical profile and the risk factors of Brazilian COVID-19 patients can assist in the decision making of physicians in the implementation of early and most appropriate measures for poor prognosis patients. However, these reports are missing. Here we present a comprehensive study that addresses this demand. Methods This data-driven study was based on the Brazilian Ministry of Health Database (SIVEP-Gripe) regarding notified cases of hospitalized COVID-19 patients during the period from February 26th to August 10th, 2020. Demographic data, clinical symptoms, comorbidities and other additional information of patients were analyzed. Results The hospitalization rate was higher for male gender (56.56%) and for older age patients of both sexes. Overall, the lethality rate was quite high (41.28%) among hospitalized patients, especially those over 60 years of age. Most prevalent symptoms were cough, dyspnoea, fever, low oxygen saturation and respiratory distress. Cardiac disease, diabetes, obesity, kidney disease, neurological disease, and pneumopathy were the most prevalent comorbidities. A high prevalence of hospitalized COVID-19 patients with cardiac disease (65.7%) and diabetes (53.55%) and with a high lethality rate of around 50% was observed. The intensive care unit (ICU) admission rate was 39.37% and of these 62.4% died. 24.4% of patients required invasive mechanical ventilation (IMV), with high mortality among them (82.98%). The main mortality risk predictors were older age and IMV requirement. In addition, socioeconomic conditions have been shown to significantly influence the disease outcome, regardless of age and comorbidities. Conclusion Our study provides a comprehensive overview of the hospitalized Brazilian COVID-19 patients profile and the mortality risk factors. The analysis also evidenced that the disease outcome is influenced by multiple factors, as unequally affects different segments of population.	[de Souza, Fernanda Sumika Hojo; Guidoni, Daniel Ludovico] Univ Fed Sao Joao del Rei, Dept Comp Sci, Sao Joao Del Rei, MG, Brazil; [Hojo-Souza, Natalia Satchiko] Oswaldo Cruz Fdn Minas, Lab Immunopathol, Belo Horizonte, MG, Brazil; [Batista, Ben Deivide de Oliveira] Fed Univ Sao Joao, Dept Stat Phys & Math, Sao Joao Del Rei, MG, Brazil; [da Silva, Cristiano Maciel] Univ Fed Sao Joao del Rei, Dept Technol, Sao Joao Del Rei, MG, Brazil	Universidade Federal de Sao Joao del-Rei; Universidade Federal de Sao Joao del-Rei	de Souza, FSH (corresponding author), Univ Fed Sao Joao del Rei, Dept Comp Sci, Sao Joao Del Rei, MG, Brazil.	fsumika@ufsj.edu.br		Souza, Fernanda Sumika/0000-0003-1432-1967	Federal University of Sao Joao del-Rei (UFSJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310728/2018-5, 303933/2017-8]	Federal University of Sao Joao del-Rei (UFSJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was partially funded by the Federal University of Sao Joao del-Rei (UFSJ https://www.ufsj.edu.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq http://www.cnpq.br), grants 310728/2018-5 and 303933/2017-8 given to the following authors: DLG and CMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; CFM, 2021, CONS FED MED MED INV; Chang TH, 2020, J FORMOS MED ASSOC, V119, P982, DOI 10.1016/j.jfma.2020.04.007; Collett D., 2014, MODELLING SURVIVAL D, DOI [10. 1201/b18041, DOI 10.1201/B18041]; Davidson-Pilon C, 2020, CAMDAVIDSONPILON LIF, DOI [10.5281/zenodo.4002777, DOI 10.5281/ZENODO.4002777]; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Di Gennaro F, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030141; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Gao F, 2020, DIABETES CARE, V43, pE72, DOI 10.2337/dc20-0682; Ge Y, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821000066; Grandbastien M, 2020, J ALLER CL IMM-PRACT, V8, P2600, DOI 10.1016/j.jaip.2020.06.032; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; KIM L, 2020, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1012; Lam S, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173451; Li H, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105951; Liu S, 2020, CLIN REV ALLERG IMMU, V59, P78, DOI 10.1007/s12016-020-08797-3; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262; Perez-Lopez FR, 2020, MATURITAS, V141, P59, DOI 10.1016/j.maturitas.2020.06.017; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Schindler T, 2020, INACTIVATED TRIVALEN, DOI 10.1136/bmjebm-2020-111549; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Souza FSH, 2020, PREDICTING DIS OUTCO; Stensrud MJ, 2020, JAMA-J AM MED ASSOC, V323, P1401, DOI 10.1001/jama.2020.1267; Sultana J, 2020, EXPERT REV VACCINES, V19, P919, DOI 10.1080/14760584.2020.1825951; Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742; WHO. World Health Organization, 2020, COR DIS COVID 19 DAS; WHO. World Health Organization, 2020, WHO ANN COVID 19 OUT; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	39	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248580	10.1371/journal.pone.0248580	http://dx.doi.org/10.1371/journal.pone.0248580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735272	gold, Green Submitted, Green Published			2022-12-26	WOS:000631029700127
J	Opiyo, MA; Ngowo, HS; Mapua, SA; Mpingwa, M; Nchimbi, N; Matowo, NS; Majambere, S; Okumu, FO				Opiyo, Mercy A.; Ngowo, Halfan S.; Mapua, Salum A.; Mpingwa, Monica; Nchimbi, Nuru; Matowo, Nancy S.; Majambere, Silas; Okumu, Fredros O.			Sub-lethal aquatic doses of pyriproxyfen may increase pyrethroid resistance in malaria mosquitoes	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; ANOPHELES-GAMBIAE-S.S.; PIPERONYL BUTOXIDE; DIPTERA-CULICIDAE; CROSS-RESISTANCE; AEDES-AEGYPTI; EFFICACY; DELTAMETHRIN; BIOEFFICACY; ARABIENSIS	Background Pyriproxyfen (PPF), an insect growth hormone mimic is widely used as a larvicide and in some second-generation bed nets, where it is combined with pyrethroids to improve impact. It has also been evaluated as a candidate for auto-dissemination by adult mosquitoes to control Aedes and Anopheles species. We examined whether PPF added to larval habitats of pyrethroid-resistant malaria vectors can modulate levels of resistance among emergent adult mosquitoes. Methodology Third-instar larvae of pyrethroid-resistant Anopheles arabiensis (both laboratory-reared and field-collected) were reared in different PPF concentrations, between 1x10(-9) milligrams active ingredient per litre of water (mgAI/L) and 1x10(-4) mgAI/L, or no PPF at all. Emergent adults escaping these sub-lethal exposures were tested using WHO-standard susceptibility assays on pyrethroids (0.75% permethrin and 0.05% deltamethrin), carbamates (0.1% bendiocarb) and organochlorides (4% DDT). Biochemical basis of pyrethroid resistance was investigated by pre-exposure to 4% PBO. Bio-efficacies of long-lasting insecticide-treated nets, Olyset(R) and PermaNet 2.0 were also examined against adult mosquitoes with or without previous aquatic exposure to PPF. Results Addition of sub-lethal doses of PPF to larval habitats of pyrethroid-resistant An. arabiensis, consistently resulted in significantly reduced mortalities of emergent adults when exposed to pyrethroids, but not to bendiocarb or DDT. Mortality rates after exposure to Olyset(R) nets, but not PermaNet 2.0 were also reduced following aquatic exposures to PPF. Pre-exposure to PBO followed by permethrin or deltamethrin resulted in significant increases in mortality, compared to either insecticide alone. Conclusions Partially-resistant mosquitoes exposed to sub-lethal aquatic concentrations of PPF may become more resistant to pyrethroids than they already are without such pre-exposures. Studies should be conducted to examine whether field applications of PPF, either by larviciding or other means actually exacerbates pyrethroid-resistance in areas where signs of such resistance already exist in wild the vector populations. The studies should also investigate mechanisms underlying such magnification of resistance, and how this may impact the potential of PPF-based interventions in areas with pyrethroid resistance.	[Opiyo, Mercy A.; Ngowo, Halfan S.; Mapua, Salum A.; Mpingwa, Monica; Nchimbi, Nuru; Matowo, Nancy S.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Ifakara, Tanzania; [Opiyo, Mercy A.] Hosp Clin Barcelona, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Opiyo, Mercy A.] Ctr Invest Saude Manhica CISM, Maputo, Mozambique; [Ngowo, Halfan S.; Okumu, Fredros O.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Matowo, Nancy S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Matowo, Nancy S.] Univ Basel, Basel, Switzerland; [Matowo, Nancy S.] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Majambere, Silas] KEMRI Headquarters, PAMCA, Nairobi, Kenya; [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	Ifakara Health Institute; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Glasgow; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Opiyo, MA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Ifakara, Tanzania.; Opiyo, MA (corresponding author), Hosp Clin Barcelona, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.; Opiyo, MA (corresponding author), Ctr Invest Saude Manhica CISM, Maputo, Mozambique.	mercy.opiyo@isglobal.org	Mapua, Salum Abdallah/HGB-8797-2022; Ngowo, Halfan/AFS-8039-2022	Mapua, Salum Abdallah/0000-0002-3309-4328; Ngowo, Halfan/0000-0003-2789-0261; Okumu, Fredros/0000-0003-2731-5654; Opiyo, Mercy/0000-0003-0432-0418; Matowo, Nancy/0000-0002-2302-3796	Bill and Melinda Gates Foundation [OPP52644]; Wellcome Trust; Association of Physicians of Great Britain and Ireland [WT104029/Z/14/Z]; Wellcome Trust Intermediate Research Fellowship [WT102350/Z/13/Z]; World Health Organization; Special Program for Research and Training in Tropical Diseases [B40445]; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program [CEX2018-000806-S]; Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development (AECID)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust); Association of Physicians of Great Britain and Ireland; Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); World Health Organization(World Health Organization); Special Program for Research and Training in Tropical Diseases; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program(Spanish Government); Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development (AECID)(Spanish Government)	This work was funded by the Bill and Melinda Gates Foundation (Grant Numbers: OPP52644) awarded to Dr. Fredros Okumu. N.S.M received financial support from Wellcome Trust and the Association of Physicians of Great Britain and Ireland (Grant number: WT104029/Z/14/Z), while H.S.N, and F.O.O were supported by a Wellcome Trust Intermediate Research Fellowship (Grant number: WT102350/Z/13/Z) and a grant from World Health Organization, Special Program for Research and Training in Tropical Diseases (Grant No. B40445). We acknowledge the support from the Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002213; Allossogbe M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1727-x; Bagi J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0721-4; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bingham G, 2007, PEST MANAG SCI, V63, P276, DOI 10.1002/ps.1336; Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Briet OJT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-77; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Choi L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012736.pub2; Chouaibou M, 2014, ACTA TROP, V130, P108, DOI 10.1016/j.actatropica.2013.10.020; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Darriet F, 2013, PEST MANAG SCI, V69, P905, DOI 10.1002/ps.3446; Devine GJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-142; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Djenontin A, 2015, PARASITE, V22, DOI 10.1051/parasite/2015027; Etang J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1420-x; Fakoorziba MR, 2009, ENVIRON TOXICOL, V24, P19, DOI 10.1002/tox.20386; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Gleave K, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012776.pub2, 10.1002/14651858.C0012776.pub2]; Gong YH, 2013, INT J BIOL SCI, V9, P863, DOI 10.7150/ijbs.6744; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hemingway J, 2015, NATURE, V526, P198, DOI 10.1038/526198a; Karatolos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031077; Khan HAA, 2016, PARASITOL RES, V115, P1385, DOI 10.1007/s00436-015-4872-6; Kolaczinski JH, 2004, J MED ENTOMOL, V41, P930, DOI 10.1603/0022-2585-41.5.930; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Lwetoijera D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-161; Lwetoijera DW, 2014, AM J TROP MED HYG, V90, P852, DOI 10.4269/ajtmh.13-0550; Mbare O, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-280; Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093603; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045; Okia M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-130; Okumu F, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03321-6; Okumu Fredros O, 2012, Malar J, V11, P378, DOI 10.1186/1475-2875-11-378; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; R Core Team R, 2011, R LANG ENV STAT COMP; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Scott JM, 2017, J MED ENTOMOL, V54, P236, DOI 10.1093/jme/tjw133; Shah RM, 2015, ACTA TROP, V142, P149, DOI 10.1016/j.actatropica.2014.11.016; Staedke SG, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3382-8; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Vijayan V. A., 2007, Journal of Communicable Diseases, V39, P159; White MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095640; WHO, 2006, WHO SPEC EV PUBL HLT; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2019, LIST WHO PREQ VECT C; WHO, 2013, TEST PROC INS RES MA; WHO, 2013, SUPPL MEAS MAL VECT; World Health Organization, 2013, GUID LAB FIELD TEST; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504; World Health Organization, 2020, PREQ VECT CONTR PREQ; Yapabandara AMGM, 2004, J AM MOSQUITO CONTR, V20, P395; Yewhalaw D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-159; Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001	58	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248538	10.1371/journal.pone.0248538	http://dx.doi.org/10.1371/journal.pone.0248538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735241	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000631029700035
J	Yao, YW; Dai, QH; Gao, RX; Gan, YX; Yi, XS				Yao, Yiwen; Dai, Quanhou; Gao, Ruxue; Gan, Yixian; Yi, Xingsong			Effects of rainfall intensity on runoff and nutrient loss of gently sloping farmland in a karst area of SW China	PLOS ONE			English	Article							NITROGEN LOSS; ROCKY DESERTIFICATION; SOIL-EROSION; AVAILABLE NITROGEN; BARE SLOPES; SEDIMENT; PHOSPHORUS; ERODIBILITY; SIMULATION	Nutrient losses from sloping farmland in karst areas lead to the decline in land productivity and nonpoint source pollution. A specially tailored steel channel with an adjustable slope and underground hole fissures was used to simulate the microenvironment of the "dual structure" of the surface and underground of sloping farmland in a karst area. The artificial rainfall simulation method was used to explore the surface and underground runoff characteristics and nutrient losses from sloping farmland under different rainfall intensities. The effect of rainfall intensity on the nutrient loss of farmland on karst sloping land was clarified. The results showed that the surface was the main route of runoff and nutrient loss during the rainy season on sloping farmland in karst areas. The influence of rainfall intensity on the nutrients in surface runoff was more substantial than that on underground runoff nutrients. Nutrient loss was more likely to occur underground than on the surface. The losses of total nitrogen, total phosphorus, and total potassium in surface and underground runoff initially increased and then gradually stabilized with the extension of rainfall duration and increased with increasing rainfall intensity and the amount of nutrient runoff. The output of nutrients through surface runoff accounted for a high proportion of the total, and underground runoff was responsible for a low proportion. Although the amount of nutrients output by underground runoff was small, it could directly cause groundwater pollution. The research results provide a theoretical reference for controlling land source pollution from sloping farming in karst areas.	[Yao, Yiwen; Dai, Quanhou; Gao, Ruxue; Gan, Yixian; Yi, Xingsong] Guizhou Univ, Inst Soil Eros & Ecol Restorat, Inst Forest Resources & Environm Guizhou, Coll Forestry, Guiyang, Peoples R China	Guizhou University	Dai, QH (corresponding author), Guizhou Univ, Inst Soil Eros & Ecol Restorat, Inst Forest Resources & Environm Guizhou, Coll Forestry, Guiyang, Peoples R China.	qhdairiver@163.com		quanhou, DAI/0000-0002-7273-5140	First-level discipline construction project in Guizhou Province, China [GNYL[2017]007]; National Natural Science Foundation of China [41671275, 41461057]; China Postdoctoral Science Foundation [2020M673296]	First-level discipline construction project in Guizhou Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the First-level discipline construction project in Guizhou Province, China to YY (GNYL[2017]007) and the National Natural Science Foundation of China to QD (41671275, 41461057). In addition, we appreciate the project support provided by the Funded by China Postdoctoral Science Foundation to YY (2020M673296).	Amin AEA, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138489; Ao C, 2019, GEODERMA, V353, P372, DOI 10.1016/j.geoderma.2019.07.026; Bhagowati B, 2019, ECOHYDROL HYDROBIOL, V19, P155, DOI 10.1016/j.ecohyd.2018.03.002; Chen Ling, 2013, Huanjing Kexue, V34, P2151; Cheng YT, 2018, CATENA, V166, P21, DOI 10.1016/j.catena.2018.03.015; Dai Q, 2015, SOLID EARTH, V6, P985, DOI 10.5194/se-6-985-2015; Dai QH, 2017, LAND DEGRAD DEV, V28, P1922, DOI 10.1002/ldr.2711; Dai QH, 2017, CATENA, V152, P218, DOI 10.1016/j.catena.2017.01.013; Deuschle D, 2019, GEODERMA, V340, P157, DOI 10.1016/j.geoderma.2019.01.010; Fetahi T, 2019, AFR J AQUAT SCI, V44, P303, DOI 10.2989/16085914.2019.1663722; Flynn RM, 2010, WATER RES, V44, P1138, DOI 10.1016/j.watres.2009.11.032; [伏文兵 Fu Wenbing], 2015, [水土保持学报, Journal of Soil and Water Conservation], V29, P11; Gao RX, 2019, ENVIRON SCI POLLUT R, V26, P26900, DOI 10.1007/s11356-019-05838-z; Glibert PM, 2020, HARMFUL ALGAE, V91, DOI 10.1016/j.hal.2019.03.001; Idowu OJ, 2002, HYDROL PROCESS, V16, P2339, DOI 10.1002/hyp.1006; Jiang JY, 2018, ENVIRON SCI POLLUT R, V25, P20241, DOI 10.1007/s11356-018-2104-1; Kenta I., 2019, JAPANESE SOC PEDOLOG, V55, P355, DOI [10.18920/pedologist.55.3_355, DOI 10.18920/PEDOLOGIST.55.3_355]; Kogovsek J, 2014, J HYDROL, V519, P1205, DOI 10.1016/j.jhydrol.2014.08.047; [孔刚 KONG Gang], 2008, [土壤通报, Journal of Soil Science], V39, P1395; Kothyari BP, 2004, J HYDROL, V293, P137, DOI 10.1016/j.jhydrol.2004.01.011; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Marques MJ, 2007, SCI TOTAL ENVIRON, V378, P161, DOI 10.1016/j.scitotenv.2007.01.043; Matichenkov V, 2020, SOIL TILL RES, V196, DOI 10.1016/j.still.2019.104450; MCISAAC GF, 1991, J ENVIRON QUAL, V20, P663, DOI 10.2134/jeq1991.00472425002000030026x; Molder B, 2015, AGR WATER MANAGE, V152, P31, DOI 10.1016/j.agwat.2014.12.010; Peng XD, 2020, ENVIRON EARTH SCI, V79, DOI 10.1007/s12665-019-8708-z; Peng XD, 2018, ENG GEOL, V243, P10, DOI 10.1016/j.enggeo.2018.06.007; RADULOVICH R, 1989, SOIL SCI SOC AM J, V53, P556, DOI 10.2136/sssaj1989.03615995005300020042x; Ros MBH, 2020, J ENVIRON QUAL, V49, P496, DOI 10.1002/jeq2.20043; Song XW, 2017, ECOL EVOL, V7, P10131, DOI 10.1002/ece3.3502; Suescun D, 2017, REG ENVIRON CHANGE, V17, P827, DOI 10.1007/s10113-016-1071-7; Tang YQ, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5419-6; The State Environmental Protection Administration, 2002, WAT WAST MON AN METH, V4th; Wang FE, 2018, J ENVIRON QUAL, V47, P922, DOI 10.2134/jeq2017.12.0469; Wang GQ, 2014, J HYDROL, V514, P180, DOI 10.1016/j.jhydrol.2014.04.028; Wu L, 2018, CATENA, V170, P51, DOI 10.1016/j.catena.2018.06.007; Xiang Da-bing, 2010, Yingyong Shengtai Xuebao, V21, P1461; Xie XJ, 2004, ENVIRON GEOCHEM HLTH, V26, P237, DOI 10.1023/B:EGAH.0000039586.12907.e9; Xing WM, 2016, CATENA, V139, P73, DOI 10.1016/j.catena.2015.12.008; Yadav GS, 2019, ECOL INDIC, V105, P303, DOI 10.1016/j.ecolind.2017.08.071; Yan X, 2015, LAND DEGRAD DEV, V26, P193, DOI 10.1002/ldr.2209; Yan YJ, 2018, GEODERMA, V330, P30, DOI 10.1016/j.geoderma.2018.05.026; Yan YC, 2013, PLANT SOIL, V369, P585, DOI 10.1007/s11104-013-1606-3; Yang J, 2013, INT SOIL WATER CONSE, V1, P49; Yang LX, 2020, ENVIRON SCI POLLUT R, V27, P12866, DOI 10.1007/s11356-018-04067-0; Zhang CH, 2017, PROG PHYS GEOG, V41, P450, DOI 10.1177/0309133317714246; [张文源 Zhang Wenyuan], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1776; [郑永春 Zheng Yongchun], 2002, [长江流域资源与环境, Resources and Environment in the Yangtze Valley], V11, P461	48	14	14	22	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0246505	10.1371/journal.pone.0246505	http://dx.doi.org/10.1371/journal.pone.0246505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735193	gold, Green Published			2022-12-26	WOS:000631029700085
J	Charles, M; Richard, M; Reichler, MR; Koama, JB; Morose, W; Fitter, DL				Charles, Macarthur; Richard, Milo; Reichler, Mary R.; Koama, Jean Baptiste; Morose, Willy; Fitter, David L.			Treatment success for patients with tuberculosis receiving care in areas severely affected by Hurricane Matthew - Haiti, 2016	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; PROGRAM	Background On October 4, 2016, Hurricane Matthew struck southwest Haiti as a category 4 storm. The goal of this study was to evaluate the impact of the hurricane on tuberculosis (TB) services and patient outcomes in the three severely affected departments-Sud, Grand'Anse, and Nippes-of southwest Haiti. Methods We developed a standard questionnaire to assess a convenience sample of health facilities in the affected areas, a patient tracking form, and a line list for tracking all patients with drug-susceptible TB registered in care six months before the hurricane. We analyzed data from the national TB electronic surveillance system to determine outcomes for all patients receiving anti-TB treatment in the affected areas. We used logistic regression analysis to determine factors associated with treatment success. Results Of the 66 health facilities in the three affected departments, we assessed 31, accounting for 536 (45.7%) of 1,174 TB patients registered in care when Hurricane Matthew made landfall in Haiti. Three (9.7%) health facilities sustained moderate to severe damage, whereas 18 (58.1%) were closed for <1 week, and five (16.1%) for >= 1 week. Four weeks after the hurricane, 398 (73.1%) of the 536 patients in the assessed facilities were located. Treatment success in the affected departments one year after the hurricane was 81.4%. Receiving care outside the municipality of residence (adjusted odds ratio [aOR]: 0.46, 95% confidence interval [CI]: 0.27-0.80) and HIV positivity (aOR: 0.31, 95% CI: 0.19-0.51) or unknown HIV status (aOR: 0.49, 95% CI: 0.33-0.74) were associated with significantly lower rates of treatment success. Conclusions Despite major challenges, a high percentage of patients receiving anti-TB treatment before the hurricane were located and successfully treated in southwest Haiti. The lessons learned and results presented here may help inform policies and guidelines in similar settings for effective TB control after a natural disaster.	[Charles, Macarthur; Koama, Jean Baptiste; Fitter, David L.] Ctr Dis Control & Prevent, Port Au Prince, Haiti; [Richard, Milo; Morose, Willy] Minist Sante Publ & Populat, Programme Natl Lutte TB PNLT, Port Au Prince, Haiti; [Reichler, Mary R.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Charles, Macarthur] Ctr Dis Control & Prevent, Global TB Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA; [Fitter, David L.] Ctr Dis Control & Prevent, Immunizat Syst Branch, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Charles, M (corresponding author), Ctr Dis Control & Prevent, Port Au Prince, Haiti.; Charles, M (corresponding author), Ctr Dis Control & Prevent, Global TB Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA.	xzk9@cdc.gov		Koama, Timbila Jean Baptiste/0000-0002-3242-8496	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [GH15-152702/1U2GGH0001643-02]	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention	The work in this manuscript was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of GH15-152702/1U2GGH0001643-02.	[Anonymous], 2011, REVISION AUTOMATED R; [Anonymous], WORLD RISK REPORT 20; [Anonymous], NATL HURRICANE CENTE; Charles M, 2017, AM J TROP MED HYG, V97, P49, DOI 10.4269/ajtmh.16-0863; DeGraw C., 2006, Morbidity and Mortality Weekly Report, V55, P332; Djimeu EW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210327; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; Ford N, 2008, INT J TUBERC LUNG D, V12, P1104; Gadoev J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128907; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Herce ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3392-2; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Jacobson KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127024; Keellings D, 2019, GEOPHYS RES LETT, V46, P2964, DOI 10.1029/2019GL082077; Kimbrough W, 2012, LANCET INFECT DIS, V12, P950, DOI 10.1016/S1473-3099(12)70225-6; Knutson TR, 2015, J CLIMATE, V28, P7203, DOI 10.1175/JCLI-D-15-0129.1; Koenig SP, 2015, B WORLD HEALTH ORGAN, V93, P498, DOI 10.2471/BLT.14.145649; Lew W, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.2.HYN_009, 10.5365/wpsar.2015.6.2.HYN_009]; Liang SY, 2018, EMERG MED CLIN N AM, V36, P835, DOI 10.1016/j.emc.2018.07.002; Miner MC, 2010, PUBLIC HEALTH REP, V125, P518, DOI 10.1177/003335491012500405; Munn-Mace G, 2018, HEALTH POLICY PLANN, V33, P247, DOI 10.1093/heapol/czx157; Ogbudebe CL, 2018, HEALTH SERV INSIGHTS, V11, DOI 10.1177/1178632918757490; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pan American Health Organization, 2016, 25 PAN AM HLTH ORG; Puttkammer NH, 2014, REV PANAM SALUD PUBL, V36, P238; Ruru Y, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1510592; Salyer SJ, 2015, INT J TUBERC LUNG D, V19, P1045, DOI 10.5588/ijtld.15.0051; Schnaubelt ER, 2018, PUBLIC HEALTH ACTION, V8, P154, DOI 10.5588/pha.18.0043; Sowah LA, 2014, JAIDS-J ACQ IMM DEF, V67, pE123, DOI 10.1097/QAI.0000000000000315; Swaminathan S, 2010, CLIN INFECT DIS, V50, P1377, DOI 10.1086/652147; Tripathy JP, 2013, PUBLIC HEALTH ACTION, V3, P235, DOI 10.5588/pha.13.0044; UN OCHA, 2016, 19 UN OCHA; Chung WS, 2007, INT J TUBERC LUNG D, V11, P59; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2013, WHOHTMTB201304; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2005, FIELD MAN COMM DIS C; World Health Organization United Nations High Commissioner for Refugees, 2007, TUB CAR CONTR REF DI; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247750	10.1371/journal.pone.0247750	http://dx.doi.org/10.1371/journal.pone.0247750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730043	Green Published, gold			2022-12-26	WOS:000630345000025
J	Feke, A; Vanderwall, M; Liu, W; Gendron, JM				Feke, Ann; Vanderwall, Morgan; Liu, Wei; Gendron, Joshua M.			Functional domain studies uncover novel roles for the ZTL Kelch repeat domain in clock function	PLOS ONE			English	Article							CIRCADIAN CLOCK; AFFINITY PURIFICATION; TARGETED DEGRADATION; EVENING COMPLEX; SCFZTL COMPLEX; LOV-DOMAIN; ARABIDOPSIS; ZEITLUPE; PROTEIN; FKF1	The small LOV/F-box/Kelch family of E3 ubiquitin ligases plays an essential role in the regulation of plant circadian clocks and flowering time by sensing dusk. The family consists of three members, ZEITLUPE (ZTL), LOV KELCH PROTEIN 2 (LKP2), and FLAVIN-BINDING KELCH REPEAT F-BOX PROTEIN 1 (FKF1), which share a unique protein domain architecture allowing them to act as photoreceptors that transduce light signals via altering stability of target proteins. Despite intensive study of this protein family we still lack important knowledge about the biochemical and functional roles of the protein domains that comprise these unique photoreceptors. Here, we perform comparative analyses of transgenic lines constitutively expressing the photoreceptor LOV domain or the Kelch repeat protein-protein interaction domains of ZTL, FKF1, and LKP2. Expression of each domain alone is sufficient to disrupt circadian rhythms and flowering time, but each domain differs in the magnitude of effect. Immunoprecipitation followed by mass spectrometry with the ZTL Kelch repeat domain identified a suite of potential interacting partners. Furthermore, the ZTL Kelch repeat domain can interact with the ZTL homologs, LKP2 and FKF1, and the LOV domain of ZTL itself. This suggests a hypothesis that the Kelch repeat domain of ZTL may mediate inter- and intra-molecular interactions of the three LOV/F-box/Kelch proteins and provides added insight into the composition of the protein complexes and an additional role for the Kelch repeat domain.	[Feke, Ann; Vanderwall, Morgan; Liu, Wei; Gendron, Joshua M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Gendron, JM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	Joshua.gendron@yale.edu	Liu, Wei/GRJ-0814-2022	Liu, Wei/0000-0002-5693-4086; Vanderwall, Morgan/0000-0001-8875-7996	National Science Foundation (EAGER) [1548538]; National Institutes of Health [R35 GM128670, T32 GM007499]; Gruber Foundation; National Science Foundation [GRFP DGE-1122492]; Forest BH and Elizabeth DW Brown Fund Fellowship	National Science Foundation (EAGER)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gruber Foundation; National Science Foundation(National Science Foundation (NSF)); Forest BH and Elizabeth DW Brown Fund Fellowship	This work was supported by the National Science Foundation (EAGER #1548538) and the National Institutes of Health (R35 GM128670) to J. M.G; by the National Institutes of Health (T32 GM007499), the Gruber Foundation, and the National Science Foundation (GRFP DGE-1122492) to A.F.; and the Forest BH and Elizabeth DW Brown Fund Fellowship to W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HK, 2019, J EXP BOT, V70, P2741, DOI 10.1093/jxb/erz099; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Cha JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-016-0014-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Edelstein Arthur D, 2014, J Biol Methods, V1; Feke A, 2019, ELIFE, V8, DOI 10.7554/eLife.44558; Feke AM, 2020, GENETICS, V215, P699, DOI 10.1534/genetics.120.303199; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fujiwara S, 2008, J BIOL CHEM, V283, P23073, DOI 10.1074/jbc.M803471200; Fukamatsu Y, 2005, PLANT CELL PHYSIOL, V46, P1340, DOI 10.1093/pcp/pci144; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Huang H, 2016, DATA BRIEF, V8, P56, DOI 10.1016/j.dib.2016.05.014; Huang H, 2016, MOL CELL PROTEOMICS, V15, P201, DOI 10.1074/mcp.M115.054064; Hwang DY, 2019, MOL CELLS, V42, P693, DOI 10.14348/molcells.2019.0199; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ito S, 2012, MOL PLANT, V5, P573, DOI 10.1093/mp/sss013; Kevei E, 2006, PLANT PHYSIOL, V140, P933, DOI 10.1104/pp.105.074864; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kim J, 2013, DEVELOPMENT, V140, P4060, DOI 10.1242/dev.096651; Kim TS, 2011, P NATL ACAD SCI USA, V108, P16843, DOI 10.1073/pnas.1110406108; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Lee CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11769-7; Lee CM, 2018, PLANT PHYSIOL, V177, P1170, DOI 10.1104/pp.18.00331; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mengin V, 2017, PLANT CELL ENVIRON, V40, P2608, DOI 10.1111/pce.13000; Moore A, 2014, METHODS MOL BIOL, V1158, P13, DOI 10.1007/978-1-4939-0700-7_2; Nakasako M, 2005, FEBS LETT, V579, P1067, DOI 10.1016/j.febslet.2004.12.078; Nakasone Y, 2010, BIOPHYS J, V99, P3831, DOI 10.1016/j.bpj.2010.10.005; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Pudasaini A, 2017, ELIFE, V6, DOI 10.7554/eLife.21646; Pudasaini A, 2013, BIOCHEMISTRY-US, V52, P7150, DOI 10.1021/bi401027n; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Shim JS, 2017, PLANT PHYSIOL, V173, P5, DOI 10.1104/pp.16.01327; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Takase T, 2011, PLANT J, V67, P608, DOI 10.1111/j.1365-313X.2011.04618.x; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yasuhara M, 2004, J EXP BOT, V55, P2015, DOI 10.1093/jxb/erh226; Zoltowski BD, 2014, ENZYMES, V35, P213, DOI 10.1016/B978-0-12-801922-1.00009-9	56	3	3	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0235938	10.1371/journal.pone.0235938	http://dx.doi.org/10.1371/journal.pone.0235938			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730063	gold, Green Submitted, Green Published			2022-12-26	WOS:000630345000048
J	Turnier, L; Eakin, M; Woo, H; Dransfield, M; Parekh, T; Krishnan, JA; Kanner, R; Cooper, CB; Woodruff, PG; Wise, R; Han, MLK; Romero, K; Paulin, LM; Peters, S; Drummond, B; Bleecker, ER; Bowler, R; Comellas, AP; Couper, D; Paine, R; Martinez, F; Barr, G; Putcha, N; Hansel, NN				Turnier, Leonard; Eakin, Michelle; Woo, Han; Dransfield, Mark; Parekh, Trisha; Krishnan, Jerry A.; Kanner, Richard; Cooper, Christopher B.; Woodruff, Prescott G.; Wise, Robert; Han, MeiLan K.; Romero, Karina; Paulin, Laura M.; Peters, Stephen; Drummond, Brad; Bleecker, Eugene R.; Bowler, Russell; Comellas, Alejandro P.; Couper, David; Paine, Robert; Martinez, Fernando; Barr, Graham; Putcha, Nirupama; Hansel, Nadia N.			The influence of social support on COPD outcomes mediated by depression	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HOSPITAL ANXIETY	Background The purpose of this study was to explore the association between perceived social support and COPD outcomes and to determine whether the associations are mediated by depressive symptoms. Methods Subjects with COPD who were enrolled as part of SPIROMICS were included in this analysis. Questionnaires relating to quality of life, symptom burden, and functional status were administered at annual clinic visits for over a 3 year period. In both cross-sectional and longitudinal analyses, we examined the association of social support as measured by the FACIT-F with COPD outcomes. Cross sectional analyses used multivariable linear or logistic regression, adjusting for covariates. For longitudinal analyses, generalized linear mixed models with random intercepts were used. Models were adjusted with and without depressive symptoms and mediation analyses performed. Results Of the 1831 subjects with COPD, 1779 completed the FACIT-F questionnaire. In adjusted cross-sectional analysis without depressive symptoms, higher perceived social support was associated with better quality of life, well-being, 6 minute walk distance, and less dyspnea. When also adjusting for depressive symptoms, all associations between social support and COPD outcomes were attenuated and no longer statistically significant. Mediation analysis suggested that depressive symptoms explained the majority (> = 85%) of the association between social support and measured COPD outcomes. Results of the longitudinal analysis were consistent with the cross-sectional analyses. There was no association between social support and odds of exacerbations. Conclusion Higher social support was associated with better COPD outcomes across several measures of morbidity including quality of life, respiratory symptoms, and functional status. In addition, these associations were largely attenuated when accounting for depressive symptoms suggesting that the beneficial association of social support with COPD outcomes may be largely mediated by the association between social support and depression.	[Turnier, Leonard; Eakin, Michelle; Woo, Han; Wise, Robert; Romero, Karina; Paulin, Laura M.; Putcha, Nirupama; Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Johns Hopkins Dept Med, Baltimore, MD 21205 USA; [Dransfield, Mark; Parekh, Trisha] Univ Alabama Birmingham, Birmingham, AL USA; [Krishnan, Jerry A.] Univ Illinois, Chicago, IL USA; [Kanner, Richard; Paine, Robert] Univ Utah, Sch Med, Salt Lake City, UT USA; [Cooper, Christopher B.] Univ Calif Los Angeles, Los Angeles, CA USA; [Woodruff, Prescott G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Han, MeiLan K.] Univ Michigan, Ann Arbor, MI USA; [Peters, Stephen; Bleecker, Eugene R.] Wake Forest Baptist Hlth, Winston Salem, NC USA; [Drummond, Brad] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Bowler, Russell] Natl Jewish Hlth, Denver, CO USA; [Comellas, Alejandro P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Couper, David] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Martinez, Fernando] Weill Med Coll, New York, NY USA; [Barr, Graham] Columbia Univ, Med Ctr, New York, NY USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Jewish Health; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Columbia University	Hansel, NN (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Dept Med, Baltimore, MD 21205 USA.	nhansel1@jhmi.edu		Paulin, Laura/0000-0003-0265-6858; Comellas, Alejandro/0000-0003-1521-7520; Krishnan, Jerry/0000-0001-5525-4778	NIH/NHLBI [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880]; Foundation for the NIH; COPD Foundation from AstraZeneca/MedImmune; Bayer; Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc.; Chiesi Farmaceutici S.p.A.; Forest Research Institute, Inc.; GlaxoSmithKline; Grifols Therapeutics, Inc.; Ikaria, Inc.; Novartis Pharmaceuticals Corporation; Nycomed GmbH; ProterixBio; Regeneron Pharmaceuticals, Inc.; Sanofi; Sunovion; Takeda Pharmaceutical Company; Theravance Biopharma; Mylan; National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health [P50MD010431]; NIH NIEHS [R01ES023500]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation from AstraZeneca/MedImmune(AstraZenecaMedimmune); Bayer(Bayer AG); Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc.(Boehringer Ingelheim); Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc); Forest Research Institute, Inc.; GlaxoSmithKline(GlaxoSmithKline); Grifols Therapeutics, Inc.; Ikaria, Inc.; Novartis Pharmaceuticals Corporation(Novartis); Nycomed GmbH; ProterixBio; Regeneron Pharmaceuticals, Inc.(Regeneron); Sanofi; Sunovion; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Theravance Biopharma; Mylan; National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health; NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	SPIROMICS was supported by contracts from the NIH/NHLBI (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C), and a grant from the NIH/NHLBI (U01 HL137880, and supplemented by contributions made through the Foundation for the NIH and the COPD Foundation from AstraZeneca/MedImmune; Bayer; Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc..; Chiesi Farmaceutici S.p.A.; Forest Research Institute, Inc.; GlaxoSmithKline; Grifols Therapeutics, Inc.; Ikaria, Inc.; Novartis Pharmaceuticals Corporation; Nycomed GmbH; ProterixBio; Regeneron Pharmaceuticals, Inc.; Sanofi; Sunovion; Takeda Pharmaceutical Company; and Theravance Biopharma and Mylan. Research reported in this manuscript was also supported by the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health under award number [P50MD010431]. Spiromics Aire was supported by NIH NIEHS (R01ES023500.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barton C, 2015, COPD, V12, P690, DOI 10.3109/15412555.2015.1008691; Blakemore A, 2014, INT J CHRONIC OBSTR, V9, P501, DOI 10.2147/COPD.S58136; Celli B, 2016, AM J RESP CRIT CARE, V194, P1483, DOI 10.1164/rccm.201508-1653OC; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Coultas David B, 2007, COPD, V4, P23, DOI 10.1080/15412550601169190; D. o. P. H. Centers for Disease Control and Prevention, 2018, CHRONIC OBSTRUCTIVE; De Sajal, 2011, Indian J Chest Dis Allied Sci, V53, P35; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Kasikci MK, 2007, J CLIN NURS, V16, P1468, DOI 10.1111/j.1365-2702.2006.01782.x; KEELECARD G, 1993, PUBLIC HEALTH NURS, V10, P245, DOI 10.1111/j.1525-1446.1993.tb00060.x; Lenferink A, 2018, EXPERT REV RESP MED, V12, P623, DOI 10.1080/17476348.2018.1489723; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; McCathie HCF, 2002, EUR RESPIR J, V19, P47, DOI 10.1183/09031936.02.00240702; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Negi H, 2014, INDIAN J MED RES, V139, P402; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Stern AF, 2014, OCCUP MED-OXFORD, V64, P393, DOI 10.1093/occmed/kqu024; Strom JL, 2012, CURR DIABETES REP, V12, P769, DOI 10.1007/s11892-012-0317-0; Uchino BN, 2012, SOC SCI MED, V74, P949, DOI 10.1016/j.socscimed.2011.11.023; van Buuren S, 2011, J STAT SOFTW, V45, P1; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; Xiaolian Jiang, 2002, Nurs Health Sci, V4, P41, DOI 10.1046/j.1442-2018.2002.00100.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	27	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0245478	10.1371/journal.pone.0245478	http://dx.doi.org/10.1371/journal.pone.0245478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730034	gold, Green Published			2022-12-26	WOS:000630345000063
J	Wang, S; Yang, XX; Wang, W; Zhang, YK; Li, TJ; Zhao, L; Bao, YR; Meng, XS				Wang, Shuai; Yang, Xinxin; Wang, Wei; Zhang, Yunkun; Li, Tianjiao; Zhao, Lin; Bao, Yongrui; Meng, Xiansheng			Interpretation of the absorbed constituents and pharmacological effect of Spica Schizonepetae extract on non-small cell lung cancer	PLOS ONE			English	Article								As a traditional Chinese medicine (TCM) with a usage history of over 2,000 years in China, Spica Schizonepetae possesses definite clinical activity in the treatment of non-small cell lung cancer (NSCLC). However, its active ingredients and mechanism of action remain unclear at present. The further exploration of its active components and underlying mechanism will provide a basis for the development of candidate anti-tumor drugs. Our previous study explored the chemical constituents of Spica Schizonepetae extract (SSE). On this basis, molecular networking technology was applied in analyzing the QTOF-MS/MS data of rat plasma after intragastric administration of SSE using the GNPS database platform. A total of 26 components were found, including 9 proterotype components and 17 metabolites, which revealed the potential active ingredients of SSE. Later, the Lewis lung cancer mouse model was established, and the inhibition rate and histopathological sections were used as the indicators to investigate the anti-tumor effect of SSE, whereas the body weight, survival rate, thymus index and spleen index served as the indicators to explore the pharmacological effects of SSE on improving mouse immunity. The results showed that SSE had comparable anti-tumor efficacy to cisplatin, which enhanced the immunity, improved the quality of life, and extended the survival time of lung cancer mice. Furthermore, human A549 lung tumor cells were selected to explore the mechanism of SSE in treating NSCLC based on cell metabonomics. After data mining by the MPP software, 23 differential endogenous metabolites were identified between SSE and tumor groups. Moreover, results of pathway enrichment analysis using the MetaboAnalyst 4.0 software indicated that these metabolites were mainly enriched in four metabolic pathways (p < 0.1). By adopting the network pharmacology method, the metabolic pathways discovered by cell metabolomics were verified against the ChEMBL, STITCH, UniProt and TCGA databases, and differences in the underlying mechanism between cells and humans were found. It was proved that SSE affected the metabolism of purine, arachidonic acid and histidine to exert the anti-tumor efficacy. Furthermore, the multi-target, multi-pathway, and immunoenhancement mechanism of SSE in anti-tumor treatment was revealed, which provided a scientific basis for new drug development and the rational application of Spica Schizonepetae in clinic.	[Wang, Shuai; Yang, Xinxin; Wang, Wei; Li, Tianjiao; Zhao, Lin; Bao, Yongrui; Meng, Xiansheng] Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Peoples R China; [Wang, Shuai; Yang, Xinxin; Li, Tianjiao; Bao, Yongrui; Meng, Xiansheng] Liaoning Multidimens Anal Tradit Chinese Med Tech, Dalian, Peoples R China; [Zhang, Yunkun] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China	Liaoning University of Traditional Chinese Medicine; Dalian Medical University	Bao, YR; Meng, XS (corresponding author), Liaoning Univ Tradit Chinese Med, Coll Pharm, Dalian, Peoples R China.; Bao, YR; Meng, XS (corresponding author), Liaoning Multidimens Anal Tradit Chinese Med Tech, Dalian, Peoples R China.	byr1026@163.com; mxsvvv@163.com	yang, xin/HGU-9981-2022	Bao, Yongrui/0000-0003-0588-2113; Wang, Shuai/0000-0002-8895-5199	Liaoning Key Research and Development Project [2020JH2/10300088]; Natural Science Foundation of Liaoning Province [2019-ZD-0946]; Liaoning Provincial TCM Modernization Research and Innovation Team Project [LT2017015]; National Key Research and Development Project [2018YFC1704805]; Youth Program of Education Department of Liaoning Province [L201725]; Liaoning Province Distinguished Professor Support Program, China [187]	Liaoning Key Research and Development Project; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Liaoning Provincial TCM Modernization Research and Innovation Team Project; National Key Research and Development Project; Youth Program of Education Department of Liaoning Province; Liaoning Province Distinguished Professor Support Program, China	Xiansheng Meng, the Liaoning Key Research and Development Project (2020JH2/10300088); Shuai Wang, the Natural Science Foundation of Liaoning Province (2019-ZD-0946); Xiansheng Meng, the Liaoning Provincial TCM Modernization Research and Innovation Team Project (LT2017015); Xinxin Yang, the National Key Research and Development Project (2018YFC1704805); Wei Wang, the Youth Program of Education Department of Liaoning Province (L201725).; This work received the support of the Liaoning Province Distinguished Professor Support Program (Liao Jiao Fa [2014] No.187), China.	Anwar J, 2013, FOOD CHEM TOXICOL, V56, P459, DOI 10.1016/j.fct.2013.02.030; Boudreau LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031833; Brandao RD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3409; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01110-x; Chung TW, 2004, FASEB J, V18, P1670, DOI 10.1096/fj.04-2126com; Ferraz-Filha ZS, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/2712108; Flesner BK, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0290-8; Huang CY, 2011, TOXICOL IN VITRO, V25, P1274, DOI 10.1016/j.tiv.2011.04.014; Jiang ZQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020447; Kang OH, 2010, MOLECULES, V15, P385, DOI 10.3390/molecules15010385; Li Yaoyuan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3375; Li YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/383608; Li ZH, 2018, TALANTA, V189, P606, DOI 10.1016/j.talanta.2018.07.020; Lin YH, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/6514705; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; Luo LK, 2019, J CHROMATOGR B, V1129, DOI 10.1016/j.jchromb.2019.121791; Mahboubi-Rabbani M, 2021, CURR MED CHEM, V28, P1143, DOI 10.2174/0929867326666191210104820; Pauff JM, 2009, J NAT PROD, V72, P725, DOI 10.1021/np8007123; Quinn RA, 2017, TRENDS PHARMACOL SCI, V38, P143, DOI 10.1016/j.tips.2016.10.011; Radhika R, 2018, J BIOMOL STRUCT DYN, V36, P1369, DOI 10.1080/07391102.2017.1323013; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wang BS, 2012, FOOD CHEM TOXICOL, V50, P526, DOI 10.1016/j.fct.2011.12.010; Wang S, 2019, J LIQ CHROMATOGR R T, V42, P605, DOI 10.1080/10826076.2019.1646274; Wang XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18997; Yarla NS, 2016, SEMIN CANCER BIOL, V40-41, P48, DOI 10.1016/j.semcancer.2016.02.001; Yin J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01697; Yu ST, 2019, J PHARMACEUT BIOMED, V166, P281, DOI 10.1016/j.jpba.2019.01.020	28	3	3	9	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248700	10.1371/journal.pone.0248700	http://dx.doi.org/10.1371/journal.pone.0248700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730076	gold, Green Published			2022-12-26	WOS:000630345000073
J	Chen, YC; Hsieh, HH; Chang, HC; Wang, HC; Lin, WJ; Lin, JJ				Chen, Ying-Chieh; Hsieh, Hsi-Hsien; Chang, Hsi-Chi; Wang, Hsin-Chiao; Lin, Wey-Jinq; Lin, Jing-Jer			CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 STABILIZATION; CANCER-CELLS; PHOSPHORYLATION; PHOSPHATASE; KINASE; ACCUMULATION; CYCLE; OVEREXPRESSION; DEGRADATION; CHECKPOINT	The phosphatase cell division cycle 25B (Cdc25B) regulates cell cycle progression. Increased Cdc25B levels are often detected in cancer cell lines and human cancers and have been implicated in contributing to tumor growth, potentially by providing cancer cells with the ability to bypass checkpoint controls. However, the specific mechanism by which increased Cdc25B impacts tumor progression is not clear. Here we analyzed The Cancer Genome Atlas (TCGA) database and found that patients with high CDC25B expression had the expected poor survival. However, we also found that high CDC25B expression had a p53-dependent tumor suppressive effect in lung cancer and possibly several other cancer types. Looking in more detail at the tumor suppressive function of Cdc25B, we found that increased Cdc25B expression caused inhibition of cell growth in human normal fibroblasts. This effect was not due to alteration of specific cell cycle stage or inhibition of apoptosis, nor by induction of the DNA damage response. Instead, increased CDC25B expression led cells into senescence. We also found that p53 was required to induce senescence, which might explain the p53-dependent tumor suppressive function of Cdc25B. Mechanistically, we found that the Cdc25B phosphatase activity was required to induce senescence. Further analysis also found that Cdc25B stabilized p53 through binding and dephosphorylating p53. Together, this study identified a tumor-suppressive function of Cdc25B that is mediated through a p53-dependent senescence pathway.	[Chen, Ying-Chieh; Hsieh, Hsi-Hsien; Chang, Hsi-Chi; Lin, Wey-Jinq; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Wang, Hsin-Chiao; Lin, Jing-Jer] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Lin, WJ; Lin, JJ (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.; Lin, JJ (corresponding author), Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei, Taiwan.	wjlin@ym.edu.tw; jingjerlin@ntu.edu.tw		LIN, JING-JER/0000-0001-8250-7398; Hsieh, Hsi-Hsien/0000-0002-1734-6417	National Taiwan University [Aim for Top University Project] [104R8955-2, 108L9014]; Ministry of Science and Technology [MOST104-2311-B-002-028-MY3, MOST1042321-B-002-036]	National Taiwan University [Aim for Top University Project]; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Taiwan University [Aim for Top University Project under grants 104R8955-2 and 108L9014]; the Ministry of Science and Technology [MOST104-2311-B-002-028-MY3 and MOST1042321-B-002-036].	Al-Matouq J, 2019, MOL CARCINOGEN, V58, P1691, DOI 10.1002/mc.23075; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Bean LJH, 2002, J BIOL CHEM, V277, P1864, DOI 10.1074/jbc.M108881200; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Boutros R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067822; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cai X, 2008, P NATL ACAD SCI USA, V105, P16958, DOI 10.1073/pnas.0804608105; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Escarpe P, 2003, MOL THER, V8, P332, DOI 10.1016/S1525-0016(03)00167-9; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Gatti A, 2000, BIOCHEMISTRY-US, V39, P9837, DOI 10.1021/bi992454i; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Ma ZQ, 1999, ONCOGENE, V18, P4564, DOI 10.1038/sj.onc.1202809; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Miyata H, 2001, CANCER RES, V61, P3188; Mullee LI, 2016, CHROMOSOME RES, V24, P35, DOI 10.1007/s10577-015-9503-7; NAGATA A, 1991, NEW BIOL, V3, P959; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scian MJ, 2008, ONCOGENE, V27, P2583, DOI 10.1038/sj.onc.1210898; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Sohn R, 2005, BIOCHEMISTRY-US, V44, P16563, DOI 10.1021/bi0516879; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Yao Y, 1999, ONCOGENE, V18, P5159, DOI 10.1038/sj.onc.1202908; Yeh PY, 2001, BIOCHEM BIOPH RES CO, V284, P880, DOI 10.1006/bbrc.2001.5043	49	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100564	10.1016/j.jbc.2021.100564	http://dx.doi.org/10.1016/j.jbc.2021.100564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745968	gold, Green Published			2022-12-26	WOS:000672866400537
J	O'Brien, BJ; Singer, HA; Adam, AP; Ginnan, RG				O'Brien, Brendan J.; Singer, Harold A.; Adam, Alejandro P.; Ginnan, Roman G.			CaMKII delta is upregulated by pro-inflammatory cytokine IL-6 in a JAK/STAT3-dependent manner to promote angiogenesis	FASEB JOURNAL			English	Article						angiogenesis; CaMKII; cell motility; endothelial biology; STAT3 signaling		Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a ubiquitous serine threonine kinase with established roles in physiological and pathophysiological vascular remodeling. Based on our previous study demonstrating that CaMKII delta promotes thrombin-induced endothelial permeability and recent reports that CaMKII may contribute to inflammatory remodeling in the heart, we investigated CaMKII delta-dependent regulation of endothelial function downstream of an interleukin-6 (IL-6)/JAK/STAT3 signaling axis. Upon treatment with IL-6 and its soluble receptor (sIL-6r), CaMKII delta expression is significantly induced in HUVEC. Using pharmacological inhibitors of JAK and siRNA targeting STAT3, we demonstrated that activation of STAT3 is sufficient to induce CaMKII delta expression. Under these conditions, rather than promoting IL-6-induced permeability, we found that CaMKII delta promotes endothelial cell migration as measured by live cell imaging of scratch wound closure and single-cell motility analysis. In a similar manner, endothelial cell proliferation was attenuated upon knockdown of CaMKII delta as determined by growth curves, cell cycle analysis, and capacitance of cell-covered electrodes as measured by ECIS. Using inducible endothelial-specific STAT3 knockout mice, we demonstrate that STAT3 signaling promotes developmental angiogenesis in the neonatal mouse retina assessed at postnatal day 6. CaMKII delta expression in retinal endothelium was attenuated in these animals as measured by qPCR. STAT3's effects on angiogenesis were phenocopied by the endothelial-specific knockout of CaMKII delta, with significantly reduced vascular outgrowth and number of junctions in the developing P6 retina. For the first time, we demonstrate that transcriptional regulation of CaMKII delta by STAT3 promotes endothelial motility, proliferation, and in vivo angiogenesis.	[O'Brien, Brendan J.; Singer, Harold A.; Adam, Alejandro P.; Ginnan, Roman G.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA	Albany Medical College	Ginnan, RG (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.	ginnanr@amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235; O'Brien, Brendan/0000-0001-9425-7832	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI) [HL049426]	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI)	HHS, NIH, National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL049426	Aggarwal S, 2011, EXP CLIN CARDIOL, V16, P11; Alsaffar H, 2018, AM J PHYSIOL-CELL PH, V314, pC589, DOI 10.1152/ajpcell.00235.2017; Ashraf S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122442; Babon JJ, 2014, SEMIN IMMUNOL, V26, P13, DOI 10.1016/j.smim.2013.12.004; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cheneby J, 2020, NUCLEIC ACIDS RES, V48, pD180, DOI 10.1093/nar/gkz945; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Fantin Alessandro, 2015, Methods Mol Biol, V1332, P177, DOI 10.1007/978-1-4939-2917-7_13; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Gao P, 2017, ONCOTARGET, V8, P69139, DOI 10.18632/oncotarget.19932; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Ginnan R, 2012, BIOCHEM J, V444, P105, DOI 10.1042/BJ20120152; Gopinathan G, 2015, CANCER RES, V75, P3098, DOI 10.1158/0008-5472.CAN-15-1227; Hamik A, 2006, ARTERIOSCL THROM VAS, V26, P1936, DOI 10.1161/01.ATV.0000232542.42968.e3; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1571, DOI 10.1093/rheumatology/kes093; Kokje VBC, 2016, ATHEROSCLEROSIS, V251, P139, DOI 10.1016/j.atherosclerosis.2016.06.021; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Saddouk F Z, 2017, Adv Pharmacol, V78, P171, DOI 10.1016/bs.apha.2016.08.003; Saddouk FZ, 2016, FASEB J, V30, P1051, DOI 10.1096/fj.15-279158; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Saneyoshi T, 2019, NEURON, V102, P1199, DOI 10.1016/j.neuron.2019.04.012; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Stahl A, 2012, BLOOD, V120, P2925, DOI 10.1182/blood-2012-04-422527; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Toussaint F, 2015, CELL CALCIUM, V58, P275, DOI 10.1016/j.ceca.2015.06.005; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Walker S, 2016, BLOOD, V127, P948, DOI 10.1182/blood-2015-06-654277; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xiao J, 2020, INT J CARDIOL, V312, P100, DOI 10.1016/j.ijcard.2020.03.072	43	4	4	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21437	10.1096/fj.202002755R	http://dx.doi.org/10.1096/fj.202002755R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749880	Green Accepted			2022-12-26	WOS:000635216100073
J	VanAken, SM; Newton, D; VanEpps, JS				VanAken, Shannon M.; Newton, Duane; VanEpps, J. Scott			Improved diagnostic prediction of the pathogenicity of bloodstream isolates of Staphylococcus epidermidis	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIMICROBIAL RESISTANCE; CLINICAL-SIGNIFICANCE; BIOFILM FORMATION; METHICILLIN; AUREUS; GENES; IDENTIFICATION; MECHANISMS; HOMOLOG	With an estimated 440,000 active cases occurring each year, medical device associated infections pose a significant burden on the US healthcare system, costing about $9.8 billion in 2013. Staphylococcus epidermidis is the most common cause of these device-associated infections, which typically involve isolates that are multi-drug resistant and possess multiple virulence factors. S. epidermidis is also frequently a benign contaminant of otherwise sterile blood cultures. Therefore, tests that distinguish pathogenic from non-pathogenic isolates would improve the accuracy of diagnosis and prevent overuse/misuse of antibiotics. Attempts to use multi-locus sequence typing (MLST) with machine learning for this purpose had poor accuracy (similar to 73%). In this study we sought to improve the diagnostic accuracy of predicting pathogenicity by focusing on phenotypic markers (i.e., antibiotic resistance, growth fitness in human plasma, and biofilm forming capacity) and the presence of specific virulence genes (i.e., mecA, ses1, and sdrF). Commensal isolates from healthy individuals (n = 23), blood culture contaminants (n = 21), and pathogenic isolates considered true bacteremia (n = 54) were used. Multiple machine learning approaches were applied to characterize strains as pathogenic vs non-pathogenic. The combination of phenotypic markers and virulence genes improved the diagnostic accuracy to 82.4% (sensitivity: 84.9% and specificity: 80.9%). Oxacillin resistance was the most important variable followed by growth rate in plasma. This work shows promise for the addition of phenotypic testing in clinical diagnostic applications.	[VanAken, Shannon M.; VanEpps, J. Scott] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Newton, Duane] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [VanEpps, J. Scott] Univ Michigan, Biomed Engn, Ann Arbor, MI 48109 USA; [VanEpps, J. Scott] Univ Michigan, Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [VanEpps, J. Scott] Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA; [VanEpps, J. Scott] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	VanEpps, JS (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.; VanEpps, JS (corresponding author), Univ Michigan, Biomed Engn, Ann Arbor, MI 48109 USA.; VanEpps, JS (corresponding author), Univ Michigan, Macromol Sci & Engn, Ann Arbor, MI 48109 USA.; VanEpps, JS (corresponding author), Univ Michigan, Michigan Ctr Integrat Res Crit Care, Ann Arbor, MI 48109 USA.; VanEpps, JS (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	jvane@med.umich.edu		VanEpps, J. Scott/0000-0002-0805-0913	National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [AI-128006]; A. Alfred Taubman Medical Research Institute	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); A. Alfred Taubman Medical Research Institute	This work was supported by National Institutes of Health (NIH; https://www.nih.gov/), National Institute of Allergy and Infectious Diseases (NIAID; https://www.niaid.nih.gov/), AI-128006 (JSV) as well as the A. Alfred Taubman Medical Research Institute, https://www.taubmaninstitute.org/(JSV).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi M, 2020, J INFECT DEV COUNTR, V14, P28, DOI 10.3855/jidc.11025; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Asaad AM, 2016, INFECT DIS-NOR, V48, P356, DOI 10.3109/23744235.2015.1122833; Balasubramanian D, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx005; Ballhausen B, 2014, ANTIMICROB AGENTS CH, V58, P3791, DOI 10.1128/AAC.02731-13; Banerjee R, 2015, CLIN INFECT DIS, V61, P1071, DOI 10.1093/cid/civ447; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Bertelli C, 2018, BIOINFORMATICS, V34, P2161, DOI 10.1093/bioinformatics/bty095; Blumenthal KG, 2019, LANCET, V393, P183, DOI 10.1016/S0140-6736(18)32218-9; Bresco MS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01401; Buttner H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00014; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Chon JW, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050659; Cikman A, 2019, J INFECT PUBLIC HEAL, V12, P528, DOI 10.1016/j.jiph.2019.01.063; Clinical and Laboratory Standards Institute, PA2018, V13th; Connolly J, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00337-17; Czekaj T, 2015, MICROBIOL-SGM, V161, P2061, DOI 10.1099/mic.0.000178; Dadgostar P, 2019, INFECT DRUG RESIST, V12, P3903, DOI 10.2147/IDR.S234610; Dargere S, 2018, CLIN MICROBIOL INFEC, V24, P964, DOI 10.1016/j.cmi.2018.03.030; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Elzi L, 2012, CLIN MICROBIOL INFEC, V18, pE355, DOI 10.1111/j.1469-0691.2012.03964.x; Evans DR, 2020, ELIFE, V9, DOI 10.7554/eLife.53886; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Giulieri SG, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000324; Goering RV, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00558-19; Haddad O, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3457-2; Heilmann C, 2019, CLIN MICROBIOL INFEC, V25, P1071, DOI 10.1016/j.cmi.2018.11.012; Hossain B, 2016, PEDIATR INFECT DIS J, V35, pS45, DOI 10.1097/INF.0000000000001106; Hussain Z, 2000, J CLIN MICROBIOL, V38, P2051; Kadry A., 2016, ZAGAZIG J PHARM SCI, V25, P39; Karakullukcu A, 2017, DIAGN MICR INFEC DIS, V87, P291, DOI 10.1016/j.diagmicrobio.2016.12.006; Kitti T, 2019, J GLOB INFECT DIS, V11, P112, DOI 10.4103/jgid.jgid_118_18; Kleinschmidt S, 2015, FUTURE MICROBIOL, V10, P1859, DOI 10.2217/fmb.15.98; Koksal F, 2009, MICROBIOL RES, V164, P404, DOI 10.1016/j.micres.2007.03.004; Luong TT, 2002, J BACTERIOL, V184, P3623, DOI 10.1128/JB.184.13.3623-3629.2002; Meng XR, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01487; Meric G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07368-7; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Mohamed H, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1253-x; Morgenstern M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148437; Morioka S, 2018, INFECT DIS-NOR, V50, P660, DOI 10.1080/23744235.2018.1451917; Murugesan S, 2019, J CLIN DIAGN RES, V13, pDC10, DOI 10.7860/JCDR/2019/40266.12888; Najar-Peerayeh S, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11188; Nasaj M, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-4938-0; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Nguyen TH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00090; Noshak MA, 2019, GENE REP, V17, DOI 10.1016/j.genrep.2019.100531; Olia AHG, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104262; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paterson GK, 2014, TRENDS MICROBIOL, V22, P42, DOI 10.1016/j.tim.2013.11.003; Qi XQ, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02574; Seng R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184172; Sharma Prannda, 2014, Interdiscip Perspect Infect Dis, V2014, P787458, DOI 10.1155/2014/787458; Trivedi S, 2017, J INFECT DIS, V215, P1846, DOI 10.1093/infdis/jix213; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; Wolfe CM, 2014, J INFECT PUBLIC HEAL, V7, P224, DOI 10.1016/j.jiph.2014.01.001; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; Yonemoto K, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00894-18; Zapotoczna M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005671; Zlatian O, 2018, EXP THER MED, V16, P4499, DOI 10.3892/etm.2018.6737	63	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0241457	10.1371/journal.pone.0241457	http://dx.doi.org/10.1371/journal.pone.0241457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770084	Green Submitted, Green Published, gold			2022-12-26	WOS:000634833500023
J	Al Dhaheri, AS; Bataineh, MF; Mohamad, MN; Ajab, A; Al Marzouqi, A; Jarrar, AH; Habib-Mourad, C; Abu Jamous, DO; Ali, HI; Al Sabbah, H; Hasan, H; Stojanovska, L; Hashim, M; Abd Elhameed, OA; Obaid, RRS; ElFeky, S; Saleh, ST; Osaili, TM; Ismail, LC				Al Dhaheri, Ayesha S.; Bataineh, Mo'ath F.; Mohamad, Maysm N.; Ajab, Abir; Al Marzouqi, Amina; Jarrar, Amjad H.; Habib-Mourad, Carla; Abu Jamous, Dima O.; Ali, Habiba I.; Al Sabbah, Haleama; Hasan, Hayder; Stojanovska, Lily; Hashim, Mona; Abd Elhameed, Osama A.; Obaid, Reyad R. Shaker; ElFeky, Samar; Saleh, Sheima T.; Osaili, Tareq M.; Ismail, Leila Cheikh			Impact of COVID-19 on mental health and quality of life: Is there any effect? A cross-sectional study of the MENA region	PLOS ONE			English	Article							GENERAL-POPULATION; SEX-DIFFERENCES; HONG-KONG; STRESS; EPIDEMIC; MERS; CORONAVIRUS; RESPONSES; OUTBREAK; ANXIETY	The COVID-19 pandemic is a major health crisis that has changed the life of millions globally. The purpose of this study was to assess the effect of the pandemic on mental health and quality of life among the general population in the Middle East and North Africa (MENA) region. A total of 6142 adults from eighteen countries within the MENA region completed an online questionnaire between May and June 2020. Psychological impact was assessed using the Impact of Event Scale-Revised (IES-R) and the social and family support impact was assessed with questions from the Perceived Support Scale (PSS). The IES-R mean score was 29.3 (SD = 14.8), corresponding to mild stressful impact with 30.9% reporting severe psychological impact. Most participants (45%-62%) felt horrified, apprehensive, or helpless due to COVID-19. Furthermore, over 40% reported increased stress from work and financial matters. Higher IES-R scores were found among females, participants aged 26-35 years, those with lower educational level, and participants residing in the North Africa region (p<0.005). About 42% reported receiving increased support from family members, 40.5% were paying more attention to their mental health, and over 40% reported spending more time resting since the pandemic started. The COVID-19 pandemic was associated with mild psychological impact while it also encouraged some positive impact on family support and mental health awareness among adults in the MENA region. Clinical interventions targeted towards vulnerable groups such as females and younger adults are needed.	[Al Dhaheri, Ayesha S.; Mohamad, Maysm N.; Jarrar, Amjad H.; Ali, Habiba I.; Stojanovska, Lily] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates; [Bataineh, Mo'ath F.] Hashemite Univ, Fac Phys Educ & Sport Sci, Dept Sport Rehabil, Zarqa, Jordan; [Ajab, Abir; Hasan, Hayder; Hashim, Mona; Obaid, Reyad R. Shaker; Saleh, Sheima T.; Osaili, Tareq M.; Ismail, Leila Cheikh] Univ Sharjah, Dept Clin Nutr & Dietet, Coll Hlth Sci, Sharjah, U Arab Emirates; [Ajab, Abir; Al Marzouqi, Amina; Abu Jamous, Dima O.; Hasan, Hayder; Hashim, Mona; Obaid, Reyad R. Shaker; Saleh, Sheima T.; Osaili, Tareq M.; Ismail, Leila Cheikh] Res Inst Med & Hlth Sci, Sharjah, U Arab Emirates; [Al Marzouqi, Amina] Univ Sharjah, Coll Hlth Sci, Dept Hlth Serv Adm, Sharjah, U Arab Emirates; [Habib-Mourad, Carla] Amer Univ Beirut, Dept Nutr, Fac Agr & Food Sci, Beirut, Lebanon; [Al Sabbah, Haleama] Zayed Univ, Coll Nat & Hlth Sci, Dubai, U Arab Emirates; [Stojanovska, Lily] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Hashim, Mona] Univ Sains Malaysia, Sch Hlth Sci, Nutr & Dietet Program, Kubang Kerian, Kelantan, Malaysia; [Abd Elhameed, Osama A.] Port Fouad Hosp, Egyptian Minist Hlth, Port Said, Egypt; [ElFeky, Samar] World Hlth Org, Reg Off Eastern Mediterranean Reg, Community Based Initiat & Hlth Older People, Cairo, Egypt; [Osaili, Tareq M.] Jordan Univ Sci & Technol, Fac Agr, Dept Nutr & Food Technol, Irbid, Jordan; [Ismail, Leila Cheikh] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England	United Arab Emirates University; Hashemite University; University of Sharjah; University of Sharjah; American University of Beirut; Zayed University; Victoria University; Universiti Sains Malaysia; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Jordan University of Science & Technology; University of Oxford	Al Dhaheri, AS (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates.	ayesha_aldhaheri@uaeu.ac.ae	Hasan, Hayder/J-4620-2019; Al Sabbah, Haleama/AAD-8798-2020	Hasan, Hayder/0000-0001-5580-1911; Al Sabbah, Haleama/0000-0001-7357-5823; Jarrar, Amjad/0000-0001-7185-6330; Shaker Obaid, Reyad/0000-0002-8440-8307; Cheikh Ismail, Leila/0000-0003-3048-7481; Ajab, Abir/0000-0002-0615-0347; Ali, Habiba I./0000-0003-2685-1244; Saleh, Sheima/0000-0003-2871-1341; N Mohamad, Maysm/0000-0002-6396-6625; Bataineh, Moath/0000-0001-8469-9581; Al Marzouqi, Amina/0000-0003-3370-1818				Agostini T., 2018, 13 ALPS ADR PSYCH C, P86; Al Shehri AM, 2015, MED TEACH, V37, pS88, DOI 10.3109/0142159X.2015.1006610; Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005; Alagaili AN, 2014, MBIO, V5, DOI [10.1128/mBio.00884-14, 10.1128/mBio.01482-14]; Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192; Alkwiese M, MED LETT CDC FDA, P189, DOI [10.1101/2020.05.07.20090225, DOI 10.1101/2020.05.07.20090225]; Ammar A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061583; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Baloch Z, 2020, J INFECT PUBLIC HEAL, V13, P1247, DOI 10.1016/j.jiph.2020.06.034; Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Boserup B, 2020, AM J EMERG MED, V38, P2753, DOI 10.1016/j.ajem.2020.04.077; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown SM, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104699; Brunet A, 2003, CAN J PSYCHIAT, V48, P56, DOI 10.1177/070674370304800111; Christianson Steven, 2012, Medsurg Nurs, V21, P321; Chua SE, 2004, CAN J PSYCHIAT, V49, P391, DOI 10.1177/070674370404900609; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Czosnek L, 2019, MENT HEALTH PHYS ACT, V16, P140, DOI 10.1016/j.mhpa.2018.11.001; Davico C., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3576933, DOI 10.2139/SSRN.3576933]; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Deschasaux-Tanguy M, 2021, AM J CLIN NUTR, V113, P924, DOI 10.1093/ajcn/nqaa336; Di Crosta A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567367; El-Zoghby SM, 2020, J COMMUN HEALTH, V45, P689, DOI 10.1007/s10900-020-00853-5; Fawaz M, 2020, INT J SOC PSYCHIATR, V66, P666, DOI 10.1177/0020764020932207; Felmingham K, 2010, J ABNORM PSYCHOL, V119, P241, DOI 10.1037/a0017551; Franzke AS, 2019, INTERNET RES ETHICAL; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Gostin L, 2004, TEMPLE LAW REV, V77, P155; Holmes S, 2009, INT J NURS STUD, V46, P394, DOI 10.1016/j.ijnurstu.2008.08.004; Imboden MT, 2019, PROG CARDIOVASC DIS, V62, P157, DOI 10.1016/j.pcad.2018.12.003; Jimenez-Pavon D, 2020, PROG CARDIOVASC DIS, V63, P386, DOI 10.1016/j.pcad.2020.03.009; Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303; Kilani HA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243524; Lau JTF, 2006, J INFECTION, V53, P114, DOI 10.1016/j.jinf.2005.10.019; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Lee K, 2009, GLOB INST, P1; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lippi G, 2020, EUR J PREV CARDIOL, V27, P906, DOI 10.1177/2047487320916823; Ma ZF, 2020, INT J SOC PSYCHIATR, V66, P770, DOI 10.1177/0020764020935489; Maeng LY, 2015, HORM BEHAV, V76, P106, DOI 10.1016/j.yhbeh.2015.04.002; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1872; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Ozemek C, 2018, PROG CARDIOVASC DIS, V61, P484, DOI 10.1016/j.pcad.2018.11.005; Pecanha T, 2020, AM J PHYSIOL-HEART C, V318, pH1441, DOI [10.1152/ajpheart.00268.2020, 10.1152/ajpheart.00268.2020.]; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Soni M, 2013, NEUROBIOL LEARN MEM, V104, P32, DOI 10.1016/j.nlm.2013.04.003; Tang BH, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121537; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; UNDP, 2020, COVID 19 AR REG; Vanaken L, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00738; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang YN, 2021, PSYCHOL HEALTH MED, V26, P13, DOI 10.1080/13548506.2020.1746817; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Women U, 2020, ISSUE BRIEF COVID 19; World Health Organization, 2020, 157 WHO; World Health Organization, 2020, COVID 19 UPD 12 SUMM, DOI 10.21203/rs.3.rs-35816/v1; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381; Zhou XY, 2020, TELEMED E-HEALTH, V26, P377, DOI 10.1089/tmj.2020.0068	65	42	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249107	10.1371/journal.pone.0249107	http://dx.doi.org/10.1371/journal.pone.0249107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765015	Green Published, gold			2022-12-26	WOS:000634832800037
J	Lambebo, A; Temiru, D; Belachew, T				Lambebo, Abera; Temiru, Deselegn; Belachew, Tefera			Frequency of relapse for severe acute malnutrition and associated factors among under five children admitted to health facilities in Hadiya Zone, South Ethiopia	PLOS ONE			English	Article							MODERATE ACUTE MALNUTRITION	Background Severe acute malnutrition is a common cause of morbidity and mortality among under five children in Ethiopia. A child may experience more than one episode of SAM depending on the improvement of the underlying factors. However, there is no study that determined the frequency of relapse of SAM cases after discharge in Ethiopia. Objective To identify the frequency of relapse and associated factors among children discharged after undergoing treatment for SAM in Hadiya Zone, South, Ethiopia. Methods An institution based retrospective cohort study was done among children admitted to health posts for treatment of SAM from 2014/2015-2019/2020 under-five children's after discharge in health post for severe acute malnutrition in the last five years in Hadiya zone, SNNPR, Ethiopia. Both first admission data and relapse data were abstracted from the records of the SAM children from Aguste 1-30 /2020 Using a data collection format. Data were coded and edited manually, then doubly entered into Epi-Data statistical software version 3.1 and then exported to SPSS for windows version 26. After checking all the assumptions finally Negative binomial regression for poison has been used. All tests were two sided and P values <0.05 were used to declare statistical significance. Results In the last five year there were the proportion of relapsed cases were 9.6%, 95% CI: (7.7%, 11.7%) On multivariable negative binomial regression model, after adjusting for background variables relapse of severe acute undernutrition was significantly associated with having edema during admission with (IRR = 2.21, 95% CI:1.303-3.732), being in the age group of 6-11 months (IRR = 4.74,95% CI:1.79-12.53), discharge MUAC for the first admission (P = 0.001, IRR = 0.37, 95% CI:0.270-0.50) increase the risk of incidence rate ratio(IRR) relapse case of severe acute under nutrition. Conclusion Frequency of SAM relapse was positively associated with age, having edema during admission, while it was negatively associated with discharge MUAC. The results imply the need for reviewing the discharge criteria taking into account the recovery of MUAC as a marker for lean tissue accretion, especially in edematous children and those in the younger age.	[Lambebo, Abera] Debre Berhan Univ, Collage Hlth Sci, Inst Med & Hlth Sci, Dept Publ Hlth, Debre Berhan, Ethiopia; [Temiru, Deselegn; Belachew, Tefera] Jimma Univ, Fac Publ Hlth, Dept Nutr & Dietet, Jimma, Ethiopia	Jimma University	Lambebo, A (corresponding author), Debre Berhan Univ, Collage Hlth Sci, Inst Med & Hlth Sci, Dept Publ Hlth, Debre Berhan, Ethiopia.	lambebo70@gmail.com						Abitew DB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231524; Akparibo R, 2015, RELATIONSHIPS RECOVE; Ali E, 2013, T ROY SOC TROP MED H, V107, P319, DOI 10.1093/trstmh/trt018; Bank World., 2012, COMBATING MALNUTRITI; Briend A, 2019, HDB FAMINE STARVATIO, P705, DOI [10.1007/978-3-319-55387-0_11, DOI 10.1007/978-3-319-55387-0_11]; Bsma, 2017, SEVERE CHILDHOOD MAL, P3; Di Giovanni V, 2016, J NUTR, V146, P2436, DOI 10.3945/jn.116.239145; Fabiansen C, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0679; Global Data, 2021, TOP TRENDS BEAUT GRO; Harshal T., 2012, VARIOUS ANTHROPOMETR; KDe. Comparative national and regional figures comes from the World Bank publication, 2007, WP 2991 ARCHIVED WAY; Plaza U, UNICEF STRATEGIC PLA; Stobaugh HC, 2017, AM J CLIN NUTR, V106, P657, DOI 10.3945/ajcn.116.149799; Tadesse AW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121339; Trehan I, 2015, J PEDIATR GASTR NUTR, V60, P544, DOI 10.1097/MPG.0000000000000639; UNICEF, 2019, STATE WORLDS CHILDRE, DOI DOI 10.18356/A4D964A5-EN; VALENTINA PEVERI., 1997, NUTR IDENTITY HADIYA; WHO UNICEF, 2009, 20 AVENUE APPIA, V1211; WHO Wh, ORGANIZATION; WHO WHO, 2013, GUIDELINE UPDATES MA; Wikipedia, ETHIOPIA FREE ENCYCL; World Health Organization, 2009, WHO CHILD GROWTH STA	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249232	10.1371/journal.pone.0249232	http://dx.doi.org/10.1371/journal.pone.0249232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765081	Green Published, gold			2022-12-26	WOS:000634832800047
J	Selveindran, SM; Samarutilake, GDN; Vera, DS; Brayne, C; Hill, C; Kolias, A; Joannides, AJ; Hutchinson, PJA; Rubiano, AM				Selveindran, Santhani M.; Samarutilake, Gurusinghe D. N.; Vera, David Santiago; Brayne, Carol; Hill, Christine; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.; Rubiano, Andres M.			Prevention of road traffic collisions and associated neurotrauma in Colombia: An exploratory qualitative study	PLOS ONE			English	Article								Introduction Neurotrauma is an important but preventable cause of death and disability worldwide, with the majority being associated with road traffic collisions (RTCs). The greatest burden is seen in low -and middle- income countries (LMICs) where variations in the environment, infrastructure, population and habits can challenge the success of conventional preventative approaches. It is therefore necessary to understand local perspectives to allow for the development and implementation of context-specific strategies which are effective and sustainable. Methods This study took place in Colombia where qualitative data collection was carried out with ten key informants between October and November 2019. Semi-structured interviews were conducted and explored perceptions on RTCs and neurotrauma, preventative strategies and interventions, and the role of research in prevention. Interview transcripts were analysed by thematic analysis using a framework approach. Results Participants' confirmed that RTCs are a significant problem in Colombia with neurotrauma as an important outcome. Human and organisational factors were identified as key causes of the high rates of RTCs. Participants described the current local preventative strategies, but were quick to discuss limitations and challenges to their success. Key barriers reported were poor attitudes and knowledge, particularly in the community. Suggestions were provided on ways to improve prevention through better education and awareness, stricter enforcement and new policies on prevention, proper budgeting and resource allocation, as well as through collaboration and changes in attitudes and leadership. Participants identified four key research areas they felt would influence prevention of RTCs and associated neurotrauma: causes of RTCs; consequences and impact of RTCs; public involvement in research; improving prevention. Conclusion RTCs are a major problem in Colombia despite the current preventative strategies and interventions. Findings from this study have a potential to influence policy, practice and research by illustrating different solutions to the challenges surrounding prevention and by highlighting areas for further research.	[Selveindran, Santhani M.; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.] Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Selveindran, Santhani M.; Vera, David Santiago; Brayne, Carol; Hill, Christine; Kolias, Angelos; Joannides, Alexis J.; Hutchinson, Peter J. A.; Rubiano, Andres M.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Samarutilake, Gurusinghe D. N.] Minist Hlth, Directorate Healthcare Qual & Safety, Colombo, Sri Lanka; [Samarutilake, Gurusinghe D. N.; Brayne, Carol; Hill, Christine] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Vera, David Santiago; Rubiano, Andres M.] Meditech Fdn, Cali, Colombia; [Rubiano, Andres M.] Univ El Bosque, Neurosci Inst, Bogota, Colombia	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; Universidad El Bosque	Selveindran, SM (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England.; Selveindran, SM (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	ss2604@medschl.cam.ac.uk		M Selveindran, Santhani/0000-0002-3734-1189; Brayne, Carol/0000-0001-5307-663X	National Institute for Health Research (NIHR) [RG89187]; UK Government	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Government	This research was commissioned by the National Institute for Health Research (NIHR) (Grant Number: RG89187) using UK aid from the UK Government. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Alonso F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122828; Asaba E, 2018, SCAND J OCCUP THER, V25, P309, DOI 10.1080/11038128.2018.1541224; Astbury NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238645; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Centers for Disase Control and Prevention, 2014, REPORT C TRAUMATIC B; Coles E, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0566-8; Cook N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026514; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhibi M, 2019, INT J INJ CONTROL SA, V26, P99, DOI 10.1080/17457300.2018.1482926; Dijkink S, 2017, J TRAUMA ACUTE CARE, V83, P917, DOI 10.1097/TA.0000000000001633; DiPietro G., 2009, 4 IRTAD C; Elliott B., 2003, P AUSTRALASIAN ROAD, V7, P246; Elmendorf W. F., 2006, Arboriculture & Urban Forestry, V32, P54; Essex R, 2019, J ROY SOC MED, V112, P456, DOI 10.1177/0141076819865867; European Transport Safety Council, 2019, STATUS TRAFFIC SAFET; Federacion de Aseguaradores Colombianos, 2018, COSTOS ACCIDENTALIDA; Federation Internationale de l'Automobile (FIA), 2017, 3500LIVES CAMPAIGN G; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; GOTTESMAN II, 1989, SCHIZOPHRENIA BULL, V15, P5, DOI 10.1093/schbul/15.1.5; Gururaj G., 2005, NATL I MENTAL HLTH N; Hackett A, 2018, NURSE RES, V26, P8, DOI 10.7748/nr.2018.e1580; Heydari S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226249; Hispanics In Philanthropy (HIP) Give, 2014, 5 FAMOUS COLOMBIANS; Holmes BD, 2019, INT J INJ CONTROL SA, V26, P194, DOI 10.1080/17457300.2018.1535512; Howat P, 2001, J COMMUN HEALTH, V26, P257, DOI 10.1023/A:1010304511244; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jull J, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0696-3; Khorasani-Zavareh D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-486; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Kiragu AW, 2017, J PEDIATR INTENSIVE, V6, P52, DOI 10.1055/s-0036-1584676; Knoll J, 2017, J ACAD MARKET SCI, V45, P55, DOI 10.1007/s11747-016-0503-8; Kwon SC, 2018, TRANSL BEHAV MED, V8, P683, DOI 10.1093/tbm/ibx026; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McKenna F., 2010, ROAD SAFETY ED ARE W; McKenna SA, 2013, ACTION RES-LONDON, V11, P113, DOI 10.1177/1476750312473342; Ministerio de Transporte, 2015, PLAN NACL SEGURIDAD; Mohan D., ROAD TRAFFIC INJURY; Parsons JA., 2019, ENCY SURVEY RES METH, P406; Pratt B, 2019, HEALTH POLICY PLANN, V34, P346, DOI 10.1093/heapol/czz041; Quitian-Reyes H, 2017, J CLIN EPIDEMIOL, V86, P101, DOI 10.1016/j.jclinepi.2016.04.017; Razmkon Ali, 2013, Bull Emerg Trauma, V1, P5; Reynolds TA, 2017, ANNU REV PUBL HEALTH, V38, P507, DOI 10.1146/annurev-publhealth-032315-021412; Rodriguez Deysi Yasmin, 2003, Inj Control Saf Promot, V10, P29; Hernandez JMR, 2016, CIENC SAUDE COLETIVA, V21, P3793, DOI 10.1590/1413-812320152112.06732015; Rodriguez-Hernandez JM., 2017, ARCH MED, V9, DOI [10.21767/1989-5216.1000228, DOI 10.21767/1989-5216.1000228]; Rojas IC, 2019, P 13 WORLD C; Rolison JJ, 2018, ACCIDENT ANAL PREV, V115, P11, DOI 10.1016/j.aap.2018.02.025; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Stange KC., 2013, ARHQ PUBLICATION NO; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Synnot A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019481; Tetali S, 2013, INJURY, V44, pS17, DOI 10.1016/S0020-1383(13)70208-0; The British Institute of Traffic Education Research (BITER) and The Transport Research Laboratory (TRL), ROAD SAFETY ED SECON; The World Bank, 2019, WORLD INCOME REGION; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vergel E., 2018, PAVING PATHWAYS CHAN; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2004, WORLD REPORT ROAD TR; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000	63	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249004	10.1371/journal.pone.0249004	http://dx.doi.org/10.1371/journal.pone.0249004			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765057	Green Published, gold			2022-12-26	WOS:000634832800003
J	Shrestha, S; Singhal, S; Sens, DA; Somji, S; Davis, BA; Guyer, R; Breen, S; Kalonick, M; Garrett, SH				Shrestha, Swojani; Singhal, Sandeep; Sens, Donald A.; Somji, Seema; Davis, Bethany A.; Guyer, Rachel; Breen, Spencer; Kalonick, Matthew; Garrett, Scott H.			Elevated glucose represses lysosomal and mTOR-related genes in renal epithelial cells composed of progenitor CD133(+) cells	PLOS ONE			English	Article								Hyperglycemia is one of the major health concern in many parts of the world. One of the serious complications of high glucose levels is diabetic nephropathy. The preliminary microarray study performed on primary human renal tubular epithelial (hRTE) cells exposed to high glucose levels showed a significant downregulation of mTOR as well as its associated genes as well as lysosomal genes. Based on this preliminary data, the expression of various lysosomal genes as well as mTOR and its associated genes were analyzed in hRTE cells exposed to 5.5, 7.5, 11 and 16 mM glucose. The results validated the microarray analysis, which showed a significant decrease in the mRNA as well as protein expression of the selected genes as the concentration of glucose increased. Co-localization of lysosomal marker, LAMP1 with mTOR showed lower expression of mTOR as the glucose concentration increased, suggesting decrease in mTOR activity. Although the mechanism by which glucose affects the regulation of lysosomal genes is not well known, our results suggest that high levels of glucose may lead to decrease in mTOR expression causing the cells to enter an anabolic state with subsequent downregulation of lysosomal genes.	[Shrestha, Swojani; Singhal, Sandeep; Sens, Donald A.; Somji, Seema; Guyer, Rachel; Breen, Spencer; Kalonick, Matthew; Garrett, Scott H.] Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58202 USA; [Davis, Bethany A.] Translat Genom Res Inst, Phoenix, AZ USA	University of North Dakota Grand Forks; Translational Genomics Research Institute	Garrett, SH (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Pathol, Grand Forks, ND 58202 USA.	scott.garrett@und.edu		Davis, Bethany/0000-0001-9477-0847; Shrestha, Swojani/0000-0003-4798-3799	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE IDeA program from the National Institute of General Medical Sciences, NIH [P20 GM103442]; ND INBRE; NIH COBRE IDeA grant from the National Institute of General Medical Sciences, NIH [5P20GM113123]	Department of Pathology; School of Medicine and Health Sciences, University of North Dakota; ND INBRE IDeA program from the National Institute of General Medical Sciences, NIH; ND INBRE; NIH COBRE IDeA grant from the National Institute of General Medical Sciences, NIH	The research described was supported by funds provided by the Department of Pathology and the School of Medicine and Health Sciences, University of North Dakota. Undergraduate research, graduate student mentoring, core facilities for bioinformatics, statistics, and gene expression were supported by the ND INBRE IDeA program P20 GM103442 from the National Institute of General Medical Sciences, NIH. The FACS analysis core is a joint venture supported by the ND INBRE and the NIH COBRE IDeA grant, 5P20GM113123 from the National Institute of General Medical Sciences, NIH.	Bathula CS, 2008, TOXICOL SCI, V102, P310, DOI 10.1093/toxsci/kfn004; Bendavit G, 2016, J BIOL CHEM, V291, P25476, DOI 10.1074/jbc.M116.760249; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; BYLANDER JE, 1990, DIABETES, V39, P949, DOI 10.2337/diabetes.39.8.949; Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016; de Haan JB, 2011, DIABETES, V60, P2683, DOI 10.2337/db11-1072; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Garrett SH, 1998, ENVIRON HEALTH PERSP, V106, P587, DOI 10.2307/3434234; Gewin LS, 2018, MATRIX BIOL, V68-69, P248, DOI 10.1016/j.matbio.2018.02.006; Gilbert RE, 2017, DIABETES, V66, P791, DOI 10.2337/db16-0796; Haynes W., 2013, ENCY SYSTEMBIOL, P78, DOI [10.1007/978-1-4419-9863-7_1215, DOI 10.1007/978-1-4419-9863-7_1215]; HAZENMARTIN DJ, 1989, KIDNEY INT, V35, P31, DOI 10.1038/ki.1989.5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim D, 2002, KIDNEY INT, V61, P464, DOI 10.1046/j.1523-1755.2002.00153.x; Kim Hae-Young, 2014, Restor Dent Endod, V39, P74, DOI 10.5395/rde.2014.39.1.74; Kirch Wilhelm, 2008, PEARSONS CORRELATION, P1090, DOI [DOI 10.1007/978-1-4020-5614-7_2569, 10.1007/978-1-4020-5614-7_2569]; Lawrence RE, 2019, NAT CELL BIOL, V21, P133, DOI 10.1038/s41556-018-0244-7; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Myers J. L., 2010, RES DESIGN STAT ANAL; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Peto R, 2011, BRIT J CANCER, V104, P1057, DOI 10.1038/bjc.2011.79; Rabanal-Ruiz Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030818; Romagnani P, 2014, STEM CELL RES, V12, P828, DOI 10.1016/j.scr.2013.12.011; Romagnani P, 2013, NAT REV NEPHROL, V9, P137, DOI 10.1038/nrneph.2012.290; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Rowan S, 2018, BBA-MOL BASIS DIS, V1864, P3631, DOI 10.1016/j.bbadis.2018.08.036; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; Settembre C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016907; Shrestha S, 2019, TOXICOL APPL PHARM, V375, P5, DOI 10.1016/j.taap.2019.05.007; Shrestha S, 2017, TOXICOL APPL PHARM, V331, P116, DOI 10.1016/j.taap.2017.05.038; Slusser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120132; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Song PN, 2019, AM J PHYSIOL-RENAL, V317, pF207, DOI 10.1152/ajprenal.00120.2019; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Surendran K, 2014, PEDIATR NEPHROL, V29, P2253, DOI 10.1007/s00467-013-2652-z; TODD JH, 1993, IN VITRO CELL DEV-AN, V29A, P371; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Wang W, 2017, ONCOTARGET, V8, P111770, DOI 10.18632/oncotarget.22907; Zeni L, 2017, J NEPHROL, V30, P701, DOI 10.1007/s40620-017-0423-9	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248241	10.1371/journal.pone.0248241	http://dx.doi.org/10.1371/journal.pone.0248241			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764985	gold, Green Published			2022-12-26	WOS:000634832800085
J	Puwanant, S; Sinphurmsukskul, S; Krailak, L; Nakaviroj, P; Boonbumrong, N; Siwamogsatham, S; Chettakulanurak, K; Ariyachaipanich, A; Boonyaratavej, S				Puwanant, Sarinya; Sinphurmsukskul, Supanee; Krailak, Laddawan; Nakaviroj, Pavinee; Boonbumrong, Noppawan; Siwamogsatham, Sarawut; Chettakulanurak, Krailerk; Ariyachaipanich, Aekarach; Boonyaratavej, Smonporn			The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure	PLOS ONE			English	Article								Background We sought to investigate the impact of the COVID-19 pandemic and the Tele-HF Clinic (Tele-HFC) program on cardiovascular death, heart failure (HF) rehospitalization, and heart transplantation rates in a cohort of ambulatory HF patients during and after the peak of the pandemic. Methods Using the HF clinic database, we compared data of patients with HF before, during, and after the peak of the pandemic (January 1 to March 17 [pre-COVID], March 17 to May 31 [peak-COVID], and June 1 to October 1 [post-COVID]). During peak-COVID, all patients were managed by Tele-HFC or hospitalization. After June 1, patients chose either a face-to-face clinic visit or a continuous tele-clinic visit. Results Cardiovascular death and medical titration rates were similar in peak-COVID compared with all other periods. HF readmission rates were significantly lower in peak-COVID (8.7% vs. 2.5%, p<0.001) and slightly increased (3.5%) post-COVID. Heart transplant rates were substantially increased in post-COVID (4.5% vs. peak-COVID [0%], p = 0.002). After June 1, 38% of patients continued with the Tele-HFC program. Patients managed by the Tele-HFC program for <6 months were less likely to have HF with reduced ejection fraction (73% vs. 54%, p = 0.005) and stage-D HF (33% vs. 14%, p = 0.001), and more likely to achieve the target neurohormonal blockade dose (p<0.01), compared with the >= 6-month Tele-HFC group. Conclusions HF rehospitalization and transplant rates significantly declined during the pandemic in ambulatory care of HF. However, reduction in these rates did not affect subsequent 5-month hospitalization and cardiovascular mortality in the setting of Tele-HFC program and continuum of advanced HF therapies.	[Puwanant, Sarinya; Sinphurmsukskul, Supanee; Krailak, Laddawan; Nakaviroj, Pavinee; Boonbumrong, Noppawan; Siwamogsatham, Sarawut; Chettakulanurak, Krailerk; Ariyachaipanich, Aekarach; Boonyaratavej, Smonporn] Chulalongkorn Univ, Div Cardiol, Dept Med, Fac Med, Bangkok, Thailand; [Puwanant, Sarinya; Sinphurmsukskul, Supanee; Krailak, Laddawan; Nakaviroj, Pavinee; Boonbumrong, Noppawan; Siwamogsatham, Sarawut; Chettakulanurak, Krailerk; Ariyachaipanich, Aekarach; Boonyaratavej, Smonporn] King Chulalongkorn Mem Hosp, Cardiac Ctr, Thai Red Cross Soc, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society	Puwanant, S (corresponding author), Chulalongkorn Univ, Div Cardiol, Dept Med, Fac Med, Bangkok, Thailand.; Puwanant, S (corresponding author), King Chulalongkorn Mem Hosp, Cardiac Ctr, Thai Red Cross Soc, Bangkok, Thailand.	spuwanant@gmail.com						Andersson C, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007274; Ansari M, 2003, CIRCULATION, V107, P2799, DOI 10.1161/01.CIR.0000070952.08969.5B; Boyne JJJ, 2012, EUR J HEART FAIL, V14, P791, DOI 10.1093/eurjhf/hfs058; Bromage DI, 2020, EUR J HEART FAIL, V22, P978, DOI 10.1002/ejhf.1925; Chaudhry SI, 2007, J CARD FAIL, V13, P56, DOI 10.1016/j.cardfail.2006.09.001; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Cleland JGF, 2005, J AM COLL CARDIOL, V45, P1654, DOI 10.1016/j.jacc.2005.01.050; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Dendale P, 2012, EUR J HEART FAIL, V14, P333, DOI 10.1093/eurjhf/hfr144; Dickinson MG, 2018, J CARD FAIL, V24, P682, DOI 10.1016/j.cardfail.2018.08.011; Dunagan WC, 2005, J CARD FAIL, V11, P358, DOI 10.1016/j.cardfail.2004.12.004; Gallagher BD, 2017, J CARD FAIL, V23, P345, DOI 10.1016/j.cardfail.2016.11.001; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Gorodeski EZ, 2020, J CARD FAIL, V26, P448, DOI 10.1016/j.cardfail.2020.04.008; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Moyer-Knox D, 2004, J CARD FAIL, V10, P219, DOI 10.1016/j.cardfail.2003.09.009; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Wilcox JE, 2020, J AM COLL CARDIOL, V76, P719, DOI 10.1016/j.jacc.2020.05.075; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	19	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249043	10.1371/journal.pone.0249043	http://dx.doi.org/10.1371/journal.pone.0249043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755715	gold, Green Published			2022-12-26	WOS:000632916600012
J	Zou, JN; Sun, L; Wang, BR; Zou, Y; Xu, S; Ding, YJ; Shen, LJ; Huang, WC; Jiang, XJ; Chen, SM				Zou, Jia-Ni; Sun, Liu; Wang, Bin-Ru; Zou, You; Xu, Shan; Ding, Yong-Jun; Shen, Li-Jun; Huang, Wen-Cai; Jiang, Xiao-Jing; Chen, Shi-Ming			The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; EXERCISE CAPACITY; IMPACT	The characteristics and evolution of pulmonary fibrosis in patients with coronavirus disease 2019 (COVID-19) have not been adequately studied. AI-assisted chest high-resolution computed tomography (HRCT) was used to investigate the proportion of COVID-19 patients with pulmonary fibrosis, the relationship between the degree of fibrosis and the clinical classification of COVID-19, the characteristics of and risk factors for pulmonary fibrosis, and the evolution of pulmonary fibrosis after discharge. The incidence of pulmonary fibrosis in patients with severe or critical COVID-19 was significantly higher than that in patients with moderate COVID-19. There were significant differences in the degree of pulmonary inflammation and the extent of the affected area among patients with mild, moderate and severe pulmonary fibrosis. The IL-6 level in the acute stage and albumin level were independent risk factors for pulmonary fibrosis. Ground-glass opacities, linear opacities, interlobular septal thickening, reticulation, honeycombing, bronchiectasis and the extent of the affected area were significantly improved 30, 60 and 90 days after discharge compared with at discharge. The more severe the clinical classification of COVID-19, the more severe the residual pulmonary fibrosis was; however, in most patients, pulmonary fibrosis was improved or even resolved within 90 days after discharge.	[Zou, Jia-Ni; Huang, Wen-Cai] Gen Hosp Cent Theater Command PLA, Dept Radiol, Wuhan, Hubei, Peoples R China; [Sun, Liu] Gen Hosp Cent Theater Command PLA, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Wang, Bin-Ru] Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Zou, You; Xu, Shan; Ding, Yong-Jun; Shen, Li-Jun; Chen, Shi-Ming] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Jiang, Xiao-Jing] Gen Hosp Cent Theater Command PLA, Dept Infect Dis, Wuhan, Hubei, Peoples R China; [Chen, Shi-Ming] Wuhan Univ, Renmin Hosp, Inst Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Chen, SM (corresponding author), Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China.; Chen, SM (corresponding author), Wuhan Univ, Renmin Hosp, Inst Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China.	shimingchen0468@163.com			National Natural Science Foundation of China [81770981, 82002863]; Wuhan Municipality Young and Middle-aged Medical Talent Cultivation Program [[2018]116]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Municipality Young and Middle-aged Medical Talent Cultivation Program	This study was supported by grant 81770981 and 82002863 from the National Natural Science Foundation of China and grant [2018]116 from Wuhan Municipality Young and Middle-aged Medical Talent Cultivation Program.	Baratella E, 2020, J BRAS PNEUMOL, V46, DOI 10.36416/1806-3756/e20200226; Camiciottoli G, 2007, CHEST, V131, P672, DOI 10.1378/chest.06-1401; China National Health Commission, 2020, DIAGNOSIS TREATMENT, V7th; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16; Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440; George PM, 2020, LANCET RESP MED, V8, P807, DOI 10.1016/S2213-2600(20)30225-3; Hui DS, 2005, CHEST, V128, P2247, DOI 10.1378/chest.128.4.2247; Jacob J, 2018, EUR RADIOL, V28, P1318, DOI 10.1007/s00330-017-5053-z; Li Meng, 2020, Radiol Infect Dis, V7, P51, DOI 10.1016/j.jrid.2020.04.001; Moitra S, 2015, CURR OPIN PULM MED, V21, P114, DOI 10.1097/MCP.0000000000000136; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Qi XL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.91; Sheng GH, 2020, CHEST, V157, P1175, DOI 10.1016/j.chest.2019.10.032; Spagnolo P, 2015, PHARMACOL THERAPEUT, V152, P18, DOI 10.1016/j.pharmthera.2015.04.005; Wan SX, 2020, BRIT J HAEMATOL, V189, P428, DOI 10.1111/bjh.16659; Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244; Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047; Zhang PX, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0084-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zinellu A, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13427; Zou Y, 2020, J INFECT DIS, V222, P1784, DOI 10.1093/infdis/jiaa301	23	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248957	10.1371/journal.pone.0248957	http://dx.doi.org/10.1371/journal.pone.0248957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755708	gold, Green Published			2022-12-26	WOS:000632916600001
J	Locatelli, I; Trachsel, B; Rousson, V				Locatelli, Isabella; Traechsel, Bastien; Rousson, Valentin			Estimating the basic reproduction number for COVID-19 in Western Europe	PLOS ONE			English	Article							COMPUTATION; DYNAMICS; MODELS	Objective To estimate the basic reproduction number (R-0) for COVID-19 in Western Europe. Methods Data (official statistics) on the cumulative incidence of COVID-19 at the start of the outbreak (before any confinement rules were declared) were retrieved in the 15 largest countries in Western Europe, allowing us to estimate the exponential growth rate of the disease. The rate was then combined with estimates of the distribution of the generation interval as reconstructed from the literature. Results Despite the possible unreliability of some official statistics about COVID-19, the spread of the disease appears to be remarkably similar in most European countries, allowing us to estimate an average R-0 in Western Europe of 2.2 (95% CI: 1.9-2.6). Conclusions The value of R-0 for COVID-19 in Western Europe appears to be significantly lower than that in China. The proportion of immune persons in the European population required to stop the outbreak could thus be closer to 50% than to 70%.	[Locatelli, Isabella; Traechsel, Bastien; Rousson, Valentin] Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland	University of Lausanne	Rousson, V (corresponding author), Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland.	valentin.rousson@unisante.ch		Trachsel, Bastien/0000-0002-4519-094X; Rousson, Valentin/0000-0001-8092-4446				Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Billah MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242128; Chintalapudi N, 2020, INT J INFECT DIS, V96, P327, DOI 10.1016/j.ijid.2020.05.029; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Ganyani T., 2020, EUROSURVEILLANCE, V25, P2000257; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Hilton J, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008031; Hyafil A, 2021, GAC SANIT, V35, P453, DOI 10.1016/j.gaceta.2020.05.003; Ioannidis J., FIASCO MAKING CORONA; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kirkwood B. R., 2003, MED STAT; Li Q., 2020, NEW ENGL J MED, V382, P1199; Musa SS, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00718-y; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Ogden RT, 2006, BIOSTATISTICS, V7, P115, DOI 10.1093/biostatistics/kxi044; Schweder T, 2002, SCAND J STAT, V29, P309, DOI 10.1111/1467-9469.00285; TUKEY JW, 1972, Q APPL MATH, V30, P51, DOI 10.1090/qam/99740; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; You C, 2020, INT J HYG ENVIR HEAL, V228, DOI 10.1016/j.ijheh.2020.113555; Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050; Zhao S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa033	28	28	28	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248731	10.1371/journal.pone.0248731	http://dx.doi.org/10.1371/journal.pone.0248731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730041	Green Published, gold			2022-12-26	WOS:000630345000051
J	Rettew, DC; McGinnis, EW; Copeland, W; Nardone, HY; Bai, Y; Rettew, J; Devadenam, V; Hudziak, JJ				Rettew, David C.; McGinnis, Ellen W.; Copeland, William; Nardone, Hilary Y.; Bai, Yang; Rettew, Jeff; Devadenam, Vinay; Hudziak, James J.			Personality trait predictors of adjustment during the COVID pandemic among college students	PLOS ONE			English	Article								Personality traits have been found to be related to a variety of health outcomes. The aim of this study was to examine how personality traits were associated with adjustment to the COVID pandemic in college students. The sample included 484 first-year university students (76% female) attending a northeastern university who completed the Big Five Inventory (BFI) personality assessment at the beginning of a semester that was disrupted by the COVID pandemic. Using a phone-based app, students completed daily ratings of mood, perceived stress levels, and engagement in a number of health promotion activities (exercise, mindfulness, adequate sleep, etc.) throughout the semester both before and after the onset of the pandemic (e.g., a within-person longitudinal design). Results, as expected, showed that mood and wellness indices generally declined during the COVID period, although stress levels actually decreased. Further, irrespective of COVID, improved mood, less perceived stress and greater participation in health promotion activities were significantly associated with a number of personality traits including neuroticism (lower), extraversion (higher), agreeableness (higher), and conscientiousness (higher). Of primary interest, mixed-effects models were used to test how major personality traits interacted with any changes in daily ratings from the pre-COVID to COVID period. Significant interactions terms were found suggesting differential impacts of the COVID epidemic for students with low versus high levels of particular traits. Higher levels of extraversion, for example, were found to be related to decreases in mood as the pandemic progressed in contrast to those with lower extraversion, for whom there was a slight increase in mood over time. These data support the conclusion that personality traits are related to mental health and can play a role in a person's ability to cope with major stressful events. Different traits may also be more adaptive to different types of stressors.	[Rettew, David C.; McGinnis, Ellen W.; Copeland, William; Hudziak, James J.] Univ Vermont, Dept Psychiat, Larner Coll Med, Vermont Ctr Children Youth & Families, Burlington, VT 05405 USA; [Rettew, David C.] Vermont Dept Mental Hlth, Child Adolescent & Family Unit, Waterbury, VT 05671 USA; [Nardone, Hilary Y.; Rettew, Jeff; Devadenam, Vinay; Hudziak, James J.] Univ Vermont, Wellness Environm, Burlington, VT USA; [Bai, Yang] Univ Utah, Dept Hlth & Kinesiol, Salt Lake City, UT USA; [Bai, Yang] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT USA	University of Vermont; University of Vermont; Utah System of Higher Education; University of Utah; University of Vermont	Rettew, DC (corresponding author), Univ Vermont, Dept Psychiat, Larner Coll Med, Vermont Ctr Children Youth & Families, Burlington, VT 05405 USA.; Rettew, DC (corresponding author), Vermont Dept Mental Hlth, Child Adolescent & Family Unit, Waterbury, VT 05671 USA.	david.rettew@med.uvm.edu	Copeland, William E/N-5413-2014	Copeland, William E/0000-0002-1348-7781; Rettew, David/0000-0002-4584-1634; Rettew, Jeffrey/0000-0002-4238-5979; Bai, Yang/0000-0001-6751-3896	Conrad Hilton Foundation	Conrad Hilton Foundation	This work was supported by a grant to Dr. Jim Hudziak from the Conrad Hilton Foundation (https://www.hiltonfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM., 2009, ACHENBACH SYSTEM EMP; [Anonymous], 2013, CHILD TEMPERAMENT NE; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Bogg T, 2013, ANN BEHAV MED, V45, P278, DOI 10.1007/s12160-012-9454-6; Bucher MA, 2019, CLIN PSYCHOL REV, V70, P51, DOI 10.1016/j.cpr.2019.04.002; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Copeland WE, 2021, J AM ACAD CHILD PSY, V60, P134, DOI 10.1016/j.jaac.2020.08.466; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Eley DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160028; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Healthline Media, 2020, HEALTHL MENT HLTH IN; Hudziak JJ, 2017, CHILD ADOL PSYCH CL, V26, P381, DOI 10.1016/j.chc.2016.12.016; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Lipson SK, 2019, PSYCHIAT SERV, V70, P60, DOI 10.1176/appi.ps.201800332; McAdams TA., 2015, ART SCI PERSONALITY; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Moran L, 2017, J RES PERS, V67, P61, DOI 10.1016/j.jrp.2016.03.003; Oshio A, 2018, PERS INDIV DIFFER, V127, P54, DOI 10.1016/j.paid.2018.01.048; Pedrelli P, 2015, ACAD PSYCHIATR, V39, P503, DOI 10.1007/s40596-014-0205-9; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Robins RW, 2001, J PERS, V69, P617, DOI 10.1111/1467-6494.694157; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Strickhouser JE, 2017, HEALTH PSYCHOL, V36, P797, DOI 10.1037/hea0000475; Tian FY, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112992; Twenge JM, 2020, J CLIN PSYCHOL, V76, P2170, DOI 10.1002/jclp.23064; Wachs TD, 2006, ANN NY ACAD SCI, V1094, P28, DOI 10.1196/annals.1376.004	28	18	18	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248895	10.1371/journal.pone.0248895	http://dx.doi.org/10.1371/journal.pone.0248895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730075	gold, Green Published			2022-12-26	WOS:000630345000050
J	Wargnies, M; Plazolles, N; Schenk, R; Villafraz, O; Dupuy, JW; Biran, M; Bachmaier, S; Baudouin, H; Clayton, C; Boshart, M; Bringaud, F				Wargnies, Marion; Plazolles, Nicolas; Schenk, Robin; Villafraz, Oriana; Dupuy, Jean-William; Biran, Marc; Bachmaier, Sabine; Baudouin, Helene; Clayton, Christine; Boshart, Michael; Bringaud, Frederic			Metabolic selection of a homologous recombination-mediated gene loss protects Trypanosoma brucei from ROS production by glycosomal fumarate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASPARTATE OXIDASE; DEHYDROGENASE GENE; ESCHERICHIA-COLI; LINEAR AMPLICONS; ENZYME; AMPLIFICATION; EXPRESSION; IDENTIFICATION; SUPEROXIDE; GENERATION	The genome of trypanosomatids rearranges by using repeated sequences as platforms for amplification or deletion of genomic segments. These stochastic recombination events have a direct impact on gene dosage and foster the selection of adaptive traits in response to environmental pressure. We provide here such an example by showing that the phosphoenolpyruvate carboxykinase (PEPCK) gene knockout (Delta pepck) leads to the selection of a deletion event between two tandemly arranged fumarate reductase (FRDg and FRDm2) genes to produce a chimeric FRDg-m2 gene in the Delta pepck* cell line. FRDg is expressed in peroxisome-related organelles, named glycosomes, expression of FRDm2 has not been detected to date, and FRDg-m2 is nonfunctional and cytosolic. Reexpression of FRDg significantly impaired growth of the Delta pepck* cells, but FRD enzyme activity was not required for this negative effect. Instead, glycosomal localization as well as the covalent flavinylation motif of FRD is required to confer growth retardation and intracellular accumulation of reactive oxygen species (ROS). The data suggest that FRDg, similar to Escherichia coli FRD, can generate ROS in a flavin-dependent process by transfer of electrons from NADH to molecular oxygen instead of fumarate when the latter is unavailable, as in the Delta pepck background. Hence, growth retardation is interpreted as a consequence of increased production of ROS, and rearrangement of the FRD locus liberates Delta pepck* cells from this obstacle. Interestingly, intracellular production of ROS has been shown to be required to complete the parasitic cycle in the insect vector, suggesting that FRDg may play a role in this process.	[Wargnies, Marion; Plazolles, Nicolas; Villafraz, Oriana; Baudouin, Helene; Bringaud, Frederic] Univ Bordeaux, UMR 5234, Microbiol Fondamentale & Pathogenicite MFP, CNRS, Bordeaux, France; [Wargnies, Marion; Biran, Marc; Baudouin, Helene; Bringaud, Frederic] Univ Bordeaux, CNRS, Ctr Resonance Magnet Syst Biol CRMSB, UMR 5536, Bordeaux, France; [Schenk, Robin; Bachmaier, Sabine; Boshart, Michael] Ludwig Maximilians Univ Munchen, Genet, Fak Biol, Martinsried, Germany; [Dupuy, Jean-William] Univ Bordeaux, Plateforme Proteome, Bordeaux, France; [Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, Univ Heidelberg ZBMH, Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Munich; UDICE-French Research Universities; Universite de Bordeaux; Ruprecht Karls University Heidelberg	Bringaud, F (corresponding author), Univ Bordeaux, UMR 5234, Microbiol Fondamentale & Pathogenicite MFP, CNRS, Bordeaux, France.; Bringaud, F (corresponding author), Univ Bordeaux, CNRS, Ctr Resonance Magnet Syst Biol CRMSB, UMR 5536, Bordeaux, France.; Boshart, M (corresponding author), Ludwig Maximilians Univ Munchen, Genet, Fak Biol, Martinsried, Germany.	boshart@lmu.de; frederic.bringaud@u-bordeaux.fr	Dupuy, Jean-William JWD/F-5335-2012; Boshart, Michael/A-2700-2011	Dupuy, Jean-William JWD/0000-0002-2448-4797; Boshart, Michael/0000-0002-5070-2663; PLAZOLLES, Nicolas/0000-0002-7186-3765; Bachmaier, Sabine/0000-0001-7416-8613; VILLAFRAZ, Oriana/0000-0001-6927-7276; Baudouin, Helene/0000-0002-3480-0685; Clayton, Christine/0000-0002-6384-0731	Faculty of Biology of LMU	Faculty of Biology of LMU	Work in the Munich lab was supported by a student research fellowship and the BioNa junior career award of the Faculty of Biology of LMU to R. S. and S. B., respectively.	Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Bassarak B, 2011, CELL PHYSIOL BIOCHEM, V27, P411, DOI 10.1159/000327968; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2015, MOL MICROBIOL, V96, P917, DOI 10.1111/mmi.12990; BRUN R, 1979, ACTA TROP, V36, P289; Chiasson D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46171-2; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Denise H, 1999, EUR J BIOCHEM, V259, P339, DOI 10.1046/j.1432-1327.1999.00048.x; Deramchia K, 2014, J BIOL CHEM, V289, P17365, DOI 10.1074/jbc.M114.567230; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dolezelova E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000741; Dubessay P, 2001, NUCLEIC ACIDS RES, V29, P3231, DOI 10.1093/nar/29.15.3231; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Elahian F, 2014, CRIT REV BIOTECHNOL, V34, P134, DOI 10.3109/07388551.2012.732031; GARVEY EP, 1986, SCIENCE, V233, P535, DOI 10.1126/science.3726545; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; GRONDIN K, 1993, NUCLEIC ACIDS RES, V21, P1895, DOI 10.1093/nar/21.8.1895; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Harlow E., 1988, ANTIBODIES LAB MANUA; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2007, MOL BIOCHEM PARASIT, V151, P129, DOI 10.1016/j.molbiopara.2006.10.004; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Meehan BM, 2012, MICROBIOL-SGM, V158, P539, DOI 10.1099/mic.0.054403-0; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mulindwa J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006280; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; NASU S, 1982, J BIOL CHEM, V257, P626; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; OLMO A, 1995, NUCLEIC ACIDS RES, V23, P2856, DOI 10.1093/nar/23.15.2856; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P21, DOI 10.1111/j.1432-1033.1977.tb11566.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; PATNAIK PK, 1994, MOL BIOCHEM PARASIT, V66, P153, DOI 10.1016/0166-6851(94)90047-7; Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schenk R, 2021, FEBS J, V288, P5430, DOI 10.1111/febs.15812; Serebryakova MV, 2018, BIOCHIMIE, V149, P34, DOI 10.1016/j.biochi.2018.03.013; Song J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005436; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Tedeschi G, 1996, EUR J BIOCHEM, V239, P427, DOI 10.1111/j.1432-1033.1996.0427u.x; TURRENS JF, 1987, MOL BIOCHEM PARASIT, V25, P55, DOI 10.1016/0166-6851(87)90018-1; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; van der Reest J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04003-3; Wargnies M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007502; WILSON K, 1994, J BIOL CHEM, V269, P28979; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	57	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100548	10.1016/j.jbc.2021.100548	http://dx.doi.org/10.1016/j.jbc.2021.100548			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741344	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400521
J	Zhang, Z; Wen, HQ; Peng, BJ; Weng, J; Zeng, FH				Zhang, Zhi; Wen, Huiqing; Peng, Bangjian; Weng, Jun; Zeng, Fanhong			CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis	FASEB JOURNAL			English	Article						CFLAR; cyclin&#8208; dependent kinase inhibitor 2A; fatty liver disease; lipogenesis; PIAS1; PRMT1; SUMOylation		Previous literature has indicated that cyclin-dependent kinase inhibitor 2 A (CDKN2A) is upregulated, while the Protein Inhibitor of Activated STAT1 (PIAS1) is downregulated in the liver tissues of obese mice. The current study aimed to investigate the relationship between CDKN2A and PIAS1 in the lipogenesis of fatty liver disease. In the C57BL/6J db/db mouse model and hepatocyte model of fatty liver, the expression pattern of CDKN2A, PIAS1, Protein arginine methyltransferase 1 (PRMT1) and CASP8 and FADD-like apoptosis regulator (CFLAR) was characterized by RNA quantitative and Western blot analysis. The lipogenesis-related genes (Srebp1c and Fas) in the liver tissues and cells were employed in the assessment of lipogenesis in response to gain- or loss-of-function of CDKN2A, PIAS1, PRMT1, and CFLAR, while triglyceride and fat content were evaluated in relation to fat accumulation. Western blot analysis was conducted to determine c-Jun amino-terminal kinase (JNK) phosphorylation, while the ubiquitination of CFLAR and SUMOylation of PIAS1 was examined by immunoprecipitation. PIAS1 and CFLAR were downregulated, while CDKN2A, PRMT1, and phosphorylation of JNK was elevated in the tissues and cells of the fatty liver models. Our results suggested that CDKN2A enhanced the SUMOylation of PIAS1 to reduce the expression of PIAS1. PRMT1 downregulated CFLAR by triggering its ubiquitination, while CFLAR repressed phosphorylation of JNK. The in vitro and in vivo results indicated that CDKN2A silencing prevented lipogenesis and fat accumulation by impairing the PRMT1-dependent ubiquitination of CFLAR and blocking the phosphorylation of JNK. Taken together, the central observations of our study demonstrate that targeting CDKN2A contributes to the suppression of lipogenesis and fat accumulation in fatty liver disease. The findings of our study highlight the potential of CDKN2A as a promising target against fatty liver.	[Zhang, Zhi; Wen, Huiqing; Peng, Bangjian] Southern Med Univ, Affiliated Hosp 5, Dept Hepatobiliary Surg, 566,Dongcheng Ave, Guangzhou 510900, Guangdong, Peoples R China; [Weng, Jun; Zeng, Fanhong] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhang, Z (corresponding author), Southern Med Univ, Affiliated Hosp 5, Dept Hepatobiliary Surg, 566,Dongcheng Ave, Guangzhou 510900, Guangdong, Peoples R China.	mshijizhang@163.com						Alagu J, 2018, J IMMUNOL, V201, P451, DOI 10.4049/jimmunol.1800327; Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617; Baidal JAW, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8390; Bantubungi K, 2014, DIABETES, V63, P3199, DOI 10.2337/db13-1921; Christen V, 2007, J VIROL, V81, P159, DOI 10.1128/JVI.01292-06; Gao B, 2016, GASTROENTEROLOGY, V150, P1704, DOI 10.1053/j.gastro.2016.01.025; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Li MY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1064-8; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21810; Liu Y, 2015, DIABETES, V64, P4061, DOI 10.2337/db15-0278; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Liu YY, 2019, ACTA PHARM SIN B, V9, P745, DOI 10.1016/j.apsb.2019.02.006; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marchesini G, 2016, HEPATOLOGY, V63, P2032, DOI 10.1002/hep.28392; Mitterberger MC, 2014, J GERONTOL A-BIOL, V69, P13, DOI 10.1093/gerona/glt043; Musso G, 2016, DIABETES CARE, V39, P1830, DOI 10.2337/dc15-1182; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Pal A, 2016, DIABETES, V65, P527, DOI 10.2337/db15-0602; Park MJ, 2014, J HEPATOL, V61, P1151, DOI 10.1016/j.jhep.2014.06.032; Qiao XN, 2019, ENDOCRINOLOGY, V160, P2773, DOI 10.1210/en.2019-00504; Rabhi N, 2018, MOL METAB, V8, P65, DOI 10.1016/j.molmet.2017.11.012; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; Wang PX, 2017, NAT MED, V23, P439, DOI 10.1038/nm.4290; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056; Zeng L, 2014, INT J CLIN EXP MED, V7, P1624; Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5; Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011; Zhang YL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.403139; Zhuge BZ, 2017, BIOCHEM BIOPH RES CO, V494, P687, DOI 10.1016/j.bbrc.2017.10.149	31	1	1	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21230	10.1096/fj.202000683R	http://dx.doi.org/10.1096/fj.202000683R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769609				2022-12-26	WOS:000635216100007
J	Zalat, MM; Hamed, MS; Bolbol, SA				Zalat, Marwa Mohamed; Hamed, Mona Sami; Bolbol, Sarah Abdelhalim			The experiences, challenges, and acceptance of e-learning as a tool for teaching during the COVID-19 pandemic among university medical staff	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; TECHNOLOGY; WORK	Background e-learning was underutilized in the past especially in developing countries. However, the current crisis of the COVID-19 pandemic forced the entire world to rely on it for education. Objectives To estimate the university medical staff perceptions, evaluate their experiences, recognize their barriers, challenges of e-learning during the COVID-19 pandemic, and investigate factors influencing the acceptance and use of e-learning as a tool teaching within higher education. Methods Data was collected using an electronic questionnaire with a validated Technology Acceptance Model (TAM) for exploring factors that affect the acceptance and use of e-learning as a teaching tool among medical staff members, Zagazig University, Egypt. Results The majority (88%) of the staff members agreed that the technological skills of giving the online courses increase the educational value of the experience of the college staff. The rate of participant agreement on perceived usefulness, perceived ease of use, and acceptance of e-learning was (77.1%, 76.5%, and 80.9% respectively). The highest barriers to e-learning were insufficient/ unstable internet connectivity (40%), inadequate computer labs (36%), lack of computers/ laptops (32%), and technical problems (32%). Younger age, teaching experience less than 10 years, and being a male are the most important indicators affecting e-learning acceptance. Conclusion This study highlights the challenges and factors influencing the acceptance, and use of e-learning as a tool for teaching within higher education. Thus, it will help to develop a strategic plan for the successful implementation of e-learning and view technology as a positive step towards evolution and change.	[Zalat, Marwa Mohamed; Hamed, Mona Sami; Bolbol, Sarah Abdelhalim] Zagazig Univ, Dept Commun Environm & Occupat Med, Fac Med, Zagazig, Egypt; [Zalat, Marwa Mohamed] Taibah Univ, Dept Family & Community Med, Coll Med, Medina, Saudi Arabia	Egyptian Knowledge Bank (EKB); Zagazig University; Taibah University	Zalat, MM (corresponding author), Zagazig Univ, Dept Commun Environm & Occupat Med, Fac Med, Zagazig, Egypt.; Zalat, MM (corresponding author), Taibah Univ, Dept Family & Community Med, Coll Med, Medina, Saudi Arabia.	marwazalat79@gmail.com	Zalat, Marwa Mohamed/F-5901-2019	Zalat, Marwa Mohamed/0000-0002-9479-1346; OSWAL, RAJESH/0000-0002-8894-4457				Adamus T., 2009, 5 EUR S GEND ICT DIG; Assareh A, 2011, PROCEDIA COMPUT SCI, V3, DOI 10.1016/j.procs.2010.12.129; Bhardwaj A, 2015, Kathmandu Univ Med J (KUMJ), V13, P12; Bhuasiri W, 2012, COMPUT EDUC, V58, P843, DOI 10.1016/j.compedu.2011.10.010; Bozzon R, 2017, EUR EDUC RES J, V16, P332, DOI 10.1177/1474904116669364; Chokri B., 2012, EUR SCI J, V8; Cuadrado-Garcia M, 2010, PROCD SOC BEHV, V2, P367, DOI 10.1016/j.sbspro.2010.03.027; Dhawan S, 2020, J ED TECHNOL SYST, V49, P5, DOI [10.1177/0047239520934018, DOI 10.1177/0047239520934018]; Durbin B., 2018, STUDY TEACHING ELECT, P1; Fischer SH, 2014, INT J MED INFORM, V83, P624, DOI 10.1016/j.ijmedinf.2014.06.005; Gahtani S., 2001, Information Resources Management Journal, V14, P37, DOI 10.4018/irmj.2001070104; Goldschmidt K, 2020, J PEDIATR NURS, V53, P88, DOI 10.1016/j.pedn.2020.04.013; Hannafin M, 2003, HANDBOOK OF DISTANCE EDUCATION, P245; Hodgkinson-Williams C, 2008, BRIT J EDUC TECHNOL, V39, P433, DOI 10.1111/j.1467-8535.2008.00841.x; Hong KS, 2003, EDUC TECHNOL SOC, V6, P116; Jamlan M., 2004, INT REV RES OPEN DIS, V5; Kanwal F, 2017, IEEE ACCESS, V5, P10968, DOI 10.1109/ACCESS.2017.2714379; Medhat MA, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010368; Mohammadyari S, 2015, COMPUT EDUC, V82, P11, DOI 10.1016/j.compedu.2014.10.025; Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785; Mutisya DN., 2016, E-LEARNING DIGITAL M, V13, P140, DOI [10.1177/2042753016672902, DOI 10.1177/2042753016672902]; Napitupulu D., 2018, ADV INTELLIGENT SYST, V144, P247, DOI [10.2991/icedutech-17.2018.49, DOI 10.2991/ICEDUTECH-17.2018.49]; Nawaz A., 2013, ROLE CONTEXTUAL FACT; Nguyen Q. L. H. T. T., 2020, UNIVERSAL J ED RES, V8, P1759, DOI [DOI 10.13189/UJER.2020.080512, 10.13189/ujer.2020.080512]; Nimarpreet Kaur, 2020, National Journal of Physiology, Pharmacy and Pharmacology, V10, P563, DOI 10.5455/njppp.2020.10.04096202028042020; Oncu S, 2011, COMPUT EDUC, V57, P1098, DOI 10.1016/j.compedu.2010.12.009; Pietrosanto A., 2006, FRONT ED C 36 ANN SA, P1; Poon W., 2004, INT J EDUC MANAG, V18, P374, DOI [10.1108/09513540410554031, DOI 10.1108/09513540410554031]; Qureshi IA, 2012, KNOWL MANAG E-LEARN, V4, P310; Sampsize, SAMPL SIZ PREV SURV; Singh V, 2019, AM J DISTANCE EDUC, V33, P289, DOI 10.1080/08923647.2019.1663082; Toffoletti K, 2016, GENDER WORK ORGAN, V23, P489, DOI 10.1111/gwao.12133; Totaro M., 2005, J COLL TEACHING LEAR, V2, P13; Tullis JG, 2011, J MEM LANG, V64, P109, DOI 10.1016/j.jml.2010.11.002; World Health Organization, COR DIS COVID 2019 S; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y	36	70	70	15	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248758	10.1371/journal.pone.0248758	http://dx.doi.org/10.1371/journal.pone.0248758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770079	gold, Green Published			2022-12-26	WOS:000634833500001
J	Kehl, T; Biermann, D; Briem-Richter, A; Schoen, G; Olfe, J; Sachweh, JS; Fischer, L; Schaefer, H; Kozlik-Feldmann, R; Gottschalk, U				Kehl, Torben; Biermann, Daniel; Briem-Richter, Andrea; Schoen, Gerhard; Olfe, Jakob; Sachweh, Joerg S.; Fischer, Lutz; Schaefer, Hansjoerg; Kozlik-Feldmann, Rainer; Gottschalk, Urda			Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease	PLOS ONE			English	Article							NEURODEVELOPMENTAL OUTCOMES; SCLEROSING CHOLANGITIS; CARDIAC-SURGERY; CHILDREN; PREVALENCE; VENTRICLE; ETIOLOGY; FAILURE; INJURY	Patients undergoing complex pediatric cardiac surgery in early infancy are at risk of postoperative secondary end-organ dysfunction. The aim of this study was to determine specific risk factors promoting the development of peri- and postoperative hepatopathy after surgery for congenital heart disease. In this retrospective study, we identified 20 consecutive patients operated between 2011 and 2019 from our institutional cohort who developed significant postsurgical hepatic dysfunction. These patients were compared to a control group of 30 patients with comparable initial cardiac conditions and STS-EACTS risk score. Patients who developed hepatopathy in the intensive care unit have chronic cholestasis and decreased liver synthesis. The impact of postoperative hepatopathy on morbidity was marked. In six patients (30%), liver transplantation was executed as ultima ratio, and two (10%) were listed for liver transplantation. The overall mortality related to postoperative hepatopathy is high: We found nine patients (45%) having severe hepatopathy and mostly multiple organ dysfunction who died in the postoperative course. According to risk analysis, postoperative right and left heart dysfunction in combination with a postoperative anatomical residuum needing a re-operation or re-intervention in the postoperative period is associated with a high risk for the development of cardiac hepatopathy. Furthermore, postoperative complications (pleural effusion, heart rhythm disorders, etc.), postoperative infections, and the need for parenteral nutrition also raise the risk for cardiac hepatopathy. Further investigations are needed to reduce hepatic complications and improve the general prognosis of such complex patients.	[Kehl, Torben; Olfe, Jakob; Kozlik-Feldmann, Rainer; Gottschalk, Urda] Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Pediat Cardiol, Hamburg, Germany; [Biermann, Daniel; Sachweh, Joerg S.] Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Cardiac Surg Congenital Heart Dis, Hamburg, Germany; [Briem-Richter, Andrea] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany; [Fischer, Lutz] Univ Med Ctr Hamburg Eppendorf, Dept Visceral Transplantat, Hamburg, Germany; [Schaefer, Hansjoerg] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kehl, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Pediat Cardiol, Hamburg, Germany.	t.kehl@uke.de		Kehl, Torben/0000-0002-9044-8954				Aad G, 2012, PHYS LETT B, V716, P1, DOI 10.1016/j.physletb.2012.08.020; Algra SO, 2014, CIRCULATION, V129, P224, DOI 10.1161/CIRCULATIONAHA.113.003312; Allen H.D., 2016, MOSS ADAMS HEART DIS; Alonso-Gonzalez R, 2017, INT J CARDIOL, V249, P169, DOI 10.1016/j.ijcard.2017.08.050; Asrani SK, 2012, HEPATOLOGY, V56, P1160, DOI 10.1002/hep.25692; Boehne M, 2017, J CARDIAC SURG, V32, P116, DOI 10.1111/jocs.12879; Brooling J., 2017, SECONDARY SCLEROSING, DOI [10.1007/s11894-017-0583-8, DOI 10.1007/S11894-017-0583-8]; Brosig CL, 2018, CONGENIT HEART DIS, V13, P700, DOI 10.1111/chd.12632; de Gonzalez AKK, 2017, GASTROENTEROL CLIN N, V46, P421, DOI 10.1016/j.gtc.2017.01.012; de Leval MR, 2010, NAT REV CARDIOL, V7, P520, DOI 10.1038/nrcardio.2010.99; Duke T, 1997, J THORAC CARDIOV SUR, V114, P1042, DOI 10.1016/S0022-5223(97)70018-7; Engler S, 2003, GUT, V52, P688, DOI 10.1136/gut.52.5.688; Ford RM, 2015, TRANSPLANT REV-ORLAN, V29, P33, DOI 10.1016/j.trre.2014.11.003; Fujimoto Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148666; Gelbmann CM, 2007, AM J GASTROENTEROL, V102, P1221, DOI 10.1111/j.1572-0241.2007.01118.x; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; JAMIESON WRE, 1982, CAN J SURG, V25, P538; Kamath BM, 2018, J PEDIATR GASTR NUTR, V67, P148, DOI 10.1097/MPG.0000000000001958; KAUL S, 1984, AM HEART J, V107, P526, DOI 10.1016/0002-8703(84)90095-4; Leonhardt S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0861-5; Lindinger A, 2010, KLIN PADIATR, V222, P321, DOI 10.1055/s-0030-1254155; Madsen NL, 2017, KIDNEY INT, V92, P751, DOI 10.1016/j.kint.2017.02.021; Mainwaring RD, 2016, SEMIN THORAC CARDIOV, V28, P418, DOI 10.1053/j.semtcvs.2016.07.003; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Moghal NE, 1998, CLIN NEPHROL, V49, P91; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; O'Brien SM, 2009, J THORAC CARDIOV SUR, V138, P1139, DOI 10.1016/j.jtcvs.2009.03.071; Philip J, 2018, WORLD J PEDIATR CONG, V9, P470, DOI 10.1177/2150135116640786; Pigula FA, 2007, PEDIATR TRANSPLANT, V11, P461, DOI 10.1111/j.1399-3046.2007.00734.x; Rollins CK, 2014, CIRCULATION, V130, pE124, DOI 10.1161/CIRCULATIONAHA.114.008556; Saleh M, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S86420; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schwartz MC, 2012, J THORAC CARDIOV SUR, V143, P904, DOI 10.1016/j.jtcvs.2011.08.038; SHERLOCK S, 1968, BRIT MED J, V3, P515, DOI 10.1136/bmj.3.5617.515; Shteyer E, 2011, PEDIATR INT, V53, P725, DOI 10.1111/j.1442-200X.2011.03356.x; Sinzobahamvya N, 2013, THORAC CARDIOV SURG, V61, P278, DOI 10.1055/s-0032-1328922; Stephens EH, 2020, WORLD J PEDIATR CONG, V11, P316, DOI 10.1177/2150135120903977; Stoylen A, 2003, SCAND CARDIOVASC J, V37, P253, DOI 10.1080/14017430310015000; Welke KF, 2008, CARDIOL YOUNG, V18, P222, DOI 10.1017/S1047951108002953	40	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248776	10.1371/journal.pone.0248776	http://dx.doi.org/10.1371/journal.pone.0248776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765046	Green Published, gold			2022-12-26	WOS:000634832800036
J	Nasonovs, A; Garcia-Diaz, M; Bogenhagen, DF				Nasonovs, Aleksandrs; Garcia-Diaz, Miguel; Bogenhagen, Daniel F.			A549 cells contain enlarged mitochondria with independently functional clustered mtDNA nucleoids	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MOUSE L-CELLS; DNA REPLICATION; MICROSCOPY; INHIBITOR; FISSION; FORMS; SEGREGATION; SB-431542; MECHANISM	Mitochondria are commonly viewed as highly elongated organelles with regularly spaced mtDNA genomes organized as compact nucleoids that generate the local transcripts essential for production of mitochondrial ribosomes and key components of the respiratory chain. In contrast, A549 human lung carcinoma cells frequently contain apparently swollen mitochondria harboring multiple discrete mtDNA nucleoids and RNA processing granules in a contiguous matrix compartment. While this seemingly aberrant mitochondrial morphology is akin to "mito-bulbs" previously described in cells exposed to a variety of genomic stressors, it occurs in A549 cells under typical culture conditions. We provide a detailed confocal and super-resolution microscopic investigation of the incidence of such mito-bulbs in A549 cells. Most mito-bulbs appear stable, engage in active replication and transcription, and maintain respiration but feature an elevated oxidative environment. High concentrations of glucose and/or L-glutamine in growth media promote a greater incidence of mito-bulbs. Furthermore, we demonstrate that treatment of A549 cells with TGF beta suppresses the formation of mito-bulbs while treatment with a specific TGF beta pathway inhibitor substantially increases incidence. This striking heterogeneity of mitochondrial form and function may play an important role in a variety of diseases involving mitochondrial dysfunction.	[Nasonovs, Aleksandrs; Garcia-Diaz, Miguel; Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu		Bogenhagen, Daniel/0000-0002-9993-2574	National Institutes of Health [1S10OD020096-01A1, 1R01 GM112790-01A1]; NIH Office of the Director [1S10OD016405-01]; National Institute of General Medical Sciences [T32 GM007518]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health (https://www.nih.gov/), 1R01 GM112790-01A1 to DFB; by NIH Office of the Director (http://dx.doi.org/10.13039/100000052), 1S10OD016405-01; by the National Institutes of Health, 1S10OD020096-01A1; and by National Institute of General Medical Sciences http://dx.doi.org/10.13039/100000057, T32 GM007518 to MGD. The funders played no role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Alan L, 2016, TOXICOL APPL PHARM, V302, P31, DOI 10.1016/j.taap.2016.04.011; Allen JR, 2013, PHYS CHEM CHEM PHYS, V15, P18771, DOI 10.1039/c3cp53719f; Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Busch KB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0442; Camara J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-2; Chandrasekharan A, 2019, REDOX BIOL, V20, P379, DOI 10.1016/j.redox.2018.10.013; Chiche J, 2010, J CELL PHYSIOL, V222, P648, DOI 10.1002/jcp.21984; Cowdry EV, 1918, CONTRIB EMBRYOL, V8, P41; Dalla Rosa I, 2014, NUCLEIC ACIDS RES, V42, P8500, DOI 10.1093/nar/gku513; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110; Feric M, 2021, EMBO J, V40, DOI 10.15252/embj.2020107165; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hagiwara H, 2010, METHODS MOL BIOL, V657, P145, DOI 10.1007/978-1-60761-783-9_11; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Haley JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00344; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Javadov S, 2018, MITOCHONDRION, V38, P58, DOI 10.1016/j.mito.2017.08.004; Jourdain AA, 2016, J CELL BIOL, V212, P611, DOI 10.1083/jcb.201507125; Kasashima K, 2011, EXP CELL RES, V317, P210, DOI 10.1016/j.yexcr.2010.10.008; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Koh RY, 2015, MOL MED REP, V11, P3808, DOI 10.3892/mmr.2015.3193; Kopek BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077209; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kumar S, 2016, MOL CELL, V62, P520, DOI 10.1016/j.molcel.2016.04.010; LOUD AV, 1968, J CELL BIOL, V37, P27, DOI 10.1083/jcb.37.1.27; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; NICHOLLS DG, 2013, BIOENERGETICS; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Perez-Jannotti RM, 2001, J BIOL CHEM, V276, P48978, DOI 10.1074/jbc.M107177200; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rey T, 2020, NAT CELL BIOL, V22, P1180, DOI 10.1038/s41556-020-00584-8; Ryu CW, 2017, AM J RESP CRIT CARE, V196, P1571, DOI 10.1164/rccm.201612-2480OC; Salewskij K, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148091; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stephan T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48838-2; TANDLER B, 1986, ANN NY ACAD SCI, V488, P65; Tauber J, 2013, INT J BIOCHEM CELL B, V45, P593, DOI 10.1016/j.biocel.2012.11.019; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Tyumentsev MA, 2018, J ALZHEIMERS DIS, V63, P1075, DOI 10.3233/JAD-180065; van den Bogaard EHJ, 2009, PHARM RES-DORDR, V26, P1172, DOI 10.1007/s11095-009-9838-x; Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolf DM, 2019, EMBO J, V38, DOI 10.15252/embj.2018101056; Youle RJ, 2019, SCIENCE, V365, P655, DOI 10.1126/science.aaw9855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zahedi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34455-y; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316	73	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249047	10.1371/journal.pone.0249047	http://dx.doi.org/10.1371/journal.pone.0249047			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765066	Green Published, gold			2022-12-26	WOS:000634832800057
J	Yadav, S; Lokala, U; Daniulaityte, R; Thirunarayan, K; Lamy, F; Sheth, A				Yadav, Shweta; Lokala, Usha; Daniulaityte, Raminta; Thirunarayan, Krishnaprasad; Lamy, Francois; Sheth, Amit			"When they say weed causes depression, but it's your fav antidepressant": Knowledge-aware attention framework for relationship extraction	PLOS ONE			English	Article							CANNABIS USE; WEB; NETWORKS; TRENDS; PREVALENCE	With the increasing legalization of medical and recreational use of cannabis, more research is needed to understand the association between depression and consumer behavior related to cannabis consumption. Big social media data has potential to provide deeper insights about these associations to public health analysts. In this interdisciplinary study, we demonstrate the value of incorporating domain-specific knowledge in the learning process to identify the relationships between cannabis use and depression. We develop an end-to-end knowledge infused deep learning framework (Gated-K-BERT) that leverages the pre-trained BERT language representation model and domain-specific declarative knowledge source (Drug Abuse Ontology) to jointly extract entities and their relationship using gated fusion sharing mechanism. Our model is further tailored to provide more focus to the entities mention in the sentence through entity-position aware attention layer, where ontology is used to locate the target entities position. Experimental results show that inclusion of the knowledge-aware attentive representation in association with BERT can extract the cannabis-depression relationship with better coverage in comparison to the state-of-the-art relation extractor.	[Yadav, Shweta; Thirunarayan, Krishnaprasad] Wright State Univ, Dayton, OH 45435 USA; [Lokala, Usha; Sheth, Amit] Univ South Carolina, Columbia, SC 29208 USA; [Daniulaityte, Raminta] Arizona State Univ, Tempe, AZ USA; [Lamy, Francois] Mahidol Univ, Salaya, Nakhon Pathom, Thailand	University System of Ohio; Wright State University Dayton; University of South Carolina System; University of South Carolina Columbia; Arizona State University; Arizona State University-Tempe; Mahidol University	Yadav, S (corresponding author), Wright State Univ, Dayton, OH 45435 USA.	shweta@knoesis.org		Daniulaityte, Raminta/0000-0001-6507-3866; LAMY, Francois/0000-0001-6542-1381	National Institute on Drug Abuse (NIDA) 397 Grant [5R01DA039454-02, R21DA044518]	National Institute on Drug Abuse (NIDA) 397 Grant	We acknowledge partial support from the National Institute on Drug Abuse (NIDA) 397 Grant No. 5R01DA039454-02: "Trending: Social media analysis to monitor cannabis and synthetic cannabinoid use" and Grant Number: R21DA044518: "eDarkTrends: Monitoring Cryptomarkets to Identify Emerging Trends of Illicit Synthetic Opioids Use.	Akbik A., 2019, P 2019 C N AM CHAPT, V1, P724, DOI DOI 10.18653/V1/N19-1078; [Anonymous], 2019, MAJOR DEPRESSION; [Anonymous], DRUG ABUSE ONTOLOGY; [Anonymous], 2014, ENCY SOCIAL NETWORK, DOI 10.1007/978-1-4614-6170-8_345; Bekoulis Giannis, 2018, P 2018 C EMP METH NA, P2830, DOI DOI 10.18653/V1/D18-1307; Beltagy I, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P3615; Bojanowski P., 2016, ARXIV PREPRINT ARXIV; Bridgeman Mary Barna, 2017, P T, V42, P180; Budney AJ, 2004, AM J PSYCHIAT, V161, P1967, DOI 10.1176/appi.ajp.161.11.1967; Burns L, 2014, DRUG TEST ANAL, V6, P840, DOI 10.1002/dta.1613; Cameron D, 2013, J BIOMED INFORM, V46, P985, DOI 10.1016/j.jbi.2013.07.007; Cavazos-Rehg PA, 2018, AM J HEALTH PROMOT, V32, P880, DOI 10.1177/0890117116686574; Chen C, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00105; Chen XL, 2018, J AM MED INFORM ASSN, V25, P300, DOI 10.1093/jamia/ocx121; Choi SP, 2018, J INF SCI, V44, P60, DOI 10.1177/0165551516673485; ChunYang Liu, 2013, Advanced Data Mining and Applications. 9th International Conference, ADMA 2013. Proceedings: LNCS 8347, P231, DOI 10.1007/978-3-642-53917-6_21; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Corazza O, 2013, HUM PSYCHOPHARM CLIN, V28, P317, DOI 10.1002/hup.2299; Daniulaityte R, 2017, J STUD ALCOHOL DRUGS, V78, P910, DOI 10.15288/jsad.2017.78.910; Nguyen DQ, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING: SYSTEM DEMONSTRATIONS, P9; Schier ARD, 2014, CNS NEUROL DISORD-DR, V13, P953, DOI 10.2174/1871527313666140612114838; Devlin J., 2018, ARXIV181004805; Gaur M, 2018, CIKM'18: PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P753, DOI 10.1145/3269206.3271732; Gukasyan N, 2020, DRUG ALCOHOL DEPEN, V208, DOI 10.1016/j.drugalcdep.2020.107867; Guo ZJ, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P241; He ZQ, 2018, AAAI CONF ARTIF INTE, P5795; Hewitt J., 2019, P 2019 C N AM CHAPTE, P4129, DOI DOI 10.18653/V1/N19-1419; Hinton G. E., 2012, ARXIV12070580, DOI DOI 10.9774/GLEAF.978-1-909493-38-42; Irving J., 2020, SCHIZOPHRENIA BULL; King DB, 2015, ACS SYM SER, V1214, P1; Kumar A., 2016, P 13 INT C NAT LANG, P188; Kumar R, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P1955, DOI 10.1145/3366423.3380263; Lamy FR, 2020, DRUG ALCOHOL DEPEN, V213, DOI 10.1016/j.drugalcdep.2020.108115; Lamy FR, 2018, DRUG ALCOHOL DEPEN, V183, P248, DOI 10.1016/j.drugalcdep.2017.10.039; Lamy FR, 2017, INT J DRUG POLICY, V44, P121, DOI 10.1016/j.drugpo.2017.05.007; Lankenau SE, 2018, INT J DRUG POLICY, V52, P62, DOI 10.1016/j.drugpo.2017.11.018; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Lee J, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11060785; Li J, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/6789520; Li PF, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P229; Liang D., 2017, P REPL4NLP, P43, DOI [10.18653/v1/ w17- 2606, DOI 10.18653/V1/W17-2606]; Lin C, 2019, P 2 CLIN NAT LANG PR, V2, P65, DOI DOI 10.18653/V1/W19-1908; Liu P., 2016, IJCAI; Lokala U, 2019, COMPUT MATH ORGAN TH, V25, P48, DOI 10.1007/s10588-018-09283-0; Maillard J, 2019, NAT LANG ENG, V25, P433, DOI 10.1017/S1351324919000184; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mowery D.L., 2016, P WORKSHOP COMPUTATI, P182, DOI DOI 10.5210/OJPHI.V8I1.6561; Ningthoujam D, 2019, ARXIV PREPRINT ARXIV; Patel R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009888; Peng Y., 2017, BIONLP 2017, P29, DOI [10.18653/v1/W17-2304, DOI 10.18653/V1/W17-2304]; Room R, 2014, ADDICTION, V109, P345, DOI 10.1111/add.12355; Roth D., 2010, P 23 INT C; Shi P, 2019, SIMPLE BERT MODELS R; Shweta, 2016, INT C PATT RECOG, P3128, DOI 10.1109/ICPR.2016.7900115; Trisedya BD, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P229; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wang HY, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P1371; Weinberger AH, 2018, PSYCHOL MED, V48, P1308, DOI 10.1017/S0033291717002781; Wen DS, 2018, LECT NOTES COMPUT SC, V10699, P321, DOI 10.1007/978-3-319-73830-7_32; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Womack SR, 2016, J STUD ALCOHOL DRUGS, V77, P287, DOI 10.15288/jsad.2016.77.287; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wu F, 2019, PR MACH LEARN RES, V97; Xue K, 2019, IEEE INT C BIOINFORM, P892, DOI 10.1109/BIBM47256.2019.8983370; Yadav S., 2016, P CLIN NATURAL LANGU, P32; Yadav S, 2020, ACM T MULTIM COMPUT, V16, DOI 10.1145/3372328; Yadav S, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P5234; Yadav S, 2019, KNOWL-BASED SYST, V166, P18, DOI 10.1016/j.knosys.2018.11.020; Yang Z., 2016, P 2016 C N AM CHAPTE, P1480; Yang ZW, 2021, ANIM BIOTECHNOL, V32, P67, DOI 10.1080/10495398.2019.1653901; Young AS, 2008, PSYCHIAT SERV, V59, P1391, DOI 10.1176/appi.ps.59.12.1391; Zeiler M.D., 2012, ARXIV12125701; Zeng D., 2014, COLING; Zhang Y., 2017, EMNLP, P35, DOI [10.18653/v1/D17-1004, DOI 10.18653/V1/D17-1004, 10.18653/v1/d17-1004]; Zhou DY, 2018, ARTIF INTELL MED, V87, P1, DOI 10.1016/j.artmed.2018.03.001; Zhou HW, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2873-7	78	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248299	10.1371/journal.pone.0248299	http://dx.doi.org/10.1371/journal.pone.0248299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33764983	gold, Green Submitted, Green Published			2022-12-26	WOS:000634832800092
J	Loffler, F; Wesp, V; Konig-Ries, B; Klan, F				Loeffler, Felicitas; Wesp, Valentin; Koenig-Ries, Birgitta; Klan, Friederike			Dataset search in biodiversity research: Do metadata in data repositories reflect scholarly information needs?	PLOS ONE			English	Article							ANNOTATION; ECOLOGY	The increasing amount of publicly available research data provides the opportunity to link and integrate data in order to create and prove novel hypotheses, to repeat experiments or to compare recent data to data collected at a different time or place. However, recent studies have shown that retrieving relevant data for data reuse is a time-consuming task in daily research practice. In this study, we explore what hampers dataset retrieval in biodiversity research, a field that produces a large amount of heterogeneous data. In particular, we focus on scholarly search interests and metadata, the primary source of data in a dataset retrieval system. We show that existing metadata currently poorly reflect information needs and therefore are the biggest obstacle in retrieving relevant data. Our findings indicate that for data seekers in the biodiversity domain environments, materials and chemicals, species, biological and chemical processes, locations, data parameters and data types are important information categories. These interests are well covered in metadata elements of domain-specific standards. However, instead of utilizing these standards, large data repositories tend to use metadata standards with domain-independent metadata fields that cover search interests only to some extent. A second problem are arbitrary keywords utilized in descriptive fields such as title, description or subject. Keywords support scholars in a full text search only if the provided terms syntactically match or their semantic relationship to terms used in a user query is known.	[Loeffler, Felicitas; Wesp, Valentin; Koenig-Ries, Birgitta] Friedrich Schiller Univ Jena, Dept Math & Comp Sci, Heinz Nixdorf Chair Distributed Informat Syst, Jena, Germany; [Koenig-Ries, Birgitta; Klan, Friederike] Michael Stifel Ctr Data Driven & Simulat Sci, Jena, Germany; [Koenig-Ries, Birgitta] German Ctr Integrat Biodivers Res iDiv, Halle, Germany; [Klan, Friederike] German Aerosp Ctr, DLR Inst Data Sci, Citizen Sci Grp, Jena, Germany	Friedrich Schiller University of Jena; Helmholtz Association; German Aerospace Centre (DLR)	Loffler, F (corresponding author), Friedrich Schiller Univ Jena, Dept Math & Comp Sci, Heinz Nixdorf Chair Distributed Informat Syst, Jena, Germany.	felicitas.loeffler@uni-jena.de		Konig-Ries, Birgitta/0000-0002-2382-9722; Klan, Friederike/0000-0002-1856-7334; Loffler, Felicitas/0000-0001-6423-7427	Deutsche Forschungsgemeinschaft (DFG) [229241684, 218627073, 433052568]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge the Collaborative Research Centre AquaDiva (CRC 1076 AquaDiva, DFG Project Number: 218627073) of the Friedrich Schiller University Jena, the GFBio project (DFG Project Number: 229241684) and the Open Access Publication Fund of the Thueringer Universitaetsund Landesbibliothek Jena (DFG Project Number: 433052568), all funded by the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiadou S, 2004, J BIOMED INFORM, V37, P393, DOI 10.1016/j.jbi.2004.08.011; Andersson AF, PUBLISHING SEQUENCE; [Anonymous], 2014, SAN DIEGO CA FORCE11; [Anonymous], 2017, 230811 ISO; [Anonymous], RDA METADATA STANDAR; AquaDiva, 2020, CRC AQUADIVA; Arino AH., 2013, BIODIVERS INFORM, V8; Bei X, 2014, FUTURE GENER COMP SY, V32, P187, DOI 10.1016/j.future.2012.12.003; Bernstein A, 2019, P ISWC 2019 SAT TRAC, P237; Chamanara J, 2017, PROC VLDB ENDOW, V10, P1877, DOI 10.14778/3137765.3137798; Chapman A, 2020, VLDB J, V29, P251, DOI 10.1007/s00778-019-00564-x; Cook B, 2012, EGU GEN ASS HELD 22, P11863; Croft B., 2009, SEARCH ENGINES INFOR; Culina A, 2018, NAT ECOL EVOL, V2, P420, DOI 10.1038/s41559-017-0458-2; Cunningham H, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P168; Cunningham H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002854; Dakka W, 2008, PROC INT CONF DATA, P466, DOI 10.1109/ICDE.2008.4497455; DataONE, 2019, IND DOC; DataONE, 2019, QUANT FAIR MET IMPR; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Ernst P, 2016, PROCEEDINGS OF 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL-2016): SYSTEM DEMONSTRATIONS, P19; Faessler E, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017): SYSTEM DEMONSTRATIONS, P91, DOI 10.18653/v1/P17-4016; FAITH DP, 2013, BIODIVERS INFORM, V8, P41; Feddoul Leila, 2019, Semantic Systems. The Power of AI and Knowledge Graphs. 15th International Conference, SEMANTiCS 2019. Proceedings: Lecture Notes in Computer Science (LNCS 11702), P310, DOI 10.1007/978-3-030-33220-4_23; Fenner M, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0031-8; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; GBIF, 2018, GBIF SCI REV 2018; GBIF: The Global Biodiversity Information Facility, 2020, WHAT IS GBIF, DOI DOI 10.15468/39OMEI; GFBio, 2020, GERM FED BIOL DAT; Goodman A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003542; Gregory K., 2020, HARVARD DATA SCI REV, DOI [10.1162/99608f92.30a5e938, DOI 10.1162/99608F92.30A5E938]; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hart EM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005097; Hartig O., 2017, HONEY BEE VERSUS API, P98; Hearst MA, 2006, COMMUN ACM, V49, P59, DOI 10.1145/1121949.1121983; Hersh W, 2009, INFORM RETRIEVAL, V12, P1, DOI 10.1007/s10791-008-9076-6; Hildebrand M, 2006, LECT NOTES COMPUT SC, V4273, P272; Hu W, 2017, DATABASE-OXFORD, P1, DOI 10.1093/database/bax059; idiv, 2019, GERMAN CTR INTEGRATI; Jonquet C, 2017, P 2 SEM BIOD WORKSH; Jurafsky D., 2019, SPEECH LANGUAGE PROC, V3rd; Jurburg SD, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01204-9; Kacprzak E, 2019, J WEB SEMANT, V55, P37, DOI 10.1016/j.websem.2018.11.003; Khalsa S, 2018, SURVEY CURRENT PRACT; Kilicoglu H, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2045-1; Klan F, 2017, P 2 INT WORKSH SEM B; Konig-Ries B, 2014, INFORMATIK 2014; Krallinger M, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McDonald R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S6; Michel F., 2018, BIODIVERSITY INFORM, V2, P25836, DOI 10.3897/biss.2.25836; Michener WK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004525; Moreno-Vega J, 2018, LECT NOTES COMPUT SC, V11136, P301, DOI 10.1007/978-3-030-00671-6_18; Naderi N, 2011, BIOINFORMATICS, V27, P2721, DOI 10.1093/bioinformatics/btr452; Nature, 2018, NATURE; Nentidis A., 2017, BIONLP, P48; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Paliouras G, 2013, D3 1; Pangaea, 2019, DATA PUBLISHER EARTH; Parker TH, 2016, TRENDS ECOL EVOL, V31, P711, DOI 10.1016/j.tree.2016.07.002; Pfaff CT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186170; Quarfoot D, 2016, AM STAT, V70, P373, DOI 10.1080/00031305.2016.1141708; Ramakers JJC, 2018, NAT ECOL EVOL, V2, P1093, DOI 10.1038/s41559-018-0577-4; RDA-FAIR Data Maturity Model WG, FAIR DAT MAT MOD SPE; Roberts K, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax068; Sansone SA, 2019, NAT BIOTECHNOL, V37, P358, DOI 10.1038/s41587-019-0080-8; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Thessen Anne E., 2012, Advances in Bioinformatics, V2012, P391574, DOI 10.1155/2012/391574; Unger C, 2014, LECT NOTES COMPUT SC, V8714, P100, DOI 10.1007/978-3-319-10587-1_2; White R. W., 2009, EXPLORATORY SEARCH Q; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	73	5	6	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0246099	10.1371/journal.pone.0246099	http://dx.doi.org/10.1371/journal.pone.0246099			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760822	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000633030400010
J	Malmgren, J; Guo, BY; Kaplan, HG				Malmgren, Judith; Guo, Boya; Kaplan, Henry G.			Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020	PLOS ONE			English	Article							UNITED-STATES	Background As the coronavirus (COVID-19) epidemic passed initial infection peak in Washington State, phased re-opening lifted stay-at-home orders and restrictions leading to increased non-essential work, social activities and gathering, especially among younger persons. Methods A longitudinal cohort analysis of Washington State Department of Health COVID-19 confirmed case age distribution 1) March-April 2020 (N = 13,934) and 2) March-August 2020 (N = 76,032) for proportional change over time using chi square tests for significance. Results From March 1st to April 19, 2020 COVID-19 age distribution shifted with a 10% decline in cases age 60 years and older and a 20% increase in age 0-19/20-39 years (chi-square = 223.10, p < .001). Number of cases over the initial analysis period were 0-19 years n = 515, 20-39 years n = 4078, 40-59 years n = 4788, 60-79 years n = 3221, 80+ years n = 1332. After the peak (March 22, 2020), incidence declined in older age groups and increased among age 0-19 and 20-39 age groups from 20% to 40% of total cases by April 19 and 50% by May 3. During this time testing expanded with more testing among older age groups and less testing among younger age groups while case positivity shifted young. Percent positive cases age 0-19/20-39 years through August 2020 increased to a consistent average of 60% [age 0-19 increased to 19% (N = 10257), age 20-39 increased to 42% (N = 30215)]. Conclusions An increased sustained proportion of COVID-19 incidence is present among children (age 0-19) and young adults (age 20-39) indicating an elevated role in disease spread during the epidemic creating a possible reservoir of disease with spillover risk to more vulnerable older persons and those with comorbid conditions. Media savvy age-appropriate messaging to enhance mitigation compliance among less vulnerable, more mobile and lower priority vaccination age groups will be a continued necessity and priority to reduce overall population incidence.	[Malmgren, Judith; Guo, Boya] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Kaplan, Henry G.] Swedish Canc Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; Swedish Cancer Institute; Swedish Medical Center	Malmgren, J (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	jmalmgren@seanet.com		Malmgren, Judith/0000-0001-6939-8828; Guo, Boya/0000-0002-8508-4084				[Anonymous], 2019, MICR EXC VERS 10; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; Canning David, 2020, medRxiv, DOI 10.1101/2020.04.19.20065219; Centers for Disease Control and Prevention, COLL U HIGH LEARN; Centers for Disease Control and Prevention, HLTH DEP REP CAS MUL; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Dingens AS, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-18178-1, 10.1101/2020.05.26.20114124]; Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Goldstein E, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.17.2000596; Governor of Washington, PROCLAMATION GOVERNO; Grijalva CG, 2020, MMWR-MORBID MORTAL W, V69, P1631, DOI [10.15585/mmwr.mm6944e1, 10.15585/mmwr. mm6944e1]; Guo B., COVID 19 CONFIRMED C, DOI [10.1101/2020.05.21.20109389, DOI 10.1101/2020.05.21.20109389]; Holshue Michelle L, 2020, N Engl J Med, V382, P929, DOI 10.1056/NEJMoa2001191; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Jung CY, 2020, INT J INFECT DIS, V99, P266, DOI 10.1016/j.ijid.2020.08.001; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Lerner AM, 2020, JAMA-J AM MED ASSOC, V324, P1935, DOI 10.1001/jama.2020.21946; Salvatore PP, 2020, MMWR-MORBID MORTAL W, V69, P1419, DOI 10.15585/mmwr.mm6939e4; Schwartz NG, 2020, MMWR-MORBID MORTAL W, V69, P1457, DOI 10.15585/mmwr.mm6940e2; Seattle WA, COVID 19 PROJ STAT W; Sergeant ESG, 2018, EPITOOLS EPIDEMIOLOG; Stangroom J., SOCIAL SCI STAT; Washington State Department of Health, 2020, NOVEL CORONAVIRUS OU; Washington State Department of Health, STAT COVID 19 OUTBR; Wilson RF, 2020, MMWR-MORBID MORTAL W, V69, P1497, DOI 10.15585/mmwr.mm6941e2; Yu XH, 2020, INT J INFECT DIS, V98, P200, DOI 10.1016/j.ijid.2020.06.101	28	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0243042	10.1371/journal.pone.0243042	http://dx.doi.org/10.1371/journal.pone.0243042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760808	Green Published, gold			2022-12-26	WOS:000633030400047
J	Neyer, S; Witthoft, M; Cropley, M; Pawelzik, M; Lugo, RG; Sutterlin, S				Neyer, Sabrina; Witthoeft, Michael; Cropley, Mark; Pawelzik, Markus; Lugo, Ricardo Gregorio; Sutterlin, Stefan			Reduction of depressive symptoms during inpatient treatment is not associated with changes in heart rate variability	PLOS ONE			English	Article							MAJOR DEPRESSION; NEUROVISCERAL INTEGRATION; MYOCARDIAL-INFARCTION; EMOTION REGULATION; RISK; DISORDER; DISEASE; PSYCHOTHERAPY; RELIABILITY; THERAPY	Vagally mediated heart rate variability (HRV) is a psychophysiological indicator of mental and physical health. Limited research suggests there is reduced vagal activity and resulting lower HRV in patients with Major Depressive Disorder (MDD); however little is actually known about the association between HRV and symptoms of depression and whether the association mirrors symptom improvement following psychotherapy. The aim of this study was to investigate the association between antidepressant therapy, symptom change and HRV in 50 inpatients (68% females; 17-68 years) with a diagnosis of MDD. Severity of depressive symptoms was assessed by self-report (Beck Depression Inventory II) and the Hamilton Rating Scale of Depression. Measures of vagally mediated HRV (root mean square of successive differences and high-frequency) were assessed at multiple measurement points before and after inpatient psychotherapeutic and psychiatric treatment. Results showed an expected negative correlation between HRV and depressive symptoms at intake. Depressive symptoms improved (d = 0.84) without corresponding change in HRV, demonstrating a de-coupling between this psychophysiological indicator and symptom severity. To our knowledge, this study is the first to examine an association between HRV and depressive symptoms before and after psychotherapy. The observed de-coupling of depression and HRV, and its methodological implications for future research are discussed.	[Neyer, Sabrina; Pawelzik, Markus] Eos Klin, Munster, Germany; [Witthoeft, Michael] Johannes Gutenberg Univ Mainz, Dept Clin Psychol Psychotherapy & Expt Psychopath, Mainz, Germany; [Cropley, Mark] Univ Surrey, Sch Psychol, Guildford, Surrey, England; [Lugo, Ricardo Gregorio] Norwegian Univ Sci & Technol, Dept Informat Secur & Commun Technol, Gjovik, Norway; [Lugo, Ricardo Gregorio; Sutterlin, Stefan] Ostfold Univ Coll, Fac Hlth & Welf Sci, Halden, Norway; [Sutterlin, Stefan] Oslo Univ Hosp, Div Clin Neurosci, Oslo, Norway	Johannes Gutenberg University of Mainz; University of Surrey; Norwegian University of Science & Technology (NTNU); Ostfold University College; University of Oslo	Neyer, S (corresponding author), Eos Klin, Munster, Germany.	s.denninghaus@gmail.com		Cropley, Mark/0000-0002-8483-1797				Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Alvares GA, 2016, J PSYCHIATR NEUROSCI, V41, P89, DOI 10.1503/jpn.140217; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Barton DA, 2007, J HYPERTENS, V25, P2117, DOI 10.1097/HJH.0b013e32829baae7; Bassett D, 2016, AUST NZ J PSYCHIAT, V50, P511, DOI 10.1177/0004867415622689; Beauchaine TP, 2015, INT J PSYCHOPHYSIOL, V98, P338, DOI 10.1016/j.ijpsycho.2015.08.004; Beck A, 1993, MANUAL BECK DEPRESSI; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x; Biosign GmbH, 2020, BIOSIGN HRV SCANNER; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Brunoni AR, 2013, INT J NEUROPSYCHOPH, V16, P1937, DOI 10.1017/S1461145713000497; Caldwell YT, 2018, INT J PSYCHOPHYSIOL, V131, P96, DOI 10.1016/j.ijpsycho.2018.01.001; Camm AJ, 1996, EUR HEART J, V17, P354; CARNEY RM, 1987, AM J CARDIOL, V60, P1273, DOI 10.1016/0002-9149(87)90607-2; Carney RM, 2000, PSYCHOSOM MED, V62, P639, DOI 10.1097/00006842-200009000-00007; Carney RM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.181; Carr O, 2018, EVID-BASED MENT HEAL, V21, P22, DOI 10.1136/eb-2017-102760; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Cropley M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00027; Cuijpers P, 2019, EPIDEMIOL PSYCH SCI, V28, P21, DOI 10.1017/S2045796018000057; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; De Rubeis J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150375; Deutsche Gesellschaft f??r Psychiatrie und Psychotherapie Psychosomatik und Nervenheilkunde (DGPP), 2015, S3 LEITLINIENATIONAL; Di Simplicio M, 2012, PSYCHOL MED, V42, P1775, DOI 10.1017/S0033291711002479; Dinas PC, 2013, INT J CARDIOL, V163, P109, DOI 10.1016/j.ijcard.2011.10.140; Drieling T, 2007, INT J METH PSYCH RES, V16, P230, DOI 10.1002/mpr.226; Eikeseth FF, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.558145; Field A., 2018, DISCOVERING STAT USI, V5th, DOI DOI 10.1016/B978-012691360-6/50012-4; Flatt AA, 2016, J STRENGTH COND RES, V30, P378, DOI 10.1519/JSC.0000000000001095; Fydrich T., 1997, STRUKTURIERTES KLINI; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gidron Y, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100371; Glassman AH, 2007, ARCH GEN PSYCHIAT, V64, P1025, DOI 10.1001/archpsyc.64.9.1025; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Harte CB, 2013, ANN BEHAV MED, V46, P73, DOI 10.1007/s12160-013-9476-8; Hausberg M, 2007, J HYPERTENS, V25, P2004, DOI 10.1097/HJH.0b013e3282ef9819; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Heathers JAJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00177; https://www.who.int/news-room/fact-sheets/detail/depression, 2020, FACT SHEET DEPRESSIO; IBM Corp, 2016, IBM SPSS STAT WIND V; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Kemp AH, 2013, INT J PSYCHOPHYSIOL, V89, P288, DOI 10.1016/j.ijpsycho.2013.06.018; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Khandoker AH, 2017, MED BIOL ENG COMPUT, V55, P793, DOI 10.1007/s11517-016-1557-y; Kim W, 2009, PSYCHIAT INVEST, V6, P245, DOI 10.4306/pi.2009.6.4.245; Kircanski K, 2019, DEPRESS ANXIETY, V36, P63, DOI 10.1002/da.22843; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kluttig A, 2010, INT J CARDIOL, V145, P375, DOI 10.1016/j.ijcard.2010.02.048; Koval P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081536; Krejci J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205115; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Lehofer M, 1997, BIOL PSYCHIAT, V42, P914, DOI 10.1016/S0006-3223(96)00494-5; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; Licht CMM, 2009, HYPERTENSION, V53, P631, DOI 10.1161/HYPERTENSIONAHA.108.126698; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Meyer PW, 2016, J NEURAL TRANSM, V123, P1107, DOI 10.1007/s00702-016-1584-8; MILLER IW, 1985, PSYCHIAT RES, V14, P131, DOI 10.1016/0165-1781(85)90057-5; Nahshoni E, 2004, PSYCHOSOMATICS, V45, P129, DOI 10.1176/appi.psy.45.2.129; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; O'Regan C, 2015, PSYCHOL MED, V45, P623, DOI 10.1017/S0033291714001767; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055; Pintor L, 2003, J AFFECT DISORDERS, V73, P237, DOI 10.1016/S0165-0327(01)00480-3; POST RM, 1992, AM J PSYCHIAT, V149, P999; Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123; Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73; Quintana DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00805; RECHLIN T, 1994, BIOL PSYCHIAT, V36, P705, DOI 10.1016/0006-3223(94)91181-9; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Schiweck C, 2019, PSYCHOL MED, V49, P200, DOI 10.1017/S0033291718001988; Schneider R, 2012, MED HYPOTHESES, V78, P744, DOI 10.1016/j.mehy.2012.02.022; Schramm E, 2011, J AFFECT DISORDERS, V129, P109, DOI 10.1016/j.jad.2010.08.003; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Terhardt J, 2013, CLIN NEUROPHARMACOL, V36, P198, DOI 10.1097/WNF.0b013e3182a76fbb; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Uhlig S, 2020, BIOL PSYCHOL, V154, DOI 10.1016/j.biopsycho.2020.107905; Vallejo M, 2005, CLIN AUTON RES, V15, P292, DOI 10.1007/s10286-005-0272-9; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Wheeler A, 2014, BEHAV CHANGE, V31, P175, DOI 10.1017/bec.2014.14; WHISMAN MA, 1991, J CONSULT CLIN PSYCH, V59, P282, DOI 10.1037/0022-006X.59.2.282; Williams DP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00261; Wittchen, 1997, HANDANWEISUNG; Wittchen H-U., 1997, INTERVIEWHEFT BEURTE; Yeragani VK, 2002, BIOL PSYCHIAT, V52, P418, DOI 10.1016/S0006-3223(02)01394-X	99	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248686	10.1371/journal.pone.0248686	http://dx.doi.org/10.1371/journal.pone.0248686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755668	Green Published, gold			2022-12-26	WOS:000632916600025
J	Umair, M; Ikram, A; Salman, M; Khurshid, A; Alam, M; Badar, N; Suleman, R; Tahir, F; Sharif, S; Montgomery, J; Whitmer, S; Klena, J				Umair, Massab; Ikram, Aamer; Salman, Muhammad; Khurshid, Adnan; Alam, Masroor; Badar, Nazish; Suleman, Rana; Tahir, Faheem; Sharif, Salmaan; Montgomery, Joel; Whitmer, Shannon; Klena, John			Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan	PLOS ONE			English	Article							SPIKE PROTEIN; CORONAVIRUS	Since its emergence in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide including Pakistan. During the pandemic, whole genome sequencing has played an important role in understanding the evolution and genomic diversity of SARS-CoV-2. Although an unprecedented number of SARS-CoV-2 full genomes have been submitted in GISAID and NCBI, data from Pakistan is scarce. We report the sequencing, genomic characterization, and phylogenetic analysis of five SARS-CoV-2 strains isolated from patients in Pakistan. The oropharyngeal swabs of patients that were confirmed positive for SARS-CoV-2 through real-time RT-PCR at National Institute of Health, Pakistan, were selected for whole-genome sequencing. Sequencing was performed using NEBNext Ultra II Directional RNA Library Prep kit for Illumina (NEW ENGLAND BioLabs Inc., MA, US) and Illumina iSeq 100 instrument (Illumina, San Diego, US). Based on whole-genome analysis, three Pakistani SARS-CoV-2 strains clustered into the 20A (GH) clade along with the strains from Oman, Slovakia, United States, and Pakistani strain EPI_ISL_513925. The two 19B (S)-clade strains were closely related to viruses from India and Oman. Overall, twenty-nine amino acid mutations were detected in the current study genome sequences, including fifteen missense and four novel mutations. Notably, we have found a D614G (aspartic acid to glycine) mutation in spike protein of the sequences from the GH clade. The G614 variant carrying the characteristic D614G mutation has been shown to be more infectious that lead to its rapid spread worldwide. This report highlights the detection of GH and S clade strains and G614 variant from Pakistan warranting large-scale whole-genome sequencing of strains prevalent in different regions to understand virus evolution and to explore their genetic diversity.	[Umair, Massab; Ikram, Aamer; Salman, Muhammad; Khurshid, Adnan; Alam, Masroor; Badar, Nazish; Suleman, Rana; Tahir, Faheem; Sharif, Salmaan] Natl Inst Hlth, Islamabad, Pakistan; [Montgomery, Joel; Whitmer, Shannon; Klena, John] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Umair, M (corresponding author), Natl Inst Hlth, Islamabad, Pakistan.	m.umair@nih.org.pk						[Anonymous], PAKISTAN CONFIRMS 1; Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; Eden J.S., 2020, VIRUS EVOL, V6, pv, DOI [10.1093/ve/veaa027, DOI 10.1093/ve/veaa027]; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambaro F, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.26.2001200; Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Hu J., 2020, D614G MUTATION SARS, DOI 10.1101/2020.06.20.161323; Jesus JGd, 2020, REV I MED TROPICAL S, V62; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu ZX, 2020, J MED VIROL, V92, P595, DOI 10.1002/jmv.25726; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; Ortega JT, 2020, EXCLI J, V19, P410, DOI 10.17179/excli2020-1167; Munnink BOB, 2020, NAT MED, V26, P1802, DOI 10.1038/s41591-020-1128-5; Ozono S., 2020, BIORXIV, DOI 10.1101/2020.06.15.151779; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; World Health Organization, 2022, WEEKL OP UPD COVID 1; Yurkovetskiy Leonid, 2020, Cell, V183, P739, DOI [10.1101/2020.07.04.187757, 10.1016/j.cell.2020.09.032]; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4	26	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248371	10.1371/journal.pone.0248371	http://dx.doi.org/10.1371/journal.pone.0248371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755704	Green Published, gold			2022-12-26	WOS:000632916600037
J	Jing, CY; Fu, YP; Zhou, C; Zhang, MX; Yi, Y; Huang, JL; Gan, W; Zhang, J; Zheng, SS; Zhang, BH; Qiu, SJ				Jing, Chu-Yu; Fu, Yi-Peng; Zhou, Cheng; Zhang, Mei-Xia; Yi, Yong; Huang, Jin-Long; Gan, Wei; Zhang, Juan; Zheng, Su-Su; Zhang, Bo-Heng; Qiu, Shuang-Jian			Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis	ONCOGENE			English	Article								Intrahepatic cholangiocarcinoma (ICC) is a highly fatal malignancy characterized by a vast amount of intra-tumoral fibroblasts. These fibroblasts are potentially implicated in maintaining the high aggressiveness of ICC, whereas its pro-cancer mechanisms remain scarcely reported. Here, by establishing co-culture models of ICC cells and hepatic stellate cells (HSCs), we identified that HSCs triggered the expression of nuclear receptor family 4 subgroup A member 2 (NR4A2), a transcription factor previously reported as a molecular switch between inflammation and cancer, in ICC cells. Functionally, NR4A2 promotes tumor proliferation, metastatic potentiality and represents an independent prognostic indicator for overall survival in ICC patients. Mechanistically, NR4A2 upregulates osteopontin (OPN) expression through transcriptional activation and thereby augments the activity of Wnt/beta-catenin signaling. Intriguingly, in the context of co-culture, vascular endothelial growth factor (VEGF), a previously proved NR4A2 stimulus, not only enhances NR4A2 expression, but also can be blunted by the interference of the NR4A2-OPN axis. Altogether, this study suggests the NR4A2/OPN/Wnt signaling axis to be a pivotal executor of HSC-instigated cancer-promoting roles in ICC, and the NR4A2/OPN/VEGF positive feedback loop may help to reinforce the effect.	[Jing, Chu-Yu; Zhou, Cheng; Yi, Yong; Huang, Jin-Long; Gan, Wei; Zhang, Juan; Zheng, Su-Su; Zhang, Bo-Heng; Qiu, Shuang-Jian] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Chinese Minis, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Jing, Chu-Yu; Zhou, Cheng; Yi, Yong; Huang, Jin-Long; Gan, Wei; Zhang, Juan; Zheng, Su-Su; Zhang, Bo-Heng; Qiu, Shuang-Jian] Fudan Univ, Shanghai Med Sch, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Fu, Yi-Peng] Fudan Univ, Dept Breast Surg, Obstet & Gynecol Hosp, 419 Fangxie Rd, Shanghai 200090, Peoples R China; [Zhou, Cheng; Yi, Yong; Huang, Jin-Long; Gan, Wei; Qiu, Shuang-Jian] Fudan Univ, Zhongshan Hosp, Dept Liver Surg & Transplantat, 180 Fenglin Rd, Shanghai 200032, Peoples R China; [Zhang, Mei-Xia] Nanchang Univ, Dept Gastroenterol, Affiliated Hosp 1, 17 Yongwaizheng St, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Bo-Heng] Fudan Univ, Ctr Evidence Based Med, Shanghai Med Sch, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Nanchang University; Fudan University	Zhang, BH; Qiu, SJ (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Chinese Minis, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Zhang, BH; Qiu, SJ (corresponding author), Fudan Univ, Shanghai Med Sch, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Fu, YP (corresponding author), Fudan Univ, Dept Breast Surg, Obstet & Gynecol Hosp, 419 Fangxie Rd, Shanghai 200090, Peoples R China.; Qiu, SJ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Liver Surg & Transplantat, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Zhang, BH (corresponding author), Fudan Univ, Ctr Evidence Based Med, Shanghai Med Sch, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	fyp0076@163.com; zhang.boheng@zs-hospital.sh.cn; qiu.shuangjian@zs-hospital.sh.cn		Jing, Chuyu/0000-0001-8057-4677; Fu, Yi-Peng/0000-0002-4229-6714	National Natural Science Foundation of China [81772510, 81902419, 81902993, 82072677, 82072672]; National Key Research and Development Program of China [2017YFC0908101, 2017YFC0908102]; Research Programs of Science and Technology Commission Foundation of Shanghai [18XD1401100]; Medical and Health Key Programs of Science and Technology Plan of Xiamen [3502Z20191105]; Research and Development Program of Zhongshan Hospital, Fudan University [2020ZSFZ13, 2019ZSFZ13, 2018ZSFZ055, ZSLC62, 2019-275, 2020-312, 2021-353]; 2020 Youth Talent Program of Obstetrics & Gynecology Hospital of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Research Programs of Science and Technology Commission Foundation of Shanghai; Medical and Health Key Programs of Science and Technology Plan of Xiamen; Research and Development Program of Zhongshan Hospital, Fudan University; 2020 Youth Talent Program of Obstetrics & Gynecology Hospital of Fudan University	This project is supported by the National Natural Science Foundation of China (NO.81772510; NO.81902419; NO.81902993; NO. 82072677, NO. 82072672); National Key Research and Development Program of China (NO.2017YFC0908101 and NO.2017YFC0908102); Research Programs of Science and Technology Commission Foundation of Shanghai (NO.18XD1401100); Medical and Health Key Programs of Science and Technology Plan of Xiamen (NO.3502Z20191105); 2020 Youth Talent Program of Obstetrics & Gynecology Hospital of Fudan University obtained by Dr. YiPeng Fu and Research and Development Program of Zhongshan Hospital, Fudan University (NO. 2020ZSFZ13, NO. 2019ZSFZ13, NO. 2018ZSFZ055, NO. ZSLC62, NO. ZHZS17, NO. 2019-275, NO. 2020-312, NO. 2021-353).	Ahmed M, 2016, CANCER CELL, V30, P432, DOI 10.1016/j.ccell.2016.08.002; Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001; [Anonymous], CANCER DISCOV, V7; Bertuccio P, 2019, J HEPATOL, V71, P104, DOI 10.1016/j.jhep.2019.03.013; Bridgewater J, 2014, J HEPATOL, V60, P1268, DOI 10.1016/j.jhep.2014.01.021; Cadamuro M, 2013, HEPATOLOGY, V58, P1042, DOI 10.1002/hep.26384; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cheng JT, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.7; Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003; Crean D, 2015, J IMMUNOL, V195, P1436, DOI 10.4049/jimmunol.1402039; Cuiffo BG, 2014, CELL STEM CELL, V15, P762, DOI 10.1016/j.stem.2014.10.001; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Gentilini A, 2012, J HEPATOL, V57, P813, DOI 10.1016/j.jhep.2012.06.012; Goradel NH, 2019, J CELL PHYSIOL, V234, P5683, DOI 10.1002/jcp.27411; Han YF, 2012, WORLD J GASTROENTERO, V18, P6865, DOI 10.3748/wjg.v18.i47.6865; Han YF, 2013, EUR J CANCER, V49, P3420, DOI 10.1016/j.ejca.2013.06.001; Han YF, 2013, CANCER-AM CANCER SOC, V119, P3436, DOI 10.1002/cncr.28228; Ji JL, 2015, HEPATOLOGY, V62, P481, DOI 10.1002/hep.27822; Jing CY, 2018, ONCOLOGIST, V23, P1482, DOI 10.1634/theoncologist.2017-0439; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karki K, 2020, J NEURO-ONCOL, V146, P25, DOI 10.1007/s11060-019-03349-y; Kothari AN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040039; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Li L, 2017, HEPATOLOGY, V65, P501, DOI 10.1002/hep.28735; Li P, 2015, CELL RES, V25, P588, DOI 10.1038/cr.2015.51; McEvoy C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00007; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Okabe H, 2009, ANN SURG ONCOL, V16, P2555, DOI 10.1245/s10434-009-0568-4; Paule B, 2007, ONCOLOGY-BASEL, V72, P105, DOI 10.1159/000111117; Primrose JN, 2019, LANCET ONCOL, V20, P663, DOI 10.1016/S1470-2045(18)30915-X; Raja R, 2014, ONCOGENE, V33, P2053, DOI 10.1038/onc.2013.171; Ramchandani D, 2015, BBA-REV CANCER, V1855, P202, DOI 10.1016/j.bbcan.2015.02.003; Saha SK, 2016, ONCOLOGIST, V21, P594, DOI 10.1634/theoncologist.2015-0446; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shigeishi H, 2011, CANCER LETT, V307, P227, DOI 10.1016/j.canlet.2011.04.008; Sirica AE, 2019, HEPATOLOGY, V69, P1803, DOI 10.1002/hep.30289; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Sulpice L, 2013, HEPATOLOGY, V58, P1992, DOI 10.1002/hep.26577; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Wu LM, 2018, BRIT J HAEMATOL, V183, P445, DOI 10.1111/bjh.15548; Zagani R, 2009, GASTROENTEROLOGY, V137, P1358, DOI 10.1053/j.gastro.2009.06.039; Zhao DZ, 2011, INT J CANCER, V128, P2602, DOI 10.1002/ijc.25600; Zheng Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0226-x; Zhu Y, 2019, GUT, V68, P1653, DOI 10.1136/gutjnl-2019-318419	48	7	7	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2910	2922		10.1038/s41388-021-01705-9	http://dx.doi.org/10.1038/s41388-021-01705-9		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742120				2022-12-26	WOS:000630675000006
J	Loncarevic, IF; Toepfer, S; Hubold, S; Klingner, S; Kanitz, L; Ellinger, T; Steinmetzer, K; Ernst, T; Hochhaus, A; Ermantraut, E				Loncarevic, Ivan Francisco; Toepfer, Susanne; Hubold, Stephan; Klingner, Susanne; Kanitz, Lea; Ellinger, Thomas; Steinmetzer, Katrin; Ernst, Thomas; Hochhaus, Andreas; Ermantraut, Eugen			Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RESIDUAL DISEASE DETECTION; LEUKEMIA; PCR; EUROPE; GENES	Precise quantification of molecular targets in a biological sample across a wide dynamic range is a key requirement in many diagnostic procedures, such as monitoring response to therapy or detection of measurable residual disease. State of the art digital PCR assays provide for a dynamic range of four orders of magnitude. However digital assays are complex and require sophisticated microfluidic tools. Here we present an assay format that enables ultra-precise quantification of RNA targets in a single measurement across a dynamic range of more than six orders of magnitude. The approach is based on hydrogel beads that provide for microfluidic free compartmentalization of the sample as they are used as nanoreactors for reverse transcription, PCR amplification and combined real time and digital detection of gene transcripts. We have applied these nanoreactor beads for establishing an assay for the detection and quantification of BCR-ABL1 fusion transcripts. The assay has been characterized for its precision and linear dynamic range. A comparison of the new method against conventional real time RT-PCR analysis (reference method) with clinical samples from patients with chronic myeloid leukemia (CML) revealed excellent concordance with Pearsons correlation coefficient of 0.983 and slope of 1.08.	[Loncarevic, Ivan Francisco; Toepfer, Susanne; Hubold, Stephan; Klingner, Susanne; Kanitz, Lea; Ellinger, Thomas; Steinmetzer, Katrin; Ermantraut, Eugen] BLINK AG, Jena, Germany; [Ernst, Thomas; Hochhaus, Andreas] Univ Klinikum Jena, Klin Innere Med Abt Hamatol & Internist Onkol 2, Jena, Germany	Friedrich Schiller University of Jena	Loncarevic, IF (corresponding author), BLINK AG, Jena, Germany.	ivan@blink-dx.com		Loncarevic, Ivan/0000-0002-2763-5765	German Federal Ministry of Education and Research (BMBF) [031B0526A]; Free State of Thuringia; European Regional Development Fund; EU [2017 FE 9005]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Free State of Thuringia(European Commission); European Regional Development Fund(European Commission); EU(European Commission)	The authors' affiliation BLINK AG received funding for this study in the form of grants from The German Federal Ministry of Education and Research (BMBF) (Grant No. 031B0526A) and from Free State of Thuringia and European Regional Development Fund (Grant No. EU 2017 FE 9005). BLINK AG used these grants to provide support in the form of salaries to TE, EE, SH, IL, ST, and SK. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu AS, 2017, SLAS TECHNOL, V22, P369, DOI 10.1177/2472630317705680; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bonecker Simone, 2015, Rev. Bras. Hematol. Hemoter., V37, P142, DOI 10.1016/j.bjhh.2014.08.003; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Cross NCP, 2016, LEUKEMIA, V30, P1844, DOI 10.1038/leu.2016.90; Cross NCP, 2015, LEUKEMIA, V29, P999, DOI 10.1038/leu.2015.29; Demaree B, 2018, METHOD CELL BIOL, V148, P119, DOI 10.1016/bs.mcb.2018.10.002; Donoser M, 2006, 2006 IEEE COMPUTER S, V1, P553, DOI DOI 10.1109/CVPR.2006.107; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Hatori MN, 2018, ANAL CHEM, V90, P9813, DOI 10.1021/acs.analchem.8b01759; Hochhaus A, 2020, LEUKEMIA, V34, P966, DOI 10.1038/s41375-020-0776-2; Jones Gerwyn M, 2016, Biomol Detect Quantif, V10, P31; Kiss MM, 2008, ANAL CHEM, V80, P8975, DOI 10.1021/ac801276c; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Majumdar N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118833; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; Morley Alexander A, 2014, Biomol Detect Quantif, V1, P1; Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271; Rio Donald C, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5439; Shanmuganathan N, 2018, HEMATOL-AM SOC HEMAT, P168, DOI 10.1182/asheducation-2018.1.168; Steinmetzer Katrin, 2018, EP patent, Patent No. [EP3343223A1, 3343223]; Streets AM, 2014, CURR OPIN BIOTECH, V25, P69, DOI 10.1016/j.copbio.2013.08.013; Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159004	23	0	0	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0242529	10.1371/journal.pone.0242529	http://dx.doi.org/10.1371/journal.pone.0242529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735175	Green Submitted, gold, Green Published			2022-12-26	WOS:000631029700076
J	Ojha, RB; Shrestha, S; Khadka, YG; Panday, D; Islam, R				Ojha, Roshan Babu; Shrestha, Shova; Khadka, Yajna Gajadhar; Panday, Dinesh; Islam, Rafiq			Potassium nutrient response in the rice-wheat cropping system in different agro-ecozones of Nepal	PLOS ONE			English	Article							INDO-GANGETIC PLAINS; SOIL; YIELD; FIXATION; RELEASE; MANAGEMENT; FERTILITY; DYNAMICS; LOSSES; CLAY	Most of the soils of Nepal had a higher potassium (K, expressed as K2O) level inherently. Later in 1976, the Government of Nepal has recommended K fertilizer rate at 30 kg K2O ha(-1) in rice-wheat cropping systems. However, those crops began showing K deficiency symptoms in recent decades, which could be due to a large portion of soils with depleted K level or the insufficient input of K fertilizer for crop production. This study explored a limitation of K nutrient in the crops by establishing field trials from 2009-2014 at three agro-ecozones i.e., inner-Terai (2009-2010), high-Hills (2011-2012), and Terai (2012-2014) in Nepal. Seven rates of K fertilizer at 0, 15, 30, 45, 60, 75, and 90 kg K2O ha(-1) were replicated four times in a randomized complete block design, where crop yields and yield-attributing parameters of rice-wheat cropping system were recorded. Results revealed that an increase in K rates from 45 to 75 kg K2O ha(-1) under inner-Terai and Terai conditions and 45 to 60 kg ha(-1) under high-Hills conditions produced significantly higher grain yields compared to the recommended K dose. Economically, the optimum rate of K fertilizer should not exceed 68 kg K2O ha(-1) for rice in all agro-ecozones, or 73 kg K2O ha(-1) for wheat in inner-Terai and 60 kg K2O ha(-1) for wheat in high-Hills and Terai. Our findings suggest to increase potassium application in between 1.5 to 2.5 times of the current K fertilizer rate in rice-wheat cropping system of Nepal that need to be tested further in different locations and crop varieties.	[Ojha, Roshan Babu; Shrestha, Shova; Khadka, Yajna Gajadhar] Nepal Agr Res Council, Soil Sci Div, Khumaltar, Lalitpur, Nepal; [Panday, Dinesh] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Ojha, RB (corresponding author), Nepal Agr Res Council, Soil Sci Div, Khumaltar, Lalitpur, Nepal.	roshanbachhan@gmail.com	Panday, Dinesh/M-1667-2017; Ojha, Roshan Babu/AAC-3863-2020	Panday, Dinesh/0000-0001-8452-3797; Ojha, Roshan Babu/0000-0002-8133-981X	Nepal Agricultural Research Council, Singhadurbar Plaza, Kathmandu, Nepal	Nepal Agricultural Research Council, Singhadurbar Plaza, Kathmandu, Nepal	Nepal Agricultural Research Council, Singhadurbar Plaza, Kathmandu, Nepal funded the project from the regular budget only to conduct the multi-location field trials. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya GP, 2007, LAND DEGRAD DEV, V18, P486, DOI 10.1002/ldr.792; [Anonymous], 1993, SOIL SAMPLING METHOD, DOI DOI 10.1016/B978-0-12-415955-6.00001-3; Bajracharya RM, 2009, ENVIRON SCI ENG TECH, P111; BAUMLER R, 1994, CATENA, V22, P85, DOI 10.1016/0341-8162(94)90019-1; Bhatt R, 2016, INT SOIL WATER CONSE, V4, P64, DOI 10.1016/j.iswcr.2015.12.001; Bijay-Singh Y.S, 2003, NATL AGR TECH PROJEC, P161; Brady N.C, 2000, NATURE PROPERTIES SO; BREMNER J. M., 1960, JOUR AGRIC SCI, V55, P11, DOI 10.1017/S0021859600021572; Carson B., 1992, LAND FARMER FUTURE; Chapagain T., 2010, EFFECTS INTEGRATED P; Chen ZS, 2015, WOR SOIL BOOK SER, P63, DOI 10.1007/978-94-017-9726-9_6; Dinesh Panday, 2012, Hydro Nepal: Journal of Water, Energy and Environment, VSpecial Iss., P91; Diwakar J, 2010, SCI WORLD, V6, DOI [DOI 10.3126/SW.V6I6.2638, 10.3126/sw.v6i6.2638]; Fausti S, 2017, PRACTICAL MATHEMATICS FOR PRECISION FARMING, P181, DOI 10.2134/practicalmath2016.0027; Gami SK, 2001, BIOL FERT SOILS, V34, P73, DOI 10.1007/s003740100377; Gauchan D, 1999, FARMING SYSTEMS RES; Gupta R, 2007, CROP PROT, V26, P436, DOI 10.1016/j.cropro.2006.04.030; Gurung D.B, 2013, P REG CONS IMPR WHEA, P224; Havlin J.L., 2016, PEARSON ED INDIA; Hobbs PR, 2003, COMP ASSESS WAT MAN, V1, P239, DOI 10.1079/9780851996691.0239; Joshy D., 1997, **DROPPED REF**, V1, P80; Koirala P, 2019, GEOSCIENCES, V9, DOI 10.3390/geosciences9040147; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Lu DJ, 2017, FIELD CROP RES, V214, P38, DOI 10.1016/j.fcr.2017.08.025; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Maskey S.L., 2000, P WORKSH COMP INT PL; MOALD, 2018, ANN FERT CONS TREND; MOPE, 2002, NEP NAT ACT PROGR LA; MORTLAND M. M., 1957, SOIL SCI SOC AMER PROC, V21, P381; Nagendra H, 2005, ECOL SOC, V10; Ojha R.B., 2018, AGRO ECOLOGY SUSTAIN; Ojha RB, 2014, INT J SCI RES AGR SC, V1, P165; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Panday D, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1600460; Panday D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206350; Pandey S, 2018, J CROP IMPROV, V32, P19, DOI 10.1080/15427528.2017.1387837; Panwar AS, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010122; Paudel S. P., 2011, Journal of Agriculture and Environment, V12, P127; Pokharel D, 2018, COGENT FOOD AGR, V4, DOI 10.1080/23311932.2018.1557582; Ponnamperuma F.N, 1981, TEXT SERIES LECT DEL; Prasad R, 2004, CURR SCI INDIA, V87, P1334; Regmi AP, 2002, BIOL FERT SOILS, V36, P240, DOI 10.1007/s00374-002-0525-x; RIGHI D, 1986, GEODERMA, V39, P141, DOI 10.1016/0016-7061(86)90072-8; Samal SK, 2017, EUR J AGRON, V90, P198, DOI 10.1016/j.eja.2017.08.006; Schneider A, 1997, EUR J SOIL SCI, V48, P263, DOI 10.1111/j.1365-2389.1997.tb00546.x; Shah P.B, 1996, P SOIL FERT PLANT NU, P78; Shaikh K, 2007, SOIL ENVRON, V26, P1; Shakya BM, 2019, WATER-SUI, V11, DOI 10.3390/w11102184; Sharma R. C., 2007, Asian Journal of Plant Sciences, V6, P638; Shrestha CH, 2011, J CIV SOC, V7, P41, DOI 10.1080/17448689.2011.553420; Simonsson M, 2007, GEODERMA, V140, P188, DOI 10.1016/j.geoderma.2007.04.002; Simonsson M, 2016, BIOGEOCHEMISTRY, V131, P77, DOI 10.1007/s10533-016-0266-9; Simonsson M, 2009, GEODERMA, V151, P109, DOI 10.1016/j.geoderma.2009.03.018; SSD, 2015, ANN SOIL REP; Subedi R, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10081129; Takeshima H., 2016, INT FOOD POLICY RES; Tandon HL, 1988, POTASSIUM RES AGR PR; THOMAS G. W., 1968, "The Role of Potassium in Agriculture'". American Society of Agronomy et al. Madison., V1968, P269; Tiwari K. N., 1992, RICE WHEAT CROPPING, P93; Tiwari KR, 2010, NUTR CYCL AGROECOSYS, V86, P241, DOI 10.1007/s10705-009-9289-0; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017; von Westarp S, 2004, CAN J SOIL SCI, V84, P323, DOI 10.4141/S03-053; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003	63	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248837	10.1371/journal.pone.0248837	http://dx.doi.org/10.1371/journal.pone.0248837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735327	gold, Green Published			2022-12-26	WOS:000631029700009
J	Pouw, N; van de Maat, J; Veerman, K; ten Oever, J; Janssen, N; Abbink, E; Reijers, M; de Mast, Q; Hoefsloot, W; van Crevel, R; Slieker, K; van Apeldoorn, M; Blaauw, M; Dofferhoff, A; Hoogerwerf, J				Pouw, Niels; van de Maat, Josephine; Veerman, Karin; ten Oever, Jaap; Janssen, Nico; Abbink, Evertine; Reijers, Monique; de Mast, Quirijn; Hoefsloot, Wouter; van Crevel, Reinout; Slieker, Kitty; van Apeldoorn, Marjan; Blaauw, Marc; Dofferhoff, Anton; Hoogerwerf, Jacobien			Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study	PLOS ONE			English	Article							ICU	Objective To describe clinical characteristics, disease course and outcomes in a large and well-documented cohort of hospitalized COVID-19 patients in the Netherlands. Methods We conducted a multicentre retrospective cohort study in The Netherlands including 952 of 1183 consecutively hospitalized patients that were admitted to participating hospitals between March 2nd, 2020, and May 22nd, 2020. Clinical characteristics and laboratory parameters upon admission and during hospitalization were collected until July 1(st). Results The median age was 69 years (IQR 58-77 years) and 605 (63.6%) were male. Cardiovascular disease was present in 558 (58.6%) patients. The median time of onset of symptoms prior to hospitalization was 7 days (IQR 5-10). A non ICU admission policy was applicable in 312 (32.8%) patients and in 165 (56.3%) of the severely ill patients admitted to the ward. At admission and during hospitalization, severely ill patients had higher values of CRP, LDH, ferritin and D-dimer with higher neutrophil counts and lower lymphocyte counts. Overall in-hospital mortality was 25.1% and 183 (19.1%) patients were admitted to ICU, of whom 56 (30.6%) died. Patients aged >= 70 years had high mortality, both at the ward (52.4%) and ICU (47.4%). The median length of ICU stay was 8 days longer in patients aged >= 70 years compared to patients aged <= 60 years. Conclusion Hospitalized COVID-19 patients aged >= 70 years had high mortality and longer ICU stay compared to patients aged <= 60 years. These findings in combination with the patient burden of an ICU admission and possible long term complications after discharge should encourage us to further investigate the benefit of ICU admission in elderly and fragile COVID-19-patients.	[Pouw, Niels; van de Maat, Josephine; ten Oever, Jaap; Janssen, Nico; Abbink, Evertine; de Mast, Quirijn; Hoefsloot, Wouter; van Crevel, Reinout; Blaauw, Marc; Hoogerwerf, Jacobien] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Pouw, Niels; van de Maat, Josephine; ten Oever, Jaap; Janssen, Nico; Abbink, Evertine; de Mast, Quirijn; Hoefsloot, Wouter; van Crevel, Reinout; Blaauw, Marc; Hoogerwerf, Jacobien] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Veerman, Karin] St Maartens Clin, Dept Internal Med, Nijmegen, Netherlands; [Reijers, Monique] Radboud Univ Nijmegen, Dept Pulm Dis, Med Ctr, Nijmegen, Netherlands; [Slieker, Kitty; Blaauw, Marc] Bernhoven Hosp, Dept Internal Med, Uden, Netherlands; [van Apeldoorn, Marjan] Jeroen Bosch Hosp, Dept Internal Med, Shertogenbosch, Netherlands; [Dofferhoff, Anton] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Sint Maartens Clinic; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Canisius-Wilhelmina Hospital	Hoogerwerf, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands.; Hoogerwerf, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands.	Jacobien.Hoogerwerf@radboudumc.nl	Veerman, Karin/AHD-3097-2022; Oever, Jaap ten/P-6617-2015; Janssen, Nico/R-5973-2017	Veerman, Karin/0000-0002-3175-6316; Oever, Jaap ten/0000-0003-2397-0125; Pouw, Niels/0000-0001-9356-8540; de Mast, Quirijn/0000-0001-6056-157X; Janssen, Nico/0000-0002-9629-8627				Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Blanch L, 2016, J CRIT CARE, V36, P301, DOI 10.1016/j.jcrc.2016.06.014; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Botta M, 2021, LANCET RESP MED, V9, P139, DOI 10.1016/S2213-2600(20)30459-8; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Organization WH, CLIN MAN COVID 19 WE; Organization WH, WHO COR DIS COVID 19; Orsini Jose, 2014, J Clin Med Res, V6, P463, DOI 10.14740/jocmr1939w; Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; RIVM. National institute for Public Health and the Environment, PAT NOV COR COVID 19; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Specialists FoM, TRIAG THUISB VERS VE; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; WHO. World Health Organization, WHO ANN COVID 19 OUT; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; World Health O, 2020, WHOCOVID19LABORATORY; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047; Zheng YL, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104366; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248713	10.1371/journal.pone.0248713	http://dx.doi.org/10.1371/journal.pone.0248713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735205	Green Published, gold			2022-12-26	WOS:000631029700004
J	Tomprou, M; Kim, YJ; Chikersal, P; Woolley, AW; Dabbish, LA				Tomprou, Maria; Kim, Young Ji; Chikersal, Prerna; Woolley, Anita Williams; Dabbish, Laura A.			Speaking out of turn: How video conferencing reduces vocal synchrony and collective intelligence	PLOS ONE			English	Article							COMPUTER-MEDIATED COMMUNICATION; DYNAMICS; MIND; OUTCOMES; RAPPORT; ABILITY; TEAMS; TRUST; WORK	Collective intelligence (CI) is the ability of a group to solve a wide range of problems. Synchrony in nonverbal cues is critically important to the development of CI; however, extant findings are mostly based on studies conducted face-to-face. Given how much collaboration takes place via the internet, does nonverbal synchrony still matter and can it be achieved when collaborators are physically separated? Here, we hypothesize and test the effect of nonverbal synchrony on CI that develops through visual and audio cues in physically-separated teammates. We show that, contrary to popular belief, the presence of visual cues surprisingly has no effect on CI; furthermore, teams without visual cues are more successful in synchronizing their vocal cues and speaking turns, and when they do so, they have higher CI. Our findings show that nonverbal synchrony is important in distributed collaboration and call into question the necessity of video support.	[Tomprou, Maria; Woolley, Anita Williams] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Kim, Young Ji] Univ Calif Santa Barbara, Dept Commun, Santa Barbara, CA 93106 USA; [Chikersal, Prerna; Dabbish, Laura A.] Carnegie Mellon Univ, Human Comp Interact Inst, Pittsburgh, PA 15213 USA	Carnegie Mellon University; University of California System; University of California Santa Barbara; Carnegie Mellon University	Tomprou, M (corresponding author), Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA.	mtomprou@cmu.edu		Tomprou, Maria/0000-0003-3173-1677	National Science Foundation [CNS-1205539];  [OAC-1322278];  [OAC-1322254]	National Science Foundation(National Science Foundation (NSF)); ; 	This material is based upon work supported by the National Science Foundation under grant numbers CNS-1205539 (url: https://www.nsf.gov/awardsearch/showAward?AWD_ID= 1205539&HistoricalAwards=false) Author who received the award: L.D., OAC-1322278 (url:https://nsf.gov/awardsearch/showAward?AWD_ID= 1322278) (Author who received the award A.W.), and OAC-1322254 (url:.https://nsf.gov/awardsearch/showAward?AWD_ID=1322254) (Author who received the award A.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal I, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00112; Akinola M, 2016, P NATL ACAD SCI USA, V113, P9774, DOI 10.1073/pnas.1603443113; [Anonymous], 2006, P CHI EXT ABSTR HUM; APPLE W, 1979, J PERS SOC PSYCHOL, V37, P715, DOI 10.1037/0022-3514.37.5.715; Baimel A, 2018, J EXP SOC PSYCHOL, V74, P281, DOI 10.1016/j.jesp.2017.10.008; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bear A, 2016, P NATL ACAD SCI USA, V113, P936, DOI 10.1073/pnas.1517780113; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; BERNIERI FJ, 1994, PERS SOC PSYCHOL B, V20, P303, DOI 10.1177/0146167294203008; Bernstein E, 2018, P NATL ACAD SCI USA, V115, P8734, DOI 10.1073/pnas.1802407115; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Burgoon JK, 2002, J COMMUN, V52, P657, DOI 10.1093/joc/52.3.657; Buzzanell PM, 2018, J APPL COMMUN RES, V46, P1, DOI 10.1080/00909882.2017.1412086; Carney DR, 2003, EMOTION, V3, P194, DOI 10.1037/1528-3542.3.2.194; Chikersal P, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P873, DOI 10.1145/2998181.2998250; Culnan MJ., 1987, INFORM TECHNOLOGIES; Curhan JR, 2007, J APPL PSYCHOL, V92, P802, DOI 10.1037/0021-9010.92.3.802; Curry O, 2012, J COGN CULT, V12, P147, DOI 10.1163/156853712X633974; DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554; Darves C., 2002, 7 INT C SPOK LANG PR; Degottex Gilles, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P960, DOI 10.1109/ICASSP.2014.6853739; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; DUNCAN S, 1972, J PERS SOC PSYCHOL, V23, P283, DOI 10.1037/h0033031; Engel D, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3769, DOI 10.1145/2702123.2702259; Engel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115212; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Gordon DM, 2016, SCI AM, V314, P44; Guerrero L., 1999, NONVERBAL COMMUNICAT; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; Johnson D. W., 1996, HDB RES ED COMMUNICA, P1017; Julien D, 2000, CAN J BEHAV SCI, V32, P84, DOI 10.1037/h0087103; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kittur A, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P37; Knapp ML, 2013, CENGAGE LEARNING; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Krych-Appelbaum M, 2007, INTERACT STUD, V8, P267, DOI 10.1075/is.8.2.05kry; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Levinson SC, 2016, TRENDS COGN SCI, V20, P6, DOI 10.1016/j.tics.2015.10.010; Levitan Rivka, 2012, P 2012 C N AM CHAPT, P11; LINDSKOLD S, 1978, PSYCHOL BULL, V85, P772, DOI 10.1037/0033-2909.85.4.772; Lodato TJ, 2016, NEW MEDIA SOC, V18, P539, DOI 10.1177/1461444816629467; Lubold N, 2014, IEEE W SP LANG TECH, P288, DOI 10.1109/SLT.2014.7078589; Lubold Nichola, 2014, P 2014 ACM WORKSHOP, P5; Lumsden J, 2012, J EXP SOC PSYCHOL, V48, P746, DOI 10.1016/j.jesp.2011.12.007; Marlow SL, 2017, HUM RESOUR MANAGE R, V27, P575, DOI 10.1016/j.hrmr.2016.12.005; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Monster D, 2016, PHYSIOL BEHAV, V156, P24, DOI 10.1016/j.physbeh.2016.01.004; O'Mahony S, 1999, RES ORGAN BEHAV, V21, P125; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; PARKER EB, 1978, CONTEMP SOCIOL, V7, P32, DOI 10.2307/2065899; Pedott Paula Renata, 2014, Audiol., Commun. Res., V19, P153, DOI 10.1590/S2317-64312014000200009; Ramirez A, 2002, HUM COMMUN RES, V28, P213, DOI 10.1093/hcr/28.2.213; Riedl C, 2017, ACAD MANAG DISCOV, V3, P382, DOI 10.5465/amd.2015.0097; Satyanarayanan M., 2016, TECHNICAL REPORT CMU; Schulze J, 2017, ORGAN PSYCHOL REV, V7, P66, DOI 10.1177/2041386616675522; Shaw M. E, 1971, GROUP DYNAMICS PSYCH; Team I., 2017, FORBES INSIGHTS; Vacharkulksemsuk T, 2012, J EXP SOC PSYCHOL, V48, P399, DOI 10.1016/j.jesp.2011.07.015; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Valentine MA, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P3523, DOI 10.1145/3025453.3025811; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Vicaria IM, 2016, J NONVERBAL BEHAV, V40, P335, DOI 10.1007/s10919-016-0238-8; Walther JB, 1996, COMMUN RES, V23, P3, DOI 10.1177/009365096023001001; WALTHER JB, 1992, HUM COMMUN RES, V19, P50, DOI 10.1111/j.1468-2958.1992.tb00295.x; WALTHER JB, 1992, COMMUN RES, V19, P52, DOI 10.1177/009365092019001003; WIEMANN JM, 1975, J COMMUN, V25, P75, DOI 10.1111/j.1460-2466.1975.tb00582.x; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	68	8	8	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247655	10.1371/journal.pone.0247655	http://dx.doi.org/10.1371/journal.pone.0247655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735258	Green Published, gold			2022-12-26	WOS:000631029700123
J	Jangmo, A; Kuja-Halkola, R; Perez-Vigil, A; Almqvist, C; Bulik, CM; D'Onofrio, B; Lichtenstein, P; Ahnemark, E; Werner-Kiechle, T; Larsson, H				Jangmo, Andreas; Kuja-Halkola, Ralf; Perez-Vigil, Ana; Almqvist, Catarina; Bulik, Cynthia M.; D'Onofrio, Brian; Lichtenstein, Paul; Ahnemark, Ewa; Werner-Kiechle, Tamara; Larsson, Henrik			Attention-deficit/hyperactivity disorder and occupational outcomes: The role of educational attainment, comorbid developmental disorders, and intellectual disability	PLOS ONE			English	Article								Background Individuals with ADHD are at increased risk for poor occupational outcomes. Educational attainment and psychiatric comorbidity may be important contributing factors for these outcomes, but the role of these factors is not well characterized. This study aimed to investigate the associations between ADHD and occupational outcomes, and to examine the influence of educational attainment, comorbid developmental disorders and intellectual disability on these associations. Methods We linked the Swedish population graduating from compulsory school 1998-2008 (N = 1.2 millions) to population-wide register-based data on clinical psychiatric diagnoses and medications, objective annual measures of educational, and occupational outcomes. Individuals were followed for between 6 to 16 years after graduation. Results Individuals with ADHD had annually on average 17 percent lower income, ratio = 0.83 (95% CI 0.83-0.84), 12.19 (11.89-12.49) more days of unemployment, and a higher likelihood of receiving disability pension, odds-ratio = 19.0 (18.4-19.6), compared to controls. Comorbid diagnoses of intellectual disability and developmental disorder explained most of the association between ADHD and disability pension, while lifetime educational attainment partially explained associations between ADHD and all occupational outcomes. Analyses of occupational trajectories found that income was lower and unemployment elevated relative to controls with the same educational attainment. Higher educational attainment correlated with higher income similarly among individuals with ADHD and controls after accounting for individual background factors. Conclusions The occupational burden associated with ADHD is substantial. Comorbid developmental disorders, intellectual disability and educational difficulties (e.g., failing grades) from childhood to adulthood are important factors to consider when designing interventions to improve occupational outcomes in individuals with ADHD.	[Jangmo, Andreas; Kuja-Halkola, Ralf; Almqvist, Catarina; Bulik, Cynthia M.; D'Onofrio, Brian; Lichtenstein, Paul; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Perez-Vigil, Ana] Hosp Clin Barcelona, Clin Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Bulik, Cynthia M.] Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC USA; [Bulik, Cynthia M.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA; [D'Onofrio, Brian] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Ahnemark, Ewa] Shire Sweden AB, Med Affairs, Stockholm, Sweden; [Werner-Kiechle, Tamara] Shire Int GmbH, Global Med Affairs, Zug, Switzerland; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden	Karolinska Institutet; University of Barcelona; Hospital Clinic de Barcelona; Karolinska Institutet; Karolinska University Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington; Orebro University	Jangmo, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	andreas.jangmo@ki.se	Kuja-Halkola, Ralf/ABA-5061-2020; Larsson, Henrik/GYD-5161-2022	Kuja-Halkola, Ralf/0000-0002-3765-2067; Werner-Kiechle, Tamara/0000-0001-9145-3790; Jangmo, Andreas/0000-0001-6928-4791; Larsson, Henrik/0000-0002-6851-3297	Swedish Research Council (Vetenskapsradet) [2018-02599]; Shire International GmbH; Swedish Research Council [538-2013-8864]; Shire	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Shire International GmbH; Swedish Research Council(Swedish Research CouncilEuropean Commission); Shire	This study received funding from the Swedish Research Council (Vetenskapsradet, award: 2018-02599), and through a grant from Shire International GmbH, a member of Takeda group of companies, Zug, Switzerland. Dr. Bulik acknowledges funding from the Swedish Research Council (award: 538-2013-8864). Although the sponsor (Shire) was involved in the design, collection, analysis, interpretation of the data, and writing of the report, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication in PlosOne was made by the authors independently.	Adamou M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-59; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Anker E, 2019, ADHD-ATTEND DEFICIT, V11, P159, DOI 10.1007/s12402-018-0260-2; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Beauchaine TP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1551; Card DE., 2010, HDB LABOR EC, V3A, P1277; Copeland WE, 2015, JAMA PSYCHIAT, V72, P892, DOI 10.1001/jamapsychiatry.2015.0730; de Graaf R, 2008, OCCUP ENVIRON MED, V65, P835, DOI 10.1136/oem.2007.038448; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Fayyad J, 2017, ADHD-ATTEND DEFICIT, V9, P47, DOI 10.1007/s12402-016-0208-3; Fergusson DM, 2013, J AM ACAD CHILD PSY, V52, P709, DOI 10.1016/j.jaac.2013.04.008; Fleming M, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0691; Fletcher JM, 2014, HEALTH ECON, V23, P159, DOI 10.1002/hec.2907; Fredriksen M, 2014, ADHD-ATTEND DEFICIT, V6, P87, DOI 10.1007/s12402-014-0126-1; Gaure S, 2013, R J, V5, P105; Gordon CT, 2019, CLIN CHILD FAM PSYCH, V22, P316, DOI 10.1007/s10567-019-00274-4; Greven CU, 2014, J CHILD PSYCHOL PSYC, V55, P39, DOI 10.1111/jcpp.12090; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Halmoy A, 2009, J ATTEN DISORD, V13, P175, DOI 10.1177/1087054708329777; Hechtman L, 2016, J AM ACAD CHILD PSY, V55, P945, DOI 10.1016/j.jaac.2016.07.774; Helgesson M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4504-4; Jangmo A, 2019, J AM ACAD CHILD PSY, V58, P423, DOI 10.1016/j.jaac.2018.11.014; Jennum P, 2020, EUR NEUROPSYCHOPHARM, V37, P29, DOI 10.1016/j.euroneuro.2020.04.010; Jensen CM, 2015, ADHD-ATTEND DEFICIT, V7, P27, DOI 10.1007/s12402-014-0142-1; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Knapp M, 2011, J MENT HEALTH POLICY, V14, P137; Kupper T, 2012, INT ARCH OCC ENV HEA, V85, P837, DOI 10.1007/s00420-012-0794-0; Kuriyan AB, 2013, J ABNORM CHILD PSYCH, V41, P27, DOI 10.1007/s10802-012-9658-z; Larsson H, 2013, BRIT J PSYCHIAT, V203, P103, DOI 10.1192/bjp.bp.112.120808; Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8; Nigg JT, 2013, CLIN PSYCHOL REV, V33, P215, DOI 10.1016/j.cpr.2012.11.005; Nordin M, 2010, ECON EDUC REV, V29, P1047, DOI 10.1016/j.econedurev.2010.05.005; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Rietveld CA, 2019, EUR J HEALTH ECON, V20, P949, DOI 10.1007/s10198-019-01055-0; Roy A, 2017, J AM ACAD CHILD PSY, V56, P687, DOI 10.1016/j.jaac.2017.05.020; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Soendergaard HM, 2015, DAN MED J, V62; Stammann Amrei, 2016, ESTIMATING FIXED EFF; Stergiakouli E, 2017, INT J EPIDEMIOL, V46, P421, DOI 10.1093/ije/dyw216; Sun SH, 2019, JAMA PSYCHIAT, V76, P1141, DOI 10.1001/jamapsychiatry.2019.1944; Vergunst F, 2019, JAMA PEDIATR, V173, P334, DOI 10.1001/jamapediatrics.2018.5375; Verhoef E, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-018-0324-2	44	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247724	10.1371/journal.pone.0247724	http://dx.doi.org/10.1371/journal.pone.0247724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730071	gold, Green Published			2022-12-26	WOS:000630345000037
J	Haindrich, AC; Ernst, V; Naguleswaran, A; Oliveres, QF; Roditi, I; Rentsch, D				Haindrich, Alexander C.; Ernst, Viona; Naguleswaran, Arunasalam; Oliveres, Quentin-Florian; Roditi, Isabel; Rentsch, Doris			Nutrient availability regulates proline/alanine transporters in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; AMINO-ACID PERMEASE; HIGH-AFFINITY; GLOSSINA-MORSITANS; PROLINE METABOLISM; ACTIVE-TRANSPORT; PROCYCLIC FORMS; TSETSE-FLIES; LEISHMANIA; PROTEIN	Trypanosoma brucei is a species of unicellular parasite that can cause severe diseases in livestock and humans, including African trypanosomiasis and Chagas disease. Adaptation to diverse environments and changes in nutritional conditions is essential for T. brucei to establish an infection when changing hosts or during invasion of different host tissues. One such adaptation is the ability of T. brucei to rapidly switch its energy metabolism from glucose metabolism in the mammalian blood to proline catabolism in the insect stages and vice versa. However, the mechanisms that support the parasite's response to nutrient availability remain unclear. Using RNAseq and qRT-PCR, we investigated the response of T. brucei to amino acid or glucose starvation and found increased mRNA levels of several amino acid transporters, including all genes of the amino acid transporter AAT7-B subgroup. Functional characterization revealed that AAT7-B members are plasma membrane-localized in T. brucei and when expressed in Saccharomyces cerevisiae supported the uptake of proline, alanine, and cysteine, while other amino acids were poorly recognized. All AAT7-B members showed a preference for proline, which is transported with high or low affinity. RNAi-mediated AAT7-B downregulation resulted in a reduction of intracellular proline concentrations and growth arrest under low proline availability in cultured procyclic form parasites. Taken together, these results suggest a role of AAT7-B transporters in the response of T. brucei to proline starvation and proline catabolism.	[Haindrich, Alexander C.; Ernst, Viona; Oliveres, Quentin-Florian; Rentsch, Doris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Naguleswaran, Arunasalam; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern; University of Bern	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	doris.rentsch@ips.unibe.ch		Haindrich, Alexander C./0000-0001-6484-2846; Roditi, Isabel/0000-0003-2812-6513; Rentsch, Doris/0000-0003-4313-7683; Naguleswaran, Arunasalam/0000-0002-9509-485X	Swiss National Science Foundation [CRSII3_141913, 31003A_182426]; University of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern	This work was supported by the Swiss National Science Foundation CRSII3_141913 and 31003A_182426 (DR) and the University of Bern.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Aoki JI, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006025; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Armenteros JJA, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900429; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BALOGUN RA, 1974, COMP BIOCHEM PHYSIOL, V49, P215, DOI 10.1016/0300-9629(74)90110-8; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BROWN R C, 1973, International Journal for Parasitology, V3, P691, DOI 10.1016/0020-7519(73)90095-7; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; BURSELL E, 1963, J INSECT PHYSIOL, V9, P439, DOI 10.1016/0022-1910(63)90054-4; BURSELL E, 1966, COMP BIOCHEM PHYSIOL, V19, P809, DOI 10.1016/0010-406X(66)90437-3; Capewell P, 2016, ELIFE, V5, DOI 10.7554/eLife.17716; CHAPPELL LH, 1972, PARASITOLOGY, V64, P379, DOI 10.1017/S0031182000045455; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; CUNNINGHAM I, 1974, Acta Tropica, V31, P83; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Ebikeme CE, 2008, PARASITOLOGY, V135, P585, DOI 10.1017/S0031182008004241; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Ghaddar K, 2014, MOL CELL BIOL, V34, P4447, DOI 10.1128/MCB.00699-14; Girard RMBM, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00338-18; Goldman-Pinkovich A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005494; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Haanstra JR, 2011, MOL MICROBIOL, V79, P94, DOI 10.1111/j.1365-2958.2010.07435.x; HARGROVE JW, 1976, J INSECT PHYSIOL, V22, P309, DOI 10.1016/0022-1910(76)90040-8; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Inbar E, 2013, BIOCHEM J, V449, P555, DOI 10.1042/BJ20121262; ISOUN TT, 1978, ACTA TROP, V35, P287; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; Jackson AP, 2015, PARASITOLOGY, V142, pS40, DOI 10.1017/S0031182014000894; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Jones NG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003886; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; KWART M, 1993, PLANT J, V4, P993, DOI 10.1046/j.1365-313X.1993.04060993.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LHOSTIS C, 1993, BIOCHEM J, V291, P297, DOI 10.1042/bj2910297; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Macedo JP, 2017, FASEB J, V31, P4649, DOI 10.1096/fj.201700311R; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; Marchese L, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020036; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Mathieu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168775; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Mogk S, 2017, BIOL REV, V92, P1675, DOI 10.1111/brv.12301; Muller LSM, 2018, NATURE, V563, P121, DOI 10.1038/s41586-018-0619-8; Naguleswaran A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4600-6; NEWPORT GR, 1977, J PARASITOL, V63, P15, DOI 10.2307/3280098; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; PATEL NY, 1981, INSECT SCI APPL, V1, P383, DOI 10.1017/S1742758400000722; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Qiu YJ, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00366-18, 10.1128/msphere.00366-18]; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Rico E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26303-w; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rolin S, 1998, MOL BIOCHEM PARASIT, V93, P251, DOI 10.1016/S0166-6851(98)00046-2; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Savage AF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168877; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Sbicego S, 1999, MOL BIOCHEM PARASIT, V104, P311, DOI 10.1016/S0166-6851(99)00157-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlisselberg D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16289; Shaked-Mishan P, 2006, MOL MICROBIOL, V60, P30, DOI 10.1111/j.1365-2958.2006.05060.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; SIMON MW, 1983, MOL BIOCHEM PARASIT, V9, P47, DOI 10.1016/0166-6851(83)90056-7; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Smith Terry K, 2017, F1000Res, V6, DOI 10.12688/f1000research.10342.2; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Szoor B, 2020, TRENDS PARASITOL, V36, P266, DOI 10.1016/j.pt.2019.12.011; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; Tanowitz HB, 2017, TRENDS PARASITOL, V33, P276, DOI 10.1016/j.pt.2016.11.008; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; van Grinsven KWA, 2009, EUKARYOT CELL, V8, P1307, DOI 10.1128/EC.00091-09; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Vieira LL, 1996, BIOCHEM J, V319, P691, DOI 10.1042/bj3190691; Vigneron A, 2020, P NATL ACAD SCI USA, V117, P2613, DOI 10.1073/pnas.1914423117; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; WILLIAMSON J, 1956, Ann Trop Med Parasitol, V50, P334; WILLIAMSON J, 1961, EXP PARASITOL, V11, P161, DOI 10.1016/0014-4894(61)90023-6; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zoltner M, 2020, J BIOL CHEM, V295, P8331, DOI 10.1074/jbc.RA120.012355	124	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100566	10.1016/j.jbc.2021.100566	http://dx.doi.org/10.1016/j.jbc.2021.100566			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745971	Green Published, gold			2022-12-26	WOS:000672866400539
J	Davidyan, A; Pathak, S; Baar, K; Bodine, SC				Davidyan, Arik; Pathak, Suraj; Baar, Keith; Bodine, Sue C.			Maintenance of muscle mass in adult male mice is independent of testosterone	PLOS ONE			English	Article								Testosterone is considered a potent anabolic agent in skeletal muscle with a well-established role in adolescent growth and development in males. However, the role of testosterone in the regulation of skeletal muscle mass and function throughout the lifespan has yet to be fully established. While some studies suggest that testosterone is important for the maintenance of skeletal muscle mass, an understanding of the role this hormone plays in young, adult, and old males with normal and low serum testosterone levels is lacking. We investigated the role testosterone plays in the maintenance of muscle mass by examining the effect of orchiectomy-induced testosterone depletion in C57Bl6 male mice at ages ranging from early postnatal through old age (1.5-, 5-, 12-, and 24-month old mice). Following 28 days of testosterone depletion, we assessed mass and fiber cross-sectional-area (CSA) of the tibialis anterior, gastrocnemius, and quadriceps muscles. In addition, we measured global rates of protein synthesis and degradation using the SuNSET method, western blots, and enzyme activity assays. Twenty-eight days of testosterone depletion resulted in reduced muscle mass in the two youngest cohorts, but had no effect in the two oldest cohorts. Mean CSA decreased only in the youngest cohort and only in the tibialis anterior muscle. Testosterone depletion resulted in a general increase in proteasome activity at all ages. No change in protein synthesis was detected at the terminal time point. These data suggest that within physiological serum concentrations, testosterone may not be critical for the maintenance of muscle mass in mature male mice; however, in young mice testosterone is crucial for normal growth.	[Davidyan, Arik; Pathak, Suraj; Baar, Keith] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Davidyan, Arik] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Baar, Keith] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Bodine, Sue C.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of California System; University of California Davis; Oklahoma Medical Research Foundation; University of California System; University of California Davis; University of Iowa	Bodine, SC (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	sue-bodine@uiowa.edu		Davidyan, Arik/0000-0001-9003-8528; Pathak, Suraj/0000-0002-0009-1972	NIH [UL1 TR000002]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research funded by NIH UL1 TR000002	Augusto V., 2004, SKELETAL MUSCLE FIBE, V21, P89; Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879; Basualto-Alarcon C, 2013, MED SCI SPORT EXER, V45, P1712, DOI 10.1249/MSS.0b013e31828cf5f3; Blaauw B, 2013, COMPR PHYSIOL, V3, P1645, DOI 10.1002/cphy.c130009; Bodine SC, 2015, ADV EXP MED BIOL, V872, P145, DOI 10.1007/978-1-4939-2895-8_7; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Clay CA, 2007, PHYS THER, V87, P1325, DOI 10.2522/ptj.20060302; Dalbo VJ, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12622; De Naeyer H, 2014, EUR J APPL PHYSIOL, V114, P751, DOI 10.1007/s00421-013-2800-y; Dubois V, 2016, ENDOCRINOLOGY, V157, P648, DOI 10.1210/en.2015-1713; FREDETTE BJ, 1991, DEV BIOL, V143, P1, DOI 10.1016/0012-1606(91)90050-D; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; GORI Z, 1969, EXP MOL PATHOL, V10, P199, DOI 10.1016/0014-4800(69)90040-9; Haren MT, 2011, INT J ANDROL, V34, P55, DOI 10.1111/j.1365-2605.2010.01061.x; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Hohl A., 2017, TESTOSTERONE BASIC C; Jiao QN, 2009, AM J PHYSIOL-ENDOC M, V297, pE1222, DOI 10.1152/ajpendo.00473.2009; Jorgenson KW, 2019, EXERC SPORT SCI REV, V47, P258, DOI 10.1249/JES.0000000000000198; Kelly DM, 2015, OBES REV, V16, P581, DOI 10.1111/obr.12282; Klostermann A, 2018, J SPORT EXERCISE PSY, V40, P82, DOI 10.1123/jsep.2017-0277; KOUMANS JTM, 1991, AM J ANAT, V192, P418, DOI 10.1002/aja.1001920409; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Liverman CT, 2004, TESTOSTERONE AGING C; MAYER M, 1975, AM J PHYSIOL, V229, P1381, DOI 10.1152/ajplegacy.1975.229.5.1381; O'Reilly MW, 2014, J STEROID BIOCHEM, V143, P277, DOI 10.1016/j.jsbmb.2014.04.008; Pires-Oliveira M, 2010, J APPL PHYSIOL, V108, P266, DOI 10.1152/japplphysiol.00490.2009; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Rossetti ML, 2018, MOL CELL ENDOCRINOL, V473, P178, DOI 10.1016/j.mce.2018.01.017; Rossetti ML, 2017, MOL CELL ENDOCRINOL, V447, P35, DOI 10.1016/j.mce.2017.02.031; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Serra C, 2013, ENDOCRINOLOGY, V154, P4594, DOI 10.1210/en.2013-1004; Shin MJ, 2018, WORLD J MENS HEALTH, V36, P192, DOI 10.5534/wjmh.180001; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Starka L, 2009, J STEROID BIOCHEM, V116, P118, DOI 10.1016/j.jsbmb.2009.05.008; Traish AM, 2011, AM J MED, V124, P578, DOI 10.1016/j.amjmed.2010.12.027; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Wilkinson DJ, 2017, J PHYSIOL-LONDON, V595, P2873, DOI 10.1113/JP272277; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao WD, 2008, J STEROID BIOCHEM, V110, P125, DOI 10.1016/j.jsbmb.2008.03.024	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0240278	10.1371/journal.pone.0240278	http://dx.doi.org/10.1371/journal.pone.0240278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764986	Green Published, gold, Green Submitted			2022-12-26	WOS:000634832800011
J	Dersjant-Li, Y; Davin, R; Christensen, T; Kwakernaak, C				Dersjant-Li, Yueming; Davin, Roger; Christensen, Trine; Kwakernaak, Cees			Effect of two phytases at two doses on performance and phytate degradation in broilers during 1-21 days of age	PLOS ONE			English	Article							DIETARY CALCIUM; MICROBIAL PHYTASE; NUTRIENT UTILIZATION; GROWTH-PERFORMANCE; DIGESTIVE DYNAMICS; DIFFERENT SEGMENTS; DIGESTIBILITY; PHOSPHORUS; IMPACTS; STARCH	The effect of two microbial phytases at two dose-levels on performance and apparent ileal digestibility (AID) of nutrients in broilers fed European-type diets was studied. A total of 1,200 d-old Ross 308 male broilers were randomly assigned to 5 treatments with 30 birds/pen and 8 pens/treatment. A nutritionally adequate positive control (PC) diet was tested against 4 experimental diets containing reduced total P, retainable P, Ca and Na as per the recommended nutritional contribution for Buttiauxella phytase (Phy B) at 1,000 FTU/kg (-1.87 g/kg, -1.59 g/kg, -1.99 g/kg and -0.4 g/kg vs. PC, respectively). Experimental diets were supplemented with Phy B at 500 FTU/kg or 1,000 FTU/kg, or Citrobacter phytase (Phy C) at 1,000 FTU/kg or 2,000 FTU/kg. Diets were based on corn, soybean meal, rapeseed meal and sunflower meal and formulated by phase (starter 1-10 d, grower 11-21 d) in crumbled or pelleted form. Overall (d 1-21), at 1,000 FTU/kg, birds fed Phy C exhibited lower BWG (-2.7%), FI (-3.4%) and tibia ash (-2.2%) vs. PC (P < 0.05), and reduced BWG (-3.6%), FI (-3.9%) and tibia ash (-1.8%) vs. Phy B (P < 0.05). Phy B at 1,000 FTU/kg and Phy C at 2,000 FTU/kg maintained performance equivalent to the PC. Digestibility of Ca did not differ among phytase treatments but at 1,000 FTU/kg AID P was greater with Phy B than Phy C (72.3% vs. 62.7%, P < 0.05). Ileal phytate (myo-inositol hexakisphosphate, IP6) digestibility was greatest with Phy B at 1,000 FTU/kg which was higher than Phy C at 1,000 FTU/kg (87.6 vs. 60.6%, P < 0.05). The findings indicate a higher phytate degradation rate of Phy B than Phy C at equivalent dose-level and this is correlated to the performance of the broilers.	[Dersjant-Li, Yueming] Danisco Anim Nutr IFF, Leiden, Netherlands; [Davin, Roger; Kwakernaak, Cees] Schothorst Feed Res, Lelystad, Netherlands; [Christensen, Trine] Danisco Anim Nutr IFF, Brabrand, Denmark		Dersjant-Li, Y (corresponding author), Danisco Anim Nutr IFF, Leiden, Netherlands.	Yueming.dersjant-li@iff.com	Davin, Roger/D-1949-2013	Davin, Roger/0000-0003-2391-4879	Danisco Animal Nutrition	Danisco Animal Nutrition	This research was funded by Danisco Animal Nutrition in the form of research materials and provided support via salary to authors YDL and TC. These authors were collaborators of the study conceptualization, project administration/supervision and manuscript preparation (original draft and review & editing). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amerah AM, 2014, POULTRY SCI, V93, P906, DOI 10.3382/ps.2013-03465; Angel R, 2002, J APPL POULTRY RES, V11, P471, DOI 10.1093/japr/11.4.471; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; AOAC, 1990, OFFICIAL METHODS ANA; AOAC, 1995, 99143 AOAC, V16th ed.; ASTM International, 2016, STANDARD TEST METHOD, DOI DOI 10.1520/D5298-16; Aviagen, 2014, ROSS BROIL NUTR SPEC; Bello A, 2019, POULTRY SCI, V98, P5789, DOI 10.3382/ps/pez375; Dersjant-Li Y, 2019, ANIM FEED SCI TECH, V253, P166, DOI 10.1016/j.anifeedsci.2019.05.018; Dersjant-Li Y, 2018, ANIM FEED SCI TECH, V242, P95, DOI 10.1016/j.anifeedsci.2018.05.013; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; ISO 30024, 2009, 30024 ISO; ISO 6496, 1999, 6496 ISO; Kim SW, 2018, POULTRY SCI, V97, P4306, DOI 10.3382/ps/pey304; Lee SA, 2018, BRIT POULTRY SCI, V59, P568, DOI 10.1080/00071668.2018.1496403; LEI XG, 1994, J ANIM SCI, V72, P139, DOI 10.2527/1994.721139x; Li W, 2018, ANIM FEED SCI TECH, V238, P9, DOI 10.1016/j.anifeedsci.2018.01.021; Li W, 2017, POULTRY SCI, V96, P3626, DOI 10.3382/ps/pex170; Li W, 2016, POULTRY SCI, V95, P581, DOI 10.3382/ps/pev354; Liu SY, 2014, ANIM FEED SCI TECH, V197, P164, DOI 10.1016/j.anifeedsci.2014.08.005; Menezes-Blackburn D, 2015, J AGR FOOD CHEM, V63, P6142, DOI 10.1021/acs.jafc.5b01996; Olukosi OA, 2020, POULTRY SCI, V99, P1528, DOI 10.1016/j.psj.2019.11.018; Qian H, 1997, POULTRY SCI, V76, P37, DOI 10.1093/ps/76.1.37; Ravindran V, 2006, POULTRY SCI, V85, P82, DOI 10.1093/ps/85.1.82; Ravindran V, 1999, POULTRY SCI, V78, P699, DOI 10.1093/ps/78.5.699; Ravindran V., 1995, Poultry and Avian Biology Reviews, V6, P125; Rodehutscord M, 2012, POULTRY SCI, V91, P965, DOI 10.3382/ps.2011-01943; Selle PH, 2007, ANIM FEED SCI TECH, V135, P1, DOI 10.1016/j.anifeedsci.2006.06.010; Selle PH, 2009, LIVEST SCI, V124, P126, DOI 10.1016/j.livsci.2009.01.006; Selle PH, 2000, NUTR RES REV, V13, P255, DOI 10.1079/095442200108729098; Short FJ, 1996, ANIM FEED SCI TECH, V59, P215, DOI 10.1016/0377-8401(95)00916-7; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; Tamim NM, 2004, POULTRY SCI, V83, P1358, DOI 10.1093/ps/83.8.1358; Truong HH, 2014, ANIM FEED SCI TECH, V198, P248, DOI 10.1016/j.anifeedsci.2014.10.007; Truong HH, 2015, ANIM FEED SCI TECH, V209, P240, DOI 10.1016/j.anifeedsci.2015.08.012; Watson BC, 2006, POULTRY SCI, V85, P493, DOI 10.1093/ps/85.3.493	37	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0247420	10.1371/journal.pone.0247420	http://dx.doi.org/10.1371/journal.pone.0247420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765064	gold, Green Published			2022-12-26	WOS:000634832800059
J	Herman, B; Sirichokchatchawan, W; Pongpanich, S; Nantasenamat, C				Herman, Bumi; Sirichokchatchawan, Wandee; Pongpanich, Sathirakorn; Nantasenamat, Chanin			Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG; DIAGNOSIS; MODELS	Background and objectives Diagnosis of Pulmonary Rifampicin Resistant Tuberculosis (RR-TB) with the Drug-Susceptibility Test (DST) is costly and time-consuming. Furthermore, GeneXpert for rapid diagnosis is not widely available in Indonesia. This study aims to develop and evaluate the CUHAS-ROBUST model performance, an artificial-intelligence-based RR-TB screening tool. Methods A cross-sectional study involved suspected all type of RR-TB patients with complete sputum Lowenstein Jensen DST (reference) and 19 clinical, laboratory, and radiology parameter results, retrieved from medical records in hospitals under the Faculty of Medicine, Hasanuddin University Indonesia, from January 2015-December 2019. The Artificial Neural Network (ANN) models were built along with other classifiers. The model was tested on participants recruited from January 2020-October 2020 and deployed into CUHAS-ROBUST (index test) application. Sensitivity, specificity, and accuracy were obtained for assessment. Results A total of 487 participants (32 Multidrug-Resistant/MDR 57 RR-TB, 398 drug-sensitive) were recruited for model building and 157 participants (23 MDR and 21 RR) in prospective testing. The ANN full model yields the highest values of accuracy (88% (95% CI 85-91)), and sensitivity (84% (95% CI 76-89)) compare to other models that show sensitivity below 80% (Logistic Regression 32%, Decision Tree 44%, Random Forest 25%, Extreme Gradient Boost 25%). However, this ANN has lower specificity among other models (90% (95% CI 86-93)) where Logistic Regression demonstrates the highest (99% (95% CI 97-99)). This ANN model was selected for the CUHAS-ROBUST application, although still lower than the sensitivity of global GeneXpert results (87.5%). Conclusion The ANN-CUHAS ROBUST outperforms other AI classifiers model in detecting all type of RR-TB, and by deploying into the application, the health staff can utilize the tool for screening purposes particularly at the primary care level where the GeneXpert examination is not available. Trial registration NCT04208789.	[Herman, Bumi; Sirichokchatchawan, Wandee; Pongpanich, Sathirakorn] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Nantasenamat, Chanin] Mahidol Univ, Fac Med Technol, Salaya, Nakhon Pathom, Thailand	Chulalongkorn University; Mahidol University	Herman, B; Pongpanich, S (corresponding author), Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand.	bumiherman@med.unhas.ac.id; sathirakorn.p@chula.ac.th	Nantasenamat, Chanin/AAD-1032-2019; Herman, Bumi/AAA-7282-2021	Nantasenamat, Chanin/0000-0003-1040-663X; Herman, Bumi/0000-0001-8206-6764; Sirichokchatchawan, Wandee/0000-0002-4502-1425	project of Artificial Intelligence for Drug-resistant Tuberculosis by the 100th Anniversary Chulalongkorn University Doctoral Scholarship; 90th Anniversary Chulalongkorn University Ratchadaphiseksomphot Endowment Fund	project of Artificial Intelligence for Drug-resistant Tuberculosis by the 100th Anniversary Chulalongkorn University Doctoral Scholarship; 90th Anniversary Chulalongkorn University Ratchadaphiseksomphot Endowment Fund(Chulalongkorn University)	This study is funded under the project of Artificial Intelligence for Drug-resistant Tuberculosis by the 100th Anniversary Chulalongkorn University Doctoral Scholarship and 90th Anniversary Chulalongkorn University Ratchadaphiseksomphot Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun OI, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00938; Ahmed MO, 2018, MICROB DRUG RESIST, V24, P590, DOI 10.1089/mdr.2017.0147; Al-Shayea QK, 2011, INT J COMPUT SCI ISS, V8, P150; Alhashimi FH, 2018, PRAGMAT OBS RES, V9, P55, DOI 10.2147/POR.S172613; Alwosheel A, 2018, J CHOICE MODEL, V28, P167, DOI 10.1016/j.jocm.2018.07.002; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bhatta L, 2020, INT J CHRONIC OBSTR, V15, P225, DOI 10.2147/COPD.S228958; Blank S, 2019, RESAMPLING STATS EXC; Bobitt J, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180385; Caulfield Adam J, 2016, J Clin Tuberc Other Mycobact Dis, V4, P33, DOI 10.1016/j.jctube.2016.05.005; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Eesa A.S., 2017, SCI J U ZAKHO, V5, P319, DOI DOI 10.25271/2017.5.4.381; Evora LHRA, 2017, NEUROCOMPUTING, V265, P116, DOI 10.1016/j.neucom.2016.08.151; Gilpin C, 2016, THER ADV INFECT DIS, V3, P145, DOI 10.1177/2049936116673553; Gunther F, 2010, R J, V2, P30; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hall L, 2011, JOVE-J VIS EXP, DOI 10.3791/3094; Hata K, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-11; Huda W, 2015, AM J ROENTGENOL, V204, pW126, DOI 10.2214/AJR.14.13116; Jaeger S, 2018, INT J COMPUT ASS RAD, V13, P1915, DOI 10.1007/s11548-018-1857-9; Jin J, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931629; Johnson JM, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0192-5; Joshi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201731; Kaur Ramandeep, 2016, J Lab Physicians, V8, P96, DOI 10.4103/0974-2727.180789; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Kisi O, 2005, INDIAN J ENG MATER S, V12, P434; Little RR, 2019, CLIN CHEM, V65, P839, DOI 10.1373/clinchem.2018.296962; LORIAN V, 1967, DIS CHEST, V51, P275, DOI 10.1378/chest.51.3.275; Manca DP, 2015, CAN FAM PHYSICIAN, V61, P846; Martinez D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082; Meyer AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180572; Nie FP, 2018, COMMUN INF SYST, V18, P37; Orlando S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200523; Parekh BS, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00064-18; Pearce EC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/401896; Phillips PPJ, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0955-9; Pradipta IS, 2018, J INFECTION, V77, P469, DOI 10.1016/j.jinf.2018.10.004; R Core Team, 2020, R LANG ENV STAT COMP; Ramalho DMP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2669-1; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, VVolume 5, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Rivas A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18072048; Rohini K, 2016, INDIAN J CLIN BIOCHE, V31, P332, DOI 10.1007/s12291-015-0535-8; Rusanov A, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-51; Saia R, 2019, KDIR: PROCEEDINGS OF THE 11TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL 1: KDIR, P202, DOI 10.5220/0008377702020213; Sariko ML, 2016, J INFECT DEV COUNTR, V10, P423, DOI 10.3855/jidc.7324; Schonfeld N, 2012, LUNG INDIA, V29, P309, DOI 10.4103/0970-2113.102794; Singh UB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149258; Soeroto AY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213017; Stinson K., 2014, GLOBAL LAB INITIATIV, P147; Sturkenboom MGG, 2016, EUR RESPIR J, V48, P1237, DOI 10.1183/13993003.00986-2016; The World Health Organization, 2019, WHO CONSOLIDATED GUI; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P108; Varghese B, 2013, INT J MYCOBACT, V2, P14, DOI 10.1016/j.ijmyco.2012.11.003; Wang YXJ, 2018, QUANT IMAG MED SURG, V8, P161, DOI 10.21037/qims.2018.03.06; Weber KT, 2007, GISCI REMOTE SENS, V44, P237, DOI 10.2747/1548-1603.44.3.237; Weng CH, 2016, TELEMAT INFORM, V33, P277, DOI 10.1016/j.tele.2015.08.006; Willis BH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000746; World Health Organization, 2021, 10 THREATS GLOB HLTH	61	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249243	10.1371/journal.pone.0249243	http://dx.doi.org/10.1371/journal.pone.0249243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765092	Green Published, gold			2022-12-26	WOS:000634832800007
J	Kayadjanian, N; Vrana-Diaz, C; Bohonowych, J; Strong, TV; Morin, J; Potvin, D; Schwartz, L				Kayadjanian, Nathalie; Vrana-Diaz, Caroline; Bohonowych, Jessica; Strong, Theresa V.; Morin, Josee; Potvin, Diane; Schwartz, Lauren			Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome	PLOS ONE			English	Article								Objectives Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by maladaptive behaviors, amongst which hyperphagia is a life-long concern for individuals with PWS and their caregivers. The current study examined the contribution of hyperphagia and other factors to caregiver burden across lifespan, in 204 caregivers of individuals with PWS living in the US, using the Zarit Burden Interview (ZBI) and the hyperphagia questionnaire (HQ-CT). Results We found a strong relationship between ZBI and HQ-CT especially in individuals with PWS older than 4 y and showed that HQ-CT scores of individuals with PWS is positively correlated with ZBI scores of their caregivers. The weight status of individuals with PWS was not associated with HQ-CT and ZBI scores, except for obese individuals who had significantly higher HQ-CT scores when compared to normal weight PWS individuals. We looked at PWS symptoms and care-related issues that impacted individuals and caregivers the most. We found that care-related tasks had the biggest negative impact on caregivers of children aged 0-4 y, whereas anxiety, temper tantrums, and oppositional behaviors of older individuals with PWS had the biggest impact on their caregivers concomitant with their high caregiver burden. Finally, we assessed the variability of HQ-CT and ZBI over 6 months in a subgroup of 83 participants. Overall, neither measure differed between 6 months and baseline. Most individual's absolute HQ-CT score changes were between 0-2 units, whereas absolute ZBI score changes were between 0-6 points. Changes in the caregiver's or individual's life had little or no effect on HQ-CT and ZBI scores. Conclusions This study demonstrates a relationship between hyperphagia and caregiver burden and sheds light on predominant symptoms in children and adolescents that likely underly PWS caregiver burden. The stability and relationship between HQ-CT and ZBI support ZBI as an additional outcome measure in PWS clinical trials.	[Kayadjanian, Nathalie; Vrana-Diaz, Caroline; Bohonowych, Jessica; Strong, Theresa V.; Schwartz, Lauren] Fdn Prader Willi Res, Walnut, CA 91789 USA; [Kayadjanian, Nathalie; Strong, Theresa V.; Schwartz, Lauren] PWS Clin Trial Consortium, Walnut, CA 91789 USA; [Strong, Theresa V.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Morin, Josee; Potvin, Diane] Excelsus Stat, Montreal, PQ, Canada; [Schwartz, Lauren] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle	Kayadjanian, N (corresponding author), Fdn Prader Willi Res, Walnut, CA 91789 USA.; Kayadjanian, N (corresponding author), PWS Clin Trial Consortium, Walnut, CA 91789 USA.	kayadjanian@gmail.com	Strong, Theresa/GSM-6652-2022	Strong, Theresa/0000-0001-6783-8703; Vrana-Diaz, Caroline/0000-0001-9037-2761	PWSClinical Trial Consortium	PWSClinical Trial Consortium	The study was funded by the PWSClinical Trial Consortium (www.pwsctc.org) who provided support in the form of publication costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DP is the owner and JM is employed by Excelsus Statistics. The funder provided support in the form of consulting fees for authors [DP and JM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Allas S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190849; Beardsmore A, 1998, J INTELL DISABIL RES, V42, P463, DOI 10.1046/j.1365-2788.1998.4260463.x; Beinart N, 2012, DEMENT GER COGN D EX, V2, P638, DOI 10.1159/000345777; Bello-Mojeed M.A., 2013, OA AUTISM, V1, P4; Boer H, 2002, LANCET, V359, P135, DOI 10.1016/S0140-6736(02)07340-3; Bohonowych J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090713; Butler Merlin G, 2017, Genet Med, V19, P635, DOI 10.1038/gim.2016.178; Cadman T, 2012, J AM ACAD CHILD PSY, V51, P879, DOI 10.1016/j.jaac.2012.06.017; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Clarke DJ, 1996, J INTELL DISABIL RES, V40, P159, DOI 10.1046/j.1365-2788.1996.743743.x; Clarke DJ, 2002, BRIT J PSYCHIAT, V180, P358, DOI 10.1192/bjp.180.4.358; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Dimitropoulos A, 2001, AM J MENT RETARD, V106, P39, DOI 10.1352/0895-8017(2001)106<0039:EOCBAT>2.0.CO;2; Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216; DYKENS EM, 1992, J AM ACAD CHILD PSY, V31, P1131, DOI 10.1097/00004583-199211000-00023; Dykens EM, 1996, J CHILD PSYCHOL PSYC, V37, P995, DOI 10.1111/j.1469-7610.1996.tb01496.x; Etnfeld S, 1999, J INTELLECT DEV DIS, V24, P349; Fehnel SE, 2015, VALUE HEALTH, V18, pA25, DOI 10.1016/j.jval.2015.03.154; Feighan SM, 2020, J INTELL DISABIL RES, V64, P158, DOI 10.1111/jir.12707; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hodapp RM, 1997, J AUTISM DEV DISORD, V27, P11, DOI 10.1023/A:1025865004299; Jang M, 2019, JMIR RES PROTOC, V8, DOI 10.2196/11865; Kayadjanian N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194655; Key AP, 2018, DEV NEUROPSYCHOL, V43, P152, DOI 10.1080/87565641.2017.1367395; Kimonis V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221615; Kimonis VE, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110898; Lanfranchi S, 2012, AJIDD-AM J INTELLECT, V117, P207, DOI 10.1352/1944-7558-117.3.207; Lopez-Bastida B, 2016, EUR J HEALTH ECON, V17, P99, DOI 10.1007/s10198-016-0788-z; Mazaheri MM, 2013, J INTELL DISABIL RES, V57, P861, DOI 10.1111/j.1365-2788.2012.01634.x; McCandless SE, 2017, DIABETES OBES METAB, V19, P1751, DOI 10.1111/dom.13021; Miller JL, 2012, J CLIN ENDOCR METAB, V97, P3837, DOI 10.1210/jc.2012-2543; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d; O'Neill LP, 2016, RES DEV DISABIL, V51-52, P116, DOI 10.1016/j.ridd.2015.12.017; Reddy LA, 2007, J AUTISM DEV DISORD, V37, P830, DOI 10.1007/s10803-006-0210-2; Rice LJ, 2018, AM J MED GENET A, V176, P2292, DOI 10.1002/ajmg.a.40480; Rice LJ, 2015, AM J MED GENET C, V169, P182, DOI 10.1002/ajmg.c.31442; Sanchez-Ortiga R, 2012, CLIN ENDOCRINOL, V77, P86, DOI 10.1111/j.1365-2265.2011.04303.x; Shoffstall AJ, 2016, J PEDIATR-US, V175, P137, DOI 10.1016/j.jpeds.2016.05.018; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Sinnema M, 2011, RES DEV DISABIL, V32, P604, DOI 10.1016/j.ridd.2010.12.014; Strong TV, 2018, SUMMARY IMPACT PWS I; Tsai JH, 2018, J MED ECON, V21, P1230, DOI 10.1080/13696998.2018.1528980; van den Borne HW, 1999, PATIENT EDUC COUNS, V38, P205, DOI 10.1016/S0738-3991(99)00004-X; WHITMAN BY, 1987, AM J MED GENET, V28, P897, DOI 10.1002/ajmg.1320280415; Wigren M, 2005, J INTELL DISABIL RES, V49, P449, DOI 10.1111/j.1365-2788.2005.00690.x; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072640	48	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248739	10.1371/journal.pone.0248739	http://dx.doi.org/10.1371/journal.pone.0248739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765021	Green Published, gold			2022-12-26	WOS:000634832800091
J	Liu, P; Cao, B; Wang, YT; Wei, ZP; Ye, JF; Wei, HX				Liu, Ping; Cao, Baohui; Wang, Yutao; Wei, Zhongping; Ye, Jingfeng; Wei, Hongxu			Spectral effect of streetlamps on urban trees: A simulated study on tissue water, nitrogen, and carbohydrate contents in maple and oak	PLOS ONE			English	Article								Streetlamps enforce night lighting on urban forest trees, but scarce information is available concerning the ecophysiological performance of street trees under these conditions. In this study, maple (Acer truncatum Bunge) and oak (Quercus mongolica Fisch. ex Ledeb.) seedlings were cultured with simulated exposure to streetlamp spectra in white (red/green/blue, 7.7:1.0:2.2) and red plus blue (RB; red/green/blue, 4.6:0.0:1.0) lights with photosynthetic photon flux rate of 80 mu mol m(-2) s(-1) in a 18-h photoperiod. Nitrogen (N) was loaded through 15 weekly applications to an amount of 80 mg N plant(-1) to mimic the mineral N deposition to landscape trees. Variables of biomass, carbohydrate accumulation, N and water contents were rarely found difference between the two LED-spectra treatments for both species. Compared to the un-lighted control, the RB spectrum lowered N concentration in oak seedlings and water content in maple seedlings. The white light spectrum resulted in an increase of starch concentration. Carbohydrate concentration had a positive relationship with biomass and N content across two species but a negative relationship with water content in maple seedlings. Overall, streetlamp-lights imposed effects on tree growth by a prolonged photoperiod instead of specific spectrum. Maple had a strong response of water uptake to streetlamp lighting at the cost of carbohydrate consumption, but oak had scarce demand of water-use for growth.	[Liu, Ping; Cao, Baohui; Wang, Yutao] Shenyang Agr Univ, Coll Forestry, Shenyang, Liaoning, Peoples R China; [Wei, Zhongping; Ye, Jingfeng] Liaoning Acad Forestry Sci, Shenyang, Liaoning, Peoples R China; [Wei, Hongxu] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Jilin, Peoples R China; [Wei, Hongxu] Univ Chinese Acad Sci, Beijing, Peoples R China	Shenyang Agricultural University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YT (corresponding author), Shenyang Agr Univ, Coll Forestry, Shenyang, Liaoning, Peoples R China.; Wei, HX (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Jilin, Peoples R China.; Wei, HX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	ytw730@syau.edu.cn; weihongxu@iga.ac.cn		Wei, Hongxu/0000-0002-7108-5342	Liaoning Key Research and Development Program [2020JH2/10200033]; Central Financial Forestry Science and Technology Promotion Demonstration Fund Project [Liao [2017]TG10]	Liaoning Key Research and Development Program; Central Financial Forestry Science and Technology Promotion Demonstration Fund Project	This study was funded by the Liaoning Key Research and Development Program to PL (Grant No. 2020JH2/10200033) and the Central Financial Forestry Science and Technology Promotion Demonstration Fund Project to PL (Grant No. Liao [2017]TG10).	Ali AM, 2017, SUSTAIN CITIES SOC, V28, P420, DOI 10.1016/j.scs.2016.10.001; An BY, 2018, NOT BOT HORTI AGROBO, V46, P440, DOI 10.15835/nbha46211065; Apostol KG, 2015, CAN J FOREST RES, V45, P1711, DOI 10.1139/cjfr-2015-0106; Astolfi S, 2012, NOT BOT HORTI AGROBO, V40, P31; Baidu Cyclopedia, BAIDU CYCLOPEDIA; Bian ZH, 2018, ENVIRON EXP BOT, V153, P63, DOI 10.1016/j.envexpbot.2018.05.010; Clavijo-Herrera J, 2018, HORTICULTURAE, V4, DOI 10.3390/horticulturae4030016; Curatti L, 2008, PLANTA, V228, P617, DOI 10.1007/s00425-008-0764-7; Druege U, 2000, ANN BOT-LONDON, V85, P687, DOI 10.1006/anbo.2000.1132; Fan XX, 2013, RES CROP, V14, P555; Feng MY., 2020, WATER-SUI, V12, P17; Fu Y, 2017, SILVA FENN, V51, DOI 10.14214/sf.1607; Gangadhar BH, 2012, HORTSCIENCE, V47, P1729, DOI 10.21273/HORTSCI.47.12.1729; Garcia-Caparros P, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020284; Hernandez-Bedolla J, 2017, WATER-SUI, V9, DOI 10.3390/w9030213; Horowitz ME, 2009, CAN J FOREST RES, V39, P2294, DOI 10.1139/X09-144; Kruger EL, 1997, CAN J FOREST RES, V27, P1841, DOI 10.1139/cjfr-27-11-1841; Lanoue J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01076; Lei TT, 2005, PHYTON-ANN REI BOT A, V45, P145; Leonardos ED, 2019, CAN J PLANT SCI, V99, P639, DOI 10.1139/cjps-2018-0245; Li HM, 2013, SCI HORTIC-AMSTERDAM, V150, P117, DOI 10.1016/j.scienta.2012.10.009; Li XW, 2018, FORESTS, V9, DOI 10.3390/f9010029; Li XW, 2017, SOIL SCI PLANT NUTR, V63, P153, DOI 10.1080/00380768.2017.1312518; Li ZJ, 2019, EARTH SPACE SCI, V6, P2200, DOI 10.1029/2019EA000759; Liu CF, 2012, URBAN FOR URBAN GREE, V11, P121, DOI 10.1016/j.ufug.2011.03.002; Liu H, 2018, SCI HORTIC-AMSTERDAM, V236, P10, DOI 10.1016/j.scienta.2018.03.027; Maevskaya SN, 2005, RUSS J PLANT PHYSL+, V52, P304, DOI 10.1007/s11183-005-0046-1; Massetti L, 2018, URBAN FOR URBAN GREE, V34, P71, DOI 10.1016/j.ufug.2018.05.015; Matsuda R, 2004, PLANT CELL PHYSIOL, V45, P1870, DOI 10.1093/pcp/pch203; Montagnoli A, 2018, PLANT BIOSYST, V152, P515, DOI 10.1080/11263504.2018.1435583; Onoda Y, 2009, NEW PHYTOL, V182, P698, DOI 10.1111/j.1469-8137.2009.02786.x; Parker WC, 2008, TREE PHYSIOL, V28, P797, DOI 10.1093/treephys/28.5.797; Pennisi G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50783-z; Retzlaff WA, 2001, CAN J FOREST RES, V31, P960, DOI 10.1139/x01-017; Ribbons RR, 2018, BIOGEOCHEMISTRY, V140, P145, DOI 10.1007/s10533-018-0480-8; SAEBO A, 1995, PLANT CELL TISS ORG, V41, P177, DOI 10.1007/BF00051588; Sarala M, 2013, TREES-STRUCT FUNCT, V27, P1193, DOI 10.1007/s00468-013-0841-9; Scartazza A, 1998, AUST J PLANT PHYSIOL, V25, P489, DOI 10.1071/PP98017; Shi TG, 2015, CHINESE GEOGR SCI, V25, P684, DOI 10.1007/s11769-015-0773-y; Singh AS, 2017, PLANT CELL TISS ORG, V129, P209, DOI 10.1007/s11240-017-1170-2; Sloan JL, 2018, CAN J FOREST RES, V48, P1067, DOI 10.1139/cjfr-2018-0087; Thomas KA, 2010, US NPN TECHNICAL SER, V2010; Vashum K.T., 2012, J ECOSYST ECOGRAPHY, V2, P1, DOI [10.4172/2157-7625.1000116, DOI 10.4172/2157-7625.1000116]; Von Fircks Y, 1998, TREE PHYSIOL, V18, P243; Wang Z, 2017, IFOREST, V10, P715, DOI 10.3832/ifor2302-010; Wang Z, 2016, J FORESTRY RES, V27, P569, DOI 10.1007/s11676-015-0203-0; Wei Hong-xu, 2011, Yingyong Shengtai Xuebao, V22, P1731; Wei HX, 2020, FORESTS, V11, DOI 10.3390/f11010044; Wei HX, 2020, INT J AGRIC BIOL, V23, P644, DOI 10.17957/IJAB/15.1336; Wei HX, 2019, ANN FOR RES, V62, P125, DOI 10.15287/afr.2019.1395; Wei HX, 2019, NOT BOT HORTI AGROBO, V47, P887, DOI 10.15835/nbha47311390; Wei HX, 2017, URBAN FOR URBAN GREE, V28, P63, DOI 10.1016/j.ufug.2017.10.006; Wei HX, 2017, IFOREST, V10, P15, DOI 10.3832/ifor1988-009; Wei HX, 2014, J PLANT NUTR, V37, P279, DOI 10.1080/01904167.2013.859697; Wei HX, 2013, SOIL SCI PLANT NUTR, V59, P933, DOI 10.1080/00380768.2013.864957; Zhang YQ, 2019, PHYSIOL PLANTARUM, V167, P144, DOI 10.1111/ppl.12876; Zhao J, 2019, SOIL SCI PLANT NUTR, V65, P358, DOI 10.1080/00380768.2019.1631715	57	10	10	11	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248463	10.1371/journal.pone.0248463	http://dx.doi.org/10.1371/journal.pone.0248463			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765023	gold, Green Published			2022-12-26	WOS:000634832800108
J	Ram, S; Hoff, BA; Bell, AJ; Galban, S; Fortuna, AB; Weinheimer, O; Wielputz, MO; Robinson, TE; Newman, B; Vummidi, D; Chughtai, A; Kazerooni, EA; Johnson, TD; Han, MK; Hatt, CR; Galban, CJ				Ram, Sundaresh; Hoff, Benjamin A.; Bell, Alexander J.; Galban, Stefanie; Fortuna, Aleksa B.; Weinheimer, Oliver; Wielputz, Mark O.; Robinson, Terry E.; Newman, Beverley; Vummidi, Dharshan; Chughtai, Aamer; Kazerooni, Ella A.; Johnson, Timothy D.; Han, MeiLan K.; Hatt, Charles R.; Galban, Craig J.			Improved detection of air trapping on expiratory computed tomography using deep learning	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; CT; CLASSIFICATION; REGISTRATION; DISEASE; COPD	Background Radiologic evidence of air trapping (AT) on expiratory computed tomography (CT) scans is associated with early pulmonary dysfunction in patients with cystic fibrosis (CF). However, standard techniques for quantitative assessment of AT are highly variable, resulting in limited efficacy for monitoring disease progression. Objective To investigate the effectiveness of a convolutional neural network (CNN) model for quantifying and monitoring AT, and to compare it with other quantitative AT measures obtained from threshold-based techniques. Materials and methods Paired volumetric whole lung inspiratory and expiratory CT scans were obtained at four time points (0, 3, 12 and 24 months) on 36 subjects with mild CF lung disease. A densely connected CNN (DN) was trained using AT segmentation maps generated from a personalized threshold-based method (PTM). Quantitative AT (QAT) values, presented as the relative volume of AT over the lungs, from the DN approach were compared to QAT values from the PTM method. Radiographic assessment, spirometric measures, and clinical scores were correlated to the DN QAT values using a linear mixed effects model. Results QAT values from the DN were found to increase from 8.65% +/- 1.38% to 21.38% +/- 1.82%, respectively, over a two-year period. Comparison of CNN model results to intensity-based measures demonstrated a systematic drop in the Dice coefficient over time (decreased from 0.86 +/- 0.03 to 0.45 +/- 0.04). The trends observed in DN QAT values were consistent with clinical scores for AT, bronchiectasis, and mucus plugging. In addition, the DN approach was found to be less susceptible to variations in expiratory deflation levels than the threshold-based approach. Conclusion The CNN model effectively delineated AT on expiratory CT scans, which provides an automated and objective approach for assessing and monitoring AT in CF patients.	[Ram, Sundaresh; Hoff, Benjamin A.; Bell, Alexander J.; Galban, Stefanie; Fortuna, Aleksa B.; Vummidi, Dharshan; Chughtai, Aamer; Kazerooni, Ella A.; Hatt, Charles R.; Galban, Craig J.] Univ Michigan, Dept Radiol, Michigan Med, Ann Arbor, MI 48109 USA; [Ram, Sundaresh; Galban, Craig J.] Univ Michigan, Dept Biomed Engn, Michigan Med, Ann Arbor, MI 48109 USA; [Weinheimer, Oliver; Wielputz, Mark O.] Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Weinheimer, Oliver; Wielputz, Mark O.] German Lung Res Ctr DZL, Translat Lung Res Ctr, Heidelberg TLRC, Heidelberg, Germany; [Robinson, Terry E.] Stanford Univ, Dept Pediat, Ctr Excellence Pulm Biol, Sch Med, Stanford, CA 94305 USA; [Newman, Beverley] Lucile Packard Childrens Hosp Stanford, Dept Pediat Radiol, Stanford, CA USA; [Kazerooni, Ella A.; Han, MeiLan K.] Univ Michigan, Dept Internal Med, Michigan Med, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Hatt, Charles R.] Imbio LLC, Minneapolis, MN USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ruprecht Karls University Heidelberg; Stanford University; Lucile Packard Children's Hospital (LPCH); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Galban, CJ (corresponding author), Univ Michigan, Dept Radiol, Michigan Med, Ann Arbor, MI 48109 USA.; Galban, CJ (corresponding author), Univ Michigan, Dept Biomed Engn, Michigan Med, Ann Arbor, MI 48109 USA.	cgalban@med.umich.edu	Weinheimer, Oliver/AAN-3652-2021; Wielpütz, Mark Oliver/ADP-0499-2022	Wielpütz, Mark Oliver/0000-0001-6962-037X	NHLBI/NIH [R01HL139690, R44HL140890, R01HL150023]; CF Foundation [LAMA20AB0]; Novartis Institute of Biomedical Research	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CF Foundation; Novartis Institute of Biomedical Research	This study was supported by the following grants funded to the people's initials indicated by their side:. NHLBI/NIH R01HL139690: CJG. NHLBI/NIH R44HL140890: CJG, CH. NHLBI/NIH R01HL150023: CJG, MH, CH. CF Foundation Grant LAMA20AB0: CJG, VL. Novartis Institute of Biomedical Research: TER The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Charles R. Hatt is an employee and stock option holder at Imbio LLC.	Bankier AA, 2008, RADIOGRAPHICS, V28, P919, DOI 10.1148/rg.284085035; Belloli EA, 2017, AM J RESP CRIT CARE, V195, P942, DOI 10.1164/rccm.201604-0732OC; Boes JL, 2015, TOMOGRAPHY, V1, P69, DOI 10.18383/j.tom.2015.00148; Boski M, 2017, 2017 10TH INTERNATIONAL WORKSHOP ON MULTIDIMENSIONAL (ND) SYSTEMS (NDS); Boudewijn IM, 2015, EUR RESPIR J, V46, P1193, DOI 10.1183/09031936.00009415; Cheplygina V, 2018, IEEE J BIOMED HEALTH, V22, P1486, DOI 10.1109/JBHI.2017.2769800; Council NR., 2006, HLTH RISKS EXP LOW L; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Galban CJ, 2014, BIOL BLOOD MARROW TR, V20, P1592, DOI 10.1016/j.bbmt.2014.06.014; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Goris ML, 2003, CHEST, V123, P1655, DOI 10.1378/chest.123.5.1655; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hatt CR, 2019, 2019 IEEE DATA SCIENCE WORKSHOP (DSW), P213, DOI 10.1109/DSW.2019.8755594; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kligerman SJ, 2015, RADIOGRAPHICS, V35, P1360, DOI 10.1148/rg.2015140308; Konietzke P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194557; Kuo WY, 2014, AM J RESP CRIT CARE, V189, P1328, DOI 10.1164/rccm.201311-2099CI; Labaki WW, 2017, AM J RESP CRIT CARE, V196, P1372, DOI 10.1164/rccm.201703-0451PP; Martinez CH, 2017, AM J RESP CRIT CARE, V195, P464, DOI 10.1164/rccm.201604-0871OC; Mascalchi M, 2017, J THORAC DIS, V9, P3319, DOI 10.21037/jtd.2017.08.17; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Ram S, 2020, 2020 IEEE SW S IM AN; Ram S, 2020, I S BIOMED IMAGING; Ram S, 2018, IEEE SW SYMP IMAG, P89; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Robinson TE, 1999, AM J ROENTGENOL, V172, P1636, DOI 10.2214/ajr.172.6.10350305; Robinson TE, 2020, PEDIATR PULM, V55, P929, DOI 10.1002/ppul.24646; Robinson TE, 2009, ACAD RADIOL, V16, P1134, DOI 10.1016/j.acra.2009.02.018; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Sudre CH, 2017, LECT NOTES COMPUT SC, V10553, P240, DOI 10.1007/978-3-319-67558-9_28; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Weinheimer O, 2017, P SPIE; Weinheimer O, 2019, ACAD RADIOL, V26, P1202, DOI 10.1016/j.acra.2018.11.001; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2019, P SPIE; Yamashita R., 2018, INSIGHTS IMAGING, V9, P611, DOI [10.1007/s13244-018-0639-9, DOI 10.1007/s13244-018-0639-9]	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248902	10.1371/journal.pone.0248902	http://dx.doi.org/10.1371/journal.pone.0248902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760861	Green Submitted, gold, Green Published			2022-12-26	WOS:000633030400057
J	Perlemoine, P; Marcoux, PR; Picard, E; Hadji, E; Zelsmann, M; Mugnier, G; Marchet, A; Resch, G; O'Connell, L; Lacot, E				Perlemoine, Prisca; Marcoux, Pierre R.; Picard, Emmanuel; Hadji, Emmanuel; Zelsmann, Marc; Mugnier, Gregoire; Marchet, Aurelie; Resch, Gregory; O'Connell, Larry; Lacot, Eric			Phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth	PLOS ONE			English	Article								The growing number of drug-resistant bacterial infections worldwide is driving renewed interest in phage therapy. Based on the use of a personalized cocktail composed of highly specific bacterial viruses, this therapy relies on a range of tests on agar media to determine the most active phage on a given bacterial target (phage susceptibility testing), or to isolate new lytic phages from an environmental sample (enrichment of phage banks). However, these culture-based techniques are still solely interpreted through direct visual detection of plaques. The main objective of this work is to investigate computer-assisted methods in order to ease and accelerate diagnosis in phage therapy but also to study phage plaque growth kinetics. For this purpose, we designed a custom wide-field lensless imaging device, which allows continuous monitoring over a very large area sensor (3.3 cm(2)). Here we report bacterial susceptibility to Staphylococcus aureus phage in 3 hr and estimation of infectious titer in 8 hr 20 min. These are much shorter time-to-results than the 12 to 24 hours traditionally needed, since naked eye observation and counting of phage plaques is still the most widely used technique for susceptibility testing prior to phage therapy. Moreover, the continuous monitoring of the samples enables the study of plaque growth kinetics, which enables a deeper understanding of the interaction between phage and bacteria. Finally, thanks to the 4.3 mu m resolution, we detect phage-resistant bacterial microcolonies of Klebsiella pneumoniae inside the boundaries of phage plaques and thus show that our prototype is also a suitable device to track phage resistance. Lensless imaging is therefore an all-in-one method that could easily be implemented in cost-effective and compact devices in phage laboratories to help with phage therapy diagnosis.	[Perlemoine, Prisca; Marcoux, Pierre R.] Univ Grenoble Alpes, Dept Microtechnol Biol & Hlth, LETI, CEA, Grenoble, France; [Picard, Emmanuel; Hadji, Emmanuel] Univ Grenoble Alpes, CEA, SINAPS, PHELIQS,DEPHY,IRIG,DRF, Grenoble, France; [Zelsmann, Marc; Mugnier, Gregoire] Univ Grenoble Alpes, CEA, CNRS, LTM Micro & Nanotechnol Hlth, Grenoble, France; [Marchet, Aurelie; Resch, Gregory] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [O'Connell, Larry] Univ Grenoble Alpes, CEA, SyMMES, IRIG,DRF, Grenoble, France; [Lacot, Eric] Univ Grenoble Alpes, Lab Interdisciplinaire Phys, CNRS UMR 5588, St Martin Dheres, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Lausanne; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Perlemoine, P; Marcoux, PR (corresponding author), Univ Grenoble Alpes, Dept Microtechnol Biol & Hlth, LETI, CEA, Grenoble, France.	pierre.marcoux@cea.fr; prisca.perlemoine@gmail.com	Marcoux, Pierre R/A-5877-2009; Marcoux, Pierre R./GQA-4774-2022; hadji, emmanuel/AAW-9293-2021; Marcoux, Pierre R./AAA-7128-2021	Marcoux, Pierre R/0000-0003-3855-9662; Marcoux, Pierre R./0000-0003-3855-9662; hadji, emmanuel/0000-0001-5740-6018; Marcoux, Pierre R./0000-0003-3855-9662; Perlemoine, Prisca/0000-0001-7490-3622; resch, gregory/0000-0003-2341-4591; O'Connell, Larry/0000-0002-9551-3444				Abedon Stephen T, 2011, Bacteriophage, V1, P66; Abedon Stephen T., 2009, V501, P161, DOI 10.1007/978-1-60327-164-6_17; Adams MH, 1959, BACTERIOPHAGES; Carvalho C, 2010, LETT APPL MICROBIOL, V50, P192, DOI 10.1111/j.1472-765X.2009.02774.x; Castro-Mejia JL, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0131-4; Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799; Dias RS, 2013, J ANIM SCI, V91, P3930, DOI 10.2527/jas.2012-5884; Ferry T, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.570572; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; GOYAL SM, 1980, APPL ENVIRON MICROB, V39, P85, DOI 10.1128/AEM.39.1.85-91.1980; Han C, 2014, ANALYST, V139, P3727, DOI 10.1039/c3an02323k; Jault P, 2019, LANCET INFECT DIS, V19, P35, DOI 10.1016/S1473-3099(18)30482-1; KAPLAN DA, 1981, GENE, V13, P221, DOI 10.1016/0378-1119(81)90027-5; KOCH AL, 1964, J THEOR BIOL, V6, P413, DOI 10.1016/0022-5193(64)90056-6; Lee Y, 1996, BIOTECHNOL BIOENG, V52, P438, DOI 10.1002/(SICI)1097-0290(19961105)52:3<438::AID-BIT11>3.0.CO;2-F; Lee Y, 1996, NAT BIOTECHNOL, V14, P491, DOI 10.1038/nbt0496-491; Leshkasheli L, 2019, J GLOB ANTIMICROB RE, V19, P255, DOI 10.1016/j.jgar.2019.05.005; Los JM, 2008, APPL ENVIRON MICROB, V74, P5113, DOI 10.1128/AEM.00306-08; Maeda Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174723; Mattila S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01271; Mitarai N, 2016, J BACTERIOL, V198, P1783, DOI 10.1128/JB.00965-15; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P482, DOI 10.1111/j.1472-765X.2005.01781.x; Oechslin F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070351; Oechslin F, 2017, J INFECT DIS, V215, P703, DOI 10.1093/infdis/jiw632; Ortega-Cejas V, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031909; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozcan A, 2008, LAB CHIP, V8, P98, DOI 10.1039/b713695a; Philipson CW, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040188; Pirnay JP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020064; POSTIC B, 1961, J CLIN INVEST, V40, P2064, DOI 10.1172/JCI104432; Pouillot F, 2012, ANTIMICROB AGENTS CH, V56, P3568, DOI 10.1128/AAC.06330-11; PRIMROSE SB, 1977, J APPL BACTERIOL, V42, P417, DOI 10.1111/j.1365-2672.1977.tb00709.x; Ravat F, 2015, Ann Burns Fire Disasters, V28, P13; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEELEY ND, 1982, J APPL BACTERIOL, V53, P1, DOI 10.1111/j.1365-2672.1982.tb04729.x; Ujmajuridze A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01832; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; YIN J, 1992, BIOPHYS J, V61, P1540, DOI 10.1016/S0006-3495(92)81958-6; Zhang YB, 2018, ACS PHOTONICS, V5, P2081, DOI 10.1021/acsphotonics.8b00343	39	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248917	10.1371/journal.pone.0248917	http://dx.doi.org/10.1371/journal.pone.0248917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755710	Green Published, gold			2022-12-26	WOS:000632916600003
J	Mishima, K; Itano, O; Matsuda, S; Suzuki, S; Onishi, A; Tamura, M; Inoue, M; Abe, Y; Yagi, H; Hibi, T; Kitago, M; Shinoda, M; Kitagawa, Y				Mishima, Kohei; Itano, Osamu; Matsuda, Sachiko; Suzuki, Shunichi; Onishi, Akira; Tamura, Masashi; Inoue, Masanori; Abe, Yuta; Yagi, Hiroshi; Hibi, Taizo; Kitago, Minoru; Shinoda, Masahiro; Kitagawa, Yuko			Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: An orthotopic xenograft model	PLOS ONE			English	Article							MOUSE MODELS	Hepatocellular carcinoma (HCC) is the fifth most common primary tumor and the third leading cause of cancer-related deaths worldwide. Rodent models of HCC have contributed to the advancement of studies investigating liver carcinogenesis, tumor-host interactions, and drug screening. However, their small size renders them unsuitable for surgical or clinical imaging studies, necessitating the development of larger-size HCC models. Here, we developed a xenograft model of human HCC in X-linked interleukin-2 receptor gamma chain gene (Il2rg)-targeted severe combined immunodeficient (SCID) pigs. HepG2 cell suspension in serum-free medium containing 50% membrane matrix was directly injected into the liver parenchyma of eight X-linked Il2rg-targeted SCID pigs (6.6-15.6 kg) via ultrasonography-guided percutaneous puncture. Tumor engraftment was evaluated weekly using ultrasonography, and cone-beam computed tomography was performed during arterial portography (CTAP) and hepatic arteriography (CTHA) to evaluate the hemodynamics of engrafted tumors. The engrafted tumors were histologically analyzed following necropsy and assessed for pathological similarities to human HCCs. Macroscopic tumor formation was observed in seven of the eight pigs (simple nodular tumors in three and multinodular tumors in four). Engrafted tumors were identified as low-echoic upon ultrasonography and as perfusion-defect nodules on the CTAP images. Meanwhile, CTHA showed that the tumors were hyperattenuating. Further, histopathological findings of the engrafted tumors were consistent with those of human HCC. In conclusion, the porcine model of human HCC, successfully generated herein, might help develop more effective therapeutic strategies for HCC.	[Mishima, Kohei; Itano, Osamu; Matsuda, Sachiko; Abe, Yuta; Yagi, Hiroshi; Kitago, Minoru; Shinoda, Masahiro; Kitagawa, Yuko] Keio Univ, Dept Surg, Sch Med, Tokyo, Japan; [Itano, Osamu] Int Univ Hlth & Welf, Dept Hepatobiliary Pancreat & Gastrointestinal Su, Sch Med, Chiba, Japan; [Suzuki, Shunichi; Onishi, Akira] Natl Agr & Food Res Org, Div Anim Sci, Inst Agrobiol Sci, Ibaraki, Japan; [Onishi, Akira] Nihon Univ, Coll Bioresource Sci, Dept Anim Sci & Resources, Fujisawa, Kanagawa, Japan; [Tamura, Masashi; Inoue, Masanori] Keio Univ, Dept Radiol, Sch Med, Tokyo, Japan; [Hibi, Taizo] Kumamoto Univ, Dept Transplantat & Pediat Surg, Grad Sch Med Sci, Kumamoto, Japan	Keio University; International University of Health & Welfare; National Agriculture & Food Research Organization - Japan; Nihon University; Keio University; Kumamoto University	Itano, O (corresponding author), Keio Univ, Dept Surg, Sch Med, Tokyo, Japan.; Itano, O (corresponding author), Int Univ Hlth & Welf, Dept Hepatobiliary Pancreat & Gastrointestinal Su, Sch Med, Chiba, Japan.	itano@iuhw.ac.jp			JSPS KAKENHI [JP15K06809]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K06809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro J, 2012, CELL TRANSPLANT, V21, P1383, DOI 10.3727/096368912X640501; Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Boettcher AN, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00559; Cressman ENK, 2018, CARDIOVASC INTER RAD, V41, P1611, DOI 10.1007/s00270-018-2003-3; Ellebrecht DB, 2018, SURG ENDOSC, V32, P4966, DOI 10.1007/s00464-018-6258-1; He L, 2015, ONCOTARGET, V6, P23306, DOI 10.18632/oncotarget.4202; Heindryckx F, 2009, INT J EXP PATHOL, V90, P367, DOI 10.1111/j.1365-2613.2009.00656.x; Ho J, 2018, ONCOLOGY-BASEL, V95, P360, DOI 10.1159/000491092; Li X, 2006, CARDIOVASC INTER RAD, V29, P420, DOI 10.1007/s00270-005-0099-8; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Mitchell J, 2016, ONCOLOGY-BASEL, V91, P90, DOI 10.1159/000446074; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Rai R, 2005, CANCER BIOL THER, V4, P635, DOI 10.4161/cbt.4.6.1707; Schachtschneider KM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00190; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Swindle M.M, 2007, SWINE LAB SURG ANEST; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wu YS, 2016, INT J CLIN EXP PATHO, V9, P6835	18	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248352	10.1371/journal.pone.0248352	http://dx.doi.org/10.1371/journal.pone.0248352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750947	Green Published, gold			2022-12-26	WOS:000631967100013
J	Janska, P; Knejzlik, Z; Perumal, AS; Jurok, R; Tokarova, V; Nicolau, DV; Stepanek, F; Kaspar, O				Janska, Petra; Knejzlik, Zdenek; Perumal, Ayyappasamy Sudalaiyadum; Jurok, Radek; Tokarova, Viola; Nicolau, Dan, V; Stepanek, Frantisek; Kaspar, Ondrej			Effect of physicochemical parameters on the stability and activity of garlic alliinase and its use for in-situ allicin synthesis	PLOS ONE			English	Article							C-S LYASES; ALLIUM-SATIVUM; BIOCHEMICAL-CHARACTERIZATION; PHYSICAL-PROPERTIES; HIGHER-PLANTS; ENZYME; PRINCIPLE; STABILIZATION; PURIFICATION; MOISTURE	Garlic is a well-known example of natural self-defence system consisting of an inactive substrate (alliin) and enzyme (alliinase) which, when combined, produce highly antimicrobial allicin. Increase of alliinase stability and its activity are of paramount importance in various applications relying on its use for in-situ synthesis of allicin or its analogues, e.g., pulmonary drug delivery, treatment of superficial injuries, or urease inhibitors in fertilizers. Here, we discuss the effect of temperature, pH, buffers, salts, and additives, i.e. antioxidants, chelating agents, reducing agents and cosolvents, on the stability and the activity of alliinase extracted from garlic. The effects of the storage temperature and relative humidity on the stability of lyophilized alliinase was demonstrated. A combination of the short half-life, high reactivity and non-specificity to particular proteins are reasons most bacteria cannot deal with allicin's mode of action and develop effective defence mechanism, which could be the key to sustainable drug design addressing serious problems with escalating emergence of multidrug-resistant (MDR) bacterial strains.	[Janska, Petra; Knejzlik, Zdenek; Tokarova, Viola; Stepanek, Frantisek; Kaspar, Ondrej] Univ Chem & Technol Prague, Dept Chem Engn, Prague, Czech Republic; [Knejzlik, Zdenek] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Perumal, Ayyappasamy Sudalaiyadum; Nicolau, Dan, V] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Jurok, Radek] Univ Chem & Technol Prague, Dept Organ Chem, Prague, Czech Republic	University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; McGill University; University of Chemistry & Technology, Prague	Kaspar, O (corresponding author), Univ Chem & Technol Prague, Dept Chem Engn, Prague, Czech Republic.	kasparo@vscht.cz	Stepanek, Frantisek/C-1218-2009; Kašpar, Ondřej/AAM-5149-2020; Tokárová, Viola/AAN-5312-2021	Stepanek, Frantisek/0000-0001-9288-4568; Kašpar, Ondřej/0000-0001-5353-6069; Tokárová, Viola/0000-0002-8740-415X; Sudalaiyadum Perumal, Ayyappasamy/0000-0002-1360-9152; Janska, Petra/0000-0002-6254-0390	Technology Agency of the Czech Republic [TJ01000313]; Canadian Natural Sciences and Engineering Research Council [RGPIN-2016-05019]; University of Chemistry and Technology in Prague [A1_FCHI_2020_004, A1_FCHI_2020_005]	Technology Agency of the Czech Republic; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Chemistry and Technology in Prague	Technology Agency of the Czech Republic (https://www.tacr.cz/en/) - grant no. TJ01000313, receivers: VT, OK, PJ - Canadian Natural Sciences and Engineering Research Council (https://www.nserc-crsng.gc.ca/index_eng.asp) - grant no. RGPIN-2016-05019, receivers: DVN, ASP - Specific university research grants of the University of Chemistry and Technology in Prague (https://www.vscht.cz/?jazyk=en) - grant No. A1_FCHI_2020_004 and A1_FCHI_2020_005, receivers: PJ, FS, VT, OK.	Abdelraheem EMM, 2019, REACT CHEM ENG, V4, P1878, DOI 10.1039/c9re00301k; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Anastas P.T., 1998, FRONTIERS, V640; Balcao VM, 2015, ADV DRUG DELIVER REV, V93, P25, DOI 10.1016/j.addr.2014.10.005; Beniwal V., 2014, IND ENZYMES TRENDS S; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breen ED, 2001, PHARMACEUT RES, V18, P1345, DOI 10.1023/A:1013054431517; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Chhabria S, 2018, SAUDI J BIOL SCI, V25, P1429, DOI 10.1016/j.sjbs.2016.01.003; Clark SA, 1998, J FOOD BIOCHEM, V22, P91, DOI 10.1111/j.1745-4514.1998.tb00233.x; Drago GA, 2001, FOCUS BIOTECHNOL, V4, P361; ELLMORE GS, 1994, AM J BOT, V81, P89, DOI 10.2307/2445567; FAGAIN C, 1995, BBA-PROTEIN STRUCT M, V1252, P1, DOI 10.1016/0167-4838(95)00133-F; GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011; GUPTA K. C., 1955, ANTIBIOT AND CHEMOTHER, V5, P24; HAGEMAN MJ, 1988, DRUG DEV IND PHARM, V14, P2047, DOI 10.3109/03639048809152002; Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; JANSEN H, 1989, PLANTA MED, P434, DOI 10.1055/s-2006-962059; Keusgen M, 2008, PLANTA MED, V74, P73, DOI 10.1055/s-2007-993777; Krest I, 1999, PLANTA MED, V65, P139, DOI 10.1055/s-1999-13975; Krest I, 2000, J AGR FOOD CHEM, V48, P3753, DOI 10.1021/jf990521+; Kuettner EB, 2002, ARCH BIOCHEM BIOPHYS, V402, P192, DOI 10.1016/S0003-9861(02)00088-7; Kyung KH, 2012, CURR OPIN BIOTECH, V23, P142, DOI 10.1016/j.copbio.2011.08.004; Lancaster JE, 2000, PLANT PHYSIOL, V122, P1269, DOI 10.1104/pp.122.4.1269; LAWSON LD, 1992, PLANTA MED, V58, P345, DOI 10.1055/s-2006-961482; Lee CY, 2011, INT J MOL SCI, V12, P3263, DOI 10.3390/ijms12053263; Li CY, 2020, TRENDS BIOTECHNOL, V38, P729, DOI 10.1016/j.tibtech.2019.12.008; Liu Q, 2019, BIOTECHNOL ADV, V37, P530, DOI 10.1016/j.biotechadv.2018.10.011; Mallika T., 2014, J ACAD IND RES, V2, P599; Marchese A, 2016, TRENDS FOOD SCI TECH, V52, P49, DOI 10.1016/j.tifs.2016.03.010; Marion P, 2017, GREEN CHEM, V19, P4973, DOI 10.1039/c7gc02006f; Martins N, 2016, FOOD CHEM, V211, P41, DOI 10.1016/j.foodchem.2016.05.029; MAZELIS M, 1968, BIOCHEM J, V108, P725, DOI 10.1042/bj1080725; Musah RA, 2009, PLANT PHYSIOL, V151, P1304, DOI 10.1104/pp.109.142430; Nair SK, 2020, J BIOL CHEM, V295, P335, DOI 10.1074/jbc.REV119.011586; NOCK LP, 1987, PLANT PHYSIOL, V85, P1079, DOI 10.1104/pp.85.4.1079; NOCK LP, 1986, ARCH BIOCHEM BIOPHYS, V249, P27, DOI 10.1016/0003-9861(86)90556-4; RABINKOV A, 1994, APPL BIOCHEM BIOTECH, V48, P149, DOI 10.1007/BF02788739; Reiter J, 2020, INT J MED MICROBIOL, V310, DOI 10.1016/j.ijmm.2019.151359; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma SS, 2019, LECT N MECH ENG, P469, DOI 10.1007/978-981-13-6412-9_46; Shin I., 2018, J PHARM PHARMACOL, V6, P437, DOI [10.17265/2328-2150/2018.05.001, DOI 10.17265/2328-2150/2018.05.001]; Silva C, 2018, CRIT REV BIOTECHNOL, V38, P335, DOI 10.1080/07388551.2017.1355294; STOLL A, 1951, HELV CHIM ACTA, V34, P481, DOI 10.1002/hlca.19510340212; STOLL A, 1951, ADV ENZYMOL REL S BI, V11, P377; STOLL A, 1949, HELV CHIM ACTA, V32, P866, DOI 10.1002/hlca.19490320330; TOBKIN HE, 1979, ARCH BIOCHEM BIOPHYS, V193, P150, DOI 10.1016/0003-9861(79)90018-3; Weiner L, 2009, PROTEIN SCI, V18, P196, DOI 10.1002/pro.10; Yutani M, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-2; Zbacnik TJ, 2017, J PHARM SCI-US, V106, P713, DOI 10.1016/j.xphs.2016.11.014; Zhou J, 2009, AFR J BIOTECHNOL, V8; Zhou JQ, 2009, ENZYME MICROB TECH, V45, P299, DOI 10.1016/j.enzmictec.2009.07.007	54	6	7	10	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248878	10.1371/journal.pone.0248878	http://dx.doi.org/10.1371/journal.pone.0248878			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740023	gold, Green Published			2022-12-26	WOS:000631030200005
J	Luo, YY; Ren, D				Luo, Yuanyuan; Ren, Da			Influence of the enterprise's intelligent performance evaluation model using neural network and genetic algorithm on the performance compensation of the merger and acquisition parties in the commitment period	PLOS ONE			English	Article							RISK-MANAGEMENT	The purpose is to study the performance compensation of the bid purchased during the mergers and acquisitions (M&A) process. An intelligent model of enterprise performance appraisal is built to analyze the performances of the acquired enterprises. First, the evaluation indicators of enterprise performance are selected from both financial and non-financial aspects. An enterprise performance appraisal model is established based on the neural networks and optimized by the factor analysis method and Genetic Algorithm (GA). The principal factors affecting enterprise performance are analyzed. Then the M&A parties' performances during the M&A commitment period under the earnings compensation mechanism are analyzed quantitatively. Corresponding hypotheses and evaluation indicators are established. Mean test results and regression analyses demonstrate that the hypotheses proposed are valid under particular circumstances. Introducing the earnings compensation mechanism during the M&A process can improve the enterprise performance effectively so that the earnings forecasted in the commitment period are significantly higher than the historical profitability. Hence, the earnings compensation mechanism plays a positive role in guiding enterprise performance. Comparison with models proposed in previous research reveals that the output error ratio of the designed corporate performance evaluation model is 1.16%, which can effectively evaluate corporate performance. The above results provide a reference for studying the impact of the earnings compensation mechanism on enterprise performance during the M&A process.	[Luo, Yuanyuan; Ren, Da] Tianjing Univ, Coll Management & Econ, Tianjing City, Peoples R China	Tianjin University	Luo, YY (corresponding author), Tianjing Univ, Coll Management & Econ, Tianjing City, Peoples R China.	yuanyuanluo@tju.edu.cn						Aaldering LJ, 2019, EXPERT SYST APPL, V125, P221, DOI 10.1016/j.eswa.2019.02.004; Albizri A, 2019, INT J DISCL GOV, V16, P206, DOI 10.1057/s41310-019-00067-9; Amewu G, 2019, MANAG DECIS ECON, V40, P672, DOI 10.1002/mde.3037; Bari M W., 2019, SAGE OPEN, V9, P210; Cai DM, 2019, APPL COGN LINGUIST, V39, P57, DOI 10.1515/9783110629460-004; Cai W, 2020, J CLEAN PROD, V245, DOI 10.1016/j.jclepro.2019.118849; Chidambaram S, 2019, CLUSTER COMPUT, V22, P189, DOI 10.1007/s10586-018-2036-z; Dahooie JH, 2019, ECON RES-EKON ISTRAZ, V32, P1088, DOI 10.1080/1331677X.2019.1613250; Hirsch B., 2020, INT PUBLIC MANAG J, V3, P1; Jana C, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11010075; Jiang L, 2019, EURASIP J WIREL COMM, DOI 10.1186/s13638-018-1318-8; Jiang ZG, 2019, ENERG CONVERS MANAGE, V198, DOI 10.1016/j.enconman.2019.111844; Ketprapakorn N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11143772; Krishnamurti C, 2019, PAC-BASIN FINANC J, V57, DOI 10.1016/j.pacfin.2019.101193; Liu JC, 2019, J CLEAN PROD, V236, DOI 10.1016/j.jclepro.2019.06.302; Majumdar S.K., 2020, ANTITRUST BULL, V65, P120, DOI [10.1177/0003603X19898903, DOI 10.1177/0003603X19898903]; Masmoudi K, 2019, EXPERT SYST APPL, V127, P157, DOI 10.1016/j.eswa.2019.03.014; Mohamed EA., 2021, INTELL SYS ACC FIN M, P1; Moldavska A, 2019, J MANUF SYST, V50, P53, DOI 10.1016/j.jmsy.2018.11.004; Razminiene K, 2019, EQUILIBRIUM, V14, P537, DOI 10.24136/eq.2019.026; Sandeep NV, 2019, INT J MULTIDISCIPLIN, V9, P214; Sarraf F, 2020, EVAL PROGRAM PLANN, V79, DOI 10.1016/j.evalprogplan.2019.101762; Shad MK, 2019, J CLEAN PROD, V208, P415, DOI 10.1016/j.jclepro.2018.10.120; Shi HL, 2020, IEEE ACCESS, V8, P45726, DOI 10.1109/ACCESS.2020.2976608; Shih K.-H., 2019, J ACCOUNT FINANC MAN, V14, P49; Tao QZ, 2019, J BUS RES, V104, P215, DOI 10.1016/j.jbusres.2019.07.019; Wang J, 2017, IEEE INFOCOM SER, DOI 10.1007/s12083-017-0556-6; Xi F, 2019, CLUSTER COMPUT, V22, P2255, DOI 10.1007/s10586-018-2596-y; Xie XT, 2020, INT J COMPUT SCI MAT, V12, P192; Ya DC., 2019, INT J ENTREPRENEURSH, V2, P01, DOI 10.35631/ijemp.28001; Yang GJ, 2020, INT J EMBED SYST, V13, P387; Yang J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051375; Yang QF, 2019, COGN SYST RES, V56, P50, DOI 10.1016/j.cogsys.2019.02.001; Zhao Y., 2020, ACAD J BUSINESS MANA, V2, P32; Zhou L, 2019, PROC CIRP, V83, P759, DOI 10.1016/j.procir.2019.05.014	35	3	3	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248727	10.1371/journal.pone.0248727	http://dx.doi.org/10.1371/journal.pone.0248727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739973	gold, Green Published			2022-12-26	WOS:000631030200022
J	Sendic, S; Mansouri, L; Lundberg, S; Nopp, A; Jacobson, SH; Lundahl, J				Sendic, Senka; Mansouri, Ladan; Lundberg, Sigrid; Nopp, Anna; Jacobson, Stefan H.; Lundahl, Joachim			B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy	PLOS ONE			English	Article								Background IgA nephropathy (IgAN) advances from multiple pathogenic "hits" resulting in poorly O-galactosylated IgA1 glycoforms (Gd-IgA1), production of antibodies and glomerular deposition of immune complexes. A sequence of immune responses arising from plasma cells, T cells and antigen presenting cells (APCs), causes glomerular injury. This study was designed to phenotype subsets of B cells, monocytes and T cells in the peripheral circulation and their association with inflammatory cytokines and kidney function in patients with IgAN, healthy controls (HC) and disease controls with autosomal dominant polycystic kidney disease (ADPKD). Methods Patients with IgAN (n = 13), median estimated glomerular filtration rate (eGFR) of 57 ml/min/1.73m(2) (IQR 42-84), patients with ADPKD (n = 13) matched for kidney function, gender and age and gender and age-matched HC (n = 13) were recruited. CD3+ and CD3- peripheral blood mononuclear cells were isolated and profiled based on their specific surface markers for different subsets of monocytes, B and T cells and analyzed by flow cytometry. Cytokines were analyzed by ELISA. Results We observed a significant decrease in the proportion of pre-switched B cells and plasmablasts, but an increase in long-lived plasma cells in the peripheral circulation of IgAN patients compared to HC. The proportion of non-classical monocytes was significantly higher in IgAN patients compared to both HC and ADPKD. We also report an association between sCD40L levels and the proportion of pre-switched B cells, as well as sCD40L and MCP-1 levels and albuminuria in IgAN patients. Conclusions We applied an easy-access method to analyze subsets of immune cells as well as relevant inflammatory mediators in IgAN patients. Our data demonstrate an altered B cell profile that indicates a pathophysiological role of the B cell lineage and an increased proportion of non-classical monocytes that suggests their role in the disease process.	[Sendic, Senka; Lundberg, Sigrid; Jacobson, Stefan H.] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Nephrol, Stockholm, Sweden; [Mansouri, Ladan; Nopp, Anna; Lundahl, Joachim] Soder Sjukhuset, Karolinska Inst, Clin Sci & Educ, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Sendic, S (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Nephrol, Stockholm, Sweden.	senka.sendic@sll.se	Lundberg, Sigrid/AGM-4891-2022	Lundberg, Sigrid/0000-0003-1224-5200	Stockholm County Council ALF [20200276]; Swedish Renal Foundation Njurfonden [F2018-0035]; Swedish Society of Nephrology; Swedish Society of Medicine [1038]	Stockholm County Council ALF(Stockholm County Council); Swedish Renal Foundation Njurfonden; Swedish Society of Nephrology; Swedish Society of Medicine	This study was supported by grants from: Stockholm County Council ALF (Grant 20200276, S.J.), the Swedish Renal Foundation Njurfonden (Grant F2018-0035, S.L), Swedish Society of Nephrology (S.S.) and Swedish Society of Medicine (Grant 1038 Eric & Ebba Jonssons Fond, S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugakani G, 2017, J IMMUNOL, V198, P4618, DOI 10.4049/jimmunol.1501761; BJORCK P, 1994, IMMUNOLOGY, V83, P430; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Burbano C, 2014, ARTHRITIS RHEUMATOL, V66, P3371, DOI 10.1002/art.38860; Buren M, 2007, CONTRIB NEPHROL, V157, P50, DOI 10.1159/000102304; Cols CE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041389; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Cox SN, 2015, NEPHROL DIAL TRANSPL, V30, P1122, DOI 10.1093/ndt/gfv017; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Halim L, 2017, CELL REP, V20, P757, DOI 10.1016/j.celrep.2017.06.079; HARPER SJ, 1994, KIDNEY INT, V45, P836, DOI 10.1038/ki.1994.110; He LY, 2014, RENAL FAILURE, V36, P407, DOI 10.3109/0886022X.2013.862809; Hiepe F, 2016, NAT REV NEPHROL, V12, P232, DOI 10.1038/nrneph.2016.20; Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339; Hotta O, 1999, KIDNEY INT, V55, P1927, DOI 10.1046/j.1523-1755.1999.00431.x; Huang JL, 2016, J AM SOC NEPHROL, V27, P69, DOI 10.1681/ASN.2014090856; Kiryluk K, 2014, J CLIN INVEST, V124, P2325, DOI 10.1172/JCI74475; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Lai KN, 2012, NAT REV NEPHROL, V8, P275, DOI 10.1038/nrneph.2012.58; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Magistroni R, 2015, KIDNEY INT, V88, P974, DOI 10.1038/ki.2015.252; MELLIS SJ, 1983, J BIOL CHEM, V258, P1557; Ruszkowski J, 2019, CLIN EXP NEPHROL, V23, P291, DOI 10.1007/s10157-018-1665-0; Samy E, 2017, INT REV IMMUNOL, V36, P3, DOI 10.1080/08830185.2016.1276903; SCHENA FP, 1990, AM J MED, V89, P209; Schwabe RF, 1999, CLIN EXP IMMUNOL, V117, P153; Si R, 2020, IMMUNOL INVEST, V49, P178, DOI 10.1080/08820139.2019.1683026; Smith AC, 2006, J AM SOC NEPHROL, V17, P1192, DOI 10.1681/ASN.2005101115; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; VANKOOTEN C, 1994, EUR J IMMUNOL, V24, P787, DOI 10.1002/eji.1830240402; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Wallquist C, 2013, SCAND J IMMUNOL, V78, P538, DOI 10.1111/sji.12115; Xin G, 2013, J NEPHROL, V26, P683, DOI 10.5301/jn.5000218; Yang LC, 2017, INT UROL NEPHROL, V49, P353, DOI 10.1007/s11255-016-1444-3; Yeo SC, 2018, PEDIATR NEPHROL, V33, P763, DOI 10.1007/s00467-017-3699-z; Zheng NY, 2017, MOL MED REP, V15, P1925, DOI 10.3892/mmr.2017.6190; Zhu HQ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00512; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248056	10.1371/journal.pone.0248056	http://dx.doi.org/10.1371/journal.pone.0248056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740017	Green Published, gold, Green Submitted			2022-12-26	WOS:000631030200041
J	Spekker, O; Hunt, DR; Berthon, W; Paja, L; Molnar, E; Palfi, G; Schultz, M				Spekker, Olga; Hunt, David R.; Berthon, William; Paja, Laszlo; Molnar, Erika; Palfi, Gyorgy; Schultz, Michael			Tracking down the White Plague. Chapter three: Revision of endocranial abnormally pronounced digital impressions as paleopathological diagnostic criteria for tuberculous meningitis	PLOS ONE			English	Article								Abnormally pronounced digital impressions (APDIs) on the endocranial surface develop secondary to a prolonged rise in the intracranial pressure. This can result from a number of pathological conditions, including hydrocephalus due to tuberculous meningitis (TBM). APDIs have been described with relation to TBM not only in the modern medical literature but also in several paleopathological studies. However, APDIs are not pathognomonic for TBM and their diagnostic value for identifying TBM in past human populations has not been evaluated in identified pre-antibiotic era skeletons. To assess the diagnostic value of APDIs for the first time, a macroscopic investigation was performed on skeletons from the Terry Collection (Smithsonian Institution, Washington, DC, USA). Our material consisted of 234 skeletons with tuberculosis (TB) as the cause of death (TB group) and 193 skeletons with non-tuberculous (NTB) causes of death (NTB group). The macroscopic examination focused on the stage of the prominence and frequency of APDIs in the TB group and NTB group. To determine the significance of difference (if any) in the frequency of APDIs between the two groups, chi(2) testing of our data was conducted. We found that APDIs were twice as common in the TB group than in the NTB group. The chi(2) comparison of the frequencies of APDIs revealed a statistically significant difference between the two groups. In addition, APDIs with more pronounced stages were recorded more frequently in the TB group. Our results indicate that APDIs can be considered as diagnostic criteria for TBM in the paleopathological practice. With suitable circumspection, their utilization provides paleopathologists with a stronger basis for identifying TB and consequently, with a more sensitive means of assessing TB frequency in past human populations.	[Spekker, Olga; Berthon, William; Paja, Laszlo; Molnar, Erika; Palfi, Gyorgy] Univ Szeged, Dept Biol Anthropol, Szeged, Hungary; [Hunt, David R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA; [Berthon, William] PSL Univ, Ecole Prat Hautes Etud EPHE, Chaire Anthropol Biol Paul Broca, Paris, France; [Schultz, Michael] Univ Med Gottingen, Inst Anat & Embryol, Zentrum Anat, Gottingen, Germany	Szeged University; Smithsonian Institution; Smithsonian National Museum of Natural History; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Gottingen	Spekker, O (corresponding author), Univ Szeged, Dept Biol Anthropol, Szeged, Hungary.	olga.spekker@gmail.com	Spekker, Olga/ABA-4710-2021	Spekker, Olga/0000-0002-0350-1906; Hunt, David/0000-0003-1316-3418; Berthon, William/0000-0003-1776-4798	Tempus Public Foundation [77466]; NTP-NFTO-16 of the Hungarian Ministry of Human Capacities & Human Capacities Grant Management Office [1116]; University of Szeged Open Access Fund [4932]; National Research, Development and Innovation Office (Hungary) [K 125561]	Tempus Public Foundation; NTP-NFTO-16 of the Hungarian Ministry of Human Capacities & Human Capacities Grant Management Office; University of Szeged Open Access Fund; National Research, Development and Innovation Office (Hungary)	This work was funded by the Hungarian State Eotvos Fellowship 2016 (77466) of the Tempus Public Foundation, the NTP-NFTO-16 (1116) of the Hungarian Ministry of Human Capacities & Human Capacities Grant Management Office, and the University of Szeged Open Access Fund (4932) to OS. The National Research, Development and Innovation Office (Hungary) (K 125561) provided funding for GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert E, 1889, LEHRE HIRNDRUCK KR 3, V3, P73; Altenburger H., 1939, HDB INNEREN MED KRAN, V5, P571; Arbelaez A, 2004, SEMIN ROENTGENOL, V39, P474, DOI 10.1016/j.ro.2004.06.003; Aschoff L, 1936, LEHRBUCH STUDIERNDE, VBand, P386; Assis S, 2011, INT J PALEOPATHOL, V1, P155, DOI 10.1016/j.ijpp.2012.02.009; Baker BJ, 1999, TUBERCULOSIS PRESENT, P301; Bano S, 2012, NEUROIMAGING CLIN AP, P467, DOI [10.5772/24964, DOI 10.5772/24964]; Be NA, 2009, CURR MOL MED, V9, P94, DOI 10.2174/156652409787581655; Belier B., 1914, HDB ATLAS GESAMTEN T; Bell W E, 1978, Curr Probl Pediatr, V8, P1, DOI 10.1016/S0045-9380(78)80005-X; Bergerhoff W., 1963, HDB MED RADIOL 1, V7, P277; Bergerhoff W., 1963, HDB MED RADIOL 1, V7, P292; Bernaerts A, 2003, EUR RADIOL, V13, P1876, DOI 10.1007/s00330-002-1608-7; Bill P., 2006, CONTINUING MED ED, V24, P505; Boldsen JL, 2001, AM J PHYS ANTHROPOL, V115, P380, DOI 10.1002/ajpa.1094; Bostroem A., 1939, HDB INNEREN MED KR 1, V5, P631; Bostroem A., 1939, HDB INNEREN MED KR 1, V5, P711; BOULAY G, 1956, ACTA RADIOL, V46, P112, DOI 10.3109/00016925609170820; Brancusi F, 2012, FUTURE MICROBIOL, V7, P1101, DOI [10.2217/fmb.12.86, 10.2217/FMB.12.86]; Burkhardt L., 1970, HDB SPEZIELLEN PATHO, V9, P1; Bushe K-A., 1968, CHIRURGIE GEHIRNS RU, DOI [10.1055/s-0028-1105212, DOI 10.1055/S-0028-1105212]; Chason JL., 1971, PATHOLOGY, V2, P1781, DOI [10.3171/jns.1971.34.5.0693, DOI 10.3171/JNS.1971.34.5.0693]; Chaudhary V, 2017, CAN ASSOC RADIOL J, V68, P161, DOI 10.1016/j.carj.2016.10.007; Clara M, 1942, NERVENSYSTEM MENSCHE; Connolly CA, 2011, J PEDIATR NURS, V26, P230, DOI 10.1016/j.pedn.2010.01.011; Desai Vela, 2014, Int J Clin Pediatr Dent, V7, P47, DOI 10.5005/jp-journals-10005-1233; Donald PR, 2005, J INFECTION, V50, P193, DOI 10.1016/j.jinf.2004.02.010; du Boulay GH, 1980, PRINCIPLES XRAY DIAG, P1; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gandhi AS, 2016, INT J CONT PEDIAT, V3, P1210, DOI [10.18203/2349-3291.ijcp20162788, DOI 10.18203/2349-3291.IJCP20162788]; Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x; Garg RK, 1999, POSTGRAD MED J, V75, P133, DOI 10.1136/pgmj.75.881.133; Gauba C., 2005, APOLLO MED, V2, P21, DOI [10.1016/S0976-0016(12)60056-8, DOI 10.1016/S0976-0016(12)60056-8]; Giacon M, 2008, THESIS PADOVA U PADO; Gray H., 1942, ANATOMY HUMAN BODY; Hershkovitz I, 2002, AM J PHYS ANTHROPOL, V118, P201, DOI 10.1002/ajpa.10077; Huebschmann P., 1928, TUBERKULOSE IHRE GRE, V5; Hunt DR, 2005, AM J PHYS ANTHROPOL, V127, P406, DOI 10.1002/ajpa.20135; Katti MK, 2004, MED SCI MONITOR, V10, pRA215; Katzenstein E, 1956, SCHADELHIRNTRAUMA HI; Kehrer HE, 1955, HYDROCEPHALUS INTERN; KELLEY MA, 1984, AM J PHYS ANTHROPOL, V65, P381, DOI 10.1002/ajpa.1330650407; Korner O., 1925, OHENHEILKUNDE GEGENW, V3; Lange J., 1939, HDB INNEREN MED KR 1, V5, P482; M?nard V., 1888, TUBERCULOSE VERTEBRA; Maczel M., 2003, DIAGNOSTIC CRITERIA; Mahomed N, 2012, SA J RADIOL, V16, P25, DOI 10.4102/sajr.v16i1.229; Mariotti V, 2015, AM J PHYS ANTHROPOL, V157, P389, DOI 10.1002/ajpa.22727; Matos V, 2006, AM J PHYS ANTHROPOL, V130, P190, DOI 10.1002/ajpa.20309; Morgado TC, 2013, WORLD NEUROSURG, V80, pE255, DOI 10.1016/j.wneu.2012.09.021; Nielsen N., 2013, NURSING CARE PEDIAT, P37, DOI [10.1007/978-3-642-32554-0_2, DOI 10.1007/978-3-642-32554-0_2]; Oldberg E, 1944, ARCH NEURO PSYCHIATR, V52, P230, DOI 10.1001/archneurpsyc.1944.02290330069006; Ortner DJ, 2003, IDENTIFICATION PATHO, P227; Ostertag B., 1941, PATHOLOGIE RAUMFORDE; Palfi Gyoergy, 2012, Acta Biologica Szegediensis, V56, P1; Paul Siba, 2014, Nurs Child Young People, V26, P30, DOI 10.7748/ncyp2014.02.26.1.30.e214; Paul Siba, 2013, Nurs Child Young People, V25, P31, DOI 10.7748/ncyp2013.12.25.10.31.e214; Pedersen DD, 2019, INT J PALEOPATHOL, V27, P88, DOI 10.1016/j.ijpp.2019.01.001; Pemmaiah D.C., 2015, J MED SCI HLTH, V1, P46; Rajashekar HK, 2014, J EVOL MED DENT SCI-, V3, P9031, DOI 10.14260/jemds/2014/3164; Rajshekhar V, 2009, NEUROL INDIA, V57, P368, DOI 10.4103/0028-3886.55572; Raut T, 2013, J INFECTION, V66, P330, DOI 10.1016/j.jinf.2012.12.009; ROBERTS C, 1994, AM J PHYS ANTHROPOL, V95, P169, DOI 10.1002/ajpa.1330950205; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Rodriguez-Martin C., 1998, CAMBRIDGE ENCY HUMAN, P118; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; Rothschild BM., 1999, TUBERCULOSIS PRESENT, P291; Santos AL, 2006, AM J PHYS ANTHROPOL, V130, P38, DOI 10.1002/ajpa.20160; Santos AL, 2001, AM J PHYS ANTHROPOL, V115, P38, DOI 10.1002/ajpa.1054; Schmaus G., 1907, GRUNDRISS PATHOLOGIS; Schueller M, 2003, INTERNATIONAL HANDBOOK ON FINANCIAL REFORM, P73, DOI 10.1016/B978-012528628-2/50043-0; Schuller A., 1941, CONFIN NEUROL, V3, P253, DOI [10.1159/000106215, DOI 10.1159/000106215]; Schultz M, 2001, YEARB PHYS ANTHROPOL, V44, P106, DOI 10.1002/ajpa.10024; Schultz M., 1999, TUBERCULOSIS PRESENT, P503; Schultz M., 1993, SPUREN UNSPEZIFISCHE; Schultz M, 2015, TUBERCULOSIS, V95, pS80, DOI 10.1016/j.tube.2015.02.035; Schultze F., 1901, KRANKHEITEN HIRNHAUT; Spekker O, 2018, THESIS U SZEGED SZEG, DOI [10.14232/phd.9714, DOI 10.14232/PHD.9714]; Spekker O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238444; Spekker O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230418; Taheri MS, 2015, RADIOL RES PRACT, V2015, DOI 10.1155/2015/202806; Templin O., 1994, HOMO, V45, pS130; Templin O, 1993, THESIS U GOTTINGEN G; Teschler-Nicola M, 1996, FREIE U BERLIN ZUSAM, P65; van Toorn R, 2014, SEMIN PEDIATR NEUROL, V21, P12, DOI 10.1016/j.spen.2014.01.006; Vinnard Christopher, 2009, Curr HIV/AIDS Rep, V6, P139, DOI 10.1007/s11904-009-0019-7; Wepler W., 1961, LEHRBUCH SPEZIELLEN, P651; Winland K., 1997, AM J PHYS ANTHROPOL, V24, P243	89	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0249020	10.1371/journal.pone.0249020	http://dx.doi.org/10.1371/journal.pone.0249020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740029	Green Accepted, gold, Green Published			2022-12-26	WOS:000631030200044
J	Charest, M; Sharma, M; Chris, A; Schnubb, A; Knox, DC; Wilton, J; Shahin, R; Chan, A; Mishra, S; Grace, D; Bayoumi, AM; Maxwell, J; Bogoch, II; Tan, DHS				Charest, Maxime; Sharma, Malika; Chris, Allison; Schnubb, Alexandre; Knox, David C.; Wilton, James; Shahin, Rita; Chan, Arlene; Mishra, Sharmistha; Grace, Daniel; Bayoumi, Ahmed M.; Maxwell, John; Bogoch, Isaac I.; Tan, Darrell H. S.			Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; PROVIDERS; MEN; DIAGNOSIS; KNOWLEDGE; ATTITUDES; SEX	Pre-exposure prophylaxis (PrEP) is traditionally prescribed by HIV specialist physicians. Given finite specialist resources, there is a need to scale up PrEP delivery by decentralizing services via other healthcare professionals. We aimed to assess the feasibility of delivering PrEP to men who have sex with men (MSM) through primary care physicians and sexual health clinic nurses. We piloted a multi-component, implementation and dissemination research program to increase provision of PrEP through primary care physicians and sexual health clinic nurses in Toronto, Canada. Community-based organizations (CBOs) provided prospective participants with information cards that contained links to an online module on engaging providers in a conversation about PrEP. In our patient-initiated continuing medical education (PICME) strategy, participants saw their family doctors and gave them the card, which also contained a link to a Continuing Medical Education module. In the nurse-led strategy, participants visited one of two participating clinics to obtain PrEP. We administered an optional online questionnaire to patients and providers at baseline and six months. CBOs distributed 3043 cards. At least 339 men accessed the online module and 196 completed baseline questionnaires. Most (55%) intended to visit nurses while 21% intended to consult their physicians. Among 45 men completing follow-up questionnaires at 6 months, 31% reported bringing cards to their physicians and obtaining PrEP through them; sexual health clinics delivered PrEP to 244 patients. Participants who went through the PICME approach reported no changes in relationships with their providers. Nurses showed fidelity to PrEP prescribing guidelines. Nurse-led PrEP and patient-initiated continuing medical education (PICME) for primary care physicians are feasible strategies to increase PrEP uptake. Nurse-led PrEP delivery was preferred by most patients.	[Charest, Maxime] Univ Toronto, Ontario Inst Studies Educ, Toronto, ON, Canada; [Charest, Maxime; Schnubb, Alexandre; Mishra, Sharmistha; Tan, Darrell H. S.] St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada; [Sharma, Malika; Mishra, Sharmistha; Bayoumi, Ahmed M.; Bogoch, Isaac I.; Tan, Darrell H. S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sharma, Malika] Casey House, Toronto, ON, Canada; [Sharma, Malika; Knox, David C.] Maple Leaf Med Clin, Toronto, ON, Canada; [Chris, Allison; Shahin, Rita] Toronto Publ Hlth, Toronto, ON, Canada; [Wilton, James] Univ British Columbia, Ctr Dis Control, Vancouver, BC, Canada; [Chan, Arlene] Womens Coll Hosp, Toronto, ON, Canada; [Mishra, Sharmistha; Bayoumi, Ahmed M.; Tan, Darrell H. S.] St Michaels Hosp, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada; [Mishra, Sharmistha] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Mishra, Sharmistha; Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Grace, Daniel] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada; [Maxwell, John] AIDS Comm Toronto, Toronto, ON, Canada; [Bogoch, Isaac I.; Tan, Darrell H. S.] Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of British Columbia; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Tan, DHS (corresponding author), St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada.; Tan, DHS (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Tan, DHS (corresponding author), St Michaels Hosp, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.; Tan, DHS (corresponding author), Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.	darrell.tan@gmail.com		Wilton, James/0000-0002-2295-7511; Charest, Maxime/0000-0003-1727-7340	Canadian Institutes of Health Research [HIM 145368]; CIHR Canadian HIV Trials Network [CTN 303]; Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario [16-004]; CIHR Canadian HIV Trials Network; DHST; Canadian Institutes of Health Research; Ontario HIV Treatment Network; Tier 2 Canada Research Chair in HIV prevention and STI research; Canada Research Chair in Sexual and Gender Minority Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario; CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); DHST; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Tier 2 Canada Research Chair in HIV prevention and STI research; Canada Research Chair in Sexual and Gender Minority Health	This work was supported by the Canadian Institutes of Health Research (grant number HIM 145368 to DHST, SM and DCK), the CIHR Canadian HIV Trials Network (grant number CTN 303 to DHST, SM and DCK) and the Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario (grant number 16-004 to DHST, SM and DCK). MS was supported by a Postdoctoral Fellowship from the CIHR Canadian HIV Trials Network, and DHST, SM and IIB were supported by a New Investigator Award from the Canadian Institutes of Health Research and Ontario HIV Treatment Network during the conduct of this work. DHST is currently supported by a Tier 2 Canada Research Chair in HIV prevention and STI research. DG was supported by his Canada Research Chair in Sexual and Gender Minority Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Blackstock OJ, 2017, J GEN INTERN MED, V32, P62, DOI 10.1007/s11606-016-3903-z; Brown AE, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.25.30553; Calabrese SK, 2019, CLIN INFECT DIS, V69, P884, DOI 10.1093/cid/ciz046; Clifford-Rashotte M, 2021, CAN J NURS RES, V53, P145, DOI 10.1177/0844562120924269; Collins A., 2017, ABC NEWS NEWSPAPER I; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Dulai J., 2015, SEX NOW CANADA; Grace D, 2018, AIDS PATIENT CARE ST, V32, P24, DOI 10.1089/apc.2017.0153; Haddad N, 2019, Can Commun Dis Rep, V45, P304, DOI 10.14745/ccdr.v45i12a01; Hojilla JC, 2018, AIDS BEHAV, V22, P1096, DOI 10.1007/s10461-017-2009-x; Katz DA, 2016, SEX TRANSM DIS, V43, P249, DOI 10.1097/OLQ.0000000000000423; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Land E., 2017, BETA BLOG; MacLean DR, 1996, CAN J PUBLIC HEALTH, V87, pS40; News CBC, 2019, CBC NEWS NEWSPAPER I; O'Byrne P, 2018, J ASSOC NURSE AIDS C, V29, P550, DOI 10.1016/j.jana.2018.02.004; O'Byrne P, 2015, PUBLIC HEALTH NURS, V32, P256, DOI 10.1111/phn.12123; Pathela P, 2015, CLIN INFECT DIS, V61, P281, DOI 10.1093/cid/civ289; Pathela P, 2013, CLIN INFECT DIS, V57, P1203, DOI 10.1093/cid/cit437; Petroll AE, 2017, AIDS BEHAV, V21, P1256, DOI 10.1007/s10461-016-1625-1; Rabin B. A., 2012, DISSEMINATION IMPLEM; Rana J, 2018, CAN J PUBLIC HEALTH, V109, P342, DOI 10.17269/s41997-018-0064-3; Schmidt HMA, 2018, SEX HEALTH, V15, P595, DOI 10.1071/SH18076; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Seidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018; Selfridge M, 2020, PUBLIC HEALTH NURS, V37, P871, DOI 10.1111/phn.12813; Sharma M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3324-2; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Tan DHS, 2017, CAN MED ASSOC J, V189, pE1448, DOI 10.1503/cmaj.170494; Turner L, 2018, J ASSOC NURSE AIDS C, V29, P83, DOI 10.1016/j.jana.2017.11.002; US Public Health Service, 2014, PREVENTION CFDCA; World Health Organisation, 2008, TASK SHIFT GLOB REC	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248626	10.1371/journal.pone.0248626	http://dx.doi.org/10.1371/journal.pone.0248626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735209	Green Published, gold			2022-12-26	WOS:000631029700113
J	DiDiodato, G; Hassan, S; Cooley, K				DiDiodato, Giulio; Hassan, Samah; Cooley, Kieran			Elicitation of stakeholder viewpoints about medical cannabis research for pain management in critically ill ventilated patients: A Q-methodology study	PLOS ONE			English	Article								Objectives To determine acceptability of medical cannabis research in critically ill patients. Design Q-methodology survey. Setting Convenience sample of healthcare providers and the general public were recruited at an acute care community hospital in Ontario, Canada. Participants In the first phase, 63 respondents provided 197 unique viewpoints in response to a topic statement about medical cannabis use in critically ill patients. Twenty-five viewpoints were selected for the q-sample. In the second phase, 99 respondents ranked these viewpoints according to an a priori quasi normal distribution ranging from +4 (most agree) to -4 (least agree). Factor analysis was combined with comments provided by survey respondents to label and describe the extracted factors. Results The factor labels were hoping and caring (factor 1), pragmatic progress (factor 2), and cautious/conservative and protectionist (factor 3). Factor 1 describes a viewpoint of unequivocal support for medical cannabis research in this population with few caveats. Factor 2 describes a viewpoint of cautious support with a need to monitor for unintended adverse effects. Factor 3 describes a viewpoint of ensuring that current analgosedation techniques are optimized before exposing patients to another potentially harmful drug. Conclusions Using a q-methodology design, we were able to sample and describe the viewpoints that exist about medical cannabis research in critically ill patients. Three factors emerged that seemed to adequately describe the relative ranking of q-statements by the majority of respondents. Combining the distinguishing statements along with respondent comments allowed us to determine that the majority support medical cannabis research in critically ill patients.	[DiDiodato, Giulio] McMaster Univ, Med Ctr, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [DiDiodato, Giulio] Royal Victoria Reg Hlth Ctr, Ctr Educ & Res, Barrie, ON, Canada; [Hassan, Samah; Cooley, Kieran] Canadian Coll Naturopath Med, Toronto, ON, Canada; [Cooley, Kieran] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, Australia; [Cooley, Kieran] Pacific Coll Oriental Med, Chicago, IL USA	McMaster University; University of Technology Sydney	DiDiodato, G (corresponding author), McMaster Univ, Med Ctr, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; DiDiodato, G (corresponding author), Royal Victoria Reg Hlth Ctr, Ctr Educ & Res, Barrie, ON, Canada.	didiodatog@rvh.on.ca		DiDiodato, Giulio/0000-0003-2836-8037; Cooley, Kieran/0000-0001-7960-6504	Canopy Health Innovation; Royal Victoria Regional Health Centre Foundation	Canopy Health Innovation; Royal Victoria Regional Health Centre Foundation	This study was funded by Canopy Health Innovation in the form of an unrestricted educational grant awarded to GD, KC, and SH. In addition, the Royal Victoria Regional Health Centre Foundation provided funding to cover the publication costs associated with this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Royal Victoria Regional Health Centre Foundation for their support of the publication costs.	Akhtar-Danesh N, 2018, STATA J, V18, P432, DOI 10.1177/1536867X1801800209; Barnes MP, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3230; Brown S.R., 1993, OPERANT SUBJECTIVITY, V16, P91, DOI DOI 10.15133/J.OS.1993.002; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Dolgin E, 2018, NATURE, V555, P300, DOI 10.1038/d41586-018-03070-2; Freeman TP., 2019, BMJ-BRIT MED J, V1141, pL1141, DOI [10.1136/bmj.l1141, DOI 10.1136/BMJ.L1141]; Ibanez Borja, 2018, Eur Heart J, V39, P119, DOI 10.1093/eurheartj/ehx393; Karanges EA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022101; Keyhani S, 2018, ANN INTERN MED, V169, P282, DOI 10.7326/M18-0810; Ko GD, 2016, J PAIN RES, V9, P735, DOI 10.2147/JPR.S98182; Kross EK, 2019, JAMA-J AM MED ASSOC, V321, P649, DOI 10.1001/jama.2019.0072; Lotsch J, 2018, EUR J PAIN, V22, P471, DOI 10.1002/ejp.1148; Manuzak JA, 2018, CLIN INFECT DIS, V66, P1872, DOI 10.1093/cid/cix1116; Martyn JAJ, 2019, NEW ENGL J MED, V380, P365, DOI 10.1056/NEJMra1800222; Mayor S., 2019, BMJ-BRIT MED J, DOI [10.1136/bmj.l574, DOI 10.1136/BMJ.L574, DOI 10.1136/BMJ.1574]; Mouhamed Y, 2018, DRUG HEALTHC PATIENT, V10, P45, DOI 10.2147/DHPS.S158592; Pun BT, 2019, CRIT CARE MED, V47, P3, DOI 10.1097/CCM.0000000000003482; Ramlo S, 2015, SAGE HDB MIX METHODS, V2010, P505; ROOTMAN I, 1979, DRUG ALCOHOL DEPEN, V4, P425, DOI 10.1016/0376-8716(79)90075-9; Schmid AB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025530; Stenner P., 2016, DOING Q METHODOLOGY, V0887; Sznitman SR, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0082-x; Woodhams SG, 2017, NEUROPHARMACOLOGY, V124, P105, DOI 10.1016/j.neuropharm.2017.06.015	23	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248475	10.1371/journal.pone.0248475	http://dx.doi.org/10.1371/journal.pone.0248475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735318	Green Published, gold			2022-12-26	WOS:000631029700067
J	Perry, A; Loh, F; Adamo, L; Zhang, KW; Deych, E; Foraker, R; Mann, DL				Perry, Andrew; Loh, Francis; Adamo, Luigi; Zhang, Kathleen W.; Deych, Elena; Foraker, Randi; Mann, Douglas L.			Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR IMPLANTATION TRIAL; HEART-FAILURE; COMORBIDITIES; NORMALIZATION; OUTCOMES	Background Patients with heart failure (HF) with recovered ejection fraction (HFrecEF) are a recently identified cohort that are phenotypically and biologically different from HFrEF and HFpEF patients. Whether there are unique phenotypes among HFrecEF patients is not known. Methods We studied all patients at a large medical center, who had an improvement in LVEF from <= 35% to >= 50% (LVrecEF) between January 1, 2005 and December 31, 2013. We identified a set of 11 clinical variables and then performed unsupervised clustering analyses to identify unique clinical phenotypes among patients with LVrecEF, followed by a Kaplan-Meier analysis to identify differences in survival and the proportion of LVrecEF patients who maintained an LVEF >= 50% during the study period. Results We identified 889 patients with LVrecEF who clustered into 7 unique phenotypes ranging in size from 37 to 420 patients. Kaplan-Meier analysis demonstrated significant differences in mortality across clusters (logrank p<0.0001), with survival ranging from 14% to 87% at 1000 days, as well as significant differences in the proportion of LVrecEF patients who maintained an LVEF >= 50%. Conclusion There is significant clinical heterogeneity among patients with LVrecEF. Clinical outcomes are distinct across phenotype clusters as defined by clinical cardiac characteristics and co-morbidities. Clustering algorithms may identify patients who are at high risk for recurrent HF, and thus be useful for guiding treatment strategies for patients with LVrecEF.	[Perry, Andrew; Adamo, Luigi; Zhang, Kathleen W.; Deych, Elena; Mann, Douglas L.] Washington Univ, Cardiovasc Div, Dept Med, Sch Med, St Louis, MO 63110 USA; [Loh, Francis; Foraker, Randi] Washington Univ, Inst Informat, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Mann, DL (corresponding author), Washington Univ, Cardiovasc Div, Dept Med, Sch Med, St Louis, MO 63110 USA.	dmann@wustl.edu	Mann, Douglas Lowell/AAQ-3524-2021	Perry, Andrew S./0000-0003-3342-6158				Adamo L, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003788; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Basuray A, 2014, CIRCULATION, V129, P2380, DOI 10.1161/CIRCULATIONAHA.113.006855; Cioffi G, 2004, J CARD FAIL, V10, P250, DOI 10.1016/j.cardfail.2003.10.002; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Florea VG, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003123; Givertz Michael M, 2013, Curr Heart Fail Rep, V10, P321, DOI 10.1007/s11897-013-0157-5; Halliday BP, 2019, LANCET, V393, P61, DOI 10.1016/S0140-6736(18)32484-X; Hellawell JL, 2012, CARDIOVASC THER, V30, P172, DOI 10.1111/j.1755-5922.2010.00247.x; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kutyifa V, 2013, J AM COLL CARDIOL, V61, P936, DOI 10.1016/j.jacc.2012.11.051; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lupon J, 2018, J AM COLL CARDIOL, V72, P591, DOI 10.1016/j.jacc.2018.05.042; Lupon J, 2017, EUR J HEART FAIL, V19, P1615, DOI 10.1002/ejhf.824; Mann DL, 2012, J AM COLL CARDIOL, V60, P2465, DOI 10.1016/j.jacc.2012.06.062; Merlo M, 2015, J AM HEART ASSOC, V4, DOI [10.1161/JAHA.114.001504, 10.1161/JAHA.114.000570]; Park CS, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011077; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Ruwald MH, 2014, CIRCULATION, V130, P2278, DOI 10.1161/CIRCULATIONAHA.114.011283; Schiffer WB, 2020, J CARD FAIL, V26, pS48; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Stolfo D, 2015, AM J CARDIOL, V115, P1137, DOI 10.1016/j.amjcard.2015.01.549; Swat SA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009841; Thavendiranathan P, 2013, J AM COLL CARDIOL, V61, P77, DOI 10.1016/j.jacc.2012.09.035; Wilcox JE, 2020, J AM COLL CARDIOL, V76, P719, DOI 10.1016/j.jacc.2020.05.075; Wilcox JE, 2016, JAMA CARDIOL, V1, P507, DOI 10.1001/jamacardio.2016.1356; Zafrir B, 2018, EUR HEART J, V39, P4277, DOI 10.1093/eurheartj/ehy626	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248317	10.1371/journal.pone.0248317	http://dx.doi.org/10.1371/journal.pone.0248317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735249	gold, Green Published			2022-12-26	WOS:000631029700005
J	Yamanaka, Y; Yoshida, K				Yamanaka, Yoshikazu; Yoshida, Katsutoshi			Simple gravitational particle swarm algorithm for multimodal optimization problems	PLOS ONE			English	Article							OPTIMAL-DESIGN; ADAPTATION	In real world situations, decision makers prefer to have multiple optimal solutions before making a final decision. Aiming to help the decision makers even if they are non-experts in optimization algorithms, this study proposes a new and simple multimodal optimization (MMO) algorithm called the gravitational particle swarm algorithm (GPSA). Our GPSA is developed based on the concept of "particle clustering in the absence of clustering procedures". Specifically, it simply replaces the global feedback term in classical particle swarm optimization (PSO) with an inverse-square gravitational force term between the particles. The gravitational force mutually attracts and repels the particles, enabling them to autonomously and dynamically generate sub-swarms in the absence of algorithmic clustering procedures. Most of the sub-swarms gather at the nearby global optima, but a small number of particles reach the distant optima. The niching behavior of our GPSA was tested first on simple MMO problems, and then on twenty MMO benchmark functions. The performance indices (peak ratio and success rate) of our GPSA were compared with those of existing niching PSOs (ring-topology PSO and fitness Euclidean-distance ratio PSO). The basic performance of our GPSA was comparable to that of the existing methods. Furthermore, an improved GPSA with a dynamic parameter delivered significantly superior results to the existing methods on at least 60% of the tested benchmark functions.	[Yamanaka, Yoshikazu; Yoshida, Katsutoshi] Utsunomiya Univ, Dept Mech & Intelligent Engn, Utsunomiya, Tochigi, Japan	Utsunomiya University	Yamanaka, Y (corresponding author), Utsunomiya Univ, Dept Mech & Intelligent Engn, Utsunomiya, Tochigi, Japan.	yyamanaka@cc.utsunomiya-u.ac.jp		Yamanaka, Yoshikazu/0000-0003-2158-3244	Japan Society for the Promotion of Science, KAKENHI [JP17H06552]; KAKENHI [JP18H01391]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, https://www.jsps.go.jp, KAKENHI Grant Numbers JP17H06552 to YY; and KAKENHI Grant Numbers JP18H01391 to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrari A, 2017, 2017014 COIN; Ahrari A, 2017, EVOL COMPUT, V25, P439, DOI [10.1162/evco_a_00182, 10.1162/EVCO_a_00182]; Beasley D, 1993, EVOL COMPUT, V1, P101, DOI 10.1162/evco.1993.1.2.101; Blackwell T, 2006, IEEE T EVOLUT COMPUT, V10, P459, DOI 10.1109/TEVC.2005.857074; Blackwell TM, 2002, P GEN EV COMP C, P19; Chatterjee A, 2006, COMPUT OPER RES, V33, P859, DOI 10.1016/j.cor.2004.08.012; Cho DH, 2001, IEEE T IND APPL, V37, P994, DOI 10.1109/28.936389; Dai HL, 2016, WATER SCI TECHNOL, V73, P223, DOI 10.2166/wst.2015.489; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; Fieldsend JE, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2593, DOI 10.1109/CEC.2014.6900309; Gholami M, 2016, COMPOS STRUCT, V139, P254, DOI 10.1016/j.compstruct.2015.12.019; Gong YJ, 2018, IEEE T NEUR NET LEAR, V29, P2944, DOI 10.1109/TNNLS.2017.2708712; Harik G., 1995, P 6 INT C GENETIC AL, P24; Jong D., 1975, ANAL BEHAV CLASS GEN; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kronfeld M., 2009, P GERM C BIO HALL GE, P191; Li JP, 2002, EVOL COMPUT, V10, P207, DOI 10.1162/106365602760234081; Li X, 2013, BENCHMARK FUNCTIONS, DOI DOI 10.1016/j.gene.2013.03.114; Li XD, 2004, LECT NOTES COMPUT SC, V3102, P105; Li XD, 2017, IEEE T EVOLUT COMPUT, V21, P518, DOI 10.1109/TEVC.2016.2638437; Li XD, 2010, IEEE T EVOLUT COMPUT, V14, P150, DOI 10.1109/TEVC.2009.2026270; Li XD, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P78; Liao JX, 2012, KSII T INTERNET INF, V6, P1106, DOI 10.3837/tiis.2012.04.009; Luh GC, 2011, COMPUT STRUCT, V89, P2221, DOI 10.1016/j.compstruc.2011.08.013; Ma DX, 2015, ASIAN J CONTROL, V17, P1435, DOI 10.1002/asjc.1050; MAHFOUD SW, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P27; Maree SC, 2018, GECCO'18: PROCEEDINGS OF THE 2018 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P857, DOI 10.1145/3205455.3205477; Maree SC, 2019, BENCHMARKING HILL VA; Mehmood S, 2015, J REAL-TIME IMAGE PR, V10, P75, DOI 10.1007/s11554-012-0256-7; Qu BY, 2013, IEEE T EVOLUT COMPUT, V17, P387, DOI 10.1109/TEVC.2012.2203138; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Sareni B., 1998, IEEE Transactions on Evolutionary Computation, V2, P97, DOI 10.1109/4235.735432; Shi Y., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1945, DOI 10.1109/CEC.1999.785511; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sun C, 2007, IEEE INT C NETW SENS, P368, DOI 10.1109/ICNSC.2007.372807; WARD A, 1995, SLOAN MANAGE REV, V36, P43; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xiaodong Yin, 1993, Artificial Neural Nets and Genetic Algorithms. Proceedings of the International Conference, P450; Zhang JH, 2014, NEUROCOMPUTING, V123, P308, DOI 10.1016/j.neucom.2013.07.025	43	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248470	10.1371/journal.pone.0248470	http://dx.doi.org/10.1371/journal.pone.0248470			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735313	gold, Green Published			2022-12-26	WOS:000631029700077
J	Haanes, H; Gjelsvik, R				Haanes, Hallvard; Gjelsvik, Runhild			Reduced soil fauna decomposition in a high background radiation area	PLOS ONE			English	Article							PLANT LITTER DECOMPOSITION; ECOSYSTEM SERVICES; FEN COMPLEX; MASS-LOSS; TERRESTRIAL; RADIONUCLIDES; RICH; BIODIVERSITY; IMPACT; RATES	Decomposition of litter and organic matter is a very important soil ecosystem function where soil fauna play an important role. Knowledge of the responses in decomposition and soil fauna to different stressors is therefore crucial. However, the extent to which radioactivity may affect soil fauna is not so well known. There are some results showing effects on soil fauna at uranium mines and near Chernobyl from relatively high levels of anthropogenic radionuclides. We hypothesize that naturally occurring radionuclides affect soil fauna and thus litter decomposition, which will covary with radionuclide levels when accounting for important soil parameters. We have therefore used standardised litterbags with two different mesh sizes filled with birch leaves (Betula pubescens) to assess litter decomposition in an area with enhanced levels of naturally occurring radionuclides in the thorium (Th-232) and uranium (U-238) decay chains while controlling for variation in important soil parameters like pH, organic matter content, moisture and large grain size. We show that decomposition rate is higher in litterbags with large mesh size compared to litterbags with a fine mesh size that excludes soil fauna. We also find that litter dried at room temperature is decomposed at a faster rate than litter dried in oven (60 degrees C). This was surprising given the associated denaturation of proteins and anticipated increased nutritional level but may be explained by the increased stiffness of oven-dried litter. This result is important since different studies often use either oven-dried or room temperature-dried litter. Taking the above into account, we explore statistical models to show large and expected effects of soil parameters but also significant effects on litter decomposition of the naturally occurring radionuclide levels. We use the ERICA tool to estimate total dose rate per coarse litterbag for four different model organisms, and in subsequent different statistical models we identify that the model including the dose rates of a small tube-shape is the best statistical model. In another statistical model including soil parameters and radionuclide distributions, Ra-226 (or uranium precursory radionuclides) explain variation in litter decomposition while Ra-228 (and precursors) do not. This may hint to chemical toxicity effects of uranium. However, when combining this model with the best model, the resulting simplified model is equal to the tube-shape dose-rate model. There is thus a need for more research on how naturally occurring radionuclides affect soil fauna, but the study at hand show the importance of an ecosystem approach and the ecosystem parameter soil decomposition.	[Haanes, Hallvard; Gjelsvik, Runhild] Norwegian Radiat & Nucl Safety Author, Osteras, Norway; [Haanes, Hallvard; Gjelsvik, Runhild] NMBU, Ctr Environm Radioact CERAD CoE, As, Norway	Norwegian University of Life Sciences	Haanes, H (corresponding author), Norwegian Radiat & Nucl Safety Author, Osteras, Norway.; Haanes, H (corresponding author), NMBU, Ctr Environm Radioact CERAD CoE, As, Norway.	Hallvard.Haanes@dsa.no		Haanes, Hallvard/0000-0001-8820-7839	Research Council of Norway through its Centres of Excellence funding scheme [223268/F50]	Research Council of Norway through its Centres of Excellence funding scheme	This work was supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223268/F50. This was received by HH and RG at Norwegian Radiation and Nuclear Safety Authority (DSA) thorough the Centre for Environmental Radioactivity, CERAD, Centre of Excellence CoE (https://www.nmbu.no/en/services/centers/cerad).	ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; Andre A, 2009, ENVIRON POLLUT, V157, P2368, DOI 10.1016/j.envpol.2009.03.023; [Anonymous], 1997, USE SOIL MICROCOSMS; [Anonymous], 2021, LANG ENV STAT COMP; Antunes SC, 2011, SCI TOTAL ENVIRON, V410, P87, DOI 10.1016/j.scitotenv.2011.09.003; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1007, DOI 10.1016/S0038-0717(99)00014-0; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Begon M., 1996, ECOLOGY INDIVIDUALS, P1065; Bezuidenhout J, 2020, J APPL GEOPHYS, V181, DOI 10.1016/j.jappgeo.2020.104135; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V58, P147, DOI 10.1016/j.soilbio.2012.12.001; Bonzom JM, 2016, SCI TOTAL ENVIRON, V562, P596, DOI 10.1016/j.scitotenv.2016.04.006; Brechignac F., 2012, ECOSYSTEM APPROACH E; Briones MJI, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00007; Brown JE, 2008, J ENVIRON RADIOACTIV, V99, P1371, DOI 10.1016/j.jenvrad.2008.01.008; Brown JE, 2016, J ENVIRON RADIOACTIV, V153, P141, DOI 10.1016/j.jenvrad.2015.12.011; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burrows LA, 2002, EUR J SOIL BIOL, V38, P245, DOI 10.1016/S1164-5563(02)01153-6; Cagno S, 2020, J ENVIRON RADIOACTIV, V219, DOI 10.1016/j.jenvrad.2020.106273; Carcamo HA, 2001, CAN J FOREST RES, V31, P1195, DOI 10.1139/cjfr-31-7-1195; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Cragg RG, 2001, SOIL BIOL BIOCHEM, V33, P2073, DOI 10.1016/S0038-0717(01)00138-9; De Deyn GB, 2005, TRENDS ECOL EVOL, V20, P625, DOI 10.1016/j.tree.2005.08.009; de Vries FT, 2013, P NATL ACAD SCI USA, V110, P14296, DOI 10.1073/pnas.1305198110; Dorsey A, 2004, US DEP HEAL HUM SERV; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Forster B, 2006, EUR J SOIL BIOL, V42, pS171, DOI 10.1016/j.ejsobi.2006.07.011; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Freitas AC, 2014, ARCH ENVIRON CON TOX, V67, P601, DOI 10.1007/s00244-014-0035-5; Frouz J, 2018, GEODERMA, V332, P161, DOI 10.1016/j.geoderma.2017.08.039; Frouz J, 2015, EUR J SOIL BIOL, V68, P18, DOI 10.1016/j.ejsobi.2015.03.002; Fu H, 2010, BIORESOURCE TECHNOL, V101, P2034, DOI 10.1016/j.biortech.2009.10.045; GALE H. J., 1967, ANN OCCUP HYG, V10, P39; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Haanes H, 2018, ATMOS POLLUT RES, V9, P1000, DOI 10.1016/j.apr.2018.03.007; Haanes H, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2019.134485; Haanes H, 2019, RADIAT RES, V192, P431, DOI 10.1667/RR15403.1; Haanes H, 2016, J ENVIRON RADIOACTIV, V162, P23, DOI 10.1016/j.jenvrad.2016.05.005; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hegyi G, 2015, ANN ZOOL FENN, V52, P257, DOI 10.5735/086.052.0502; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huhta V, 2007, PEDOBIOLOGIA, V50, P489, DOI 10.1016/j.pedobi.2006.08.006; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; International Atomic Energy Agency, 2014, TECHNICAL REPORTS SE, V476; Kampichler C, 2009, BIOL REV, V84, P375, DOI 10.1111/j.1469-185X.2009.00078.x; Keith LS, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P881, DOI 10.1016/B978-012369413-3/50100-2; Keith S, 2013, TOXICOLOGICAL PROFIL; Keitt T., 2019, **DATA OBJECT**; Koch-Steindl H, 2001, RADIAT ENVIRON BIOPH, V40, P93, DOI 10.1007/s004110100098; Lai JL, 2016, J ENVIRON RADIOACTIV, V160, P93, DOI 10.1016/j.jenvrad.2016.04.023; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lavelle P., 1995, Plant-soil interactions at low pH: principles and management. Proceedings of the Third International Symposium, Brisbane, Queensland, Australia, 12-16 September 1993., P201; Lourenco J, 2012, ECOTOX ENVIRON SAFE, V75, P46, DOI 10.1016/j.ecoenv.2011.08.024; Menta C., 2012, SOIL FAUNA DIVERSITY; Moody SA, 2001, PLANT ECOL, V154, P27, DOI 10.1023/A:1012965610170; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; NIELSEN GERALD A., 1964, SOIL SCI SOC AMER PROC, V28, P426; Ohtsuka Y, 2015, J RADIOANAL NUCL CH, V303, P1441, DOI 10.1007/s10967-014-3498-y; PARMELEE RW, 1993, ENVIRON TOXICOL CHEM, V12, P1477, DOI 10.1002/etc.5620120815; PATHAK JP, 1978, J SCI FOOD AGR, V29, P835, DOI 10.1002/jsfa.2740291002; Pebesma E.J., 2005, R NEWS, V5; Peng Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124605; Pokarzhevskii AD, 1997, BIOGEOCHEMISTRY, V39, P1, DOI 10.1023/A:1005857427940; Popic JM, 2014, ENVIRON SCI-PROC IMP, V16, P1124, DOI 10.1039/c3em00569k; Popic JM, 2012, SCI TOTAL ENVIRON, V414, P167, DOI 10.1016/j.scitotenv.2011.10.064; Popic JM, 2012, J ENVIRON MONITOR, V14, P193, DOI 10.1039/c1em10726g; Popic JM, 2011, J ENVIRON MONITOR, V13, P1730, DOI 10.1039/c1em10107b; SETALA H, 1991, ECOLOGY, V72, P665, DOI 10.2307/2937206; SETALA H, 1995, ECOLOGY, V76, P1844, DOI 10.2307/1940716; SETALA H, 1990, BIOL FERT SOILS, V10, P163; Setala Heikki, 2005, P236, DOI 10.1017/CBO9780511541926.014; SIMON SL, 1987, J ENVIRON RADIOACTIV, V5, P123, DOI 10.1016/0265-931X(87)90028-2; STRANDEN E, 1985, HEALTH PHYS, V48, P415, DOI 10.1097/00004032-198504000-00003; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tormala T., 1979, AGR FOOD SCI, V51; Ulanovsky A, 2008, J ENVIRON RADIOACTIV, V99, P1440, DOI 10.1016/j.jenvrad.2008.01.010; Van den Brink PJ, 2005, ENVIRON TOXICOL CHEM, V24, P820, DOI 10.1897/04-268R.1; Vandenhove H, 2009, J ENVIRON RADIOACTIV, V100, P697, DOI 10.1016/j.jenvrad.2009.03.014; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Williams M., 2004, TOXICOLOGICAL PROFIL; Zaitsev AS, 2014, PEDOBIOLOGIA, V57, P5, DOI 10.1016/j.pedobi.2013.09.005; Zhang WD, 2015, SOIL BIOL BIOCHEM, V82, P81, DOI 10.1016/j.soilbio.2014.12.016	86	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247793	10.1371/journal.pone.0247793	http://dx.doi.org/10.1371/journal.pone.0247793			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730078	gold, Green Published			2022-12-26	WOS:000630345000024
J	Hovnanian, ALD; Costa, ELV; Hoette, S; Fernandes, CJCS; Jardim, CVP; Dias, BA; Morinaga, LTK; Amato, MBP; Souza, R				Hovnanian, Andre L. D.; Costa, Eduardo L., V; Hoette, Susana; Fernandes, Caio J. C. S.; Jardim, Carlos V. P.; Dias, Bruno A.; Morinaga, Luciana T. K.; Amato, Marcelo B. P.; Souza, Rogerio			Electrical impedance tomography in pulmonary arterial hypertension	PLOS ONE			English	Article								The characterization of pulmonary arterial hypertension (PAH) relies mainly on right heart catheterization (RHC). Electrical impedance tomography (EIT) provides a non-invasive estimation of lung perfusion that could complement the hemodynamic information from RHC. To assess the association between impedance variation of lung perfusion (Delta Z(Q)) and hemodynamic profile, severity, and prognosis, suspected of PAH or worsening PAH patients were submitted simultaneously to RHC and EIT. Measurements of Delta Z(Q) were obtained. Based on the results of the RHC, 35 patients composed the PAH group, and eight patients, the normopressoric (NP) group. PAH patients showed a significantly reduced Delta Z(Q) compared to the NP group. There was a significant correlation between Delta Z(Q) and hemodynamic parameters, particularly with stroke volume (SV) (r = 0.76; P < 0.001). At 60 months, 15 patients died (43%) and 1 received lung transplantation; at baseline they had worse hemodynamics, and reduced Delta Z(Q) when compared to survivors. Patients with low Delta Z(Q) (<= 154.6%.Kg) presented significantly worse survival (P = 0.033). Delta Z(Q) is associated with hemodynamic status of PAH patients, with disease severity and survival, demonstrating EIT as a promising tool for monitoring patients with pulmonary vascular disease.	[Hovnanian, Andre L. D.; Costa, Eduardo L., V; Hoette, Susana; Fernandes, Caio J. C. S.; Jardim, Carlos V. P.; Dias, Bruno A.; Morinaga, Luciana T. K.; Amato, Marcelo B. P.; Souza, Rogerio] Univ Sao Paulo, Hosp Clin, Heart Inst, Pulm Div, Sao Paulo, Brazil	Universidade de Sao Paulo	Hovnanian, ALD (corresponding author), Univ Sao Paulo, Hosp Clin, Heart Inst, Pulm Div, Sao Paulo, Brazil.	ahovnanian@yahoo.com.br	Souza, Rogerio/I-3584-2013	Souza, Rogerio/0000-0003-2789-9143; HOVNANIAN, ANDRE/0000-0003-2924-3818	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). http://www.fapesp.br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JL, 2015, CHEST, V147, P495, DOI 10.1378/chest.14-1036; Bachmann MC, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2195-6; Borges JB, 2012, J APPL PHYSIOL, V112, P225, DOI 10.1152/japplphysiol.01090.2010; Boucly A, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00279-2018; Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017; Braun F, 2020, J CLIN MONIT COMPUT, V34, P903, DOI 10.1007/s10877-019-00402-z; Braun F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191870; Costa ELV, 2005, VASC PHARMACOL, V43, P143, DOI 10.1016/j.vph.2005.05.004; Costa ELV., 2013, CLIN PULM MED, V20, P178; Ramos FJD, 2018, ANESTH ANALG, V126, P102, DOI 10.1213/ANE.0000000000002271; Delcroix M, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00248-2018; Eyuboglu B M, 1987, Clin Phys Physiol Meas, V8 Suppl A, P167, DOI 10.1088/0143-0815/8/4A/021; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Frerichs I, 2007, PHYSIOL MEAS, V28, pS261, DOI 10.1088/0967-3334/28/7/S19; Frost AE, 2011, CHEST, V139, P128, DOI 10.1378/chest.10-0075; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gavilanes F, 2014, J BRAS PNEUMOL, V40, P609, DOI 10.1590/S1806-37132014000600004; Hellige G, 2011, CRIT CARE, V15, DOI 10.1186/cc10231; Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 2011, CHEST, V139, P1263, DOI 10.1378/chest.10-2868; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Proenca M, 2014, IEEE T BIOMED CIRCUI, V8, P605; Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x; Smit HJ, 2006, RESPIRATION, V73, P597, DOI 10.1159/000088694; Smit HJ, 2004, EUR J APPL PHYSIOL, V92, P45, DOI 10.1007/s00421-004-1043-3; Smit HJ, 2002, PHYSIOL MEAS, V23, P237, DOI 10.1088/0967-3334/23/1/324; Tanaka H, 2008, CLINICS, V63, P363, DOI 10.1590/S1807-59322008000300013; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Vonk-Noordegraaf A, 2012, AM J CARDIOL, V110, p25S, DOI 10.1016/j.amjcard.2012.06.013; Weatherald J, 2018, CIRCULATION, V137, P693, DOI 10.1161/CIRCULATIONAHA.117.029254; Whyte K, 2012, EUR RESPIR J, V39, P313, DOI 10.1183/09031936.00019911	33	3	3	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248214	10.1371/journal.pone.0248214	http://dx.doi.org/10.1371/journal.pone.0248214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730110	Green Published, gold			2022-12-26	WOS:000630345000052
J	Vicens, P; Heredia, L; Bustamante, E; Perez, Y; Domingo, JL; Torrente, M				Vicens, Paloma; Heredia, Luis; Bustamante, Edgar; Perez, Yolanda; Domingo, Jose L.; Torrente, Margarita			Does living close to a petrochemical complex increase the adverse psychological effects of the COVID-19 lockdown?	PLOS ONE			English	Article							AIR-POLLUTION; STRESS; HEALTH; IMPULSIVITY; ANXIETY; ASSOCIATION; ADAPTATION; CHILDREN; INDUSTRY; IMPACT	The petrochemical industry has made the economic development of many local communities possible, increasing employment opportunities and generating a complex network of closely-related secondary industries. However, it is known that petrochemical industries emit air pollutants, which have been related to different negative effects on mental health. In addition, many people around the world are being exposed to highly stressful situations deriving from the COVID-19 pandemic and the lockdowns adopted by national and regional governments. The present study aims to analyse the possible differential effects on various psychological outcomes (stress, anxiety, depression and emotional regulation strategies) stemming from the COVID-19 pandemic and consequent lockdown experienced by individuals living near an important petrochemical complex and subjects living in other areas, nonexposed to the characteristic environmental pollutants emitted by these kinds of complex. The sample consisted of 1607 subjects who answered an ad hoc questionnaire on lockdown conditions, the Perceived Stress Scale (PSS), the Hospital Anxiety and Depression Scale (HADS), the Barratt Impulsivity Scale (BIS) and the Emotional Regulation Questionnaire (ERQ). The results indicate that people living closer to petrochemical complexes reported greater risk perception [K = 73.42, p < 0.001, with a medium size effect (eta(2) = 0.061)]. However, no significant relationship between psychological variables and proximity to the focus was detected when comparing people living near to or far away from a chemical/petrochemical complex. Regarding the adverse psychological effects of the first lockdown due to COVID-19 on the general population in Catalonia, we can conclude that the conditions included in this survey were mainly related to changes in the participants' impulsivity levels, with different total impulsivity scores being obtained if they had minors in their care (p<0.001), if they had lost their jobs, if they were working (p<0.001), if they were not telecommuting (p<0.001), if they went out to work (p<0.001) or if they established routines (p = 0.009). However, we can also be fairly certain that the economic effects are going to be worse than those initially detected in this study. More research will be necessary to corroborate our results.	[Vicens, Paloma; Heredia, Luis; Torrente, Margarita] Univ Rovira & Virgili, CRAMC Res Ctr Behav Assessment, Dept Psychol, Tarragona, Spain; [Vicens, Paloma; Heredia, Luis; Domingo, Jose L.; Torrente, Margarita] Univ Rovira & Virgili, Sch Med, Lab Toxicol & Environm Hlth, TECNATOX, Reus, Spain; [Bustamante, Edgar; Perez, Yolanda] Univ Rovira & Virgili, Dept Geog, GRATET, Vila Seca, Spain; [Torrente, Margarita] Univ Rovira & Virgili, Dept Psychol, Campus Sescelades, Tarragona, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Universitat Rovira i Virgili	Torrente, M (corresponding author), Univ Rovira & Virgili, CRAMC Res Ctr Behav Assessment, Dept Psychol, Tarragona, Spain.; Torrente, M (corresponding author), Univ Rovira & Virgili, Sch Med, Lab Toxicol & Environm Hlth, TECNATOX, Reus, Spain.; Torrente, M (corresponding author), Univ Rovira & Virgili, Dept Psychol, Campus Sescelades, Tarragona, Spain.	margarita.torrente@urv.cat	Vicens, Paloma/T-5194-2017; Domingo, Jose L/E-8327-2014; Heredia, Luis/C-3610-2019	Vicens, Paloma/0000-0003-0732-5070; Heredia, Luis/0000-0001-9330-9418; Bustamante Picon, Edgar/0000-0002-2905-8324; Torrente, Margarita/0000-0002-8901-6345				Adamkiewicz G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-73; Adler LA, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1555; Aungudornpukdee Piraya, 2010, Journal of the Medical Association of Thailand, V93, P285; Auxemery Y, 2018, ENCEPHALE, V44, P403, DOI 10.1016/j.encep.2018.02.003; Axelsson G, 2013, INT J ENV RES PUB HE, V10, P1418, DOI 10.3390/ijerph10041418; BARRATT ES, 1987, J RES PERS, V21, P453, DOI 10.1016/0092-6566(87)90032-8; Bergmann S, 2020, SCI TOTAL ENVIRON, V716, DOI 10.1016/j.scitotenv.2020.136985; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Broitman D, 2020, ENVIRON RES, V182, DOI 10.1016/j.envres.2019.109088; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bueno-Notivol J, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2020.07.007; Burby RJ, 1999, J PLAN EDUC RES, V19, P15, DOI 10.1177/0739456X9901900102; Burningham K, 2004, J RISK RES, V7, P213, DOI 10.1080/1366987042000158721; Cabello R, 2013, EUR J PSYCHOL ASSESS, V29, P234, DOI 10.1027/1015-5759/a000150; Calderon-Garciduenas L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00613; Chen PC, 1998, ENVIRON HEALTH PERSP, V106, P331, DOI 10.2307/3434039; Chiang TY, 2016, ENVIRON INT, V96, P1, DOI 10.1016/j.envint.2016.08.009; Coban A, 2020, NOROPSIKIYATRI ARS, V57, P37, DOI 10.29399/npa.23654; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2016, PERSPECT PSYCHOL SCI, V11, P456, DOI 10.1177/1745691616646305; Dalley JW, 2017, NAT REV NEUROSCI, V18, P158, DOI 10.1038/nrn.2017.8; Domingo JL, 2020, ENVIRON RES, V186, DOI 10.1016/j.envres.2020.109495; Frydman I, 2020, COMPR PSYCHIAT, V97, DOI 10.1016/j.comppsych.2019.152155; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; HALLMAN WK, 1992, J SOC ISSUES, V48, P101, DOI 10.1111/j.1540-4560.1992.tb01947.x; Hauptman M, 2020, J ALLERGY CLIN IMMUN, V145, P119, DOI 10.1016/j.jaci.2019.08.038; Jephcote C, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.05.006; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lisboa L, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00023515; Luginaah IN, 2002, HEALTH PLACE, V8, P177, DOI 10.1016/S1353-8292(01)00041-7; Margo-Dermer E, 2019, PUBLIC HEALTH, V172, P1, DOI 10.1016/j.puhe.2019.03.024; Marques M, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.139122; McEwen BS, 2020, J NEUROSCI, V40, P12, DOI 10.1523/JNEUROSCI.0733-19.2019; Morales-Vives F, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565634; Nadal M, 2009, ENVIRON INT, V35, P227, DOI 10.1016/j.envint.2008.06.001; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Onur OS, 2016, INT J PSYCHIAT CLIN, V20, P218, DOI 10.1080/13651501.2016.1220580; Oquendo MA, 2001, EUR J PSYCHIAT, V15, P147; Peek MK, 2008, J EPIDEMIOL COMMUN H, V62, P106, DOI 10.1136/jech.2006.049858; Peek MK, 2009, J EPIDEMIOL COMMUN H, V63, P792, DOI 10.1136/jech.2008.079806; Peters A, 2017, PROG NEUROBIOL, V156, P164, DOI 10.1016/j.pneurobio.2017.05.004; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Restubog SLD, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103440; Reynolds BW, 2019, NEUROPSYCHOLOGY, V33, P212, DOI 10.1037/neu0000510; Samson, 2015, OPEN J STAT, V5, P754, DOI DOI 10.4236/OJS.2015.57075; Shing EZ, 2016, J CLIN PSYCHOL, V72, P1287, DOI 10.1002/jclp.22327; Sluis RA, 2017, J BEHAV THER EXP PSY, V57, P172, DOI 10.1016/j.jbtep.2017.05.009; Terol MC., 2007, ANSIEDAD ESTRES, V13, P163; THONGTIP S, 2019, ENVIRONMENTASIA, V12, P140, DOI DOI 10.14456/ea.2019.54; Thongtip S, 2020, SAINS MALAYS, V49, P573, DOI 10.17576/jsm-2020-4903-12; Verhaegh BPM, 2019, ENVIRON RES, V178, DOI 10.1016/j.envres.2019.108710; Vichit-Vadakan N, 2011, EPIDEMIOLOGY, V22, pS194, DOI 10.1097/01.ede.0000392276.19875.12; Wong QJJ, 2019, BEHAV THER, V50, P571, DOI 10.1016/j.beth.2018.09.004; Yang CY, 2002, ARCH ENVIRON HEALTH, V57, P461, DOI 10.1080/00039890209601438; Yaribeygi H, 2017, EXCLI J, V16, P1057, DOI 10.17179/excli2017-480; Zaccarelli-Marino MA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183464; Zhang M, 2013, J OCCUP ENVIRON MED, V55, P1001, DOI 10.1097/JOM.0b013e31829f3142; Zheng H, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.135505; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0249058	10.1371/journal.pone.0249058	http://dx.doi.org/10.1371/journal.pone.0249058			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730077	Green Submitted, Green Published, gold			2022-12-26	WOS:000630345000026
J	Walker, R; Eriksson, A; Ruiz, C; Newton, TH; Casalegno, F				Walker, Richard; Eriksson, Anders; Ruiz, Camille; Newton, Taylor Howard; Casalegno, Francesco			Stabilization of cultural innovations depends on population density: Testing an epidemiological model of cultural evolution against a global dataset of rock art sites and climate-based estimates of ancient population densities	PLOS ONE			English	Article							DEMOGRAPHY; REVOLUTION; EMERGENCE; SIZE	Demographic models of human cultural evolution have high explanatory potential but weak empirical support. Here we use a global dataset of rock art sites and climate and genetics-based estimates of ancient population densities to test a new model based on epidemiological principles. The model focuses on the process whereby a cultural innovation becomes endemic in a population, predicting that this cannot occur unless population density exceeds a critical threshold. Analysis of the data, using a Bayesian statistical framework, shows that the model has stronger empirical support than a proportional model, where detection is directly proportional to population density, or a null model, where rock art detection ratios and population density are independent. Results for different geographical areas and periods are compatible with the predictions of the model and confirm its superiority with respect to the null model. Re-analysis of the rock art data, using a second set of independent population estimates, again supports the superiority of the model. Although the available data is sparse and the analysis cannot exclude all possible sources of bias, this is evidence that population density above a critical threshold may be a necessary condition for the maintenance of rock art as a stable part of a population's cultural repertoire. Methods similar to those described can be used to test the model for other classes of archaeological artifact and to compare it against other models.	[Walker, Richard; Newton, Taylor Howard; Casalegno, Francesco] Ecole Polytech Fed Lausanne, Blue Brain Project, Lausanne, Switzerland; [Eriksson, Anders] Univ Tartu, Inst Genom cGEM, Tartu, Estonia; [Ruiz, Camille] Ateneo Manila Univ, Manila, Philippines	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tartu; Ateneo de Manila University	Walker, R (corresponding author), Ecole Polytech Fed Lausanne, Blue Brain Project, Lausanne, Switzerland.; Eriksson, A (corresponding author), Univ Tartu, Inst Genom cGEM, Tartu, Estonia.	Richard.Walker@epfl.ch; Anders.Eriksson@ut.ee		Ruiz, Camille Marie/0000-0002-4443-3313				Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; BEDNARIK RG, 1994, J WORLD PREHIST, V8, P351, DOI 10.1007/BF02221090; Buchanan B, 2016, ARCHAEOL ANTHROP SCI, V8, P625, DOI 10.1007/s12520-015-0245-4; Collard M., 2005, CAN J ARCHAEOL J CAN, V29, P1; Collard M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0242; Collard M, 2013, CURR ANTHROPOL, V54, pS388, DOI 10.1086/673881; Collard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072628; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Galway-Witham J, 2019, J QUATERNARY SCI, V34, P355, DOI 10.1002/jqs.3137; Grove M, 2016, J ARCHAEOL SCI, V74, P75, DOI 10.1016/j.jas.2016.09.002; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2016, P NATL ACAD SCI USA, V113, pE6724, DOI 10.1073/pnas.1610005113; Hethcote W.W., 1989, Biomathematics (Berlin), V18, P119; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; KLEIN RG, 1995, J WORLD PREHIST, V9, P167, DOI 10.1007/BF02221838; Klein RG, 2001, J ANTHROPOL RES, V57, P1; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Laland KN., 2018, DARWINS UNFINISHED S; Lycett SJ, 2010, QUATERN INT, V211, P55, DOI 10.1016/j.quaint.2008.12.001; Mary-Rousseliere G., 1980, QITDLARSSUAQ HIST MI; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Oswalt WH., 1976, ANTHROPOLOGICAL ANAL; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Premo LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015582; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Rasmussen K., 2010, PEOPLE POLAR N RECOR; Read D., 2012, UCLA HUM COMPLEX SYS, V2012; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; SATTENSPIEL L, 1987, HUM BIOL, V59, P411; Scerri EML, 2018, TRENDS ECOL EVOL, V33, P582, DOI 10.1016/j.tree.2018.05.005; Sean Ulm., AUSTARCH DATABASE 14; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Shennan S., 2015, EMERGING TRENDS SOCI; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Tomasello M., 2009, CULTURAL ORIGINS HUM; Vaesen K, 2016, P NATL ACAD SCI USA, V113, pE2241, DOI 10.1073/pnas.1520288113; Zwiefelhofer D., FINDLATITUDE LONGITU	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247973	10.1371/journal.pone.0247973	http://dx.doi.org/10.1371/journal.pone.0247973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730059	Green Published, gold			2022-12-26	WOS:000630345000071
J	Yakubu, UM; Morano, KA				Yakubu, Unekwu M.; Morano, Kevin A.			Suppression of aggregate and amyloid formation by a novel intrinsically disordered region in metazoan Hsp110 chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; SUBSTRATE-BINDING; DISTINCT; STRESS; DISAGGREGATION; PROTEOSTASIS; HUNTINGTIN	Molecular chaperones maintain proteostasis by ensuring the proper folding of polypeptides. Loss of proteostasis has been linked to numerous neurodegenerative disorders including Alzheimer's, Parkinson's, and Huntington's disease. Hsp110 is related to the canonical Hsp70 class of protein-folding molecular chaperones and interacts with Hsp70 as a nucleotide exchange factor (NEF). In addition to its NEF activity, Hsp110 possesses an Hsp70-like substrate-binding domain (SBD) whose biological roles remain undefined. Previous work in Drosophila melanogaster has implicated the sole Hsp110 gene (Hsc70cb) in proteinopathic neurodegeneration. We hypothesize that in addition to its role as an Hsp70 NEF, Drosophila Hsp110 may function as a protective protein "holdase," preventing the aggregation of unfolded polypeptides via the SBD-beta subdomain. We demonstrate for the first time that Drosophila Hsp110 effectively prevents aggregation of the model substrate citrate synthase. We also report the discovery of a redundant and heretofore unknown potent holdase capacity in a 138-aminoacid region of Hsp110 carboxyl terminal to both SBD-beta and SBD-alpha (henceforth called the C-terminal extension). This sequence is highly conserved in metazoan Hsp110 genes, completely absent from fungal representatives, and is computationally predicted to contain an intrinsically disordered region (IDR). We demonstrate that this IDR sequence within the human Hsp110s, Apg-1 and Hsp105 alpha, inhibits the formation of amyloid A beta-42 and alpha-synuclein fibrils in vitro but cannot mediate fibril disassembly. Together these findings establish capacity for metazoan Hsp110 chaperones to suppress both general protein aggregation and amyloidogenesis, raising the possibility of exploitation of this IDR for therapeutic benefit.	[Yakubu, Unekwu M.; Morano, Kevin A.] McGovern Med Sch UTHlth, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Yakubu, Unekwu M.] MD Anderson UTHlth Grad Sch UTHlth, Houston, TX USA		Morano, KA (corresponding author), McGovern Med Sch UTHlth, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	kevin.a.morano@uth.tmc.edu		Yakubu, Unekwu/0000-0003-2230-0066	National Institutes of Health [R01GM127287, R21AG051046]; Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences	We thank Drs. Bo Hu, Pratick Khara, and Kohei Kishida (Department of Microbiology and Molecular Genetics, McGovern Medical School) for expert assistance with transmission electron microscopy image acquisition and interpretation. We thank Dr Sheng Zhang from the McGovern Medical School Institute of Molecular Medicine for providing the Hsc70cb expression plasmid and numerous stimulating discussions. This study was supported by the National Institutes of Health (R01GM127287 and R21AG051046) and the Russell and Diana Hawkins Family Foundation Discovery Fellowship from the MD Anderson UTHealth Graduate School of Biomedical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Boczek EE, 2018, J CELL BIOL, V217, P1173, DOI 10.1083/jcb.201803015; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Cox D, 2017, CELL STRESS CHAPERON, V22, P589, DOI 10.1007/s12192-017-0785-x; Davis AK, 2020, CELL MOL LIFE SCI, V77, P977, DOI 10.1007/s00018-019-03302-2; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Garcia VM, 2017, MOL BIOL CELL, V28, P2066, DOI 10.1091/mbc.E17-01-0070; Garcia VM, 2016, ANAL BIOCHEM, V508, P9, DOI 10.1016/j.ab.2016.05.016; Garvey M, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030067; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; McGurk L, 2015, GENETICS, V201, P377, DOI 10.1534/genetics.115.179457; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ota H, 2017, BIOCHEM BIOPH RES CO, V494, P602, DOI 10.1016/j.bbrc.2017.10.099; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Raju M, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201700095; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Scior A, 2018, EMBO J, V37, P282, DOI 10.15252/embj.201797212; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Song YY, 2013, P NATL ACAD SCI USA, V110, P5428, DOI 10.1073/pnas.1303279110; Taguchi YV, 2019, P NATL ACAD SCI USA, V116, P24310, DOI 10.1073/pnas.1903268116; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Trivedi R., 2019, SCI REP-UK, V9, P1; Tsai CJ, 2015, J BIOL CHEM, V290, P24816, DOI 10.1074/jbc.M115.678367; Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webster JM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01047; Wentink AS, 2020, NATURE, V587, P483, DOI 10.1038/s41586-020-2904-6; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yakubu UM, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200282; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	63	8	8	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100567	10.1016/j.jbc.2021.100567	http://dx.doi.org/10.1016/j.jbc.2021.100567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753171	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400540
J	Kim, BS; Jang, T; Yoo, SE; Lee, JM; Kim, E				Kim, Bok-Seok; Jang, Taeik; Yoo, Sung-Eun; Lee, Jae Moon; Kim, Eunhee			Fas-associated factor 1 induces the accumulation of alpha-synuclein through autophagic suppression in dopaminergic neurons	FASEB JOURNAL			English	Article						macroautophagy; Parkinson&apos; s disease; striatum; substantia nigra		Impairment of protein clearance mechanisms leads to alpha-synuclein accumulation in dopaminergic neurons, contributing to the pathogenesis of Parkinson's disease (PD). Based on the finding that Fas-associated factor 1 (FAF1), a positive modulator of PD, colocalizes with alpha-synuclein in PD patient brains, we investigated the existence of pathological interplay between FAF1 and alpha-synuclein. Monomeric and high-molecular-weight forms of alpha-synuclein were increased in FAF1-overexpressing SH-SY5Y cells. In particular, alpha-synuclein turnover was accelerated by genetic depletion of FAF1 in SH-SY5Y cells. Therefore, we questioned whether FAF1 is involved in the alpha-synuclein clearance process. Autophagy inhibitors, but not proteasome inhibitors, restored concurrent attenuation of alpha-synuclein expression by FAF1 depletion in SH-SY5Y cells. Moreover, we found alterations in autophagy markers in SH-SY5Y cells caused by FAF1 overexpression, indicating that FAF1 disturbed alpha-synuclein clearance through the autophagy-lysosome pathway. Indeed, FAF1 activated the mammalian target of rapamycin (mTOR) pathway, subsequently suppressing autophagosome formation. Consistently, alpha-synuclein-mediated mitochondrial dysfunction was observed in FAF1-overexpressing SH-SY5Y cells. Furthermore, FAF1 overexpression using stereotaxic injection of adeno-associated virus led to alpha-synuclein accumulation and autophagy dysregulation in the PD model mice. Taken together, our results reveal a novel role for FAF1: that of a negative regulator of autophagic alpha-synuclein clearance.	[Kim, Bok-Seok; Jang, Taeik; Kim, Eunhee] Chungnam Natl Univ, Dept Biol Sci, 99 Daehak Ro, Daejeon 34134, South Korea; [Yoo, Sung-Eun; Lee, Jae Moon] Kainos Med Inc, Seongnam, South Korea	Chungnam National University	Kim, E (corresponding author), Chungnam Natl Univ, Dept Biol Sci, 99 Daehak Ro, Daejeon 34134, South Korea.	eunhee@cnu.ac.kr			Korea Health Industry Development Institute (KHIDI) [HI16C0947]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI16C0947, HI16C0947 and HI16C0947	Ahn TB, 2008, NEUROLOGY, V70, P43, DOI 10.1212/01.wnl.0000271080.53272.c7; Alvarez-Erviti L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.73; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Antonia RJ, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan5850; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2008, NEUROBIOL DIS, V31, P309, DOI 10.1016/j.nbd.2008.05.006; Bian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060184; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Cartier AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034713; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; El-Masry OS, 2015, ONCOL REP, V34, P1675, DOI 10.3892/or.2015.4198; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Giacoppo S, 2017, NEUROREPORT, V28, P996, DOI 10.1097/WNR.0000000000000871; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hamano T, 2009, INT J CLIN EXP PATHO, V2, P561; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Jang MS, 2008, J BIOL CHEM, V283, P32344, DOI 10.1074/jbc.M804199200; Kam TI, 2018, SCIENCE, V362, P557, DOI 10.1126/science.aat8407; Kim C, 2015, CELL REP, V13, P771, DOI 10.1016/j.celrep.2015.09.044; Kim Han-Joon, 2013, Exp Neurobiol, V22, P77, DOI 10.5607/en.2013.22.2.77; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim JH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006398; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lim GGY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073235; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Lopez-Perez O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38500-2; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Olsen BB, 2003, FEBS LETT, V546, P218, DOI 10.1016/S0014-5793(03)00575-1; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Sala G, 2014, BRAIN RES, V1546, P46, DOI 10.1016/j.brainres.2013.12.017; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Sul JW, 2013, HUM MOL GENET, V22, P1558, DOI 10.1093/hmg/ddt006; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trojanowski JQ, 1999, BRAIN PATHOL, V9, P733; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xie F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15021; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yu CS, 2016, CELL DEATH DIFFER, V23, P1873, DOI 10.1038/cdd.2016.99; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	66	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21363	10.1096/fj.202001371RR	http://dx.doi.org/10.1096/fj.202001371RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749937				2022-12-26	WOS:000635216100027
J	Saika, A; Nagatake, T; Hirata, SI; Sawane, K; Adachi, J; Abe, Y; Isoyama, J; Morimoto, S; Node, E; Tiwari, P; Hosomi, K; Matsunaga, A; Honda, T; Tomonaga, T; Arita, M; Kabashima, K; Kunisawa, J				Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Honda, Tetsuya; Tomonaga, Takeshi; Arita, Makoto; Kabashima, Kenji; Kunisawa, Jun			omega 3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor alpha	FASEB JOURNAL			English	Article						12&#8208; hydroxyeicosapentaenoic acid; allergic contact dermatitis; keratinocytes; lipid metabolite; retinoid X receptor	POLYUNSATURATED FATTY-ACIDS; T-CELLS; 17,18-EPOXYEICOSATETRAENOIC ACID; ANTIINFLAMMATORY ACTIONS; NEUTROPHIL INFILTRATION; SKIN INFLAMMATION; LIPID-METABOLISM; IMMUNE EVENTS; RESOLVIN E2; RECRUITMENT	omega 3 fatty acids show potent bioactivities via conversion into lipid mediators; therefore, metabolism of dietary lipids is a critical determinant in the properties of omega 3 fatty acids in the control of allergic inflammatory diseases. However, metabolic progression of omega 3 fatty acids in the skin and their roles in the regulation of skin inflammation remains to be clarified. In this study, we found that 12-hydroxyeicosapentaenoic acid (12-HEPE), which is a 12-lipoxygenase metabolite of eicosapentaenoic acid, was the prominent metabolite accumulated in the skin of mice fed omega 3 fatty acid-rich linseed oil. Consistently, the gene expression levels of Alox12 and Alox12b, which encode proteins involved in the generation of 12-HEPE, were much higher in the skin than in the other tissues (eg, gut). We also found that the topical application of 12-HEPE inhibited the inflammation associated with contact hypersensitivity by inhibiting neutrophil infiltration into the skin. In human keratinocytes in vitro, 12-HEPE inhibited the expression of two genes encoding neutrophil chemoattractants, CXCL1 and CXCL2, via retinoid X receptor alpha. Together, the present results demonstrate that the metabolic progression of dietary omega 3 fatty acids differs in different organs, and identify 12-HEPE as the dominant omega 3 fatty acid metabolite in the skin.	[Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res, Lab Vaccine Mat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan; [Saika, Azusa; Nagatake, Takahiro; Hirata, So-ichiro; Sawane, Kento; Morimoto, Sakiko; Node, Eri; Tiwari, Prabha; Hosomi, Koji; Matsunaga, Ayu; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan; [Saika, Azusa; Sawane, Kento; Kunisawa, Jun] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Sawane, Kento] Nippon Flour Mills Co Ltd, Innovat Ctr, Atsugi, Kanagawa, Japan; [Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Tomonaga, Takeshi] NIBIOHN, Lab Proteome Res, Osaka, Japan; [Adachi, Jun; Abe, Yuichi; Isoyama, Junko; Tomonaga, Takeshi] NIBIOHN, Lab Prote Drug Discovery, Osaka, Japan; [Abe, Yuichi] Aichi Canc Ctr, Res Inst, Div Mol Diag, Nagoya, Aichi, Japan; [Matsunaga, Ayu] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Honda, Tetsuya; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Honda, Tetsuya] Hamamatsu Univ, Sch Med, Dept Dermatol, Shizuoka, Japan; [Arita, Makoto] Keio Univ, Fac Pharm, Div Physiol Chem & Metab, Tokyo, Japan; [Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan; [Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Kunisawa, Jun] Kobe Univ, Grad Sch Med, Dept Microbiol & Immunol, Kobe, Hyogo, Japan; [Kunisawa, Jun] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Dent, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Aichi Cancer Center; Azabu University; Kyoto University; Hamamatsu University School of Medicine; Keio University; RIKEN; Yokohama City University; Kobe University; University of Tokyo; Osaka University	Kunisawa, J (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res, Lab Vaccine Mat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.; Kunisawa, J (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	kunisawa@nibiohn.go.jp	Nagatake, Takahiro/AAL-1995-2020; Tiwari, Prabha/GQR-2661-2022; Tiwari, Prabha/GPF-6552-2022; Adachi, Jun/H-2813-2014	Tiwari, Prabha/0000-0002-7143-7504; Adachi, Jun/0000-0003-1220-3246; Hirata, So-ichiro/0000-0002-9503-4646	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science KAKENHI [JP19K07617, 19K08790, 15H05897, 18H02674, 18H02150, 15H05790, 20H00534]; Japan Agency for Medical Research and Development (AMED) [JP20ek0410062s0202, JP19gm1210006, JP20ek0410062h0002, JP20ak0101068h0004, JP20gm1010006h004]; Ministry of Health and Welfare of Japan; Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation(Canon Foundation)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: JP19K07617, 19K08790, 15H05897, 18H02674, 18H02150, 15H05790 and 20H00534; Japan Agency for Medical Research and Development (AMED, Grant/ Award Number: JP20ek0410062s0202, JP19gm1210006, JP20ek0410062h0002, JP20ak0101068h0004 and JP20gm1010006h004; Ministry of Health and Welfare of Japan; Public/Private R&D Investment Strategic Expansion Program: PRISM; Cross-ministerial Strategic Innovation Promotion Program: SIP; Grant for Joint Research Project of the Institute of Medical Science; University of Tokyo; Ono Medical Research Foundation; Canon Foundation	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Alinaghi F, 2019, CONTACT DERMATITIS, V80, P77, DOI 10.1111/cod.13119; Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; Bedi S, 2017, J LIPID RES, V58, P393, DOI 10.1194/jlr.M072447; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]; Calder PC, 2008, P NUTR SOC, V67, P409, DOI 10.1017/S0029665108008690; Cattani F, 2006, EUR CYTOKINE NETW, V17, P42; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Christensen AD, 2014, IMMUN INFLAMM DIS, V2, P21, DOI 10.1002/iid3.16; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; ClinicalTrials.gov Website, EFFICACY SAFETY RX 1; ClinicalTrials.gov Website, STUDY RX 10045 TREAT; Coll T, 2010, PPAR RES, V2010, DOI 10.1155/2010/368467; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Dilulio NA, 1999, EUR J IMMUNOL, V29, P3485, DOI 10.1002/(SICI)1521-4141(199911)29:11<3485::AID-IMMU3485>3.0.CO;2-B; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Ecker J, 2009, BIOCHEM BIOPH RES CO, V388, P660, DOI 10.1016/j.bbrc.2009.08.048; Engeman T, 2004, J LEUKOCYTE BIOL, V76, P941, DOI 10.1189/jlb.0304193; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hirakata T, 2019, FASEB J, V33, P3392, DOI 10.1096/fj.201801805R; Hirata S, 2020, ALLERGY, V75, P1939, DOI 10.1111/all.14217; Honda T, 2016, P JPN ACAD B-PHYS, V92, P20, DOI 10.2183/pjab.92.20; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; Isobe Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26325-4; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jiang M, 2019, FASEB J, V33, P13241; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kish DD, 2012, J IMMUNOL, V189, P2191, DOI 10.4049/jimmunol.1102729; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Latif MA, 2015, ASIAN PAC J ALLERGY, V33, P33, DOI 10.12932/AP0499.33.1.2015; Lee HY, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/916497; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2001, DEVELOPMENT, V128, P675; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lin ZC, 2018, FASEB J, V32, P6783, DOI 10.1096/fj.201800354; Lo HM, 2014, ACTA PHARMACOL SIN, V35, P339, DOI 10.1038/aps.2013.182; Bargut TCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075059; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marzano AV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01059; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; MCARDLE JJ, 1992, EXP AGING RES, V18, P87, DOI 10.1080/03610739208253915; Moniaga CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15319; Nagakura T, 2000, EUR RESPIR J, V16, P861, DOI 10.1183/09031936.00.16586100; Nagatake T, 2018, J ALLERGY CLIN IMMUN, V142, P470, DOI 10.1016/j.jaci.2017.09.053; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Onuki M, 2019, INT IMMUNOL, V31, P251, DOI 10.1093/intimm/dxy089; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Rauschenberger T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01917; Saika A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00036; Sanz MJ, 2012, J IMMUNOL, V189, P411, DOI 10.4049/jimmunol.1102942; Sawada Y, 2015, J EXP MED, V212, P1921, DOI 10.1084/jem.20150381; Sawane K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122868; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Tiwari P, 2019, ALLERGY, V74, P1522, DOI 10.1111/all.13762; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Walsh CM, 2019, ELIFE, V8, DOI [10.7554/elife.48448, 10.7554/eLife.48448]; Wang W, 2019, J NAT MED-TOKYO, V73, P419, DOI 10.1007/s11418-018-01277-1; Wang WH, 2014, AM J PHYSIOL-RENAL, V307, pF453, DOI 10.1152/ajprenal.00123.2014; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	80	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21354	10.1096/fj.202001687R	http://dx.doi.org/10.1096/fj.202001687R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749892	hybrid			2022-12-26	WOS:000635216100003
J	Zhang, N; Ye, FM; Zhou, Y; Zhu, W; Xie, CP; Zheng, HQ; Chen, H; Chen, JH; Xie, XJ				Zhang, Na; Ye, Feiming; Zhou, Yu; Zhu, Wei; Xie, Cuiping; Zheng, Haiqiong; Chen, Han; Chen, Jinghai; Xie, Xiaojie			Cardiac ankyrin repeat protein contributes to dilated cardiomyopathy and heart failure	FASEB JOURNAL			English	Article						calcium homeostasis; cardiac ankyrin repeat protein; dilated cardiomyopathy; heart failure		Cardiac ankyrin repeat protein (CARP) is a cardiac-specific stress-response protein which exerts diverse effects to modulate cardiac remodeling in response to pathological stimuli. We examined the role of CARP in postnatal cardiac development and function under basal conditions in mice. Transgenic mice that selectively overexpressed CARP in heart (CARP Tg) exhibited dilated cardiac chambers, impaired heart function, and cardiac fibrosis as assessed by echocardiography and histological staining. Furthermore, the mice had a shorter lifespan and reduced survival rate in response to ischemic acute myocardial infarction. Immunofluorescence demonstrated the overexpressed CARP protein was predominantly accumulated in the nuclei of cardiomyocytes. Microarray analysis revealed that the nuclear localization of CARP was associated with the suppression of calcium-handling proteins. In vitro experiments revealed that CARP overexpression resulted in decreased cell contraction and calcium transient. In post-mortem cardiac specimens from patients with dilated cardiomyopathy and end-stage heart failure, CARP was significantly increased. Taken together, our data identified CARP as a crucial contributor in dilated cardiomyopathy and heart failure which was associated with its regulation of calcium-handling proteins.	[Zhang, Na; Ye, Feiming; Zhou, Yu; Zhu, Wei; Xie, Cuiping; Zheng, Haiqiong; Chen, Han; Chen, Jinghai; Xie, Xiaojie] Zhejiang Univ, Affiliated Hosp 2, Cardiovasc Key Lab Zhejiang Prov, Dept Cardiol,Sch Med, Hangzhou, Peoples R China; [Zhang, Na] Hangzhou Normal Univ, Sch Med, Hangzhou, Peoples R China; [Chen, Jinghai] Zhejiang Univ, Inst Translat Med, Hangzhou, Peoples R China	Zhejiang University; Hangzhou Normal University; Zhejiang University	Xie, XJ (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Cardiovasc Key Lab Zhejiang Prov, Dept Cardiol,Sch Med, Hangzhou, Peoples R China.	xiexj@zju.edu.cn		Xie, Xiaojie/0000-0001-8421-2737	National Natural Science Foundation of China [31171392, 81571932, 81700380, 82000403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31171392, 81571932, 81700380, and 82000403)	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Almodovar-Garcia K, 2014, MOL CELL BIOL, V34, P1500, DOI 10.1128/MCB.01357-13; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bogomolovas J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/273936; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104040; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Gercek M, 2017, AM J PATHOL, V187, P752, DOI 10.1016/j.ajpath.2016.12.018; Ghosh AK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063825, 10.1371/journal.pone.0069949]; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hutchinson KR, 2015, J MOL CELL CARDIOL, V79, P104, DOI 10.1016/j.yjmcc.2014.10.020; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Jia YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160755; Kar P, 2016, MOL CELL, V64, P746, DOI 10.1016/j.molcel.2016.11.011; Lange S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12120; Ling SSM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071362; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sarikhani M, 2018, J BIOL CHEM, V293, P5281, DOI 10.1074/jbc.RA117.000915; Shen L, 2015, CLIN SCI, V128, P665, DOI 10.1042/CS20140586; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Wu QQ, 2017, CLIN SCI, V131, P2319, DOI 10.1042/CS20171167; Yang J, 2018, J BIOL CHEM, V293, P794, DOI 10.1074/jbc.M117.812289; Yano M, 2006, NAT CLIN PRACT CARD, V3, P43, DOI 10.1038/ncpcardio0419; Zhang N, 2016, BBA-MOL CELL RES, V1863, P3040, DOI 10.1016/j.bbamcr.2016.09.024; Zhang N, 2016, J ZHEJIANG UNIV-SC B, V17, P333, DOI 10.1631/jzus.B1500247; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Zima AV, 2016, REV PHYSIOL BIOCH P, V171, P39, DOI 10.1007/112_2016_2; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	43	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21488	10.1096/fj.201902802RR	http://dx.doi.org/10.1096/fj.201902802RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734499				2022-12-26	WOS:000635216100023
J	Zhong, L				Zhong, Ling			A dynamic pandemic model evaluating reopening strategies amid COVID-19	PLOS ONE			English	Article							EPIDEMIC MODEL; QUARANTINE; OUTBREAK; SPREAD; IMPACT; SARS; TRAVEL	Among over 200 COVID-19 affected countries, some are fighting to "flatten the curve", while some others are considering reopening after lockdown. It remains unclear how different reopening strategies obstruct the local virus containment and impact the economy. We develop a model with travelers across heterogeneous epicenters. A low-risk area attempts to safely reopen utilizing internal policies, such as social distancing and contact tracing, and external policies, including capacity quota, quarantine, and tests. Simulations based on the COVID-19 scenario show that external policies differ in efficacy. They can substitute each other and complement internal policies. Simultaneous relaxation of both channels may lead to a new wave of COVID-19 and large economic costs. This work highlights the importance of quantitative assessment prior to implementing reopening strategies.	[Zhong, Ling] Cheung Kong Grad Sch Business, Dept Econ, Beijing, Peoples R China		Zhong, L (corresponding author), Cheung Kong Grad Sch Business, Dept Econ, Beijing, Peoples R China.	lingzhong@ckgsb.edu.cn			ASEAN Business Research Initiative Grant	ASEAN Business Research Initiative Grant	The study was funded by the ASEAN Business Research Initiative Grant, awarded to LZ, grant number "454-4500-Ling Zhong."	Adler L., 2020, USC BROOKINGS SCHAEF; ALLEN LJS, 1994, MATH BIOSCI, V124, P83, DOI 10.1016/0025-5564(94)90025-6; [Anonymous], 2021, QUARANTINE HOTELS HK; Berger D. W., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26901; Brauer F, 2019, TEXTS APPL MATH, V69, P457, DOI 10.1007/978-1-4939-9828-9_14; Cevik M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n224; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Civil Aviation Administration of China, 2020, NOTICE FURTHER REDUC; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; De La Garza A, 2020, WHAT IS CONTACT TRAC; Edlund S, 2011, EPIDEMICS-NETH, V3, P135, DOI 10.1016/j.epidem.2011.04.002; El Kihal F, 2017, INT J ADV APPL MATH, V4, P60; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fu SC, 2016, J NONLINEAR CONVEX A, V17, P1739; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Gupta AG, 2005, J INFECTION, V50, P386, DOI 10.1016/j.jinf.2004.08.006; Hale T., 2020, OXFORD COVID 19 GOVT, P25; Hsieh YH, 2007, J THEOR BIOL, V244, P729, DOI 10.1016/j.jtbi.2006.09.015; Huang Y., 2020, HARVARD BUS REV; Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Krishnapriya P, 2017, J COMPUT APPL MATH, V324, P155, DOI 10.1016/j.cam.2017.04.030; Lee Bruce Y., 2020, CORONAVIRUS MEDICAL; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; National Center for Immunization and Respiratory Diseases (NCIRD), 2020, DIVISION VIRAL DIS; National Health Commission, 2020, COR SIT REP AUG 2; Pedigo S., 2020, OUR CITIES CAN REOPE; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Rae M, 2020, PETERSON KAISER HLTH; Rafiq M, 2020, ADV DIFFER EQU-NY, V2020, DOI 10.1186/s13662-020-02994-2; Sattenspiel L, 2003, B MATH BIOL, V65, P1, DOI 10.1006/bulm.2002.0317; Schaeffer D., 2020, ABC NEWS; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; Statista, RESIDENT POPULATION; U.S. National Travel and Tourism Office, 2017, NONRESIDENT ARRIVALS; U.S. Travel Association, 2019, US TRAVEL TOURISM OV; Uria D., 2020, CALIFORNIA OREGON OU; Wang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02344-z; Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3; WHO, 2020, REPORT WHO CHINA JOI; WHO Global World Health Organization, 2020, CRIT REL COVID 19 PA; World Health Organization, COR DIS COVID 19 SIT; Worldometers.info, 2020, CORONAVIRUS RECOVERE; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zakary O, 2017, MATH METHOD APPL SCI, V40, P1265, DOI 10.1002/mma.4048; Zarebski Alexander E, 2017, Infect Dis Model, V2, P56, DOI 10.1016/j.idm.2016.12.004; Zhang R., ARXIV200202586 PREPR; Zlojutro A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38665-w	50	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248302	10.1371/journal.pone.0248302	http://dx.doi.org/10.1371/journal.pone.0248302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770097	gold, Green Published			2022-12-26	WOS:000634833500058
J	Kinney, N; Kang, L; Bains, H; Lawson, E; Husain, M; Husain, K; Sandhu, I; Shin, Y; Carter, JK; Anandakrishnan, R; Michalak, P; Garner, H				Kinney, Nick; Kang, Lin; Bains, Harpal; Lawson, Elizabeth; Husain, Mesam; Husain, Kumayl; Sandhu, Inderjit; Shin, Yongdeok; Carter, Javan K.; Anandakrishnan, Ramu; Michalak, Pawel; Garner, Harold			Ethnically biased microsatellites contribute to differential gene expression and glutathione metabolism in Africans and Europeans	PLOS ONE			English	Article								Approximately three percent of the human genome is occupied by microsatellites: a type of short tandem repeat (STR). Microsatellites have well established effects on (a) the genetic structure of diverse human populations and (b) expression of nearby genes. These lines of inquiry have uncovered 3,984 ethnically biased microsatellite loci (EBML) and 28,375 expression STRs (eSTRs), respectively. We hypothesize that a combination of EBML, eSTRs, and gene expression data (RNA-seq) can be used to show that microsatellites contribute to differential gene expression and phenotype in human populations. In fact, our previous study demonstrated a degree of mutual overlap between EBML and eSTRs but fell short of quantifying effects on gene expression. The present work aims to narrow the gap. First, we identify 313 overlapping EBML/eSTRs and recapitulate their mutual overlap. The 313 EBML/eSTRs are then characterized across ethnicity and tissue type. We use RNA-seq data to pursue validation of 49 regions that affect whole blood gene expression; 32 out of 54 affected genes are differentially expressed in Africans and Europeans. We quantify the relative contribution of these 32 genes to differential expression; fold change tends to be less than other differentially expressed genes. Repeat length correlates with expression for 15 of the 32 genes; two are conspicuously involved in glutathione metabolism. Finally, we repurpose a mathematical model of glutathione metabolism to investigate how a single polymorphic microsatellite affects phenotype. We conclude with a testable prediction that microsatellite polymorphisms affect GPX7 expression and oxidative stress in Africans and Europeans.	[Kinney, Nick; Kang, Lin; Bains, Harpal; Lawson, Elizabeth; Husain, Mesam; Husain, Kumayl; Sandhu, Inderjit; Shin, Yongdeok; Anandakrishnan, Ramu; Michalak, Pawel; Garner, Harold] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Kinney, Nick; Kang, Lin; Anandakrishnan, Ramu; Michalak, Pawel; Garner, Harold] Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA; [Carter, Javan K.] Univ Colorado Boulder, Boulder, CO USA; [Michalak, Pawel] Univ Haifa, Inst Evolut, Haifa, Israel; [Kinney, Nick] Edward Via Coll Osteopath Med, Ctr Bioinformat & Genet, Blacksburg, VA 24060 USA	University of Colorado System; University of Colorado Boulder; University of Haifa	Kinney, N (corresponding author), Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA.; Kinney, N (corresponding author), Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA.; Kinney, N (corresponding author), Edward Via Coll Osteopath Med, Ctr Bioinformat & Genet, Blacksburg, VA 24060 USA.	nkinney06@gmail.com	; Kinney, Nicholas/I-7168-2016	Bains, Harpal/0000-0002-4699-7104; Kinney, Nicholas/0000-0002-4563-1813; SHIN, YONGDEOK/0000-0002-7853-5334				Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Budis J, 2019, BIOINFORMATICS, V35, P1310, DOI 10.1093/bioinformatics/bty791; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Dashnow H, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1505-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Feairheller DL, 2011, CTS-CLIN TRANSL SCI, V4, P32, DOI 10.1111/j.1752-8062.2011.00264.x; Fotsing SF, 2019, NAT GENET, V51, P1652, DOI 10.1038/s41588-019-0521-9; Freedman BI, 2007, NEPHROL DIAL TRANSPL, V22, P1131, DOI 10.1093/ndt/gfl717; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; Hannan AJ, 2012, ADV EXP MED BIOL, V769, P1; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Highnam G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks981; Holtz LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028647; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; JAIN SK, 1994, METABOLISM, V43, P306, DOI 10.1016/0026-0495(94)90097-3; Jain SK, 1996, CLIN CHIM ACTA, V253, P181, DOI 10.1016/0009-8981(96)06371-1; Jain SK, 2013, BIOCHEM BIOPH RES CO, V437, P7, DOI 10.1016/j.bbrc.2013.06.004; Jain SK, 2013, ANTIOXID REDOX SIGN, V18, P1154, DOI 10.1089/ars.2012.4843; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kalyanaraman B, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101721; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Kinney N, 2019, NUCLEIC ACIDS RES, V47, pD39, DOI 10.1093/nar/gky969; Lammertyn L, 2015, CLIN EXP HYPERTENS, V37, P511, DOI 10.3109/10641963.2015.1013123; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Dongsheng, 2013, Frontiers in Genetics, V4, P127, DOI 10.3389/fgene.2013.00127; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Meloni R, 1998, HUM MOL GENET, V7, P423, DOI 10.1093/hmg/7.3.423; Mitra I., 2020, CONTRIBUTION NOVO TA; Mousavi N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz501; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Polonikov A, 2020, ACS INFECT DIS, V6, P1558, DOI 10.1021/acsinfecdis.0c00288; Reed MC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-8; Reis JP, 2008, AM J CLIN NUTR, V88, P1469, DOI 10.3945/ajcn.2008.26447; Richie JP, 2011, NUTR CANCER, V63, P367, DOI 10.1080/01635581.2011.535967; Rivero-Hinojosa S, 2020, NEURO-ONCOLOGY, V22, P152, DOI 10.1093/neuonc/noz179; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Tang HB, 2017, AM J HUM GENET, V101, P700, DOI 10.1016/j.ajhg.2017.09.013; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249148	10.1371/journal.pone.0249148	http://dx.doi.org/10.1371/journal.pone.0249148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765058	gold, Green Published			2022-12-26	WOS:000634832800098
J	Heise, M; Fink, A; Baumert, J; Heidemann, C; Du, Y; Frese, T; Carmienke, S				Heise, Marcus; Fink, Astrid; Baumert, Jens; Heidemann, Christin; Du, Yong; Frese, Thomas; Carmienke, Solveig			Patterns and associated factors of diabetes self-management: Results of a latent class analysis in a German population-based study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH INTERVIEW; CARE; MELLITUS; EDUCATION; ADULTS; BARRIERS; OUTCOMES; LIFE	Objective Few studies on diabetes self-management considered the patterns and relationships of different self-management behaviours (SMB). The aims of the present study are 1) to identify patterns of SMB among persons with diabetes, 2) to identify sociodemographic and disease-related predictors of SMB among persons with diabetes. Research design and methods The present analysis includes data of 1,466 persons (age 18 to 99 years; 44.0% female; 56.0% male) with diabetes (type I and II) from the population-based study German Health Update 2014/2015 (GEDA 2014/2015-EHIS). We used latent class analysis in order to distinguish different patterns of self-management behaviours among persons with diabetes. The assessment of SMB was based on seven self-reported activities by respondents (dietary plan, diabetes-diary, diabetes health pass, self-assessment of blood glucose, self-examination of feet, retinopathy-screenings and assessment of HbA1c). Subsequent multinomial latent variable regressions identified factors that were associated with self-management behaviour. Results Latent class analysis suggested a distinction between three patterns of SMB. Based on modal posterior probabilities 42.8% of respondents showed an adherent pattern of diabetes self-management with above-average frequency in all seven indicators of SMB. 32.1% showed a nonadherent pattern with a below-average commitment in all seven forms of SMB. Another 25.1% were assigned to an ambivalent type, which showed to be adherent with regard to retinopathy screenings, foot examinations, and the assessment of HbA1c, yet nonadherent with regard to all other forms of SMB. In multivariable regression analyses, participation in Diabetes Self-Management Education programs (DSME) was the most important predictor of good self-management behaviour (marginal effect = 51.7 percentage points), followed by attentiveness towards one's personal health (31.0 percentage points). Respondents with a duration of illness of less than 10 years (19.5 percentage points), employed respondents (7.5 percentage points), as well as respondents with a high socioeconomic status (24.7 percentage points) were more likely to show suboptimal forms of diabetes self-management. Discussion In the present nationwide population-based study, a large proportion of persons with diabetes showed suboptimal self-management behaviour. Participation in a DSME program was the strongest predictor of good self-management. Results underline the need for continual and consistent health education for patients with diabetes.	[Heise, Marcus; Frese, Thomas; Carmienke, Solveig] Martin Luther Univ Halle Wittenberg, Inst Gen Practice & Family Med, Med Fac, Halle, Saale, Germany; [Fink, Astrid] Martin Luther Univ Halle Wittenberg, Inst Med Sociol, Med Fac, Halle, Saale, Germany; [Baumert, Jens; Heidemann, Christin; Du, Yong] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Robert Koch Institute	Heise, M (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Gen Practice & Family Med, Med Fac, Halle, Saale, Germany.	marcus.heise@medizin.uni-halle.de		Heidemann, Christin/0000-0002-9413-2148; Heise, Marcus/0000-0002-8419-6412	Robert Koch Institute; German Federal Ministry of Health	Robert Koch Institute; German Federal Ministry of Health	This work was supported by the Robert Koch Institute and the German Federal Ministry of Health, no specific grant number.	Adu MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217771; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2018, QUALITTSSICHERUNGSBE; Arnold-Womer N, 2008, EXP CLIN ENDOCR DIAB, V116, P123, DOI 10.1055/s-2007-990297; Aronson R, 2018, DIABETES RES CLIN PR, V137, P128, DOI 10.1016/j.diabres.2017.10.028; Arzneimittelkommission Der Deutschen Arzteschaft (AkdA) ABDA-Bundesvereinigung Deutscher Apothekerverbande Deutsche Diabetes-Gesellschaft (DDG) Deutsche Gesellschaft Fur Allgemeinmedizin Und Familienmedizin (DEGAM) Fachkommission Diabetes Der Sachsischen Landesarztekammer (FKDS) Verband Der Diabetesberatungs- Und Schulungsberufe Deutschland (VDBD), 2012, NATL VERSORGUNGSLEIT, V1; Arzneimittelkommission Der Deutschen Arzteschaft (AkdA) Deutsche Diabetes Gesellschaft (DDG) Deutsche Gesellschaft Fur Allgemeinmedizin Und Familienmedizin (DEGAM) Deutsche Gesellschaft Fur Innere Medizin (DGIM) (Vertreten Durch Die DDG) Verband Der Diabetesberatungs- Und Schulungsberufe Deutschland (VDBD) Arztliches Zentrum Fur Qualitat In Der Medizin (AZQ)., 2013, NATL VERSORGUNGSLEIT, V1; Asparouhov, 2012, MPLUS WEB NOTES, V15; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; Becker J, 2020, PRIM CARE DIABETES, V14, P508, DOI 10.1016/j.pcd.2020.01.004; Bhaloo T, 2018, CHRONIC ILLN, V14, P243, DOI 10.1177/1742395317736372; Campbell DJT, 2017, DIABETES EDUCATOR, V43, P78, DOI 10.1177/0145721716679276; Carmienke S, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2019-001066; Carter P A, 1998, J Nurs Meas, V6, P195; Collins LM, 2009, LATENT CLASS LATENT; Der Gemeinsame Bundesausschuss, 2011, BESCHLUSS BANZ; Deutsche Diabetes-Hilfe, 2020, DTSCH GES 2021 BEST; Du Y, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000135; Fink A, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0924-3; Goffrier B., 2017, ADM PRAVALENZEN INZI, DOI [10.1007/s00103-017-2552-7, DOI 10.1007/S00103-017-2552-7]; Haines L, 2018, HEALTH EDUC BEHAV, V45, P668, DOI 10.1177/1090198117752783; Heidemann Christin, 2019, J Health Monit, V4, P11, DOI 10.25646/5986; Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.816; Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Jiang XJ, 2019, WORLDV EVID-BASED NU, V16, P151, DOI 10.1111/wvn.12354; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Klonoff David C, 2011, J Diabetes Sci Technol, V5, P1529; Kristianingrum ND, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0981-2; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lange C, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0208-6; Laxy M, 2014, DIABETES CARE, V37, P1604, DOI 10.2337/dc13-2533; Little R., 2014, STAT ANAL MISSING DA, V2; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Matricciani L, 2015, DIABETES EDUCATOR, V41, P106, DOI 10.1177/0145721714560441; McCarthy MM, 2018, DIABETES CARE, V41, P1608, DOI 10.2337/dc17-2597; Mehring M, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0236-y; Milo RB, 2019, J CLIN NURS, V28, P1737, DOI 10.1111/jocn.14779; Murray CM, 2016, PRIM CARE DIABETES, V10, P179, DOI 10.1016/j.pcd.2015.10.007; Muthen L, 2007, MUTH N MUTH N; Ngo-Metzger Q, 2012, J GEN INTERN MED, V27, P432, DOI 10.1007/s11606-011-1910-7; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Nylund-Gibson K, 2019, STRUCT EQU MODELING, V26, P967, DOI 10.1080/10705511.2019.1590146; Odgers-Jewell K, 2017, DIABETIC MED, V34, P1027, DOI 10.1111/dme.13340; Pastor DA, 2007, CONTEMP EDUC PSYCHOL, V32, P8, DOI 10.1016/j.cedpsych.2006.10.003; Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x; Pintaudi B, 2015, J PSYCHOSOM RES, V79, P348, DOI 10.1016/j.jpsychores.2015.08.010; Piper CN, 2015, SOUTH MED J, V108, P212, DOI 10.14423/SMJ.0000000000000258; Powers M.A., DIABETES SELF MANAGE; Rohan JM, 2011, PEDIATR DIABETES, V12, P611, DOI 10.1111/j.1399-5448.2010.00752.x; Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568; Sa&beta; A-C., 2017, J HLTH MONITORING, V2, P1; Saad AMJ, 2018, DIABETES RES CLIN PR, V137, P28, DOI 10.1016/j.diabres.2017.12.014; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Scheidt-Nave C., 2019, DIABETES DEUTSCHLAND; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; StataCorp, 2019, STAT REL 16 STAT SOF; Tonnies T, 2019, DIABETIC MED, V36, P1217, DOI 10.1111/dme.13902; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209	63	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248992	10.1371/journal.pone.0248992	http://dx.doi.org/10.1371/journal.pone.0248992			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740024	gold, Green Published			2022-12-26	WOS:000631030200007
J	Hohlfeld, ASJ; Mathebula, L; Pienaar, ED; Abrams, A; Lutje, V; Ndwandwe, D; Kredo, T				Hohlfeld, Ameer S. J.; Mathebula, Lindi; Pienaar, Elizabeth D.; Abrams, Amber; Lutje, Vittoria; Ndwandwe, Duduzile; Kredo, Tamara			Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; RESEARCH PARTNERSHIPS; GUIDELINES; QUALITY; ETHICS	Background Mycobacterium Tuberculosis (TB) poses a substantial burden in sub-Saharan Africa and is the leading cause of death amongst infectious diseases. Randomised controlled trials (RCTs) are regarded as the gold standard for evaluating the effectiveness of interventions. We aimed to describe published TB treatment trials conducted in Africa. Methods This is a cross-sectional study of published TB trials conducted in at least one African country. In November 2019, we searched three databases using the validated Africa search filter and Cochrane's sensitive trial string. Published RCTs conducted in at least one African country were included for analysis. Records were screened for eligibility. Co-reviewers assisted with duplicate data extraction. Extracted data included: the country where studies were conducted, publication dates, ethics statement, trial registration number, participant's age range. We used Cochrane's Risk of Bias criteria to assess methodological quality. Results We identified 10,495 records; 175 trials were eligible for inclusion. RCTs were published between 1952 and 2019. The median sample size was 206 participants (interquartile range: 73-657). Most trials were conducted in South Africa (n = 83) and were drug therapy trials (n = 130). First authors were from 30 countries globally. South Africa had the most first authors (n = 55); followed by the United States of America (USA) (n = 28) and Great Britain (n = 14) with fewer other African countries contributing to the first author tally. Children under 13 years of age eligible to participate in the trials made up 17/175 trials (9.71%). International governments (n = 29) were the most prevalent funders. Ninety-four trials provided CONSORT flow diagrams. Methodological quality such as allocation concealment and blinding were poorly reported or unclear in most trials. Conclusions By mapping African TB trials, we were able to identify potential research gaps. Many of the global north's researchers were found to be the lead authors in these African trials. Few trials tested behavioural interventions compared to drugs, and far fewer tested interventions on children compared to adults to improve TB outcomes. Lastly, funders and researchers should ensure better methodological quality reporting of trials.	[Hohlfeld, Ameer S. J.; Pienaar, Elizabeth D.; Ndwandwe, Duduzile; Kredo, Tamara] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Mathebula, Lindi] Communicable Dis Control, Dept Hlth, Cape Town, South Africa; [Abrams, Amber] Univ Cape Town, Future Water Inst, Cape Town, South Africa; [Lutje, Vittoria] Cochrane Infect Dis Grp, Liverpool, Merseyside, England; [Kredo, Tamara] Stellenbosch Univ, Dept Med, Clin Pharmacol Div, Cape Town, South Africa	South African Medical Research Council; National Institute for Communicable Diseases (NICD); University of Cape Town; Stellenbosch University	Hohlfeld, ASJ (corresponding author), South African Med Res Council, Cochrane South Africa, Cape Town, South Africa.	Ameer.hohlfield@mrc.ac.za	Abrams, Amber L/AAC-7533-2022; Ndwandwe, Duduzile/L-2296-2013	Abrams, Amber L/0000-0003-1416-7891; Ndwandwe, Duduzile/0000-0001-7129-3865; Hohlfeld, Ameer Steven-Jorg/0000-0003-1710-1265				[Anonymous], 2011, STAT DAT AN STAT SOF; Chaccour J, 2018, LANCET GLOB HEALTH, V6, pE497, DOI 10.1016/S2214-109X(18)30110-4; Creswell J, 2014, B WORLD HEALTH ORGAN, V92, P459, DOI 10.2471/BLT.13.133116; Drain PK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192413; Edejer TTT, 1999, BMJ-BRIT MED J, V319, P438, DOI 10.1136/bmj.319.7207.438; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Joseph PD, 2015, BRIT J CLIN PHARMACO, V79, P357, DOI 10.1111/bcp.12305; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, V4; Lutje V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-61; Partsinevelou A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-106; Pienaar E, 2011, HEALTH INFO LIBR J, V28, P210, DOI [10.1111/j.1471-1842.2011.00936.x, 10.1111/J.1471-1842.2011.00936.x]; Raviglione M., 2013, GLOB STRAT TARG TUB; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Smith E, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-42; Su Y, 2020, LANCET INFECT DIS; United Nations, 2021, SUSTAIN DEV; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; World Health Organisation, 2018, GLOBAL TUBERCULOSIS; World Health Organisation, 2020, CLIN TRIALS CHILDR; World Health Organization, 2017, 2016 ANN REP COMM DI; Zeeneldin AA, 2016, J ADV RES, V7, P37, DOI 10.1016/j.jare.2015.01.003; Zhang Li, 2006, BMC Med Res Methodol, V6, P23, DOI 10.1186/1471-2288-6-23	26	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248621	10.1371/journal.pone.0248621	http://dx.doi.org/10.1371/journal.pone.0248621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739989	gold, Green Published, Green Accepted			2022-12-26	WOS:000631030200050
J	Jakinala, P; Lingampally, N; Hameeda, B; Sayyed, RZ; Khan, MY; Elsayed, EA; El Enshasy, H				Jakinala, Parameshwar; Lingampally, Nageshwar; Hameeda, Bee; Sayyed, R. Z.; Khan M., Yahya; Elsayed, Elsayed Ahmed; El Enshasy, Hesham			Silver nanoparticles from insect wing extract: Biosynthesis and evaluation for antioxidant and antimicrobial potential	PLOS ONE			English	Article							GREEN SYNTHESIS; LEAF EXTRACT; ANTIBACTERIAL ACTIVITY; GOLD NANOPARTICLES; MEDIATED SYNTHESIS; IN-VITRO; IMPACT	Silver nanoparticles (AgNPs) are among the most widely synthesized and used nanoparticles (NPs). AgNPs have been traditionally synthesized from plant extracts, cobwebs, microorganisms, etc. However, their synthesis from wing extracts of common insect; Mang mao which is abundantly available in most of the Asian countries has not been explored yet. We report the synthesis of AgNPs from M. mao wings extract and its antioxidant and antimicrobial activity. The synthesized AgNPs were spherical, 40-60 nm in size and revealed strong absorption plasmon band around at 430 nm. Highly crystalline nature of these particles as determined by Energy-dispersive X-ray analysis and X-ray diffraction further confirmed the presence of AgNPs. Hydrodynamic size and zeta potential of AgNPs were observed to be 43.9 nm and -7.12 mV, respectively. Fourier-transform infrared spectroscopy analysis revealed the presence of characteristic amide proteins and aromatic functional groups. Thin-layer chromatography (TLC) and Gas chromatography-mass spectroscopy (GC-MS) analysis revealed the presence of fatty acids in the wings extract that may be responsible for biosynthesis and stabilization of AgNPs. Further, SDS-PAGE of the insect wing extract protein showed the molecular weight of 49 kDa. M. mao silver nanoparticles (MMAgNPs) exhibit strong antioxidant, broad-range antibacterial and antifungal activities, (66.8 to 87.0%), broad-range antibacterial and antifungal activities was found with maximum zone of inhibition against Staphylococcus aureus MTCC 96 (35 +/- 0.4 mm) and Fusarium oxysporum f. sp. ricini (86.6 +/- 0.4) which signifies their biomedical and agricultural potential.	[Jakinala, Parameshwar; Lingampally, Nageshwar; Hameeda, Bee] Osmania Univ, Dept Microbiol, Hyderabad, Telangana, India; [Sayyed, R. Z.] PSGVP Mandals Arts Sci & Commerce Coll, Dept Microbiol, Shahada, Maharashtra, India; [Khan M., Yahya] Kalam Biotech Pvt Ltd, Hyderabad, India; [Elsayed, Elsayed Ahmed] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Elsayed, Elsayed Ahmed] Natl Res Ctr, Chem Nat & Microbial Prod Dept, Cairo 1, Egypt; [El Enshasy, Hesham] Univ Teknol Malaysia UTM, Inst Bioprod Dev IBD, Skudai, Johor Bahru, Malaysia; [El Enshasy, Hesham] City Sci Res & Technol Applicat CSRTA, Alexandria, Egypt	Osmania University; King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Universiti Teknologi Malaysia; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	Hameeda, B (corresponding author), Osmania Univ, Dept Microbiol, Hyderabad, Telangana, India.	drhami2009@gmail.com	Hameeda, B./AAV-4635-2021; Sayyed, R Z/Q-4313-2016; El Enshasy, Hesham Ali/D-3733-2014	Sayyed, R Z/0000-0002-1553-1213; El Enshasy, Hesham Ali/0000-0002-9712-2033; Parameshwar Jakinala, Dr./0000-0001-6362-066X; Bee, Hameeda/0000-0002-9161-9567	UGC-RGNF [F1-17.1/2014-15/RGNF-2014-15-SC-TEL-86198]; DST-PURSE [C-DST-PURSE-II/43/2018]; King Saud University, Riyadh, KSA [RSP-2020/52]	UGC-RGNF(University Grants Commission, India); DST-PURSE; King Saud University, Riyadh, KSA(King Saud University)	This study was supported by UGC-RGNF in the form of a fellowship (F1-17.1/2014-15/RGNF-2014-15-SC-TEL-86198) to JP and, DST-PURSE in the form of funding (C-DST-PURSE-II/43/2018) awarded to H B. The authors extend their appreciation for King Saud University, Riyadh, KSA, for funding the work through Researchers Supporting Project (Project No. RSP-2020/52). Kalam Biotech Pvt. Ltd provided support in the form of a salary for YK. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abdelghany TM, 2018, BIONANOSCIENCE, V8, P5, DOI 10.1007/s12668-017-0413-3; Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a; Ahmed S, 2016, J RADIAT RES APPL SC, V9, P1, DOI 10.1016/j.jrras.2015.06.006; Al-Shmgani HSA, 2017, ARTIF CELL NANOMED B, V45, P1234, DOI 10.1080/21691401.2016.1220950; Badoei-dalfard A, 2019, BIOCATAL AGR BIOTECH, V20, DOI 10.1016/j.bcab.2019.101257; Bahrami-Teimoori B, 2017, J EXP NANOSCI, V12, P129, DOI 10.1080/17458080.2017.1279355; Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034; Basu S, 2016, APPL NANOSCI, V6, P1, DOI 10.1007/s13204-015-0407-9; Belteky P, 2019, INT J NANOMED, V14, P667, DOI 10.2147/IJN.S185965; Buckner JS, 2003, ARCH INSECT BIOCHEM, V53, P66, DOI 10.1002/arch.10086; Chandrasekhar N, 2017, APPL NANOSCI, V7, P851, DOI 10.1007/s13204-017-0624-5; Chowdhury S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-365; Dalir SJB, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03624; Das CGA, 2020, BIOCATAL AGR BIOTECH, V27, DOI 10.1016/j.bcab.2020.101593; Dey A, 2015, J IND ENG CHEM, V24, P181, DOI 10.1016/j.jiec.2014.09.027; Dhanasekaran D, 2013, J EXP NANOSCI, V8, P579, DOI 10.1080/17458080.2011.577099; Farrag HMM, 2020, EXP PARASITOL, V219, DOI 10.1016/j.exppara.2020.108031; Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856; Ghaffari-Moghaddam M, 2014, J IND ENG CHEM, V20, P739, DOI 10.1016/j.jiec.2013.09.005; Golebiowski M, 2011, ANAL BIOANAL CHEM, V399, P3177, DOI 10.1007/s00216-010-4439-4; Govindappa M, 2018, RESULTS PHYS, V9, P400, DOI 10.1016/j.rinp.2018.02.049; Iijima M, 2016, J ASIAN CERAM SOC, V4, P277, DOI 10.1016/j.jascer.2016.05.003; Ivanova EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067893; Jakinala P, 2019, ECOTOX ENVIRON SAFE, V182, DOI 10.1016/j.ecoenv.2019.109372; Kagithoju S, 2015, 3 BIOTECH, V5, P709, DOI 10.1007/s13205-014-0272-3; Kedi PBE, 2018, INT J NANOMED, V13, P8537, DOI 10.2147/IJN.S174530; Khan SA, 2014, RSC ADV, V4, P7729, DOI 10.1039/c3ra43888k; Kucukbay FZ, 2012, NAT PROD RES, V26, P1668, DOI 10.1080/14786419.2011.599808; Kumar SA, 2007, BIOTECHNOL APPL BIOC, V47, P191, DOI 10.1042/BA20060205; Kumar V, 2016, J IND ENG CHEM, V37, P224, DOI 10.1016/j.jiec.2016.03.032; Lateef A, 2016, APPL NANOSCI, V6, P863, DOI 10.1007/s13204-015-0492-9; Linklater DP, 2021, NAT REV MICROBIOL, V19, P8, DOI 10.1038/s41579-020-0414-z; Mohanta YK, 2018, MOLECULES, V23, DOI 10.3390/molecules23030655; Netala VR, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0433-7; Nguyen SHT, 2013, COLLOID SURFACE B, V106, P126, DOI 10.1016/j.colsurfb.2013.01.042; Patil MP, 2018, MICROB PATHOGENESIS, V121, P184, DOI 10.1016/j.micpath.2018.05.040; Rafique M, 2017, ARTIF CELL NANOMED B, V45, P1272, DOI 10.1080/21691401.2016.1241792; Ramkumar SRS, 2017, RSC ADV, V7, P34548, DOI 10.1039/c6ra28328d; Rane AN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00878; Rani SU, 2009, J EXP NANOSCI, V4, P285, DOI 10.1080/17458080903115338; Reddy AS, 2009, MATER LETT, V63, P1227, DOI 10.1016/j.matlet.2009.02.028; Seifert E, 2014, J CHEM INF MODEL, V54, P1552, DOI 10.1021/ci500161d; Selvakumar P, 2018, J PHOTOCH PHOTOBIO B, V182, P52, DOI 10.1016/j.jphotobiol.2018.03.018; Siddiqi KS, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0334-5; Simpson Richard J, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4313; Singh P, 2015, INT J NANOMED, V10, P2567, DOI 10.2147/IJN.S72313; Sinha SN, 2015, APPL NANOSCI, V5, P703, DOI 10.1007/s13204-014-0366-6; Soman S, 2016, J PHOTOCH PHOTOBIO B, V163, P391, DOI 10.1016/j.jphotobiol.2016.08.033; Varadavenkatesan T, 2020, MATER TODAY-PROC, V23, P39, DOI 10.1016/j.matpr.2019.05.441; Veerasamy R, 2011, J SAUDI CHEM SOC, V15, P113, DOI 10.1016/j.jscs.2010.06.004; Yugandhar P, 2015, 3 BIOTECH, V5, P1031, DOI 10.1007/s13205-015-0307-4; Zhang QX, 2017, ENVIRON SCI POLLUT R, V24, P25000, DOI 10.1007/s11356-017-0179-8	52	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0241729	10.1371/journal.pone.0241729	http://dx.doi.org/10.1371/journal.pone.0241729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735177	Green Published, gold, Green Submitted			2022-12-26	WOS:000631029700097
J	Saddler, K; Zhang, JS; Sul, J; Patel, P; Castro-Lainez, M; Stevens, ML; Kosler, S; Lowery, E; Sierra-Hoffman, M				Saddler, Kimberly; Zhang, Jason; Sul, Jennifer; Patel, Pruthvi; Castro-Lainez, Miriams; Stevens, Mark L.; Kosler, Sheryl; Lowery, Emily; Sierra-Hoffman, Miguel			Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital	PLOS ONE			English	Article							SINGLE-DOSE ORITAVANCIN; STAPHYLOCOCCUS-AUREUS SKIN; EMERGENCY-DEPARTMENT; ADMISSIONS; MANAGEMENT; SEVERITY	Background Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults with acute bacterial skin and skin structure infections (ABSSSI). Its concentration-dependent activity and prolonged half-life provide a convenient single-dose alternative to multi-dose daily therapies for ABSSSI. This retrospective cohort study was conducted to quantify the clinical and economic advantages of using oritavancin compared to other antibiotic agents that have been historically effective for ABSSSI. Methods Seventy-nine patients received oritavancin who had failed previous outpatient antibiotic therapy (OPAT) for cellulitis or abscess and were subsequently readmitted to the hospital as an inpatient between 2016 and 2018. These patients were compared to a cohort of 28 patients receiving other antibiotics following OPAT failure and subsequent hospitalization for these two infection types. The primary clinical end point was average length of stay (aLOS) and secondary endpoints included readmission rates for the same indication at 30 and 90 days after discharge and the average hospital cost (aHC). Results A total of 107 patients were hospitalized for treatment of cellulitis or abscess. Demographic characteristics of both the oritavancin and comparator groups were similar except for the presence of diabetes. The primary clinical endpoint showed a non-significant decrease in aLOS between the oritavancin group versus comparator (2.12 days versus 2.59 days; p = 0.097). The secondary endpoints revealed lower readmission rates associated with oritavancin treatment at 30 and 90 days; the average hospital cost was 5.9% lower for patients that received oritavancin. Conclusion The results of this study demonstrate that oritavancin provides not only a single-dose alternative to multi-day therapies for skin and skin structure infections, but also a clinical and economic advantage compared to other antibiotic agents.	[Saddler, Kimberly] DeTar Healthcare Syst, Dept Pharm, Victoria, TX 77901 USA; [Zhang, Jason; Sul, Jennifer] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA; [Patel, Pruthvi] DeTar Healthcare Syst, DeTar Family Med Residency Program, Victoria, TX USA; [Castro-Lainez, Miriams] Univ Nacl Autonoma Honduras, Hosp Escuela Univ, Fac Ciencias Med, Blvd Suyapa, Tegucigalpa, Honduras; [Stevens, Mark L.; Sierra-Hoffman, Miguel] Texas A&M Coll Med, Affiliated DeTar Family Med Residency, Victoria, TX USA; [Kosler, Sheryl] DeTar Healthcare Syst, Victoria, TX USA; [Lowery, Emily] Univ Texas Austin, Austin, TX 78712 USA	Universidad Nacional Autonoma de Honduras; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin	Saddler, K (corresponding author), DeTar Healthcare Syst, Dept Pharm, Victoria, TX 77901 USA.	kim.saddler@detar.com		Stevens, Mark/0000-0002-1813-6403; Saddler, Kimberly/0000-0001-9673-4241	DeTar Healthcare System	DeTar Healthcare System	DeTar Healthcare System provided support in the form of a salary for author KS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Corey GR, 2016, INT J ANTIMICROB AG, V48, P528, DOI 10.1016/j.ijantimicag.2016.07.019; Corey GR, 2015, CLIN INFECT DIS, V60, P254, DOI 10.1093/cid/ciu778; Corey GR, 2014, NEW ENGL J MED, V370, P2180, DOI 10.1056/NEJMoa1310422; Deck DH, 2016, INFECT DIS THER, V5, P353, DOI 10.1007/s40121-016-0119-9; Di Gennaro F, 2020, J GLOB ANTIMICROB RE, V23, P167, DOI 10.1016/j.jgar.2020.08.022; Eells SJ, 2016, ANTIMICROB AGENTS CH, V60, P2941, DOI 10.1128/AAC.02626-15; Ektare V, 2015, J MED ECON, V18, P1092, DOI 10.3111/13696998.2015.1078339; Eron Lawrence J., 2003, Journal of Antimicrobial Chemotherapy, V52, pi3; Fast Facts on U.S, 2019, HOSPITALS; FDA, 2018, FRAM FDAS REAL WORLD; Fritz SA, 2020, CLIN INFECT DIS, V70, P2715, DOI 10.1093/cid/ciz977; Jernigan JA, 2020, NEW ENGL J MED, V382, P1309, DOI 10.1056/NEJMoa1914433; Kaye KS, 2019, CLIN INFECT DIS, V68, pS193, DOI 10.1093/cid/ciz002; Kaye KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143276; Lee GC, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0175-8; Lodise TP, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw274; Lodise TP, 2016, CLIN THER, V38, P136, DOI 10.1016/j.clinthera.2015.11.014; Lodise Thomas P, 2015, Hosp Pract (1995), V43, P137, DOI 10.1080/21548331.2015.1076325; Miller LG, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1071-0; Morgan E, 2019, CLIN INFECT DIS, V68, P453, DOI 10.1093/cid/ciy509; Sulham K, 2014, VALUE HEALTH, V17, pA282, DOI 10.1016/j.jval.2014.03.1642; Sulham K, 2018, ASM MICROBE; Talan DA, 2015, WEST J EMERG MED, V16, P89, DOI 10.5811/westjem.2014.11.24133; Tun K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206893; US Food and Drug Administration, 2013, ACUTE BACTERIAL SKIN	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248129	10.1371/journal.pone.0248129	http://dx.doi.org/10.1371/journal.pone.0248129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735185	gold, Green Published			2022-12-26	WOS:000631029700081
J	Leonel, TF; Pepe, ESG; Castellane, TCL; Vantini, JD; Funnicelli, MIG; Lemos, EGD				Leonel, Tatiane Fernanda; Gomes Pepe, Elisangela Soares; Luque Castellane, Tereza Cristina; Vantini, Juliana da Silva; Goncalves Funnicelli, Michelli Inacio; de Macedo Lemos, Eliana Gertrudes			Bagasse minority pathway expression: Real time study of GH2 beta-mannosidases from bacteroidetes	PLOS ONE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; ENZYMATIC-HYDROLYSIS; GENOME SEQUENCE; DATABASE; CHITINOPHAGA; MANNAN; OLIGOSACCHARIDES; COFFEE; PCR	After being isolated from a sugarcane pile, the bacterium Chitinophaga sp. CB10 demonstrated to be a rich source of carbohydrases, with 350 predicted CAZyme domains. CB10 was able to grow on carbohydrates of different structural complexities: glucose, carboxymethylcellulose, corn starch, galactomannan, Aloe vera gum and sugarcane bagasse. The sugarcane bagasse is a rich source of complex polymers, and the diversity of metabolites released by its enzymatic hydrolysis has an important role for green chemistry, including minority pathways such as the degradation of mannan conjugates. In this sense, CB10 demonstrated considerable levels of gene expression for mannanases, and was stable for a period of 96-144 hours in the presence of sugarcane bagasse as sole carbon source. The bacterium showed respectively 4.8x and 5.6x expression levels for two genes predicted for GH2 beta-mannosidase: one located within a gene cluster identified as "polysaccharide utilization loci" (PUL), and another a classic beta-mannosidase. These enzymes shared less than 45% of identity with enzymes characterized from the genus Chitinophaga belonging to the phylum Bacteroidetes. The degree of novelty-as demonstrated by the low identity with previously characterized enzymes; the remarkable capability to grow in different substrates; mannanase activity, evidenced by the release of residual oligosaccharides in the cultivation with galactomannan (HPLC-RID, 12.3 mMol); associated to the ability of mannanases expression in a low concentration of inductor conditions (sugarcane bagasse, 0.2%) indicate the high potential for the application of CB10 as a source of enzymes in the production of oligosaccharides from biomass. This capacity might prove to be very valuable for the biorefinery process of pre-biotic precursors and other functional oligosaccharides focused on the food and pharmaceutical industries.	[Leonel, Tatiane Fernanda; Gomes Pepe, Elisangela Soares; Luque Castellane, Tereza Cristina; Vantini, Juliana da Silva; Goncalves Funnicelli, Michelli Inacio; de Macedo Lemos, Eliana Gertrudes] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Jaboticabal, SP, Brazil; [Leonel, Tatiane Fernanda; Gomes Pepe, Elisangela Soares; Luque Castellane, Tereza Cristina; Vantini, Juliana da Silva; Goncalves Funnicelli, Michelli Inacio; de Macedo Lemos, Eliana Gertrudes] Dept Technol, Lab Biochem & Plant Microorganisms, Jaboticabal, SP, Brazil; [Leonel, Tatiane Fernanda; Goncalves Funnicelli, Michelli Inacio] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Grad Program Agr & Livestock Microbiol, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Lemos, EGD (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Jaboticabal, SP, Brazil.; Lemos, EGD (corresponding author), Dept Technol, Lab Biochem & Plant Microorganisms, Jaboticabal, SP, Brazil.	eliana.lemos@unesp.br	de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Inacio Gonçalves Funnicelli, Michelli/GSM-7929-2022	de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Luque Castellane, Tereza Cristina/0000-0002-7290-5314	Capes Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]; FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; CNPQ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Capes Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	TFL, Capes 001 Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior https://www.capes.gov.br/EGML FAPESP, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo http://www.fapesp.br/CNPQ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://www.cnpq.br/CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior https://www.capes.gov.br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt B, 2010, STAND GENOMIC SCI, V3, P15, DOI 10.4056/sigs.1012662; [Anonymous], arbohydrate-Active enZYmes Database. Glycoside Hydrolase family classification; Asano I, 2003, FOOD SCI TECHNOL RES, V9, P62, DOI 10.3136/fstr.9.62; Bradley PR., 1992, BRIT HERBAL PHARM; Brienzo M., 2016, FOODWASTE, P155; Bushnell LD, 1941, J BACTERIOL, V41, P653, DOI 10.1128/JB.41.5.653-673.1941; Cano ME, 2020, FERMENTATION-BASEL, V6, DOI 10.3390/fermentation6010031; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cote N, 2006, BIOCHEM J, V394, P675, DOI 10.1042/BJ20051436; Desiderato JG, 2018, GENET MOL BIOL, V41, P507, DOI [10.1590/1678-4685-GMB-2017-0155, 10.1590/1678-4685-gmb-2017-0155]; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dong WW, 2018, ANTON LEEUW INT J G, V111, P265, DOI 10.1007/s10482-017-0947-y; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huang L, 2018, NUCLEIC ACIDS RES, V46, pD516, DOI 10.1093/nar/gkx894; Ishii J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0600-4; Jian HL, 2013, INT J BIOL MACROMOL, V55, P282, DOI 10.1016/j.ijbiomac.2013.01.025; Jin DC, 2018, INT J SYST EVOL MICR, V68, P2209, DOI 10.1099/ijsem.0.002811; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Kilic S, 2014, NUCLEIC ACIDS RES, V42, pD156, DOI 10.1093/nar/gkt1123; Kim DY, 2011, BIORESOURCE TECHNOL, V102, P9185, DOI 10.1016/j.biortech.2011.06.073; Kishi LT, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01056-16, 10.1128/genomea.01056-16]; Kong XK, 2019, INT J SYST EVOL MICR, V69, P1783, DOI 10.1099/ijsem.0.003395; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamb J, 2005, J ARCHAEOL SCI, V32, P1433, DOI 10.1016/j.jas.2005.03.020; Larsbrink J, 2017, J PROTEOMICS, V156, P63, DOI 10.1016/j.jprot.2017.01.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Costa DAL, 2019, APPL MICROBIOL BIOT, V103, P535, DOI 10.1007/s00253-018-9500-9; Lv YY, 2018, INT J SYST EVOL MICR, V68, P2139, DOI 10.1099/ijsem.0.002700; Malgas S, 2015, WORLD J MICROB BIOT, V31, P1167, DOI 10.1007/s11274-015-1878-2; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martin C, 2011, CELL CHEM TECHNOL, V45, P487; McKee LS, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02231-18; McKee LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139932; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Omori WP, 2019, GENET MOL BIOL, V42, P145, DOI [10.1590/1678-4685-GMB-2017-0376, 10.1590/1678-4685-gmb-2017-0376]; PARKINSON PG, 1983, TAXON, V32, P605, DOI 10.2307/1221730; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Proenca DN, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0262-2; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGKHOBOL V, 1981, INT J SYST BACTERIOL, V31, P285, DOI 10.1099/00207713-31-3-285; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Song YJ, 2018, J AGR FOOD CHEM, V66, P11055, DOI 10.1021/acs.jafc.8b03878; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urdiain M, 2004, FOOD ADDIT CONTAM A, V21, P619, DOI 10.1080/02652030410001713889; Wang CL, 2019, INT J SYST EVOL MICR, V69, P909, DOI 10.1099/ijsem.0.003212; Wang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078507; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418; Zong YY, 2019, INT J SYST EVOL MICR, V69, P2114, DOI 10.1099/ijsem.0.003445; ZUCKERKANDL EMILE, 1965, P97	61	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247822	10.1371/journal.pone.0247822	http://dx.doi.org/10.1371/journal.pone.0247822			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730062	gold, Green Published			2022-12-26	WOS:000630345000001
J	Taki, K; Takagi, H; Hirose, T; Sun, RN; Yaginuma, H; Mizoguchi, A; Kobayashi, T; Sugiyama, M; Tsunekawa, T; Onoue, T; Hagiwara, D; Ito, Y; Iwama, S; Suga, H; Banno, R; Sakano, D; Kume, S; Arima, H				Taki, Keigo; Takagi, Hiroshi; Hirose, Tomonori; Sun, Runan; Yaginuma, Hiroshi; Mizoguchi, Akira; Kobayashi, Tomoko; Sugiyama, Mariko; Tsunekawa, Taku; Onoue, Takeshi; Hagiwara, Daisuke; Ito, Yoshihiro; Iwama, Shintaro; Suga, Hidetaka; Banno, Ryoichi; Sakano, Daisuke; Kume, Shoen; Arima, Hiroshi			Dietary sodium chloride attenuates increased beta-cell mass to cause glucose intolerance in mice under a high-fat diet	PLOS ONE			English	Article								Excessive sodium salt (NaCl) or fat intake is associated with a variety of increased health risks. However, whether excessive NaCl intake accompanied by a high-fat diet (HFD) affects glucose metabolism has not been elucidated. In this study, C57BL/6J male mice were fed a normal chow diet (NCD), a NCD plus high-NaCl diet (NCD plus NaCl), a HFD, or a HFD plus high-NaCl diet (HFD plus NaCl) for 30 weeks. No significant differences in body weight gain, insulin sensitivity, and glucose tolerance were observed between NCD-fed and NCD plus NaCl-fed mice. In contrast, body and liver weights were decreased, but the weight of epididymal white adipose tissue was increased in HFD plus NaCl-fed compared to HFD-fed mice. HFD plus NaCl-fed mice had lower plasma glucose levels in an insulin tolerance test, and showed higher plasma glucose and lower plasma insulin levels in an intraperitoneal glucose tolerance test compared to HFD-fed mice. The beta-cell area and number of islets were decreased in HFD plus NaCl-fed compared to HFD-fed mice. Increased Ki67-positive beta-cells, and increased expression levels of Ki67, CyclinB1, and CyclinD1 mRNA in islets were observed in HFD-fed but not HFD plus NaCl-fed mice when compared to NCD-fed mice. Our data suggest that excessive NaCl intake accompanied by a HFD exacerbates glucose intolerance, with impairment in insulin secretion caused by the attenuation of expansion of beta-cell mass in the pancreas.	[Taki, Keigo; Takagi, Hiroshi; Hirose, Tomonori; Sun, Runan; Yaginuma, Hiroshi; Mizoguchi, Akira; Kobayashi, Tomoko; Sugiyama, Mariko; Tsunekawa, Taku; Onoue, Takeshi; Hagiwara, Daisuke; Ito, Yoshihiro; Iwama, Shintaro; Suga, Hidetaka; Banno, Ryoichi; Arima, Hiroshi] Nagoya Univ, Dept Endocrinol & Diabet, Grad Sch Med, Showa Ku, Nagoya, Aichi, Japan; [Banno, Ryoichi] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan; [Sakano, Daisuke; Kume, Shoen] Tokyo Inst Technol, Sch Life Sci & Technol, Dept Life Sci & Technol, Midori Ku, Yokohama, Kanagawa, Japan	Nagoya University; Nagoya University; Tokyo Institute of Technology	Takagi, H (corresponding author), Nagoya Univ, Dept Endocrinol & Diabet, Grad Sch Med, Showa Ku, Nagoya, Aichi, Japan.	htakagi@med.nagoya-u.ac.jp			JSPS KAKENHI [JP17K17803, 19K20180]; Chukyo Longevity Foundation in 2019	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Chukyo Longevity Foundation in 2019	This study was supported by JSPS KAKENHI Grant Numbers JP17K17803 and 19K20180 to HT; and Chukyo Longevity Foundation in 2019 to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimochi H, 2005, J MOL NEUROSCI, V27, P293, DOI 10.1385/JMN:27:3:293; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; DeClercq VC, 2016, J NUTR, V146, P1189, DOI 10.3945/jn.115.227496; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fonseca-Alaniz MH, 2008, OBESITY, V16, P1186, DOI 10.1038/oby.2008.69; Garofalo C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060732; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; Ito Y, 2013, J NEUROSCI, V 33, P17166, DOI 10.1523/JNEUROSCI.0897-13.2013; Kikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095451; Kitao N, 2018, METABOLISM, V85, P48, DOI 10.1016/j.metabol.2018.03.010; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Lasheen NN, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12443; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Ogihara T, 2001, DIABETES, V50, P573, DOI 10.2337/diabetes.50.3.573; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Prada PD, 2000, HYPERTENSION, V35, P424, DOI 10.1161/01.HYP.35.1.424; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rachek LI, 2014, PROG MOL BIOL TRANSL, V121, P267, DOI 10.1016/B978-0-12-800101-1.00008-9; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Stamateris RE, 2013, AM J PHYSIOL-ENDOC M, V305, pE149, DOI 10.1152/ajpendo.00040.2013; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; SUTHERLAND TM, 1974, GENETICS, V78, P525; Tajima K, 2017, AM J PHYSIOL-ENDOC M, V313, pE367, DOI 10.1152/ajpendo.00447.2016; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; Weidemann BJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11123; WHO, 2012, GUID SOD INT AD CHIL; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang XB, 2005, DIABETES, V54, P712, DOI 10.2337/diabetes.54.3.712	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248065	10.1371/journal.pone.0248065	http://dx.doi.org/10.1371/journal.pone.0248065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730054	gold, Green Published			2022-12-26	WOS:000630345000076
J	Hutcherson, RJ; Gabbard, RD; Castellanos, AJ; Travers, JB; Kemp, MG				Hutcherson, Rebekah J.; Gabbard, Ryan D.; Castellanos, Amber J.; Travers, Jeffrey B.; Kemp, Michael G.			Age and insulin-like growth factor-1 impact PCNA monoubiquitination in UVB-irradiated human skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE ETA; INDUCED PYRIMIDINE DIMERS; TRANSLESION SYNTHESIS; REPAIR; REPLICATION; CARCINOMA; SURVIVAL	Nonmelanoma skin cancers occur primarily in individuals over the age of 60 and are characterized by an abundance of ultraviolet (UV) signature mutations in keratinocyte DNA. Though geriatric skin removes UV photoproducts from DNA less efficiently than young adult skin, it is not known whether the utilization of other prosurvival but potentially mutagenic DNA damage tolerance systems such as translesion synthesis (TLS) is altered in older individuals. Using monoubiquitination of the replicative DNA polymerase clamp protein PCNA (proliferating cell nuclear antigen) as a biochemical marker of TLS pathway activation, we find that UVB exposure of the skin of individuals over the age of 65 results in a higher level of PCNA monoubiquitination than in the skin of young adults. Furthermore, based on previous reports showing a role for deficient insulin-like growth factor-1 (IGF-1) signaling in altered UVB DNA damage responses in geriatric human skin, we find that both pharmacological inhibition of the IGF-1 receptor (IGF-1R) and deprivation of IGF-1 potentiate UVB-induced PCNA monoubiquitination in both human skin ex vivo and keratinocytes in vitro. Interestingly, though the TLS DNA polymerase Pol eta can accurately replicate the major photoproducts induced in DNA by UV radiation, we find that it fails to accumulate on chromatin in the absence of IGF-1R signaling and that this phenotype is correlated with increased mutagenesis in keratinocytes in vitro. Thus, altered IGF-1/IGF-1R signaling in geriatric skin may predispose epidermal keratinocytes to carry out a more mutagenic form of DNA synthesis following UVB exposure.	[Hutcherson, Rebekah J.; Gabbard, Ryan D.; Castellanos, Amber J.; Travers, Jeffrey B.; Kemp, Michael G.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Travers, Jeffrey B.] Wright State Univ, Boonshoft Sch Med, Dept Dermatol, Dayton, OH 45435 USA; [Travers, Jeffrey B.] Dayton Vet Affairs Med Ctr, Dayton, OH USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton	Kemp, MG (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	mike.kemp@wright.edu		Kemp, Michael/0000-0001-8203-0745; Castellanos, Amber/0000-0002-4623-115X	Wright State University; National Institute of General Medical Sciences [GM130583]; National Institute on Aging [AG048946]; Veterans Administration (Clinical VA Merit Award) [1101CX000809]	Wright State University; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Administration (Clinical VA Merit Award)(US Department of Veterans Affairs)	This work was supported by start-up funding by Wright State University (to M. G. K.) and by grants from the National Institute of General Medical Sciences (GM130583 to M. G. K.), the National Institute on Aging (AG048946 to J. B. T.), and the Veterans Administration (Clinical VA Merit Award 1101CX000809 to J. B. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the US Veterans Administration.	Alkawar AMM, 2020, PHOTOCHEM PHOTOBIOL, V96, P1332, DOI 10.1111/php.13279; Andrade-Lima LC, 2015, J CELL SCI, V128, P150, DOI 10.1242/jcs.161596; BARRECA A, 1992, J CELL PHYSIOL, V151, P262, DOI 10.1002/jcp.1041510207; BRANCHET MC, 1990, GERONTOLOGY, V36, P28; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Cordonnier AM, 1999, MUTAT RES-DNA REPAIR, V435, P111, DOI 10.1016/S0921-8777(99)00047-6; Cruet-Hennequart S, 2010, SUBCELL BIOCHEM, V50, P189, DOI 10.1007/978-90-481-3471-7_10; FENSKE NA, 1986, J AM ACAD DERMATOL, V15, P571, DOI 10.1016/S0190-9622(86)70208-9; FERBER A, 1993, J BIOL CHEM, V268, P17883; Fernandez TL, 2015, EXP DERMATOL, V24, P235, DOI 10.1111/exd.12637; FREEMAN SE, 1988, J INVEST DERMATOL, V90, P814, DOI 10.1111/1523-1747.ep12462039; Gohler T, 2011, J CELL BIOL, V192, P219, DOI 10.1083/jcb.201008076; Gupta V, 2019, CLIN DERMATOL, V37, P430, DOI 10.1016/j.clindermatol.2019.07.010; Johnson GE, 2012, METHODS MOL BIOL, V817, P55, DOI 10.1007/978-1-61779-421-6_4; Kanao R., 2017, MUTAT RES, VS0027- 5107, P30081; Kemp MG, 2019, J INVEST DERMATOL, V139, P448, DOI 10.1016/j.jid.2018.07.039; Kemp MG, 2017, J BIOL CHEM, V292, P1231, DOI 10.1074/jbc.M116.765883; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Lerner LK, 2017, NUCLEIC ACIDS RES, V45, P1270, DOI 10.1093/nar/gkw1196; Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Loesch MM, 2016, MOL ONCOL, V10, P1245, DOI 10.1016/j.molonc.2016.06.002; MARKS R, 1981, BRIT J DERMATOL, V104, P627, DOI 10.1111/j.1365-2133.1981.tb00748.x; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Pilzecker B, 2019, NUCLEIC ACIDS RES, V47, P7163, DOI 10.1093/nar/gkz531; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Spandau DF, 2012, J INVEST DERMATOL, V132, P1591, DOI 10.1038/jid.2012.29; Travers JB, 2013, DERMATOL SURG, V39, P967, DOI 10.1111/dsu.12138; Waraky A, 2017, J BIOL CHEM, V292, P18227, DOI 10.1074/jbc.M117.781492; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; Xu GG, 2000, MUTAT RES-DNA REPAIR, V459, P195, DOI 10.1016/S0921-8777(99)00069-5; Yamada M, 2006, ARCH DERMATOL RES, V297, P294, DOI 10.1007/s00403-005-0618-0; Yang C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236291	38	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100570	10.1016/j.jbc.2021.100570	http://dx.doi.org/10.1016/j.jbc.2021.100570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753168	gold, Green Published			2022-12-26	WOS:000672866400543
J	Kong, CS; Ordonez, AA; Turner, S; Tremaine, T; Muter, J; Lucas, ES; Salisbury, E; Vassena, R; Tiscornia, G; Fouladi-Nashta, AA; Hartshorne, G; Brosens, JJ; Brighton, PJ				Kong, Chow-Seng; Ordonez, Alexandra Almansa; Turner, Sarah; Tremaine, Tina; Muter, Joanne; Lucas, Emma S.; Salisbury, Emma; Vassena, Rita; Tiscornia, Gustavo; Fouladi-Nashta, Ali A.; Hartshorne, Geraldine; Brosens, Jan J.; Brighton, Paul J.			Embryo biosensing by uterine natural killer cells determines endometrial fate decisions at implantation	FASEB JOURNAL			English	Article						decidualization; embryo implantation; endometrium; hyaluronan; senescence; uterine natural killer cells	RECURRENT PREGNANCY LOSS; HYALURONAN; EXPRESSION; CD44; DECIDUALIZATION; INVASION; PATHWAY; SULFATE; BINDING; SYSTEM	Decidualizing endometrial stromal cells (EnSC) critically determine the maternal response to an implanting conceptus, triggering either menstruation-like disposal of low-fitness embryos or creating an environment that promotes further development. However, the mechanism that couples maternal recognition of low-quality embryos to tissue breakdown remains poorly understood. Recently, we demonstrated that successful transition of the cycling endometrium to a pregnancy state requires selective elimination of pro-inflammatory senescent decidual cells by activated uterine natural killer (uNK) cells. Here we report that uNK cells express CD44, the canonical hyaluronan (HA) receptor, and demonstrate that high molecular weight HA (HMWHA) inhibits uNK cell-mediated killing of senescent decidual cells. In contrast, low molecular weight HA (LMWHA) did not attenuate uNK cell activity in co-culture experiments. Killing of senescent decidual cells by uNK cells was also inhibited upon exposure to medium conditioned by IVF embryos that failed to implant, but not successful embryos. Embryo-mediated inhibition of uNK cell activity was reversed by recombinant hyaluronidase 2 (HYAL2), which hydrolyses HMWHA. We further report a correlation between the levels of HYAL2 secretion by human blastocysts, morphological scores, and implantation potential. Taken together, the data suggest a pivotal role for uNK cells in embryo biosensing and endometrial fate decisions at implantation.	[Kong, Chow-Seng; Muter, Joanne; Lucas, Emma S.; Salisbury, Emma; Hartshorne, Geraldine; Brosens, Jan J.; Brighton, Paul J.] Univ Warwick, Warwick Med Sch, Ctr Early Life, Coventry CV2 2DX, W Midlands, England; [Ordonez, Alexandra Almansa; Vassena, Rita; Tiscornia, Gustavo] Eugin Clin, Barcelona, Spain; [Turner, Sarah; Hartshorne, Geraldine] Univ Hosp Coventry & Warwickshire NHS Trust, Ctr Reprod Med, Coventry, W Midlands, England; [Tremaine, Tina; Fouladi-Nashta, Ali A.] Univ London, Royal Vet Coll, Comparat Biomed Sci, Hatfield, Herts, England; [Muter, Joanne; Brosens, Jan J.] Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of London; University of London Royal Veterinary College; University of Warwick	Brosens, JJ (corresponding author), Univ Warwick, Warwick Med Sch, Ctr Early Life, Coventry CV2 2DX, W Midlands, England.	J.J.Brosens@warwick.ac.uk			Wellcome Trust (Wellcome) [212233/Z/18/Z]; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia [GENCAT 2018 DI 103]; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation; Clinica Eugin Intramural Fund; Tommy's	Wellcome Trust (Wellcome); Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Clinica Eugin Intramural Fund; Tommy's	Tommy's; Wellcome Trust (Wellcome), Grant/Award Number: 212233/Z/18/Z; Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia, Grant/Award Number: GENCAT 2018 DI 103; WPH Charitable Trust (W P H Charitable Trust); University Hospital Coventry and Warwickshire (UHCW) NHS Trust; Torres Quevedo Program of the Spanish Ministry of Science and Innovation; Clinica Eugin Intramural Funding	Al-Sabbagh M, 2011, ENDOCRINOLOGY, V152, P730, DOI 10.1210/en.2010-0899; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Baggenstoss BA, 2017, GLYCOBIOLOGY, V27, P154, DOI 10.1093/glycob/cww089; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Berkhout RP, 2018, J ASSIST REPROD GEN, V35, P659, DOI 10.1007/s10815-017-1107-z; Berkhout RP, 2020, HUM REPROD, V35, P1797, DOI 10.1093/humrep/deaa149; Biase FH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000046; Brighton, 2016, BIO PROTOCOL, V6; Brighton PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.31274; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; BROWN JJG, 1992, DIFFERENTIATION, V52, P61, DOI 10.1111/j.1432-0436.1992.tb00500.x; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Critchley HOD, 2020, PHYSIOL REV, V100, P1149, DOI 10.1152/physrev.00031.2019; Erkenbrack EM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005594; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Ewington LJ, 2019, J OBSTET GYNAECOL RE, V45, P258, DOI 10.1111/jog.13837; Feng RZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08689; Foo L, 2020, PAEDIATR PERINAT EP, V34, P495, DOI 10.1111/ppe.12613; Fouladi-Nashta AA, 2017, REPRODUCTION, V153, pR43, DOI [10.1530/REP-16-0240, 10.1530/rep-16-0240]; Fukui A, 2017, J OBSTET GYNAECOL RE, V43, P1678, DOI 10.1111/jog.13448; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 2019, CURR BIOL, V29, pR455, DOI 10.1016/j.cub.2019.04.040; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; Katano K, 2013, FERTIL STERIL, V100, P1629, DOI 10.1016/j.fertnstert.2013.07.1996; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Lucas ES, 2016, STEM CELLS, V34, P346, DOI 10.1002/stem.2222; Macklon Nick S, 2014, Biol Reprod, V91, P98, DOI 10.1095/biolreprod.114.122846; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Marei WFA, 2016, THERIOGENOLOGY, V86, P940, DOI 10.1016/j.theriogenology.2016.03.017; Marei WFA, 2013, MOL HUM REPROD, V19, P590, DOI 10.1093/molehr/gat032; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; McCoy RC, 2017, TRENDS GENET, V33, P448, DOI 10.1016/j.tig.2017.04.001; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Muter J, 2018, ENDOCRINOLOGY, V159, P994, DOI 10.1210/en.2017-03064; Ochiai A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1511-7; Ohno-Nakahara M, 2004, J BIOCHEM, V135, P567, DOI 10.1093/jb/mvh069; RIPELLINO JA, 1985, J HISTOCHEM CYTOCHEM, V33, P1060, DOI 10.1177/33.10.4045184; Rowley JE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031036; Ruane PT, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoz033; Sague SL, 2004, J INTERF CYTOK RES, V24, P301, DOI 10.1089/107999004323065093; Salamonsen LA, 2001, CELL TISSUE RES, V306, P335, DOI 10.1007/s004410100452; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Starostik MR, 2020, GENOME RES, V30, P814, DOI 10.1101/gr.262774.120; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takahashi H, 2014, PLACENTA, V35, P163, DOI 10.1016/j.placenta.2013.12.009; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Weimar CHE, 2013, HUM REPROD UPDATE, V19, P542, DOI 10.1093/humupd/dmt025; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yasuo T, 2008, J REPROD IMMUNOL, V78, P1, DOI 10.1016/j.jri.2007.09.002; Zhu R, 2013, PLACENTA, V34, P784, DOI 10.1016/j.placenta.2013.05.009; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	64	17	18	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21336	10.1096/fj.202002217R	http://dx.doi.org/10.1096/fj.202002217R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749894	hybrid, Green Published			2022-12-26	WOS:000635216100101
J	Recchiuti, A; Patruno, S; Mattoscio, D; Isopi, E; Pomilio, A; Lamolinara, A; Iezzi, M; Pecce, R; Romano, M				Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Lamolinara, Alessia; Iezzi, Manuela; Pecce, Romina; Romano, Mario			Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages	FASEB JOURNAL			English	Article						omega-3 fatty acids; COVID-19; resolution; respiratory viruses; specialized proresolving lipid mediators	PSEUDOMONAS-AERUGINOSA; INFLUENZA-VIRUS; RESOLUTION; MEDIATORS; REGULATOR; EXPRESSION; MICRORNAS; MECHANISMS; DISEASE	An excessive, non-resolving inflammatory response underlies severe COVID-19 that may have fatal outcomes. Therefore, the investigation of endogenous pathways leading to resolution of inflammation is of interest to uncover strategies for mitigating inflammation in people with SARS-CoV-2 infection. This becomes particularly urgent in individuals with preexisting pathologies characterized by chronic respiratory inflammation and prone to bacterial infection, such as cystic fibrosis (CF). Here, we analyzed the immune responses to SARS-CoV-2 virion spike 1 glycoprotein (S1) of macrophages (M phi) from volunteers with and without CF and tested the efficacy of resolvins (Rv) D1 and D2 in regulating the inflammatory and antimicrobial functions of M phi exposed to S1. S1 significantly increased chemokine release, including interleukin (IL)-8, in CF and non-CF M phi, while it enhanced IL-6 and tumor necrosis factor (TNF)-alpha in non-CF M phi, but not in CF cells. S1 also triggered the biosynthesis of RvD1 and modulated microRNAs miR-16, miR-29a, and miR-103, known to control the inflammatory responses. RvD1 and RvD2 treatment abated S1-induced inflammatory responses in CF and non-CF M phi, significantly reducing the release of select chemokines and cytokines including IL-8 and TNF-alpha. RvD1 and RvD2 both restored the expression of miR-16 and miR-29a, while selectively increasing miR-223 and miR-125a, which are involved in NF-kappa B activation and M phi inflammatory polarization. During Pseudomonas aeruginosa infection, S1 stimulated the M phi phagocytic activity that was further enhanced by RvD1 and RvD2. These results provide a map of molecular responses to SARS-CoV-2 in M phi, key determinants of COVID-19-related inflammation, unveiling some peculiarity in the response of cells from individuals with CF. They also demonstrate beneficial, regulatory actions of RvD1 and RvD2 on SARS-CoV-2-induced inflammation.	[Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Pecce, Romina; Romano, Mario] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Polacchi,13, I-66100 Chieti, Italy; [Recchiuti, Antonio; Patruno, Sara; Mattoscio, Domenico; Isopi, Elisa; Pomilio, Antonella; Lamolinara, Alessia; Iezzi, Manuela; Pecce, Romina; Romano, Mario] Univ G dAnnunzio, Ctr Adv Studies & Technol, Chieti, Italy; [Lamolinara, Alessia; Iezzi, Manuela] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Recchiuti, A (corresponding author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Polacchi,13, I-66100 Chieti, Italy.	a.recchiuti@unich.it	Romano, Mario/I-7986-2012; Iezzi, Manuela/AAB-7939-2019; lamolinara, alessia/AAB-8833-2019; Mattoscio, Domenico/K-1411-2018; recchiuti, antonio/K-7670-2016; Patruno, Sara/P-7868-2018	Romano, Mario/0000-0001-8512-1458; Iezzi, Manuela/0000-0002-6296-6498; lamolinara, alessia/0000-0002-7421-4509; Mattoscio, Domenico/0000-0002-2149-2855; recchiuti, antonio/0000-0002-1409-5261; Patruno, Sara/0000-0002-8425-7844; ISOPI, ELISA/0000-0002-4520-6139	Cystic Fibrosis Foundation (CF Foundation) [RECCHI19I0, ROMANO19IO, RECCHI20G1]; Ministero della Salute (Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Cystic Fibrosis Foundation (CF Foundation); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	Cystic Fibrosis Foundation (CF Foundation), Grant/Award Number: RECCHI19I0, ROMANO19IO and RECCHI20G1; Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: L.548/93; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: Ex 60% (2019-2020)	Akkaya-Ulum YZ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80097-4; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Bruscia EM, 2016, J INNATE IMMUN, V8, P550, DOI 10.1159/000446825; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Centers for Disease Control Prevention, PEOPL WHO AR HIGH RI; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Codagnone M, 2018, MUCOSAL IMMUNOL, V11, P35, DOI 10.1038/mi.2017.36; Croasdell A, 2016, FASEB J, V30, P3181, DOI 10.1096/fj.201600375R; Curtale G, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00799; Eickmeier O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171249; Fattorini L, 2020, ANN I SUPER SANITA, V56, P359, DOI 10.4415/ANN_20_03_14; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Gilroy DW, 2019, BRIT J PHARMACOL, V176, P1009, DOI 10.1111/bph.14587; Gromovsky AD, 2018, ARTERIOSCL THROM VAS, V38, P218, DOI 10.1161/ATVBAHA.117.309660; Heltshe SL, 2015, CLIN INFECT DIS, V60, P703, DOI 10.1093/cid/ciu944; Hisert KB, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01219; Hisert KB, 2017, AM J RESP CRIT CARE, V195, P1617, DOI [10.1164/rccm.201609-1954OC, 10.1164/rccm.201609-1954oc]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsu YL, 2018, MOL THER, V26, P568, DOI 10.1016/j.ymthe.2017.11.016; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lescoat A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030894; Li CX, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23590; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Matte A, 2019, BLOOD, V133, P252, DOI 10.1182/blood-2018-07-865378; Mattoscio D., 2020, RESOLVIN D1 D2 REDUC, DOI DOI 10.1101/2020.08.28.255463; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McClenaghan E., 2020, J CYSTIC FIBROSIS; Montgomery ST, 2018, J CYST FIBROS, V17, P715, DOI 10.1016/j.jcf.2018.05.006; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Motwani MP, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94463; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Perretti M, 2017, MOL ASPECTS MED, V58, P57, DOI 10.1016/j.mam.2017.04.005; Ramon S, 2014, J IMMUNOL, V193, P6031, DOI 10.4049/jimmunol.1302795; Recchiuti A, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00252; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; Roesch EA, 2018, PEDIATR PULM, V53, pS30, DOI 10.1002/ppul.24129; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Spite Matthew, 2014, Cell Metab, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stefani S, 2017, INT J MED MICROBIOL, V307, P353, DOI 10.1016/j.ijmm.2017.07.004; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Wang HM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1031440; Wang ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep25602; Watanabe Y, 2004, MICROBIOL IMMUNOL, V48, P875, DOI 10.1111/j.1348-0421.2004.tb03619.x; World Health Organization, COR DIS COVID 19 OUT; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x	58	13	13	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21441	10.1096/fj.202001952R	http://dx.doi.org/10.1096/fj.202001952R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749902	Green Published, Green Submitted			2022-12-26	WOS:000635216100068
J	Mason, EO; Goldgur, Y; Robev, D; Freywald, A; Nikolov, DB; Himanen, JP				Mason, Emilia O.; Goldgur, Yehuda; Robev, Dorothea; Freywald, Andrew; Nikolov, Dimitar B.; Himanen, Juha P.			Structure of the EphB6 receptor ectodomain	PLOS ONE			English	Article								Eph receptors are the largest group amongst the receptor tyrosine kinases and are divided into two subgroups, A and B, based on ligand binding specificities and sequence conservation. Through ligand-induced and ligand-independent activities, Ephs play central roles in diverse biological processes, including embryo development, regulation of neuronal signaling, immune responses, vasculogenesis, as well as tumor initiation, progression, and metastasis. The Eph extracellular regions (ECDs) are constituted of multiple domains, and previous structural studies of the A class receptors revealed how they interact with ephrin ligands and simultaneously mediate Eph-Eph clustering necessary for biological activity. Specifically, EphA structures highlighted a model, where clustering of ligand-bound receptors relies on two distinct receptor/receptor interfaces. Interestingly, most unliganded A class receptors also form an additional, third interface, between the ligand binding domain (LBD) and the fibronectin III domain (FN3) of neighboring molecules. Structures of B-class Eph ECDs, on the other hand, have never been reported. To further our understanding of Eph receptor function, we crystallized the EphB6-ECD and determined its three-dimensional structure using X-ray crystallography. EphB6 has important functions in both normal physiology and human malignancies and is especially interesting because this atypical receptor innately lacks kinase activity and our understanding of the mechanism of action is still incomplete. Our structural data reveals the overall EphB6-ECD architecture and shows EphB6-LBD/FN3 interactions similar to those observed for the unliganded A class receptors, suggesting that these unusual interactions are of general importance to the Eph group. We also observe unique structural features, which likely reflect the atypical signaling properties of EphB6, namely the need of co-receptor(s) for this kinase-inactive Eph. These findings provide new valuable information on the structural organization and mechanism of action of the B-class Ephs, and specifically EphB6, which in the future will assist in identifying clinically relevant targets for cancer therapy.	[Mason, Emilia O.; Goldgur, Yehuda; Robev, Dorothea; Nikolov, Dimitar B.; Himanen, Juha P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA; [Freywald, Andrew] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada	Memorial Sloan Kettering Cancer Center; University of Saskatchewan	Nikolov, DB; Himanen, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	nikolovd@mskcc.org; himanenj@mskcc.org		Mason, Emilia/0000-0002-1454-9526	National Institutes of Health [R01-NS038486]; NIH [P41 GM103403, DE-AC02-06CH11357]; U. S. DOE	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. DOE(United States Department of Energy (DOE))	D.B.N., R01-NS038486, National Institutes of Health, www.nih.gov; APS, P41 GM103403 and DE-AC02-06CH11357, NIH and U. S. DOE, www.grants.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada M, 2014, CELL SIGNAL, V26, P2879, DOI 10.1016/j.cellsig.2014.08.031; Allonby O, 2014, CELL SIGNAL, V26, P2645, DOI 10.1016/j.cellsig.2014.08.007; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bailey CM, 2014, MOL CANCER RES, V12, P1303, DOI 10.1158/1541-7786.MCR-13-0673; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Buckens OJ, 2020, EXPERT OPIN INV DRUG, V29, P567, DOI 10.1080/13543784.2020.1762566; Chen JQ, 2017, CANCER LETT, V408, P155, DOI 10.1016/j.canlet.2017.08.014; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; El Zawily AM, 2016, ONCOTARGET, V7, P77865, DOI 10.18632/oncotarget.12838; Fan YH, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105147; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox BP, 2011, CANCER GENOM PROTEOM, V8, P185; Freywald A, 2002, J BIOL CHEM, V277, P3823, DOI 10.1074/jbc.M108011200; Freywald A, 2003, J BIOL CHEM, V278, P10150, DOI 10.1074/jbc.M208179200; Gu Y, 2016, J CLIN PATHOL, V69, P448, DOI 10.1136/jclinpath-2015-203160; Hafner C, 2003, INT J ONCOL, V23, P1553; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Himanen JP, 2012, SEMIN CELL DEV BIOL, V23, P35, DOI 10.1016/j.semcdb.2011.10.025; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu JX, 2017, CANCER BIOMARK, V19, P241, DOI 10.3233/CBM-160256; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Mateo-Lozano S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43702; Miao H, 2012, SEMIN CELL DEV BIOL, V23, P16, DOI 10.1016/j.semcdb.2011.10.013; Mohamed ER, 2015, ONCOL LETT, V9, P1672, DOI 10.3892/ol.2015.2925; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Phan NN, 2020, INT J CLIN EXP PATHO, V13, P1220; Long NP, 2017, ONCOTARGET, V8, P109436, DOI 10.18632/oncotarget.22689; Nikolov DB, 2014, CELL ADHES MIGR, V8, P360, DOI 10.4161/19336918.2014.971684; Nikolov DB, 2013, BBA-PROTEINS PROTEOM, V1834, P2160, DOI 10.1016/j.bbapap.2013.04.020; Overman RC, 2014, PROTEIN SCI, V23, P627, DOI 10.1002/pro.2445; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Peng LB, 2014, J MOL HISTOL, V45, P555, DOI 10.1007/s10735-014-9577-0; Petty A, 2018, EUR J MED CHEM, V143, P1261, DOI 10.1016/j.ejmech.2017.10.026; Salem AF, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13050090; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sharonov GV, 2014, J BIOL CHEM, V289, P14955, DOI 10.1074/jbc.M114.558783; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Szymanowska-Narloch A, 2013, ADV MED SCI-POLAND, V58, P196, DOI 10.2478/ams-2013-0025; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tome CML, 2012, J BIOL CHEM, V287, P14012, DOI 10.1074/jbc.M111.311670; Toosi BM, 2018, ONCOGENE, V37, P4073, DOI 10.1038/s41388-018-0228-x; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Wang YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19215-2; Wu JE, 2020, THERANOSTICS, V10, P8903, DOI 10.7150/thno.45785; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu D, 2016, ONCOTARGET, V7, P31111, DOI 10.18632/oncotarget.9080; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000	70	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0247335	10.1371/journal.pone.0247335	http://dx.doi.org/10.1371/journal.pone.0247335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770085	Green Published, gold			2022-12-26	WOS:000634833500055
J	Nehme, Z; Pasquereau, S; Ahmad, SH; Coaquette, A; Molimard, C; Monnien, F; Algros, MP; Adotevi, O; Assaf, MD; Feugeas, JP; Herbein, G				Nehme, Zeina; Pasquereau, Sebastien; Haidar Ahmad, Sandy; Coaquette, Alain; Molimard, Chloe; Monnien, Franck; Algros, Marie-Paule; Adotevi, Olivier; Diab Assaf, Mona; Feugeas, Jean-Paul; Herbein, Georges			Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus	ONCOGENE			English	Article								A growing body of evidence is recognizing human cytomegalovirus (HCMV) as a potential oncogenic virus. We hereby provide the first experimental in vitro evidence for HCMV as a reprogramming vector, through the induction of dedifferentiation of mature human mammary epithelial cells (HMECs), generation of a polyploid giant cancer cell (PGCC) phenotype characterized by sustained growth of blastomere-like cells, in concordance with the acquisition of embryonic stem cells characteristics and epithelial-mesenchymal plasticity. HCMV presence parallels the succession of the observed cellular and molecular events potentially ensuing the transformation process. Correlation between PGCCs detection and HCMV presence in breast cancer tissue further validates our hypothesis in vivo. Our study indicates that some clinical HCMV strains conserve the potential to transform HMECs and fit with a "blastomere-like" model of oncogenesis, which may be relevant in the pathophysiology of breast cancer and other adenocarcinoma, especially of poor prognosis.	[Nehme, Zeina; Pasquereau, Sebastien; Haidar Ahmad, Sandy; Herbein, Georges] Univ Bourgogne France Comte, Dept Pathogens & Inflammat, EPILAB, EA4266, Besancon, France; [Nehme, Zeina; Haidar Ahmad, Sandy; Diab Assaf, Mona] Lebanese Univ, Beirut, Lebanon; [Coaquette, Alain; Herbein, Georges] CHRU Besancon, Dept Virol, Besancon, France; [Molimard, Chloe; Monnien, Franck; Algros, Marie-Paule] CHRU Besancon, Dept Pathol, Besancon, France; [Adotevi, Olivier; Feugeas, Jean-Paul] Univ Bourgogne Franche Comte, Interact Greffon Hote Tumeur Ingn Cellulaire & Ge, INSERM, EFS BFC,UMR1098,RIGHT, Besancon, France	Universite de Franche-Comte; Lebanese University; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte	Herbein, G (corresponding author), Univ Bourgogne France Comte, Dept Pathogens & Inflammat, EPILAB, EA4266, Besancon, France.; Herbein, G (corresponding author), CHRU Besancon, Dept Virol, Besancon, France.	georges.herbein@univ-fcomte.fr	Adotevi, Olivier/AAX-8290-2021	Pasquereau, Sebastien/0000-0002-9291-797X; Nehme, Zeina/0000-0002-4750-6389; adotevi, olivier/0000-0002-7742-136X; Haidar Ahmad, sandy/0000-0001-5375-0874	University of Franche-Comte; Region Franche-Comte; municipality of Habbouch	University of Franche-Comte; Region Franche-Comte(Region Bourgogne-Franche-Comte); municipality of Habbouch	This work was supported by grants from the University of Franche-Comte, and the Region Franche-Comte. Z.N. is a recipient of a doctoral scholarship from the municipality of Habbouch. The funders had no role in the data collection, analysis, patient recruitment, or decision to publish. We thank DImaCell Imaging Ressource Center, University of Bourgogne Franche-Comte, Faculty of Health Sciences, 25000 Besancon, France for technical support.	Al Moussawi F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30109-1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aloia A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0652-6; Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chuang PK, 2019, P NATL ACAD SCI USA, V116, P3518, DOI 10.1073/pnas.1816946116; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Cobbs CS, 2002, CANCER RES, V62, P3347; Cojohari O, 2016, J VIROL, V90, P6443, DOI 10.1128/JVI.00214-16; Collins-McMillen D, 2019, P NATL ACAD SCI USA, V116, P17492, DOI 10.1073/pnas.1900783116; Coronel R, 2015, J VIROL, V89, P5615, DOI 10.1128/JVI.00305-15; Dai XF, 2015, AM J CANCER RES, V5, P2929; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Fei F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0277-8; Fornara O, 2016, CELL DEATH DIFFER, V23, P261, DOI 10.1038/cdd.2015.91; FURUKAWA T, 1984, VIROLOGY, V137, P191, DOI 10.1016/0042-6822(84)90023-0; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; GEDER L, 1976, SCIENCE, V192, P1134, DOI 10.1126/science.179143; HEIEREN MH, 1988, TRANSPLANTATION, V46, P426, DOI 10.1097/00007890-198809000-00018; Hein SM, 2016, ONCOGENE, V35, P1461, DOI 10.1038/onc.2015.206; Herbein G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.567116; Hoffding MK, 2015, STEM CELL RES, V14, P39, DOI 10.1016/j.scr.2014.11.003; Huang YH, 2014, HISTOPATHOLOGY, V64, P494, DOI 10.1111/his.12257; Huesing A, 2012, J MED GENET, V49, P601, DOI 10.1136/jmedgenet-2011-100716; Jha HC, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010018; Khan KA, 2009, J IMMUNOL, V182, P7784, DOI 10.4049/jimmunol.0803800; Knudsen ES, 2015, CELL CYCLE, V14, P109, DOI 10.4161/15384101.2014.967118; Kumar A, 2018, EBIOMEDICINE, V30, P167, DOI 10.1016/j.ebiom.2018.03.015; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Lepiller Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059591; Ling GQ, 2012, ONCOL LETT, V4, P1264, DOI 10.3892/ol.2012.916; Liu JS, 2020, SEMIN CANCER BIOL, V60, P380, DOI 10.1016/j.semcancer.2019.09.005; Liu JS, 2018, SEMIN CANCER BIOL, V53, P1, DOI 10.1016/j.semcancer.2018.07.004; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Lu X, 2014, ONCOGENE, V33, P2655, DOI 10.1038/onc.2013.209; Luo JF, 2017, AM J TRANSL RES, V9, P5671; Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09; Manners O, 2018, CURR OPIN VIROL, V32, P60, DOI 10.1016/j.coviro.2018.08.014; McFarlane S, 2011, VIROLOGY, V414, P83, DOI 10.1016/j.virol.2011.03.005; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Morales-Sanchez A, 2014, VIRUSES-BASEL, V6, P4047, DOI 10.3390/v6104047; Munz C, 2019, NAT REV MICROBIOL, V17, P691, DOI 10.1038/s41579-019-0249-7; Newbold RF, 2002, MUTAGENESIS, V17, P539, DOI 10.1093/mutage/17.6.539; Niu N, 2017, ONCOGENE, V36, P4887, DOI 10.1038/onc.2017.72; Niu N, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.75; Oberstein A, 2017, P NATL ACAD SCI USA, V114, pE8244, DOI 10.1073/pnas.1710799114; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Rodilla V, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040103; Romaniuk A, 2019, MOL BIOL REP, V46, P1401, DOI 10.1007/s11033-018-4496-x; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Soroceanu L, 2015, CANCER RES, V75, P3065, DOI 10.1158/0008-5472.CAN-14-3307; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Taher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056795; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tsai HL, 1996, J BIOL CHEM, V271, P3534; Wang D, 2014, ONCOTARGET, V5, P10803, DOI 10.18632/oncotarget.2506; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Weljie AM, 2011, INT J BIOCHEM CELL B, V43, P981, DOI 10.1016/j.biocel.2010.08.009; White E, 2006, CELL DEATH DIFFER, V13, P1371, DOI 10.1038/sj.cdd.4401941; Xiong SM, 2019, TRENDS CELL BIOL, V29, P623, DOI 10.1016/j.tcb.2019.05.001; Yamashita N, 2018, CLIN BREAST CANCER, V18, pE1003, DOI 10.1016/j.clbc.2018.02.002; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Yu W, 2017, STEM CELL RES, V19, P139, DOI 10.1016/j.scr.2017.01.011; Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825	76	15	16	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3030	3046		10.1038/s41388-021-01715-7	http://dx.doi.org/10.1038/s41388-021-01715-7		MAR 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33767437				2022-12-26	WOS:000632820300001
J	Toya, T; Ozcan, I; Corban, MT; Sara, JD; Marietta, EV; Ahmad, A; Horwath, IE; Loeffler, DL; Murray, JA; Lerman, LO; Lerman, A				Toya, Takumi; Ozcan, Ilke; Corban, Michel T.; Sara, Jaskanwal D.; Marietta, Eric V.; Ahmad, Ali; Horwath, Irina E.; Loeffler, Darrell L.; Murray, Joseph A.; Lerman, Lilach O.; Lerman, Amir			Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease	PLOS ONE			English	Article								Osteogenic endothelial progenitor cells (EPCs) contribute to impaired endothelial repair and promote coronary artery disease (CAD) and vascular calcification. Immature EPCs expressing osteocalcin (OCN) has been linked to unstable CAD; however, phenotypic regulation of OCN-expressing EPCs is not understood. We hypothesized that gut-microbiome derived pro-inflammatory substance, trimethylamine N-oxide (TMAO) might be associated with mobilization of OCN-expressing EPCs. This study aimed to investigate the association between dysbiosis, TMAO, and circulating mature and immature OCN-expressing EPCs levels in patients with and without CAD. We included 202 patients (CAD N = 88; no CAD N = 114) who underwent assessment of EPCs using flow cytometry and gut microbiome composition. Mature and immature EPCs co-staining for OCN were identified using cell surface markers as CD34+/CD133-/kinase insert domain receptor (KDR)+ and CD34-/CD133+/KDR+ cells, respectively. The number of observed operational taxonomy units (OTU), index of microbial richness, was used to identify patients with dysbiosis. The number of immature OCN-expressing EPCs were higher in patients with CAD or dysbiosis than patients without. TMAO levels were not associated with circulating levels of OCN-expressing EPCs. The relative abundance of Ruminococcus gnavus was moderately correlated with circulating levels of immature OCN-expressing EPCs, especially in diabetic patients. Gut dysbiosis was associated with increased levels of TMAO, immature OCN-expressing EPCs, and CAD. The relative abundance of Ruminococcus gnavus was correlated with immature OCN-expressing EPCs, suggesting that the harmful effects of immature OCN-expressing EPCs on CAD and potentially vascular calcification might be mediated by gut microbiome-derived systemic inflammation.	[Toya, Takumi; Ozcan, Ilke; Corban, Michel T.; Sara, Jaskanwal D.; Ahmad, Ali; Loeffler, Darrell L.; Lerman, Amir] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Toya, Takumi] Natl Def Med Coll, Div Cardiol, Tokorozawa, Saitama, Japan; [Marietta, Eric V.; Horwath, Irina E.; Murray, Joseph A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; National Defense Medical College - Japan; Mayo Clinic; Mayo Clinic	Lerman, A (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.	Lerman.Amir@mayo.edu	Ahmad, Ali/GWU-8635-2022	Ahmad, Ali/0000-0001-9669-8009; Toya, Takumi/0000-0002-4681-2798	SonomaCeuticals, LLC, dba Whole-Vine Products; Mayo Clinic	SonomaCeuticals, LLC, dba Whole-Vine Products; Mayo Clinic	This study was sponsored by unrestricted grants from SonomaCeuticals, LLC, dba Whole-Vine Products (info@wholevine.com) and Mayo Clinic (https://www.mayoclinic.org) to AL. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Al-Hijji M, 2019, MAYO CLIN PROC, V94, P652, DOI 10.1016/j.mayocp.2019.01.005; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Breban M, 2017, ANN RHEUM DIS, V76, P1614, DOI 10.1136/annrheumdis-2016-211064; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chou RH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40638-y; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Collin J, 2015, INT J CARDIOL, V181, P57, DOI 10.1016/j.ijcard.2014.11.156; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Evenepoel P, 2020, TOXINS, V12, DOI 10.3390/toxins12050285; Flammer AJ, 2012, EUR HEART J, V33, P2963, DOI 10.1093/eurheartj/ehs234; Gossl M, 2008, J AM COLL CARDIOL, V52, P1314, DOI 10.1016/j.jacc.2008.07.019; Gossl M, 2012, J AM COLL CARDIOL, V60, P1945, DOI 10.1016/j.jacc.2012.07.042; Gossl M, 2010, EUR HEART J, V31, P2909, DOI 10.1093/eurheartj/ehq373; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Griffin JL, 2015, CIRC-CARDIOVASC GENE, V8, P187, DOI 10.1161/CIRCGENETICS.114.000219; Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kawakami R, 2020, ARTERIOSCL THROM VAS, V40, P1838, DOI 10.1161/ATVBAHA.118.314087; Kirsch SH, 2010, J CHROMATOGR B, V878, P3338, DOI 10.1016/j.jchromb.2010.10.016; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Leal V, 2019, STEM CELL REV REP, V15, P35, DOI 10.1007/s12015-018-9857-2; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Ma SC, 2020, AGING-US, V12, P10795, DOI 10.18632/aging.103293; Madonna R, 2016, MECH AGEING DEV, V159, P22, DOI 10.1016/j.mad.2016.03.005; Marques FZ, 2018, NAT REV CARDIOL, V15, P20, DOI 10.1038/nrcardio.2017.120; Min Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10440-5; Peris P, 2013, MAYO CLIN PROC, V88, P46, DOI 10.1016/j.mayocp.2012.08.019; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Prisco AR, 2015, AM J PHYSIOL-HEART C, V308, pH1368, DOI 10.1152/ajpheart.00496.2014; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tang WHW, 2019, NAT REV CARDIOL, V16, P137, DOI 10.1038/s41569-018-0108-7; Tang WHW, 2017, CIRCULATION, V135, P1008, DOI 10.1161/CIRCULATIONAHA.116.024251; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Toya T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227147; Toya T, 2020, EUR J PREV CARDIOL, V27, P608, DOI 10.1177/2047487319884246; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu HY, 2021, CELL MOL LIFE SCI, V78, P675, DOI 10.1007/s00018-020-03514-x; Xu ZM, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00160; Yamagata K, 2019, J CARDIOVASC PHARM, V74, P558, DOI 10.1097/FJC.0000000000000747; Zhang Q, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00675; Zhang YM, 2009, AM J PHYSIOL-HEART C, V296, pH1675, DOI 10.1152/ajpheart.00665.2008; Zheng HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166026; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	49	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249187	10.1371/journal.pone.0249187	http://dx.doi.org/10.1371/journal.pone.0249187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765061	Green Published, gold			2022-12-26	WOS:000634832800039
J	Twarog, S; Szwarc, K; Wronka-Pospiech, M; Dobrowolska, M; Urbanek, A				Twarog, Sebastian; Szwarc, Krzysztof; Wronka-Pospiech, Martyna; Dobrowolska, Malgorzata; Urbanek, Anna			Multiple probabilistic traveling salesman problem in the coordination of drug transportation-In the context of sustainability goals and Industry 4.0	PLOS ONE			English	Article							HARMONY SEARCH ALGORITHM	Improving the effectiveness of route planning, especially in road transport deliveries is a challenge we need to face in the context of advancing climate change and the sustainable development goals. The main aim of the paper is to demonstrate the above average and utilitarian significance of the multiple probabilistic traveling salesman problem (MPTSP) in the coordination and modeling of sustainable product transportation, which is a novelty at the theoretical, conceptual, methodological and empirical level. We propose a new, hybrid algorithm of solving MPTSP instances (it connects harmony search, k-means and 2-opt), which can be successfully used in economic practice for coordination and modeling of Industry 4.0. The effectiveness of proposed approach is tested using a case study of drugs distribution services and datasets obtained from the transportation enterprise located in Poland. The study focuses on the issue of planning routes, with particular emphasis on the changing demand of customers. It should be stressed that this work may be of interest to researchers but also to management practitioners. The value added of this research lies in the innovative modeling the coordination of sustainable drug transportation as an instance of MPTSP and proposing an effective method to solve it. The main research results confirm that proposed method contributes to overall sustainability of studied supply chain.	[Twarog, Sebastian] Univ Econ Katowice, Dept Social Logist, Katowice, Poland; [Szwarc, Krzysztof] Univ Silesia Katowice, Inst Comp Sci, Katowice, Poland; [Wronka-Pospiech, Martyna] Univ Econ Katowice, Dept Entrepreneurship & Management Innovat, Katowice, Poland; [Dobrowolska, Malgorzata] Silesian Tech Univ, Dept Pedag, Gliwice, Poland; [Urbanek, Anna] Univ Econ Katowice, Dept Transport, Katowice, Poland	University of Economics in Katowice; University of Silesia in Katowice; University of Economics in Katowice; Silesian University of Technology; University of Economics in Katowice	Twarog, S (corresponding author), Univ Econ Katowice, Dept Social Logist, Katowice, Poland.; Szwarc, K (corresponding author), Univ Silesia Katowice, Inst Comp Sci, Katowice, Poland.	sebastian.twarog@ue.katowice.pl; krzysztof.szwarc@us.edu.pl	Urbanek, Anna/T-1286-2017	Urbanek, Anna/0000-0003-4217-9064; Szwarc, Krzysztof/0000-0003-3341-1511; Twarog, Sebastian/0000-0003-0855-7965				Adamson G, 2017, J MANUF SYST, V43, P305, DOI 10.1016/j.jmsy.2016.12.003; [Anonymous], CONCORDE; Barma P S, 2019, DECIS MAKING, V2, P1, DOI 10.31181/dmame1902089b; Barreto L, 2017, PROCEDIA MANUF, V13, P1245, DOI 10.1016/j.promfg.2017.09.045; Bektas T, 2006, OMEGA-INT J MANAGE S, V34, P209, DOI 10.1016/j.omega.2004.10.004; Bianchi L., 2002, P 3 INT WORKSH ANT A, P176; Boryczka U, 2018, LECT NOTES ARTIF INT, V10751, P341, DOI 10.1007/978-3-319-75417-8_32; Cam O.N., 2020, DECIS MAKING, V3, P22, DOI [10.31181/dmame2003132h, DOI 10.31181/DMAME2003132H]; Carter JR., 1995, J BUS LOGIST, V16, P189; Chassein A, 2016, OPTIM LETT, V10, P1479, DOI 10.1007/s11590-015-0949-5; Consortium S., 2017, SINGL INN EUR TRANSP; DITTMAR H, 1995, J AM PLANN ASSOC, V61, P7, DOI 10.1080/01944369508975615; Erisoglu M, 2011, PATTERN RECOGN LETT, V32, P1701, DOI 10.1016/j.patrec.2011.07.011; Fahim A., 2006, J ZHEJIANG U SCI A, V7, P1626, DOI 10.1631/jzus.2006.A1626; Fujii S, 2001, ENVIRON BEHAV, V33, P796, DOI 10.1177/00139160121973241; Geem Z. W., 2000, THESIS KOREA U; GENDREAU M, 1994, MANAGE SCI, V40, P1276, DOI 10.1287/mnsc.40.10.1276; Goldman T, 2006, TECHNOL SOC, V28, P261, DOI 10.1016/j.techsoc.2005.10.007; Gruchmann T, 2018, INT J LOGIST MANAG, V29, P1255, DOI 10.1108/IJLM-08-2017-0200; Guner AR, 2017, TRANSPORT RES E-LOG, V97, P251, DOI 10.1016/j.tre.2016.10.014; Hakovirta M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093727; Iris C, 2019, TRANSPORT RES B-METH, V122, P365, DOI 10.1016/j.trb.2019.02.013; Iris C, 2018, TRANSPORT RES B-METH, V111, P113, DOI 10.1016/j.trb.2018.03.009; Jaillet P., 1985, THESIS MIT; Kagermann H., 2013, RECOMMENDATIONS IMPL; Kielkowicz K., 2012, CZASOPISMO TECHNICZN, V1-AC, P115; Kiraly A, 2016, J CLEAN PROD, V111, P253, DOI 10.1016/j.jclepro.2015.05.036; Lee Jay, 2015, Manufacturing Letters, V3, P18, DOI 10.1016/j.mfglet.2014.12.001; Lee Jay, 2013, Manufacturing Letters, V1, P38, DOI 10.1016/j.mfglet.2013.09.005; Lee KS, 2005, COMPUT METHOD APPL M, V194, P3902, DOI 10.1016/j.cma.2004.09.007; Litman T., 2006, INT J GLOB ENVIR ISS, V6, P331, DOI [DOI 10.1504/IJGENVI.2006.010889, 10.1504/IJGENVI.2006.010889]; Malek M., 1989, Annals of Operations Research, V21, P59, DOI 10.1007/BF02022093; MALONE TW, 1994, ACM COMPUT SURV, V26, P87, DOI 10.1145/174666.174668; Malone TW, 1990, P 1990 ACM C COMP SU, P357, DOI DOI 10.1145/99332.99367; Montreuil Benoit, 2011, Logistics Research, V3, P71, DOI 10.1007/s12159-011-0045-x; Nee A. Y. C., 2013, IFAC P, V46, P15, DOI [10.3182/20130619-3-RU-3018.00637, DOI 10.3182/20130619-3-RU-3018.00637]; Nowakowski P, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138726; Nowakowski P, 2018, TRANSPORT RES D-TR E, V63, P1, DOI 10.1016/j.trd.2018.04.007; OECD, 1996, SUSTAINABLE TRANSPOR; Omidvar A., 2012, 2012 IEEE International Energy Conference (ENERGYCON 2012), P1089, DOI 10.1109/EnergyCon.2012.6347732; Oncan T, 2009, COMPUT OPER RES, V36, P637, DOI 10.1016/j.cor.2007.11.008; Pena JM, 1999, PATTERN RECOGN LETT, V20, P1027, DOI 10.1016/S0167-8655(99)00069-0; Rittinghouse J. W., 2009, CLOUD COMPUTING IMPL; Roy A., 2019, DECIS MAKING, V2, P100, DOI [10.31181/dmame1902076r, 10.1016/j.tre.2016.10.014]; Simatupang TM, 2004, SUPPLY CHAIN MANAG, V9, P256, DOI 10.1108/13598540410544953; Skinderowicz R, 2016, LECT NOTES ARTIF INT, V9876, P91, DOI 10.1007/978-3-319-45246-3_9; Skinderowicz R, 2011, LECT NOTES ARTIF INT, V6923, P495, DOI 10.1007/978-3-642-23938-0_50; Steg L., 2005, J TRANSP GEOGR, V13, P59, DOI DOI 10.1016/J.JTRANGEO.2004.11.003; Stock T, 2016, PROC CIRP, V40, P536, DOI 10.1016/j.procir.2016.01.129; Strandhagen JO, 2017, ADV MANUF, V5, P359, DOI 10.1007/s40436-017-0198-1; Szoltysek J., 2010, TRANSPORT LOGISTICS, P99; Szoltysek J, 2011, POL J MANAG STUD, V4, P23; Szwarc K, 2020, LECT NOTES ARTIF INT, V12033, P226, DOI 10.1007/978-3-030-41964-6_20; Szwarc K, 2019, LECT NOTES ARTIF INT, V11432, P203, DOI 10.1007/978-3-030-14802-7_18; Twarog S., 2019, ACTA U LODZIENSIS FO, V6, P111, DOI [10.18778/0208-6018.345.06, DOI 10.18778/0208-6018.345.06]; Venturini G, 2017, TRANSPORT RES D-TR E, V54, P142, DOI 10.1016/j.trd.2017.05.002; Wachs M, 2010, TRANSPORT RES REC, P5, DOI 10.3141/2163-01; Wang GG, 2016, SOFT COMPUT, V20, P273, DOI 10.1007/s00500-014-1502-7; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wu B, 2012, COMPUT MATH APPL, V64, P2621, DOI 10.1016/j.camwa.2012.06.026; Xu LD, 2014, IEEE T IND INFORM, V10, P2233, DOI 10.1109/TII.2014.2300753; Yang XS, 2009, STUD COMPUT INTELL, V191, P1, DOI 10.1109/MILCOM.2009.5379772; Yavas V, 2020, TRANSPORT RES E-LOG, V135, DOI 10.1016/j.tre.2020.101864; Zezulka F, 2016, IFAC PAPERSONLINE, V49, P8, DOI 10.1016/j.ifacol.2016.12.002; Zhang L, 2014, ENTERP INF SYST-UK, V8, P167, DOI 10.1080/17517575.2012.683812; Zheng BC, 2014, EXPERT SYST APPL, V41, P1476, DOI 10.1016/j.eswa.2013.08.044; Zhou HL, 2018, APPL SOFT COMPUT, V64, P564, DOI 10.1016/j.asoc.2017.12.031; Zhou YQ, 2016, MODEL OPTIM SCI TECH, V7, P255, DOI 10.1007/978-3-319-26245-1_12	69	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249077	10.1371/journal.pone.0249077	http://dx.doi.org/10.1371/journal.pone.0249077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765056	Green Published, gold			2022-12-26	WOS:000634832800052
J	Seid, M; Minyihun, A; Tilahun, G; Atnafu, A; Amare, G				Seid, Mohammed; Minyihun, Amare; Tilahun, Gizachew; Atnafu, Asmamaw; Amare, Getasew			Willingness to pay for cataract surgery and associated factors among cataract patients in Outreach Site, North West Ethiopia	PLOS ONE			English	Article							VISUAL IMPAIRMENT; VISION 2020; OF-LIFE; HEALTH; BARRIERS; STATE; COST; DETERMINANTS; CHINA; INDIA	Introduction In Ethiopia, cataract surgery is mainly provided by donors free of charge through outreach programs. Assessing willingness to pay for patients for cataract surgery will help explain how the service is valued by the beneficiaries and design a domestic source of finance to sustain a program. Although knowledge concerning willingness to pay for cataract surgery is substantive for developing a cost-recovery model, the existed knowledge is limited and not well-addressed. Therefore, the study aimed to assess willingness to pay for cataract surgery and associated factors among cataract patients in Outreach Site, North West Ethiopia. Methods A cross-sectional outreach-based study was conducted on 827 cataract patients selected through a simple random sampling method in Tebebe Gion Specialized Hospital, North West Ethiopia, from 10/11/2018 to 14/11/2018. The data were collected using a contingent valuation elicitation approach to elicit the participants' maximum willingness to pay through face to face questionnaire interviews. The descriptive data were organized and presented using summary statistics, frequency distribution tables, and figures accordingly. Factors assumed to be associate with a willingness to pay were identified using a Tobit regression model with a p-value of <0.05 and confidence interval (CI not equal 0). Results The study involved 827 cataract patients, and their median age was 65years. About 55% of the participants were willing to pay for the surgery. The average amount of money willing to pay was 17.5USD (95% CI; 10.5, 35.00) and It was significantly associated with being still worker (beta = 26.66, 95% CI: 13.03, 40.29), being educated (beta = 29.16, 95% CI: 2.35, 55.97), free from ocular morbidity (beta = 28.48, 95% CI: 1.08, 55.90), duration with the condition, (beta = -1.69, 95% CI: -3.32, -0.07), admission laterality (beta = 21.21, 95% CI: 3.65, 38.77) and remained visual ability (beta = -0.29, 95% CI (-0.55, -0.04). Conclusions Participants' willingness to pay for cataract surgery in outreach Sites is much lower than the surgery's actual cost. Early intervention and developing a cost-recovery model with multi-tiered packages attributed to the neediest people as in retired, less educated, severely disabled is strategic to increase the demand for service uptake and service accessibility.	[Seid, Mohammed; Tilahun, Gizachew] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Optometry, Gondar, Ethiopia; [Minyihun, Amare; Atnafu, Asmamaw; Amare, Getasew] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Syst & Policy, Gondar, Ethiopia	University of Gondar; University of Gondar	Amare, G (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Syst & Policy, Gondar, Ethiopia.	getasewa23@gmail.com		Minyihun, Amare/0000-0002-7996-6451; Belete, Gizachew Tilahun/0000-0002-6015-2730				Addisu Z, 2011, ETHIOP J HEALTH SCI, V21, P47; [Anonymous], 1995, EVALUATING HLTH RISK; BATEMAN IJ, 2002, ECOL ECON; Blumenschein K, 2001, J HEALTH ECON, V20, P441, DOI 10.1016/S0167-6296(01)00075-3; Calia P., 1998, BIAS EFFICIENCY SING, DOI [10.2139/ssrn.158412, DOI 10.2139/SSRN.158412]; Chan FWK, 2009, INVEST OPHTH VIS SCI, V50, P3636, DOI 10.1167/iovs.08-3025; Colenbrander A., 2002, P 29 INT C OPHTH; Dean WH, 2012, OPHTHAL EPIDEMIOL, V19, P265, DOI 10.3109/09286586.2012.708085; Demissie, 2014, INT J OPTHALMOL EYE, V2, P65; Dolan P., 2004, DISCRETE CHOICE EXPT; Fattore G, 2008, HEALTH ECON, V17, pS71, DOI 10.1002/hec.1324; Finkelstein A, 2009, AM ECON REV, V99, P116, DOI 10.1257/aer.99.2.116; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Fletcher AE, 1997, ARCH OPHTHALMOL-CHIC, V115, P767, DOI 10.1001/archopht.1997.01100150769013; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; Friedman DS, 2002, BRIT J OPHTHALMOL, V86, P885, DOI 10.1136/bjo.86.8.885; Geneau R, 2008, SOC SCI MED, V66, P558, DOI 10.1016/j.socscimed.2007.09.016; Group W.B, 2020, OUT OF POCKET EXPEND; Habtamu E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-480; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; He MG, 2007, OPHTHALMOLOGY, V114, P411, DOI 10.1016/j.ophtha.2006.09.012; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Henningsen A., 2010, R PACKAGE VIGNETTES, V5, P12; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Ibrahim N, 2018, OPHTHAL EPIDEMIOL, V25, P227, DOI 10.1080/09286586.2017.1408845; Islam MN, 2019, HEALTH ECON REV, V9, DOI 10.1186/s13561-019-0249-3; Islam MN, 2019, APPL HEALTH ECON HEA, V17, P545, DOI 10.1007/s40258-019-00478-3; Jadoon Z, 2007, BRIT J OPHTHALMOL, V91, P1269, DOI 10.1136/bjo.2006.106914; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Ko F, 2012, ACTA OPHTHALMOL, V90, pE54, DOI 10.1111/j.1755-3768.2011.02207.x; Lansingh VC, 2007, OPHTHALMOLOGY, V114, P1670, DOI 10.1016/j.ophtha.2006.12.013; Leon R, 2003, SCOT J POLIT ECON, V50, P174, DOI 10.1111/1467-9485.5002004; Lewallen S, 2006, BRIT J OPHTHALMOL, V90, P11, DOI 10.1136/bjo.2005.079715; Lewallen S, 2005, BRIT J OPHTHALMOL, V89, P1237, DOI 10.1136/bjo.2005.068791; Lillard LA, 1997, J BUS ECON STAT, V15, P254, DOI 10.2307/1392309; Long JS, 1997, REGRESSION MODELS CA, V7, P219; LUMME P, 1993, INT OPHTHALMOL, V17, P313; McLeod DM, 1999, LAND ECON, V75, P115, DOI 10.2307/3146996; Mehari Zelalem Addisu, 2013, Middle East Afr J Ophthalmol, V20, P229, DOI 10.4103/0974-9233.114798; Nosratnejad S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157470; Organization W.H., 2013, UNIVERSAL EYE HLTH G; Porter D.C., 1999, ESSENTIALS ECONOMETR, V2; Radhakrishnan M, 2015, OPHTHAL EPIDEMIOL, V22, P34, DOI 10.3109/09286586.2013.783083; Shrestha MK, 2004, BRIT J OPHTHALMOL, V88, P319, DOI 10.1136/bjo.2003.026260; Snellingen T, 1998, BRIT J OPHTHALMOL, V82, P1424, DOI 10.1136/bjo.82.12.1424; STIGLER GJ, 1977, AM ECON REV, V67, P76; System A.E., DRIVING COST HIGH QU; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; Wang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142858; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wooldridge J. M., 2016, INTRO ECONOMETRICS M; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204; Zhang MZ, 2011, OPHTHAL EPIDEMIOL, V18, P179, DOI 10.3109/09286586.2011.580884	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248618	10.1371/journal.pone.0248618	http://dx.doi.org/10.1371/journal.pone.0248618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760830	gold, Green Published			2022-12-26	WOS:000633030400042
J	Wilson, BJ; Thompson, KR; McGreevy, PD				Wilson, Bethany J.; Thompson, Kirrilly R.; McGreevy, Paul D.			The race that segments a nation: Findings from a convenience poll of attitudes toward the Melbourne Cup Thoroughbred horse race, gambling and animal cruelty	PLOS ONE			English	Article							SOCIAL LICENSE; RISK-FACTORS; AUSTRALIA	The annual Melbourne Cup Thoroughbred horse race has iconic status among many Australians but sits in the context of increasing criticism of the welfare of Thoroughbred racing horses and the ethics of gambling. Despite heated debates and protests playing out in the public domain, there is scant empirical research to document Australian attitudes to the Melbourne Cup, or horse racing more generally. Specifically, little is known about how support for or against the Melbourne Cup correlate with age, gender, income and level of education. To provide a more nuanced understanding of attitudes towards the cup beyond the rudimentary binaries of those who are 'for' or 'against' gambling and horse racing, the purpose of the study was to identify clusters of people with particular views. An opportunistic survey collected data on respondents' gender, age, place of residence, weekly income, employment status and highest level of education, and sought their level of agreement with six statements about the Melbourne Cup, gambling and animal cruelty. Ordinal logistic regression and Chi-square analysis were used to evaluate the age and gender of respondents in clusters respectively. Agreement with the statements revealed some significant associations. Male respondents were at greater odds for agreement with the statement: I regularly bet on horse races (OR = 2.39; 95% CI = 1.78-3.22) as were respondents aged 18-19 years (OR = 2.88; 95% CI = 1.13-7.35) and 20-24 years (OR = 1.90; 95% CI 1.00-3.62) compared with the median 35-40 years age bracket. Agreement with the statement: I will watch the Melbourne Cup but will not place a bet was more likely among the full-time employed (OR = 1.60; 95% CI = 1.10-2.32), for those aged 20-24 years (OR = 1.85; 95% CI = 1.16-2.95). The odds of increasing agreement with the statement: I have never been interested in the Melbourne Cup were multiplied by 0.87 (95% CI = 0.82-0.92) with each successive five-year age bracket. The most useful of the predictor variables for agreement was level of education. The odds of increasing with the statement: I have become less interested in the Melbourne Cup over recent years because of my concerns with gambling were multiplied by 1.09 (95% CI = 1.02-1.15) for each increased level of education. Agreement with the statement: I have become less interested in the Melbourne Cup because of my concerns about animal cruelty was weaker amongst male respondents (OR = 0.62; 95% CI = 0.48-0.80), and those in increasing age brackets (OR = 0.88; 95% CI = 0.83-0.93). A series of six clusters were identified that show how certain attributes of respondents characterise their responses. The authors labelled these clusters "Devotees" (n = 313; 30.4% of respondents), "Flaneurs" (n = 244; 21.8% of respondents), "Disapprovers" (n = 163; 15.9% of respondents), "Casuals" (n = 148; 14.4% of respondents), "Gamblers" (n = 126; 12.3% of respondents) and "Paradoxical-voters" (n = 54; 5.3% of respondents). The implications for support of the Melbourne Cup are explored.	[Wilson, Bethany J.; McGreevy, Paul D.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Thompson, Kirrilly R.] Univ South Australia, Business Sch, Adelaide, SA, Australia	University of Sydney; University of South Australia	Wilson, BJ (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	bethany.wilson@sydney.edu.au	, Kirrilly/J-1003-2014	, Kirrilly/0000-0002-2758-6537; Wilson, Bethany/0000-0001-8279-1931	RSPCA Australia; Sydney School of Veterinary Science	RSPCA Australia; Sydney School of Veterinary Science	Funding for this study was received from RSPCA Australia. BW https://www.rspca.org.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding was provided by the Sydney School of Veterinary Science.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1997, MODERN APPL STAT S P, DOI DOI 10.1007/978-1-4757-2719-7; Arluke A., 1996, REGARDING ANIMALS; Bell RJW, 2007, NEW ZEAL VET J, V55, P13, DOI 10.1080/00480169.2007.36729; Chien PM., 2014, CAUTHE 2014 TOURISM, P963; Crispe EJ, 2019, EQUINE VET J, V51, P45, DOI 10.1111/evj.12957; Cusack CM, 2009, SPORT SOC, V12, P876, DOI 10.1080/17430430903053109; Cusack CM., 2013, MELBOURNE CUP AUSTR, P50; Delfabbro P, 2012, ADDICTION, V107, P1556, DOI 10.1111/j.1360-0443.2012.03802.x; Duncan E, 2018, GEOFORUM, V96, P318, DOI 10.1016/j.geoforum.2018.08.020; Evans D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015622; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Gainsbury S, 2012, COMPUT HUM BEHAV, V28, P1388, DOI 10.1016/j.chb.2012.02.024; Gainsbury SM, 2018, NEW MEDIA SOC, V20, P2990, DOI 10.1177/1461444817738783; Graham R, 2016, ANIMALS, V6, DOI 10.3390/ani6050032; Heleski C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051706; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Hing N, 2016, J GAMBL STUD, V32, P511, DOI 10.1007/s10899-015-9548-8; Hitchens PL, 2019, VET J, V245, P29, DOI 10.1016/j.tvjl.2018.11.014; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Hood J, 2017, ANIMALS, V7, DOI 10.3390/ani7010004; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; Maechler M., 2019, CLUSTER ANAL BASICS; Markwell K, 2017, ANN LEIS RES, V20, P594, DOI 10.1080/11745398.2016.1251326; McGreevy PD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192843; McGreevy PD, 2013, J VET BEHAV, V8, P395, DOI 10.1016/j.jveb.2013.03.003; McGreevy PD, 2009, J VET BEHAV, V4, P193, DOI 10.1016/j.jveb.2008.08.001; McGreevy PD., 2018, CONVERSATION; McLean AN, 2010, J VET BEHAV, V5, P203, DOI 10.1016/j.jveb.2010.04.003; McManus P., 2013, GLOBAL HORSERACING I; McManus P, 2014, LEISURE STUD, V33, P400, DOI 10.1080/02614367.2012.748088; McManus P, 2012, SOC CULT GEOGR, V13, P399, DOI 10.1080/14649365.2012.688852; Meldrum-Hanna C., 2019, 730 REPORTS; Montoya D, 2012, SOC ANIM, V20, P273, DOI 10.1163/156853012X627789; Munro L, 2001, SOC ANIM, V9, P43, DOI 10.1163/156853001300108982; Murphy Kathryn, 2018, GUARDIAN; Narayan PK, 2004, ECON REC, V80, P193, DOI 10.1111/j.1475-4932.2004.00172.x; SILBERMAN MS, 1988, J ZOO WILDLIFE MED, V19, P161, DOI 10.2307/20094884; Thompson K, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10111985; Tong L, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112094; Winter C, 2017, ANN LEIS RES, V20, P578, DOI 10.1080/11745398.2016.1265458; Winter C, 2014, ANN LEIS RES, V17, P359, DOI 10.1080/11745398.2014.950676; Worthington AC, 2007, ECON PAP, V26, P170, DOI 10.1111/j.1759-3441.2007.tb01014.x	43	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248945	10.1371/journal.pone.0248945	http://dx.doi.org/10.1371/journal.pone.0248945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760873	gold, Green Published, Green Accepted			2022-12-26	WOS:000633030400055
J	Matyas, JR; Klein, C; Ponjevic, D; Duncan, NA; Kawchuk, GN				Matyas, John Robert; Klein, Claudia; Ponjevic, Dragana; Duncan, Neil A.; Kawchuk, Gregory N.			Repetitive in vivo manual loading of the spine elicits cellular responses in porcine annuli fibrosi	PLOS ONE			English	Article								Back pain and intervertebral disc degeneration are prevalent, costly, and widely treated by manual therapies, yet the underlying causes of these diseases are indeterminate as are the scientific bases for such treatments. The present studies characterize the effects of repetitive in vivo manual loads on porcine intervertebral disc cell metabolism using RNA deep sequencing. A single session of repetitive manual loading applied to the lumbar spine induced both up- and down-regulation of a variety of genes transcribed by cells in the ventral annuli fibrosi. The effect of manual therapy at the level of loading was greater than at a level distant to the applied load. Gene ontology and molecular pathway analyses categorized biological, molecular, and cellular functions influenced by repetitive manual loading, with over-representation of membrane, transmembrane, and pericellular activities. Weighted Gene Co-expression Network Analysis discerned enrichment in genes in pathways of inflammation and skeletogenesis. The present studies support previous findings of intervertebral disc cell mechanotransduction, and are the first to report comprehensively on the repertoire of gene targets influenced by mechanical loads associated with manual therapy interventions. The present study defines the cellular response of repeated, low-amplitude loads on normal healthy annuli fibrosi and lays the foundation for future work defining how healthy and diseased intervertebral discs respond to single or low-frequency manual loads typical of those applied clinically.	[Matyas, John Robert; Ponjevic, Dragana] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Klein, Claudia] Univ Calgary, Fac Vet Med, Dept Clin & Vet Clin Sci, Calgary, AB, Canada; [Duncan, Neil A.] Univ Calgary, Schulich Sch Engn, Dept Civil Engn, Calgary, AB, Canada; [Kawchuk, Gregory N.] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada; [Klein, Claudia] Fed Res Inst Anim Hlth, Inst Farm Anim Genet, Friedrich Loeffler Inst, Neustadt, Germany	University of Calgary; University of Calgary; University of Calgary; University of Alberta; Friedrich Loeffler Institute	Matyas, JR (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.	jmatyas@ucalgary.ca	Duncan, Neil/C-8260-2009	Duncan, Neil/0000-0002-9782-3681	NIH [5R21AT4055-2]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by a NIH grant 5R21AT4055-2 to authors GK and NAD. https://www.nih.gov/Funders did not play a role in study design, data collection, decision to publish, or manuscript preparation.	Barczewska M, 2017, J MOL NEUROSCI, V63, P50, DOI 10.1007/s12031-017-0956-3; Bialosky JE, 2009, MANUAL THER, V14, P531, DOI 10.1016/j.math.2008.09.001; BOGDUK N, 1983, SPINE, V8, P286, DOI 10.1097/00007632-198304000-00009; Botz B, 2016, J MOL NEUROSCI, V59, P260, DOI 10.1007/s12031-016-0732-9; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; Crean JKG, 1997, SPINE, V22, P2877, DOI 10.1097/00007632-199712150-00010; de Campos TF, 2017, J PHYSIOTHER, V63, P120, DOI 10.1016/j.jphys.2017.02.012; Grant M, 2016, TISSUE ENG PART C-ME, V22, P636, DOI [10.1089/ten.tec.2016.0049, 10.1089/ten.TEC.2016.0049]; Hartman RA, 2012, J BIOMECH, V45, P382, DOI 10.1016/j.jbiomech.2011.10.036; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; HERZOG W, 1993, SPINE, V18, P1206, DOI 10.1097/00007632-199307000-00014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8; Iatridis JC, 2011, SPINE, V36, P203, DOI 10.1097/BRS.0b013e3181cec247; Jansen KA, 2015, BBA-MOL CELL RES, V1853, P3043, DOI 10.1016/j.bbamcr.2015.05.007; Kawchuk GN, 2010, SPINE, V35, P1983, DOI 10.1097/BRS.0b013e3181ddd0a3; Kawchuk GN, 2009, MANUAL THER, V14, P480, DOI 10.1016/j.math.2008.11.001; Koerner JD, 2014, SPINE, V39, P1917, DOI 10.1097/BRS.0000000000000590; MacLean JJ, 2008, J ORTHOP RES, V26, P579, DOI 10.1002/jor.20560; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Marchuk L, 1998, BBA-GEN SUBJECTS, V1379, P171, DOI 10.1016/S0304-4165(97)00094-9; O'Connell GD, 2011, J ORTHOP RES, V29, P547, DOI 10.1002/jor.21232; Parolin M, 2010, Evid Based Spine Care J, V1, P67, DOI 10.1055/s-0028-1100919; Peng B, 2005, J BONE JOINT SURG BR, V87B, P62, DOI 10.1302/0301-620X.87B1.15708; R Core Team, 2020, R LANG ENV STAT COMP; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Stochkendahl MJ, 2018, EUR SPINE J, V27, P60, DOI 10.1007/s00586-017-5099-2; Stokes IAF, 2006, STUD HEALTH TECHNOL, V123, P182; Travascio F, 2014, J BIOMECH, V47, P2269, DOI 10.1016/j.jbiomech.2014.04.046; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wiesenfeld-Hallin Z, 2005, NEUROPEPTIDES, V39, P207, DOI 10.1016/j.npep.2004.12.017; Wong AYL, 2015, SPINE, V40, P1329, DOI 10.1097/BRS.0000000000000981; Wong JJ, 2017, EUR J PAIN, V21, P201, DOI 10.1002/ejp.931; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248104	10.1371/journal.pone.0248104	http://dx.doi.org/10.1371/journal.pone.0248104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755684	gold, Green Published			2022-12-26	WOS:000632916600045
J	Pejam, F; Ardebili, ZO; Ladan-Moghadam, A; Danaee, E				Pejam, Fatemeh; Ardebili, Zahra Oraghi; Ladan-Moghadam, Alireza; Danaee, Elham			Zinc oxide nanoparticles mediated substantial physiological and molecular changes in tomato	PLOS ONE			English	Article								There has long been debate about how nanoproducts meet agricultural requirements. This study aimed to investigate tomato responses to the long-time foliar application of zinc oxide nanoparticles (ZnO-NP; 0 and 3 mgl(-1)) or bulk type (BZnO). Both ZnO-NP and BZnO treatments, especially the nanoform, were significantly capable of improving growth, biomass, and yield. The ZnO-NP treatment upregulated the expression of the R2R3MYB transcription factor by 2.6 folds. The BZnO and ZnO-NP treatments transcriptionally up-regulated WRKY1 gene by 2.5 and 6.4 folds, respectively. The bHLH gene was also upregulated in response to BZnO (2.3-fold) or ZnO-NP (4.7-fold). Moreover, the ZnO-NP application made a contribution to upregulation in the EREB gene whereas the bulk compound did not make a significant change. Upregulation in the HsfA1a gene also resulted from the ZnO-NP (2.8-fold) or BZnO (1.6-fold) supplementation. The MKK2 and CAT genes displayed a similar upregulation trend in response to the supplements by an average of 3-folds. While the application of ZnO-NP slightly down-regulated the histone deacetylases (HDA3) gene by 1.9-fold, indicating epigenetic modification. The supplements, especially the nano-product, enhanced concentrations of K, Fe, and Zn in both leaves and fruits. The concentrations of Chla, Chlb, and carotenoids were increased in response to the BZnO or ZnO-NP treatments. Likewise, BZnO or ZnO-NP mediated an increase in activity of nitrate reductase and proline content in leaves. These treatments increased soluble phenols and phenylalanine ammonia-lyase activity. With a similar trend, the BZnO or ZnO-NP application improved the activities of catalase and peroxidase enzymes. The reinforcement in metaxylem and secondary tissues resulted from the applied supplements. This study provides comprehensive comparative evidence on how ZnO-NPs may remodel the chromatin ultrastructure and transcription program, and confer stress tolerance in crops. This study also underlines the necessity of providing integrated transcriptome and proteome data in future studies.	[Pejam, Fatemeh; Ardebili, Zahra Oraghi] Islamic Azad Univ, Dept Biol, Garmsar Branch, Garmsar, Iran; [Ladan-Moghadam, Alireza; Danaee, Elham] Islamic Azad Univ, Dept Hort, Garmsar Branch, Garmsar, Iran	Islamic Azad University; Islamic Azad University	Ladan-Moghadam, A (corresponding author), Islamic Azad Univ, Dept Hort, Garmsar Branch, Garmsar, Iran.	ladanmoghadam.alireza@gmail.com	Danaee, Elham/AAM-7916-2021; ardebili, zahra oraghi/Q-7985-2019	Danaee, Elham/0000-0003-2494-2011; ardebili, zahra oraghi/0000-0002-1705-3796				Abbasi BA, 2021, MICROSC RES TECHNIQ, V84, P192, DOI 10.1002/jemt.23577; Abbasi BA, 2020, MICROSC RES TECHNIQ, V83, P1308, DOI 10.1002/jemt.23522; Abbasi BA, 2020, J MOL STRUCT, V1218, DOI 10.1016/j.molstruc.2020.128490; Abedi S, 2021, ENVIRON SCI POLLUT R, V28, P3136, DOI 10.1007/s11356-020-10706-2; Babajani A, 2019, ENVIRON SCI POLLUT R, V26, P24430, DOI 10.1007/s11356-019-05676-z; Bandyopadhyay S, 2015, SCI TOTAL ENVIRON, V515, P60, DOI 10.1016/j.scitotenv.2015.02.014; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUDOINEAGAN LD, 1985, PLANT PHYSIOL, V78, P438, DOI 10.1104/pp.78.3.438; Bradfield SJ, 2017, PLANT PHYSIOL BIOCH, V110, P128, DOI 10.1016/j.plaphy.2016.04.008; Dimkpa CO, 2019, SCI TOTAL ENVIRON, V688, P926, DOI 10.1016/j.scitotenv.2019.06.392; Dong Y, 2014, BIOCHEM BIOPH RES CO, V450, P453, DOI 10.1016/j.bbrc.2014.05.139; Faizan M, 2018, PHOTOSYNTHETICA, V56, P678, DOI 10.1007/s11099-017-0717-0; Faizan M, 2020, EFFECTS ZINC OXIDE N, P83, DOI [10.1007/978-3-030-33996-8_4, DOI 10.1007/978-3-030-33996-8_4]; Gao CH, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10030319; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Ghasempour M, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1934-y; Hu QJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04104-x; Huang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192367; Hussain A, 2018, ENVIRON POLLUT, V242, P1518, DOI 10.1016/j.envpol.2018.08.036; Iqbal J, 2020, MICROSC RES TECHNIQ, V83, P706, DOI 10.1002/jemt.23460; Iranbakhsh A., 2021, PLANT RESPONSES NANO; Iranbakhsh A, 2020, PLASMA CHEM PLASMA P, V40, P527, DOI 10.1007/s11090-020-10058-2; Khan ZS, 2019, ENVIRON SCI POLLUT R, V26, P19859, DOI 10.1007/s11356-019-05333-5; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Maret W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112285; Nandhini M, 2019, CROP PROT, V121, P103, DOI 10.1016/j.cropro.2019.03.015; Nazerieh H., 2018, Acta Agriculturae Slovenica, V111, P357, DOI 10.14720/aas.2018.111.2.11; Neysanian M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244207; Ohashi-Ito K, 2014, CURR BIOL, V24, P2053, DOI 10.1016/j.cub.2014.07.050; Behbahani SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235556; Rizwan M, 2019, ENVIRON POLLUT, V248, P358, DOI 10.1016/j.envpol.2019.02.031; Safari M, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2694-8; Salah SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14278; Sheteiwy MS, 2017, PLANT GROWTH REGUL, V83, P27, DOI 10.1007/s10725-017-0281-4; Sotoodehnia-Korani S, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114727; Sun LL, 2020, ENVIRON SCI-NANO, V7, P3587, DOI [10.1039/d0en00723d, 10.1039/D0EN00723D]; SYM GJ, 1984, J SCI FOOD AGR, V35, P725, DOI 10.1002/jsfa.2740350703; Tiwari JK, 2020, PLANT PHYSIOL BIOCH, V154, P171, DOI 10.1016/j.plaphy.2020.05.041; Ullah I, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1215395; Moghadam AV, 2022, J PLANT GROWTH REGUL, V41, P271, DOI 10.1007/s00344-021-10305-6; Venkatachalam P, 2017, PLANT PHYSIOL BIOCH, V110, P59, DOI 10.1016/j.plaphy.2016.08.022; Zhang P, 2020, PLANT CELL ENVIRON, V43, P1925, DOI 10.1111/pce.13784	42	12	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248778	10.1371/journal.pone.0248778	http://dx.doi.org/10.1371/journal.pone.0248778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750969	gold, Green Published			2022-12-26	WOS:000631967100003
J	Tang, GY; Xu, PL; Li, PX; Zhu, JQ; Chen, GX; Shan, L; Wan, SB				Tang, Guiying; Xu, Pingli; Li, Pengxiang; Zhu, Jieqiong; Chen, Guangxia; Shan, Lei; Wan, Shubo			Cloning and functional characterization of seed-specific LEC1A promoter from peanut (Arachis hypogaea L.)	PLOS ONE			English	Article								LEAFY COTYLEDON1 (LEC1) is a HAP3 subunit of CCAAT-binding transcription factor, which controls several aspects of embryo and postembryo development, including embryo morphogenesis, storage reserve accumulation and skotomorphogenesis. Herein, using the method of chromosomal walking, a 2707bp upstream sequence from the ATG initiation codon site of AhLEC1A which is a homolog of Arabidopsis LEC1 was isolated in peanut. Its transcriptional start site confirmed by 5' RACE was located at 82 nt from 5' upstream of ATG. The bioinformatics analysis revealed that there existed many tissue-specific elements and light responsive motifs in its promoter. To identify the functional region of the AhLEC1A promoter, seven plant expression vectors expressing the GUS (beta-glucuronidase) gene, driven by 5' terminal series deleted fragments of AhLEC1A promoter, were constructed and transformed into Arabidopsis. Results of GUS histochemical staining showed that the regulatory region containing 82bp of 5' UTR and 2228bp promoter could facilitate GUS to express preferentially in the embryos at different development periods of Arabidopsis. Taken together, it was inferred that the expression of AhLEC1A during seed development of peanut might be controlled positively by several seed-specific regulatory elements, as well as negatively by some other regulatory elements inhibiting its expression in other organs. Moreover, the GUS expression pattern of transgenic seedlings in darkness and in light was relevant to the light-responsive elements scattered in AhLEC1A promoter segment, implying that these light-responsive elements harbored in the AhLEC1A promoter regulate skotomorphogenesis of peanut seeds, and AhLEC1A expression was inhibited after the germinated seedlings were transferred from darkness to light.	[Tang, Guiying; Xu, Pingli; Li, Pengxiang; Zhu, Jieqiong; Shan, Lei; Wan, Shubo] Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China; [Li, Pengxiang; Zhu, Jieqiong; Shan, Lei; Wan, Shubo] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China; [Chen, Guangxia] Shandong Acad Grape, Jinan, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Normal University	Shan, L; Wan, SB (corresponding author), Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Shandong, Peoples R China.; Shan, L; Wan, SB (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.	shlei1025@sina.com; wansb@saas.ac.cn			National Key R&D Program of China [2018YFD1000906]; Major Basic Research Project of Natural Science Foundation of Shandong Province [2018GHZ007]	National Key R&D Program of China; Major Basic Research Project of Natural Science Foundation of Shandong Province	Our work was funded by the National Key R&D Program of China (2018YFD1000906), and the Major Basic Research Project of Natural Science Foundation of Shandong Province (2018GHZ007). In addition, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2005, J EXP BOT, V56, P37, DOI 10.1093/jxb/eri004; ALLEN RD, 1989, PLANT CELL, V1, P623, DOI 10.1105/tpc.1.6.623; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baud S, 2016, PLANT PHYSIOL, V171, P1099, DOI 10.1104/pp.16.00034; BORELLO U, 1993, PLANT J, V4, P611, DOI 10.1046/j.1365-313X.1993.04040611.x; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Brocard-Gifford IM, 2003, PLANT PHYSIOL, V131, P78, DOI 10.1104/pp.011916; BUSTOS MM, 1991, EMBO J, V10, P1469, DOI 10.1002/j.1460-2075.1991.tb07667.x; Cagliari A, 2014, GENOMICS, V103, P380, DOI 10.1016/j.ygeno.2014.03.005; Cal M, 2007, PLANT BIOTECHNOL J, V5, P664, DOI 10.1111/j.1467-7652.2007.00271.x; Calvenzani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042902; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chen CH, 2002, PLANT PHYSIOL, V129, P706, DOI 10.1104/pp.001057; [陈高 Chen Gao], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P214; Elahi N, 2016, PLANT PHYSIOL BIOCH, V100, P52, DOI 10.1016/j.plaphy.2015.12.022; ELMAYAN T, 1995, TRANSGENIC RES, V4, P388, DOI 10.1007/BF01973757; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Harada JJ, 2001, J PLANT PHYSIOL, V158, P405, DOI 10.1078/0176-1617-00351; Harada JJ, 2012, SEED SCI RES, V22, pS15, DOI 10.1017/S0960258511000304; Huang MK, 2015, PLANT CELL, V27, P3099, DOI 10.1105/tpc.15.00750; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211941; Jo L, 2020, P NATL ACAD SCI USA, V117, P1223, DOI 10.1073/pnas.1918441117; Junker A, 2012, PLANT J, V71, P427, DOI 10.1111/j.1365-313X.2012.04999.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; LESSARD PA, 1991, PLANT MOL BIOL, V16, P397, DOI 10.1007/BF00023991; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Luo QL, 2013, PLANT CELL TISS ORG, V114, P109, DOI 10.1007/s11240-013-0310-6; MEINKE DW, 1992, SCIENCE, V258, P1647, DOI 10.1126/science.258.5088.1647; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Pelletier JM, 2017, P NATL ACAD SCI USA, V114, pE6710, DOI 10.1073/pnas.1707957114; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Redman J, 2002, PLANT CELL REP, V21, P180, DOI 10.1007/s00299-002-0472-x; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Roscoe TT, 2015, PLANT CELL PHYSIOL, V56, P1215, DOI 10.1093/pcp/pcv049; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; TAKAIWA F, 1991, PLANT MOL BIOL, V17, P875, DOI 10.1007/BF00037068; Tan HL, 2011, PLANT PHYSIOL, V156, P1577, DOI 10.1104/pp.111.175000; Tang GY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00260; Tang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139213; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Tapia G, 2005, PLANT PHYSIOL, V138, P2075, DOI 10.1104/pp.105.059766; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Thum KE, 2001, PLANT MOL BIOL, V47, P353, DOI 10.1023/A:1011616400264; Verdier J, 2008, PLANT CELL PHYSIOL, V49, P1263, DOI 10.1093/pcp/pcn116; Wang Y, 2011, J PLANT DIS PROTECT, V118, P69, DOI 10.1007/BF03356384; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; Yamauchi D, 2001, PLANT CELL PHYSIOL, V42, P635, DOI 10.1093/pcp/pce079; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Ye J, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008149; Yin DM, 2020, ADV SCI, V7, DOI 10.1002/advs.201901672; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967	72	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0242949	10.1371/journal.pone.0242949	http://dx.doi.org/10.1371/journal.pone.0242949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750972	Green Published, Green Submitted, gold			2022-12-26	WOS:000631967100022
J	Drouilly, M; Nattrass, N; O'Riain, MJ				Drouilly, Marine; Nattrass, Nicoli; O'Riain, M. Justin			Beauty or beast? Farmers' dualistic views and the influence of aesthetic appreciation on tolerance towards black-backed jackal and caracal	PLOS ONE			English	Article							LARGE CARNIVORES; ATTITUDES; SOUTH; PREDATORS; CONFLICT; LIVESTOCK; SHEEP; CONSERVATION; PERCEPTIONS; LANDSCAPE	Various species of wild, adaptable, medium-sized carnivores occur outside of protected areas, often coming into contact with people and their domestic animals. Negative human-carnivore interactions can lead to antagonistic attitudes and behavior directed at such species. In the South African Karoo, a semi-arid rangeland, the predation of small-livestock by mesopredators is common and farmers typically use a combination of non-lethal and lethal methods to try and prevent livestock losses. We used ethnographic field observations and semi-structured interviews as part of a mixed methods approach, including the quantitative and qualitative analysis of farmers' narratives to illustrate the nuanced ways in which sheep farmers relate to the two mesopredators that consume the most livestock on their farms; black-backed jackal and caracal. Overall, farmers attributed negative characteristics to jackal and caracal but farmers' narratives provided evidence of complex perceptions in that the animals were admired as well as disliked. Both species were seen as charismatic due to traits such as their physical appearance, their "cunning" nature and their remarkable adaptability to human activities, including lethal control. Aesthetic appreciation was an important predictor of tolerance towards both species whereas negative attitudes were associated with the perception that mesopredators should only occur within protected areas. Attitudes towards jackals also appeared to have been affected by cultural representations of them as "thieves". We showed that perceiving mesopredators as beautiful increased the average marginal probability of a farmer tolerating them, and that this strong relationship held when controlling for other covariates such as livestock predation. We advocate the importance of understanding the cultural and aesthetic aspects of predators and considering existing positive dimensions of human-wildlife relationships that may encourage increased farmers' tolerance, which might promote coexistence.	[Drouilly, Marine; Nattrass, Nicoli; O'Riain, M. Justin] Univ Cape Town, Inst Communities & Wildlife Africa, Cape Town, South Africa; [Drouilly, Marine] Panthera, New York, NY 10018 USA	University of Cape Town	Drouilly, M (corresponding author), Univ Cape Town, Inst Communities & Wildlife Africa, Cape Town, South Africa.; Drouilly, M (corresponding author), Panthera, New York, NY 10018 USA.	marinedrouilly@gmail.com		Nattrass, Nicoli/0000-0002-8422-5631	National Research Foundation (NRF) [GT 2251]	National Research Foundation (NRF)	MD was supported by grant GT 2251 from the WWF-Nedbank Greentrust (www.wwf.org.za/wwf_nedbank_gt_funding/).MJO and NN were supported by the National Research Foundation (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K, 2014, ECOLOGY, V95, P631, DOI 10.1890/13-1452.1; Armstrong K., 2006, SHORT HIST MYTH; Avenant NL, 2008, MAMMALIA, V72, P258, DOI 10.1515/MAMM.2008.041; Barton K., 2022, MULTIMODEL INFERENCE; Beinart W., 2003, TRANSITION; Beinart William, 2008, RISE CONSERVATION S; Medina SPB, 2020, ANTHROZOOS, V33, P597, DOI 10.1080/08927936.2020.1799547; Bhatia S, 2020, ORYX, V54, P621, DOI 10.1017/S003060531800159X; Breck SW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38543-5; Carlson A., 2008, NATURE AESTHETICS EN; Conradie B, 2017, AFR J AGRIC RESOUR E, V12, P217; Conradie B, 2015, AGREKON, V54, P1, DOI 10.1080/03031853.2015.1065186; de Pinho JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088842; de Wet J., 2010, WAT PRAAT JY AFRIKAA, V4th; Dean RJ., 1999, KAROO ECOLOGICAL PAT; Deustua Aris Iris, 2008, Ecol. apl., V7, P43; Dhee Athreya V., 2019, PEOPLE NATURE, V1, P376, DOI [10.1002/pan3.10039, DOI 10.1002/PAN3.10039]; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drouilly M., 2019, THESIS U CAPE TOWN; Drouilly M, 2019, BIODIVERS CONSERV, P1; Drouilly M, 2018, AFR J RANGE FOR SCI, V35, P245, DOI 10.2989/10220119.2018.1522669; Drouilly M, 2018, BIOL CONSERV, V224, P16, DOI 10.1016/j.biocon.2018.05.013; Drouilly M, 2018, J WILDLIFE MANAGE, V82, P507, DOI 10.1002/jwmg.21407; Du Plessis JJ, 2015, AFR J WILDL RES, V45, P138, DOI 10.3957/056.045.0138; Ericsson G, 2003, BIOL CONSERV, V111, P149, DOI 10.1016/S0006-3207(02)00258-6; Fehlmann G, 2021, BIOSCIENCE, V71, P40, DOI 10.1093/biosci/biaa129; Fontein J., 2014, DOING ANTHROPOLOGICA, P55; Fox J., 2019, R COMPANION APPL REG, V.; Frank B, 2016, HUM DIMENS WILDL, V21, P297, DOI 10.1080/10871209.2016.1151965; Frank B, 2016, SOC NATUR RESOUR, V29, P738, DOI 10.1080/08941920.2015.1103388; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Herrmann TM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-41; HEWSON R, 1984, J APPL ECOL, V21, P843, DOI 10.2307/2405051; Hu B, 2006, STAT SINICA, V16, P847; Humphries BD, 2015, AFR J ECOL, V53, P540, DOI 10.1111/aje.12247; Ingold T., 2000, PERCEPTION ENV ESSAY, P61, DOI DOI 10.4324/9780203466025; JARVIS MJF, 1980, OSTRICH, V51, P215, DOI 10.1080/00306525.1980.9633568; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Kansky R, 2016, BIOL CONSERV, V201, P137, DOI 10.1016/j.biocon.2016.07.002; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Kok OB, 2004, BIOL J LINN SOC, V83, P527, DOI 10.1111/j.1095-8312.2004.00409.x; Leeper T, 2018, PACKAGE MARGINS MARG; Liordos V, 2017, SCI TOTAL ENVIRON, V595, P25, DOI 10.1016/j.scitotenv.2017.03.241; Lischka SA, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.07.034; MacDonald DW, 2001, CONSERV BIOL SER, V5, P524; MacDonald DW, 2020, ORYX, P1; Majic A, 2010, BIOL CONSERV, V143, P255, DOI 10.1016/j.biocon.2009.09.010; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; McGranahan C., 2014, TEACHING ANTHR, V4, P23; Minnie L, 2016, J APPL ECOL, V53, P379, DOI 10.1111/1365-2664.12581; Mkonyi FJ, 2017, HUM DIMENS WILDL, V22, P314, DOI 10.1080/10871209.2017.1323356; Mucina L., 2006, VEGETATION SO AFRICA, P325; Muriuki MW, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1117-2; Nattrass N, 2017, BRIEF HIST PREDATORS; Nattrass Nicoli, 2020, Journal of Urban Ecology, V6, pjuaa019, DOI 10.1093/jue/juaa019; Nattrass N, 2020, MAMMAL REV, V50, P101, DOI 10.1111/mam.12179; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Negri S., 2010, COUGAR ECOL CONSERV, P306; Newcomb TM., 1950, SOC PSYCHOL-GERMANY; Newing H, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P1; Norton EC, 2018, HEALTH SERV RES, V53, P859, DOI 10.1111/1475-6773.12712; OLI MK, 1994, BIOL CONSERV, V68, P63, DOI 10.1016/0006-3207(94)90547-9; Pirie TJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3369; Puri R., 2010, CONDUCT RES CONSERV, P107; R Core Team, 2017, R LANG ENV STAT COMP; Ramesh T, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-016-1072-3; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Rowley I., 1970, CSIRO Wildl. Res., V15, P79; Rust NA, 2016, ANTHROZOOS, V29, P653, DOI 10.1080/08927936.2016.1228758; Saito Y, 1998, ENVIRON ETHICS, V20, P135, DOI 10.5840/enviroethics199820228; Stewart D., 2001, AFRICAN MYTHS LEGEND; Tafalla M., 2017, AESTHETIC APPRECIATI, V15; Tensen L, 2018, J MAMMAL, V99, P1411, DOI 10.1093/jmammal/gyy127; Thorn M, 2015, ORYX, V49, P270, DOI 10.1017/S0030605313000744; Van Niekerk, 2010, COST PREDATION SMALL; Vaske J.J., 2012, HUMAN DIMENSIONS WIL, P43; Venter JM., 1986, KAROO BIOME PRELIM S, P39; Vucetich J., 2014, OXFORD HDB ANIM STUD, P411; Warren JT, 2001, J ZOOL, V254, P195, DOI 10.1017/S095283690100070X; Western Cape Department of Agriculture, W CAP AGRISTATS 2013; Western Cape Department of Agriculture, 2017, AGRIWORKER HOUS CENS; Williams VL, 2016, J ETHNOPHARMACOL, V179, P265, DOI 10.1016/j.jep.2015.12.024; Wittenberg H, 2014, CRIT ARTS, V28, P593, DOI 10.1080/02560046.2014.929218; Wolch JR, 1997, SOC ANIM, V5, P95, DOI 10.1163/156853097X00015; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zeileis A, 2006, J STAT SOFTW, V16; Zimmermann A, 2005, ORYX, V39, P406, DOI 10.1017/S0030605305000992	91	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248977	10.1371/journal.pone.0248977	http://dx.doi.org/10.1371/journal.pone.0248977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740027	Green Published, gold			2022-12-26	WOS:000631030200037
J	Esquer, H; Zhou, Q; Nemkov, T; Abraham, AD; Rinaldetti, S; Chen, YC; Zhang, XH; Orman, MV; D'Alessandro, A; Ferrer, M; Messersmith, WA; LaBarbera, DV				Esquer, Hector; Zhou, Qiong; Nemkov, Travis; Abraham, Adedoyin D.; Rinaldetti, Sebastien; Chen, Yu-Chi; Zhang, Xiaohu; Orman, Michael, V; D'Alessandro, Angelo; Ferrer, Marc; Messersmith, Wells A.; LaBarbera, Daniel, V			Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer	ONCOGENE			English	Article								Epithelial-mesenchymal transition (EMT) is a driving force in promoting malignant cancer, including initiation, growth, and metastasis. EMT is a dynamic process that can undergo a mesenchymal-epithelial transition (MET) and partial transitions between both phenotypes, termed epithelial-mesenchymal plasticity (EMP). In cancer, the acquisition of EMP results in a spectrum of phenotypes, promoting tumor cell heterogeneity and resistance to standard of care therapy. Here we describe a real-time fluorescent dual-reporter for vimentin and E-cadherin, biomarkers of the mesenchymal and epithelial cell phenotypes, respectively. Stable dual-reporter cell lines generated from colorectal (SW620), lung (A549), and breast (MDA-MB-231) cancer demonstrate a spectrum of EMT cell phenotypes. We used the dual-reporter to isolate the quasi epithelial, epithelial/mesenchymal, and mesenchymal phenotypes. Although EMT is a dynamic process, these isolated quasi-EMTphenotypes remain stable to spontaneous EMP in the absence of stimuli and during prolonged cell culture. However, the quasi-EMT phenotypes can readily be induced to undergo EMT or MET with growth factors or small molecules. Moreover, isolated EMT phenotypes display different tumorigenic properties and are morphologically and metabolically distinct. 3D high-content screening of similar to 23,000 compounds using dual-reporter mesenchymal SW620 tumor organoids identified small molecule probes that modulate EMT, and a subset of probes that effectively induced MET. The tools, probes, and models described herein provide a coherent mechanistic understanding of mesenchymal cell plasticity. Future applications utilizing this technology and probes are expected to advance our understanding of EMT and studies aimed at therapeutic strategies targeting EMT.	[Esquer, Hector; Zhou, Qiong; Abraham, Adedoyin D.; Rinaldetti, Sebastien; Orman, Michael, V; LaBarbera, Daniel, V] Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus CU AMC, Aurora, CO 80045 USA; [Nemkov, Travis; D'Alessandro, Angelo] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Chen, Yu-Chi; Zhang, Xiaohu; Ferrer, Marc] NIH, Early Translat Branch, Natl Ctr Adv Translat Sci NCATS, Rockville, MD USA; [D'Alessandro, Angelo; Messersmith, Wells A.; LaBarbera, Daniel, V] Univ Colorado Canc Ctr UCCC, Aurora, CO 80045 USA; [D'Alessandro, Angelo; Messersmith, Wells A.; LaBarbera, Daniel, V] Univ Colorado, Anschutz Med Campus, Aurora, CO 80045 USA; [Messersmith, Wells A.] Univ Colorado, Div Med Oncol, Sch Med, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	LaBarbera, DV (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus CU AMC, Aurora, CO 80045 USA.; LaBarbera, DV (corresponding author), Univ Colorado Canc Ctr UCCC, Aurora, CO 80045 USA.; LaBarbera, DV (corresponding author), Univ Colorado, Anschutz Med Campus, Aurora, CO 80045 USA.	daniel.labarbera@cuanschutz.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Rinaldetti, Sebastien/0000-0003-1053-3831; Esquer, Hector/0000-0002-1911-1523	Department of Defense Peer Reviewed Cancer Research Program [W81XWH-18-1-0142]; NIH NCI [1R01CA251361-01]; The ALSAM Foundation Therapeutic Innovation Grant; NIH Training Grant [5T32HL7171-42]; Cancer Foundation of Luxembourg; UCCC NIH NCI designated cancer center [P30CA046934]	Department of Defense Peer Reviewed Cancer Research Program(United States Department of Defense); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The ALSAM Foundation Therapeutic Innovation Grant; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation of Luxembourg; UCCC NIH NCI designated cancer center	This research was supported in part by grants awarded to DVL from the Department of Defense Peer Reviewed Cancer Research Program (W81XWH-18-1-0142), the NIH NCI (1R01CA251361-01), and The ALSAM Foundation Therapeutic Innovation Grant. TN was supported by a NIH Training Grant (5T32HL7171-42). SR was supported by the Cancer Foundation of Luxembourg. We thank the Eli Lilly and Company Open Innovation Drug Discovery Program, particularly Evan Castetter and Maria Jose Lorite, for providing the BIC library. We also thank CU AMC shared resource laboratories, including the Drug Discovery and Development Shared Resource (HTS/HCS Discovery Arm), MS Metabolomics, Flow Cytometry, and NMR. These shared resources are supported in part by the UCCC NIH NCI designated cancer center (P30CA046934). We are grateful to Claudia Esquer for graphic design input of Fig. 6.	Abraham AD, 2019, J MED CHEM, V62, P10182, DOI 10.1021/acs.jmedchem.9b01065; Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Bai FW, 2012, J BIOL CHEM, V287, P30653, DOI 10.1074/jbc.M112.385583; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Bighetti-Trevisan RL, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9618065; Buchser W., 2004, ASSAY GUIDANCE MANUA; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Choi BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15139-5; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cojoc M, 2015, CANCER RES, V75, P1482, DOI 10.1158/0008-5472.CAN-14-1924; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Esquer H, 2020, SLAS DISCOV, V25, P734, DOI 10.1177/2472555220926921; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hale JS, 2014, STEM CELLS, V32, P1746, DOI 10.1002/stem.1716; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jacobsen A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24982-z; Jia DY, 2019, P NATL ACAD SCI USA, V116, P3909, DOI 10.1073/pnas.1816391116; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; Kroger C, 2019, P NATL ACAD SCI USA, V116, P7353, DOI 10.1073/pnas.1812876116; Lee Sang-Kyu, 2018, Advances in Biological Regulation, V68, P46, DOI 10.1016/j.jbior.2018.01.001; Leggett SE, 2016, INTEGR BIOL-UK, V8, P1133, DOI 10.1039/c6ib00139d; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcucci F, 2016, NAT REV DRUG DISCOV, V15, P311, DOI 10.1038/nrd.2015.13; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; McDonald PC, 2015, PRINCIPLES OF STEM CELL BIOLOGY AND CANCER: FUTURE APPLICATIONS AND THERAPEUTICS, P103; Moore SF, 2013, J BIOL CHEM, V288, P3918, DOI 10.1074/jbc.M112.429936; Nemkov T, 2019, METHODS MOL BIOL, V1978, P13, DOI 10.1007/978-1-4939-9236-2_2; Nemkov T, 2017, RAPID COMMUN MASS SP, V31, P663, DOI 10.1002/rcm.7834; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Richardson F, 2012, ANTICANCER RES, V32, P537; Rodriguez-Pinilla SM, 2007, J CLIN PATHOL, V60, P1006, DOI 10.1136/jcp.2006.042143; San-Millan I, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01536; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sciacovelli M, 2017, FEBS J, V284, P3132, DOI 10.1111/febs.14090; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Toiyama Y, 2013, CARCINOGENESIS, V34, P2548, DOI 10.1093/carcin/bgt282; Vlachostergios PJ, 2015, CANCER BIOMARK, V15, P725, DOI 10.3233/CBM-150514; Voon DC, 2017, MOL ONCOL, V11, P878, DOI 10.1002/1878-0261.12082; Walenta S, 2003, J CANCER RES CLIN, V129, P321, DOI 10.1007/s00432-003-0450-x; Wang CH, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1265-2; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Ye HB, 2016, CELL STEM CELL, V19, P23, DOI 10.1016/j.stem.2016.06.001; Ye ZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163162; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Ying M, 2016, ONCOGENE, V35, P4358, DOI [10.1038/onc.2015.503, 10.1038/onc.2016.29]; Yun JA, 2014, ONCOLOGY-BASEL, V86, P318, DOI 10.1159/000360794; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang FX, 2018, PROG NEUROBIOL, V171, P72, DOI 10.1016/j.pneurobio.2018.09.006; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XJ, 2013, INT J BIOL SCI, V9, P1108, DOI 10.7150/ijbs.7232	59	7	7	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2884	2897		10.1038/s41388-021-01728-2	http://dx.doi.org/10.1038/s41388-021-01728-2		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742123	Green Accepted			2022-12-26	WOS:000630675000001
J	Solomonov, Y; Hadad, N; Pikovsky, O; Levy, R				Solomonov, Yulia; Hadad, Nurit; Pikovsky, Oleg; Levy, Rachel			Lumenato protects normal human dermal fibroblasts from neutrophil-induced collagen-3 damage in co-cultures	PLOS ONE			English	Article								Collagen is the major structural protein in the extracellular matrix of skin produced by fibroblasts. UV exposure results in infiltration of neutrophils within the epidermis and dermis, inducing collagen damage and contributing to the process of photo-aging. Collagen-3 is an integral structural component with collagen-1, and is an important regulator of collagen-1 fibrillogenesis. Addition of neutrophils activated with TNF alpha to normal human dermal fibroblast cultures, but not their supernatant, caused significant collagen-3 damage. To study whether Lumenato can protect from collagen-3 damage, it was added to co-cultures of Normal human dermal fibroblasts and neutrophils activated with TNF alpha. Lumenato prevented collagen-3 damage induced by activated neutrophils in a dose-dependent manner in the co-cultures. Lumenato also induced a low rate of collagen-3 synthesis in a dose-dependent manner detected by pro-collagen-3 secretion, but did not affect fibroblast cell number. Although Lumenato inhibited MMP-8, MMP-9, and elastase secreted from neutrophils, its main effect was in inhibiting both NADPH oxidase-producing superoxides and MPO activity-producing halides in a dose-dependent manner that correlated with protection from collagen-3 damage. In conclusion, the results suggest that Lumenato induces low levels of collagen-3 that may contribute for skin health and is very effective in defending the co-cultures from collagen-3 damage by inhibiting free radicals secreted from neutrophils, thus, indicating Lumenato's possible potential for skin protection.	[Solomonov, Yulia; Hadad, Nurit; Levy, Rachel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Immunol & Infect Dis Lab, Beer Sheva, Israel; [Pikovsky, Oleg] Soroka Univ, Blood Bank & Pheresis Unit, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center	Levy, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Immunol & Infect Dis Lab, Beer Sheva, Israel.	ral@bgu.ac.il		Pikovsky, Oleg/0000-0001-7711-5410	Lycored Ltd., Beer-Sheva, Israel [2016-2020]	Lycored Ltd., Beer-Sheva, Israel	This study received support in the form of a grant (number 2016-2020) awarded to RL by Lycored Ltd., Beer-Sheva, Israel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALBRICH JM, 1982, FEBS LETT, V144, P157, DOI 10.1016/0014-5793(82)80591-7; Arber N, 1997, CANCER RES, V57, P1569; Bielenberg DR, 1998, J INVEST DERMATOL, V111, P864, DOI 10.1046/j.1523-1747.1998.00378.x; Casini A, 1997, HEPATOLOGY, V25, P361; Cheng W, 2011, AFR J BIOTECHNOL, V10, P2524; Cho S, 2008, J DERMATOL SCI, V50, P123, DOI 10.1016/j.jdermsci.2007.11.009; DEWALD B, 1982, J CLIN INVEST, V70, P518, DOI 10.1172/JCI110643; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x; Gonzalez S, 1996, PHOTODERMATOL PHOTO, V12, P45, DOI 10.1111/j.1600-0781.1996.tb00175.x; Hadad N, 2017, NEUROMOL MED, V19, P436, DOI 10.1007/s12017-017-8459-5; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; Harty MW, 2010, AM J PATHOL, V176, P1271, DOI 10.2353/ajpath.2010.090527; HRUZA LL, 1993, J INVEST DERMATOL, V100, pS35, DOI 10.1111/1523-1747.ep12355240; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KAGAN V, 1992, FREE RADICAL RES COM, V16, P51, DOI 10.3109/10715769209049159; Kawaguchi Y, 1996, ARCH DERMATOL RES, V288, P39, DOI 10.1007/BF02505041; Kim HH, 2006, J LIPID RES, V47, P921, DOI 10.1194/jlr.M500420-JLR200; KUHN K, 1987, STRUCTURE FUNCTION C, P1; KUIVANIEMI H, 1995, J INVEST DERMATOL, V105, P352, DOI 10.1111/1523-1747.ep12320704; Lee SE, 2019, INT J MOL MED, V44, P1641, DOI 10.3892/ijmm.2019.4320; LEVY R, 1990, BIOCHEM BIOPH RES CO, V170, P1114, DOI 10.1016/0006-291X(90)90508-K; Li Q, 2003, J LEUKOCYTE BIOL, V74, P412, DOI 10.1189/jlb.0801757; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Liu XY, 2019, APPL BIOCHEM BIOTECH, V189, P729, DOI 10.1007/s12010-019-03027-9; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MCKENNA SM, 1988, BIOCHEM J, V254, P685, DOI 10.1042/bj2540685; Melendez-Martinez AJ, 2015, ARCH BIOCHEM BIOPHYS, V572, P188, DOI 10.1016/j.abb.2015.01.003; MURPHY G, 1980, BIOCHEM J, V192, P517, DOI 10.1042/bj1920517; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Othman RA, 2011, NUTR REV, V69, P371, DOI 10.1111/j.1753-4887.2011.00399.x; Park HJ, 2009, J INVEST DERMATOL, V129, P843, DOI 10.1038/jid.2008.320; Polte T, 2004, FREE RADICAL BIO MED, V36, P1566, DOI 10.1016/j.freeradbiomed.2004.04.003; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Rhie GE, 2001, J INVEST DERMATOL, V117, P1212, DOI 10.1046/j.0022-202x.2001.01469.x; Rijken F, 2005, BRIT J DERMATOL, V152, P321, DOI 10.1111/J.1365-2133.2004.06335.X; Rijken F, 2004, J INVEST DERMATOL, V122, P1448, DOI 10.1111/j.0022-202X.2004.22609.x; Rijken F, 2011, CLIN PHARMACOL THER, V89, P120, DOI 10.1038/clpt.2010.221; Rijken F, 2009, J INVEST DERM SYMP P, V14, P67, DOI 10.1038/jidsymp.2009.15; Robinson MK, 2009, J DRUGS DERMATOL, V8, pS8; Sagy-Bross C, 2013, NEUROCHEM INT, V63, P541, DOI 10.1016/j.neuint.2013.09.007; SEGAL AW, 1983, BIOCHEM J, V210, P215, DOI 10.1042/bj2100215; Solomonov Y., 2018, J NUTR FOOD SCI, V08, DOI [10.4172/2155-9600.1000653, DOI 10.4172/2155-9600.1000653]; STALLMACH A, 1992, GASTROENTEROLOGY, V102, P1920, DOI 10.1016/0016-5085(92)90314-O; TAKASAGO T, 1992, ELECTROPHORESIS, V13, P373, DOI 10.1002/elps.1150130176; TALWAR HS, 1995, J INVEST DERMATOL, V105, P285, DOI 10.1111/1523-1747.ep12318471; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; THOMAS EL, 1979, INFECT IMMUN, V23, P522, DOI 10.1128/IAI.23.2.522-531.1979; Urschitz J, 2002, J INVEST DERMATOL, V119, P3, DOI 10.1046/j.1523-1747.2002.01829.x; vanDalen CJ, 1997, BIOCHEM J, V327, P487; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WATANABE H, 1990, J BIOCHEM-TOKYO, V108, P753, DOI 10.1093/oxfordjournals.jbchem.a123277; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Wood LC, 1996, J INVEST DERMATOL, V106, P397, DOI 10.1111/1523-1747.ep12343392; Yan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061946; Yin YX, 2018, BIOORG MED CHEM LETT, V28, P1525, DOI 10.1016/j.bmcl.2018.03.073; Zhang LJ, 2019, J NUTR BIOCHEM, V69, P19, DOI 10.1016/j.jnutbio.2019.03.009	59	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248183	10.1371/journal.pone.0248183	http://dx.doi.org/10.1371/journal.pone.0248183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730073	Green Published, gold			2022-12-26	WOS:000630345000077
J	Motizuki, M; Koinuma, D; Yokoyama, T; Itoh, Y; Omata, C; Miyazono, K; Saitoh, M; Miyazawa, K				Motizuki, Mitsuyoshi; Koinuma, Daizo; Yokoyama, Takashi; Itoh, Yuka; Omata, Chiho; Miyazono, Kohei; Saitoh, Masao; Miyazawa, Keiji			TGF-beta-induced cell motility requires downregulation of ARHGAPs to sustain Rac1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; STRUCTURAL BASIS; SMAD PROTEINS; DNA-BINDING; MH1 DOMAIN; COMPLEX; ACTIVATION; MEMBRANE; FILGAP; ROLES	Transforming growth factor-beta (TGF-beta) signaling promotes cancer progression. In particular, the epithelial-mesenchymal transition (EMT) induced by TGF-beta is considered crucial to the malignant phenotype of cancer cells. Here, we report that the EMT-associated cellular responses induced by TGF-beta are mediated by distinct signaling pathways that diverge at Smad3. By expressing chimeric Smad1/Smad3 proteins in SMAD3 knockout A549 cells, we found that the beta 4 region in the Smad3 MH1 domain is essential for TGF-beta-induced cell motility, but is not essential for other EMT-associated responses including epithelial marker downregulation. TGF-beta was previously reported to enhance cell motility by activating Rac1 via phosphoinositide 3-kinase. Intriguingly, TGF-beta-dependent signaling mediated by Smad3's beta 4 region causes the downregulation of multiple mRNAs that encode GTPase activating proteins that target Rac1 (ARHGAPs), thereby attenuating Rac1 inactivation. Therefore, two independent pathways downstream of TGF-beta type I receptor contribute cooperatively to sustained Rac1 activation, thereby leading to enhanced cell motility.	[Motizuki, Mitsuyoshi; Yokoyama, Takashi; Itoh, Yuka; Omata, Chiho; Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Grad Sch Med, Dept Biochem, Kofu, Yamanashi, Japan; [Koinuma, Daizo; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan; [Saitoh, Masao] Univ Yamanashi, Ctr Med Educ & Sci, Grad Sch Med, Kofu, Yamanashi, Japan	University of Yamanashi; University of Tokyo; University of Yamanashi	Miyazawa, K (corresponding author), Univ Yamanashi, Grad Sch Med, Dept Biochem, Kofu, Yamanashi, Japan.	kmiyazawa@yamanashi.ac.jp	Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05150, 15H05774]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05150] (K. Miyazawa) and [15H05774] (K. Miyazono).	Nieto MA, 2017, NAT CELL BIOL, V19, P416, DOI 10.1038/ncb3520; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Campa Carlo C, 2015, Small GTPases, V6, P71, DOI 10.4161/21541248.2014.989789; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Duan D, 2019, J BIOL CHEM, V294, P8490, DOI 10.1074/jbc.RA118.005763; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Grocott T, 2007, NUCLEIC ACIDS RES, V35, P890, DOI 10.1093/nar/gkl1105; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Hubchak SC, 2009, AM J PHYSIOL-RENAL, V297, pF1316, DOI 10.1152/ajprenal.00345.2009; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Itoh Y, 2019, J BIOL CHEM, V294, P15466, DOI 10.1074/jbc.RA119.009877; Kawasaki N, 2018, CANCER SCI, V109, P2211, DOI 10.1111/cas.13626; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kusanagi K, 2001, J BIOL CHEM, V276, P28155, DOI 10.1074/jbc.M103371200; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Liu T, 2017, ONCOGENE, V36, P362, DOI 10.1038/onc.2016.204; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Motizuki M, 2015, J BIOCHEM, V158, P435, DOI 10.1093/jb/mvv054; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Muller PM, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0488-x; Nakano N, 2020, J BIOL CHEM, V295, P9033, DOI 10.1074/jbc.RA120.013596; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nguyen Lan K, 2018, Small GTPases, V9, P316, DOI 10.1080/21541248.2016.1224399; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Saitoh M, 2016, ONCOGENE, V35, P1049, DOI 10.1038/onc.2015.161; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Su J, 2020, NATURE, V577, P566, DOI 10.1038/s41586-019-1897-5; Sundqvist A, 2018, NUCLEIC ACIDS RES, V46, P1180, DOI 10.1093/nar/gkx1190; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Tsubakihara Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113672; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600	55	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100545	10.1016/j.jbc.2021.100545	http://dx.doi.org/10.1016/j.jbc.2021.100545			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741342	gold, Green Published			2022-12-26	WOS:000672866400518
J	Yazici, AT; Gianti, E; Kasimova, MA; Lee, BH; Carnevale, V; Rohacs, T				Yazici, Aysenur Torun; Gianti, Eleonora; Kasimova, Marina A.; Lee, Bo-Hyun; Carnevale, Vincenzo; Rohacs, Tibor			Dual regulation of TRPV1 channels by phosphatidylinositol via functionally distinct binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID 1 TRPV1; ION-CHANNEL; PHOSPHOINOSITIDE REGULATION; MOLECULAR DETERMINANTS; CAPSAICIN RECEPTOR; ACTIVATION; PI(4,5)P-2; 4,5-BISPHOSPHATE; DYNAMICS; PROTEIN	Regulation of the heat- and capsaicin-activated transient receptor potential vanilloid 1 (TRPV1) channel by phosphoinositides is complex and controversial. In the most recent TRPV1 cryo-EM structure, endogenous phosphatidylinositol (PtdIns) was detected in the vanilloid binding site, and phosphoinositides were proposed to act as competitive vanilloid antagonists. This model is difficult to reconcile with phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P-2] being a well-established positive regulator of TRPV1. Here we show that in the presence of PtdIns(4,5)P-2 in excised patches, PtdIns, but not PtdIns(4)P, partially inhibited TRPV1 activity at low, but not at high capsaicin concentrations. This is consistent with PtdIns acting as a competitive vanilloid antagonist. However, in the absence of PtdIns(4,5)P-2, PtdIns partially stimulated TRPV1 activity. We computationally identified residues, which are in contact with PtdIns, but not with capsaicin in the vanilloid binding site. The I703A mutant of TRPV1 showed increased sensitivity to capsaicin, as expected when removing the effect of an endogenous competitive antagonist. I703A was not inhibited by PtdIns in the presence of PtdIns(4,5)P-2, but it was still activated by PtdIns in the absence of PtdIns(4,5)P-2 indicating that inhibition, but not activation by PtdIns proceeds via the vanilloid binding site. In molecular dynamics simulations, PtdIns was more stable than PtdIns(4,5)P-2 in this inhibitory site, whereas PtdIns(4,5)P-2 was more stable than PtdIns in a previously identified, nonoverlapping, putative activating binding site. Our data indicate that phosphoinositides regulate channel activity via functionally distinct binding sites, which may explain some of the complexities of the effects of these lipids on TRPV1.	[Yazici, Aysenur Torun; Lee, Bo-Hyun; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Gianti, Eleonora; Kasimova, Marina A.; Carnevale, Vincenzo] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Kasimova, Marina A.] Novo Nordisk, Malov, Denmark	Rutgers State University New Brunswick; Rutgers State University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.; Carnevale, V (corresponding author), Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA.	vincenzo.carnevale@temple.edu; tibor.rohacs@rutgers.edu	; Carnevale, Vincenzo/D-8015-2014	Gianti, Eleonora/0000-0003-2892-2771; Lee, Bo Hyun/0000-0003-2652-8797; Yazici, Aysenur/0000-0002-1715-0107; Carnevale, Vincenzo/0000-0002-1918-8280; Rohacs, Tibor/0000-0003-3580-2575	National Institutes of Health [NS055159]; National Science Foundation [ACI-1614804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health Grants NS055159 (to T. R.), and National Science Foundation Grant ACI-1614804 (V.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Beard H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082849; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chernov-Rogan T, 2019, P NATL ACAD SCI USA, V116, P26008, DOI 10.1073/pnas.1913929116; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hughes TET, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06753-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasimova MA, 2018, J PHYS CHEM LETT, V9, P1260, DOI 10.1021/acs.jpclett.7b03396; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poblete H, 2015, J BIOL CHEM, V290, P2086, DOI 10.1074/jbc.M114.613620; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Rohacs Tibor, 2013, Methods Mol Biol, V998, P119, DOI 10.1007/978-1-62703-351-0_9; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Seabrook GR, 2002, J PHARMACOL EXP THER, V303, P1052, DOI 10.1124/jpet.102.040394; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sun XH, 2015, J BIOL CHEM, V290, P4741, DOI 10.1074/jbc.M114.611459; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Wisnoskey BJ, 2003, BIOCHEM J, V372, P517, DOI 10.1042/BJ20021574; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046	45	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100573	10.1016/j.jbc.2021.100573	http://dx.doi.org/10.1016/j.jbc.2021.100573			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766560	gold, Green Published			2022-12-26	WOS:000672866400546
J	Castro-Sepulveda, M; Fernandez-Verdejo, R; Tunon-Suarez, M; Morales-Zuniga, J; Troncoso, M; Jannas-Vela, S; Zbinden-Foncea, H				Castro-Sepulveda, Mauricio; Fernandez-Verdejo, Rodrigo; Tunon-Suarez, Mauro; Morales-Zuniga, Jorge; Troncoso, Mayarling; Jannas-Vela, Sebastian; Zbinden-Foncea, Hermann			Low abundance of Mfn2 protein correlates with reduced mitochondria-SR juxtaposition and mitochondrial cristae density in human men skeletal muscle: Examining organelle measurements from TEM images	FASEB JOURNAL			English	Article						MICOS complex; mitochondria dynamics; organelle communication; repeatability; reproducibility; transmission electron microscopy		The role of mitofusin 2 (Mfn2) in the regulation of skeletal muscle (SM) mitochondria-sarcoplasmic (SR) juxtaposition, mitochondrial morphology, mitochondrial cristae density (MCD), and SM quality has not been studied in humans. In in vitro studies, whether Mfn2 increases or decreases mitochondria-SR juxtaposition remains controversial. Transmission electron microscopy (TEM) images are commonly used to measure the organelle juxtaposition, but the measurements are performed "by-hand," thus potentially leading to between-rater differences. The purposes of this study were to: (1) examine the repeatability and reproducibility of mitochondrial-SR juxtaposition measurement from TEM images of human SM between three raters with different experience and (2) compare the mitochondrial-SR juxtaposition, mitochondrial morphology, MCD (stereological-method), and SM quality (cross-sectional area [CSA] and the maximum voluntary contraction [MVC]) between subjects with high abundance (Mfn2-HA; n = 6) and low abundance (Mfn2-LA; n = 6) of Mfn2 protein. The mitochondria-SR juxtaposition had moderate repeatability and reproducibility, with the most experienced raters showing the best values. There were no differences between Mfn2-HA and Mfn2-LA groups in mitochondrial size, distance from mitochondria to SR, CSA, or MVC. Nevertheless, the Mfn2-LA group showed lower mitochondria-SR interaction, MCD, and VO2max. In conclusion, mitochondrial-SR juxtaposition measurement depends on the experience of the rater, and Mfn2 protein seems to play a role in the metabolic control of human men SM, by regulating the mitochondria-SR interaction.	[Castro-Sepulveda, Mauricio; Tunon-Suarez, Mauro; Jannas-Vela, Sebastian; Zbinden-Foncea, Hermann] Univ Finis Terrae, Fac Med, Escuela Kinesiol, Santiago, Chile; [Castro-Sepulveda, Mauricio] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Fernandez-Verdejo, Rodrigo] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Morales-Zuniga, Jorge] Clin Sports Med Deport, Lab Ciencias Deporte, Vina Del Mar, Chile; [Troncoso, Mayarling] Univ Chile, Fac Chem & Pharmaceut Sci, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Troncoso, Mayarling] Univ Chile, Fac Med, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Zbinden-Foncea, Hermann] Ctr Salud Deport, Clin Santa Maria, Santiago, Chile	Universidad Finis Terrae; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile	Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Univ Finis Terrae, Fac Med, Escuela Kinesiol, Santiago, Chile.; Castro-Sepulveda, M; Zbinden-Foncea, H (corresponding author), Av Pedro Valdivia 1509, Providencia, Chile.	mcastro@uft.cl; hzbinden@uft.cl		Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281	Universidad Finis Terrae [CAI 2019]	Universidad Finis Terrae	This study was funded by Research Grant awarded to MCS by Universidad Finis Terrae (Grant no. CAI 2019)	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Arribat Y, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13179; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Castro-Sepulveda M, 2020, AM J PHYSIOL-ENDOC M, V318, pE848, DOI 10.1152/ajpendo.00025.2020; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Csordas G, 2018, TRENDS CELL BIOL, V28, P523, DOI 10.1016/j.tcb.2018.02.009; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; del Campo A, 2018, AGING-US, V10, P34, DOI 10.18632/aging.101358; Distefano G, 2017, J GERONTOL A-BIOL, V72, P535, DOI 10.1093/gerona/glw102; Echeverria F, 2021, BRIT J NUTR, V126, P825, DOI 10.1017/S000711452000481X; Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609; Faustini G, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4246350; Fernandez-Verdejo R, 2020, OBESITY, V28, P1110, DOI 10.1002/oby.22783; Fernandez-Verdejo R, 2018, AM J PHYSIOL-ENDOC M, V315, pE715, DOI 10.1152/ajpendo.00126.2018; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Filadi R, 2017, P NATL ACAD SCI USA, V114, pE2266, DOI 10.1073/pnas.1616040114; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Galgani JE, 2021, OBES REV, V22, DOI 10.1111/obr.13131; Huang TY, 2019, METABOLISM, V98, P53, DOI 10.1016/j.metabol.2019.06.009; Hernandez-Alvarez MI, 2019, CELL, V177, P881, DOI 10.1016/j.cell.2019.04.010; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; Kalkhoran SB, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13437; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mingrone G, 2005, DIABETOLOGIA, V48, P2108, DOI 10.1007/s00125-005-1918-9; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Penailillo L, 2020, J STRENGTH COND RES, V34, P2895, DOI 10.1519/JSC.0000000000002732; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Sebastian D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084; Sood A, 2014, P NATL ACAD SCI USA, V111, P16017, DOI 10.1073/pnas.1408061111; Sugiura A, 2017, NATURE, V542, P251, DOI 10.1038/nature21375; Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Yang RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep07990	38	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21553	10.1096/fj.202002615RR	http://dx.doi.org/10.1096/fj.202002615RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749943				2022-12-26	WOS:000635216100050
J	Meng, LK; Yuan, W; Chi, HJ; Han, RJ; Zhang, YP; Pan, XB; Meng, J; Liu, Y; Song, JW; Zhong, JC; Liu, XY				Meng, Liukun; Yuan, Wen; Chi, Hongjie; Han, Ruijuan; Zhang, Yeping; Pan, Xiangbin; Meng, Jian; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan			Genetic deletion of CMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterial hypertension	FASEB JOURNAL			English	Article						capillary morphogenesis gene&#8208; 2; congenital heart disease; pulmonary vascular remodeling	CAPILLARY MORPHOGENESIS; PROGRESSION; ACTIVATION; APOPTOSIS; TRIGGERS	Pulmonary arterial hypertension (PAH) secondary to congenital heart disease (CHD-PAH) with systemic-to-pulmonary shunt (SPS) is characterized by proliferative vascular remodeling. Capillary morphogenesis gene-2 (CMG2) plays a key role in cell proliferation and apoptosis. This study aimed to determine the role of CMG2 in the pathogenesis of SPS-induced PAH. CMG2 levels were significantly downregulated in pulmonary arterioles from patients with Eisenmenger syndrome and rats with SPS-induced PAH. CMG2 was highly expressed in several cells including human pulmonary arterial smooth muscle cells (HPASMCs). CMG2(-/-) rats exhibited more severe PAH and pulmonary vascular remodeling than wild-type rats when exposed to SPS for 8 weeks. Overexpression of CMG2 significantly inhibited proliferation and promoted apoptosis of HPASMCs, while knockdown of CMG2 promoted cell proliferation and inhibited cell apoptosis. Next-generation sequencing and subsequent validation results suggested that PI3K-AKT was the most prominent signaling pathway regulated by differentially expressed genes (DEGs) in CMG2(-/-) rat lungs. Our work identified a novel role for CMG2 in SPS-induced PAH based on the findings that CMG2 deficiency exacerbates SPS-induced vascular remodeling in the development of PAH, indicating that CMG2 might act as a potential target for the treatment of CHD-PAH.	[Meng, Liukun; Pan, Xiangbin; Meng, Jian] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing, Peoples R China; [Yuan, Wen; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing 100020, Peoples R China; [Yuan, Wen; Chi, Hongjie; Zhang, Yeping; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Hypertens Res, Beijing 100020, Peoples R China; [Chi, Hongjie; Zhang, Yeping; Liu, Ying; Song, Jiawei; Zhong, Jiuchang; Liu, Xiaoyan] Capital Med Univ, Beijing Chao Yang Hosp, Heart Ctr, Beijing 100020, Peoples R China; [Han, Ruijuan] Baotou Cent Hosp, Dept Cardiol, Inner Mongolia, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Capital Medical University; Capital Medical University; Capital Medical University	Liu, XY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing 100020, Peoples R China.; Zhong, JC; Liu, XY (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Key Lab Hypertens Res, Beijing 100020, Peoples R China.; Zhong, JC (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Heart Ctr, Beijing 100020, Peoples R China.	jiuchangzhong@aliyun.com; lxy-213@163.com	Liu, XiaoYan/GQA-7216-2022	Zhong, Jiuchang/0000-0002-2315-3515	National Natural Science Foundation [81500038, 82070325, 81400034, 81770253, 81370362]; Beijing Hospitals Authority Youth Programme [QML20200305]; Beijing Natural Science Foundation [7172078, 7172182]; National Major Research Plan Training Program of China [91849111, 91339108]; Beijing Chaoyang Hospital [CYXX-2017-36]; Open Foundation from Beijing Key Laboratory of Hypertension Research [2019GXY-KFKT-02]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2019MS08062]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Hospitals Authority Youth Programme; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Major Research Plan Training Program of China; Beijing Chaoyang Hospital; Open Foundation from Beijing Key Laboratory of Hypertension Research; Natural Science Foundation of Inner Mongolia Autonomous Region of China	This work was supported by National Natural Science Foundation (81500038, 82070325, 81400034; 81770253; 81370362), Beijing Hospitals Authority Youth Programme (QML20200305), Beijing Natural Science Foundation (7172078 and 7172182), the National Major Research Plan Training Program of China (91849111; 91339108), Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program (CYXX-2017-36), Open Foundation from Beijing Key Laboratory of Hypertension Research (2019GXY-KFKT-02), and research grants from Natural Science Foundation of Inner Mongolia Autonomous Region of China (2019MS08062).	Abrami L, 2010, P NATL ACAD SCI USA, V107, P1420, DOI 10.1073/pnas.0910782107; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Bell SE, 2001, J CELL SCI, V114, P2755; Burgi J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15861; Casas-Alba D, 2018, HUM MUTAT, V39, P1752, DOI 10.1002/humu.23638; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cozma C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1183-5; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; El-Kamah GY, 2010, BRIT J DERMATOL, V163, P213, DOI 10.1111/j.1365-2133.2010.09769.x; Fang X, 2016, J CARDIOVASC PHARM, V67, P164, DOI 10.1097/FJC.0000000000000333; Friebe S, 2016, TOXINS, V8, DOI 10.3390/toxins8030069; Greither T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122648; Hanks S, 2003, AM J HUM GENET, V73, P791, DOI 10.1086/378418; Ji CD, 2018, ONCOGENE, V37, P3953, DOI 10.1038/s41388-018-0226-z; Lin SC, 2019, THERANOSTICS, V9, P620, DOI 10.7150/thno.30655; Liu X, 2015, ACTA PHYSIOL, V213, P505, DOI 10.1111/apha.12352; Liu XY, 2017, AM J HYPERTENS, V30, P182, DOI 10.1093/ajh/hpw125; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Meng LK, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13263; Meng LK, 2013, J THORAC CARDIOV SUR, V146, P1220, DOI 10.1016/j.jtcvs.2013.01.018; Pullamsetti SS, 2014, AM J RESP CRIT CARE, V189, P394, DOI 10.1164/rccm.201308-1543PP; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sun JJ, 2016, TOXINS, V8, DOI 10.3390/toxins8020034; Tan J, 2018, J PATHOL, V245, P160, DOI 10.1002/path.5062; Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025; Ye L, 2014, J CANCER RES CLIN, V140, P957, DOI 10.1007/s00432-014-1650-2	28	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21421	10.1096/fj.202000299R	http://dx.doi.org/10.1096/fj.202000299R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749907				2022-12-26	WOS:000635216100045
J	Blasi, MA; Maceroni, M; Caputo, CG; Sammarco, MG; Scupola, A; Lenkowicz, J; Schinzari, G; Rossi, E; Pagliara, MM				Blasi, Maria Antonietta; Maceroni, Martina; Caputo, Carmela Grazia; Sammarco, Maria Grazia; Scupola, Andrea; Lenkowicz, Jacopo; Schinzari, Giovanni; Rossi, Ernesto; Pagliara, Monica Maria			Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center	PLOS ONE			English	Article								Introduction and purpose Choroidal metastases (CM) are the most common intraocular malignancies. With longer survival rates for cancer patients, CM will be increasingly encountered. We evaluated clinical and ultrasonographic (US) characteristics of CM in order to identify diagnostic biomarkers that correlate with the primary tumor site. Methods The medical records of all patients with CM evaluated at the Ocular Oncology Unit between February 2010 and March 2020 were analyzed. Results 82 eyes of 70 patients were included. The primary cancer site was lung in 26 patients (37%), breast in 23 (33%), kidney in 9 (13%), gastrointestinal in 5 (7%), thyroid in 5 (7%), parathyroids and prostate respectively in 2 (3%). Fifty-five patients (78%) had other systemic metastases at the time of ocular diagnosis. Ten (14%) patients had no history of primary cancer. Bilateral CM were found in 20 patients (29%); fifty-six eyes (68%) had a single CM. The epicenter of CM was predominantly macula (43 eyes, 52%). The mean thickness was 4,1 mm (range 1,8-12,3). US structure was inhomogeneous in 67 eyes (82%). Reflectivity was mainly medium (39%) and medium-low (39%). In particular, CM from lung cancer showed lower reflectivity than those from the breast (p = 0,02). CM deriving from lung cancer were typically dome-shaped, whereas CM originating from breast were characteristically plateau shaped (p = 0,02). Seventy-four (91%) eyes presented fluid on optical coherence tomography. Conclusion We significatively found that CM from lung cancer generally appear dome-shaped with medium-low internal reflectivity, whereas those from breast cancer typically present a plateau appearance and higher internal reflectivity. Though it is hard to identify the site of the primary tumor relying exclusively on clinical and US aspects, morphology and internal reflectivity can be considered as diagnostic biomarkers. Thus, the origin of the primary tumor can be suspected by integrating a constellation of findings.	[Blasi, Maria Antonietta; Maceroni, Martina; Schinzari, Giovanni] Univ Cattolica Sacro Cuore, Rome, Italy; [Blasi, Maria Antonietta; Maceroni, Martina; Caputo, Carmela Grazia; Sammarco, Maria Grazia; Scupola, Andrea; Pagliara, Monica Maria] Fdn Policlin Univ A Gemelli, IRCCS, UOC Oncol Oculare, Rome, Italy; [Lenkowicz, Jacopo] Fdn Policlin Univ A Gemelli, IRCCS, Rome, Italy; [Schinzari, Giovanni; Rossi, Ernesto] Fdn Policlin Univ A Gemelli, IRCCS, Oncol Med, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maceroni, M (corresponding author), Univ Cattolica Sacro Cuore, Rome, Italy.; Maceroni, M (corresponding author), Fdn Policlin Univ A Gemelli, IRCCS, UOC Oncol Oculare, Rome, Italy.	maceronimartina@gmail.com	Pagliara, Monica maria/AAK-5569-2021; Rossi, Ernesto/AAB-7519-2022	Pagliara, Monica maria/0000-0001-5817-6672; Rossi, Ernesto/0000-0002-6442-1707; Scupola, Andrea/0000-0003-4150-3504; Lenkowicz, Jacopo/0000-0002-8366-1474; CAPUTO, CARMELA GRAZIA/0000-0002-3634-2737				Amer R, 2004, OPHTHALMOLOGICA, V218, P372, DOI 10.1159/000080939; Ayres B, 2017, OPTOMETRY VISION SCI, V94, P851, DOI 10.1097/OPX.0000000000001097; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; BLOCH RS, 1971, ARCH OPHTHALMOL-CHIC, V85, P673; Demirci H, 2003, AM J OPHTHALMOL, V136, P264, DOI 10.1016/S0002-9394(03)00192-2; Demirci H, 2014, RETINA-J RET VIT DIS, V34, P1354, DOI 10.1097/IAE.0000000000000083; DEPOTTER P, 1993, CANCER, V71, P2791, DOI 10.1002/1097-0142(19930501)71:9<2791::AID-CNCR2820710917>3.0.CO;2-Y; Egleston BL, 2009, SEMIN ONCOL, V36, P506, DOI 10.1053/j.seminoncol.2009.09.003; EliassiRad B, 1996, BRIT J OPHTHALMOL, V80, P125, DOI 10.1136/bjo.80.2.125; EMANUEL M, 1974, J MAINE MED ASSOC, V65, P273; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; FERRY AP, 1974, ARCH OPHTHALMOL-CHIC, V92, P276, DOI 10.1001/archopht.1974.01010010286003; FREEDMAN MI, 1987, ARCH OPHTHALMOL-CHIC, V105, P1215, DOI 10.1001/archopht.1987.01060090073031; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Haimovici R, 1997, OPHTHALMOLOGY, V104, P1152, DOI 10.1016/S0161-6420(97)30169-9; HARBOUR JW, 1994, OPHTHALMOLOGY, V101, P1084; HOLBACH LM, 1990, AM J OPHTHALMOL, V110, P441, DOI 10.1016/S0002-9394(14)77038-2; KINDERMANN WR, 1981, OPHTHALMOLOGY, V88, P1347; Konstantinidis L, 2017, ASIA-PAC J OPHTHALMO, V6, P208, DOI 10.22608/APO.201712; Konstantinidis L, 2014, BRIT J OPHTHALMOL, V98, P92, DOI 10.1136/bjophthalmol-2013-303519; Ossoinig KC., 1983, INTRAOCULAR TUMORS, P154; PERRI P, 1992, ACTA OPHTHALMOL, V70, P96; Ramaesh K, 1999, EYE, V13, P247, DOI 10.1038/eye.1999.60; Shah SU, 2014, OPHTHALMOLOGY, V121, P352, DOI 10.1016/j.ophtha.2013.07.014; Shields CL, 1997, OPHTHALMOLOGY, V104, P1265, DOI 10.1016/S0161-6420(97)30148-1; Sobottka B, 1999, Curr Opin Ophthalmol, V10, P164, DOI 10.1097/00055735-199906000-00002; Ward SD, 2000, AM J OPHTHALMOL, V130, P681, DOI 10.1016/S0002-9394(00)00604-8; Wiegel T, 1998, BRIT J OPHTHALMOL, V82, P1159, DOI 10.1136/bjo.82.10.1159	28	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249210	10.1371/journal.pone.0249210	http://dx.doi.org/10.1371/journal.pone.0249210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765045	gold, Green Published			2022-12-26	WOS:000634832800075
J	Taube, M; Peltonen, M; Sjoholm, K; Palmqvist, R; Andersson-Assarsson, JC; Jacobson, P; Svensson, PA; Carlsson, LMS				Taube, Magdalena; Peltonen, Markku; Sjoeholm, Kajsa; Palmqvist, Richard; Andersson-Assarsson, Johanna C.; Jacobson, Peter; Svensson, Per-Arne; Carlsson, Lena M. S.			Long-term incidence of colorectal cancer after bariatric surgery or usual care in the Swedish Obese Subjects study	PLOS ONE			English	Article								Bariatric surgery in patients with obesity is generally considered to reduce cancer risk in patients with obesity. However, for colorectal cancer some studies report an increased risk with bariatric surgery, whereas others report a decreased risk. These conflicting results demonstrate the need of more long-term studies analyzing the effect of bariatric surgery on colorectal cancer risk. Therefore, data from the Swedish Obese Subjects (SOS) study, ClinicalTrials.gov identifier: NCT01479452, was used to examine the impact of bariatric surgery on long-term incidence of colorectal cancer. The SOS study includes 2007 patients who underwent bariatric surgery and 2040 contemporaneously matched controls who received conventional obesity treatment. Patients in the surgery group underwent gastric bypass (n = 266), banding (n = 376) or vertical banded gastroplasty (n = 1365). Information on colorectal cancer events was obtained from the Swedish National Cancer Registry. Median follow-up was 22.2 years (inter-quartile range 18.3-25.2). During follow up there were 58 colorectal cancer events in the surgery group and 67 colorectal cancer events in the matched control group with a hazard ratio (HR) of 0.79 (95% CI:0.55-1.12; p = 0.183). After adjusting for age, body mass index, alcohol intake, smoking status, and diabetes, the adjusted HR was 0.89 (95% CI:0.62-1.29; p = 0.551). When analyzing rectal cancer events separately- 19 events in the surgery group and 31 events in the control group-a decreased risk of rectal cancer with surgery was observed (HR = 0.56; 95% CI:0.32-0.99; p = 0.045, adjusted HR = 0.61 (95% CI:0.34-1.10; p = 0.099), while the risk of colon cancer was unchanged. To conclude- in this long-term, prospective study, bariatric surgery was not associated with altered colorectal cancer risk.	[Taube, Magdalena; Sjoeholm, Kajsa; Andersson-Assarsson, Johanna C.; Jacobson, Peter; Svensson, Per-Arne; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Peltonen, Markku] Natl Inst Hlth & Welf, Publ Hlth Promot Unit, Helsinki, Finland; [Peltonen, Markku] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Solna, Sweden; [Palmqvist, Richard] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Svensson, Per-Arne] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden	University of Gothenburg; Finland National Institute for Health & Welfare; Karolinska Institutet; Umea University; University of Gothenburg	Taube, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.	Magdalena.Taube@gu.se	Andersson-Assarsson, Johanna/M-2524-2019; Carlsson, Lena/F-7570-2018; Peltonen, Markku/F-3037-2015	Andersson-Assarsson, Johanna/0000-0001-9082-8589; Carlsson, Lena/0000-0003-4145-6242; Peltonen, Markku/0000-0002-3767-4223; Sjoholm, Kajsa/0000-0003-0146-8193; Taube, Magdalena/0000-0002-7944-9673	Swedish Research Council [2017-01707]; Swedish government [ALFGBG-717881, ALFGBG-717891]; Swedish county councils, the ALF agreement [ALFGBG-717881, ALFGBG-717891]; Swedish Diabetes Foundation [2019417]; Swedish Heart-Lung Foundation [20180410]; Novo Nordisk Foundation [NNF 19OC0057184]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government; Swedish county councils, the ALF agreement; Swedish Diabetes Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	LMSC has recieved grants from the Swedish Research Council (2017-01707), the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-717881 and ALFGBG-717891), the Swedish Diabetes Foundation (2019417), The Swedish Heart-Lung Foundation (20180410) and the Novo Nordisk Foundation (NNF 19OC0057184) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2009, OBESITY, V17, P796, DOI 10.1038/oby.2008.610; Afshar S, 2018, OBES SURG, V28, P945, DOI 10.1007/s11695-017-2953-6; Afshar S, 2014, OBES SURG, V24, P1793, DOI 10.1007/s11695-014-1359-y; Anveden A, 2017, GYNECOL ONCOL, V145, P224, DOI 10.1016/j.ygyno.2017.02.036; Bailly L, 2020, JAMA SURG, V155, P395, DOI 10.1001/jamasurg.2020.0089; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Christou NV, 2008, SURG OBES RELAT DIS, V4, P691, DOI 10.1016/j.soard.2008.08.025; Davidson LE, 2020, JAMA SURG, V155, P402, DOI 10.1001/jamasurg.2020.0090; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Kant P, 2014, OBESITY, V22, P202, DOI 10.1002/oby.20493; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Mackenzie H, 2018, BRIT J SURG, V105, P1650, DOI 10.1002/bjs.10914; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sainsbury A, 2008, CANCER EPIDEM BIOMAR, V17, P1401, DOI 10.1158/1055-9965.EPI-07-2874; Schauer DP, 2019, ANN SURG, V269, P95, DOI 10.1097/SLA.0000000000002525; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Tao WJ, 2020, INT J CANCER, V147, P728, DOI 10.1002/ijc.32770; Tee MC, 2013, SURG ENDOSC, V27, P4449, DOI 10.1007/s00464-013-3127-9; Torgerson JS, 2003, AM J GASTROENTEROL, V98, P1032, DOI 10.1016/S0002-9270(03)00147-3	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248550	10.1371/journal.pone.0248550	http://dx.doi.org/10.1371/journal.pone.0248550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764991	gold, Green Published			2022-12-26	WOS:000634832800005
J	Book, GA; Meda, SA; Janssen, R; Dager, AD; Poppe, A; Stevens, MC; Assaf, M; Glahn, D; Pearlson, GD				Book, Gregory A.; Meda, Shashwath A.; Janssen, Ronald; Dager, Alecia D.; Poppe, Andrew; Stevens, Michael C.; Assaf, Michal; Glahn, David; Pearlson, Godfrey D.			Effects of weather and season on human brain volume	PLOS ONE			English	Article							MRI; ABNORMALITIES; PRESSURE; MIGRAINE; MOTION; ONSET	We present an exploratory cross-sectional analysis of the effect of season and weather on Freesurfer-derived brain volumes from a sample of 3,279 healthy individuals collected on two MRI scanners in Hartford, CT, USA over a 15 year period. Weather and seasonal effects were analyzed using a single linear regression model with age, sex, motion, scan sequence, time-of-day, month of the year, and the deviation from average barometric pressure, air temperature, and humidity, as covariates. FDR correction for multiple comparisons was applied to groups of non-overlapping ROIs. Significant negative relationships were found between the left- and right- cerebellum cortex and pressure (t = -2.25, p = 0.049; t = -2.771, p = 0.017). Significant positive relationships were found between left- and right- cerebellum cortex and white matter between the comparisons of January/June and January/September. Significant negative relationships were found between several subcortical ROIs for the summer months compared to January. An opposing effect was observed between the supra- and infra-tentorium, with opposite effect directions in winter and summer. Cohen's d effect sizes from monthly comparisons were similar to those reported in recent psychiatric big-data publications, raising the possibility that seasonal changes and weather may be confounds in large cohort studies. Additionally, changes in brain volume due to natural environmental variation have not been reported before and may have implications for weather-related and seasonal ailments.	[Book, Gregory A.; Meda, Shashwath A.; Janssen, Ronald; Dager, Alecia D.; Poppe, Andrew; Stevens, Michael C.; Assaf, Michal; Pearlson, Godfrey D.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA; [Dager, Alecia D.; Stevens, Michael C.; Assaf, Michal; Glahn, David; Pearlson, Godfrey D.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Glahn, David] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA	Hartford Hospital; Yale University; Harvard University; Boston Children's Hospital	Book, GA (corresponding author), Hartford Hosp, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.	gregory.a.book@gmail.com	Stevens, Michael C/M-7678-2017	Stevens, Michael C/0000-0002-3799-5465				Akutagawa Osamu, 2007, Archives of Gynecology and Obstetrics, V275, P249, DOI 10.1007/s00404-006-0259-3; Annweiler C, 2015, MATURITAS, V80, P312, DOI 10.1016/j.maturitas.2014.12.011; Becker WJ, 2011, CEPHALALGIA, V31, P387, DOI 10.1177/0333102410385583; Book GA, 2013, NEUROINFORMATICS, V11, P495, DOI 10.1007/s12021-013-9194-1; Cioffi I, 2017, J ORAL REHABIL, V44, P333, DOI 10.1111/joor.12498; Clayton NS, 1997, BEHAV PROCESS, V41, P237, DOI 10.1016/S0376-6357(97)00050-8; EDWARDS FA, 1988, NEUROSCI LETT, V84, P266, DOI 10.1016/0304-3940(88)90518-6; Fan CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep33596; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hallam KT, 2006, ACTA NEUROPSYCHIATR, V18, P154, DOI 10.1111/j.1601-5215.2006.00147.x; Hoffmann J, 2015, ANN CLIN TRANSL NEUR, V2, P22, DOI 10.1002/acn3.139; Jehn M, 2002, AM J HYPERTENS, V15, P941, DOI 10.1016/S0895-7061(02)02999-0; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jia YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026802; Jimsheleishvili S., 2020, STATPEARLS INTERNET, P941; Klingberg E, 2015, ENDOCRINE, V49, P800, DOI 10.1007/s12020-015-0548-3; Kristal-Boneh, 1996, Blood Press Monit, V1, P87; Kurlansik SL, 2012, AM FAM PHYSICIAN, V86, P1037; Lazaro J, 2018, BRAIN STRUCT FUNCT, V223, P2823, DOI 10.1007/s00429-018-1666-5; Lim ASP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002647; Lim ASP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14931; Luo Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16921-1; Ma Jia, 2015, Zhonghua Nei Ke Za Zhi, V54, P945; Mackey S, 2019, AM J PSYCHIAT, V176, P119, DOI 10.1176/appi.ajp.2018.17040415; Meyer C, 2016, P NATL ACAD SCI USA, V113, P3066, DOI 10.1073/pnas.1518129113; Meyers SM, 2016, J MAGN RESON IMAGING, V44, P296, DOI 10.1002/jmri.25168; Miller MA, 2015, HIPPOCAMPUS, V25, P534, DOI 10.1002/hipo.22390; Nakamura K, 2015, NEUROIMAGE, V118, P126, DOI 10.1016/j.neuroimage.2015.05.077; Owens N, 2003, PSYCHOL MED, V33, P163, DOI 10.1017/S0033291702006712; Ozeki K, 2015, INT J BIOMETEOROL, V59, P447, DOI 10.1007/s00484-014-0859-8; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pope CA, 1999, AM J RESP CRIT CARE, V159, P365, DOI 10.1164/ajrccm.159.2.9702103; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Schmaal L, 2015, BIOL PSYCHIAT, V77, DOI 10.1038/mp.2015.69; Spelman T, 2014, ANN NEUROL, V76, P880, DOI 10.1002/ana.24287; Stergiou GS, 2015, HYPERTENS RES, V38, P869, DOI 10.1038/hr.2015.96; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044195; Trefler A, 2016, NEUROIMAGE, V133, P41, DOI 10.1016/j.neuroimage.2016.02.034; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; Van Ombergen A, 2018, NEW ENGL J MED, V379, P1678, DOI 10.1056/NEJMc1809011; Whelan CD, 2018, BRAIN, V141, P391, DOI 10.1093/brain/awx341; Yaskin VA, 2011, ZH OBSHCH BIOL, V72, P27	44	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0236303	10.1371/journal.pone.0236303	http://dx.doi.org/10.1371/journal.pone.0236303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760826	gold, Green Published, Green Submitted			2022-12-26	WOS:000633030400038
J	Doughty, H; Milner-Gulland, EJ; Lee, JSH; Oliver, K; Carrasco, LR; Verissimo, D				Doughty, Hunter; Milner-Gulland, E. J.; Lee, Janice Ser Huay; Oliver, Kathryn; Carrasco, L. Roman; Verissimo, Diogo			Evaluating a large-scale online behaviour change intervention aimed at wildlife product consumers in Singapore	PLOS ONE			English	Article							METAANALYSIS; PERCEPTIONS; MEDICINE; MEDIA; NEWS	Interventions to shift the behaviour of consumers using unsustainable wildlife products are key to threatened species conservation. Whether these interventions are effective is largely unknown due to a dearth of detailed evaluations. We previously conducted a country-level online behaviour change intervention targeting consumers of the Critically Endangered saiga antelope (Saiga tatarica) horn in Singapore. To evaluate intervention impact, we carried out in-person consumer surveys with >2,000 individuals pre- and post-intervention (2017 and 2019), and 93 in-person post-intervention surveys with traditional Chinese medicine (TCM) shopkeepers (2019). The proportion of self-reported high-usage saiga horn consumers in the target audience (Chinese Singaporean women aged 35-59) did not change significantly from pre- to post-intervention (24.4% versus 22.6%). However, post-intervention the target audience was significantly more likely than the non-target audience to accurately recall the intervention message and to report a decrease in saiga horn usage (4% versus 1% reported a behaviour change). Within the target audience, high-usage consumers were significantly more likely than lower-usage consumers to recall the message and report a behaviour change. Across respondents who reported a decrease in saiga horn usage, they cited the intervention message as a specific reason for their behaviour change significantly more than other reasons. Additionally, across all respondents, the belief that saiga is a common species in the wild decreased significantly from pre- to post-intervention. TCM shopkeepers, however, cited factors such as price and availability as the strongest influences on saiga horn sales. In sum, the intervention did significantly influence some consumers but the reduction of high-usage consumer frequency was not significant at the population level. We explore reasons for these findings, including competing consumer influences, characteristics of the intervention, and evaluation timing. This work suggests our intervention approach has potential, and exemplifies a multi-pronged in-person evaluation of an online wildlife trade consumer intervention.	[Doughty, Hunter; Milner-Gulland, E. J.; Verissimo, Diogo] Univ Oxford, Dept Zool, Oxford, England; [Doughty, Hunter; Milner-Gulland, E. J.; Verissimo, Diogo] Univ Oxford, Oxford Martin Programme Illegal Wildlife Trade, Oxford, England; [Lee, Janice Ser Huay] Nanyang Technol Univ Singapore, Asian Sch Environm, Singapore, Singapore; [Oliver, Kathryn] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Carrasco, L. Roman] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Verissimo, Diogo] San Diego Zoo, Inst Conservat Res, Escondido, CA USA	University of Oxford; University of Oxford; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; Zoological Society of San Diego	Doughty, H (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Doughty, H (corresponding author), Univ Oxford, Oxford Martin Programme Illegal Wildlife Trade, Oxford, England.	hunterldoughty@gmail.com	Oliver, Kathryn/I-9905-2019; Carrasco, Luis R/H-8017-2012	Oliver, Kathryn/0000-0002-4326-5258; Carrasco, Luis R/0000-0002-2894-1473; Doughty, Hunter/0000-0001-5203-5115	Oxford University through the Oxford Martin Programme on the Illegal Wildlife Trade	Oxford University through the Oxford Martin Programme on the Illegal Wildlife Trade	This research was funded by Oxford University through the Oxford Martin Programme on the Illegal Wildlife Trade (grant held by author EJMG). The funder provided support in the form of salaries for authors (EJMG, DV) and fieldwork costs but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section of the manuscript.	Allcott H, 2014, AM ECON REV, V104, P3003, DOI 10.1257/aer.104.10.3003; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; [Anonymous], 2019, WORLD BANK ANAL INT; Baylis K, 2016, CONSERV LETT, V9, P58, DOI 10.1111/conl.12180; Burke HM, 2019, EVAL PROGRAM PLANN, V77, DOI 10.1016/j.evalprogplan.2019.101721; Byrne D, 2013, EVALUATION-US, V19, P217, DOI 10.1177/1356389013495617; Capurro D., 2014, J MED INTERNET RES, V16, P79, DOI [10.2196/jmir.267924642014, DOI 10.2196/JMIR.267924642014]; Cavatorta E., 2017, COMPLEMENTS ALTERNAT; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chang L, 2015, QUAL HEALTH RES, V25, P241, DOI 10.1177/1049732314551991; Chung VCH, 2014, HEALTH EXPECT, V17, P622, DOI 10.1111/j.1369-7625.2012.00794.x; CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora),, 2018, 17 M STAND COMM 2018; CMS (Convention on the Conservation of Migratory Species of Wild Animals), MEMORANDUM UNDERSTAN; DEFLEUR ML, 1991, SOCIOL INQ, V61, P148, DOI 10.1111/j.1475-682X.1991.tb00273.x; Doughty H., 2021, USING THEORY EVIDENC, DOI [10.1002/pan3.10189, DOI 10.1002/PAN3.10189]; Doughty H, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.272; Doughty H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222038; Fox J, 2002, COX PROPORTIONAL HAZ; Greenfield S., 2018, SOC MARK Q; Haustein S, 2013, CURR OPIN ENV SUST, V5, P197, DOI 10.1016/j.cosust.2013.04.009; Ho D., 2018, WHITWORTH PACKAGE MA; Israel G.D., 1992, FLORIDA COOPERATIVE; John FAVS, 2014, J APPL ECOL, V51, P1479, DOI 10.1111/1365-2664.12352; LaCroix JM, 2014, JAIDS-J ACQ IMM DEF, V66, pS329, DOI 10.1097/QAI.0000000000000230; Lanthorn H., 2016, WORKING PAPER EXTERN; Lenzner T, 2010, APPL COGNITIVE PSYCH, V24, P1003, DOI 10.1002/acp.1602; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Liu XB, 2012, SUSTAIN DEV, V20, P293, DOI 10.1002/sd.484; Loebnitz N, 2016, FOOD QUAL PREFER, V50, P102, DOI 10.1016/j.foodqual.2016.02.003; Molden DC, 2014, SOC COGNITION, V32, P1; MRC NIHR. (UK Medical Research Council UK National Institute for Health Research), 2019, DEVELOPING EVALUATIN; Olmedo A, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12365; Park T, 2020, MENU CHANGE; R Core TeamR, LANG ENV STAT COMP; Rafferty A., 2015, KING HELE S ANALYSIN; Schmidt S, 2015, J ADVERTISING, V44, P415, DOI 10.1080/00913367.2015.1018460; Sherry JL., 1997, J INT COMMUNICATION, V4, P75; Snyder LB, 2004, J HEALTH COMMUN, V9, P71, DOI 10.1080/10810730490271548; Spence W, 2013, COMPLEMENT THER CLIN, V19, P63, DOI 10.1016/j.ctcp.2013.02.003; 't Sas-Rolfes M, 2019, ANNU REV ENV RESOUR, V44, P201, DOI 10.1146/annurev-environ-101718-033253; Thomas-Walters L, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.248; Tonkin-Crine S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0436-0; UNEP (United Nations Environment Programme), WILD LIFE CAMPAIGN 2; URA (Urban Redevelopment Authority), 2019, MASTER PLAN 2014; Verissimo D, 2019, CONSERV BIOL, V33, P623, DOI 10.1111/cobi.13227; WCS Peru (Wildlife Conservation Society), SI COMPRAS ERES C MP; Weeks BE, 2012, HEALTH COMMUN, V27, P158, DOI 10.1080/10410236.2011.571757; White H, 2018, J DEV EFFECT, V10, P17, DOI 10.1080/19439342.2018.1439078; Wojnicka K, 2016, EVAL PROGRAM PLANN, V57, P39, DOI 10.1016/j.evalprogplan.2016.04.001; Wu Tim, 2016, ATTENTION MERCHANTS, V1st; Wynes S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae5d7; Young W, 2017, RESOUR CONSERV RECY, V117, P195, DOI 10.1016/j.resconrec.2016.10.016; Zheng MH, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012818; Zhou CQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140556	54	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248144	10.1371/journal.pone.0248144	http://dx.doi.org/10.1371/journal.pone.0248144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760837	Green Published, gold			2022-12-26	WOS:000633030400068
J	Kim, GR; Zhao, TW; Kee, HJ; Kee, SJ; Jeong, MH				Kim, Gwi Ran; Zhao, Tingwei; Kee, Hae Jin; Kee, Seung-Jung; Jeong, Myung Ho			MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA	PLOS ONE			English	Article								Vascular remodeling and contraction contribute to the development of hypertension. We investigated the role of miR-212-5p and its downstream target in vascular smooth muscle cell (VSMC) proliferation, migration, and contraction. MicroRNA microarray and PCR analyses showed that miR-212-5p expression was increased with angiotensin II treatment in vivo and in vitro. Moreover, miR-212-5p mimic treatment attenuated and miR-212-5p inhibitor treatment increased VSMC proliferation and migration. Additionally, miR-212-5p mimic treatment suppressed VSMC contraction and related gene expression [Ras homolog gene family member A (RhoA) and Rho-associated protein kinase 2], while miR-212-5p inhibitor treatment exerted opposite effects. Bioinformatics analysis revealed that platelet-activating factor acetylhydrolase 1B2 (PAFAH1B2) is a target of miR-212-5p. miR-212-5p mimic treatment significantly reduced and miR-212-5p inhibitor treatment increased PAFAH1B2 expression. Furthermore, PAFAH1B2 expression was decreased in angiotensin II-treated aortic tissues and VSMCs. PAFAH1B2 was ubiquitously expressed in most adult rat tissues. In the vasculature, PAFAH1B2 was only distributed in the cytoplasm. PAFAH1B2 overexpression decreased A10 cell proliferation, while PAFAH1B2 knockdown increased A10 cell proliferation and cyclin D1 mRNA levels. PAFAH1B2 knockdown stimulated VSMC contraction and RhoA expression. These results suggest that miR-212-5p and PAFAH1B2 are novel negative regulators of VSMC proliferation, migration, and contraction in hypertension.	[Kim, Gwi Ran; Zhao, Tingwei; Kee, Hae Jin; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Heart Res Ctr, Gwangju, South Korea; [Kim, Gwi Ran; Zhao, Tingwei; Kee, Hae Jin; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Hypertens Heart Failure Res Ctr, Gwangju, South Korea; [Kee, Seung-Jung] Chonnam Natl Univ, Med Sch & Hosp, Dept Lab Med, Gwangju, South Korea; [Jeong, Myung Ho] Chonnam Natl Univ, Dept Cardiol, Med Sch, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University	Kee, HJ; Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Hypertens Heart Failure Res Ctr, Gwangju, South Korea.; Jeong, MH (corresponding author), Chonnam Natl Univ, Dept Cardiol, Med Sch, Gwangju, South Korea.	sshjkee@empas.com; myungho@chollian.net	Kee, Hae Jin/ABC-9979-2021	Kee, Hae Jin/0000-0002-9774-4828; gi, seungjeong/0000-0001-9708-5837	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1527]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1D1A1B07047213]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1527) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1B07047213).	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Chang JW, 2015, ACS CHEM BIOL, V10, P925, DOI 10.1021/cb500893q; Chen C, 2018, EXP THER MED, V15, P159, DOI 10.3892/etm.2017.5428; Chen QS, 2015, J MOL CELL CARDIOL, V89, P75, DOI 10.1016/j.yjmcc.2015.10.017; Chen WJ, 2020, J CELL MOL MED, V24, P2392, DOI 10.1111/jcmm.14966; Choe N, 2015, CELL SIGNAL, V27, P1056, DOI 10.1016/j.cellsig.2014.12.022; Choe N, 2013, ATHEROSCLEROSIS, V229, P348, DOI 10.1016/j.atherosclerosis.2013.05.009; Ding W, 2016, TUMOR BIOL, V37, P6255, DOI 10.1007/s13277-015-4462-3; Fabian MR, 2010, PROG MOL SUBCELL BIO, V50, P1, DOI 10.1007/978-3-642-03103-8_1; Feng SD, 2019, INT J BIOL SCI, V15, P2615, DOI 10.7150/ijbs.36995; Horton AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39078-5; Huang SC, 2017, CELL PHYSIOL BIOCHEM, V42, P2492, DOI 10.1159/000480212; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jin L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15925-1; Jin L, 2017, J HYPERTENS, V35, P1502, DOI 10.1097/HJH.0000000000001327; Jusic A, 2019, HYPERTENSION, V74, P477, DOI 10.1161/HYPERTENSIONAHA.119.13412; Kim GR, 2016, J HYPERTENS, V34, P2206, DOI 10.1097/HJH.0000000000001081; Klimczak D, 2017, BLOOD PRESSURE, V26, P2, DOI 10.3109/08037051.2016.1167355; Kohnz RA, 2015, ACS CHEM BIOL, V10, P1624, DOI 10.1021/acschembio.5b00053; Kumarswamy R, 2014, EUR HEART J, V35, P3224, DOI 10.1093/eurheartj/ehu344; Li K, 2017, YONSEI MED J, V58, P234, DOI 10.3349/ymj.2017.58.1.234; Li ML, 2017, BIOCHEM BIOPH RES CO, V493, P270, DOI 10.1016/j.bbrc.2017.09.031; Li R, 2018, ONCOL LETT, V15, P3357, DOI 10.3892/ol.2017.7640; Lin JF, 2018, EUR REV MED PHARMACO, V22, P8415, DOI 10.26355/eurrev_201812_16540; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Lv ZD, 2017, CELL PHYSIOL BIOCHEM, V44, P1785, DOI 10.1159/000485785; Ma C, 2018, BIOCHEM BIOPH RES CO, V501, P654, DOI 10.1016/j.bbrc.2018.05.039; Marques FZ, 2015, ADV EXP MED BIOL, V888, P215, DOI 10.1007/978-3-319-22671-2_11; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Park EJ, 2018, AM J PHYSIOL-RENAL, V314, pF329, DOI 10.1152/ajprenal.00358.2017; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Shi X, 2018, BIOCHEM BIOPH RES CO, V505, P699, DOI 10.1016/j.bbrc.2018.09.156; Sun SF, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00381; Tu L, 2019, ONCOTARGETS THER, V12, P5729, DOI 10.2147/OTT.S206932; Ungaro F, 2017, GASTROENTEROLOGY, V153, P1363, DOI 10.1053/j.gastro.2017.07.048; Wang DD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020324; Wirth A, 2010, BBA-MOL BASIS DIS, V1802, P1276, DOI 10.1016/j.bbadis.2010.05.002; Ye YZ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1028-1; Yi LY, 2020, J INTERF CYTOK RES, V40, P159, DOI 10.1089/jir.2019.0141; Yu B, 2017, ONCOL LETT, V13, P2459, DOI 10.3892/ol.2017.5702; Yu X, 2014, INT J MOL MED, V34, P923, DOI 10.3892/ijmm.2014.1853; Zhang BY, 2019, MED SCI MONITOR, V25, P7581, DOI 10.12659/MSM.916522; Zheng GH, 2014, MOL BIOL REP, V41, P7141, DOI 10.1007/s11033-014-3597-4	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0249146	10.1371/journal.pone.0249146	http://dx.doi.org/10.1371/journal.pone.0249146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760887	Green Published, gold			2022-12-26	WOS:000633030400043
J	Krishnan, A; Weikum, D; Cravero, C; Kamarulzaman, A; Altice, FL				Krishnan, Archana; Weikum, Damian; Cravero, Claire; Kamarulzaman, Adeeba; Altice, Frederick L.			Assessing mobile technology use and mHealth acceptance among HIV-positive men who have sex with men and transgender women in Malaysia	PLOS ONE			English	Article								Background Mobile health (mHealth) can be beneficial in monitoring the complex healthcare regimen for people with HIV that includes adhering to medication and refraining from risky practices such as unsafe sex and injection drug use. Not only is mHealth often implemented without appropriate feasibility and acceptability research, but there is limited mHealth research among key HIV-positive populations such as men who have sex with men (MSM) and transgender women (TGW). Methods This study assessed access to and use of mobile technology and acceptability of mHealth among 150 HIV-positive MSM and TGW who were prescribed antiretroviral therapy (ART) in Malaysia-an emerging economy with rapid telecommunications growth and societal stigma against these groups. Results Findings among the 114 MSM and 36 TGW reveal high levels of depression (42%), stigma (2.53/4.00) and risky sexual behavior (30%), and suboptimal ART adherence (22%). On the other hand, the sample had excellent access to smartphones (75.3%) and the internet (78%), and had high acceptance of mHealth especially for those with suboptimal ART adherence. Conclusion In settings like Malaysia where homosexuality and cross-dressing are socially and legally stigmatized, HIV prevention and treatment strategies delivered using an mHealth platform have the potential to overcome in-person barriers.	[Krishnan, Archana] SUNY Albany, Dept Commun, Albany, NY 12222 USA; [Weikum, Damian; Altice, Frederick L.] Yale Sch Publ Hlth, New Haven, CT USA; [Cravero, Claire] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kamarulzaman, Adeeba; Altice, Frederick L.] Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Altice, Frederick L.] Yale Sch Med, Infect Dis Sect, AIDS Program, New Haven, CT USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Universiti Malaya; Yale University	Krishnan, A (corresponding author), SUNY Albany, Dept Commun, Albany, NY 12222 USA.	archana.krishnan@aya.yale.edu			Yale College Research Fellowship; NIDA career development grant [K24 DA017072]	Yale College Research Fellowship; NIDA career development grant	This study was funded through a Yale College Research Fellowship (DW) and a NIDA career development grant K24 DA017072 (FLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bolding G, 2004, AIDS CARE, V16, P993, DOI 10.1080/09540120412331292453; Cafazzo JA, 2012, J MED INTERNET RES, V14, P171, DOI 10.2196/jmir.2058; Catalani Caricia, 2013, Open AIDS J, V7, P17, DOI 10.2174/1874613620130812003; Chew LD, 2004, FAM MED, V36, P588; COHEN S, 1988, CLAR SYMP, P31; Earnshaw VA, 2014, TROP MED INT HEALTH, V19, P672, DOI 10.1111/tmi.12306; Ferro EG, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw219; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Guadamuz TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126658; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Karanja S, 2011, PAN AFR MED J, V10; Katz David L, 2008, J Diabetes Sci Technol, V2, P147; Krishnan A, 2017, MOB MEDIA COMMUN, V5, P194, DOI 10.1177/2050157917692390; Krishnan A, 2015, AIDS CARE, V27, P273, DOI 10.1080/09540121.2014.963014; Leach-Lemens C., 2009, HIV AIDS TREAT PRACT, V137, P7; Lim MSC, 2008, INT J STD AIDS, V19, P287, DOI 10.1258/ijsa.2007.007264; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malaysia Department of Statistics, 2015, ICT USE ACCESS INDIV; Malaysia Ministry of Health, 2016, GLOBAL AIDS RESPONSE; Maru DSR, 2008, AIDS BEHAV, V12, P284, DOI 10.1007/s10461-007-9336-2; Miller CWT, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/670525; NQAPIA, FACT SHEET STATE LGB; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rich KM, 2018, LGBT HEALTH, V5, P477, DOI 10.1089/lgbt.2017.0186; Rich KM, 2018, AIDS CARE, V30, P1341, DOI 10.1080/09540121.2018.1476657; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2003, AIDS, V17, P2419, DOI 10.1097/00002030-200311210-00003; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	39	1	1	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248705	10.1371/journal.pone.0248705	http://dx.doi.org/10.1371/journal.pone.0248705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755693	gold, Green Published			2022-12-26	WOS:000632916600043
J	Narukawa, M; Takahashi, S; Kamiyoshihara, A; Matsumiya, K; Misaka, T				Narukawa, Masataka; Takahashi, Suzuka; Kamiyoshihara, Aya; Matsumiya, Kentaro; Misaka, Takumi			Comparison between the timing of the occurrence of taste sensitivity changes and short-term memory decline due to aging in SAMP1 mice	PLOS ONE			English	Article							GENE-EXPRESSION; AGE; THRESHOLDS; SYSTEM; MODEL	Several studies have suggested that cognitive impairment affects taste sensitivity. However, the mechanism behind this is still unclear. In this study, we focused on short-term memory. Using senescence-accelerated mouse prone 1 (SAMP1) mice, we compared whether the effects of aging are observed earlier in taste sensitivity or short-term memory. We used 8-week-old mice as the young group, and 70- and 80-week-old mice as aged groups. Taste sensitivity was evaluated using a 48-hour two-bottle preference test, and short-term memory was evaluated using the Y-maze test. SAMP1 mice showed apparently changes in taste sensitivity at 70-weeks-old. However, the influence of aging on spontaneous alternation behavior, which is indicative of short-term memory alterations, was not observed in 70-week-old mice. At 80-weeks-old, the influence of aging was observed, and spontaneous alternation behavior was significantly decreased. This suggests that age-dependent changes in taste sensitivity occur prior to short-term memory function decline. In addition, there was no significant influence of aging on the mRNA expression of long-term potentiation-related genes in the hippocampus of 80-week-old mice. Therefore, the age-related decline of short-term memory may not affect taste sensitivity.	[Narukawa, Masataka; Takahashi, Suzuka; Kamiyoshihara, Aya; Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Narukawa, Masataka] Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan; [Matsumiya, Kentaro] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	University of Tokyo; Kyoto Womens University; Kyoto University	Narukawa, M; Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Narukawa, M (corresponding author), Kyoto Womens Univ, Dept Food & Nutr, Kyoto, Japan.	narukawa@kyoto-wu.ac.jp; amisaka@mail.ecc.u-tokyo.ac.jp	Matsumiya, Kentaro/O-5269-2019	Matsumiya, Kentaro/0000-0001-8957-9845	Japan Society for the Promotion of Science [16H03045, 19H02905]; Salt Science Research Foundation [16D3, 17D3, 18D3, 2046]; Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency [JPMJTR194F]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Salt Science Research Foundation; Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency	This work was supported in part by a Grant-in-Aid for Scientific Research (B) 16H03045 and 19H02905 to Masataka Narukawa from the Japan Society for the Promotion of Science, by The Salt Science Research Foundation No. 16D3, 17D3, 18D3 and 2046 to Masataka Narukawa, and by the Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (Grant No. JPMJTR194F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-78; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; HYDE RJ, 1981, NEUROBIOL AGING, V2, P315, DOI 10.1016/0197-4580(81)90041-5; Iannilli E, 2017, J NEUROSCI RES, V95, P1927, DOI 10.1002/jnr.24071; Kiely KM., 2014, ENCY QUALITY LIFE WE, P974, DOI [10.1007/978-94-007-0753-5_426, DOI 10.1007/978-94-007-0753-5_426]; Kouzuki M, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01691-7; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mojet J, 2001, CHEM SENSES, V26, P845, DOI 10.1093/chemse/26.7.845; Narukawa M, 2020, J ALZHEIMERS DIS, V76, P997, DOI 10.3233/JAD-200284; Narukawa M, 2020, GERONTOLOGY, V66, P275, DOI 10.1159/000504962; Narukawa M, 2018, EXP GERONTOL, V113, P64, DOI 10.1016/j.exger.2018.09.016; Narukawa M, 2017, NEUROSCIENCE, V358, P249, DOI 10.1016/j.neuroscience.2017.06.054; Ogawa T, 2017, AURIS NASUS LARYNX, V44, P168, DOI [10.1016/j.an1.2016.06.010, 10.1016/j.anl.2016.06.010]; Sakai M, 2016, INT PSYCHOGERIATR, V28, P511, DOI 10.1017/S1041610215001337; Sanada F, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00012; Sergi G, 2017, CRIT REV FOOD SCI, V57, P3684, DOI 10.1080/10408398.2016.1160208; Steinbach S, 2010, J NEUROL, V257, P238, DOI 10.1007/s00415-009-5300-6; Strosznajder JB, 2004, NEUROSCI LETT, V370, P175, DOI 10.1016/j.neulet.2004.08.013; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; TAKEDA T, 1994, INT CONGR SER, V1062, P15; Tsao FHC, 2020, J ALZHEIMERS DIS REP, V4, P67, DOI 10.3233/ADR-200168; WEIFFENBACH JM, 1982, J GERONTOL, V37, P372, DOI 10.1093/geronj/37.3.372	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248673	10.1371/journal.pone.0248673	http://dx.doi.org/10.1371/journal.pone.0248673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755681	gold, Green Published			2022-12-26	WOS:000632916600005
J	Zhang, YL; Han, J				Zhang, Yaling; Han, Jin			Differential privacy fuzzy C-means clustering algorithm based on gaussian kernel function	PLOS ONE			English	Article							MODEL	Fuzzy C-means clustering algorithm is one of the typical clustering algorithms in data mining applications. However, due to the sensitive information in the dataset, there is a risk of user privacy being leaked during the clustering process. The fuzzy C-means clustering of differential privacy protection can protect the user's individual privacy while mining data rules, however, the decline in availability caused by data disturbances is a common problem of these algorithms. Aiming at the problem that the algorithm accuracy is reduced by randomly initializing the membership matrix of fuzzy C-means, in this paper, the maximum distance method is firstly used to determine the initial center point. Then, the gaussian value of the cluster center point is used to calculate the privacy budget allocation ratio. Additionally, Laplace noise is added to complete differential privacy protection. The experimental results demonstrate that the clustering accuracy and effectiveness of the proposed algorithm are higher than baselines under the same privacy protection intensity.	[Zhang, Yaling; Han, Jin] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology	Han, J (corresponding author), Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China.	1518377562@qq.com			Key Research and Development Program of Shaanxi [2019GY-028]	Key Research and Development Program of Shaanxi	This work is supported by the Key Research and Development Program of Shaanxi (Program No. 2019GY-028, http://ywgl.snstd.gov.cn/egrantweb) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese D., 2012, MLPY MACHINE LEARNIN; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Buhmann MD, 2003, C MO AP C M, DOI 10.1017/CBO9780511543241; Dua D., 2019, UC IRVINE MACHINE LE; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Dwork C, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1866739.1866758; Dwork C, 2010, PROC APPL MATH, V135, P174; Gong MG, 2013, IEEE T IMAGE PROCESS, V22, P573, DOI 10.1109/TIP.2012.2219547; Guan ZT, 2019, FUTURE GENER COMP SY, V98, P60, DOI 10.1016/j.future.2019.01.058; Hu QH, 2010, INT J APPROX REASON, V51, P453, DOI 10.1016/j.ijar.2010.01.004; Jiang Z., 2018, COMPUTER SYSTEMS APP, P28; Li N, 2007, INT CONF NANO MICRO, P692, DOI 10.1109/icde.2007.367856; Li ZW, 2020, KNOWL-BASED SYST, V196, DOI 10.1016/j.knosys.2020.105791; Machanavajjhala A., 2007, ACM T KNOWL DISCOV D, V1; McSherry F, 2009, ACM SIGMOD/PODS 2009 CONFERENCE, P19; Powers D. M, 2011, ARXIV201016061; Qing Yang, 2010, Proceedings 2010 3rd International Conference on Intelligent Networks and Intelligent Systems (ICINIS 2010), P393, DOI 10.1109/ICINIS.2010.171; Ren J, 2017, 2017 IEEE SECOND INTERNATIONAL CONFERENCE ON DATA SCIENCE IN CYBERSPACE (DSC), P133, DOI 10.1109/DSC.2017.64; Ren M, 2019, INT J COMPUT INTELL, V18, DOI 10.1142/S1469026819500081; Shakiba A, 2018, 2018 6TH IRANIAN JOINT CONGRESS ON FUZZY AND INTELLIGENT SYSTEMS (CFIS), P91, DOI 10.1109/CFIS.2018.8336640; Shuwen C., 2018, SMALL MICROCOMPUTER, V39; Sieranoja PFaS., 2018, CLUSTERING BASIC BEN; Stetco A, 2015, EXPERT SYST APPL, V42, P7541, DOI 10.1016/j.eswa.2015.05.014; Su D, 2016, CODASPY'16: PROCEEDINGS OF THE SIXTH ACM CONFERENCE ON DATA AND APPLICATION SECURITY AND PRIVACY, P26, DOI 10.1145/2857705.2857708; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Xu X., 2019, APDPK MEANS NEW DIFF, P1737; Yanming F, 2019, NETINFO SECURITY, P43; Yin XS, 2012, KNOWL-BASED SYST, V35, P304, DOI 10.1016/j.knosys.2012.05.016; Zhai Dong-hai, 2014, Application Research of Computers, V31, P713, DOI 10.3969/j.issn.1001-3695.2014.03.017; Zhang YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206832; Zou KQ, 2008, FUZZY OPTIM DECIS MA, V7, P409, DOI 10.1007/s10700-008-9048-8	32	3	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248737	10.1371/journal.pone.0248737	http://dx.doi.org/10.1371/journal.pone.0248737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755689	Green Published, gold			2022-12-26	WOS:000632916600029
J	Cheng, C; Pei, XF; Li, SW; Yang, J; Li, CX; Tang, JJ; Hu, KS; Huang, GF; Min, WP; Sang, Y				Cheng, Chun; Pei, Xiaofeng; Li, Si-Wei; Yang, Jun; Li, Chenxi; Tang, Jianjun; Hu, Kaishun; Huang, Guofu; Min, Wei-Ping; Sang, Yi			CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing beta-catenin	ONCOGENE			English	Article								Radiation resistance is a major cause of lung cancer treatment failure. Armadillo (ARM) superfamily proteins participate in various fundamental cellular processes; however, whether ARM proteins regulate radiation resistance is not fully understood. Here, we used an unbiased CRISPR/Cas9 library screen and identified plakophilin 2 (PKP2), a member of the ARM superfamily of proteins, as a critical driver of radiation resistance in lung cancer. The PKP2 level was significantly higher after radiotherapy than before radiotherapy, and high PKP2 expression after radiotherapy predicted poor overall survival (OS) and postprogression survival (PPS). Mechanistically, mass spectrometry analysis identified that PKP2 was methylated at the arginine site and interacted with protein arginine methyltransferase 1 (PRMT1). Methylation of PKP2 by PRMT1 stabilized beta-catenin by recruiting USP7, further inducing LIG4, a key DNA ligase in nonhomologous end-joining (NHEJ) repair. Concomitantly, PKP2-induced radioresistance depended on facilitating LIG4-mediated NHEJ repair in lung cancer. More strikingly, after exposure to irradiation, treatment with the PRMT1 inhibitor C-7280948 abolished PKP2-induced radioresistance, and C-7280948 is a potential radiosensitizer in lung cancer. In summary, our results demonstrate that targeting the PRMT1/PKP2/beta-catenin/LIG4 pathway is an effective approach to overcome radiation resistance in lung cancer.	[Cheng, Chun; Yang, Jun; Li, Chenxi; Huang, Guofu; Sang, Yi] Nanchang Univ, Affiliated Hosp 3, Dept Ctr Lab, Jiangxi Key Lab Canc Metastasis & Precis Treatmen, Nanchang, Jiangxi, Peoples R China; [Pei, Xiaofeng] Sun Yat Sen Univ, Canc Ctr, Affiliated Hosp 5, Dept Thorac Oncol, Zhuhai, Guangdong, Peoples R China; [Li, Si-Wei] Huazhong Univ Sci & Technol, Dept Oncol, Tongji Huangzhou Hosp, Wuhan, Hubei, Peoples R China; [Tang, Jianjun] Nanchang Univ, Dept Resp, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Hu, Kaishun] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Med Res Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Min, Wei-Ping] Univ Western Ontario, Dept Surg Pathol & Oncol, London, ON, Canada	Nanchang University; Sun Yat Sen University; Huazhong University of Science & Technology; Nanchang University; Sun Yat Sen University; Western University (University of Western Ontario)	Sang, Y (corresponding author), Nanchang Univ, Affiliated Hosp 3, Dept Ctr Lab, Jiangxi Key Lab Canc Metastasis & Precis Treatmen, Nanchang, Jiangxi, Peoples R China.	ndsfy001889@ncu.edu.cn		Hu, Kaishun/0000-0003-2157-6239; Sang, Yi/0000-0001-6534-0741	special fund for Jiangxi Key Laboratory [20171BCD40026]; Jiangxi Provincial Natural Science Foundation of China [20192BAB215039]; Natural Science Foundation of China [81772821]	special fund for Jiangxi Key Laboratory; Jiangxi Provincial Natural Science Foundation of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the special fund for Jiangxi Key Laboratory (20171BCD40026 to YS), the Jiangxi Provincial Natural Science Foundation of China (20192BAB215039 to YS) and the Natural Science Foundation of China (81772821 to KH).	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Arimoto K, 2014, MOL CELL BIOL, V34, P3843, DOI 10.1128/MCB.00758-14; Biau J, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01009; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Chang JY, 2013, CANCER-AM CANCER SOC, V119, P3402, DOI 10.1002/cncr.28217; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Coon D, 2008, CLIN LUNG CANCER, V9, P217, DOI 10.3816/CLC.2008.n.032; Demirag GG, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-1; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dubash AD, 2016, J CELL BIOL, V212, P425, DOI 10.1083/jcb.201507018; Fischer-Keso R, 2014, MOL CELL BIOL, V34, P4244, DOI 10.1128/MCB.00766-14; Gul IS, 2017, CELL MOL LIFE SCI, V74, P525, DOI 10.1007/s00018-016-2319-6; Hao XL, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152438; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hsu JHR, 2017, CANCER RES, V77, P4613, DOI 10.1158/0008-5472.CAN-17-0216; Jeong YK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030871; Jun S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10994; Kanamoto T, 2002, EMBO J, V21, P1219, DOI 10.1093/emboj/21.5.1219; Kim BH, 2020, CLIN CANCER RES, V26, P265, DOI 10.1158/1078-0432.CCR-19-0610; Kim MR, 2015, MOL CANCER RES, V13, P319, DOI 10.1158/1541-7786.MCR-14-0098-T; Laird JH, 2018, CLIN CANCER RES, V24, P5143, DOI 10.1158/1078-0432.CCR-18-0401; Lee SY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-016-0577-4; Li D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05286-2; Martin-Padron J, 2020, ONCOGENE, V39, P5479, DOI 10.1038/s41388-019-1129-3; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Montenegro MF, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.85; Montenegro MF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70289-3; Nanavaty P, 2014, CANCER CONTROL, V21, P9, DOI 10.1177/107327481402100102; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Niell N, 2018, INT J CANCER, V142, P792, DOI 10.1002/ijc.31104; Novellasdemunt L, 2017, CELL REP, V21, P612, DOI 10.1016/j.celrep.2017.09.072; Rubin SM, 2019, NATURE, V569, P343, DOI 10.1038/d41586-019-01319-y; SEOL JH, 2018, MUTAT RES-FUND MOL M, V809, P81, DOI DOI 10.1016/J.MRFMMM.2017.07.002; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Su DX, 2018, J CLIN INVEST, V128, P4280, DOI 10.1172/JCI120518; Suchankova J, 2014, EUR J HISTOCHEM, V58, P1, DOI 10.4081/ejh.2014.2389; Takahashi H, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.08.049; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Vadnais C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03817-5; Vartak SV, 2018, FEBS J, V285, P3959, DOI 10.1111/febs.14661; Wang Y, 2016, FEBS LETT, V590, P4586, DOI 10.1002/1873-3468.12485; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Wu CYJ, 2020, NEURO-ONCOLOGY, V22, P253, DOI 10.1093/neuonc/noz189; Wu CT, 2015, J MOL MED, V93, P73, DOI 10.1007/s00109-014-1206-6; Yang JH, 2014, NUCLEIC ACIDS RES, V42, P9908, DOI 10.1093/nar/gku705; Zhan TZ, 2019, SEMIN CANCER BIOL, V55, P106, DOI 10.1016/j.semcancer.2018.04.001; Zhang BL, 2019, ACTA BIOCH BIOPH SIN, V51, P375, DOI 10.1093/abbs/gmz015; Zhang DP, 2017, NEUROPATHOLOGY, V37, P207, DOI 10.1111/neup.12363; Zhou WQ, 2019, ONCOTARGETS THER, V12, P8275, DOI 10.2147/OTT.S220536	52	7	7	3	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2842	2857		10.1038/s41388-021-01692-x	http://dx.doi.org/10.1038/s41388-021-01692-x		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742119				2022-12-26	WOS:000630675000003
J	Nair, AB; Shah, J; Jacob, S; Al-Dhubiab, BE; Sreeharsha, N; Morsy, MA; Gupta, S; Attimarad, M; Shinu, P; Venugopala, KN				Nair, Anroop B.; Shah, Jigar; Jacob, Shery; Al-Dhubiab, Bandar E.; Sreeharsha, Nagaraja; Morsy, Mohamed A.; Gupta, Sumeet; Attimarad, Mahesh; Shinu, Pottathil; Venugopala, Katharigatta N.			Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections	PLOS ONE			English	Article								In situ gels have been extensively explored as ocular drug delivery system to enhance bioavailability and efficacy. The objective of present study was to design, formulate and evaluate ion-activated in situ gel to enhance the ocular penetration and therapeutic performance of moxifloxacin in ophthalmic delivery. A simplex lattice design was utilized to examine the effect of various factors on experimental outcomes of the in situ gel system. The influence of polymers (independent variables) such as gellan gum (X-1), sodium alginate (X-2), and HPMC (X-3) on gel strength, adhesive force, viscosity and drug release after 10 h (Q(10)) were assessed. Selected formulation (MH7) was studied for ex vivo permeation, in vivo irritation and pharmacokinetics in rabbits. Data revealed that increase in concentration of polymers led to higher gel strength, adhesive force and viscosity, however, decreases the drug release. MH7 exhibited all physicochemical properties within acceptable limits and was stable for 6 months. Release profile of moxifloxacin from MH7 was comparable to the check point batches and followed Korsmeyer-Peppas matrix diffusion-controlled mechanism. Ocular irritation study signifies that selected formulation is safe and non-irritant for ophthalmic administration. In vivo pharmacokinetics data indicates significant improvement of moxifloxacin bioavailability (p < 0.0001) from MH7, as evidenced by higher C-max (727 +/- 56 ng/ml) and greater AUC (2881 +/- 108 ng h/ml), when compared with commercial eye drops (C-max; 503 +/- 85 ng/ml and AUC; 978 +/- 86 ng h/ml). In conclusion, developed in situ gel system (MH7) could offers a more effective and extended ophthalmic therapy of moxifloxacin in ocular infections when compared to conventional eye drops.	[Nair, Anroop B.; Al-Dhubiab, Bandar E.; Sreeharsha, Nagaraja; Morsy, Mohamed A.; Attimarad, Mahesh; Venugopala, Katharigatta N.] King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa, Saudi Arabia; [Shah, Jigar] Nirma Univ, Inst Pharm, Dept Pharmaceut, Ahmadabad, Gujarat, India; [Jacob, Shery] Gulf Med Univ, Coll Pharm, Dept Pharmaceut Sci, Ajman, U Arab Emirates; [Sreeharsha, Nagaraja] Vidya Siri Coll Pharm, Dept Pharmaceut, Bangalore, Karnataka, India; [Morsy, Mohamed A.] Menia Univ, Fac Med, Dept Pharmacol, El Minia, Egypt; [Gupta, Sumeet] Maharishi Markandeshwar Deemed Be Univ, MM Coll Pharm, Dept Pharmacol, Mullana, India; [Shinu, Pottathil] King Faisal Univ, Coll Clin Pharm, Dept Biomed Sci, Al Hasa, Saudi Arabia; [Venugopala, Katharigatta N.] Durban Univ Technol, Dept Biotechnol & Food Technol, Durban, South Africa	King Faisal University; Nirma University; Egyptian Knowledge Bank (EKB); Minia University; Maharishi Markandeshwar University; King Faisal University; Durban University of Technology	Nair, AB (corresponding author), King Faisal Univ, Coll Clin Pharm, Dept Pharmaceut Sci, Al Hasa, Saudi Arabia.	anair@kfu.edu.sa	Nair, Anroop/L-9995-2014; Venugopala, Katharigatta N./M-4030-2016; Gupta, Sumeet/AAN-1797-2021; Morsy, Mohamed/G-4809-2010	Nair, Anroop/0000-0003-2850-8669; Venugopala, Katharigatta N./0000-0003-0680-1549; Gupta, Sumeet/0000-0003-2980-7791; Morsy, Mohamed/0000-0002-6752-9094	King Faisal University, Al-Ahsa, Saudi Arabia [1811021]; King Faisal University	King Faisal University, Al-Ahsa, Saudi Arabia; King Faisal University	This research was funded by Deanship of Scientific Research, King Faisal University, Al-Ahsa, Saudi Arabia (Research Project number 1811021).; The authors thank the Deanship of Scientific Research at King Faisal University for the support to complete this project.	Abdelaziz AA, 2012, BRAZ J MICROBIOL, V43, P1291, DOI 10.1590/S1517-83822012000400008; Agrahari V, 2016, DRUG DELIV TRANSL RE, V6, P735, DOI 10.1007/s13346-016-0339-2; Al-Dhubiab BE, 2016, DRUG DELIV, V23, P2154, DOI 10.3109/10717544.2014.948644; Ferreira KSA, 2018, ARQ BRAS OFTALMOL, V81, P510, DOI 10.5935/0004-2749.20180090; Anroop B, 2005, J DRUG DELIV SCI TEC, V15, P187, DOI 10.1016/S1773-2247(05)50025-X; Balasubramaniam Jagdish, 2003, Acta Pharmaceutica (Zagreb), V53, P251; Bhalerao H, 2019, AAPS PHARMSCITECH, V20, DOI 10.1208/s12249-019-1489-6; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Dubald M, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10010010; Ei-Laithy HM, 2011, ARCH PHARM RES, V34, P1663, DOI 10.1007/s12272-011-1011-5; Giram PS, 2018, MAT SCI ENG C-MATER, V92, P526, DOI 10.1016/j.msec.2018.06.031; Giuliano E, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030159; Harsha Sree N, 2015, Drug Des Devel Ther, V9, P273, DOI 10.2147/DDDT.S66654; Irimia T, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10111221; Jacob S, 2020, BIOMATER RES, V24, DOI 10.1186/s40824-020-0184-8; Jacob S, 2018, DRUG DEVELOP RES, V79, P97, DOI 10.1002/ddr.21427; Jones DS, 2002, J PHARM SCI, V91, P2090, DOI 10.1002/jps.10195; Khan N, 2015, PHARM DEV TECHNOL, V20, P662, DOI 10.3109/10837450.2014.910807; Khurana LK, 2018, CURR PHARM DESIGN, V24, P1434, DOI 10.2174/1381612824666180403115106; Kotreka UK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172306; Kumbhar SA, 2020, INT J PHARMACEUT, V586, DOI 10.1016/j.ijpharm.2020.119499; Mahor A, 2016, J COLLOID INTERF SCI, V483, P132, DOI 10.1016/j.jcis.2016.08.018; Makwana S B, 2016, Results Pharma Sci, V6, P1, DOI 10.1016/j.rinphs.2015.06.001; Moisseiev E, 2015, EYE, V29, P815, DOI 10.1038/eye.2015.47; Nair A, 2018, DRUG DEVELOP RES, V79, P373, DOI 10.1002/ddr.21461; Nair A, 2009, SKIN RES TECHNOL, V15, P187, DOI 10.1111/j.1600-0846.2009.00350.x; Nair AB, 2019, MOLECULES, V24, DOI 10.3390/molecules24244566; Nair AB, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11101699; Nair AB, 2018, J DRUG DELIV SCI TEC, V47, P351, DOI 10.1016/j.jddst.2018.08.014; Nair AB, 2017, INDIAN J PHARM EDUC, V51, P571, DOI 10.5530/ijper.51.4.86; Pahuja P, 2012, EXPERT OPIN DRUG DEL, V9, P837, DOI 10.1517/17425247.2012.690733; Paradkar MU, 2017, J DRUG DELIV SCI TEC, V39, P113, DOI 10.1016/j.jddst.2017.03.005; Pathak MK, 2013, DRUG DEV IND PHARM, V39, P780, DOI 10.3109/03639045.2012.707203; Ranch KM, 2019, INT J PHARMACEUT, V554, P264, DOI 10.1016/j.ijpharm.2018.11.016; Reed K, 2016, J OCUL PHARMACOL TH, V32, P574, DOI 10.1089/jop.2016.0084; Salunke SR, 2016, INT J BIOL MACROMOL, V87, P41, DOI 10.1016/j.ijbiomac.2016.02.044; Shah H, 2019, DARU, V27, P59, DOI 10.1007/s40199-019-00242-x; Shah J, 2020, ASIAN J PHARM SCI, V15, P786, DOI 10.1016/j.ajps.2019.05.001; Shah J, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11050230; Sheshala R, 2019, INDIAN J PHARM EDUC, V53, P654, DOI 10.5530/ijper.53.4.127; Singh G, 2020, INDIAN J PHARM EDUC, V54, P921, DOI 10.5530/ijper.54.4.186; Souto EB, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11090460; Speciale A, 2002, INT J ANTIMICROB AG, V19, P111, DOI 10.1016/S0924-8579(01)00486-1; Tsai CH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092830; Varela-Fernandez R, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12030269; Wilson SL, 2015, TOXICOLOGY, V327, P32, DOI 10.1016/j.tox.2014.11.003; Wu YM, 2019, ASIAN J PHARM SCI, V14, P1, DOI 10.1016/j.ajps.2018.04.008	47	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248857	10.1371/journal.pone.0248857	http://dx.doi.org/10.1371/journal.pone.0248857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739996	Green Published, gold			2022-12-26	WOS:000631030200032
J	Min, KW; Kim, DH; Son, BK; Moon, KM; Kim, SM; Rahaman, MI; Kim, SW; Kim, EK; Kwon, MJ; Koh, YW; Oh, IH				Min, Kyueng-Whan; Kim, Dong-Hoon; Son, Byoung Kwan; Moon, Kyoung Min; Kim, So Myoung; Intazur Rahaman, Md.; Kim, So Won; Kim, Eun-Kyung; Kwon, Mi Jung; Koh, Young Wha; Oh, Il Hwan			High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer	PLOS ONE			English	Article							GLUCOSE TRANSPORTERS; DRUG-SENSITIVITY; GLUT1; CARCINOMA; OVEREXPRESSION; METABOLISM; INVASION; RECEPTOR; SUBTYPES; BETA	High expression of glucose transporter family members, which augment glucose uptake and glycolytic flux, has been shown to play a pivotal role in the proliferation and survival of tumor cells, contributing to the energy supply, biosynthesis and homeostasis of cancer cells. Among the many members, solute carrier family 2 member 1 (SLC2A1) encodes a glucose transporter, GLUT1, that is critical in the metabolism of glucose, which is an energy source for cell growth that contributes to cancer progression and development. The aim of this study was to analyze the survival and genetic changes/immune profiles in patients with gastric cancer with high SLC2A1 expression and to provide treatment for improving prognosis. This study investigated the clinicopathologic parameters, the proportion of immune cells and gene sets affecting SLC2A1 expression in 279 and 415 patients with gastric cancer from the Eulji Hospital cohort and The Cancer Genome Atlas, respectively. We assessed the response to conventional chemotherapy drugs, including fluorouracil, a compound of fluoropyrimidine S-1, oxaliplatin, and all-trans-retinoic acid (ATRA), in gastric cancer cell lines with high SLC2A1 expression. High SLC2A1 expression was associated with poor prognosis, cancer cell proliferation, decreased immune cells, including CD8 T cells and B cells, and a low prognostic nutrition index, representing body nutrition-related status. In pathway network analysis, SLC2A1 was indirectly linked to the retinoic signaling pathway and negatively regulated immune cells/receptors. In the drug response analysis, the drug ATRA inhibited gastric cancer cell lines with high SLC2A1 expression. Treatment involving the use of SLC2A1 could contribute to better clinical management/research for patients with gastric cancer.	[Min, Kyueng-Whan] Hanyang Univ, Coll Med, Guri Hosp, Dept Pathol, Guri, Gyeonggi Do, South Korea; [Kim, Dong-Hoon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pathol, Seoul, South Korea; [Son, Byoung Kwan; Oh, Il Hwan] Eulji Univ, Sch Med, Eulji Hosp, Dept Internal Med, Seoul, South Korea; [Moon, Kyoung Min] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Internal Med, Kangnung, Gangwon Do, South Korea; [Kim, So Myoung; Intazur Rahaman, Md.; Kim, So Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, Seoul, South Korea; [Kim, Eun-Kyung] Eulji Univ, Sch Med, Eulji Hosp, Dept Pathol, Seoul, South Korea; [Kwon, Mi Jung] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Pathol, Anyang, Gyeonggi Do, South Korea; [Koh, Young Wha] Ajou Univ, Sch Med, Dept Pathol, Suwon, Gyeonggi Do, South Korea	Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Eulji University; University of Ulsan; University of Ulsan; Asan Medical Center; Eulji University; Hallym University; Ajou University	Son, BK (corresponding author), Eulji Univ, Sch Med, Eulji Hosp, Dept Internal Med, Seoul, South Korea.	sbk1026@eulji.ac.kr	Min, Kyueng-Whan/F-3981-2017	Min, Kyueng-Whan/0000-0002-4757-9211; Son, Byoung Kwan/0000-0002-9299-5476; Md Intazur, Rahaman/0000-0002-8208-4484	Daewon Pharmaceutical Co., Ltd.	Daewon Pharmaceutical Co., Ltd.	YES This study was supported by Daewon Pharmaceutical Co., Ltd. in 2018. (To Byoung Kwan Son). The funding organization did not play any role in our study and provided only financial support. We have reviewed the author roles in the Author Contribution section and confirm the previous statements are correctly stated.	Bartley AN, 2017, J CLIN ONCOL, V35, P446, DOI 10.1200/JCO.2016.69.4836; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; Brooks EA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0226; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feng WM, 2017, ONCOTARGET, V8, P56850, DOI 10.18632/oncotarget.18090; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geissmann F, 2003, J EXP MED, V198, P623, DOI 10.1084/jem.20030390; Goldman NA, 2006, MODERN PATHOL, V19, P1429, DOI 10.1038/modpathol.3800656; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kim IH, 2018, ANN SURG ONCOL, V25, P1176, DOI 10.1245/s10434-018-6375-z; Koh YW, 2017, LUNG CANCER, V104, P31, DOI 10.1016/j.lungcan.2016.12.003; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu Y, 2018, CANCER CELL, V33, P721, DOI 10.1016/j.ccell.2018.03.010; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nguyen PH, 2016, ONCOGENE, V35, P5619, DOI 10.1038/onc.2016.87; Oh S, 2017, BMB REP, V50, P132, DOI 10.5483/BMBRep.2017.50.3.189; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Peng XX, 2018, CELL REP, V23, P255, DOI 10.1016/j.celrep.2018.03.077; Piatkiewicz P, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0152-6; REMMELE W, 1987, PATHOLOGE, V8, P138; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sasaki H, 2012, MOL MED REP, V5, P599, DOI 10.3892/mmr.2011.736; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wan HS, 2001, CANCER RES, V61, P556; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamada A, 2006, ANN NUCL MED, V20, P597, DOI 10.1007/BF02984657; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111	38	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0245075	10.1371/journal.pone.0245075	http://dx.doi.org/10.1371/journal.pone.0245075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735188	Green Published, gold			2022-12-26	WOS:000631029700116
J	Huang, ZF; Bai, XH; Yin, C; Liu, YQ				Huang Zhan-Fang; Bai, Xiao-Hong; Yin, Chao; Liu, Yong-Qiang			Numerical analysis for the vertical bearing capacity of composite pile foundation system in liquefiable soil under sine wave vibration	PLOS ONE			English	Article								Composite pile foundation has been widely used in ground engineering. This composite pile foundation system has complex pile-soil interactions under seismic loading. The calculation of vertical bearing capacity of composite pile foundation is still an unsolved problem if the soil around piles is partially or completely liquefied under seismic loading. We have completed indoor shaking table model tests to measure the vertical bearing capacity in a liquefiable soil foundation under seismic loading. This paper will use a numerical approach to analyze the change of this vertical bearing capacity under seismic loading. Firstly, the Goodman contact element is improved to include the Rayleigh damping. Such an improvement can well describe the reflection and absorption of seismic waves at the interface of soil and piles. Secondly, the Biot's dynamic consolidation theory incorporated an elastoplastic model is applied to simulate the soil deformation and the generation and accumulation of pore water pressure under seismic loading. Thirdly, after verification with our indoor shaking table test data, this approach is used to investigate the effects of pile spacing on liquefaction resistance of the composite pile foundation in liquefiable soil. The time histories of pore water pressure ratio (PPR ') are calculated for the liquefiable soil and the vertical bearing capacity in partially liquefied soil is calculated and compared with our indoor shaking table test data at the 3D, 3.5D, 4D, 5D and 6D cases (D is the pile diameter). It is found that the pile spacing has some influence on the extent of soil liquefaction between piles. The vertical bearing capacity varies with liquefaction extent of inter-pile soil. The optimization of pile spacing varies with liquefaction extent. These results may provide some reference for the design of composite pile foundation under seismic loading.	[Huang Zhan-Fang; Yin, Chao; Liu, Yong-Qiang] Shandong Univ Technol, Sch Construct Engn, Zibo, Shandong, Peoples R China; [Bai, Xiao-Hong] Taiyuan Univ Technol, Sch Architecture & Civil Engn, Taiyuan, Shanxi, Peoples R China	Shandong University of Technology; Taiyuan University of Technology	Huang, ZF (corresponding author), Shandong Univ Technol, Sch Construct Engn, Zibo, Shandong, Peoples R China.	1294191132@qq.com			national natural science foundation of china(CN) [51808327]; natural science foundation of shanxi province [20100321070]	national natural science foundation of china(CN)(National Natural Science Foundation of China (NSFC)); natural science foundation of shanxi province(Natural Science Foundation of Shanxi Province)	1.the national natural science foundation of china(CN) 51808327 Xiaohong Bai 2. natural science foundation of shanxi province(CN) 20100321070 Chao Yin.	Al-Isawi A. T., 2019, GEO-CONGRESS 2019. Earthquake Engineering and Soil Dynamics. Selected Papers from Sessions of the Eighth International Conference on Case Histories in Geotechnical Engineering, P252; Amar S.P, 2018, J GEOTECH GEOENVIRON, V144, P06018007, DOI [10.1061/%28ASCE%29GT.1943-5606.0001927, DOI 10.1061/%28ASCE%29GT.1943-5606.0001927]; DEEKS AJ, 1994, J ENG MECH-ASCE, V120, P25, DOI 10.1061/(ASCE)0733-9399(1994)120:1(25); Gong X.N, 1996, ADV SOIL MECH, V1st ed, P120; Huang F., 4 GEOCH INT C GEOCH, V259, P49, DOI [10.1061/9780784480021.007, DOI 10.1061/9780784480021.007]; Huang Z.F, 2013, VIBRATION SHOCK, V32, P153; Huang ZF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229532; Iwasaki T., 1984, International Journal of Soil Dynamics and Earthquake Engineering, V3, P49, DOI 10.1016/0261-7277(84)90027-5; Li PZ, 2011, ADV MATER RES-SWITZ, V163-167, P4048, DOI 10.4028/www.scientific.net/AMR.163-167.4048; Liang X.C, 2021, PORT WATERWAY ENG, P137; Liu L.P, 2004, THESIS CHONGQING U; Makris N, 1997, SOIL DYN EARTHQ ENG, V16, P113, DOI 10.1016/S0267-7261(96)00037-1; Mao C.Q., 2007, HUNAN I ENG, V17, P83; Nadarajah R, 2010, ADV IN ANAL, V199, DOI [10.1061/41095%28365%29307, DOI 10.1061/41095%28365%29307]; Nomura S., 1991, ADV GEOTECHNICAL ENG, V1, P743; Onoue A., 1988, SOILS FOUND, V28, P160; Onoue A., 1987, SOILS FOUND, V27, P42, DOI DOI 10.3208/SANDF1972.27.2_42; Paramasivam Balaji, 2019, GEO-CONGRESS 2019. Earthquake Engineering and Soil Dynamics. Selected Papers from Sessions of the Eighth International Conference on Case Histories in Geotechnical Engineering, P66; Pietrzak G, 1999, COMPUT METHOD APPL M, V177, P351, DOI 10.1016/S0045-7825(98)00388-0; Qi C.X., 2007, THESIS TIANJIN U; Stanton J, 1988, SHAKING TABLE TESTS; Su L, 2018, J GEOTECH GEOENVIRON, V144, DOI 10.1061/(ASCE)GT.1943-5606.0001977; Tamura S, 2000, P WORLD C EARTHQ EN; [王建华 Wang Jianhua], 2004, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V26, P616; WANG Wen-shao, 1981, J HYDRAULIC ENG, P22; Wu Y.W, 1995, J TONGJI U, V23, P360; Xia D.Z, 2009, ROCK SOIL MECH, V30, P10; Xu Bin, 2009, Journal of Southeast University (Natural Science Edition), V39, P495, DOI 10.3969/j.issn.1001-0505.2009.03.015; Zhang J, 2017, J PERFORM CONSTR FAC, V31, DOI 10.1061/(ASCE)CF.1943-5509.0001056; [邹佑学 Zou Youxue], 2019, [工程力学, Engineering Mechanics], V36, P152	30	0	0	10	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248502	10.1371/journal.pone.0248502	http://dx.doi.org/10.1371/journal.pone.0248502			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730066	Green Published, gold			2022-12-26	WOS:000630345000072
J	Stewart, M; Rodriguez-Watson, C; Albayrak, A; Asubonteng, J; Belli, A; Brown, T; Cho, K; Das, R; Eldridge, E; Gatto, N; Gelman, A; Gerlovin, H; Goldberg, SL; Hansen, E; Hirsch, J; Ho, YL; Ip, A; Izano, M; Jones, J; Justice, AC; Klesh, R; Kuranz, S; Lam, C; Mao, QQ; Mataraso, S; Mera, R; Posner, DC; Rassen, JA; Siefkas, A; Schrag, A; Tourassi, G; Weckstein, A; Wolf, F; Bhat, A; Winckler, S; Sigal, EV; Allen, J				Stewart, Mark; Rodriguez-Watson, Carla; Albayrak, Adem; Asubonteng, Julius; Belli, Andrew; Brown, Thomas; Cho, Kelly; Das, Ritankar; Eldridge, Elizabeth; Gatto, Nicolle; Gelman, Alice; Gerlovin, Hanna; Goldberg, Stuart L.; Hansen, Eric; Hirsch, Jonathan; Ho, Yuk-Lam; Ip, Andrew; Izano, Monika; Jones, Jason; Justice, Amy C.; Klesh, Reyna; Kuranz, Seth; Lam, Carson; Mao, Qingqing; Mataraso, Samson; Mera, Robertino; Posner, Daniel C.; Rassen, Jeremy A.; Siefkas, Anna; Schrag, Andrew; Tourassi, Georgia; Weckstein, Andrew; Wolf, Frank; Bhat, Amar; Winckler, Susan; Sigal, Ellen, V; Allen, Jeff			COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients	PLOS ONE			English	Article								Background The COVID-19 pandemic remains a significant global threat. However, despite urgent need, there remains uncertainty surrounding best practices for pharmaceutical interventions to treat COVID-19. In particular, conflicting evidence has emerged surrounding the use of hydroxychloroquine and azithromycin, alone or in combination, for COVID-19. The COVID-19 Evidence Accelerator convened by the Reagan-Udall Foundation for the FDA, in collaboration with Friends of Cancer Research, assembled experts from the health systems research, regulatory science, data science, and epidemiology to participate in a large parallel analysis of different data sets to further explore the effectiveness of these treatments. Methods Electronic health record (EHR) and claims data were extracted from seven separate databases. Parallel analyses were undertaken on data extracted from each source. Each analysis examined time to mortality in hospitalized patients treated with hydroxychloroquine, azithromycin, and the two in combination as compared to patients not treated with either drug. Cox proportional hazards models were used, and propensity score methods were undertaken to adjust for confounding. Frequencies of adverse events in each treatment group were also examined. Results Neither hydroxychloroquine nor azithromycin, alone or in combination, were significantly associated with time to mortality among hospitalized COVID-19 patients. No treatment groups appeared to have an elevated risk of adverse events. Conclusion Administration of hydroxychloroquine, azithromycin, and their combination appeared to have no effect on time to mortality in hospitalized COVID-19 patients. Continued research is needed to clarify best practices surrounding treatment of COVID-19.	[Stewart, Mark; Sigal, Ellen, V; Allen, Jeff] Friends Canc Res, Washington, DC 20036 USA; [Rodriguez-Watson, Carla; Bhat, Amar; Winckler, Susan; Sigal, Ellen, V] US FDA, Reagan Udall Fdn, Washington, DC 20204 USA; [Albayrak, Adem; Eldridge, Elizabeth; Gelman, Alice; Jones, Jason] Hlth Catalyst, Salt Lake City, UT USA; [Asubonteng, Julius; Mera, Robertino] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Belli, Andrew; Hansen, Eric] COTA Inc, Boston, MA USA; [Brown, Thomas; Hirsch, Jonathan; Izano, Monika; Schrag, Andrew; Wolf, Frank] Syapse, San Francisco, CA USA; [Cho, Kelly; Gerlovin, Hanna; Ho, Yuk-Lam; Posner, Daniel C.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Cho, Kelly] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Das, Ritankar; Lam, Carson; Mao, Qingqing; Mataraso, Samson; Siefkas, Anna] Dascena, Oakland, CA USA; [Gatto, Nicolle; Rassen, Jeremy A.; Weckstein, Andrew] Aetion, New York, NY USA; [Goldberg, Stuart L.; Ip, Andrew] Hackensack Univ, Div Outcomes & Value Res, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA; [Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Justice, Amy C.] Yale Univ, Sch Med & Publ Hlth, New Haven, CT USA; [Klesh, Reyna] HealthVerity, Philadelphia, PA USA; [Kuranz, Seth] TriNetX, Cambridge, MA USA; [Tourassi, Georgia] Oak Ridge Natl Lab, Natl Ctr Computat Sci, Oak Ridge, TN USA	US Food & Drug Administration (FDA); Gilead Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hackensack University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Allen, J (corresponding author), Friends Canc Res, Washington, DC 20036 USA.	jallen@focr.org	Goldberg, Stuart/GXG-1919-2022	Asubonteng, Julius/0000-0001-8991-3276; Allen, Jeffrey/0000-0001-9957-6664; Posner, Daniel C/0000-0002-3056-6924; Siefkas, Anna/0000-0001-8379-6523; Gerlovin, Hanna/0000-0002-6700-2129; Albayrak, Adem/0000-0002-6436-3164				[Anonymous], 2020, CORONAVIRUS DIS 2019; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Chief Investigators of the RECOVERY Trial, 2020, NO CLIN BENEFIT USE; Cortegiani A, 2020, J CRIT CARE, V57, P279, DOI 10.1016/j.jcrc.2020.03.005; Fiolet T, 2021, CLIN MICROBIOL INFEC, V27, P19, DOI 10.1016/j.cmi.2020.08.022; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Greenwell B., 2020, Gbm: Generalized Boosted Regression Models. R Package Version, 2.1.8; Greifer N., 2020, WEIGHTIT WEIGHTING C; Ip A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237693; Jones M., 2020, NATURAL LANGUAGE PRO; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Ridgeway G., 2007, GEN BOOSTED MODELS G; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Singh AK, 2020, DIABETES METAB SYND, V14, P589, DOI 10.1016/j.dsx.2020.05.017; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237	15	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248128	10.1371/journal.pone.0248128	http://dx.doi.org/10.1371/journal.pone.0248128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730088	gold, Green Submitted, Green Published			2022-12-26	WOS:000630345000029
J	Wang, ZZ; Li, K; Maskey, AR; Huang, WH; Toutov, AA; Yang, N; Srivastava, K; Geliebter, J; Tiwari, R; Miao, MS; Li, XM				Wang, Zhen-Zhen; Li, Kun; Maskey, Anish R.; Huang, Weihua; Toutov, Anton A.; Yang, Nan; Srivastava, Kamal; Geliebter, Jan; Tiwari, Raj; Miao, Mingsan; Li, Xiu-Min			A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study	FASEB JOURNAL			English	Article						anti-viral; apoptosis; berberine; computational modeling; COVID-19 and SARS	RESPIRATORY SYNDROME CORONAVIRUS; NF-KAPPA-B; CELL-CYCLE ARREST; CYTOKINE STORM; CYCLOOXYGENASE ACTIVITY; SIGNALING PATHWAYS; ANTIVIRAL ACTIVITY; INHIBITOR BINDING; INDUCED APOPTOSIS; NATURAL-PRODUCT	The novel coronavirus disease, COVID-19, has grown into a global pandemic and a major public health threat since its breakout in December 2019. To date, no specific therapeutic drug or vaccine for treating COVID-19 and SARS has been FDA approved. Previous studies suggest that berberine, an isoquinoline alkaloid, has shown various biological activities that may help against COVID-19 and SARS, including antiviral, anti-allergy and inflammation, hepatoprotection against drug- and infection-induced liver injury, as well as reducing oxidative stress. In particular, berberine has a wide range of antiviral activities such as anti-influenza, anti-hepatitis C, anti-cytomegalovirus, and anti-alphavirus. As an ingredient recommended in guidelines issued by the China National Health Commission for COVID-19 to be combined with other therapy, berberine is a promising orally administered therapeutic candidate against SARS-CoV and SARS-CoV-2. The current study comprehensively evaluates the potential therapeutic mechanisms of berberine in preventing and treating COVID-19 and SARS using computational modeling, including target mining, gene ontology enrichment, pathway analyses, protein-protein interaction analysis, and in silico molecular docking. An orally available immunotherapeutic-berberine nanomedicine, named NIT-X, has been developed by our group and has shown significantly increased oral bioavailability of berberine, increased IFN-gamma production by CD8+ T cells, and inhibition of mast cell histamine release in vivo, suggesting a protective immune response. We further validated the inhibition of replication of SARS-CoV-2 in lung epithelial cells line in vitro (Calu3 cells) by berberine. Moreover, the expression of targets including ACE2, TMPRSS2, IL-1 alpha, IL-8, IL-6, and CCL-2 in SARS-CoV-2 infected Calu3 cells were significantly suppressed by NIT-X. By supporting protective immunity while inhibiting pro-inflammatory cytokines; inhibiting viral infection and replication; inducing apoptosis; and protecting against tissue damage, berberine is a promising candidate in preventing and treating COVID-19 and SARS. Given the high oral bioavailability and safety of berberine nanomedicine, the current study may lead to the development of berberine as an orally, active therapeutic against COVID-19 and SARS.	[Wang, Zhen-Zhen; Miao, Mingsan] Henan Univ Chinese Med, Acad Chinese Med Sci, Zhengzhou, Peoples R China; [Wang, Zhen-Zhen; Maskey, Anish R.; Yang, Nan; Srivastava, Kamal; Geliebter, Jan; Tiwari, Raj; Li, Xiu-Min] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Li, Kun] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Huang, Weihua] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Toutov, Anton A.] Fuzionaire Inc, The Woodlands, TX USA; [Yang, Nan; Srivastava, Kamal] Gen Nutraceut Technol, Elmsford, NY USA; [Geliebter, Jan; Tiwari, Raj; Li, Xiu-Min] New York Med Coll, Sch Med, Dept Otolaryngol, Valhalla, NY 10595 USA	Henan University of Traditional Chinese Medicine; New York Medical College; University of Iowa; New York Medical College; New York Medical College	Li, XM (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	XiuMin_Li@NYMC.edu	li, xiu/GXV-1745-2022	Huang, Weihua/0000-0003-1176-3719; Wang, Zhenzhen/0000-0001-6961-4367	Henan University of Chinese Medicine [CTIM-01-2019]; Scientific Research Foundation [KYQD 2019-05]; Henan Province Scientific and Technological Project [202102310472]	Henan University of Chinese Medicine; Scientific Research Foundation; Henan Province Scientific and Technological Project	This research was founded by Henan University of Chinese Medicine, visiting fellowship grant to ZZW (CTIM-01-2019), Scientific Research Foundation (KYQD 2019-05), and Henan Province Scientific and Technological Project (NO. 202102310472). Study of Integrative Medicine for Immunology and Wellness, New York Medical College.	Afrin LB, 2020, INT J INFECT DIS, V100, P327, DOI 10.1016/j.ijid.2020.09.016; Alter P, 2001, CARDIOVASC PATHOL, V10, P229, DOI 10.1016/S1054-8807(01)00077-1; Amin M, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12984; [Anonymous], 2000, Altern Med Rev, V5, P175; [Anonymous], 2020, CORRECTION LANCET IN, DOI [10.1016/S1473-3099(20)30144-4, DOI 10.1016/S1473-3099(20)30144-4]; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Aviv A, 2020, FASEB J, V34, P7247, DOI 10.1096/fj.202001025; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blake JF, 2014, BIOORG MED CHEM LETT, V24, P2635, DOI 10.1016/j.bmcl.2014.04.068; Botwina P, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030344; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Chen IY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00050; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Chen XW, 2012, SCI WORLD J, DOI 10.1100/2012/708292; Chen XY, 2018, MOL MED REP, V18, P4468, DOI 10.3892/mmr.2018.9476; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Conti P, 2020, J BIOL REG HOMEOS AG, V34, P1629, DOI 10.23812/20-2EDIT; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Coskun M, 2011, CLIN CHIM ACTA, V412, P513, DOI 10.1016/j.cca.2010.12.020; Criado PR, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14068; Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382; DassaultSystemesBIOVIAD, 2020, DISCOVERY STUDIO, V2020; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Eleftheriou P, 2020, MOLECULES, V25, DOI 10.3390/molecules25112529; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fujikura D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072065; Fukuda K, 1999, PLANTA MED, V65, P381, DOI 10.1055/s-2006-960795; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Garner TP, 2016, MOL CELL, V63, P485, DOI 10.1016/j.molcel.2016.06.010; Germoush MO, 2014, J CANCER RES CLIN, V140, P1103, DOI 10.1007/s00432-014-1665-8; Gil C, 2020, J MED CHEM, V63, P12359, DOI 10.1021/acs.jmedchem.0c00606; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Hao G, 2015, XENOBIOTICA, V45, P1024, DOI 10.3109/00498254.2015.1034223; Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hinks TSC, 2016, J ALLERGY CLIN IMMUN, V138, P61, DOI 10.1016/j.jaci.2015.11.020; Ho YT, 2009, ANTICANCER RES, V29, P4063; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L., 2020, MEDRXIV 2020 2020031; Hui DSC, 2003, RESPIROLOGY, V8, pS20, DOI 10.1046/j.1440-1843.2003.00520.x; Hung TC, 2019, PHYTOMEDICINE, V53, P62, DOI 10.1016/j.phymed.2018.09.025; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Kim TS, 2003, IMMUNOLOGY, V109, P407, DOI 10.1046/j.1365-2567.2003.01673.x; Kimura H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00276; Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1789, DOI 10.1002/jmv.25900; Laurencikiene J, 2001, J IMMUNOL, V167, P3257, DOI 10.4049/jimmunol.167.6.3257; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee CH, 2004, J IMMUNOL, V172, P7841, DOI 10.4049/jimmunol.172.12.7841; Lee CH, 2007, PHARMACOL RES, V56, P193, DOI 10.1016/j.phrs.2007.06.003; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li FN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020327; Li Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/289264; Lin CC, 2006, ANTICANCER RES, V26, P1097; Lin JP, 2006, WORLD J GASTROENTERO, V12, P21, DOI 10.3748/wjg.v12.i1.21; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lingeswaran M, 2020, INDIAN J CLIN BIOCHE, V35, P260, DOI 10.1007/s12291-020-00897-3; Liu CS, 2016, FITOTERAPIA, V109, P274, DOI 10.1016/j.fitote.2016.02.001; Liu H, 2020, J LEUKOCYTE BIOL, V108, P253, DOI 10.1002/JLB.3MA0320-358RR; Liu M, 2007, FASEB J, V21, P1586, DOI 10.1096/fj.06-6589com; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu YF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2503703; Luganini A, 2019, ANTIVIR RES, V164, P52, DOI 10.1016/j.antiviral.2019.02.006; Mahmoud MA, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2039897; Malone RW., 2020, RES SQ; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Marshall HD, 2011, J VIROL, V85, P5929, DOI 10.1128/JVI.02516-10; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Elizalde MM, 2018, VIROLOGY, V513, P160, DOI 10.1016/j.virol.2017.10.016; Mirhadi E, 2018, BIOMED PHARMACOTHER, V104, P465, DOI 10.1016/j.biopha.2018.05.067; Mizutani T, 2006, FEMS IMMUNOL MED MIC, V46, P236, DOI 10.1111/j.1574-695X.2005.00028.x; Mizutani T, 2004, BIOCHEM BIOPH RES CO, V319, P1228, DOI 10.1016/j.bbrc.2004.05.107; Mosaddeghi P., 2020, PREPRINTS; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Narkhede RR, 2020, NAT PRODUCT BIOPROSP, V10, P297, DOI 10.1007/s13659-020-00253-1; Nienhold R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18854-2; Nieto-Torres JL, 2015, VIROLOGY, V485, P330, DOI 10.1016/j.virol.2015.08.010; Oczypok EA, 2017, PAEDIATR RESPIR REV, V23, P40, DOI 10.1016/j.prrv.2017.03.012; Pinero J, 2020, NUCLEIC ACIDS RES, V48, pD845, DOI 10.1093/nar/gkz1021; Pizzorno A, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104878; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; Qin X, 2010, J IMMUNOL, V185, P1855, DOI 10.4049/jimmunol.0903853; Qiu YY, 2017, MOL CELL ENDOCRINOL, V443, P89, DOI 10.1016/j.mce.2017.01.009; Raaben M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-55; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Rojas A, 2020, INFLAMM RES, V69, P641, DOI 10.1007/s00011-020-01353-x; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Rott D, 2003, J AM COLL CARDIOL, V41, P1812, DOI 10.1016/S0735-1097(03)00304-8; Russell B, 2020, ECANCERMEDICALSCIENC, V14, P1, DOI 10.3332/ecancer.2020.1022; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sharif PM, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155066; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Sun J, 2020, LIVER INT, V40, P1278, DOI 10.1111/liv.14470; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tai CJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040908; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thio CLP, 2019, J ALLERGY CLIN IMMUN, V144, P682, DOI 10.1016/j.jaci.2019.03.008; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Venkataraman T, 2017, ANTIVIR RES, V143, P142, DOI 10.1016/j.antiviral.2017.03.022; Rosa SGV, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.40; Walsh MJ, 2004, HEPATOLOGY, V39, P1230, DOI 10.1002/hep.20179; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang HQ, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0674-4; Wang JX, 2016, ONCOTARGET, V7, P76076, DOI 10.18632/oncotarget.12589; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang Q, 2012, INVEST OPHTH VIS SCI, V53, P2395, DOI 10.1167/iovs.11-8982; Wang YX, 2020, NUCLEIC ACIDS RES, V48, pD1031, DOI 10.1093/nar/gkz981; Warowicka A, 2020, ARCH VIROL, V165, P1935, DOI 10.1007/s00705-020-04706-3; Wen CY, 2020, NEUROTOX RES, V38, P59, DOI 10.1007/s12640-020-00178-0; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiu SY, 2020, J MED CHEM, V63, P12256, DOI 10.1021/acs.jmedchem.0c00502; Xu LL, 2018, EUR J PHARMACOL, V819, P161, DOI 10.1016/j.ejphar.2017.11.013; Yan FG, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110142; Yan TT, 2020, FASEB J, V34, P6017, DOI 10.1096/fj.202000782; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Yan YQ, 2018, PHYTOTHER RES, V32, P2560, DOI 10.1002/ptr.6196; Yang IW, 1996, N-S ARCH PHARMACOL, V354, P102; Yang N, 2017, INT IMMUNOPHARMACOL, V45, P120, DOI 10.1016/j.intimp.2017.01.009; Yang N, 2014, ANN ALLERG ASTHMA IM, V113, P556, DOI 10.1016/j.anai.2014.07.021; Yang Y, 2020, INT J BIOL SCI, V16, P1708, DOI 10.7150/ijbs.45538; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yazdi S, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00032; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Yip NKY, 2013, ONCOL REP, V30, P1107, DOI 10.3892/or.2013.2543; Yu CS, 2006, FASEB J, V20, pA1131; Yu H., 2017, Patent No. [2017/056822, 2017056822]; Yue Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0917-y; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zhang J, 2014, INT J MOL MED, V33, P1209, DOI 10.3892/ijmm.2014.1695; Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393; Zhang X, 2007, VIROLOGY, V365, P324, DOI 10.1016/j.virol.2007.04.009; Zhao HY, 2006, J MED CHEM, V49, P4455, DOI 10.1021/jm060465l; Zhou H, 2017, BIOMED PHARMACOTHER, V89, P864, DOI 10.1016/j.biopha.2017.03.003; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	166	18	18	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21360	10.1096/fj.202001792R	http://dx.doi.org/10.1096/fj.202001792R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749932	Green Published			2022-12-26	WOS:000635216100017
J	Lee, EJ; Kim, SJ; Bae, J; Lee, EJ; Kwon, OD; Jeong, HY; Kim, Y; Jeong, HB				Lee, Eung-Joon; Kim, Seung Jae; Bae, Jeonghoon; Lee, Eun Ji; Kwon, Oh Deog; Jeong, Han-Yeong; Kim, Yongsung; Jeong, Hae-Bong			Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke	PLOS ONE			English	Article								Background and purpose Previous studies have reported that early hospital arrival improves clinical outcomes in patients with acute ischemic stroke; however, whether early arrival is associated with favorable outcomes regardless of reperfusion therapy and the type of stroke onset time is unclear. Thus, we investigated the impact of onset-to-door time on outcomes and evaluated the predictors of pre-hospital delay after ischemic stroke. Methods Consecutive acute ischemic stroke patients who arrived at the hospital within five days of onset from September 2019 to May 2020 were selected from the prospective stroke registries of Seoul National University Hospital and Chung-Ang University Hospital of Seoul, Korea. Patients were divided into early (onset-to-door time, <= 4.5 h) and late (>4.5 h) arrivers. Multivariate analyses were performed to assess the effect of early arrival on clinical outcomes and predictors of late arrival. Results Among the 539 patients, 28.4% arrived early and 71.6% arrived late. Early hospital arrival was significantly associated with favorable outcomes (three-month modified Rankin Scale [mRS]: 0-2, adjusted odds ratio [aOR]: 2.03, 95% confidence interval: [CI] 1.04-3.96) regardless of various confounders, including receiving reperfusion therapy and type of stroke onset time. Furthermore, a lower initial National Institute of Health Stroke Scale (NIHSS) score (aOR: 0.94, 95% CI: 0.90-0.97), greater pre-stroke mRS score (aOR: 1.58, 95% CI: 1.18-2.13), female sex (aOR: 1.71, 95% CI: 1.14-2.58), unclear onset time, and <= 6 years of schooling (aOR: 1.76, 95% CI: 1.03-3.00 compared to >12 years of schooling) were independent predictors of late arrival. Conclusions Thus, the onset-to-door time of <= 4.5 h is crucial for better clinical outcome, and lower NIHSS score, greater pre-stroke mRS score, female sex, unclear onset times, and <= 6 years of schooling were independent predictors of late arrival. Therefore, educating about the importance of early hospital arrival after acute ischemic stroke should be emphasized. More strategic efforts are needed to reduce the prehospital delay by understanding the predictors of late arrival.	[Lee, Eung-Joon; Bae, Jeonghoon; Jeong, Han-Yeong] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kim, Seung Jae] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Family Med, Seoul, South Korea; [Kim, Seung Jae] Catholic Univ Korea, Seoul St Marys Hosp, Int Healthcare Ctr, Coll Med, Seoul, South Korea; [Lee, Eun Ji] Soonchunhyang Univ, Seoul Hosp, Dept Radiol, Seoul, South Korea; [Kwon, Oh Deog] Republic Korea Navy 2nd Fleet Med Corps, Pyeongtaek Si, Gyeonggi Do, South Korea; [Kim, Yongsung; Jeong, Hae-Bong] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Soonchunhyang University; Chung Ang University; Chung Ang University Hospital	Jeong, HB (corresponding author), Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea.	hbjeong315@gmail.com		Kim, Yongsung/0000-0001-6347-763X; Jeong, HaeBong/0000-0002-4937-288X; Kim, Seung Jae/0000-0001-8885-7137	Korea Centers for Disease Control & Prevention, Republic of Korea [2020ER620200]	Korea Centers for Disease Control & Prevention, Republic of Korea	This research was supported by a fund (#2020ER620200) by the Korea Centers for Disease Control & Prevention, Republic of Korea (http://www.kdca.go.kr).	Adeoye O, 2009, AM J EMERG MED, V27, P141, DOI 10.1016/j.ajem.2008.02.004; Berglund A, 2017, MATURITAS, V99, P47, DOI 10.1016/j.maturitas.2017.02.007; Berglund A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007661; Copeland LA., 2020, ENEUROLOGICALSCI, V21, P100285, DOI [10.1016/j.ensci.2020.100285, DOI 10.1016/J.ENSCI.2020.100285]; Demaerschalk BM, 2016, STROKE, V47, P581, DOI 10.1161/STR.0000000000000086; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Evenson KR, 2009, INT J STROKE, V4, P187, DOI 10.1111/j.1747-4949.2009.00276.x; Faiz KW, 2014, J STROKE CEREBROVASC, V23, P534, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.007; Faiz KW, 2013, EMERG MED J, V30, P669, DOI 10.1136/emermed-2012-201543; Fang J, 2011, CLIN NEUROL NEUROSUR, V113, P85, DOI 10.1016/j.clineuro.2010.09.004; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Gibler WB, 2002, ANN EMERG MED, V39, P123, DOI 10.1067/mem.2002.121402; Gorelick PB, 2013, J STROKE, V15, P78, DOI 10.5853/jos.2013.15.2.78; Jin HQ, 2012, STROKE, V43, P362, DOI 10.1161/STROKEAHA.111.623512; Jorgensen HS, 1996, NEUROLOGY, V47, P383, DOI 10.1212/WNL.47.2.383; Kang DW, 2012, STROKE, V43, P3278, DOI 10.1161/STROKEAHA.112.675926; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kim J, 2019, GERIATR GERONTOL INT, V19, P352, DOI 10.1111/ggi.13615; Kim YJ, 2016, INT J STROKE, V11, P212, DOI 10.1177/1747493015616513; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Kwon YD, 2010, EUR NEUROL, V64, P207, DOI 10.1159/000319176; la Rosa FD, 2012, STROKE, V43, P1591, DOI 10.1161/STROKEAHA.111.645986; Lees KR, 2002, LANCET NEUROL, V1, P41, DOI 10.1016/S1474-4422(02)00005-4; Leon-Jimenez C, 2014, NEUROLOGIA, V29, P200, DOI 10.1016/j.nrl.2013.05.003; Madsen TE, 2016, J STROKE CEREBROVASC, V25, P504, DOI 10.1016/j.jstrokecerebrovasdis.2015.10.026; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Matsuo R, 2017, STROKE, V48, P3049, DOI 10.1161/STROKEAHA.117.018132; Naganuma M, 2009, CEREBROVASC DIS, V28, P33, DOI 10.1159/000215941; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Rosamond WD, 1998, ACAD EMERG MED, V5, P45, DOI 10.1111/j.1553-2712.1998.tb02574.x; Rossnagel K, 2004, ANN EMERG MED, V44, P476, DOI 10.1016/j.annemergmed.2004.06.019; Smith MA, 1998, ANN INTERN MED, V129, P190, DOI 10.7326/0003-4819-129-3-199808010-00005; Smith MA, 2010, STROKE, V41, P905, DOI 10.1161/STROKEAHA.110.578112; Song D, 2015, J STROKE, V17, P159, DOI 10.5853/jos.2015.17.2.159; Tong D, 2012, STROKE, V43, P1912, DOI 10.1161/STROKEAHA.111.644963; Turan Tanya N, 2005, J Stroke Cerebrovasc Dis, V14, P272, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.002; Wouters A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00153	38	4	4	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0247829	10.1371/journal.pone.0247829	http://dx.doi.org/10.1371/journal.pone.0247829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765030	gold, Green Published			2022-12-26	WOS:000634832800086
J	Pobee, RA; Setorglo, J; Klevor, M; Murray-Kolb, LE				Pobee, Ruth A.; Setorglo, Jacob; Klevor, Moses; Murray-Kolb, Laura E.			The prevalence of anemia and iron deficiency among pregnant Ghanaian women, a longitudinal study	PLOS ONE			English	Article							NATIONAL-HEALTH	Background Gestational iron deficiency (ID) can be deleterious to mother and fetus. However, iron status is not routinely measured during pregnancy in Ghana. Therefore, the scope of ID in this population is unknown. Objective To determine the prevalence of anemia and ID across pregnancy in the Central Region of Ghana. Methods Women were recruited during their 1(st) trimester of pregnancy (< 13 weeks; n = 116) and followed through to their 2(nd) (n = 71) and 3(rd) (n = 71) trimesters. Data on socio-demographic variables, weekly intake of iron-rich foods and vitamin C-rich fruits were collected. Blood samples were drawn and the concentrations of hemoglobin (Hb), ferritin (Ft), serum iron (sFe), total iron binding capacity (TIBC), were measured; transferrin saturation (TSAT) was calculated. Repeated measures ANOVA was used to determine change in anemia and iron variables over time with groups categorized by 1(st) trimester iron status. Results Participants were 27.1 +/- 5.2 years, on average. Prevalence of anemia (Hb <11.0 g/dL) was 37%, 63%, 58%; ID (Ft <15 mu g/L) was 16%, 20%, 38%; and iron deficiency anemia (IDA; based on low Ft and Hb) was 6%, 12%, 25% in 1(st), 2(nd) and 3(rd) trimesters, respectively. Significant changes in Hb, Ft and TIBC occurred across time. Iron status at 1(st) trimester had a significant effect on 2(nd) but not 3(rd) trimester iron status. Conclusions ID is prevalent in pregnant Ghanaian women, especially during the 3(rd) trimester. Anemia is a major public health problem during pregnancy in Ghana with a significant proportion due to factors other than ID.	[Pobee, Ruth A.; Murray-Kolb, Laura E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Setorglo, Jacob; Klevor, Moses] Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cape Coast	Murray-Kolb, LE (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	lem118@psu.edu		JACOB, SETORGLO/0000-0002-2691-1764; Murray-Kolb, Laura/0000-0002-5836-9471	College of Health and Human Development Pilot; Pennsylvania State University; Africana Research Center; American Association of University Women (AAUW)	College of Health and Human Development Pilot; Pennsylvania State University; Africana Research Center; American Association of University Women (AAUW)	This research was funded by the College of Health and Human Development Pilot Funding (https://hhd.psu.edu), The Pennsylvania State University, a grant from the Africana Research Center (https://arc.la.psu.edu), The Pennsylvania State University and The American Association of University Women (AAUW) (https://www.aauw.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Alper BS, 2000, J FAM PRACTICE, V49, P829; [Anonymous], 2014, GHAN DEM HLTH SURV; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; DAOUDA H, 1991, INT J VITAM NUTR RES, V61, P46; Engmann C, 2008, INT J GYNECOL OBSTET, V101, P62, DOI 10.1016/j.ijgo.2007.09.032; Heinbuch U, 1994, PROGRAMME INTEGR DEV, V39; HUEBERS HA, 1987, CLIN CHEM, V33, P273; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Mei ZG, 2011, AM J CLIN NUTR, V93, P1312, DOI 10.3945/ajcn.110.007195; Miller EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112216; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Obirikorang C., 2015, British Journal of Medicine and Medical Research, V6, P823, DOI 10.9734/BJMMR/2015/14786; Osungbade KO, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/454601; Park CY, 2014, J ACAD NUTR DIET, V114, P1967, DOI 10.1016/j.jand.2014.04.025; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Scholl TO, 2000, J NUTR, V130, p443S, DOI 10.1093/jn/130.2.443S; SPRING, 2016, GHAN LANDSC AN AN PR, V64; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Stoltzfus RJ., 1999, GUIDELINES USE IRON; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S	24	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248754	10.1371/journal.pone.0248754	http://dx.doi.org/10.1371/journal.pone.0248754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760869	Green Published, gold			2022-12-26	WOS:000633030400012
J	Manze, MG; Romero, DR; De, P; Hartnett, J; Roberts, L				Manze, Meredith G.; Romero, Diana R.; De, Prabal; Hartnett, Josette; Roberts, Lynn			The association of pregnancy control, emotions, and beliefs with pregnancy desires: A new perspective on pregnancy intentions	PLOS ONE			English	Article							UNINTENDED PREGNANCY; REPRODUCTIVE HEALTH; PRIMARY-CARE; BLACK-WOMEN; AMBIVALENCE; PROTECTION; CONSTRUCT; HAPPINESS; RISK	Context Standard pregnancy intentions measures do not always align with how people approach pregnancy. Studies that have investigated beyond a binary framework found that those with "ambivalent" feelings towards pregnancy are less likely to use contraception consistently, but the reasons for this are unclear. We sought to gain a nuanced understanding of pregnancy desires, and how perceptions about pregnancy are associated with contraceptive use. Methods We used non-probability quota sampling based on sex, age, and geographic region for a web-based survey of heterosexual men and women, aged 21-44 years, who could become pregnant/impregnate and were not currently pregnant (n = 1,477; 51% female). The survey was created using unique items informed by recent literature. Bivariate and multivariable analyses explored relationships between various perceptions about pregnancy with pregnancy desires categorized as: wanting a pregnancy, not wanting a pregnancy, and not trying but would be okay with a pregnancy. We conducted a sub-group analysis of those who were not trying but would be okay with a pregnancy (n = 460), using descriptive statistics to examine how consistent contraceptive use was associated with emotions and beliefs about avoiding pregnancy. Results After adjustment, those who felt that pregnancy may not always be avoidable, but instead determined by fate/higher power, or a natural process that happens when it is meant to, were significantly more likely (aOR: 1.83, 95% CI: 1.05-3.36; aOR: 2.21, 95% CI: 1.29-3.76, respectively) to report not trying but being okay with pregnancy, whereas those with negative feelings about a pregnancy were less likely to feel okay about a pregnancy (aOR: 0.11, 95% CI: 0.08-0.15), versus not wanting a pregnancy. In the sub-group analysis, those who felt pregnancy was determined by fate/higher power or a natural process were more likely to report not using contraception consistently (70%, 68%, respectively). Conclusions Those who state they are not trying but would be okay with pregnancy may not use contraception consistently because of beliefs that pregnancy is predetermined. Our findings support less categorical and more multidimensional approaches to measuring fertility intentions, with important implications for reproductive health service provision.	[Manze, Meredith G.; Romero, Diana R.; Roberts, Lynn] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Community Hlth & Social Sci, New York, NY 10021 USA; [De, Prabal] CUNY, Grad Ctr, Econ Program, New York, NY USA; [De, Prabal] CUNY City Coll, Dept Econ & Business, New York, NY USA; [Hartnett, Josette] Stamford Hosp, Off Res & Clin Trials, Stamford, CT USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY); Stamford Hospital	Manze, MG (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Community Hlth & Social Sci, New York, NY 10021 USA.	Meredith.manze@sph.cuny.edu	Hartnett, Josette/ADT-6095-2022	Hartnett, Josette/0000-0002-7475-4265; Manze, Meredith/0000-0002-0768-9467; De, Prabal/0000-0002-0043-3207	City University of New York (CUNY) Graduate School of Public Health and Health Policy	City University of New York (CUNY) Graduate School of Public Health and Health Policy	Author: MGM Grant Number: N/A Mechanism: Dean's Mentored Research Award grant Funder: City University of New York (CUNY) Graduate School of Public Health and Health Policy The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken ARA, 2016, PERSPECT SEX REPRO H, V48, P147, DOI 10.1363/48e10316; Aiken ARA, 2015, SOC SCI MED, V132, P149, DOI 10.1016/j.socscimed.2015.03.038; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Bellanca HK, 2013, CONTRACEPTION, V88, P3, DOI 10.1016/j.contraception.2013.05.003; Blake SM, 2007, PERSPECT SEX REPRO H, V39, P194, DOI 10.1363/3919407; Borrero S, 2015, CONTRACEPTION, V91, P150, DOI 10.1016/j.contraception.2014.09.014; Campbell A A, 2000, Matern Child Health J, V4, P163, DOI 10.1023/A:1009519329226; Carter MW, 2012, AM J PUBLIC HEALTH, V102, P449, DOI 10.2105/AJPH.2011.300461; Daniels Kimberly, 2014, NCHS Data Brief, P1; Ewing AC, 2017, CONTEMP CLIN TRIALS, V54, P1, DOI 10.1016/j.cct.2016.12.014; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Gilliam ML, 2009, J PEDIATR ADOL GYNEC, V22, P97, DOI 10.1016/j.jpag.2008.05.008; Gomez AM, 2019, PERSPECT SEX REPRO H, V51, P7, DOI 10.1363/psrh.12088; Gomez AM, 2018, WOMEN HEALTH ISS, V28, P408, DOI 10.1016/j.whi.2018.07.001; Higgins JA, 2012, PERSPECT SEX REPRO H, V44, P236, DOI 10.1363/4423612; Jones HE, 2020, CONTRACEPTION, V101, P226, DOI 10.1016/j.contraception.2019.12.003; Jones J, 2012, 55 NAT HLTH STAT; Kottke M, 2015, J PEDIATR ADOL GYNEC, V28, P543, DOI 10.1016/j.jpag.2015.04.008; Lopez Iris, 2008, MATTERS CHOICE PUERT; Luker KC, 1999, FAM PLANN PERSPECT, V31, P248, DOI 10.2307/2991574; Macleod CI, 2016, J PUBLIC HEALTH-UK, V38, pE384, DOI 10.1093/pubmed/fdv123; Manze MG, 2020, ETHNIC DIS, V30, P525, DOI 10.18865/ed.30.4.525; Manze MG, 2020, CONTRACEPTION, V101, P91, DOI 10.1016/j.contraception.2019.11.004; Manze MG, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0793-7; McQuillan J, 2011, MATERN CHILD HLTH J, V15, P178, DOI 10.1007/s10995-010-0604-9; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Mumford SL, 2016, FERTIL STERIL, V106, P1453, DOI 10.1016/j.fertnstert.2016.07.1067; Novak NL, 2018, AM J PUBLIC HEALTH, V108, P611, DOI 10.2105/AJPH.2018.304369; Orr ST, 2008, ANN EPIDEMIOL, V18, P545, DOI 10.1016/j.annepidem.2008.03.005; Paterno MT, 2017, J RACIAL ETHN HEALTH, V4, P184, DOI 10.1007/s40615-016-0217-0; Potter JE, 2019, CONTRACEPTION, V100, P1, DOI 10.1016/j.contraception.2019.02.005; Roberts Dorothy., 1998, KILLING BLACK BODY; Rocca CH, 2019, MED CARE, V57, P152, DOI 10.1097/MLR.0000000000001048; Sable M R, 2000, Matern Child Health J, V4, P191, DOI 10.1023/A:1009527631043; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schwarz EB, 2007, CONTRACEPTION, V75, P305, DOI 10.1016/j.contraception.2006.12.002; Schwarz EB, 2012, ANN FAM MED, V10, P516, DOI 10.1370/afm.1404; Tone A, 2008, CONTROLLING REPROD A; Whaley AL, 2003, J NATL MED ASSOC, V95, P702	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0249032	10.1371/journal.pone.0249032	http://dx.doi.org/10.1371/journal.pone.0249032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755705	Green Published, gold			2022-12-26	WOS:000632916600049
J	Blackberg, A; Fernstrom, N; Sarbrant, E; Rasmussen, M; Sunnerhagen, T				Blackberg, Anna; Fernstrom, Nils; Sarbrant, Emma; Rasmussen, Magnus; Sunnerhagen, Torgny			Antibody kinetics and clinical course of COVID-19 a prospective observational study	PLOS ONE			English	Article								Background Serological response and association to clinical manifestation is important for understanding the pathogenesis of COVID-19. Materials and methods A prospective observational study was conducted where antibody responses of IgG and IgA towards SARS-CoV-2 spike protein were studied over time in patients with COVID-19. Possible associations between antibody titers and outcome were analyzed. Results Forty patients with COVID-19, hospitalized at Skane University hospital, Sweden, between April and June 2020 were included. IgG antibody responses were detected for all patients with the highest levels four weeks after COVID-19 diagnosis. Levels of IgA were generally higher at diagnosis and decreased towards baseline 4 weeks after confirmed COVID-19. Patients with severe COVID-19 had higher levels of antibodies directed against SARS-CoV-2 spike protein compared with patients with mild disease. Conclusion IgG and IgA antibodies towards the spike protein follow different kinetics during COVID-19 and patients with severe disease develop higher antibody levels.	[Blackberg, Anna; Fernstrom, Nils; Sarbrant, Emma; Rasmussen, Magnus; Sunnerhagen, Torgny] Lund Univ, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden; [Blackberg, Anna; Rasmussen, Magnus] Skane Univ Hosp, Clin Infect Dis, Lund, Sweden; [Sunnerhagen, Torgny] Reg Skane, Off Med Serv, Dept Clin Microbiol, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Blackberg, A (corresponding author), Lund Univ, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden.; Blackberg, A (corresponding author), Skane Univ Hosp, Clin Infect Dis, Lund, Sweden.	anna.blackberg@med.lu.se	Sunnerhagen, Torgny/C-1148-2015	Sunnerhagen, Torgny/0000-0002-9240-2378; Blackberg, Anna/0000-0003-2778-5314; Rasmussen, Magnus/0000-0003-1588-5473	Royal Physiographic Society of Lund [41252]; Sigurd and Elsa Golje Foundation [LA2020-0189]; Swedish Government Funds for Clinical Research (ALF)	Royal Physiographic Society of Lund; Sigurd and Elsa Golje Foundation; Swedish Government Funds for Clinical Research (ALF)	TS received grants from the Royal Physiographic Society of Lund (grant number: 41252) and from Sigurd and Elsa Golje Foundation (grant number: LA2020-0189). AB received grant from the Swedish Government Funds for Clinical Research (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Chao YX, 2020, BRAIN BEHAV IMMUN, V87, P182, DOI 10.1016/j.bbi.2020.05.057; Esakandari H, 2020, BIOL PROCED ONLINE, V22, DOI 10.1186/s12575-020-00128-2; Figueiredo-Campos P, 2020, EUR J IMMUNOL, V50, P2025, DOI 10.1002/eji.202048970; Hagman K, 2021, CLIN INFECT DIS, V73, pE2995, DOI 10.1093/cid/ciaa1285; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Liu XM, 2020, EMERG MICROBES INFEC, V9, P1269, DOI 10.1080/22221751.2020.1773324; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lou B, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00763-2020; Marklund E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241104; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Senneby E, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.005; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515; Ujike M, 2015, VIRUSES-BASEL, V7, P1700, DOI 10.3390/v7041700; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang YQ, 2020, J CLIN INVEST, V130, P5235, DOI [10.1172/JCI138759., 10.1172/JCI138759]; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11	23	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248918	10.1371/journal.pone.0248918	http://dx.doi.org/10.1371/journal.pone.0248918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750984	gold, Green Published			2022-12-26	WOS:000631967100031
J	Li, J; Song, CL; Wang, T; Ye, YL; Du, JR; Li, SH; Zhu, JM				Li, Jian; Song, Can-Lei; Wang, Tang; Ye, Yu-Long; Du, Jian-Ru; Li, Shu-Hua; Zhu, Jian-Min			Etiological and epidemiological characteristics of severe acute respiratory infection caused by multiple viruses and Mycoplasma pneumoniae in adult patients in Jinshan, Shanghai: A pilot hospital-based surveillance study	PLOS ONE			English	Article								Background Severe acute respiratory infection (SARI) results in a tremendous disease burden worldwide. Available research on active surveillance among hospitalized adult patients suffering from SARI in China is limited. This pilot study aimed to identify associated etiologies and describe the demographic, epidemiological and clinical profiles of hospitalized SARI patients aged over 16 years in Jinshan, Shanghai. Methods Active surveillance was conducted at 1 sentinel hospital in Jinshan district, Shanghai, from April 2017 to March 2018. Hospitalized SARI patients aged over 16 years old were enrolled, and nasopharyngeal swabs were collected within 24 hours of admission and tested for multiple respiratory viruses (including 18 common viruses) and Mycoplasma pneumoniae with real-time polymerase chain reaction. Demographic, epidemiological and clinical information was obtained from case report forms. Results In total, 397 SARI patients were enrolled; the median age was 68 years, and 194 (48.9%) patients were male. A total of 278 (70.0%) patients had at least one underlying chronic medical condition. The most frequent symptoms were cough (99.2%) and sputum production (88.4%). The median duration of hospitalization was 10 days. A total of 250 infection patients (63.0%) were positive for at least one pathogen, of whom 198 (49.9%) were positive for a single pathogen and 52 (13.1%) were positive for multiple pathogens. The pathogens identified most frequently were M. pneumoniae (23.9%, 95/397), followed by adenovirus (AdV) (11.6%, 46/397), influenza virus A/H3N2 (Flu A/H3N2) (11.1%, 44/397), human rhinovirus (HRhV) (8.1%, 32/397), influenza virus B/Yamagata (Flu B/Yamagata) (6.3%, 25/397), pandemic influenza virus A/H1N1 (Flu A/pH1N1) (4.0%, 16/397), parainfluenza virus (PIV) type 1 (2.0%, 8/397), human coronavirus (HCoV) type NL63 (2.0%, 8/397), HCoV 229E (1.5%, 6/397), HCoV HKU1 (1.5%, 6/397), PIV 3 (1.5%, 6/397), human metapneumovirus (HMPV) (1.5%, 6/397), PIV 4 (1.3%, 5/397), HCoV OC43 (1.0%, 4/397), influenza virus B/Victoria (Flu B/Victoria) (0.5%, 2/397), respiratory syncytial virus (RSV) type B (0.5%, 2/397), and human bocavirus (HBoV) (0.3%, 1/397). The seasonality of pathogen-confirmed SARI patients had a bimodal distribution, with the first peak in the summer and the second peak in the winter. Statistically significant differences were observed with respect to the rates of dyspnea, radiographically diagnosed pneumonia and the presence of at least one comorbidity in patients who were infected with only M. pneumoniae, AdV, HRhV, Flu A/H3N2, Flu A /pH1N1 or Flu B/Yamagata. The differences in the positivity rates of the above 6 pathogens among the different age groups were nonsignificant. Conclusions M. pneumoniae, AdV and Flu A/H3N2 were the main pathogens detected in hospitalized SARI patients aged over 16 years old in Jinshan district, Shanghai. Our findings highlight the importance of sustained multipathogen surveillance among SARI patients in sentinel hospitals, which can provide useful information on SARI etiologies, epidemiology, and clinical characteristics.	[Li, Jian] Shanghai Jiao Tong Univ, Ruijin Hosp, Clin Res Ctr, Sch Med, Shanghai, Peoples R China; [Song, Can-Lei; Wang, Tang; Li, Shu-Hua; Zhu, Jian-Min] Jinshan Dist Ctr Dis Control & Prevent, Dept Acute Infect Dis Control, Shanghai, Peoples R China; [Ye, Yu-Long; Du, Jian-Ru] Jinshan Dist Ctr Dis Control & Prevent, Dept Microbiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Li, J (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Clin Res Ctr, Sch Med, Shanghai, Peoples R China.; Zhu, JM (corresponding author), Jinshan Dist Ctr Dis Control & Prevent, Dept Acute Infect Dis Control, Shanghai, Peoples R China.	nclijian@163.com; zhujm12@163.com			Research Project of Shanghai Municipal Health Commission [201940428]; Infectious Disease and Epidemiology Project of the 6th Jinshan District Medical Key Specialty Construction [JSZK2019B05]	Research Project of Shanghai Municipal Health Commission; Infectious Disease and Epidemiology Project of the 6th Jinshan District Medical Key Specialty Construction	This work was supported by the Research Project of Shanghai Municipal Health Commission (201940428) for Can-Lei Song and the Infectious Disease and Epidemiology Project of the 6th Jinshan District Medical Key Specialty Construction (JSZK2019B05) for Shu-Hua Li. The funder had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	[Anonymous], 2020, MAN LAB DIAGN VIV SO; [Anonymous], 2020, WHO GLOB TECHN CONS; [Anonymous], 2020, JINSH STAT YB 2018; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Butsashvili Maia, 2012, Influenza Res Treat, V2012, P480763, DOI 10.1155/2012/480763; Byington CL, 2004, PEDIATRICS, V113, P1662, DOI 10.1542/peds.113.6.1662; Chakhunashvili G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201497; Costa C, 2011, ARCH VIROL, V156, P1439, DOI 10.1007/s00705-011-0986-z; Elhakim MM, 2020, J PUBLIC HEALTH-UK, V42, P525, DOI 10.1093/pubmed/fdz053; Fica A, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.1; FOY HM, 1973, AM J EPIDEMIOL, V97, P93, DOI 10.1093/oxfordjournals.aje.a121493; Goktas S, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.39132; Hasman H, 2009, J MED MICROBIOL, V58, P408, DOI 10.1099/jmm.0.006098-0; Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Louie JK, 2005, CLIN INFECT DIS, V41, P262, DOI 10.1086/430915; Lui G, 2009, RESPIROLOGY, V14, P1098, DOI 10.1111/j.1440-1843.2009.01637.x; Meerhoff TJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0722-x; Mikulska M, 2014, ANN HEMATOL, V93, P669, DOI 10.1007/s00277-013-1912-0; Nguenha N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194138; Razanajatovo Norosoa Harline, 2018, PLoS One, V13, pe0205124, DOI 10.1371/journal.pone.0205124; Subramoney K, 2018, HEALTH SCI REP-US, V1, DOI 10.1002/hsr2.59; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Waites KB, 2017, CLIN MICROBIOL REV, V30, P747, DOI 10.1128/CMR.00114-16; WALD TG, 1995, ANN INTERN MED, V123, P588, DOI 10.7326/0003-4819-123-8-199510150-00004; Wang KQ, 2017, J THORAC DIS, V9, P4502, DOI [10.21037/jtd.2018.11.11, 10.21037/jtd.2017.10.107]; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, GLOBAL BURDEN DIS; Xu WT, 2018, JPN J INFECT DIS, V71, P134, DOI [10.7883/yoken.jjid.2017.412, 10.7883/yoken.JJID.2017.412]; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205; Zhang Y, 2018, EMERG INFECT DIS, V24, P2098, DOI 10.3201/eid2411.171410; Zhao YJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4385-5	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248750	10.1371/journal.pone.0248750	http://dx.doi.org/10.1371/journal.pone.0248750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750952	gold, Green Published			2022-12-26	WOS:000631967100009
J	Labiris, G; Panagiotopoulou, EK; Perente, A; Chatzimichael, E; Fotiadis, I; Taliantzis, S; Konstantinidis, A; Dardabounis, D				Labiris, Georgios; Panagiotopoulou, Eirini-Kanella; Perente, Asli; Chatzimichael, Eleftherios; Fotiadis, Ioannis; Taliantzis, Sergios; Konstantinidis, Aristeidis; Dardabounis, Doukas			Determinants of compliance to the facemask directive in Greece: A population study	PLOS ONE			English	Article							CARE	Purpose Primary objective of this study was to identify potential difficulties and/or discomfort when using a facemask. Moreover, to explore the impact of spectacles, contact lenses and visual acuity on the compliance to the facemask directive. Methods This is a prospective study that was conducted at the Department of Ophthalmology, University Hospital of Alexandroupolis, Greece between June 2020 and August 2020. Greek speaking citizens with permanent residency in Greece above 18 years old were included. A custom questionnaire (DeMask-20) was constructed and validated, which pertained to the perceived difficulty and discomfort when using a facemask. It contained 20 items grouped in 8 subscales (driving, near vision, distance vision, ocular discomfort, role limitation, collaboration, dependency on others, emotional stress). Perceived difficulty and discomfort when using a facemask, compliance and correlations of compliance with DeMask-20 scores, demographics, spectacle and/or contact lens use, and visual acuity were evaluated. Results The number of factors was determined through factor analysis. Cronbach's alpha ranged from 0.716 for the "Role limitation" subscale to 0.938 for "Ocular discomfort" subscale. 1,214 participants (402 men, 812 women, mean age 36.79 +/- 12.50 years) completed the DeMask-20 instrument. Mean DeMask-20 score of all study participants was 3.79 +/- 0.71. Significant differences in DeMask-20 score were detected in gender (p = 0.009), spectacle use (p = 0.034), contact lens use (p = 0.049), and binocular distance visual acuity (bDVA) (p = 0.001). Mean compliance of all participants was 4.05 +/- 0.96. Men, people <50 years and spectacle wearers showed significantly worse compliance (p<0.05). Moreover, professional workers and professional drivers demonstrated significantly better compliance (p = 0.008 and p = 0.047). Significant correlation was detected between compliance and DeMask-20 score (p<0.001, R-2 = 0.471). Significant correlations were detected with driving, near vision, distance vision, collaboration, role limitation, emotional stress (p<0.05, R-2: 0.386-0.493). Conclusions Factor analysis suggested that the DeMask-20 instrument demonstrates adequate validity, while Cronbach's alpha indicated sufficient internal consistency of all subscales. This study provided the necessary methods that could evaluate compliance trends and the efficacy of healthcare interventions against COVID-19. Our outcomes suggest that young males who use spectacles should be targeted by Greek Healthcare authorities in order to improve compliance rates.	[Labiris, Georgios; Panagiotopoulou, Eirini-Kanella; Perente, Asli; Chatzimichael, Eleftherios; Fotiadis, Ioannis; Taliantzis, Sergios; Konstantinidis, Aristeidis; Dardabounis, Doukas] Univ Hosp Alexandroupolis, Dept Ophthalmol, Dragana, Alexandroupolis, Greece		Labiris, G (corresponding author), Univ Hosp Alexandroupolis, Dept Ophthalmol, Dragana, Alexandroupolis, Greece.	labiris@usa.net	Konstantinidis, Aristeidis/AFG-8241-2022	Konstantinidis, Aristeidis/0000-0001-5419-956X; Panagiotopoulou, Eirini - Kanella/0000-0003-0826-3959; Labiris, Georgios/0000-0003-4364-1943; Chatzimichael, Eleftherios/0000-0003-4283-5260				[Anonymous], COVID 19 COR PAND; Bothra A, 2020, J EUR ACAD DERMATOL, V34, pE549, DOI 10.1111/jdv.16692; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; Chou R, 2020, ANN INTERN MED, V173, P542, DOI 10.7326/M20-3213; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Chughtai AA, 2016, ANN OCCUP HYG, V60, P619, DOI 10.1093/annhyg/mew008; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI DOI 10.1016/j.idm.2020.04.001; Esposito S, 2020, EUR J PEDIATR, V179, P1267, DOI 10.1007/s00431-020-03674-9; European Centre for Disease Prevention and Control, 2020, DOWNL HIST DAT 14 DE; Farrand KF, 2017, AM J OPHTHALMOL, V182, P90, DOI 10.1016/j.ajo.2017.06.033; Field A, 2013, DISCOVERING STAT USI; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Greek National Public Health Organization, COVID 19 SURV REP; Greenhalgh T, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1435; Javid B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1442; King FM, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2009; Lim ECH, 2006, ACTA NEUROL SCAND, V113, P199, DOI 10.1111/j.1600-0404.2005.00560.x; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Martel J, 2013, AM J INFECT CONTROL, V41, P14, DOI 10.1016/j.ajic.2011.12.019; Martin GP, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2017; Morishima M, 2018, WORK, V61, P303, DOI 10.3233/WOR-182801; Moshirfar M, 2020, OPHTHALMOL THER, V9, P397, DOI 10.1007/s40123-020-00282-6; Ong JJY, 2020, HEADACHE, V60, P864, DOI 10.1111/head.13811; Rebmann T, 2013, AM J INFECT CONTROL, V41, P1218, DOI 10.1016/j.ajic.2013.02.017; Sim SW, 2014, SINGAP MED J, V55, P160; Snedecor GW., 2013, STAT METHODS 8, V146; Solomou I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144924; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; WHO, 2020, RISK ASSESSMENT MANA	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248929	10.1371/journal.pone.0248929	http://dx.doi.org/10.1371/journal.pone.0248929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740025	gold, Green Published			2022-12-26	WOS:000631030200045
J	Shaharir, SS; Chua, SH; Mohd, R; Mustafar, R; Noh, MM; Shahril, NS; Said, MSM; Rajalingham, S				Shaharir, Syahrul Sazliyana; Chua, Siew Huoy; Mohd, Rozita; Mustafar, Ruslinda; Noh, Malehah Mohd; Shahril, Nor Shuhaila; Said, Mohd Shahrir Mohamed; Rajalingham, Sakthiswary			Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort	PLOS ONE			English	Article								Avascular necrosis of bone (AVN) is increasingly being recognized as a complication of SLE and causes significant disability due to pain and mobility limitations. We studied the prevalence and factors associated with avascular necrosis (AVN) in a multiethnic SLE cohort. SLE patients who visited the outpatient clinic from October 2017 to April 2019 were considered eligible. Their medical records were reviewed to identify patients who developed symptomatic AVN, as confirmed by either magnetic resonance imaging or plain radiography. Subsequently, their SLE disease characteristics and treatment were compared with the characteristics of patients who did not have AVN. Multivariable logistic regression analyses were performed to determine the independent factors associated with AVN among the multiethnic SLE cohort. A total of 390 patients were recruited, and the majority of them were females (92.6%); the patients were predominantly of Malay ethnicity (59.5%), followed by Chinese (35.9%) and Indian (4.6%). The prevalence of symptomatic AVN was 14.1%, and the mean age of AVN diagnosis was 37.6 +/- 14.4 years. Both univariate and multivariable logistic regression analyses revealed that a longer disease duration, high LDL-C (low density lipoprotein cholesterol), positive anti-cardiolipin (aCL) IgG and anti-dsDNA results, a history of an oral prednisolone dose of more than 30 mg daily for at least 4 weeks and osteoporotic fractures were significantly associated with AVN. On the other hand, hydroxychloroquin (HCQ), mycophenolate mofetil (MMF) and bisphosphonate use were associated with a lower risk of AVN. No associations with ethnicity were found. In conclusion, several modifiable risk factors were found to be associated with AVN, and these factors may be used to identify patients who are at high risk of developing such complications. The potential protective effects of HCQ, MMF and bisphosphonates warrant additional studies.	[Shaharir, Syahrul Sazliyana; Said, Mohd Shahrir Mohamed; Rajalingham, Sakthiswary] Univ Kebangsaan Malaysia, Dept Internal Med, Rheumatol Unit, Med Ctr UKMMC, Kuala Lumpur, Malaysia; [Chua, Siew Huoy] Int Med Univ, Dept Internal Med, Kuala Lumpur, Malaysia; [Mohd, Rozita; Mustafar, Ruslinda] Univ Kebangsaan Malaysia, Dept Internal Med, Nephrol Unit, Med Ctr UKMMC, Kuala Lumpur, Malaysia; [Noh, Malehah Mohd] Univ Malaysia Sabah, Dept Med, Kota Kinabalu, Sabah, Malaysia; [Shahril, Nor Shuhaila] Putrajaya Hosp, Dept Med, Putrajaya, Malaysia	Universiti Kebangsaan Malaysia; International Medical University Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaysia Sabah	Shaharir, SS (corresponding author), Univ Kebangsaan Malaysia, Dept Internal Med, Rheumatol Unit, Med Ctr UKMMC, Kuala Lumpur, Malaysia.	sazliyana@ukm.edu.my	Sakthiswary, Rajalingham/E-8565-2017		Fundamental Research Grant Scheme, Ministry of Education Malaysia [FRGS/1/2018/SKK02/UKM/03/1]	Fundamental Research Grant Scheme, Ministry of Education Malaysia	SSS received financial grant from the Fundamental Research Grant Scheme, Ministry of Education Malaysia (FRGS/1/2018/SKK02/UKM/03/1).	Abbott KC, 2002, KIDNEY INT, V62, P2250, DOI 10.1046/j.1523-1755.2002.00667.x; ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; Agarwala S, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1152-7; Al Saleh Jamal, 2010, Egypt J Immunol, V17, P29; ASHERSON RA, 1993, J RHEUMATOL, V20, P284; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Blazer A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182483; Buckley L, 2017, ARTHRITIS RHEUMATOL, V69, P1521, DOI 10.1002/art.40137; Campbell S, 2009, CANCER-AM CANCER SOC, V115, P4127, DOI 10.1002/cncr.24474; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chan K L, 2012, Open Orthop J, V6, P449, DOI 10.2174/1874325001206010449; Cozen L, 1998, Am J Orthop (Belle Mead NJ), V27, P352; DIMANT J, 1978, J RHEUMATOL, V5, P136; DUBOIS EL, 1960, JAMA-J AM MED ASSOC, V174, P966, DOI 10.1001/jama.1960.03030080028005; Fardet L, 2017, CLIN EPIDEMIOL, V9, P545, DOI 10.2147/CLEP.S143563; FELSON DT, 1987, LANCET, V1, P902; Felten R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212931; Fialho SCMS, 2007, LUPUS, V16, P239, DOI 10.1177/0961203307076771; Friedman DJ, 2021, CLIN J AM SOC NEPHRO, V16, P294, DOI 10.2215/CJN.15161219; Gladman DD, 2001, J RHEUMATOL, V28, P761; Golder V, 2013, LUPUS, V22, P1425, DOI 10.1177/0961203313500547; Gurion R, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0008-x; Gurion R, 2013, ARTHRITIS RHEUM-US, V65, pS536; Hamza SMH, 2019, EGYPT RHEUMATOL, V41, P295, DOI 10.1016/j.ejr.2018.12.007; Jones AN., 2017, RHEUMATOLOGY, V56; LI XRQ., 2013, INT J RHEUM DIS, V16, P1; Mok CC, 1998, BRIT J RHEUMATOL, V37, P895; Mok MY, 2000, ANN RHEUM DIS, V59, P462, DOI 10.1136/ard.59.6.462; Mont MA, 1997, J RHEUMATOL, V24, P654; Nevskaya T, 2017, CLIN EXP RHEUMATOL, V35, P700; Olsen NJ, 2013, RHEUMATOL INT, V33, P2585, DOI 10.1007/s00296-013-2783-3; ONO K, 1992, CLIN ORTHOP RELAT R, P89; Paydas S, 2011, TRANSPL P, V43, P863, DOI 10.1016/j.transproceed.2011.02.072; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pritchett JW, 2001, CLIN ORTHOP RELAT R, P173; Rascu A, 1996, LUPUS, V5, P323, DOI 10.1177/096120339600500414; Ruiz-Arruza I, 2014, RHEUMATOLOGY, V53, P1470, DOI 10.1093/rheumatology/keu148; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Shaharir SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166270; Shigemura T, 2011, RHEUMATOLOGY, V50, P2023, DOI 10.1093/rheumatology/ker277; SMITH FE, 1976, ANN RHEUM DIS, V35, P227, DOI 10.1136/ard.35.3.227; Tektonidou MG, 2003, ARTHRITIS RHEUM-US, V48, P732, DOI 10.1002/art.10835; Tse SM, 2017, LUPUS, V26, P715, DOI 10.1177/0961203316676384; Uea-Areewongsa P, 2009, JCR-J CLIN RHEUMATOL, V15, P345, DOI 10.1097/RHU.0b013e3181ba3423; Wang T, 2016, INT J CLIN EXP MED, V9, P8085; Yang XY, 2007, PHARMAZIE, V62, P930, DOI 10.1691/ph.2007.12.7583; Yin JH, 2017, INT J CLIN EXP MED, V10, P10133; Yip K, 2019, ARTHRITIS RHEUMATOL, V71	48	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248845	10.1371/journal.pone.0248845	http://dx.doi.org/10.1371/journal.pone.0248845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739994	gold, Green Published			2022-12-26	WOS:000631030200021
J	Greiner, C; Grainger, S; Farrow, S; Davis, A; Su, JL; Saybolt, MD; Wilensky, R; Madden, S; Sum, ST				Greiner, Cherry; Grainger, Stephanie; Farrow, Samantha; Davis, Alena; Su, Jimmy L.; Saybolt, Matthew D.; Wilensky, Robert; Madden, Sean; Sum, Stephen T.			Robust quantitative assessment of collagen fibers with picrosirius red stain and linearly polarized light as demonstrated on atherosclerotic plaque samples	PLOS ONE			English	Article							MICROSCOPY; THICKNESS; SECTION	Collagen is an important component in maintaining structural integrity and functionality of tissues and is modulated in various biological processes. Its visualization and possible quantification using histopathological stains can be important for understanding disease progression or therapeutic response. Visualization of collagen fiber with the histological stain picrosirius red (PSR) is enhanced with polarized light and quantitative analysis is possible using circular polarizers. However, linear polarizers are more commonly available and easier to optically align. The objective of the present study is to demonstrate a novel image acquisition technique and analysis method using linearly polarized light. The proposed imaging technique is based on image acquisition at multiple slide rotation angles, which are co-registered to form a composite image used for quantitative analysis by pixel intensity or pixel counting. The technique was demonstrated on multiple human coronary samples with varying histopathologies and developed specifically to analyze cap collagen in atherosclerotic plaque. Pixel counting image analysis was found to be reproducible across serial tissue sections and across different users and sufficiently sensitive to detect differences in cap structural integrity that are likely relevant to prediction of rupture risk. The benefit of slide rotation angle under linear polarization to acquire images represents a feasible and practical implementation for expanding the general utility of PSR for quantitative analysis.	[Greiner, Cherry; Grainger, Stephanie; Farrow, Samantha; Sum, Stephen T.] Infraredx, Bedford, MA 01730 USA; [Davis, Alena] Cytiva, Marlborough, MA USA; [Su, Jimmy L.] Philips Healthcare, Cambridge, MA USA; [Saybolt, Matthew D.] Hackensack Meridian Jersey Shore Univ, Med Ctr, Neptune, NJ USA; [Wilensky, Robert] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Madden, Sean] Lumicell, Newton, MA USA	Philips; Philips Healthcare; Jersey Shore University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Greiner, C (corresponding author), Infraredx, Bedford, MA 01730 USA.	cgreiner@infraredx.com			Infraredx	Infraredx	Infraredx provided support in the form of salaries to authors but did not have an additional role in the study design, methods development, data collection or analysis, decision to publish or preparation of the manuscript. In addition to salaries, Infraredx provided funding for microscope parts, tissue samples, histology processing, and the fee for manuscript publication.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; BURLEIGH MC, 1992, ATHEROSCLEROSIS, V96, P71, DOI 10.1016/0021-9150(92)90039-J; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Cardoso L, 2014, ANN BIOMED ENG, V42, P415, DOI 10.1007/s10439-013-0855-x; Chamie D, 2011, CURR CARDIOVASC IMAG, V4, P276, DOI 10.1007/s12410-011-9090-8; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Drifka CR, 2016, J HISTOCHEM CYTOCHEM, V64, P519, DOI 10.1369/0022155416659249; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1982, HISTOCHEMISTRY, V74, P153, DOI 10.1007/BF00495061; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kini AS, 2017, J AM COLL CARDIOL, V69, P644, DOI 10.1016/j.jacc.2016.10.028; Libby P, 2003, AM J CARDIOL, V91, p4B, DOI 10.1016/S0002-9149(02)03267-8; Marcos-Garces V, 2017, J MICROSC-OXFORD, V267, P130, DOI 10.1111/jmi.12553; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Perree J, 2002, PHOTOCHEM PHOTOBIOL, V75, P68, DOI 10.1562/0031-8655(2002)075<0068:UAPRLN>2.0.CO;2; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rich L., BRAZ J MORPHOL SCI, V22, P97; Rittie L, 2017, METHODS MOL BIOL, V1627, P395, DOI 10.1007/978-1-4939-7113-8_26; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Vassiliadis E, 2013, AM J TRANSL RES, V5, P1; Waksman R., 2019, LANCET, DOI [10.1016/S0140-6736%2819%2931794-5, DOI 10.1016/S0140-6736%2819%2931794-5]; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Yagi Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S15	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248068	10.1371/journal.pone.0248068	http://dx.doi.org/10.1371/journal.pone.0248068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735190	gold, Green Published			2022-12-26	WOS:000631029700117
J	Skutschas, PP; Gvozdkova, VA; Averianov, AO; Lopatin, AV; Martin, T; Schellhorn, R; Kolosov, PN; Markova, VD; Kolchanov, VV; Grigoriev, DV; Kuzmin, IT; Vitenko, DD				Skutschas, Pavel P.; Gvozdkova, Vera A.; Averianov, Alexander O.; Lopatin, Alexey, V; Martin, Thomas; Schellhorn, Rico; Kolosov, Petr N.; Markova, Valentina D.; Kolchanov, Veniamin V.; Grigoriev, Dmitry, V; Kuzmin, Ivan T.; Vitenko, Dmitry D.			Wear patterns and dental functioning in an Early Cretaceous stegosaur from Yakutia, Eastern Russia	PLOS ONE			English	Article								Isolated stegosaurian teeth from the Early Cretaceous high-latitude (palaeolatitude estimate of N 62 degrees- 66.5 degrees) Teete locality in Yakutia (Eastern Siberia, Russia) are characterized by a labiolingually compressed, slightly asymmetrical and mesiodistally denticulated (9-14 denticles) crown, a pronounced ring-like cingulum, as well as a "complex network of secondary ridges". The 63 teeth (found during on-site excavation in 2012, 2017-2019 and screen-washing in 2017-2019) most likely belong to one species of a derived (stegosaurine) stegosaur. Most of the teeth exhibit a high degree of wear and up to three wear facets has been observed on a single tooth. The prevalence of worn teeth with up to three wear facets and the presence of different types of facets (including steeply inclined and groove-like) indicate the tooth-tooth contact and precise dental occlusion in the Teete stegosaur. The microwear pattern (mesiodistally or slightly obliquely oriented scratches; differently oriented straight and curved scratches on some wear facets) suggest a complex jaw mechanism with palinal jaw motion. Histological analysis revealed that the Teete stegosaur is characterized by relatively short tooth formation time (95 days) and the presence of a "wavy enamel pattern". Discoveries of a "wavy enamel pattern" in the Teete stegosaur, in a Middle Jurassic stegosaur from Western Siberia, and in the basal ceratopsian Psittacosaurus, suggest that this histological feature is common for different ornithischian clades, including ornithopods, marginocephalians, and thyreophorans. A juvenile tooth in the Teete sample indicates that stegosaurs were year-round residents and reproduced in high latitudes. The combination of high degree of tooth wear with formation of multiple wear facets, complex jaw motions, relatively short tooth formation time and possibly high tooth replacement rates is interpreted as a special adaptation for a life in high-latitude conditions or, alternatively, as a common stegosaurian adaptation making stegosaurs a successful group of herbivorous dinosaurs in the Middle Jurassic-Early Cretaceous and enabeling them to live in both low- and high-latitude ecosystems.	[Skutschas, Pavel P.; Gvozdkova, Vera A.; Markova, Valentina D.; Kolchanov, Veniamin V.; Grigoriev, Dmitry, V; Kuzmin, Ivan T.; Vitenko, Dmitry D.] St Petersburg State Univ, Vertebrate Zool Dept, Univ Skaya Emb 7-9, St Petersburg, Russia; [Averianov, Alexander O.] Russian Acad Sci, Zool Inst, Univ Skaya Emb 1, St Petersburg, Russia; [Lopatin, Alexey, V] Russian Acad Sci, Borissiak Paleontol Inst, Profsouznaya Ul 123, Moscow, Russia; [Martin, Thomas; Schellhorn, Rico] Rheinische Friedrich Wilhelms Univ Bonn, Inst Geosci, Sect Paleontol, Bonn, Germany; [Kolosov, Petr N.] Russian Acad Sci, Inst Diamond & Precious Met Geol, Siberian Branch, Yakutsk, Russia	Saint Petersburg State University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; University of Bonn; Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences	Skutschas, PP (corresponding author), St Petersburg State Univ, Vertebrate Zool Dept, Univ Skaya Emb 7-9, St Petersburg, Russia.	skutschas@mail.ru	Kolchanov, Veniamin/AGG-6111-2022; Kuzmin, Ivan/ABF-5127-2021; Skutschas, Pavel/D-5143-2013; Averianov, Alexander/M-8490-2013	Kolchanov, Veniamin/0000-0001-6644-3486; Kuzmin, Ivan/0000-0003-3086-2237; Skutschas, Pavel/0000-0001-8093-2905; Schellhorn, Rico/0000-0003-4890-3025; Grigoriev, Dmitry/0000-0002-3521-5402; Averianov, Alexander/0000-0001-5948-0799	Russian Foundation for Basic Research [17-54-12041-NNIO]; Deutsche Forschungsgemeinschaft (DFG) [MA 1643/221]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support was provided by the Russian Foundation for Basic Research (project 17-54-12041-NNIO) and the Deutsche Forschungsgemeinschaft (DFG grant MA 1643/221). The work of P.N.K. at the Diamond and Precious Metals Geology Institute, Siberian Branch of the Russian Academy of Sciences was carried out at the expense of government task financing.	Averianov A.O., 2009, Trudy Zoologicheskogo Instituta, V313, P153; Averianov Alexander, 2016, Global Geology - English Edition, V19, P187; Averianov A, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.019998, 10.1371/journal.pone.0199983]; Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; Averianov AO, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1762089; Averianov AO, 2020, LETHAIA, V53, P362, DOI 10.1111/let.12362; Barrett PM, 2001, LIFE O PAST, P25; Becerra MG., 2020, ACTA PALAEONTOL POL, V65, pXXX; Billon-Bruyat JP, 2010, SWISS J GEOSCI, V103, P143, DOI 10.1007/s00015-010-0028-y; Buffetaut E, 2004, PALAEOGEOGR PALAEOCL, V214, P225, DOI 10.1016/j.palaeo.2004.02.050; Chen J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205206; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Escaso F, 2007, NATURWISSENSCHAFTEN, V94, P367, DOI 10.1007/s00114-006-0209-8; Fiorillo AR, 2010, PALAEOGEOGR PALAEOCL, V295, P376, DOI 10.1016/j.palaeo.2010.02.029; Fiorillo Anthony R., 2001, Historical Biology, V15, P323, DOI 10.1080/0891296021000037327; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Galton Peter M., 2007, P17; Gilmore CW, 1914, B US NATN MUS, V89, P1; Godefroit P, 2009, NATURWISSENSCHAFTEN, V96, P495, DOI 10.1007/s00114-008-0499-0; Hammer W.H., 1997, ENCY DINOSAURS, P562; Hao BQ, 2018, ACTA GEOL SIN-ENGL, V92, P431, DOI 10.1111/1755-6724.13535; Hwang SH, 2011, BIOL REV, V86, P183, DOI 10.1111/j.1469-185X.2010.00142.x; Kolosov PN, 2009, PALEONTOL J+, V43, P201, DOI 10.1134/S0031030109020129; Kurzanov SM, 2003, PALEONTOLOG J, V37, P53; Lautenschlager S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26495; Lopatin A V, 2008, Dokl Biol Sci, V419, P107, DOI 10.1134/S0012496608020117; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Nabavizadeh A, 2016, ANAT REC, V299, P1358, DOI 10.1002/ar.23455; Nabavizadeh A, 2016, ANAT REC, V299, P271, DOI 10.1002/ar.23306; Osi A, 2014, ANAT REC, V297, P1165, DOI 10.1002/ar.22910; Poropat SF, 2018, ALCHERINGA, V42, P157, DOI 10.1080/03115518.2018.1453085; Reichel M, 2010, SWISS J GEOSCI, V103, P235, DOI 10.1007/s00015-010-0025-1; Rich TH, 2002, SCIENCE, V295, P979, DOI 10.1126/science.1068920; Skutschas PP, 2020, CRETACEOUS RES, V106, DOI 10.1016/j.cretres.2019.07.016; Skutschas PP, 2018, ACTA PALAEONTOL POL, V63, P519, DOI 10.4202/app.00498.2018; Tumanova TA, 2018, PALEONTOL J+, V52, P1771, DOI 10.1134/S0031030118140186; Wings O, 2015, PALAEONTOL Z, V89, P485, DOI 10.1007/s12542-014-0227-3; Woodruff DC, 2019, ACTA PALAEONTOL POL, V64, P461, DOI 10.4202/app.00585.2018	40	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248163	10.1371/journal.pone.0248163	http://dx.doi.org/10.1371/journal.pone.0248163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730093	Green Published, gold			2022-12-26	WOS:000630345000032
J	Voronina, N; Aichmuller, C; Kolb, T; Korshunov, A; Ryzhova, M; Barnholtz-Sloan, J; Cioffi, G; Sill, M; von Deimling, A; Pfister, SM; Gronych, J; Jones, DTW; Frisen, J; Zapatka, M; Ernst, A				Voronina, Natalia; Aichmueller, Christian; Kolb, Thorsten; Korshunov, Andrey; Ryzhova, Marina; Barnholtz-Sloan, Jill; Cioffi, Gino; Sill, Martin; von Deimling, Andreas; Pfister, Stefan M.; Gronych, Jan; Jones, David T. W.; Frisen, Jonas; Zapatka, Marc; Ernst, Aurelie			The age of adult pilocytic astrocytoma cells	ONCOGENE			English	Article								Adult pilocytic astrocytomas (PAs) have been regarded as indistinguishable from pediatric PAs in terms of genome-wide expression and methylation patterns. It has been unclear whether adult PAs arise early in life and remain asymptomatic until adulthood, or whether they develop during adulthood. We sought to determine the age and origin of adult human PAs using two types of "marks" in the genomic DNA. First, we analyzed the DNA methylation patterns of adult and pediatric PAs to distinguish between PAs of different anatomic locations (n = 257 PA and control brain tissues). Second, we measured the concentration of nuclear bomb test-derived C-14 in genomic DNA (n = 14 cases), which indicates the time point of the formation of human cell populations. Our data suggest that adult and pediatric PAs developing in the infratentorial brain are closely related and potentially develop from precursor cells early in life, whereas supratentorial PAs might show age and location-specific differences.	[Voronina, Natalia; Kolb, Thorsten; Ernst, Aurelie] DKFZ, Grp Genome Instabil Tumors, Heidelberg, Germany; [Aichmueller, Christian; Zapatka, Marc] DKFZ Heidelberg Ctr Personalized Oncol HIPO, DKFZ, Div Mol Genet, Heidelberg, Germany; [Aichmueller, Christian; Zapatka, Marc] German Canc Consortium DKTK, Heidelberg, Germany; [Korshunov, Andrey; von Deimling, Andreas] DKFZ, Heidelberg Univ Hosp, Dept Neuropathol, Heidelberg, Germany; [Korshunov, Andrey; von Deimling, Andreas] DKFZ, CCU Neuropathol, Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Moscow, Russia; [Barnholtz-Sloan, Jill; Cioffi, Gino] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Barnholtz-Sloan, Jill; Cioffi, Gino] Cent Brain Tumor Registry US, Hinsdale, IL USA; [Sill, Martin; Pfister, Stefan M.] Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany; [Sill, Martin; Pfister, Stefan M.] DKFZ, Div Pediat Neurooncol, Heidelberg, Germany; [Sill, Martin; Pfister, Stefan M.] DKFZ, German Canc Consortium DKTK, Heidelberg, Germany; [Sill, Martin; Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Gronych, Jan] DKFZ, Div Pediat Neurooncol, Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany; [Gronych, Jan] DKFZ, German Canc Consortium DKTK, Heidelberg, Germany; [Jones, David T. W.] Hopp Childrens Canc Ctr Heidelberg KiTZ, Pediat Glioma Res Grp, Heidelberg, Germany; [Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Gronych, Jan] Roche Diagnost Deutschland GmbH, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Case Western Reserve University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet	Ernst, A (corresponding author), DKFZ, Grp Genome Instabil Tumors, Heidelberg, Germany.	a.ernst@dkfz.de	Barnholtz-Sloan, Jill/A-4817-2011; von Deimling, Andreas/F-7774-2013; Zapatka, Marc/G-9896-2013; Pfister, Stefan M/F-6860-2013	Barnholtz-Sloan, Jill/0000-0001-6190-9304; von Deimling, Andreas/0000-0002-5863-540X; Zapatka, Marc/0000-0001-8287-5967; Pfister, Stefan M/0000-0002-5447-5322	Else Kroner-Fresenius Foundation; Fritz Thyssen Foundation; Wilhelm Sander Foundation; Centers for Disease Control and Prevention (CDC) [75D30119C06056]; American Brain Tumor Association; Sontag Foundation; Musella Foundation; National Brain Tumor Society; Children's Brain Tumor Foundation; Uncle Kory Foundation; Zelda Dorin Tetenbaum Memorial Fund; Cancer Prevention and Research Institute of Texas (CPRIT) [RP160097T]; Novocure	Else Kroner-Fresenius Foundation; Fritz Thyssen Foundation; Wilhelm Sander Foundation; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Brain Tumor Association; Sontag Foundation; Musella Foundation; National Brain Tumor Society; Children's Brain Tumor Foundation; Uncle Kory Foundation; Zelda Dorin Tetenbaum Memorial Fund; Cancer Prevention and Research Institute of Texas (CPRIT); Novocure(Novocure Limited)	We thank the Else Kroner-Fresenius Foundation, the Fritz Thyssen Foundation and the Wilhelm Sander Foundation for funding. We thank Peter Lichter for the discussions. We thank Helena Lonnqvist for support with the DNA extraction, Frauke Devens and Michaela Hergt for support with the immunohistology and Andrea Wittmann for help with tumor tissue collection. We thank the team of the Department of Physics of the Uppsala University for the AMS measurements, and Karl Hakansson and Lars Beckel in particular. We thank Nada Jabado and Almos Klekner for kindly searching for potentially suitable samples, even though the tissues did not meet the criteria for retrospective birth-dating, we are very grateful to both of them for trying to help. Funding for CBTRUS was provided by the Centers for Disease Control and Prevention (CDC) under contract no. 75D30119C06056, the American Brain Tumor Association, The Sontag Foundation, Novocure, the Musella Foundation, National Brain Tumor Society, the Children's Brain Tumor Foundation, the Uncle Kory Foundation, the Zelda Dorin Tetenbaum Memorial Fund, as well as private and in-kind donations. QTO is supported by a Research Training Grant from the Cancer Prevention and Research Institute of Texas (CPRIT; RP160097T). Contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.	Aichmuller CF, 2020, NEURO-ONCOLOGY, V22, P1327, DOI 10.1093/neuonc/noaa035; Antonelli Manila, 2018, Oncotarget, V9, P13807, DOI 10.18632/oncotarget.24480; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Brokinkel B, 2015, NEUROPATH APPL NEURO, V41, P258, DOI 10.1111/nan.12145; Buhl JL, 2019, CLIN CANCER RES, V25, P1851, DOI 10.1158/1078-0432.CCR-18-1965; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Huttner HB, 2018, EBIOMEDICINE, V27, P176, DOI 10.1016/j.ebiom.2017.12.020; Janzarik WG, 2007, NEUROPEDIATRICS, V38, P61, DOI 10.1055/s-2007-984451; Korber V, 2019, CANCER CELL, V35, P692, DOI 10.1016/j.ccell.2019.02.007; Kratz CP, 2017, CLIN CANCER RES, V23, pE38, DOI 10.1158/1078-0432.CCR-17-0408; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Magrini S, 2013, J NEURO-ONCOL, V115, P103, DOI 10.1007/s11060-013-1200-9; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mitoma H, 2020, CEREBELLUM, V19, P131, DOI 10.1007/s12311-019-01091-9; Moran S, 2016, LANCET ONCOL, V17, P1386, DOI 10.1016/S1470-2045(16)30297-2; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Sexton-Oates A, 2018, MOL ONCOL, V12, P1219, DOI 10.1002/1878-0261.12062; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Theeler BJ, 2014, NEURO-ONCOLOGY, V16, P841, DOI 10.1093/neuonc/not246; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Zheng SJC, 2018, NAT METHODS, V15, P1059, DOI 10.1038/s41592-018-0213-x	29	4	4	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2830	2841		10.1038/s41388-021-01738-0	http://dx.doi.org/10.1038/s41388-021-01738-0		MAR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33731860	hybrid, Green Published			2022-12-26	WOS:000629880400001
J	Welty, FK; Schulte, F; Alfaddagh, A; Elajami, TK; Bistrian, BR; Hardt, M				Welty, Francine K.; Schulte, Fabian; Alfaddagh, Abdulhamied; Elajami, Tarec K.; Bistrian, Bruce R.; Hardt, Markus			Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid plus resolvin E1) to leukotriene B-4	FASEB JOURNAL			English	Article						coronary plaque regression; inflammation; metabololipidomics; omega&#8208; 3 fatty acids; resolvins		Inflammation in arterial walls leads to coronary artery disease (CAD). We previously reported that a high omega-3 fatty index was associated with prevention of progression of coronary atherosclerosis, a disease of chronic inflammation in the arterial wall. However, the mechanism of such benefit is unclear. The two main omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are precursors of specialized pro-resolving lipid mediators (SPMs)-resolvins and maresins-which actively resolve chronic inflammation. To explore whether SPMs are associated with coronary plaque progression, levels of SPMs and proinflammatory mediators (leukotriene B-4 [LTB4] and prostaglandins) were measured using liquid chromatography-tandem mass spectrometry in 31 statin-treated patients with stable CAD randomized to either EPA and DHA, 3.36 g daily, or no EPA/DHA (control). Coronary plaque volume was measured by coronary computed tomographic angiography at baseline and at 30-month follow-up. Higher plasma levels of EPA+DHA were associated with significantly increased levels of two SPMs-resolvin E1 and maresin 1-and 18-hydroxy-eicosapentaenoic acid (HEPE), the precursor of resolvin E1. Those with low plasma EPA+DHA levels had a low (18-HEPE+resolvin E1)/LTB4 ratio and significant plaque progression. Those with high plasma EPA+DHA levels had either low (18-HEPE+resolvin E1)/LTB4 ratios with significant plaque progression or high (18-HEPE+resolvin E1)/LTB4 ratios with significant plaque regression. These findings suggest that an imbalance between pro-resolving and proinflammatory lipid mediators is associated with plaque progression and potentially mediates the beneficial effects of EPA and DHA in CAD patients.	[Welty, Francine K.; Alfaddagh, Abdulhamied; Elajami, Tarec K.] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, SL 423,330 Brookline Ave, Boston, MA 02215 USA; [Schulte, Fabian; Hardt, Markus] Forsyth Inst, Cambridge, MA USA; [Schulte, Fabian; Hardt, Markus] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Bistrian, Bruce R.] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Harvard University; Beth Israel Deaconess Medical Center	Welty, FK (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, SL 423,330 Brookline Ave, Boston, MA 02215 USA.	fwelty@bidmc.harvard.edu	Hardt, Markus/M-8569-2019	Hardt, Markus/0000-0002-2300-216X	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [P50 HL 083813, UL1 TR001102]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P50 HL 083813 and UL1 TR001102	Alfaddagh A, 2019, ATHEROSCLEROSIS, V285, P153, DOI 10.1016/j.atherosclerosis.2019.04.213; Alfaddagh A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006981; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Artiach G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01327; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Bayturan O, 2010, J AM COLL CARDIOL, V55, P2736, DOI 10.1016/j.jacc.2010.01.050; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Carracedo M, 2019, CARDIOVASC RES, V115, P1557, DOI 10.1093/cvr/cvy316; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113480; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Hauser TH, 2016, JAMA CARDIOL, V1, P413, DOI 10.1001/jamacardio.2016.0605; Khosa F, 2013, ATHEROSCLEROSIS, V226, P428, DOI 10.1016/j.atherosclerosis.2012.11.033; Laguna-Fernandez A, 2018, CIRCULATION, V138, P1693, DOI 10.1161/CIRCULATIONAHA.117.032801; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Liu GZ, 2018, FASEB J, V32, P5413, DOI 10.1096/fj.201800173R; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Parashar K, 2020, FASEB J, V34, P7733, DOI 10.1096/fj.201902196R; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Sampson UK, 2012, CURR ATHEROSCLER REP, V14, P1, DOI 10.1007/s11883-011-0219-7; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Yang Rong, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1426s95	43	17	17	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21448	10.1096/fj.202002471R	http://dx.doi.org/10.1096/fj.202002471R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749913	Green Accepted			2022-12-26	WOS:000635216100085
J	Yuan, QC; Gong, H; Du, M; Mao, XY				Yuan, Qi-chen; Gong, Han; Du, Min; Mao, Xue-ying			Supplementation of milk polar lipids to obese dams improves neurodevelopment and cognitive function in male offspring	FASEB JOURNAL			English	Article						cognitive function; insulin resistance; maternal obesity; neurodevelopment; polar lipids&#8208; enriched milk fat globule membrane		Milk contains about 4% fat globules with its surface covered by polar lipids. Despite the abundant consumption of dairy products, the biological effects of dietary milk polar lipids on metabolic health have only been sparsely examined. Maternal obesity results in neurodevelopmental disorders and cognitive impairment in offspring. Considering the importance of maternal nutrition, the effects of polar lipids-enriched milk fat globule membrane (MFGM-PL) supplementation to dams during pregnancy and lactation on neurodevelopment and its long-term programming effects on offspring cognition were examined. Female Sprague-Dawley rats consumed 8-week control diet (CON) or high-fat diet (HFD) to induce obesity before mating. Then, female rats were fed CON or HFD with or without the supplementation of 400 mg/kg body weight MFGM-PL during pregnancy and lactation. The offspring were fed 11-week HFD after weaning. MFGM-PL supplementation to obese dams suppressed body weight gain and hyperinsulinemia in both dams and offspring. Offspring born to obese dams displayed delayed neurological reflexes development, impaired neurogenesis before weaning, and cognitive impairment in adulthood, which were recovered by maternal MFGM-PL supplementation. Insulin resistance and aberrant brain-derived neurotrophic factor signaling were induced in the hippocampus of neonatal and adult offspring due to maternal and progeny HFD, but recovered by maternal MFGM-PL administration. This study demonstrates that maternal MFGM-PL supplementation can promote neurodevelopment and exert long-term effects against HFD-induced cognitive impairment in offspring via alleviating hippocampal insulin resistance. Hence, MFGM-PL is a promising ingredient for exerting beneficial programming effects on the brain health of offspring.	[Yuan, Qi-chen; Gong, Han; Mao, Xue-ying] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Key Lab Precis Nutr & Food Qual, Key Lab Funct Dairy,Minist Educ, Beijing, Peoples R China; [Yuan, Qi-chen; Gong, Han; Mao, Xue-ying] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	China Agricultural University; China Agricultural University; Washington State University	Mao, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	maoxueying@cau.edu.cn		Yuan, Qichen/0000-0001-9588-0968	National Natural Science Foundation of China [31871806]; Beijing Dairy Industry Innovation Team [BAIC06-2020]; National Key Research Development Program of China [2019YFC1605000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team; National Key Research Development Program of China	National Natural Science Foundation of China, Grant/Award Number: 31871806; Beijing Dairy Industry Innovation Team, Grant/Award Number: BAIC06-2020; National Key Research Development Program of China, Grant/Award Number: 2019YFC1605000	Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Brink LR, 2019, J NUTR BIOCHEM, V69, P163, DOI [10.1016/j.jnutbio.2019.03.013, 10.1016/j.jnutbio.2019.0]; Brink LR, 2018, J NUTR BIOCHEM, V58, P131, DOI 10.1016/j.jnutbio.2018.05.004; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Puentes AD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092154; del Bas JM, 2015, INT J OBESITY, V39, P7, DOI 10.1038/ijo.2014.159; Derbyshire E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061731; Dewettinck K, 2008, INT DAIRY J, V18, P436, DOI 10.1016/j.idairyj.2007.10.014; Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S, DOI 10.1093/ajcn/71.1.315s; Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fischer LM, 2010, AM J CLIN NUTR, V92, P336, DOI 10.3945/ajcn.2010.29459; Graf AE, 2016, BRAIN BEHAV IMMUN, V58, P369, DOI 10.1016/j.bbi.2016.08.005; Hari S, 2015, BIOSCI BIOTECH BIOCH, V79, P1172, DOI 10.1080/09168451.2015.1012150; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Heni M, 2014, ACTA DIABETOL, V51, P679, DOI 10.1007/s00592-013-0546-y; Kamel AS, 2018, MOL NEUROBIOL, V55, P8188, DOI 10.1007/s12035-018-0966-3; Kern W, 2006, DIABETOLOGIA, V49, P2790, DOI 10.1007/s00125-006-0409-y; Lamothe S, 2008, J DAIRY RES, V75, P439, DOI 10.1017/S002202990800349X; Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Li TG, 2020, FASEB J, V34, P4619, DOI 10.1096/fj.201901867RRR; Liu HN, 2014, J NUTR, V144, P1903, DOI 10.3945/jn.114.199828; Mahizir D, 2016, MOL NUTR FOOD RES, V60, P8, DOI 10.1002/mnfr.201500289; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Mi YS, 2017, FASEB J, V31, P4998, DOI 10.1096/fj.201700400RR; Mitchell MD, 2012, PLACENTA, V33, P312, DOI 10.1016/j.placenta.2011.12.018; Motta-Teixeira LC, 2018, HORM BEHAV, V105, P146, DOI 10.1016/j.yhbeh.2018.08.006; Moukarzel S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33603-8; Norris T, 2021, J MATERN-FETAL NEO M, V34, P3313, DOI 10.1080/14767058.2019.1683539; Page KC, 2014, AM J PHYSIOL-REG I, V306, pR527, DOI 10.1152/ajpregu.00319.2013; Ribes-Navarro A, 2019, MOL NEUROBIOL, V56, P454, DOI 10.1007/s12035-018-1091-z; Sangusa G, 2018, MOL NEUROBIOL, V55, P6984, DOI 10.1007/s12035-017-0863-1; Schipper L, 2016, J NUTR, V146, P1155, DOI 10.3945/jn.115.224998; Schmitz L, 2018, PSYCHONEUROENDOCRINO, V89, P46, DOI 10.1016/j.psyneuen.2017.12.023; Sona C, 2018, NEUROBIOL DIS, V118, P94, DOI 10.1016/j.nbd.2018.07.002; TAKAMIZAWA K, 1986, BIOCHIM BIOPHYS ACTA, V879, P73; Tome-Carneiro J, 2018, MOL NEUROBIOL, V55, P7285, DOI 10.1007/s12035-018-0934-y; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Velazquez R, 2013, NEUROBIOL DIS, V58, P92, DOI 10.1016/j.nbd.2013.04.016; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Widen EM, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12481; Yamada M, 1997, J BIOL CHEM, V272, P30334, DOI 10.1074/jbc.272.48.30334; Yan ZH, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700461; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yuan QC, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103435; Zhu C, 2018, EXP CELL RES, V368, P159, DOI 10.1016/j.yexcr.2018.04.019; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	54	6	7	10	37	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21454	10.1096/fj.202001974RRR	http://dx.doi.org/10.1096/fj.202001974RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749945				2022-12-26	WOS:000635216100074
J	Aronsson, L; Andersson, R; Ansari, D				Aronsson, Linus; Andersson, Roland; Ansari, Daniel			Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas	PLOS ONE			English	Article								Prediction of long-term survival in patients with invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas may aid in patient assessment, risk stratification and personalization of treatment. This study aimed to investigate the predictive ability of artificial neural networks (ANN) and LASSO regression in terms of 5-year disease-specific survival. ANN work in a non-linear fashion, having a potential advantage in analysis of variables with complex correlations compared to regression models. LASSO is a type of regression analysis facilitating variable selection and regularization. A total of 440 patients undergoing surgical treatment for invasive IPMN of the pancreas registered in the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2016 were analyzed. The dataset was prior to analysis randomly split into a modelling and test set (7:3). The accuracy, precision and F1 score for predicting mortality were 0.82, 0.83 and 0.89, respectively for ANN with variable selection compared to 0.79, 0.85 and 0.87, respectively for the LASSO-model. ANN using all variables showed similar accuracy, precision and F1 score of 0.81, 0.85 and 0.88, respectively compared to a logistic regression analysis. McNemar ' s test showed no statistical difference between the models. The models showed high and similar performance with regard to accuracy and precision for predicting 5-year survival status.	[Aronsson, Linus; Andersson, Roland; Ansari, Daniel] Lund Univ, Skane Univ Hosp, Dept Surg, Clin Sci Lund, Lund, Sweden	Lund University; Skane University Hospital	Ansari, D (corresponding author), Lund Univ, Skane Univ Hosp, Dept Surg, Clin Sci Lund, Lund, Sweden.	daniel.ansari@med.lu.se			Magnus Bergvall Foundation; Inga and John Hains Foundation for Medical Research; Clas Groschinsky Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperup Foundation; Erik and Angelica Sparre Research Foundation; Emil and Wera Cornell Foundation; Ida Persson Research Foundation; Anna Lisa and Sven-Eric Lundgren Foundation for Medical Research and Governmental Funding of Clinical Research within the National Health Service (ALF)	Magnus Bergvall Foundation; Inga and John Hains Foundation for Medical Research; Clas Groschinsky Foundation; Gunnar Nilsson Foundation; Gyllenstiernska Krapperup Foundation; Erik and Angelica Sparre Research Foundation; Emil and Wera Cornell Foundation; Ida Persson Research Foundation; Anna Lisa and Sven-Eric Lundgren Foundation for Medical Research and Governmental Funding of Clinical Research within the National Health Service (ALF)	D.A. This work was supported by the Magnus Bergvall Foundation, the Inga and John Hains Foundation for Medical Research, the Clas Groschinsky Foundation, the Gunnar Nilsson Foundation, the Gyllenstiernska Krapperup Foundation, the Erik and Angelica Sparre Research Foundation, the Emil and Wera Cornell Foundation, the Henning and Ida Persson Research Foundation, the Anna Lisa and Sven-Eric Lundgren Foundation for Medical Research and Governmental Funding of Clinical Research within the National Health Service (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay V, 2016, ANN SURG, V263, P162, DOI 10.1097/SLA.0000000000001173; Aronsson L, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.37; Aronsson L, 2019, INT J SURG, V71, P91, DOI 10.1016/j.ijsu.2019.09.014; Bartosch-Harlid A, 2008, BRIT J SURG, V95, P817, DOI 10.1002/bjs.6239; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; Corral JE, 2019, PANCREAS, V48, P805, DOI 10.1097/MPA.0000000000001327; Del Chiaro M, 2018, GUT, V67, P789, DOI 10.1136/gutjnl-2018-316027; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Kimura K, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-360; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Kurita Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43314-3; Kuwahara T, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000045; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P2737, DOI 10.1158/1055-9965.EPI-08-0417; Maker AV, 2019, J AM COLL SURGEONS, V228, P721, DOI 10.1016/j.jamcollsurg.2019.02.040; Noone AM, 2016, MED CARE, V54, pE55, DOI 10.1097/MLR.0000000000000073; R Core Team, 2020, R LANG ENV STAT COMP; Riall TS, 2007, J AM COLL SURGEONS, V204, P803, DOI 10.1016/j.jamcollsurg.2007.01.015; Shen XY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00248; Sun K, 2017, IEEE T NEUR NET LEAR, V28, P1386, DOI 10.1109/TNNLS.2016.2542866; Tanaka M, 2017, PANCREATOLOGY, V17, P738, DOI 10.1016/j.pan.2017.07.007; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Venables WN., 2002, MODERN APPL STAT S 4; Wasif N, 2010, CANCER-AM CANCER SOC, V116, P3369, DOI 10.1002/cncr.25070	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249206	10.1371/journal.pone.0249206	http://dx.doi.org/10.1371/journal.pone.0249206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765078	Green Published, gold			2022-12-26	WOS:000634832800065
J	Dantas, LF; Peres, IT; Bastos, LSL; Marchesi, JF; de Souza, GFG; Gelli, JGM; Baiao, FA; Macaira, P; Hamacher, S; Bozza, FA				Dantas, Leila F.; Peres, Igor T.; Bastos, Leonardo S. L.; Marchesi, Janaina F.; de Souza, Guilherme F. G.; Gelli, Joao Gabriel M.; Baiao, Fernanda A.; Macaira, Paula; Hamacher, Silvio; Bozza, Fernando A.			App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning	PLOS ONE			English	Article							COVID-19; CLASSIFICATION; BRAZIL	Background Tests are scarce resources, especially in low and middle-income countries, and the optimization of testing programs during a pandemic is critical for the effectiveness of the disease control. Hence, we aim to use the combination of symptoms to build a predictive model as a screening tool to identify people and areas with a higher risk of SARS-CoV-2 infection to be prioritized for testing. Materials and methods We performed a retrospective analysis of individuals registered in "Dados do Bem," a Brazilian app-based symptom tracker. We applied machine learning techniques and provided a SARS-CoV-2 infection risk map of Rio de Janeiro city. Results From April 28 to July 16, 2020, 337,435 individuals registered their symptoms through the app. Of these, 49,721 participants were tested for SARS-CoV-2 infection, being 5,888 (11.8%) positive. Among self-reported symptoms, loss of smell (OR[95%CI]: 4.6 [4.4-4.9]), fever (2.6 [2.5-2.8]), and shortness of breath (2.1 [1.6-2.7]) were independently associated with SARS-CoV-2 infection. Our final model obtained a competitive performance, with only 7% of false-negative users predicted as negatives (NPV = 0.93). The model was incorporated by the "Dados do Bem" app aiming to prioritize users for testing. We developed an external validation in the city of Rio de Janeiro. We found that the proportion of positive results increased significantly from 14.9% (before using our model) to 18.1% (after the model). Conclusions Our results showed that the combination of symptoms might predict SARS-Cov-2 infection and, therefore, can be used as a tool by decision-makers to refine testing and disease control strategies.	[Dantas, Leila F.; Peres, Igor T.; Bastos, Leonardo S. L.; de Souza, Guilherme F. G.; Gelli, Joao Gabriel M.; Baiao, Fernanda A.; Macaira, Paula; Hamacher, Silvio] Pontifical Catholic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RJ, Brazil; [Marchesi, Janaina F.] Pontifical Catholic Univ Rio De Janeiro, Inst Tecgraf, Rio De Janeiro, RJ, Brazil; [Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas INI, Rio De Janeiro, RJ, Brazil; [Bozza, Fernando A.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil	Pontificia Universidade Catolica do Rio de Janeiro; Pontificia Universidade Catolica do Rio de Janeiro; Fundacao Oswaldo Cruz; IDOR - Instituto D'Or de Ensino e Pesquisa	Bozza, FA (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas INI, Rio De Janeiro, RJ, Brazil.; Bozza, FA (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.	bozza.fernando@gmail.com	Bozza, Fernando A/A-2618-2013; Bastos, Leonardo S L/AAQ-6069-2021; Peres, Igor Tona/GWQ-6665-2022; Marchesi, Janaina/AAH-2233-2022; hamacher, silvio/C-3325-2013; Marchesi, Janaina/AFL-9964-2022; Dantas, Leila Figueiredo/U-5407-2019	Bozza, Fernando A/0000-0003-4878-0256; Bastos, Leonardo S L/0000-0001-7833-0403; hamacher, silvio/0000-0002-3980-0342; Marchesi, Janaina/0000-0002-0262-5384; Peres, Igor/0000-0001-9863-4690; Dantas, Leila/0000-0001-8910-0961	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [169049/2017-5, 306802/2015-5, 403863/2016-3, 310523/2016-8, 144636/2019-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88887.178844/2018-00, 001]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Pontificia Universidade Catolica do Rio de Janeiro (PUC-Rio)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Pontificia Universidade Catolica do Rio de Janeiro (PUC-Rio)	We would like to thank all collaborators from "Dados do Bem", which specified and developed the application, and supported data collection. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant numbers 169049/2017-5 to L.F.D., 306802/2015-5 and 403863/2016-3 to S.H., 310523/2016-8 to F.A.B., 144636/2019-0 to I.T.P.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Finance Code 001 (Grant number 88887.178844/2018-00 to L.S.L.B); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); and Pontificia Universidade Catolica do Rio de Janeiro (PUC-Rio).	Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4; Ahmed F, 2020, LANCET PUBLIC HEALTH, V5, pE240, DOI 10.1016/S2468-2667(20)30085-2; Allen William E, 2020, medRxiv, DOI 10.1101/2020.06.09.20126813; [Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; Brandstetter S, 2020, PEDIAT ALLERG IMM-UK, V31, P841, DOI 10.1111/pai.13278; Callahan A, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0300-0; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chicco D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6413-7; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Hallal PC, 2020, LANCET GLOB HEALTH, V8, pE1390, DOI 10.1016/S2214-109X(20)30387-9; Lunardon N, 2014, R J, V6, P79; Mehl A, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/21364; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Passarelli PC, 2020, AM J DENT, V33, P135; Peres IT, 2021, PUBLIC HEALTH, V192, P15, DOI 10.1016/j.puhe.2021.01.005; Prado Marcelo Freitas do, 2020, Rev. bras. ter. intensiva, V32, P224, DOI [10.5935/0103-507X.20200030, 10.5935/0103-507x.20200030]; Quer G, 2021, NAT MED, V27, P73, DOI 10.1038/s41591-020-1123-x; Rabhi S, 2019, METHOD INFORM MED, V58, P31, DOI 10.1055/s-0039-1677692; Ranzani OT, 2021, LANCET RESP MED, V9, P407, DOI 10.1016/S2213-2600(20)30560-9; Vanhoeyveld J, 2018, DATA MIN KNOWL DISC, V32, P25, DOI 10.1007/s10618-017-0517-y; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhu GK, 2020, DISCRETE DYN NAT SOC, V2020, DOI 10.1155/2020/6152041	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248920	10.1371/journal.pone.0248920	http://dx.doi.org/10.1371/journal.pone.0248920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765050	Green Submitted, Green Published, gold			2022-12-26	WOS:000634832800080
J	Neiers, F; Jarriault, D; Menetrier, F; Briand, L; Heydel, JM				Neiers, Fabrice; Jarriault, David; Menetrier, Franck; Briand, Loic; Heydel, Jean-Marie			The odorant metabolizing enzyme UGT2A1: Immunolocalization and impact of the modulation of its activity on the olfactory response	PLOS ONE			English	Article								Odorant metabolizing enzymes (OMEs) are expressed in the olfactory epithelium (OE) where they play a significant role in the peripheral olfactory process by catalyzing the fast biotransformation of odorants leading either to their elimination or to the synthesis of new odorant stimuli. The large family of OMEs gathers different classes which interact with a myriad of odorants alike and complementary to olfactory receptors. Thus, it is necessary to increase our knowledge on OMEs to better understand their function in the physiological process of olfaction. This study focused on a major olfactory UDP-glucuronosyltransferase (UGT): UGT2A1. Immunohistochemistry and immunogold electronic microscopy allowed to localize its expression in the apical part of the sustentacular cells and originally at the plasma membrane of the olfactory cilia of the olfactory sensory neurons, both locations in close vicinity with olfactory receptors. Moreover, using electroolfactogram, we showed that a treatment of the OE with beta-glucuronidase, an enzyme which counterbalance the UGTs activity, increased the response to eugenol which is a strong odorant UGT substrate. Altogether, the results supported the function of the olfactory UGTs in the vertebrate olfactory perireceptor process.	[Neiers, Fabrice; Jarriault, David; Menetrier, Franck; Briand, Loic; Heydel, Jean-Marie] Univ Bourgogne Franche Comte, CNRS, INRAE, AgroSup Dijon,Ctr Sci Gout & Alimentat, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Neiers, F; Heydel, JM (corresponding author), Univ Bourgogne Franche Comte, CNRS, INRAE, AgroSup Dijon,Ctr Sci Gout & Alimentat, Dijon, France.	fabrice.neiers@u-bourgogne.fr; jean-marie.heydel@u-bourgogne.fr	Neiers, Fabrice/AAM-1637-2021	Neiers, Fabrice/0000-0002-8965-4929; Heydel, jean-Marie/0000-0002-6089-9922	Agence Nationale de la Recherche [ANR-18-CE92-0018-01];  [ANR-16-CE21-0004-01]	Agence Nationale de la Recherche(French National Research Agency (ANR)); 	The authors received funding for this work JMH: Agence Nationale de la Recherche grant number ANR-18-CE92-0018-01 https://anr.fr FN: Agence Nationale de la Recherche ANR-16-CE21-0004-01 https://anr.fr The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock KW, 2009, BIOCHEM PHARMACOL, V77, P1458, DOI 10.1016/j.bcp.2008.12.004; Bushey RT, 2012, J PHARMACOL EXP THER, V343, P712, DOI 10.1124/jpet.112.198770; Bushey RT, 2011, PHARMACOGENET GENOM, V21, P55, DOI 10.1097/FPC.0b013e328341db05; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; CUSCHIERI A, 1974, J ANAT, V118, P477; Debat H, 2007, J PROTEOME RES, V6, P1985, DOI 10.1021/pr0606575; Faure P, 2016, CHEM SENSES, V41, P15, DOI 10.1093/chemse/bjv055; Gao X, 2015, XENOBIOTICA, V45, P197, DOI 10.3109/00498254.2014.966174; Hanser HI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10080-z; Heydel JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220259; Heydel JM, 2019, DRUG METAB REV, V51, P224, DOI 10.1080/03602532.2019.1632890; Heydel JM, 2013, ANAT REC, V296, P1333, DOI 10.1002/ar.22735; Heydel JM, 2010, DRUG METAB REV, V42, P74, DOI 10.3109/03602530903208363; Heydel JM, 2001, MOL BRAIN RES, V90, P83, DOI 10.1016/S0169-328X(01)00080-8; HORBACH ME, 1994, EUR J BIOCHEM, V222, P91, DOI 10.1111/j.1432-1033.1994.tb18845.x; Iida A, 2002, J HUM GENET, V47, P505, DOI 10.1007/s100380200075; Ijichi C, 2019, CHEM SENSES, V44, P465, DOI 10.1093/chemse/bjz041; Jedlitschky G, 1999, BIOCHEM J, V340, P837, DOI 10.1042/0264-6021:3400837; Kuhlmann K, 2014, MOL CELL PROTEOMICS, V13, P1828, DOI 10.1074/mcp.M113.035378; LAZARD D, 1991, NATURE, V349, P790, DOI 10.1038/349790a0; Leclerc S, 2002, MOL BRAIN RES, V107, P201, DOI 10.1016/S0169-328X(02)00455-2; Legendre A, 2014, CHEM SENSES, V39, P425, DOI 10.1093/chemse/bju013; LETT E, 1992, BIOCHEM PHARMACOL, V43, P1649, DOI 10.1016/0006-2952(92)90225-8; Loch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075716; Loeper J, 1998, MOL PHARMACOL, V54, P8, DOI 10.1124/mol.54.1.8; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Miksys S, 2009, NEUROPSYCHOPHARMACOL, V34, P634, DOI 10.1038/npp.2008.110; Nagashima A, 2010, J NEUROSCI, V30, P16391, DOI 10.1523/JNEUROSCI.2527-10.2010; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Qazi SS, 2011, DRUG METAB DISPOS, V39, P1122, DOI 10.1124/dmd.111.039362; Radominska-Pandya A, 2005, CURR DRUG METAB, V6, P141, DOI 10.2174/1389200053586127; Robert-Hazotte A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39495-6; Robert-Hazotte A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39404-x; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; Schilling B, 2010, CHEMOECOLOGY, V20, P135, DOI 10.1007/s00049-009-0035-5; Schwartz M, 2020, CHEM SENSES, V45, P645, DOI 10.1093/chemse/bjaa055; Singh SP, 2002, J BIOL CHEM, V277, P4232, DOI 10.1074/jbc.M109678200; Sutliff AK, 2019, J PHARMACOL EXP THER, V369, P234, DOI 10.1124/jpet.118.255935; Thiebaud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059547; Uno Y, 2019, BIOCHEM PHARMACOL, V163, P335, DOI 10.1016/j.bcp.2019.03.002; Wolf A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35776-8; Yoshikawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35102-2; Ziegler K, 2015, J BIOL CHEM, V290, P7622, DOI 10.1074/jbc.M114.634428	43	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249029	10.1371/journal.pone.0249029	http://dx.doi.org/10.1371/journal.pone.0249029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765098	Green Published, gold			2022-12-26	WOS:000634832800097
J	Kurtz, SL; De Pascalis, R; Meierovics, AI; Elkins, KL				Kurtz, Sherry L.; De Pascalis, Roberto; Meierovics, Anda, I; Elkins, Karen L.			Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity	PLOS ONE			English	Article								CCR2 is the major chemokine receptor that regulates appropriate trafficking of inflammatory monocytes, but the role of this chemokine receptor and its ligands during primary and secondary infection with intracellular infections remains incompletely understood. Here we used murine infection with the Live Vaccine Strain (LVS) of Francisella tularensis to evaluate the role of CCR2 during primary and secondary parenteral responses to this prototype intracellular bacterium. We find that mice deficient in CCR2 are highly compromised in their ability to survive intradermal infection with LVS, indicating the importance of this receptor during primary parenteral responses. Interestingly, this defect could not be readily attributed to the activities of the known murine CCR2 ligands MCP-1/CCL2, MCP-3/CCL7, or MCP-5/CCL12. Nonetheless, CCR2 knockout mice vaccinated by infection with low doses of LVS generated optimal T cell responses that controlled the intramacrophage replication of Francisella, and LVS-immune CCR2 knockout mice survived maximal lethal Francisella challenge. Thus, fully protective adaptive immune memory responses to this intracellular bacterium can be readily generated in the absence of CCR2.	[Kurtz, Sherry L.; De Pascalis, Roberto; Meierovics, Anda, I; Elkins, Karen L.] US FDA, Div Bacterial Parasit & Allergen Prod, Lab Mucosal Pathogens & Cellular Immunol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Kurtz, SL; Elkins, KL (corresponding author), US FDA, Div Bacterial Parasit & Allergen Prod, Lab Mucosal Pathogens & Cellular Immunol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	sherry.kurtz@fda.hhs.gov; karen.elkins@fda.hhs.gov		Kurtz, Sherry/0000-0002-2281-8984	internal CBER/FDA (U.S. government) operating funds	internal CBER/FDA (U.S. government) operating funds	This work was funded by internal CBER/FDA (U.S. government) operating funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Conlan J Wayne, 2011, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1914s93; Cowley SC, 2008, J INFECT DIS, V198, P284, DOI 10.1086/589620; D'Elia R, 2011, FEMS IMMUNOL MED MIC, V62, P348, DOI 10.1111/j.1574-695X.2011.00817.x; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Dunlap MD, 2018, MUCOSAL IMMUNOL, V11, P1727, DOI 10.1038/s41385-018-0071-y; Dyer DP, 2019, IMMUNITY, V50, P378, DOI 10.1016/j.immuni.2019.01.009; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins Karen L, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1425s93; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Espinosa V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003940; Forestal CA, 2003, J IMMUNOL, V171, P2563, DOI 10.4049/jimmunol.171.5.2563; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Girkin J, 2015, J IMMUNOL, V194, P4924, DOI 10.4049/jimmunol.1401362; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Marazioti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071207; Meierovics AI, 2016, J EXP MED, V213, P2793, DOI 10.1084/jem.20160637; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Pietras EM, 2011, CELL RES, V21, P1068, DOI 10.1038/cr.2011.59; Qidwai T, 2016, HUM IMMUNOL, V77, P961, DOI 10.1016/j.humimm.2016.06.010; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Ryden P, 2013, MOL IMMUNOL, V54, P58, DOI 10.1016/j.molimm.2012.10.043; Schaible U E, 1999, Adv Immunol, V71, P267; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; TARNVIK A, 1992, IMMUNOLOGY, V76, P349; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wuthrich M, 2012, IMMUNITY, V36, P680, DOI 10.1016/j.immuni.2012.02.015; Yamasaki R., 2012, CLIN EXP NEUROIMMUNO, V3, P16, DOI [DOI 10.1111/J.1759-1961.2011.00024.X, 10.1111/j.1759-1961.2011.00024.x]	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0249142	10.1371/journal.pone.0249142	http://dx.doi.org/10.1371/journal.pone.0249142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760886	gold, Green Published			2022-12-26	WOS:000633030400054
J	Polenogova, OV; Noskov, YA; Yaroslavtseva, ON; Kryukova, NA; Alikina, T; Klementeva, TN; Andrejeva, J; Khodyrev, VP; Kabilov, MR; Kryukov, VY; Glupov, VV				Polenogova, Olga, V; Noskov, Yury A.; Yaroslavtseva, Olga N.; Kryukova, Natalya A.; Alikina, Tatyana; Klementeva, Tatyana N.; Andrejeva, Jelizaveta; Khodyrev, Viktor P.; Kabilov, Marsel R.; Kryukov, Vadim Yu; Glupov, Viktor V.			Influence of Bacillus thuringiensis and avermectins on gut physiology and microbiota in Colorado potato beetle: Impact of enterobacteria on susceptibility to insecticides	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; MIDGUT MICROBIOTA; ALPHA-AMYLASE; RESISTANCE; COLEOPTERA; BACTERIA; MOTH; LEPIDOPTERA; NOCTUIDAE; TOXINS	Gut physiology and the bacterial community play crucial roles in insect susceptibility to infections and insecticides. Interactions among Colorado potato beetle Leptinotarsa decemlineata (Say), its bacterial associates, pathogens and xenobiotics have been insufficiently studied. In this paper, we present our study of the survival, midgut histopathology, activity of digestive enzymes and bacterial communities of L. decemlineata larvae under the influence of Bacillus thuringiensis var. tenebrionis (morrissoni) (Bt), a natural complex of avermectins and a combination of both agents. Moreover, we estimated the impact of culturable enterobacteria on the susceptibility of the larvae to Bt and avermectins. An additive effect between Bt and avermectins was established regarding the mortality of the larvae. Both agents led to the destruction of midgut tissues, a decrease in the activity of alpha-amylases and alkaline proteinases, a decrease in the Spiroplasma leptinotarsae relative abundance and a strong elevation of Enterobacteriaceae abundance in the midgut. Moreover, an elevation of the enterobacterial CFU count was observed under the influence of Bt and avermectins, and the greatest enhancement was observed after combined treatment. Insects pretreated with antibiotics were less susceptible to Bt and avermectins, but reintroduction of the predominant enterobacteria Enterobacter ludwigii, Citrobacter freundii and Serratia marcescens increased susceptibility to both agents. We suggest that enterobacteria play an important role in the acceleration of Bt infection and avermectin toxicoses in L. decemlineata and that the additive effect between Bt and avermectin may be mediated by alterations in the bacterial community.	[Polenogova, Olga, V; Noskov, Yury A.; Yaroslavtseva, Olga N.; Kryukova, Natalya A.; Klementeva, Tatyana N.; Andrejeva, Jelizaveta; Khodyrev, Viktor P.; Kryukov, Vadim Yu; Glupov, Viktor V.] Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Noskov, Yury A.; Kryukov, Vadim Yu] Natl Res Tomsk State Univ, Tomsk, Russia; [Alikina, Tatyana; Kabilov, Marsel R.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia	Russian Academy of Sciences; Tomsk State University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Polenogova, OV (corresponding author), Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia.	ovp0408@yandex.ru	yaroslavtseva, olga/O-2381-2016; Kryukov, Vadim Yu/S-3441-2017; Kryukova, Natalia A/ABB-4421-2021; Kabilov, Marsel R./B-6669-2013; Polenogova, Olga/R-2443-2017; Noskov, Yury A./E-3889-2014; Klementeva, Tatyana/AGJ-2814-2022; Klementeva, Tatyana/AAM-2785-2021; Alikina, Tatyana/AAT-5226-2021	Kryukov, Vadim Yu/0000-0001-9762-903X; Kryukova, Natalia A/0000-0001-8335-3730; Kabilov, Marsel R./0000-0003-2777-0833; Polenogova, Olga/0000-0003-3438-3217; Noskov, Yury A./0000-0001-8752-3979; Klementeva, Tatyana/0000-0003-1668-8412; Yaroslavtseva, Olga/0000-0002-3575-7164	Russian Science Foundation [19-76-00032]; Russian Foundation for Basic Research [18-34-20060]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	O.V.P. received grant from the Russian Science Foundation (project no. 19-76-00032). https://www.rscf.ru/.The parts of the study "Electron microscopy" and "Identification of bacteria" were funded by Russian Foundation for Basic Research (project no. 18-34-20060) (O.N. Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuo-El-Mahasen MM., 2007, SCI J FS MENUFIA U, V21, P71; Akhanaev Yu. B., 2017, Entomological Review, V97, P158, DOI 10.1134/s0013873817020026; Aljedani DM, 2017, SAUDI J BIOL SCI, V24, P1007, DOI 10.1016/j.sjbs.2016.12.007; Alves J, 2010, J VECTOR ECOL, V35, P307, DOI 10.1111/j.1948-7134.2010.00087.x; Alyokhin A, 2013, INSECT PESTS OF POTATO: GLOBAL PERSPECTIVES ON BIOLOGY AND MANAGEMENT, P543, DOI 10.1016/B978-0-12-386895-4.00019-3; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; ANDERSON TE, 1989, J ECON ENTOMOL, V82, P83, DOI 10.1093/jee/82.1.83; Bani AR., 2010, MUN ENT ZOOL, V5, P716; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Blackburn MB, 2008, BIOL CONTROL, V46, P434, DOI 10.1016/j.biocontrol.2008.05.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO A, 1992, J INVERTEBR PATHOL, V60, P237, DOI 10.1016/0022-2011(92)90004-N; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caccia S, 2016, P NATL ACAD SCI USA, V113, P9486, DOI 10.1073/pnas.1521741113; Chauhan VK, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00662; Cheng DF, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0236-z; Chougule NP, 2008, J INSECT PHYSIOL, V54, P563, DOI 10.1016/j.jinsphys.2007.12.005; Cully DF, 1996, PARASITOLOGY, V113, pS191, DOI 10.1017/S0031182000077970; Darvishzadeh Ali, 2014, Arthropods, V3, P138; Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793; Fernandez MD, 2019, PEST MANAG SCI, V75, P79, DOI 10.1002/ps.5195; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Devaki K., 2004, Indian Journal of Plant Protection, V32, P34; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dominguez-Arrizabalaga M, 2019, INSECTS, V10, DOI 10.3390/insects10090259; Drinyaev VA, 1999, APPL BIOCHEM MICRO+, V35, P177; Dubovskiy IM, 2016, VIRULENCE, V7, P860, DOI 10.1080/21505594.2016.1164367; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC., 2016, BIORXIV, DOI [10.1101/074161, DOI 10.1101/074161, 10.1101/2020.05.12.088096]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Elpidina EN, 2001, ARCH INSECT BIOCHEM, V48, P217, DOI 10.1002/arch.10001; Gomes AFF, 2020, J PEST SCI, V93, P833, DOI 10.1007/s10340-020-01202-0; Furlong MJ, 2001, J ECON ENTOMOL, V94, P344, DOI 10.1603/0022-0493-94.2.344; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Gurevich VV, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122519; Hackett KJ, 1992, BIOL CONTROL, V2, P218, DOI 10.1016/1049-9644(92)90062-I; Hackett KJ, 1996, INT J SYST BACTERIOL, V46, P906, DOI 10.1099/00207713-46-4-906; Harrison RL, 2010, TOXINS, V2, P935, DOI 10.3390/toxins2050935; Hernandez-Martinez P, 2008, J INVERTEBR PATHOL, V97, P245, DOI 10.1016/j.jip.2007.11.001; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Igolkina AA, 2018, ECOL INDIC, V94, P446, DOI 10.1016/j.ecolind.2018.06.060; Jiang J, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00541-17, 10.1128/aem.00541-17]; KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2; Kryukov VY, 2019, FUNGAL BIOL-UK, V123, P927, DOI 10.1016/j.funbio.2019.09.012; Kryukov VY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80565-x; Kumar S., 2015, J BIOFERTIL BIOPESTI, V6, pe127, DOI [10.4172/2155-6202.1000e127, DOI 10.4172/2155-6202.1000E127]; Li H, 2018, MOLECULES, V23, DOI 10.3390/molecules23061290; Li SZ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01478; Lightwood DJ, 2000, APPL ENVIRON MICROB, V66, P5174, DOI 10.1128/AEM.66.12.5174-5181.2000; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; MICHAUD D, 1995, INSECT BIOCHEM MOLEC, V25, P1041, DOI 10.1016/0965-1748(95)00044-V; Noskov YA, 2021, MICROB ECOL, V81, P493, DOI 10.1007/s00248-020-01567-w; Noskov YA, 2019, PEERJ, V7, DOI 10.7717/peerj.7931; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Paramasiva I, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-200; Poirier L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15209-8; Polenogova OV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40301-6; Razik MARAMA El-Raheem AMA, 2019, BLATTELLA GERMANICA, V9, P7, DOI [10.3923/ajbmb.2019.7.16, DOI 10.3923/AJBMB.2019.7.16]; Robertson JL, 1992, PESTICIDE BIOASSAYS, DOI [10.1201/9781315373775, DOI 10.1201/9781315373775]; Rouze R, 2019, MICROBES ENVIRON, V34, P226, DOI 10.1264/jsme2.ME18169; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Shao YQ, 2017, CELL CHEM BIOL, V24, P66, DOI 10.1016/j.chembiol.2016.11.015; Singh A, 2019, SOIL BIOL, V55, P413, DOI 10.1007/978-3-030-18933-4_19; Singh G, 2007, B ENTOMOL RES, V97, P351, DOI 10.1017/S0007485307005019; Skuhrovec J., 2015, URODA, V5, P89; Song P, 2012, J INVERTEBR PATHOL, V109, P318, DOI 10.1016/j.jip.2012.01.009; Talaei-Hassanloui R, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00406; Tomilova OG, 2016, J INVERTEBR PATHOL, V140, P8, DOI 10.1016/j.jip.2016.08.008; Valencia-Jimenez A, 2008, J AGR FOOD CHEM, V56, P2315, DOI 10.1021/jf0733564; van Frankenhuyzen K, 2010, J INVERTEBR PATHOL, V103, P124, DOI 10.1016/j.jip.2009.12.008; Veloso RV, 2013, INSECT SCI, V20, P358, DOI 10.1111/j.1744-7917.2012.01529.x; Wang GH, 2020, CELL HOST MICROBE, V27, P213, DOI 10.1016/j.chom.2020.01.009; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wraight SP, 2005, J INVERTEBR PATHOL, V90, P139, DOI 10.1016/j.jip.2005.09.005; Xia XF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00025; Yoon YJ, 2004, APPL MICROBIOL BIOT, V63, P626, DOI 10.1007/s00253-003-1491-4; Zhang F, 2018, PEST MANAG SCI, V74, P438, DOI 10.1002/ps.4726	81	7	7	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248704	10.1371/journal.pone.0248704	http://dx.doi.org/10.1371/journal.pone.0248704			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760838	Green Published, gold			2022-12-26	WOS:000633030400056
J	Jerng, HH; Patel, JM; Khan, TA; Arenkiel, BR; Pfaffinger, PJ				Jerng, Henry H.; Patel, Jay M.; Khan, Tamor A.; Arenkiel, Benjamin R.; Pfaffinger, Paul J.			Light-regulated voltage-gated potassium channels for acute interrogation of channel function in neurons and behavior	PLOS ONE			English	Article							K+ CHANNEL; MOLECULAR-BASIS; T1 DOMAIN; EXPRESSION; INACTIVATION; AUREOCHROME; DIVERSITY; PROTEINS; CELLS; BLOCK	Voltage-gated potassium (Kv) channels regulate the membrane potential and conductance of excitable cells to control the firing rate and waveform of action potentials. Even though Kv channels have been intensely studied for over 70 year, surprisingly little is known about how specific channels expressed in various neurons and their functional properties impact neuronal network activity and behavior in vivo. Although many in vivo genetic manipulations of ion channels have been tried, interpretation of these results is complicated by powerful homeostatic plasticity mechanisms that act to maintain function following perturbations in excitability. To better understand how Kv channels shape network function and behavior, we have developed a novel optogenetic technology to acutely regulate Kv channel expression with light by fusing the light-sensitive LOV domain of Vaucheria frigida Aureochrome 1 to the N-terminus of the Kv1 subunit protein to make an Opto-Kv1 channel. Recording of Opto-Kv1 channels expressed in Xenopus oocytes, mammalian cells, and neurons show that blue light strongly induces the current expression of Opto-Kv1 channels in all systems tested. We also find that an Opto-Kv1 construct containing a dominant-negative pore mutation (Opto-Kv1(V400D)) can be used to down-regulate Kv1 currents in a blue light-dependent manner. Finally, to determine whether Opto-Kv1 channels can elicit light-dependent behavioral effect in vivo, we targeted Opto-Kv1 (V400D) expression to Kv1.3-expressing mitral cells of the olfactory bulb in mice. Exposure of the bulb to blue light for 2-3 hours produced a significant increase in sensitivity to novel odors after initial habituation to a similar odor, comparable to behavioral changes seen in Kv1.3 knockout animals. In summary, we have developed novel photoactivatable Kv channels that provide new ways to interrogate neural circuits in vivo and to examine the roles of normal and disease-causing mutant Kv channels in brain function and behavior.	[Jerng, Henry H.; Patel, Jay M.; Khan, Tamor A.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Arenkiel, Benjamin R.] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	paulp@bcm.edu		Pfaffinger, Paul/0000-0003-3108-7797; Arenkiel, Benjamin/0000-0001-9047-2420; Patel, Jay/0000-0003-2746-5716	National Institutes of Health [UF1NS111692, U54HD083092, NS111692]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grants: UF1NS111692 (PJP, BRA) U54HD083092 (BRA) NS111692(JP) U54HD083092 to the BCM IDDRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Carrillo-Reid L, 2019, ELIFE, V8, DOI 10.7554/eLife.40818; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V414, P179, DOI 10.1113/jphysiol.1989.sp017683; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Dorrbaum AR, 2018, ELIFE, V7, DOI 10.7554/eLife.34202; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fortin DL, 2011, J NEUROPHYSIOL, V106, P488, DOI 10.1152/jn.00251.2011; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Glantz ST, 2016, P NATL ACAD SCI USA, V113, pE1442, DOI 10.1073/pnas.1509428113; Grusch M, 2014, EMBO J, V33, P1713, DOI 10.15252/embj.201387695; Guo WN, 2000, CIRC RES, V87, P73, DOI 10.1161/01.RES.87.1.73; Herman E, 2015, BIOCHEMISTRY-US, V54, P1484, DOI 10.1021/bi501509z; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kessi M, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00614; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Kunjilwar K, 2013, J NEUROCHEM, V126, P462, DOI 10.1111/jnc.12309; LICHTINGHAGEN R, 1990, EMBO J, V9, P4399, DOI 10.1002/j.1460-2075.1990.tb07890.x; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Mei Y, 2012, BIOL PSYCHIAT, V71, P1033, DOI 10.1016/j.biopsych.2012.02.019; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; Nakatani Y, 2015, BIOCHEMISTRY-US, V54, P3302, DOI 10.1021/acs.biochem.5b00320; PFAFFINGER PJ, 1991, J NEUROSCI, V11, P918; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Prince A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062695; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; Pryazhnikov E, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00027; Pudasaini A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00018; Rowan MJM, 2014, J NEUROSCI, V34, P6611, DOI 10.1523/JNEUROSCI.4208-13.2014; Sahu G, 2019, CELL REP, V28, P2427, DOI 10.1016/j.celrep.2019.07.075; Sandoz G, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00006; Schwappach B., 2000, NEURON, V26, P155, DOI [10.1016/s0896-6273%2800%2981146-0, DOI 10.1016/S0896-6273%2800%2981146-0]; Seifert S, 2018, ACS CHEM BIOL, V13, P1914, DOI 10.1021/acschembio.8b00159; SHEN NV, 1993, NEURON, V11, P67; Shen WX, 2020, J CLIN INVEST, V130, P2593, DOI 10.1172/JCI133398; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sinnen BL, 2017, NEURON, V93, P646, DOI 10.1016/j.neuron.2016.12.037; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tichy AM, 2019, J MOL BIOL, V431, P3046, DOI 10.1016/j.jmb.2019.05.033; Tucker Chandra L, 2014, Curr Protoc Cell Biol, V64, DOI 10.1002/0471143030.cb1716s64; van Leyen K, 2005, J NEUROCHEM, V92, P824, DOI 10.1111/j.1471-4159.2004.02915.x; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zhan XQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16250-4; Zimmerman SP, 2016, BIOCHEMISTRY-US, V55, P5264, DOI 10.1021/acs.biochem.6b00529; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	58	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248688	10.1371/journal.pone.0248688	http://dx.doi.org/10.1371/journal.pone.0248688			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755670	gold, Green Published			2022-12-26	WOS:000632916600021
J	Iwamoto, N; Patel, B; Song, KM; Mason, R; Bolivar-Wagers, S; Bergamaschi, C; Pavlakis, GN; Berger, E; Roederer, M				Iwamoto, Nami; Patel, Bhavik; Song, Kaimei; Mason, Rosemarie; Bolivar-Wagers, Sara; Bergamaschi, Cristina; Pavlakis, George N.; Berger, Edward; Roederer, Mario			Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV	PLOS ONE			English	Article								Achieving a functional cure is an important goal in the development of HIV therapy. Eliciting HIV-specific cellular immune responses has not been sufficient to achieve durable removal of HIV-infected cells due to the restriction on effective immune responses by mutation and establishment of latent reservoirs. Chimeric antigen receptor (CAR) T cells are an avenue to potentially develop more potent redirected cellular responses against infected T cells. We developed and tested a range of HIV- and SIV-specific chimeric antigen receptor (CAR) T cell reagents based on Env-binding proteins. In general, SHIV/SIV CAR T cells showed potent viral suppression in vitro, and adding additional CAR molecules in the same transduction resulted in more potent viral suppression than single CAR transduction. Importantly, the primary determinant of virus suppression potency by CAR was the accessibility to the Env epitope, and not the neutralization potency of the binding moiety. However, upon transduction of autologous T cells followed by infusion in vivo, none of these CAR T cells impacted either acquisition as a test of prevention, or viremia as a test of treatment. Our study illustrates limitations of the CAR T cells as possible antiviral therapeutics.	[Iwamoto, Nami; Patel, Bhavik; Song, Kaimei; Mason, Rosemarie; Roederer, Mario] NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Patel, Bhavik; Bolivar-Wagers, Sara; Bergamaschi, Cristina; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21701 USA; [Berger, Edward] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), NIAID, ImmunoTechnol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	roederer@nih.gov		Iwamoto, Nami/0000-0002-5442-1500; Roederer, Mario/0000-0001-7448-7040	VRC; NCI	VRC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research programs of the VRC and NCI; the funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors received salary support from the NIH.	Ali A, 2016, J VIROL, V90, P6999, DOI 10.1128/JVI.00805-16; Anthony-Gonda K, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5685; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2018, CYTOKINE, V108, P213, DOI 10.1016/j.cyto.2018.01.011; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bolton DL, 2010, J IMMUNOL, V184, P303, DOI 10.4049/jimmunol.0902413; Chertova E, 2013, J BIOL CHEM, V288, P18093, DOI 10.1074/jbc.M113.461756; Claiborne DT, 2015, P NATL ACAD SCI USA, V112, pE1480, DOI 10.1073/pnas.1421607112; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Deeks SG, 2002, MOL THER, V5, P788, DOI 10.1006/mthe.2002.0611; Deleage C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0387-9; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Haran KP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00492; Hombach AA, 2019, MOL THER, V27, P1825, DOI 10.1016/j.ymthe.2019.06.007; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Liu L, 2015, J VIROL, V89, P6685, DOI 10.1128/JVI.00474-15; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Sattler A, 2015, EUR J IMMUNOL, V45, P2286, DOI 10.1002/eji.201445313; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Verri WA, 2007, EUR J IMMUNOL, V37, P3373, DOI 10.1002/eji.200737488; Waldmann TA, 2011, BLOOD, V117, P4787, DOI 10.1182/blood-2010-10-311456; Watson DC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006902; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhen Anjie, 2017, PLoS Pathog, V13, pe1006753, DOI 10.1371/journal.ppat.1006753	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248973	10.1371/journal.pone.0248973	http://dx.doi.org/10.1371/journal.pone.0248973			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33752225	Green Published, gold			2022-12-26	WOS:000631967100018
J	Ambrose, C; Su, LH; Wu, L; Dufort, FJ; Sanford, T; Birt, A; Hackel, BJ; Hombach, A; Abken, H; Lobb, RR; Rennert, PD				Ambrose, Christine; Su, Lihe; Wu, Lan; Dufort, Fay J.; Sanford, Thomas; Birt, Alyssa; Hackel, Benjamin J.; Hombach, Andreas; Abken, Hinrich; Lobb, Roy R.; Rennert, Paul D.			Anti-CD19 CAR T cells potently redirected to kill solid tumor cells	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTOR; B-CELLS; THERAPY; IMMUNOTHERAPY; ACTIVATION; CD19; LEUKEMIA; GLIOBLASTOMA; EXPRESSION; ANTIBODIES	Successful CAR T cell therapy for the treatment of solid tumors requires exemplary CAR T cell expansion, persistence and fitness, and the ability to target tumor antigens safely. Here we address this constellation of critical attributes for successful cellular therapy by using integrated technologies that simplify development and derisk clinical translation. We have developed a CAR-CD19 T cell that secretes a CD19-anti-Her2 bridging protein. This cell therapy strategy exploits the ability of CD19-targeting CAR T cells to interact with CD19 on normal B cells to drive expansion, persistence and fitness. The secreted bridging protein potently binds to Her2-positive tumor cells, mediating CAR-CD19 T cell cytotoxicity in vitro and in vivo. Because of its short half-life, the secreted bridging protein will selectively accumulate at the site of highest antigen expression, ie. at the tumor. Bridging proteins that bind to multiple different tumor antigens have been created. Therefore, antigen-bridging CAR-CD19 T cells incorporate critical attributes for successful solid tumor cell therapy. This platform can be exploited to attack tumor antigens on any cancer.	[Ambrose, Christine; Su, Lihe; Wu, Lan; Dufort, Fay J.; Sanford, Thomas; Birt, Alyssa; Lobb, Roy R.; Rennert, Paul D.] Aleta Biotherapeut, Natick, MA 01760 USA; [Hackel, Benjamin J.] Univ Minnesota, Minneapolis, MN USA; [Hombach, Andreas; Abken, Hinrich] Univ Cologne, Cologne, Germany; [Abken, Hinrich] Regensburg Univ, Regensburg, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Cologne; University of Regensburg	Rennert, PD (corresponding author), Aleta Biotherapeut, Natick, MA 01760 USA.	paul.rennert@aletabio.com		Rennert, Paul/0000-0002-4573-3764; Hombach, Andreas/0000-0001-9328-8442	Advent Life Science Partners	Advent Life Science Partners	Aleta Biotherapeutics is wholly funded by Advent Life Science Partners, a venture capital firm. Therefore we would like to state the following - Advent Life Sciences did not play a role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of salaries for authors [CA, LS, LW, FJD, AB, PDR], and paid consulting fees [RRL] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Ajina A, 2018, MOL CANCER THER, V17, P1795, DOI 10.1158/1535-7163.MCT-17-1097; Akhavan D, 2019, IMMUNOL REV, V290, P60, DOI 10.1111/imr.12773; Alabanza L, 2017, MOL THER, V25, P2452, DOI 10.1016/j.ymthe.2017.07.013; Arndt C, 2020, CANCERS, V12, DOI 10.3390/cancers12051302; Balakrishnan A, 2019, CLIN CANCER RES, V25, P7506, DOI 10.1158/1078-0432.CCR-19-1479; Bannas P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01603; Bouchkouj N, 2019, CLIN CANCER RES, V25, P1702, DOI 10.1158/1078-0432.CCR-18-2743; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Buitrago J, 2019, CLIN J ONCOL NURS, V23, P42, DOI 10.1188/19.CJON.S1.42-48; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Callahan C, 2019, CLIN J ONCOL NURS, V23, P35, DOI 10.1188/19.CJON.S1.35-41; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Castellarin M, 2018, GENE THER, V25, P165, DOI 10.1038/s41434-018-0007-x; Cheadle EJ, 2010, J IMMUNOL, V184, P1885, DOI 10.4049/jimmunol.0901440; Chmielewski M, 2015, EXPERT OPIN BIOL TH, V15, P1145, DOI 10.1517/14712598.2015.1046430; Choi BD, 2019, NAT BIOTECHNOL, V37, P1049, DOI 10.1038/s41587-019-0192-1; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Dai XF, 2019, BIOTECHNOL ADV, V37, P239, DOI 10.1016/j.biotechadv.2018.12.002; De Oliveira SN, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-23; DiNofia AM, 2019, HEMASPHERE, V3, DOI 10.1097/HS9.0000000000000279; Duong MT, 2019, MOL THER-ONCOLYTICS, V12, P124, DOI 10.1016/j.omto.2018.12.009; Dustin ML, 2001, J CLIN IMMUNOL, V21, P258, DOI 10.1023/A:1010927208180; El-Hallak M, 2007, J PEDIATR-US, V150, P376, DOI 10.1016/j.jpeds.2006.10.067; Ellerman D, 2019, METHODS, V154, P102, DOI 10.1016/j.ymeth.2018.10.026; Feng KC, 2018, PROTEIN CELL, V9, P838, DOI 10.1007/s13238-017-0440-4; Finney OC, 2019, J CLIN INVEST, V129, P2123, DOI 10.1172/JCI125423; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Forsberg MH, 2018, THER CLIN RISK MANAG, V14, P1573, DOI 10.2147/TCRM.S146309; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Frigault MJ, 2019, BLOOD, V134, P860, DOI 10.1182/blood.2019001694; GarciaCozar FJ, 1996, CLIN EXP IMMUNOL, V104, P72, DOI 10.1046/j.1365-2249.1996.d01-648.x; Goebeler ME, 2020, NAT REV CLIN ONCOL, V17, P418, DOI 10.1038/s41571-020-0347-5; Gonzalez-Sapienza G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00977; Grada Z, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.32; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Guedan S, 2019, MOL THER-METH CLIN D, V12, P145, DOI 10.1016/j.omtm.2018.12.009; He XY, 2019, LEUKEMIA, V33, P2102, DOI 10.1038/s41375-019-0437-5; Hegde M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17175-8; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hryniewicki AT, 2018, J EMERG MED, V55, P489, DOI 10.1016/j.jemermed.2018.07.005; Johnson LA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4963; Junghans RP, 2016, PROSTATE, V76, P1257, DOI 10.1002/pros.23214; Klesmith JR, 2019, MOL PHARMACEUT, V16, P3544, DOI 10.1021/acs.molpharmaceut.9b00418; Knoblich K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005046; Knochelmann HM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01740; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Ma L, 2019, SCIENCE, V365, P162, DOI 10.1126/science.aav8692; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Mardiana S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2293; Mayya V, 2019, J IMMUNOL, V203, P601, DOI 10.4049/jimmunol.1801687; Mestermann K, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau5907; Neelapu SS, 2019, HEMATOL ONCOL, V37, P48, DOI 10.1002/hon.2595; Nicholson IC, 1997, MOL IMMUNOL, V34, P1157, DOI 10.1016/S0161-5890(97)00144-2; O'Leary MC, 2019, CLIN CANCER RES, V25, P1142, DOI 10.1158/1078-0432.CCR-18-2035; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Park JH, 2016, BLOOD, V127, P3312, DOI 10.1182/blood-2016-02-629063; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; PETRU E, 1990, GYNECOL ONCOL, V38, P155, DOI 10.1016/0090-8258(90)90032-G; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Qin HY, 2018, MOL THER-ONCOLYTICS, V11, P127, DOI 10.1016/j.omto.2018.10.006; Reinhard K, 2020, SCIENCE, V367, P446, DOI 10.1126/science.aay5967; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Sato S, 1997, J IMMUNOL, V159, P3278; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Schneider D, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0246-1; Schultz L, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2127; Singh N, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0406-4; Slaney CY, 2018, CANCER DISCOV, V8, P924, DOI 10.1158/2159-8290.CD-18-0297; Stampouloglou E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000591; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; Timmers M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01613; Tu SF, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01350; Wall DA, 2020, CURR ONCOL, V27, pS115, DOI 10.3747/co.27.5283; Wang DR, 2019, JOVE-J VIS EXP, DOI 10.3791/59275; Weber EW, 2019, BLOOD ADV, V3, P711, DOI 10.1182/bloodadvances.2018028720; Wu BX, 2019, EXP HEMATOL ONCOL, V8, DOI 10.1186/s40164-019-0151-z; Yang YM, 2017, BLOOD, V130; Ying ZT, 2019, NAT MED, V25, P947, DOI 10.1038/s41591-019-0421-7	80	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247701	10.1371/journal.pone.0247701	http://dx.doi.org/10.1371/journal.pone.0247701			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735268	gold, Green Submitted, Green Published			2022-12-26	WOS:000631029700064
J	Chanyalew, H; Girma, E; Birhane, T; Chanie, MG				Chanyalew, Haile; Girma, Eshetu; Birhane, Tesfaye; Chanie, Muluken Genetu			Male partner involvement in HIV testing and counseling among partners of pregnant women in the Delanta District, Ethiopia	PLOS ONE			English	Article								Background Only screening a pregnant mother is not satisfactory to prevent mother-to-child transmission of HIV (PMTCT). A male partner's involvement in HIV testing and counseling is also critical for PMTCT, however, it is one of the biggest challenges in Ethiopia. This study aimed to assess a male partner's involvement in HIV testing and counseling and associated factors among partners of pregnant women in the Delanta District, Northern Ethiopia. Methods A community-based cross-sectional study design was conducted in the Delanta District from March 15 to May 10, 2018. During the study period, 609 male partners were involved. A binary and multiple logistic regression model was used to examine the association between variables. Results Out of all, 325 (53.7% at 95% CI: 49.6 to 57.5) of male partners were involved in HIV testing and counseling in the District. Male partners who were living together, ever heard about HIV from health professionals, pregnant women's antenatal care (ANC) visit, partner visited the PMTCT clinic with wife, and partner and wife discussion before HIV testing and counseling were factors associated with male partner involvement. Conclusion The proportion of male partner involvement was found to be low as compared to the national standards. Local health authorities and health care workers need to develop and conduct interventions that help partners with their wife to live together, improve their awareness about HIV and testing, ANC visit by pregnant women, and encourage having home discussion before HIV testing through counseling, by so doing finally raise the level of male partner involvement in HIV testing and counseling.	[Chanyalew, Haile] Delanta Dist Hlth Off, Delanta, South Wollo, Ethiopia; [Girma, Eshetu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Birhane, Tesfaye; Chanie, Muluken Genetu] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dessie, Ethiopia	Addis Ababa University	Chanie, MG (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dessie, Ethiopia.	mlkngnt@gmail.com		Genetu Chanie, MULUKEN/0000-0001-7059-1449				Alemu Z, 2016, MALE PARTNERS INVOLV; Amanuel, 2013, AFRICAN J AIDS HIV R, V1, P16; [Anonymous], 2015, FACTSH WHO CONS GUID; [Anonymous], 2016, DETERMINANTS MALE PA; Assefa Fekede., 2014, E ETHIOPIA, V2, P182; Birhane T, 2015, J PREGNANCY, V2015, DOI 10.1155/2015/960830; Coulibaly M, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0569-y; Degefa Tadele Belato, 2017, CASE LEMO DISTRICT H; Delanta Woreda Government communication office 2009, 2009, ANN REPORT DELANTA W; Ekaete Francis, 2016, INVOLVEMENT HLTH CAR; Haile F., 2014, MALE PARTNER INVOLVE; Joint United Nations Programme on HIV/AIDS (UNAIDS), 1999, PREV HIV TRANSM MON; Lemma E., 2017, J WOMENS HLTH CARE, V6, P2167; Molla Godif, 2015, EVIDENCE ETHIOPIAN D; Motlagabo G, 2017, FACTORS ASS MALE PAR; Mulusew T, 2015, MALE INVOLVEMENT PRE; Organization W.H., 2007, PREV MOTH TO CHILD T; The Ethiopian Public Health Institute, 2017, HIV RELATED ESTIMATE; Tilahun M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/763876; UNAIDS, 2017, FACT SHEET GLOB HIV	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248436	10.1371/journal.pone.0248436	http://dx.doi.org/10.1371/journal.pone.0248436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730107	gold, Green Published			2022-12-26	WOS:000630345000012
J	Lahmer, T; Kriescher, S; Herner, A; Rothe, K; Spinner, CD; Schneider, J; Mayer, U; Neuenhahn, M; Hoffmann, D; Geisler, F; Heim, M; Schneider, G; Schmid, RM; Huber, W; Rasch, S				Lahmer, Tobias; Kriescher, Silja; Herner, Alexander; Rothe, Kathrin; Spinner, Christoph D.; Schneider, Jochen; Mayer, Ulrich; Neuenhahn, Michael; Hoffmann, Dieter; Geisler, Fabian; Heim, Markus; Schneider, Gerhard; Schmid, Roland M.; Huber, Wolfgang; Rasch, Sebastian			Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study	PLOS ONE			English	Article								Background Superinfections, including invasive pulmonary aspergillosis (IPA), are well-known complications of critically ill patients with severe viral pneumonia. Aim of this study was to evaluate the incidence, risk factors and outcome of IPA in critically ill patients with severe COVID-19 pneumonia. Methods We prospectively screened 32 critically ill patients with severe COVID-19 pneumonia for a time period of 28 days using a standardized study protocol for oberservation of developement of COVID-19 associated invasive pulmonary aspergillosis (CAPA). We collected laboratory, microbiological, virological and clinical parameters at defined timepoints in combination with galactomannan-antigen-detection from nondirected bronchial lavage (NBL). We used logistic regression analyses to assess if COVID-19 was independently associated with IPA and compared it with matched controls. Findings CAPA was diagnosed at a median of 4 days after ICU admission in 11/32 (34%) of critically ill patients with severe COVID-19 pneumonia as compared to 8% in the control cohort. In the COVID-19 cohort, mean age, APACHE II score and ICU mortality were higher in patients with CAPA than in patients without CAPA (36% versus 9.5%; p<0.001). ICU stay (21 versus 17 days; p = 0.340) and days of mechanical ventilation (20 versus 15 days; p = 0.570) were not different between both groups. In regression analysis COVID-19 and APACHE II score were independently associated with IPA. Interpretation CAPA is highly prevalent and associated with a high mortality rate. COVID-19 is independently associated with invasive pulmonary aspergillosis. A standardized screening and diagnostic approach as presented in our study can help to identify affected patients at an early stage.	[Lahmer, Tobias; Herner, Alexander; Spinner, Christoph D.; Schneider, Jochen; Mayer, Ulrich; Geisler, Fabian; Schmid, Roland M.; Huber, Wolfgang; Rasch, Sebastian] Tech Univ Munich, Klin & Poliklin Innere Med 2, Klinikum Rechts Isar, Munich, Germany; [Kriescher, Silja; Heim, Markus; Schneider, Gerhard] Tech Univ Munich, Klin & Poliklin Aneasthesiol & Intens Med, Klinikum Rechts Isar, Munich, Germany; [Rothe, Kathrin; Neuenhahn, Michael] Tech Univ Munich, Inst Mikrobiol Immunol & Hyg, Munich, Germany; [Hoffmann, Dieter] Tech Univ Munich, Inst Virol, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Lahmer, T (corresponding author), Tech Univ Munich, Klin & Poliklin Innere Med 2, Klinikum Rechts Isar, Munich, Germany.	TobiasLahmer@me.com		Spinner, Christoph/0000-0002-3875-5367; Rasch, Sebastian/0000-0002-7917-8017				ABBOTT JD, 1952, BRIT MED J, V1, P523, DOI 10.1136/bmj.1.4757.523; Alhazzani Waleed, 2020, Intensive Care Med, V46, P854, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bartoletti M, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1065, DOI 10.1093/CID/CIAA1065]; Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC; D'Haese J, 2012, J CLIN MICROBIOL, V50, P1258, DOI 10.1128/JCM.06423-11; Donnelly JP, 2020, CLIN INFECT DIS, V71, P1367, DOI 10.1093/cid/ciz1008; Koehler P., 2020, LANCET INFECT DIS, V14, DOI [10.1016/S1473-3099%2820%2930847-1, DOI 10.1016/S1473-3099%2820%2930847-1]; Koehler P, 2020, MYCOSES, V63, P528, DOI 10.1111/myc.13096; Lahmer T, 2020, CLIN MICROBIOL INFEC, V26, P1428, DOI 10.1016/j.cmi.2020.05.032; Ledoux MP, 2020, SEMIN RESP CRIT CARE, V41, P80, DOI 10.1055/s-0039-3401990; Leeflang MMG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394.pub2; Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; Rizzo P, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0791-5; Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Ullmann AJ, 2018, CLIN MICROBIOL INFEC, V24, pE1, DOI 10.1016/j.cmi.2018.01.002; Van Biesen S, 2020, AM J RESP CRIT CARE, V202, P1171, DOI 10.1164/rccm.202005-2018LE; van de Veerdonk FL, 2017, AM J RESP CRIT CARE, V196, P524, DOI [10.1164/rccm.201612-2540LE, 10.1164/rccm.201612-2540le]; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Verweij PE., 2020, LANCET MICROBE, V1, pE55, DOI [10.1016/S2666-5247%2820%2930027-6, DOI 10.1016/S2666-5247%2820%2930027-6]; Wauters J, 2012, INTENS CARE MED, V38, P1761, DOI 10.1007/s00134-012-2673-2; White L., 2021, CLIN INFECT DIS, V73, pe1634, DOI [10.2139/ssrn.3644400, DOI 10.2139/SSRN.3644400, 10.1093/cid/ciaa1298, DOI 10.1093/CID/CIAA1298]; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	56	56	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0238825	10.1371/journal.pone.0238825	http://dx.doi.org/10.1371/journal.pone.0238825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730058	gold, Green Submitted, Green Published			2022-12-26	WOS:000630345000078
J	Lawson, AB; Kim, J				Lawson, Andrew B.; Kim, Joanne			Space-time covid-19 Bayesian SIR modeling in South Carolina	PLOS ONE			English	Article								The Covid-19 pandemic has spread across the world since the beginning of 2020. Many regions have experienced its effects. The state of South Carolina in the USA has seen cases since early March 2020 and a primary peak in early April 2020. A lockdown was imposed on April 6th but lifting of restrictions started on April 24th. The daily case and death data as reported by NCHS (deaths) via the New York Times GitHUB repository have been analyzed and approaches to modeling of the data are presented. Prediction is also considered and the role of asymptomatic transmission is assessed as a latent unobserved effect. Two different time periods are examined and one step prediction is provided. The results suggest that both socio-economic disadvantage, asymptomatic transmission and spatial confounding are important ingredients in any model pertaining to county level case dynamics.	[Lawson, Andrew B.; Kim, Joanne] Med Univ South Carolina, Dept Publ Hlth Sci, Div Biostat & Bioinformat, Charleston, SC 29425 USA	Medical University of South Carolina	Lawson, AB (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Div Biostat & Bioinformat, Charleston, SC 29425 USA.	lawsonab@musc.edu						[Anonymous], COVID 19 PANDEMIC PL; [Anonymous], STAN WIKI 2020; Banks D., 2020, HARVARD DATA SCI REV, DOI [10.1162/99608f92.a1f00368, DOI 10.1162/99608F92.A1F00368]; Calafiore GC, 2020, ANNU REV CONTROL, V50, P361, DOI 10.1016/j.arcontrol.2020.10.005; Calvetti D, 2020, ARXIV200504365V2; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lawson A., 2018, BAYESIAN DIS MAPPING, V3rd; Lawson AB, 2010, SPAT SPATIO-TEMPORAL, V1, P187, DOI 10.1016/j.sste.2010.03.001; Morton A, 2005, J R STAT SOC C-APPL, V54, P575, DOI 10.1111/j.1467-9876.2005.05366.x; Rouabah MT, 2020, ARXIV200513516V4; Sartorius B., 2021, SCI REP-UK; Spiegelhalter DJ, 2014, J R STAT SOC B, V76, P485, DOI 10.1111/rssb.12062; Wen HY, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.07.025; Zhou Y., 2020, SPATIOTEMPORAL EPIDE, DOI [DOI 10.1162/99608F92.79-1F45E, 10.1162/99608f92.79e1f45e, DOI 10.1162/99608F92.79E1F45E, 10.1162/99608f92.79-1f45e]	15	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0242777	10.1371/journal.pone.0242777	http://dx.doi.org/10.1371/journal.pone.0242777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730035	Green Submitted, Green Published, gold			2022-12-26	WOS:000630345000004
J	Sangphukieo, A; Laomettachit, T; Ruengjitchatchawalya, M				Sangphukieo, Apiwat; Laomettachit, Teeraphan; Ruengjitchatchawalya, Marasri			PhotoModPlus: A web server for photosynthetic protein prediction from genome neighborhood features	PLOS ONE			English	Article							SP PCC 6803; CHROMATIC ACCLIMATION; NAD(P)H DEHYDROGENASE; NADPH DEHYDROGENASE; ELECTRON-TRANSPORT; IRON-DEFICIENCY; PHOTOSYSTEM-I; HIGH LIGHT; SYNECHOCYSTIS; SUBUNIT	A new web server called PhotoModPlus is presented as a platform for predicting photosynthetic proteins via genome neighborhood networks (GNN) and genome neighborhood-based machine learning. GNN enables users to visualize the overview of the conserved neighboring genes from multiple photosynthetic prokaryotic genomes and provides functional guidance on the query input. In the platform, we also present a new machine learning model utilizing genome neighborhood features for predicting photosynthesis-specific functions based on 24 prokaryotic photosynthesis-related GO terms, namely PhotoModGO. The new model performed better than the sequence-based approaches with an F1 measure of 0.872, based on nested five-fold cross-validation. Finally, we demonstrated the applications of the webserver and the new model in the identification of novel photosynthetic proteins. The server is user-friendly, compatible with all devices, and available at bicep.kmutt.ac.th/photomod.	[Sangphukieo, Apiwat; Laomettachit, Teeraphan; Ruengjitchatchawalya, Marasri] King Mongkuts Univ Technol Thonburi KMUTT, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Sangphukieo, Apiwat] KMUTT, Sch Informat Technol, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] KMUTT, Biotechnol Program, Sch Bioresources & Technol, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] KMUTT, Algal Biotechnol Res Grp, Pilot Plant Dev & Training Inst, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Ruengjitchatchawalya, M (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.; Ruengjitchatchawalya, M (corresponding author), KMUTT, Biotechnol Program, Sch Bioresources & Technol, Bangkok, Thailand.; Ruengjitchatchawalya, M (corresponding author), KMUTT, Algal Biotechnol Res Grp, Pilot Plant Dev & Training Inst, Bangkok, Thailand.	marasri.rue@kmutt.ac.th		Sangphukieo, Apiwat/0000-0001-5210-5398; Laomettachit, Teeraphan/0000-0003-3194-1391	Petchra Pra JomKlao Doctoral Scholarship from King Mongkut's University of Technology Thonburi [13/2558]; National Research Council of Thailand [NRMJ: 2559A30602134, 60000108]	Petchra Pra JomKlao Doctoral Scholarship from King Mongkut's University of Technology Thonburi; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was partly supported by Petchra Pra JomKlao Doctoral Scholarship (No: 13/2558) from King Mongkut's University of Technology Thonburi and a research grant (NRMJ: 2559A30602134#60000108) from the National Research Council of Thailand (http://en.nrct.go.th).The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. There was no additional external funding received for this study.	Ashkenazi S, 2012, BIOINFORMATICS, V28, P3203, DOI 10.1093/bioinformatics/bts608; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boutell MR, 2004, PATTERN RECOGN, V37, P1757, DOI 10.1016/j.patcog.2004.03.009; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28361; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eva C, 2019, PLANT SCI, V280, P433, DOI 10.1016/j.plantsci.2018.11.010; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Gao FD, 2016, PLANT PHYSIOL, V170, P752, DOI 10.1104/pp.15.01430; Grossman A, 2019, MICROBIOL-SGM, V165, P697, DOI 10.1099/mic.0.000788; Han LY, 2005, NEW PHYTOL, V168, P109, DOI 10.1111/j.1469-8137.2005.01482.x; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Ho MY, 2017, PHOTOSYNTH RES, V131, P187, DOI 10.1007/s11120-016-0303-5; Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7; Ishikawa M, 2009, PLANT CELL PHYSIOL, V50, P773, DOI 10.1093/pcp/pcp027; Jiang YX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1037-6; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Kizawa A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00193; Knoppova J, 2016, PLANT CELL PHYSIOL, V57, P1921, DOI 10.1093/pcp/pcw115; Kojima K, 2006, PHYSIOL PLANTARUM, V128, P507, DOI 10.1111/j.1399-3054.2006.00781.x; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Kulmanov M, 2020, BIOINFORMATICS, V36, P422, DOI 10.1093/bioinformatics/btz595; Lechno-Yossef S, 2020, NEW PHYTOL, V225, P793, DOI 10.1111/nph.16195; Lee HD, 2015, 24 INT JOINT C ART I; Li YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155290; Liu BJ, 2015, GENE, V563, P196, DOI 10.1016/j.gene.2015.03.025; Maurino VG, 2013, J EXP BOT, V64, P743, DOI 10.1093/jxb/ers263; Mi HL, 2001, PHOTOSYNTH RES, V70, P167, DOI 10.1023/A:1017946524199; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Muzzopappa F, 2017, PLANT PHYSIOL, V175, P1283, DOI 10.1104/pp.17.01040; Nurnberg DJ, 2018, SCIENCE, V360, P1210, DOI 10.1126/science.aar8313; Olsen MT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00604; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Psomopoulos FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052854; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Raman Karthik, 2010, Autom Exp, V2, P2, DOI 10.1186/1759-4499-2-2; Rast A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00605; Read J, 2016, J MACH LEARN RES, V17; Read J, 2014, IEEE DATA MINING, P941, DOI 10.1109/ICDM.2014.38; Rudolf JD, 2016, J IND MICROBIOL BIOT, V43, P261, DOI 10.1007/s10295-015-1671-0; Sanfilippo JE, 2019, ANNU REV MICROBIOL, V73, P407, DOI 10.1146/annurev-micro-020518-115738; Sanfilippo JE, 2016, P NATL ACAD SCI USA, V113, P6077, DOI 10.1073/pnas.1600625113; Sangphukieo A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64053-w; Sarkar D., 2015, BIORESOUR BIOPROCESS, V2, P17, DOI [10.1186/s40643-015-0045-9, DOI 10.1186/S40643-015-0045-9]; Saur M, 2017, STRUCTURE, V25, P1380, DOI 10.1016/j.str.2017.07.001; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Singh JS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00529; Skunca N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002533; Tanaka Y, 1997, PLANT CELL PHYSIOL, V38, P1311, DOI 10.1093/oxfordjournals.pcp.a029123; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Vasylenko T, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S1-S8; Walter J, 2019, BBA-BIOENERGETICS, V1860, P519, DOI 10.1016/j.bbabio.2019.04.007; Wang Linhua, 2018, F1000Res, V7, DOI 10.12688/f1000research.16415.1; Wang XZ, 2016, PLANT PHYSIOL, V171, P864, DOI 10.1104/pp.15.01796; Warren PB, 2004, J MOL BIOL, V342, P1379, DOI 10.1016/j.jmb.2004.07.074; Wiltbank LB, 2016, MBIO, V7, DOI 10.1128/mBio.02130-15; Zer H, 2018, PLANT J, V93, P235, DOI 10.1111/tpj.13770; Zhao JH, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02183; Zhao JH, 2014, CHINESE SCI BULL, V59, P4484, DOI 10.1007/s11434-014-0596-8; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275; Zheng Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-243	68	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248682	10.1371/journal.pone.0248682	http://dx.doi.org/10.1371/journal.pone.0248682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730083	gold, Green Submitted, Green Published			2022-12-26	WOS:000630345000027
J	Kotlar, RM; Jones, ND; Senavirathne, G; Gardner, AM; Messer, RK; Tan, YY; Rabe, AJ; Fishel, R; Yoder, KE				Kotlar, Randi M.; Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.			Retroviral prototype foamy virus intasome binding to a nucleosome target does not determine integration efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CORE PARTICLES; DNA; PROTEINS; DOMAINS; SITES; MECHANISM; AFFINITY	Retroviral integrases must navigate host DNA packaged as chromatin during integration of the viral genome. Prototype foamy virus (PFV) integrase (IN) forms a tetramer bound to two viral DNA (vDNA) ends in a complex termed an intasome. PFV IN consists of four domains: the amino terminal extension domain (NED), amino terminal domain (NTD), catalytic core domain (CCD), and carboxyl terminal domain (CTD). The domains of the two inner IN protomers have been visualized, as well as the CCDs of the two outer IN protomers. However, the roles of the amino and carboxyl terminal domains of the PFV intasome outer subunits during integration to a nucleosome target substrate are not clear. We used the well-characterized 601 nucleosome to assay integration activity as well as intasome binding. PFV intasome integration to 601 nucleosomes occurs in clusters at four independent sites. We find that the outer protomer NED and NTD domains have no significant effects on integration efficiency, site selection, or binding. The CTDs of the outer PFV intasome subunits dramatically affect nucleosome binding but have little effect on total integration efficiency. The outer PFV IN CTDs did significantly alter the integration efficiency at one site. Histone tails also significantly affect intasome binding, but have little impact on PFV integration efficiency or site selection. These results indicate that binding to nucleosomes does not correlate with integration efficiency and suggests most intasome-binding events are unproductive.	[Kotlar, Randi M.; Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Coll Med, Canc Biol & Genet, Columbus, OH 43210 USA; [Jones, Nathan D.; Senavirathne, Gayan; Gardner, Anne M.; Messer, Ryan K.; Tan, Yow Yong; Rabe, Anthony J.; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kotlar, Randi M.] Tessera Therapeut, Cambridge, MA USA; [Jones, Nathan D.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Yoder, KE (corresponding author), Ohio State Univ, Coll Med, Canc Biol & Genet, Columbus, OH 43210 USA.; Yoder, KE (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.	yoder.176@osu.edu	Yoder, Kristine/E-4353-2011	Yoder, Kristine/0000-0002-5598-9018; Senavirathne, Gayan/0000-0002-9113-4201; Kotlar, Randi/0000-0002-2513-6479; Gardner, Anne/0000-0001-7095-772X	National Institutes of Health [AI099854, AI126742]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (AI099854 to K. E. Y. and AI126742 to K. E. Y. and R. F.). Funding for open access charge: National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Brehove M, 2015, J BIOL CHEM, V290, P22612, DOI 10.1074/jbc.M115.661363; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Coffin J, 1997, RETROVIRUSES; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Engelman AN, 2017, CURR OPIN STRUC BIOL, V47, P23, DOI 10.1016/j.sbi.2017.04.005; Gracey LE, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-13; Guo H, 2003, P NATL ACAD SCI USA, V100, P3743, DOI 10.1073/pnas.0737062100; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hart DJ, 1999, NUCLEIC ACIDS RES, V27, P1063, DOI 10.1093/nar/27.4.1063; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jones ND, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36725-1; Jones ND, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11409; Li M, 2016, PROTEIN SCI, V25, P472, DOI 10.1002/pro.2837; Li M, 2012, METHOD ENZYMOL, V513, P29, DOI 10.1016/B978-0-12-391938-0.00002-1; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mackler R. M., 2018, J VIS EXP, V57453; Mackler RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212764; Maertens GN, 2016, NUCLEIC ACIDS RES, V44, P364, DOI 10.1093/nar/gkv1347; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; MILLS JB, 1994, BIOCHEMISTRY-US, V33, P1797, DOI 10.1021/bi00173a024; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wilson MD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12007-w; Winans S, 2017, J VIROL, V91, DOI 10.1128/JVI.00082-17; Yang ZY, 2007, J BIOL CHEM, V282, P7930, DOI 10.1074/jbc.M610584200; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950	51	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100550	10.1016/j.jbc.2021.100550	http://dx.doi.org/10.1016/j.jbc.2021.100550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744295	gold, Green Published			2022-12-26	WOS:000672866400523
J	Romana-Souza, B; Chen, L; Leonardo, TR; Chen, ZL; DiPietro, LA				Romana-Souza, Bruna; Chen, Lin; Leonardo, Trevor R.; Chen, Zhenlong; DiPietro, Luisa A.			Dermal fibroblast phagocytosis of apoptotic cells: A novel pathway for wound resolution	FASEB JOURNAL			English	Article						apoptosis; endothelial cell; fibroblasts; milk fat globule&#8208; EGF factor 8 protein; phagocytosis; wound healing		The effective clearance of apoptotic cells is an essential step in the resolution of healing wounds. In particular, blood vessel regression during wound resolution produces a significant number of apoptotic endothelial cells (ApoEC) that must be cleared. In considering the fate of ApoEC and the presence of fibroblasts during wound resolution, we hypothesized that fibroblasts might serve as phagocytes involved in endothelial cell removal. The current study investigated whether dermal fibroblasts engulf ApoEC, whether this uptake alters the phenotype of dermal fibroblasts, and the biological molecules involved. In both in vitro and in vivo studies, following ApoEC engulfment, fibroblasts acquired a pro-healing phenotype (increased cell migration, contractility, alpha-smooth muscle actin expression, and collagen deposition). In addition, fibroblast uptake of ApoEC was shown to be mediated in part by the milk fat globule-EGF factor 8 protein/integrin alpha(v)beta(5) pathway. Our study demonstrates a novel function of fibroblasts in the clearance of ApoEC and suggests that this capability has significant implications for tissue repair and fibrosis.	[Romana-Souza, Bruna] Univ Estado Rio De Janeiro, Tissue Repair Lab, 381 Marechal Rondon Ave, BR-20950003 Rio De Janeiro, RJ, Brazil; [Chen, Lin; DiPietro, Luisa A.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, 801 S Paulina St, Chicago, IL 60612 USA; [Leonardo, Trevor R.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL USA; [Chen, Zhenlong] Univ Illinois, Dept Anesthesiol, Chicago, IL USA	Universidade do Estado do Rio de Janeiro; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Romana-Souza, B (corresponding author), Univ Estado Rio De Janeiro, Tissue Repair Lab, 381 Marechal Rondon Ave, BR-20950003 Rio De Janeiro, RJ, Brazil.; DiPietro, LA (corresponding author), Univ Illinois, Ctr Wound Healing & Tissue Regenerat, 801 S Paulina St, Chicago, IL 60612 USA.	bruna.romana.souza@uerj.br; Ldipiet@uic.edu	Chen, Zhenlong/AAQ-9578-2021; Romana-Souza, Bruna/O-9104-2017	Romana-Souza, Bruna/0000-0001-5665-8694	National Institutes of Health [NIH R01 GM50875, F31 DE028747]; National Council of Research (CNPq) [203109/2018-0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council of Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by National Institutes of Health grants: NIH R01 GM50875 (LAD) and F31 DE028747 (TRL). In addition, the authors thank National Council of Research (CNPq) for its support of BRS's postdoctoral scholarship (Number: 203109/2018-0)	Akasaka Y, 2000, LAB INVEST, V80, P345, DOI 10.1038/labinvest.3780039; Akasaka Y, 2001, WOUND REPAIR REGEN, V9, P501, DOI 10.1046/j.1524-475x.2001.00501.x; Arai S, 2018, SEMIN IMMUNOPATHOL, V40, P567, DOI 10.1007/s00281-018-0717-6; Barth ND, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01708; Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; De Felice B, 2009, MOL CELL BIOCHEM, V327, P191, DOI 10.1007/s11010-009-0057-x; Dimmeler S, 2000, CIRC RES, V87, P434; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gurevich DB, 2018, EMBO J, V37, DOI 10.15252/embj.201797786; Han CZ, 2016, NATURE, V539, P570, DOI 10.1038/nature20141; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Laplante P, 2017, J INVEST DERMATOL, V137, P2005, DOI 10.1016/j.jid.2017.04.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Messadi DV, 1999, WOUND REPAIR REGEN, V7, P511, DOI 10.1046/j.1524-475X.1999.00511.x; Michalczyk ER, 2020, ADV WOUND CARE, V9, P1, DOI 10.1089/wound.2019.1019; Michalczyk ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29465-9; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nakaya M, 2017, J CLIN INVEST, V127, P383, DOI 10.1172/JCI83822; Ngo P, 2006, METH MOL B, V341, P103; Perez B, 2012, J BIOL CHEM, V287, P16029, DOI 10.1074/jbc.M112.340489; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwegler M, 2015, BIOL CELL, V107, P372, DOI 10.1111/boc.201400090; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Uchiyama A, 2017, J DERMATOL SCI, V86, P187, DOI 10.1016/j.jdermsci.2017.02.285; Uchiyama A, 2015, J INVEST DERMATOL, V135, P1157, DOI 10.1038/jid.2014.515; Watson EC, 2017, CELL MOL LIFE SCI, V74, P4387, DOI 10.1007/s00018-017-2577-y; Wietecha MS, 2015, AM J PHYSIOL-HEART C, V309, pH812, DOI 10.1152/ajpheart.00153.2015; Wietecha MS, 2013, CURR TOP MICROBIOL, V367, P3, DOI 10.1007/82_2012_287; Wood W, 2000, DEVELOPMENT, V127, P5245; Yoon H, 2020, EXP EYE RES, V194, DOI 10.1016/j.exer.2020.108017; Zeng RJ, 2018, CELL TISSUE RES, V374, P217, DOI 10.1007/s00441-018-2830-1; Zhang MZ, 2017, AM J TRANSL RES, V9, P5548; Zomer HD, 2018, J DERMATOL SCI, V90, P3, DOI 10.1016/j.jdermsci.2017.12.009	45	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21443	10.1096/fj.202002078R	http://dx.doi.org/10.1096/fj.202002078R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749877	Green Accepted			2022-12-26	WOS:000635216100063
J	Xie, X; Chen, H; Zhang, LL; Chan, D; Hill, WG; Zeidel, ML; Yu, WQ				Xie, Xiang; Chen, Huan; Zhang, Lanlan; Chan, Daniel; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun			Molecular mechanisms of voiding dysfunction in a novel mouse model of acute urinary retention	FASEB JOURNAL			English	Article						integrin signaling; lower urinary tract symptoms; purinergic signaling; smooth muscle contractility; urodynamics	INTEGRIN-LINKED KINASE; ACUTE OVERDISTENSION; SUBSEQUENT CATHETERIZATION; TRACT FUNCTION; ATP RELEASE; BLADDER; MATRIX; MICE; MECHANOSENSITIVITY; CONTRACTILITY	Acute urinary retention (AUR) is a common urological emergency and affects a significant patient population. The inability to eliminate urine may lead to permanent damage to the bladder's structure and functioning. However, we know little about the underlying molecular sequelae to the urine retention. To closely mirror the potential high pressures that patients with AUR could experience, we catheterized anesthetized female mice via the urethra and filled the bladder by pumping saline (25 mu L/min) into the bladder lumen to 50 cm or 80 cm water pressure. A water column with designated height (50 or 80 cm) was then adjusted to maintain constant pressure in the bladder lumen for 30 minutes. Functional and morphological evaluations were performed from 0 to 24 hours after AUR treatment. Mice exhibited incontinence and overactivity with diminished voiding pressure. Significant injury was confirmed which revealed bladders with disrupted urothelial barrier, edematous lamina propria, and distorted muscle bundles. Bladder smooth muscle (BSM) from pressure-treated mice have significantly diminished contraction force, suggesting that bladder voiding dysfunction can be attributed to impaired BSM contractility. Indeed, dysregulation of acetylcholine and purinergic signaling pathways were demonstrated, indicating that reduced efficacy of these pathways contributes to impaired BSM contractility. Finally, altered expression of beta 1-integrin and extracellular matrix mediated mechanotransduction pathways were detected, suggesting a profound remodeling process. These data demonstrated an easy to perform, quantifiable, and reproducible AUR mouse model, which mimics well the characteristics of human AUR patients, and our data generate new insights into the molecular mechanisms that occur following AUR.	[Xie, Xiang; Chen, Huan; Zhang, Lanlan; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun] Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA; [Xie, Xiang; Chen, Huan; Zhang, Lanlan; Hill, Warren G.; Zeidel, Mark L.; Yu, Weiqun] Harvard Med Sch, Boston, MA 02115 USA; [Chan, Daniel] Brown Univ Harvard Summer Res Program Kidney Med, Providence, RI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yu, WQ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, RN380B,99 Brookline Ave, Boston, MA 02215 USA.	wyu2@bidmc.harvard.edu		Chan, Daniel Y./0000-0002-7507-3218; Chen, Huan/0000-0002-6487-7923				Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Baldini G, 2009, ANESTHESIOLOGY, V110, P1139, DOI 10.1097/ALN.0b013e31819f7aea; Berggren T, 1998, UROL RES, V26, P325, DOI 10.1007/s002400050064; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bross S, 1999, EUR UROL, V36, P354, DOI 10.1159/000019999; Carere M, 2018, CAN J EMERG MED, V20, P640, DOI 10.1017/cem.2017.408; Cathcart P, 2006, J UROLOGY, V176, P200, DOI 10.1016/S0022-5347(06)00509-X; Chen H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18167-4; Chen H, 2017, AM J PHYSIOL-RENAL, V313, pF1274, DOI 10.1152/ajprenal.00318.2017; CHEN MW, 1994, MOL CELL BIOCHEM, V132, P39, DOI 10.1007/BF00925673; Choong S, 2000, BJU INT, V85, P186, DOI 10.1046/j.1464-410x.2000.00409.x; Dubey D, 2001, BJU INT, V88, P178, DOI 10.1046/j.1464-410x.2001.02273.x; Dwivedi A, 2008, BASIC RES CARDIOL, V103, P244, DOI 10.1007/s00395-007-0693-9; Ens G, 2015, TRANSL ANDROL UROL, V4, P624, DOI 10.3978/j.issn.2223-4683.2015.09.04; Etafy MH, 2017, UROL ANNALS, V9, P339, DOI 10.4103/0974-7796.216320; Furuya K, 2005, J CELL SCI, V118, P3289, DOI 10.1242/jcs.02453; Hao Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122112; Ho B, 2008, AM J PATHOL, V173, P278, DOI 10.2353/ajpath.2008.071046; Horton ER, 2016, EXP CELL RES, V343, P7, DOI 10.1016/j.yexcr.2015.10.025; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Kanasaki K, 2013, FASEB J, V27, P1950, DOI 10.1096/fj.12-223404; KATO K, 1988, J UROLOGY, V140, P880, DOI 10.1016/S0022-5347(17)41849-0; Khara S, 2019, BRIT J HOSP MED, V80, pC103, DOI 10.12968/hmed.2019.80.7.C103; KITADA S, 1989, J UROLOGY, V141, P166, DOI 10.1016/S0022-5347(17)40633-1; LASANEN LT, 1992, SCAND J UROL NEPHROL, V26, P253, DOI 10.3109/00365599209180878; LAWSON JD, 1952, J UROLOGY, V67, P951, DOI 10.1016/S0022-5347(17)68439-8; LAWSON JD, 1951, J UROLOGY, V66, P678, DOI 10.1016/S0022-5347(17)74397-2; Leppilahti M, 1999, UROL RES, V27, P272, DOI 10.1007/s002400050122; Leppilahti M, 1997, SCAND J UROL NEPHROL, V31, P517, DOI 10.3109/00365599709030654; Li WJ, 2011, APOPTOSIS, V16, P574, DOI 10.1007/s10495-011-0588-y; Mahavadi S, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13495; Oelke M, 2015, UROLOGY, V86, P654, DOI 10.1016/j.urology.2015.06.025; Ohmasa F, 2010, EUR J PHARMACOL, V635, P194, DOI 10.1016/j.ejphar.2010.02.052; Piraprez M., 2017, REV MED LIEGE, V72, p529; Rajandram R, 2016, AM J PHYSIOL-RENAL, V310, pF885, DOI 10.1152/ajprenal.00483.2015; Reitz A, 2004, EUR UROL, V46, P235, DOI 10.1016/j.eururo.2004.04.009; Saito M, 2001, J UROLOGY, V165, P1745, DOI 10.1016/S0022-5347(05)66406-3; Saito M, 2010, MOL CELL BIOCHEM, V333, P109, DOI 10.1007/s11010-009-0210-6; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Selius BA, 2008, AM FAM PHYSICIAN, V77, P643; Shimizu S, 2009, BJU INT, V104, P713, DOI 10.1111/j.1464-410X.2009.08471.x; Swartzberg K., 2017, CASE REP EMERG MED, V2017; Takahara N, 2014, AM J RESP CELL MOL, V51, P772, DOI 10.1165/rcmb.2014-0008OC; TAMMELA TLJ, 1993, J UROLOGY, V150, P1533, DOI 10.1016/S0022-5347(17)35836-6; TANAGHO E A, 1970, British Journal of Urology, V42, P175, DOI 10.1111/j.1464-410X.1970.tb10019.x; TAYLOR DE, 1963, LANCET, V2, P1033; Thomas K, 2005, BJU INT, V95, P72, DOI 10.1111/j.1464-410X.2004.05254.x; TONG YC, 1992, J UROLOGY, V148, P1347, DOI 10.1016/S0022-5347(17)36906-9; Upadhyay J, 2003, J UROLOGY, V169, P750, DOI 10.1016/S0022-5347(05)64007-4; Vecchione C, 2009, HYPERTENSION, V54, P1028, DOI 10.1161/HYPERTENSIONAHA.109.136572; Walker NF, 2016, NEUROUROL URODYNAM, V35, P866, DOI 10.1002/nau.22851; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wu YD, 2016, AM J PHYSIOL-LUNG C, V311, pL893, DOI 10.1152/ajplung.00299.2016; Yu WQ, 2015, AM J PHYSIOL-RENAL, V309, pE864, DOI 10.1152/ajprenal.00175.2015; Yu WQ, 2014, FASEB J, V28, P5288, DOI 10.1096/fj.14-255885; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014; Yu WQ, 2013, FASEB J, V27, P1895, DOI 10.1096/fj.12-219006	58	1	1	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21447	10.1096/fj.202002415R	http://dx.doi.org/10.1096/fj.202002415R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742688				2022-12-26	WOS:000635216100082
J	Bernardino-Sgherri, J; Siberchicot, C; Auvre, F; Busso, D; Brocas, C; El Masri, G; Lioutsko, A; Ferri, F; Radicella, JP; Romeo, PH; Bravard, A				Bernardino-Sgherri, Jacqueline; Siberchicot, Capucine; Auvre, Frederic; Busso, Didier; Brocas, Clementine; El Masri, Ghazi; Lioutsko, Anna; Ferri, Federica; Radicella, J. Pablo; Romeo, Paul-Henri; Bravard, Anne			Tumor resistance to radiotherapy is triggered by an ATM/TAK1-dependent-increased expression of the cellular prion protein	ONCOGENE			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; STEM-CELLS; TAK1; TRANSCRIPTION; INHIBITION; ACTIVATION; SURVIVAL; ATM	In solid cancers, high expression of the cellular prion protein (PrPC) is associated with stemness, invasiveness, and resistance to chemotherapy, but the role of PrPC in tumor response to radiotherapy is unknown. Here, we show that, in neuroblastoma, breast, and colorectal cancer cell lines, PrPC expression is increased after ionizing radiation (IR) and that PrPC deficiency increases radiation sensitivity and decreases radiation-induced radioresistance in tumor cells. In neuroblastoma cells, IR activates ATM that triggers TAK1-dependent phosphorylation of JNK and subsequent activation of the AP-1 transcription factor that ultimately increases PRNP promoter transcriptional activity through an AP-1 binding site in the PRNP promoter. Importantly, we show that this ATM-TAK1-PrPC pathway mediated radioresistance is activated in all tumor cell lines studied and that pharmacological inhibition of TAK1 activity recapitulates the effects of PrPC deficiency. Altogether, these results unveil how tumor cells activate PRNP to acquire resistance to radiotherapy and might have implications for therapeutic targeting of solid tumors radioresistance.	[Bernardino-Sgherri, Jacqueline; Ferri, Federica; Romeo, Paul-Henri; Bravard, Anne] Univ Paris Saclay, Univ Paris, Genet Stabil Stem Cells & Radiat, LRTS,UMRE008,Inserm,U1274,CEA, Fontenay Aux Roses, France; [Bernardino-Sgherri, Jacqueline; Siberchicot, Capucine; Auvre, Frederic; El Masri, Ghazi; Lioutsko, Anna; Radicella, J. Pablo; Bravard, Anne] Univ Paris Saclay, Univ Paris, Genet Stabil Stem Cells & Radiat, LRIG,UMRE008,CEA, Fontenay Aux Roses, France; [Busso, Didier; Brocas, Clementine] Univ Paris Saclay, Univ Paris, Genet Stabil Stem Cells & Radiat, CIGEX,UMRE008,Inserm,U1274,CEA, Fontenay Aux Roses, France; [Auvre, Frederic] CEA, LGRK, DRF, IBFJ,iRCM,SCSR, Evry, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bernardino-Sgherri, J; Bravard, A (corresponding author), Univ Paris Saclay, Univ Paris, Genet Stabil Stem Cells & Radiat, LRTS,UMRE008,Inserm,U1274,CEA, Fontenay Aux Roses, France.; Bernardino-Sgherri, J; Bravard, A (corresponding author), Univ Paris Saclay, Univ Paris, Genet Stabil Stem Cells & Radiat, LRIG,UMRE008,CEA, Fontenay Aux Roses, France.	Jacqueline.bernardino@cea.fr; anne.bravard@cea.fr	Radicella, J. Pablo/AAU-3178-2020	Radicella, J. Pablo/0000-0002-8807-7226; BRAVARD, Anne/0000-0002-0314-9092; Bernardino-Sgherri, Jacqueline/0000-0003-3980-4041	DIM-Stem-Pole; INSERM; Foundation ARC; CEA; French National Electricity Company (EDF); Transverse Division No 4 [4]; Radiobiology Program (PRIONRAD) of the French Alternative Energies and Atomic Energy Commission (CEA)	DIM-Stem-Pole; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Foundation ARC; CEA(French Atomic Energy Commission); French National Electricity Company (EDF); Transverse Division No 4; Radiobiology Program (PRIONRAD) of the French Alternative Energies and Atomic Energy Commission (CEA)	The authors thank Guillaume Pitton for lentiviruses productions; Nathalie Dechamps for flow cytometric cell sorting, at the IRCM Flow Cytometry Shared Resource (established by equipment grants from DIM-Stem-Pole, INSERM, Foundation ARC, and CEA); Marilene Lopes (Lab of Neurobiology and Stem Cells, Sao-Paulo, Brazil) for kindly providing the plasmid used for generating SH-SY5Y CRISPR KO cells; Sophie Mouillet-Richard, Francois Leteurtre and Jerome Lebeau for providing colorectal, and breast cancer cell lines.This work was supported by the French National Electricity Company (EDF), the Transverse Division No 4 (Segment no 4 Radiobiology headed by Christophe Carles) and the Radiobiology Program (PRIONRAD) of the French Alternative Energies and Atomic Energy Commission (CEA).	Atkinson CJ, 2019, MOL ONCOL, V13, P725, DOI 10.1002/1878-0261.12411; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Berger ND, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0283; Bravard A, 2015, NUCLEIC ACIDS RES, V43, P904, DOI 10.1093/nar/gku1342; Buch K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-1; Cheng YY, 2014, MOL CARCINOGEN, V53, P686, DOI 10.1002/mc.22021; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Du L, 2013, CANCER RES, V73, P2682, DOI 10.1158/0008-5472.CAN-12-3759; Fan YH, 2013, APOPTOSIS, V18, P1224, DOI 10.1007/s10495-013-0864-0; Gil M, 2016, BIOCHEM BIOPH RES CO, V470, P213, DOI 10.1016/j.bbrc.2016.01.038; Giorgia M, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20222; Guan S, 2017, ONCOTARGET, V8, P33666, DOI 10.18632/oncotarget.16895; Han MW, 2014, ANTICANCER RES, V34, P1449; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Iglesia RP, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0518-1; Kefayat A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55605-w; Le Corre D, 2019, EBIOMEDICINE, V46, P94, DOI 10.1016/j.ebiom.2019.07.036; Lee JH, 2018, BIOMOL THER, V26, P313, DOI 10.4062/biomolther.2017.033; Liu XJ, 2017, CELL RES, V27, P764, DOI 10.1038/cr.2017.41; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Martin-Lanneree S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00055; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Piro G, 2015, BRIT J CANCER, V113, P878, DOI 10.1038/bjc.2015.283; Qin KF, 2009, J BIOL CHEM, V284, P4582, DOI 10.1074/jbc.M808410200; Ryskalin L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205107; Salvesen O, 2019, NEUROCHEM INT, V130, DOI 10.1016/j.neuint.2018.11.010; Santoro R, 2017, DRUG RESIST UPDATE, V33-35, P36, DOI 10.1016/j.drup.2017.10.004; Schulz A, 2019, CANCERS, V11, DOI 10.3390/cancers11060862; Siberchicot C, 2020, HAEMATOLOGICA, V105, P1216, DOI 10.3324/haematol.2018.205716; Span PN, 2019, CANCERS, V11, DOI 10.3390/cancers11101555; Wang ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32737; Watt NT, 2007, FREE RADICAL BIO MED, V43, P959, DOI 10.1016/j.freeradbiomed.2007.06.004; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Wiegmans AP, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124092; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Zhou SN, 2020, CRIT REV ONCOL HEMAT, V150, DOI 10.1016/j.critrevonc.2020.102961; Zhuang DX, 2012, INT J CANCER, V130, P309, DOI 10.1002/ijc.25985	39	9	9	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2021	40	19					3460	3469		10.1038/s41388-021-01746-0	http://dx.doi.org/10.1038/s41388-021-01746-0		MAR 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SB1JB	33767435				2022-12-26	WOS:000632820300006
J	Jaimes, JD; Slavickova, A; Hurych, J; Cinek, O; Nichols, B; Vodolanova, L; Cerny, K; Havlik, J				Jaimes, Jose Diogenes; Slavickova, Andrea; Hurych, Jakub; Cinek, Ondrej; Nichols, Ben; Vodolanova, Lucie; Cerny, Karel; Havlik, Jaroslav			Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using H-1 NMR and 16S rRNA gene profiling	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; CONTRIBUTES; ADIPOSITY; CHOLINE; IMPACT; INDEX	Characterization of metabolites and microbiota composition from human stool provides powerful insight into the molecular phenotypic difference between subjects with normal weight and those with overweight/obesity. The aim of this study was to identify potential metabolic and bacterial signatures from stool that distinguish the overweight/obesity state in children/adolescents. Using H-1 NMR spectral analysis and 16S rRNA gene profiling, the fecal metabolic profile and bacterial composition from 52 children aged 7 to 16 was evaluated. The children were classified into three groups (16 with normal-weight, 17 with overweight, 19 with obesity). The metabolomic analysis identified four metabolites that were significantly different (p < 0.05) among the study groups based on one-way ANOVA testing: arabinose, butyrate, galactose, and trimethylamine. Significantly different (p < 0.01) genus-level taxa based on edgeR differential abundance tests were genus Escherichia and Tyzzerella subgroup 3. No significant difference in alpha-diversity was detected among the three study groups, and no significant correlations were found between the significant taxa and metabolites. The findings support the hypothesis of increased energy harvest in obesity by human gut bacteria through the growing observation of increased fecal butyrate in children with overweight/obesity, as well as an increase of certain monosaccharides in the stool. Also supported is the increase of trimethylamine as an indicator of an unhealthy state.	[Jaimes, Jose Diogenes; Slavickova, Andrea; Havlik, Jaroslav] Czech Univ Life Sci Prague, Dept Food Sci, Prague, Czech Republic; [Hurych, Jakub; Cinek, Ondrej; Vodolanova, Lucie] Charles Univ Prague, Motol Univ Hosp, Dept Med Microbiol, Fac Med 2, Prague, Czech Republic; [Cinek, Ondrej] Charles Univ Prague, Motol Univ Hosp, Dept Paediat, Fac Med 2, Prague, Czech Republic; [Nichols, Ben] Univ Glasgow, Sch Med Dent & Nursing, Coll Med Vet & Life Sci, Glasgow Royal Infirm,Human Nutr, Glasgow, Lanark, Scotland; [Cerny, Karel] Olivova Childrens Med Inst, Ricany, Czech Republic	Czech University of Life Sciences Prague; Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital; University of Glasgow	Havlik, J (corresponding author), Czech Univ Life Sci Prague, Dept Food Sci, Prague, Czech Republic.	havlik@af.czu.cz	Hurych, Jakub/AEL-5399-2022; Havlík, Jaroslav/F-3371-2011	Hurych, Jakub/0000-0002-9813-5290; Havlík, Jaroslav/0000-0003-1900-0951; Jaimes, Jose Diogenes/0000-0002-1598-1855	Ministry of Education, Youth and Sports of the Czech Republic [INTER-COST LTC19008, LM2018100]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Funding for this research was provided by the Ministry of Education, Youth and Sports of the Czech Republic, research grants INTER-COST LTC19008 and METROFOOD-CZ research infrastructure project LM2018100, both awarded to JH. The funder website is https://www.msmt.cz/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaak EE, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.11.11; Brahe LK, 2013, OBES REV, V14, P950, DOI 10.1111/obr.12068; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057; de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dietz WH, 1998, PEDIATRICS, V101, P518; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gao XL, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0384-x; Goffredo M, 2016, J CLIN ENDOCR METAB, V101, P4367, DOI 10.1210/jc.2016-1797; Hansen NW, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111590; Hjorth MF, 2018, ANNU REV NUTR, V38, P245, DOI 10.1146/annurev-nutr-082117-051606; Alvarez-Mercado AI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030068; Jonsson V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2386-y; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kallus SJ, 2012, J CLIN GASTROENTEROL, V46, P16, DOI 10.1097/MCG.0b013e31823711fd; Kelly TN, 2016, CIRC RES, V119, P956, DOI 10.1161/CIRCRESAHA.116.309219; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Larive CK, 2015, ANAL CHEM, V87, P133, DOI 10.1021/ac504075g; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li LW, 2014, ACTA POLYM SIN, P1, DOI 10.3724/SP.J.1105.2014.13390; Liu YH, 2019, AM J CLIN NUTR, V110, P701, DOI 10.1093/ajcn/nqz139; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37589; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Markley JL, 2017, CURR OPIN BIOTECH, V43, P34, DOI 10.1016/j.copbio.2016.08.001; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morales P, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.20; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Murugesan S, 2018, EUR J CLIN MICROBIOL, V37, P621, DOI 10.1007/s10096-017-3143-0; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; R Core Team, 2020, R LANG ENV STAT COMP; Radjabzadeh D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57734-z; Rangel-Huerta OD, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1553-y; Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Riva A, 2017, ENVIRON MICROBIOL, V19, P95, DOI 10.1111/1462-2920.13463; Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Statni zdravotni ustav (Czech National Institute of Public Health), 2006, HODNOCEN R STU V VOJ; Thorsen J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0208-8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; UNICEF, 2019, CHILDREN FOOD NUTR G; Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144; Vignoli A, 2019, ANGEW CHEM INT EDIT, V58, P968, DOI 10.1002/anie.201804736; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; WHO, 2019, BMI FOR AGE 5 19 YEA; Yan SJ, 2016, SCI BULL, V61, P1151, DOI 10.1007/s11434-016-1142-7; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang AH, 2012, ANALYST, V137, P293, DOI 10.1039/c1an15605e; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8160545; Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7	65	6	6	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0247378	10.1371/journal.pone.0247378	http://dx.doi.org/10.1371/journal.pone.0247378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765008	Green Accepted, gold, Green Published			2022-12-26	WOS:000634832800113
J	Leight, J; Hensly, C; Chissano, M; Ali, L				Leight, Jessica; Hensly, Catherine; Chissano, Marcos; Ali, Liza			Short-term effects of the COVID-19 state of emergency on contraceptive access and utilization in Mozambique	PLOS ONE			English	Article								The COVID-19 pandemic has increasingly disrupted the global delivery of preventive health care services, as a large number of governments have issued state of emergency orders halting service delivery. However, there is limited evidence on the realized effects of the pandemic and associated emergency orders on access to services in low-income country contexts to date. To address this gap, this paper analyzes administrative data on utilization of contraceptive health services by women referred via community health promoters in two large urban and peri-urban areas of Mozambique. We focus on the period immediately surrounding the national state of emergency declaration linked to the COVID-19 pandemic on March 31, 2020. Data reported for 109,129 women served by 132 unique promoters and 192 unique public health facilities is analyzed using logistic regression, interrupted time series analysis and hazard analysis. The results demonstrate that the imposition of the state of emergency is associated with a modest short-term drop in both service provision and utilization, followed by a relatively rapid rebound. We conclude that in this context, the accessibility of reproductive health services was not dramatically reduced during the first phase of the pandemic-related emergency.	[Leight, Jessica] Int Food Policy Res Inst, Washington, DC 20036 USA; [Hensly, Catherine] Amer Univ, Dept Econ, Washington, DC 20016 USA; [Chissano, Marcos; Ali, Liza] Populat Serv Int, Maputo, Mozambique	CGIAR; International Food Policy Research Institute (IFPRI); American University	Leight, J (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	J.Leight@cgiar.org		Hensly, Catherine/0000-0001-8453-8163; Leight, Jessica/0000-0002-1691-9682	federal Office of Evaluation Sciences	federal Office of Evaluation Sciences	JL (based at IFPRI and prior to that American University) received a grant from the federal Office of Evaluation Sciences (oes.gsa.gov) linked to this project. CH received compensation from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310; Ballard M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002550; Chandir S, 2020, LANCET GLOB HEALTH, V8, pE1118, DOI 10.1016/S2214-109X(20)30290-4; da Cruz DM, 2020, CORONAVIRUS LEGAL GU; Demographic and Health Survey Program, 2015, MOZ STAND AIS; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Greenleaf AR, 2019, CONTRACEPTION, V99, P170, DOI 10.1016/j.contraception.2018.11.006; Hall KS, 2020, LANCET, V395, P1175, DOI 10.1016/S0140-6736(20)30801-1; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) Com a Assistencia Tecnica de ICF., 2018, INQ IND IM MAL HIV S; Nanda K, 2020, GLOB HEALTH-SCI PRAC, V8, P166, DOI 10.9745/GHSP-D-20-00119; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; ONU, 2015, TRANSF OUR WORLD 203; Pathfinder International, 2018, IFPP REACH ENG MAR H; Pathfinder International, 2020, INT FAM PLANN PROGR; Population Services International (PSI), 2018, WORLD MALARIA REPORT; Population Services International (PSI), 2018, CONN SAR HARV TECHN, P5; Riley T, 2020, INT PERSPECT SEX R H, V46, P73, DOI 10.1363/46e9020; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Sochas L, 2017, HEALTH POLICY PLANN, V32, P32, DOI 10.1093/heapol/czx108; Thorne JG, 2020, SEX REPROD HLTH MATT, V28, DOI 10.1080/26410397.2020.1763577; UN, 2019, CONTR US METH 2019, DOI [10.18356/1bd58a10-en, DOI 10.18356/1BD58A10-EN]; United Nations, 2020, MON STAT STAT OP COV; United Nations [UN], 2019, FAM PLANN 2030 AG SU; United States Agency for International Development (USAID), 2020, INT FAM PLANN PROGR; United States Agency for International Development (USAID) Mozambique, 2020, INT FAM PLANN PROGR, P1; World Bank, 2020, FERT RAT TOT BIRTHS; World Health Organization (WHO), 2020, WHO2019NCOV, P61; Yulisman L., 2020, STRAITS TIMES 0512	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249195	10.1371/journal.pone.0249195	http://dx.doi.org/10.1371/journal.pone.0249195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765080	Green Published, gold			2022-12-26	WOS:000634832800053
J	Pei, J; Cho, YJ; See, YP; Pascoe, EM; Viecelli, AK; Francis, RS; van Eps, C; Isbel, NM; Campbell, SB; Clayton, PA; Chapman, J; Collins, M; Lim, W; Tang, W; Wong, G; Hawley, CM; Johnson, DW				Pei, Juan; Cho, Yeoungjee; See, Yong Pey; Pascoe, Elaine M.; Viecelli, Andrea K.; Francis, Ross S.; van Eps, Carolyn; Isbel, Nicole M.; Campbell, Scott B.; Clayton, Philip A.; Chapman, Jeremy; Collins, Michael; Lim, Wai; Tang, Wen; Wong, Germaine; Hawley, Carmel M.; Johnson, David W.			Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysis	PLOS ONE			English	Article							SURVIVAL BENEFIT; DISEASE; CKD; AKI; RECOVERY; PATIENT	Background The need for kidney transplantation drives efforts to expand organ donation. The decision to accept organs from donors with acute kidney injury (AKI) can result in a clinical dilemma in the context of conflicting reports from published literature. Material and methods This observational study included all deceased donor kidney transplants performed in Australia and New Zealand between 1997 and 2017. The association of donor-AKI, defined according to KDIGO criteria, with all-cause graft failure was evaluated by multivariable Cox regression. Secondary outcomes included death-censored graft failure, death, delayed graft function (DGF) and acute rejection. Results The study included 10,101 recipients of kidneys from 5,774 deceased donors, of whom 1182 (12%) recipients received kidneys from 662 (11%) donors with AKI. There were 3,259 (32%) all-cause graft failures, which included 1,509 deaths with functioning graft. After adjustment for donor, recipient and transplant characteristics, donor AKI was not associated with all-cause graft failure (adjusted hazard ratio [HR] 1.11, 95% CI 0.99-1.26), death-censored graft failure (HR 1.09, 95% CI 0.92-1.28), death (HR 1.15, 95% CI 0.98-1.35) or graft failure when death was evaluated as a competing event (sub-distribution hazard ratio [sHR] 1.07, 95% CI 0.91-1.26). Donor AKI was not associated with acute rejection but was associated with DGF (adjusted odds ratio [OR] 2.27, 95% CI 1.92-2.68). Conclusion Donor AKI stage was not associated with any kidney transplant outcome, except DGF. Use of kidneys with AKI for transplantation appears to be justified.	[Pei, Juan] Xiamen Univ, Dept Nephrol, Xiamen, Peoples R China; [Pei, Juan] Fujian Med Univ, First Hosp 1, Xiamen, Peoples R China; [Pei, Juan; Cho, Yeoungjee; See, Yong Pey; Viecelli, Andrea K.; Francis, Ross S.; van Eps, Carolyn; Isbel, Nicole M.; Campbell, Scott B.; Hawley, Carmel M.; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Pei, Juan; Cho, Yeoungjee; See, Yong Pey; Pascoe, Elaine M.; Viecelli, Andrea K.; Hawley, Carmel M.; Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Fac Med, Brisbane, Qld, Australia; [Pei, Juan; Cho, Yeoungjee; Clayton, Philip A.; Collins, Michael; Hawley, Carmel M.; Johnson, David W.] South Australian Hlth & Med Res Inst SAHMRI, Australia & New Zealand Dialysis & Transplant ANZ, Adelaide, SA, Australia; [See, Yong Pey] Tan Tock Seng Hosp, Dept Renal Med, Novena, Singapore; [Clayton, Philip A.] Univ Adelaide, Dept Med, Adelaide, SA, Australia; [Clayton, Philip A.] Royal Adelaide Hosp, Cent & Northern Adelaide Renal & Transplantat Ser, Adelaide, SA, Australia; [Chapman, Jeremy; Wong, Germaine] Western Sydney Local Hlth Dist, Dept Renal Med, Westmead Hosp, Sydney, NSW, Australia; [Collins, Michael] Auckland Dist Hlth Board, Dept Renal Med, Auckland City Hosp, Auckland, New Zealand; [Lim, Wai] Sir Charles Gairdner Hosp, Dept Renal Med, Nedlands, WA, Australia; [Tang, Wen] Peking Univ Third Hosp, Dept Nephrol, Beijing, Peoples R China; [Hawley, Carmel M.; Johnson, David W.] Translat Res Inst, Brisbane, Qld, Australia	Xiamen University; Fujian Medical University; University of Queensland; South Australian Health & Medical Research Institute (SAHMRI); Tan Tock Seng Hospital; University of Adelaide; Royal Adelaide Hospital; University of Sydney; Auckland City Hospital; Auckland District Health Board; University of Western Australia; Peking University	Johnson, DW (corresponding author), Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia.; Johnson, DW (corresponding author), Univ Queensland, Australasian Kidney Trials Network, Fac Med, Brisbane, Qld, Australia.; Johnson, DW (corresponding author), South Australian Hlth & Med Res Inst SAHMRI, Australia & New Zealand Dialysis & Transplant ANZ, Adelaide, SA, Australia.; Johnson, DW (corresponding author), Translat Res Inst, Brisbane, Qld, Australia.	david.johnson2@health.qld.gov.au	Francis, Ross/A-7757-2011; Johnson, David/F-2897-2011	Francis, Ross/0000-0002-3995-7040; Johnson, David/0000-0001-5491-3460; Pei, Juan/0000-0003-4184-7120				Ali T, 2015, QJM-INT J MED, V108, P803, DOI 10.1093/qjmed/hcv033; Boffa C, 2017, AM J TRANSPLANT, V17, P411, DOI 10.1111/ajt.13966; Chawla LS, 2017, NAT REV NEPHROL, V13, P241, DOI 10.1038/nrneph.2017.2; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Domagala P, 2019, RENAL FAILURE, V41, P167, DOI 10.1080/0886022X.2019.1590209; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gill JS, 2005, KIDNEY INT, V68, P2345, DOI 10.1111/j.1523-1755.2005.00696.x; Hall IE, 2015, AM J TRANSPLANT, V15, P1623, DOI 10.1111/ajt.13144; Hall IE, 2019, KIDNEY INT, V95, P199, DOI 10.1016/j.kint.2018.08.047; Heilman RL, 2015, AM J TRANSPLANT, V15, P2143, DOI 10.1111/ajt.13260; Heilman RL, 2019, TRANSPLANTATION, V103, pE263, DOI 10.1097/TP.0000000000002792; Israni AK, 2014, J AM SOC NEPHROL, V25, P1842, DOI 10.1681/ASN.2013070784; Jung CW, 2013, TRANSPL P, V45, P2941, DOI 10.1016/j.transproceed.2013.08.048; Kayler LK, 2009, AM J TRANSPLANT, V9, P367, DOI 10.1111/j.1600-6143.2008.02505.x; Kim JH, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0461-5; Lee MH, 2014, J CRIT CARE, V29, P432, DOI 10.1016/j.jcrc.2013.12.016; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lim WH, 2019, TRANSPLANTATION, V103, P412, DOI 10.1097/TP.0000000000002275; Maggiore U, 2015, NEPHROL DIAL TRANSPL, V30, P217, DOI 10.1093/ndt/gfu212; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Pieringer H, 2005, CLIN TRANSPLANT, V19, P391, DOI 10.1111/j.1399-0012.2005.00360.x; Randhawa PS, 1999, TRANSPLANTATION, V67, P103, DOI 10.1097/00007890-199901150-00018; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Schutte-Nutgen K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213608; See EJ, 2019, KIDNEY INT, V95, P160, DOI 10.1016/j.kint.2018.08.036; Shi MJ, 2016, J AM SOC NEPHROL, V27, P2331, DOI 10.1681/ASN.2015060613; Stratta RJ, 2004, ANN SURG, V239, P688, DOI 10.1097/01.sla.0000124296.46712.67; Takaori K, 2016, NEPHRON, V134, P172, DOI 10.1159/000448081; Tanaka S, 2014, AM J PHYSIOL-RENAL, V307, pF1187, DOI 10.1152/ajprenal.00425.2014; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zamir O., 1998, Proceedings of the 21st Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P46, DOI 10.1145/290941.290956	35	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249000	10.1371/journal.pone.0249000	http://dx.doi.org/10.1371/journal.pone.0249000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765036	gold, Green Published			2022-12-26	WOS:000634832800017
J	Pozderac, C; Skinner, B				Pozderac, Calvin; Skinner, Brian			Superspreading of SARS-CoV-2 in the USA	PLOS ONE			English	Article								A number of epidemics, including the SARS-CoV-1 epidemic of 2002-2004, have been known to exhibit superspreading, in which a small fraction of infected individuals is responsible for the majority of new infections. The existence of superspreading implies a fat-tailed distribution of infectiousness (new secondary infections caused per day) among different individuals. Here, we present a simple method to estimate the variation in infectiousness by examining the variation in early-time growth rates of new cases among different subpopulations. We use this method to estimate the mean and variance in the infectiousness, beta, for SARS-CoV-2 transmission during the early stages of the pandemic within the United States. We find that sigma (beta)/mu (beta) greater than or similar to 3.2, where mu (beta) is the mean infectiousness and sigma (beta) its standard deviation, which implies pervasive superspreading. This result allows us to estimate that in the early stages of the pandemic in the USA, over 81% of new cases were a result of the top 10% of most infectious individuals.	[Pozderac, Calvin; Skinner, Brian] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pozderac, C (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.	pozderac.16@osu.edu		Pozderac, Calvin/0000-0001-9372-6043				Adegboye OA, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/6725284; Althaus CL, 2015, LANCET INFECT DIS, V15, P507, DOI 10.1016/S1473-3099(15)70135-0; Althouse BM, 2020, STOCHASTICITY HETERO; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Hasan A., 2020, SUPERSPREADING EARLY, DOI [10.1101/2020.06.30.20143560, DOI 10.1101/2020.06.30.20143560]; Hebert-Dufresne Laurent, 2020, J R Soc Interface, V17, P20200393, DOI 10.1098/rsif.2020.0393; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167; Lau MS., 2020, CHARACTERIZING SUPER, DOI [10.1101/2020.06.20.20130476, DOI 10.1101/2020.06.20.20130476]; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lu Fred S, 2020, medRxiv, DOI 10.1101/2020.04.18.20070821; Madani K, 2020, MEDIUM, DOI DOI 10.1038/S41591-020-0962-9; Mahajan A., 2020, ESTIMATION UNDETECTE, DOI [10.1101/2020.06.21.20136580, DOI 10.1101/2020.06.21.20136580]; Melsew YA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3870-1; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Muniz-Rodriguez K, 2020, EMERG INFECT DIS, V26, P1912, DOI 10.3201/eid2608.200219; Murray J. D., 2001, MATH BIOL, V18; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Pedersen M, 2020, QUANTIFYING UNDETECT, DOI [10.13140/RG.2.2.11753.85600, DOI 10.13140/RG.2.2.11753.85600]; Pozderac C., PYTHON CODE USED ANA; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sneppen K., 2020, MEDRXIV, DOI [10.1101/2020.05.17.20104745, DOI 10.1101/2020.05.17.20104745]; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Vespignani A, 2020, NAT REV PHYS, V2, P279, DOI 10.1038/s42254-020-0178-4; Weiner Z., 2020, PROJECTIONS EARLY WA; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhou L, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00685-4	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248808	10.1371/journal.pone.0248808	http://dx.doi.org/10.1371/journal.pone.0248808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765004	Green Submitted, Green Published, gold			2022-12-26	WOS:000634832800041
J	Farooq, N; Chuan, B; Mahmud, H; El Khoudary, SR; Nouraie, SM; Evankovich, J; Yang, LB; Dunlap, D; Bain, W; Kitsios, G; Zhang, YZ; O'Donnell, CP; McVerry, BJ; Shah, FA				Farooq, Nauman; Chuan, Byron; Mahmud, Hussain; El Khoudary, Samar R.; Nouraie, Seyed Mehdi; Evankovich, John; Yang, Libing; Dunlap, Daniel; Bain, William; Kitsios, Georgios; Zhang, Yingze; O'Donnell, Christopher P.; McVerry, Bryan J.; Shah, Faraaz Ali			Association of the systemic host immune response with acute hyperglycemia in mechanically ventilated septic patients	PLOS ONE			English	Article							INSULIN-RESISTANCE; HOSPITAL MORTALITY; SEVERE SEPSIS; SOLUBLE ST2; TNF-ALPHA; PENTRAXIN 3; PROCALCITONIN; CYTOKINE; RECEPTOR; GLUCOSE	Hyperglycemia during sepsis is associated with increased organ dysfunction and higher mortality. The role of the host immune response in development of hyperglycemia during sepsis remains unclear. We performed a retrospective analysis of critically ill adult septic patients requiring mechanical ventilation (n = 153) to study the relationship between hyperglycemia and ten markers of the host injury and immune response measured on the first day of ICU admission (baseline). We determined associations between each biomarker and: (1) glucose, insulin, and c-peptide levels at the time of biomarker collection by Pearson correlation; (2) average glucose and glycemic variability in the first two days of ICU admission by linear regression; and (3) occurrence of hyperglycemia (blood glucose>180mg/dL) by logistic regression. Results were adjusted for age, pre-existing diabetes mellitus, severity of illness, and total insulin and glucocorticoid dose. Baseline plasma levels of ST2 and procalcitonin were positively correlated with average blood glucose and glycemic variability in the first two days of ICU admission in unadjusted and adjusted analyses. Additionally, higher baseline ST2, IL-1ra, procalcitonin, and pentraxin-3 levels were associated with increased risk of hyperglycemia. Our results suggest associations between the host immune response and hyperglycemia in critically ill septic patients particularly implicating the interleukin-1 axis (IL-1ra), the interleukin-33 axis (ST2), and the host response to bacterial infections (procalcitonin, pentraxin-3).	[Farooq, Nauman] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Chuan, Byron; Nouraie, Seyed Mehdi; Evankovich, John; Dunlap, Daniel; Bain, William; Kitsios, Georgios; Zhang, Yingze; O'Donnell, Christopher P.; McVerry, Bryan J.; Shah, Faraaz Ali] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Mahmud, Hussain] Univ Pittsburgh, Div Endocrinol & Metab, Pittsburgh, PA USA; [El Khoudary, Samar R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Yang, Libing] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Bain, William; Shah, Faraaz Ali] VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA; [Kitsios, Georgios; McVerry, Bryan J.] Univ Pittsburgh, Ctr Med & Microbiome, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shah, FA (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Shah, FA (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.	shahfa@upmc.edu	McVerry, Bryan/AAS-7790-2021; Nouraie, Seyed Mehdi/O-4071-2018	McVerry, Bryan/0000-0002-1175-4874; Nouraie, Seyed Mehdi/0000-0001-7465-0581; El Khoudary, Samar/0000-0003-2913-0821; Bain, William/0000-0001-8506-0552	National Institutes of Health [5K23GM122069, 5K23HL139987, 5K08HL144820, 5P01HL114453]; Veterans Health Administration [IK2BX004886]; Clinical and Translational Science Institute at the University of Pittsburgh through the National Institutes of Health [UL1-TR-000005]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration(US Department of Veterans Affairs); Clinical and Translational Science Institute at the University of Pittsburgh through the National Institutes of Health	FAS received funding for this work by National Institutes of Health (https://www.nih.gov/) (5K23GM122069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GK received funding for this work by National Institutes of Health (https://www.nih.gov/) (5K23HL139987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JE received funding for this work by National Institutes of Health (https://www.nih.gov/) (5K08HL144820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BJM received funding for this work by National Institutes of Health (https://www.nih.gov/) (5P01HL114453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WB received funding for this work by Veterans Health Administration (https://www.va.gov/health/) (IK2BX004886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Statistical support was provided by the Clinical and Translational Science Institute at the University of Pittsburgh through the National Institutes of Health Grant UL1-TR-000005 (https://www.nih.gov/).	Abbasi A, 2010, J CLIN ENDOCR METAB, V95, pE26, DOI 10.1210/jc.2010-0305; Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728; Caironi P, 2017, EUR J CLIN INVEST, V47, P73, DOI 10.1111/eci.12704; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Cekmez F, 2016, CLIN LAB, V62, P751, DOI 10.7754/Clin.Lab.2014.141013; Chao HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170408; Chousterman BG, 2017, SEMIN IMMUNOPATHOL, V39, P517, DOI 10.1007/s00281-017-0639-8; Coglianese EE, 2012, CLIN CHEM, V58, P1673, DOI 10.1373/clinchem.2012.192153; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Ehses JA, 2008, BIOCHEM SOC T, V36, P340, DOI 10.1042/BST0360340; Fan J, 1996, SHOCK, V6, P164, DOI 10.1097/00024382-199609010-00002; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Hasan A, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/7901062; Hoogerwerf JJ, 2010, INTENS CARE MED, V36, P630, DOI 10.1007/s00134-010-1773-0; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Hur M, 2015, ANN LAB MED, V35, P570, DOI 10.3343/alm.2015.35.6.570; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Karzai W, 1997, INFECTION, V25, P329, DOI 10.1007/BF01740811; Kitsios GD, 2019, CRIT CARE MED, V47, P1724, DOI 10.1097/CCM.0000000000004018; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee YT, 2018, J INFECTION, V76, P1, DOI 10.1016/j.jinf.2017.10.016; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Leonidou L, 2008, AM J MED SCI, V336, P467, DOI 10.1097/MAJ.0b013e318176abb4; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lin YH, 2016, DIABETES RES CLIN PR, V118, P140, DOI 10.1016/j.diabres.2016.06.006; Lu JL, 2019, INT IMMUNOPHARMACOL, V70, P9, DOI 10.1016/j.intimp.2019.02.018; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MEHTA VK, 1994, EUR J ENDOCRINOL, V130, P208, DOI 10.1530/eje.0.1300208; MEIKLE AW, 1977, AM J MED, V63, P200, DOI 10.1016/0002-9343(77)90233-9; Miller AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047830; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Muller B, 2001, SWISS MED WKLY, V131, P595; Nakamura M, 2012, CRIT CARE, V16, DOI 10.1186/cc11301; Oshikawa K, 2002, CLIN EXP ALLERGY, V32, P1520, DOI 10.1046/j.1365-2745.2002.01494.x; Qu W, 2018, J ENDOCRINOL INVEST, V41, P455, DOI 10.1007/s40618-017-0742-7; Saberi F, 2008, JPEN-PARENTER ENTER, V32, P227, DOI 10.1177/0148607108316195; SANDLER S, 1990, ENDOCRINOLOGY, V126, P1288, DOI 10.1210/endo-126-2-1288; Sarkar SK, 1997, J AM STAT ASSOC, V92, P1601, DOI 10.2307/2965431; Sechterberger MK, 2013, CRIT CARE, V17, DOI 10.1186/cc12572; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Singamsetty S, 2016, APPL PHYSIOL NUTR ME, V41, P12, DOI 10.1139/apnm-2015-0213; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takashi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196526; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; van Asseldonk EJP, 2015, CLIN IMMUNOL, V160, P155, DOI 10.1016/j.clim.2015.06.003; van Vught LA, 2016, CRIT CARE MED, V44, P1338, DOI 10.1097/CCM.0000000000001650; Wang R, 2016, J INVEST MED, V64, P1124, DOI 10.1136/jim-2016-000082; Wang XS, 2019, EXP THER MED, V18, P722, DOI 10.3892/etm.2019.7611; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Xu H, 2017, MILITARY MED RES, V4, P1, DOI 10.1186/s40779-017-0115-8; Yu WK, 2003, WORLD J GASTROENTERO, V9, P1824, DOI 10.3748/wjg.v9.i8.1824; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	62	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248853	10.1371/journal.pone.0248853	http://dx.doi.org/10.1371/journal.pone.0248853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755703	Green Published, gold			2022-12-26	WOS:000632916600033
J	Makizaki, Y; Uemoto, T; Yokota, H; Yamamoto, M; Tanaka, Y; Ohno, H				Makizaki, Yutaka; Uemoto, Taiki; Yokota, Haruka; Yamamoto, Miyuki; Tanaka, Yoshiki; Ohno, Hiroshi			Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis	PLOS ONE			English	Article								A treatment option for constipation that improves the quality of life is needed since available laxatives do not effectively improve the quality of life in patients with constipation. A significant association between gut dysbiosis and constipation is recognized, suggesting that probiotics may be an important option for management of constipation. The underlying mechanism by which probiotics improve constipation remains unclear. In this study, we aimed to evaluate the effects of the probiotic Bifidobacterium bifidum G9-1 (BBG9-1) on loperamide-induced delayed colonic transit constipation and to elucidate its mechanism of action. First, the effect of BBG9-1 was evaluated in a rat model of constipation induced by subcutaneous administration of loperamide. BBG9-1 improved constipation parameters (number of feces, fecal water content, and fecal hardness) in constipated rats. Next, the relationship of organic acids and neurotransmitters to gut microbiota was investigated. BBG9-1 improved dysbiosis and prevented a decrease in butyric acid concentration in the gut, increased serum serotonin, and suppressed an increase in dopamine and a decrease in acetylcholine in serum. Further, an increase in the expression level of tryptophan hydroxylase 1, a 5-HT-synthetizing enzyme, was observed. These results suggest that BBG9-1 improves dysbiosis, which results in an increase in organic acids and improvement of neurotransmission. These actions may increase intestinal mobility, finally leading to alleviating constipation. The probiotic BBG9-1 may, therefore, be a potential option for the treatment of constipation.	[Makizaki, Yutaka; Uemoto, Taiki; Yokota, Haruka; Yamamoto, Miyuki; Tanaka, Yoshiki; Ohno, Hiroshi] Biofermin Pharmaceut Co Ltd, R&D Ctr, Kobe, Hyogo, Japan		Tanaka, Y (corresponding author), Biofermin Pharmaceut Co Ltd, R&D Ctr, Kobe, Hyogo, Japan.	tanaka_yoshiki@biofermin.co.jp		makizaki, yutaka/0000-0001-7971-7503	Biofermin Pharmaceutical Co., Ltd.	Biofermin Pharmaceutical Co., Ltd.	Biofermin Pharmaceutical Co., Ltd. provided support for this study in the form of salaries for YM, TU, HY, MY, YT, and HO. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bharucha AE, 2013, GASTROENTEROLOGY, V144, P218, DOI 10.1053/j.gastro.2012.10.028; Cao HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10835-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Forootan M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010631; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Jahng J, 2012, NEUROGASTROENT MOTIL, V24, P185, DOI 10.1111/j.1365-2982.2011.01819.x; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Koebnick C, 2003, CAN J GASTROENTEROL, V17, P655, DOI 10.1155/2003/654907; Kommers MJ, 2019, J ALTERN COMPLEM MED, V25, P1163, DOI 10.1089/acm.2019.0134; Lawson PA., 2020, BERGEYS MANUAL SYSTE, P1, DOI [10.1002/9781118960608.gbm01644, DOI 10.1002/9781118960608.GBM01644]; Li F, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9010159; Makizaki Y, 2019, BIOSCI MICROB FOOD H, V38, P49, DOI 10.12938/bmfh.18-020; Matsuki T., 2006, Journal of Intestinal Microbiology, V20, P259; Patel, 2015, BERGEYS MANUAL SYSTE, DOI [10.1002/9781118960608.gbm00671, DOI 10.1002/9781118960608.GBM00671]; Peppas G, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-5; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; SOHJI Y, 1978, FOLIA PHARMACOL JPN, V74, P155, DOI 10.1254/fpj.74.155; Wald A, 2007, ALIMENT PHARM THER, V26, P227, DOI 10.1111/j.1365-2036.2007.03376.x; Waller PA, 2011, SCAND J GASTROENTERO, V46, P1057, DOI 10.3109/00365521.2011.584895; Wang H, 2019, TROP J PHARM RES, V18, P1197, DOI 10.4314/tjpr.v18i6.8; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang LL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020318; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yarullina DR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235985; Zhu LX, 2014, PHYSIOL GENOMICS, V46, P679, DOI 10.1152/physiolgenomics.00082.2014	30	8	8	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248584	10.1371/journal.pone.0248584	http://dx.doi.org/10.1371/journal.pone.0248584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750988	gold, Green Published			2022-12-26	WOS:000631967100028
J	Ford, L; Glass, K; Williamson, DA; Sintchenko, V; Robson, JMB; Lancsar, E; Stafford, R; Kirk, MD				Ford, Laura; Glass, Kathryn; Williamson, Deborah A.; Sintchenko, Vitali; Robson, Jennifer M. B.; Lancsar, Emily; Stafford, Russell; Kirk, Martyn D.			Cost of whole genome sequencing for non-typhoidal Salmonella enterica	PLOS ONE			English	Article							PUBLIC-HEALTH SURVEILLANCE; UNITED-STATES; OUTBREAK; TYPHIMURIUM; INFECTIONS; FOOD; EPIDEMIOLOGY; PATHOGENS; AUSTRALIA	Background While whole genome sequencing (WGS) may be more expensive than traditional testing and polymerase chain reaction (PCR), simple cost comparisons ignore the potential for WGS to reduce the societal costs of non-typhoidal Salmonella enterica through public health action to prevent illness. Methods We determined how many cases the use of WGS data would need to prevent to be cost-equal to serotyping and MLVA, or culture independent testing based on PCR in Australia. We then examined the costs and cost-savings of current typing methods compared with WGS in outbreak scenarios. Results A median of 275 (90% CrI -55-775) or 1.9% (90% CrI -0.4%-5.4%) of notified serotyped Salmonella cases would need to be prevented for WGS to be cost-equal to current typing methods and 1,550 (90% CrI 820-2,725) or 9.6% of all notified Salmonella cases would need to be prevented to be cost-equal to PCR. WGS is likely to result in cost savings in prolonged outbreaks, where data can support earlier public health action. Conclusions Despite currently having a higher cost per isolate, routine WGS of Salmonella was no more expensive than existing typing methods or PCR where >2% of illness was averted.	[Ford, Laura; Glass, Kathryn; Lancsar, Emily; Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Williamson, Deborah A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Sintchenko, Vitali] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, NSW Hlth Pathol, Sydney, NSW, Australia; [Robson, Jennifer M. B.] Sullivan Nicolaides Pathol, Brisbane, Qld, Australia; [Stafford, Russell] Queensland Dept Hlth, Herston, Qld, Australia	Australian National University; University of Melbourne; University of Sydney; University of Sydney; Queensland Health	Ford, L (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.	u4924611@alumni.anu.edu.au		Glass, Kathryn/0000-0001-5905-1310; Ford, Laura/0000-0002-6253-9672; Lancsar, Emily/0000-0003-2404-6735	Australian Government Research Training Program (RTP) Scholarship; National Health & Medical Research Council [APP1145997, APP1123854, APP1123879]	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Laura Ford is supported by an Australian Government Research Training Program (RTP) Scholarship. The National Health & Medical Research Council provided research fellowship funding for Martyn D. Kirk (APP1145997), Deborah A. Williamson (APP1123854) and Vitali Sintchenko (APP1123879). Jennifer M.B. Robson is employed by Sullivan Nicolaides Pathology. These funders provided support in the form of salaries for authors LF, MDK, DAW, VS and JMBR, but did not have any additional role in the study design, data collection and analysis, decision to published, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Angelo KM, 2015, MMWR-MORBID MORTAL W, V64, P144; [Anonymous], 2018, SALM PUBL DAT; [Anonymous], 2018, INFL CALC; [Anonymous], 2018, MED IT REP; [Anonymous], 2018, MBS ONL; [Anonymous], 2018, WHOL GEN SEQ FOODB D; [Anonymous], F11 EXCHANGE RATES M; Bell RL, 2016, MICROB BIOTECHNOL, V9, P279, DOI 10.1111/1751-7915.12359; Besser JM, 2018, FOOD MICROBIOL, V71, P55, DOI 10.1016/j.fm.2017.08.018; Cronquist AB, 2012, CLIN INFECT DIS, V54, pS432, DOI 10.1093/cid/cis267; Denehy EJ, 2011, COMMUN DIS INTELL, V35, P192; Deng XY, 2016, ANNU REV FOOD SCI T, V7, P353, DOI 10.1146/annurev-food-041715-033259; Ford L, 2018, FOODBORNE PATHOG DIS, V15, P161, DOI 10.1089/fpd.2017.2352; Ford L, 2018, FOODBORNE PATHOG DIS, V15, P285, DOI 10.1089/fpd.2017.2353; Ford L, 2019, J FOOD PROTECT, V82, P1607, DOI [10.4315/0362-028X.JFP-19-105, 10.4315/0362-028x.jfp-19-105]; Ford L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163989; Inns T, 2017, EPIDEMIOL INFECT, V145, P289, DOI 10.1017/S0950268816001941; Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242; Jain S, 2019, FOOD RES INT, V116, P802, DOI 10.1016/j.foodres.2018.09.014; Luna S, 2018, MMWR-MORBID MORTAL W, V67, P1098, DOI 10.14745/ccdr.v44i10a05; May FJ, 2017, COMMUN DIS INTELL, V41, pE223; Ross IL, 2011, CURR MICROBIOL, V62, P1034, DOI 10.1007/s00284-010-9820-1; Scharff RL, 2016, AM J PREV MED, V50, pS66, DOI 10.1016/j.amepre.2015.09.018; Siira L., 2019, EURO SURVEILL, V24; Todd K, 2016, E COMMUNICATION 1210; Ung A, 2019, EUROSURVEILLANCE, V24, P32, DOI 10.2807/1560-7917.ES.2019.24.3.1700703; Vohra R., 2019, INTRO NEW MULTIPLEX; Waldram A, 2018, FOOD MICROBIOL, V71, P39, DOI 10.1016/j.fm.2017.02.012; Williamson DA, 2019, MED J AUSTRALIA, V210, P295, DOI 10.5694/mja2.50063	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248561	10.1371/journal.pone.0248561	http://dx.doi.org/10.1371/journal.pone.0248561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739986	gold, Green Published			2022-12-26	WOS:000631030200025
J	Mantri, S; Klawson, E; Albert, S; Rapoport, R; Precht, C; Glancey, S; Daeschler, M; Mamikonyan, E; Kopil, CM; Marras, C; Chahine, LM				Mantri, Sneha; Klawson, Emily; Albert, Steven; Rapoport, Robyn; Precht, Chelle; Glancey, Sarah; Daeschler, Margaret; Mamikonyan, Eugenia; Kopil, Catherine M.; Marras, Connie; Chahine, Lana M.			The experience of care partners of patients with Parkinson's disease psychosis	PLOS ONE			English	Article								Background Parkinson's disease psychosis (PDP) has a major impact on quality of life and care partner burden; however, little is known about the lived experiences of care partners in managing PDP. Objective To understand how care partners of individuals with PDP experience their role and articulate their needs related to psychosis. Methods This was a qualitative study of semi-structured telephone interviews. Recruitment was conducted online via the clinical study matching tool, Fox Trial Finder; study activities took place remotely via telephone interviews. Transcripts of the phone interviews were analyzed by grounded theory methods, and a codebook of key themes that emerged from the analysis was developed. Results Nine care partners (all female) were interviewed. Discussion topics in the codebook included (1) care partner burden and guilt; (2) communication with medical professionals; (3) coping strategies; (4) emotional reactions of the care partner to psychosis; (5) sources of knowledge about PD psychosis; (6) attitudes towards medications for PDP; (7) strategies to care for loved ones with psychosis; (8) psychosis triggers. Conclusions This qualitative analysis uncovers important aspects of the care partner experience, including challenges in navigating the medical system and communicating with professionals. Providers treating patients with PDP should be aware of these constraints and provide added support for strained care partners.	[Mantri, Sneha] Duke Univ, Dept Neurol, Durham, NC 27708 USA; [Klawson, Emily; Albert, Steven] Univ Pittsburgh, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Rapoport, Robyn; Precht, Chelle; Glancey, Sarah] SSRS, Glen Mills, PA USA; [Daeschler, Margaret; Kopil, Catherine M.] Michael J Fox Fdn Parkinsons Res, New York, NY USA; [Mamikonyan, Eugenia] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Marras, Connie] Univ Toronto, Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Chahine, Lana M.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mantri, S (corresponding author), Duke Univ, Dept Neurol, Durham, NC 27708 USA.	sneha.mantri@duke.edu		Albert, Steven/0000-0001-6786-9956	Michael J. Fox Foundation for Parkinson's Research through the Parkinson Disease Education Consortium (PDEC) [MJFF-007856]; ACADIA Pharmaceuticals; Adamas Pharmaceuticals; Intec Pharma; Lundbeck Inc.; Sunovion Pharmaceuticals; MJFF; Parkinson's Foundation (PF); Cerevel Therapeutics; Canadian Institutes of Health Research; PF; International Parkinsons and Movement Disorder Society; UPMC Competitive Medical Research Fund; National Institutes of Health	Michael J. Fox Foundation for Parkinson's Research through the Parkinson Disease Education Consortium (PDEC); ACADIA Pharmaceuticals; Adamas Pharmaceuticals; Intec Pharma; Lundbeck Inc.(Lundbeck Corporation); Sunovion Pharmaceuticals; MJFF; Parkinson's Foundation (PF); Cerevel Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PF; International Parkinsons and Movement Disorder Society; UPMC Competitive Medical Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Michael J. Fox Foundation for Parkinson's Research michaeljfox.org, award number MJFF-007856) through the Parkinson Disease Education Consortium (PDEC). The Consortium is sponsored by the following industry partners: ACADIA Pharmaceuticals, Adamas Pharmaceuticals, Intec Pharma, Lundbeck Inc., and Sunovion Pharmaceuticals. Author SM receives research support from MJFF, from the Parkinson's Foundation (PF), and from Cerevel Therapeutics, was a paid consultant to MJFF, and received consulting fees from Deep Brain Innovations, LLC. Author CM receives research support from MJFF, from the Canadian Institutes of Health Research, from PF, and from the International Parkinsons and Movement Disorder Society. Author LMC receives research support from MJFF, receives research support from the UPMC Competitive Medical Research Fund, receives research support from the National Institutes of Health, receives royalties from Elsevier (for authorship), and receives royalties from Wolters Kluwel (for authorship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215384; Balash Y, 2019, ACTA NEUROL SCAND, V140, P17, DOI 10.1111/ane.13095; Berger S, 2019, DISABIL REHABIL, V41, P887, DOI 10.1080/09638288.2017.1413427; Boersma I, 2017, J PALLIAT MED, V20, P930, DOI 10.1089/jpm.2016.0325; Factor SA, 2016, NEUROLOGY, V86, P2278, DOI 10.1212/WNL.0000000000002670; Frank A. W., 2013, WOUNDED STORYTELLER; Fredericks D, 2017, AM J MANAG CARE, V23, pS83; Gibson G, 2013, INT J GERIATR PSYCH, V28, P626, DOI 10.1002/gps.3869; Grun D, 2016, J AM MED DIR ASSOC, V17, P626, DOI 10.1016/j.jamda.2016.03.004; Lennaerts-Kats H., 2020, J PARK DIS; Martinez-Martin P, 2019, MOVEMENT DISORD, V34, P236, DOI 10.1002/mds.27579; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P629, DOI 10.1016/j.parkreldis.2015.03.024; Mosley PE, 2017, J GERIATR PSYCH NEUR, V30, P235, DOI 10.1177/0891988717720302; Poon AWC, 2018, HEALTH SOC CARE COMM, V26, P412, DOI 10.1111/hsc.12530; Rocker C, 2015, J PARKINSON DIS, V5, P55, DOI 10.3233/JPD-140522; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Tan SB, 2012, J CLIN NURS, V21, P2235, DOI 10.1111/j.1365-2702.2012.04146.x; Voss T, 2013, PARKINSONISM RELAT D, V19, P295, DOI 10.1016/j.parkreldis.2012.10.022	18	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248968	10.1371/journal.pone.0248968	http://dx.doi.org/10.1371/journal.pone.0248968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740031	gold, Green Published			2022-12-26	WOS:000631030200019
J	Zhang, G; Yang, Y; Hu, H; Liu, KY; Li, BY; Zhu, Y; Wang, ZY; Wu, QF; Mei, YD				Zhang, Guang; Yang, Yang; Hu, Hao; Liu, Kaiyue; Li, Bingyan; Zhu, Yu; Wang, Zhongyu; Wu, Qingfa; Mei, Yide			Energy stress-induced linc01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis	ONCOGENE			English	Article								Cancer cells undergo metabolic adaption to sustain their survival and growth under metabolic stress conditions, yet the underlying mechanism remains largely unclear. It is also not known if lncRNAs contribute to this metabolic adaption of cancer cells. Here we show that linc01564 is induced in response to glucose deprivation by the transcription factor ATF4. Linc01564 functions to facilitate hepatocellular carcinoma cell survival under glucose deprivation by activating the serine synthesis pathway. Mechanistically, linc01564 acts as a competing endogenous RNA for miR-107/103a-3p and attenuates the inhibitory effect of miR-107/103a-3p on PHGDH, the rate-limiting enzyme of the serine synthesis pathway, thereafter leading to increased PHGDH expression. Furthermore, linc01564 is able to promote hepatocellular carcinogenesis via PHGDH. Together, these findings suggest that linc01564 is an important player in the regulation of metabolic adaption of cancer cells and also implicate linc01564 as a potential therapeutic target for cancer.	[Zhang, Guang; Yang, Yang; Hu, Hao; Liu, Kaiyue; Li, Bingyan; Zhu, Yu; Wang, Zhongyu; Wu, Qingfa; Mei, Yide] Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med,CAS Key Lab Innate Immun & Chr, Affiliated Hosp 1,USTC,Hefei Natl Lab Phys Sci Mi, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Mei, YD (corresponding author), Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med,CAS Key Lab Innate Immun & Chr, Affiliated Hosp 1,USTC,Hefei Natl Lab Phys Sci Mi, Hefei, Anhui, Peoples R China.	meiyide@ustc.edu.cn			Ministry of Science and Technology of China [2019YFA0802600]; National Natural Science Foundation of China [91957108, 31671487, 31871440]; Collaborative Innovation Programs of Hefei Science Center, CAS [2019HSC-CIP010]; Fundamental Research Funds For Central Universities [WK9110000007, YD2070002007]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Programs of Hefei Science Center, CAS; Fundamental Research Funds For Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Ministry of Science and Technology of China (2019YFA0802600), National Natural Science Foundation of China (91957108, 31671487, and 31871440), Collaborative Innovation Programs of Hefei Science Center, CAS (2019HSC-CIP010), and the Fundamental Research Funds For Central Universities (WK9110000007 and YD2070002007).	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deng SJ, 2019, CANCER RES, V79, P1398, DOI 10.1158/0008-5472.CAN-18-0419; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang YA, 2018, BIOINFORMATICS, V34, P812, DOI 10.1093/bioinformatics/btx672; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li XX, 2018, MOL CELL, V69, P480, DOI 10.1016/j.molcel.2018.01.001; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Liu J, 2020, J CLIN INVEST, V130, P3253, DOI 10.1172/JCI132876; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Ma ML, 2019, HEPATOLOGY, V70, P215, DOI 10.1002/hep.30602; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Nilsson LM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002573; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Reid MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07868-6; Samanta D, 2016, CANCER RES, V76, P4430, DOI 10.1158/0008-5472.CAN-16-0530; Silva-Fisher JM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15547-8; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; Su XY, 2017, ANAL CHEM, V89, P5941, DOI 10.1021/acs.analchem.7b00396; Sullivan MR, 2019, CELL METAB, V29, P1410, DOI 10.1016/j.cmet.2019.02.015; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Tang JY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11447-8; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Turco C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00427; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang CF, 2019, P NATL ACAD SCI USA, V116, P14620, DOI 10.1073/pnas.1903432116; Wang Y, 2016, BIOCHEM BIOPH RES CO, V480, P455, DOI 10.1016/j.bbrc.2016.10.070; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12606-7; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Xiao ZD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00902-z; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yao RW, 2019, NAT CELL BIOL, V21, P542, DOI 10.1038/s41556-019-0311-8; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang BX, 2017, CELL REP, V19, P2289, DOI 10.1016/j.celrep.2017.05.067; Zhu JH, 2016, TRANSL ONCOL, V9, P592, DOI 10.1016/j.tranon.2016.08.003	73	8	8	5	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2936	2951		10.1038/s41388-021-01749-x	http://dx.doi.org/10.1038/s41388-021-01749-x		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742121				2022-12-26	WOS:000630655600002
J	Zolkipli-Cunningham, Z; Naviaux, JC; Nakayama, T; Hirsch, CM; Monk, JM; Li, KF; Wang, L; Le, TP; Meinardi, S; Blake, DR; Naviaux, RK				Zolkipli-Cunningham, Zarazuela; Naviaux, Jane C.; Nakayama, Tomohiro; Hirsch, Charlotte M.; Monk, Jonathan M.; Li, Kefeng; Wang, Lin; Le, Thuy P.; Meinardi, Simone; Blake, Donald R.; Naviaux, Robert K.			Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder	PLOS ONE			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASE; FALSE DISCOVERY RATE; ADENOSINE-TRIPHOSPHATE; PURINE METABOLISM; CARBON-MONOXIDE; STRESS-RESPONSE; STEM-CELLS; T-CELLS; MITOCHONDRIAL; ABNORMALITIES	Since 2012, studies in mice, rats, and humans have suggested that abnormalities in purinergic signaling may be a final common pathway for many genetic and environmental causes of autism spectrum disorder (ASD). The current study in mice was conducted to characterize the bioenergetic, metabolomic, breathomic, and behavioral features of acute hyperpurinergia triggered by systemic injection of the purinergic agonist and danger signal, extracellular ATP (eATP). Responses were studied in C57BL/6J mice in the maternal immune activation (MIA) model and controls. Basal metabolic rates and locomotor activity were measured in CLAMS cages. Plasma metabolomics measured 401 metabolites. Breathomics measured 98 volatile organic compounds. Intraperitoneal eATP dropped basal metabolic rate measured by whole body oxygen consumption by 74% +/- 6% (mean +/- SEM) and rectal temperature by 6.2 +/- 0.3C in 30 minutes. Over 200 metabolites from 37 different biochemical pathways where changed. Breathomics showed an increase in exhaled carbon monoxide, dimethylsulfide, and isoprene. Metabolomics revealed an acute increase in lactate, citrate, purines, urea, dopamine, eicosanoids, microbiome metabolites, oxidized glutathione, thiamine, niacinamide, and pyridoxic acid, and decreased folate-methylation-1-carbon intermediates, amino acids, short and medium chain acyl-carnitines, phospholipids, ceramides, sphingomyelins, cholesterol, bile acids, and vitamin D similar to some children with ASD. MIA animals were hypersensitive to postnatal exposure to eATP or poly(IC), which produced a rebound increase in body temperature that lasted several weeks before returning to baseline. Acute hyperpurinergia produced metabolic and behavioral changes in mice. The behaviors and metabolic changes produced by ATP injection were associated with mitochondrial functional changes that were profound but reversible.	[Zolkipli-Cunningham, Zarazuela; Naviaux, Jane C.; Nakayama, Tomohiro; Monk, Jonathan M.; Li, Kefeng; Wang, Lin; Le, Thuy P.; Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Zolkipli-Cunningham, Zarazuela; Naviaux, Jane C.; Nakayama, Tomohiro; Le, Thuy P.] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA; [Hirsch, Charlotte M.; Meinardi, Simone; Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Monk, Jonathan M.; Li, Kefeng; Wang, Lin; Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA; [Zolkipli-Cunningham, Zarazuela] Childrens Hosp Philadelphia, Mitochondrial Med Frontier Program, Philadelphia, PA 19104 USA; [Nakayama, Tomohiro] Ibaraki Prefectural Univ Hlth Sci, Dept Pediat, Ami, Ibaraki, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA.; Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA.	rnaviaux@health.ucsd.edu	Nakayama, Tomohiro/GYU-0303-2022; Li, Kefeng/U-9431-2018	Li, Kefeng/0000-0002-7233-4347	UCSD Christini Fund; William Wright Family Foundation; Lennox Foundation; JMS Fund; N of One Foundation; Westreich Foundation; Kirbie and Katie Mano Family Foundation; Brent Kaufman Family Foundation; Malone Family Foundation; Cannistraro Family Foundation; UCSD Mitochondrial Research Fund; Aloe Family Autism Research Fund; Novice Researcher Award from the Gerber Foundation; NIH [U54-NS078059-02]	UCSD Christini Fund; William Wright Family Foundation; Lennox Foundation; JMS Fund; N of One Foundation; Westreich Foundation; Kirbie and Katie Mano Family Foundation; Brent Kaufman Family Foundation; Malone Family Foundation; Cannistraro Family Foundation; UCSD Mitochondrial Research Fund; Aloe Family Autism Research Fund; Novice Researcher Award from the Gerber Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the UCSD Christini Fund, William Wright Family Foundation, the Lennox Foundation, the JMS Fund, the N of One Foundation, the Westreich Foundation, the Kirbie and Katie Mano Family Foundation, the Brent Kaufman Family Foundation, the Malone Family Foundation, the Daniel and Kelly White Family, the Cannistraro Family Foundation, the UCSD Mitochondrial Research Fund, the Aloe Family Autism Research Fund, the Harb and Spilo families, and grassroots support from over 2000 individuals from around the world who have each provided gifts in the past year to support Naviaux Lab research. Funding for the mass spectrometers was provided by a gift from the Jane Botsford Johnson Foundation. ZZ was recipient of a Novice Researcher Award from the Gerber Foundation, and an NIH U54-NS078059-02 grant in support of a North American Mitochondrial Disease Consortium (NAMDC) Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, where to publish, or preparation of the manuscript.	Adams JB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030369; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bakken IJ, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0167-5; Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014; Barcena C, 2018, CELL REP, V24, P2392, DOI 10.1016/j.celrep.2018.07.089; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; Beijer S, 2010, J PAIN SYMPTOM MANAG, V40, P520, DOI 10.1016/j.jpainsymman.2010.01.023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Bird L, 2012, NAT REV IMMUNOL, V12, P229, DOI 10.1038/nri3195; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Breiman L., 2001, MACH LEARN, V45, P5; Briuglia S, 2021, J MOL NEUROSCI, V71, P1357, DOI 10.1007/s12031-020-01782-7; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; BURNSTOCK G, 1970, BRIT J PHARMACOL, V40, P668, DOI 10.1111/j.1476-5381.1970.tb10646.x; Burnstock G, 2020, ADV EXP MED BIOL, V1202, P1, DOI 10.1007/978-3-030-30651-9_1; Burnstock Geoffrey, 2018, Brain Neurosci Adv, V2, p2398212818817494, DOI 10.1177/2398212818817494; Burnstock G, 2017, CELL TISSUE RES, V370, P1, DOI 10.1007/s00441-017-2618-8; Burnstock G, 2014, PURINERG SIGNAL, V10, P189, DOI 10.1007/s11302-013-9396-x; Burnstock G, 2009, EXP PHYSIOL, V94, P20, DOI [10.1113/expphysiol.2008.043620, 10.3410/B1-46]; Cameron JL, 2017, J NEUROSCI, V37, P10783, DOI 10.1523/JNEUROSCI.1822-17.2017; Carlin JL, 2017, NEUROPHARMACOLOGY, V114, P101, DOI 10.1016/j.neuropharm.2016.11.026; Chavez CE, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00460; Cheffer A, 2018, MOL PSYCHIATR, V23, P94, DOI 10.1038/mp.2017.188; Cheikhi A, 2019, FREE RADICAL BIO MED, V130, P528, DOI 10.1016/j.freeradbiomed.2018.11.028; Cheroni C, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00370-1; Chia JSM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11608-9; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; COLEMAN M, 1985, J AUTISM DEV DISORD, V15, P1, DOI 10.1007/BF01837894; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Curran LK, 2007, PEDIATRICS, V120, pE1386, DOI 10.1542/peds.2007-0360; Davies KJA, 2016, MOL ASPECTS MED, V49, P1, DOI 10.1016/j.mam.2016.04.007; Dehorter N, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00283; Eagleson KL, 2020, NEUROBIOL STRESS, V13, DOI 10.1016/j.ynstr.2020.100251; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Fan KQ, 2019, CELL, V179, P864, DOI 10.1016/j.cell.2019.10.001; Fasano A, 2017, J PEDIATR-US, V188, P15, DOI 10.1016/j.jpeds.2017.05.038; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Fradejas N, 2013, BIOCHEM J, V450, P427, DOI 10.1042/BJ20121713; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2020, SEMIN PEDIATR NEUROL, V35, DOI 10.1016/j.spen.2020.100829; Galbraith S, 2011, J INFECT DIS, V204, P1632, DOI 10.1093/infdis/jir612; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GELMONT D, 1981, BIOCHEM BIOPH RES CO, V99, P1456, DOI 10.1016/0006-291X(81)90782-8; Gevi F, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0109-5; Ghimire S, 2018, IMMUNOBIOLOGY, V223, P239, DOI 10.1016/j.imbio.2017.10.014; Ghosh S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15002-7; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gorr TA, 2017, ACTA PHYSIOL, V219, P409, DOI 10.1111/apha.12747; Grabowska-Polanowska B, 2017, J CHROMATOGR B, V1060, P103, DOI 10.1016/j.jchromb.2017.05.030; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Grkovic I, 2019, CURR NEUROPHARMACOL, V17, P84, DOI 10.2174/1570159X15666170518151541; Grunebaum E, 2013, CURR OPIN ALLERGY CL, V13, P630, DOI 10.1097/ACI.0000000000000006; Hand SC, 2016, AM J PHYSIOL-REG I, V310, pR1193, DOI 10.1152/ajpregu.00250.2015; Heil M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00578; Hendren RL, 2016, J CHILD ADOL PSYCHOP, V26, P774, DOI 10.1089/cap.2015.0159; Hertz-Picciotto I, 2018, AUTISM RES, V11, P554, DOI 10.1002/aur.1938; HILL SD, 1977, DEV PSYCHOBIOL, V10, P579, DOI 10.1002/dev.420100612; Hirsch MM, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107930; HOEY ED, 1994, ENDOCRINOLOGY, V134, P1553, DOI 10.1210/en.134.3.1553; Horvath G, 2019, J NEUROSCI, V39, P2542, DOI 10.1523/JNEUROSCI.1895-18.2019; Howes OD, 2017, BIOL PSYCHIAT, V81, P9, DOI 10.1016/j.biopsych.2016.07.014; Howsmon DP, 2018, BIOENG TRANSL MED, V3, P156, DOI 10.1002/btm2.10095; Howsmon DP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005385; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hurwitz BJ, 2008, CLIN THER, V30, P1102, DOI 10.1016/j.clinthera.2008.06.013; Illes P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051108; Illes P, 2020, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00331; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Jyonouchi H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194731; Kaneko K, 2014, BIOL PHARM BULL, V37, P709, DOI 10.1248/bpb.b13-00967; Karl T, 2001, J APPL PHYSIOL, V91, P762, DOI 10.1152/jappl.2001.91.2.762; Kim Y, 2020, P NATL ACAD SCI USA, V117, P8900, DOI 10.1073/pnas.1913788117; King J, 2010, J THEOR BIOL, V267, P626, DOI 10.1016/j.jtbi.2010.09.028; Kozumbo WJ, 2019, J CELL COMMUN SIGNAL, V13, P273, DOI 10.1007/s12079-019-00517-7; Kratzer JT, 2014, P NATL ACAD SCI USA, V111, P3763, DOI 10.1073/pnas.1320393111; Kushiyama A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8603164; Langeroudi AG, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu085; Ledderose C, 2021, J LEUKOCYTE BIOL, V109, P497, DOI 10.1002/JLB.2HI0520-191R; Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Li KF, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1264-1; Licznerski P, 2020, CELL, V182, P1170, DOI 10.1016/j.cell.2020.07.008; Lin HY, 2020, ANTIOXID REDOX SIGN, V33, P66, DOI 10.1089/ars.2019.7737; Lockhart RA, 2007, CAN J STAT, V35, P125, DOI 10.1002/cjs.5550350111; Lu V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09045-9; Mackes NK, 2020, P NATL ACAD SCI USA, V117, P641, DOI 10.1073/pnas.1911264116; Makrides V, 2014, COMPR PHYSIOL, V4, P367, DOI 10.1002/cphy.c130028; Martorell A, 2020, NEUROBIOL DIS, V146, DOI 10.1016/j.nbd.2020.105132; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; McKay DM, 2020, AM J PHYSIOL-GASTR L, V318, pG748, DOI 10.1152/ajpgi.00031.2020; Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032; Michaletti A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15612-1; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; Minakova E, 2018, BIRTH DEFECTS RES, V110, P1539, DOI 10.1002/bdr2.1416; Morello G, 2018, MOL NEUROBIOL, V55, P1299, DOI 10.1007/s12035-017-0393-x; Muhlebner A, 2019, J ANAT, V235, P521, DOI 10.1111/joa.12956; Nakamura K, 2015, NEUROPATHOLOGY, V35, P432, DOI 10.1111/neup.12204; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Naviaux JC, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-1; Naviaux RK, 2020, MITOCHONDRION, V51, P40, DOI 10.1016/j.mito.2019.12.005; Naviaux RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219531; Naviaux RK, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020027; Naviaux RK, 2018, MITOCHONDRION, V43, P1, DOI 10.1016/j.mito.2017.12.007; Naviaux RK, 2019, MITOCHONDRION, V46, P278, DOI 10.1016/j.mito.2018.08.001; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Naviaux RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057380; Naviaux RK, 2009, MOL GENET METAB, V96, P133, DOI 10.1016/j.ymgme.2008.11.164; Nishi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071022; NYHAN WL, 1969, J PEDIATR, V74, P20, DOI 10.1016/S0022-3476(69)80004-1; Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240; Page T, 2000, BBA-MOL BASIS DIS, V1500, P291, DOI 10.1016/S0925-4439(99)00113-1; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Pelegrin P, 2021, BIOCHEM PHARMACOL, V187, DOI 10.1016/j.bcp.2020.114385; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Pittman K, 2013, J INNATE IMMUN, V5, P315, DOI 10.1159/000347132; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Sacco R, 2015, PSYCHIAT RES-NEUROIM, V234, P239, DOI 10.1016/j.pscychresns.2015.08.016; Sakaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059778; Saurman V, 2020, DIGEST DIS SCI, V65, P818, DOI 10.1007/s10620-020-06133-5; Schreiner Philipp, 2020, Immunohorizons, V4, P201, DOI 10.4049/immunohorizons.2000006; Seo DR, 2008, EXP MOL MED, V40, P19, DOI 10.3858/emm.2008.40.1.19; Sharon C, 2015, ONCOTARGET, V6, P15332, DOI 10.18632/oncotarget.3684; Shattuck EC, 2015, AM J PHYS ANTHROPOL, V157, P1, DOI 10.1002/ajpa.22698; Silvani A, 2018, PHYSIOLOGY, V33, P182, DOI 10.1152/physiol.00007.2018; Siso S, 2010, ACTA NEUROPATHOL, V120, P689, DOI 10.1007/s00401-010-0743-5; Smith D, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/017101; Smith M, 2012, BBA-BIOENERGETICS, V1817, P1796, DOI 10.1016/j.bbabio.2012.04.004; Solek CM, 2018, DEV DYNAM, V247, P588, DOI 10.1002/dvdy.24612; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Stucki D, 2020, TOXICOL LETT, V333, P251, DOI 10.1016/j.toxlet.2020.08.010; Stussman B, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.01025; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Theoharides TC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153611; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vincenzi F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228710; von Frisch, 1942, Z VERGL PHYSIOL, V29, P46, DOI [10.1007/BF00304445, DOI 10.1007/BF00304445]; von Frisch K, 1938, NATURWISSENSCHAFTEN, V26, P601; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697; Warner GJ, 2000, J BIOL CHEM, V275, P28110; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yardeni T, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw3159; Yoshida K, 2020, J IMMUNOL, V204, P3077, DOI 10.4049/jimmunol.1900954; Zhang MJ, 2013, J CEREBR BLOOD F MET, V33, P157, DOI 10.1038/jcbfm.2012.146; Zhao ZY, 2014, METABOLOMICS, V10, P63, DOI 10.1007/s11306-013-0552-7	159	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248771	10.1371/journal.pone.0248771	http://dx.doi.org/10.1371/journal.pone.0248771			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735311	Green Published, gold			2022-12-26	WOS:000631029700043
J	Luo, NJ; Yue, F; Jia, ZH; Chen, JJ; Deng, Q; Zhao, YJ; Kuang, SH				Luo, Nanjian; Yue, Feng; Jia, Zhihao; Chen, Jingjuan; Deng, Qing; Zhao, Yongju; Kuang, Shihuan			Reduced electron transport chain complex I protein abundance and function in Mfn2-deficient myogenic progenitors lead to oxidative stress and mitochondria swelling	FASEB JOURNAL			English	Article						Mfn2; mitochondrion; myogenesis; myogenic progenitor cells; oxidative respiration	SKELETAL-MUSCLE; MITOFUSIN 2; INSULIN-RESISTANCE; SATELLITE CELLS; FIBER TYPES; STEM-CELLS; MFN2; FUSION; METABOLISM; EXPRESSION	Mitochondrial remodeling through fusion and fission is crucial for progenitor cell differentiation but its role in myogenesis is poorly understood. Here, we characterized the function of mitofusin 2 (Mfn2), a mitochondrial outer membrane protein critical for mitochondrial fusion, in muscle progenitor cells (myoblasts). Mfn2 expression is upregulated during myoblast differentiation in vitro and muscle regeneration in vivo. Targeted deletion of Mfn2 gene in myoblasts (Mfn2(MKO)) increases oxygen-consumption rates (OCR) associated with the maximal respiration and spare respiratory capacity, and increased levels of reactive oxygen species (ROS). Skeletal muscles of Mfn2(MKO) mice exhibit robust mitochondrial swelling with normal mitochondrial DNA content. Additionally, mitochondria isolated from Mfn2(MKO) muscles have reduced OCR at basal state and for complex I respiration, associated with decreased levels of complex I proteins NDUFB8 (NADH ubiquinone oxidoreductase subunit B8) and NDUFS3 (NADH ubiquinone oxidoreductase subunit S3). However, Mfn2(MKO) has no obvious effects on myoblast differentiation, muscle development and function, and muscle regeneration. These results demonstrate a novel role of Mfn2 in regulating mitochondrial complex I protein abundance and respiratory functions in myogenic progenitors and myofibers.	[Luo, Nanjian; Yue, Feng; Jia, Zhihao; Chen, Jingjuan; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, 2070 Creighton Hall Anim Sci,270 S Russell St, W Lafayette, IN 47907 USA; [Luo, Nanjian; Zhao, Yongju] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China; [Deng, Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Deng, Qing; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Deng, Qing; Kuang, Shihuan] Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Southwest University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), Purdue Univ, Dept Anim Sci, 2070 Creighton Hall Anim Sci,270 S Russell St, W Lafayette, IN 47907 USA.	skuang@purdue.edu		Kuang, Shihuan/0000-0001-9180-3180; Luo, Nanjian/0000-0002-4371-5378; Deng, Qing/0000-0002-9254-9951	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR071649]; U.S. Department of Agriculture (USDA) [NC1184]; China Scholarship Council (CSC) [201806990052]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R35GM119787]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); China Scholarship Council (CSC)(China Scholarship Council); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR071649; U.S. Department of Agriculture (USDA), Grant/Award Number: NC1184; China Scholarship Council (CSC), Grant/Award Number: 201806990052; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35GM119787	Ainbinder A, 2015, CELL CALCIUM, V57, P14, DOI 10.1016/j.ceca.2014.11.002; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bell MR, 2019, J APPL PHYSIOL, V126, P341, DOI 10.1152/japplphysiol.00719.2018; Bhattacharya D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00480; Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Galindo MF, 2003, BRIT J PHARMACOL, V139, P797, DOI 10.1038/sj.bjp.0705309; Gouspillou G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00446; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jia ZH, 2019, ELIFE, V8, DOI 10.7554/eLife.47097; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kawalec M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134162; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu XW, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0916-9; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Mahdaviani K, 2017, EMBO REP, V18, P1123, DOI 10.15252/embr.201643827; Mancini G, 2019, CELL REP, V26, P2849, DOI 10.1016/j.celrep.2019.02.039; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Nabben M, 2011, BBA-BIOENERGETICS, V1807, P1095, DOI 10.1016/j.bbabio.2011.04.003; Nie Q, 2014, MOL BIOL REP, V41, P6975, DOI 10.1007/s11033-014-3584-9; Olah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134227; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Pala F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212977; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Segales J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1208, DOI 10.1152/ajpendo.00546.2012; Seo BJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123893; Sheffield-Moore M, 2004, TRENDS ENDOCRIN MET, V15, P110, DOI 10.1016/j.tem.2004.02.009; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Westerblad H, 2010, EXP CELL RES, V316, P3093, DOI 10.1016/j.yexcr.2010.05.019; Wilson JD, 2005, BIOPHYS J, V88, P2929, DOI 10.1529/biophysj.104.054528; Wolf C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101289; Wyckelsma VL, 2017, J PHYSIOL-LONDON, V595, P3345, DOI 10.1113/JP273950; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	59	1	1	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21426	10.1096/fj.202002464R	http://dx.doi.org/10.1096/fj.202002464R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749882	Green Accepted			2022-12-26	WOS:000635216100060
J	Jung, S; Estrella, N; Pfaffl, MW; Hartmann, S; Ewald, F; Menzel, A				Jung, Stephan; Estrella, Nicole; Pfaffl, Michael W.; Hartmann, Stephan; Ewald, Franziska; Menzel, Annette			Impact of elevated air temperature and drought on pollen characteristics of major agricultural grass species	PLOS ONE			English	Article							GROUP-V ALLERGENS; PHL P 5; MONOCLONAL-ANTIBODIES; POACEAE POLLEN; CLIMATE-CHANGE; QUANTIFICATION; TRENDS; VARIABILITY; AMBROSIA; ELISA	Grass pollen allergens are known to be one of the major triggers of hay fever with an increasing number of humans affected by pollen associated health impacts. Climate change characterized by increasing air temperature and more frequent drought periods might affect plant development and pollen characteristics. In this study a one-year (2017) field experiment was conducted in Bavaria, Germany, simulating drought by excluding rain and elevated air temperature by installing a heating system to investigate their effects primarily on the allergenic potential of eight selected cultivars of the two grass species timothy and perennial ryegrass. It could be shown for timothy that especially under drought and heat conditions the allergen content is significantly lower accompanied by a decrease in pollen weight and protein content. In perennial ryegrass the response to drought and heat conditions in terms of allergen content, pollen weight, and protein content was more dependent on the respective cultivar probably due to varying requirements for their growth conditions and tolerance to drought and heat. Results support recommendations which cultivars should be grown preferentially. The optimal choice of grass species and respective cultivars under changing climate conditions should be a major key aspect for the public health sector in the future.	[Jung, Stephan; Estrella, Nicole; Ewald, Franziska; Menzel, Annette] Tech Univ Munich, TUM Sch Life Sci, Dept Life Sci Syst, Freising Weihenstephan, Germany; [Pfaffl, Michael W.] Tech Univ Munich, Dept Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Hartmann, Stephan] Bayer Landesanstalt Landwirtschaft, Inst Plant Prod & Plant Breeding, Freising Weihenstephan, Germany; [Menzel, Annette] Tech Univ Munich, Inst Adv Study, Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Jung, S (corresponding author), Tech Univ Munich, TUM Sch Life Sci, Dept Life Sci Syst, Freising Weihenstephan, Germany.	sjung@wzw.tum.de	Pfaffl, Michael/G-6622-2013; Menzel, Annette/B-1105-2013	Pfaffl, Michael/0000-0002-3192-1019; Menzel, Annette/0000-0002-7175-2512; Estrella, Nicole/0000-0002-1028-0048	MICMoR Fellowship through KIT/IMK-IFU	MICMoR Fellowship through KIT/IMK-IFU	This work was supported by a MICMoR Fellowship through KIT/IMK-IFU to S. Jung.	Alan S, 2018, INT J BIOMETEOROL, V62, P1325, DOI 10.1007/s00484-018-1536-0; Albertine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111712; Aloisi I, 2018, ATMOS ENVIRON, V178, P231, DOI 10.1016/j.atmosenv.2018.01.051; Anderegg WRL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013284118; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Behrendt H, 2001, CURR OPIN IMMUNOL, V13, P709, DOI 10.1016/S0952-7915(01)00283-7; Bundessortenamt, 2018, OST 80 30627 HANN BE; Bundessortenamt, 2019, OST 80 30627 HANN BE; CHAPMAN MD, 1988, ALLERGY, V43, P7, DOI 10.1111/j.1398-9995.1988.tb05042.x; Chen ML, 2016, PLANT PHYSIOL, V172, P341, DOI 10.1104/pp.16.00625; Craine JM, 2010, ECOLOGY, V91, P2132, DOI 10.1890/09-1242.1; Cui TF, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121258; D'Amato G, 1998, ALLERGY, V53, P567, DOI 10.1111/j.1398-9995.1998.tb03932.x; D'Amato G, 2001, RESP MED, V95, P606, DOI 10.1053/rmed.2001.1112; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; De Linares C, 2010, INT ARCH ALLERGY IMM, V152, P49, DOI 10.1159/000260083; Duffort O, 2008, INT ARCH ALLERGY IMM, V145, P283, DOI 10.1159/000110887; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; EMBERLIN J, 1994, ALLERGY, V49, P15, DOI 10.1111/j.1398-9995.1994.tb04233.x; Fahlbusch B, 2000, CLIN EXP ALLERGY, V30, P1645, DOI 10.1046/j.1365-2222.2000.00926.x; FAHLBUSCH B, 1994, CLIN EXP ALLERGY, V24, P752, DOI 10.1111/j.1365-2222.1994.tb00986.x; FAHLBUSCH B, 1993, CLIN EXP ALLERGY, V23, P747, DOI 10.1111/j.1365-2222.1993.tb00362.x; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Garcia-Mozo H, 2016, SCI TOTAL ENVIRON, V548, P221, DOI 10.1016/j.scitotenv.2016.01.005; Gehrig R, 2006, AEROBIOLOGIA, V22, P27, DOI 10.1007/s10453-005-9013-8; Hrabina M., 2008, Clinical and Experimental Allergy Reviews, V8, P7, DOI 10.1111/j.1472-9733.2008.00126.x; Rodriguez-Rajo FJ, 2011, AEROBIOLOGIA, V27, P1, DOI 10.1007/s10453-010-9170-2; Jung S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193958; KLYSNER S, 1992, CLIN EXP ALLERGY, V22, P491, DOI 10.1111/j.1365-2222.1992.tb00152.x; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Makra L, 2014, CARPATH J EARTH ENV, V9, P207; Marcucci Francesco, 2012, Clin Mol Allergy, V10, P7, DOI 10.1186/1476-7961-10-7; Martinez-Sancho E, 2017, FORESTS, V8, DOI 10.3390/f8110450; Matyasovszky I, 2015, THEOR APPL CLIMATOL, V122, P181, DOI 10.1007/s00704-014-1280-2; Meier U., 2001, ERWEITERTE BBCH MONO, V2; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Menzel Annette, 2021, Front Allergy, V2, P627863, DOI 10.3389/falgy.2021.627863; Menzel A, 2020, GLOBAL CHANGE BIOL, V26, P2599, DOI 10.1111/gcb.15000; Menzel A, 2019, NAT ECOL EVOL, V3, P716, DOI 10.1038/s41559-019-0873-7; Minero FJG, 1998, ALLERGY, V53, P266, DOI 10.1111/j.1398-9995.1998.tb03886.x; PETERSEN A, 1995, J ALLERGY CLIN IMMUN, V95, P987, DOI 10.1016/S0091-6749(95)70099-4; Prank M, 2013, AGR FOREST METEOROL, V182, P43, DOI 10.1016/j.agrformet.2013.08.003; R Core Team, 2013, R LANG ENV STAT COMP; Recio M, 2010, AGR FOREST METEOROL, V150, P931, DOI 10.1016/j.agrformet.2010.02.012; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schappi GF, 1996, INT ARCH ALLERGY IMM, V110, P364, DOI 10.1159/000237329; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz, 2013, PHENOLOGY INTEGRATIV; SUPHIOGLU C, 1992, LANCET, V339, P569, DOI 10.1016/0140-6736(92)90864-Y; Taeger S, 2015, PLANT BIOLOGY, V17, P361, DOI 10.1111/plb.12245; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248759	10.1371/journal.pone.0248759	http://dx.doi.org/10.1371/journal.pone.0248759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770086	Green Published, gold			2022-12-26	WOS:000634833500002
J	Luo, J; Tan, XJ; Ye, L; Wang, CL				Luo, Jiao; Tan, Xiujun; Ye, Ling; Wang, Chenglin			C-Jun N-terminal kinase (JNK) pathway activation is essential for dental papilla cells polarization	PLOS ONE			English	Article								During tooth development, dental papilla cells differentiate into odontoblasts with polarized morphology and cell function. Our previous study indicated that the C-Jun N-terminal kinase (JNK) pathway regulates human dental papilla cell adhesion, migration, and formation of focal adhesion complexes. The aim of this study was to further examine the role of the JNK pathway in dental papilla cell polarity formation. Histological staining, qPCR, and Western Blot suggested the activation of JNK signaling in polarized mouse dental papilla tissue. After performing an in vitro tooth germ organ culture and cell culture, we found that JNK inhibitor SP600125 postponed tooth germ development and reduced the polarization, migration and differentiation of mouse dental papilla cells (mDPCs). Next, we screened up-regulated polarity-related genes during dental papilla development and mDPCs or A11 differentiation. We found that Prickle3, Golga2, Golga5, and RhoA were all up-regulated, which is consistent with JNK signaling activation. Further, constitutively active RhoA mutant (RhoA Q63L) partly rescued the inhibition of SP600125 on cell differentiation and polarity formation of mDPCs. To sum up, this study suggests that JNK signaling has a positive role in the formation of dental papilla cell polarization.	[Luo, Jiao; Tan, Xiujun; Ye, Ling; Wang, Chenglin] Sichuan Univ, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Luo, Jiao; Tan, Xiujun; Ye, Ling; Wang, Chenglin] Sichuan Univ, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China; [Luo, Jiao; Tan, Xiujun; Ye, Ling; Wang, Chenglin] Sichuan Univ, Dept Cariol, Chengdu, Sichuan, Peoples R China; [Luo, Jiao; Tan, Xiujun; Ye, Ling; Wang, Chenglin] Sichuan Univ, Endodont West China Hosp Stomatol, Chengdu, Sichuan, Peoples R China; [Tan, Xiujun] Chongqing Med Univ, Dept Endodont, Coll Stomatol, Chongqing, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Chongqing Medical University	Wang, CL (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; Wang, CL (corresponding author), Sichuan Univ, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China.; Wang, CL (corresponding author), Sichuan Univ, Dept Cariol, Chengdu, Sichuan, Peoples R China.; Wang, CL (corresponding author), Sichuan Univ, Endodont West China Hosp Stomatol, Chengdu, Sichuan, Peoples R China.	wxonet@163.com	ye, ling/AFP-0048-2022	ye, ling/0000-0002-8417-7676; Wang, Chenglin/0000-0002-6117-6996	National Natural Science Foundation of China [81200759, 81873708, 81825005]; Sichuan Province Science and Technology Support Program [2016JY0022, 2019YFS0035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Science and Technology Support Program	The study was supported by the National Natural Science Foundation of China (nsfc.gov.cn, 81200759, 81873708 for CW, 81825005 for LY) and Sichuan Province Science and Technology Support Program (kjt.sc.gov.cn, 2016JY0022 for CW, 2019YFS0035 for LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Caddy J, 2010, DEV CELL, V19, P138, DOI 10.1016/j.devcel.2010.06.008; Choi SJ, 2010, DEV BIOL, V344, P682, DOI 10.1016/j.ydbio.2010.05.499; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Geetha-Loganathan P, 2014, J BIOL CHEM, V289, P24153, DOI 10.1074/jbc.M113.522003; Heinonen K, 2011, WNT4 ENHANCES MURINE; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jiang N, 2017, ACS NANO, V11, P7736, DOI 10.1021/acsnano.7b01087; Jimenez-Rojo L, 2010, B GIRSO, V49, P102; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Komulainen E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020440; Lesot H, 2001, Adv Dent Res, V15, P8; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Maurin JC, 2009, J ENDODONT, V35, P992, DOI 10.1016/j.joen.2009.04.009; MOHAMED SS, 1983, J ANAT, V136, P735; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Narhi K, 2010, METHODS MOL BIOL, V666, P253, DOI 10.1007/978-1-60761-820-1_16; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishikawa S, 2015, ACTA HISTOCHEM CYTOC, V48, P37, DOI 10.1267/ahc.14046; Nishikawa S, 2012, J HISTOCHEM CYTOCHEM, V60, P376, DOI 10.1369/0022155412438887; Oshima Masamitsu, 2012, Methods Mol Biol, V887, P149, DOI 10.1007/978-1-61779-860-3_14; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Sahu SK, 2015, EMBO J, V34, P2162, DOI 10.15252/embj.201490693; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Wang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069440; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523; Zheng LW, 2014, INT J ORAL SCI, V6, P205, DOI 10.1038/ijos.2014.60; Zhou C, 2015, BIOMATERIALS, V63, P35, DOI 10.1016/j.biomaterials.2015.06.004	31	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0233944	10.1371/journal.pone.0233944	http://dx.doi.org/10.1371/journal.pone.0233944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770099	gold, Green Published, Green Submitted			2022-12-26	WOS:000634833500012
J	Keokenchanh, S; Kounnavong, S; Midorikawa, K; Ikeda, W; Morita, A; Kitajima, T; Sokejima, S				Keokenchanh, Sengtavanh; Kounnavong, Sengchanh; Midorikawa, Kaoru; Ikeda, Wakaha; Morita, Akemi; Kitajima, Takumi; Sokejima, Shigeru			Prevalence of anemia and its associated factors among children aged 6-59 months in the Lao People's Democratic Republic: A multilevel analysis	PLOS ONE			English	Article							DETERMINANTS; INFANTS; IRON; RISK	Anemia is a major public health concern among children aged <5 years in the Lao People's Democratic Republic. Thus far, no study has determined the factors associated with anemia among children aged <5 years in the Lao People's Democratic Republic using a nationwide representative sample. Therefore, this study aimed to evaluate the prevalence of anemia and its associated factors with multilevel variations among children aged 6-59 months. This quantitative, cross-sectional study used a nationally representative sample from the Lao Social Indicator Survey II, 2017. Children aged 6-59 months tested for anemia were included in this study through multistage sampling approaches. Anemia was defined as a hemoglobin level of <11.0 g/dL. Multilevel binary logistic regression analyses were used to determine the adjusted effect of the factors associated with anemia. Among the 5,087 children included, the overall prevalence of anemia was 43.0%. Three factors were associated with higher odds of developing anemia-male sex (adjusted odds ratio, 1.16; 95% confidence interval, 1.01-1.34), underweight (adjusted odds ratio, 1.30; 95% confidence interval, 1.09-1.55), and residence in central provinces (adjusted odds ratio, 1.59; 95% confidence interval, 1.30-1.95) and southern provinces (adjusted odds ratio, 1.42; 95% confidence interval, 1.11-1.81). However, the other three factors-age, educational level of the household head, and Hmong-Mien ethnicity-were inversely associated with anemia. To resolve the problem regarding the severity of the anemia among children aged <5 years in the Lao People's Democratic Republic. Our findings highlight the need for designing an effective approach to address each factor associated with childhood anemia. Interventions should focus on the prevention of childhood anemia, which is considered a major priority of public health intervention in the Lao People's Democratic Republic.	[Keokenchanh, Sengtavanh; Morita, Akemi; Kitajima, Takumi; Sokejima, Shigeru] Mie Univ, Dept Publ Hlth & Occupat Med, Grad Sch Med, Tsu, Mie, Japan; [Keokenchanh, Sengtavanh] Cabinet Minist Hlth, Foreign Relat Div, Sisattanack Dist, Laos; [Kounnavong, Sengchanh] Minist Hlth, Lao Trop & Publ Hlth Inst, Sisattanack Dist, Laos; [Midorikawa, Kaoru] Suzuka Univ, Fac Child Educ, Suzuka, Mie, Japan; [Ikeda, Wakaha; Sokejima, Shigeru] Mie Univ Hosp, Epidemiol Ctr Dis Control & Prevent, Tsu, Mie, Japan	Mie University; Mie University	Keokenchanh, S (corresponding author), Mie Univ, Dept Publ Hlth & Occupat Med, Grad Sch Med, Tsu, Mie, Japan.; Keokenchanh, S (corresponding author), Cabinet Minist Hlth, Foreign Relat Div, Sisattanack Dist, Laos.	keokenchanh.sengtavanh@gmail.com		Keokenchanh, Sengtavanh/0000-0001-6834-1555				Akiyama T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1548-3; Accinelli RA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226846; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Boulom S, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1785736; Domellof M, 2004, AM J CLIN NUTR, V79, P111; Engidaye G, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7293-0; Friel J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7040054; Gao WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062883; Gebreegziabiher G, 2014, ANEMIA, V2014, DOI 10.1155/2014/245870; Gebreweld A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218961; Goswmai S, 2015, J PEDIAT-BRAZIL, V91, P471, DOI 10.1016/j.jped.2014.09.009; Gregory T., 2016, EXPLORING CHANGE AUS; Harding KL, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12478; Jorgensen P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-59; Zuffo CRK, 2016, J PEDIAT-BRAZIL, V92, P353, DOI 10.1016/j.jped.2015.09.007; Konstantyner T, 2012, ANEMIA, V2012, DOI 10.1155/2012/850681; Kounnavong Sengchanh, 2011, Trop Med Health, V39, P95, DOI 10.2149/tmh.2011-13; Lao Statistics Bureau, LAO SOC IND SURV 2 L; Mahmood Azizah, 2018, Malaysian Applied Biology, V47, P71; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Melku M, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0547-0; Ministry of Health of the Lao People's Democratic Republic, 2008, NAT NUTR POL; Ministry of Health of the Lao People's Democratic Republic, 2009, NAT NUTR STRAT PLAN; Moschovis PP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019654; Nambiema A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6547-1; Nanthavong Naphavanh, 2017, Parasite Epidemiol Control, V2, P114, DOI 10.1016/j.parepi.2017.06.001; Ncogo P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176613; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Onphanhdala P, 2007, ASIAN ECON J, V21, P405, DOI 10.1111/j.1467-8381.2007.00264.x; Osazuwa F, 2011, N AM J MED SCI, V3, P30, DOI 10.4297/najms.2011.330; Osungbade KO., 2012, ANEMIA, V3, P116, DOI DOI 10.5772/29148; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Phongluxa K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-328; Rahman MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219170; Rakesh PS, 2019, INDIAN J HEMATOL BLO, V35, P114, DOI 10.1007/s12288-018-1001-6; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Thorne CJ, 2013, PAEDIATR INT CHILD H, V33, P151, DOI 10.1179/2046905513Y.0000000060; UNICEF in East Asia and Pacific, 2018, LAO SOC IND SURV HIG; UNICEF WHO.  World Bank, 2020, LEVELS TRENDS CHILD, V24, P1; Wang FL, 2016, J NUTR, V146, P1707, DOI 10.3945/jn.116.232967; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2020, FACT SHEETS MALN; WHO, 2006, WHO CHILD GROWTH STA; Xing Y, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-336; Yang WF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1127; Zetterstrom R, 2004, ACTA PAEDIATR, V93, P436, DOI 10.1080/08035250410027535	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248969	10.1371/journal.pone.0248969	http://dx.doi.org/10.1371/journal.pone.0248969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765048	Green Published, gold			2022-12-26	WOS:000634832800023
J	Ruiz, D; Bajwa, ST; Vanani, N; Bajwa, TA; Cavanaugh, DJ				Ruiz, Daniela; Bajwa, Saffia T.; Vanani, Naisarg; Bajwa, Tanvir A.; Cavanaugh, Daniel J.			Slowpoke functions in circadian output cells to regulate rest: Activity rhythms	PLOS ONE			English	Article								The circadian system produces similar to 24-hr oscillations in behavioral and physiological processes to ensure that they occur at optimal times of day and in the correct temporal order. At its core, the circadian system is composed of dedicated central clock neurons that keep time through a cell-autonomous molecular clock. To produce rhythmic behaviors, time-of-day information generated by clock neurons must be transmitted across output pathways to regulate the downstream neuronal populations that control the relevant behaviors. An understanding of the manner through which the circadian system enacts behavioral rhythms therefore requires the identification of the cells and molecules that make up the output pathways. To that end, we recently characterized the Drosophila pars intercerebralis (PI) as a major circadian output center that lies downstream of central clock neurons in a circuit controlling rest:activity rhythms. We have conducted single-cell RNA sequencing (scRNAseq) to identify potential circadian output genes expressed by PI cells, and used cell-specific RNA interference (RNAi) to knock down expression of similar to 40 of these candidate genes selectively within subsets of PI cells. We demonstrate that knockdown of the slowpoke (slo) potassium channel in PI cells reliably decreases circadian rest:activity rhythm strength. Interestingly, slo mutants have previously been shown to have aberrant rest:activity rhythms, in part due to a necessary function of slo within central clock cells. However, rescue of slo in all clock cells does not fully reestablish behavioral rhythms, indicating that expression in non-clock neurons is also necessary. Our results demonstrate that slo exerts its effects in multiple components of the circadian circuit, including PI output cells in addition to clock neurons, and we hypothesize that it does so by contributing to the generation of daily neuronal activity rhythms that allow for the propagation of circadian information throughout output circuits.	[Ruiz, Daniela; Bajwa, Saffia T.; Vanani, Naisarg; Bajwa, Tanvir A.; Cavanaugh, Daniel J.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Cavanaugh, DJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	dcavanaugh1@luc.edu		Cavanaugh, Daniel/0000-0002-0068-3222; Vanani, Naisarg/0000-0001-7916-227X	National Institute of General Medical Sciences [R15GM128170]; Brain and Behavior Research Foundation [24045]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brain and Behavior Research Foundation	This work was supported by the National Institute of General Medical Sciences, www.nigms.nih.gov/, Grant R15GM128170 to D.J. C, and the Brain and Behavior Research Foundation, https://www.bbrfoundation.org/, Young Investigator Grant #24045 to D.J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi KC, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006613; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Alpert MH, 2020, CURR BIOL, V30, P2275, DOI 10.1016/j.cub.2020.04.038; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Bai L, 2018, CELL REP, V22, P3416, DOI 10.1016/j.celrep.2018.03.014; Barber AF, 2016, GENE DEV, V30, P2596, DOI 10.1101/gad.288258.116; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Cavey M, 2016, NAT NEUROSCI, V19, P587, DOI 10.1038/nn.4263; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Diaz MM, 2019, CURR BIOL, V29, P13, DOI 10.1016/j.cub.2018.11.005; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dreyer AP, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008478; Dubowy C, 2017, GENETICS, V205, P1373, DOI 10.1534/genetics.115.185157; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Fujiwara Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01276; Hamasaka Y, 2007, J COMP NEUROL, V505, P32, DOI 10.1002/cne.21471; Helfrich-Forster C, 2007, COLD SPRING HARB SYM, V72, P517, DOI 10.1101/sqb.2007.72.063; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hewes RS, 2000, GENETICS, V155, P1711; Ito C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00008; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Jepson JEC, 2012, PLOS GENET, V8, P549, DOI 10.1371/journal.pgen.1002671; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; King AN, 2020, EUR J NEUROSCI, V51, P268, DOI 10.1111/ejn.14092; King AN, 2017, CURR BIOL, V27, P1915, DOI 10.1016/j.cub.2017.05.089; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kunst M, 2014, CURR BIOL, V24, P2652, DOI 10.1016/j.cub.2014.09.077; Liang XT, 2019, NEURON, V102, P843, DOI 10.1016/j.neuron.2019.03.028; Liang XT, 2016, SCIENCE, V351, P976, DOI 10.1126/science.aad3997; Luo WY, 2012, AGING CELL, V11, P428, DOI 10.1111/j.1474-9726.2012.00800.x; Martelli C, 2017, CELL REP, V20, P464, DOI 10.1016/j.celrep.2017.06.043; Mattis J, 2016, TRENDS ENDOCRIN MET, V27, P192, DOI 10.1016/j.tem.2016.02.003; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Nagy D, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008158; Nassel DR, 2019, PROG NEUROBIOL, V179, DOI 10.1016/j.pneurobio.2019.02.003; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sundram V, 2012, J BIOL RHYTHM, V27, P183, DOI 10.1177/0748730412440667; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Tirian L., 2017, VT GAL4 LEXA SPLIT G; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zytnicki M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1816-4	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249215	10.1371/journal.pone.0249215	http://dx.doi.org/10.1371/journal.pone.0249215			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765072	gold, Green Published			2022-12-26	WOS:000634832800082
J	Tesema, GA; Yeshaw, Y; Worku, MG; Tessema, ZT; Teshale, AB				Tesema, Getayeneh Antehunegn; Yeshaw, Yigizie; Worku, Misganaw Gebrie; Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu			Pooled prevalence and associated factors of chronic undernutrition among under-five children in East Africa: A multilevel analysis	PLOS ONE			English	Article							LINEAR GROWTH; BIRTH-WEIGHT; PRESCHOOL-CHILDREN; MATERNAL EDUCATION; NUTRITIONAL-STATUS; SCHOOL-CHILDREN; RURAL-AREAS; DETERMINANTS; MALNUTRITION; AGE	Background Childhood undernutrition is the leading cause of under-five mortality and morbidity in the world particularly in East African countries. Although there are studies on child undernutrition in different East African countries, our search of the literature revealed that there is limited evidence of a pooled analysis of these studies. Therefore, this study aimed to investigate the pooled prevalence and associated factors of chronic undernutrition (i.e. stunting) among under-five children in East Africa. Methods A pooled analysis of the Demographic and Health Surveys (DHSs) in 12 East African countries was conducted. A total weighted sample of 79744 under-five children was included in the study. Mixed-effect logistic regression analysis was used to identify significant factors associated with chronic undernutrition since the DHS data has a hierarchical structure. The intra-class correlation coefficient (ICC), Median Odds Ratio (MOR), Likelihood Ratio (LR)-test, and deviance was used for model comparison. Variables with p-value <0.2 in the bivariable mixed-effect logistic regression analysis were considered for the multivariable analysis. In the multivariable multilevel analysis model, the Adjusted Odds Ratio (AOR) with the 95% Confidence Interval (CI) were reported for significant factors. Results The pooled prevalence of chronic undernutrition among underfive children in East Africa was 33.3% (95% CI: 32.9%, 35.6%) ranging from 21.9% in Kenya to 53% in Burundi. Children whose mothers lived in rural area (AOR = 1.11, 95% CI: 1.06, 1.16), born to mother who had no formal education (AOR = 1.42, 95% CI: 1.34, 1.50) and primary education (AOR = 1.37, 95% CI: 1.31, 1.44), being in poor household (AOR = 1.66, 95% CI: 1.58, 1.74), and middle household (AOR = 1.42, 95% CI: 1.35, 1.49), child aged 36-48 months (AOR = 1.09, 95% CI: 1.04, 1.14), being male (AOR = 1.19, 95% CI: 1.15, 1.23), 2(nd) - 4(th) birth order (AOR = 1.08, 95% CI: 1.03, 1.13), and above 4(th) 1.27 (AOR = 1.27, 95% CI: 1.19, 1.35), home delivery 1.09 (AOR = 1.09, 95% CI: 1.05, 1.13), small size at birth (AOR = 1.35, 95% CI: 1.29, 1.40) and being multiple births (AOR = 1.98, 95% CI: 1.81, 2.17) were associated with increased odds of stunting. While, antenatal care visit (AOR = 0.89, 95% CI: 0.86, 0.93), mothers aged 25-34 (AOR = 0.83, 95% CI: 0.79, 0.86) and <greater than or equal to> 35 years (AOR = 0.76, 95% CI: 0.72, 0.81), large size at birth (AOR = 0.85, 95% CI: 0.81, 0.88), and family size >8 (AOR = 0.92, 95% CI: 0.87, 0.98) were associated with decreased odds of stunting. Conclusion The study revealed that stunting among under-five children remains a major public health problem in East Africa. Therefore, to improve child nutrition status the governmental and non-governmental organizations should design public health interventions targeting rural residents, and the poorest households. Furthermore, enhancing health facility delivery, ANC visit, and maternal health education is vital for reducing child chronic undernutrition.	[Tesema, Getayeneh Antehunegn; Yeshaw, Yigizie; Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Sch Med, Dept Human Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Sch Med, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Tesema, GA (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	getayenehantehunegn@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Tadesse, Zemenu/ABG-1690-2021; Yeshaw, Yigizie/L-6336-2019	Yeshaw, Yigizie/0000-0003-4587-7925; Tadesse, Zemenu/0000-0003-3878-7956				Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Adekanmbi VT, 2013, MATERN CHILD NUTR, V9, P244, DOI 10.1111/j.1740-8709.2011.00361.x; Aguayo VM, 2016, MATERN CHILD NUTR, V12, P121, DOI 10.1111/mcn.12259; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; Allen LH, 2006, J PEDIATR GASTR NUTR, V43, pS8, DOI 10.1097/01.mpg.0000255845.99905.20; Aryastami NK, 2017, BMC NUTR, V3, P16, DOI [10.1186/s40795-017-0130-x, DOI 10.1186/S40795-017-0130-X]; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Batiro B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189106; Bloss E, 2004, J TROP PEDIATRICS, V50, P260, DOI 10.1093/tropej/50.5.260; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chilton M, 2007, INDIAN J MED RES, V126, P262; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Daelmans B, 2013, MATERN CHILD NUTR, V9, P116, DOI 10.1111/mcn.12083; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Deshmukh Pradeep R, 2013, Med J Armed Forces India, V69, P213, DOI 10.1016/j.mjafi.2012.10.004; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Fan S., 2014, INT FOOD POLICY RES; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; FERGUSON EL, 1989, AM J CLIN NUTR, V50, P1450, DOI 10.1093/ajcn/50.6.1450; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Ghodsi D, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.190605; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Haddad L, 2015, J NUTR, V145, P663, DOI 10.3945/jn.114.206078; Haile D, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0129-9; Hassanzadeh J, 2013, IRAN RED CRESCENT ME, V15, P363, DOI 10.5812/ircmj.3525; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; Vu HD, 2018, AM J PERINAT, V35, P707, DOI 10.1055/s-0037-1608876; Kadi K., 2011, STATE CLIMATE INFORM; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; Khattak AM, 2007, GOMAL J MED SCI, V5, P17; Khuwaja S, 2005, J TROP PEDIATRICS, V51, P72, DOI 10.1093/tropej/fmh067; Kikafunda JK, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e45; Kjellen M, 2001, HLTH ENV; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Kruger H S, 2005, Curationis, V28, P40; Lelijveld N, 2016, LANCET GLOB HEALTH, V4, pE654, DOI 10.1016/S2214-109X(16)30133-4; Leroy JL, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0458-9; Mansori Kamyar, 2018, Med J Islam Repub Iran, V32, P103, DOI 10.14196/mjiri.32.103; Medhin G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-27; Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Moges B., 2015, J CLIN RES BIOETH, V6, P1, DOI DOI 10.3390/IJERPH14050509; Mukhopadhyay K, 2013, ACTA PAEDIATR, V102, P278, DOI 10.1111/apa.12113; Nyaradi A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00097; Paudel R, 2012, Kathmandu Univ Med J (KUMJ), V10, P18; Pembe AB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-35; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Ramli, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-64; Rao VG, 2005, INDIAN J MED RES, V122, P43; Reinhard I., 2000, USE STUNTING WASTING; Reinhardt Kristina, 2014, Front Nutr, V1, P13, DOI 10.3389/fnut.2014.00013; Riley ID, 2004, HANDBOOK OF NUTRITION AND IMMUNITY, P265; Saunders J, 2010, CLIN MED, V10, P624, DOI 10.7861/clinmedicine.10-6-624; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Shekar M, 2017, HEALTH POLICY PLANN, V32, P657, DOI 10.1093/heapol/czw184; Shrimpton R., 2003, ANAL CAUSES CHILD ST; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Som S, 2007, ANN HUM BIOL, V34, P632, DOI 10.1080/03014460701671772; Sunguya BF, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-65; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239; Torlesse H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3339-8; Uauy R, 2008, ANN MED, V40, P11, DOI 10.1080/07853890701704683; Walker SP, 2002, PUBLIC HEALTH NUTR, V5, P391, DOI 10.1079/PHN2002275; Wamani H., 2007, BMC Pediatrics, V7; World Health Organization, 2009, GLOB STAT REP ROAD S	78	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248637	10.1371/journal.pone.0248637	http://dx.doi.org/10.1371/journal.pone.0248637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765094	gold, Green Published			2022-12-26	WOS:000634832800054
J	Wagatsuma, K; Koolhof, IS; Shobugawa, Y; Saito, R				Wagatsuma, Keita; Koolhof, Iain S.; Shobugawa, Yugo; Saito, Reiko			Shifts in the epidemic season of human respiratory syncytial virus associated with inbound overseas travelers and meteorological conditions in Japan, 2014-2017: An ecological study	PLOS ONE			English	Article								Few studies have examined the effects of inbound overseas travelers and meteorological conditions on the shift in human respiratory syncytial virus (HRSV) season in Japan. This study aims to test whether the number of inbound overseas travelers and meteorological conditions are associated with the onset week of HRSV epidemic season. The estimation of onset week for 46 prefectures (except for Okinawa prefecture) in Japan for 4-year period (2014-2017) was obtained from previous papers based on the national surveillance data. We obtained data on the yearly number of inbound overseas travelers and meteorological (yearly mean temperature and relative humidity) conditions from Japan National Tourism Organization (JNTO) and Japan Meteorological Agency (JMA), respectively. Multi-level mixed-effects linear regression analysis showed that every 1 person (per 100,000 population) increase in number of overall inbound overseas travelers led to an earlier onset week of HRSV epidemic season in the year by 0.02 week (coefficient -0.02; P<0.01). Higher mean temperature and higher relative humidity were also found to contribute to an earlier onset week by 0.30 week (coefficient -0.30; P<0.05) and 0.18 week (coefficient -0.18; P<0.01), respectively. Additionally, models that included the number of travelers from individual countries (Taiwan, South Korea, and China) except Australia showed that both the number of travelers from each country and meteorological conditions contributed to an earlier onset week. Our analysis showed the earlier onset week of HRSV epidemic season in Japan is associated with increased number of inbound overseas travelers, higher mean temperature, and relative humidity. The impact of international travelers on seasonality of HRSV can be further extended to investigations on the changes of various respiratory infectious diseases especially after the coronavirus disease 2019 (COVID-19) pandemic.	[Wagatsuma, Keita; Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan; [Koolhof, Iain S.] Univ Tasmania, Sch Med, Coll Hlth & Med, Hobart, Tas, Australia; [Shobugawa, Yugo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Act Aging, Niigata, Japan; [Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Infect Dis Res Ctr, Niigata Univ Myanmar IDRC, Niigata, Japan	Niigata University; University of Tasmania; Niigata University; Niigata University	Wagatsuma, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan.	waga@med.niigata-u.ac.jp		Koolhof, Iain/0000-0002-9923-7416	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) [15fm0108009h000119fm0108009h0005]; Health and Labor Sciences Research Grants, Ministry of Health, Labor and Welfare, Japan [H30Shinkougyousei-Shitei-002]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Health and Labor Sciences Research Grants, Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) [grant number 15fm0108009h000119fm0108009h0005]; and the Health and Labor Sciences Research Grants, Ministry of Health, Labor and Welfare, Japan [grant number H30Shinkougyousei-Shitei-002] (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Baker RE, 2020, P NATL ACAD SCI USA, V117, P30547, DOI 10.1073/pnas.2013182117; Belderok SM, 2013, EMERG INFECT DIS, V19, P925, DOI 10.3201/eid1906.111864; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bont Louis, 2009, Paediatr Respir Rev, V10 Suppl 1, P16, DOI 10.1016/S1526-0542(09)70008-9; Britton PN, 2020, LANCET CHILD ADOLESC, V4, pE42, DOI 10.1016/S2352-4642(20)30307-2; Chen ZR, 2014, ARCH VIROL, V159, P631, DOI 10.1007/s00705-013-1863-8; Cliff A, 2004, BRIT MED BULL, V69, P87, DOI 10.1093/bmb/ldh011; Di Giallonardo F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090476; Furuse Y, 2020, JPN J INFECT DIS, V73, P391, DOI 10.7883/yoken.JJID.2020.271; Ge XL, 2018, MED SCI MONITOR, V24, P1856, DOI 10.12659/MSM.908483; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Henderson JC, 2017, INT J TOUR RES, V19, P89, DOI 10.1002/jtr.2088; Hibino A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192085; Hogan AB, 2016, EPIDEMICS-NETH, V16, P49, DOI 10.1016/j.epidem.2016.05.001; Hsu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110166; Htwe KTZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210550; Japan Meteorological Agency (JMA), MET STAT; Japan National Tourism Organization (JNTO), JAP TOUR STAT; Kim CK, 2010, J KOREAN MED SCI, V25, P342, DOI 10.3346/jkms.2010.25.3.342; Kuitunen I, 2020, PEDIATR INFECT DIS J, V39, pE423, DOI 10.1097/INF.0000000000002845; Kwon YS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2897-4; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Liu PC, 2018, JPN J INFECT DIS, V71, P39, DOI [10.7883/yoken.JJID.2017.323, 10.7883/yoken.jjid.2017.323]; Morley C, 2018, EPIDEMIOL INFECT, V146, P757, DOI 10.1017/S0950268818000614; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; National Institute of Infectious Diseases (NIID), NAT EP SURV INF DIS; National Institute of Infectious Diseases (NIID), INF DIS WEEKL REP ID; Nolen LD., 2020, CLIN INFECT DIS, pCIAA1328, DOI [10.1093/cid/ciaa1328, DOI 10.1093/CID/CIAA1328]; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Nyoka R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178323; Paynter S, 2015, AUST NZ J PUBL HEAL, V39, P8, DOI 10.1111/1753-6405.12347; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Price RHM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37481-y; Sasaki A, 2007, J INFECTION, V55, P179, DOI 10.1016/j.jinf.2007.04.004; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Shobugawa Y, 2017, EPIDEMIOL INFECT, V145, P272, DOI 10.1017/S095026881600220X; Tang JW, 2010, EPIDEMIOL INFECT, V138, P226, DOI 10.1017/S0950268809990410; Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771; The Ministry of Health Labor and Welfare Japan (MHLW), NOT PHYS VET INF DIS; Tian DD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173409; Trenholme A., 2021, EMERG INFECT DIS, V27, DOI [10.3201/eid2702.204041, DOI 10.3201/EID2702.204041]; Yamagami H, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00039; Yeoh Daniel K, 2021, Clin Infect Dis, V72, P2199, DOI 10.1093/cid/ciaa1475; Yu JX, 2019, EMERG INFECT DIS, V25, P1127, DOI 10.3201/eid2506.180532	45	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248932	10.1371/journal.pone.0248932	http://dx.doi.org/10.1371/journal.pone.0248932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765037	Green Published, Green Accepted, gold			2022-12-26	WOS:000634832800032
J	Goodin, DS; Khankhanian, P; Gourraud, PA; Vince, N				Goodin, Douglas S.; Khankhanian, Pouya; Gourraud, Pierre-Antoine; Vince, Nicolas			The nature of genetic and environmental susceptibility to multiple sclerosis	PLOS ONE			English	Article							RISK	Objective To understand the nature of genetic and environmental susceptibility to multiple sclerosis (MS) and, by extension, susceptibility to other complex genetic diseases. Background Certain basic epidemiological parameters of MS (e.g., population-prevalence of MS, recurrence-risks for MS in siblings and twins, proportion of women among MS patients, and the time-dependent changes in the sex-ratio) are well-established. In addition, more than 233 genetic-loci have now been identified as being unequivocally MS-associated, including 32 loci within the major histocompatibility complex (MHC), and one locus on the X chromosome. Despite this recent explosion in genetic associations, however, the association of MS with the HLA-DRB1*15:01 similar to HLA-DQB1* 06:02 similar to a1 (H+) haplotype has been known for decades. Design/Methods We define the "genetically-susceptible" subset (G) to include everyone with any non-zero life-time chance of developing MS. Individuals who have no chance of developing MS, regardless of their environmental experiences, belong to the mutually exclusive "non-susceptible" subset (G-). Using these well-established epidemiological parameters, we analyze, mathematically, the implications that these observations have regarding the genetic-susceptibility to MS. In addition, we use the sex-ratio change (observed over a 35-year interval in Canada), to derive the relationship between MS-probability and an increasing likelihood of a sufficient environmental exposure. Results We demonstrate that genetic-susceptibitly is confined to less than 7.3% of populations throughout Europe and North America. Consequently, more than 92.7% of individuals in these populations have no chance whatsoever of developing MS, regardless of their environmental experiences. Even among carriers of the HLA-DRB1* 15:01 similar to HLA-DQB1* 06:02 similar to a1 haplotype, far fewer than 32% can possibly be members the (G) subset. Also, despite the current preponderance of women among MS patients, women are less likely to be in the susceptible (G) subset and have a higher environmental threshold for developing MS compared to men. Nevertheless, the penetrance of MS in susceptible women is considerably greater than it is in men. Moreover, the response-curves for MS-probability in susceptible individuals increases with an increasing likelihood of a sufficient environmental exposure, especially among women. However, these environmental response-curves plateau at under 50% for women and at a significantly lower level for men. Conclusions The pathogenesis of MS requires both a genetic predisposition and a suitable environmental exposure. Nevertheless, genetic-susceptibility is rare in the population (< 7.3%) and requires specific combinations of non-additive genetic risk-factors. For example, only a minority of carriers of the HLA-DRB1* 15:01 similar to HLA-DQB1* 06:02 similar to a1 haplotype are even in the (G) subset and, thus, genetic-susceptibility to MS in these carriers must result from the combined effect this haplotype together with the effects of certain other (as yet, unidentified) genetic factors. By itself, this haplotype poses no MS-risk. By contrast, a sufficient environmental exposure (however many events are involved, whenever these events need to act, and whatever these events might be) is common, currently occurring in, at least, 76% of susceptible individuals. In addition, the fact that environmental response-curves plateau well below 50% (especially in men), indicates that disease pathogenesis is partly stochastic. By extension, other diseases, for which monozygotic-twin recurrence-risks greatly exceed the disease-prevalence (e.g., rheumatoid arthritis, diabetes, and celiac disease), must have a similar genetic basis.	[Goodin, Douglas S.; Gourraud, Pierre-Antoine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Khankhanian, Pouya] Univ Penn, Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA; [Gourraud, Pierre-Antoine; Vince, Nicolas] Univ Nantes, Ctr Rech Transplantat & Immunol UMR 1064, INSERM, Nantes, France; [Gourraud, Pierre-Antoine; Vince, Nicolas] CHU Nantes, Inst Transplantat Urol Nephrol ITUN, Nantes, France	University of California System; University of California San Francisco; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Vince, Nicolas/K-5882-2019; Gourraud, Pierre-Antoine FD/O-3024-2015	Vince, Nicolas/0000-0002-3767-6210; 				ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Bager P, 2006, AM J EPIDEMIOL, V163, P1112, DOI 10.1093/aje/kwj148; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Bashinskaya VV, 2015, HUM GENET, V134, P1143, DOI 10.1007/s00439-015-1601-2; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Chao MJ, 2008, P NATL ACAD SCI USA, V105, P13069, DOI 10.1073/pnas.0801042105; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; ENGELL T, 1989, ACTA NEUROL SCAND, V79, P428, DOI 10.1111/j.1600-0404.1989.tb03811.x; Fisher LD, 1993, BIOSTATISTICS, P786; Freeman JB, 2013, BEHAV RES METHODS, V45, P83, DOI 10.3758/s13428-012-0225-x; Freund JE., 1980, MATH STAT, P452; GEORGI W, 1961, SCHWEIZ MED WSCHR, V91, P605; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; Goodin DS, 2016, HAND CLINIC, V138, P173, DOI 10.1016/B978-0-12-802973-2.00011-2; Goodin DS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190043; Goodin DS, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0575-6; Goodin DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105207; Goodin DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090034; Goodin DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047875; Goodin DS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-101; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hankins GVD, 2005, PAEDIATR PERINAT EP, V19, P8, DOI 10.1111/j.1365-3016.2005.00609.x; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Hansen T, 2005, MULT SCLER J, V11, P500, DOI 10.1191/1352458505ms1202oa; Herrera B, 2007, MULT SCLER J, V13, P856, DOI 10.1177/1352458507076961; Hofker MH, 2014, BBA-MOL BASIS DIS, V1842, P1889, DOI 10.1016/j.bbadis.2014.05.002; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; JACOBSON HI, 1969, ANN MATH STAT, V40, P1746, DOI 10.1214/aoms/1177697386; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Khankhanian P, 2015, J MED GENET, V52, P587, DOI 10.1136/jmedgenet-2015-103071; Kingwell E, 2012, J NEUROL NEUROSUR PS, V83, P61, DOI 10.1136/jnnp-2011-300616; Kingwell E, 2018, CAUSES CONTRIBUTE DE; Koch-Henriksen N, 2017, J NEUROL NEUROSUR PS, V88, P626, DOI 10.1136/jnnp-2017-315907; Kuusisto H, 2008, EUR J NEUROL, V15, P1106, DOI 10.1111/j.1468-1331.2008.02262.x; Liguori M., 2000, Neurological Sciences, V21, pS825; Lill CM, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00130; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Longo DL, 2012, HARRISONS PRINCIPLES; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; O'Gorman C, 2013, NEUROEPIDEMIOLOGY, V40, P1, DOI 10.1159/000341902; Okuda DT, 2011, NEUROLOGY, V76, P686, DOI 10.1212/WNL.0b013e31820d8b1d; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Patsopoulos NA, 2019, SCIENCE, V365, P1417, DOI 10.1126/science.aav7188; Ragonese P, 2010, EUR J NEUROL, V17, P391, DOI 10.1111/j.1468-1331.2009.02814.x; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sadovnick AD, 2005, LANCET NEUROL, V4, P611, DOI 10.1016/S1474-4422(05)70170-8; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scalfari A, 2013, NEUROLOGY, V81, P184, DOI 10.1212/WNL.0b013e31829a3388; Sundstrom P, 2003, J NEUROL NEUROSUR PS, V74, P29, DOI 10.1136/jnnp.74.1.29; Torkildsen NG, 2008, MULT SCLER J, V14, P1191, DOI 10.1177/1352458508093890; Vince N., GENETIC SUSCEP UNPUB; VOST A, 1964, J PATHOL BACTERIOL, V88, P463, DOI 10.1002/path.1700880209; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; Wechsler IS, 1922, ARCH NEURO PSYCHIATR, V8, P59, DOI 10.1001/archneurpsyc.1922.02190130062009; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	76	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0246157	10.1371/journal.pone.0246157	http://dx.doi.org/10.1371/journal.pone.0246157			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750973	gold, Green Submitted, Green Published			2022-12-26	WOS:000631967100015
J	Moorman, VR; Brayton, AM				Moorman, Veronica R.; Brayton, Alexandra M.			Identification of individual components of a commercial wheat germ acid phosphatase preparation	PLOS ONE			English	Article							GIBBERELLIC-ACID; SEQUENCE; CHROMATOGRAPHY; PURIFICATION; EXPRESSION; ISOENZYME; DATABASE; ENZYMES; SEARCH; GENES	Wheat germ acid phosphatase (WGAP) is a commercial preparation of partially purified protein commonly used in laboratory settings for non-specific enzymatic dephosphorylation. It is known that these preparations contain multiple phosphatase isozymes and are still relatively crude. This study therefore aimed to identify the protein components of a commercial preparation of wheat germ acid phosphatase using mass spectroscopy and comparative genomics. After one post-purchase purification step, the most prevalent fifteen proteins in the mixture included heat shock proteins, beta-amylases, glucoseribitol dehydrogenases, enolases, and an aminopeptidase. While not among the most abundant components, eight unique dephosphorylation enzymes were also present including three purple acid phosphatases. Furthermore, it is shown that some of these correspond to previously isolated isozymes; one of which has been also previously shown by transcriptome data to be overexpressed in wheat seeds. In summary, this study identified the major components of WGAP including phosphatases and hypothesizes the most active components towards a better understanding of this commonly used laboratory tool.	[Moorman, Veronica R.; Brayton, Alexandra M.] Kettering Univ, Dept Chem & Biochem, Flint, MI 48504 USA	Kettering University	Moorman, VR (corresponding author), Kettering Univ, Dept Chem & Biochem, Flint, MI 48504 USA.	vmoorman@kettering.edu		Moorman, Veronica/0000-0001-7127-1631	National Science Foundation [1560169]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation (https://www.nsf.gov/) Research Experience for Undergraduates grant (Award #1560169). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff P., 1976, EXPT APPROACH BIOL, Vix, DOI [10.1016/0091-6749%2876%2990010-5, DOI 10.1016/0091-6749%2876%2990010-5]; AKIYAMA T, 1981, PLANT CELL PHYSIOL, V22, P1023; AKIYAMA T, 1986, AGR BIOL CHEM TOKYO, V50, P437, DOI 10.1080/00021369.1986.10867384; Aldrich S., PRODUCT INFORM ACID; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bonomi F., 1981, BIOCHEM EDUC, V9, P12; Brunauer LS, 2008, J CHEM EDUC, V85, P683; Chang A., 2003, CLASS 3 1 HYDROLASES, V2nd ed; CHAUDHARY A, 1995, MOL BIOL CELL, V6, P653; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Cooper I, 2019, TOXICOL APPL PHARM, V384, DOI 10.1016/j.taap.2019.114782; Crick DC., 1991, J NEUROCHEM, V57, P1354, DOI [10.1111/j.1471-4159.1991.tb08301.x, DOI 10.1111/J.1471-4159.1991.TB08301.X]; Dionisio G, 2011, PLANT PHYSIOL, V156, P1087, DOI 10.1104/pp.110.164756; El Baidouri M, 2017, NEW PHYTOL, V213, P1477, DOI 10.1111/nph.14113; Faba Rodriguez R., 2018, STRUCTURE FUNCTION S, DOI [10.1039/c8fo00286j, DOI 10.1039/C8FO00286J]; Ferguson GM, 1998, ABSTR PAP AM CHEM S, V215, pU219; Fox SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096855; GLIMCHER MJ, 1990, BIOMATERIALS, V11, P7; Hegeman CE, 2001, PLANT PHYSIOL, V126, P1598, DOI 10.1104/pp.126.4.1598; JOYCE BK, 1960, J BIOL CHEM, V235, P2278; Katho K., 2002, NUCLEIC ACIDS RES, V30, P3059, DOI [10.1093/nar/gkf436, DOI 10.1093/NAR/GKF436]; Kawarasaki Y, 1996, PLANT SCI, V119, P67, DOI 10.1016/0168-9452(96)04477-9; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim MK, 2015, PHYSIOL PLANTARUM, V153, P58, DOI 10.1111/ppl.12242; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; Kulkarni S, 2010, J CHEM EDUC, V87, P958, DOI 10.1021/ed100320r; Lioliou MG, 2008, CRYST GROWTH DES, V8, P1390, DOI 10.1021/cg700754s; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; MACKO V, 1967, PHYTOCHEMISTRY, V6, P465; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0692-1; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Pearce S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0368-2; Pfeifer M, 2014, SCIENCE, V345, DOI 10.1126/science.1250091; Piperberg JB, 1997, MOL BIOL CELL, V8, P2659; Rasmussen SR, 2004, EUR J PUBLIC HEALTH, V14, P95, DOI 10.1093/eurpub/14.1.95; SALUJA D, 1989, PLANT SCI, V62, P1, DOI 10.1016/0168-9452(89)90182-9; Sayers EW, 2020, NUCLEIC ACIDS RES, V48, pD9, DOI 10.1093/nar/gkz899; Schenk G, 2013, COORDIN CHEM REV, V257, P473, DOI 10.1016/j.ccr.2012.03.020; Schuchardt Sven, 2007, EXS, V97, P141, DOI 10.1007/978-3-7643-7439-6_7; SINGER TP, 1948, J BIOL CHEM, V174, P11; Smith RA., 1988, J CHEM EDUC, V65, P902, DOI [10.1021/ed065p902, DOI 10.1021/ED065P902]; Sun MJ, 2017, SOIL SCI SOC AM J, V81, P61, DOI 10.2136/sssaj2016.07.0219; Sure B., 1946, J BIOL CHEM, V162, P139; Switzer RL., 1977, EXPT BIOCH, Vxii; Taylor ATS, 2005, BIOCHEM MOL BIOL EDU, V33, P16, DOI 10.1002/bmb.2005.494033010430; Tian J, 2015, ANNU PLANT REV, V48, P265, DOI 10.1002/9781118958841.ch10; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; VANETTEN RL, 1991, ARCH BIOCHEM BIOPHYS, V288, P634, DOI 10.1016/0003-9861(91)90246-F; VERJEE ZHM, 1969, EUR J BIOCHEM, V9, P439, DOI 10.1111/j.1432-1033.1969.tb00628.x; Wang JB, 2014, PLANTA, V240, P103, DOI 10.1007/s00425-014-2066-6; WAYMACK PP, 1991, ARCH BIOCHEM BIOPHYS, V288, P621, DOI 10.1016/0003-9861(91)90245-E	57	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248717	10.1371/journal.pone.0248717	http://dx.doi.org/10.1371/journal.pone.0248717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750963	gold, Green Published			2022-12-26	WOS:000631967100008
J	Prompetchara, E; Ketloy, C; Tharakhet, K; Kaewpang, P; Buranapraditkun, S; Techawiwattanaboon, T; Sathean-anan-kun, S; Pitakpolrat, P; Watcharaplueksadee, S; Phumiamorn, S; Wijagkanalan, W; Patarakul, K; Palaga, T; Ruxrungtham, K				Prompetchara, Eakachai; Ketloy, Chutitorn; Tharakhet, Kittipan; Kaewpang, Papatsara; Buranapraditkun, Supranee; Techawiwattanaboon, Teerasit; Sathean-anan-kun, Suwitra; Pitakpolrat, Patrawadee; Watcharaplueksadee, Supaporn; Phumiamorn, Supaporn; Wijagkanalan, Wassana; Patarakul, Kanitha; Palaga, Tanapat; Ruxrungtham, Kiat			DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice	PLOS ONE			English	Article							VIRUS; IMMUNOGENICITY; PROTECTION; SARS; DISEASE	More than 65 million people have been confirmed infection with SARS-CoV-2 and more than 1 million have died from COVID-19 and this pandemic remains critical worldwide. Effective vaccines are one of the most important strategies to limit the pandemic. Here, we report a construction strategy of DNA vaccine candidates expressing full length wild type SARS-CoV-2 spike (S) protein, S1 or S2 region and their immunogenicity in mice. All DNA vaccine constructs of pCMVkan-S, -S1 and -S2 induced high levels of specific binding IgG that showed a balance of IgG1/IgG2a response. However, only the sera from mice vaccinated with pCMKkan-S or -S1 DNA vaccines could inhibit viral RBD and ACE2 interaction. The highest neutralizing antibody (NAb) titer was found in pCMVkan-S group, followed by -S1, while -S2 showed the lowest PRNT50 titers. The geometric mean titers (GMTs) were 2,551, 1,005 and 291 for pCMVkan-S, -S1 and -S2, respectively. pCMVkan-S construct vaccine also induced the highest magnitude and breadth of T cells response. Analysis of IFN-gamma positive cells after stimulation with SARS-CoV-2 spike peptide pools were 2,991, 1,376 and 1,885 SFC/10(6) splenocytes for pCMVkan-S, -S1 and -S2, respectively. Our findings highlighted that full-length S antigen is more potent than the truncated spike (S1 or S2) in inducing of neutralizing antibody and robust T cell responses.	[Prompetchara, Eakachai; Ketloy, Chutitorn; Tharakhet, Kittipan; Kaewpang, Papatsara; Buranapraditkun, Supranee; Techawiwattanaboon, Teerasit; Sathean-anan-kun, Suwitra; Pitakpolrat, Patrawadee; Patarakul, Kanitha; Ruxrungtham, Kiat] Chulalongkorn Univ, Chula Vaccine Res Ctr Chula VRC, Fac Med, Ctr Excellence Vaccine Res & Dev, Bangkok, Thailand; [Prompetchara, Eakachai; Ketloy, Chutitorn; Tharakhet, Kittipan; Pitakpolrat, Patrawadee] Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok, Thailand; [Prompetchara, Eakachai; Ketloy, Chutitorn; Patarakul, Kanitha; Palaga, Tanapat; Ruxrungtham, Kiat] Chulalongkorn Univ, Integrated Frontier Biotechnol Emerging Dis, Bangkok, Thailand; [Buranapraditkun, Supranee] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok, Thailand; [Techawiwattanaboon, Teerasit; Sathean-anan-kun, Suwitra; Patarakul, Kanitha] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok, Thailand; [Watcharaplueksadee, Supaporn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med,Who Collaborating Ctr Res & Training Vira, Thai Red Cross Emerging Infect Dis Hlth Sci Ctr, Bangkok, Thailand; [Phumiamorn, Supaporn] Inst Biol Prod, Dept Med Sci, Minist Publ Hlth, Nonthaburi, Thailand; [Wijagkanalan, Wassana] BioNet Asia Co Ltd, Bangkok, Thailand; [Palaga, Tanapat] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Ministry of Public Health - Thailand; Chulalongkorn University	Ketloy, C (corresponding author), Chulalongkorn Univ, Chula Vaccine Res Ctr Chula VRC, Fac Med, Ctr Excellence Vaccine Res & Dev, Bangkok, Thailand.; Ketloy, C (corresponding author), Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok, Thailand.; Ketloy, C (corresponding author), Chulalongkorn Univ, Integrated Frontier Biotechnol Emerging Dis, Bangkok, Thailand.	Chutitorn.K@chula.ac.th	Ketloy, Chutitorn/ACW-3484-2022	Ruxrungtham, Kiat/0000-0001-7348-2352; techawiwattanaboon, teerasit/0000-0002-8188-9934; Ketloy, Chutitorn/0000-0002-7043-8062	National Vaccine Institute (NVI) [2563. 1/8]; National Research Council of Thailand (NTCT); Emerging Infectious Diseases and Vaccines Cluster; Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University [RAMF-29/63]; Grants for Development of New Faculty Staff, Ratchadapiseksompote Endowment Fund [DNS 63_031_30_009_2]	National Vaccine Institute (NVI); National Research Council of Thailand (NTCT); Emerging Infectious Diseases and Vaccines Cluster; Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University); Grants for Development of New Faculty Staff, Ratchadapiseksompote Endowment Fund	This study was funded by National Vaccine Institute (NVI), grant no. 2563. 1/8, National Research Council of Thailand (NTCT), Emerging Infectious Diseases and Vaccines Cluster, Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University and Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, grant no RAMF-29/63. The authors would like to thank the Second Century Fund (C2F), Chulalongkorn University. EP was also supported by the Grants for Development of New Faculty Staff, Ratchadapiseksompote Endowment Fund, grant no DNS 63_031_30_009_2. WWis BioNet-Asia Co., Ltd consultant. The funder provided support in the form of budget for research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	Agrawal AS, 2016, HUM VACC IMMUNOTHER, V12, P2351, DOI 10.1080/21645515.2016.1177688; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Brian D., 2020, SARS COV 2 RECEPTOR; Carl Zimmer, 2020, NEW YORK TIMES; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1101/2020.06.11.145920, 10.1038/s41586-020-2622-0]; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; Farrera-Soler L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238089; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Forde GM, 2005, NAT BIOTECHNOL, V23, P1059, DOI 10.1038/nbt0905-1059; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Helmy YA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041225; Hu H, 2009, VACCINE, V27, P1758, DOI 10.1016/j.vaccine.2009.01.021; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Kar T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67749-1; Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Khan Kishwar Hayat, 2013, Germs, V3, P26, DOI 10.11599/germs.2013.1034; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Li J, 2013, VIRAL IMMUNOL, V26, P126, DOI 10.1089/vim.2012.0076; Li Y, 2020, CELL MOL IMMUNOL, V17, P1095, DOI 10.1038/s41423-020-00523-5; Luo F, 2018, VIROL SIN, V33, P201, DOI 10.1007/s12250-018-0009-2; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Poh CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16638-2; Prompetchara E, 2015, ASIAN PAC J ALLERGY, V33, P182, DOI [10.12932/AP0508.33.3.2015, 10.12932/ap0508.33.3.2015]; Prompetchara E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092643; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Samrat SK, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198141; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Smith TRF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16505-0; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Tebas P, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100689; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1101/2020.05.13.093195, 10.1038/s41586-020-2608-y]; van Riel D, 2020, NAT MATER, V19, P810, DOI 10.1038/s41563-020-0746-0; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035069; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walsh Edward E, 2020, medRxiv, DOI 10.1101/2020.08.17.20176651; Wang YF, 2021, J MED VIROL, V93, P892, DOI 10.1002/jmv.26320; WHO, 2020, DRAFT LANDSC COVID C; WHO, 2020, WHO DIRECTOR GEN OPE; WHO. Statement on the second meeting of the International Health Regulations, 2020, EM COMM REG OUTBR NO; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2; Xiong XL, 2020, NAT STRUCT MOL BIOL, V27, P934, DOI 10.1038/s41594-020-0478-5; Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhang BZ, 2020, CELL RES, V30, P702, DOI 10.1038/s41422-020-0366-x; Zhao JC, 2010, J VIROL, V84, P9318, DOI 10.1128/JVI.01049-10	59	15	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248007	10.1371/journal.pone.0248007	http://dx.doi.org/10.1371/journal.pone.0248007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750975	Green Published, gold			2022-12-26	WOS:000631967100029
J	Anand, NM; Liya, DH; Pradhan, AK; Tayal, N; Bansal, A; Donakonda, S; Jainarayanan, AK				Anand, Nithishwer Mouroug; Liya, Devang Haresh; Pradhan, Arpit Kumar; Tayal, Nitish; Bansal, Abhinav; Donakonda, Sainitin; Jainarayanan, Ashwin Kumar			A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing	PLOS ONE			English	Article							CORONAVIRUS; PROTEIN; COVID-19	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a novel human coronavirus strain (HCoV) was initially reported in December 2019 in Wuhan City, China. This acute infection caused pneumonia-like symptoms and other respiratory tract illness. Its higher transmission and infection rate has successfully enabled it to have a global spread over a matter of small time. One of the major concerns involving the SARS-COV-2 is the mutation rate, which enhances the virus evolution and genome variability, thereby making the design of therapeutics difficult. In this study, we identified the most common haplotypes from the haplotype network. The conserved genes and population level variants were analysed. Non-Structural Protein 10 (NSP10), Nucleoprotein, Papain-like protease (Plpro or NSP3) and 3-Chymotrypsin like protease (3CLpro or NSP5), which were conserved at the highest threshold, were used as drug targets for molecular dynamics simulations. Darifenacin, Nebivolol, Bictegravir, Alvimopan and Irbesartan are among the potential drugs, which are suggested for further pre-clinical and clinical trials. This particular study provides a comprehensive targeting of the conserved genes. We also identified the mutation frequencies across the viral genome.	[Anand, Nithishwer Mouroug; Liya, Devang Haresh] Indian Inst Sci Educ & Res, Dept Phys Sci, Mohali, India; [Pradhan, Arpit Kumar] Ludwig Maximilian Univ Munich, Grad Sch Syst Neurosci, Munich, Germany; [Pradhan, Arpit Kumar] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany; [Tayal, Nitish] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India; [Bansal, Abhinav] Indian Inst Sci Educ & Res, Dept Chem Sci, Mohali, India; [Donakonda, Sainitin] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Jainarayanan, Ashwin Kumar] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Jainarayanan, Ashwin Kumar] Univ Oxford, Interdisciplinary Biosci DTP, Oxford, England	Indian Institute of Science Education & Research (IISER) - Mohali; University of Munich; Technical University of Munich; Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Technical University of Munich; University of Oxford; University of Oxford	Pradhan, AK (corresponding author), Ludwig Maximilian Univ Munich, Grad Sch Syst Neurosci, Munich, Germany.; Pradhan, AK (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany.; Jainarayanan, AK (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.; Jainarayanan, AK (corresponding author), Univ Oxford, Interdisciplinary Biosci DTP, Oxford, England.	Arpit.Pradhan@campus.lmu.de; ashwin.jainarayanan@dtc.ox.ac.uk		/0000-0003-0852-7141				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bouvet M, 2014, J BIOL CHEM, V289, P25783, DOI 10.1074/jbc.M114.577353; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Briciu Corina, 2015, Clujul Med, V88, P208, DOI 10.15386/cjmed-395; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chiu SW, 2009, J PHYS CHEM B, V113, P2748, DOI 10.1021/jp807056c; Cinaroglu SS, 2019, J CHEM INF MODEL, V59, P3846, DOI 10.1021/acs.jcim.9b00346; Deeks ED, 2018, DRUGS, V78, P1817, DOI 10.1007/s40265-018-1010-7; Douguet D, 2005, J MED CHEM, V48, P2457, DOI 10.1021/jm0492296; Elmezayen AD, 2021, J BIOMOL STRUCT DYN, V39, P2980, DOI 10.1080/07391102.2020.1758791; Forni V, 2011, INTEGR BLOOD PRESS C, V4, P17, DOI 10.2147/IBPC.S12211; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Hegde SS, 2006, BRIT J PHARMACOL, V147, pS80, DOI 10.1038/sj.bjp.0706560; Hilas Olga, 2009, P T, V34, P188; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Kannan S, 2020, EUR REV MED PHARMACO, V24, P2006, DOI 10.26355/eurrev_202002_20378; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Khan RJ, 2021, J BIOMOL STRUCT DYN, V39, P2679, DOI 10.1080/07391102.2020.1753577; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leslie JB, 2007, DRUG TODAY, V43, P611, DOI 10.1358/dot.2007.43.9.1086176; Lewis Edmund J, 2003, Clin Exp Nephrol, V7, P1, DOI 10.1007/s101570300000; Li T., 2020, J GEOPHYS ENG, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Nadeem MS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9040307; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Raoult D, 2020, CELL STRESS, V4, P66, DOI 10.15698/cst2020.04.216; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Skerjanec A, 2006, CLIN PHARMACOKINET, V45, P325, DOI 10.2165/00003088-200645040-00001; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657; ul Qamar MT, 2020, J PHARM ANAL, V10, P313, DOI 10.1016/j.jpha.2020.03.009; Wang LS, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105948; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xia S, 2020, CELL RES, V30, P343, DOI 10.1038/s41422-020-0305-x; Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472; Zabirowicz ES., 2018, PHARM POSTOPERATIVE, V2, P671, DOI [10.1016/B978-0-323-48110-6.00034-X, DOI 10.1016/B978-0-323-48110-6.00034-X]; Zeuli J, 2019, DRUG TODAY, V55, P669, DOI 10.1358/dot.2019.55.11.3068796; Zinner N, 2008, INT J CLIN PRACT, V62, P1664, DOI 10.1111/j.1742-1241.2008.01893.x	47	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248553	10.1371/journal.pone.0248553	http://dx.doi.org/10.1371/journal.pone.0248553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735271	gold, Green Published			2022-12-26	WOS:000631029700011
J	Jang, H; Ross, TM				Jang, Hyesun; Ross, Ted M.			Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles	PLOS ONE			English	Article							INFLUENZA-VIRUSES; HUMAN INFECTION; REPLICATION; PROTECTION; ORIGIN	Background A systemic evaluation of the antigenic differences of the H7 influenza hemagglutinin (HA) proteins, especially for the viruses isolated after 2016, are limited. The purpose of this study was to investigate the antigenic differences of major H7 strains with an ultimate aim to discover H7 HA proteins that can elicit protective receptor-binding antibodies against co-circulating H7 influenza strains. Method A panel of eight H7 influenza strains were selected from 3,633 H7 HA amino acid sequences identified over the past two decades (2000-2018). The sequences were expressed on the surface of virus like particles (VLPs) and used to vaccinate C57BL/6 mice. Serum samples were collected and tested for hemagglutination-inhibition (HAI) activity. The vaccinated mice were challenged with lethal dose of H7N9 virus, A/Anhui/1/2013. Results VLPs expressing the H7 HA antigens elicited broadly reactive antibodies each of the selected H7 HAs, except the A/Turkey/Italy/589/2000 (Italy/00) H7 HA. A putative glycosylation due to an A169T substitution in antigenic site B was identified as a unique antigenic profile of Italy/00. Introduction of the putative glycosylation site (H7 HA-A169T) significantly altered the antigenic profile of HA of the A/Anhui/1/2013 (H7N9) strain. Conclusion This study identified key amino acid mutations that result in severe vaccine mismatches for future H7 epidemics. Future universal influenza vaccine candidates will need to focus on viral variants with these key mutations.	[Jang, Hyesun; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu		Ross, Ted/0000-0003-1947-7469	U.S. NIH/NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs) [75N93019C00052]; University of Georgia (UGA) [UGA-001]; Georgia Research Alliance [GRA-001]	U.S. NIH/NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs); University of Georgia (UGA); Georgia Research Alliance	This work was funded, in part, by the U.S. NIH/NIAID Collaborative Influenza Vaccine Innovation Centers (CIVICs) contract 75N93019C00052 and by the University of Georgia (UGA) (UGA-001). In addition, TMR is supported by the Georgia Research Alliance (GRA-001) as an Eminent Scholar.	Alvarado-Facundo E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149149; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P633; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2017, J VIROL, V91, DOI 10.1128/JVI.00672-17; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Benoit A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv067; Carter DM, 2016, J VIROL, V90, P4720, DOI 10.1128/JVI.03152-15; Chang PX, 2020, J VIROL, V94, DOI 10.1128/JVI.00216-20; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Dong J, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104776; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gianchecchi E, 2019, HUM VACC IMMUNOTHER, V15, P1021, DOI 10.1080/21645515.2019.1565269; Guo L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22045; Habibzadeh F, 2016, BIOCHEM MEDICA, V26, P297, DOI 10.11613/BM.2016.034; Hatta M, 2018, EMERG INFECT DIS, V24, P75, DOI 10.3201/eid2401.171240; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huang Y, 2020, J VIROL, V94, DOI 10.1128/JVI.01432-19; Iqbal M, 2012, VIROLOGY, V433, P282, DOI 10.1016/j.virol.2012.08.001; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Naguib MM, 2019, FEMS MICROBIOL REV, V43, P608, DOI 10.1093/femsre/fuz019; Oh DY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00080; Schmeisser F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117108; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Shi JZ, 2018, CELL HOST MICROBE, V24, P558, DOI 10.1016/j.chom.2018.08.006; Stadlbauer D, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00502-17; Sutton TC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090461; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Unal I, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/3762651; Wood JM, 2003, VACCINE, V21, P1786, DOI 10.1016/S0264-410X(03)00073-2; Yu DS, 2019, EUROSURVEILLANCE, V24, P13, DOI 10.2807/1560-7917.ES.2019.24.21.1900273; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0246613	10.1371/journal.pone.0246613	http://dx.doi.org/10.1371/journal.pone.0246613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735274	Green Published, Green Submitted, gold			2022-12-26	WOS:000631029700065
J	Nichols, ZG; Rikard, S; Alavi, SMH; Walton, WC; Butts, IAE				Nichols, Zoe G.; Rikard, Scott; Alavi, Sayyed Mohammad Hadi; Walton, William C.; Butts, Ian A. E.			Regulation of sperm motility in Eastern oyster (Crassostrea virginica) spawning naturally in seawater with low salinity	PLOS ONE			English	Article							SEA-URCHIN SPERM; CARP CYPRINUS-CARPIO; MEMBRANE HYPERPOLARIZATION; ION CHANNELS; FERTILIZING ABILITY; POTASSIUM CHANNELS; FISH SPERMATOZOA; TROUT SPERM; FRESH-WATER; INITIATION	Oyster aquaculture is expanding worldwide, where many farms rely on seed produced by artificial spawning. As sperm motility and velocity are key determinants for fertilization success, understanding the regulation of sperm motility and identifying optimal environmental conditions can increase fertility and seed production. In the present study, we investigated the physiological mechanisms regulating sperm motility in Eastern oyster, Crassostrea virginica. Sperm motility was activated in ambient seawater with salinity 4-32 PSU with highest motility and velocity observed at 12-24 PSU. In artificial seawater (ASW) with salinity of 20 PSU, sperm motility was activated at pH 6.5-10.5 with the highest motility and velocity recorded at pH 7.5-10.0. Sperm motility was inhibited or totally suppressed in Na+, K+, Ca2+, and Mg2+-free ASW at 20 PSU. Applications of K+ (500 mu M glybenclamide and 10-50 mM 4-aminopyridine), Ca2+ (1-50 mu M mibefradil and 10-200 mu M verapamil), or Na+ (0.2-2.0 mM amiloride) channel blockers into ASW at 20 PSU inhibited or suppressed sperm motility and velocity. Chelating extracellular Ca2+ ions by 3.0 and 3.5 mM EGTA resulted in a significant reduction and full suppression of sperm motility by 4 to 6 min post-activation. These results suggest that extracellular K+, Ca2+, and Na+ ions are involved in regulation of ionic-dependent sperm motility in Eastern oyster. A comparison with other bivalve species typically spawning at higher salinities or in full-strength seawater shows that ionic regulation of sperm motility is physiologically conserved in bivalves. Elucidating sperm regulation in C. virginica has implications to develop artificial reproduction, sperm short-term storage, or cryopreservation protocols, and to better predict how changes in the ocean will impact oyster spawning dynamics.	[Nichols, Zoe G.; Rikard, Scott; Walton, William C.; Butts, Ian A. E.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Rikard, Scott; Walton, William C.] Auburn Univ, Shellfish Lab, Dauphin Isl, AL USA; [Alavi, Sayyed Mohammad Hadi] Univ Tehran, Sch Biol, Coll Sci, Tehran, Iran	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Tehran	Butts, IAE (corresponding author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA.	iab0007@auburn.edu			Alabama Agriculture Experimental Station; USDA National Institute of Food and Agriculture, Hatch project [1013854]	Alabama Agriculture Experimental Station; USDA National Institute of Food and Agriculture, Hatch project	This research was supported by the Alabama Agriculture Experimental Station and the USDA National Institute of Food and Agriculture, Hatch project (1013854 to I.A.E.B.).	Alavi SMH, 2019, THERIOGENOLOGY, V136, P143, DOI 10.1016/j.theriogenology.2019.06.038; Alavi SMH, 2014, REPRODUCTION, V147, P331, DOI 10.1530/REP-13-0418; Alavi SMH, 2006, CELL BIOL INT, V30, P1, DOI 10.1016/j.cellbi.2005.06.004; Alavi SMH, 2005, CELL BIOL INT, V29, P101, DOI 10.1016/j.cellbi.2004.11.021; BARNES R.S.K., 1993, INVERTEBRATES SYNTHE; Beirao J, 2019, THERIOGENOLOGY, V133, P201, DOI 10.1016/j.theriogenology.2019.03.034; BILLARD R, 1995, AQUACULTURE, V129, P95, DOI 10.1016/0044-8486(94)00231-C; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BOITANO S, 1991, J CELL SCI, V98, P343; Boulais M, 2019, THERIOGENOLOGY, V136, P15, DOI 10.1016/j.theriogenology.2019.06.025; Boulais M, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031427; Boulais M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128538; Browne RK, 2015, THERIOGENOLOGY, V83, P1, DOI 10.1016/j.theriogenology.2014.09.018; Browne RK, 2019, THERIOGENOLOGY, V133, P187, DOI 10.1016/j.theriogenology.2019.03.035; BUTLER PA, 1949, BIOL BULL, V96, P263, DOI 10.2307/1538361; Butts IAE, 2010, THERIOGENOLOGY, V73, P873, DOI 10.1016/j.theriogenology.2009.11.011; Butts IAE, 2013, COMP BIOCHEM PHYS A, V166, P147, DOI 10.1016/j.cbpa.2013.05.011; Butts IAE, 2011, COMP BIOCHEM PHYS A, V159, P16, DOI 10.1016/j.cbpa.2011.01.014; CALABRESE A, 1969, Veliger, V11, P235; Vilchez MC, 2016, COMP BIOCHEM PHYS A, V198, P51, DOI 10.1016/j.cbpa.2016.04.008; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; CHRISTEN R, 1986, J PHYSIOL-LONDON, V379, P347, DOI 10.1113/jphysiol.1986.sp016257; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; Cosson J, 2010, J FISH BIOL, V76, P240, DOI 10.1111/j.1095-8649.2009.02504.x; Cosson Jacky J., 2008, P63; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Demoy-Schneider M, 2012, THERIOGENOLOGY, V77, P53, DOI 10.1016/j.theriogenology.2011.07.014; Detweiler C, 1998, J EXP ZOOL, V281, P139, DOI 10.1002/(SICI)1097-010X(19980601)281:2&lt;139::AID-JEZ8&gt;3.0.CO;2-P; Dong QX, 2002, J SHELLFISH RES, V21, P719; Dzyuba V, 2014, REPROD BIOL, V14, P165, DOI 10.1016/j.repbio.2013.12.005; Ewart JW, 1993, NE REGIONAL AQUACULT; FAURE C, 1994, J COMP PHYSIOL B, V164, P444, DOI 10.1007/BF00714581; Food and Agriculture Organization of the United Nations, FISH AQ STAT; Ford Susan E., 1996, P581; GATTI JL, 1985, J BIOL CHEM, V260, P7599; Guerrero A., 2020, REPROD AQUATIC ANIMA, P249, DOI [10.1007/978-981-15-2290-1_13, DOI 10.1007/978-981-15-2290-1_13]; Ikenaga J., 2020, REPROD AQUATIC ANIMA, P31, DOI DOI 10.1007/978-981-15-2290-1_4; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Izumi H, 1999, DEV BIOL, V213, P246, DOI 10.1006/dbio.1999.9367; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHNSON CH, 1983, DEV BIOL, V98, P493, DOI 10.1016/0012-1606(83)90378-0; JONES R, 1978, COMP BIOCHEM PHYS B, V61, P365, DOI 10.1016/0305-0491(78)90138-4; KADAM AL, 1990, INVERTEBR REPROD DEV, V17, P33, DOI 10.1080/07924259.1990.9672085; Kennedy VS, 1996, J SHELLFISH RES, V15, P177; Kho KH, 2001, ZOOL SCI, V18, P919, DOI 10.2108/zsj.18.919; Kinnby A, 2015, CRASSOSTREA GIGAS TH; Krasznai Z, 2000, P NATL ACAD SCI USA, V97, P2052, DOI 10.1073/pnas.040558097; Krasznai Z, 2003, AQUAT LIVING RESOUR, V16, P445, DOI 10.1016/S0990-7440(03)00054-8; KRASZNAI Z, 1995, AQUACULTURE, V129, P123, DOI 10.1016/0044-8486(94)00234-F; Legendre M, 2016, THERIOGENOLOGY, V86, P1251, DOI 10.1016/j.theriogenology.2016.04.066; Levitan Don R., 1995, P123; Linhart O, 2008, J APPL ICHTHYOL, V24, P386, DOI 10.1111/j.1439-0426.2008.01138.x; Linhart O, 1999, J FISH BIOL, V55, P1344, DOI 10.1111/j.1095-8649.1999.tb02080.x; Linhart O, 2005, REPRODUCTION, V130, P705, DOI 10.1530/rep.1.00541; Magana-Carrasco A, 2018, ECOSIS RECUR AGROPEC, V5, P239, DOI [10.19136/era.a5nl4.1236, 10.19136/era.a5n14.1236]; Mizuno K, 2009, BIOL CELL, V101, P91, DOI 10.1042/BC20080032; Morisawa M, 2008, J APPL ICHTHYOL, V24, P362, DOI 10.1111/j.1439-0426.2008.01126.x; Morita M, 2004, J EXP BIOL, V207, P337, DOI 10.1242/jeb.00748; Morita M, 2003, J EXP BIOL, V206, P913, DOI 10.1242/jeb.00153; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nishigaki T, 1996, ZYGOTE, V4, P237, DOI 10.1017/S0967199400003154; Nomura M, 2004, CELL MOTIL CYTOSKEL, V59, P28, DOI 10.1002/cm.20020; ODA S, 1993, CELL MOTIL CYTOSKEL, V25, P171, DOI 10.1002/cm.970250206; Ohta H, 2007, FISHERIES SCI, V73, P107, DOI 10.1111/j.1444-2906.2007.01308.x; Ozbay G., 2017, OYSTERS BIOL CONSUMP, P1; Paniagua-Chavez CG, 1998, J SHELLFISH RES, V17, P231; Prytherch HF., 1928, B BUREAU FISHERIES, V4, P429; ROTHSCHILD, 1948, J EXP BIOL, V25, P344; Rurangwa E, 2004, AQUACULTURE, V234, P1, DOI 10.1016/j.aquaculture.2003.12.006; Serrano-Martin X, 2006, ANTIMICROB AGENTS CH, V50, P4214, DOI 10.1128/AAC.00617-06; Shiba K, 2006, CELL MOTIL CYTOSKEL, V63, P623, DOI 10.1002/cm.20149; Shumway Sandra E., 1996, P467; Song YP, 2009, AQUACULTURE, V287, P311, DOI 10.1016/j.aquaculture.2008.10.018; Spilke J, 2005, J AGRON CROP SCI, V191, P47, DOI 10.1111/j.1439-037X.2004.00120.x; Suquet M, 2010, THERIOGENOLOGY, V74, P111, DOI 10.1016/j.theriogenology.2010.01.021; Suquet M, 2018, AQUAT LIVING RESOUR, V31, DOI 10.1051/alr/2018008; TAKAI H, 1995, J CELL SCI, V108, P1175; Tan WX, 2019, GEN COMP ENDOCR, V279, P60, DOI 10.1016/j.ygcen.2018.12.002; TANIMOTO S, 1988, DEV GROWTH DIFFER, V30, P117; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Vignier J, 2017, ENVIRON POLLUT, V225, P270, DOI 10.1016/j.envpol.2016.11.052; Vines CA, 2002, P NATL ACAD SCI USA, V99, P2026, DOI 10.1073/pnas.042700899; Wachten D, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028225; Yang HP, 2012, AQUACULTURE, V344, P223, DOI 10.1016/j.aquaculture.2012.03.018; Yoshida M, 2008, CELL MOL LIFE SCI, V65, P3446, DOI 10.1007/s00018-008-8230-z; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599; Zilli L, 2008, BIOL REPROD, V79, P356, DOI 10.1095/biolreprod.108.068296	88	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0243569	10.1371/journal.pone.0243569	http://dx.doi.org/10.1371/journal.pone.0243569			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735238	gold, Green Published			2022-12-26	WOS:000631029700102
J	Ohene, SA; Bonsu, F; Adusi-Poku, Y; Dzata, F; Bakker, M				Ohene, Sally-Ann; Bonsu, Frank; Adusi-Poku, Yaw; Dzata, Francisca; Bakker, Mirjam			Case finding of tuberculosis among mining communities in Ghana	PLOS ONE			English	Article							PREVALENCE; MINERS; YIELD; RISK; SETTINGS; DISTRICT; OUTCOMES	Background Data on active TB case finding activities among artisanal gold mining communities (AMC) is limited. The study assessed the yield of TB cases from the TB screening activities among AMC in Ghana, the factors associated with TB in these communities and the correlation between the screening methods and a diagnosis of TB. Methods We conducted secondary data analyses of NTP program data collected from TB case finding activities using symptom screening and mobile X-ray implemented in hard to reach AMC. Yield of TB cases, number needed to screen (NNS) and the number needed to test (NNT) to detect a TB case were assessed and logistic regression were conducted to assess factors associated with TB. The performance of screening methods chest X-ray and symptoms in the detection of TB cases was also evaluated. Results In total 10,441 people from 78 communities in 24 districts were screened, 55% were female and 60% (6,296) were in the aged 25 to 54 years. Ninety-five TB cases were identified, 910 TB cases per 100,000 population screened; 5.6% of the TB cases were rifampicin resistant. Being male (aOR 5.96, 95% CI 3.25-10.92, P < 0.001), a miner (aOR 2.70, 95% CI 1.47-4.96, P = 0.001) and age group 35 to 54 years (aOR 2.27, 95% CI 1.35-3.84, P = 0.002) were risk factors for TB. NNS and NNT were 110 and 24 respectively.; Cough of any duration had the strongest association with X-ray suggestive of TB with a correlation coefficient of 0.48. Cough was most sensitive for a diagnosis of TB; sensitivity of 86.3% (95% CI 79.4-93.2) followed by X-ray, sensitivity 81.1% (95% CI 71.7-88.4). The specificities of the symptoms and X-rays ranged from 80.2% (cough) to 97.3% (sputum). Conclusion The high risk of TB in the artisanal mining communities and in miners in this study reinforces the need to target these populations with outreach programs particularly in hard to reach areas. The diagnostic value of cough highlights the usefulness of symptom screening in this population that may be harnessed even in the absence of X-ray to identify those suspected to have TB for further evaluation.	[Ohene, Sally-Ann] WHO, Country Off, Accra, Ghana; [Bonsu, Frank; Adusi-Poku, Yaw; Dzata, Francisca] Natl TB Control Program, Ghana Hlth Serv, Accra, Ghana; [Bakker, Mirjam] KIT Royal Trop Inst, Global Hlth Amsterdam, Amsterdam, Netherlands	World Health Organization; Ghana Health Service	Ohene, SA (corresponding author), WHO, Country Off, Accra, Ghana.	salohene@yahoo.com						[Anonymous], 2016, ARTISANAL SMALL SCAL; [Anonymous], 2013, SYST SCREEN ACT TUB; [Anonymous], GLOBAL FUND FIGHT HI; [Anonymous], TUBERCULOSIS MINERS; Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; Bonsu F, 2020, INT J TUBERC LUNG D, V24, P321, DOI 10.5588/ijtld.19.0163; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Calys-Tagoe BNL, 2015, INT J ENV RES PUB HE, V12, P7922, DOI 10.3390/ijerph120707922; Chanda-Kapata P, 2016, ASIAN PAC J TROP BIO, V6, P803, DOI 10.1016/j.apjtb.2016.06.015; Choun K, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1646024; Churchyard GJ, 2000, INT J TUBERC LUNG D, V4, P705; Creswell J, 2019, J CLIN TUBER OTH MYC, V14, P1, DOI 10.1016/j.jctube.2018.11.002; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Ghana Health Service/Ministry of Health, NAT TUB HLTH SECT ST; Ghana Health Service/Ministry of Health, 2013, END TERM COMPR EXT R; Ghana Statistical Service, 2010 POP HOUS CENS D; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hinson G, MINING MINERALS SUST; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lewis JJ, 2009, AM J RESP CRIT CARE, V180, P1271, DOI 10.1164/rccm.200806-846OC; Mantey J, 2017, J MIN ENVIRON, V8, P11, DOI 10.22044/jme.2016.627; Morasert T, 2018, INT J TUBERC LUNG D, V22, P1203, DOI 10.5588/ijtld.17.0654; Myint O, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0291-5; Naidoo RN, 2005, AM J IND MED, V48, P217, DOI 10.1002/ajim.20207; Nakua EK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7560-0; Ngosa K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3547-2; Nguyen DTM, 2016, INT J TUBERC LUNG D, V20, P211, DOI 10.5588/ijtld.15.0705; Owusu-Nimo F, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00534; Saidu IA, 2014, GLOB J MED PUBLIC HL, V3, P1; Samuel A., 2012, INT J MODERN SOCIAL, P38; STEWART J. L., 1929, Brit. J. Tuberculosis, V23, P6; STOP TB Partnership, 2015, TB KEY POP BRIEF MIN; Stop TB Partnership, GHAN TUB TB SIT 2018; Stop TB Partnership, 2017, DAT ACT TUB KEY VULN; Stop TB Partnership TB Reach, 2015, IMPR TUB CAS DET COM; Stuckler D, 2011, AM J PUBLIC HEALTH, V101, P524, DOI 10.2105/AJPH.2009.175646; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, END TB STRAT GLOB ST; World Health Organization, 2016, CHEST RAD TUB DET SU; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yakovleva N, 2007, RESOUR POLICY, V32, P29, DOI 10.1016/j.resourpol.2007.03.002	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248718	10.1371/journal.pone.0248718	http://dx.doi.org/10.1371/journal.pone.0248718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735298	gold, Green Published			2022-12-26	WOS:000631029700006
J	Pradhan, A; Raju, S; Nithya, DJ; Panda, AK; Wagh, RD; Maske, MR; Bhavani, RV				Pradhan, Aliza; Raju, S.; Nithya, D. J.; Panda, Akshaya Kumar; Wagh, Rupal D.; Maske, Mahesh R.; Bhavani, R. V.			Farming System for Nutrition-a pathway to dietary diversity: Evidence from India	PLOS ONE			English	Article							SENSITIVE AGRICULTURE; YOUNG-CHILDREN; HOUSEHOLD FOOD; INTERVENTIONS; BIODIVERSITY; PROGRAMS; OUTCOMES; WOMEN	Farming is the main livelihood of a majority of people in India. The country is also home to a large population of undernourished people. This indicates potential for mainstreaming the nutrition dimension in the farming system to impact on nutrition outcomes. A Farming System for Nutrition (FSN) study was conducted in two agro-ecologically different locations from 2013-2018, to explore the feasibility of nutrition-sensitive agricultural interventions. The baseline survey in 2013-2014 revealed that the population in the study area was largely undernourished and that household diets were cereal-dominated. The FSN model was designed in consultation with community members, to increase availability of nutrient-dense cereals and pulses, by enhancing production and crop diversification at the farm level, promoting cultivation of nutrient-rich fruits and vegetables in nutrition gardens and supporting interventions to promote access to animal foods. Nutrition awareness initiatives were undertaken to build capacity at the local level and translate production diversity to consumption diversity. An endline survey was conducted in 2017 (July-October), following three years of intervention. Crop, vegetable and animal food production and food consumption was compared with the baseline data. There was evidence of higher production and consumption of nutrient rich foods, improved household dietary diversity; and understanding and acceptance of nutrition-sensitive agriculture. The number of items consumed under each food group, frequency of consumption of food and average per capita intake of nutrient-rich foods were found to have improved. The results provide evidence regarding feasibility of location-specific FSN models to promote sustainable and healthy diets, using locally available plant and animal food resources, to address nutrition deficiencies in farm families.	[Pradhan, Aliza] ICAR Natl Inst Abiot Stress Management, Pune, Maharashtra, India; [Raju, S.; Nithya, D. J.; Panda, Akshaya Kumar; Bhavani, R. V.] MS Swaminathan Res Fdn MSSRF, Chennai, Tamil Nadu, India; [Maske, Mahesh R.] Borlaug Inst South Asia BISA, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Abiotic Stress Management	Bhavani, RV (corresponding author), MS Swaminathan Res Fdn MSSRF, Chennai, Tamil Nadu, India.	bhavjoy@gmail.com	Pradhan, Aliza/HCI-6305-2022	R V, Bhavani/0000-0002-3737-6613	Leveraging Agriculture for Nutrition in South Asia (LANSA) [PO5773]; UK government	Leveraging Agriculture for Nutrition in South Asia (LANSA); UK government	This paper is part of the research generated by the Leveraging Agriculture for Nutrition in South Asia (LANSA -Grant number PO5773) research consortium, and is funded by UK Aid from the UK government. The views expressed do not necessarily reflect the UK Government's official policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GUIDE MEASURING DIET; [Anonymous], 2007, AGR NUTR PATHW SYN O; Bamji MS, 2021, EUR J CLIN NUTR, V75, P1001, DOI 10.1038/s41430-020-00760-x; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Bhaskar AVV, 2017, FOOD SECUR, V9, P981, DOI 10.1007/s12571-017-0721-z; Bhavani RV., 2018, BLOG LEVERAGING AGR; Bird FA, 2019, FOOD POLICY, V82, P39, DOI 10.1016/j.foodpol.2018.10.015; Birdi Tannaz J, 2015, Glob J Health Sci, V8, P10, DOI 10.5539/gjhs.v8n4p10; Boedecker J, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12803; Cunningham K, 2015, MATERN CHILD NUTR, V11, P1, DOI 10.1111/mcn.12125; Deaconu A, 2019, ECOL FOOD NUTR, V58, P142, DOI 10.1080/03670244.2019.1570179; DFID (Department For International Development), 2014, CAN AGR INT PROM NUT, P70; Djokoto J. G., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-016-0082-4; Du L., 2014, LEVERAGING AGR NUTR; Food and Agriculture Organization of United Nation, 2013, STAT FOOD AGR 2013 F; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P205, DOI 10.1111/j.1365-3016.2012.01282.x; Government of India Ministry of Health and Family Welfare, 2017, NATL FAMILY HLTH SUR; Herforth A, 2014, NTR; Herforth A., 2010, THESIS CORNELL U ITH; Herforth A, 2015, FOOD SECUR, V7, P505, DOI 10.1007/s12571-015-0455-8; Johns T, 2007, FOOD POLICY, V32, P1, DOI 10.1016/j.foodpol.2006.03.014; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Kadiyala S, 2014, ANN NY ACAD SCI, V1331, P43, DOI 10.1111/nyas.12477; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kerr R. B., 2019, Sustainable diets: linking nutrition and food systems, P53, DOI 10.1079/9781786392848.0053; Kerr RB, 2019, AGR ECOSYST ENVIRON, V279, P109, DOI 10.1016/j.agee.2019.04.004; Kjeldsberg C, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12593; Kumar N, 2018, J DEV EFFECT, V10, P341, DOI 10.1080/19439342.2018.1478874; Masset E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8222; Miller DD, 2013, FOOD POLICY, V42, P115, DOI 10.1016/j.foodpol.2013.06.008; Murty PVVS, 2016, AGR RES, V5, P210, DOI 10.1007/s40003-016-0206-x; Nagarajan S, 2014, CURR SCI INDIA, V107, P959; Narayanan R, 2018, MSSRFRR1851; Narayanan R, 2019, STUD ED ADULTS-NIACE, V51, P213, DOI 10.1080/02660830.2019.1573782; National Institute of Nutrition, 2011, DIETARY GUIDELINES I; Nithya DJ, 2018, MSSRFRR1845; Osei A, 2017, FOOD NUTR BULL, V38, P49, DOI 10.1177/0379572116676427; Pandey VL, 2016, FOOD POLICY, V62, P28, DOI 10.1016/j.foodpol.2016.05.002; Pandit S., 2018, FSN CHF INTERVENTION; Pant J, 2014, AQUACULTURE, V418, P1, DOI 10.1016/j.aquaculture.2013.09.027; Pinstrup-Andersen P, 2013, LANCET, V382, P375, DOI 10.1016/S0140-6736(13)61053-3; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Pradhan A, 2017, MSSRFRR1742; Rajendran S., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-017-0127-3; Rampal P, 2018, MSSRF RR1847; Rao N, 2020, FEM ECON, V26, P95, DOI 10.1080/13545701.2019.1632470; Rosenberg AM, 2018, FOOD POLICY, V80, P10, DOI 10.1016/j.foodpol.2018.07.008; Ruel MT, 2018, GLOB FOOD SECUR-AGR, V17, P128, DOI 10.1016/j.gfs.2018.01.002; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Schreinemachers P, 2016, J DEV EFFECT, V8, P473, DOI 10.1080/19439342.2016.1231704; Schreinemachers P, 2015, FOOD SECUR, V7, P97, DOI 10.1007/s12571-014-0408-7; Underwood Barbara A., 2000, Food and Nutrition Bulletin, V21, P356; Wagh R, 2018, AM J FOOD TECHNOL, V5, P43; Welch RM., 2014, LINKING AGR PRODUCTI; Wiggins S., 2013, SMALLHOLDER AGR CONT	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248698	10.1371/journal.pone.0248698	http://dx.doi.org/10.1371/journal.pone.0248698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735281	Green Published, gold			2022-12-26	WOS:000631029700110
J	Shin, YJ; Vu, H; Lee, JH; Kim, HD				Shin, Yoo-Jin; Vu, Huong; Lee, Jong-Ho; Kim, Hyun-Duck			Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study	PLOS ONE			English	Article							OXIDATIVE STRESS; HEAD; PERIODONTITIS; EXPRESSION; SERUM; MATRIX-METALLOPROTEINASE-9; CLASSIFICATION; EPIDEMIOLOGY; BIOMARKERS; INVASION	Over 90% of oral cancers are oral squamous cell carcinoma (OSCC). Hitherto, early detection marker for OSCC has not been available. Hence, this study aimed to evaluate the diagnostic and prognostic ability of salivary matrix-metalloproteinase-9 (MMP-9) and 8-hydroxydeoxyguanosine (8-OHdG) for OSCC. Total of 318 participants with 106 cases and 212 controls were included: OSCC cases were from Seoul National University Dental Hospital and age, sex, and smoking matched controls were from Yangpyeong cohort. Unstimulated saliva was collected to determine MMP-9 and 8-OHdG using sensitive enzyme-linked immunosorbent assay. Multivariable linear regression and analysis of covariance (ANCOVA) were applied to evaluate the adjusted association of markers with OSCC. Wilcoxon sign rank sum test and Friedman test for median were applied to evaluate follow-up level of MMP-9 after surgery. Receiver operating characteristic curve was obtained for diagnostic ability. Salivary MMP-9 was associated with OSCC (ANCOVA and multivariable linear regression, p<0.05), while 8-OHdG was not. The diagnostic ability of MMP-9 was area under curve of 0.96 (100% specificity and 89.6% sensitivity, p<0.001). MMP-9 decreased dramatically after tumor surgery (p<0.05). Salivary MMP-9 could be a critical diagnostic and prognostic marker for OSCC.	[Shin, Yoo-Jin; Vu, Huong; Kim, Hyun-Duck] Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, Seoul, South Korea; [Shin, Yoo-Jin; Lee, Jong-Ho] Seoul Natl Univ, Oral Canc Ctr, Dent Hosp, Seoul, South Korea; [Shin, Yoo-Jin; Lee, Jong-Ho] Seoul Natl Univ, Dept Oral & Maxillofacial Surg, Dent Hosp, Seoul, South Korea; [Lee, Jong-Ho; Kim, Hyun-Duck] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, HD (corresponding author), Seoul Natl Univ, Sch Dent, Dept Prevent & Social Dent, Seoul, South Korea.; Kim, HD (corresponding author), Seoul Natl Univ, Dent Res Inst, Seoul, South Korea.	hyundkim@snu.ac.kr		Vu, Huong/0000-0001-7675-6048	Bio & Medical Technology Development Program of the National Research Foundation (NFR) - Ministry of Science and ICT, KOREA [NRF-2017M3A9B6062984]	Bio & Medical Technology Development Program of the National Research Foundation (NFR) - Ministry of Science and ICT, KOREA	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NFR) funded by the Ministry of Science and ICT, KOREA (NRF-2017M3A9B6062984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha-Hosseini F, 2012, J ORAL PATHOL MED, V41, P736, DOI 10.1111/j.1600-0714.2012.01172.x; Al Kawas S, 2012, ARCH ORAL BIOL, V57, P1, DOI 10.1016/j.archoralbio.2011.06.013; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Cheng YSL, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-3; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Das S, 2007, SUPPORT CARE CANCER, V15, P1399, DOI 10.1007/s00520-007-0266-3; Fritz AG., 2000, INT CLASSIFICATION D, Vvii, P240; Ghallab NA, 2017, CLIN ORAL INVEST, V21, P937, DOI 10.1007/s00784-016-1846-8; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Henson BS, 2010, METHODS MOL BIOL, V666, P21, DOI 10.1007/978-1-60761-820-1_2; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kaur J, 2016, CLIN ORAL INVEST, V20, P315, DOI 10.1007/s00784-015-1506-4; Kernohan MD, 2010, ARCH OTOLARYNGOL, V136, P1235, DOI 10.1001/archoto.2010.214; Kim HD, 2016, J CLIN PERIODONTOL, V43, P1032, DOI 10.1111/jcpe.12607; Kim HD, 2014, J PERIODONTOL, V85, P1676, DOI 10.1902/jop.2014.140061; Kreppel M, 2010, J SURG ONCOL, V102, P443, DOI 10.1002/jso.21547; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Lazar L, 2015, ROM J MORPHOL EMBRYO, V56, P1441; MALAMUD D, 1992, BRIT MED J, V305, P207, DOI 10.1136/bmj.305.6847.207; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Peacock ZS, 2008, J AM DENT ASSOC, V139, P1346, DOI 10.14219/jada.archive.2008.0046; Peisker A, 2017, MED ORAL PATOL ORAL, V22, pE270, DOI 10.4317/medoral.21626; Ribeiro KDC, 2000, ARCH OTOLARYNGOL, V126, P1079; Riedel F, 2000, INT J ONCOL, V17, P1099; Ruokolainen H, 2004, CLIN CANCER RES, V10, P3110, DOI 10.1158/1078-0432.CCR-03-0530; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Shpitzer T, 2007, J CANCER RES CLIN, V133, P613, DOI 10.1007/s00432-007-0207-z; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Totan A, 2015, BIOTECH HISTOCHEM, V90, P552, DOI 10.3109/10520295.2015.1016115; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wong DTW, 2012, OPER DENT, V37, P562, DOI 10.2341/12-143-BL	39	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248167	10.1371/journal.pone.0248167	http://dx.doi.org/10.1371/journal.pone.0248167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735248	gold, Green Published			2022-12-26	WOS:000631029700023
J	Sigel, K; Kong, CY; Rehmani, S; Bates, S; Gould, M; Stone, K; Kale, M; Park, YH; Crothers, K; Bhora, F; Wisnivesky, J				Sigel, Keith; Kong, Chung Yin; Rehmani, Sadiq; Bates, Susan; Gould, Michael; Stone, Kimberly; Kale, Minal; Park, Yeun-Hee; Crothers, Kristina; Bhora, Faiz; Wisnivesky, Juan			Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities	PLOS ONE			English	Article							BODY RADIATION-THERAPY; QUALITY-OF-LIFE; SUBLOBAR RESECTION; LIMITED RESECTION; LOBECTOMY; SURGERY; OUTCOMES; RISK; RADIOTHERAPY; PREVALENCE	Background Veterans are at increased risk of lung cancer and many have comorbidities such as chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD). We used simulation modeling to assess projected outcomes associated with different management strategies of Veterans with stage I non-small cell lung cancer (NSCLC) with COPD and/or CAD. Patients and methods Using data from a cohort of 14,029 Veterans (years 2000-2015) with NSCLC we extended a well-validated mathematical model of lung cancer to represent the management and outcomes of Veterans with stage I NSCLC with COPD, with or without comorbid CAD. We simulated multiple randomized trials to compare treatment with lobectomy, limited resection, or stereotactic body radiation therapy (SBRT). Model output estimated expected quality adjusted life years (QALY) of Veterans with stage I NSCLC according to age, tumor size, histologic subtype, COPD severity and CAD diagnosis. Results For Veterans <70 years old lobectomy was associated with greater projected quality-adjusted life expectancy regardless of comorbidity status. For most combinations of tumors and comorbidity profiles there was no dominant treatment for Veterans >= 80 years of age, but less invasive treatments were often superior to lobectomy. Dominant treatment choices differed by CAD status for older patients in a third of scenarios, but not for patients Conclusions The harm/benefit ratio of treatments for stage I NSCLC among Veterans may vary according to COPD severity and the presence of CAD. This information can be used to direct future research study design for Veterans with stage I lung cancer and COPD and/or CAD.	[Sigel, Keith; Kong, Chung Yin; Rehmani, Sadiq; Stone, Kimberly; Kale, Minal; Wisnivesky, Juan] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Bates, Susan; Park, Yeun-Hee] James J Peters VA Med Ctr, Bronx, NY USA; [Bates, Susan; Park, Yeun-Hee] Columbia Univ, Sch Med, New York, NY USA; [Gould, Michael] Kaiser Permanente Southern Calif, Los Angeles, CA USA; [Crothers, Kristina] Univ Washington, Sch Med, Seattle, WA USA; [Crothers, Kristina] Puget Sound VA Med Ctr, Seattle, WA USA; [Bhora, Faiz] Nuvance Hlth, Danbury, CT USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Columbia University; Kaiser Permanente; University of Washington; University of Washington Seattle	Sigel, K (corresponding author), Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA.	keith.sigel@mssm.edu	Bates, Susan/AFP-9514-2022; Sigel, Keith Magnus/AAZ-7898-2021	Sigel, Keith Magnus/0000-0002-4051-4861; Kong, Chung Yin/0000-0001-6431-7830	Department of Defense [W81XWH-16-1-0356, LC150146]	Department of Defense(United States Department of Defense)	This work was supported by the Department of Defense (GRANT W81XWH-16-1-0356, LC150146 to JPW). The funding source had no role in the design, conduct, or analysis of the study or in the decision to submit the manuscript for publication.	Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Brunelli A, 2013, CHEST, V143, pE166, DOI 10.1378/chest.12-2395; Bryant AK, 2018, ANN THORAC SURG, V105, P425, DOI 10.1016/j.athoracsur.2017.07.048; Du W, 2006, CANCER, V106, P420, DOI 10.1002/cncr.21638; Ellis LM, 2014, J CLIN ONCOL, V32, P1277, DOI 10.1200/JCO.2013.53.8009; Ezer N, 2015, J THORAC ONCOL, V10, P1201, DOI 10.1097/JTO.0000000000000600; Force SD, 2006, ANN THORAC SURG, V81, P2020, DOI 10.1016/j.athoracsur.2006.01.050; Ginsberg Robert J., 1995, Annals of Thoracic Surgery, V60, P615, DOI 10.1016/0003-4975(95)00537-U; Grutters JPC, 2010, THORAX, V65, P903, DOI 10.1136/thx.2010.136390; Gulack BC, 2016, ANN THORAC SURG, V102, P1814, DOI 10.1016/j.athoracsur.2016.06.032; Hanmer J, 2009, VALUE HEALTH, V12, P958, DOI 10.1111/j.1524-4733.2009.00535.x; HARRIS RE, 1989, CANCER-AM CANCER SOC, V64, P1160, DOI 10.1002/1097-0142(19890901)64:5<1160::AID-CNCR2820640533>3.0.CO;2-B; Howlader N, 2013, SEER CANC STAT REV 1, V2017; Janssen-Heijnen MLG, 1998, LUNG CANCER, V21, P105, DOI 10.1016/S0169-5002(98)00039-7; Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66; Kanzaki R, 2017, SURG TODAY, V47, P27, DOI 10.1007/s00595-016-1355-z; Kates M, 2011, CHEST, V139, P491, DOI 10.1378/chest.09-2547; Khullar OV, 2015, J THORAC ONCOL, V10, P1625, DOI 10.1097/JTO.0000000000000664; Landreneau RJ, 1997, J THORAC CARDIOV SUR, V113, P691, DOI 10.1016/S0022-5223(97)70226-5; Manser R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004699.pub2; McKinney WP, 1997, PUBLIC HEALTH REP, V112, P212; McMahon PM, 2012, RISK ANAL, V32, pS117, DOI 10.1111/j.1539-6924.2011.01652.x; Moller A, 2012, J THORAC ONCOL, V7, P406, DOI 10.1097/JTO.0b013e3182398e82; Pallis AG, 2011, LUNG CANCER, V74, P149, DOI 10.1016/j.lungcan.2011.05.025; Raviv S, 2011, AM J RESP CRIT CARE, V183, P1138, DOI 10.1164/rccm.201008-1274CI; Robinson CG, 2013, J THORAC ONCOL, V8, P192, DOI 10.1097/JTO.0b013e31827ce361; Sandri A, 2017, J THORAC CARDIOV SUR, V154, P352, DOI 10.1016/j.jtcvs.2017.03.042; Shirvani SM, 2014, JAMA SURG, V149, P1244, DOI 10.1001/jamasurg.2014.556; Subramanian MP, 2018, CANCERS, V10, DOI 10.3390/cancers10090310; Tandberg DJ, 2018, CANCER-AM CANCER SOC, V124, P667, DOI 10.1002/cncr.31196; Tanner NT, 2013, CHEST, V144, P1783, DOI 10.1378/chest.13-0056; Wada H, 1998, J THORAC CARDIOV SUR, V115, P70, DOI 10.1016/S0022-5223(98)70444-1; Wiener RS, 2014, ANN INTERN MED, V161, P445, DOI 10.7326/M14-1352; Wisnivesky JP, 2005, CHEST, V128, P1461, DOI 10.1378/chest.128.3.1461; Wisnivesky JP, 2010, ANN SURG, V251, P550, DOI 10.1097/SLA.0b013e3181c0e5f3; Yazgan S, 2005, SURG TODAY, V35, P823, DOI 10.1007/s00595-004-3035-7; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zullig LL, 2012, MIL MED, V177, P693, DOI 10.7205/MILMED-D-11-00434	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248067	10.1371/journal.pone.0248067	http://dx.doi.org/10.1371/journal.pone.0248067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735217	Green Published, gold			2022-12-26	WOS:000631029700119
J	Taki, Y; Vincenot, CE; Sato, Y; Inoue-Murayama, M				Taki, Yuto; Vincenot, Christian E.; Sato, Yu; Inoue-Murayama, Miho			Genetic diversity and population structure in the Ryukyu flying fox inferred from remote sampling in the Yaeyama archipelago	PLOS ONE			English	Article							PTEROPUS-DASYMALLUS; ISLAND; CONSERVATION; SOFTWARE	The Ryukyu flying fox (Pteropus dasymallus) is distributed throughout the island chain spanning across southern Japan, Taiwan, and possibly the Philippines. Although P. dasymallus is listed as VU (vulnerable) in the IUCN Red List, only few genetic works have been conducted to support its conservation. In this study we analyzed 19 markers (mtDNA haplotypes and 18 microsatellite markers) to evaluate genetic diversity and investigate the genetic structure of this species. mtDNA analysis was conducted with 142 DNA remote samples, mostly from faeces, and wing tissues collected on eight islands (Miyako, Ishigaki, Kohama, Kuroshima, Hateruma, Taketomi, Iriomote, Yonaguni). 39 haplotypes were identified in 526bp of the control region, and haplotype network showed no clear genetic structure. Microsatellite analysis was also conducted with 155 samples collected on six islands (Miyako, Ishigaki, Kohama, Taketomi, Iriomote, Yonaguni). It showed that the Yonaguni population exhibits low genetic diversity, high inbreeding, and clear genetic differentiation from other populations. Gene flow between Ishigaki and Miyako through small stepstone islands might be preventing inbreeding of the Miyako population. We provide for the first time indirect proof of long-distance inter-island dispersal in the Ryukyu flying fox and revealed genetic diversity, gene flow and genetic differentiation among the archipelago's populations. These results will be useful for delineating conservation units and designing specific conservation policies for each island based on metapopulation genetic structure.	[Taki, Yuto; Sato, Yu; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Taki, Yuto; Vincenot, Christian E.] Isl Bat Res Grp IBRG, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan; [Vincenot, Christian E.] Kyoto Univ, Dept Social Informat, Kyoto, Japan; [Sato, Yu] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Sato, Yu] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Inoue-Murayama, Miho] Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; National Institute for Environmental Studies - Japan	Inoue-Murayama, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.; Vincenot, CE (corresponding author), Isl Bat Res Grp IBRG, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan.; Vincenot, CE (corresponding author), Kyoto Univ, Dept Social Informat, Kyoto, Japan.; Inoue-Murayama, M (corresponding author), Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan.	mmurayama@wrc.kyoto-u.ac.jp; vincenot@i.kyoto-u.ac.jp		Vincenot, Christian/0000-0002-2386-1626	KAKENHI [20H00420]; Pro Natura Japan; Leading graduate program in Primatology and Wildlife Science	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pro Natura Japan; Leading graduate program in Primatology and Wildlife Science	This work was financially supported by KAKENHI No. 20H00420 for M.I.-M., and Leading graduate program in Primatology and Wildlife Science. Sample collection and initial genetics works were performed under KAKENHI No. 17K15054 and Pro Natura Japan support granted to C.E.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2017, ECOL EVOL, V7, P8670, DOI 10.1002/ece3.3213; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brown VA, 2011, CONSERV GENET, V12, P933, DOI 10.1007/s10592-011-0196-y; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Florens FBV, 2019, J NAT CONSERV, V47, P58, DOI 10.1016/j.jnc.2018.11.008; Florens FBV, 2017, J NAT CONSERV, V40, P85, DOI 10.1016/j.jnc.2017.10.002; Florens FBV, 2018, SCIENCE, V362, P409, DOI 10.1126/science.aav5161; FUNAKOSHI K, 1993, J ZOOL, V230, P221, DOI 10.1111/j.1469-7998.1993.tb02684.x; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee YF, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0146-8; Lee YF, 2009, CONTRIB ZOOL, V78, P51, DOI 10.1163/18759866-07802002; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; McConkey KR, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv088; Nakamoto A, 2009, ECOL RES, V24, P405, DOI 10.1007/s11284-008-0516-y; Nuwer R., 2019, NATL GEOGRPHIC; O'Brien J, 2007, CONSERV GENET, V8, P1073, DOI 10.1007/s10592-006-9263-1; Okada A, 2014, ACTA CHIROPTEROL, V16, P15, DOI 10.3161/150811014X683237; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Oleksy RZ, 2019, MOV ECOL, V7, DOI 10.1186/s40462-019-0156-6; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Preble J, MAMMAL REV; Pritchard JK, 2000, GENETICS, V155, P945; Rousset F, 1997, TRENDS ECOL EVOL, V12, P313, DOI 10.1016/S0169-5347(97)01104-X; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tait J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109810; Taki Y., 2020, CONSERV GENET RESOUR; Vincenot CE, GOOD DNA FRUIT UNPUB; Vincenot CE., 2017, PTEROPUS DASYMALLUS; Vincenot C, 2016, NATURE, V539, P168, DOI 10.1038/539168d; Vincenot CE, 2017, MAMM BIOL, V83, P71, DOI 10.1016/j.mambio.2016.11.006; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Vincenot CE, 2015, GLOB ECOL CONSERV, V3, P526, DOI 10.1016/j.gecco.2015.02.005; Vincenot CE, 2015, MAMM BIOL, V80, P273, DOI 10.1016/j.mambio.2015.03.003; Voigt C.C., 2016, BATS ANTHROPOCENE CO; Weerach C, AMIDST NETS TYPHOONS; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Westcott DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22294-w	41	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248672	10.1371/journal.pone.0248672	http://dx.doi.org/10.1371/journal.pone.0248672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735322	gold, Green Published			2022-12-26	WOS:000631029700015
J	Kesavardhana, S; Samir, P; Zheng, M; Malireddi, RKS; Karki, R; Sharma, BR; Place, DE; Briard, B; Vogel, P; Kanneganti, TD				Kesavardhana, Sannula; Samir, Parimal; Zheng, Min; Malireddi, R. K. Subbarao; Karki, Rajendra; Sharma, Bhesh Raj; Place, David E.; Briard, Benoit; Vogel, Peter; Kanneganti, Thirumala-Devi			DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; NS1 PROTEIN; RNA; RECOGNITION; INFECTION; CASPASE-1; ROLES; INTERLEUKIN-1-BETA; REPLICATION; STRATEGIES	Viruses and hosts have coevolved for millions of years, leading to the development of complex host-pathogen interactions. Influenza A virus (IAV) causes severe pulmonary pathology and is a recurrent threat to human health. Innate immune sensing of IAV triggers a complex chain of host responses. IAV has adapted to evade host defense mechanisms, and the host has coevolved to counteract these evasion strategies. However, the molecular mechanisms governing the balance between host defense and viral immune evasion is poorly understood. Here, we show that the host protein DEAD-box helicase 3 X-linked (DDX3X) is critical to orchestrate a multifaceted antiviral innate response during IAV infection, coordinating the activation of the nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 (NLRP3) inflammasome, assembly of stress granules, and type I interferon (IFN) responses. DDX3X activated the NLRP3 inflammasome in response to WT IAV, which carries the immune evasive nonstructural protein 1 (NS1). However, in the absence of NS1, DDX3X promoted the formation of stress granules that facilitated efficient activation of type I IFN signaling. Moreover, induction of DDX3X-containing stress granules by external stimuli after IAV infection led to increased type I IFN signaling, suggesting that NS1 actively inhibits stress granule-mediated host responses and DDX3X-mediated NLRP3 activation counteracts this action. Furthermore, the loss of DDX3X expression in myeloid cells caused severe pulmonary pathogenesis and morbidity in IAV-infected mice. Together, our findings show that DDX3X orchestrates alternate modes of innate host defense which are critical to fight against NS1-mediated immune evasion strategies during IAV infection.	[Kesavardhana, Sannula; Samir, Parimal; Zheng, Min; Malireddi, R. K. Subbarao; Karki, Rajendra; Sharma, Bhesh Raj; Place, David E.; Briard, Benoit; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kesavardhana, Sannula] Indian Inst Sci, Dept Biochem, Bengaluru 560012, Karnataka, India; [Briard, Benoit] Univ Tours, INSERM, Ctr Etud Pathol Resp UMR 1100, Tours, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Indian Institute of Science (IISC) - Bangalore; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Samir, Parimal/N-4144-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Place, David/ABD-6703-2021; Sharma, Bhesh Raj/H-3782-2014	Samir, Parimal/0000-0001-7655-5713; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Place, David/0000-0002-1904-4164; Sharma, Bhesh Raj/0000-0003-3609-833X	US NIH [AR056296, CA253095, AI101935, AI124346]; American Lebanese Syrian Associated Charities	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by grants from the US NIH (AR056296, CA253095, AI101935, and AI124346) and the American Lebanese Syrian Associated Charities to T. D. -K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Chen CY, 2016, HUM MOL GENET, V25, P2905, DOI 10.1093/hmg/ddw143; Cheong WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126456; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hondele M, 2019, NATURE, V573, P144, DOI 10.1038/s41586-019-1502-y; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Li Q, 2014, J BIOMED RES, V28, P282, DOI 10.7555/JBR.27.20130047; Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Moriyama M, 2016, J VIROL, V90, P4105, DOI 10.1128/JVI.00120-16; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy EA, 2011, J INTERF CYTOK RES, V31, P501, DOI 10.1089/jir.2010.0143; Nogales A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120708; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oslund KL, 2011, FUTURE VIROL, V6, P951, DOI 10.2217/FVL.11.63; Park ES, 2019, EMBO J, V38, DOI 10.15252/embj.201899475; Park HS, 2018, J VIROL, V92, DOI [10.1128/JVI.00022-18, 10.1128/jvi.00022-18]; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raman SNT, 2016, J VIROL, V90, P3661, DOI 10.1128/JVI.03010-15; Reineke LC, 2015, J VIROL, V89, P2575, DOI 10.1128/JVI.02791-14; Samir P, 2019, TRENDS IMMUNOL, V40, P1082, DOI 10.1016/j.it.2019.10.005; Samir P, 2019, NATURE, V573, P590, DOI 10.1038/s41586-019-1551-2; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tsai WC, 2014, ANNU REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zheng M, 2015, J VIROL, V89, P10273, DOI 10.1128/JVI.00919-15	56	13	13	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100579	10.1016/j.jbc.2021.100579	http://dx.doi.org/10.1016/j.jbc.2021.100579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766561	gold, Green Published			2022-12-26	WOS:000672866400552
J	Le Garf, S; Sibille, B; Mothe-Satney, I; Eininger, C; Fauque, P; Murdaca, J; Chinetti, G; Neels, JG; Rousseau, AS				Le Garf, Sebastien; Sibille, Brigitte; Mothe-Satney, Isabelle; Eininger, Cyril; Fauque, Philippe; Murdaca, Joseph; Chinetti, Giulia; Neels, Jaap G.; Rousseau, Anne-Sophie			Alpha-lipoic acid supplementation increases the efficacy of exercise- and diet-induced obesity treatment and induces immunometabolic changes in female mice and women	FASEB JOURNAL			English	Article						antioxidant; diet; exercise; immunometabolism; inflammation; regulatory T cells; T lymphocyte; translational study	REGULATORY T-CELLS; VISCERAL ADIPOSE-TISSUE; OXIDATIVE STRESS; UNIQUE POPULATION; ACTIVATION; TREG; FAT; INFLAMMATION; ASSOCIATION; METABOLISM	The decrease in the regulatory T cells (Tregs) population is highly involved in adipose tissue inflammation and insulin resistance in obesity. Tregs depend on fatty acids via beta-oxidation for immunosuppressive function adapting their antioxidant systems to allow survival to oxidative stress. In this study, we have hypothesized that a dietary supplementation with alpha-lipoic acid (ALA), a powerful antioxidant, would improve immunometabolism when added to the classical strategy of obesity treatment. First, we showed by in vitro experiments that ALA favors the polarization of mice CD4 + T cells toward Tregs. Next, we have carried out a translational study where female obese mice and women were supplemented with ALA or vehicle/placebo (mice: 2.5 g(ALA)/kg(food); 6 weeks(;) women: 600 mg(ALA)/day, 8 weeks) while following a protocol including regular exercise and a change in diet. Fatty acid oxidation potential and activity of nuclear erythroid-related factor 2 (NRF2) of mouse secondary lymphoid tissues were improved by ALA supplementation. ALA reduced visceral adipose tissue (VAT) mass and preserved Tregs in VAT in mice. In women, ALA supplementation induced significant metabolic changes of circulating CD4 + T cells including increased oxidative capacity and fatty acid oxidation, ameliorated their redox status, and improved the reduction of visceral fat mass. While appropriate biological markers are still required to be used in clinics to judge the effectiveness of long-term obesity treatment, further studies in female mice and women are needed to determine whether these immunometabolic changes would reduce VAT mass-associated risk for secondary health issues arising from obesity.	[Le Garf, Sebastien; Sibille, Brigitte; Mothe-Satney, Isabelle; Murdaca, Joseph; Neels, Jaap G.; Rousseau, Anne-Sophie] Univ Cote dAzur, INSERM, C3M, Nice, France; [Eininger, Cyril; Fauque, Philippe] Polyclin Oxford, Cannes, France; [Chinetti, Giulia] Univ Cote dAzur, CHU Nice, INSERM, C3M, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Rousseau, AS (corresponding author), Univ Cote dAzur, Mediterranean Ctr Mol Med C3M, Team 9 Metab Challenges Immune Cells Obes Diabet, INSERM,U1065, Batiment Univ Archimed 151 Route Ginestiere, F-06204 Nice 3, France.	Anne-Sophie.ROUSSEAU@univ-cotedazur.fr	Neels, Jaap G/F-5534-2010; Sibille, Brigitte/Q-8240-2016; MOTHE-SATNEY, ISABELLE/Q-6377-2016; chinetti, giulia/Q-6901-2016	Neels, Jaap G/0000-0002-5900-8395; Sibille, Brigitte/0000-0001-6806-0454; MOTHE-SATNEY, ISABELLE/0000-0002-2693-8385; Anne-Sophie, Rousseau/0000-0002-7672-0237; Le Garf, Sebastien/0000-0001-7253-0121; chinetti, giulia/0000-0001-8048-8138	Agence Francaise de Lutte contre le Dopage (AFLD) [201700016]; Institut National de la Sante et de la Recherche Medicale (Inserm)	Agence Francaise de Lutte contre le Dopage (AFLD); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Agence Francaise de Lutte contre le Dopage (AFLD), Grant/Award Number: 201700016; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ahnstedt H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00659; Anderson EK, 2013, DIABETES, V62, P3180, DOI 10.2337/db12-1076; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bjorkman F, 2016, EUR J APPL PHYSIOL, V116, P1627, DOI 10.1007/s00421-016-3412-0; Blackburn GL., 2002, EATING DISORDERS OBE, V2nd ed, P484; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chen XF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1580967; Christensen P, 2018, DIABETES OBES METAB, V20, P2840, DOI 10.1111/dom.13466; Cluxton D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00115; Cui J, 2016, FREE RADICAL RES, V50, P1106, DOI 10.1080/10715762.2016.1210140; Deiuliis JA, 2011, LIPIDS, V46, P1021, DOI 10.1007/s11745-011-3603-8; Deng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15725; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gupte AA, 2009, J APPL PHYSIOL, V106, P1425, DOI 10.1152/japplphysiol.91210.2008; Huang KC, 2004, OBES RES, V12, P840, DOI 10.1038/oby.2004.101; Ishikawa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230885; Jezek P, 2018, ANTIOXID REDOX SIGN, V29, P667, DOI 10.1089/ars.2017.7225; Klaus S, 2012, GENES NUTR, V7, P369, DOI 10.1007/s12263-011-0260-8; Le Garf S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205182; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868; Maurovich-Horvat P, 2007, INT J OBESITY, V31, P500, DOI 10.1038/sj.ijo.0803454; McCarty MF, 2009, MED HYPOTHESES, V72, P29, DOI 10.1016/j.mehy.2008.07.043; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Namazi N, 2018, CLIN NUTR, V37, P419, DOI 10.1016/j.clnu.2017.06.002; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Panda S., 2013, BIO-PROTOCOL, V3, pe323, DOI DOI 10.21769/BIOPROTOC.323; Patwardhan RS, 2020, FREE RADICAL RES, V54, P947, DOI 10.1080/10715762.2020.1745202; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Rahimlou M, 2019, CLIN NUTR ESPEN, V32, P16, DOI 10.1016/j.clnesp.2019.03.015; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Rousseau AS, 2016, FASEB J, V30, P1287, DOI 10.1096/fj.15-280453; Sen CK, 1997, FREE RADICAL BIO MED, V22, P1241, DOI 10.1016/S0891-5849(96)00552-7; Sena CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092706; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02716; Sireesh D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22913-6; Pereira LMS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00605; SUZUKI YJ, 1992, BIOCHEM BIOPH RES CO, V189, P1709, DOI 10.1016/0006-291X(92)90275-P; Tyrrell DJ, 2015, EXP GERONTOL, V70, P84, DOI 10.1016/j.exger.2015.07.015; Vasanthakumar A, 2020, NATURE, V579, P581, DOI 10.1038/s41586-020-2040-3; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Wang KC, 2013, CLIN SCI, V125, P329, DOI 10.1042/CS20120560; Wirth A, 1998, OBES RES, V6, P393, DOI 10.1002/j.1550-8528.1998.tb00370.x; Yadav V, 2010, MULT SCLER J, V16, P387, DOI 10.1177/1352458509359722; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075; Zhang Q, 2018, J CELL MOL MED, V22, P4335, DOI 10.1111/jcmm.13723; Zou JH, 2018, CELL MOL IMMUNOL, V15, P630, DOI 10.1038/cmi.2017.36	55	4	5	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21312	10.1096/fj.202001817RR	http://dx.doi.org/10.1096/fj.202001817RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742689				2022-12-26	WOS:000635216100055
J	Khan, MA; Hussain, K; Shah, MA				Khan, Mohd Asgar; Hussain, Khursheed; Shah, Manzoor A.			Ecological restoration of habitats invaded by Leucanthemum vulgare that alters key ecosystem functions	PLOS ONE			English	Article							EXOTIC PLANT INVASIONS; OX-EYE DAISY; SPECIES RICHNESS; POTHWAR REGION; DIVERSITY; IMPACTS; BIODIVERSITY; GROWTH	Precise assessment of the impacts of invasive alien species (IAS) on ecosystem structure and functions is paramount for implementing appropriate management and restoration strategies. Here we investigated the impacts of Leucanthemum vulgare (ox-eye daisy), an aggressive invader in Kashmir Himalaya, on species diversity and primary productivity. We also evaluated bunch of strategies for the ecological restoration of the habitats invaded by this species. We found that uninvaded plots harbored on an average of 6.11 (+/- 2.92) more species per 1m(2) of quadrat than invaded plots. At multivariate scale, the ordination (nMDS) and ANOSIM exhibited significant differences between invaded and uninvaded plots with R = 0.7889 and p < 0.001. The decrease in diversity indices in invaded as compared to uninvaded plots was associated with more productive plant communities due to Leucanthemum invasion. Higher altitude Gulmarg site was more affected by Leucanthemum invasion than lower altitude Drung site. We tested different approaches for restoration and management of invaded habitats that include herbicide treatment at seedling stage, herbicide treatment before and after flowering stage, mowing and herbicide treatment together, joint mowing, digging and herbicide treatment and Leucanthemum uprooting. Among these treatments, uprooting and combined digging, mowing and herbicide treatment proved to be most effective in controlling Leucanthemum invasion. The implications of these results for effective management of ecologically sensitive and socio-culturally important landscapes are discussed.	[Khan, Mohd Asgar; Hussain, Khursheed; Shah, Manzoor A.] Univ Kashmir, Dept Bot, Srinagar, Jammu & Kashmir, India	University of Kashmir	Shah, MA (corresponding author), Univ Kashmir, Dept Bot, Srinagar, Jammu & Kashmir, India.	mashah@uok.edu.in			University Grants Commission under its CPEPA programme; MHRD under the RUSA project	University Grants Commission under its CPEPA programme(University Grants Commission, India); MHRD under the RUSA project	The financial support provided by the University Grants Commission under its CPEPA programme and MHRD under the RUSA project to MAS is gratefully acknowledged.	Afreen T, 2018, J PLANT ECOL, V11, P751, DOI 10.1093/jpe/rtx045; Ahmad R, 2019, FLORA, V260, DOI 10.1016/j.flora.2019.151481; Alexander JM, 2011, P NATL ACAD SCI USA, V108, P656, DOI 10.1073/pnas.1013136108; [Anonymous], 1984, FLOWERS HIMALAYA, DOI DOI 10.1111/J.1756-1051.1985.TB02073.X; BARBOUR MG, 1978, OECOLOGIA, V37, P93, DOI 10.1007/BF00349995; Barney JN, 2015, ECOL EVOL, V5, P2878, DOI 10.1002/ece3.1551; Benson J., 2012, NATURE NSW, V56, P24; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clements DR, 2004, CAN J PLANT SCI, V84, P343, DOI 10.4141/P02-112; Cole DE., 1999, INTEGRATED CONTROL O; Dar GH., 2020, BIODIVERSITY HIMALAY, P3, DOI DOI 10.1007/978-981-32-9174-4; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Foxcroft LC, 2017, BIOL INVASIONS, V19, P1353, DOI 10.1007/s10530-016-1367-z; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Georgia AE, 1942, MANUAL WEEDS DESCRIP; Gooden B, 2009, FOREST ECOL MANAG, V257, P960, DOI 10.1016/j.foreco.2008.10.040; Grove S, 2014, TECHNICAL REPORT SUB, P36; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Hejda M, 2017, DIVERS DISTRIB, V23, P997, DOI 10.1111/ddi.12596; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Holmes PM, 2020, INVAD NAT SPRING SER, V14, P665, DOI 10.1007/978-3-030-32394-3_23; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hulme PE, 2006, J APPL ECOL, V43, P43, DOI 10.1111/j.1365-2664.2005.01102.x; Jacobs J., 2008, ECOLOGY MANAGEMENT O; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Khuroo AA, 2010, CURR SCI INDIA, V98, P600; Lee MR, 2012, OECOLOGIA, V170, P457, DOI 10.1007/s00442-012-2309-9; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Magharri E, 2015, REC NAT PROD, V9, P538; Magurran A E, 1998, Trends Ecol Evol, V13, P165, DOI 10.1016/S0169-5347(97)01290-1; Mangold J, 2017, INVASIVE PLANTS MONT; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDougall K, 2018, ECOL MANAG RESTOR, V19, P4, DOI 10.1111/emr.12296; McDougall KL, 2011, DIVERS DISTRIB, V17, P103, DOI 10.1111/j.1472-4642.2010.00713.x; McLeod ML, 2016, J ECOL, V104, P994, DOI 10.1111/1365-2745.12584; Olson B. E., 1999, BIOL MANAGEMENT NOXI, P282; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Qureshi H, 2019, ANN BOT-COENOL PLANT, V9, P73, DOI 10.13133/2239-3129/14411; Qureshi H, 2018, APPL ECOL ENV RES, V16, P5799, DOI 10.15666/aeer/1605_57995813; Ravindranath N.H., 2007, CARBON INVENTORY MET; Richardson DM, 2008, PERSPECT PLANT ECOL, V10, P161, DOI 10.1016/j.ppees.2008.03.001; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Rowland D., 2012, MECH INVASION HIERAC; SANDERS P, 1994, P NZ PLAN P, V47, P62; Stainton A., 1988, FLOWERS HIMALAYA; Stellick CE., 2020, METAMORPHOSIS-AFR; Stutz S, 2016, BIOL INVASIONS, V18, P2077, DOI 10.1007/s10530-016-1152-z; Tan PY, 2020, LANDSCAPE URBAN PLAN, V200, DOI 10.1016/j.landurbplan.2020.103837; Tererai F, 2013, FOREST ECOL MANAG, V297, P84, DOI 10.1016/j.foreco.2013.02.016; Timsina B, 2011, FLORA, V206, P233, DOI 10.1016/j.flora.2010.09.004; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Vanderhoeven S, 2005, PLANT SOIL, V275, P169, DOI 10.1007/s11104-005-1257-0; Vila M, 2017, INVAD NAT SPRING SER, V12, P1, DOI 10.1007/978-3-319-45121-3_1; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3	60	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0246665	10.1371/journal.pone.0246665	http://dx.doi.org/10.1371/journal.pone.0246665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770078	gold, Green Published			2022-12-26	WOS:000634833500027
J	Carney, BC; Travis, TE; Moffatt, LT; Johnson, LS; McLawhorn, MM; Simbulan-Rosenthal, CM; Rosenthal, DS; Shupp, JW				Carney, Bonnie C.; Travis, Taryn E.; Moffatt, Lauren T.; Johnson, Laura S.; McLawhorn, Melissa M.; Simbulan-Rosenthal, Cynthia M.; Rosenthal, Dean S.; Shupp, Jeffrey W.			Hypopigmented burn hypertrophic scar contains melanocytes that can be signaled to re-pigment by synthetic alpha-melanocyte stimulating hormone in vitro	PLOS ONE			English	Article								There are limited treatments for dyschromia in burn hypertrophic scars (HTSs). Initial work in Duroc pig models showed that regions of scar that are light or dark have equal numbers of melanocytes. This study aims to confirm melanocyte presence in regions of hypo- and hyper-pigmentation in an animal model and patient samples. In a Duroc pig model, melanocyte presence was confirmed using en face staining. Patients with dyschromic HTSs had demographic, injury details, and melanin indices collected. Punch biopsies were taken of regions of hyper-, hypo-, or normally pigmented scar and skin. Biopsies were processed to obtain epidermal sheets (ESs). A subset of ESs were en face stained with melanocyte marker, S100 beta. Melanocytes were isolated from a different subset. Melanocytes were treated with NDP alpha -MSH, a pigmentation stimulator. mRNA was isolated from cells, and was used to evaluate gene expression of melanin-synthetic genes. In patient and pig scars, regions of hyper-, hypo-, and normal pigmentation had significantly different melanin indices. S100 beta en face staining showed that regions of hyper- and hypo-pigmentation contained the same number of melanocytes, but these cells had different dendricity/activity. Treatment of hypo-pigmented melanocytes with NDP alpha -MSH produced melanin by microscopy. Melanin-synthetic genes were upregulated in treated cells over controls. While traditionally it may be thought that hypopigmented regions of burn HTS display this phenotype because of the absence of pigment-producing cells, these data show that inactive melanocytes are present in these scar regions. By treating with a pigment stimulator, cells can be induced to re-pigment.	[Carney, Bonnie C.; Moffatt, Lauren T.; Simbulan-Rosenthal, Cynthia M.; Rosenthal, Dean S.; Shupp, Jeffrey W.] Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Carney, Bonnie C.; Travis, Taryn E.; Moffatt, Lauren T.; Johnson, Laura S.; McLawhorn, Melissa M.; Shupp, Jeffrey W.] MedStar Hlth Res Inst, Firefighters Burn & Surg Res Lab, Washington, DC 20010 USA; [Carney, Bonnie C.; Travis, Taryn E.; Moffatt, Lauren T.; Johnson, Laura S.; Shupp, Jeffrey W.] Georgetown Univ, Sch Med, Dept Surg, Washington, DC 20007 USA; [Travis, Taryn E.; Johnson, Laura S.; Shupp, Jeffrey W.] MedStar Washington Hosp Ctr, Dept Surg, Burn Ctr, Washington, DC 20010 USA	Georgetown University; MedStar Health Research Institute; Georgetown University; MedStar Washington Hospital Center	Shupp, JW (corresponding author), Georgetown Univ, Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.; Shupp, JW (corresponding author), MedStar Hlth Res Inst, Firefighters Burn & Surg Res Lab, Washington, DC 20010 USA.; Shupp, JW (corresponding author), Georgetown Univ, Sch Med, Dept Surg, Washington, DC 20007 USA.; Shupp, JW (corresponding author), MedStar Washington Hosp Ctr, Dept Surg, Burn Ctr, Washington, DC 20010 USA.	jeffrey.w.shupp@medstar.net	Johnson, Laura S/ABE-5478-2020; Shupp, Jeffrey/AAW-3481-2021	Johnson, Laura S/0000-0001-6969-2648; Simbulan-Rosenthal, Ph.D, Cynthia M./0000-0002-5070-0342	Georgetown University Medical Center Student Research Grant Program	Georgetown University Medical Center Student Research Grant Program	This research was funded in part by the Georgetown University Medical Center Student Research Grant Program. The authors declare no conflicts of interest. There was no additional external funding received for this study.	Alkhalil A, 2019, PIGM CELL MELANOMA R, V32, P643, DOI 10.1111/pcmr.12780; Bombaro KM, 2003, BURNS, V29, P299, DOI 10.1016/S0305-4179(03)00067-6; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Carney BC., 2014, EPLASTY, V14, P45; Carney BC., 2018, LATEST ARTICLES, DOI [10.1097/gox.0000000000001642, DOI 10.1097/GOX.0000000000001642]; Carney BC, 2020, J BURN CARE RES, V41, P339, DOI 10.1093/jbcr/irz168; Carney BC, 2019, J BURN CARE RES, V40, P58, DOI 10.1093/jbcr/iry045; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; Dean NR, 2002, APPL IMMUNOHISTO M M, V10, P199, DOI 10.1097/01.PAI.0000024456.81006.99; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dutta S, 2020, BURNS, V46, P906, DOI 10.1016/j.burns.2019.10.003; Gilchrest BA, 2011, J INVEST DERMATOL, V131, P6, DOI [10.1038/jid.2010.325, 10.1038/skinbio.2011.6]; Greenhalgh DG, 2015, J BURN CARE RES, V36, P247, DOI 10.1097/BCR.0000000000000224; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HUNT G, 1994, J CELL SCI, V107, P205; Kirkpatrick LD, 2021, WOUND REPAIR REGEN, V29, P117, DOI 10.1111/wrr.12869; Millonig G, 2001, LAB INVEST, V81, P639, DOI 10.1038/labinvest.3780273; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Scott G, 2002, PIGM CELL RES, V15, P322, DOI 10.1034/j.1600-0749.2002.02056.x; Sood RF, 2015, J INVEST DERMATOL, V135, P2394, DOI 10.1038/jid.2015.197; Supp DM, 2020, J BURN CARE RES, V41, P751, DOI 10.1093/jbcr/iraa029; Swope VB, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092667; Swope VB, 2012, J INVEST DERMATOL, V132, P2255, DOI 10.1038/jid.2012.135; Travis TE, 2015, J BURN CARE RES, V36, P77, DOI 10.1097/BCR.0000000000000154	24	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248985	10.1371/journal.pone.0248985	http://dx.doi.org/10.1371/journal.pone.0248985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765043	Green Published, gold			2022-12-26	WOS:000634832800109
J	Mantilla-Rojas, C; Yu, M; Rinella, ES; Lynch, RM; Perry, A; Jaimes-Alvarado, J; Anderson, KR; Barba, E; Bourgeois, EJ; Konganti, K; Threadgill, DW				Mantilla-Rojas, Carolina; Yu, Ming; Rinella, Erica S.; Lynch, Rachel M.; Perry, Amie; Jaimes-Alvarado, Jorge; Anderson, Kathryn R.; Barba, Estefania; Bourgeois, Evann J.; Konganti, Kranti; Threadgill, David W.			A molecular subtype of colorectal cancers initiates independently of epidermal growth factor receptor and has an accelerated growth rate mediated by IL10-dependent anergy	ONCOGENE			English	Article							CELL LUNG-CANCER; MOUSE MODELS; COLON; MUTATIONS; CETUXIMAB; MICE; CARCINOMAS; INHIBITOR; GEFITINIB; ADENOMAS	Although epidermal growth factor receptor (EGFR)-targeted therapies are approved for colorectal cancer (CRC) treatment, only 15% of CRC patients respond to EGFR inhibition. Here, we show that colorectal cancers (CRC) can initiate and grow faster through an EGFR-independent mechanism, irrespective of the presence of EGFR, in two different mouse models using tissue-specific ablation of Egfr. The growth benefit in the absence of EGFR is also independent of Kras status. An EGFR-independent gene expression signature, also observed in human CRCs, revealed that anergy-inducing genes are overexpressed in EGFR-independent polyps, suggesting increased infiltration of anergic lymphocytes promotes an accelerated growth rate that is partially caused by escape from cell-mediated immune responses. Many genes in the EGFR-independent gene expression signature are downstream targets of interleukin 10 receptor alpha (IL10RA). We further show that IL10 is detectable in serum from mice with EGFR-independent colon polyps. Using organoids in vitro and Src ablation in vivo, we show that IL10 contributes to growth of EGFR-independent CRCs, potentially mediated by the well-documented role of SRC in IL10 signaling. Based on these data, we show that the combination of an EGFR inhibitor with an anti-IL10 neutralizing antibody results in decreased cell proliferation in organoids and in decreased polyp size in pre-clinical models harboring EGFR-independent CRCs, providing a new therapeutic intervention for CRCs resistant to EGFR inhibitor therapies.	[Mantilla-Rojas, Carolina; Threadgill, David W.] Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX 77843 USA; [Mantilla-Rojas, Carolina; Lynch, Rachel M.; Perry, Amie; Jaimes-Alvarado, Jorge; Anderson, Kathryn R.; Barba, Estefania; Bourgeois, Evann J.; Threadgill, David W.] Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Yu, Ming; Rinella, Erica S.; Lynch, Rachel M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Yu, Ming] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Rinella, Erica S.] GeneDx, Gaithersburg, MD USA; [Perry, Amie] Thompson Bishop Sparks State Diagnost Lab, Auburn, AL USA; [Konganti, Kranti; Threadgill, David W.] Texas A&M Univ, Texas A&M Inst Genome Sci & Soc, College Stn, TX 77843 USA; [Threadgill, David W.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Threadgill, David W.] Texas A&M Univ, Dept Nutr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Threadgill, DW (corresponding author), Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX 77843 USA.; Threadgill, DW (corresponding author), Texas A&M Univ, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Threadgill, DW (corresponding author), Texas A&M Univ, Texas A&M Inst Genome Sci & Soc, College Stn, TX 77843 USA.; Threadgill, DW (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Threadgill, DW (corresponding author), Texas A&M Univ, Dept Nutr, College Stn, TX 77843 USA.	dwt@tamu.edu		Lynch, Rachel/0000-0001-8164-0744; Mantilla Rojas, Carolina/0000-0002-3320-2122	NIH [R01 CA092479]; NIEHS [P30 ES029067]; Tom and Jean McMullin Chair of Genetics;  [F31 AT002835];  [F32 CA168301];  [T32 OD011083]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Tom and Jean McMullin Chair of Genetics; ; ; 	This work was supported by fellowships F31 AT002835 (ESR), F32 CA168301 (RML), T32 OD011083 (AP), and by NIH grants R01 CA092479 (DWT), NIEHS P30 ES029067, and the Tom and Jean McMullin Chair of Genetics (DWT). We thank members of the Threadgill lab for constructive criticism on manuscript drafts; Dr. Andrew Hillhouse and the Texas A&M Institute for Genome Sciences and Society's (TIGSS) Molecular Genomics Core for RNAseq data generation; and Kristen Hanneman for mouse husbandry. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://ca ncergenome.nih.gov..	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen L, 2019, ONCOL REP, V42, P595, DOI 10.3892/or.2019.7206; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Herbeuval JP, 2004, J IMMUNOL, V172, P4630, DOI 10.4049/jimmunol.172.7.4630; Hsu TI, 2016, ONCOTARGET, V7, P20840, DOI 10.18632/oncotarget.7894; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jackstadt R, 2016, J PATHOL, V238, P141, DOI 10.1002/path.4645; Jackute J, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0241-4; Kamizato M, 2009, J GASTROENTEROL, V44, P1172, DOI 10.1007/s00535-009-0119-6; Karapetis CS, 2014, CLIN CANCER RES, V20, P744, DOI 10.1158/1078-0432.CCR-13-0606; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mager LF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00096; Martinelli E, 2009, CLIN EXP IMMUNOL, V158, P1, DOI 10.1111/j.1365-2249.2009.03992.x; Martins M, 2018, ADV EXP MED BIOL, V1110, P113, DOI 10.1007/978-3-030-02771-1_8; MASUI H, 1984, CANCER RES, V44, P1002; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moran AE, 2004, J BIOL CHEM, V279, P43261, DOI 10.1074/jbc.M404276200; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Mounir M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006701; Olson TJP, 2014, CANCER PREV RES, V7, P105, DOI 10.1158/1940-6207.CAPR-13-0163; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, JNCI-J NATL CANCER I, V96, P1117, DOI 10.1093/jnci/djh244; Parseghian CM, 2019, CLIN CANCER RES, V25, P6899, DOI 10.1158/1078-0432.CCR-19-0823; Pizarro TT, 2000, AM J PHYSIOL-GASTR L, V278, pG665, DOI 10.1152/ajpgi.2000.278.5.G665; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Ren JZ, 2019, J CANCER RES CLIN, V145, P1111, DOI 10.1007/s00432-019-02883-6; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Saqib Uzma, 2018, Oncotarget, V9, P17937, DOI 10.18632/oncotarget.24788; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schumacher D, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008076; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yang YH, 2014, J CANCER RES CLIN, V140, P1927, DOI 10.1007/s00432-014-1741-0; Zhao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139598	51	2	2	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2021	40	17					3047	3059		10.1038/s41388-021-01752-2	http://dx.doi.org/10.1038/s41388-021-01752-2		MAR 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RV2NJ	33767440	Green Accepted			2022-12-26	WOS:000632820300005
J	Parry, C; Wang, YW; Lin, SW; Barchenger, DW				Parry, Catherine; Wang, Yen-Wei; Lin, Shih-wen; Barchenger, Derek W.			Reproductive compatibility in Capsicum is not necessarily reflected in genetic or phenotypic similarity between species complexes	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; DIVERSITY; WILD; SOLANACEAE; BACCATUM; ANNUUM; INTROGRESSION; POPULATION; RESISTANCE; PEPPER	Wild relatives of domesticated Capsicum represent substantial genetic diversity and thus sources of traits of potential interest. Furthermore, the hybridization compatibility between members of Capsicum species complexes remains unresolved. Improving our understanding of the relationship between Capsicum species relatedness and their ability to form hybrids is a highly pertinent issue. Through the development of novel interspecific hybrids in this study, we demonstrate interspecies compatibility is not necessarily reflected in relatedness according to established Capsicum genepool complexes. Based on a phylogeny constructed by genotyping using simple sequence repeat (SSR) markers and with a portion of the waxy locus, and through principal component analysis (PCA) of phenotypic data, we clarify the relationships among wild and domesticated Capsicum species. Together, the phylogeny and hybridization studies provide evidence for the misidentification of a number of species from the World Vegetable Center genebank included in this study. The World Vegetable Center holds the largest collection of Capsicum genetic material globally, therefore this may reflect a wider issue in the misidentification of Capsicum wild relatives. The findings presented here provide insight into an apparent disconnect between compatibility and relatedness in the Capsicum genus, which will be valuable in identifying candidates for future breeding programs.	[Parry, Catherine] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Wang, Yen-Wei; Lin, Shih-wen; Barchenger, Derek W.] World Vegetable Ctr, Tainan 74151, Taiwan	University of Bath	Barchenger, DW (corresponding author), World Vegetable Ctr, Tainan 74151, Taiwan.	derek.barchenger@worldveg.org	Parry, Catherine/GWV-4200-2022		Ministry of Science and Technology (MOST) of Taiwan [107-2311-B-125 -001 -MY3]; United States Agency for International Development (USAID); Australian Centre for International Agricultural Research (ACIAR), Germany; Australian Centre for International Agricultural Research (ACIAR), Thailand; Australian Centre for International Agricultural Research (ACIAR), Philippines; Australian Centre for International Agricultural Research (ACIAR), Korea; Australian Centre for International Agricultural Research (ACIAR), Japan; UK aid from the UK government	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Australian Centre for International Agricultural Research (ACIAR), Germany; Australian Centre for International Agricultural Research (ACIAR), Thailand; Australian Centre for International Agricultural Research (ACIAR), Philippines; Australian Centre for International Agricultural Research (ACIAR), Korea; Australian Centre for International Agricultural Research (ACIAR), Japan; UK aid from the UK government(CGIAR)	Funding for this research was provided by the Ministry of Science and Technology (MOST) of Taiwan (Project ID:107-2311-B-125 -001 -MY3) and long-term strategic donors to the World Vegetable Center: Taiwan, UK aid from the UK government, United States Agency for International Development (USAID), Australian Centre for International Agricultural Research (ACIAR), Germany, Thailand, Philippines, Korea, and Japan.	Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Guzman FA, 2020, GENET RESOUR CROP EV, V67, P569, DOI 10.1007/s10722-019-00801-w; Albrecht E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-68; Albrecht E, 2012, GENET RESOUR CROP EV, V59, P517, DOI 10.1007/s10722-011-9700-y; Ali A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36630-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2020, **DATA OBJECT**; Barchenger DW, 2019, COMPEND PL GENOME, P9, DOI 10.1007/978-3-319-97217-6_2; Barchenger DW., 2019, N AM CROP WILD RELAT, P225; Bosland PW, 2000, HORTSCIENCE, V35, P1321, DOI 10.21273/HORTSCI.35.7.1321; Campos KP, 2004, 17 INT PEPP C, P20; Garcia CC, 2016, ANN BOT-LONDON, V118, P35, DOI 10.1093/aob/mcw079; Carvalho SIC, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16039689; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33293; Choong CY., 1998, THESIS U READING; Costa LV, 2009, CROP BREED APPL BIOT, V9, P37, DOI 10.12702/1984-7033.v09n01a06; Monteiro CED, 2011, CROP BREED APPL BIOT, V11, P241, DOI 10.1590/S1984-70332011000300006; Luna-Ruiz JD, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00048; de Souza Macedo V., 2017, CYTOGENETIC EVALUATI, V66, P612, DOI [10.15446/acag.v66n4.59162, DOI 10.15446/ACAG.V66N4.59162]; Eggink PM, 2014, THEOR APPL GENET, V127, P373, DOI 10.1007/s00122-013-2225-3; Emboden WA, 1962, BUTLER U BOT STUD, V14, P108, DOI [10.1080/00231940.1962.11757638, DOI 10.1080/00231940.1962.11757638]; FAO, 2010, 2 REP STAT WORLDS PL; Gioia T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211342; Gramazio P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01477; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirsch CN, 2013, G3-GENES GENOM GENET, V3, P1003, DOI 10.1534/g3.113.005595; Horikoshi M., 2016, R PACKAGE VERSION 4; Huang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156633; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; Ince AG, 2010, BIOCHEM GENET, V48, P83, DOI 10.1007/s10528-009-9297-4; IPGRI AVRDC and CATIE, 1995, DESCR CAPS CAPS SPP; Jarret RL, 2004, GA J SCI, V62, P117; Jimenez RC., 2019, THESIS U CALIFORNIA; Kamvorn W, 2014, SCI HORTIC-AMSTERDAM, V179, P9, DOI 10.1016/j.scienta.2014.09.003; Kassambara A., 2017, EXTRACT VISUALIZE RE; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kenyon L., 2017, WORLD VEGETABLE CTR; Khoury CK, 2020, DIVERS DISTRIB, V26, P209, DOI 10.1111/ddi.13008; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lin TH, 2020, HORTSCIENCE, V55, pS109; LOAIZAFIGUEROA F, 1989, PLANT SYST EVOL, V165, P159, DOI 10.1007/BF00936000; McCoy JE, 2019, HORTSCIENCE, V54, P4, DOI 10.21273/HORTSCI13596-18; MCLEOD MJ, 1983, EVOLUTION, V37, P562, DOI [10.2307/2408269, 10.1111/j.1558-5646.1983.tb05573.x]; Mongkolporn O, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P43, DOI 10.1007/978-3-642-20450-0_4; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; OECD, 2006, SER HARM REG OV BIOT, V36, P11; Olango TM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0250-8; Onus AN, 2004, ANN BOT-LONDON, V94, P289, DOI 10.1093/aob/mch139; Oyama K, 2006, GENET RESOUR CROP EV, V53, P553, DOI 10.1007/s10722-004-2363-1; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Pickersgill B., 1991, CYTOGENETICS EVOLUTI; Rai VP, 2013, PHYSIOL MOL BIOL PLA, V19, P575, DOI 10.1007/s12298-013-0185-3; Shipunov A., 2020, R PACKAGE VERSION 1; Shiragaki K, 2020, HORTICULTURAE, V6, DOI 10.3390/horticulturae6040087; Tam SM, 2009, THEOR APPL GENET, V119, P973, DOI 10.1007/s00122-009-1102-6; Tong N, 1999, EUPHYTICA, V109, P71, DOI 10.1023/A:1003421217077; van Zonneveld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134663; Votava EJ, 2002, CONSERV GENET, V3, P123, DOI 10.1023/A:1015216504565; Votava EJ., 2012, PEPPERS VEGETABLE SP, V2nd ed.; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Wickham H., 2020, GGPLOT2 CREATE ELEGA, DOI DOI 10.1093/BIOINFORMATICS/BTR406; Yoon JB, 2006, BREEDING SCI, V56, P31, DOI 10.1270/jsbbs.56.31	65	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0243689	10.1371/journal.pone.0243689	http://dx.doi.org/10.1371/journal.pone.0243689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760824	Green Submitted, Green Published, gold			2022-12-26	WOS:000633030400040
J	Umamaheswaran, G; Kadambari, D; Muthuvel, SK; Kumar, NAN; Dubashi, B; Dkhar, SA; Adithan, C				Umamaheswaran, Gurusamy; Kadambari, Dharanipragada; Muthuvel, Suresh Kumar; Kumar, Naveena A. N.; Dubashi, Biswajit; Dkhar, Steven Aibor; Adithan, Chandrasekaran			Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer	PLOS ONE			English	Article								Letrozole, an aromatase inhibitor (AI), is the first-line adjuvant drug for treating hormone receptor-positive (HR+) breast cancer in postmenopausal women. However, harmful adverse events (AEs) and significant differences in drug response among individuals remain a significant problem in clinical application. Current evidence suggests that the observed individual variation in the treatment outcomes of AI is conferred by genetic variants. Hence, in this study, we examined the association of TCL1A gene polymorphisms with letrozole-induced AEs. The study subjects were postmenopausal HR+ breast cancer patients who were receiving adjuvant letrozole. Genomic DNA was isolated by a routine standard phenol-chloroform method. In total, 198 South Indian patients were genotyped for four single nucleotide polymorphisms (SNPs) in the TCL1A gene loci by the TaqMan allelic discrimination assay using the RT-PCR system. We used the odds ratio and 95% confidence interval to assess the genetic association. Musculoskeletal (MS) AEs and vasomotor symptoms (VMSs) are the most common side effects observed in the study cohort. Among 198 patients, 81 experienced musculoskeletal toxicity, reporting MS-AEs, 57 had VMSs, and 33 of them had both. The most frequently identified polymorphic variants in the patient series were rs11849538 (G), with an allele frequency of about 27.3%, followed by rs7158782-G (27.3%), rs7159713-G (25.8%), and rs2369049-G (22.5%). The genetic association analysis indicated no significant difference in the proportion of TCL1A gene variants between patients with and without AEs on either MS-AEs or VMSs. Though we observed high LD in all patient groups, the inferred haplotypes displayed a non-significant association with letrozole-induced specific AEs. However, the SNP functionality analysis by RegulomeDB provided a 2b rank score for rs7158782, suggesting a potential biological function. Our findings suggest that TCL1A gene polymorphisms may not play any role in the prediction of letrozole-induced AEs in South Indian HR+ breast cancer patients.	[Umamaheswaran, Gurusamy; Dkhar, Steven Aibor; Adithan, Chandrasekaran] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Ctr Adv Res Pharmacogen, Dept Pharmacol, Pondicherry, India; [Kadambari, Dharanipragada; Kumar, Naveena A. N.] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Surg, Pondicherry, India; [Kadambari, Dharanipragada; Kumar, Naveena A. N.] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Med Educ, Pondicherry, India; [Muthuvel, Suresh Kumar] Pondicherry Univ, Ctr Bioinformat, Sch Life Sci, Pondicherry, India; [Dubashi, Biswajit] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Reg Canc Ctr, Dept Med Oncol, Pondicherry, India; [Adithan, Chandrasekaran] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Clin Pharmacol, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Pondicherry University; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Umamaheswaran, G (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Ctr Adv Res Pharmacogen, Dept Pharmacol, Pondicherry, India.	umagenes@gmail.com	GURUSAMY, UMAMAHESWARAN/G-8815-2013	GURUSAMY, UMAMAHESWARAN/0000-0002-8709-9159; Kumar, Naveena AN/0000-0002-1759-1500	JIPMER intramural research Grant [(1)/2010]	JIPMER intramural research Grant	The work was funded by JIPMER intramural research Grant (No. End.7(1)/2010 dated 21.02.2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of research materials for authors (UG and DK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Artigalas O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0373-9; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Crew KD, 2007, J CLIN ONCOL, V25, P3877, DOI 10.1200/JCO.2007.10.7573; Ferraldeschi R, 2012, BREAST CANCER RES TR, V133, P1191, DOI 10.1007/s10549-012-2010-z; FU TB, 1994, CANCER RES, V54, P6297; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Henry NL, 2013, BREAST CANCER RES TR, V138, P807, DOI 10.1007/s10549-013-2504-3; Ho MF, 2018, J PHARMACOL EXP THER, V365, P700, DOI 10.1124/jpet.118.247718; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Leyland-Jones B, 2015, BREAST CANCER RES TR, V151, P373, DOI 10.1007/s10549-015-3378-3; Lintermans A, 2016, EUR J CANCER, V56, P31, DOI 10.1016/j.ejca.2015.12.013; Liu MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3137; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Pekarsky Y, 2001, ONCOGENE, V20, P5638, DOI 10.1038/sj.onc.1204596; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Umamaheswaran G, 2020, BREAST CANCER RES TR, V182, P147, DOI 10.1007/s10549-020-05656-9; Umamaheswaran G, 2014, BIOIMPACTS, V4, P95, DOI 10.5681/bi.2014.016; Umamaheswaran G, 2014, INDIAN J MED RES, V139, P27; Wang JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133964; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068798; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wei CY, 2012, HUM MOL GENET, V21, pR58, DOI 10.1093/hmg/dds341; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247989	10.1371/journal.pone.0247989	http://dx.doi.org/10.1371/journal.pone.0247989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760860	gold, Green Published			2022-12-26	WOS:000633030400001
J	Pillai, A; Keyes, KM; Susser, E				Pillai, Aravind; Keyes, Katherine M.; Susser, Ezra			Antidepressant prescriptions and adherence in primary care in India: Insights from a cluster randomized control trial	PLOS ONE			English	Article								Background The World Health Organization recommends that treatment of depression in low and middle-income countries with a scarcity of psychiatrists could be done in primary care and should include prescription of antidepressant medications for moderate and severe depression. Little is known, however, about the actual practices of antidepressant prescription by primary care physicians in low and middle-income countries, nor about adherence by people receiving such prescriptions. In a large study of primary care clinics in Goa, India, we examined the relationship of actual to recommended prescribing practices for depression, among all patients who screened positive for common mental disorder. We also examined other patient and clinic characteristics associated with antidepressant prescription, and self-reported adherence over a one-month period. Methods Patients attending 24 primary care clinics were screened for common mental disorders. Those who screened positive were eligible to enroll in a trial to assess the effectiveness of a collaborative stepped care (CSC) intervention for mental disorders. Physicians in the 12 intervention and 12 control clinics (usual care) were free to prescribe antidepressants and follow-up interviews were conducted at 2, 6 and 12 months. Screening results were shared with the physician, but they were blinded to the diagnosis generated later using a standardized diagnostic interview administered by a health counsellor. We categorized these later diagnoses as "moderate/severe depression", "mild depression or non-depression diagnosis", and "no diagnosis". We used a two-level hierarchical logistic regression model to examine diagnostic and other factors associated with antidepressant prescription and one-month adherence. Results Overall, about 47% of screened positive patients (n = 1320) received an antidepressant prescription: 60% of those with moderate/severe depression, 48% of those with mild depression or non-depression diagnosis, and 31% with no diagnosis. Women (OR 1.29; 95%CI 1.04-1.60) and older adults (OR 1.80; 95%CI 1.32-2.47) were more likely to receive an antidepressant prescription. While the overall rate of antidepressant prescription was similar in clinics with and without CSC, patients without any diagnosis were more likely to receive a prescription (OR 2.20 95% CI 1.03-4.70) in the usual care clinics. About 47% of patients adhered to antidepressant treatment for one month or more and adherence was significantly better among older adults (OR 3.92; 95% CI 1.70-8.93) and those who received antidepressant as part of the CSC treatment model (OR 6.10 95% CI 3.67-10.14) compared with those attending the usual care clinic. Conclusion Antidepressants were widely prescribed following screening in primary care, but prescription patterns were in poor accord with WHO recommendations. The data suggest under-prescription for people with moderate/severe depression; over-prescription for people with mild depression or non-depression diagnoses; and over-prescription for people with no disorders. For all diagnoses adherence was low, especially in usual care clinics. To address these concerns, there is an urgent need to study and develop strategies in primary care practices to limit unnecessary antidepressant prescriptions, target prescription for those patients who clearly benefit, and to improve adherence to antidepressant treatment.	[Pillai, Aravind; Keyes, Katherine M.; Susser, Ezra] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Pillai, A (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	apillai@caa.columbia.edu	Pillai, Aravind/I-7344-2013	Pillai, Aravind/0000-0001-6997-2607	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The MANAS trial was funded by the Wellcome Trust. However, the authors received no funding for the specific research reported in this article.	Abbing-Karahagopian V, 2014, EUR J CLIN PHARMACOL, V70, P849, DOI 10.1007/s00228-014-1676-z; Andrew Gracy, 2012, BMC Res Notes, V5, P499, DOI 10.1186/1756-0500-5-499; [Anonymous], 2019, POSITION STATEMENT A; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Arroll B, 2016, J PRIM HEALTH CARE, V8, P325, DOI 10.1071/HC16008; Baumeister H, 2012, J AFFECT DISORDERS, V139, P240, DOI 10.1016/j.jad.2011.05.025; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Chatterjee S, 2008, WORLD PSYCHIATRY, V7, P39; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P4; Dowrick C., 2016, BJPSYCH ADV, V22, P99; Gers L, 2018, THER ADV DRUG SAF, V9, P373, DOI 10.1177/2042098618778974; Goldberg D Williams P., 1988, USERS GUIDE GHQ; Heath I, 1999, BRIT MED J, V318, P439; Hung CI, 2014, CURR OPIN PSYCHIATR, V27, P344, DOI 10.1097/YCO.0000000000000086; Hyde J, 2005, BRIT J GEN PRACT, V55, P755; Jacob K S, 2011, Indian J Psychiatry, V53, P195, DOI 10.4103/0019-5545.86798; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Maust DT, 2017, PSYCHIAT SERV, V68, P449, DOI 10.1176/appi.ps.201600197; Ministry of Health and Family Welfare Government of India, 2018, NAT MENT HLTH PROGR; National Collaborating Centre for Mental, 2010, DEPR TREATM MAN DEPR; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Olfson M, 2016, JAMA INTERN MED, V176, P1482, DOI 10.1001/jamainternmed.2016.5057; Organization WH, 2009, MENT HLTH SYST SEL L; Padmanathan P, 2016, EPIDEMIOL PSYCH SCI, V25, P4, DOI 10.1017/S2045796015000803; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V., 2012, BRIT J PSYCHIAT, V200, P166; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Pereira J, 1999, Indian J Psychiatry, V41, P358; Petrovic M., 2005, PHARMACOTHERAPY DEPR; Rao TSS, 2017, INDIAN J PSYCHIAT, V59, P157, DOI 10.4103/psychiatry.IndianJPsychiatry_202_17; Raykov T, 2015, EDUC PSYCHOL MEAS, V75, P1063, DOI 10.1177/0013164414564052; Reynolds CF, 2017, WORLD PSYCHIATRY, V16, P316, DOI 10.1002/wps.20459; Rivero-Santana A, 2013, PATIENT PREFER ADHER, V7, P151, DOI 10.2147/PPA.S39382; Samples H, 2015, PSYCHIAT SERV, V66, P455, DOI 10.1176/appi.ps.201400021; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Schwenk TL, 1996, GEN HOSP PSYCHIAT, V18, P407, DOI 10.1016/S0163-8343(96)00062-X; WHO, 2017, DEPR OTH COMM MENT D; Wong J, 2016, JAMA-J AM MED ASSOC, V315, P2230, DOI 10.1001/jama.2016.3445; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization and Calouste Gulbenkian Foundation, 2014, INT RESP MENT DIS OT	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248641	10.1371/journal.pone.0248641	http://dx.doi.org/10.1371/journal.pone.0248641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33739982	Green Published, gold			2022-12-26	WOS:000631030200024
J	Campos-Delgado, DU; Gutierrez-Navarro, O; Salinas-Martinez, R; Duran, E; Mejia-Rodriguez, AR; Velazquez-Duran, MJ; Jo, JA				Campos-Delgado, Daniel U.; Gutierrez-Navarro, Omar; Salinas-Martinez, Ricardo; Duran, Elvis; Mejia-Rodriguez, Aldo R.; Velazquez-Duran, Miguel J.; Jo, Javier A.			Blind deconvolution estimation by multi-exponential models and alternated least squares approximations: Free-form and sparse approach	PLOS ONE			English	Article							LIFETIME IMAGING MICROSCOPY; FLUORESCENCE LIFETIME; DECAY	The deconvolution process is a key step for quantitative evaluation of fluorescence lifetime imaging microscopy (FLIM) samples. By this process, the fluorescence impulse responses (FluoIRs) of the sample are decoupled from the instrument response (InstR). In blind deconvolution estimation (BDE), the FluoIRs and InstR are jointly extracted from a dataset with minimal a priori information. In this work, two BDE algorithms are introduced based on linear combinations of multi-exponential functions to model each FluoIR in the sample. For both schemes, the InstR is assumed with a free-form and a sparse structure. The local perspective of the BDE methodology assumes that the characteristic parameters of the exponential functions (time constants and scaling coefficients) are estimated based on a single spatial point of the dataset. On the other hand, the same exponential functions are used in the whole dataset in the global perspective, and just the scaling coefficients are updated for each spatial point. A least squares formulation is considered for both BDE algorithms. To overcome the nonlinear interaction in the decision variables, an alternating least squares (ALS) methodology iteratively solves both estimation problems based on non-negative and constrained optimizations. The validation stage considered first synthetic datasets at different noise types and levels, and a comparison with the standard deconvolution techniques with a multi-exponential model for FLIM measurements, as well as, with two BDE methodologies in the state of the art: Laguerre basis, and exponentials library. For the experimental evaluation, fluorescent dyes and oral tissue samples were considered. Our results show that local and global perspectives are consistent with the standard deconvolution techniques, and they reached the fastest convergence responses among the BDE algorithms with the best compromise in FluoIRs and InstR estimation errors.	[Campos-Delgado, Daniel U.; Salinas-Martinez, Ricardo; Mejia-Rodriguez, Aldo R.; Velazquez-Duran, Miguel J.] Univ Autonoma San Luis Potosi, Fac Ciencias, San Luis Potosi, San Luis Potosi, Mexico; [Campos-Delgado, Daniel U.] Univ Autonoma San Luis Potosi, Inst Invest Comunicac Opt, San Luis Potosi, San Luis Potosi, Mexico; [Gutierrez-Navarro, Omar] Univ Autonoma Aguascalientes, Dept Biomed Engn, Aguascalientes, Aguascalientes, Mexico; [Duran, Elvis] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Jo, Javier A.] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA	Universidad Autonoma de San Luis Potosi; Universidad Autonoma de San Luis Potosi; Universidad Autonoma de Aguascalientes; Texas A&M University System; Texas A&M University College Station; University of Oklahoma System; University of Oklahoma - Norman	Campos-Delgado, DU (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias, San Luis Potosi, San Luis Potosi, Mexico.; Campos-Delgado, DU (corresponding author), Univ Autonoma San Luis Potosi, Inst Invest Comunicac Opt, San Luis Potosi, San Luis Potosi, Mexico.	ducd@fciencias.uaslp.mx	Campos-Delgado, Daniel U./A-8439-2018	Campos-Delgado, Daniel U./0000-0002-1555-0131; Duran Sierra, Elvis De Jesus/0000-0003-0077-8499	National Institute of Health (NIH) [R01CA218739]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP180588]; CONACYT [254637]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the National Institute of Health (NIH) (R01CA218739), Cancer Prevention and Research Institute of Texas (CPRIT grant RP180588), and by CONACYT through a Basic Research Grant (Ref #254637).	Anthony N., 2009, FLIM MICROSCOPY BIOL, P67; Campos-Delgado DU, 2019, IEEE ACCESS, V7, P178539, DOI 10.1109/ACCESS.2019.2958985; Campos-Delgado DU, 2015, OPT EXPRESS, V23, P23748, DOI 10.1364/OE.23.023748; Campos-Delgado DU, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.075010; Campos-Delgado DU, 2015, BIOMED OPT EXPRESS, V6, P2088, DOI 10.1364/BOE.6.002088; Dabir AS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103342; Datta R, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.7.071203; De Giorgi V, 2009, J EUR ACAD DERMATOL, V23, P314, DOI 10.1111/j.1468-3083.2008.03045.x; Duran-Sierra E, 2020, ORAL ONCOL, V105, DOI 10.1016/j.oraloncology.2020.104635; Fereidouni F, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086006; Fereidouni F, 2012, OPT EXPRESS, V20, P12729, DOI 10.1364/OE.20.012729; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Galletly NP, 2008, BRIT J DERMATOL, V159, P152, DOI 10.1111/j.1365-2133.2008.08577.x; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gutierrez-Navarro O, 2014, OPT EXPRESS, V22, P12255, DOI 10.1364/OE.22.012255; Jabbour JM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046012; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; Jo JA, 2004, J BIOMED OPT, V9, P743, DOI 10.1117/1.1752919; Jo JA, 2020, 2020 IEEE INT AUT M, P1; Kaye B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169337; Lau Y, 2020, 8 INT C LEARN REPR, P1; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Liu J, 2012, PHYS MED BIOL, V57, P843, DOI 10.1088/0031-9155/57/4/843; Liu LX, 2019, J INNOV OPT HEAL SCI, V12, DOI 10.1142/S1793545819300040; Madsen K., 2004, METHODS NONLINEAR LE; Marcu L., 2014, FLUORESCENCE LIFETIM; Mycek MA, 1998, GASTROINTEST ENDOSC, V48, P390, DOI 10.1016/S0016-5107(98)70009-4; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; O'Donnell M, 2010, J NUCL MED, V51, p38S, DOI 10.2967/jnumed.109.068155; Park J, 2012, ATHEROSCLEROSIS, V220, P394, DOI 10.1016/j.atherosclerosis.2011.10.034; Pelet S, 2004, BIOPHYS J, V87, P2807, DOI 10.1529/biophysj.104.045492; Pengo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078504; Periasamy A., 2009, FLIM MICROSCOPY BIOL; Proakis J. G., 2006, DIGIT SIGNAL PROCESS, V4; Qin BJ, 2016, IEEE T INSTRUM MEAS, V65, P874, DOI 10.1109/TIM.2016.2516318; Romano RA, 2020, PHOTODIAGN PHOTODYN, V30, DOI 10.1016/j.pdpdt.2020.101704; Salinas-Martinez R, 2018, LAT AM OPT PHOT C OP; Shrestha S, 2010, OPT LETT, V35, P2558, DOI 10.1364/OL.35.002558; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Walsh AJ, 2014, CANCER RES, V74, P5184, DOI 10.1158/0008-5472.CAN-14-0663; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; YOUNG FW, 1976, PSYCHOMETRIKA, V41, P505, DOI 10.1007/BF02296972	43	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248301	10.1371/journal.pone.0248301	http://dx.doi.org/10.1371/journal.pone.0248301			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735228	Green Published, gold			2022-12-26	WOS:000631029700061
J	Hammad, MA; Alqarni, TM				Hammad, Mohammad Ahmed; Alqarni, Turki Mahdi			Psychosocial effects of social media on the Saudi society during the Coronavirus Disease 2019 pandemic: A cross-sectional study	PLOS ONE			English	Article							COVID-19; DEPRESSION; OUTBREAK; ANXIETY; SCALE; LONELINESS; MESSAGES; IMPACT; LONG	The Coronavirus Disease 2019 (COVID-19) pandemic has been posing a substantial challenge to human survival and well-being, which rely on the actions and behaviors of individuals. It is essential that accurate information is distributed; however, misinformation has been spread via social media. Consequently, the resulting panic has to be addressed while putting essential public health measures in place. It is also important to explore the link between the social media exposure and well-being. Therefore, in the current study, we aimed to identify the levels of anxiety, depression, and social isolation among individuals during the COVID-19 pandemic. Additionally, we explored the relationship between exposure to misleading social media news and anxiety, depression, and social isolation. A cross sectional design was employed to collect data from 371 Saudi participants (aged 16-60 years), using the Generalized Anxiety Disorder-7, Centre for Epidemiological Studies Depression Scale, and de Jong Gierveld Loneliness Scale. Results showed that the prevalence of anxiety, depression, and social isolation was 47.82%, 47.57%, and 46.42%, respectively. Further, more than 83% of the participants reported using social media frequently during the pandemic. We found that exposure to misinformation via social media has a significant positive relationship with anxiety, depression, and social isolation. However, Due to the cross-sectional nature of this study it cannot be determined whether social media causes negative mental health outcomes, or if individuals experiencing greater depression, anxiety and social isolation turn to social media more than others, or if some third variable might explain both. Based on our findings, we present specific suggestions related to the COVID-19 pandemic to the government of Saudi Arabia. Minoring and filtering out misleading information with the cooperation of the World Health Organization (WHO) can promote the spread of accurate news in Saudi Arabia.	[Hammad, Mohammad Ahmed; Alqarni, Turki Mahdi] Najran Univ, Dept Special Educ, Fac Educ, Najran, Saudi Arabia	Najran University	Hammad, MA (corresponding author), Najran Univ, Dept Special Educ, Fac Educ, Najran, Saudi Arabia.	hammadeg73@yahoo.com		Alqarni, Dr.Turki/0000-0003-3413-7307; hammad, mohammad/0000-0003-3554-4916	Deanship of Scientific Research, Najran University, The Kingdom of Saudi Arabia [NU/SHED/18/018]	Deanship of Scientific Research, Najran University, The Kingdom of Saudi Arabia	Financial support from Deanship of Scientific Research, Najran University, The Kingdom of Saudi Arabia, (NU/SHED/18/018), is gratefully acknowledged.	Ahmad AR, 2020, J MED INTERNET RES, V22, DOI 10.2196/19556; Al-Habib A., 2019, TECHNICAL REPORT SAU; Amedie J., 2015, IMPACT SOCIAL MEDIA; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arabiya A., 2020, SAUDI PROSECUTION CO; Atlani-Duault L, 2020, LANCET PUBLIC HEALTH, V5, pE137, DOI 10.1016/S2468-2667(20)30033-5; Bastani Peivand, 2020, J Med Internet Res, DOI 10.2196/18932; Berryman C, 2018, PSYCHIAT QUART, V89, P307, DOI 10.1007/s11126-017-9535-6; Bin Naeem S, 2020, HEALTH INFO LIBR J, V37, P233, DOI 10.1111/hir.12311; Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5; Coyne SM, 2020, COMPUT HUM BEHAV, V104, DOI 10.1016/j.chb.2019.106160; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; DATAREPORTAL, 2020, DIG 2020 SAUD AR; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Drouin M, 2020, CYBERPSYCH BEH SOC N, V23, P727, DOI 10.1089/cyber.2020.0284; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Ferguson CJ, 2019, SUICIDE LIFE-THREAT, V49, P1178, DOI 10.1111/sltb.12517; Ferguson CJ, 2014, J YOUTH ADOLESCENCE, V43, P1, DOI 10.1007/s10964-012-9898-9; Frances A.J., 2000, DIAGNOSTIC STAT MANU; Fuoco MA., 2020, TIME SOCIAL DISTANCI; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Garg K, 2019, INDIAN J PSYCHIAT, V61, P104, DOI 10.4103/psychiatry.IndianJPsychiatry_7_18; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155; Hossain MT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238974; Hua JL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072309; IBM, 2012, SPSS STAT VERS 21; Imperatori C, 2020, CYBERPSYCH BEH SOC N, V23, P782, DOI 10.1089/cyber.2020.0339; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Jalloh MF, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000471; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Kayes A, 2020, AUTOMATED MEASUREMEN; Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696; Kim B, 2020, CYBERPSYCH BEH SOC N, V23, P519, DOI 10.1089/cyber.2020.0201; Lai D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240326; Lee Julian, 2020, BLOOMBERG; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120; Lin LY, 2016, DEPRESS ANXIETY, V33, P323, DOI 10.1002/da.22466; Llewellyn S, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1160; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; McKendry RA, 2020, NATURE, V580, P29, DOI 10.1038/d41586-020-00908-6; Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469; Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3; Mohammed A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2167-6; Murri R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238414; Newby J.M., 2020, PLOS ONE, DOI [10.1101/2020.05.03.20089961, DOI 10.1371/JOURNAL.PONE.0236562]; Oh O., 2010, ICIS; Oh O, 2013, MIS QUART, V37, P407, DOI 10.25300/MISQ/2013/37.2.05; Orben A, 2019, NAT HUM BEHAV, V3, P173, DOI 10.1038/s41562-018-0506-1; Organization WH, WHO DIR GEN REM MED; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Patel MP, 2020, INDIAN J NEPHROL, V30, P188, DOI 10.4103/ijn.IJN_216_20; Peng EYC, 2010, J FORMOS MED ASSOC, V109, P524, DOI 10.1016/S0929-6646(10)60087-3; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Sidik SM, 2012, J PRIM HEALTH CARE, V4, P5; Soltaninejad K, 2020, INT J OCCUP ENV MED, V11, P148, DOI 10.34172/ijoem.2020.1983; Sood S, 2020, RES HUMAN MED ED, P23; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Statistics GAf, INT US SAUD AR SAUD; Thelwall M., 2020, ARXIV PREPRINT ARXIV, P793; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Vilar R., 2018, PAIDEIA RIBEIRAO PRE, V28; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wiederhold BK., 2020, SOCIAL MEDIA USE SOC; Zhang MWB, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2827; Zheng Y, 2020, ANATOLIA, V31, P337, DOI 10.1080/13032917.2020.1747208; Zhong QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125096	78	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248811	10.1371/journal.pone.0248811	http://dx.doi.org/10.1371/journal.pone.0248811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735309	gold, Green Published			2022-12-26	WOS:000631029700036
J	Takemura, M; Haneda, T; Idei, H; Miki, T; Okada, N				Takemura, Momo; Haneda, Takeshi; Idei, Hikari; Miki, Tsuyoshi; Okada, Nobuhiko			A Salmonella type III effector, PipA, works in a different manner than the PipA family effectors GogA and GtgA	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NF-KAPPA-B; ESCHERICHIA-COLI; PATHOGENICITY ISLAND; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; PROTEIN; SECRETION; GENES; SOPB	Nuclear factor-kappa B (NF-kappa B) plays a critical role in the host defense against microbial pathogens. Many pathogens modulate NF-kappa B signaling to establish infection in their host. Salmonella enterica serovar Typhimurium (S. Typhimurium) possesses two type III secretion systems (T3SS-1 and T3SS-2) and directly injects many effector proteins into host cells. It has been reported that some effectors block NF-kappa B signaling, but the molecular mechanism of the inactivation of NF-kappa B signaling in S. Typhimurium is poorly understood. Here, we identified seven type III effectors-GogA, GtgA, PipA, SseK1, SseK2, SseK3, and SteE-that inhibited NF-kappa B activation in HeLa cells stimulated with TNF-alpha. We also determined that only GogA and GtgA are involved in regulation of the activation of NF-kappa B in HeLa cells infected with S. Typhimurium. GogA, GtgA, and PipA are highly homologous to one another and have the consensus zinc metalloprotease HEXXH motif. Our experiments demonstrated that GogA, GtgA, and PipA each directly cleaved NF-kappa B p65, whereas GogA and GtgA, but not PipA, inhibited the NF-kappa B activation in HeLa cells infected with S. Typhimurium. Further, expressions of the gogA or gtgA gene were induced under the SPI-1-and SPI-2-inducing conditions, but expression of the pipA gene was induced only under the SPI-2-inducing condition. We also showed that PipA was secreted into RAW264.7 cells through T3SS-2. Finally, we indicated that PipA elicits bacterial dissemination in the systemic stage of infection of S. Typhimurium via a T3SS-1-independent mechanism. Collectively, our results suggest that PipA, GogA and GtgA contribute to S. Typhimurium pathogenesis in different ways.	[Takemura, Momo; Haneda, Takeshi; Idei, Hikari; Miki, Tsuyoshi; Okada, Nobuhiko] Kitasato Univ, Sch Pharm, Microbiol Lab, Minato Ku, Tokyo, Japan	Kitasato University	Haneda, T (corresponding author), Kitasato Univ, Sch Pharm, Microbiol Lab, Minato Ku, Tokyo, Japan.	hanedat@pharm.kitasato-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [15K08470, 19K07543, 25293106, 18K07119]; Kitasato University	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University	This study was supported in part by Japan Society for the Promotion of Science KAKENHI grants 15K08470 and 19K07543 (to T. H.) and 25293106 and 18K07119 (to N.O.) and by a Kitasato University Research Grant for Young Researchers (2012 to T.H.).	Addwebi TM, 2014, POULTRY SCI, V93, P871, DOI 10.3382/ps.2013-03710; Bakowski MA, 2007, CELL MICROBIOL, V9, P2839, DOI 10.1111/j.1462-5822.2007.01000.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Borton MA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0264-8; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; El Qaidi S, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00435; El Qaidi S, 2017, J BIOL CHEM, V292, P11423, DOI 10.1074/jbc.M117.790675; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Gotoh H, 2003, MICROB PATHOGENESIS, V34, P227, DOI 10.1016/S0882-4010(03)00034-2; Gulati A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02822; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Haneda T, 2012, CELL MICROBIOL, V14, P485, DOI 10.1111/j.1462-5822.2011.01733.x; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; Haneda T, 2009, INFECT IMMUN, V77, P2932, DOI 10.1128/IAI.00172-09; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Jaslow SL, 2018, CELL REP, V23, P3525, DOI 10.1016/j.celrep.2018.05.072; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Pilar AVC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002773; Raffatellu M, 2005, INFECT IMMUN, V73, P146, DOI 10.1128/IAI.73.1.146-154.2005; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Ramos-Marques E, 2017, VIRULENCE, V8, P719, DOI 10.1080/21505594.2016.1229727; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Rolhion N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005653; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; Shames SR, 2011, CELL MICROBIOL, V13, P1542, DOI 10.1111/j.1462-5822.2011.01640.x; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Stapels DAC, 2018, SCIENCE, V362, P1156, DOI 10.1126/science.aat7148; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Sun H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005484; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546; Wood MW, 1998, MOL MICROBIOL, V29, P883, DOI 10.1046/j.1365-2958.1998.00984.x; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zurawski DV, 2008, INFECT IMMUN, V76, P369, DOI 10.1128/IAI.00684-07	52	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248975	10.1371/journal.pone.0248975	http://dx.doi.org/10.1371/journal.pone.0248975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735297	Green Published, gold			2022-12-26	WOS:000631029700106
J	Benny, PA; Al-Akwaa, FM; Dirkx, C; Schlueter, RJ; Wolfgruber, TK; Chern, IY; Hoops, S; Knights, D; Garmire, LX				Benny, Paula A.; Al-Akwaa, Fadhl M.; Dirkx, Corbin; Schlueter, Ryan J.; Wolfgruber, Thomas K.; Chern, Ingrid Y.; Hoops, Suzie; Knights, Dan; Garmire, Lana X.			Placentas delivered by pre-pregnant obese women have reduced abundance and diversity in the microbiome	FASEB JOURNAL			English	Article						Microbiome; Obesity; Placenta; Pregnancy; 16S sequencing	GUT MICROBIOME; TERM; PRETERM; SEQUENCES; MEMBRANES; SAMPLES; MODE; GENE; TOOL	Maternal pre-pregnancy obesity may have an impact on both maternal and fetal health. We examined the microbiome recovered from placentas in a multi-ethnic maternal pre-pregnant obesity cohort, through an optimized microbiome protocol to enrich low bacterial biomass samples. We found that the microbiomes recovered from the placentas of obese pre-pregnant mothers are less abundant and less diverse when compared to those from mothers of normal pre-pregnancy weight. Microbiome richness also decreases from the maternal side to the fetal side, demonstrating heterogeneity by geolocation within the placenta. In summary, our study shows that the microbiomes recovered from the placentas are associated with pre-pregnancy obesity. Importance Maternal pre-pregnancy obesity may have an impact on both maternal and fetal health. The placenta is an important organ at the interface of the mother and fetus, and supplies nutrients to the fetus. We report that the microbiomes enriched from the placentas of obese pre-pregnant mothers are less abundant and less diverse when compared to those from mothers of normal pre-pregnancy weight. More over, the microbiomes also vary by geolocation within the placenta.	[Benny, Paula A.; Wolfgruber, Thomas K.] Univ Hawaii, Ctr Canc, Dept Epidemiol, Honolulu, HI 96822 USA; [Al-Akwaa, Fadhl M.; Garmire, Lana X.] Univ Michigan, Dept Computat Med & Bioinformat, North Campus Res Complex, Ann Arbor, MI 48109 USA; [Dirkx, Corbin] Univ Minnesota Twin Cities, Univ Minnesota, Genom Ctr, Minneapolis, MN USA; [Schlueter, Ryan J.; Chern, Ingrid Y.] Univ Hawaii, Dept Obstet & Gynaecol, Honolulu, HI 96822 USA; [Hoops, Suzie; Knights, Dan] Univ Minnesota, Coll Biol Sci, BioTechnol Inst, Minneapolis, MN USA; [Hoops, Suzie; Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Schlueter, Ryan J.] Atlanta Perinatal Associates, Atlanta, GA USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Hawaii System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Garmire, LX (corresponding author), Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, NCRC, Room 3366,Bldg 520,1600 Huron Pkwy, Ann Arbor, MI 48105 USA.	lgarmire@med.umich.edu	Hoops, Susan L/AGF-1383-2022	Hoops, Susan/0000-0001-5273-5795	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [K01ES025434]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20 COBRE GM103457]; HHS | NIH | U.S. National Library of Medicine (NLM) [R01 LM012373]; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD084633]	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | U.S. National Library of Medicine (NLM); HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: K01ES025434; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20 COBRE GM103457; HHS | NIH | U.S. National Library of Medicine (NLM), Grant/Award Number: R01 LM012373; HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01 HD084633	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chu DM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0330-z; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Doyle RM, 2014, PLACENTA, V35, P1099, DOI 10.1016/j.placenta.2014.10.007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leiby JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0575-4; Li X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01882; Liu YY, 2019, FERTIL STERIL, V112, P707, DOI 10.1016/j.fertnstert.2019.05.015; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Megli C, 2016, AM J OBSTET GYNECOL, V214, pS271, DOI 10.1016/j.ajog.2015.10.540; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Parnell LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11514-4; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rogers GB, 2013, J CLIN MICROBIOL, V51, P4029, DOI 10.1128/JCM.02164-13; Seferovic MD, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.036; Stanislawski MA, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0091-8; Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022; Walker RW, 2017, PEDIATR OBES, V12, P3, DOI 10.1111/ijpo.12217; Wu YJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4458; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315	36	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21524	10.1096/fj.202002184RR	http://dx.doi.org/10.1096/fj.202002184RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742690	Green Published			2022-12-26	WOS:000635216100039
J	Narapareddy, L; Rhon-Calderon, EA; Vrooman, LA; Baeza, J; Nguyen, DK; Mesaros, C; Lan, YM; Garcia, BA; Schultz, RM; Bartolomei, MS				Narapareddy, Laren; Rhon-Calderon, Eric A.; Vrooman, Lisa A.; Baeza, Josue; Nguyen, Duy K.; Mesaros, Clementina; Lan, Yemin; Garcia, Benjamin A.; Schultz, Richard M.; Bartolomei, Marisa S.			Sex-specific effects of in vitro fertilization on adult metabolic outcomes and hepatic transcriptome and proteome in mouse	FASEB JOURNAL			English	Article						assisted reproductive technologies; developmental origins of health and disease; long&#8208; term health; metabolic outcomes; sex&#8208; specific	ASSISTED REPRODUCTIVE TECHNOLOGIES; ELEMENT-BINDING PROTEIN-1C; DEVELOPMENTAL ORIGINS; VASCULAR DYSFUNCTION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; HEALTH OUTCOMES; GENE-EXPRESSION; MESSENGER-RNA; LIVER	Although in vitro fertilization (IVF) is associated with adverse perinatal outcomes, there is increasing concern about the long-term and sex-specific health implications. Augmenting our IVF mouse model to longitudinally investigate metabolic outcomes in offspring from optimal neonatal litter sizes, we found sex-specific metabolic outcomes in IVF offspring. IVF-conceived females had higher body weight and cholesterol levels compared to naturally conceived females, whereas IVF-conceived males had higher levels of triglycerides and insulin, and increased body fat composition. Through adult liver transcriptomics and proteomics, we identified sexually dimorphic dysregulation of the sterol regulatory element-binding protein (SREBP) pathways that are associated with the sex-specific phenotypes. We also found that global loss of DNA methylation in placenta was linked to higher cholesterol levels in IVF-conceived females. Our findings indicate that IVF procedures have long-lasting sex-specific effects on metabolic health of offspring and lay the foundation to utilize the placenta as a predictor of long-term outcomes.	[Narapareddy, Laren] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Narapareddy, Laren; Rhon-Calderon, Eric A.; Vrooman, Lisa A.; Nguyen, Duy K.; Lan, Yemin; Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Epigenet Inst, 9-122 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Baeza, Josue; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Mesaros, Clementina; Bartolomei, Marisa S.] Univ Penn, Ctr Excellence Environm Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Richard M.] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA	Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Bartolomei, MS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Epigenet Inst, 9-122 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bartolom@pennmedicine.upenn.edu		Bartolomei, Marisa/0000-0001-9410-5222	National Institutes of Child Health and Human Development [HD092266, HD068157]; National Institute of General Medical Sciences [GM110174]; National Institute of Nursing Research [T32NR007100]; Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship [HD089623]; National Institute of Environmental Health Sciences [P30-ES013508]	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institutes of Child Health and Human Development HD092266 and HD068157 (MSB), the National Institute of General Medical Sciences GM110174 (BAG), the National Institute of Nursing Research T32NR007100 (LN), Ruth L. Kirshstein National Service Award Individual Postdoctoral Fellowship HD089623 (LAV), and the National Institute of Environmental Health Sciences P30-ES013508 (Center for Excellence in Environmental Toxicology).	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calle A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100743; Carbon S., 2018, **DATA OBJECT**, DOI [10.5281/ZENODO.3873405, DOI 10.5281/ZENODO.3873405]; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chen M, 2017, J DEV ORIG HLTH DIS, V8, P388, DOI 10.1017/S2040174417000228; Chen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113155; Chen MX, 2014, DIABETES, V63, P3189, DOI 10.2337/db14-0103; Chen SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10596; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Collier AC, 2009, J STEROID BIOCHEM, V116, P21, DOI 10.1016/j.jsbmb.2009.04.005; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; de Waal E, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114785; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Erion KA, 2017, CURR OBES REP, V6, P178, DOI 10.1007/s13679-017-0261-z; European Society of Human Reproduction and Embryology, 2020, ART FACT SHEET; Feuer SK, 2014, ENDOCRINOLOGY, V155, P4554, DOI 10.1210/en.2014-1465; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Fortier AL, 2014, MOL CELL ENDOCRINOL, V388, P51, DOI 10.1016/j.mce.2014.03.003; Garcia-Calzon S, 2018, J CLIN ENDOCR METAB, V103, P4395, DOI 10.1210/jc.2018-00423; Gessulat S, 2019, NAT METHODS, V16, P509, DOI 10.1038/s41592-019-0426-7; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Hattori H, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0623-3; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Intapad S, 2014, PHYSIOLOGY, V29, P122, DOI 10.1152/physiol.00045.2013; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luke B, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.10.003; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Meng Y, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0194-5; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Miles HL, 2007, J CLIN ENDOCR METAB, V92, P3441, DOI 10.1210/jc.2006-2465; Moro E, 2003, METABOLISM, V52, P616, DOI 10.1053/meta.2003.50102; Nagy A., 2014, MANIPULATING MOUSE E, V4 th, P604; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Parra-Vargas M, 2020, CELL METAB, V32, P334, DOI 10.1016/j.cmet.2020.07.014; Pino LK, 2020, MOL CELL PROTEOMICS, V19, P1088, DOI 10.1074/mcp.P119.001913; Pontesilli M, 2015, REPROD BIOMED ONLINE, V30, P258, DOI 10.1016/j.rbmo.2014.11.006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rexhaj E, 2015, AM J PHYSIOL-HEART C, V309, pH1151, DOI 10.1152/ajpheart.00621.2014; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; Sang J, 2019, BRIT J NUTR, V122, P1062, DOI 10.1017/S0007114519001740; Schieve LA, 2007, MATERN CHILD HLTH J, V11, P517, DOI 10.1007/s10995-007-0202-7; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Searle BC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15346-1; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stern JE, 2018, J ASSIST REPROD GEN, V35, P1585, DOI 10.1007/s10815-018-1238-x; Sui LL, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.124248; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Thoma ME, 2013, FERTIL STERIL, V99, P1324, DOI 10.1016/j.fertnstert.2012.11.037; Vrooman LA, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.186551; Vrooman LA, 2017, REPROD TOXICOL, V68, P72, DOI 10.1016/j.reprotox.2016.07.015; Wang WR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24813-1; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Whidden L, 2016, HUM MOL GENET, V25, P4649, DOI 10.1093/hmg/ddw293; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100	71	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21523	10.1096/fj.202002744R	http://dx.doi.org/10.1096/fj.202002744R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734487	Green Accepted			2022-12-26	WOS:000635216100041
J	Alkhateeb, H; El Fathi, A; Ghanbari, M; Haidar, A				Alkhateeb, Haneen; El Fathi, Anas; Ghanbari, Milad; Haidar, Ahmad			Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes	PLOS ONE			English	Article							INDUCED TRANSLOCATION; INSULIN SENSITIVITY; ARTIFICIAL PANCREAS; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; SKELETAL-MUSCLE; TRANSPORT; INTENSITY; RESISTANCE; CHILDREN	The artificial pancreas is a closed-loop insulin delivery system that automatically regulates glucose levels in individuals with type 1 diabetes. In-silico testing using simulation environments accelerates the development of better artificial pancreas systems. Simulation environments need an accurate model that captures glucose dynamics during exercise to simulate real-life scenarios. We proposed six variations of the Bergman Minimal Model to capture the physiological effects of moderate exercise on glucose dynamics in individuals with type 1 diabetes. We estimated the parameters of each model with clinical data using a Bayesian approach and Markov chain Monte Carlo methods. The data consisted of measurements of plasma glucose, plasma insulin, and oxygen consumption collected from a study of 17 adults with type 1 diabetes undergoing aerobic exercise sessions. We compared the models based on the physiological plausibility of their parameters estimates and the deviance information criterion. The best model features (i) an increase in glucose effectiveness proportional to exercise intensity, and (ii) an increase in insulin action proportional to exercise intensity and duration. We validated the selected model by reproducing results from two previous clinical studies. The selected model accurately simulates the physiological effects of moderate exercise on glucose dynamics in individuals with type 1 diabetes. This work offers an important tool to develop strategies for exercise management with the artificial pancreas.	[Alkhateeb, Haneen; Ghanbari, Milad] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [El Fathi, Anas] McGill Univ, Dept Elect & Comp Engn, Montreal, PQ, Canada; [Haidar, Ahmad] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Haidar, A (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	ahmad.haidar@mcgill.ca	El Fathi, Anas/AAW-7415-2020; El Fathi, Anas/GYD-9666-2022	El Fathi, Anas/0000-0001-7837-1555; 				Al Khalifah RA, 2016, DIABETIC MED, V33, P1686, DOI 10.1111/dme.13070; [Anonymous], USERS MANUAL YSI 230; Ben Brahim Najib, 2015, J Diabetes Sci Technol, V9, P1185, DOI 10.1177/1932296815607864; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bohn B, 2015, DIABETES CARE, V38, P1536, DOI 10.2337/dc15-0030; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Breton MD, 2014, DIABETES TECHNOL THE, V16, P506, DOI 10.1089/dia.2013.0333; Breton Marc D, 2008, J Diabetes Sci Technol, V2, P169; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Cobelli C, 2006, P DIAB TECHN M ATL G; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Craig E. Taplin, 2018, TYPE 1 DIABETES MELL; Dalla Man Chiara, 2007, J Diabetes Sci Technol, V1, P323; Derouich M, 2002, J BIOMECH, V35, P911, DOI 10.1016/S0021-9290(02)00055-6; DOUEN AG, 1990, FEBS LETT, V261, P256, DOI 10.1016/0014-5793(90)80566-2; Ewings SM, 2015, STAT METHODS MED RES, V24, P342, DOI 10.1177/0962280214520732; Foster NC, 2019, DIABETES TECHNOL THE, V21, P66, DOI 10.1089/dia.2018.0384; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; FUSHIKI T, 1989, AM J PHYSIOL, V256, pE580, DOI 10.1152/ajpendo.1989.256.5.E580; Galassetti PR, 2006, PEDIATR DIABETES, V7, P16, DOI 10.1111/j.1399-543X.2006.00140.x; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE556, DOI 10.1152/ajpendo.1991.261.5.E556; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE795, DOI 10.1152/ajpendo.1991.261.6.E795; GOODYEAR LJ, 1990, AM J PHYSIOL, V258, pE667, DOI 10.1152/ajpendo.1990.258.4.E667; Guelfi KJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE865, DOI 10.1152/ajpendo.00533.2006; Haidar A, 2016, IEEE CONTR SYST MAG, V36, P28, DOI 10.1109/MCS.2016.2584318; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; HANSEN I, 1986, AM J PHYSIOL, V250, pE269, DOI 10.1152/ajpendo.1986.250.3.E269; Harmer AR, 2007, DIABETES CARE, V30, P1269, DOI 10.2337/dc06-1790; Hernandez-Ordonez M, 2008, J BIOMECH, V41, P744, DOI 10.1016/j.jbiomech.2007.11.028; Hobbs Nicole, 2019, J Diabetes Sci Technol, V13, P718, DOI 10.1177/1932296818820550; Hovorka R, 2002, AM J PHYSIOL-ENDOC M, V282, pE992, DOI 10.1152/ajpendo.00304.2001; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Kanderian Sami S, 2009, J Diabetes Sci Technol, V3, P1047; Kim J, 2007, ANN BIOMED ENG, V35, P69, DOI [10.1007/s10439-006-9201-x, 10.1007/s10439-006-9210-x]; Lenart PJ, 2002, IFAC P VOLUMES, V35, P247, DOI [10.3182/20020721-6-ES-1901.01350, DOI 10.3182/20020721-6-ES-1901.01350]; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mallad A, 2015, AM J PHYSIOL-ENDOC M, V308, pE1106, DOI 10.1152/ajpendo.00014.2015; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Man Chiara Dalla, 2009, J Diabetes Sci Technol, V3, P56; McMahon SK, 2007, J CLIN ENDOCR METAB, V92, P963, DOI 10.1210/jc.2006-2263; NESHER R, 1985, AM J PHYSIOL, V249, pC226, DOI 10.1152/ajpcell.1985.249.3.C226; Nguyen TTP, 2019, DIABETES, V68, DOI 10.2337/db19-62-LB; Palumbo MC, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006073; PLOUG T, 1984, AM J PHYSIOL, V247, pE726, DOI 10.1152/ajpendo.1984.247.6.E726; Rabasa-Lhoret R, 2001, DIABETES CARE, V24, P625, DOI 10.2337/diacare.24.4.625; Resalat N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217301; RICHTER EA, 1989, J APPL PHYSIOL, V66, P876; Riddell MC, 2017, LANCET DIABETES ENDO, V5, P377, DOI 10.1016/S2213-8587(17)30014-1; Riddell Michael C, 2015, J Diabetes Sci Technol, V9, P1217, DOI 10.1177/1932296815609370; RIZZA RA, 1982, DIABETES, V31, P663, DOI 10.2337/diabetes.31.8.663; ROMERES D., 2019, AM DIABETES ASS; Roy Anirban, 2007, J Diabetes Sci Technol, V1, P338; Schneider K., 2020, THESIS ETH ZURICH; Shetty VB, 2016, J CLIN ENDOCR METAB, V101, P972, DOI 10.1210/jc.2015-4026; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; Szadkowska A, 2008, DIABETIC MED, V25, P282, DOI 10.1111/j.1464-5491.2007.02357.x; Taleb N, 2016, DIABETOLOGIA, V59, P2561, DOI 10.1007/s00125-016-4107-0; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Visentin Roberto, 2018, J Diabetes Sci Technol, V12, P273, DOI 10.1177/1932296818757747; WALLBERGHENRIKSSON H, 1988, J APPL PHYSIOL, V65, P909, DOI 10.1152/jappl.1988.65.2.909; Wilinska Malgorzata E, 2010, J Diabetes Sci Technol, V4, P132; Xie JY, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4041522; Zaharieva DP, 2019, DIABETES CARE, V42, P824, DOI 10.2337/dc18-2204; ZORZANO A, 1986, AM J PHYSIOL, V251, pE21, DOI 10.1152/ajpendo.1986.251.1.E21	69	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248280	10.1371/journal.pone.0248280	http://dx.doi.org/10.1371/journal.pone.0248280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TU	33770092	Green Published, gold			2022-12-26	WOS:000634833500030
J	Rosenthal, A; Stover, E; Haar, RJ				Rosenthal, Annie; Stover, Eric; Haar, Rohini J.			Health and social impacts of California wildfires and the deficiencies in current recovery resources: An exploratory qualitative study of systems-level issues	PLOS ONE			English	Article							CONSEQUENCES; DISASTER; ILLNESS	Background Wildfires in California have become more deadly and destructive in recent years, and four of the ten most destructive fires occurred in 2017 and 2018. Through interviews with service providers, this article explores how these recent wildfires have impacted surrounding communities and the role various recovery resources have played in responding to the short- and long-term health and social needs of survivors. Methods Using a purposive sampling methodology, we interviewed 21 health and social service personnel who assisted in wildfire recovery efforts in California in 2017 and 2018. The study participants worked or volunteered in medical facilities, social services agencies and philanthropy/nonprofit organizations located in communities affected by wildfires. Participants were asked about three common, overarching themes that fire-impacted communities navigate post-disaster: health issues, social issues, and response and recovery resources. Inductive coding was used to identify common subthemes. Results The two most frequently discussed social issues during interviews were housing and employment access. Mental and emotional well-being and access to health resources were identified as being the most challenging health concerns that survivors face post-disaster. Participants also identified the following private and public recovery resources that survivors use to attempt to restabilize following the fire: community support, county agencies, the Federal Emergency Management Agency (FEMA,) insurance companies and philanthropic organizations. However, participants noted that the cumulative impacts of these efforts still leave many of their patients and clients without the resources needed to restabilize emotionally, financially and physically. Finally, participants spoke about the community-wide, downstream impacts of wildfires, noting that "survivors" are not only those whose health is immediately compromised by the disaster. Conclusion Given the worsening wildfire seasons in California, we must increase our understanding of both the scope of the health and social issues that survivors navigate following a disaster, as well as the effectiveness and sustainability of recovery resources available to survivors. We must also understand the "ripple effect" that wildfires have on surrounding communalities, impacting housing access, social services, and health care access. More research and support, especially during the current COVID-19 pandemic, is urgently needed to improve our ability to support the health and social needs of wildfire survivors in the future.	[Rosenthal, Annie] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA; [Stover, Eric] Univ Calif Berkeley, Sch Law, Human Rights Ctr, Boalt Hall, Berkeley, CA 94720 USA; [Haar, Rohini J.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rosenthal, A (corresponding author), Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA.	Abrosenthal@berkeley.edu		Haar, Rohini/0000-0002-9049-984X; Rosenthal, Annie/0000-0002-7398-0754				Abatzoglou JT, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/aba135; Alexander C., 2019, SFCHRONICLECOM; Alexandre PM, 2015, INT J WILDLAND FIRE, V24, P138, DOI 10.1071/WF13197; American Red C, 2018, CALIFORNIA WILDFIRES; [Anonymous], 2019, TOP 20 DEADLIEST CAL; [Anonymous], 2019, TOP 20 MOST DESTRUCT; [Anonymous], 2019, ESTIMATED RISKS SHOR; [Anonymous], 2019, KSBY NEWS; Camp Fire Butte County Resource Group #CampFire, NEEDHUB; Dohrenwend PB, 2013, WEST J EMERG MED, V14, P79, DOI 10.5811/westjem.2012.10.6917; Dombeck MP, 2004, CONSERV BIOL, V18, P883, DOI 10.1111/j.1523-1739.2004.00491.x; FEMA.gov, INTERIM HOUSING RESO; Fire C, INCIDENTS OVERVIEW; Foundation NVC, CAMP FIRE RECOVERY; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Harnett S., 2018, LOW INCOME COMMUNITI; Johnson C., MOST HOMEOWNERS ARE; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Knutson T., 2017, CLIMATE SCI SPECIAL, V1, DOI DOI 10.7930/J0CJ8BNN; Laugharne J, 2011, CURR OPIN PSYCHIATR, V24, P72, DOI 10.1097/YCO.0b013e32833f5e4e; Leonhardt D., 2020, NEW YORK TIMES; Lindell M.K., 2006, FUNDAMENTALS EMERGEN; Liu JC, 2015, ENVIRON RES, V136, P120, DOI 10.1016/j.envres.2014.10.015; Maida CA., 1989, J TRAUMA STRESS, V2, P37; Marshall GN, 2007, PSYCHIAT SERV, V58, P509, DOI 10.1176/appi.ps.58.4.509; Masson-Delmotte V., 2018, GLOBAL WARMING 1 5 C; McFarlane AC, 1997, SOC PSYCH PSYCH EPID, V32, P261, DOI 10.1007/BF00789038; Nielsen-Pincus M, 2014, FOREST POLICY ECON, V38, P199, DOI 10.1016/j.forpol.2013.08.010; Peacock W.G., 2007, HDB DISASTER RES, P258, DOI DOI 10.1007/978-0-387-32353-4_15; Peacock WG, 2014, J AM PLANN ASSOC, V80, P356, DOI 10.1080/01944363.2014.980440; Proctor CR., 2020, AWWA WATER SCI, V2, DOI DOI 10.1002/AWS2.1183; Program TFaRA, WELCOME FIRE PERIMET; Radeloff VC, 2018, P NATL ACAD SCI USA, V115, P3314, DOI 10.1073/pnas.1718850115; Rezaeian M, 2013, J RES MED SCI, V18, P1103; Schoennagel T, 2017, P NATL ACAD SCI USA, V114, P4582, DOI 10.1073/pnas.1617464114; Sellers F, 2019, WASH POST; United States Environmental Protection A, 2016, PARTICULATE MATTER P; Wettstein ZS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007492; WILSON SH, 1993, PUBLIC HEALTH, V107, P153, DOI 10.1016/S0033-3506(05)80436-6	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0248617	10.1371/journal.pone.0248617	http://dx.doi.org/10.1371/journal.pone.0248617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770088	gold, Green Published			2022-12-26	WOS:000634833500040
J	Jang, S; Ogunmoroti, O; Zhao, D; Fashanu, OE; Tibuakuu, M; Benson, EM; Norby, F; Otvos, JD; Heckbert, SR; Szklo, M; Michos, ED				Jang, Sunyoung; Ogunmoroti, Oluseye; Zhao, Di; Fashanu, Oluwaseun E.; Tibuakuu, Martin; Benson, Eve-Marie; Norby, Faye; Otvos, James D.; Heckbert, Susan R.; Szklo, Moyses; Michos, Erin D.			The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article								Background Emerging evidence has implicated that inflammation contributes to the pathogenesis of atrial fibrillation (AF). GlycA is a novel marker of systemic inflammation with low intra-individual variability and high analytic precision. GlycA has been associated with incident cardiovascular disease (CVD) independent of other inflammatory markers. However, whether GlycA is associated with AF, specifically, has yet to be established. We examined the association between GlycA and AF in a multi-ethnic cohort. Methods We studied 6,602 MESA participants aged 45-85, with no clinical CVD at baseline, with data on GlycA and incident AF. We used multivariable-adjusted Cox models to evaluate the association between GlycA and incident AF. We also examined other inflammatory markers [high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL6) and fibrinogen] and incident AF for comparison. Results The mean (SD) age was 62 (10) years, 53% women. The mean plasma GlycA was 381 (62) mu mol/L. Over median follow-up of 12.9 years, 869 participants experienced AF. There was no statistically significant association between GlycA and incident AF after adjusting for sociodemographics, CVD risk factors, and other inflammatory markers [Hazard Ratio (95% CI) per 1 SD increment in GlycA: 0.97 (0.88-1.06)]. Neither hsCRP nor fibrinogen was associated with incident AF in same model. In contrast, IL-6 was independently associated with incident AF [HR 1.12 per 1 SD increment (1.05-1.19)]. Conclusions Although GlycA has been associated with other CVD types, we found that GlycA was not associated with AF. More research will be required to understand why IL-6 was associated with AF but not GlycA. Clinical trial registration MESA is not a clinical trial. However, the cohort is registered at: URL: https://clinicaltrials.gov/ct2/show/NCT00005487 Unique identifier: NCT00005487.	[Jang, Sunyoung; Ogunmoroti, Oluseye; Zhao, Di; Tibuakuu, Martin; Michos, Erin D.] Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD 21205 USA; [Zhao, Di; Benson, Eve-Marie; Szklo, Moyses; Michos, Erin D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Fashanu, Oluwaseun E.] St Agnes Hosp, Dept Med, Baltimore, MD USA; [Norby, Faye] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Otvos, James D.] Lab Corp Amer Holdings, Morrisville, NC USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Michos, ED (corresponding author), Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD 21205 USA.; Michos, ED (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	edonnell@jhmi.edu	Norby, Faye/FNA-7255-2022	Norby, Faye/0000-0002-1975-0405; Ogunmoroti, Oluseye/0000-0001-5216-2544; Jang, Sunyoung/0000-0002-5836-6094	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, R01 HL127659]; National Center for Advancing Translational Sciences [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]; Blumenthal Scholars Award in Preventive Cardiology at Johns Hopkins University; Dean's Research Fund at Johns Hopkins University School of Medicine	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Blumenthal Scholars Award in Preventive Cardiology at Johns Hopkins University; Dean's Research Fund at Johns Hopkins University School of Medicine	The MESA study was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, and R01 HL127659 from the National Heart, Lung, and Blood Institute (NHLBI), and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from the National Center for Advancing Translational Sciences. EDM and DZ are additionally funded by the Blumenthal Scholars Award in Preventive Cardiology at Johns Hopkins University. SJ was supported by the Dean's Research Fund at Johns Hopkins University School of Medicine. The aforementioned NHBLI funding agency provided financial support of the study for participant recruitment and data collection, as well as support in the form of salaries for authors OO, SRH, MS, and EDM (paid to their respective institution). The aforementioned Johns Hopkins funding source provided support in form of salaries for authors EDM, DZ, and SJ. The commercial affiliation Laboratory Corporation of America Holdings (LabCorp) provided support in the form salary for JDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akinkuolie AO, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003822; Akinkuolie AO, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001221; Alegret JM, 2013, EUR J CLIN INVEST, V43, P324, DOI 10.1111/eci.12047; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Amdur RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148189; Benson EMA, 2018, CLIN CARDIOL, V41, P1439, DOI 10.1002/clc.23069; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Cainzos-Achirica M, 2018, ATHEROSCLEROSIS, V278, P217, DOI 10.1016/j.atherosclerosis.2018.09.034; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Chung CP, 2016, LUPUS, V25, P296, DOI 10.1177/0961203315617842; Duprez DA, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006557; Duprez DA, 2016, CLIN CHEM, V62, P1020, DOI 10.1373/clinchem.2016.255828; Duprez DA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002295; Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928; Ezeigwe A, 2019, ATHEROSCLEROSIS, V282, P91, DOI 10.1016/j.atherosclerosis.2019.01.011; Fashanu OE, 2019, ANGIOLOGY, V70, P737, DOI 10.1177/0003319719845185; da Silva RMFL, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0639-0; Gutierrez A, 2015, J CARDIOVASC PHARM, V66, P523, DOI 10.1097/FJC.0000000000000313; Harada M, 2015, CIRC J, V79, P495, DOI 10.1253/circj.CJ-15-0138; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Jang S, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007067; January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Joshi AA, 2016, CIRC RES, V119, P1242, DOI 10.1161/CIRCRESAHA.116.309637; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marott SCW, 2010, J AM COLL CARDIOL, V56, P789, DOI 10.1016/j.jacc.2010.02.066; Mukamal KJ, 2006, AM J CARDIOL, V98, P75, DOI 10.1016/j.amjcard.2006.01.067; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Navarro SL, 2012, CANCER EPIDEM BIOMAR, V21, P1167, DOI 10.1158/1055-9965.EPI-12-0110; Ormseth MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0646-x; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Pena JM, 2012, EUR HEART J, V33, P531, DOI 10.1093/eurheartj/ehr460; Tibuakuu M, 2019, AIDS, V33, P547, DOI 10.1097/QAD.0000000000002079; Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398; Vella CA, 2017, MED SCI SPORT EXER, V49, P915, DOI 10.1249/MSS.0000000000001179; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Whelton SP, 2014, AM J CARDIOL, V113, P644, DOI 10.1016/j.amjcard.2013.11.009	40	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248644	10.1371/journal.pone.0248644	http://dx.doi.org/10.1371/journal.pone.0248644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765041	gold, Green Published			2022-12-26	WOS:000634832800077
J	Shen, GM; Ou, SY; He, C; Liu, J; He, L				Shen, Guang Mao; Ou, Shi Yuan; He, Chu; Liu, Jie; He, Lin			Full length sequencing reveals novel transcripts of detoxification genes along with related alternative splicing events and lncRNAs in Phyllotreta striolata	PLOS ONE			English	Article							CYTOCHROME-P450; GENERATION; RESISTANCE; ISOFORMS; CABBAGE; PROTEIN	The striped flea beetle, Phyllotreta striolata (Fabricius), damages crops in the Brassicaceae. The genetic data for this pest are insufficient to reveal its insecticide resistance mechanisms or to develop molecular markers for resistance monitoring. We used PacBio Iso-Seq technology to sequence the full-length transcriptome of P. striolata. After isoform sequence clustering and removal of redundant transcripts, a total of 41,293 transcripts were obtained, and 35,640 of these were annotated in the database of gene products. Structure analysis uncovered 4,307 alternative splicing events, and 3,836 sequences were recognized as lncRNAs. Transcripts with the complete coding region of important detoxification enzymes were further classified. There were 57 transcripts of P450s distributed in CYP2, CYP3, CYP4, and Mito CYP clades, 29 transcripts of ESTs from 4 functional groups, 17 transcripts of GSTs classified into 5 families, 51 transcripts of ABCs distributed in 6 families, and 19 transcripts of UGTs. Twenty-five lncRNAs were predicted to be regulators of these detoxification genes. Full-length transcriptome sequencing is an efficient method for molecular study of P. striolata and it is also useful for gene function analysis.	[Shen, Guang Mao; Ou, Shi Yuan; He, Chu; Liu, Jie; He, Lin] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Shen, Guang Mao; Ou, Shi Yuan; Liu, Jie; He, Lin] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China; [Shen, Guang Mao; Ou, Shi Yuan; Liu, Jie; He, Lin] Southwest Univ, State Cultivat Base Crop Stress Biol Southern Mt, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China; Southwest University - China	He, L (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.; He, L (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.; He, L (corresponding author), Southwest Univ, State Cultivat Base Crop Stress Biol Southern Mt, Chongqing, Peoples R China.	helinok@vip.tom.com			National Key R&D Program of China [2017YFD0200900]; Fundamental Research Funds for the Central Universities [SWU115073]; Chongqing Postgraduate Research and Innovation Project [CYS19105]; National Student's Program for Innovation and Entrepreneurship Training Program [X202010635501]	National Key R&D Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chongqing Postgraduate Research and Innovation Project; National Student's Program for Innovation and Entrepreneurship Training Program	This study was funded in part by the National Key R&D Program of China (2017YFD0200900) to GM.S., Fundamental Research Funds for the Central Universities (SWU115073) to GM.S., Chongqing Postgraduate Research and Innovation Project (CYS19105) to L.H., and National Student's Program for Innovation and Entrepreneurship Training Program (X202010635501) to C.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bozzolan F, 2014, INSECT MOL BIOL, V23, P539, DOI 10.1111/imb.12100; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; [陈秀 Chen Xiu], 2020, [植物保护, Plant Protection], V46, P272; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; Gao S, 2016, RNA BIOL, V13, P820, DOI 10.1080/15476286.2016.1197481; Gao Y, 2020, PESTIC BIOCHEM PHYS, V167, DOI 10.1016/j.pestbp.2020.104596; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Ibrahim SS, 2016, INSECT BIOCHEM MOLEC, V68, P23, DOI 10.1016/j.ibmb.2015.10.015; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li XX, 2017, PEST MANAG SCI, V73, P1402, DOI 10.1002/ps.4469; Liang ZK, 2018, INSECT SCI, V25, P726, DOI 10.1111/1744-7917.12472; Liu FL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16057-2; [刘欢 Liu Huan], 2018, [环境昆虫学报, Journal of Environmental Entomology], V40, P461; Liu XX, 2017, MOL ECOL RESOUR, V17, P1243, DOI 10.1111/1755-0998.12670; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Makita Y, 2017, DNA RES, V24, P159, DOI 10.1093/dnares/dsw056; Mason J, 2020, J ECON ENTOMOL, V113, P887, DOI 10.1093/jee/toz355; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Schadt EE, 2010, HUM MOL GENET, V19, pR227, DOI 10.1093/hmg/ddq416; Seong KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23355; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Shi Y, 2018, INSECT BIOCHEM MOLEC, V93, P79, DOI 10.1016/j.ibmb.2017.12.006; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soroka J, 2018, CAN ENTOMOL, V150, P100, DOI 10.4039/tce.2017.60; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan C, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2133-z; Tian Y, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01126; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wan PJ, 2013, PESTIC BIOCHEM PHYS, V107, P360, DOI 10.1016/j.pestbp.2013.10.004; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang XL, 2019, INSECT BIOCHEM MOLEC, V104, P58, DOI 10.1016/j.ibmb.2018.12.005; Wei P, 2020, PEST MANAG SCI, V76, P1142, DOI 10.1002/ps.5627; Wu ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153067; Xiao D, 2015, PEST MANAG SCI, V71, P523, DOI 10.1002/ps.3800; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yang X, 2020, P NATL ACAD SCI USA, V117, P10246, DOI 10.1073/pnas.1913603117; Zhu B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3748-9; Zhu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-174	54	3	3	8	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248749	10.1371/journal.pone.0248749	http://dx.doi.org/10.1371/journal.pone.0248749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760871	Green Published, gold			2022-12-26	WOS:000633030400061
J	Andres, M; Leon-Ramirez, JM; Moreno-Perez, O; Sanchez-Paya, J; Gaya, I; Esteban, V; Ribes, I; Torrus-Tendero, D; Gonzalez-de-la-Aleja, P; Llorens, P; Boix, V; Gil, J; Merino, E				Andres, Mariano; Leon-Ramirez, Jose-Manuel; Moreno-Perez, Oscar; Sanchez-Paya, Jose; Gaya, Ignacio; Esteban, Violeta; Ribes, Isabel; Torrus-Tendero, Diego; Gonzalez-de-la-Aleja, Pilar; Llorens, Pere; Boix, Vicente; Gil, Joan; Merino, Esperanza		COVID19-ALC Res Grp	Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; UNIT; PNEUMONIA; MORTALITY; TRIAGE	Introduction This study analyzed the impact of a categorized approach, based on patients' prognosis, on major outcomes and explanators in patients hospitalized for COVID-19 pneumonia in an academic center in Spain. Methods Retrospective cohort study (March 3 to May 2, 2020). Patients were categorized according to the followed clinical management, as maximum care or limited therapeutic effort (LTE). Main outcomes were all-cause mortality and need for invasive mechanical ventilation (IMV). Baseline factors associated with outcomes were analyzed by multiple logistic regression, estimating odds ratios (OR; 95%CI). Results Thirty-hundred and six patients were hospitalized, median age 65.0 years, 57.8% males, 53.3% Charlson index >= 3. The overall all-cause fatality rate was 15.0% (n = 46). Maximum care was provided in 238 (77.8%), IMV was used in 38 patients (16.0%), and 5.5% died. LTE was decided in 68 patients (22.2%), none received IMV and fatality was 48.5%. Independent risk factors of mortality under maximum care were lymphocytes <790/mm(3), troponin T >15ng/L and hypotension. Advanced age, lymphocytes 240pg/mL independently associated with IMV requirement. Conclusion Overall fatality in the cohort was 15% but markedly varied regarding the decided approach (maximum care versus LTE), translating into nine-fold higher mortality and different risk factors.	[Andres, Mariano] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Rheumatol, Alicante, Spain; [Andres, Mariano; Moreno-Perez, Oscar; Llorens, Pere; Boix, Vicente] Miguel Hernandez Univ, Dept Clin Med, Elche, Spain; [Leon-Ramirez, Jose-Manuel; Gil, Joan] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Pneumol, Alicante, Spain; [Moreno-Perez, Oscar] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Endocrinol & Nutr, Alicante, Spain; [Sanchez-Paya, Jose] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Prevent Med, Alicante, Spain; [Ribes, Isabel; Gonzalez-de-la-Aleja, Pilar] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Internal Med, Alicante, Spain; [Torrus-Tendero, Diego; Boix, Vicente; Merino, Esperanza] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Infect Dis Unit, Alicante, Spain; [Torrus-Tendero, Diego] Miguel Hernandez Univ, Parasitol Area, Elche, Spain; [Llorens, Pere] Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Dept Emergency, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Merino, E (corresponding author), Alicante Gen Univ Hosp, Inst Sanit & Biomed Res ISABIAL, Infect Dis Unit, Alicante, Spain.	merino_luc@gmail.com	García-Manso, Ignacio Gayá/H-2043-2019; Merino, Esperanza/AAV-3244-2021; Villodre, Celia/AAR-3642-2021; Boix, Vicente/AAH-1607-2020; Merino de Lucas, Esperanza/AFQ-1126-2022; Andrés, Mariano/G-7708-2017	García-Manso, Ignacio Gayá/0000-0001-7228-061X; Villodre, Celia/0000-0002-3532-932X; Boix, Vicente/0000-0002-7015-3948; Merino de Lucas, Esperanza/0000-0003-3854-4874; Andrés, Mariano/0000-0002-0219-9055; Ribes, Isabel/0000-0003-1906-0890; Gonzalez de la Aleja, Pilar/0000-0001-9360-7394				[Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 2020, NEW ENGL J MED, DOI [DOI 10.1002/jmv.25685, DOI 10.1056/NEJMC2005203]; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bi QF, 2020, LANCET INFECT DIS, V20, P148, DOI 10.1016/S1473-3099(20)30369-8; Borobia AM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061733; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; Drame M, 2020, J MED VIROL, V92, P2312, DOI 10.1002/jmv.25996; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Garrouste-Orgeas M, 2006, INTENS CARE MED, V32, P1045, DOI 10.1007/s00134-006-0169-7; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guidet B, 2017, JAMA-J AM MED ASSOC, V318, P1450, DOI 10.1001/jama.2017.13889; Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Hausmann LRM, 2009, MED CARE, V47, P1009, DOI 10.1097/MLR.0b013e3181a80fdc; He RY, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104361; Hoffmann M, 2020, CELL, DOI [DOI 10.1016/J.CELL.2020.02.052, 10.1016/j.cell.2020.02.052]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inciardi RM, 2020, JAMA CARDIOL, V5, P819, DOI 10.1001/jamacardio.2020.1096; JI Y, 2020, NEW ENGL J MED, V0008, DOI DOI 10.1016/S2214-109X(20)30068-1; Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Khan S, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00310; LAGUNASRANGEL F, 2020, EUR HEART J-ACUTE CA, DOI DOI 10.1002/JMV.25819; Lescure FX, 2020, LANCET INFECT DIS, V20, P697, DOI 10.1016/S1473-3099(20)30200-0; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Cruz MP, 2021, REV CLIN ESP, V221, P55, DOI [10.1016/j.rce.2020.03.001, 10.1016/j.rceng.2020.03.001]; Qian GQ, 2020, QJM-INT J MED, V113, P474, DOI 10.1093/qjmed/hcaa089; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richardson S, 2020, JAMA, DOI [DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.6775]; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Tersalvi G, 2020, J CARD FAIL, V26, P470, DOI 10.1016/j.cardfail.2020.04.009; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; VINCENT JL, 2020, LANCET GLOB HEALTH, DOI DOI 10.1177/2048872620922788; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248869	10.1371/journal.pone.0248869	http://dx.doi.org/10.1371/journal.pone.0248869			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755683	Green Published, gold			2022-12-26	WOS:000632916600040
J	Kawakami, T; Jensen, MK; Slavney, A; Deane, PE; Milano, A; Raghavan, V; Ford, B; Chu, ET; Sams, AJ; Boyko, AR				Kawakami, Takeshi; Jensen, Meghan K.; Slavney, Andrea; Deane, Petra E.; Milano, Ausra; Raghavan, Vandana; Ford, Brett; Chu, Erin T.; Sams, Aaron J.; Boyko, Adam R.			R-locus for roaned coat is associated with a tandem duplication in an intronic region of USH2A in dogs and also contributes to Dalmatian spotting	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; SELECTION; USHERIN; PIGMENTATION; POPULATION; VARIANTS; COLOR; GENE; EXPRESSION; MUTATION	Structural variations (SVs) represent a large fraction of all genetic diversity, but how this genetic diversity is translated into phenotypic and organismal diversity is unclear. Explosive diversification of dog coat color and patterns after domestication can provide a unique opportunity to explore this question; however, the major obstacle is to efficiently collect a sufficient number of individuals with known phenotypes and genotypes of hundreds of thousands of markers. Using customer-provided information about coat color and patterns of dogs tested on a commercial canine genotyping platform, we identified a genomic region on chromosome 38 that is strongly associated with a mottled coat pattern (roaning) by genome-wide association study. We identified a putative causal variant in this region, an 11-kb tandem duplication (11,131,835-11,143,237) characterized by sequence read coverage and discordant reads of whole-genome sequence data, microarray probe intensity data, and a duplication-specific PCR assay. The tandem duplication is in an intronic region of usherin gene (USH2A), which was perfectly associated with roaning but absent in non-roaned dogs. We detected strong selection signals in this region characterized by reduced nucleotide diversity (pi), increased runs of homozygosity, and extended haplotype homozygosity in Wirehaired Pointing Griffons and Australian Cattle Dogs (typically roaned breeds), as well as elevated genetic difference (F-ST) between Wirehaired Pointing Griffon (roaned) and Labrador Retriever (non-roaned). Surprisingly, all Dalmatians (N = 262) carried the duplication embedded in identical or similar haplotypes with roaned dogs, indicating this region as a shared target of selection during the breed's formation. We propose that the Dalmatian's unique spots were a derived coat pattern by establishing a novel epistatic interaction between roaning "R-locus" on chromosome 38 and an uncharacterized modifier locus. These results highlight the utility of consumer-oriented genotype and phenotype data in the discovery of genomic regions contributing to phenotypic diversity in dogs.	[Kawakami, Takeshi; Jensen, Meghan K.; Slavney, Andrea; Deane, Petra E.; Milano, Ausra; Raghavan, Vandana; Ford, Brett; Chu, Erin T.; Sams, Aaron J.; Boyko, Adam R.] Embark Vet Inc, Boston, MA 02111 USA; [Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Deane, Petra E.] Mascoma LLC, Lallemand Corp, Libanon, NH USA; [Chu, Erin T.] Amazon Web Serv Inc, Seattle, WA USA	Cornell University; Mascoma Corporation	Kawakami, T; Boyko, AR (corresponding author), Embark Vet Inc, Boston, MA 02111 USA.; Boyko, AR (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	adam@embarkvet.com; tkawakami@embarkvet.com	Kawakami, Takeshi/B-9060-2009	Kawakami, Takeshi/0000-0002-9204-6852	Embark Veterinary, Inc.	Embark Veterinary, Inc.	This study was funded by Embark Veterinary, Inc. and the participants that provided DNA and phenotypic information via Embark's web-based platform. The funder only provided financial support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Bhattacharya G, 2002, HEARING RES, V163, P1, DOI 10.1016/S0378-5955(01)00344-6; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charlier C, 1996, MAMM GENOME, V7, P138, DOI 10.1007/s003359900034; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Cho IC, 2011, GENES GENOM, V33, P17, DOI 10.1007/s13258-010-0108-4; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Coile C., 2015, ENCY DOG BREEDS, V3rd, DOI [10.1257/aer.p20151062, DOI 10.1257/AER.P20151062]; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Finch Justin, 2017, Int J Womens Dermatol, V3, P170, DOI 10.1016/j.ijwd.2017.01.003; Fontanesi L, 2010, ANIM GENET, V41, P478, DOI 10.1111/j.1365-2052.2010.02054.x; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Guo YL, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00361; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hedan B, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050386; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Kaelin CB, 2013, ANNU REV ANIM BIOSCI, V1, P125, DOI 10.1146/annurev-animal-031412-103659; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Korberg IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104363; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Little CC., 1957, INHERITANCE COAT COL; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mariat D, 2003, GENET SEL EVOL, V35, P119, DOI 10.1051/gse:2002039; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; Plassais J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09373-w; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sams AJ, 2019, G3-GENES GENOM GENET, V9, P117, DOI 10.1534/g3.118.200836; SCHAIBLE RH, 1976, GENETICS, V83, pS68; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2009, J HERED, V100, pS66, DOI 10.1093/jhered/esp029; Seitz JJ, 1999, MAMM GENOME, V10, P710, DOI 10.1007/s003359901076; Sponenberg D. P., 2001, The genetics of the dog, P61, DOI 10.1079/9780851995205.0061; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Talenti A, 2018, J HERED, V109, P315, DOI 10.1093/jhered/esx093; Vasiliadis Danae, 2020, Canine Med Genet, V7, P3, DOI 10.1186/s40575-020-00082-y; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	50	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248233	10.1371/journal.pone.0248233	http://dx.doi.org/10.1371/journal.pone.0248233			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755696	Green Published, gold			2022-12-26	WOS:000632916600006
J	Zaya, DN; Leicht-Young, SA; Pavlovic, NB; Ashley, MV				Zaya, David N.; Leicht-Young, Stacey A.; Pavlovic, Noel B.; Ashley, Mary V.			Heterospecific pollination by an invasive congener threatens the native American bittersweet, Celastrus scandens	PLOS ONE			English	Article							POLLEN RECEIPT; ALIEN PLANT; GENE FLOW; HYBRIDIZATION; ORBICULATUS; IMPACTS; FITNESS; INTROGRESSION; CONSEQUENCES; COMMUNITIES	Invasive plants have the potential to interfere with native species' reproductive success through a number of mechanisms, including heterospecific pollination and hybridization. This study investigated reproductive interactions between a native North American woody vine (American bittersweet, Celastrus scandens) and an introduced congener (oriental bittersweet, C. orbiculatus). The decline of C. scandens in the eastern portion of its range is coincident with the introduction and spread of C. orbiculatus, and the two species are known to hybridize. The relationship between proximity and floral production of conspecific and heterospecific males on fertilization and hybridization rates was measured at a field site in northwestern Indiana, USA where both species occur and reproduce. We found that the invasive vine had an extreme advantage in both male and female floral production, producing nearly 200 times more flowers per staminate plant and 65 times more flowers per pistillate plant than the native. Using nuclear microsatellite DNA markers we found that hybridization rates were asymmetric; 39% of the C. scandens seeds tested were hybrids, compared to only 1.6% of C. orbiculatus seeds. The asymmetric hybridization rates were likely not solely due to greater abundance of C. orbiculatus pollen because experimental hand crosses revealed that C. scandens had a higher rate (41%) of heterospecific fertilization than C. orbiculatus (2.4%). We previously reported that few hybrids were observed in the wild, and hybrids had greatly reduced fecundity. Thus, in our system, the threat posed by heterospecific pollen is not replacement by hybrids or introgression, but rather asymmetric reproductive interference. Reproductive interference extended to distances as great as 100 meters, thus, efforts to conserve the native species must reduce its exposure to C. orbiculatus over a relatively large spatial scale.	[Zaya, David N.; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60612 USA; [Leicht-Young, Stacey A.; Pavlovic, Noel B.] US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN USA; [Zaya, David N.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Leicht-Young, Stacey A.] RK&K, Baltimore, MD USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of the Interior; United States Geological Survey; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Zaya, DN (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60612 USA.; Zaya, DN (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	dzaya1@illinois.edu		Pavlovic, Noel/0000-0002-2335-2274	University of Illinois at Chicago; United State Geological Survey; Illinois State Academy of Science; National Park Service, through the Great Lakes Research and Education Center; Chicago Wilderness	University of Illinois at Chicago; United State Geological Survey; Illinois State Academy of Science; National Park Service, through the Great Lakes Research and Education Center; Chicago Wilderness	DNZ was awarded funding from the University of Illinois at Chicago. NBP and SALY were awarded funding from the United State Geological Survey. DNZ and MVA were awarded funding from Chicago Wilderness. DNZ was awarded funding from the Illinois State Academy of Science. DNZ was awarded funding from the National Park Service, through the Great Lakes Research and Education Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial entity RK&K provided support in the form of salaries for author SLY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Albrecht M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0773; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 2018, MULTIMODEL INFERENCE; Anttila CK, 1998, AM J BOT, V85, P1597, DOI 10.2307/2446487; Arceo-Gomez G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44626-0; Arceo-Gomez G, 2016, J ECOL, V104, P1003, DOI 10.1111/1365-2745.12586; Arceo-Gomez G, 2016, OIKOS, V125, P718, DOI 10.1111/oik.02594; Ashman TL, 2013, AM J BOT, V100, P1061, DOI 10.3732/ajb.1200496; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Ayres DR, 2008, DIVERS DISTRIB, V14, P187, DOI 10.1111/j.1472-4642.2007.00414.x; Balao F, 2015, NEW PHYTOL, V206, P448, DOI 10.1111/nph.13156; Barbour RC, 2002, NEW FOREST, V23, P177, DOI 10.1023/A:1020389432492; BARNES WJ, 1974, ECOLOGY, V55, P40, DOI 10.2307/1934616; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brizicky GC., 1964, J ARNOLD ARBORETUM, V45, P206; Burgess KS, 2008, NEW PHYTOL, V177, P276, DOI 10.1111/j.1469-8137.2007.02244.x; Burgess KS, 2005, MOL ECOL, V14, P3471, DOI 10.1111/j.1365-294X.2005.02670.x; Burns JH, 2019, NEW PHYTOL, V223, P2063, DOI 10.1111/nph.15935; Butcher PA, 2005, CONSERV GENET, V6, P213, DOI 10.1007/s10592-004-7830-x; Del Tredici Peter, 2014, Arnoldia (Jamaica Plain), V71, P2; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dietzsch AC, 2011, OECOLOGIA, V167, P469, DOI 10.1007/s00442-011-1987-z; DREYER GD, 1987, B TORREY BOT CLUB, V114, P260, DOI 10.2307/2996463; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fike J, 1999, J VEG SCI, V10, P483, DOI 10.2307/3237183; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HOU DING, 1955, ANN MISSOURI BOT GARDEN, V42, P215, DOI 10.2307/2394657; Johnson MG, 2016, CONSERV GENET, V17, P593, DOI 10.1007/s10592-015-0808-z; Leicht SA., 2005, THESIS U CONNECTICUT; Leicht-Young SA, 2007, J TORREY BOT SOC, V134, P441, DOI 10.3159/07-RA-028.1; Leicht-Young SA, 2007, OECOLOGIA, V154, P273, DOI 10.1007/s00442-007-0839-3; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; MARTIN FW, 1970, B TORREY BOT CLUB, V97, P1, DOI 10.2307/2483984; Matsumoto T, 2010, BIOL INVASIONS, V12, P1617, DOI 10.1007/s10530-009-9574-5; McNab W. H., 1987, Northern Journal of Applied Forestry, V4, P174; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Nakagawa S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0213; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Patterson, 1974, THESIS DUKE U; Pavlovic NB, 2011, J TORREY BOT SOC, V138, P85, DOI 10.3159/10-RA-055.1; Pearse IS, 2019, ECOL LETT, V22, P1214, DOI 10.1111/ele.13284; Pooler MR, 2002, SOUTHEAST NAT, V1, P69, DOI 10.1656/1528-7092(2002)001[0069:IHBTNB]2.0.CO;2; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Prentis PJ, 2007, NEW PHYTOL, V176, P902, DOI 10.1111/j.1469-8137.2007.02217.x; R Core Team, 2021, R LANGUAGE ENV STAT; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Seebens H, 2018, P NATL ACAD SCI USA, V115, pE2264, DOI 10.1073/pnas.1719429115; Steward AM, 2003, J TORREY BOT SOC, V130, P143, DOI 10.2307/3557536; Suarez-Marino A, 2019, AM J BOT, V106, P1308, DOI 10.1002/ajb2.1361; Van Drunen WE, 2015, P NATL ACAD SCI USA, V112, P8929, DOI 10.1073/pnas.1501720112; Vila M, 1998, ECOL APPL, V8, P1196, DOI 10.2307/2640972; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wagenius S, 2007, AM NAT, V169, P383, DOI 10.1086/511313; Wesselingh RA, 2007, NEW PHYTOL, V174, P26, DOI 10.1111/j.1469-8137.2007.01997.x; WYMAN DONALD, 1950, ARNOLDIA, V10, P81; Young J., 1992, SEEDS WOODY PLANTS N; Zalapa JE, 2009, AM J BOT, V96, P1116, DOI 10.3732/ajb.0800334; Zaya DN, 2015, BIOL INVASIONS, V17, P2975, DOI 10.1007/s10530-015-0926-z; Zhang D, 2018, R PACKAGE VERSION 1; Zhang DB, 2017, AM STAT, V71, P310, DOI 10.1080/00031305.2016.1256839	63	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248635	10.1371/journal.pone.0248635	http://dx.doi.org/10.1371/journal.pone.0248635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755682	Green Published, gold			2022-12-26	WOS:000632916600002
J	Cao, H; Qiang, L; Chen, J; Johnson, KM; McNiven, MA; Razidlo, GL				Cao, Hong; Qiang, Li; Chen, Jing; Johnson, Katherine M.; McNiven, Mark A.; Razidlo, Gina L.			Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells	PLOS ONE			English	Article								The process by which tumor cells mechanically invade through the surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. Matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation plays an important role in this invasive process. Defining the contribution and interaction between these MMPs during invasion remains a key interest in the development of targeted anti-metastatic therapies. In this study we have utilized multiple different stromal fibroblasts and tumor cells to define the relative contributions between cancer cells and stromal cells during MMP-dependent matrix remodeling and pancreatic (PDAC) tumor cell invasion. We find that tumor cells co-cultured with the conditioned medium from stromal fibroblasts exhibited a substantial increase in invadopodial-based matrix degradation and transwell invasion. This increase is dependent on pro-MMP2 expressed and secreted by stromal fibroblasts. Further, the pro-MMP2 from the stromal fibroblasts is activated by MT1-MMP expressed on the tumor cells. Depletion of MT1-MMP, the known activator of MMP2, in tumor cells largely blocked matrix remodeling, even in the presence of stromal cell medium. In summary, these findings implicate an important interplay between MT1-MMP from tumor cells and MMP2 from fibroblasts as a key component for ECM remodeling and invasion.	[Cao, Hong; Qiang, Li; Chen, Jing; Johnson, Katherine M.; McNiven, Mark A.; Razidlo, Gina L.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Qiang, Li; McNiven, Mark A.; Razidlo, Gina L.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	McNiven, MA; Razidlo, GL (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.; McNiven, MA; Razidlo, GL (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	mcniven.mark@mayo.edu; razidlo.gina@mayo.edu		Razidlo, Gina/0000-0002-9042-2738	National Institutes of Health National Cancer Institute [R01 CA104125]; NIDDK [P30DK084567, P50 CA102701]; Mayo Clinic Sydney Luckman Family Predoctoral Fellowship	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic Sydney Luckman Family Predoctoral Fellowship	This work was supported by R01 CA104125 from National Institutes of Health National Cancer Institute (to M.A. McNiven and G. L. Razidlo), NIDDK P30DK084567 Mayo Clinic Center for Cell Signaling in Gastroenterology, P50 CA102701 Mayo Clinic SPORE in Pancreatic Cancer, and the Mayo Clinic Sydney Luckman Family Predoctoral Fellowship (to L. Qiang). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkasalias T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051532; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Bloomston M, 2002, ANN SURG ONCOL, V9, P668, DOI 10.1245/aso.2002.9.7.668; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cannon Andrew, 2018, Genes Cancer, V9, P78, DOI 10.18632/genesandcancer.171; Cao H, 2016, ONCOGENE, V35, P1099, DOI 10.1038/onc.2015.163; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cui QY, 2018, ONCOL LETT, V16, P3537, DOI 10.3892/ol.2018.9092; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Ellenrieder V, 2000, INT J CANCER, V85, P14, DOI 10.1002/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.3.CO;2-F; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Erdogan B, 2017, J CELL BIOL, V216, P3799, DOI 10.1083/jcb.201704053; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Grunwald B, 2016, MOL CANCER RES, V14, P1147, DOI 10.1158/1541-7786.MCR-16-0180; Guo S, 2018, INT J BIOL SCI, V14, P2083, DOI 10.7150/ijbs.25720; Han XX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05906-x; Horimoto Y, 2012, CELL ADHES MIGR, V6, P193, DOI 10.4161/cam.20631; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Jakubowska K, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/9895721; Juiz NA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00246; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kim D, 2016, MOL MED REP, V14, P277, DOI 10.3892/mmr.2016.5282; Kim DK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214553; Knapinska AM, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020077; Kwa MQ, 2019, CLIN EXP METASTAS, V36, P71, DOI 10.1007/s10585-019-09959-0; Li H, 2017, ONCOL LETT, V14, P5865, DOI 10.3892/ol.2017.6924; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Qiang L, 2019, J CELL BIOL, V218, P317, DOI 10.1083/jcb.201802032; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Ren B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0858-1; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Saha S, 2016, ACS NANO, V10, P10636, DOI 10.1021/acsnano.6b02231; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Schneiderhan W, 2007, J CELL SCI, V120, P512, DOI 10.1242/jcs.03347; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Sun QQ, 2018, THERANOSTICS, V8, P5072, DOI 10.7150/thno.26546; Taguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089605; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248111	10.1371/journal.pone.0248111	http://dx.doi.org/10.1371/journal.pone.0248111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740019	Green Published, gold			2022-12-26	WOS:000631030200012
J	Freitas, PFS; Coelho, AQ; Bruschini, H; Rovner, ES; Gomes, CM				Freitas, Pedro F. S.; Coelho, Augusto Q.; Bruschini, Homero; Rovner, Eric S.; Gomes, Cristiano M.			Severe urinary tract damage secondary to primary bladder neck obstruction in women	PLOS ONE			English	Article								Objective To present the clinical and radiological characteristics of women with severe structural deterioration of the bladder and upper urinary tract secondary to Primary Bladder Neck Obstruction (PBNO), and their outcomes after bladder neck incision (BNI). Methods Retrospective evaluation of adult women who underwent BNI for PBNO at one institution. Patients were assessed for symptoms, renal function, structural abnormalities of the urinary tract and video-urodynamics. PBNO diagnosis was confirmed with video-urodynamics in all patients. BNI was performed at the 4-5 and/or 7-8 o'clock positions. Postoperative symptoms, PVR, uroflowmetry and renal function were evaluated and compared to baseline. Results Median patient age was 56.5 years (range 40-80). All presented with urinary retention-four were on clean intermittent Catheterization (CIC) and two with a Foley catheter. All patients had bladder wall thickening and diverticula. Four women had elevated creatinine levels, bilateral hydronephrosis was present in five (83.3%). After BNI, all patients resumed spontaneous voiding without the need for CIC. Median Qmax significantly improved from 2.0 [1.0-4.0] mL/s to 15 [10-22.7] mL/s (p = 0.031). Median PVR decreased from 150 to 46 [22-76] mL (p = 0.031). There were no postoperative complications. Creatinine levels returned to normal in 3/4 (75%) patients. Conclusion PBNO in women may result in severe damage to the bladder and upper urinary tract. Despite severe structural abnormalities of the bladder, BNI was effective in reducing symptoms and improving structural and functional abnormalities of the lower and upper urinary tract.	[Freitas, Pedro F. S.; Coelho, Augusto Q.; Bruschini, Homero; Gomes, Cristiano M.] Univ Sao Paulo, Dept Urol, Sch Med, Sao Paulo, SP, Brazil; [Rovner, Eric S.] Med Univ South Carolina, Dept Urol, Charleston, SC 29425 USA	Universidade de Sao Paulo; Medical University of South Carolina	Gomes, CM (corresponding author), Univ Sao Paulo, Dept Urol, Sch Med, Sao Paulo, SP, Brazil.	crismgomes@uol.com.br						Abrams P, 1999, BJU INT, V84, P14; Ammirati E, 2017, UROLOG J, V84, P109, DOI 10.5301/uro.5000203; Athanasopoulos A, 2009, INT UROGYNECOL J, V20, P217, DOI 10.1007/s00192-008-0749-x; AXELROD SL, 1987, J UROLOGY, V137, P497, DOI 10.1016/S0022-5347(17)44086-9; Blaivas JG, 2004, J UROLOGY, V171, P1172, DOI 10.1097/01.ju.0000112929.34864.2c; Brucker BM, 2012, UROLOGY, V80, P55, DOI 10.1016/j.urology.2012.04.011; Chassagne S, 1998, UROLOGY, V51, P408, DOI 10.1016/S0090-4295(97)00634-1; DIOKNO AC, 1984, J UROLOGY, V132, P294, DOI 10.1016/S0022-5347(17)49601-7; GRONBAEK K, 1992, SCAND J UROL NEPHROL, V26, P113, DOI 10.1080/00365599.1992.11690441; Hickling D, 2012, CURR UROL REP, V13, P356, DOI 10.1007/s11934-012-0267-8; Hoffman DS, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-016-0586-2; Jin XB, 2012, UROLOGY, V79, P310, DOI 10.1016/j.urology.2011.11.004; Kumar A, 1999, J UROLOGY, V162, P2061, DOI 10.1016/S0022-5347(05)68101-3; Kuo HC, 2005, UROLOGY, V66, P1005, DOI 10.1016/j.urology.2005.05.047; Lemack GE, 2006, NAT CLIN PRACT UROL, V3, P38, DOI 10.1038/ncpuro0378; Markic D, 2014, WIEN KLIN WOCHENSCHR, V126, P217, DOI 10.1007/s00508-014-0502-z; Nitti VW, 1999, J UROLOGY, V161, P1535, DOI 10.1016/S0022-5347(05)68947-1; Peng CH, 2005, UROLOGY, V65, P275, DOI 10.1016/j.urology.2004.09.019; Pischedda A, 2005, UROL INT, V74, P256, DOI 10.1159/000083559; Sussman Rachael D, 2019, Rev Urol, V21, P53; Trockman BA, 1996, J UROLOGY, V156, P1418, DOI 10.1016/S0022-5347(01)65605-2; Zhang P, 2014, UROLOGY, V83, P762, DOI 10.1016/j.urology.2013.10.084	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248938	10.1371/journal.pone.0248938	http://dx.doi.org/10.1371/journal.pone.0248938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740013	gold, Green Published			2022-12-26	WOS:000631030200038
J	Boudreau, V; Reynaud, Q; Denis, A; Colomba, J; Touzet, S; Desjardins, K; Bourdy, SP; Durieu, I; Rabasa-Lhoret, R				Boudreau, Valerie; Reynaud, Quitterie; Denis, Angelique; Colomba, Johann; Touzet, Sandrine; Desjardins, Katherine; Bourdy, Stephanie Poupon; Durieu, Isabelle; Rabasa-Lhoret, Remi			Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period	PLOS ONE			English	Article							LUNG-FUNCTION; ASSOCIATION; TRENDS; ABNORMALITIES	Objective To report the clinical profile associated with G60 and I60 over a 4-year prospective observational period in 2 large cohorts of adult patients with CF. Methods 319 patients were included (210 Canadian and 119 French) and classified according to their inclusion G60 (>= or < 11.1 mmol/L) and the median inclusion I60 (>= or < 24 mU/I). Forced expiratory volume in 1 second (FEV1), body mass index (BMI) were collected on OGTT days. Linear mixed regression models were used to assess the effect of G60 and I60. Results High G60 was not associated to a lower FEV1 at inclusion and the follow-up decline was not higher in the high G60 group (Coefficient [95% CI]: -3.4 [-7.4;0.6], p = 0.0995.). There was no significant association between BMI and G60. Patients with high I60 tended to have a higher mean BMI (+0.5 kg/m(2) [0.0 to 1.1], p = 0.05) but no interaction over time was observed. Conclusions High G60 is not associated with a lower lung function at inclusion nor its decline over a 4-year follow-up. High I60 is slightly associated to a higher weight at inclusion, but not with BMI evolution over time in adult patients.	[Boudreau, Valerie; Colomba, Johann; Desjardins, Katherine; Rabasa-Lhoret, Remi] Montreal Clin Res Inst, Montreal, PQ, Canada; [Boudreau, Valerie; Colomba, Johann; Rabasa-Lhoret, Remi] Univ Montreal, Dept Nutr Med, Montreal, PQ, Canada; [Reynaud, Quitterie; Durieu, Isabelle] Hosp Civils Lyon, Serv Med Interne, Ctr Reference Adulte Mucoviscidose, F-69495 Pierre Benite, France; [Reynaud, Quitterie; Durieu, Isabelle] Univ Lyon, Equipe Accueil Hlth Serv & Performance Res HESPER, Lyon, France; [Denis, Angelique; Touzet, Sandrine; Bourdy, Stephanie Poupon] Hosp Civils Lyon, Pole Sante Publ, Lyon, France; [Denis, Angelique; Touzet, Sandrine; Bourdy, Stephanie Poupon] Univ Lyon, Equipe Accueil Hlth Serv & Performance Res HESPER, Lyon, France; [Rabasa-Lhoret, Remi] Ctr Hosp Univ Montreal, Cyst Fibrosis Clin, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; CHU Lyon; CHU Lyon; Universite de Montreal	Reynaud, Q (corresponding author), Hosp Civils Lyon, Serv Med Interne, Ctr Reference Adulte Mucoviscidose, F-69495 Pierre Benite, France.; Reynaud, Q (corresponding author), Univ Lyon, Equipe Accueil Hlth Serv & Performance Res HESPER, Lyon, France.	quitterie.reynaud@chu-lyon.fr		Touzet, Sandrine/0000-0002-0354-7920	association Vaincre la Mucoviscidose [RC20140501069]; Canadian Cystic Fibrosis Foundation [2883]; Canadian Institute of Health Research; Fonds de recherche du Quebec - Sante scholarships; Direction des relations internationales (DRI) of the Universite de Montreal; J-A DeSeve Diabetes research chair	association Vaincre la Mucoviscidose; Canadian Cystic Fibrosis Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante scholarships(Fonds de la Recherche en Sante du Quebec); Direction des relations internationales (DRI) of the Universite de Montreal; J-A DeSeve Diabetes research chair	This work was supported by a grant to ID from the association Vaincre la Mucoviscidose (#RC20140501069), an operating grant to RRL from the Canadian Cystic Fibrosis Foundation (#2883), and funds to RRL: the Direction des relations internationales (DRI) of the Universite de Montreal and the J-A DeSeve Diabetes research chair. VB was supported by the Canadian Institute of Health Research and by the Fonds de recherche du Quebec - Sante scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman SM, 2016, PEDIATR CLIN N AM, V63, P699, DOI 10.1016/j.pcl.2016.04.009; Boudreau V, 2016, CAN J DIABETES, V40, P466, DOI 10.1016/j.jcjd.2016.08.221; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; Brodsky J, 2011, DIABETES CARE, V34, P292, DOI 10.2337/dc10-1604; Canada CF., 2015, CYST FIBR CAN 2014 2; Colomba J, 2019, J CYST FIBROS, V18, P551, DOI 10.1016/j.jcf.2019.01.009; Coriati A, 2016, ACTA DIABETOL, V53, P359, DOI 10.1007/s00592-015-0791-3; Coriati A, 2016, J CYST FIBROS, V15, P127, DOI 10.1016/j.jcf.2015.03.001; Coriati A, 2014, J CLIN ENDOCR METAB, V99, P1767, DOI 10.1210/jc.2013-2756; Coriati A, 2013, APPL PHYSIOL NUTR ME, V38, P1254, DOI 10.1139/apnm-2013-0022; Costa M, 2007, J CYST FIBROS, V6, P376, DOI 10.1016/j.jcf.2007.02.005; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Frost F, 2018, J CYST FIBROS, V17, P798, DOI 10.1016/j.jcf.2018.05.005; Hameed S, 2010, DIABETES CARE, V33, P221, DOI 10.2337/dc09-1492; Hammana I, 2009, J CYST FIBROS, V8, P128, DOI 10.1016/j.jcf.2008.11.002; Hankinson JL, 1998, EUR RESPIR J, V11, P787; Lanng S, 2001, Paediatr Respir Rev, V2, P253, DOI 10.1053/prrv.2001.0148; Lewis C, 2015, AM J RESP CRIT CARE, V191, P194, DOI 10.1164/rccm.201403-0576OC; Milla CE, 2000, AM J RESP CRIT CARE, V162, P891, DOI 10.1164/ajrccm.162.3.9904075; Moran A, 2018, PEDIATR DIABETES, V19, P64, DOI 10.1111/pedi.12732; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Moran A, 2009, DIABETES CARE, V32, P1783, DOI 10.2337/dc09-0585; Pedreira CC, 2005, PEDIATR PULM, V39, P276, DOI 10.1002/ppul.20162; Prentice B, 2016, EXPERT REV RESP MED, V10, P799, DOI 10.1080/17476348.2016.1190646; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Reynaud Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40592-9; Reynaud Q, 2018, J CYST FIBROS, V17, P400, DOI 10.1016/j.jcf.2017.09.010; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Stephenson AL, 2013, AM J CLIN NUTR, V97, P872, DOI 10.3945/ajcn.112.051409; Vallis M, 2013, CAN J DIABETES, V37, P1, DOI 10.1016/j.jcjd.2013.02.020	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0246897	10.1371/journal.pone.0246897	http://dx.doi.org/10.1371/journal.pone.0246897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735186	gold, Green Published			2022-12-26	WOS:000631029700002
J	Wetherbee, R; Birkemoe, T; Burner, RC; Sverdrup-Thygeson, A				Wetherbee, Ross; Birkemoe, Tone; Burner, Ryan C.; Sverdrup-Thygeson, Anne			Veteran trees have divergent effects on beetle diversity and wood decomposition	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; SAPROXYLIC BEETLES; FOREST MANAGEMENT; DEAD WOOD; LITTER DECOMPOSITION; FUNGAL DIVERSITY; BIODIVERSITY; INSECTS; FIELD; EXCLUSION	Veteran hollow trees are keystone structures in ecosystems and provide important habitat for a diverse set of organisms, many of which are involved in the process of decomposition. Since veteran trees are 'islands' of high biodiversity, they provide a unique system in which to study the relationship between biodiversity and decomposition of wood. We tested this relationship with a balanced experiential design, where we quantified the taxonomic and functional diversity of beetles directly involved in the process of decomposing wood, and measured the decomposition of experimentally added bundles of small diameter wood around 20 veteran trees and 20 nearby young trees in southern Norway. We found that the diversity (both taxonomic and functional) of wood-decomposing beetles was significantly higher around the veteran trees, and beetle communities around veteran trees consisted of species with a greater preference for larger diameter wood. We extracted few beetles from the experimentally added wood bundles, regardless of the tree type that they were placed near, but decomposition rates were significantly lower around veteran trees. We speculate that slower decomposition rates around veteran trees could have been a result of a greater diversity of competing fungi, which has been found to decrease decay rates. Veteran trees provide an ecological legacy within anthropogenic landscapes, enhance biodiversity and influence wood decomposition. Actions to protect veteran trees are urgently needed in order to save these valuable organisms and their associated biodiversity.	[Wetherbee, Ross; Birkemoe, Tone; Burner, Ryan C.; Sverdrup-Thygeson, Anne] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway	Norwegian University of Life Sciences	Wetherbee, R (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.	ross.wetherbee@nmbu.no	Burner, Ryan/AAF-6638-2020; Sverdrup-Thygeson, Anne/AAW-7779-2021; Wetherbee, Ross/HCI-0677-2022	Burner, Ryan/0000-0002-7314-9506; Sverdrup-Thygeson, Anne/0000-0002-3122-2250; 				Angers VA, 2012, CAN J FOREST RES, V42, P157, DOI [10.1139/X11-167, 10.1139/x11-167]; [Anonymous], 2018, INT SCI POL PLATF BI; Axelsson R., 2002, INSEKTS GNAG BARK; Barry KE, 2019, TRENDS ECOL EVOL, V34, P167, DOI 10.1016/j.tree.2018.10.013; Brin A, 2011, J INSECT CONSERV, V15, P653, DOI 10.1007/s10841-010-9364-5; Burner RC., 2021, FOREST ECOL MANAG; CAILLIEZ F, 1983, PSYCHOMETRIKA, V48, P305, DOI 10.1007/BF02294026; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Courbaud B, 2017, METHODS ECOL EVOL, V8, P1347, DOI 10.1111/2041-210X.12773; Cox P, 2001, BIOL FERT SOILS, V33, P246, DOI 10.1007/s003740000315; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; EDMONDS RL, 1989, CAN J FOREST RES, V19, P853, DOI 10.1139/x89-130; Ferro ML, 2014, COLEOPTS BULL, V68, P681, DOI 10.1649/0010-065X-68.4.681; Ferro ML, 2009, COLEOPTS BULL, V63, P239, DOI 10.1649/1141.1; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gillespie MAK, 2017, ECOL EVOL, V7, P1091, DOI 10.1002/ece3.2732; Gossner MM, 2013, CONSERV BIOL, V27, P605, DOI 10.1111/cobi.12023; Gough LA, 2014, BIOL CONSERV, V180, P75, DOI 10.1016/j.biocon.2014.09.034; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Halbritter AH, 2020, METHODS ECOL EVOL, V11, P22, DOI 10.1111/2041-210X.13331; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Heilmann-Clausen J, 2004, FOREST ECOL MANAG, V201, P105, DOI 10.1016/j.foreco.2004.07.010; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jacobsen RM, 2018, FUNCT ECOL, V32, P2571, DOI 10.1111/1365-2435.13196; Jacobsen RM, 2017, FUNGAL ECOL, V29, P76, DOI 10.1016/j.funeco.2017.06.006; Jacobsen RM, 2015, ECOL EVOL, V5, P4896, DOI 10.1002/ece3.1751; Janssen P, 2017, BIOL CONSERV, V205, P1, DOI 10.1016/j.biocon.2016.11.021; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E, DOI [10.1002/ece3.1862 26811775, DOI 10.1002/ECE3.186226811775]; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; Lefcheck JS, 2015, ECOLOGY, V96, P2973, DOI 10.1890/14-1977.1; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Majekova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149270; Melguizo-Ruiz N, 2020, J ANIM ECOL, V89, P334, DOI 10.1111/1365-2656.13101; Moretti M, 2017, FUNCT ECOL, V31, P558, DOI 10.1111/1365-2435.12776; Muller J, 2014, ANIM CONSERV, V17, P154, DOI 10.1111/acv.12075; Muller J, 2015, J APPL ECOL, V52, P753, DOI 10.1111/1365-2664.12421; Muller K., 2018, **DATA OBJECT**; Paillet Y, 2013, FOCUS MANAGING FORES; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parmain G, 2018, INSECT CONSERV DIVER, V11, P100, DOI 10.1111/icad.12234; Pillai P, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2645; Pilskog HE, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev145; R Development Core Team, 2017, R LANG ENV STAT COMP; Rayner A. D. M., 1988, Fungal decomposition of wood. Its biology and ecology.; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Sandstrom J, 2019, J APPL ECOL, V56, P1770, DOI 10.1111/1365-2664.13395; Sarkar D, 2008, USE R, P1; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Seibold S, 2018, FOREST ECOL MANAG, V409, P564, DOI 10.1016/j.foreco.2017.11.052; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; Seibold S, 2015, CONSERV BIOL, V29, P382, DOI 10.1111/cobi.12427; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Sverdrup-Thygeson A., 2011, HULE EIKER HOTSPOT H; Sverdrup-Thygeson A, 2017, FOREST ECOL MANAG, V403, P96, DOI 10.1016/j.foreco.2017.08.003; Sverdrup-Thygeson A, 2010, BIODIVERS CONSERV, V19, P837, DOI 10.1007/s10531-009-9739-7; Sverdrup-Thygeson A, 2009, PENSOFT SER FAUNIST, P13; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Ulyshen MD, 2016, APPL SOIL ECOL, V105, P25, DOI 10.1016/j.apsoil.2016.03.017; Ulyshen MD, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00365.1; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Vavrova P, 2009, FOREST ECOL MANAG, V257, P401, DOI 10.1016/j.foreco.2008.09.017; Vogel S, 2021, INSECT CONSERV DIVER, V14, P132, DOI 10.1111/icad.12442; Wetherbee R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75723-0; Wetherbee R, 2020, ECOL EVOL, V10, P819, DOI 10.1002/ece3.5940; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31066; Zuur AF, 2009, STAT BIOL HLTH, P269	76	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248756	10.1371/journal.pone.0248756	http://dx.doi.org/10.1371/journal.pone.0248756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735317	Green Published, gold			2022-12-26	WOS:000631029700063
J	Wipf, HML; Coleman-Derr, D				Wipf, Heidi M. L.; Coleman-Derr, Devin			Evaluating domestication and ploidy effects on the assembly of the wheat bacterial microbiome	PLOS ONE			English	Article							RNA GENE DATABASE; RHIZOSPHERE MICROBIOME; MYCORRHIZAL FUNGI; ROOT MICROBIOME; GENOME; WILD; POLYPLOIDY; EVOLUTION; TRITICUM; STRESS	While numerous studies implicate the microbiome in host fitness, contributions of host evolution to microbial recruitment remain largely uncharacterized. Past work has shown that plant polyploidy and domestication can influence plant biotic and abiotic interactions, yet impacts on broader microbiome assembly are still unknown for many crop species. In this study, we utilized three approaches-two field studies and one greenhouse-based experiment-to determine the degree to which patterns in bacterial community assembly in wheat (Triticum sp.) roots and rhizospheres are attributable to the host factors of ploidy level (2n, 4n, 6n) and domestication status (cultivated vs. wild). Profiling belowground bacterial communities with 16S rRNA gene amplicon sequencing, we analyzed patterns in diversity and composition. From our initial analyses of a subsetted dataset, we observed that host ploidy level was statistically significant in explaining variation in alpha and beta diversity for rhizosphere microbiomes, as well as correlated with distinct phylum-level shifts in composition, in the field. Using a reduced complexity field soil inoculum and controlled greenhouse conditions, we found some evidence suggesting that genomic lineage and ploidy level influence root alpha and beta diversity (p-value<0.05). However, in a follow-up field experiment using an expanded set of Triticum genomes that included both wild and domesticated varieties, we did not find a strong signal for either diploid genome lineages, domestication status, or ploidy level in shaping rhizosphere bacterial communities. Taken together, these results suggest that while host ploidy and domestication may have some minor influence on microbial assembly, these impacts are subtle and difficult to assess in belowground compartments for wheat varieties. By improving our understanding of the degree to which host ploidy and cultivation factors shape the plant microbiome, this research informs perspectives on what key driving forces may underlie microbiome structuring, as well as where future efforts may be best directed towards fortifying plant growth by microbial means. The greatest influence of the host on the wheat microbiome appeared to occur in the rhizosphere compartment, and we suggest that future work focuses on this environment to further characterize how host genomic and phenotypic changes influence plant-microbe communications.	[Wipf, Heidi M. L.; Coleman-Derr, Devin] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Coleman-Derr, Devin] USDA ARS, Plant Gene Express Ctr, Albany, CA 94710 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Coleman-Derr, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Coleman-Derr, D (corresponding author), USDA ARS, Plant Gene Express Ctr, Albany, CA 94710 USA.	colemanderr@berkeley.edu		Wipf, Edi/0000-0002-1025-9310	US Department of Agriculture [CRIS 2030-21430-008-00D]; NSF-GRFP	US Department of Agriculture(United States Department of Agriculture (USDA)); NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was funded in part by a grant from the US Department of Agriculture (CRIS 2030-21430-008-00D), as well as with support from a NSF-GRFP to HW.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Cardinale M, 2015, ENVIRON MICROBIOL, V17, P239, DOI 10.1111/1462-2920.12686; Carvalhais LC, 2015, MOL PLANT MICROBE IN, V28, P1049, DOI 10.1094/MPMI-01-15-0016-R; Cave-Radet A., PHENANTHRENE CONTAMI, DOI [10.1101/625657, DOI 10.1101/625657]; Chandra A, 2010, PLANT PHYSIOL BIOCH, V48, P27, DOI 10.1016/j.plaphy.2009.10.003; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Compant S, 2019, J ADV RES, V19, P29, DOI 10.1016/j.jare.2019.03.004; De Jesus-Gonzalez L, 2003, PLANT CELL REP, V21, P809, DOI 10.1007/s00299-003-0587-8; Deng BL, 2012, PLANT GROWTH REGUL, V66, P37, DOI 10.1007/s10725-011-9626-6; Deng S., GENOME WIDE ASS STUD, DOI [10.1101/2020.02.21.960377, DOI 10.1101/2020.02.21.960377]; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Fitzpatrick CR, 2018, P NATL ACAD SCI USA, V115, pE1157, DOI 10.1073/pnas.1717617115; Forrester NJ, 2018, ANN BOT-LONDON, V121, P209, DOI 10.1093/aob/mcx121; Griesbach RJ, 1996, PHYTOCHEMISTRY, V42, P361, DOI 10.1016/0031-9422(95)00893-4; Haichar FE, 2014, SOIL BIOL BIOCHEM, V77, P69, DOI 10.1016/j.soilbio.2014.06.017; Hartman K, 2019, BIOCHEM J, V476, P2705, DOI 10.1042/BCJ20180615; He P, 2003, PLANT MOL BIOL, V52, P401, DOI 10.1023/A:1023965400532; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Iannucci A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02124; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jaiswal AK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.604566; Lavania UC, 2012, PLANT J, V71, P539, DOI 10.1111/j.1365-313X.2012.05006.x; Levin D. A, 2002, OX ECOL EV; LEVIN SA, 1990, THEOR POPUL BIOL, V37, P171, DOI 10.1016/0040-5809(90)90034-S; Liu JA, 2010, J MICROBIOL, V48, P728, DOI 10.1007/s12275-010-0139-1; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsuoka Y, 2014, INT REV CEL MOL BIO, V309, P199, DOI 10.1016/B978-0-12-800255-1.00004-1; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Naylor D, 2017, ISME J, V11, P2691, DOI 10.1038/ismej.2017.118; Niwa Y, 2003, ECOTOX ENVIRON SAFE, V55, P70, DOI 10.1016/S0147-6513(02)00095-7; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Perez-Jaramillo JE, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0519-z; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Ponsford JCB., WHOLE GENOME DUPLICA, DOI [10.1101/822726, DOI 10.1101/822726]; Powell AF, 2016, AM J BOT, V103, P1771, DOI 10.3732/ajb.1600060; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Renny-Byfield S, 2014, AM J BOT, V101, P1711, DOI 10.3732/ajb.1400119; Roucou A, 2018, J APPL ECOL, V55, P25, DOI 10.1111/1365-2664.13029; Saleh B, 2008, CR BIOL, V331, P703, DOI 10.1016/j.crvi.2008.06.007; Simmons T, 2018, JOVE-J VIS EXP, DOI 10.3791/57561; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Sudova R, 2014, AM J BOT, V101, P26, DOI 10.3732/ajb.1300262; Sugiyama Shu-ichi, 2006, Grassland Science, V52, P155, DOI 10.1111/j.1744-697X.2006.00062.x; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; TANG CS, 1995, ACS SYM SER, V582, P142; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Tesitelova T, 2013, NEW PHYTOL, V199, P1022, DOI 10.1111/nph.12348; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei F, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01659; Whitehead SR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0034; Zachow C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00415; Zimin AV, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix097	68	8	8	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248030	10.1371/journal.pone.0248030	http://dx.doi.org/10.1371/journal.pone.0248030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735198	Green Published, gold			2022-12-26	WOS:000631029700020
J	Berger, LM; Ferrari, G; Leturcq, M; Panico, L; Solaz, A				Berger, Lawrence M.; Ferrari, Giulia; Leturcq, Marion; Panico, Lidia; Solaz, Anne			COVID-19 lockdowns and demographically-relevant Google Trends: A cross-national analysis	PLOS ONE			English	Article							ECONOMIC RECESSION; GREAT RECESSION; FERTILITY; DIVORCE; COUNTRIES; IMPACT; RATES; POSTPONEMENT; NETHERLANDS; FRANCE	The spread of COVID-19 and resulting local and national lockdowns have a host of potential consequences for demographic trends. While impacts on mortality and, to some extent, short-term migration flows are beginning to be documented, it is too early to measure actual consequences for family demography. To gain insight into potential future consequences of the lockdown for family demography, we use cross-national Google Trends search data to explore whether trends in searches for words related to fertility, relationship formation, and relationship dissolution changed following lockdowns compared to average, pre-lockdown levels in Europe and the United States. Because lockdowns were not widely anticipated or simultaneous in timing or intensity, we exploit variability over time and between countries (and U.S. states). We use a panel event-study design and difference-in-differences methods, and account for seasonal trends and average country-level (or state-level) differences in searches. We find statistically significant impacts of lockdown timing on changes in searches for terms such as wedding and those related to condom use, emergency contraception, pregnancy tests, and abortion, but little evidence of changes in searches related to fertility. Impacts for union formation and dissolution tended to only be statistically significant at the start of a lockdown with a return to average-levels about 2 to 3 months after lockdown initiation, particularly in Europe. Compared to Europe, returns to average search levels were less evident for the U.S., even 2 to 3 months after lockdowns were introduced. This may be due to the fact, in the U.S., health and social policy responses were less demarcated than in Europe, such that economic uncertainty was likely of larger magnitude. Such pandemic-related economic uncertainty may therefore have the potential to slightly increase already existing polarization in family formation behaviours in the U.S. Alongside contributing to the wider literature on economic uncertainty and family behaviors, this paper also proposes strategies for efficient use of Google Trends data, such as making relative comparisons and testing sensitivity to outliers, and provides a template and cautions for their use in demographic research when actual demographic trends data are not yet available.	[Berger, Lawrence M.] Univ Wisconsin, Madison, WI USA; [Ferrari, Giulia; Leturcq, Marion; Panico, Lidia; Solaz, Anne] Inst Natl Etud Demog Ined, Paris, France	University of Wisconsin System; University of Wisconsin Madison	Solaz, A (corresponding author), Inst Natl Etud Demog Ined, Paris, France.	solaz@ined.fr		Panico, Lidia/0000-0001-9291-7622; Solaz, Anne/0000-0001-6421-9093				Aassve A, 2020, SCIENCE, V369, P370, DOI 10.1126/science.abc9520; Abouk R, 2021, PUBLIC HEALTH REP, V136, P245, DOI 10.1177/0033354920976575; Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; Adsera A, 2004, J POPUL ECON, V17, P17, DOI 10.1007/s00148-003-0166-x; Adsera A, 2011, EUR J POPUL, V27, P1, DOI 10.1007/s10680-010-9222-x; Amato PR, 2011, SOC SCI RES, V40, P705, DOI 10.1016/j.ssresearch.2010.12.012; Arenas-Arroyo E., 2020, CANT LEAVE YOU NOW I; Bel L-P., 2020, COVID 19 FAMILY STRE; Bhutta N., 2020, DISPARITIES WEALTH R; Billari F, 2013, ANN M POP ASS AM NEW; Billari FC, 2019, POP STUD-J DEMOG, V73, P297, DOI 10.1080/00324728.2019.1584327; Boberg-Fazlic N., 2017, DIS FERTILITY EVIDEN; Brodeur A, 2021, J ECON SURV, V35, P1007, DOI 10.1111/joes.12423; Brodeur A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104346; Cesare N, 2018, DEMOGRAPHY, V55, P1979, DOI 10.1007/s13524-018-0715-2; Chandra S, 2018, AM J EPIDEMIOL, V187, P2585, DOI 10.1093/aje/kwy153; Cherlin A, 2013, ANN AM ACAD POLIT SS, V650, P214, DOI 10.1177/0002716213500643; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Chowdhury A, 2013, APPL ECON LETT, V20, P255, DOI 10.1080/13504851.2012.689104; Cimentada J., 2020, BEHAV ATTITUDES RESP; Cleveland R.B., 1990, J OFF STAT, V6, P3; Cohen PN, 2014, POPUL RES POLICY REV, V33, P615, DOI 10.1007/s11113-014-9323-z; Coombe J, 2021, SEX TRANSM INFECT, V97, P357, DOI 10.1136/sextrans-2020-054688; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Fischer T, 2006, EUR SOCIOL REV, V22, P519, DOI 10.1093/esr/jcl013; Fokkema T, 2008, DEMOGR RES, V19, P743, DOI 10.4054/DemRes.2008.19.21; Ghei D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200371; Girard V, 2020, POPUL SOCIET, P1; Goldstein JR, 2013, DEMOGR RES, V29, P85, DOI 10.4054/DemRes.2013.29.4; Gonzalez-Val R, 2017, REV ECON HOUSEHOLD, V15, P879, DOI 10.1007/s11150-016-9329-x; HAMPEL FR, 1974, J AM STAT ASSOC, V69, P383, DOI 10.2307/2285666; Hellerstein JK, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2914; Huebener M, 2021, REV ECON HOUSEHOLD, V19, P91, DOI 10.1007/s11150-020-09529-4; IOM International Organisation for Migration, 2020, RET UND AFGH; Kalabikhina I.E., 2020, POPUL EC, V4, P103, DOI [10.3897/popecon.4.e53891, DOI 10.3897/POPECON.4.E53891]; Lambert A., 2020, LOGEMENT TRAVAIL VOI; Leslie E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104241; Luci-Greulich A, 2014, EUR J POPUL, V30, P187, DOI 10.1007/s10680-013-9309-2; Luppi F, 2020, DEMOGR RES, V43, P1399, DOI 10.4054/DemRes.2020.43.47; McLanahan S, 2004, DEMOGRAPHY, V41, P607, DOI 10.1353/dem.2004.0033; Mellon J, 2014, J ELECT PUBLIC OPIN, V24, P45, DOI 10.1080/17457289.2013.846346; Mellon J, 2013, PS-POLIT SCI POLIT, V46, P280, DOI 10.1017/S1049096513000279; Neels K, 2013, INT J PUBLIC HEALTH, V58, P43, DOI 10.1007/s00038-012-0390-9; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Prioux F, 2003, POPULATION, V58, P623, DOI 10.2307/3271310; Rindfuss RR., 1988, 1 BIRTHS AM CHANGES; Rochim AFRF, CHAUVENETS CRITERION; Schaller J, 2013, J POPUL ECON, V26, P1007, DOI 10.1007/s00148-012-0413-0; Schanzenbach DW, 2020, MILBANK Q OPINION, V30; Schneider D, 2017, SOCIOL COMPASS, V11, DOI 10.1111/soc4.12463; Schneider D, 2015, J MARRIAGE FAM, V77, P1144, DOI 10.1111/jomf.12212; Settersten RA, 2020, ADV LIFE COURSE RES, V45, DOI 10.1016/j.alcr.2020.100360; Sobotka T, 2004, POPUL DEV REV, V30, P195, DOI 10.1111/j.1728-4457.2004.010_1.x; Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x; Stephens-Davidowitz S., 2014, HANDS ON GUIDE GOOGL; Susskind D, 2020, OXFORD REV ECON POL, V36, pS1, DOI 10.1093/oxrep/graa036; Tani M., 2020, WORKING PARENTS FINA; Tijdens K, 2020, GLO DISCUSSION PAPER; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Weber I, 2017, P INT AAAI C WEB; Wilde, 2020, COVID 19 FUTURE US F; Zagheni E, 2015, INT J MANPOWER, V36, P13, DOI 10.1108/IJM-12-2014-0261; Ziliak JP, 2021, APPL ECON PERSPECT P, V43, P132, DOI 10.1002/aepp.13099; Zweimuller J, 2019, AEA PAP P	64	3	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248072	10.1371/journal.pone.0248072	http://dx.doi.org/10.1371/journal.pone.0248072			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730055	Green Published, gold			2022-12-26	WOS:000630345000015
J	Brazzola, N; Wohland, J; Patt, A				Brazzola, Nicoletta; Wohland, Jan; Patt, Anthony			Offsetting unabated agricultural emissions with CO2 removal to achieve ambitious climate targets	PLOS ONE			English	Article							GLOBAL WARMING POTENTIALS; MEAN TEMPERATURE INCREASE; GREENHOUSE-GAS EMISSIONS; METHANE EMISSIONS; CARBON-DIOXIDE; MITIGATION; CONSUMPTION; SCENARIO; POLICIES; IMPACTS	The Representative Concentration Pathway 2.6 (RCP2.6), which is broadly compatible with the Paris Agreement's temperature goal by 1.5-2 degrees C, contains substantial reductions in agricultural non-CO2 emissions besides the deployment of Carbon Dioxide Removal (CDR). Failing to mitigate agricultural methane and nitrous oxide emissions could contribute to an overshoot of the RCP2.6 warming by about 0.4 degrees C. We explore using additional CDR to offset alternative agricultural non-CO2 emission pathways in which emissions either remain constant or rise. We assess the effects on the climate of calculating CDR rates to offset agricultural emission under two different approaches: relying on the 100-year global warming potential conversion metric (GWP100) and maintaining effective radiative forcing levels at exactly those of RCP2.6. Using a reduced-complexity climate model, we find that the conversion metric leads to a systematic underestimation of needed CDR, reaching only around 50% of the temperature mitigation needed to remain on the RCP2.6 track. This is mostly because the metric underestimates, in the near term, forcing from short-lived climate pollutants such as methane. We test whether alternative conversion metrics, the GWP20 and GWP*, are more suitable for offsetting purposes, and found that they both lead to an overestimation of the CDR requirements. Under alternative agricultural emissions pathways, holding to RCP2.6 total radiative forcing requires up to twice the amount of CDR that is already included in the RCP2.6. We examine the costs of this additional CDR, and the effects of internalizing these in several agricultural commodities. Assuming an average CDR cost by $150/tCO(2), we find increases in prices of up to 41% for beef, 14% for rice, and 40% for milk in the United States relative to current retail prices. These figures are significantly higher (for beef and rice) under a global scenario, potentially threatening food security and welfare. Although the policy delivers a mechanism to finance the early deployment of CDR, using CDR to offset remaining high emissions may well hit other non-financial constraints and can thus only support, and not substitute, emission reductions.	[Brazzola, Nicoletta; Wohland, Jan; Patt, Anthony] ETH Zurich Swiss Fed Inst Technol, Inst Environm Decis, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Brazzola, N (corresponding author), ETH Zurich Swiss Fed Inst Technol, Inst Environm Decis, Dept Environm Syst Sci, Zurich, Switzerland.	nicoletta.brazzola@usys.ethz.ch		Wohland, Jan/0000-0001-8336-0009; Brazzola, Nicoletta/0000-0002-5041-9972	ETH Postdoctoral Fellowship; ETH Foundation; Uniscientia Foundation	ETH Postdoctoral Fellowship; ETH Foundation; Uniscientia Foundation	J.W. is funded through an ETH Postdoctoral Fellowship and acknowledges support from the ETH Foundation and the Uniscientia Foundation. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2018, NPJ CLIM ATMOS SCI, V1, DOI 10.1038/s41612-018-0026-8; Allen MR, 2016, NAT CLIM CHANGE, V6, P773, DOI [10.1038/nclimate2998, 10.1038/NCLIMATE2998]; Anderson K, 2016, SCIENCE, V354, P182, DOI 10.1126/science.aah4567; [Anonymous], GEOPHYS RES LETT, DOI [10.1029/98GL01855, DOI 10.1029/98GL01855]; [Anonymous], DAIRY SYSTEMS WORLD; Bajzelj B, 2014, NAT CLIM CHANGE, V4, P924, DOI [10.1038/nclimate2353, 10.1038/NCLIMATE2353]; Banejee AV, 2007, J ECON PERSPECT, V21, P141, DOI 10.1257/jep.21.1.141; Barioni LG, 2019, FOOD SECURITY SPECIA; Bennetzen EH, 2016, GLOBAL CHANGE BIOL, V22, P763, DOI 10.1111/gcb.13120; Bertram C, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac3ec; Brodt S, 2014, FIELD CROP RES, V169, P89, DOI 10.1016/j.fcr.2014.09.007; Cain M, 2019, NPJ CLIM ATMOS SCI, V2, DOI 10.1038/s41612-019-0086-4; Denison S, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab4df4; Dennig F, 2015, P NATL ACAD SCI USA, V112, P15827, DOI 10.1073/pnas.1513967112; Edjabou LD, 2013, FOOD POLICY, V39, P84, DOI 10.1016/j.foodpol.2012.12.004; FAO, 2018, FUT FOOD AGR ALT PAT; Fesenfeld LP, 2020, NAT FOOD, V1, DOI 10.1038/s43016-020-0047-4; Forster D, 2018, GLOBAL WARMING 15 C; Forster P., 2018, MITIGATION PATHWAYS, P82; Frank S, 2019, NAT CLIM CHANGE, V9, P66, DOI 10.1038/s41558-018-0358-8; Frank S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03489-1; Frank S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8c83; Fuglestvedt JS, 2003, CLIMATIC CHANGE, V58, P267, DOI 10.1023/A:1023905326842; Fuglestvedt JS, 2000, GEOPHYS RES LETT, V27, P409, DOI 10.1029/1999GL010939; Fujimori S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aad0f7; Fuss S, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabf9f; Gernaat DEHJ, 2015, GLOBAL ENVIRON CHANG, V33, P142, DOI 10.1016/j.gloenvcha.2015.04.010; Gidden MJ, 2019, GEOSCI MODEL DEV, V12, P1443, DOI 10.5194/gmd-12-1443-2019; Hartmann C, 2020, FOOD QUAL PREFER, V80, DOI 10.1016/j.foodqual.2019.103799; Hartmann C, 2017, TRENDS FOOD SCI TECH, V61, P11, DOI 10.1016/j.tifs.2016.12.006; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; Hester RE, 2014, ROYAL SOC CHEM; Honegger M, 2018, CLIM POLICY, V18, P306, DOI 10.1080/14693062.2017.1413322; Huntingford C, 2015, ENVIRON SCI POLICY, V51, P77, DOI 10.1016/j.envsci.2015.03.013; Huppmann D, 2018, NAT CLIM CHANGE, V8, P1027, DOI 10.1038/s41558-018-0317-4; IPCC, 2019, GLOBAL WARMING 15 C; Iqbal MZ, 2019, ECON BULL, V39, P295; Karakurt I, 2012, RENEW ENERG, V39, P40, DOI 10.1016/j.renene.2011.09.006; Kubo M., 2004, Journal of Food Distribution Research, V35, P128; Lauder AR, 2013, INT J GREENH GAS CON, V12, P419, DOI 10.1016/j.ijggc.2012.11.028; Leahy S, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00069; Lomax G, 2015, ENERG POLICY, V78, P125, DOI 10.1016/j.enpol.2014.10.002; Low S, 2022, RISK ANAL, V42, P1965, DOI 10.1111/risa.13565; Low S, 2020, ENERGY RES SOC SCI, V60, DOI 10.1016/j.erss.2019.101326; Lynch J, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab6d7e; Markkanen S, 2019, CLIM POLICY, V19, P827, DOI 10.1080/14693062.2019.1596873; Meadowcroft J, 2013, CLIMATIC CHANGE, V118, P137, DOI 10.1007/s10584-012-0684-1; Millar RJ, 2017, ATMOS CHEM PHYS, V17, P7213, DOI 10.5194/acp-17-7213-2017; Monteiro CA, 2017, APPETITE, V113, P51, DOI 10.1016/j.appet.2017.02.011; Montzka SA, 2011, NATURE, V476, P43, DOI 10.1038/nature10322; Mottet, 2013, TACKLING CLIMATE CHA; Nemet GF, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabff4; Opio C., 2013, GREENHOUSE GAS EMISS; Oswald Y, 2020, NAT ENERGY, V5, P231, DOI 10.1038/s41560-020-0579-8; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parker A, 2016, NAT GEOSCI, V9, P859, DOI 10.1038/ngeo2851; Pearse R, 2014, CARBON MANAG, V5, P325; Pierrehumbert RT, 2014, ANNU REV EARTH PL SC, V42, P341, DOI 10.1146/annurev-earth-060313-054843; Popp A, 2017, GLOBAL ENVIRON CHANG, V42, P331, DOI 10.1016/j.gloenvcha.2016.10.002; Pradhan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062228; Reisinger A, 2018, GLOBAL CHANGE BIOL, V24, P1749, DOI 10.1111/gcb.13975; Reynolds JL, 2018, GLOB SUSTAIN, V1, DOI 10.1017/sus.2018.13; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Rogelj J, 2019, NATURE, V571, P335, DOI 10.1038/s41586-019-1368-z; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Rogelj J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/075003; Rosenzweig C, 2020, NAT FOOD, V1, P94, DOI 10.1038/s43016-020-0031-z; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Shine KP, 2009, CLIMATIC CHANGE, V96, P467, DOI 10.1007/s10584-009-9647-6; Shine KP, 2005, CLIMATIC CHANGE, V68, P281, DOI 10.1007/s10584-005-1146-9; Shoemaker JK, 2013, SCIENCE, V342, P1323, DOI 10.1126/science.1240162; Smith CJ., 2017, FAIR V11 SIMPLE EMIS, DOI [10.5194/gmd-2017-266, DOI 10.5194/GMD-2017-266]; Smith P, 2016, NAT CLIM CHANGE, V6, P42, DOI [10.1038/nclimate2870, 10.1038/NCLIMATE2870]; Smith SJ, 2000, CLIMATIC CHANGE, V44, P445, DOI 10.1023/A:1005584914078; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Thompson DWJ, 2015, J CLIMATE, V28, P6443, DOI 10.1175/JCLI-D-14-00830.1; Tubiello F., 2014, AGR FORESTRY OTHER L; USDA, 2020, USDA ERS MEAT PRICE; van Vuuren DP, 2017, GLOBAL ENVIRON CHANG, V42, P237, DOI 10.1016/j.gloenvcha.2016.05.008; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wirsenius S, 2011, CLIMATIC CHANGE, V108, P159, DOI 10.1007/s10584-010-9971-x; Wollenberg E, 2016, GLOBAL CHANGE BIOL, V22, P3859, DOI 10.1111/gcb.13340; World Bank, 2020, COMMODITY MARKETS	84	3	3	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247887	10.1371/journal.pone.0247887	http://dx.doi.org/10.1371/journal.pone.0247887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730045	gold, Green Published			2022-12-26	WOS:000630345000038
J	Galan-Vasquez, E; Perez-Rueda, E				Galan-Vasquez, Edgardo; Perez-Rueda, Ernesto			A landscape for drug-target interactions based on network analysis	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; NITRIC-OXIDE; INTERACTION PREDICTION; COMMUNITY STRUCTURE; COPPER; FOSTAMATINIB; DISCOVERY; VITAMIN; OPINION; BIOLOGY	In this work, we performed an analysis of the networks of interactions between drugs and their targets to assess how connected the compounds are. For our purpose, the interactions were downloaded from the DrugBank database, and we considered all drugs approved by the FDA. Based on topological analysis of this interaction network, we obtained information on degree, clustering coefficient, connected components, and centrality of these interactions. We identified that this drug-target interaction network cannot be divided into two disjoint and independent sets, i.e., it is not bipartite. In addition, the connectivity or associations between every pair of nodes identified that the drug-target network is constituted of 165 connected components, where one giant component contains 4376 interactions that represent 89.99% of all the elements. In this regard, the histamine H1 receptor, which belongs to the family of rhodopsin-like G-protein-coupled receptors and is activated by the biogenic amine histamine, was found to be the most important node in the centrality of input-degrees. In the case of centrality of output-degrees, fostamatinib was found to be the most important node, as this drug interacts with 300 different targets, including arachidonate 5-lipoxygenase or ALOX5, expressed on cells primarily involved in regulation of immune responses. The top 10 hubs interacted with 33% of the target genes. Fostamatinib stands out because it is used for the treatment of chronic immune thrombocytopenia in adults. Finally, 187 highly connected sets of nodes, structured in communities, were also identified. Indeed, the largest communities have more than 400 elements and are related to metabolic diseases, psychiatric disorders and cancer. Our results demonstrate the possibilities to explore these compounds and their targets to improve drug repositioning and contend against emergent diseases.	[Galan-Vasquez, Edgardo] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Comp & Automatizac, Ciudad Univ, Mexico City, DF, Mexico; [Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Unidad Acad Yucatan, Merida, Yucatan, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Galan-Vasquez, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Comp & Automatizac, Ciudad Univ, Mexico City, DF, Mexico.; Perez-Rueda, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Unidad Acad Yucatan, Merida, Yucatan, Mexico.	edgardo.galan@iimas.unam.mx; ernesto.perez@iimas.unam.mx	Galán-Vásquez, Edgardo/AFP-3050-2022; Perez-Rueda, Ernesto/D-7468-2016	Galán-Vásquez, Edgardo/0000-0002-9165-1241; Perez-Rueda, Ernesto/0000-0002-6879-0673	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Me'xico [IA201221, IN-209620]; CYTED [P918PTE0261]	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Me'xico(Universidad Nacional Autonoma de Mexico); CYTED	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Me ' xico (IA201221 and IN-209620) and CYTED (P918PTE0261). There was no additional external funding received for this study. The funders did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2017, NAT REV DRUG DISCOV, V16, P309, DOI 10.1038/nrd.2016.262; Anighoro A, 2014, J MED CHEM, V57, P7874, DOI 10.1021/jm5006463; [Anonymous], 2009, ENCY NEUROSCIENCE; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Bansal M, 2014, NAT BIOTECHNOL, V32, P1213, DOI 10.1038/nbt.3052; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bost M, 2016, J TRACE ELEM MED BIO, V35, P107, DOI 10.1016/j.jtemb.2016.02.006; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bussel J, 2018, AM J HEMATOL, V93, P921, DOI 10.1002/ajh.25125; Chen HL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/130620; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062975; Chen X, 2020, BRIEF BIOINFORM, V21, P47, DOI 10.1093/bib/bby098; Chen X, 2016, BRIEF BIOINFORM, V17, P696, DOI 10.1093/bib/bbv066; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16; Colson P, 2016, INT J ANTIMICROB AG, V48, P349, DOI 10.1016/j.ijantimicag.2016.07.004; Cook CCH, 1998, ALCOHOL ALCOHOLISM, V33, P317; Cui YZ, 2014, PHYSICA A, V416, P198, DOI 10.1016/j.physa.2014.08.050; Currie KS, 2014, J MED CHEM, V57, P3856, DOI 10.1021/jm500228a; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eustace J, 2015, PHYSICA A, V421, P510, DOI 10.1016/j.physa.2014.11.039; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Institute of Medicine, 2014, DRUG REP REP WORKSHS, DOI [10.17226/18731.https://doi.org/10.17226/18731, DOI 10.17226/18731.HTTPS://DOI.ORG/10.17226/18731]; Iovanovici A, 2014, INT CONF SYST THEO, P815, DOI 10.1109/ICSTCC.2014.6982519; Ishima Y, 2009, DRUG METAB PHARMACOK, V24, P308, DOI 10.2133/dmpk.24.308; Janga SC, 2009, MOL BIOSYST, V5, P1536, DOI [10.1039/b908147j, 10.1039/B908147j]; Junker B. H., 2008, WILEY SERIES BIOINFO; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Klein AB, 2010, NEUROSCIENCE, V169, P1007, DOI 10.1016/j.neuroscience.2010.05.054; Klingerman CM, 2014, SCHIZOPHRENIA BULL, V40, P327, DOI 10.1093/schbul/sbs196; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; LAMBIOTTE R, 2008, ARXIV08121770; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5; Lima AN, 2016, EXPERT OPIN DRUG DIS, V11, P225, DOI 10.1517/17460441.2016.1146250; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu C, 2020, PHYS REP, V846, P1, DOI 10.1016/j.physrep.2019.12.004; Lu JY, 2019, NEUROPSYCHOPHARMACOL, V44, P1123, DOI 10.1038/s41386-019-0332-9; Mahabadi N., 2020, RIBOFLAVIN DEFICIENC; Mancuso C, 2010, J NEUROCHEM, V113, P563, DOI 10.1111/j.1471-4159.2010.06606.x; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mendez-Lucio O, 2016, J MEX CHEM SOC, V60, P168; Meng FL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1057; Mercorelli B, 2018, TRENDS MICROBIOL, V26, P865, DOI 10.1016/j.tim.2018.04.004; Mollison PL, 2000, BRIT J HAEMATOL, V108, P13; Newland A, 2018, IMMUNOTHERAPY-UK, V10, P9, DOI 10.2217/imt-2017-0097; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Read SA, 2019, ADV NUTR, V10, P696, DOI 10.1093/advances/nmz013; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Rossetti G, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0165-9; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Ryall KA, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0055-9; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; Sharma HS., 2003, BLOOD SPINAL CORD BR; Sharma MC, 2005, RES VET SCI, V79, P113, DOI 10.1016/j.rvsc.2004.11.015; Skinner M, 2014, BRIT J PHARMACOL, V171, P2308, DOI 10.1111/bph.12559; Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Vogt I, 2010, MOL INFORM, V29, P10, DOI 10.1002/minf.200900069; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wang R, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3283-6; Wang XY, 2016, PHYSICA A, V462, P569, DOI 10.1016/j.physa.2016.06.096; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wu ZR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01134; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep30750; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhuang QX, 2018, MOL NEUROBIOL, V55, P8059, DOI 10.1007/s12035-018-0976-1	84	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247018	10.1371/journal.pone.0247018	http://dx.doi.org/10.1371/journal.pone.0247018			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730052	Green Published, gold			2022-12-26	WOS:000630345000064
J	Tan, X; Ruppanner, L; Maume, D; Hewitt, B				Tan, Xiao; Ruppanner, Leah; Maume, David; Hewitt, Belinda			Do managers sleep well? The role of gender, gender empowerment and economic development	PLOS ONE			English	Article							TIME-USE; MULTIPLE IMPUTATION; WORK; WOMEN; CONFLICT; EQUALITY; JOB; DISRUPTION; HOUSEWORK; EXPERIENCES	Work demands often disrupt sleep. The stress of higher status theory posits that workers with greater resources often experience greater stress. We extend this theory to sleep and ask: do managers report more disrupted sleep and does this vary by gender and country context? Data come from the 2012 European Social Survey Programme and our sample comprised those currently employed in their prime working age (n = 27,616; age 25-64) in 29 countries. We include country level measures of the Gender Development Index (GDI) and gross domestic product (GDP). We find that workers sleep better, regardless of gender, in countries where women are empowered. For managers, women sleep better as GDI increases and men as GDP increases. Our results suggest that men experience a sleep premium from economic development and women from gender empowerment.	[Tan, Xiao; Ruppanner, Leah; Hewitt, Belinda] Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic, Australia; [Maume, David] Univ Cincinnati, Dept Sociol, Cincinnati, OH USA	University of Melbourne; University System of Ohio; University of Cincinnati	Ruppanner, L (corresponding author), Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic, Australia.	leah.ruppanner@unimelb.edu.au	/AAF-3000-2022; Tan, Xiao/AFH-8084-2022; Tan, Xiao/AAF-2976-2022	/0000-0001-9210-439X; Tan, Xiao/0000-0001-9210-439X; Tan, Xiao/0000-0001-9210-439X	Australian Research Council [DP180101217]	Australian Research Council(Australian Research Council)	This project is funded by the Australian Research Council DP180101217.	Aazami S, 2016, IND HEALTH, V54, P50, DOI 10.2486/indhealth.2015-0086; Aguiar M, 2013, AM ECON REV, V103, P1664, DOI 10.1257/aer.103.5.1664; Antillon M, 2014, ECON HUM BIOL, V14, P22, DOI 10.1016/j.ehb.2014.03.003; Asgeirsdottir TL, 2016, ECON HUM BIOL, V20, P90, DOI 10.1016/j.ehb.2015.11.001; Bakker AB, 2004, WORK OCCUPATION, V31, P345, DOI 10.1177/0730888404266349; Barnes CM, 2012, PERS PSYCHOL, V65, P789, DOI 10.1111/peps.12002; Baxter J, 2008, AUST J SOC ISSUES, V43, P195, DOI 10.1002/j.1839-4655.2008.tb00098.x; Billing YD, 2011, GENDER WORK ORGAN, V18, P298, DOI 10.1111/j.1468-0432.2010.00546.x; Binns J, 2010, REVEALING AND CONCEALING GENDER: ISSUES OF VISIBILITY IN ORGANIZATIONS, P158; Blair-Loy M., 2003, COMPETING DEVOTIONS; Burgard SA, 2013, AM SOCIOL REV, V78, P51, DOI 10.1177/0003122412472048; Burgard SA, 2009, J HEALTH SOC BEHAV, V50, P476, DOI 10.1177/002214650905000407; Carter NM, 2010, HARVARD BUS REV, V88, P19; Chatzitheochari S, 2009, WORK EMPLOY SOC, V23, P30, DOI 10.1177/0950017008099776; Cohen PN, 2009, WORK OCCUPATION, V36, P318, DOI 10.1177/0730888409347582; Craig L, 2011, AM SOCIOL REV, V76, P834, DOI 10.1177/0003122411427673; Dahlin J, 2013, SOC SCI MED, V98, P24, DOI 10.1016/j.socscimed.2013.08.028; DePasquale N, 2019, GERONTOLOGIST, V59, P474, DOI 10.1093/geront/gnx185; Dilli S, 2019, FEM ECON, V25, P31, DOI 10.1080/13545701.2018.1442582; Drechsler J, 2015, J EDUC BEHAV STAT, V40, P69, DOI 10.3102/1076998614563393; Dregan A, 2011, INT PSYCHOGERIATR, V23, P1413, DOI 10.1017/S1041610211000664; Dregan A, 2009, SOC SCI MED, V69, P1432, DOI 10.1016/j.socscimed.2009.08.041; Eagly AH, 2003, LEADERSHIP QUART, V14, P807, DOI 10.1016/j.leaqua.2003.09.004; Fan W, 2019, J VOCAT BEHAV, V100, P102, DOI 10.1016/j.jvb.2018.10.017; Fuwa M, 2004, AM SOCIOL REV, V69, P751, DOI 10.1177/000312240406900601; Garey AI., 1995, QUAL SOCIOL, V18, P415; Hafner Marco, 2017, Rand Health Q, V6, P11; Hankins M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-355; Hislop J, 2003, SOCIOLOGY, V37, P695, DOI 10.1177/00380385030374004; Hook JL, 2012, J FAM ISSUES, V33, P415, DOI 10.1177/0192513X11425779; Hopcroft RL, 2007, SOC FORCES, V85, P1483, DOI 10.1353/sof.2007.0071; Hyyppa MT, 1997, SOC SCI MED, V45, P731, DOI 10.1016/S0277-9536(96)00407-8; International Labour Office, 2012, INT STANDARD CLASSIF, V1; Jeffrey K, 2015, EUROPEANS PERSONAL S; Jyrkinen M, 2012, WORK EMPLOY SOC, V26, P61, DOI 10.1177/0950017011426313; Kalousova L, 2019, SLEEP HEALTH, V5, P113, DOI 10.1016/j.sleh.2018.11.002; Killewald A, 2010, SOC SCI RES, V39, P987, DOI 10.1016/j.ssresearch.2010.08.005; Klasen S, 2011, FEM ECON, V17, P1, DOI 10.1080/13545701.2010.541860; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Lallukka T, 2010, J SLEEP RES, V19, P466, DOI 10.1111/j.1365-2869.2010.00821.x; las Heras M., 2017, WOMEN MANAGEMENT WOR, P85; Lowson E, 2013, SLEEP BIOL RHYTHMS, V11, P7, DOI 10.1111/j.1479-8425.2012.00585.x; Mai QD, 2019, SOC SCI MED, V237, DOI 10.1016/j.socscimed.2019.112424; Maume DJ, 2018, J MARRIAGE FAM, V80, P1040, DOI 10.1111/jomf.12488; Maume DJ, 2010, GENDER SOC, V24, P746, DOI 10.1177/0891243210386949; Maume DJ, 2009, AM SOCIOL REV, V74, P989, DOI 10.1177/000312240907400607; Maume DJ, 2001, AM BEHAV SCI, V44, P1137, DOI 10.1177/00027640121956692; Niekamp P, 2019, HEALTH ECON, V28, P437, DOI 10.1002/hec.3849; O'Neil DA, 2008, J BUS ETHICS, V80, P727, DOI 10.1007/s10551-007-9465-6; Pearlin L.I., 1983, PSYCHOSOCIAL STRESS, P3, DOI DOI 10.1016/B978-0-12-397560-7.50006-4; Perales F, 2017, SOC SCI RES, V62, P189, DOI 10.1016/j.ssresearch.2016.08.006; Rosekind MR, 2010, J OCCUP ENVIRON MED, V52, P91, DOI 10.1097/JOM.0b013e3181c78c30; Ruppanner L, 2012, WORK EMPLOY SOC, V26, P638, DOI 10.1177/0950017012445106; Ruppanner LE, 2010, SOC SCI RES, V39, P963, DOI 10.1016/j.ssresearch.2010.04.002; Schieman S, 2008, WORK OCCUPATION, V35, P296, DOI 10.1177/0730888408322448; Schieman S, 2006, J HEALTH SOC BEHAV, V47, P242, DOI 10.1177/002214650604700304; Schieman S, 2009, AM SOCIOL REV, V74, P966, DOI 10.1177/000312240907400606; Schieman S, 2009, SOC SCI MED, V69, P1616, DOI 10.1016/j.socscimed.2009.08.038; Shapiro M, 2008, J CAREER DEV, V34, P309, DOI 10.1177/0894845307311250; Sullivan SE, 2007, RES OCCUP STRESS WEL, V6, P205, DOI 10.1016/S1479-3555(06)06006-9; Treas J, 2016, SEX ROLES, V74, P495, DOI 10.1007/s11199-015-0575-9; UNDP, 2019, INCOME AVERAGES TODA; van Buuren S, 2010, EUR ASSOC METHODOL S, P173; van de Straat V, 2015, INT J PUBLIC HEALTH, V60, P643, DOI 10.1007/s00038-015-0682-y; Van de Velde S, 2013, SOCIOL HEALTH ILL, V35, P682, DOI 10.1111/j.1467-9566.2012.01521.x; Venn S, 2008, BRIT J SOCIOL, V59, P79, DOI 10.1111/j.1468-4446.2007.00183.x; Wilson F., 2017, WOMEN MANAGEMENT WOR, P107	67	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247515	10.1371/journal.pone.0247515	http://dx.doi.org/10.1371/journal.pone.0247515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730047	gold, Green Published			2022-12-26	WOS:000630345000018
J	Cho, H; Shim, WJ; Liu, YM; Shan, SO				Cho, Hyunju; Shim, Woo Jun; Liu, Yumeng; Shan, Shu-ou			J-domain proteins promote client relay from Hsp70 during tail-anchored membrane protein targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; ATPASE ACTIVITY; CHAPERONE YDJ1; SUBSTRATE; COCHAPERONE; NETWORK; DNAK; TRANSLOCATION; MECHANISM; INSERTION	J-domain proteins (JDPs) play essential roles in Hsp70 function by assisting Hsp70 in client trapping and regulating the Hsp70 ATPase cycle. Here, we report that JDPs can further enhance the targeting competence of Hsp70-bound client proteins during tail-anchored protein (TA) biogenesis. In the guided-entry-of-tail-anchored protein pathway in yeast, nascent TAs are captured by cytosolic Hsp70 and sequentially relayed to downstream chaperones, Sgt2 and Get3, for delivery to the ER. We found that two JDPs, Ydj1 and Sis1, function in parallel to support TA targeting to the ER in vivo. Biochemical analyses showed that, while Ydj1 and Sis1 differ in their ability to assist Hsp70 in TA trapping, both JDPs enhance the transfer of Hsp70-bound TAs to Sgt2. The ability of the JDPs to regulate the ATPase cycle of Hsp70 is essential for enhancing the transfer competence of Hsp70-bound TAs in vitro and for supporting TA insertion in vivo. These results demonstrate a role of JDPs in regulating the conformation of Hsp70-bound clients during membrane protein biogenesis.	[Cho, Hyunju; Shim, Woo Jun; Liu, Yumeng; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu		Shim, Woo Jun/0000-0001-9596-7393	NIH [R01 GM107368, R35 GM136321]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01 GM107368 and R35 GM136321 to S. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aprile FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08324-z; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Banerjee R, 2016, FEBS J, V283, P2853, DOI 10.1111/febs.13769; Barthel TK, 2001, J BACTERIOL, V183, P5482, DOI 10.1128/JB.183.19.5482-5490.2001; Becker J, 1996, MOL CELL BIOL, V16, P4378; Becker T, 2019, TRENDS CELL BIOL, V29, P534, DOI 10.1016/j.tcb.2019.03.007; Borgese N, 2019, PROTEIN J, V38, P289, DOI 10.1007/s10930-019-09845-4; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; Chio US, 2017, ANNU REV CELL DEV BI, V33, P417, DOI 10.1146/annurev-cellbio-100616-060839; Cho HJ, 2018, EMBO J, V37, DOI 10.15252/embj.201899264; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Craig EA, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0474-3; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Gowda NKC, 2018, NAT STRUCT MOL BIOL, V25, P83, DOI 10.1038/s41594-017-0008-2; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Imamoglu R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14245-4; Jiang YJ, 2019, SCIENCE, V365, P1313, DOI 10.1126/science.aax1280; Jores T, 2018, J CELL BIOL, V217, P3091, DOI 10.1083/jcb.201712029; Kampinga HH, 2019, CELL STRESS CHAPERON, V24, P7, DOI 10.1007/s12192-018-0948-4; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Krantz KC, 2013, J BIOL CHEM, V288, P26721, DOI 10.1074/jbc.M113.491753; Lai AL, 2017, J BIOL CHEM, V292, P8773, DOI 10.1074/jbc.M116.770404; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Opalinski L, 2018, CELL REP, V25, P2036, DOI 10.1016/j.celrep.2018.10.083; Papic D, 2013, MOL CELL BIOL, V33, P4083, DOI 10.1128/MCB.00227-13; Powis K, 2013, J CELL SCI, V126, P473, DOI 10.1242/jcs.112151; Rao M, 2016, ELIFE, V5, DOI 10.7554/eLife.21301; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2010, MOL CELL BIOL, V30, P33, DOI 10.1128/MCB.00842-09; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; WALL D, 1994, J BIOL CHEM, V269, P5446; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Weyer FA, 2017, NAT STRUCT MOL BIOL, V24, P144, DOI 10.1038/nsmb.3349; Wu S, 2020, P NATL ACAD SCI USA, V117, P7814, DOI 10.1073/pnas.1914376117; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412	59	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100546	10.1016/j.jbc.2021.100546	http://dx.doi.org/10.1016/j.jbc.2021.100546			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741343	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400519
J	Tholen, LE; Bos, C; Jansen, PWTC; Venselaar, H; Vermeulen, M; Hoenderop, JGJ; de Baaij, JHF				Tholen, Lotte E.; Bos, Caro; Jansen, Pascal W. T. C.; Venselaar, Hanka; Vermeulen, Michiel; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.			Bifunctional protein PCBD2 operates as a co-factor for hepatocyte nuclear factor 1 beta and modulates gene transcription	FASEB JOURNAL			English	Article						hepatocyte nuclear factor 1&#946; pterin&#8208; 4a&#8208; carbinolamine dehydratase 2; transcription co&#8208; factor		Hepatocyte nuclear factor 1 beta (HNF1 beta) is an essential transcription factor in development of the kidney, liver, and pancreas. HNF1 beta-mediated transcription of target genes is dependent on the cell type and the development stage. Nevertheless, the regulation of HNF1 beta function by enhancers and co-factors that allow this cell-specific transcription is largely unknown. To map the HNF1 beta interactome we performed mass spectrometry in a mouse kidney inner medullary collecting duct cell line. Pterin-4a-carbinolamine dehydratase 2 (PCBD2) was identified as a novel interaction partner of HNF1 beta. PCBD2 and its close homolog PCBD1 shuttle between the cytoplasm and nucleus to exert their enzymatic and transcriptional activities. Although both PCBD proteins share high sequence identity (48% and 88% in HNF1 recognition helix), their tissue expression patterns are unique. PCBD1 is most abundant in kidney and liver while PCBD2 is also abundant in lung, spleen, and adipose tissue. Using immunolocalization studies and biochemical analysis we show that in presence of HNF1 beta the nuclear localization of PCBD1 and PCBD2 increases significantly. Promoter luciferase assays demonstrate that co-factors PCBD1 and PCBD2 differentially regulate the ability of HNF1 beta to activate the promoters of transcriptional targets important in renal electrolyte homeostasis. Deleting the N-terminal sequence of PCBD2, not found in PCBD1, diminished the differential effects of the co-factors on HNF1 beta activity. All together these results indicate that PCBD1 and PCBD2 can exert different effects on HNF1 beta-mediated transcription. Future studies should confirm whether these unique co-factor activities also apply to HNF1 beta-target genes involved in additional processes besides ion transport in the kidney.	[Tholen, Lotte E.; Bos, Caro; Hoenderop, Joost G. J.; de Baaij, Jeroen H. F.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Jansen, Pascal W. T. C.; Vermeulen, Michiel] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci,Oncode Inst, Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Radboud Inst Mol Life Sci, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	de Baaij, JHF (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	jeroen.debaaij@radboudumc.nl	de Baaij, Jeroen/P-5704-2015; Vermeulen, Michiel/C-8883-2013; Bos, Caro/V-2390-2017	de Baaij, Jeroen/0000-0003-2372-8486; Vermeulen, Michiel/0000-0003-0836-6894; Bos, Caro/0000-0001-5016-9435; Tholen, Lotte/0000-0003-2838-8636	Nierstichting (Dutch Kidney Foundation) [17OKG07]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [Veni 016.186.012, Vici 016.130.668]; KWF Kankerbestrijding (Dutch Cancer Society)	Nierstichting (Dutch Kidney Foundation); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); KWF Kankerbestrijding (Dutch Cancer Society)	Nierstichting (Dutch Kidney Foundation), Grant/Award Number: 17OKG07; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: Veni 016.186.012 and Vici 016.130.668; KWF Kankerbestrijding (Dutch Cancer Society)	Aboudehen K, 2017, J AM SOC NEPHROL, V28, P2887, DOI 10.1681/ASN.2016101095; Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Adam M, 2017, DEVELOPMENT, V144, P3625, DOI 10.1242/dev.151142; Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Choi YH, 2013, AM J PHYSIOL-RENAL, V305, pF100, DOI 10.1152/ajprenal.00582.2012; CITRON BA, 1992, P NATL ACAD SCI USA, V89, P11891, DOI 10.1073/pnas.89.24.11891; CITRON BA, 1993, AM J HUM GENET, V53, P768; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Desgrange A, 2017, DEVELOPMENT, V144, P4704, DOI 10.1242/dev.154336; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dudziak K, 2008, KIDNEY INT, V74, P210, DOI 10.1038/ki.2008.149; Ferre S, 2014, J AM SOC NEPHROL, V25, P574, DOI 10.1681/ASN.2013040337; Ferre S, 2011, BIOCHEM BIOPH RES CO, V404, P284, DOI 10.1016/j.bbrc.2010.11.108; FICNER R, 1995, EMBO J, V14, P2034, DOI 10.1002/j.1460-2075.1995.tb07195.x; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029; Kompatscher A, 2018, AM J PHYSIOL-RENAL, V315, pF27, DOI 10.1152/ajprenal.00601.2017; Kompatscher A, 2017, KIDNEY INT, V92, P1145, DOI 10.1016/j.kint.2017.03.034; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Meyer AH, 2002, J NEUROSCI, V22, P7055; Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x; Muto Y., 2020, SINGLE CELL TRANSCRI, DOI [10.1101/2020.06.14.151167, DOI 10.1101/2020.06.14.151167]; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rho H, 2010, BIOCHEMISTRY-US, V49, P10187, DOI 10.1021/bi1015056; Rose RB, 2004, BIOCHEMISTRY-US, V43, P7345, DOI 10.1021/bi049620t; Rose RB, 2000, NAT STRUCT BIOL, V7, P744; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Thony B, 1998, AM J HUM GENET, V62, P1302, DOI 10.1086/301887; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; Verhave JC, 2016, J AM SOC NEPHROL, V27, P345, DOI 10.1681/ASN.2015050544; Von Strandmann EP, 2000, MECH DEVELOP, V91, P53, DOI 10.1016/S0925-4773(99)00269-5; VONSTRANDMANN EP, 1995, DEVELOPMENT, V121, P1217; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang DL, 2015, J BIOL CHEM, V290, P4319, DOI 10.1074/jbc.M114.616870; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Zhang DL, 2019, EUR REV MED PHARMACO, V23, P2417, DOI 10.26355/eurrev_201903_17388	51	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21366	10.1096/fj.202002022R	http://dx.doi.org/10.1096/fj.202002022R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749890	Green Published			2022-12-26	WOS:000635216100018
J	Motta, LP; da Silva, PPF; Borguezan, BM; do Amaral, JLM; Milagres, LG; Boia, MN; Ferraz, MR; Mogami, R; Nunes, RA; de Melo, PL				Motta, Leonardo Pereira; Ferreira da Silva, Pedro Paulo; Borguezan, Bruno Max; Machado do Amaral, Jorge Luis; Milagres, Lucimar Goncalves; Boia, Marcio Neves; Ferraz, Marcos Rochedo; Mogami, Roberto; Nunes, Rodolfo Acatauassu; de Melo, Pedro Lopes			An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application	PLOS ONE			English	Article							VALUES	Background COVID-19 is characterized by a rapid change in the patient's condition, with major changes occurring over a few days. We aimed to develop and evaluate an emergency system for monitoring patients with COVID-19, which may be useful in hospitals where more severe patients stay in their homes. Methodology/Principal findings The system consists of the home-based patient unit, which is set up around the patient and the hospital unit, which enables the medical staff to telemonitor the patient's condition and help to send medical recommendations. The home unit allows the data transmission from the patient to the hospital, which is performed using a cell phone application. The hospital unit includes a virtual instrument developed in LabVIEW((R)) environment that can provide a real-time monitoring of the oxygen saturation (SpO(2)), beats per minute (BPM), body temperature (BT), and peak expiratory flow (PEF). Abnormal events may be fast and automatically identified. After the design details are described, the system is validated by a 30-day home monitoring study in 12 controls and 12 patients with COVID-19 presenting asymptomatic to mild disease. Patients presented reduced SpO(2) (p<0.0001) and increased BPM values (p<0.0001). Three patients (25%) presented PEF values between 50 and 80% of the predicted. Three of the 12 monitored patients presented events of desaturation (SpO(2)<92%). The experimental results were in close agreement with the involved pathophysiology, providing clear evidence that the proposed system can be a useful tool for the remote monitoring of patients with COVID-19. Conclusions An emergency system for home monitoring of patients with COVID-19 was developed in the current study. The proposed system allowed us to quickly respond to early abnormalities in these patients. This system may contribute to conserving hospital resources for those most in need while simultaneously enabling early recognition of patients under acute deterioration, requiring urgent assessment.	[Motta, Leonardo Pereira; Ferreira da Silva, Pedro Paulo; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Motta, Leonardo Pereira; Ferreira da Silva, Pedro Paulo; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [Borguezan, Bruno Max; Milagres, Lucimar Goncalves; Boia, Marcio Neves; Mogami, Roberto; Nunes, Rodolfo Acatauassu] Univ Estado Rio De Janeiro, Fac Med Sci, Rio De Janeiro, Brazil; [Machado do Amaral, Jorge Luis] Univ Estado Rio De Janeiro, Dept Elect & Telecommun Engn, Rio De Janeiro, Brazil; [Ferraz, Marcos Rochedo] Univ Estado Rio De Janeiro, Inst Biol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil.	plopes@uerj.br	milagres, lucimar g/K-7072-2012; Melo, Pedro/E-8440-2011	milagres, lucimar g/0000-0002-0860-818X; Melo, Pedro/0000-0002-2081-6619	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/010.000166/2020, 210.099/2020]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [409380/2018-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LPM, PPFS, BMB, JLMA, LGM, MNB, MRF, RM, RAN, PLM received funding from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ under grant E-26/010.000166/2020, http://www.faperj.br/.PLM received funding from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ under grant 210.099/2020, http://www.faperj.br/.PLM received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico under grant 409380/2018-0, http://www.cnpq.br/.PLM also received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, https://www.gov.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altalag A., 2019, PULMONARY FUNCTION T; Annis T, 2020, J AM MED INFORM ASSN, V27, P1326, DOI 10.1093/jamia/ocaa097; Bashshur R, 2020, TELEMED E-HEALTH, V26, P571, DOI 10.1089/tmj.2020.29040.rb; Bielecki M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101832; Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5; Drewry AM, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03186-w; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Gerald LB, PEAK EXPIRATORY FLOW; Goldberg S, 2001, CHEST, V120, P482, DOI 10.1378/chest.120.2.482; Graham LE, 2003, TROP DOCT, V33, P36, DOI 10.1177/004947550303300118; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1182; Grutters LA, 2020, J AM MED INFORM ASSN, V27, P1825, DOI 10.1093/jamia/ocaa168; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Hall JE, GUYTON HALL TXB MED, P206; Hsiao SH, 2020, J HOSP INFECT, V105, P360, DOI 10.1016/j.jhin.2020.04.004; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; IGNACIOGARCIA JM, 1995, AM J RESP CRIT CARE, V151, P353, DOI 10.1164/ajrccm.151.2.7842191; Jennifer Y. S., 2016, COPD-J COPD FDN, V3, P398; LEINER GC, 1963, AM REV RESPIR DIS, V88, P644; Lenfant C., 1991, J ALLERGY CLIN IMMUN, V88, P439; Long B, 2020, AM J EMERG MED, V38, P1504, DOI 10.1016/j.ajem.2020.04.048; Maiolo C, 2003, J TELEMED TELECARE, V9, P67, DOI 10.1258/135763303321327902; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Mishra T, 2020, NAT BIOMED ENG, V4, P1208, DOI 10.1038/s41551-020-00640-6; Morlion B, 1999, IEEE ENG MED BIOL, V18, P71, DOI 10.1109/51.775491; Nakshbandi G, 2020, LANCET RESP MED, V8, P1172, DOI 10.1016/S2213-2600(20)30452-5; Natarajan Aravind, 2020, npj Digital Medicine, V3, DOI 10.1038/s41746-020-00363-7; O'Carroll O, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01492-2020; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Pedone C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-82; Pilcher J, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-019-1007-3; Portnoy J, 2020, J ALLER CL IMM-PRACT, V8, P1489, DOI 10.1016/j.jaip.2020.03.008; Shah S, 2020, ACAD EMERG MED, V27, P681, DOI 10.1111/acem.14053; Shingo S, 2001, EUR RESPIR J, V17, P220, DOI 10.1183/09031936.01.17202200; Tharakan S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03045-8; Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP; Torjesen I, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4151; W.H.O, 2020, REPORT WHO CHINA JOI; World Health Organization, 2013, CORONAVIRUS DIS COVI; World Health Organization WHO, GINA GLOBAL INITIATI; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037	41	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2021	16	3							e0247635	10.1371/journal.pone.0247635	http://dx.doi.org/10.1371/journal.pone.0247635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TU	33770093	Green Submitted, Green Published, gold			2022-12-26	WOS:000634833500015
J	Cingoz, A; Ozyerli-Goknar, E; Morova, T; Seker-Polat, F; Selvan, ME; Gumus, ZH; Bhere, D; Shah, KL; Solaroglu, I; Bagci-Onder, T				Cingoz, Ahmet; Ozyerli-Goknar, Ezgi; Morova, Tunc; Seker-Polat, Fidan; Esai Selvan, Myvizhi; Gumus, Zeynep Hulya; Bhere, Deepak; Shah, Khalid; Solaroglu, Ihsan; Bagci-Onder, Tugba			Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization	ONCOGENE			English	Article								Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces tumor cell-specific apoptosis, making it a prime therapeutic candidate. However, many tumor cells are either innately TRAIL-resistant, or they acquire resistance with adaptive mechanisms that remain poorly understood. In this study, we generated acquired TRAIL resistance models using multiple glioblastoma (GBM) cell lines to assess the molecular alterations in the TRAIL-resistant state. We selected TRAIL-resistant cells through chronic and long-term TRAIL exposure and noted that they showed persistent resistance both in vitro and in vivo. Among known TRAIL-sensitizers, proteosome inhibitor Bortezomib, but not HDAC inhibitor MS-275, was effective in overcoming resistance in all cell models. This was partly achieved through upregulating death receptors and pro-apoptotic proteins, and downregulating major anti-apoptotic members, Bcl-2 and Bcl-xL. We showed that CRISPR/Cas9 mediated silencing of DR5 could block Bortezomib-mediated re-sensitization, demonstrating its critical role. While overexpression of Bcl-2 or Bcl-xL was sufficient to confer resistance to TRAIL-sensitive cells, it failed to override Bortezomib-mediated re-sensitization. With RNA sequencing in multiple paired TRAIL-sensitive and TRAIL-resistant cells, we identified major alterations in inflammatory signaling, particularly in the NF-kappa B pathway. Inhibiting NF-kappa B substantially sensitized the most resistant cells to TRAIL, however, the sensitization effect was not as great as what was observed with Bortezomib. Together, our findings provide new models of acquired TRAIL resistance, which will provide essential tools to gain further insight into the heterogeneous therapy responses within GBM tumors. Additionally, these findings emphasize the critical importance of combining proteasome inhibitors and pro-apoptotic ligands to overcome acquired resistance.	[Cingoz, Ahmet; Ozyerli-Goknar, Ezgi; Seker-Polat, Fidan; Bagci-Onder, Tugba] Koc Univ, Res Ctr Translat Med, Brain Canc Res & Therapy Lab, TR-34450 Istanbul, Turkey; [Cingoz, Ahmet; Ozyerli-Goknar, Ezgi; Morova, Tunc; Seker-Polat, Fidan; Gumus, Zeynep Hulya; Solaroglu, Ihsan; Bagci-Onder, Tugba] Koc Univ, Sch Med, TR-34450 Istanbul, Turkey; [Esai Selvan, Myvizhi; Gumus, Zeynep Hulya] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Esai Selvan, Myvizhi; Gumus, Zeynep Hulya] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA; [Bhere, Deepak; Shah, Khalid] Harvard Med Sch, Brigham & Womens Hosp, Ctr Stem Cell Therapeut & Imaging, Boston, MA 02115 USA; [Solaroglu, Ihsan] Koc Univ, Sch Med, Dept Neurosurg, TR-34010 Istanbul, Turkey	Koc University; Koc University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Koc University	Bagci-Onder, T (corresponding author), Koc Univ, Res Ctr Translat Med, Brain Canc Res & Therapy Lab, TR-34450 Istanbul, Turkey.; Bagci-Onder, T (corresponding author), Koc Univ, Sch Med, TR-34450 Istanbul, Turkey.	tuonder@ku.edu.tr	Cingoz, Ahmet/AAG-4228-2019; Selvan, Myvizhi Esai/AAC-9982-2020; Onder, Tugba Bagci/AAN-1392-2021	Cingoz, Ahmet/0000-0002-1111-7752; Selvan, Myvizhi Esai/0000-0003-4640-5727; Bagci Onder, Tugba/0000-0003-3646-2613; Ozyerli Goknar, Ezgi/0000-0003-0202-8165; Gumus, Zeynep/0000-0002-7364-2202; Bhere, Deepak/0000-0003-4142-5518	Scientific and Technological Research Council of Turkey (TUBITAK) [3501]; Marie Curie FP7 Career Reintegration Grant (EC) [618673]; BAGEP; NIH/NCI [U24 CA210993]; Icahn Institute; NIH [R01CA201148]; Presidency of Turkey, Presidency of Strategy and Budget	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marie Curie FP7 Career Reintegration Grant (EC); BAGEP; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Icahn Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presidency of Turkey, Presidency of Strategy and Budget	Financial support was obtained from The Scientific and Technological Research Council of Turkey (TUBITAK) (3501), Marie Curie FP7 Career Reintegration Grant (EC Grant # 618673), and BAGEP. ZHG and ME acknowledge NIH/NCI U24 CA210993 and start-up funds from the Icahn Institute. KS acknowledges the NIH R01CA201148. The authors gratefully acknowledge the use of services and facilities of the Koc University Research Center for Translational Medicine (KUTTAM), funded by the Presidency of Turkey, Presidency of Strategy and Budget.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bagci-Onder T, 2013, ONCOGENE, V32, P2818, DOI 10.1038/onc.2012.304; Bagci-Onder T, 2011, CANCER RES, V71, P154, DOI 10.1158/0008-5472.CAN-10-1601; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Bhere D, 2015, ADV CANCER RES, V127, P159, DOI 10.1016/bs.acr.2015.04.012; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Bychkov ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109756; Chen GG, 2005, J CELL PHYSIOL, V203, P127, DOI 10.1002/jcp.20230; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cristofanon S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.163; de Wilt LHAM, 2013, CRIT REV ONCOL HEMAT, V85, P363, DOI 10.1016/j.critrevonc.2012.08.001; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Flusberg DA, 2013, MOL BIOL CELL, V24, P2186, DOI 10.1091/mbc.E12-10-0737; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Fulda S, 2015, SEMIN CANCER BIOL, V31, P84, DOI 10.1016/j.semcancer.2014.05.002; Fulda S, 2011, ONCOTARGET, V2, P418; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Han B, 2015, ONCOTARGET, V6, P17532, DOI 10.18632/oncotarget.3947; Hetschko H, 2008, J NEURO-ONCOL, V86, P265, DOI 10.1007/s11060-007-9472-6; Hoey T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001056; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Kandasamy K, 2008, MOL CANCER THER, V7, P1091, DOI 10.1158/1535-7163.MCT-07-2368; Kaya-Aksoy E, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0144-z; Khaw SL, 2009, LEUKEMIA LYMPHOMA, V50, P1069, DOI 10.1080/10428190903015644; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Koschny R, 2007, HEPATOLOGY, V45, P649, DOI 10.1002/hep.21555; Koschny R, 2014, J NEUROPATH EXP NEUR, V73, P1034, DOI 10.1097/NEN.0000000000000129; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kurt IC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.288; Lane D, 2006, MOL CANCER THER, V5, P509, DOI 10.1158/1535-7163.MCT-05-0362; Lee TJ, 2006, BIOCHEM BIOPH RES CO, V351, P1024, DOI 10.1016/j.bbrc.2006.10.163; Li Z, 2011, J BIOL CHEM, V286, P21164, DOI 10.1074/jbc.M110.207571; Lickliter JD, 2007, BRIT J CANCER, V96, P600, DOI 10.1038/sj.bjc.6603599; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Messaoudi K, 2015, DRUG DISCOV TODAY, V20, P899, DOI 10.1016/j.drudis.2015.02.011; Mitsiades N, 2002, BLOOD, V99, P2162, DOI 10.1182/blood.V99.6.2162; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; Naumann I, 2011, CLIN CANCER RES, V17, P3204, DOI 10.1158/1078-0432.CCR-10-2451; Nikrad M, 2005, MOL CANCER THER, V4, P443; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Seker F, 2019, CANCERS, V11, DOI 10.3390/cancers11111651; Senbabaoglu F, 2016, CANCER BIOL THER, V17, P546, DOI 10.1080/15384047.2016.1167292; Serrano-Saenz S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1293-3; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stavrovskaya AA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P91, DOI 10.1134/S0006297916020036; Stuckey DW, 2013, TRENDS MOL MED, V19, P685, DOI 10.1016/j.molmed.2013.08.007; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Unterkircher T, 2011, CLIN CANCER RES, V17, P4019, DOI 10.1158/1078-0432.CCR-11-0075; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Warren CFA, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1407-6; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495	70	3	3	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2021	40	18					3201	3216		10.1038/s41388-021-01697-6	http://dx.doi.org/10.1038/s41388-021-01697-6		MAR 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SE1MB	33767436				2022-12-26	WOS:000632820300004
J	Bastos, RTDM; da Silva, PT; Normando, D				da Rosa Moreira Bastos, Renata Travassos; da Silva, Priscila Teixeira; Normando, David			Reliability of qualitative occlusal tooth wear evaluation using an intraoral scanner: A pilot study	PLOS ONE			English	Article								Dental wear analysis through the use of an intraoral scanner is a reality of modern dentistry. This study aimed to investigate the reliability of qualitative tooth wear evaluation through three-dimensional images captured with an intraoral scanner and compared to clinical and photographic examinations. Eighteen adult volunteers of both genders (18 to 55 years old) were submitted to clinical exams, intraoral photographs and intraoral scanning protocol using an optical scanner (TRIOS (R) Pod, 3Shape, Copenhagen, Denmark). Occlusal tooth wear, from second to second premolars, was measured by two evaluators and reevaluated after 30 days, according to a slight modification of the method described by Mockers et al. Weighted Kappa was used to measure intra and inter-examiner agreement. The Friedman test was used to verify the differences among methods. Random and systematic errors were assessed using Bland-Altman plots. All statistical analysis was performed with p<0.05. There was a substantive agreement for clinical (K = 0.75) and photographic exams (K = 0.79) and a moderate agreement for intraoral scanner analysis (K = 0.60) for inter-examiner evaluation. A substantial intra-examiner agreement was obtained for both evaluators. No significant difference between the methods was observed (p = 0.7343 for examiner 1 and 0.8007 for examiner 2). The Bland-Altman plot confirmed no systematic errors between the methods and a random error of 0.25 with the scanner method when compared to clinical assessment. All three methods showed reliability in qualitative occlusal tooth wear evaluation. Intraoral scanning seems to be a sound and reliable tool to evaluate tooth wear when compared to traditional methods, considering the lower inter-examiner agreement and the inherent limitations of this pilot study. Further research will be necessary in order to achieve more robust evidence.	[da Rosa Moreira Bastos, Renata Travassos] Fed Univ Para, Dept Orthodont, Postgrad Program Dent, Belem, Para, Brazil; [da Silva, Priscila Teixeira] Fed Univ Para, Dent Sch, Belem, Para, Brazil; [Normando, David] Fed Univ Para, Dent Sch, Dept Orthodont, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Bastos, RTDM (corresponding author), Fed Univ Para, Dept Orthodont, Postgrad Program Dent, Belem, Para, Brazil.	rtrmbastos@gmail.com		Travassos da Rosa Moreira Bastos, Renata/0000-0002-9349-1747				Aragon MLC, 2016, EUR J ORTHODONT, V38, P429, DOI 10.1093/ejo/cjw033; Bardsley PF, 2008, CLIN ORAL INVEST, V12, pS15, DOI 10.1007/s00784-007-0184-2; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Bishop K, 1997, Quintessence Int, V28, P305; d'Incau E, 2012, ARCH ORAL BIOL, V57, P214, DOI 10.1016/j.archoralbio.2011.08.021; Dugmore C R, 2003, Int J Paediatr Dent, V13, P295, DOI 10.1046/j.1365-263X.2003.00487.x; ECCLES JD, 1979, J PROSTHET DENT, V42, P649, DOI 10.1016/0022-3913(79)90196-3; Esclassan R, 2009, ARCH ORAL BIOL, V54, P287, DOI 10.1016/j.archoralbio.2008.11.004; Farah J., 2009, DENT ADVISOR, V12, P1; Fares J, 2009, CARIES RES, V43, P119, DOI 10.1159/000209344; Ganss C, 2001, COMMUNITY DENT ORAL, V29, P264, DOI 10.1034/j.1600-0528.2001.290405.x; Gkantidis N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66534-4; GOURDON AM, 1987, J PROSTHET DENT, V57, P358, DOI 10.1016/0022-3913(87)90312-X; Grippo J O, 1991, J Esthet Dent, V3, P14, DOI 10.1111/j.1708-8240.1991.tb00799.x; Grunheid T, 2014, AM J ORTHOD DENTOFAC, V146, P673, DOI 10.1016/j.ajodo.2014.07.023; Imfeld T, 1996, EUR J ORAL SCI, V104, P151, DOI 10.1111/j.1600-0722.1996.tb00063.x; Johansson A, 2008, J ORAL REHABIL, V35, P548, DOI 10.1111/j.1365-2842.2008.01897.x; Johansson AK, 2012, INT J DENT, V2012, DOI 10.1155/2012/632907; Kaidonis JA, 2008, CLIN ORAL INVEST, V12, pS21, DOI 10.1007/s00784-007-0154-8; Larsen IB, 2000, COMMUNITY DENT ORAL, V28, P211, DOI 10.1034/j.1600-0528.2000.280307.x; Liu B, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-65; Makrygiannakis MA, 2018, J ORTHOD, V45, P260, DOI 10.1080/14653125.2018.1517469; Mangano FG, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0792-7; McKeown HF, 2005, J ORTHOD, V32, P43, DOI 10.1179/146531205225020880; Mockers O, 2004, EUR J ORTHODONT, V26, P151, DOI 10.1093/ejo/26.2.151; MOLNAR S, 1983, J DENT RES, V62, P562, DOI 10.1177/00220345830620051101; MURPHY T, 1959, AM J PHYS ANTHROPOL, V17, P167, DOI 10.1002/ajpa.1330170302; Normando D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230809; Normando D, 2013, ANGLE ORTHOD, V83, P10, DOI 10.2319/020112-91.1; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; Normando D, 2011, EUR J ORTHODONT, V33, P721, DOI 10.1093/ejo/cjq149; Pagano S, 2019, MATERIALS, V12, DOI 10.3390/ma12121958; Panos Periklis G, 2011, Orthodontics (Chic.), V12, P122; Park J, 2014, ANGLE ORTHOD, V84, P687, DOI 10.2319/081113-592.1; Richert R, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/8427595; RUSSELL MD, 1983, J ORAL REHABIL, V10, P383, DOI 10.1111/j.1365-2842.1983.tb00134.x; Sandler J, 2009, AM J ORTHOD DENTOFAC, V135, P657, DOI 10.1016/j.ajodo.2007.04.038; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; Sfondrini MF, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4103232; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; Thirumurthy V R, 2013, J Indian Prosthodont Soc, V13, P366, DOI 10.1007/s13191-012-0173-2; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; Vieira EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116138; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; WATSON IB, 1985, BRIT DENT J, V159, P144, DOI 10.1038/sj.bdj.4805660; Zero DT, 1996, EUR J ORAL SCI, V104, P162, DOI 10.1111/j.1600-0722.1996.tb00065.x	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249119	10.1371/journal.pone.0249119	http://dx.doi.org/10.1371/journal.pone.0249119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765042	Green Published, gold			2022-12-26	WOS:000634832800043
J	Fan, L; Qiu, JW; Zhao, Y; Yin, T; Li, XX; Wang, QA; Jing, JY; Zhang, JX; Wang, FX; Liu, XY; Liu, L; Zhao, Y; Zhang, YH				Fan, Ling; Qiu, Jiangwei; Zhao, Yu; Yin, Ting; Li, Xiaoxia; Wang, Qingan; Jing, Jinyun; Zhang, Jiaxing; Wang, Faxuan; Liu, Xiuying; Liu, Lan; Zhao, Yi; Zhang, Yuhong			The association between body composition and metabolically unhealthy profile of adults with normal weight in Northwest China	PLOS ONE			English	Article							HEALTHY OBESE; RISK-FACTORS; MASS INDEX; INSULIN-RESISTANCE; VISCERAL FAT; MUSCLE MASS; CONSEQUENCES; PREVALENCE; IMPEDANCE	Objective Related evidences of metabolically unhealthy profile of adults with normal weight are not well characterized in the Chinese population. This is because they cannot be effectively identified by regular measurements (such as body mass index [BMI]). To overcome this gap in literature, this study aimed at investigating the association between body composition and metabolically unhealthy profile in Chinese adults with normal weight. Methods A total of 5427 individuals with normal-weight were recruited from 15820 people living in Ningxia Hui Autonomous Region in Northwest China. Normal-weight was defined as a BMI of 18.5-23.9 kg/m(2). Metabolically unhealthy profile was assessed by the National Cholesterol Education Program Adult Treatment Panel III (ATP III). Metabolically unhealthy normal-weight (MUHNW) profile was defined in individuals who had normal weight and at least two cardiometabolic risk factors. Generalized linear model was used to investigate the association between body composition measured by bioelectrical impedance and metabolically unhealthy profile in adults with normal-weight. Results The percentage of metabolically unhealthy profile was 35.86% in adults with normal weight. Different MUHNW distributions were found between males and females depending on age. The percentage of the MUHNW profile significantly increased in women after the age of 55, contrary to men. The association between body composition and MUHNW was affected by age and sex. The increased adiposity indices (fat mass index [FMI], visceral fat level [VFL], waist circumference [WCF]), and reduced skeletal muscle mass ratio [SMR] showed significant differences between MUHNW and metabolically healthy with normal weight (MHNW) (p < 0.05). Conclusion The distribution of MUHNW differed between ages and sexes. FMI, VFL, WCF and SMR could be responsible for the MUHNW adults, providing a new insight into the potential metabolic risks for the adults with normal weight in China. This directs us in the management of the MUHNW for their early prevention.	[Fan, Ling; Qiu, Jiangwei; Zhao, Yu; Yin, Ting; Li, Xiaoxia; Wang, Qingan; Jing, Jinyun; Zhang, Jiaxing; Wang, Faxuan; Liu, Xiuying; Liu, Lan; Zhao, Yi; Zhang, Yuhong] Ningxia Med Univ, Sch Publ Hlth & Management, Yinchuan, Ningxia, Peoples R China; [Fan, Ling; Qiu, Jiangwei; Zhao, Yu; Yin, Ting; Li, Xiaoxia; Wang, Qingan; Jing, Jinyun; Zhang, Jiaxing; Wang, Faxuan; Liu, Xiuying; Liu, Lan; Zhao, Yi; Zhang, Yuhong] Key Lab Environm Factors & Chron Dis Control Ning, Yinchuan, Ningxia, Peoples R China	Ningxia Medical University	Zhao, Y; Zhang, YH (corresponding author), Ningxia Med Univ, Sch Publ Hlth & Management, Yinchuan, Ningxia, Peoples R China.; Zhao, Y; Zhang, YH (corresponding author), Key Lab Environm Factors & Chron Dis Control Ning, Yinchuan, Ningxia, Peoples R China.	zhaoyi751114@hotmail.com; zhabour@163.com		Zhao, Yi/0000-0002-0958-0350; Zhang, Yuhong/0000-0002-7110-8401	National Key Research and Development Project Ningxia Cohort from China Northwest Cohort [2017YFC0907204]; National Natural Science Foundation of China [81860603, 12061058]	National Key Research and Development Project Ningxia Cohort from China Northwest Cohort; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Project Ningxia Cohort from China Northwest Cohort (2017YFC0907204) and National Natural Science Foundation of China (81860603, 12061058).	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Caterson ID, 2002, BEST PRACT RES CL EN, V16, P595, DOI 10.1053/beem.2002.0228; Choi KM, 2013, CLIN ENDOCRINOL, V79, P364, DOI 10.1111/cen.12154; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eckel N, 2018, LANCET DIABETES ENDO, V6, P714, DOI 10.1016/S2213-8587(18)30137-2; Eckel N, 2016, EUR J PREV CARDIOL, V23, P956, DOI 10.1177/2047487315623884; Eckel N, 2015, METABOLISM, V64, P862, DOI 10.1016/j.metabol.2015.03.009; Eickemberg M, 2013, ARQ BRAS ENDOCRINOL, V57, P27, DOI 10.1590/S0004-27302013000100004; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Kim TN, 2013, J CLIN ENDOCR METAB, V98, P811, DOI 10.1210/jc.2012-3292; Liu PJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-629; Lu YC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53557-9; Mathew H, 2016, METABOLISM, V65, P73, DOI 10.1016/j.metabol.2015.10.019; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Neeland IJ, 2019, LANCET DIABETES ENDO, V7, P715, DOI 10.1016/S2213-8587(19)30084-1; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Sirdah MM, 2012, DIABETES METAB SYND, V6, P4, DOI 10.1016/j.dsx.2012.05.017; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Stefan N, 2020, LANCET DIABETES ENDO, V8, P616, DOI 10.1016/S2213-8587(20)30110-8; Stefan N, 2018, LANCET DIABETES ENDO, V6, P249, DOI 10.1016/S2213-8587(17)30292-9; Stefan N, 2017, CELL METAB, V26, P292, DOI 10.1016/j.cmet.2017.07.008; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Tatsumi Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013831; Wang B, 2015, HORM METAB RES, V47, P839, DOI 10.1055/s-0035-1559767; Wang HY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016062; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; World Health Organization, WHO MED CTR OB OV FA; Xia LL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040391; Xu L, 2011, J CLIN DENSITOM, V14, P458, DOI 10.1016/j.jocd.2011.04.001; Zhang Y, 2017, BIOSCI TRENDS, V11, P418, DOI 10.5582/bst.2017.01016; Zheng QQ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08630-8	36	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248782	10.1371/journal.pone.0248782	http://dx.doi.org/10.1371/journal.pone.0248782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765000	Green Published, gold			2022-12-26	WOS:000634832800048
J	Aztatzi-Aguilar, OG; Sierra-Vargas, MP; Ortega-Romero, M; Jimenez-Corona, AE				Gamaliel Aztatzi-Aguilar, Octavio; Patricia Sierra-Vargas, Martha; Ortega-Romero, Manolo; Eunice Jimenez-Corona, Azucena			Osteopontin's relationship with malnutrition and oxidative stress in adolescents. A pilot study	PLOS ONE			English	Article								Osteopontin (OPN) is a protein involved in inflammatory illnesses such as fibrosis and cancer; its overexpression in cardiovascular diseases promotes the biomineralization of blood vessels and other soft tissues. Moreover, there is an active component of oxidative stress related with those diseases. The present study relates serum OPN levels with nutritional condition and oxidative stress in a group of adolescents. Anthropometric measurements were performed, and fasting blood samples were analyzed to determine OPN concentrations, blood chemistry parameters (glucose, triglycerides, total cholesterol, urea, uric acid, and creatinine) and oxidative stress biomarkers (Paraoxonase-1, Glutathione S-Transferase, Catalase, NAD(P)H Quinone Oxidoreductase, free carbonyl groups and malondialdehyde). Adolescents were categorized according to body mass index (BMI) and metabolic syndrome (MetS) criteria. We found increased OPN serum concentrations in overweight and obese adolescents, as well as in adolescents with MetS. Rises in OPN correlated with arm circumference and biomarkers of lipid peroxidation; with regard to serum glucose there was a trend to positive correlation. Our results suggest that serum OPN is associated to nutritional status and could be considered as an early biomarker of low-grade inflammation and probably the early biomineralization of soft tissues in adolescence.	[Gamaliel Aztatzi-Aguilar, Octavio; Patricia Sierra-Vargas, Martha] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Toxicol & Med Ambiental, Cdmx, Mexico; [Gamaliel Aztatzi-Aguilar, Octavio] Catedras CONACyT, Cdmx, Mexico; [Patricia Sierra-Vargas, Martha] La Salle Univ, Fac Mexicana Med, Cdmx, Mexico; [Ortega-Romero, Manolo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Cdmx, Mexico; [Eunice Jimenez-Corona, Azucena] Univ Autonoma Estado Hidalgo, Escuela Super Huejutla, Huejutla, Hidalgo, Mexico	Universidad Autonoma del Estado de Hidalgo	Sierra-Vargas, MP (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Toxicol & Med Ambiental, Cdmx, Mexico.; Sierra-Vargas, MP (corresponding author), La Salle Univ, Fac Mexicana Med, Cdmx, Mexico.; Jimenez-Corona, AE (corresponding author), Univ Autonoma Estado Hidalgo, Escuela Super Huejutla, Huejutla, Hidalgo, Mexico.	mpsierra@iner.gob.mx; azucena_jimenez@uaeh.edu.mx	; Sierra Vargas, Martha Patricia/C-5097-2018	Jimenez-Corona, Azucena E./0000-0002-8987-506X; Sierra Vargas, Martha Patricia/0000-0002-1894-745X	PRODEP (Programa para el Desarrollo Profesional Docente para el tipo Superior, Secretaria de Educacion Publica grant) [UAEH-PTC763]	PRODEP (Programa para el Desarrollo Profesional Docente para el tipo Superior, Secretaria de Educacion Publica grant)	This research was funded by grants from the PRODEP (Programa para el Desarrollo Profesional Docente para el tipo Superior, Secretaria de Educacion Publica grant UAEH-PTC763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT CA, 1995, ARTERIOSCL THROM VAS, V15, P1812, DOI 10.1161/01.ATV.15.11.1812; Abo El-Asrar M, 2018, PEDIATR DIABETES, V19, P1107, DOI 10.1111/pedi.12686; Aebi H., 1983, METHOD ENZYMOL, P273; Aguilar-Morales I, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121850; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Coculescu BI, 2019, J ENZYM INHIB MED CH, V34, P783, DOI 10.1080/14756366.2019.1587418; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Gomez-Ruiz L, 2015, SPAN J FINANC ACCOUN, V44, P97, DOI 10.1080/02102412.2014.996358; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Kang B, 2017, INT J OBESITY, V41, P789, DOI 10.1038/ijo.2017.14; Kelishadi R, 2013, J RES MED SCI, V18, P178; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; KUHLBACK B, 1968, SCAND J CLIN LAB INV, V22, P37, DOI 10.3109/00365516809160734; Lamort AS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080815; LIND C, 1981, ARCH BIOCHEM BIOPHYS, V207, P217, DOI 10.1016/0003-9861(81)90027-8; Lo K, 2016, OBES REV, V17, P1258, DOI 10.1111/obr.12456; Locateli JC, 2019, J PEDIATR ENDOCR MET, V32, P1163, DOI 10.1515/jpem-2019-0037; Marrugat J, 1998, MED CLIN-BARCELONA, V111, P267; Naujoks W, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.573200; Nielsen F, 1997, CLIN CHEM, V43, P1209; Nor NSM, 2016, PEDIATR DIABETES, V17, P458, DOI 10.1111/pedi.12303; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Pedersen TX, 2013, CARDIOVASC RES, V98, P352, DOI 10.1093/cvr/cvt049; Shamah-Levy T, 2018, SALUD PUBLICA MEXICO, V60, P244, DOI 10.21149/8815; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; Standal T, 2004, EXP ONCOL, V26, P179; Strange RC, 2000, TOXICOL LETT, V112, P357, DOI 10.1016/S0378-4274(99)00230-1; Takemoto M, 2000, ARTERIOSCL THROM VAS, V20, P624, DOI 10.1161/01.ATV.20.3.624; Tousoulis D, 2013, INT J CARDIOL, V167, P1924, DOI 10.1016/j.ijcard.2012.05.001; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Xu GW, 2005, J CLIN INVEST, V115, P1060; Yaghootkar H, 2020, J INTERN MED, V288, P271, DOI 10.1111/joim.13082; Yagisawa T, 2001, J UROLOGY, V166, P1078, DOI 10.1016/S0022-5347(05)65925-3; Yoshida Akihiro, 2004, J Atheroscler Thromb, V11, P215; Zamrazilova H, 2016, J CLIN ENDOCR METAB, V101, P3088, DOI 10.1210/jc.2016-1706	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249057	10.1371/journal.pone.0249057	http://dx.doi.org/10.1371/journal.pone.0249057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765028	gold, Green Published			2022-12-26	WOS:000634832800074
J	Rwabilimbo, MM; Elewonibi, BR; Yussuf, MH; Robert, M; Msuya, SE; Mahande, MJ				Rwabilimbo, Martin M.; Elewonibi, Bilikisu R.; Yussuf, Mashavu H.; Robert, Masanja; Msuya, Sia E.; Mahande, Michael J.			Initiation of postpartum modern contraceptive methods: Evidence from Tanzania demographic and health survey	PLOS ONE			English	Article								Background Postpartum contraceptive use is vital to improve maternal and child survival. It helps to have optimal child spacing, prevent unplanned pregnancies and associated adverse birth outcomes. However, postpartum contraceptive use in Tanzania remains low. Short median interval for resumption to sex after birth among African women has been associated with adverse maternal and child health wellbeing. This study aimed to assess optimal time to contraceptive use and predictors of time to contraceptive use after birth among women of reproductive age in Tanzania. Methods A cross section study using the TDHS 2015-16 data was used. A total of 3775 postpartum women were analyzed. Information on pregnancy, births and contraceptive use were recorded over the previous 5 years with the focus on most recent birth from the contraceptive calendar. Data analysis was performed using Stata 14.0. Analysis accounted for complex survey design. Time to modern contraceptive use after birth was computed using Kaplan Meier estimate. Adjusted time ratios with 95% CI were estimated using Weibull accelerated failure time models. Results A total weighted sample of 3775 women was analyzed. The median time to contraceptive use after birth was 7(IQR: 4-13) months, while for resumption to sex afterbirth was 2(IQR: 1-5) months. Factors such as never been married (TR: 1.63; 95%CI: 1.26-2.11) and breastfeeding (TR: 5.50; 95%CI: 4.12-7.35) were associated with longer time to postpartum contraceptive use. Belonging to richest wealth quintile (TR: 0.73; 95%CI: 0.54-0.99) and adopting long acting methods (TR: 0.70; 95%CI: 0.60-0.82) increased women's likelihood of having shorter time to postpartum contraceptive use. Conclusion There was a time lag of five months from resumption of sex and initiation of postpartum contraception use. The interceptive measures to facilitate timely availing methods of women's choice and promotion of utilization of maternal health care services may reduce delays in postpartum contraceptive use.	[Rwabilimbo, Martin M.; Elewonibi, Bilikisu R.; Yussuf, Mashavu H.; Robert, Masanja; Msuya, Sia E.; Mahande, Michael J.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Rwabilimbo, Martin M.] Bukoba Reg Referral Hosp, Bukoba, Tanzania; [Elewonibi, Bilikisu R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Robert, Masanja] Mwenge Catholic Univ MWECAU, Moshi, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health	Rwabilimbo, MM (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.; Rwabilimbo, MM (corresponding author), Bukoba Reg Referral Hosp, Bukoba, Tanzania.	martinmujun@gmail.com		Yussuf, Mashavu/0000-0002-5080-2437; Rwabilimbo, martin Mujuni/0000-0002-0121-1833	DELTAS Africa Initiative [107754/Z/15/Z]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107754/Z/15/Z]; UK government	DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported through the DELTAS Africa Initiative Grant No. 107754/Z/15/Z-DELTAS Africa SSACAB. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant No. 107754/Z/15/Z) and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government.	Adeniji AO., 2014, INT J REPROD CONTRAC, V3, P1061, DOI DOI 10.5455/2320-1770.IJRCOG20141236; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alfensi F., 2018, COMP PROPORTIONAL HA; [Anonymous], 2015, TRENDS CONTR US WORL; [Anonymous], 2017, TRACK20 PROJ; Bello Folasade Adenike, 2011, ISRN Obstet Gynecol, V2011, P856586, DOI 10.5402/2011/856586; DHS, 2018, DHS CONTR CAL TUT, V2nd, P4; Do M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-6; Fagbamigbe AF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008371; Faruk A, 2018, J PHYS CONF SER, V974, DOI 10.1088/1742-6596/974/1/012008; Gaffield ME, 2014, GLOB HEALTH-SCI PRAC, V2, P4, DOI 10.9745/GHSP-D-13-00156; Hounton S, 2015, GLOBAL HEALTH ACTION, V8, P64, DOI 10.3402/gha.v8.29738; Huang YM, 2012, CONTRACEPTION, V86, P731, DOI 10.1016/j.contraception.2012.05.007; Izugbara CO, 2018, AFRICAN POPUL HLTH R; Jalang'o R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4510-6; Kazaura M, 2016, AFR HEALTH SCI, V16, P44, DOI 10.4314/ahs.v16i1.6; Keogh SC, 2015, STUD FAMILY PLANN, V46, P405, DOI 10.1111/j.1728-4465.2015.00040.x; Mahande MJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0929-5; Mcsp, 2015, FAM PLANN NEED 1 2 Y, V13, P3; MOHCDGEC, 2016, UN REP TANZ NAT ROAD, VII, P12; MOHCDGEC, 2015, HLTH SECT STRAT PLAN, VIV, P43; MoHCDGEC, 2016, TANZ DEM HEAL SURV M, P5; MoHCDGEC, 2013, NAT FAM PLANN GUID S, P15; Mushy SE, 2020, SEX REPROD HEALTHC, V24, DOI 10.1016/j.srhc.2020.100499; Ndugwa RP, 2011, J URBAN HEALTH, V88, P341, DOI 10.1007/s11524-010-9452-6; Orbe J, 2002, STAT MED, V21, P3493, DOI 10.1002/sim.1251; Padmadas SS, 2014, INT J GYNECOL OBSTET, V127, P132, DOI 10.1016/j.ijgo.2014.05.012; Sedgh G., 2016, GUTTMACHER I, P2; Stover J, 2010, MATERN CHILD HLTH J, V14, P687, DOI 10.1007/s10995-009-0505-y; vanSchalkwyk C, 2015, CHAN SCH PUBLIC HLTH, P1; Wamala R, PREDICTORS TIME TO C; Wamala R., 2017, PREDICTORS TIME TO C, V2017, P7; WHO, 2013, PROGR STRAT POSTP FA, V22, P294; Winfrey W, 2014, USE FAMILY PLANNING; World Health Organization, 2018, SEX REPR HLTH; Yazdkhasti M, 2015, IRAN J PUBLIC HEALTH, V44, P12; Zhang Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22498-0	37	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249017	10.1371/journal.pone.0249017	http://dx.doi.org/10.1371/journal.pone.0249017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765100	gold, Green Published			2022-12-26	WOS:000634832800028
J	Sebastiao, CS; Neto, Z; Martinez, P; Jandondo, D; Antonio, J; Galangue, M; de Carvalho, M; David, K; Miranda, J; Afonso, P; Ingles, L; Carrelero, RR; de Vasconcelos, JN; Morais, J				Sebastiao, Cruz S.; Neto, Zoraima; Martinez, Pedro; Jandondo, Domingos; Antonio, Janete; Galangue, Manuela; de Carvalho, Marcia; David, Kumbelembe; Miranda, Julio; Afonso, Pedro; Ingles, Luzia; Carrelero, Raisa Rivas; de Vasconcelos, Jocelyne Neto; Morais, Joana			Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA	This study aimed to investigate the characteristics related to SARS-CoV-2 in Luanda, Angola. A total of 622 individuals were screened for SARS-CoV-2 from January to September 2020. Chi-square and logistic regression were used to identify the relationship between sociodemographic characteristics and SARS-CoV-2. Of the 622 tested, 14.3% tested positive. The infection rate was the same for both genders (14.3%). Individuals >= 40 years old, from non-urbanized areas, and healthcare professionals had a higher frequency of infection. The risk of infection was very high in individuals >= 60 years old (AOR: 23.3, 95% CI: 4.83-112), in women (AOR: 1.24, 95% CI: 0.76-2.04), in Luanda (AOR: 7.40, 95% CI: 1.64-33.4), and healthcare professionals (AOR: 1.27, 95% CI: 0.60-2.71), whereas a low risk was observed in individuals from urbanized areas (AOR: 0.44, 95% CI: 0.26-0.75). Our results suggest that Angolan authorities should implement a greater effort in non-urbanized areas and among healthcare professionals since when these individuals presented any indication for a COVID-19 test, such as fever/cough/myalgia, they were more likely to test positive for SARS-CoV-2 than having some other cause for symptoms.	[Sebastiao, Cruz S.; de Vasconcelos, Jocelyne Neto] Ctr Invest Saude Angola, Caxito, Angola; [Sebastiao, Cruz S.; Neto, Zoraima; Martinez, Pedro; Jandondo, Domingos; Antonio, Janete; Galangue, Manuela; de Carvalho, Marcia; David, Kumbelembe; Miranda, Julio; Afonso, Pedro; Ingles, Luzia; Carrelero, Raisa Rivas; de Vasconcelos, Jocelyne Neto; Morais, Joana] Inst Nacl Invest Saude, Luanda, Angola; [Sebastiao, Cruz S.] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola; [Morais, Joana] Univ Agostinho Neto, Fac Med, Luanda, Angola	University Agostinho Neto; University Agostinho Neto	de Vasconcelos, JN (corresponding author), Ctr Invest Saude Angola, Caxito, Angola.; Neto, Z; de Vasconcelos, JN; Morais, J (corresponding author), Inst Nacl Invest Saude, Luanda, Angola.; Morais, J (corresponding author), Univ Agostinho Neto, Fac Med, Luanda, Angola.	jfm.morais9@gmail.com; jocelyne.vasconcelos@cisacaxito.org; jfm.morais9@gmail.com		Machado de Morais, Joana Filipa/0000-0002-4524-4055; Sebastiao, Cruz/0000-0003-1232-0119; Martinez, Pedro A./0000-0002-9886-6448; Neto, Zoraima/0000-0003-1606-9996				Amorim L, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002643; [Anonymous], LANCET, DOI DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Bulut C, 2020, TURK J MED SCI, V50, P563, DOI 10.3906/sag-2004-172; Channappanavar R, 2018, J IMMUNOL, V198, P319; Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3; Da An Gene., 2019, SUN YAT SEN U, V4, P75; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2; Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Jaillon S, 2019, CLIN REV ALLERG IMMU, V56, P308, DOI 10.1007/s12016-017-8648-x; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Ministerio da Saude de Angola, 2020, B INFORM, V269, P58; National Institute of Statistics, 2016, INQU RITO INDICADORE; National Institute of Statistics, 2016, RESULTADOS DEFINITIV; Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; World Health Organization, 2020, COVID 19 WEEKLY EPID; World Health Organization, 2020, WEEKLY EPIDEMIOLOGIC, DOI [10.1186/s13063-020-04527-4, DOI 10.1186/S13063-020-04527-4]; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	28	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249249	10.1371/journal.pone.0249249	http://dx.doi.org/10.1371/journal.pone.0249249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765102	Green Published, gold			2022-12-26	WOS:000634832800008
J	Maavara, T; Siirila-Woodburn, ER; Maina, F; Maxwell, RM; Sample, JE; Chadwick, KD; Carroll, R; Newcomer, ME; Dong, WM; Williams, KH; Steefel, CI; Bouskill, NJ				Maavara, Taylor; Siirila-Woodburn, Erica R.; Maina, Fadji; Maxwell, Reed M.; Sample, James E.; Chadwick, K. Dana; Carroll, Rosemary; Newcomer, Michelle E.; Dong, Wenming; Williams, Kenneth H.; Steefel, Carl, I; Bouskill, Nicholas J.			Modeling geogenic and atmospheric nitrogen through the East River Watershed, Colorado Rocky Mountains	PLOS ONE			English	Article							TERRESTRIAL; GROUNDWATER; ECOSYSTEM; DYNAMICS; PARALLEL; AVAILABILITY; CALIBRATION; PHOSPHORUS; SATURATION; CATCHMENTS	There is a growing understanding of the role that bedrock weathering can play as a source of nitrogen (N) to soils, groundwater and river systems. The significance is particularly apparent in mountainous environments where weathering fluxes can be large. However, our understanding of the relative contributions of rock-derived, or geogenic, N to the total N supply of mountainous watersheds remains poorly understood. In this study, we develop the High-Altitude Nitrogen Suite of Models (HAN-SoMo), a watershed-scale ensemble of process-based models to quantify the relative sources, transformations, and sinks of geogenic and atmospheric N through a mountain watershed. Our study is based in the East River Watershed (ERW) in the Upper Colorado River Basin. The East River is a near-pristine headwater watershed underlain primarily by an N-rich Mancos Shale bedrock, enabling the timing and magnitude of geogenic and atmospheric contributions to watershed scale dissolved N-exports to be quantified. Several calibration scenarios were developed to explore equifinality using >1600 N concentration measurements from streams, groundwater, and vadose zone samples collected over the course of four years across the watershed. When accounting for recycling of N through plant litter turnover, rock weathering accounts for approximately 12% of the annual dissolved N sources to the watershed in the most probable calibration scenario (0-31% in other scenarios), and 21% (0-44% in other scenarios) when considering only "new" N sources (i.e. geogenic and atmospheric). On an annual scale, instream dissolved N elimination, plant turnover (including cattle grazing) and atmospheric deposition are the most important controls on N cycling.	[Maavara, Taylor; Siirila-Woodburn, Erica R.; Maina, Fadji; Chadwick, K. Dana; Newcomer, Michelle E.; Dong, Wenming; Williams, Kenneth H.; Steefel, Carl, I; Bouskill, Nicholas J.] Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Berkeley, CA 94720 USA; [Maavara, Taylor] Yale Univ, Sch Environm, New Haven, CT 06520 USA; [Maxwell, Reed M.] Princeton Univ, Princeton Environm Inst, Civil & Environm Engn, Princeton, NJ 08544 USA; [Sample, James E.] Norwegian Inst Water Res NIVA, Grimstad, Norway; [Chadwick, K. Dana] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Carroll, Rosemary] Desert Res Inst, Reno, NV USA; [Carroll, Rosemary; Williams, Kenneth H.] Rocky Mt Biol Labs, Crested Butte, CO USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Yale University; Princeton University; Norwegian Institute for Water Research (NIVA); Stanford University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Maavara, T (corresponding author), Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Berkeley, CA 94720 USA.; Maavara, T (corresponding author), Yale Univ, Sch Environm, New Haven, CT 06520 USA.	taylor.maavara@yale.edu	Steefel, Carl I/B-7758-2010; Dong, Wenming/G-3221-2015; Chadwick, K. Dana/AGN-9988-2022; Newcomer, Michelle/L-8984-2016; Bouskill, Nick J/G-2390-2015; Williams, Kenneth Hurst/O-5181-2014; Maina, Fadji/L-6779-2018	Dong, Wenming/0000-0003-2074-8887; Newcomer, Michelle/0000-0001-5138-9026; Williams, Kenneth Hurst/0000-0002-3568-1155; Maina, Fadji/0000-0003-3126-4343	United States Department of Energy, BER Contract [DE-AC020SCH11231]; Natural Sciences and Engineering Research Council of Canada (NSERC) [PDF-516575-2018]	United States Department of Energy, BER Contract(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the United States Department of Energy (https://www.energy.gov/science/ber/biological-andenvironmental-research), BER Contract DE-AC020SCH11231 to the Lawrence Berkeley National Laboratory's Watershed Function Scientific Focus Area (SFA), and a Natural Sciences and Engineering Research Council of Canada (NSERC, https://www.nserc-crsng.gc.ca/index_ eng.asp) postdoctoral fellowship to TM (no. PDF-516575-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Akbarzadeh Z, 2019, GLOBAL BIOGEOCHEM CY, V33, P1339, DOI 10.1029/2019GB006222; Alexander RB, 2002, BIOGEOCHEMISTRY, V57, P295, DOI 10.1023/A:1015752801818; Almaraz M, 2016, BIOGEOSCIENCES, V13, P5395, DOI 10.5194/bg-13-5395-2016; Alshameri A, 2018, APPL CLAY SCI, V159, P83, DOI 10.1016/j.clay.2017.11.007; Appling AP, 2018, J GEOPHYS RES-BIOGEO, V123, P624, DOI 10.1002/2017JG004140; Ashby SF, 1996, NUCL SCI ENG, V124, P145, DOI 10.13182/NSE96-A24230; Barton L, 1999, AUST J SOIL RES, V37, P1073, DOI 10.1071/SR99009; Bauch N.J., 2003, LIMNOLOGY BLUE MESA; Benedict KB, 2013, ECOL APPL, V23, P1156, DOI 10.1890/12-1624.1; Bertilsson S, 1998, LIMNOL OCEANOGR, V43, P885, DOI 10.4319/lo.1998.43.5.0885; Boston P.J., 1985, THESIS NATL CTR ATMO; Boyer EW, 2006, ECOL APPL, V16, P2123, DOI 10.1890/1051-0761(2006)016[2123:MDITAA]2.0.CO;2; Boyle DP, 2000, WATER RESOUR RES, V36, P3663, DOI 10.1029/2000WR900207; Brooks PD, 1996, BIOGEOCHEMISTRY, V32, P93, DOI 10.1007/BF00000354; Brooks PD, 1999, HYDROL PROCESS, V13, P2177, DOI 10.1002/(SICI)1099-1085(199910)13:14/15&lt;2177::AID-HYP850&gt;3.0.CO;2-V; Burns DA, 2004, ENVIRON POLLUT, V127, P257, DOI 10.1016/S0269-7491(03)00264-1; Carroll RWH, 2018, HYDROL PROCESS, V32, P2187, DOI 10.1002/hyp.13151; Catalan N, 2016, NAT GEOSCI, V9, DOI 10.1038/ngeo2720; CHAPIN FS, 1979, J ECOL, V67, P169; Cheng FY, 2017, WATER RESOUR RES, V53, P5038, DOI 10.1002/2016WR020102; Christensen JN, 2018, SCI TOTAL ENVIRON, V637, P672, DOI 10.1016/j.scitotenv.2018.05.019; Cornell SE, 2003, ATMOS ENVIRON, V37, P2173, DOI 10.1016/S1352-2310(03)00133-X; Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118; Couture RM, 2014, ENVIRON SCI-PROC IMP, V16, P1588, DOI 10.1039/c3em00630a; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; EPA, 2018, CLEAN AIR STATUS TRE; Falco N, 2019, J GEOPHYS RES-BIOGEO, V124, P1618, DOI 10.1029/2018JG004394; Foster LM, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/aba77f; Foster LM, 2019, HYDROL PROCESS, V33, P332, DOI 10.1002/hyp.13327; Fox PM, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2019JG005419; Futter M., 2008, BHS 10 NAT HYDR S EX; Futter MN, 2009, HYDROL RES, V40, P153, DOI 10.2166/nh.2009.073; Grant RF, 2004, TREE PHYSIOL, V24, P1; Grant RF, 2001, MODELING CARBON AND NITROGEN DYNAMICS FOR SOIL MANAGEMENT, P173, DOI 10.1201/9781420032635.ch6; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P191, DOI 10.1023/A:1013024603959; HALVORSON JJ, 1992, ECOLOGY, V73, P87, DOI 10.2307/1938723; Hanson PC, 2014, LIMNOL OCEANOGR, V59, P167, DOI 10.4319/lo.2014.59.1.0167; Hofstra N, 2005, NUTR CYCL AGROECOSYS, V72, P267, DOI 10.1007/s10705-005-3109-y; Holloway JM, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000124; Holloway JM, 1999, GEOLOGY, V27, P567, DOI 10.1130/0091-7613(1999)027<0567:GNITBC>2.3.CO;2; Holloway JM, 1998, NATURE, V395, P785, DOI 10.1038/27410; Houlton BZ, 2018, SCIENCE, V360, P58, DOI 10.1126/science.aan4399; Hubbard SS, 2018, VADOSE ZONE J, V17, DOI 10.2136/vzj2018.03.0061; Iversen CM, 2017, NEW PHYTOL, V215, P15, DOI 10.1111/nph.14486; Jackson-Blake LA, 2017, WATER RESOUR RES, V53, P5382, DOI 10.1002/2016WR020132; Jackson-Blake LA, 2015, J HYDROL, V527, P641, DOI 10.1016/j.jhydrol.2015.05.001; Jefferson JL, 2017, J HYDROMETEOROL, V18, P897, DOI 10.1175/JHM-D-16-0053.1; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Jones JE, 2001, ADV WATER RESOUR, V24, P763, DOI 10.1016/S0309-1708(00)00075-0; Kollet SJ, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006004; Kollet SJ, 2006, ADV WATER RESOUR, V29, P945, DOI 10.1016/j.advwatres.2005.08.006; Kollet SJ, 2009, VADOSE ZONE J, V8, P846, DOI 10.2136/vzj2009.0005; Kuffour BNO, 2020, GEOSCI MODEL DEV, V13, P1373, DOI 10.5194/gmd-13-1373-2020; Lauerwald R, 2015, GLOBAL BIOGEOCHEM CY, V29, P534, DOI 10.1002/2014GB004941; Leadley PW, 1997, ECOL MONOGR, V67, P1, DOI 10.1890/0012-9615(1997)067[0001:AMONUB]2.0.CO;2; Legay N, 2013, BIOGEOSCIENCES, V10, P7631, DOI 10.5194/bg-10-7631-2013; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lu MC, 2017, SCI TOTAL ENVIRON, V593, P319, DOI 10.1016/j.scitotenv.2017.03.178; Maavara T, 2020, NAT REV EARTH ENV, V1, P103, DOI 10.1038/s43017-019-0019-0; Maxwell RM, 2013, ADV WATER RESOUR, V53, P109, DOI 10.1016/j.advwatres.2012.10.001; Maxwell RM, 2005, J HYDROMETEOROL, V6, P233, DOI 10.1175/JHM422.1; McGechan MB, 2004, AGR ECOSYST ENVIRON, V103, P149, DOI 10.1016/j.agee.2003.10.004; McMahon PB, 1999, WATER RESOUR RES, V35, P1629, DOI 10.1029/1999WR900004; Mekonnen ZA, 2019, NAT PLANTS, V5, P952, DOI 10.1038/s41477-019-0495-8; Montross GG, 2013, J GEOPHYS RES-BIOGEO, V118, P1068, DOI 10.1002/jgrg.20085; Morford SL, 2016, ECOLOGY, V97, P54, DOI 10.1890/15-0501.1; Morford SL, 2011, NATURE, V477, P78, DOI 10.1038/nature10415; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Pappenberger F, 2007, J HYDROL, V333, P275, DOI 10.1016/j.jhydrol.2006.08.017; Perakis SS, 2002, NATURE, V415, P416, DOI 10.1038/415416a; Ryken A, 2020, ADV WATER RESOUR, V135, DOI 10.1016/j.advwatres.2019.103473; Sebestyen SD, 2019, ENVIRON SCI TECHNOL, V53, P3620, DOI 10.1021/acs.est.9b01276; Sickman JO, 2001, WATER RESOUR RES, V37, P1445, DOI 10.1029/2000WR900371; Starrfelt J, 2014, ENVIRON SCI-PROC IMP, V16, P1578, DOI 10.1039/c3em00619k; Taylor PG, 2015, ECOLOGY, V96, P1229, DOI 10.1890/13-1418.1; Ugland R., 1991, CO 90 2, P403; USDA, 2020, COLORADO HIST SNOWPA; Vrugt JA, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006720; Wade AJ, 2002, HYDROL EARTH SYST SC, V6, P559, DOI 10.5194/hess-6-559-2002; Wan JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53205-2; Weintraub SR, 2015, ECOLOGY, V96, P1561, DOI 10.1890/14-0834.1; Wellen C, 2015, ENVIRON SCI TECHNOL, V49, P3278, DOI 10.1021/es5049557; Whitehead PG, 1998, SCI TOTAL ENVIRON, V210, P547, DOI 10.1016/S0048-9697(98)00037-0; Williams MW, 1998, ARCTIC ALPINE RES, V30, P26, DOI 10.2307/1551742; Williams MW, 1996, ENVIRON SCI TECHNOL, V30, P640, DOI 10.1021/es950383e; Winnick MJ, 2017, WATER RESOUR RES, V53, P2507, DOI 10.1002/2016WR019724; WOJCIECHOWSKI MF, 1984, ARCTIC ALPINE RES, V16, P1, DOI 10.2307/1551166; Yano Y, 2015, BIOGEOCHEMISTRY, V124, P319, DOI 10.1007/s10533-015-0100-9; Zhi W, 2019, WATER RESOUR RES, V55, P4233, DOI 10.1029/2018WR024257; Zhu Q, 2013, BIOGEOSCIENCES, V10, P7943, DOI 10.5194/bg-10-7943-2013	93	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247907	10.1371/journal.pone.0247907	http://dx.doi.org/10.1371/journal.pone.0247907			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760812	Green Published, gold			2022-12-26	WOS:000633030400036
J	Sikakulya, FK; Ssebuufu, R; Mambo, SB; Pius, T; Kabanyoro, A; Kamahoro, E; Mulumba, Y; Muhongya, JK; Kyamanywa, P				Sikakulya, Franck Katembo; Ssebuufu, Robinson; Mambo, Simon Binezero; Pius, Theophilus; Kabanyoro, Annet; Kamahoro, Elizabeth; Mulumba, Yusuf; Muhongya, Jean Kakule; Kyamanywa, Patrick			Use of face masks to limit the spread of the COVID-19 among western Ugandans: Knowledge, attitude and practices	PLOS ONE			English	Article								Background The world is grappling with an ever-changing COVID-19 pandemic using preventive measures such as personal hygiene, face masks, restrictions on travel and gatherings in communities, in addition to a race to find a vaccine. The purpose of this study was to evaluate the knowledge, attitudes and practices of the western Uganda community on the proper use of face masks to mitigate the spread of COVID-19. Methods A cross-sectional study using a structured questionnaire was carried out from 1(st) July to 10(th) July 2020 among western Ugandans of consent age of 18 years and above. Data was analysed using Stata version 14.2. Results Among the respondents (n = 1114), the mean age was 30.7 (SD 11.1), 51% were males, 53.9% married and 43% had attained secondary education. Most participants (60.1%, n = 670) had satisfactory knowledge on the use of face masks and participants at a tertiary education level [AOR 2.6 (95% CI: 1.42-4.67; p = 0.002)] were likely to have satisfactory knowledge than participants who had not education. On attitude, most respondents (69.4%) were confident enough to correctly put on a face mask; 83.4% believed that a face mask can protect against COVID-19 and 75.9% of respondents had never shared their face mask. The majority of respondents (95.2%) agreed wearing face masks in public places was important to protect themselves against COVID-19; 60.3% reported washing their hands before wearing and after removing the face mask. Unfortunately, 51.5% reported removing the face mask if they needed to talk to someone. Conclusion Despite the satisfactory knowledge, good attitude and practices, there is still much more to be done in terms of knowledge, attitude and practices among participants. Government, non-governmental organizations and civil society should improve sensitization of populations on how to behave with face masks while talking to avoid the spread of the COVID-19 among western Ugandans.	[Sikakulya, Franck Katembo; Ssebuufu, Robinson; Kyamanywa, Patrick] Kampala Int Univ Western Campus, Dept Surg, Fac Clin Med & Dent, Ishaka Bushenyi, Uganda; [Sikakulya, Franck Katembo] Univ Catholique Graben, Fac Med, Butembo, DEM REP CONGO; [Mambo, Simon Binezero] Youth Alliance Reprod Hlth, Goma, DEM REP CONGO; [Pius, Theophilus] Kampala Int Univ Western Campus, Dept Med Lab Sci, Ishaka Bushenyi, Uganda; [Kabanyoro, Annet; Kamahoro, Elizabeth] Kampala Int Univ Western Campus, Sch Nursing Sci, Ishaka Bushenyi, Uganda; [Mulumba, Yusuf] Makerere Univ, Canc Inst, Biostat, Kampala, Uganda; [Muhongya, Jean Kakule] Kampala Int Univ Western Campus, Allied Hlth Sci Dept, Ishaka Bushenyi, Uganda	Makerere University	Sikakulya, FK (corresponding author), Kampala Int Univ Western Campus, Dept Surg, Fac Clin Med & Dent, Ishaka Bushenyi, Uganda.; Sikakulya, FK (corresponding author), Univ Catholique Graben, Fac Med, Butembo, DEM REP CONGO.	francksikakulya@gmail.com	Sikakulya, Franck Katembo/AAF-7298-2019; Ssebuufu, Robinson/AAZ-1357-2020	Sikakulya, Franck Katembo/0000-0001-8101-273X; Ssebuufu, Robinson/0000-0003-2053-1696				Abebe TB, 2016, J PUBLIC HEALTH AFR, V7, P55, DOI 10.4081/jphia.2016.570; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Brief TA, 2020, EPIDEMIOLOGY, V7, P1; Chan KH, 2020, INT J EPIDEMIOL, V49, P1063, DOI 10.1093/ije/dyaa044; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Esposito S, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01260-2020; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Hager E., 2020, KNOWLEDGE ATTITUDE P, P1, DOI [10.1371/journal.pone.0236918, DOI 10.1371/JOURNAL.PONE.0236918]; Ho HSW, 2012, PUBLIC HEALTH, V126, P1001, DOI 10.1016/j.puhe.2012.09.010; Javid B, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1442; Koven S., 2020, NEW ENGL J MED, P1; Kumar J, 2020, CUREUS, V12, DOI 10.7759/cureus.7737; Lamptey E., 2020, PAN AFR MED J, V35, P1; Lee LYK, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09087-5; Nyakarahuka L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005907; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Portney IG., 2009, FDN CLIN RES APPL PR; RGoZ, 2019, ZANZ STAT ABSTR 2019; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Ssebuufu R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.618731; Usman IM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00340; Wee LE, 2020, J HOSP INFECT, V105, P113, DOI 10.1016/j.jhin.2020.04.016; World Health Organization, 2020, CONCEPT NOTE, V1; World Health Organization, 2020, GUIDING PRINCIPLES I	24	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248706	10.1371/journal.pone.0248706	http://dx.doi.org/10.1371/journal.pone.0248706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760882	Green Published, gold			2022-12-26	WOS:000633030400063
J	Mortensen, N; Jonasson, SA; Lavesson, IV; Emberland, KE; Litleskare, S; Wensaas, KA; Rortveit, G; Langeland, N; Hanevik, K				Mortensen, Nicolay; Jonasson, Solveig Aalstad; Lavesson, Ingrid Viola; Emberland, Knut Erik; Litleskare, Sverre; Wensaas, Knut-Arne; Rortveit, Guri; Langeland, Nina; Hanevik, Kurt			Characteristics of hospitalized patients during a large waterborne outbreak of Campylobacter jejuni in Norway	PLOS ONE			English	Article							DISTRIBUTION-SYSTEM; ENTERITIS	Very few reports describe all hospitalized patients with campylobacteriosis in the setting of a single waterborne outbreak. This study describes the demographics, comorbidities, clinical features, microbiology, treatment and complications of 67 hospitalized children and adults during a large waterborne outbreak of Campylobacter jejuni in Askoy, Norway in 2019, where more than 2000 people in a community became ill. We investigated factors that contributed to hospitalization and treatment choices. Data were collected from electronic patient records during and after the outbreak. Fifty adults and seventeen children were included with a biphasic age distribution peaking in toddlers and middle-aged adults. Most children, 14 out of 17, were below 4 years of age. Diarrhea was the most commonly reported symptom (99%), whereas few patients (9%) reported bloody stools. Comorbidities were frequent in adults (63%) and included cardiovascular disease, pre-existing gastrointestinal disease or chronic renal failure. Comorbidities in children (47%) were dominated by pulmonary and gastrointestinal diseases. Adult patients appeared more severely ill than children with longer duration of stay, higher levels of serum creatinine and CRP and rehydration therapy. Ninety-two percent of adult patients were treated with intravenous fluid as compared with 12% of children. Almost half of the admitted children received antibiotics. Two patients died, including a toddler. Both had significant complicating factors. The demographic and clinical findings presented may be useful for health care planning and patient management in Campylobacter outbreaks both in primary health care and in hospitals.	[Mortensen, Nicolay] Haukeland Hosp, Children & Youth Clin, Bergen, Norway; [Mortensen, Nicolay] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Jonasson, Solveig Aalstad] Haukeland Hosp, Dept Infect Dis, Bergen, Norway; [Lavesson, Ingrid Viola] Haukeland Hosp, Emergency Clin, Bergen, Norway; [Emberland, Knut Erik; Litleskare, Sverre; Wensaas, Knut-Arne] NORCE Norwegian Res Ctr, Res Unit Gen Practice, Bergen, Norway; [Emberland, Knut Erik; Rortveit, Guri] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Langeland, Nina; Hanevik, Kurt] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Hanevik, Kurt] Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Norwegian Research Centre (NORCE); University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Hanevik, K (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Hanevik, K (corresponding author), Haukeland Hosp, Dept Med, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway.	kurt.hanevik@uib.no	Hanevik, Kurt/I-1159-2012	Hanevik, Kurt/0000-0002-1466-2326; Emberland, Knut Erik/0000-0002-1635-7894	Helse Vest [F-10626]	Helse Vest	NL received a grant from Helse Vest (https://helse-vest.no/, number F-10626).	Bae Joon Yeol, 2018, Korean J Pediatr, V61, P84, DOI 10.3345/kjp.2018.61.3.84; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; Engberg Jorgen, 1998, Clin Microbiol Infect, V4, P648, DOI 10.1111/j.1469-0691.1998.tb00348.x; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Gubbels SM, 2012, SCAND J INFECT DIS, V44, P586, DOI 10.3109/00365548.2012.655773; Guzman-Herrador B, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21160; Hessulf F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1635-7; Hyllestad S, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.35.2000011; Jakopanec I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-128; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; KAPPERUD G, 1992, SCAND J INFECT DIS, V24, P741, DOI 10.3109/00365549209062459; KARMALI MA, 1979, J PEDIATR-US, V94, P527, DOI 10.1016/S0022-3476(79)80004-9; Kuhn KG, 2017, EPIDEMIOL INFECT, V145, P701, DOI 10.1017/S0950268816002788; Kuusi M, 2005, EPIDEMIOL INFECT, V133, P593, DOI 10.1017/S0950268805003808; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; NORM/NORM-VET, 2019, US ANT AG OCC ANT RE; Norway Statistics, 2019, HLTH CAR SOC REL SUR; Norwegian National Antimicrobial Guidelines for Hospitals, NORW DIR HLTH; PITKANEN T, 1983, ARCH INTERN MED, V143, P215, DOI 10.1001/archinte.143.2.215; Pitkanen T, 2008, J WATER HEALTH, V6, P365, DOI 10.2166/wh.2008.050; PONKA A, 1984, INFECTION, V12, P175, DOI 10.1007/BF01640893; Rzucidlo-Hymczak Anna, 2018, Przegl Epidemiol, V72, P337, DOI 10.32394/pe.72.3.10; Shane AL, 2017, CLIN INFECT DIS, V65, pE45, DOI 10.1093/cid/cix669; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Statistics Norway, POP REG AG CONT YEAR; Ternhag A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-70; Tracz DM, 2005, EMERG INFECT DIS, V11, P838; Uysal G, 1997, INFECTION, V25, P159, DOI 10.1007/BF02113604; Wang SC, 2008, J MICROBIOL IMMUNOL, V41, P408; White AE, 2019, CLIN INFECT DIS, V69, P1545, DOI 10.1093/cid/ciy1142; Yoo M, 2020, KOR J GASTROENTEROL, V75, P188, DOI 10.4166/kjg.2020.75.4.188	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248464	10.1371/journal.pone.0248464	http://dx.doi.org/10.1371/journal.pone.0248464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755697	gold, Green Published			2022-12-26	WOS:000632916600044
J	Saadi, A; Hampton, K; de Assis, MV; Mishori, R; Habbach, H; Haar, RJ				Saadi, Altaf; Hampton, Kathryn; de Assis, Maria Vassimon; Mishori, Ranit; Habbach, Hajar; Haar, Rohini J.			Associations between memory loss and trauma in US asylum seekers: A retrospective review of medico-legal affidavits	PLOS ONE			English	Review							REFUGEES; SEQUELAE; HEALTH	Background The U.S. immigration system mandates that persons seeking asylum prove their persecution claim is credible and their fear of returning home is well-founded. However, this population represents a highly trauma-exposed group, with neuropsychiatric symptoms consequent to prior torture or maltreatment that may interfere with cognitive function and their ability to recall their trauma. These memory lapses may be incorrectly perceived by asylum adjudicators as indicators of dishonesty and jeopardize the person's credibility and asylum claim. Our retrospective mixed methods study seeks to present associations between trauma and memory loss in a sample of persons seeking asylum to the U.S. and describe how memory impairments manifest in this trauma-exposed population. Methods We randomly selected 200 medico-legal affidavits from 1346 affidavits collected in the past 30 years, as part of the Physicians for Human Rights Asylum Network connecting clinicians with legal providers for medical and/or psychiatric affidavits of U.S. asylum seekers and persons seeking other forms of humanitarian relief (hereafter, "asylum seekers"). Data was extracted from these affidavits using a coding manual informed by the Istanbul Protocol, the global standard for torture documentation. Seven affidavits were excluded due to missing age. We used multiple logistic regression to assess the association of memory loss with neuropsychiatric diagnoses: head trauma, post-traumatic stress disorder (PTSD), and depression. We supplemented these findings with a qualitative content analysis of the affidavits documenting memory loss. Memory loss presented among the asylum seekers' affidavits in several ways: memory gaps of the traumatic event; challenges with presenting a clear chronology of the trauma, avoidance of traumatic memories, and persistent short-term memory loss interfering with daily activity. Results A majority of the sample received a neuropsychiatric diagnosis: 69% (n = 132) of asylum-seekers received a diagnosis of PTSD and 55% (n = 106) of depression. Head trauma was reported among 30% (n = 58) of affidavits. Further, 68% (n = 131) reported being subject to physical violence and 20% (n = 39) were documented as being at risk of suicide. Memory loss was documented among 21% (n = 40) asylum-seekers. In adjusted models, both PTSD and depression, but not head trauma, were associated with memory loss (p<0.05). Conclusion Stakeholders in the asylum process, spanning the medical, legal and immigration enforcement sectors, must be aware of the interplay of trauma and memory loss and how they might impact immigration proceedings for this vulnerable population.	[Saadi, Altaf] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Hampton, Kathryn; Habbach, Hajar] Phys Human Rights, New York, NY USA; [de Assis, Maria Vassimon] Univ Calif Berkeley, Dev Practice Program, Berkeley, CA 94720 USA; [Mishori, Ranit] Georgetown Univ, Sch Med, Dept Family Med, Washington, DC USA; [Haar, Rohini J.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California Berkeley; Georgetown University; University of California System; University of California Berkeley	Haar, RJ (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.	khampton@phr.org; rohinihaar@berkeley.edu		Haar, Rohini/0000-0002-9049-984X; Hampton, Kathryn/0000-0001-9598-7685				American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; [Anonymous], 2005, REMEMBERING TRAUMA; [Anonymous], 2020, REFUGEES ASYLEES; [Anonymous], CENTRAL AM REFUGEE C; Ashbaugh AR, 2018, MEMORY, V26, P106, DOI 10.1080/09658211.2017.1334801; Blackmore R, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003337; Cianciarulo MS, 2006, HARVARD J LEGIS, V43, P101; Cohen J, 2001, Med Leg J, V69, P25; Conroy MA, 2009, BERKELEY J GEND LAW, V24, P48; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Filone S., 2017, TRANSL ISSUES PSYCHO, V3, P202, DOI [10.1037/tps0000112, DOI 10.1037/TPS0000112]; Graham B, 2014, J BEHAV THER EXP PSY, V45, P375, DOI 10.1016/j.jbtep.2014.03.001; Guerra-Carrillo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182276; Hemaid F., 2018, MEM STUD; Herlihy J, 2002, BMJ-BRIT MED J, V324, P324, DOI 10.1136/bmj.324.7333.324; Holmes EA, 2017, BEHAV COGN PSYCHOTH, V45, P97, DOI 10.1017/S135246581600062X; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kalt A, 2013, AM J PUBLIC HEALTH, V103, pE30, DOI 10.2105/AJPH.2012.301136; McMurry HS, 2020, NEUROLOGY, V95, pE2605, DOI 10.1212/WNL.0000000000010929; McNally RJ, 2007, MAYO CLIN PROC, V82, P1083, DOI 10.4065/82.9.1083; McNally RJ, 2005, CAN J PSYCHIAT, V50, P817, DOI 10.1177/070674370505001302; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Moore SA, 2009, CURR OPIN PSYCHIATR, V22, P19, DOI 10.1097/YCO.0b013e328314e3bb; Narbutas N., 2018, COLUMBIA HUM RIGHTS, P48; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Paskey Stephen, 2016, SANTA CLARA LAW REV, V56, P457; Pettitt J, 2016, PROVING TORTURE DEMA; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rempell S., 2009, TEX INT LAW J, V44, P48; Saadi A, 2019, HEALTH EQUITY, V3, P431, DOI 10.1089/heq.2019.0048; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; Shin J, 2019, PHYS HUMAN RIGHTS; Toar M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-214; Towers R, 2013, RECOGNISING VICTIMS; United Nations, 2004, ISTANBUL PROTOCOL MA; Waldhauser GT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31400-x; Wenzel Thomas, 2015, Torture, V25, P51; Williams Linda M., 1999, TRAUMA MEMORY	38	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0247033	10.1371/journal.pone.0247033	http://dx.doi.org/10.1371/journal.pone.0247033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC6NY	33755695	gold, Green Published			2022-12-26	WOS:000632916600019
J	Kojima, T; Kitamura, K; Ichiyanagi, S; Watanabe, F; Yamaguchi, Y; Sato, E; Tani, D; Kako, H; Kandil, AI; Ohde, S; Miyazu, M				Kojima, Taiki; Kitamura, Kana; Ichiyanagi, Shogo; Watanabe, Fumio; Yamaguchi, Yukiko; Sato, Emi; Tani, Daisuke; Kako, Hiromi; Kandil, Ali, I; Ohde, Sachiko; Miyazu, Mitsunori			Introduction of precordial Doppler ultrasound to confirm correct peripheral venous access during general anesthesia in children: A preliminary study	PLOS ONE			English	Article								Background Delayed identification of infiltration and dysfunction of peripheral intravenous (PIV) access can lead to serious consequences during general anesthesia in children. This preliminary study aimed to describe the application of precordial Doppler ultrasound during general anesthesia in children to detect and confirm the correct PIV access and to evaluate the accuracy of this method. Methods This was a single-center, preliminary study that was conducted in children (<18 years) who were scheduled for elective surgeries between October 2019 and March 2020. Rater anesthesiologists judged the change in precordial Doppler sound (S test) before and after injection of 0.5 mL/kg of normal saline (NS) via PIV. Blood flow velocity before and after NS injection was recorded, and multiple cutoff points were set to analyze the accuracy of detecting the infiltration and dysfunction of PIV catheter (V test). Results The total incidence of peripheral infiltration and dysfunction of PIV catheter was 7/512 (1.4%). In the S test, the sensitivity, specificity, positive and negative likelihood ratios, and area under the receiver-operating characteristic curves (AUCs) were 5/7 (71.4%; 95% confidence interval [CI], 29.0%-96.3%), 490/505 (97.0%; 95% CI, 95.1%-98.3%), 24.0, 0.29, and 0.84, respectively. The V test showed that the reasonable threshold of blood flow velocity change was 1.0 m/s, with sensitivity, specificity, positive and negative likelihood ratios, and AUC of 4/7 (57.1%; 95% CI, 18.4%-90.1%), 489/505 (96.8%; 95% CI, 94.9%-98.2%), 18.0 and 0.44, and 0.84, respectively. Conclusions This preliminary study demonstrated that precordial Doppler ultrasound is a feasible, easy-to-use, and noninvasive technique with good accuracy to confirm the correct PIV access during general anesthesia in children. However, its accuracy requires further evaluation.	[Kojima, Taiki; Kitamura, Kana; Ichiyanagi, Shogo; Watanabe, Fumio; Yamaguchi, Yukiko; Sato, Emi; Tani, Daisuke; Kako, Hiromi; Miyazu, Mitsunori] Aichi Childrens Hlth & Med Ctr, Dept Anesthesiol, Obu, Aichi, Japan; [Kandil, Ali, I] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesiol, Cincinnati, OH 45229 USA; [Ohde, Sachiko] St Lukes Int Univ, Grad Sch Publ Hlth, Tokyo, Japan	Cincinnati Children's Hospital Medical Center; St. Luke's International Hospital	Kojima, T (corresponding author), Aichi Childrens Hlth & Med Ctr, Dept Anesthesiol, Obu, Aichi, Japan.	daiki_kojima@sk00106.achmc.pref.aichi.jp						Ball RD, 2013, J CLIN ANESTH, V25, P115, DOI 10.1016/j.jclinane.2012.06.018; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Burbridge MA, 2019, KOREAN J ANESTHESIOL, V72, P76, DOI 10.4097/kja.d.18.00252; Ching DLH, 2014, INT J SURG, V12, P1036, DOI 10.1016/j.ijsu.2014.08.355; Corbett M, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-018-1387-1; Gautam NK, 2017, PEDIATR ANESTH, V27, P821, DOI 10.1111/pan.13188; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heffner JE, 2002, CHEST, V121, P1916, DOI 10.1378/chest.121.6.1916; Jolley M, 2015, ANESTH ANALG, V121, P172, DOI 10.1213/ANE.0000000000000717; Keidan I, 2015, J CLIN ANESTH, V27, P585, DOI 10.1016/j.jclinane.2015.07.004; Keidan I, 2012, ANESTH ANALG, V115, P909, DOI 10.1213/ANE.0b013e318258023b; Schubert A, 2006, ANESTH ANALG, V102, P1543, DOI 10.1213/01.ane.0000198665.84248.61; Takeshita J, 2019, CRIT CARE MED, V47, pE836, DOI 10.1097/CCM.0000000000003916; Tasbihgou SR, 2018, ANAESTHESIA, V73, P112, DOI 10.1111/anae.14124; Yuan SM, 2009, ARCH CARDIOVASC DIS, V102, P549, DOI 10.1016/j.acvd.2009.04.011	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248999	10.1371/journal.pone.0248999	http://dx.doi.org/10.1371/journal.pone.0248999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750977	Green Published, gold			2022-12-26	WOS:000631967100004
J	Lin, CK; Huang, TH; Yang, CT; Shi, CS				Lin, Chin-Kuo; Huang, Tzu-Hsiung; Yang, Cheng-Ta; Shi, Chung-Sheng			Roles of lung-recruited monocytes and pulmonary Vascular Endothelial Growth Factor (VEGF) in resolving Ventilator-Induced Lung Injury (VILI)	PLOS ONE			English	Article								Monocytes and vascular endothelial growth factor (VEGF) have profound effects on tissue injury and repair. In ventilator-induced lung injury (VILI), monocytes, the majority of which are Ly6C(+high), and VEGF are known to initiate lung injury. However, their roles in post-VILI lung repair remain unclear. In this study, we used a two-hit mouse model of VILI to identify the phenotypes of monocytes recruited to the lungs during the resolution of VILI and investigated the contributions of monocytes and VEGF to lung repair. We found that the lung-recruited monocytes were predominantly Ly6C(+low) from day 1 after the insult. Meanwhile, contrary to inflammatory cytokines, pulmonary VEGF decreased upon VILI but subsequently increased significantly on days 7 and 14 after the injury. There was a strong positive correlation between VEGF expression and proliferation of alveolar epithelial cells in lung sections. The expression pattern of VEGF mRNA in lung-recruited monocytes was similar to that of pulmonary VEGF proteins, and the depletion of monocytes significantly suppressed the increase of pulmonary VEGF proteins on days 7 and 14 after VILI. In conclusion, during recovery from VILI, the temporal expression patterns of pulmonary growth factors are different from those of inflammatory cytokines, and the restoration of pulmonary VEGF by monocytes, which are mostly Ly6C(+low), is associated with pulmonary epithelial proliferation. Lung-recruited monocytes and pulmonary VEGF may play crucial roles in post-VILI lung repair.	[Lin, Chin-Kuo] Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Pulm Infect & Crit Care, Puzi, Taiwan; [Lin, Chin-Kuo; Shi, Chung-Sheng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Huang, Tzu-Hsiung] Chiayi Chang Gung Mem Hosp, Dept Resp Therapy, Puzi, Taiwan; [Yang, Cheng-Ta] Taoyuan Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan; [Yang, Cheng-Ta] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan; [Shi, Chung-Sheng] Chiayi Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Puzi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Shi, CS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.; Shi, CS (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Puzi, Taiwan.	csshi@mail.cgu.edu.tw		Lin, Chin-Kuo/0000-0002-5940-3715; Shi, Chung-Sheng/0000-0002-5548-7675	Chang Gung Medical Foundation of Taiwan [CMRPG6C0231, CMRPG6C0232]	Chang Gung Medical Foundation of Taiwan	This work was supported by the Chang Gung Medical Foundation of Taiwan (grant no. CMRPG6C0231 and CMRPG6C0232) and CKL received the grants. The URL of the foundation website is https://www.cgmh.org.tw/en/.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Atabai K, 2002, AM J PHYSIOL-LUNG C, V283, pL163, DOI 10.1152/ajplung.00396.2001; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barratt SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051269; Brempelis KJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.62; Burnham EL, 2014, EUR RESPIR J, V43, P276, DOI 10.1183/09031936.00196412; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Cross LJM, 2011, CRIT CARE CLIN, V27, P355, DOI 10.1016/j.ccc.2010.12.005; de Prost N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-28; Frank JA, 2006, CHEST, V130, P1906, DOI 10.1378/chest.130.6.1906; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Guo Q, 2011, BIOCHEM BIOPH RES CO, V413, P630, DOI 10.1016/j.bbrc.2011.09.015; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Kaner RJ, 2001, MOL MED, V7, P240, DOI 10.1007/BF03401843; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Koh H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-60; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Lahm T, 2007, SHOCK, V28, P4, DOI 10.1097/shk.0b013e31804d1998; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Loftus TJ, 2017, AM J SURG, V214, P610, DOI 10.1016/j.amjsurg.2017.06.019; Maitre B, 2001, EUR RESPIR J, V18, P100, DOI 10.1183/09031936.01.00074701; Maniscalco WM, 1997, AM J RESP CELL MOL, V16, P557, DOI 10.1165/ajrcmb.16.5.9160838; Medford ARL, 2009, J CRIT CARE, V24, P236, DOI 10.1016/j.jcrc.2008.04.003; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; Morrell ED, 2019, AM J RESP CRIT CARE, V200, P732, DOI 10.1164/rccm.201807-1381OC; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; Ohwada A, 2003, THORAX, V58, P328, DOI 10.1136/thorax.58.4.328; Patel BV, 2012, EUR RESPIR J, V39, P1162, DOI 10.1183/09031936.00093911; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Saha P, 2011, IMMUNOL CELL BIOL, V89, P2, DOI 10.1038/icb.2010.130; Sakuta T, 2001, J MED MICROBIOL, V50, P233, DOI 10.1099/0022-1317-50-3-233; Seemann S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0370-8; Shi CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165317; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Strouvalis I, 2018, RESPIROLOGY, V23, P942, DOI 10.1111/resp.13320; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Thickett DR, 2002, AM J RESP CRIT CARE, V166, P1332, DOI 10.1164/rccm.2105057; VANOUDALBLAS AB, 1982, IMMUNOBIOLOGY, V161, P186, DOI 10.1016/S0171-2985(82)80073-9; Wang FQ, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106443; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Wilson MR, 2012, CRIT CARE MED, V40, P2850, DOI 10.1097/CCM.0b013e31825b91ef; Wilson MR, 2009, AM J RESP CRIT CARE, V179, P914, DOI 10.1164/rccm.200806-877OC; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Zhang WK, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106015	54	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248959	10.1371/journal.pone.0248959	http://dx.doi.org/10.1371/journal.pone.0248959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33740009	gold, Green Published			2022-12-26	WOS:000631030200006
J	Silver, A; Perez, S; Gee, M; Xu, B; Garg, S; Will, K; Gill, A				Silver, Anita; Perez, Sean; Gee, Melanie; Xu, Bethany; Garg, Shreeya; Will, Kipling; Gill, Aman			Persistence of the ground beetle (Coleoptera: Carabidae) microbiome to diet manipulation	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL; COMMUNITIES; DIVERSITY; INSECTS; TOOLS	Host-associated microbiomes can play important roles in the ecology and evolution of their insect hosts, but bacterial diversity in many insect groups remains poorly understood. Here we examine the relationship between host environment, host traits, and microbial diversity in three species in the ground beetle family (Coleoptera: Carabidae), a group of roughly 40,000 species that synthesize a wide diversity of defensive compounds. This study used 16S amplicon sequencing to profile three species that are phylogenetically distantly related, trophically distinct, and whose defensive chemical secretions differ: Anisodactylus similis LeConte, 1851, Pterostichus serripes (LeConte, 1875), and Brachinus elongatulus Chaudoir, 1876. Wild-caught beetles were compared to individuals maintained in the lab for two weeks on carnivorous, herbivorous, or starvation diets (n = 3 beetles for each species-diet combination). Metagenomic samples from two highly active tissue types-guts, and pygidial gland secretory cells (which produce defensive compounds)-were processed and sequenced separately from those of the remaining body. Bacterial composition and diversity of these ground beetles were largely resilient to controlled changes to host diet. Different tissues within the same beetle harbor unique microbial communities, and secretory cells in particular were remarkably similar across species. We also found that these three carabid species have patterns of microbial diversity similar to those previously found in carabid beetles. These results provide a baseline for future studies of the role of microbes in the diversification of carabids.	[Silver, Anita; Perez, Sean; Gee, Melanie; Xu, Bethany; Garg, Shreeya; Will, Kipling; Gill, Aman] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Will, Kipling] Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Will, K (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Will, K (corresponding author), Univ Calif Berkeley, Essig Museum Entomol, Berkeley, CA 94720 USA.	kipwill@berkeley.edu	Will, Kipling/GPF-3648-2022	Will, Kipling/0000-0002-7056-9011; Garg, Shreeya/0000-0002-0570-3595; Silver, Anita/0000-0002-7144-4122	NSF DEB [1556957]; National Science Foundation Division of Environmental Biology	NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KW. NSF DEB #1556957. National Science Foundation Division of Environmental Biology. https://www.nsf.gov/bio/deb/about.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; Attygalle AB, 2020, SCI NAT-HEIDELBERG, V107, DOI 10.1007/s00114-020-01683-0; Bahrndorff S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169753; Blankenchip CL, 2018, PEERJ, V6, DOI 10.7717/peerj.4793; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Florez LV., 2018, NAT COMMUN, V9, P1, DOI [10.1038/s41467-017-02088-w, DOI 10.1038/S41467-017-02088-W]; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kaltenpoth M, 2014, MOL ECOL, V23, P1251, DOI 10.1111/mec.12469; Kellner RLL, 2002, INSECT BIOCHEM MOLEC, V32, P389, DOI 10.1016/S0965-1748(01)00115-1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Larochelle A., 1990, Fabreries Supplement, V5, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; McManus R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02361; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; R Core Team, 2020, R LANG ENV STAT COMP; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schwab DB, 2016, AM NAT, V188, P679, DOI 10.1086/688926; Scully ED, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1096; Stork NE, 2018, ANNU REV ENTOMOL, V63, P31, DOI 10.1146/annurev-ento-020117-043348; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Vavre F, 2014, CURR OPIN INSECT SCI, V4, P29, DOI 10.1016/j.cois.2014.08.003; Vogel H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15186; Will KW, 2000, BIOL J LINN SOC, V71, P459, DOI 10.1006/bijl.2000.0456; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wright ES, 2016, R J, V8, P352; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	45	1	1	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0241529	10.1371/journal.pone.0241529	http://dx.doi.org/10.1371/journal.pone.0241529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739998	Green Submitted, gold, Green Published			2022-12-26	WOS:000631030200030
J	Bogus, MI; Wronska, AK; Kaczmarek, A; Bogus-Sobocinska, M				Bogus, Mieczyslawa Irena; Wronska, Anna Katarzyna; Kaczmarek, Agata; Bogus-Sobocinska, Martyna			In vitro screening of 65 mycotoxins for insecticidal potential	PLOS ONE			English	Article							TOXICITY; FUNGI; EXPRESSION; CELLS; DEOXYNIVALENOL; CYTOTOXICITY; METABOLITES; BEAUVERICIN; STABILITY; TOXIN	The economic losses and threats to human and animal health caused by insects and the pathogens transmitted by them require effective and environmentally-friendly methods of controlling them. One such group of natural biocontrol agents which may be used as biopesticides is that of the entomopathogenic fungi and their toxic secondary metabolites (mycotoxins). The present in vitro work examined the insecticidal potential of 65 commercially-available mycotoxins against the insect Sf-9 cell line. Mammalian Caco-2 and THP-1 cell lines served as reference controls to select insecticidal mycotoxins harmless to mammalian cells. All tested mycotoxins significantly reduced the in vitro proliferation of the Sf-9 cells and evoked morphological changes. Ten of the mycotoxins found to strongly inhibit Sf-9 proliferation also had moderate or no effect on Caco-2 cells. The THP-1 cells were highly resistant to the tested mycotoxins: doses 10(3) times higher were needed to affect viability and morphology (1 mu g/ml for THP-1 versus 1 ng/ml for Sf-9 and Caco-2). Nine mycotoxins significantly decreased Sf-9 cell proliferation with minor effects on mammalian cells: cyclosporins B and D, cytochalasin E, gliotoxin, HC toxin, paxilline, penitrem A, stachybotrylactam and verruculogen. These may be good candidates for future biopesticide formulations.	[Bogus, Mieczyslawa Irena; Wronska, Anna Katarzyna; Kaczmarek, Agata] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [Bogus, Mieczyslawa Irena; Bogus-Sobocinska, Martyna] Biomibo Ul, Warsaw, Poland	Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences	Bogus, MI (corresponding author), Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland.; Bogus, MI (corresponding author), Biomibo Ul, Warsaw, Poland.	slawka@twarda.pan.pl	Kaczmarek, Agata/ABG-3202-2020; Wrońska, Anna/HHZ-6185-2022; Kaczmarek, Agata/ABG-3240-2020	Kaczmarek, Agata/0000-0001-7319-7973; Wrońska, Anna/0000-0001-5171-0828; Kaczmarek, Agata/0000-0001-7319-7973; Bogus, Mieczyslawa/0000-0003-4357-2335	Marshal's Office of the Mazowieckie Voivodeship [RPMA.01.02.00-14-5626/16]	Marshal's Office of the Mazowieckie Voivodeship	This work was supported by the Marshal's Office of the Mazowieckie Voivodeship grant RPMA.01.02.00-14-5626/16 awarded to commercial company BIOMIBO. The funder provided support in the form of salaries for authors MB-S and MIB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alassane-Kpembi I, 2013, TOXICOL APPL PHARM, V272, P191, DOI 10.1016/j.taap.2013.05.023; Alshannaq A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060632; Anke H, 2002, MYCOTA, V10, P109; Arora DK., 2001, SIGNIFICANCE FUNGAL, V1, P115; Asano S, 2012, J PHARMACOL EXP THER, V342, P453, DOI 10.1124/jpet.111.191072; Baines D., 2002, INSECT CELL CULTURES, P13; BENNETT JW, 1989, ADV APPL MICROBIOL, V34, P1; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bullerman LB, 2007, INT J FOOD MICROBIOL, V119, P140, DOI 10.1016/j.ijfoodmicro.2007.07.035; Charnley A. K., 2007, P159; Chen WB, 2019, MOL ECOL RESOUR, V19, P485, DOI 10.1111/1755-0998.12966; De Boevre M, 2012, WORLD MYCOTOXIN J, V5, P207, DOI 10.3920/WMJ2012.1410; Nieto CHD, 2018, FOOD CHEM TOXICOL, V118, P460, DOI 10.1016/j.fct.2018.05.057; Dowd PF., 1992, HDB APPL MYCOLOGY, P137; Escriva L, 2015, FOOD CHEM TOXICOL, V78, P185, DOI 10.1016/j.fct.2015.02.005; Fadeev RS, 2015, BIOL MEMBRANY, V32, P125, DOI 10.7868/S0233475515020061; Feng JM, 2019, J ASIAN NAT PROD RES, V21, P887, DOI 10.1080/10286020.2018.1551372; Fornelli F, 2004, J INVERTEBR PATHOL, V85, P74, DOI 10.1016/j.jip.2004.01.002; Fu Y, 2018, ELIFE, V7, DOI 10.7554/eLife.31628; Goettel MS., 2010, ENTOMOPATHOGENIC FUN, P387; Gribkoff VK, 1996, MOL PHARMACOL, V50, P206; GSCHWENDT M, 1988, BIOCHEM BIOPH RES CO, V150, P545, DOI 10.1016/0006-291X(88)90428-7; Guodong N, 2010, THESIS U ILLINOIS UR; Hu QB, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3194321; Hymery N, 2014, TOXICOL IN VITRO, V28, P940, DOI 10.1016/j.tiv.2014.04.003; Ikewaki N, 2003, MICROBIOL IMMUNOL, V47, P775, DOI 10.1111/j.1348-0421.2003.tb03435.x; Ji C, 2016, ANIM NUTR, V2, P127, DOI 10.1016/j.aninu.2016.07.003; Joung KE, 2004, ARCH PHARM RES, V27, P640, DOI 10.1007/BF02980164; Kaya, 1993, INSECT PATHOLOGY; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Koth CMM, 2009, ADV PROTEIN CHEM STR, V76, P43, DOI 10.1016/S1876-1623(08)76002-4; KRASNOFF SB, 1991, J INVERTEBR PATHOL, V58, P180, DOI 10.1016/0022-2011(91)90062-U; Loi M, 2017, TOXINS, V9, DOI 10.3390/toxins9040111; Miller JD., 1996, BIOCH MOL BIOL ENTOM, P331; Olombrada M, 2013, INSECT BIOCHEM MOLEC, V43, P39, DOI 10.1016/j.ibmb.2012.10.008; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Park SH, 2015, TOXINS, V7, P4484, DOI 10.3390/toxins7114484; Pfeiffer E, 1998, CARCINOGENESIS, V19, P1313, DOI 10.1093/carcin/19.7.1313; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Pineda-Valdes G, 2000, J FOOD PROTECT, V63, P1598, DOI 10.4315/0362-028X-63.11.1598; Pistol GC, 2014, BRIT J NUTR, V111, P452, DOI 10.1017/S0007114513002675; Pitt JI, 2000, MED MYCOL, V38, P17, DOI 10.1080/mmy.38.s1.17.22; REISS J, 1975, CHEM-BIOL INTERACT, V10, P339, DOI 10.1016/0009-2797(75)90055-1; Riley R. T., 1996, The Mycota. A comprehensive treatise on fungi as experimental systems for basic and applied research. Volume VI: Human and animal relationships., P193; Ruiz MJ, 2011, TOXICON, V58, P315, DOI 10.1016/j.toxicon.2011.07.015; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Solhaug A, 2016, BASIC CLIN PHARMACOL, V119, P533, DOI 10.1111/bcpt.12635; St. Leger Raymond J., 1996, P443; Stein RA, 2017, FOODBORNE DISEASES, 3RD EDITION, P407, DOI 10.1016/B978-0-12-385007-2.00021-8; Stump AD, 2011, ENVIRON ENTOMOL, V40, P1604, DOI 10.1603/EN11136; Tilton SC, 2014, NANOTOXICOLOGY, V8, P533, DOI 10.3109/17435390.2013.803624; Vigushin DM, 2004, MED ONCOL, V21, P21, DOI 10.1385/MO:21:1:21; Vilcinskas A, 1999, ADV PARASIT, V43, P267, DOI 10.1016/S0065-308X(08)60244-4; Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367; WEISER J, 1988, J INVERTEBR PATHOL, V51, P92, DOI 10.1016/0022-2011(88)90092-4; WEISER J, 1988, J INVERTEBR PATHOL, V51, P94, DOI 10.1016/0022-2011(88)90093-6; Zhang H, 2017, TOXICON, V129, P20, DOI 10.1016/j.toxicon.2017.01.018; Zhou HR, 2005, TOXICOL SCI, V85, P916, DOI 10.1093/toxsci/kfi146	58	6	6	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248772	10.1371/journal.pone.0248772	http://dx.doi.org/10.1371/journal.pone.0248772			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735295	Green Published, gold			2022-12-26	WOS:000631029700039
J	Hu, CL; Li, JL; Xing, X; Gao, J; Zhao, SL; Xing, LH				Hu, Chunling; Li, Junlu; Xing, Xia; Gao, Jing; Zhao, Shilong; Xing, Lihua			The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019; WUHAN; CELLS; NK	Background In December 2019, a new disease named coronavirus disease 2019 (COVID-19) was occurred. Patients who are critically ill with COVID-19 are more likely to die, especially elderly patients. We aimed to describe the effect of age on the clinical and immune characteristics of critically ill patients with COVID-19. Methods We retrospectively included 32 patients with COVID-19 who were confirmed to have COVID-19 by the local health authority and who were admitted to the first affiliated hospital of Zhengzhou University in Zhengzhou, China between January 3 and March 20, 2020. Clinical information and experimental test data were retrospectively collected for the patients. The 32 patients in this study were all in a critical condition and were classified as severe, according to the guidelines of 2019-nCoV infection from the National Health Commission of the People's Republic of China. Data were compared between those Results Of 32 patients, 13 were under 60 years old, and 19 patients were >= 60 years old. The most common symptom among all patients upon admission was fever (93.8%, 30/32). Compared to younger patients, older patients exhibited increased comorbidities. Among patients who were 60 years and older, platelet count, direct bilirubin (DBIL), indirect bilirubin(IBIL), lactate dehydrogenase (LDH), B-type natriuretic peptide (BNP), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-10 (IL-10) were significantly higher than in younger patients who were less than 60 years old. CD4+ T lymphocytes, CD8+ T lymphocytes, and NKT lymphocytes were decreased, CD4+/CD8+ T lymphocytes were significantly increased in all 32 patients, while there were no evident differences between younger and older patients. The CURB-65 (confusion, urea, respiratory, rate, blood pressure plus age >= 65 years), Acute Physiology and Chronic Health Evaluation (APACHE) II and pH value were significantly higher in older patients than in patients who were under 60 years old. However, the PaO2 and PaO2:FiO2 were lower in older patients than the younger. Compared to patients under 60 years old, patients who were 60 years and older tended to develop ARDS (15 [78.9%] vs 5 [38.5%]), septic shock (7 [36.8%] vs 0 [0.0%]) and were more likely to receive mechanical ventilation (13 [68.4%] vs 3[23.1%]). Dynamic trajectories of seven laboratory parameters were tracked on days 1, 3, 5 and 7, and significant differences in lymphocyte count (P = 0.026), D-dimer (P = 0.010), lactate dehydrogenase (P = 0.000) and C-reactive protein (P = 0.000) were observed between the two age groups. Conclusions A high proportion of critically ill patients were 60 or older. Furthermore, rapid disease progression was noted in elderly patients. Therefore, close monitoring and timely treatment should be performed in elderly COVID-19 patients.	[Hu, Chunling; Li, Junlu; Xing, Xia; Gao, Jing; Zhao, Shilong; Xing, Lihua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp, Intens Care Unit, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Xing, LH (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Resp, Intens Care Unit, Zhengzhou, Henan, Peoples R China.	xinglihua95088@163.com			National Natural Science Foundation of China [82074212]; Science and Technology Department of Henan Province (CN) [SB201901036]; Key Scientific Research Project of Colleges in Henan Province [19A320015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province (CN); Key Scientific Research Project of Colleges in Henan Province	The authors had received "National Natural Science Foundation of China (Number 82074212)", "Science and Technology Department of Henan Province (CN) (Number SB201901036)", and "Key Scientific Research Project of Colleges in Henan Province (Number 19A320015)" funding for this work.	Burki T, 2020, LANCET INFECT DIS, V20, P292, DOI 10.1016/S1473-3099(20)30076-1; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Choudhury A, 2020, J MED VIROL, V92, P2105, DOI 10.1002/jmv.25987; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Li MY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.580237; Liu Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01112-2020; Molgora M, 2017, NATURE, V551, P110, DOI 10.1038/nature24293; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Shi W, 2021, AM J PHYSIOL-LUNG C, V320, pL84, DOI 10.1152/ajplung.00355.2020; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu J, 2020, CLIN INFECT DIS, V71, P706, DOI 10.1093/cid/ciaa199; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yazar H, 2022, ARCH PHYSIOL BIOCHEM, V128, P1676, DOI 10.1080/13813455.2020.1788604; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zinellu A, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13427; Zumla A, 2020, LANCET, V395, pE35, DOI 10.1016/S0140-6736(20)30305-6	27	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248675	10.1371/journal.pone.0248675	http://dx.doi.org/10.1371/journal.pone.0248675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735325	gold, Green Published			2022-12-26	WOS:000631029700016
J	Otiang, E; Thumbi, SM; Campbell, ZA; Njagi, LW; Nyaga, PN; Palmer, GH				Otiang, Elkanah; Thumbi, Samuel M.; Campbell, Zoe A.; Njagi, Lucy W.; Nyaga, Philip N.; Palmer, Guy H.			Impact of routine Newcastle disease vaccination on chicken flock size in smallholder farms in western Kenya	PLOS ONE			English	Article							HOUSEHOLDS	Background Poultry represent a widely held economic, nutritional, and sociocultural asset in rural communities worldwide. In a recent longitudinal study in western Kenya, the reported mean number of chickens per household was 10, with increases in flock size constrained principally by mortality. Newcastle disease virus is a major cause of chicken mortality globally and hypothesized to be responsible for a large part of mortality in smallholder flocks. Our goal was to determine the impact of routine Newcastle disease virus (NDV) vaccination on flock size and use this data to guide programs to improve small flock productivity. Methods We conducted a factorial randomized controlled trial in 537 households: in 254 households all chickens were vaccinated every 3 months with I-2 NDV vaccine while chickens in 283 households served as unvaccinated controls. In both arms of the trial, all chickens were treated with endo- and ecto parasiticides every 3 months. Data on household chicken numbers and reported gains and losses were collected monthly for 18 months. Results Consistent with prior studies, the overall flock size was small but with increases in both arms of the study over time. The mean number of chickens owned at monthly census was 13.06 +/- 0.29 in the vaccinated households versus 12.06 +/- 0.20 in the control households (p = 0.0026) with significant gains in number of chicks (p = 0.06), growers (p = 0.09), and adults (p = 0.03) in the vaccinated flocks versus the controls. Household reported gains were 4.50 +/- 0.12 total chickens per month when vaccinated versus 4.15 +/- 0.11 in the non-vaccinated controls (p = 0.03). Gains were balanced by voluntary decreases, reflecting household decision-making for sales or household consumption, which were marginally higher, but not statistically significant, in vaccinated households and by involuntary losses, including mortality and loss due to predation, which were marginally higher in control households. Conclusion Quarterly NDV vaccination and parasiticidal treatment resulted in an increase in flock size by a mean of one bird per household as compared to households where the flock received only parasiticidal treatment. While results suggest that the preventable fraction of mortality attributable to Newcastle disease is comparatively small relatively to all-cause mortality in smallholder households, there was a significant benefit to vaccination in terms of flock size. Comparison with previous flock sizes in the study households indicate a more significant benefit from the combined vaccination and parasiticidal treatment, supporting a comprehensive approach to improving flock health and improving household benefits of production in the smallholder setting.	[Otiang, Elkanah; Thumbi, Samuel M.; Njagi, Lucy W.; Nyaga, Philip N.] Univ Nairobi, Coll Agr & Vet Sci, Nairobi, Kenya; [Otiang, Elkanah] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Otiang, Elkanah; Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ Global Hlth Kenya, Nairobi, Kenya; [Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Hlth, Pullman, WA 99164 USA; [Campbell, Zoe A.] Int Livestock Res Inst, Nairobi, Kenya; [Palmer, Guy H.] Univ Nairobi, Coll Hlth Sci, Nairobi, Kenya	University of Nairobi; Kenya Medical Research Institute; Washington State University; CGIAR; International Livestock Research Institute (ILRI); University of Nairobi	Palmer, GH (corresponding author), Washington State Univ Global Hlth Kenya, Nairobi, Kenya.; Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Hlth, Pullman, WA 99164 USA.; Palmer, GH (corresponding author), Univ Nairobi, Coll Hlth Sci, Nairobi, Kenya.	gpalmer@wsu.edu		Otiang, Elkanah/0000-0002-0336-3099; Palmer, Guy/0000-0001-5679-4709				Alders R., 2002, ACIAR MONOGRAPH, V86; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Apopo AA, 2020, TROP ANIM HEALTH PRO, V52, P699, DOI 10.1007/s11250-019-02059-x; Campbell ZA, 2019, VACCINE, V37, P11, DOI 10.1016/j.vaccine.2018.11.058; Campbell ZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206058; Dwinger RH, 2006, P FINAL RES COORDINA; FAO, 2014, 12 FAO; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Kingori A. M., 2010, International Journal of Poultry Science, V9, P309; Komba EV., 2012, J AGR SCI, V4; Kristjanson P, 2012, FOOD SECUR, V4, P381, DOI 10.1007/s12571-012-0194-z; Kryger K.N., 2010, SMALL HOLDER POULTRY; Lesnoff M., 2009, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V62, P49; Lowder SK, 2016, WORLD DEV, V87, P16, DOI 10.1016/j.worlddev.2015.10.041; Marangon S, 2007, REV SCI TECH OIE, V26, P265, DOI 10.20506/rst.26.1.1742; Mosites E, 2017, PUBLIC HEALTH NUTR, V20, P336, DOI [10.1017/S136898001600210X, 10.1017/s136898001600210x]; Mosites E, 2016, J NUTR, V146, P1118, DOI 10.3945/jn.115.225961; Nega M., 2012, Online Journal of Animal and Feed Research (OJAFR), V2, P244; Nyaga P, 2008, FAO POULTRY SECTOR C; Olwande PO, 2010, TROP ANIM HEALTH PRO, V42, P283, DOI 10.1007/s11250-009-9418-4; Otiang E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233691; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; UNDP, 2020, CHART PATHW MULT POV; Valdivia C., 2001, Agriculture and Human Values, V18, P27, DOI 10.1023/A:1007613031102; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Wong JT, 2017, GLOB FOOD SECUR-AGR, V15, P43, DOI 10.1016/j.gfs.2017.04.003; World Bank, 2020, POV SHAR PROSP 2020	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248596	10.1371/journal.pone.0248596	http://dx.doi.org/10.1371/journal.pone.0248596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735266	gold, Green Published			2022-12-26	WOS:000631029700066
J	Silva, RCD; de Souza, MA; da Silva, JYP; Ponciano, CD; Viera, VB; Bertozzo, CCDS; Guerra, GC; Araujo, DFD; da Conceicao, MM; Dias, CDQ; Oliveira, ME; Soares, JKB				de Franca Silva, Roberta Cristina; Albuquerque de Souza, Mikaelle; Pereira da Silva, Jaielison Yandro; Ponciano, Carolina da Silva; Viera, Vanessa Bordin; de Menezes Santos Bertozzo, Camila Carolina; Guerra, Gerlane Coelho; de Souza Araujo, Daline Fernandes; da Conceicao, Marta Maria; Querino Dias, Celina de Castro; Oliveira, Maria Elieidy; Barbosa Soares, Juliana Kessia			Evaluation of the effectiveness of macaiba palm seed kernel (Acrocomia intumescens drude) on anxiolytic activity, memory preservation and oxidative stress in the brain of dyslipidemic rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ANXIETY-RELATED BEHAVIOR; FISH-OIL; DIETARY SUPPLEMENTATION; NEUROTROPHIC FACTOR; MEMBRANE-LIPIDS; AXIS FUNCTION; ANTIOXIDANTS; GLUTATHIONE; DEFICITS	Macaiba palm seed kernel is a source of lipids and phenolic compounds. The objective of this study was to evaluate the effects of macaiba palm seed kernel on anxiety, memory, and oxidative stress in the brain of health and dyslipidemic rats. Forty rats were used, divided into 4 groups (n = 10 each): control (CONT), dyslipidemic (DG), kernel (KG), and Dyslipidemic kernel (DKG). Dyslipidemia was induced using a high fat emulsion for 14 days before treatment. KG and DKG received 1000 mg/kg of macaiba palm seed kernel per gavage for 28 days. After treatment, anxiety tests were carried out using the Open Field Test (OFT), Elevated Plus Maze (EPM), and the Object Recognition Test (ORT) to assess memory. In the animals' brain tissue, levels of malondialdehyde (MDA) and total glutathione (GSH) were quantified to determine oxidative stress. The data were treated with Two Way ANOVA followed by Tukey (p <0.05). Results demonstrated that the animals treated with kernel realized more rearing. DG and KG groomed less compared with CONT and DKG compared with all groups in OFT. KG spent more time in aversive open arms compared with CONT and DKG compared with all groups in EPM. Only DKG spent more time in the central area in EMP. KG and DKG showed a reduction in the exploration rate and MDA values (p <0.05). Data showed that macaiba palm seed kernel consumption induced anxiolytic-like behaviour and decreased lipids peroxidation in rats' brains. On the other hand, this consumption by healthy and dyslipidemic animals compromises memory.	[de Franca Silva, Roberta Cristina; Pereira da Silva, Jaielison Yandro; Ponciano, Carolina da Silva; Viera, Vanessa Bordin; de Menezes Santos Bertozzo, Camila Carolina; Barbosa Soares, Juliana Kessia] Univ Fed Campina Grande, Cuite, PB, Brazil; [Albuquerque de Souza, Mikaelle; da Conceicao, Marta Maria; Querino Dias, Celina de Castro; Oliveira, Maria Elieidy; Barbosa Soares, Juliana Kessia] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil; [Guerra, Gerlane Coelho; de Souza Araujo, Daline Fernandes] Univ Fed Rio Grande do Norte, Natal, RN, Brazil	Universidade Federal de Campina Grande; Universidade Federal da Paraiba; Universidade Federal do Rio Grande do Norte	Silva, RCD (corresponding author), Univ Fed Campina Grande, Cuite, PB, Brazil.	robertasaron@gmail.com		Silva, Jaielison Yandro/0000-0002-9297-654X	CNPQ (National Council for Scientific and Technological Development) Brazil [Universal 423166/2018-2]	CNPQ (National Council for Scientific and Technological Development) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by CNPQ (National Council for Scientific and Technological Development) Brazil -Universal 423166/2018-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JKBS is the researcher responsible for using the funding. There was no additional external funding received for this study.	Alrefaie Z, 2015, INT J VITAM NUTR RES, V85, P282, DOI 10.1024/0300-9831/a000286; Alzoubi KH, 2013, PHYSIOL BEHAV, V119, P72, DOI 10.1016/j.physbeh.2013.06.011; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andrich DE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00372; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Bahaeddin Z, 2017, NUTR NEUROSCI, V20, P317, DOI [10.1080/1028415X.2015.1126954, 10.1080/1028415x.2015.1126954]; Barbosa MQ, 2018, FOOD FUNCT, V9, P2891, DOI [10.1039/C7FO01764B, 10.1039/c7fo01764b]; Batool Z, 2018, PLANT FOOD HUM NUTR, V73, P7, DOI 10.1007/s11130-018-0655-4; Batool Z, 2016, BRAIN RES BULL, V120, P63, DOI 10.1016/j.brainresbull.2015.11.001; Bayraktar K, 2012, TURK J FISH AQUAT SC, V12, P661, DOI 10.4194/1303-2712-v12_3_14; Beilharz JE, 2015, NUTRIENTS, V7, P6719, DOI 10.3390/nu7085307; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Bora P.S., 2004, 101 NCIA TECNOLOGIA, V4, P158, DOI [10.1080/11358120409487755, DOI 10.1080/11358120409487755]; Budzynska B, 2015, PSYCHOPHARMACOLOGY, V232, P931, DOI 10.1007/s00213-014-3728-6; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Cavaliere G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00818; Czysz AH, 2013, CNS NEUROL DISORD-DR, V12, P466, DOI 10.2174/1871527311312040005; Das UN, 2003, BRAIN DEV-JPN, V25, P251, DOI 10.1016/S0387-7604(02)00221-8; Siqueira EMD, 2012, FOOD RES INT, V45, P427, DOI 10.1016/j.foodres.2011.11.005; Dias LS, 2013, IND CROP PROD, V49, P610, DOI 10.1016/j.indcrop.2013.06.005; Divneet Kaur, 2017, Pharmacognosy Journal, V9, P638, DOI 10.5530/pj.2017.5.101; Dominguez-Avila JA, 2015, FOOD CHEM, V168, P529, DOI 10.1016/j.foodchem.2014.07.092; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Egawa J, 2016, J PHYSIOL-LONDON, V594, P4565, DOI 10.1113/JP270590; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fernandes FS, 2011, NUTRITION, V27, P1040, DOI 10.1016/j.nut.2010.11.001; FOLCH J, 1957, J BIOL CHEM, V226, P497; de Melo MFFT, 2017, INT J DEV NEUROSCI, V61, P58, DOI 10.1016/j.ijdevneu.2017.06.006; Gadkari PV, 2015, FOOD BIOPROD PROCESS, V93, P122, DOI 10.1016/j.fbp.2013.12.004; Ganji A, 2017, METAB BRAIN DIS, V32, P503, DOI 10.1007/s11011-016-9940-9; Gustavsson M, 2010, NUTR RES, V30, P279, DOI 10.1016/j.nutres.2010.04.005; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; HIGBY WK, 1962, J FOOD SCI, V27, P42, DOI 10.1111/j.1365-2621.1962.tb00055.x; Hovatta I, 2010, NEUROSCI RES, V68, P261, DOI 10.1016/j.neures.2010.08.007; Hryhorczuk C, 2017, PSYCHONEUROENDOCRINO, V83, P142, DOI 10.1016/j.psyneuen.2017.06.002; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Komaki A., 2015, AVICENNA J NEURO PSY, V2, P2015, DOI [10.17795/ajnpp-27189, DOI 10.17795/AJNPP-27189]; Krolow R, 2014, CURR NEUROPHARMACOL, V12, P193, DOI 10.2174/1570159X11666131120223530; Kumar V, 2014, ROBBINS COTRAN PATHO; Lalanza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085049; Leffa DD, 2015, FOOD RES INT, V77, P649, DOI 10.1016/j.foodres.2015.10.006; Lescano CH, 2015, J MED FOOD, V18, P656, DOI 10.1089/jmf.2014.0077; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Liu LX, 2009, FOOD CHEM, V112, P35, DOI 10.1016/j.foodchem.2008.05.038; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; Markakis P., 1982, ANTHOCYANINS FOOD CO, P263; Martins S, 2011, BIOTECHNOL ADV, V29, P365, DOI 10.1016/j.biotechadv.2011.01.008; Matrisciano F, 2020, NEUROBIOL STRESS, V12, DOI 10.1016/j.ynstr.2020.100222; Mizrahi M, 2014, NANOMED-NANOTECHNOL, V10, P1353, DOI 10.1016/j.nano.2014.03.015; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Moon ML, 2014, METABOLISM, V63, P1131, DOI 10.1016/j.metabol.2014.06.002; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Muthaiyah B, 2014, J ALZHEIMERS DIS, V42, P1397, DOI 10.3233/JAD-140675; Oliveira VB, 2012, FOOD RES INT, V48, P170, DOI 10.1016/j.foodres.2012.03.011; Pase CS, 2015, J NUTR BIOCHEM, V26, P1200, DOI 10.1016/j.jnutbio.2015.05.013; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; do Nascimento ADP, 2016, J SUPERCRIT FLUID, V111, P1, DOI 10.1016/j.supflu.2016.01.013; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Perveen T., 2016, J BIOCH MOL BIOL, V49, P69; Pudell C, 2014, EUR J NEUROSCI, V39, P266, DOI 10.1111/ejn.12406; Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458; Rachetti ALF, 2013, BEHAV BRAIN RES, V237, P283, DOI 10.1016/j.bbr.2012.09.048; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Silva-Junior E.V., 2020, J OURNAL AGRONOMY CR, P1, DOI [10.1111/jac.12435, DOI 10.1111/JAC.12435]; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Stutz B, 2016, EMBO MOL MED, V8, P3, DOI 10.15252/emmm.201505749; Surveswaran S, 2007, FOOD CHEM, V102, P938, DOI 10.1016/j.foodchem.2006.06.033; Tang MM, 2018, PROSTAG LEUKOTR ESS, V128, P11, DOI 10.1016/j.plefa.2017.11.001; Upadhyay P, 2018, BIOMED PHARMACOTHER, V97, P1046, DOI 10.1016/j.biopha.2017.11.008; Voigt JP, 2005, BRAIN RES, V1046, P145, DOI 10.1016/j.brainres.2005.03.048; Warneke W, 2014, PHARMACOL BIOCHEM BE, V116, P45, DOI 10.1016/j.pbb.2013.11.016; Xu DY, 2012, LIFE SCI, V90, P30, DOI 10.1016/j.lfs.2011.10.010; YAMAMURO Y, 1995, BRAIN RES, V684, P1, DOI 10.1016/0006-8993(95)00290-7; Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	78	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0246184	10.1371/journal.pone.0246184	http://dx.doi.org/10.1371/journal.pone.0246184			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730037	gold, Green Published			2022-12-26	WOS:000630345000033
J	Jia, MQ; Gao, ZW; Gu, HJ; Zhao, CY; Liu, MQ; Liu, FH; Xie, LN; Wang, LC; Zhang, GG; Liu, YH; Han, GD				Jia, Meiqing; Gao, Zhiwei; Gu, Huijun; Zhao, Chenyu; Liu, Meiqi; Liu, Fanhui; Xie, Lina; Wang, Lichun; Zhang, Guogang; Liu, Yuhua; Han, Guodong			Effects of precipitation change and nitrogen addition on the composition, diversity, and molecular ecological network of soil bacterial communities in a desert steppe	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ORGANIC-MATTER; ENZYME-ACTIVITIES; CLIMATE-CHANGE; WATER; DEPOSITION; RESPONSES; CYCLES; PLANT; FERTILIZATION	Currently, the impact of changes in precipitation and increased nitrogen(N) deposition on ecosystems has become a global problem. In this study, we conducted a 8-year field experiment to evaluate the effects of interaction between N deposition and precipitation change on soil bacterial communities in a desert steppe using high-throughput sequencing technology. The results revealed that soil bacterial communities were sensitive to precipitation addition but were highly tolerant to precipitation reduction. Reduced precipitation enhanced the competitive interactions of soil bacteria and made the ecological network more stable. Nitrogen addition weakened the effect of water addition in terms of soil bacterial diversity and community stability, and did not have an interactive influence. Moreover, decreased precipitation and increased N deposition did not have a superimposed effect on soil bacterial communities in the desert steppe. Soil pH, moisture content, and NH4+-N and total carbon were significantly related to the structure of bacterial communities in the desert steppe. Based on network analysis and relative abundance, we identified Actinobacteria, Proteobacteria, Acidobacteria and Cyanobacteria members as the most important keystone bacteria that responded to precipitation changes and N deposition in the soil of the desert steppe. In summary, we comprehensively analyzed the responses of the soil bacterial community to precipitation changes and N deposition in a desert steppe, which provides a model for studying the effects of ecological factors on bacterial communities worldwide.	[Jia, Meiqing] Tianjin Normal Univ, Key Lab Water Resource & Environm, Tianjin, Peoples R China; [Gao, Zhiwei; Gu, Huijun; Liu, Meiqi; Liu, Fanhui; Xie, Lina; Zhang, Guogang] Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China; [Gao, Zhiwei; Gu, Huijun; Liu, Meiqi; Liu, Fanhui; Xie, Lina; Zhang, Guogang] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Zhao, Chenyu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Wang, Lichun] Jilin Acad Agr Sci, Inst Agr Environm & Resource, Changchun, Peoples R China; [Liu, Yuhua] Tianjin Agr Ecol Environm Monitoring & Agr Prod Q, Tianjin, Peoples R China; [Han, Guodong] Inner Mongolia Agr Univ, Coll Grassland Resources & Environm, Hohhot, Peoples R China	Tianjin Normal University; Tianjin Normal University; Tianjin Normal University; University of Tsukuba; Jilin Academy of Agricultural Sciences; Inner Mongolia Agricultural University	Xie, LN; Zhang, GG (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin, Peoples R China.; Xie, LN; Zhang, GG (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.; Wang, LC (corresponding author), Jilin Acad Agr Sci, Inst Agr Environm & Resource, Changchun, Peoples R China.	xielina1989@163.com; wlc1960@163.com; zhangguogang886@163.com		Gao, Zhiwei/0000-0001-7434-9836	National Natural Science Foundation of China [31770499, 31100330, 31500365, 31270502, 41403082, 31300386]; Tianjin Science and Technology Support Program [15ZCZDSF00410]; Tianjin Natural Science Foundation [12JCYBJC19700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Support Program; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin)	National Natural Science Foundation of China (31770499, 31100330, 31500365, 31270502, 41403082, 31300386), Tianjin Science and Technology Support Program (15ZCZDSF00410) and Tianjin Natural Science Foundation (12JCYBJC19700).	Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Baath E, 2015, APPL ENVIRON MICROB, V81, P7411, DOI 10.1128/AEM.02236-15; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bi J, 2012, J PLANT ECOL, V5, P320, DOI 10.1093/jpe/rtr046; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Chen QY, 2020, SCI TOTAL ENVIRON, V714, DOI 10.1016/j.scitotenv.2020.136787; Deng Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-113; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fath BD, 2007, ECOL MODEL, V208, P49, DOI 10.1016/j.ecolmodel.2007.04.029; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Jansson JK, 2020, NAT REV MICROBIOL, V18, P35, DOI 10.1038/s41579-019-0265-7; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kundzewicz ZW, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P173; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Li H, 2016, MICROB ECOL, V71, P974, DOI 10.1007/s00248-016-0730-z; Lin YC, 2013, J INTEGR AGR, V12, P2164, DOI [10.1016/S2095-3119(13)60346-9, 10.1016/s2095-3119(13)60346-9]; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Lu FM, 2011, BIOL FERT SOILS, V47, P187, DOI 10.1007/s00374-010-0522-4; Ma HK, 2016, APPL SOIL ECOL, V108, P128, DOI 10.1016/j.apsoil.2016.08.008; Ma QA, 2010, NUTR CYCL AGROECOSYS, V88, P315, DOI 10.1007/s10705-010-9356-6; Ma WJ, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134691; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Ouyang Y, 2020, EUR J SOIL BIOL, V98, DOI 10.1016/j.ejsobi.2020.103187; Qian X, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57622-6; Qiu HS, 2018, EUR J SOIL BIOL, V84, P27, DOI 10.1016/j.ejsobi.2017.12.003; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shi LL, 2018, ENVIRON POLLUT, V235, P293, DOI 10.1016/j.envpol.2017.12.083; Sun LJ, 2015, J INTEGR AGR, V14, P788, DOI 10.1016/S2095-3119(14)60773-5; Sun YF, 2018, J SOIL SEDIMENT, V18, P762, DOI 10.1007/s11368-017-1846-6; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030754; Wang NN, 2014, WORLD J MICROB BIOT, V30, P2975, DOI 10.1007/s11274-014-1725-x; Wang XH, 2017, CHEMOSPHERE, V188, P10, DOI 10.1016/j.chemosphere.2017.08.072; Wang Z, 2020, PLANT SOIL; Xu ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34801; Yan GY, 2020, PEDOSPHERE, V30, P363, DOI 10.1016/S1002-0160(19)60834-9; Zhang LH, 2018, APPL SOIL ECOL, V127, P87, DOI 10.1016/j.apsoil.2018.02.005; Zhang XM, 2014, SOIL BIOL BIOCHEM, V72, P26, DOI 10.1016/j.soilbio.2014.01.034; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zhu ZK, 2018, SOIL BIOL BIOCHEM, V116, P369, DOI 10.1016/j.soilbio.2017.11.001; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	63	11	11	34	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248194	10.1371/journal.pone.0248194	http://dx.doi.org/10.1371/journal.pone.0248194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730102	gold, Green Published			2022-12-26	WOS:000630345000016
J	Ong, JY; Pence, JT; Molik, DC; Shepherd, HAM; Goodson, HV				Ong, Joseph Y.; Pence, Julia T.; Molik, David C.; Shepherd, Heather A. M.; Goodson, Holly, V			Yeast grown in continuous culture systems can detect mutagens with improved sensitivity relative to the Ames test	PLOS ONE			English	Article								Continuous culture systems allow for the controlled growth of microorganisms over a long period of time. Here, we develop a novel test for mutagenicity that involves growing yeast in continuous culture systems exposed to low levels of mutagen for a period of approximately 20 days. In contrast, most microorganism-based tests for mutagenicity expose the potential mutagen to the biological reporter at a high concentration of mutagen for a short period of time. Our test improves upon the sensitivity of the well-established Ames test by at least 20-fold for each of two mutagens that act by different mechanisms (the intercalator ethidium bromide and alkylating agent methyl methanesulfonate). To conduct the tests, cultures were grown in small, inexpensive continuous culture systems in media containing (potential) mutagen, and the resulting mutagenicity of the added compound was assessed via two methods: a canavanine-based plate assay and whole genome sequencing. In the canavanine-based plate assay, we were able to detect a clear relationship between the amount of mutagen and the number of canavanine-resistant mutant colonies over a period of one to three weeks of exposure. Whole genome sequencing of yeast grown in continuous culture systems exposed to methyl methanesulfonate demonstrated that quantification of mutations is possible by identifying the number of unique variants across each strain. However, this method had lower sensitivity than the plate-based assay and failed to distinguish the different concentrations of mutagen. In conclusion, we propose that yeast grown in continuous culture systems can provide an improved and more sensitive test for mutagenicity.	[Ong, Joseph Y.; Pence, Julia T.; Shepherd, Heather A. M.; Goodson, Holly, V] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Molik, David C.; Goodson, Holly, V] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Ong, Joseph Y.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Pence, Julia T.] GSK, Rixensart, Belgium	University of Notre Dame; University of Notre Dame; University of California System; University of California Los Angeles; GlaxoSmithKline	Goodson, HV (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Goodson, HV (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	hgoodson@nd.edu	Goodson, Holly/AAE-6079-2022; Molik, David/AAD-2291-2022	Molik, David/0000-0003-3192-6538; Goodson, Holly/0000-0001-7942-8349	NSF [DBI 1556349]; Indiana CTSI; Glynn Family Honors Program; University of Notre Dame Chemistry, Biochemistry, Biology Interface Program (NIH) [T32GM075762]; American Water Works Association Thomas R Camp Fellowship; University of Notre Dame Center for Aquatic Conservation Fellowship; University of Notre Dame Advance Diagnostics Therapeutics	NSF(National Science Foundation (NSF)); Indiana CTSI; Glynn Family Honors Program; University of Notre Dame Chemistry, Biochemistry, Biology Interface Program (NIH); American Water Works Association Thomas R Camp Fellowship; University of Notre Dame Center for Aquatic Conservation Fellowship; University of Notre Dame Advance Diagnostics Therapeutics	This work was supported by NSF (nsf. gov) under grant DBI 1556349 to HVG. The sequencing and bioinformatics efforts were supported by a grant to HVG from the Indiana CTSI. JYO received support from the Glynn Family Honors Program. JTP received support from the University of Notre Dame Chemistry, Biochemistry, Biology Interface Program (NIH T32GM075762), American Water Works Association Thomas R Camp Fellowship, the University of Notre Dame Center for Aquatic Conservation Fellowship, and the University of Notre Dame Advance Diagnostics & Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniran A, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12203; AMES BN, 1973, P NATL ACAD SCI USA, V70, P2281, DOI 10.1073/pnas.70.8.2281; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Blank LM, 2005, BIOTECHNOL BIOENG, V90, P685, DOI 10.1002/bit.20466; BRUSICK DJ, 1980, MUTAT RES, V76, P169, DOI 10.1016/0165-1110(80)90009-3; Bull AT, 2010, J IND MICROBIOL BIOT, V37, P993, DOI 10.1007/s10295-010-0816-4; Calabrese EJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102871; Canales C, 2015, BIOTECHNOL PROGR, V31, P707, DOI 10.1002/btpr.2069; Cheng XJ, 2019, AQUACULT INT, V27, P1353, DOI 10.1007/s10499-019-00390-6; Corvi R, 2017, FOOD CHEM TOXICOL, V106, P600, DOI 10.1016/j.fct.2016.08.024; Del Rio E, 2005, BIOTECHNOL BIOENG, V91, P808, DOI 10.1002/bit.20547; Dunham M. J., 2017, CSH PROTOC, P514, DOI DOI 10.1101/PDB.TOP077610; Feretti D, 2020, ENVIRON RES, V185, DOI 10.1016/j.envres.2020.109385; Fernandez-de-Cossio-Diaz J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005835; Foustoukos DI, 2015, APPL ENVIRON MICROB, V81, P6850, DOI 10.1128/AEM.01215-15; FREI JV, 1975, MUTAT RES, V30, P89; Futakami M, 2007, J BIOCHEM, V141, P675, DOI 10.1093/jb/mvm074; GIBSON GR, 1994, FEMS MICROBIOL LETT, V118, P121, DOI 10.1016/0378-1097(94)90606-8; Grant SR, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00218-18; Gresham D, 2014, GENOMICS, V104, P399, DOI 10.1016/j.ygeno.2014.09.015; Gruz P, 2020, GENES ENVIRON, V42, DOI 10.1186/s41021-020-00154-2; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Hakura A, 1999, MUTAT RES-GEN TOX EN, V438, P29, DOI 10.1016/S1383-5718(98)00159-4; Haney J, 2015, REGUL TOXICOL PHARM, V73, P834, DOI 10.1016/j.yrtph.2015.10.011; Jansen MLA, 2005, MICROBIOL-SGM, V151, P1657, DOI 10.1099/mic.0.27577-0; Jenkins GJS, 2010, TOXICOLOGY, V278, P305, DOI 10.1016/j.tox.2009.11.016; Jodynis-Liebert J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030718; Jouhten P, 2008, BMC SYST BIOL, P2; Keren L, 2016, CELL, V166, P1282, DOI 10.1016/j.cell.2016.07.024; Kirsanov KI, 2010, MUTAT RES-GEN TOX EN, V699, P1, DOI 10.1016/j.mrgentox.2010.04.014; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieder S, 2016, BIOTECHNOL J, V11, P155, DOI 10.1002/biot.201500059; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marcus CS, 2015, CLIN NUCL MED, V40, P617, DOI 10.1097/RLU.0000000000000835; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Myszka H, 2020, BIOORG CHEM, V96, DOI 10.1016/j.bioorg.2020.103568; Nijkamp JF, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-36; Peebo K, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6030056; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; RASHID KA, 1984, J ENVIRON SCI HEAL B, V19, P95, DOI 10.1080/03601238409372417; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Robertson A, 2013, INT J MOL SCI, V14, P14024, DOI 10.3390/ijms140714024; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Saunders KA, 2000, J ANTIMICROB CHEMOTH, V45, P447, DOI 10.1093/jac/45.4.447; Singer VL, 1999, MUTAT RES-GEN TOX EN, V439, P37, DOI 10.1016/S1383-5718(98)00172-7; Soares EV, 2011, J APPL MICROBIOL, V110, P1, DOI 10.1111/j.1365-2672.2010.04897.x; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; Wen XB, 2014, BIORESOURCE TECHNOL, V161, P297, DOI 10.1016/j.biortech.2014.03.077; Winder CL, 2011, METHOD ENZYMOL, V500, P261, DOI 10.1016/B978-0-12-385118-5.00014-1; Wright J, 2011, FEMS YEAST RES, V11, P299, DOI 10.1111/j.1567-1364.2011.00719.x; Yabe T, 1996, J BACTERIOL, V178, P477, DOI 10.1128/jb.178.2.477-483.1996; Zhu YO, 2014, P NATL ACAD SCI USA, V111, pE2310, DOI 10.1073/pnas.1323011111	59	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0235303	10.1371/journal.pone.0235303	http://dx.doi.org/10.1371/journal.pone.0235303			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730086	Green Published, Green Submitted, gold			2022-12-26	WOS:000630345000055
J	Granados, JC; Richelle, A; Gutierrez, JM; Zhang, P; Zhang, XL; Bhatnagar, V; Lewis, NE; Nigam, SK				Granados, Jeffry C.; Richelle, Anne; Gutierrez, Jahir M.; Zhang, Patrick; Zhang, Xinlian; Bhatnagar, Vibha; Lewis, Nathan E.; Nigam, Sanjay K.			Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; ARYL-HYDROCARBON RECEPTOR; UREMIC TOXINS; KYNURENINE PATHWAY; CHOROID-PLEXUS; ACID; SLC22A8; REVEALS; DETERMINANTS; SECRETION	How organs sense circulating metabolites is a key question. Here, we show that the multispecific organic anion transporters of drugs, OAT1 (SLC22A6 or NKT) and OAT3 (SLC22A8), play a role in organ sensing. Metabolomics analyses of the serum of Oat1 and Oat3 knockout mice revealed changes in tryptophan derivatives involved in metabolism and signaling. Several of these metabolites are derived from the gut microbiome and are implicated as uremic toxins in chronic kidney disease. Direct interaction with the transporters was supported with cell-based transport assays. To assess the impact of the loss of OAT1 or OAT3 function on the kidney, an organ where these uptake transporters are highly expressed, knockout transcriptomic data were mapped onto a "metabolic task"-based computational model that evaluates over 150 cellular functions. Despite the changes of tryptophan metabolites in both knockouts, only in the Oat1 knockout were multiple tryptophan-related cellular functions increased. Thus, deprived of the ability to take up kynurenine, kynurenate, anthranilate, and N-formylanthranilate through OAT1, the kidney responds by activating its own tryptophan-related biosynthetic pathways. The results support the Remote Sensing and Signaling Theory, which describes how "drug" transporters help optimize levels of metabolites and signaling molecules by facilitating organ cross talk. Since OAT1 and OAT3 are inhibited by many drugs, the data implies potential for drug-metabolite interactions. Indeed, treatment of humans with probenecid, an OATinhibitor used to treat gout, elevated circulating tryptophan metabolites. Furthermore, given that regulatory agencies have recommended drugs be tested for OAT1 and OAT3 binding or transport, it follows that these metabolites can be used as endogenous biomarkers to determine if drug candidates interact with OAT1 and/or OAT3.	[Granados, Jeffry C.; Gutierrez, Jahir M.; Lewis, Nathan E.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Richelle, Anne; Lewis, Nathan E.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Zhang, Patrick] Univ Calif San Diego, Dept Biol, La Jolla, CA USA; [Zhang, Xinlian] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Biostat & Bioinformat, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Univ Calif San Diego, UC San Diego, Novo Nordisk Fdn, Ctr Biosustainabil, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	snigam@health.ucsd.edu		Gutierrez, Jahir/0000-0001-9188-4726; Zhang, Patrick/0000-0003-0241-4525; Granados, Jeffry/0000-0003-0393-7141	National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) [R01GM132938]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB009380]; NIGMS [R35GM119850]; National Institute of Allergy and Infectious Diseases (NIAID) [UH2AI153029]; Government of Mexico (CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); LIFA fellowship	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Government of Mexico (CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); LIFA fellowship	This work was supported by a grant from the National Institutes of Health (NIH) to S. K. N. from the National Institute of General Medical Sciences (NIGMS) (R01GM132938). Support for J. C. G. comes from the training grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) (T32EB009380) and a supplement to R01GM132938. This work was funded in part by generous funding from NIGMS to N. E. L. (R35GM119850), National Institute of Allergy and Infectious Diseases (NIAID) to N. E. L. (UH2AI153029), a LIFA fellowship to A. R., and a fellowship to J. M. G. from the Government of Mexico (CONACYT) and the University of California Institute for Mexico and the United States (UC-MEXUS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Some figures were generated using Biorender. This article is dedicated to the memory of Vibha Bhatnagar, MD, MPH.	Ahn SY, 2008, CURR OPIN NEPHROL HY, V17, P499, DOI 10.1097/MNH.0b013e32830b5d5d; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Brady KP, 1999, GENOMICS, V56, P254, DOI 10.1006/geno.1998.5722; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Bush KT, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133817; Bush KT, 2017, J BIOL CHEM, V292, P15789, DOI 10.1074/jbc.M117.796516; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Divorty N, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00041; Duan P, 2012, MOL PHARMACEUT, V9, P3340, DOI 10.1021/mp300365t; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062002; Engelhart DC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051791; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Evers R, 2018, CLIN PHARMACOL THER, V104, P900, DOI 10.1002/cpt.1115; Govindarajan R, 2016, CLIN PHARMACOL THER, V100, P398, DOI 10.1002/cpt.454; Granados J. C., 2021, J BIOL CHEM; Hoglund E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00158; Jansen J, 2019, P NATL ACAD SCI USA, V116, P16105, DOI 10.1073/pnas.1821809116; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lepist EI, 2017, EXPERT OPIN DRUG MET, V13, P1075, DOI 10.1080/17425255.2017.1372425; Lisowska-Myjak B, 2014, NEPHRON CLIN PRACT, V128, P303, DOI 10.1159/000369817; Liu HC, 2016, J BIOL CHEM, V291, P19474, DOI 10.1074/jbc.M116.745216; Liu Y, 2016, CELL REP, V14, P2889, DOI 10.1016/j.celrep.2016.02.079; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lowenstein J, 2016, AM J PHYSIOL-RENAL, V310, pF1351, DOI 10.1152/ajprenal.00055.2016; Lu H, 2017, PEERJ, V5, DOI 10.7717/peerj.3333; Manzella C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24213-5; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Masereeuw R, 2010, PHARMACOL THERAPEUT, V126, P200, DOI 10.1016/j.pharmthera.2010.02.007; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam AK, 2020, J BIOL CHEM, V295, P1829, DOI 10.1074/jbc.RA119.010729; Nigam SK, 2020, CLIN PHARMACOL THER, V108, P40, DOI 10.1002/cpt.1818; Nigam SK, 2019, NAT REV NEPHROL, V15, P301, DOI 10.1038/s41581-019-0111-1; Nigam SK, 2018, CURR OPIN NEPHROL HY, V27, P305, DOI 10.1097/MNH.0000000000000427; Nigam SK, 2018, ANNU REV PHARMACOL, V58, P663, DOI 10.1146/annurev-pharmtox-010617-052713; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Poeggeler B, 2007, NEUROSCIENCE, V148, P188, DOI 10.1016/j.neuroscience.2007.05.033; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Rael LT, 2018, BIOCHEM BIOPHYS REP, V15, DOI 10.1016/j.bbrep.2018.06.006; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; Richelle A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007185; Richelle A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006867; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rosenthal SB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47798-x; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Savitz J, 2020, MOL PSYCHIATR, V25, P131, DOI 10.1038/s41380-019-0414-4; Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003; Sirianni AC, 2015, J NEUROCHEM, V134, P956, DOI 10.1111/jnc.13190; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Tankiewicz A, 2003, ADV EXP MED BIOL, V527, P409; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Uwai Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1517, DOI 10.1271/bbb.130178; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; van den Brand JAJG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168117; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04949-2; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; You G, 2014, WILEY SER DRUG DISC, P1, DOI 10.1002/9781118705308; Zhao ZH, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0304-5; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	82	14	14	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100575	10.1016/j.jbc.2021.100575	http://dx.doi.org/10.1016/j.jbc.2021.100575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757768	Green Published, gold			2022-12-26	WOS:000672866400548
J	Hayek, H; Gross, L; Janvier, A; Schaeffer, L; Martin, F; Eriani, G; Allmang, C				Hayek, Hassan; Gross, Lauriane; Janvier, Aurelie; Schaeffer, Laure; Martin, Franck; Eriani, Gilbert; Allmang, Christine			eIF3 interacts with histone H4 messenger RNA to regulate its translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 3; CAP-BINDING PROTEIN; EUKARYOTIC TRANSLATION; STRUCTURAL INSIGHTS; RECOGNITION MOTIF; FACTOR 4G; COMPLEX; SUBUNIT; REPLICATION; ROLES	In eukaryotes, various alternative translation initiation mechanisms have been unveiled for the translation of specific mRNAs. Some do not conform to the conventional scanning-initiation model. Translation initiation of histone H4 mRNA combines both canonical (cap-dependent) and viral initiation strategies (no-scanning, internal recruitment of initiation factors). Specific H4 mRNA structures tether the translation machinery directly onto the initiation codon and allow massive production of histone H4 during the S phase of the cell cycle. The human eukaryotic translation initiation factor 3 (eIF3), composed of 13 subunits (a-m), was shown to selectively recruit and control the expression of several cellular mRNAs. Whether eIF3 mediates H4 mRNA translation remains to be elucidated. Here, we report that eIF3 binds to a stem-loop structure (eIF3-BS) located in the coding region of H4 mRNA. Combining cross-linking and ribonucleoprotein immunoprecipitation experiments in vivo and in vitro, we also found that eIF3 binds to H1, H2A, H2B, and H3 histone mRNAs. We identified direct contacts between eIF3c, d, e, g subunits, and histone mRNAs but observed distinct interaction patterns to each histone mRNA. Our results show that eIF3 depletion in vivo reduces histone mRNA binding and modulates histone neosynthesis, suggesting that synthesis of histones is sensitive to the levels of eIF3. Thus, we provide evidence that eIF3 acts as a regulator of histone translation.	[Hayek, Hassan; Gross, Lauriane; Janvier, Aurelie; Schaeffer, Laure; Martin, Franck; Eriani, Gilbert; Allmang, Christine] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France; [Hayek, Hassan] Temple Univ, Dept Thorac Med & Surg, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19140 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Eriani, G; Allmang, C (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, Strasbourg, France.	g.eriani@unistra.fr; c.allmang@unistra.fr	MARTIN, Franck/D-9042-2015	MARTIN, Franck/0000-0001-9724-4025; Hayek, Hassan/0000-0001-6250-0535; Eriani, Gilbert/0000-0002-8518-4675; Allmang, Christine/0000-0001-8883-0874	French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche [ANR-17-CE11-0024]; Libanese Doctoralship from the municipality of Adchit; University of Strasbourg Doctoralship	French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche(French National Research Agency (ANR)); Libanese Doctoralship from the municipality of Adchit; University of Strasbourg Doctoralship	This work was supported by the French Centre National de la Recherche CNRS; Universite de Strasbourg; Agence Nationale de la Recherche [ANR-17-CE11-0024, H4translation]; Libanese Doctoralship from the municipality of Adchit (to H. H.); University of Strasbourg Doctoralship (to L. G.).	Aitken CE, 2016, ELIFE, V5, DOI 10.7554/eLife.20934; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Cai Q, 2010, J MOL BIOL, V403, P185, DOI 10.1016/j.jmb.2010.07.054; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; de la Parra C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05539-0; de Tacca LMA, 2019, RNA, V25, P1324, DOI 10.1261/rna.070193.118; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Eriani G, 2018, RNA BIOL, V15, P1250, DOI 10.1080/15476286.2018.1518855; Erzberger JP, 2014, CELL, V159, P1227, DOI 10.1016/j.cell.2014.11.001; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gribling-Burrer AS, 2017, NUCLEIC ACIDS RES, V45, P5399, DOI 10.1093/nar/gkx031; Gross L, 2018, METHODS, V137, P3, DOI 10.1016/j.ymeth.2017.12.019; Gross L, 2017, NUCLEIC ACIDS RES, V45, P8993, DOI 10.1093/nar/gkx622; Hayek H., 2020, ADV EXPT MED BIOL, V2; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Higareda-Mendoza AE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-10; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaeger S, 2005, BIOCHIMIE, V87, P827, DOI 10.1016/j.biochi.2005.03.012; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Karaskova M, 2012, J BIOL CHEM, V287, P28420, DOI 10.1074/jbc.M112.386656; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Llacer JL, 2015, MOL CELL, V59, P399, DOI 10.1016/j.molcel.2015.06.033; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Martin F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12622; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Neusiedler J, 2012, RNA, V18, P1163, DOI 10.1261/rna.032631.112; Obayashi E, 2017, CELL REP, V18, P2651, DOI 10.1016/j.celrep.2017.02.052; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pulos-Holmes MC, 2019, ELIFE, V8, DOI 10.7554/eLife.48193; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Querido JB, 2020, SCIENCE, V369, P1220, DOI 10.1126/science.aba4904; Shah M, 2016, CELL REP, V16, P1891, DOI 10.1016/j.celrep.2016.07.006; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smith MD, 2016, STRUCTURE, V24, P886, DOI 10.1016/j.str.2016.02.024; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Sun YD, 2020, SCIENCE, V367, P700, DOI 10.1126/science.aaz7758; Szostak E, 2018, NUCLEIC ACIDS RES, V46, P4099, DOI 10.1093/nar/gky246; Takeuchi A, 2009, NUCLEIC ACIDS RES, V37, P2126, DOI 10.1093/nar/gkp078; Ujino S, 2012, VIRUS RES, V163, P390, DOI 10.1016/j.virusres.2011.10.003; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; von Moeller H, 2013, NUCLEIC ACIDS RES, V41, P7960, DOI 10.1093/nar/gkt558; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wurth L, 2014, NUCLEIC ACIDS RES, V42, P8663, DOI 10.1093/nar/gku580; Yin YT, 2018, GENE, V673, P130, DOI 10.1016/j.gene.2018.06.034; Zeman J, 2019, NUCLEIC ACIDS RES, V47, P8282, DOI 10.1093/nar/gkz570; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100578	10.1016/j.jbc.2021.100578	http://dx.doi.org/10.1016/j.jbc.2021.100578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33766559	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400551
J	Kumari, A; Shriwas, O; Sisodiya, S; Santra, MK; Guchhait, SK; Dash, R; Panda, D				Kumari, Anuradha; Shriwas, Omprakash; Sisodiya, Shailendra; Santra, Manas K.; Guchhait, Sankar K.; Dash, Rupesh; Panda, Dulal			Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of beta-catenin: Evidence of inhibition of Wnt/beta-catenin signaling as an important antitumor mechanism of microtubule-targeting agents	FASEB JOURNAL			English	Article						apoptosis; cell cycle; microtubule-targeting agents; oral squamous cell carcinoma; Wnt/beta-catenin signaling		An aberrant accumulation of nuclear beta-catenin is closely associated with the augmentation of cancer malignancy. In this work, we report that several microtubule-targeting agents (MTAs) such as vinblastine, taxol, and C12 (combretastatin-2-aminoimidazole analog) inhibit VvUt/beta-catenin sienaline in oral squamous cell carcinoma (OSCC). We showed that the inhibition of microtuhule dynamics by MTAs decreased the level of beta-catenin by increasing Axin and adenomatous polyposis coli levels and reducing the level of dishevelled. Furthermore, MTAs strongly reduced the localization of beta-catenin in the nucleus. The reduction in the level of nuclear beta-catenin was neither due to the degradation of beta-catenin in the nucleus nor due to an increase in the export of nuclear beta-catenin from the nucleus. A motor protein kinesin-2 was found to assist the nuclear transportation of beta-catenin. Interestingly, Wnt/beta-catenin signaling antagonist treatment synergized with MTAs and the activators of Wnt/beta-catenin signaling antagonized with the MTAs. C12 potently suppressed the growth of 4-Nitroquinoline 1-oxide-induced OSCC in the tongue of C57 black 6 mice and also abrogated Wnt/beta-catenin signaling pathway in the tumor. Our results provide evidence that the decrease in Wnt/beta-catenin signaling is an important antitumor effect of MTAs and the combined use of MTAs with Wnt/beta-catenin signaling antagonists could be a promising strategy for cancer chemotherapy.	[Kumari, Anuradha; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Shriwas, Omprakash; Dash, Rupesh] Inst Life Sci, Bhubaneswar, India; [Sisodiya, Shailendra; Guchhait, Sankar K.] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Mohali, Punjab, India; [Santra, Manas K.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay, Maharashtra, India.	panda@iitb.ac.in		Kumari, Anuradha/0000-0003-1829-8215	JC Bose National Fellowship [JCB/2019/000016]; Department of Science and Technology, Government of India	JC Bose National Fellowship; Department of Science and Technology, Government of India(Department of Science & Technology (India))	The work is supported by JC Bose National Fellowship (JCB/2019/000016) from the Department of Science and Technology, Government of India to DP.	Birajdar Smita Shrishail, 2014, J Oral Maxillofac Pathol, V18, P169, DOI 10.4103/0973-029X.140729; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Chaudhary V, 2016, J MED CHEM, V59, P3439, DOI 10.1021/acs.jmedchem.6b00101; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Fischer MM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700090; Follet J, 2012, BRIT J CANCER, V106, P685, DOI 10.1038/bjc.2012.6; Frenzel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027988; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Huang JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40716; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Inoue T, 2005, FEBS LETT, V579, P4978, DOI 10.1016/j.febslet.2005.08.006; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalele K, 2015, J CLIN DIAGN RES, V9, pZJ1, DOI 10.7860/JCDR/2015/13644.6416; Kan W, 2020, ELIFE, V9, DOI 10.7554/eLife.55015; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222; Khan AH, 2016, PHARMACOGENOMICS J, V16, P164, DOI 10.1038/tpj.2015.50; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kumari A, 2019, BIOCHEM PHARMACOL, V170, DOI 10.1016/j.bcp.2019.113663; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee BE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12054-7; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Liang YJ, 2020, CELL TISSUE RES, V381, P527, DOI 10.1007/s00441-020-03220-x; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Vuong LT, 2014, DEVELOPMENT, V141, P3222, DOI 10.1242/dev.106229; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu ST, 2016, AIMS MOL SCI, V3, P597, DOI 10.3934/molsci.2016.4.597; Lucas FR, 1998, J CELL SCI, V111, P1351; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mohammed MK, 2016, GENES DIS, V3, P11, DOI 10.1016/j.gendis.2015.12.004; Odajima T, 2005, HUM PATHOL, V36, P234, DOI 10.1016/j.humpath.2004.12.009; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Shi J, 2017, ENDOCR-RELAT CANCER, V24, pT83, DOI 10.1530/ERC-17-0003; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SU LK, 1995, CANCER RES, V55, P2972; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vuong LT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07605-z; Wu CW, 2004, WORLD J GASTROENTERO, V10, P3240, DOI 10.3748/wjg.v10.i22.3240; Xu YS, 2018, ARTIF CELL NANOMED B, V46, P192, DOI 10.1080/21691401.2018.1453827; Yu XM, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1031-4; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang K, 2017, ONCOTARGET, V8, P115803, DOI 10.18632/oncotarget.23253; Zhang K, 2015, CELL PROLIFERAT, V48, P249, DOI 10.1111/cpr.12161; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	52	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21539	10.1096/fj.202002594R	http://dx.doi.org/10.1096/fj.202002594R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742719				2022-12-26	WOS:000635216100048
J	Yu, Y; Yang, WJ; Bilotta, AJ; Zhao, XJ; Cong, YZ; Li, YQ				Yu, Yu; Yang, Wenjing; Bilotta, Anthony J.; Zhao, Xiaojing; Cong, Yingzi; Li, Yanqing			L-lactate promotes intestinal epithelial cell migration to inhibit colitis	FASEB JOURNAL			English	Article						ATP; IEC; intestinal homeostasis; L&#8208; lactate; migration	BARRIER FUNCTION; GUT MICROBIOTA; RHO-GTPASES; IN-VITRO; TURNOVER; RESTITUTION; ORGANIZATION; PERSISTENCE; ACTIVATION; RESPONSES	Lactate, one of the most common primary metabolites of bacteria and human cells, has been shown to play essential roles in the regulation of inflammatory diseases, including inflammatory bowel diseases. However, whether and how host-derived lactate affects intestinal epithelial homeostasis is still not completely understood. Here, we investigated how L-lactate, mainly produced by host cells, regulates intestinal epithelial cell (IEC) migration to promote intestinal wound healing. Using video microscopy and tracking individual cells, we found that L-lactate enhanced IEC migration in direction persistence and speed. Mechanistically, L-lactate promoted IEC mitochondrial ATP production. The mitochondrial ATP synthase inhibitor, oligomycin, significantly decreased IEC persistence and speed, which inhibited cell migration induced by L-lactate. Furthermore, administering mice with L-lactate suppressed colitis induced by dextran sulfate sodium. In conclusion, our study demonstrates that host-derived L-lactate promotes IEC mitochondrial ATP production to drive cell migration, promoting intestinal wound healing to alleviate intestinal inflammation.	[Yu, Yu; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Cheeloo Coll Med, Jinan, Peoples R China; [Yu, Yu; Yang, Wenjing; Bilotta, Anthony J.; Zhao, Xiaojing; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China.	liyanqing@sdu.edu.cn	Yang, Wenjing/AAE-5924-2021	Yang, Wenjing/0000-0003-1541-1892; Cong, Yingzi/0000-0003-4167-7395; Li, Yanqing/0000-0003-0575-0399				Angajala A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01605; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Bilotta AJ, 2021, CELL MOL GASTROENTER, V11, P1023, DOI 10.1016/j.jcmgh.2020.11.011; Bressan C, 2020, ELIFE, V9, DOI 10.7554/eLife.56006; Brooks GA, 2007, SPORTS MED, V37, P341, DOI 10.2165/00007256-200737040-00017; Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008; Campeau JL, 2012, INFECT IMMUN, V80, P2632, DOI 10.1128/IAI.00288-12; Certo M, 2020, WIRES SYST BIOL MED, V12, DOI 10.1002/wsbm.1474; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Daw CC, 2020, CELL, V183, P474, DOI 10.1016/j.cell.2020.08.049; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dodard G, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107855; Ellmerer M, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/390975; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Finley LWS, 2019, NATURE, V571, P39, DOI 10.1038/d41586-019-01934-9; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gal N, 2013, RHEOL ACTA, V52, P425, DOI 10.1007/s00397-013-0694-6; Goetze K, 2011, INT J ONCOL, V39, P453, DOI 10.3892/ijo.2011.1055; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Han SY, 2018, INT J MOL MED, V42, P1644, DOI 10.3892/ijmm.2018.3733; Han TY, 2013, CELL ADHES MIGR, V7, P395, DOI 10.4161/cam.26345; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Iraporda C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00651; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Krndija D, 2019, SCIENCE, V365, P705, DOI 10.1126/science.aau3429; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Lee, 2019, BIORXIV, DOI [10.1101/827998, DOI 10.1101/827998]; Lee YS, 2018, CELL HOST MICROBE, V24, P833, DOI 10.1016/j.chom.2018.11.002; Lei XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225380; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu CY, 2004, ANN NY ACAD SCI, V1011, P133, DOI 10.1196/annals.1293.014; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; Marelli-Berg FM, 2018, J LEUKOCYTE BIOL, V104, P285, DOI 10.1002/JLB.1MR1117-472R; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Pohanka M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3419034; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; Pucino V, 2019, CELL METAB, V30, P1055, DOI 10.1016/j.cmet.2019.10.004; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ramio-Lluch L, 2014, REPROD FERT DEVELOP, V26, P883, DOI 10.1071/RD13145; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Schaks M, 2019, ESSAYS BIOCHEM, V63, P483, DOI 10.1042/EBC20190015; Sittipo P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215296; Song JY, 2018, P NATL ACAD SCI USA, V115, P2850, DOI 10.1073/pnas.1801697115; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; VONJAGOW G, 1980, ANGEW CHEM INT EDIT, V19, P659, DOI 10.1002/anie.198006593; Watson Joanna R, 2017, Small GTPases, V8, P237, DOI 10.1080/21541248.2016.1215657; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Wortel IM., 2020, BIORXIV, DOI [10.1101/338459, DOI 10.1101/338459]; Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197; Zanotelli MR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12155-z	64	3	3	4	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21554	10.1096/fj.202100095R	http://dx.doi.org/10.1096/fj.202100095R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742715				2022-12-26	WOS:000635216100053
J	Fulton, JC; Amaradasa, BS; Ertek, TS; Iriarte, FB; Sanchez, T; Ji, PS; Paret, ML; Hudson, O; Ali, ME; Dufault, NS				Fulton, James C.; Amaradasa, B. Sajeewa; Ertek, Tuelin S.; Iriarte, Fanny B.; Sanchez, Tatiana; Ji, Pingsheng; Paret, Mathews L.; Hudson, Owen; Ali, Md. Emran; Dufault, Nicholas S.			Phylogenetic and phenotypic characterization of Fusarium oxysporum f. sp. niveum isolates from Florida-grown watermelon	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; HORIZONTAL GENE-TRANSFER; FORMAE-SPECIALES; FUNGUS FUSARIUM; RACE 3; POPULATION; DIFFERENTIATION; WILT; G(ST); RESISTANCE	Fusarium wilt of watermelon (Citrullus lanatus) caused by Fusarium oxysporum f. sp. niveum (Fon), has become an increasing concern of farmers in the southeastern USA, especially in Florida. Management of this disease, most often through the use of resistant cultivars and crop rotation, requires an accurate understanding of an area's pathogen population structure and phenotypic characteristics. This study improved the understanding of the state's pathogen population by completing multilocus sequence analysis (MLSA) of two housekeeping genes (BT and TEF) and two loci (ITS and IGS), aggressiveness and race-determining bioassays on 72 isolates collected between 2011 and 2015 from major watermelon production areas in North, Central, and South Florida. Multilocus sequence analysis (MLSA) failed to group race 3 isolates into a single large clade; moreover, clade membership was not apparently correlated with aggressiveness (which varied both within and between clades), and only slightly with sampling location. The failure of multilocus sequence analysis using four highly conserved housekeeping genes and loci to clearly group and delineate known Fon races provides justification for future whole genome sequencing efforts whose more robust genomic comparisons will provide higher resolution of intra-species genetic distinctions. Consequently, these results suggest that identification of Fon isolates by race determination alone may fail to detect economically important phenotypic characteristics such as aggressiveness leading to inaccurate risk assessment.	[Fulton, James C.; Paret, Mathews L.; Dufault, Nicholas S.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Amaradasa, B. Sajeewa] Inst Adv Learning & Res, Danville, VA USA; [Ertek, Tuelin S.] Zirai Mucadele Merkez Arastirma Enstitusu, Ankara, Turkey; [Ertek, Tuelin S.; Iriarte, Fanny B.; Paret, Mathews L.] Univ Florida, North Florida Res & Educ Ctr, Quincy, FL USA; [Sanchez, Tatiana] Univ Florida, Inst Food & Agr Sci, Alachua County, FL USA; [Ji, Pingsheng; Hudson, Owen; Ali, Md. Emran] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA	State University System of Florida; University of Florida; Ministry of Food, Agriculture & Livestock - Turkey; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; University of Georgia	Dufault, NS (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	nsdufault@ufl.edu	; /GVU-7300-2022	Ali, Emran/0000-0002-1957-4392; /0000-0003-4901-5417	United States Department of Agriculture, National Institute of Food and Agriculture [2014-51181-22471]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	NSD, SBA Grant #: 2014-51181-22471 United States Department of Agriculture, National Institute of Food and Agriculture, https://nifa.usda.gov/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaradasa BS, 2018, PLANT DIS, V102, P1029, DOI [10.1094/pdis-10-17-1649-pdn, 10.1094/PDIS-10-17-1649-PDN]; [Anonymous], 2006, POPULATION GENETICS; [Anonymous], 2019, 2019 CROP PRODUCTION; ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Baayen RP, 2000, PHYTOPATHOLOGY, V90, P891, DOI 10.1094/PHYTO.2000.90.8.891; Bertucci MB, 2019, WEED SCI, V67, P221, DOI 10.1017/wsc.2018.76; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Burdon JJ, 2016, PHYTOPATHOLOGY, V106, P1117, DOI 10.1094/PHYTO-01-16-0036-FI; Cantliffe DJ, 2007, ACTA HORTIC, P473; Carbone I., 2004, APPL MYCOLOGY BIOTEC, V4; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Demers JE, 2015, APPL ENVIRON MICROB, V81, P81, DOI 10.1128/AEM.02590-14; Edel-Hermann V, 2019, PHYTOPATHOLOGY, V109, P512, DOI 10.1094/PHYTO-08-18-0320-RVW; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Egel D.S., 2007, PLANT HLTH INSTR, V10, P1094, DOI [10.1094/PHI-I-2007-0122-01, DOI 10.1094/PHI-I-2007-0122-01]; Everts K.L., 2011, FIELD EVALUATION TRI, V5, pV175, DOI DOI 10.1094/PDMR05; Everts K. L., 2010, PLANT DIS MANAG REP, V4, pV066; Everts KL, 2015, CROP PROT, V73, P93, DOI 10.1016/j.cropro.2015.02.019; Fish WW., 2010, CUCURBITACEAE 2010 P, P222; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Gordon TR, 1997, ANNU REV PHYTOPATHOL, V35, P111, DOI 10.1146/annurev.phyto.35.1.111; Grunwald NJ, 2003, PHYTOPATHOLOGY, V93, P738, DOI 10.1094/PHYTO.2003.93.6.738; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hudson O, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.01004-20; HUDSON RR, 1992, GENETICS, V132, P583; Jombart T, 2017, MOL ECOL RESOUR, V17, P19, DOI 10.1111/1755-0998.12567; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Katan T, 1999, PHYTOPARASITICA, V27, P273, DOI 10.1007/BF02981483; Katan T, 1999, PHYTOPARASITICA, V27, P51, DOI 10.1007/BF02980727; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keinath A.P., 2017, COMPENDIUM CUCURBIT, V2nd ed., DOI [10.1094/9780890545744, DOI 10.1094/9780890545744]; Keinath AP, 2020, PLANT DIS, V104, P2481, DOI 10.1094/PDIS-11-19-2385-RE; Keinath AP, 2019, PLANT DIS, V103, P44, DOI 10.1094/PDIS-04-18-0709-RE; KIMURA M, 1969, GENETICS, V61, P893; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kleczewski N.M., 2011, PLANT HLTH PROG, V12, P27, DOI [10.1094/PHP-2011-1129-01-DG, DOI 10.1094/PHP-2011-1129-01-DG]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LATIN RX, 1986, PLANT DIS, V70, P297, DOI 10.1094/PD-70-297; Laurence MH, 2015, PLANT PATHOL, V64, P1068, DOI 10.1111/ppa.12350; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lievens B, 2007, ENVIRON MICROBIOL, V9, P2145, DOI 10.1111/j.1462-2920.2007.01329.x; Lin YH, 2010, NEW BIOTECHNOL, V27, P409, DOI 10.1016/j.nbt.2010.05.005; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Martyn RD, 2014, HORTICUL RE, V42, P349; MARTYN RD, 1983, PLANT DIS, V67, P493, DOI 10.1094/PD-67-493; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Munoz-Pajares AJ, 2013, METHODS ECOL EVOL, V4, P1195, DOI 10.1111/2041-210X.12118; Nei M., 1987, MOL EVOLUTIONARY GEN; Niu XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28146; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Pereira AS, 2017, SCI HORTIC-AMSTERDAM, V218, P205, DOI 10.1016/j.scienta.2017.02.030; Petkar A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219821; R Core Team, 2021, R LANGUAGE ENV STAT; Ramdial H, 2017, PHYTOPATHOLOGY, V107, P109, DOI 10.1094/PHYTO-05-16-0209-R; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Costa AES, 2018, SCI HORTIC-AMSTERDAM, V228, P181, DOI 10.1016/j.scienta.2017.10.007; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Skovgaard K, 2001, PHYTOPATHOLOGY, V91, P1231, DOI 10.1094/PHYTO.2001.91.12.1231; TAJIMA F, 1989, GENETICS, V123, P585; van Dam P, 2016, ENVIRON MICROBIOL, V18, P4087, DOI 10.1111/1462-2920.13445; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x; Zhang M, 2015, PLANT PATHOL, V64, P1076, DOI 10.1111/ppa.12355; Zhou XG, 2010, PLANT DIS, V94, P92, DOI 10.1094/PDIS-94-1-0092	73	3	3	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248364	10.1371/journal.pone.0248364	http://dx.doi.org/10.1371/journal.pone.0248364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764995	gold, Green Published			2022-12-26	WOS:000634832800076
J	Kowalik, Z; Lewandowski, P				Kowalik, Zuzanna; Lewandowski, Piotr			The gender gap in aversion to COVID-19 exposure: Evidence from professional tennis	PLOS ONE			English	Article								We study the gender differences in aversion to COVID-19 exposure using a natural experiment of the 2020 US Open. It was the first major tennis tournament after the season had been paused for six months, held with the same rules and prize money for men and women. We analyze the gender gap in the propensity to voluntarily withdraw because of COVID-19 concerns among players who were eligible and fit to play. We find that female players were significantly more likely than male players to have withdrawn from the 2020 US Open. While players from countries characterized by relatively high levels of trust and patience and relatively low levels of risk-taking were more likely to have withdrawn than their counterparts from other countries, female players exhibited significantly higher levels of aversion to pandemic exposure than male players even after cross-country differences in preferences are accounted for. About 15% of the probability of withdrawing that is explained by our model can be attributed to gender.	[Kowalik, Zuzanna; Lewandowski, Piotr] Inst Struct Res IBS, Warsaw, Poland; [Lewandowski, Piotr] IZA, Bonn, Germany	IZA Institute Labor Economics	Lewandowski, P (corresponding author), Inst Struct Res IBS, Warsaw, Poland.; Lewandowski, P (corresponding author), IZA, Bonn, Germany.	piotr.lewandowski@ibs.org.pl		Kowalik, Zuzanna/0000-0002-0389-9811; Lewandowski, Piotr/0000-0003-2506-5639				Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; [Anonymous], PASERMAN MD GENDER D; [Anonymous], 2014, ITF PROCIRCUIT REV; [Anonymous], BU HANSPAL T LIAO LI, DOI [10.2139/ssrn.3559870, DOI 10.2139/SSRN.3559870]; Balafoutas L, 2019, J ECON PSYCHOL, V75, DOI 10.1016/j.joep.2019.02.009; Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Bavel JJV, 2020, NAT HUM BEHAV, V4, P12, DOI [10.1038/s41562-019-0780-6, DOI 10.1038/S41562-019-0780-6]; Booth AL, 2012, ECON J, V122, pF56, DOI 10.1111/j.1468-0297.2011.02480.x; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Cohen-Zada D, 2017, J ECON PSYCHOL, V61, P176, DOI 10.1016/j.joep.2017.04.005; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Eckel CC, 2015, AM ECON REV, V105, P906, DOI 10.1257/aer.20130683; Ely J, 2017, J ECON PSYCHOL, V63, P135, DOI 10.1016/j.joep.2017.02.006; Falk A, 2018, Q J ECON, V133, P1645, DOI 10.1093/qje/qjy013; Falk A, 2018, SCIENCE, V362, DOI 10.1126/science.aas9899; Filippin A, 2016, MANAGE SCI, V62, P3138, DOI 10.1287/mnsc.2015.2294; Fitzgerald M, IM BREAKING PAIRE RE; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Guillaume M, 2011, MED SCI SPORT EXER, V43, P2148, DOI 10.1249/MSS.0b013e31821eb533; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004; Maquirriain J, 2016, EUR J SPORT SCI, V16, P845, DOI 10.1080/17461391.2016.1156163; Monge P, 2007, SCAND J WORK ENV HEA, V33, P293, DOI 10.5271/sjweh.1146; Moran KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164541; Moss B, 2015, INT J PERF ANAL SPOR, V15, P884, DOI 10.1080/24748668.2015.11868838; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Oreffice S, GENDER INEQUALITY CO; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	31	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249045	10.1371/journal.pone.0249045	http://dx.doi.org/10.1371/journal.pone.0249045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765075	Green Submitted, gold, Green Published			2022-12-26	WOS:000634832800060
J	Nibouche, S; Costet, L; Medina, RF; Holt, JR; Sadeyen, J; Zoogones, AS; Brown, P; Blackman, RL				Nibouche, Samuel; Costet, Laurent; Medina, Raul F.; Holt, Jocelyn R.; Sadeyen, Joelle; Zoogones, Anne-Sophie; Brown, Paul; Blackman, Roger L.			Morphometric and molecular discrimination of the sugarcane aphid, Melanaphis sacchari, (Zehntner, 1897) and the sorghum aphid Melanaphis sorghi (Theobald, 1904)	PLOS ONE			English	Article								Melanaphis sacchari (Zehntner, 1897) and Melanaphis sorghi (Theobald, 1904) are major worldwide crop pests causing direct feeding damage on sorghum and transmitting viruses to sugarcane. It is common in the scientific literature to consider these two species as synonyms, referred to as the 'sugarcane aphid', although no formal study has validated this synonymy. In this study, based on the comparison of samples collected from their whole distribution area, we use both morphometric and molecular data to better characterize the discrimination between M. sacchari and M. sorghi. An unsupervised multivariate analysis of morphometric data clearly confirmed the separation of the two species. The best discriminating characters separating these species were length of the antenna processus terminalis relative to length of hind tibia, siphunculus or cauda. However, those criteria sometimes do not allow an unambiguous identification. Bayesian clustering based on microsatellite data delimited two clusters, which corresponded to the morphological species separation. The DNA sequencing of three nuclear and three mitochondrial regions revealed slight divergence between species. In particular, the COI barcode region proved to be uninformative for species separation because one haplotype is shared by both species. In contrast, one SNP located on the nuclear EF1-alpha gene was diagnostic for species separation. Based on morphological and molecular evidence, the invasive genotype damaging to sorghum in the US, Mexico and the Caribbean since 2013 is found to be M. sorghi.	[Nibouche, Samuel; Costet, Laurent; Zoogones, Anne-Sophie] CIRAD, UMR PVBMT, St Pierre, Reunion, France; [Medina, Raul F.; Holt, Jocelyn R.] Texas A&M Univ, College Stn, TX USA; [Sadeyen, Joelle; Zoogones, Anne-Sophie] Univ La Reunion, UMR PVBMT, St Pierre, La Reunion, France; [Brown, Paul; Blackman, Roger L.] Nat Hist Museum, London, England	CIRAD; Texas A&M University System; Texas A&M University College Station; University of La Reunion; Natural History Museum London	Nibouche, S (corresponding author), CIRAD, UMR PVBMT, St Pierre, Reunion, France.	samuel.nibouche@cirad.fr	Medina, Raul/S-8294-2016	Medina, Raul/0000-0002-8697-8901	European Union: Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation internationale en Recherche agronomique pour le Developpement; National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch Program [TEX09185]; Groupe d'Interet Scientifique "Infrastructures en Biologie Santeet Agronomie"	European Union: Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation internationale en Recherche agronomique pour le Developpement; National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch Program; Groupe d'Interet Scientifique "Infrastructures en Biologie Santeet Agronomie"	This work was co-funded by the European Union: Agricultural Fund for Rural Development (https://ec.europa.eu/agriculture/capfunding_en), by the Conseil Departemental de La Reunion (http://www.cg974.fr), by the Conseil Regional de La Reunion (https://www.regionreunion.com) and by the Centre de Cooperation internationale en Recherche agronomique pour le Developpement (www.cirad.fr), as well as by the National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch Program (TEX09185 to R. F. M), and was carried out in part on the Plant Protection Platform which is co-financed by the Groupe d'Interet Scientifique "Infrastructures en Biologie Santeet Agronomie" (www.ibisa.net).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman RL., 2020, ONLINE IDENTIFICATIO; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Boukari W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230066; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046190; Cocuzza GEM, 2014, MOL ECOL RESOUR, V14, P447, DOI 10.1111/1755-0998.12199; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eastop V. F., 1953, East African Agricultural Journal, V18, P133; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Halbert Susan E., 2000, Revue Francaise d'Entomologie (Nouvelle Serie), V22, P109; Harry M, 1998, MOL PHYLOGENET EVOL, V9, P542, DOI 10.1006/mpev.1998.0508; Hollier John, 2018, Antenna, V42, P56; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Kim H, 2012, ANIM CELLS SYST, V16, P34, DOI 10.1080/19768354.2011.620621; Lee W, 2014, J ASIA-PAC ENTOMOL, V17, P617, DOI 10.1016/j.aspen.2014.06.008; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Margaritopoulos J. T., 2013, Entomologia Hellenica, V22, P23; Nibouche S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196124; Nibouche S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143704; Nibouche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106067; Paudyal S., 2019, Trends in Entomology, V15, P47; Pritchard JK, 2000, GENETICS, V155, P945; Rakauskas R, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.388.7034; Remaudiere G., 1997, CATALOGUE WORLDS APH; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAS Institute, 2010, SAS ONLINEDOC 93; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Theobald F, 1904, REPORT WELLCOME RES, P43; von Dohlen CD, 2002, MOL PHYLOGENET EVOL, V23, P257, DOI 10.1016/S1055-7903(02)00025-8; Vuillet J., 1914, AGRONOMIE COLONIALE, P137; Zehntner L, 1897, MEDEDELINGEN PROEFST, V37, P525	39	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0241881	10.1371/journal.pone.0241881	http://dx.doi.org/10.1371/journal.pone.0241881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764987	Green Submitted, Green Published, gold			2022-12-26	WOS:000634832800014
J	Yang, TH; Huang, HM; Hsu, WC; Tsao, PN; Liu, TC; Hsu, CJ; Huang, LM; Wu, CS; Weng, SM; Lu, CY; Wu, CC				Yang, Tzong-Hann; Huang, Hung-Meng; Hsu, Wei-Chung; Tsao, Po-Nien; Liu, Tien-Chen; Hsu, Chuan-Jen; Huang, Li-Min; Wu, Chuan-Song; Weng, Shih-Ming; Lu, Chun-Yi; Wu, Chen-Chi			The prevalence and demographic features of congenital cytomegalovirus infection in an urban area of East Asia: A population-based study	PLOS ONE			English	Article								Congenital cytomegalovirus (cCMV) infection is the leading environmental cause of childhood hearing impairment. However, its significance remains largely undocumented in many regions of the world. The purpose of this study was to investigate the prevalence and clinical features of cCMV infection in East Asia. Neonates born at a municipal hospital in Taipei were prospectively recruited and underwent concurrent hearing and CMV screenings. Those who failed the hearing screening or screened positive for CMV were subjected to a focused audiological and/or virological surveillance. The characteristics of the newborns and their mothers were compared between the CMV-positive and CMV-negative groups. Of the 1,532 newborns who underwent concurrent hearing and CMV screenings, seven (0.46%) were positive for cCMV infection. All seven CMV-positive newborns were asymptomatic at birth, and none of them developed hearing or other symptoms during a follow-up period of 14.4 +/- 6.3 months. The mothers of the CMV-positive newborns demonstrated higher gravidity (2.4 +/- 1.4 vs. 2.1 +/- 1.2) and parity (2.0 +/- 1.2 vs. 1.6 +/- 0.7) than those in the CMV-negative group; however, the difference did not reach statistical significance. The prevalence of cCMV infection in Taipei newborns was 0.46%, which is slightly lower than that of other populations and that of a previous report in the Taiwanese population. The relatively low prevalence in this study might be attributed to the improved public health system and decreased fertility rate in Taiwan.	[Yang, Tzong-Hann; Huang, Hung-Meng; Wu, Chuan-Song] Taipei City Hosp, Dept Otorhinolaryngol, Taipei, Taiwan; [Yang, Tzong-Hann; Weng, Shih-Ming] Natl Taipei Univ Nursing Hlth Sci, Dept Speech Language Pathol & Audiol, Taipei, Taiwan; [Yang, Tzong-Hann] Univ Taipei, Gen Educ Ctr, Taipei, Taiwan; [Huang, Hung-Meng] Taipei Med Univ, Sch Med, Dept Otolaryngol, Coll Med, Taipei, Taiwan; [Hsu, Wei-Chung; Liu, Tien-Chen; Hsu, Chuan-Jen; Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Tsao, Po-Nien; Huang, Li-Min; Lu, Chun-Yi] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Chuan-Song] Fu Jen Catholic Univ, Coll Sci & Engn, New Taipei, Taiwan; [Weng, Shih-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Chen-Chi] Natl Taiwan Univ, Biomed Pk Hosp, Dept Med Res, Hsinchu, Taiwan	Taipei City Hospital; National Taipei University of Nursing & Health Science (NTUNHS); University of Taipei; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University	Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.; Lu, CY (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ, Biomed Pk Hosp, Dept Med Res, Hsinchu, Taiwan.	cylu@ntu.edu.tw; chenchiwu@ntuh.gov.tw		LU, CHUN-YI/0000-0002-5240-2808; WU, CHEN-CHI/0000-0002-5047-2204; TSAO, PO-NIEN/0000-0002-6114-1769; Hsu, Wei-Chung/0000-0001-8583-8459	National Taiwan University Hospital [107-S3913]; Taipei City Government [10501-62-030]; Ministry of Science and Technology, Taiwan [107-2622-B-002-008-CC2]	National Taiwan University Hospital(National Taiwan University); Taipei City Government; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by research grants from the National Taiwan University Hospital (107-S3913), Taipei City Government (10501-62-030), and the Ministry of Science and Technology, Taiwan (107-2622-B-002-008-CC2.	Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Britt W., 2011, INFECT DIS FETUS NEW, P706, DOI [10.1016/B978-1-4160-6400-8.00023-7, DOI 10.1016/B978-1-4160-6400-8.00023-7]; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; Correa CD, 2018, INT ARCH OTORHINOLAR, V22, P330, DOI 10.1055/s-0037-1605377; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Huang HM, 2013, INT J PEDIATR OTORHI, V77, P1734, DOI 10.1016/j.ijporl.2013.08.004; Kenna MA, 2015, OTOLARYNG CLIN N AM, V48, P933, DOI 10.1016/j.otc.2015.07.011; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599; Lai DC, 2014, RES DEV DISABIL, V35, P3182, DOI 10.1016/j.ridd.2014.07.051; Lanzieri TM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2610; Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3; Li MC, 2015, ENVIRON RES, V137, P65, DOI 10.1016/j.envres.2014.12.002; Longnecker MP, 2004, NEUROTOXICOL TERATOL, V26, P629, DOI 10.1016/j.ntt.2004.04.007; Lu CY, 2018, J PEDIATR-US, V199, P144, DOI 10.1016/j.jpeds.2018.02.064; Mestas E, 2016, ADV NEONAT CARE, V16, P60, DOI 10.1097/ANC.0000000000000242; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766; Noyola DE, 2003, PEDIATR INFECT DIS J, V22, P89, DOI 10.1097/00006454-200301000-00022; Olusanya BO, 2015, PEDIATR INFECT DIS J, V34, P322, DOI 10.1097/INF.0000000000000555; Paixao P, 2009, EUROSURVEILLANCE, V14, P13; Sahiner F, 2015, INFECT DIS-NOR, V47, P465, DOI 10.3109/23744235.2015.1018316; Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; Tsai CH, 1996, ACTA PAEDIATR, V85, P1241, DOI 10.1111/j.1651-2227.1996.tb18237.x; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492; Wake M, 2006, PEDIATRICS, V118, P1842, DOI 10.1542/peds.2005-3168; Wang SW, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006007, 10.1097/md.0000000000006007]; Yamamoto AY, 2006, J CLIN VIROL, V36, P228, DOI 10.1016/j.jcv.2006.03.011; Yang TH, 2011, EAR HEARING, V32, P258, DOI 10.1097/AUD.0b013e3181f46a17; Yokota Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40586-7	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248801	10.1371/journal.pone.0248801	http://dx.doi.org/10.1371/journal.pone.0248801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765031	Green Published, gold			2022-12-26	WOS:000634832800071
J	Edwards, B; Biddle, N; Gray, M; Sollis, K				Edwards, Ben; Biddle, Nicholas; Gray, Matthew; Sollis, Kate			COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population	PLOS ONE			English	Article								Background High levels of vaccination coverage in populations will be required even with vaccines that have high levels of effectiveness to prevent and stop outbreaks of coronavirus. The World Health Organisation has suggested that governments take a proactive response to vaccine hesitancy 'hotspots' based on social and behavioural insights. Methods Representative longitudinal online survey of over 3000 adults from Australia that examines the demographic, attitudinal, political and social attitudes and COVID-19 health behavior correlates of vaccine hesitance and resistance to a COVID-19 vaccine. Results Overall, 59% would definitely get the vaccine, 29% had low levels of hesitancy, 7% had high levels of hesitancy and 6% were resistant. Females, those living in disadvantaged areas, those who reported that risks of COVID-19 was overstated, those who had more populist views and higher levels of religiosity were more likely to be hesitant or resistant while those who had higher levels of household income, those who had higher levels of social distancing, who downloaded the COVID-Safe App, who had more confidence in their state or territory government or confidence in their hospitals, or were more supportive of migration were more likely to intend to get vaccinated. Conclusions Our findings suggest that vaccine hesitancy, which accounts for a significant proportion of the population can be addressed by public health messaging but for a significant minority of the population with strongly held beliefs, alternative policy measures may well be needed to achieve sufficient vaccination coverage to end the pandemic.	[Edwards, Ben; Biddle, Nicholas; Gray, Matthew; Sollis, Kate] Australian Natl Univ, ANU Ctr Social Res & Methods, Melbourne, Vic, Australia	Australian National University	Edwards, B (corresponding author), Australian Natl Univ, ANU Ctr Social Res & Methods, Melbourne, Vic, Australia.	ben.edwards@anu.edu.au		Sollis, Kate/0000-0002-0636-8805; Edwards, Ben/0000-0001-6041-5054	Australian Institute of Health and Welfare (AIHW)	Australian Institute of Health and Welfare (AIHW)	The Australian Institute of Health and Welfare (AIHW) provided financial support for the collection of the August ANUpoll data presented in this paper.	Arim R., 2020, STAT CANADA CATALOGU; Bartsch SM, 2020, AM J PREV MED, V59, P493, DOI 10.1016/j.amepre.2020.06.011; Biddle N., 2020, CTR SOCIAL RES METHO; Demurtas J, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101118; Dodd RH, 2021, LANCET INFECT DIS, V21, P318, DOI 10.1016/S1473-3099(20)30559-4; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Gualano MR, 2019, HUM VACC IMMUNOTHER, V15, P918, DOI 10.1080/21645515.2018.1564437; Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x; Hale T., 2020, OXFORD COVID 19 GOVT; Hickler B, 2015, VACCINE, V33, P4155, DOI 10.1016/j.vaccine.2015.04.034; Lars Kaczmirek, 2019, CSRM METHODS SERIES; Mello MM, 2020, NEW ENGL J MED, V383, P1296, DOI 10.1056/NEJMp2020926; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Rozbroj T, 2019, PATIENT EDUC COUNS, V102, P172, DOI 10.1016/j.pec.2018.08.027; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397; Thunstrom L, 2020, COVID EC, V35, P1; Yadav S., 2020, DEMOGRAPHY INDIA, V49, P76, DOI [10.1101/2020.05.13.20100750, DOI 10.1101/2020.05.13.20100750]	21	136	137	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248892	10.1371/journal.pone.0248892	http://dx.doi.org/10.1371/journal.pone.0248892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760836	Green Published, gold, Green Submitted			2022-12-26	WOS:000633030400046
J	Kuwano, T; Izumi, H; Aslam, MR; Igarashi, Y; Bilal, M; Nishimura, A; Watanabe, Y; Nawaz, A; Kado, T; Ikuta, K; Yamamoto, S; Sasahara, M; Fujisaka, S; Yagi, K; Mori, H; Tobe, K				Kuwano, Takahide; Izumi, Hironori; Aslam, Muhammad Rahil; Igarashi, Yoshiko; Bilal, Muhammad; Nishimura, Ayumi; Watanabe, Yoshiyuki; Nawaz, Allah; Kado, Tomonobu; Ikuta, Koichi; Yamamoto, Seiji; Sasahara, Masakiyo; Fujisaka, Shiho; Yagi, Kunimasa; Mori, Hisashi; Tobe, Kazuyuki			Generation and characterization of a Meflin-CreER(T2) transgenic line for lineage tracing in white adipose tissue	PLOS ONE			English	Article								Meflin (Islr) expression has gained attention as a marker for mesenchymal stem cells, but its function remains largely unexplored. Here, we report the generation of Meflin-CreER(T2) mice with CreER(T2) inserted under the Meflin gene promoter to label Meflin-expressing cells genetically, thereby enabling their lineages to be traced. We found that in adult mice, Meflin-expressing lineage cells were present in adipose tissue stroma and had differentiated into mature adipocytes. These cells constituted Crown-like structures in the adipose tissue of mice after high-fat diet loading. Cold stimulation led to the differentiation of Meflin-expressing lineage cells into beige adipocytes. Thus, the Meflin-CreER(T2) mouse line is a useful new tool for visualizing and tracking the lineage of Meflin-expressing cells.	[Kuwano, Takahide; Aslam, Muhammad Rahil; Igarashi, Yoshiko; Bilal, Muhammad; Nishimura, Ayumi; Watanabe, Yoshiyuki; Nawaz, Allah; Kado, Tomonobu; Fujisaka, Shiho; Yagi, Kunimasa; Tobe, Kazuyuki] Univ Toyama, Dept Internal Med 1, Toyama, Toyama, Japan; [Izumi, Hironori; Mori, Hisashi] Univ Toyama, Dept Mol Neurosci, Toyama, Toyama, Japan; [Ikuta, Koichi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Immune Regulat,Sakyo Ku, Kyoto, Japan; [Yamamoto, Seiji; Sasahara, Masakiyo] Univ Toyama, Dept Pathol, Toyama, Toyama, Japan	University of Toyama; University of Toyama; Kyoto University; University of Toyama	Tobe, K (corresponding author), Univ Toyama, Dept Internal Med 1, Toyama, Toyama, Japan.	tobe@med.u-toyama.ac.jp	Nawaz, Allah/AAU-9274-2020	Nawaz, Allah/0000-0002-1979-9575; Aslam, Rahil/0000-0003-0684-9147	JSPS KAKENHI [20H03730]; Mitsubishi foundation [201910031]; Naito Foundation; Japan Diabetes Foundation; Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi foundation; Naito Foundation(Naito Memorial Foundation); Japan Diabetes Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research(B) (20H03730; https://www.jsps.go.jp/j-grantsinaid/index.html), Firstbank of toyama scholarship foundation reserch grant (https://www.first-bank.co.jp/outline/local), the Mitsubishi foundation (201910031:https://www.mitsubishi-zaidan.jp), the Naito Foundation (https://www.naito-f.or.jp/jp/index.php), Grant from Japan Diabetes Foundation (http://www.j-df.or.jp), the Uehara Memorial Foundation (https://www.ueharazaidan.or.jp) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Burl RB, 2018, CELL METAB, V28, P300, DOI 10.1016/j.cmet.2018.05.025; Cattaneo P, 2020, CELL REP, V30, P571, DOI 10.1016/j.celrep.2019.12.046; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Igarashi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32803-6; Kado T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48678-0; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22288; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Sebo ZL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166801; Singh AM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16340-3; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248267	10.1371/journal.pone.0248267	http://dx.doi.org/10.1371/journal.pone.0248267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760832	gold, Green Published			2022-12-26	WOS:000633030400064
J	Tillery, L; Barrett, K; Goldstein, J; Lassner, JW; Osterhout, B; Tran, NL; Xu, L; Young, RM; Craig, J; Chun, I; Dranow, DM; Abendroth, J; Delker, SL; Davies, DR; Mayclin, SJ; Calhoun, B; Bolejack, MJ; Staker, B; Subramanian, S; Phan, I; Lorimer, DD; Myler, PJ; Edwards, TE; Kyle, DE; Rice, CA; Morris, JC; Leahy, JW; Manetsch, R; Barrett, LK; Smith, CL; Van Voorhis, WC				Tillery, Logan; Barrett, Kayleigh; Goldstein, Jenna; Lassner, Jared W.; Osterhout, Bram; Tran, Nathan L.; Xu, Lily; Young, Ryan M.; Craig, Justin; Chun, Ian; Dranow, David M.; Abendroth, Jan; Delker, Silvia L.; Davies, Douglas R.; Mayclin, Stephen J.; Calhoun, Brandy; Bolejack, Madison J.; Staker, Bart; Subramanian, Sandhya; Phan, Isabelle; Lorimer, Donald D.; Myler, Peter J.; Edwards, Thomas E.; Kyle, Dennis E.; Rice, Christopher A.; Morris, James C.; Leahy, James W.; Manetsch, Roman; Barrett, Lynn K.; Smith, Craig L.; Van Voorhis, Wesley C.			Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba	PLOS ONE			English	Article							L-HOMOCYSTEINE HYDROLASE; SELECTIVE ALLOSTERIC INHIBITORS; GENOMICS CENTER; MENINGOENCEPHALITIS; TARGETS; PRMT1	Naegleria fowleri is a pathogenic, thermophilic, free-living amoeba which causes primary amebic meningoencephalitis (PAM). Penetrating the olfactory mucosa, the brain-eating amoeba travels along the olfactory nerves, burrowing through the cribriform plate to its destination: the brain's frontal lobes. The amoeba thrives in warm, freshwater environments, with peak infection rates in the summer months and has a mortality rate of approximately 97%. A major contributor to the pathogen's high mortality is the lack of sensitivity of N. fowleri to current drug therapies, even in the face of combination-drug therapy. To enable rational drug discovery and design efforts we have pursued protein production and crystallography-based structure determination efforts for likely drug targets from N. fowleri. The genes were selected if they had homology to drug targets listed in Drug Bank or were nominated by primary investigators engaged in N. fowleri research. In 2017, 178 N. fowleri protein targets were queued to the Seattle Structural Genomics Center of Infectious Disease (SSGCID) pipeline, and to date 89 soluble recombinant proteins and 19 unique target structures have been produced. Many of the new protein structures are potential drug targets and contain structural differences compared to their human homologs, which could allow for the development of pathogen-specific inhibitors. Five of the structures were analyzed in more detail, and four of five show promise that selective inhibitors of the active site could be found. The 19 solved crystal structures build a foundation for future work in combating this devastating disease by encouraging further investigation to stimulate drug discovery for this neglected pathogen.	[Tillery, Logan; Barrett, Kayleigh; Craig, Justin; Chun, Ian; Barrett, Lynn K.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Emerging & Re Emerging Infect Dis CERID, Seattle, WA 98195 USA; [Tillery, Logan; Barrett, Kayleigh; Craig, Justin; Chun, Ian; Dranow, David M.; Abendroth, Jan; Delker, Silvia L.; Davies, Douglas R.; Mayclin, Stephen J.; Calhoun, Brandy; Bolejack, Madison J.; Staker, Bart; Subramanian, Sandhya; Phan, Isabelle; Lorimer, Donald D.; Myler, Peter J.; Edwards, Thomas E.; Barrett, Lynn K.; Van Voorhis, Wesley C.] Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98195 USA; [Goldstein, Jenna; Lassner, Jared W.; Osterhout, Bram; Tran, Nathan L.; Xu, Lily; Young, Ryan M.; Smith, Craig L.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Dranow, David M.; Abendroth, Jan; Delker, Silvia L.; Davies, Douglas R.; Mayclin, Stephen J.; Calhoun, Brandy; Bolejack, Madison J.; Lorimer, Donald D.; Edwards, Thomas E.] UCB Pharma, Bainbridge Isl, WA USA; [Staker, Bart; Subramanian, Sandhya; Phan, Isabelle; Myler, Peter J.] Seattle Childrens Res Inst, Seattle, WA USA; [Myler, Peter J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Myler, Peter J.; Van Voorhis, Wesley C.] Univ Washington, Dept Global Hlth Pathobiol, Seattle, WA 98195 USA; [Kyle, Dennis E.; Rice, Christopher A.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Morris, James C.] Clemson Univ, Dept Genet & Biochem, Eukaryot Pathogens Innovat Ctr, Clemson, SC USA; [Leahy, James W.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Manetsch, Roman] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Manetsch, Roman] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Rice, Christopher A.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Georgia; University of Georgia; Clemson University; State University System of Florida; University of South Florida; Northeastern University; Northeastern University; University System of Georgia; University of Georgia	Van Voorhis, WC (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Emerging & Re Emerging Infect Dis CERID, Seattle, WA 98195 USA.; Van Voorhis, WC (corresponding author), Seattle Struct Genom Ctr Infect Dis, Seattle, WA 98195 USA.; Van Voorhis, WC (corresponding author), Univ Washington, Dept Global Hlth Pathobiol, Seattle, WA 98195 USA.	wesley@u.washington.edu	Myler, Peter John/AAR-9535-2021	Tillery, Logan/0000-0002-5431-3489; Kyle, Dennis/0000-0002-0238-965X; Lassner, Jared/0000-0003-1933-7458; Rice, Christopher/0000-0003-0672-9604; Tran, Nathan/0000-0002-7917-3945; Goldstein, Jenna/0000-0002-3989-1002; Edwards, Thomas/0000-0002-0474-8003; Xu, Lily/0000-0002-1200-8937	National Institute of Allergy and Infectious Diseases [HHSN272201700059C, HHSN272201200025C]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology TriCorridor [085P1000817]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology TriCorridor	This work was supported by the National Institute of Allergy and Infectious Diseases in the form of grants awarded to PM (HHSN272201700059C, HHSN272201200025C). This research also used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (contract no. DE-AC02-06CH11357). Use of the LS-CAT Sector 21 was supported by a grant from the Michigan Economic Development Corporation and the Michigan Technology TriCorridor (085P1000817). UCB Pharma provided support in the form of salaries for DMD, JA, SLD, DRD, SJM, BC, MJB, DDL, and TEE. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; Baldwin RM, 2012, CELL CYCLE, V11, P4597, DOI 10.4161/cc.22871; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Begley DW, 2011, METHOD ENZYMOL, V493, P533, DOI 10.1016/B978-0-12-381274-2.00021-2; Bellini NK, 2018, EXP PARASITOL, V187, P1, DOI 10.1016/j.exppara.2018.02.010; Bryan CM, 2011, ACTA CRYSTALLOGR F, V67, P1010, DOI 10.1107/S1744309111018367; Burke B, 2000, BIOCHEMISTRY-US, V39, P15540, DOI 10.1021/bi001835p; Cai S, 2007, BIOORGAN MED CHEM, V15, P7281, DOI 10.1016/j.bmc.2007.08.029; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi R, 2011, ACTA CRYSTALLOGR F, V67, P998, DOI 10.1107/S1744309111017374; Colon BL, 2019, J INFECT DIS, V219, P1095, DOI 10.1093/infdis/jiy622; Cope JR, 2016, CLIN INFECT DIS, V62, P774, DOI 10.1093/cid/civ1021; Czyrko J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29535-y; Debnath A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00414; Dunyak BM, 2016, J MED CHEM, V59, P9622, DOI 10.1021/acs.jmedchem.6b00411; El-Sayed A, 2020, ENVIRON SCI POLLUT R, V27, P22336, DOI 10.1007/s11356-020-08896-w; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedoriw A, 2019, CANCER CELL, V36, P100, DOI 10.1016/j.ccell.2019.05.014; Fulton MD, 2018, CHEM REC, V18, P1792, DOI 10.1002/tcr.201800082; Grace E, 2015, ANTIMICROB AGENTS CH, V59, P6677, DOI 10.1128/AAC.01293-15; Hahn HJ, 2020, ACS CHEM NEUROSCI, V11, P3089, DOI 10.1021/acschemneuro.0c00428; Hahn HJ, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090689; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaniskan HU, 2018, J MED CHEM, V61, P1204, DOI 10.1021/acs.jmedchem.7b01674; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kusakabe Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16641; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee EY, 2018, BIOCHEM PHARMACOL, V154, P424, DOI 10.1016/j.bcp.2018.06.009; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mann SA, 2020, BIOCHEM J, V477, P2971, DOI 10.1042/BCJ20200534; Mann SA, 2019, BIOORGAN MED CHEM, V27, P224, DOI 10.1016/j.bmc.2018.12.001; Marciano-Cabral F, 2007, FEMS IMMUNOL MED MIC, V51, P243, DOI 10.1111/j.1574-695X.2007.00332.x; MARTINEZ AJ, 1973, LAB INVEST, V29, P121; Matanock A, 2018, EMERG INFECT DIS, V24, P162, DOI 10.3201/eid2401.170545; Mathioudaki K, 2008, BRIT J CANCER, V99, P2094, DOI 10.1038/sj.bjc.6604807; Milanes JE, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02410-18; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; NIAID Emerging Infectious Diseases/ Pathogens, NIH NAT I ALL INF DI; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pang YLJ, 2014, WIRES RNA, V5, P461, DOI 10.1002/wrna.1224; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; Reddy MCM, 2008, PROTEIN SCI, V17, P2134, DOI 10.1110/ps.038125.108; Rice CA, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008353; Rice CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198827; Rizo-Liendo A, 2020, BIOMED PHARMACOTHER, V130, DOI 10.1016/j.biopha.2020.110583; Sainas S, 2018, ANNU REP MED CHEM, V51, P1, DOI 10.1016/bs.armc.2018.08.001; Siddiqui R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003017; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Stacy R, 2011, ACTA CRYSTALLOGR F, V67, P979, DOI 10.1107/S1744309111029204; Stocki P, 2016, MOL BIOL CELL, V27, P757, DOI 10.1091/mbc.E15-10-0729; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Tewary SK, 2019, CELL MOL LIFE SCI, V76, P2917, DOI 10.1007/s00018-019-03145-x; Unal CM, 2014, MICROBIOL MOL BIOL R, V78, P544, DOI 10.1128/MMBR.00015-14; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Oost J, 2002, FEMS MICROBIOL LETT, V212, P111, DOI 10.1016/S0378-1097(02)00720-6; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Vugia DJ, 2019, MMWR-MORBID MORTAL W, V68, P793, DOI 10.15585/mmwr.mm6836a3; Yoder JS, 2010, EPIDEMIOL INFECT, V138, P968, DOI 10.1017/S0950268809991014; Zhou WX, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007245	65	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0241738	10.1371/journal.pone.0241738	http://dx.doi.org/10.1371/journal.pone.0241738			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760815	Green Submitted, gold, Green Published			2022-12-26	WOS:000633030400053
J	Kompier, ME; Smolders, KCHJ; de Kort, YAW				Kompier, Maaike E.; Smolders, Karin C. H. J.; de Kort, Yvonne A. W.			Abrupt light transitions in illuminance and correlated colour temperature result in different temporal dynamics and interindividual variability for sensation, comfort and alertness	PLOS ONE			English	Article							HUMAN CIRCADIAN SYSTEM; BRIGHT LIGHT; TASK-PERFORMANCE; ACTION SPECTRUM; WORKING-MEMORY; SLEEPINESS; EXPOSURE; SENSITIVITY; ENVIRONMENT; VIGILANCE	Detailed insights in both visual effects of light and effects beyond vision due to manipulations in illuminance and correlated color temperature (CCT) are needed to optimize study protocols as well as to design light scenarios for practical applications. This study investigated temporal dynamics and interindividual variability in subjective evaluations of sensation, comfort and mood as well as subjective and objective measures of alertness, arousal and thermoregulation following abrupt transitions in illuminance and CCT in a mild cold environment. The results revealed that effects could be uniquely attributed to changes in illuminance or CCT. No interaction effects of illuminance and CCT were found for any of these markers. Responses to the abrupt transitions in illuminance and CCT always occurred immediately and exclusively amongst the subjective measures. Most of these responses diminished over time within the 45-minute light manipulation. In this period, no responses were found for objective measures of vigilance, arousal or thermoregulation. Significant interindividual variability occurred only in the visual comfort evaluation in response to changes in the intensity of the light. The results indicate that the design of dynamic light scenarios aimed to enhance human alertness and vitality requires tailoring to the individual to create visually comfortable environments.	[Kompier, Maaike E.; Smolders, Karin C. H. J.; de Kort, Yvonne A. W.] Eindhoven Univ Technol, Sch Innovat Sci, Human Technol Interact, Eindhoven, Netherlands	Eindhoven University of Technology	Kompier, ME (corresponding author), Eindhoven Univ Technol, Sch Innovat Sci, Human Technol Interact, Eindhoven, Netherlands.	m.e.kompier@tue.nl		Kompier, Maaike/0000-0002-9133-3809	TKI Urban Energy scheme by the Top consortium for Knowledge and Innovation -Topsector Energy of the Dutch Ministry of Economic Affairs [TEUE117001]	TKI Urban Energy scheme by the Top consortium for Knowledge and Innovation -Topsector Energy of the Dutch Ministry of Economic Affairs	This research is part of the DYNKA project (TEUE117001) funded under the TKI Urban Energy scheme by the Top consortium for Knowledge and Innovation -Topsector Energy of the Dutch Ministry of Economic Affairs (www.topsectorenergie.nl/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; [Anonymous], 2004, 9886 NENENISO; [Anonymous], 2004, 552004 ASHRAE; Aries MBC, 2020, J ENVIRON PSYCHOL, V69, DOI 10.1016/j.jenvp.2020.101409; Begemann SHA, 1997, INT J IND ERGONOM, V20, P231, DOI 10.1016/S0169-8141(96)00053-4; Boschman MC., 2018, HRMONITOR USER MANUA; Boschman MC, 2015, GSRMONITOR USER MANU; Boschman MC., 2018, HRVMONITOR USER MANU; Boyce PR, 2014, HUMAN FACTORS IN LIGHTING, 3RD EDITION, P1, DOI 10.1201/b16707; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brown TM, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12655; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Canazei M, 2014, LIGHTING RES TECHNOL, V46, P140, DOI 10.1177/1477153513475914; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; de Kort YAW, 2010, LIGHTING RES TECHNOL, V42, P345, DOI 10.1177/1477153510378150; de Kort YAW, 2019, LEUKOS, V15, P85, DOI 10.1080/15502724.2018.1558065; de Kort YAW, 2014, J ENVIRON PSYCHOL, V39, P1, DOI 10.1016/j.jenvp.2014.06.005; de Zeeuw J, 2019, J BIOL RHYTHM, V34, P410, DOI 10.1177/0748730419847845; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; Fotios S, 2017, LEUKOS, V13, P3, DOI 10.1080/15502724.2016.1159137; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Hanifin JP, 2019, PHYSIOL BEHAV, V198, P57, DOI 10.1016/j.physbeh.2018.10.004; Hommes V, 2015, CHRONOBIOL INT, V32, P750, DOI 10.3109/07420528.2015.1043012; Huang RH, 2015, COLOR RES APPL, V40, P281, DOI 10.1002/col.21885; Hubalek S, 2010, LIGHTING RES TECHNOL, V42, P33, DOI 10.1177/1477153509355632; Huebner GM, 2016, ENERGY RES SOC SCI, V15, P45, DOI 10.1016/j.erss.2016.02.008; Huiberts LM, 2017, CHRONOBIOL INT, V34, P827, DOI 10.1080/07420528.2017.1324471; Huiberts LM, 2015, BEHAV BRAIN RES, V294, P234, DOI 10.1016/j.bbr.2015.07.045; Huiberts LM, 2016, PHYSIOL BEHAV, V164, P129, DOI 10.1016/j.physbeh.2016.05.035; Juslen H. T., 2005, Lighting Research & Technology, V37, P219, DOI 10.1191/1365782805li138oa; Kent MG, 2017, BUILD ENVIRON, V113, P49, DOI 10.1016/j.buildenv.2016.09.002; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Kompier ME, 2020, BUILD ENVIRON, V186, DOI 10.1016/j.buildenv.2020.107326; Kompier ME, 2020, PHYSIOL BEHAV, V223, DOI 10.1016/j.physbeh.2020.112999; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Lasauskaite R, 2018, BIOL PSYCHOL, V132, P64, DOI 10.1016/j.biopsycho.2017.11.005; Lockley SW, 2006, SLEEP, V29, P161; Lok R, 2018, J BIOL RHYTHM, V33, P589, DOI 10.1177/0748730418796443; Mien IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096532; Min BK, 2013, BRAIN RES, V1538, P83, DOI 10.1016/j.brainres.2013.09.031; Noguchi Hiroki, 1999, Applied Human Science, V18, P117, DOI 10.2114/jpa.18.117; Park JY, 2013, NEUROSCIENCE, V247, P386, DOI 10.1016/j.neuroscience.2013.05.016; Phillips AJK, 2019, P NATL ACAD SCI USA, V116, P12019, DOI 10.1073/pnas.1901824116; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; Prayag AS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00126; Rautkyla E., 2010, J LIGHT VIS ENVIRON, V34, P59, DOI DOI 10.2150/JLVE.34.59; Revell VL, 2006, NEUROSCI LETT, V399, P96, DOI 10.1016/j.neulet.2006.01.032; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Ru TT, 2019, BUILD ENVIRON, V149, P253, DOI 10.1016/j.buildenv.2018.12.002; RUBINSTEIN EH, 1990, ANESTHESIOLOGY, V73, P541, DOI 10.1097/00000542-199009000-00027; Ruger M, 2006, AM J PHYSIOL-REG I, V290, pR1413, DOI 10.1152/ajpregu.00121.2005; Santhi N, 2012, J PINEAL RES, V53, P47, DOI 10.1111/j.1600-079X.2011.00970.x; Shamsul B.M.T., 2013, AM J PUBLIC HLTH RES, V1, P159, DOI 10.12691/ajphr-1-7-3; Sithravel R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207488; Slama H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125359; Smolders KCHJ, 2012, PHYSIOL BEHAV, V107, P7, DOI 10.1016/j.physbeh.2012.04.028; Smolders KCHJ, 2018, J BIOL RHYTHM, V33, P649, DOI 10.1177/0748730418796438; Smolders KCHJ, 2017, J ENVIRON PSYCHOL, V50, P80, DOI 10.1016/j.jenvp.2017.02.001; Smolders KCHJ, 2014, J ENVIRON PSYCHOL, V39, P77, DOI 10.1016/j.jenvp.2013.12.010; Souman JL, 2018, BEHAV BRAIN RES, V337, P228, DOI 10.1016/j.bbr.2017.09.016; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; te Kulve M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52352-w; te Kulve M, 2018, INDOOR AIR, V28, P881, DOI 10.1111/ina.12500; te Kulve M, 2018, PHYSIOL BEHAV, V185, P1, DOI 10.1016/j.physbeh.2017.12.004; te Kulve M, 2017, PHYSIOL BEHAV, V175, P72, DOI 10.1016/j.physbeh.2017.03.043; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; The Psychological Corporation, 2002, UPD WAISIII WMS III; van Hoof J, 2012, TECHNOL HEALTH CARE, V20, P11, DOI 10.3233/THC-2011-0650; Veitch J.A., 2000, LIGHT RES TECHNOL, V32, P24, DOI [10.1177/096032710003200404, DOI 10.1177/096032710003200404]; Wang X, 2019, BUILD ENVIRON, V158, P120, DOI 10.1016/j.buildenv.2019.05.012; Wei MC, 2014, J ENVIRON PSYCHOL, V39, P62, DOI 10.1016/j.jenvp.2014.04.009; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	78	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0243259	10.1371/journal.pone.0243259	http://dx.doi.org/10.1371/journal.pone.0243259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RB2TH	33750954	gold, Green Published			2022-12-26	WOS:000631967100023
J	Natukwatsa, D; Wosu, AC; Ndyomugyenyi, DB; Waibi, M; Kajungu, D				Natukwatsa, Davis; Wosu, Adaeze C.; Ndyomugyenyi, Donald Bruce; Waibi, Musa; Kajungu, Dan			An assessment of non-communicable disease mortality among adults in Eastern Uganda, 2010-2016	PLOS ONE			English	Article							VERBAL AUTOPSY; RISK-FACTORS; PREVALENCE; VALIDATION; INTERVA; HEALTH; DEATH	Background There is a dearth of studies assessing non-communicable disease (NCD) mortality within population-based settings in Uganda. We assessed mortality due to major NCDs among persons >= 30 years in Eastern Uganda from 2010 to 2016. Methods The study was carried out at the Iganga-Mayuge health and demographic surveillance site in the Iganga and Mayuge districts of Eastern Uganda. Information on cause of death was obtained through verbal autopsies using a structured questionnaire to conduct face-face interviews with carers or close relatives of the deceased. Physicians assigned likely cause of death using ICD-10 codes. Age-adjusted mortality rates were calculated using direct method, with the average population across the seven years of the study (2010 to 2016) as the standard. Age categories of 30-40, 41-50, 51-60, 61-70, and >= 71 years were used for standardization. Results A total of 1,210 deaths among persons >= 30 years old were reported from 2010 to 2016 (50.7% among women). Approximately 53% of all deaths were due to non-communicable diseases, 31.8% due to communicable diseases, 8.2% due to injuries, and 7% due to maternal-related deaths or undetermined causes. Cardiovascular diseases accounted for the largest proportion of NCD deaths in each year, and women had substantially higher cardiovascular disease mortality rates compared to men. Conversely, women had lower diabetes mortality rates than men for five of the seven years examined. Conclusions Non-communicable diseases are major causes of death among adults in Iganga and Mayuge; and cardiovascular diseases and diabetes are leading causes of NCD deaths. Efforts are needed to tackle NCD risk factors and provide NCD care to reduce associated burden and premature mortality.	[Natukwatsa, Davis; Ndyomugyenyi, Donald Bruce; Waibi, Musa; Kajungu, Dan] Makerere Univ Ctr Hlth & Populat Res, Kampala, Uganda; [Natukwatsa, Davis; Ndyomugyenyi, Donald Bruce; Waibi, Musa; Kajungu, Dan] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda; [Wosu, Adaeze C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Natukwatsa, D (corresponding author), Makerere Univ Ctr Hlth & Populat Res, Kampala, Uganda.; Natukwatsa, D (corresponding author), Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda.	natukwatsa.davis@gmail.com		Kajungu PhD, Dan/0000-0002-3363-7062				Achoki T, 2019, LANCET GLOB HEALTH, V7, pE81, DOI 10.1016/S2214-109X(18)30472-8; [Anonymous], TANZANIA STEPS SURVE; [Anonymous], 2010, PACKAGE ESSENTIAL NO; [Anonymous], 2015, HLTH 2015 MDGS MILL; [Anonymous], 2012, VERBAL AUTOPSY STAND; [Anonymous], 2013, GLOBAL ACTION PLAN P; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Bauni E, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-49; Byass P, 2002, PUBLIC HEALTH, V116, P145, DOI 10.1038/sj.ph.1900837; Byass P, 2007, PLOS MED, V4, P1715, DOI 10.1371/journal.pmed.0040333; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Huong DL, 2003, SCAND J PUBLIC HEALT, V31, P19, DOI 10.1080/14034950310015068; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kalyesubula R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216060; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kirunda BE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2506-7; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-50; Mayega RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-864; Mayega RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072554; McGrail KM, 2005, B WORLD HEALTH ORGAN, V83, P563; Misganaw A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-130; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Murphy GAV, 2013, INT J EPIDEMIOL, V42, P1740, DOI 10.1093/ije/dyt184; Nahimana MR., 2018, BMC PUBLIC HEALTH; Oti SO, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25533; Oti SO, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-21; Pariyo GW, 2020, INT J EPIDEMIOL; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Soofi SB, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0450-4; StataCorp, 2015, STAT STAT SOFTW REL; Uneke CJ, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.318.16405; van de Vijver S, 2012, ETHNIC HEALTH, V17, P651, DOI 10.1080/13557858.2012.754409; Wandera SO, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27923	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248966	10.1371/journal.pone.0248966	http://dx.doi.org/10.1371/journal.pone.0248966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739993	Green Published, gold			2022-12-26	WOS:000631030200020
J	Han, H; Yang, F; Murray, S; Mbita, G; Bangser, M; Rucinski, K; Komba, A; Casalini, C; Drake, M; Majani, E; Curran, K; Mlawa, Y; Junga, A; Zoungrana, J; Kategile, U; Ramadhani, A; Xue, QL; Baral, S				Han, Hannah; Yang, Fan; Murray, Sarah; Mbita, Gaspar; Bangser, Maggie; Rucinski, Katherine; Komba, Albert; Casalini, Caterina; Drake, Mary; Majani, Esther; Curran, Kelly; Mlawa, Yeronimo; Junga, Agnes; Zoungrana, Jeremie; Kategile, Upendo; Ramadhani, Angela; Xue, Qian-Li; Baral, Stefan			Characterizing a sexual health and HIV risk stratification scale for sexually active adolescent girls and young women (AGYW) in Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DAR-ES-SALAAM; TRANSACTIONAL SEX; REPRODUCTIVE HEALTH; STRUCTURAL DRIVERS; VULNERABILITY; BOTSWANA; MALAWI; NORMS; YOUTH	Adolescent girls and young women (AGYW) aged 15 to 24 years face disproportionately high risks of acquiring HIV and other sexually transmitted infections (STIs). A sexual health risk stratification tool can support the development and implementation of tailored HIV and STI prevention services for sub-groups of at-risk AGYW. Data were collected among sexually active AGYW aged 15 to 24 years in Tanzania between April 2015 and March 2017. Exploratory and confirmatory factor analyses were conducted to construct and assess the latent structure of a ten-item scale for rapid assessment of sexual health risks. Items with high factor loadings and minimal cross loadings were retained in the final scale. Scale performance was appraised against condomless sex (defined as unprotected vaginal or anal intercourse) reported by AGYW for construct validity. A three-factor structure of vulnerability to HIV among AGYW was supported with subscales for socioeconomic vulnerability; lack of adult support; and sexual behavioral risks. The chi-square goodness-of-fit test, root mean square error of approximation, comparative fit index, and Tucker-Lewis index indicated a strong goodness-of-fit of the three-factor scale. Cronbach alphas (0.55 for socioeconomic vulnerability, 0.55 for lack of support, and 0.48 for sexual risk) indicated sub-optimal internal consistency for all sub-scales. The factor-item and factor-factor correlations identified in these analyses were consistent with the conceptual framework of vulnerability of HIV infection in AGYW, suggesting good construct validity. The scale also demonstrated a statistically significant association with condomless sex and could be potentially used for sexual health risk stratification (OR = 1.17, 95% CI: 1.12, 1.23). The sexual health and HIV risk stratification scale demonstrated potential in identifying sexually active AGYW at high risk for HIV and other STIs. Ultimately, all AGYW in Tanzania are not at equal risk for HIV and this scale may support directing resources towards those at highest risk of HIV.	[Han, Hannah; Yang, Fan; Rucinski, Katherine; Xue, Qian-Li; Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Yang, Fan; Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Murray, Sarah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Mbita, Gaspar; Komba, Albert; Casalini, Caterina; Drake, Mary; Majani, Esther; Junga, Agnes; Zoungrana, Jeremie] Jhpiego, Dar Es Salaam, Tanzania; [Curran, Kelly] Jhpiego, Baltimore, MD USA; [Mlawa, Yeronimo] Engender Hlth, Dar Es Salaam, Tanzania; [Kategile, Upendo] US Agcy Int Dev, Dar Es Salaam, Tanzania; [Ramadhani, Angela] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Xue, Qian-Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Xue, Qian-Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jhpiego; Jhpiego; United States Agency for International Development (USAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Han, H (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	hhan0913@gmail.com	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; XUE, QIAN-LI/0000-0001-8818-7444; Murray, Sarah/0000-0002-4976-9713; Yang, Fan/0000-0003-2853-7769	United States Agency for International Development (USAID) [AID-621-A-15-00003]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was conducted under the SAUTI program which received a grant from the United States Agency for International Development (USAID), Grant number AID-621-A-15-00003. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID, PEPFAR or the United States Government. The funder provided support in the form of salaries for the co-authors at Jhpiego, but did not have any additional role in the study design, data collection and analysis. The co-author from USAID approved the submitted manuscript, but did not have control over the decision to publish. The specific roles of these authors are listed in the `author contributions' section of the application.	Abeid M, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-23; Africa, TANZANIA WORLD FACTB; Amin S., 2013, ADOLESCENT GIRLS VUL; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Birdthistle I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5789-7; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dabee S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213975; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Fielding-Miller R, 2016, SOC SCI MED, V158, P24, DOI 10.1016/j.socscimed.2016.04.005; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hess KL, 2013, PERSPECT SEX REPRO H, V45, P6, DOI 10.1363/4500613; Hokororo A, 2015, SEX TRANSM INFECT, V91, P473, DOI 10.1136/sextrans-2014-051952; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jewkes R, 2012, SOC SCI MED, V74, P1729, DOI 10.1016/j.socscimed.2011.05.020; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kaggwa EB, 2010, SOC SCI MED, V70, P1002, DOI 10.1016/j.socscimed.2009.12.002; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Kharsany Ayesha B M, 2012, World Health Popul, V13, P43; Kidman R, 2016, CHILD ABUSE NEGLECT, V51, P172, DOI 10.1016/j.chiabu.2015.10.018; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lescano CM, 2009, AM J PUBLIC HEALTH, V99, P1131, DOI 10.2105/AJPH.2007.123752; Maganja RK, 2007, AIDS CARE, V19, P974, DOI 10.1080/09540120701294286; Mason-Jones AJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006417.pub3; McCleary-Sills J, 2013, REPROD HEALTH MATTER, V21, P97, DOI 10.1016/S0968-8080(13)41682-8; Muthen B, 2013, MPLUS 7; Muthen L.K., 2012, MPLUS STAT ANAL LATE; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nyamhanga TM, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25346; Osborne J., 2008, BEST PRACTICES QUANT; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pettifor A, 2018, CURR OPIN HIV AIDS, V13, P265, DOI [10.1097/coh.0000000000000453, 10.1097/COH.0000000000000453]; Ranganathan M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4636-6; Ranganathan M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20749; Saul J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208167; Sengendo J, 1997, Health Transit Rev, V7 Suppl, P105; Shrestha R, 2016, J COMMUN HEALTH, V41, P70, DOI 10.1007/s10900-015-0065-6; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Sommarin C, 2014, JAIDS-J ACQ IMM DEF, V66, pS217, DOI 10.1097/QAI.0000000000000183; StataCorp, 2015, STAT STAT SOFTW REL; Stoebenau K, 2016, SOC SCI MED, V168, P186, DOI 10.1016/j.socscimed.2016.09.023; Stroeken K, 2012, AIDS CARE, V24, P186, DOI 10.1080/09540121.2011.596519; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC)., 2018, TANZ HIV IMP SURV TH; The Joint United Nationals Programme on HIV/AIDS, 2018, UNAIDS DATA 2018; The Joint United Nationals Programme on HIV/AIDS, 2019, WOM HIV SPOTL AD GIR; Underwood C, 2015, INT Q COMMUNITY HEAL, V35, P317, DOI 10.1177/0272684X15592762; Underwood C, 2011, SOC SCI MED, V73, P343, DOI 10.1016/j.socscimed.2011.05.044; Underwood CR, 2016, HEALTH POLICY PLANN, V31, P729, DOI 10.1093/heapol/czv123; Wamoyi J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214366; Wamoyi J, 2015, CULT HEALTH SEX, V17, P718, DOI 10.1080/13691058.2014.992044; Wamoyi J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-88; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8; Wight D, 2006, SOC SCI MED, V62, P987, DOI 10.1016/j.socscimed.2005.06.052; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Zembe YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139430	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248153	10.1371/journal.pone.0248153	http://dx.doi.org/10.1371/journal.pone.0248153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735253	Green Published, gold			2022-12-26	WOS:000631029700019
J	Li, MF; Wang, Y; Ndiwane, N; Orner, MB; Palacios, N; Mittler, B; Berlowitz, D; Kazis, LE; Xia, WM				Li, Mingfei; Wang, Ying; Ndiwane, Ndindam; Orner, Michelle B.; Palacios, Natalia; Mittler, Brant; Berlowitz, Dan; Kazis, Lewis E.; Xia, Weiming			The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension	PLOS ONE			English	Article								Background A number of studies have reported the association between the use of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin-II receptor blocker (ARB) medications and the occurrence or severity of coronavirus disease 2019 (COVID-19). Published results are inconclusive, possibly due to differences in participant comorbidities and sociodemographic backgrounds. Since ACEI and ARB are frequently used anti-hypertension medications, we aim to determine whether the use of ACEI and ARB is associated with the occurrence and severity of COVID-19 in a large study of US Veterans with hypertension. Methods Data were collected from the Department of Veterans Affairs (VA) National Corporate Data Warehouse (VA-COVID-19 Shared Data Resource) between February 28, 2020 and August 18, 2020. Using data from 228,722 Veterans with a history of hypertension who received COVID-19 testing at the VA, we investigated whether the use of ACEI or ARB over the two years prior to the index date was associated with increased odds of (1) a positive COVID-19 test, and (2) a severe outcome (hospitalization, mortality, and use of intensive care unit (ICU) and/or mechanical ventilation) among COVID-19-positive patients. We used logistic regression with and without propensity score weighting (PSW) to estimate the odds ratio (OR) and 95% confidence interval (95% CI) for the association between ACEI/ARB use and a positive COVID-19 test result. The association between medication use and COVID-19 outcome severity was examined using multinomial logistic regression comparing participants who were not hospitalized to participants who were hospitalized, were admitted to the ICU, used a mechanical ventilator, or died. All models were adjusted for relevant covariates, including demographics (age, sex, race, ethnicity), selected comorbidities, and the Charlson Comorbidity Index (CCI). Results The use of ACEI significantly decreased the odds of a positive COVID-19 test among Veterans with hypertension (OR = 0.917, (0.887, 0.948) and OR = 0.926, (0.894, 0.958) with PSW). The use of ACEI, but not of ARB, was also associated with significantly increased odds of using mechanical ventilators (OR = 1.265, (1.010, 1.584) and OR = 1.210, (1.053, 1.39) with PSW) among all COVID-19 inpatients compared to outpatients. Conclusions In this study of Veterans with hypertension, ACEI was significantly associated with decreased odds of testing positive for COVID-19. With the exception of the association of ACEI with a small non-clinically-important increase in the odds of using mechanical ventilators, neither ACEI nor ARB was found to be associated with clinical severity or mortality among COVID-19-positive Veterans. The results of this study need further corroboration and validation in other cohort samples outside the VA.	[Li, Mingfei; Ndiwane, Ndindam; Orner, Michelle B.; Kazis, Lewis E.] Bedford VA Healthcare Syst, Ctr Healthcare Org & Implementat Res CHOIR, Bedford, MA USA; [Li, Mingfei; Wang, Ying] Bentley Univ, Dept Math Sci, Waltham, MA 02452 USA; [Palacios, Natalia; Berlowitz, Dan] Univ Massachusetts Lowell, Dept Publ Hlth, Zuckerberg Coll Hlth Sci, Lowell, MA USA; [Palacios, Natalia; Xia, Weiming] Bedford VA Healthcare Syst, Geriatr Res Educ Clin Ctr, Bedford, MA 01730 USA; [Mittler, Brant] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Xia, Weiming] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Bentley University; University of Massachusetts System; University of Massachusetts Lowell; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; Boston University; Boston University	Xia, WM (corresponding author), Bedford VA Healthcare Syst, Geriatr Res Educ Clin Ctr, Bedford, MA 01730 USA.; Xia, WM (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	weiming.xia@va.gov			COVID-19 award from the Clinical Service Research and Development of the Veterans Affairs Office of Research and Development [COVID19-8900-06]; NIH [RF1AG063913]	COVID-19 award from the Clinical Service Research and Development of the Veterans Affairs Office of Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a COVID-19 award COVID19-8900-06 from the Clinical Service Research and Development of the Veterans Affairs Office of Research and Development (WX) and RF1AG063913 from the NIH (WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae DJ, 2020, AM J CARDIOL, V132, P150, DOI 10.1016/j.amjcard.2020.07.007; Baral R, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00880-6; Barochiner J, 2020, J CLIN PHARM THER, V45, P1244, DOI 10.1111/jcpt.13246; Bauer AZ., J CLIN HYPERTENS, DOI [10.1111/jch.14101 33220171, DOI 10.1111/JCH.1410133220171]; Bean DM, 2020, EUR J HEART FAIL, V22, P967, DOI 10.1002/ejhf.1924; Bravi F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235248; Chobufo MD, 2020, INT J CARDIOL HYPER, V6, DOI 10.1016/j.ijchy.2020.100044; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dublin S, 2021, AM J HYPERTENS, V34, P339, DOI 10.1093/ajh/hpaa168; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hakeam HA, 2021, J CARDIOVASC PHARM T, V26, P244, DOI 10.1177/1074248420976279; Jiang F, 2014, NAT REV CARDIOL, V11, P413, DOI 10.1038/nrcardio.2014.59; Jung SY, 2020, CLIN INFECT DIS, V71, P2121, DOI 10.1093/cid/ciaa624; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lafaurie M, 2021, FUND CLIN PHARMACOL, V35, P194, DOI 10.1111/fcp.12613; Lam KW, 2020, J INFECT DIS, V222, P1256, DOI 10.1093/infdis/jiaa447; Lee IT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19145-6; Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624; Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005; Liu X, 2020, CLIN CARDIOL, DOI 10.1002/clc.23421; Lopes RD, 2021, JAMA-J AM MED ASSOC, V325, P254, DOI 10.1001/jama.2020.25864; Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812; Platt RW, 2000, STAT MED, V19, P313, DOI 10.1002/(SICI)1097-0258(20000215)19:3<313::AID-SIM370>3.0.CO;2-K; Trifiro G, 2020, DRUG SAFETY, V43, P1297, DOI 10.1007/s40264-020-00994-5; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang YX, 2021, J MED VIROL, V93, P1370, DOI 10.1002/jmv.26625; WHO, 2020, CLIN MAN COVID 19; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu JY, 2021, CLIN INFECT DIS, V72, pE901, DOI 10.1093/cid/ciaa1592; Zhang X, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104927	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248652	10.1371/journal.pone.0248652	http://dx.doi.org/10.1371/journal.pone.0248652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735262	Green Published, gold			2022-12-26	WOS:000631029700042
J	Merino, A; Hoogduijn, MJ; Molina-Molina, M; Arias-Salgado, EG; Korevaar, SS; Baan, CC; Montes-Worboys, A				Merino, Ana; Hoogduijn, Martin J.; Molina-Molina, Maria; Arias-Salgado, Elena G.; Korevaar, Sander S.; Baan, Carla C.; Montes-Worboys, Ana			Membrane particles from mesenchymal stromal cells reduce the expression of fibrotic markers on pulmonary cells	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; ADIPOSE-TISSUE; FIBROSIS; PIRFENIDONE; FIBROBLASTS; SAFETY; STANDARDIZATION; TELOMERASE; SMAD3	Background Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited treatment options in which the telomere shortening is a strong predictive factor of poor prognosis. Mesenchymal stromal cells (MSC) administration is probed in several experimental induced lung pathologies; however, MSC might stimulate fibrotic processes. A therapy that avoids MSC side effects of transformation would be an alternative to the use of living cells. Membranes particles (MP) are nanovesicles artificially generated from the membranes of MSC containing active enzymes involved in ECM regeneration. We aimed to investigate the anti-fibrotic role of MP derived from MSC in an in vitro model of pulmonary fibrosis. Methods Epithelial cells (A549) and lung fibroblasts, from IPF patients with different telomere length, were co-cultured with MP and TGF-beta for 48h and gene expression of major pro-fibrotic markers were analyzed. Results About 90% of both types of cells effectively took up MP without cytotoxic effects. MP decreased the expression of profibrotic proteins such as Col1A1, Fibronectin and PAI-1, in A549 cells. In fibroblasts culture, there was a different response in the inhibitory effect of MP on some pro-fibrotic markers when comparing fibroblast from normal telomere length patients (FN) versus short telomere length (FS), but both types showed an inhibition of Col1A1, Tenascin-c, PAI-1 and MMP-1 gene expression after MP treatment. Conclusions MP conserve some of the properties attributed to the living MSC. This study shows that MP target lung cells, via which they may have a broad anti-fibrotic effect.	[Merino, Ana; Hoogduijn, Martin J.; Korevaar, Sander S.; Baan, Carla C.] Erasmus MC, Dept Internal Med Nephrol & Transplantat, Rotterdam, Netherlands; [Molina-Molina, Maria; Montes-Worboys, Ana] Univ Hosp Bellvitge, Pulm Dept, IDIBELL, Unit Interstitial Lung Dis, Barcelona, Spain; [Molina-Molina, Maria] Hlth Inst Carlos III, CIBER Resp Dis CIBERES, Madrid, Spain; [Arias-Salgado, Elena G.] CSIC UAM, Inst Invest Biomed, Madrid, Spain	Erasmus University Rotterdam; Erasmus MC; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Merino, A (corresponding author), Erasmus MC, Dept Internal Med Nephrol & Transplantat, Rotterdam, Netherlands.; Montes-Worboys, A (corresponding author), Univ Hosp Bellvitge, Pulm Dept, IDIBELL, Unit Interstitial Lung Dis, Barcelona, Spain.	a.merinorodriguez@erasmusmc.nl; amontesw@idibell.cat		Montes Worboys, Ana/0000-0002-3204-779X; Baan, Carla/0000-0003-2274-2788; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Garcia Arias-Salgado, Elena/0000-0002-3612-5791	PPP Allowance by Health Holland, Top Sector Life Sciences & Health, of the Dutch Ministry of Economic affairs; Institute of Health Carlos III (ISCIII) [PI18/00367]; FEDER funds/European Regional Development Fund (ERDF) - "a Way to Build Europe"; Biomedical National Research Network CIBER	PPP Allowance by Health Holland, Top Sector Life Sciences & Health, of the Dutch Ministry of Economic affairs; Institute of Health Carlos III (ISCIII); FEDER funds/European Regional Development Fund (ERDF) - "a Way to Build Europe"; Biomedical National Research Network CIBER	This collaboration project is co-funded by the PPP Allowance made available by Health Holland, Top Sector Life Sciences & Health, of the Dutch Ministry of Economic affairs to stimulate public-private partnerships, and by the Institute of Health Carlos III (ISCIII, PI18/00367), co-funded by FEDER funds/European Regional Development Fund (ERDF) - "a Way to Build Europe" and Biomedical National Research Network CIBER.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Ballester Beatriz, 2020, Oncotarget, V11, P1306, DOI 10.18632/oncotarget.27526; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Carrillo J, 2012, BLOOD CELL MOL DIS, V49, P140, DOI 10.1016/j.bcmd.2012.05.008; Chambers DC, 2014, RESPIROLOGY, V19, P1013, DOI 10.1111/resp.12343; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Craig VJ, 2015, AM J RESP CELL MOL, V53, P585, DOI 10.1165/rcmb.2015-0020TR; Da Costa Goncalves F., FRONTIERS IMMUNOLOGY; Finnicum CT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170765; Gadalla SM, 2010, AGING-US, V2, P867, DOI 10.18632/aging.100235; Geiger S, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0044-2017; Gennai S, 2015, AM J TRANSPLANT, V15, P2404, DOI 10.1111/ajt.13271; Ghadiri M, 2016, EXPERT OPIN BIOL TH, V16, P375, DOI 10.1517/14712598.2016.1124085; Glassberg MK, 2017, CHEST, V151, P971, DOI 10.1016/j.chest.2016.10.061; Goncalves FD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12121-z; Gutierrez-Rodrigues F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113747; Hisada Y, 2019, RES PRACT THROMB HAE, V3, P44, DOI 10.1002/rth2.12165; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Hoogduijn MJ, 2014, CURR OPIN ORGAN TRAN, V19, P41, DOI 10.1097/MOT.0000000000000036; Hostettler KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181946; Jenkins Gisli, 2014, Clin Med (Lond), V14 Suppl 6, ps45, DOI 10.7861/clinmedicine.14-6-s45; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; McMichael Gai L, 2009, J Biomol Tech, V20, P232; Merino A., FRONTIERS IMMUNOLOGY; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohammadipoor A, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0921-x; Molina-Molina M, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0626-4; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Najar M, 2010, CELL IMMUNOL, V264, P171, DOI 10.1016/j.cellimm.2010.06.006; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pardo A, 2016, ANN AM THORAC SOC, V13, pS417, DOI 10.1513/AnnalsATS.201605-341AW; Planas-Cerezales L, 2019, RESPIROLOGY, V24, P146, DOI 10.1111/resp.13423; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Schwich E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02046; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Sugizaki T, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0226-y; Tashiro J, 2015, TRANSL RES, V166, P554, DOI 10.1016/j.trsl.2015.09.004; Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002; Tzouvelekis A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-171; Wiest EF, 2020, CYTOTHERAPY, V22, P606, DOI 10.1016/j.jcyt.2020.04.040; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Yadid M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax8005; Zhang HW, 2017, METHODS MOL BIOL, V1522, P17, DOI 10.1007/978-1-4939-6591-5_2; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248415	10.1371/journal.pone.0248415	http://dx.doi.org/10.1371/journal.pone.0248415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730089	Green Published, gold			2022-12-26	WOS:000630345000039
J	Ma, SQ; Zhang, L; Ren, Y; Dai, W; Chen, TQ; Luo, LP; Zeng, J; Mi, K; Lang, JY; Cao, BR				Ma, Shiqi; Zhang, Lu; Ren, Yuan; Dai, Wei; Chen, Tingqing; Luo, Liping; Zeng, Juan; Mi, Kun; Lang, Jinyi; Cao, Bangrong			Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer	ONCOGENE			English	Article								Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR-activating mutations. The mechanisms underlying EGFR-TKI resistance are not fully understood. This study aimed to analyze the effects of seven EGFR ligands on EGFR-TKI sensitivity in NSCLC cells and patients. Cells with EGFR E746-A750del mutation were treated with recombinant EGFR ligands, and analyzed for cell viability, proliferation, and apoptosis. shRNA knockdown of endogenous Epiregulin (EREG) or overexpression of exogenous EREG and immunofluorescence experiments were carried out. Public gene expression datasets were used for tumor microenvironment and clinical assessment. Among the EGFR ligands, EREG significantly diminished cellular sensitivity to TKIs and was associated with decreased response to erlotinib in NSCLC patients. EREG induced AKT phosphorylation and attenuated TKI-induced cellular apoptosis in an ErbB2-dependent manner. EREG induced the formation of the EGFR/ErbB2 heterodimer regardless of gefitinib treatment. However, overexpression or knockdown of EREG in cancer cells had little impact on TKI sensitivity. Single-cell RNA sequencing data revealed that EREG was predominantly expressed in macrophages in the tumor microenvironment. In addition, EREG-enriched macrophage conditional medium induced EGFR-TKI resistance. These findings shed new light on the mechanism underlying EGFR-TKI resistance, and suggest macrophage-produced intratumoral EREG as a novel regulator and biomarker for EGFR-TKI therapy in NSCLC.	[Ma, Shiqi; Zhang, Lu; Ren, Yuan; Chen, Tingqing; Luo, Liping; Zeng, Juan; Mi, Kun; Lang, Jinyi; Cao, Bangrong] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China; [Dai, Wei] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Thorac Surg, Chengdu, Peoples R China; [Cao, Bangrong] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Biobank, Chengdu, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Lang, JY; Cao, BR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China.; Cao, BR (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Biobank, Chengdu, Peoples R China.	langjy610@163.com; caobangrong@uestc.edu.cn		Luo, Liping/0000-0002-2673-9749; lang, jinyi/0000-0002-5406-8671	National Natural Science Foundation of China [81602731]; Science and Technology Department of Sichuan Province [2019YJ0573, 2020YJ0453]; Innovation Program of Sichuan Medical Association Science for Youth [Q18009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province; Innovation Program of Sichuan Medical Association Science for Youth	This work was supported by the National Natural Science Foundation of China (Grant No. 81602731), the Science and Technology Department of Sichuan Province (Grant Nos. 2019YJ0573 and 2020YJ0453), and the Innovation Program of Sichuan Medical Association Science for Youth (Grant No. Q18009).	Bauer AK, 2017, MOL CARCINOGEN, V56, P94, DOI 10.1002/mc.22475; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chen JC, 2016, PHYSIOL REV, V96, P1025, DOI 10.1152/physrev.00030.2015; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Du ZF, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0782-4; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Hsu CC, 2020, J THORAC ONCOL, V15, P50, DOI 10.1016/j.jtho.2019.09.006; Ishikawa N, 2005, CANCER RES, V65, P9176, DOI 10.1158/0008-5472.CAN-05-1556; Kakiuchi S, 2004, HUM MOL GENET, V13, P3029, DOI 10.1093/hmg/ddh331; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kim TM, 2015, J THORAC ONCOL, V10, P1736, DOI 10.1097/JTO.0000000000000688; Lim B, 2020, CANCER CELL, V37, P456, DOI 10.1016/j.ccell.2020.03.008; Massip-Copiz M, 2018, J CELL BIOCHEM, V119, P2911, DOI 10.1002/jcb.26483; Mok T, 2016, LUNG CANCER, V98, P1, DOI 10.1016/j.lungcan.2016.04.023; Nagano T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110212; Ono T, 2020, INVEST NEW DRUG, V38, P885, DOI 10.1007/s10637-020-00919-0; Poole JA, 2020, AM J PHYSIOL-LUNG C, V318, pL180, DOI 10.1152/ajplung.00039.2019; Recondo G, 2018, NAT REV CLIN ONCOL, V15, P694, DOI 10.1038/s41571-018-0081-4; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Santoni-Rugiu E, 2019, CANCERS, V11, DOI 10.3390/cancers11070923; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Sunaga N, 2015, LUNG CANCER-TARGETS, V6, P91, DOI 10.2147/LCTT.S60427; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Vlaicu P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-197; Vollebergh MA, 2010, J THORAC ONCOL, V5, P1939, DOI 10.1097/JTO.0b013e3181f77a39; Wang YJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1277-x; Westover D, 2018, ANN ONCOL, V29, pI10, DOI 10.1093/annonc/mdx703; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	30	12	12	2	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2021	40	14					2596	2609		10.1038/s41388-021-01734-4	http://dx.doi.org/10.1038/s41388-021-01734-4		MAR 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RK3YE	33750895				2022-12-26	WOS:000626816500002
J	Johe, P; Jaenicke, E; Neuweiler, H; Schirmeister, T; Kersten, C; Hellmich, UA				Johe, Patrick; Jaenicke, Elmar; Neuweiler, Hannes; Schirmeister, Tanja; Kersten, Christian; Hellmich, Ute A.			Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROCATHEPSIN L; CATHEPSIN-L; DELETION ANALYSIS; CHAGAS-DISEASE; ACTIVE-SITE; ACTIVATION; PROTEINASE; EXPRESSION; MECHANISM; PRECURSOR	Rhodesain is the lysosomal cathepsin L-like cysteine protease of Trypanosoma brucei rhodesiense, the causative agent of Human African Trypanosomiasis. The enzyme is essential for the proliferation and pathogenicity of the parasite as well as its ability to overcome the blood-brain barrier of the host. Lysosomal cathepsins are expressed as zymogens with an inactivating prodomain that is cleaved under acidic conditions. A structure of the uncleaved maturation intermediate from a trypanosomal cathepsin L-like protease is currently not available. We thus established the heterologous expression of T. brucei rhodesiense pro-rhodesain in Escherichia coli and determined its crystal structure. The trypanosomal prodomain differs from nonparasitic pro-cathepsins by a unique, extended alpha-helix that blocks the active site and whose side-chain interactions resemble those of the antiprotozoal inhibitor K11777. Interdomain dynamics between pro- and core protease domain as observed by photoinduced electron transfer fluorescence correlation spectroscopy increase at low pH, where pro-rhodesain also undergoes autocleavage. Using the crystal structure, molecular dynamics simulations, and mutagenesis, we identify a conserved interdomain salt bridge that prevents pre-mature intramolecular cleavage at higher pH values and may thus present a control switch for the observed pH sensitivity of proenzyme cleavage in (trypanosomal) CathL-like proteases.	[Johe, Patrick; Schirmeister, Tanja; Kersten, Christian] Johannes Gutenberg Univ Mainz, Inst Pharmaceut & Biomed Sci, Mainz, Germany; [Jaenicke, Elmar] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, Mainz, Germany; [Neuweiler, Hannes] Julius Maximilians Univ, Dept Biotechnol & Biophys, Wurzburg, Germany; [Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Dept Chem, Biochem Div, Mainz, Germany; [Hellmich, Ute A.] Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany; [Hellmich, Ute A.] Friedrich Schiller Univ, Fac Chem & Earth Sci, Inst Organ Chem & Macromol Chem, Jena, Germany; [Hellmich, Ute A.] Friedrich Schiller Univ, Cluster Excellence Balance Microverse, Jena, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Wurzburg; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kersten, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharmaceut & Biomed Sci, Mainz, Germany.; Hellmich, UA (corresponding author), Johannes Gutenberg Univ Mainz, Dept Chem, Biochem Div, Mainz, Germany.; Hellmich, UA (corresponding author), Goethe Univ, Ctr Biomol Magnet Resonance BMRZ, Frankfurt, Germany.; Hellmich, UA (corresponding author), Friedrich Schiller Univ, Fac Chem & Earth Sci, Inst Organ Chem & Macromol Chem, Jena, Germany.; Hellmich, UA (corresponding author), Friedrich Schiller Univ, Cluster Excellence Balance Microverse, Jena, Germany.	kerstec@uni-mainz.de; ute.hellmich@uni-jena.de		Kersten, Christian/0000-0001-9976-7639	Carl-Zeiss Foundation; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt - State of Hesse; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [390713860]	Carl-Zeiss Foundation; Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt - State of Hesse; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	Research was supported by the Carl-Zeiss Foundation (to U. A. H.) and the Centre for Biomolecular Magnetic Resonance (BMRZ), Goethe-University Frankfurt, funded by the State of Hesse. Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2051-Project ID390713860.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bietz S, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-12; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Case D., 2017, AMBER; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ettari R, 2013, J MED CHEM, V56, P5637, DOI 10.1021/jm301424d; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; Giroud M, 2018, J MED CHEM, V61, P3350, DOI 10.1021/acs.jmedchem.7b01869; Goretzki B, 2018, STRUCTURE, V26, P1583, DOI 10.1016/j.str.2018.08.002; Grab D. J., 2009, PLOS NEGL TROP DIS, V3, P1; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Gunner MR, 2006, BBA-BIOENERGETICS, V1757, P942, DOI 10.1016/j.bbabio.2006.06.005; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HARPER E, 1972, BIOCHEM BIOPH RES CO, V46, P1956, DOI 10.1016/0006-291X(72)90076-9; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heiby JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12365-5; Huete-Perez JA, 1999, J BIOL CHEM, V274, P16249, DOI 10.1074/jbc.274.23.16249; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johe P., 2021, ACS CHEM BIOL; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Koeller CM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12980; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MARTINEZ J, 1995, FEMS MICROBIOL LETT, V129, P135, DOI 10.1016/0378-1097(95)00147-W; MCDONALD JK, 1995, ARCH BIOCHEM BIOPHYS, V323, P409, DOI 10.1006/abbi.1995.0062; McKerrow J. H., 2018, PLOS NEGL TROP DIS, V12, P4; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; MOTTRAM JC, 1989, FEBS LETT, V258, P211, DOI 10.1016/0014-5793(89)81655-2; Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NISHIMURA Y, 1989, ARCH BIOCHEM BIOPHYS, V271, P400, DOI 10.1016/0003-9861(89)90289-0; Nomura T, 1997, BIOCHEM BIOPH RES CO, V230, P143, DOI 10.1006/bbrc.1996.5905; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; PAMER EG, 1991, INFECT IMMUN, V59, P1074, DOI 10.1128/IAI.59.3.1074-1078.1991; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reif MM, 2012, BIOCHEMISTRY-US, V51, P8636, DOI 10.1021/bi300802a; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Sauer M., 2014, FLUORESC SPECTROSC M, V1076, P371; Schirmeister T, 2016, J AM CHEM SOC, V138, P8332, DOI 10.1021/jacs.6b03052; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; SMITH SM, 1989, J BIOL CHEM, V264, P20487; Steverding D, 2012, INT J PARASITOL, V42, P481, DOI 10.1016/j.ijpara.2012.03.009; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; von Hammerstein F, 2019, FEBS LETT, V593, P2204, DOI 10.1002/1873-3468.13507; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WIEDERANDERS B, 1989, ARCH BIOCHEM BIOPHYS, V272, P516, DOI 10.1016/0003-9861(89)90247-6	68	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100565	10.1016/j.jbc.2021.100565	http://dx.doi.org/10.1016/j.jbc.2021.100565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745969	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400538
J	Miyajima, K; Kawamoto, C; Hara, S; Mori-Kojima, M; Ohye, T; Sumi-Ichinose, C; Saito, N; Sasaoka, T; Metzger, D; Ichinose, H				Miyajima, Katsuya; Kawamoto, Chiaki; Hara, Satoshi; Mori-Kojima, Masayo; Ohye, Tamae; Sumi-Ichinose, Chiho; Saito, Nae; Sasaoka, Toshikuni; Metzger, Daniel; Ichinose, Hiroshi			Tyrosine hydroxylase conditional KO mice reveal peripheral tissue-dependent differences in dopamine biosynthetic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; ADRENAL-GLAND; EXPRESSION; RAT; NOREPINEPHRINE; TRANSPORTER; RELEASE; KIDNEY; ACID; 3,4-DIHYDROXYPHENYLALANINE	Dopamine (DA) exerts well-known functions in the brain as a neurotransmitter. In addition, it plays important physiological roles in peripheral organs, but it is largely unknown how and where peripheral DA is synthesized and regulated. Catecholamines in peripheral tissues are either produced within the tissue itself and/or derived from sympathetic neurons, which release neurotransmitters for uptake by peripheral tissues. To evaluate DA-producing ability of each peripheral tissue, we generated conditional KO mice (cKO mice) in which the tyrosine hydroxylase (TH) gene is ablated in the sympathoadrenal system, thus eliminating sympathetic neurons as a DA source. We then examined the alterations in the noradrenaline (NA), DA, and 3,4-dihydroxyphenylalanine (DOPA) contents in peripheral organs and performed immunohistochemical analyses of TH-expressing cells. In the heart and pancreas of cKO mice, both the TH protein and NA levels were significantly decreased, and the DA contents were decreased in parallel with NA contents, indicating that the DA supply originated from sympathetic neurons. We found TH-immunoreactive cells in the stomach and lung, where the TH protein showed a decreasing trend, but the DA levels were not decreased in cKO mice. Moreover, we found a significant correlation between the DA content in the kidney and the plasma DOPA concentration, suggesting that the kidney takes up DOPA from blood to make DA. The aforementioned data unravel differences in the DA biosynthetic pathway among tissues and support the role of sympathetic neurons as a DA supplier.	[Miyajima, Katsuya; Kawamoto, Chiaki; Hara, Satoshi; Mori-Kojima, Masayo; Ichinose, Hiroshi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Ohye, Tamae] Fujita Hlth Univ, Grad Sch Hlth Sci, Dept Genet Counseling, Toyoake, Aichi, Japan; [Sumi-Ichinose, Chiho] Fujita Hlth Univ, Sch Med, Dept Pharmacol, Toyoake, Aichi, Japan; [Saito, Nae; Sasaoka, Toshikuni] Niigata Univ, Ctr Bioresource Based Res, Brain Res Inst, Dept Comparat & Expt Med, Niigata, Japan; [Saito, Nae] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Med, Niigata, Japan; [Metzger, Daniel] Univ Strasbourg, CNRS, UMR 7104, INSERM,IGBMC,U 1258, Illkirch Graffenstaden, France	Tokyo Institute of Technology; Fujita Health University; Fujita Health University; Niigata University; Niigata University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ichinose, H (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan.	hichinos@bio.titech.ac.jp	, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394; Sumi-Ichinose, Chiho/0000-0001-5261-0853; Metzger, Daniel/0000-0002-5555-046X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H01422, 17H05555]; Smoking Research Foundation; Collaborative Research Project of Brain Research Institute, Niigata University [201930]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Collaborative Research Project of Brain Research Institute, Niigata University	This work was supported by a Grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (adaptive circuit shift grants, 15H01422 and 17H05555), the Smoking Research Foundation, and by the Collaborative Research Project (201930) of Brain Research Institute, Niigata University.	Adir Y, 2004, AM J RESP CRIT CARE, V169, P757, DOI 10.1164/rccm.200207-744OC; Banday AA, 2019, AM J PHYSIOL-RENAL, V317, pF949, DOI 10.1152/ajprenal.00135.2019; Barnard ML, 1999, AM J RESP CRIT CARE, V160, P982, DOI 10.1164/ajrccm.160.3.9812003; Cavallotti C, 2010, HEART VESSELS, V25, P432, DOI 10.1007/s00380-009-1224-4; Chiken S, 2015, CEREB CORTEX, V25, P4885, DOI 10.1093/cercor/bhv209; Cleary S, 2005, CELL TISSUE RES, V322, P443, DOI 10.1007/s00441-005-0026-y; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; EISENHOFER G, 1988, J NEUROCHEM, V51, P1204, DOI 10.1111/j.1471-4159.1988.tb03088.x; ELDRUP E, 1989, AM J PHYSIOL, V256, pE284, DOI 10.1152/ajpendo.1989.256.2.E284; Farino ZJ, 2020, MOL PSYCHIATR, V25, P2070, DOI 10.1038/s41380-018-0344-6; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; GLAVIN GB, 1990, DIGEST DIS SCI, V35, P1153, DOI 10.1007/BF01537589; Goldstein D., 1995, HYPERTENTION RES, V18, P93; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; GROSSMAN E, 1992, CLIN SCI, V83, P65, DOI 10.1042/cs0830065; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; HOLMES C, 1994, J CHROMATOGR B, V653, P131, DOI 10.1016/0378-4347(93)E0430-X; HOYLE GW, 1994, J NEUROSCI, V14, P2455; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Korner J, 2019, MOL METAB, V23, P37, DOI 10.1016/j.molmet.2019.02.008; KVETNANSKY R, 1992, J PHARMACOL EXP THER, V261, P899; LEE K, 1987, J PHARMACOL EXP THER, V240, P954; Lubomski M, 2020, J NEUROL, V267, P1377, DOI 10.1007/s00415-020-09723-5; Matsuyama N, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0757-4; Mezey E, 1996, P NATL ACAD SCI USA, V93, P10377, DOI 10.1073/pnas.93.19.10377; Mitok KA, 2018, J BIOL CHEM, V293, P5860, DOI 10.1074/jbc.RA117.001102; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Newcomer JW, 2002, ARCH GEN PSYCHIAT, V59, P337, DOI 10.1001/archpsyc.59.4.337; O'Connell DP, 1998, AM J PHYSIOL-RENAL, V274, pF232, DOI 10.1152/ajprenal.1998.274.1.F232; OOMORI Y, 1994, HISTOCHEMISTRY, V101, P313, DOI 10.1007/BF00268992; R Core Team, 2020, R LANG ENV STAT COMP; Rasheed N, 2010, EUR J PHARMACOL, V643, P121, DOI 10.1016/j.ejphar.2010.06.032; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHOMIG A, 1984, CIRC RES, V55, P689, DOI 10.1161/01.RES.55.5.689; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Soares-Da-Silva P, 2004, FASEB J, V18, P1489, DOI 10.1096/fj.04-1787com; Stanley WC, 1997, BRIT J PHARMACOL, V121, P1803, DOI 10.1038/sj.bjp.0701315; Sumi-Ichinose C, 2005, J NEUROCHEM, V95, P703, DOI 10.1111/j.1471-4159.2005.03402.x; Tokuoka H, 2011, J BIOL CHEM, V286, P43549, DOI 10.1074/jbc.M111.284729; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Wu YH, 2017, MOL MED REP, V16, P887, DOI 10.3892/mmr.2017.6620; Xu P, 2020, J MOL ENDOCRINOL, V64, P53, DOI 10.1530/JME-19-0053; Yamaguchi T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18128-x; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zheng LF, 2014, ACTA PHYSIOL, V211, P434, DOI 10.1111/apha.12229	51	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100544	10.1016/j.jbc.2021.100544	http://dx.doi.org/10.1016/j.jbc.2021.100544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33737022	Green Published, gold			2022-12-26	WOS:000672866400517
J	Buchmann, J; Baumann, N; Meng, K; Semrau, J; Kuhl, J; Pfeifer, K; Kazen, M; Vogel, H; Faller, H				Buchmann, Jana; Baumann, Nicola; Meng, Karin; Semrau, Jana; Kuhl, Julius; Pfeifer, Klaus; Kazen, Miguel; Vogel, Heiner; Faller, Hermann			Endurance and avoidance response patterns in pain patients: Application of action control theory in pain research	PLOS ONE			English	Article							LOW-BACK-PAIN; FEAR-AVOIDANCE; SELF-REGULATION; ACTION ORIENTATION; VOLITIONAL FACILITATION; MUSCULOSKELETAL PAIN; STATE ORIENTATION; PHYSICAL-ACTIVITY; INTENTION MEMORY; POSITIVE AFFECT	Background Identifying pain-related response patterns and understanding functional mechanisms of symptom formation and recovery are important for improving treatment. Objectives We aimed to replicate pain-related avoidance-endurance response patterns associated with the Fear-Avoidance Model, and its extension, the Avoidance-Endurance Model, and examined their differences in secondary measures of stress, action control (i.e., dispositional action vs. state orientation), coping, and health. Methods Latent profile analysis (LPA) was conducted on self-report data from 536 patients with chronic non-specific low back pain at the beginning of an inpatient rehabilitation program. Measures of stress (i.e., pain, life stress) and action control were analyzed as covariates regarding their influence on the formation of different pain response profiles. Measures of coping and health were examined as dependent variables. Results Partially in line with our assumptions, we found three pain response profiles of distress-avoidance, eustress-endurance, and low-endurance responses that are depending on the level of perceived stress and action control. Distress-avoidance responders emerged as the most burdened, dysfunctional patient group concerning measures of stress, action control, maladaptive coping, and health. Eustress-endurance responders showed one of the highest levels of action versus state orientation, as well as the highest levels of adaptive coping and physical activity. Low-endurance responders reported lower levels of stress as well as equal levels of action versus state orientation, maladaptive coping, and health compared to eustress-endurance responders; however, equally low levels of adaptive coping and physical activity compared to distress-avoidance responders. Conclusions Apart from the partially supported assumptions of the Fear-Avoidance and Avoidance-Endurance Model, perceived stress and dispositional action versus state orientation may play a crucial role in the formation of pain-related avoidance-endurance response patterns that vary in degree of adaptiveness. Results suggest tailoring interventions based on behavioral and functional analysis of pain responses in order to more effectively improve patients quality of life.	[Buchmann, Jana; Baumann, Nicola] Univ Trier, Dept Psychol 1, Trier, Germany; [Meng, Karin; Faller, Hermann] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Semrau, Jana; Pfeifer, Klaus] Friedrich Alexander Univ Erlangen Nurnberg, Dept Sport Sci & Sport, Erlangen, Germany; [Kuhl, Julius; Kazen, Miguel] Univ Osnabruck, Dept Psychol, Osnabruck, Germany; [Vogel, Heiner] Univ Wurzburg, Sect Med Psychol & Psychotherapy, Wurzburg, Germany	Universitat Trier; University of Wurzburg; University of Erlangen Nuremberg; University Osnabruck; University of Wurzburg	Buchmann, J; Baumann, N (corresponding author), Univ Trier, Dept Psychol 1, Trier, Germany.	j.buchmann@mail.de; nicola.baumann@uni-trier.de	Semrau, Jana/GPX-5508-2022	Semrau, Jana/0000-0001-9408-7386; Meng, Karin/0000-0002-6940-245X; Buchmann, Jana/0000-0002-6770-7719	German Pension Insurance (Deutsche Rentenversicherung Bund, s.a.); Federal Ministry of Education and Research (BMBF) within the research priority "Chronic diseases and patient orientation" [0421-FSCP-0529]; Open Access Fund of Universitat Trier; German Research Foundation (DFG) within the Open Access Publishing funding programme	German Pension Insurance (Deutsche Rentenversicherung Bund, s.a.); Federal Ministry of Education and Research (BMBF) within the research priority "Chronic diseases and patient orientation"(Federal Ministry of Education & Research (BMBF)); Open Access Fund of Universitat Trier; German Research Foundation (DFG) within the Open Access Publishing funding programme(German Research Foundation (DFG))	The data acquisition for this project was funded by the German Pension Insurance (Deutsche Rentenversicherung Bund, s.a. http://forschung.deutsche-rentenversicherung.de/ForschPortalWeb/) and the Federal Ministry of Education and Research (BMBF) within the research priority "Chronic diseases and patient orientation" (Grant number: 0421-FSCP-0529). The publication was funded by the Open Access Fund of Universita/t Trier and the German Research Foundation (DFG) within the Open Access Publishing funding programme. The funders had no role in study design of this secondary study, nor data collection and analysis, decision to publish, nor preparation of the manuscript.	Andrews NE, 2012, ARCH PHYS MED REHAB, V93, P2109, DOI 10.1016/j.apmr.2012.05.029; [Anonymous], 2013, STAT POWER ANAL BEHA; ARMENTROUT DP, 1982, J BEHAV MED, V5, P201, DOI 10.1007/BF00844809; Asmundson GJG, 2012, PAIN MANAG, V2, P295, DOI [10.2217/PMT.12.15, 10.2217/pmt.12.15]; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Baumann N, 2005, J PERS SOC PSYCHOL, V89, P781, DOI 10.1037/0022-3514.89.5.781; Baumann N, 2002, J PERS SOC PSYCHOL, V83, P1213, DOI 10.1037//0022-3514.83.5.1213; Baumann N, 2006, Z GESUNDHEITSPSYCHOL, V14, P46, DOI [10.1026/0943-8149.14.2.46, DOI 10.1026/0943-8149.14.2.46]; Baumann N, 2007, J RES PERS, V41, P239, DOI 10.1016/j.jrp.2006.05.002; BECKMANN J, 1984, J RES PERS, V18, P224, DOI 10.1016/0092-6566(84)90031-X; Beckmann J, 2004, PSYCHOL REP, V95, P1135, DOI 10.2466/PR0.95.7.1135-1153; Biebrich R, 2002, Z PSYCHOL, V210, P74, DOI 10.1026//0044-3409.210.2.74; Birk MV, 2020, J PERS, V88, P373, DOI 10.1111/jopy.12498; Bousema EJ, 2007, PAIN, V130, P279, DOI 10.1016/j.pain.2007.03.024; Bradley L A, 1978, J Behav Med, V1, P253, DOI 10.1007/BF00846678; Brunstein JC., 1990, MOTIVATIONSFORSCHUNG, V12; Campbell CM, 2010, J PAIN, V11, P876, DOI 10.1016/j.jpain.2009.12.007; Cane D, 2018, PAIN, V159, P2522, DOI 10.1097/j.pain.0000000000001357; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Esteve R, 2017, J PAIN, V18, P546, DOI 10.1016/j.jpain.2016.12.013; Fehrmann E, 2017, CLIN J PAIN, V33, P912, DOI 10.1097/AJP.0000000000000479; Ferguson SL, 2020, INT J BEHAV DEV, V44, P458, DOI 10.1177/0165025419881721; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Friederichs KM, 2020, PERS INDIV DIFFER, V161, DOI 10.1016/j.paid.2020.109970; Geiser C., 2013, DATA ANAL MPLUS; Geissner E., 2006, FRAGEBOGEN ERFASSUNG; GIBSON WA, 1959, PSYCHOMETRIKA, V24, P229, DOI 10.1007/BF02289845; Gironda RJ, 2008, PAIN MED, V9, P813, DOI 10.1111/j.1526-4637.2007.00397.x; Grebner M, 1999, SCHMERZ, V13, P19, DOI 10.1007/s004820050180; Hasenbring MI, 2014, PAIN MANAG, V4, P363, DOI [10.2217/pmt.14.36, 10.2217/PMT.14.36]; Hasenbring MI, 2012, PAIN, V153, P211, DOI 10.1016/j.pain.2011.10.019; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Hasenbring MI, 2006, EUR J PAIN, V10, P701, DOI 10.1016/j.ejpain.2005.11.004; Hofmann SG, 2019, CLIN PSYCHOL SCI, V7, P63, DOI 10.1177/2167702618805513; Hondorf M, 2010, SCHMERZ, V24, P334, DOI 10.1007/s00482-010-0944-9; Huijnen IPJ, 2011, EUR J PAIN, V15, P748, DOI 10.1016/j.ejpain.2010.11.015; JAMISON RN, 1988, J BEHAV MED, V11, P147, DOI 10.1007/BF00848262; Jostmann N., 2008, PSYCHOL GOALS, P337, DOI [10.1111/j.1467-9280.2008.02107.x, DOI 10.1111/J.1467-9280.2008.02107.X]; Jostmann N. B., 2010, HDB PERSONALITY SELF, P332, DOI DOI 10.1002/9781444318111.CH15; Jostmann NB, 2005, EUR PSYCHOL, V10, P209, DOI 10.1027/1016-9040.10.3.209; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Kanfer FH., 1996, TXB CLIN PRACTICE; Kaschel R., 2004, MOTIVATIONAL COUNSEL, P99, DOI [10.1002/syn.20045, DOI 10.1002/978047073129]; Kazen M, 2005, J PERS SOC PSYCHOL, V89, P426, DOI 10.1037/0022-3514.89.3.426; Kazen M, 2003, MOTIV EMOTION, V27, P157, DOI 10.1023/A:1025043530799; Kazen M, 2008, J RES PERS, V42, P693, DOI 10.1016/j.jrp.2007.09.005; Kindermans HPJ, 2011, J PAIN, V12, P1049, DOI 10.1016/j.jpain.2011.04.009; Kiosses DN, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2010005; Koole S.L., 2008, HDB MOTIVATION SCI P, P295; Koole SL, 2007, J EXP SOC PSYCHOL, V43, P671, DOI 10.1016/j.jesp.2006.07.001; Koole SL, 2004, J PERS SOC PSYCHOL, V87, P974, DOI 10.1037/0022-3514.87.6.974; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; KUHL J, 1986, J ABNORM PSYCHOL, V95, P247, DOI 10.1037/0021-843X.95.3.247; KUHL J, 1981, J PERS SOC PSYCHOL, V40, P155, DOI 10.1037/0022-3514.40.1.155; Kuhl J, 2004, PSYCHOL RUNDSCH, V55, P61, DOI 10.1026/0033-3042.55.2.61; Kuhl J, 2000, CONTROL OF HUMAN BEHAVIOR, MENTAL PROCESSES, AND CONSCIOUSNESS, P283; KUHL J, 1994, J PERS SOC PSYCHOL, V66, P1103, DOI 10.1037/0022-3514.66.6.1103; Kuhl J, 1999, J EXP PSYCHOL GEN, V128, P382, DOI 10.1037/0096-3445.128.3.382; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 1998, MOTIVATION SELF REGU, P15, DOI [10.1017/C809780511527869.003, DOI 10.1017/CBO9780511527869.003, 10.1017/CBO9780511527869.003]; Kuhl J, 2001, INTERAKTIONEN PSYCHI; Kuhl J., 1994, VOLITION PERSONALITY, P317; Kuhl J., 1983, DEPRESSIV KRANKE PSY, P411; Kuhl J., 1994, VOLITION PERSONALITY; Kuhl J., 1994, VOLITION PERSONALITY, P9; Kuhl J., 1994, VOLITION PERSONALITY, P375; Kuhl J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P535; Kuhl J, 2011, SOC PSYCHOL-GERMANY, V42, P74, DOI 10.1027/1864-9335/a000045; Kupriyanov R., 2014, WORLD J MED SCI, V11, P179, DOI [10.5829/idosi.wjms.2014.11.2.8433, DOI 10.5829/IDOSI.WJMS.2014.11.2.8433]; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Lazarus R.S., 1984, EMOTION ADAPTATION; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; McCracken LM, 2007, PAIN, V130, P119, DOI 10.1016/j.pain.2006.11.016; McCracken LM, 2013, J PAIN, V14, P828, DOI 10.1016/j.jpain.2013.02.009; McCracken LM, 2004, PAIN, V109, P4, DOI 10.1016/j.pain.2004.02.006; Mehta S, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/5187631; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Sullivan PB, 2018, PHYS THER, V98, P408, DOI 10.1093/ptj/pzy022; Park SH, 2010, J PAIN, V11, P1267, DOI 10.1016/j.jpain.2010.02.023; Pincus T, 2006, ARTHRITIS RHEUM-US, V54, P3999, DOI 10.1002/art.22273; Plaas H, 2014, DISABIL REHABIL, V36, P749, DOI 10.3109/09638288.2013.814723; Quirin M, 2011, COGNITION EMOTION, V25, P559, DOI 10.1080/02699931.2010.536418; Rabey M, 2019, SCAND J PAIN, V19, P743, DOI 10.1515/sjpain-2019-0073; Ruigendijk HAH, 2014, MOTIV EMOTION, V38, P659, DOI 10.1007/s11031-014-9415-4; Rusu AC, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-280; Schmitz U, 1996, PAIN, V67, P41, DOI 10.1016/0304-3959(96)03108-9; Scholich SL, 2011, SCHMERZ, V25, P184, DOI 10.1007/s00482-011-1023-6; Schrooten MGS, 2012, PAIN, V153, P1180, DOI 10.1016/j.pain.2012.01.025; Schwarzer R., 1994, SELF EFFICACY THOUGH, V2nd, P195; Selye H., 1976, PSYCHOPATHOLOGY HUMA, P137, DOI [https://doi.org/10.1007/978-1-4684-2238-2_9, DOI 10.1007/978-1-4684-2238-2_9]; Semrau J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118609; Sheffer CE, 2007, PAIN MED, V8, P312, DOI 10.1111/j.1526-4637.2006.00176.x; Smeets RJ, 2009, ARCH PHYS MED REHAB, V90, P109, DOI 10.1016/j.apmr.2008.07.009; Smeets RJEM, 2006, DISABIL REHABIL, V28, P673, DOI 10.1080/09638280500264782; Sudhaus S, 2007, SCHMERZ, V21, P202, DOI 10.1007/s00482-006-0521-4; Sullivan MJL, 1997, COGNITIVE THER RES, V21, P555, DOI 10.1023/A:1021809519002; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; Van Damme S, 2008, PAIN, V139, P1, DOI 10.1016/j.pain.2008.07.022; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Vos T, 2013, LANCET, V381, P628; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wideman TH, 2011, PAIN, V152, P376, DOI 10.1016/j.pain.2010.10.044; WILLIAMS DA, 1991, PAIN, V46, P185, DOI 10.1016/0304-3959(91)90074-8; Zautra AJ, 2005, J CONSULT CLIN PSYCH, V73, P212, DOI 10.1037/0022-006X.73.2.212	116	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248875	10.1371/journal.pone.0248875	http://dx.doi.org/10.1371/journal.pone.0248875			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765020	gold, Green Published			2022-12-26	WOS:000634832800063
J	Guo, Y; Mehrabian, Z; Johnson, MA; Miller, NR; Henderson, AD; Hamlyn, J; Bernstein, SL				Guo, Yan; Mehrabian, Zara; Johnson, Mary A.; Miller, Neil R.; Henderson, Amanda D.; Hamlyn, John; Bernstein, Steven L.			Biomarkers of lesion severity in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION)	PLOS ONE			English	Article								The rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION) is similar in many of its pathophysiological responses to clinical NAION. Like human NAION, there is significant variability in the severity of the lesion produced, and little is known of the parameters associated with rNAION induction severity or if pre- or early post-induction biomarkers can be identified that enable prediction of lesion severity and ultimate loss of retinal ganglion cells (RGCs). Adult male Sprague-Dawley outbred rats were evaluated for various parameters including physiological characteristics (heart rate, respiratory rate, temperature, hematocrit [Hct]), optic nerve head (ONH) appearance, pre- and post-induction mean diameter, and intravenous fluorescein and indocyanine green angiographic patterns of vascular leakage at 5 hours post-induction, performed using a spectral domain-optical coherence tomography (SD-OCT) instrument. Early changes were correlated with ultimate RGC loss by Brn3a (+) immunohistology. RGC loss also was correlated with the relative level of laser exposure. The severity of ONH edema 2d, but not 5hr, post induction was most closely associated with the degree of RGC loss, revealing a threshold effect, and consistent with a compartment syndrome where a minimum level of capillary compression within a tight space is responsible for damage. RGC loss increased dramatically as the degree of laser exposure increased. Neither physiological parameters nor the degree of capillary leakage 5hr post induction were informative as to the ultimate degree of RGC loss. Similar to human NAION, the rNAION model exhibits marked variability in lesion severity. Unlike clinical NAION, pre-induction ONH diameter likely does not contribute to ultimate lesion severity; however, cross-sectional ONH edema can be used as a biomarker 2d post-induction to determine randomization of subjects prior to inclusion in specific neuroprotection or neuroregeneration studies.	[Guo, Yan; Mehrabian, Zara; Johnson, Mary A.; Bernstein, Steven L.] Univ Maryland Baltimore UMB, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Miller, Neil R.; Henderson, Amanda D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, JHU Wilmer Div Neuroophthalmol, Baltimore, MD 21205 USA; [Hamlyn, John] UMB, Dept Physiol, Baltimore, MD USA; [Bernstein, Steven L.] UMB, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bernstein, SL (corresponding author), Univ Maryland Baltimore UMB, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA.; Bernstein, SL (corresponding author), UMB, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	sbernstein@som.umaryland.edu	Henderson, Amanda/AAN-3311-2021	Henderson, Amanda/0000-0002-8676-4292; Bernstein, Steven/0000-0001-7758-0136	NIH-NEI [RO1EY015304]; Hillside Foundation, Washington DC	NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hillside Foundation, Washington DC	Funding to SLB from NIH-NEI grant RO1EY015304 and the Hillside Foundation, Washington DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; Bernstein SL, 2011, INVEST OPHTH VIS SCI, V52, P904, DOI 10.1167/iovs.10-5247; Chen CS, 2008, INVEST OPHTH VIS SCI, V49, P2985, DOI 10.1167/iovs.07-1651; Goldenberg-Cohen N, 2005, INVEST OPHTH VIS SCI, V46, P2716, DOI 10.1167/iovs.04-0547; GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x; Hirabayashi K, 2019, AM J PATHOL, V189, P449, DOI 10.1016/j.ajpath.2018.10.021; Huang TL, 2016, INVEST OPHTH VIS SCI, V57, P1878, DOI 10.1167/iovs.15-19023; IANACONE DC, 1980, ARCH OPHTHALMOL-CHIC, V98, P1643; Janaky M, 2006, CLIN NEUROPHYSIOL, V117, P1158, DOI 10.1016/j.clinph.2006.01.013; Johnson MA, 2016, INVEST OPHTH VIS SCI, V57, P527, DOI 10.1167/iovs.15-17880; Kapupara K, 2019, EXP EYE RES, V181, P105, DOI 10.1016/j.exer.2018.12.007; Kerr NM, 2009, J CLIN NEUROSCI, V16, P994, DOI 10.1016/j.jocn.2009.04.002; Knott EJ, 2011, EXP EYE RES, V92, P155, DOI 10.1016/j.exer.2010.10.009; LEE HB, 1985, J NUCL MED, V26, P72; Miller NR, 2015, EYE, V29, P65, DOI 10.1038/eye.2014.144; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Muci-Mendoza R, 1999, OPHTHALMOLOGY, V106, P311, DOI 10.1016/S0161-6420(99)90055-6; Nicholson JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050021; OLVER JM, 1990, EYE, V4, P7, DOI 10.1038/eye.1990.3; Oto S, 2002, RETINA-J RET VIT DIS, V22, P187, DOI 10.1097/00006982-200204000-00009; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Prieto R, 2005, NEUROL RES, V27, P47, DOI 10.1179/016164105X18214; Salgado C, 2011, ARCH OPHTHALMOL-CHIC, V129, P1583, DOI 10.1001/archophthalmol.2011.351; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Shmonin A, 2014, INT J STROKE, V9, P793, DOI 10.1111/j.1747-4949.2012.00947.x; Sozmen EG, 2016, P NATL ACAD SCI USA, V113, pE8453, DOI 10.1073/pnas.1615322113; Tesser RA, 2003, OPHTHALMOLOGY, V110, P2031, DOI 10.1016/S0161-6420(03)00804-2; Yoneya S, 1998, INVEST OPHTH VIS SCI, V39, P1286	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0243186	10.1371/journal.pone.0243186	http://dx.doi.org/10.1371/journal.pone.0243186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764998	Green Published, Green Submitted, gold			2022-12-26	WOS:000634832800062
J	Rowlinson, E; Peters, L; Mansour, A; Mansour, H; Azazzy, N; Said, M; Samy, S; Abbas, E; Abu Elsood, H; Fahim, M; Eid, A; Reaves, E; Van Beneden, C; Hamid, S; Olsen, S; Fitzner, J; Dueger, E				Rowlinson, Emily; Peters, Lisa; Mansour, Adel; Mansour, Hoda; Azazzy, Nahed; Said, Mayar; Samy, Sahar; Abbas, Eman; Abu Elsood, Hanaa; Fahim, Manal; Eid, Alaa; Reaves, Erik; Van Beneden, Chris; Hamid, Sarah; Olsen, Sonja; Fitzner, Julia; Dueger, Erica			Comparison of common acute respiratory infection case definitions for identification of hospitalized influenza cases at a population-based surveillance site in Egypt	PLOS ONE			English	Article							CLINICAL-FEATURES; ILLNESS	Background Multiple case definitions are used to identify hospitalized patients with community-acquired acute respiratory infections (ARI). We evaluated several commonly used hospitalized ARI case definitions to identify influenza cases. Methods The study included all patients from a population-based surveillance site in Damanhour, Egypt hospitalized for a broad set of criteria consistent with community acquired ARIs. Naso- and oropharyngeal (NP/OP) swabs were tested for influenza using RT-PCR. Sensitivity, specificity and PPV for influenza identification was compared between the 2014 WHO Severe Acute Respiratory Infection (SARI) definition (fever >= 38 degrees C and cough with onset within 10 days), the 2011 WHO SARI definition (fever >= 38 degrees C and cough with onset within 7 days), the 2006 PAHO SARI definition, the International Emerging Infections Program (IEIP) pneumonia case definition, and the International Management of Childhood Illness (IMCI) case definitions for moderate and severe pneumonia. Results From June 2009-December 2012, 5768 NP/OP swabs were obtained from 6113 hospitalized ARI patients; 799 (13.9%) were influenza positive. The 2014 WHO SARI case definition captured the greatest number of ARI patients, influenza positive patients and ARI deaths compared to the other case definitions examined. Sensitivity for influenza detection was highest for the 2014 WHO SARI definition with 88.6%, compared to the 2011 WHO SARI (78.2%) the 2006 PAHO SARI (15.8%) the IEIP pneumonia (61.0%) and the IMCI moderate and severe pneumonia (33.8% and 38.9%) case definitions (IMCI applies to <5 only). Conclusions Our results support use of the 2014 WHO SARI definition for identifying influenza positive hospitalized SARI cases as it captures the highest proportion of ARI deaths and influenza positive cases. Routine use of this case definition for hospital-based surveillance will provide a solid, globally comparable foundation on which to build needed response efforts for novel pandemic viruses.	[Rowlinson, Emily; Peters, Lisa; Mansour, Adel; Mansour, Hoda; Said, Mayar; Hamid, Sarah; Dueger, Erica] US Naval Med Res Unit 3, Cairo, Egypt; [Azazzy, Nahed; Samy, Sahar; Abbas, Eman; Abu Elsood, Hanaa; Fahim, Manal; Eid, Alaa] Egyptian Minist Hlth & Populat, Cairo, Egypt; [Reaves, Erik; Van Beneden, Chris; Olsen, Sonja; Dueger, Erica] US Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Fitzner, Julia] WHO, Geneva, Switzerland; [Dueger, Erica] Sanofi Pasteur, Med Evidence Generat, Lyon, France	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Centers for Disease Control & Prevention - USA; World Health Organization; Sanofi-Aventis; Sanofi France	Rowlinson, E; Dueger, E (corresponding author), US Naval Med Res Unit 3, Cairo, Egypt.; Dueger, E (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.; Dueger, E (corresponding author), Sanofi Pasteur, Med Evidence Generat, Lyon, France.	erowlin@uw.edu; Edueger@gmail.com		Rowlinson, Emily/0000-0003-2436-1022; Hamid, Sarah/0000-0001-8164-0656	CDC; Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance Program	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance Program	This work was supported by the CDC and the Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance Program.	[Anonymous], 2007, SPSS WINDOWS; [Anonymous], 2008, GLOB BURD DIS 2004 U; [Anonymous], 2017, PANDEMIC INFLUENZA S; [Anonymous], WHO GLOBAL TECHNICAL; Babcock HM, 2008, INFECT CONT HOSP EP, V29, P921, DOI 10.1086/590663; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Breiman RF, 2013, J INFECT DIS, V208, pS167, DOI 10.1093/infdis/jit462; DAGAN R, 1989, J PEDIATR-US, V115, P351, DOI 10.1016/S0022-3476(89)80831-5; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Lau LLH, 2013, J INFECT DIS, V207, P1281, DOI 10.1093/infdis/jit034; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Moretti ML, 2011, REV SOC BRAS MED TRO, V44, P405, DOI 10.1590/S0037-86822011005000048; Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Rowlinson E, 2017, INFLUENZA OTHER RESP, V11, P23, DOI 10.1111/irv.12409; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; StataCorp, 2021, STATA STAT SOFTWARE; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248563	10.1371/journal.pone.0248563	http://dx.doi.org/10.1371/journal.pone.0248563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765010	Green Published, gold			2022-12-26	WOS:000634832800024
J	Wong, LP; Alias, H; Fuzi, AAM; Omar, IS; Mohamad Nor, A; Tan, MP; Baranovich, DL; Saari, CZ; Hamzah, SH; Cheong, KW; Poon, CH; Ramoo, V; Che, CC; Myint, K; Zainuddin, S; Chung, I				Wong, Li Ping; Alias, Haridah; Fuzi, Afiqah Alyaa Md; Omar, Intan Sofia; Mohamad Nor, Azmawaty; Tan, Maw Pin; Baranovich, Diana Lea; Saari, Che Zarrina; Hamzah, Sareena Hanim; Cheong, Ku Wing; Poon, Chiew Hwa; Ramoo, Vimala; Che, Chong Chin; Myint, Kyaimon; Zainuddin, Suria; Chung, Ivy			Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey	PLOS ONE			English	Article							STRESS SCALES DASS-21; IMPACT; ANXIETY; DEPRESSION; PREVALENCE; STUDENTS; SUICIDE; GENDER	Since the first nationwide movement control order was implemented on 18 March 2020 in Malaysia to contain the coronavirus disease 2019 (COVID-19) outbreak, to what extent the uncertainty and continuous containment measures have imposed psychological burdens on the population is unknown. This study aimed to measure the level of mental health of the Malaysian public approximately 2 months after the pandemic's onset. Between 12 May and 5 September 2020, an anonymous online survey was conducted. The target group included all members of the Malaysian population aged 18 years and above. The Depression Anxiety Stress Scale (DASS-21) was used to assess mental health. There were increased depressive, anxiety and stress symptoms throughout the study period, with the depression rates showing the greatest increase. During the end of the data collection period (4 August-5 September 2020), there were high percentages of reported depressive (59.2%) and anxiety (55.1%) symptoms compared with stress (30.6%) symptoms. Perceived health status was the strongest significant predictor for depressive and anxiety symptoms. Individuals with a poorer health perception had higher odds of developing depression (odds ratio [OR] = 5.68; 95% confidence interval [CI] 3.81-8.47) and anxiety (OR = 3.50; 95%CI 2.37-5.17) compared with those with a higher health perception. By demographics, young people-particularly students, females and people with poor financial conditions-were more vulnerable to mental health symptoms. These findings provide an urgent call for increased attention to detect and provide intervention strategies to combat the increasing rate of mental health problems in the ongoing COVID-19 pandemic.	[Wong, Li Ping; Alias, Haridah] Univ Malaya, Dept Social & Prevent Med, Ctr Epidemiol & Evidence Based Practice, Fac Med, Kuala Lumpur, Malaysia; [Fuzi, Afiqah Alyaa Md; Omar, Intan Sofia; Chung, Ivy] Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia; [Mohamad Nor, Azmawaty; Baranovich, Diana Lea] Univ Malaya, Dept Educ Psychol & Counselling, Fac Educ, Kuala Lumpur, Malaysia; [Tan, Maw Pin] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Saari, Che Zarrina] Univ Malaya, Acad Islamic Studies, Dept Akidah & Islamic Thought, Kuala Lumpur, Malaysia; [Hamzah, Sareena Hanim] Univ Malaya, Ctr Sport & Exercise Sci, Kuala Lumpur, Malaysia; [Cheong, Ku Wing; Poon, Chiew Hwa] Univ Malaya, Dept Mus, Cultural Ctr, Kuala Lumpur, Malaysia; [Ramoo, Vimala; Che, Chong Chin] Univ Malaya, Dept Nursing Sci, Fac Med, Kuala Lumpur, Malaysia; [Myint, Kyaimon] Univ Malaya, Dept Physiol, Fac Med, Kuala Lumpur, Malaysia; [Zainuddin, Suria] Univ Malaya, Fac Business & Accountancy, Dept Accountancy, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Wong, LP (corresponding author), Univ Malaya, Dept Social & Prevent Med, Ctr Epidemiol & Evidence Based Practice, Fac Med, Kuala Lumpur, Malaysia.; Chung, I (corresponding author), Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my; ivychung@ummc.edu.my	Ramoo, Vimala/C-1002-2010; WONG, LI PING/B-2782-2010; KYAIMON, MYINT/B-8822-2010; Che, Chong Chin/AAD-8778-2020; HAMZAH, SAREENA HANIM/B-9698-2010; ZAINUDDIN, SURIA/B-9869-2010; Chung, Ivy/C-3804-2012; Tan, Maw Pin/G-6917-2011; SA'ARI, CHE ZARRINA/B-8363-2010; Nor, Azmawaty Mohamad/L-6711-2016; Poon, Chiew Hwa/ABG-7735-2021	Ramoo, Vimala/0000-0001-8506-7826; WONG, LI PING/0000-0002-0107-0532; HAMZAH, SAREENA HANIM/0000-0002-1688-5531; Tan, Maw Pin/0000-0002-3400-8540; SA'ARI, CHE ZARRINA/0000-0001-9642-4091; Zainuddin, Suria/0000-0003-0520-7089	Universiti Malaya COVID-19 Implementation Research Grant [RG564-2020HWB]	Universiti Malaya COVID-19 Implementation Research Grant	This research was supported by Universiti Malaya COVID-19 Implementation Research Grant (RG564-2020HWB), which was granted to Ivy Chung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz B, 2017, HEALTH PROMOT INT, V32, P7, DOI 10.1093/heapro/daw103; Adnan N, 2021, ENVIRON DEV SUSTAIN, V23, P8089, DOI 10.1007/s10668-020-00978-6; Axinn WG, 2013, J HEALTH SOC BEHAV, V54, P444, DOI 10.1177/0022146513501518; Bibi A, 2020, INT J PSYCHOL, V55, P916, DOI 10.1002/ijop.12671; Blbas HTA, 2022, J PUBLIC HEALTH-HEID, V30, P567, DOI 10.1007/s10389-020-01325-9; Burns D, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.582882; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; CDC, BRFSS ANN SURV DAT; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Dawel A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579985; Department of Statistics Malaysia, 2019, LAB MARK REV; Elengoe Asita, 2020, Osong Public Health Res Perspect, V11, P93, DOI 10.24171/j.phrp.2020.11.3.08; Express Daily, 2020, ONE EVERYDAY; Hasan N, 2020, CHILD YOUTH SERV REV, V118, DOI 10.1016/j.childyouth.2020.105355; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hosmer DW, 2013, APPL LOGISTIC REGRES; Hou FS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09738-7; Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169; Jacques-Avino C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044617; Kamel H, 2020, SUICIDE CASES RISE P; Kecojevic A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239696; Leung H, 2020, ADDICT BEHAV, V101, DOI 10.1016/j.addbeh.2019.04.027; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lovibond S.H., 1995, MANUAL DEPRESSION AN, V2 nd ed; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Musa R, 2020, MEDITERR J CLIN PSYC, V8, DOI 10.6092/2282-1619/mjcp-2269; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Nadzir MSM, 2020, AEROSOL AIR QUAL RES, V20, P1237, DOI 10.4209/aaqr.2020.04.0163; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Oei TPS, 2013, INT J PSYCHOL, V48, P1018, DOI 10.1080/00207594.2012.755535; Osterrieder A., 2020, EC SOCIAL IMPACTS CO; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Salari N., 2020, EUR NEUROPSYCHOPHARM, V16, P1, DOI [DOI 10.1186/S12992-020-00589-W, 10.1186/s12992-020-00589-w, DOI 10.1016/j.euroneuro.2021.03.019, 10.1186/s12992-020-00589]; Schafer SK, 2020, PSYCHOTHER PSYCHOSOM, V89, P386, DOI 10.1159/000510752; Scholten S, 2017, PSYCHOL ASSESSMENT, V29, P1376, DOI 10.1037/pas0000440; Sherman AC, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113476; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wong LP, 2021, J BEHAV MED, V44, P18, DOI 10.1007/s10865-020-00172-z; Wong SYS, 2020, BRIT J GEN PRACT, V70, pE817, DOI 10.3399/bjgp20X713021; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001	42	32	32	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248916	10.1371/journal.pone.0248916	http://dx.doi.org/10.1371/journal.pone.0248916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765039	Green Published, gold			2022-12-26	WOS:000634832800056
J	Ballard, HK; Eakin, SM; Maldonado, T; Bernard, JA				Ballard, Hannah K.; Eakin, Sydney M.; Maldonado, Ted; Bernard, Jessica A.			Using high-definition transcranial direct current stimulation to investigate the role of the dorsolateral prefrontal cortex in explicit sequence learning	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; BRAIN ACTIVATION; BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; CONVENTIONAL TDCS; SINGLE-SESSION; MOTOR CORTEX; IMPLICIT; SENSORIMOTOR; CEREBELLUM	Though we have a general understanding of the brain areas involved in motor sequence learning, there is more to discover about the neural mechanisms underlying skill acquisition. Skill acquisition may be subserved, in part, by interactions between the cerebellum and prefrontal cortex through a cerebello-thalamo-prefrontal network. In prior work, we investigated this network by targeting the cerebellum; here, we explored the consequence of stimulating the dorsolateral prefrontal cortex using high-definition transcranial direct current stimulation (HD-tDCS) before administering an explicit motor sequence learning paradigm. Using a mixed within- and between- subjects design, we employed anodal (n = 24) and cathodal (n = 25) HD-tDCS (relative to sham) to temporarily alter brain function and examine effects on skill acquisition. The results indicate that both anodal and cathodal prefrontal stimulation impedes motor sequence learning, relative to sham. These findings suggest an overall negative influence of active prefrontal stimulation on the acquisition of a sequential pattern of finger movements. Collectively, this provides novel insight on the role of the dorsolateral prefrontal cortex in initial skill acquisition, when cognitive processes such as working memory are used. Exploring methods that may improve motor learning is important in developing therapeutic strategies for motor-related diseases and rehabilitation.	[Ballard, Hannah K.; Bernard, Jessica A.] Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA; [Eakin, Sydney M.; Maldonado, Ted; Bernard, Jessica A.] Texas A&M Univ, Dept Psychol & Brain Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Ballard, HK (corresponding author), Texas A&M Univ, Texas A&M Inst Neurosci, College Stn, TX 77843 USA.	hannah_ballard@tamu.edu		Ballard, Hannah/0000-0003-1892-3949				Aizenstein HJ, 2004, CEREB CORTEX, V14, P199, DOI 10.1093/cercor/bhg119; Albouy G, 2012, NEUROIMAGE, V60, P324, DOI 10.1016/j.neuroimage.2011.12.049; Anguera JA, 2012, BEHAV BRAIN RES, V228, P107, DOI 10.1016/j.bbr.2011.11.040; Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Ballard HK, 2019, J NEUROPHYSIOL, V122, P490, DOI 10.1152/jn.00036.2019; Bernard JA, 2013, CEREBELLUM, V12, P721, DOI 10.1007/s12311-013-0481-z; Bernard JA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00031; Berner MP, 2008, PSYCHOL RES-PSYCH FO, V72, P138, DOI 10.1007/s00426-006-0097-8; Bhakuni R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00076; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Buch ER, 2017, CLIN NEUROPHYSIOL, V128, P589, DOI 10.1016/j.clinph.2017.01.004; Cole L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00787; DaSilva AF, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00089; Datta A, 2016, IEEE ENG MED BIO, P1774, DOI 10.1109/EMBC.2016.7591061; Denis G, 2019, HUM MOVEMENT SCI, V67, DOI 10.1016/j.humov.2019.102507; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 2018, CURR OPIN BEHAV SCI, V20, P89, DOI 10.1016/j.cobeha.2017.11.012; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Eliassen JC, 2001, EXP BRAIN RES, V141, P269, DOI 10.1007/s002210100822; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; Foerster A, 2013, EUR J NEUROSCI, V37, P786, DOI 10.1111/ejn.12079; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gbadeyan O, 2016, J NEUROSCI, V36, P12530, DOI 10.1523/JNEUROSCI.2450-16.2016; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Greeley B, 2019, J NEUROPHYSIOL, V121, P1906, DOI 10.1152/jn.00795.2018; Hasan A, 2013, J COGNITIVE NEUROSCI, V25, P558, DOI 10.1162/jocn_a_00338; Hashemirad F, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00153; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hill AT, 2018, BRAIN STIMUL, V11, P1033, DOI 10.1016/j.brs.2018.06.005; Hill AT, 2016, BRAIN STIMUL, V9, P197, DOI 10.1016/j.brs.2015.10.006; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; Imburgio MJ, 2018, NEUROPSYCHOLOGIA, V117, P156, DOI 10.1016/j.neuropsychologia.2018.04.022; Israely S, 2019, REV NEUROSCIENCE, V30, P821, DOI 10.1515/revneuro-2019-0008; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Ke YF, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00019; Kelly RM, 2003, J NEUROSCI, V23, P8432; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kwak Y, 2012, BEHAV BRAIN RES, V230, P116, DOI 10.1016/j.bbr.2012.02.006; Kwak Y, 2010, J NEUROPHYSIOL, V103, P942, DOI 10.1152/jn.00197.2009; Leite J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024140; Mancuso LE, 2016, J COGNITIVE NEUROSCI, V28, P1063, DOI 10.1162/jocn_a_00956; Nikolin S, 2019, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00064; Nikolin S, 2015, NEUROIMAGE, V117, P11, DOI 10.1016/j.neuroimage.2015.05.019; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nozari N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084338; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pope PA, 2015, CEREB CORTEX, V25, P4551, DOI 10.1093/cercor/bhv094; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Sakai K, 1998, J NEUROSCI, V18, P1827; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Savic B, 2019, NEUROSCIENCE, V414, P77, DOI 10.1016/j.neuroscience.2019.06.034; Savic B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10128-0; Savic B, 2017, BRAIN STIMUL, V10, P567, DOI 10.1016/j.brs.2017.01.001; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Shilo G, 2019, EXP BRAIN RES, V237, P919, DOI 10.1007/s00221-019-05477-3; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Takano Y, 2011, NEUROSCI LETT, V491, P40, DOI 10.1016/j.neulet.2011.01.004; Talimkhani A, 2019, BASIC CLIN NEUROSCI, V10, P59, DOI 10.32598/bcn.9.10.350; Talsma LJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00481; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Wu YJ, 2014, BRAIN COGNITION, V91, P87, DOI 10.1016/j.bandc.2014.09.002; Zhu FF, 2015, BRAIN STIMUL, V8, P784, DOI 10.1016/j.brs.2015.02.005	73	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0246849	10.1371/journal.pone.0246849	http://dx.doi.org/10.1371/journal.pone.0246849			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735211	Green Submitted, gold, Green Published			2022-12-26	WOS:000631029700115
J	Chang, CS; Hong, SY; Kim, SY; Kim, YM; Sung, JH; Choi, SJ; Oh, SY; Roh, CR; Song, J; Huh, J; Kang, IS				Chang, Chi-Son; Hong, Sir-yeon; Kim, Seo-yeon; Kim, Yoo-min; Sung, Ji-Hee; Choi, Suk-Joo; Oh, Soo-young; Roh, Cheong-Rae; Song, Jinyoung; Huh, June; Kang, I-Seok			Prevalence of associated extracardiac anomalies in prenatally diagnosed congenital heart diseases	PLOS ONE			English	Article							CARDIOVASCULAR ANOMALIES; DEFECTS; MALFORMATIONS; MICRODELETION; ABNORMALITIES; DELETION	Objective To investigate the prevalence of extracardiac anomalies (ECA) in prenatally diagnosed congenital heart diseases (CHD), and to provide more information for counseling of women with prenatally diagnosed fetal CHD. Methods This was a retrospective cohort study of 791 cases of fetal CHD diagnosed by prenatal ultrasound from January 2005 to April 2018. Associated ECAs included extracardiac structural malformation (ECM), chromosomal anomaly, and 22q11.2 microdeletion. CHD was classified into 10 groups according to a modified anatomic and clinical classification of congenital heart defects. Results The overall prevalence of ECA in our CHD cohort was 28.6% (226/791): ECM, 25.3%; chromosomal anomaly, 11.7%; and 22q11.2 microdeletion, 5.5%. For those with ECM, ventricular septal defect (VSD) had the highest prevalence (34.5%), followed by anomalies of atrioventricular junctions and valves (28.8%) and heterotaxy (26.9%). For those with chromosomal anomaly, anomalies of atrioventricular junctions and valves had the highest prevalence (37.5%), followed by anomalies of atria and interatrial communications (25.0%) and VSD (22.9%). 22q11.2 microdeletion was detected only in those with anomalies of extrapericardial arterial trunks (14.3%) or ventricular outflow tracts (6.4%). Conclusion ECM, chromosomal anomaly, and 22q11.2 microdeletion have different prevalence according to the type of CHD.	[Chang, Chi-Son; Hong, Sir-yeon; Kim, Seo-yeon; Sung, Ji-Hee; Choi, Suk-Joo; Oh, Soo-young; Roh, Cheong-Rae] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kim, Yoo-min] Chung Ang Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Song, Jinyoung; Huh, June; Kang, I-Seok] Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, SJ (corresponding author), Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Sch Med, Seoul, South Korea.	drmaxmix.choi@samsung.com	Chang, Chi-Son/HII-5537-2022	Chang, Chi-Son/0000-0002-0169-2008				Bensemlali M, 2016, ARCH CARDIOVASC DIS, V109, P330, DOI 10.1016/j.acvd.2016.01.006; Dulgheroff FF, 2019, SAO PAULO MED J, V137, P391, DOI 10.1590/1516-3180.2019.026906082019; Egbe A, 2014, PEDIATR CARDIOL, V35, P1239, DOI 10.1007/s00246-014-0922-6; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Gawde H., 2006, Indian Journal of Pediatrics, V73, P885, DOI 10.1007/BF02859280; Houyel L, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-64; Lee Mi-Young, 2014, Obstet Gynecol Sci, V57, P11, DOI 10.5468/ogs.2014.57.1.11; McElhinney DB, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e104; Meberg A, 2007, ACTA PAEDIATR, V96, P1142, DOI 10.1111/j.1651-2227.2007.00381.x; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nell S, 2013, FETAL DIAGN THER, V33, P235, DOI 10.1159/000346564; Romosan G, 2009, ULTRASOUND OBST GYN, V34, P526, DOI 10.1002/uog.6446; Rosa Rosana Cardoso M., 2013, Rev. paul. pediatr., V31, P243; Rydberg C, 2017, ACTA OBSTET GYN SCAN, V96, P176, DOI 10.1111/aogs.13037; Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Wozniak A, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-88; Wren C, 2012, EUR J PEDIATR, V171, P281, DOI 10.1007/s00431-011-1525-3; Zyblewski SC, 2009, PEDIATR CARDIOL, V30, P1105, DOI 10.1007/s00246-009-9514-2	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248894	10.1371/journal.pone.0248894	http://dx.doi.org/10.1371/journal.pone.0248894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735284	Green Published, gold			2022-12-26	WOS:000631029700041
J	Ko, IG; Jin, JJ; Hwang, L; Kim, SH; Kim, CJ; Jeon, JW; Chung, JY; Han, JH				Ko, Il-Gyu; Jin, Jun-Jang; Hwang, Lakkyong; Kim, Sang-Hoon; Kim, Chang-Ju; Jeon, Jung Won; Chung, Jun-Young; Han, Jin Hee			Adenosine A(2A) receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway	PLOS ONE			English	Article							EXERCISE IMPROVES MEMORY; TRAUMATIC BRAIN-INJURY; REPERFUSION INJURY; STROKE MECHANISMS; HYPOXIC-ISCHEMIA; DOWN-REGULATION; ACTIVATION; APOPTOSIS; POTENTIATION; HIPPOCAMPUS	Cerebral ischemia causes tissue death owing to occlusion of the cerebral blood vessels, and cerebral ischemia activates mitogen-activated protein kinase (MAPK) and induces secretion of pro-inflammatory cytokines. Adenosine A(2A) receptor agonist, polydeoxyribonucleotide (PDRN), suppresses the secretion of pro-inflammatory cytokines and exhibits anti-inflammatory effect. In the current study, the therapeutic effect of PDRN on cerebral ischemia was evaluated using gerbils. For the induction of cerebral ischemia, the common carotid arteries were exposed, and then aneurysm clips were used to occlude the common carotid arteries bilaterally for 7 minutes. In the PDRN-treated groups, the gerbils were injected intraperitoneally with 0.3 mL of saline containing 8 mg/kg PDRN, per a day for 7 days following cerebral ischemia induction. In order to confirm the participation of the adenosine A(2A) receptor in the effects mediated by PDRN, 8 mg/kg 7-dimethyl-1-propargylxanthine (DMPX), adenosine A(2A) receptor antagonist, was treated with PDRN. In the current study, induction of ischemia enhanced the levels of pro-inflammatory cytokines and increased phosphorylation of MAPK signaling factors in the hippocampus and basolateral amygdala. However, treatment with PDRN ameliorated short-term memory impairment by suppressing the production of pro-inflammatory cytokines and inactivation of MAPK signaling factors in cerebral ischemia. Furthermore, PDRN treatment enhanced the concentration of cyclic adenosine-3,5'-monophosphate (cAMP) as well as phosphorylation of cAMP response element-binding protein (p-CREB). Co-treatment of DMPX and PDRN attenuated the therapeutic effect of PDRN on cerebral ischemia. Based on these findings, PDRN may be developed as the primary treatment in cerebral ischemia.	[Ko, Il-Gyu; Jin, Jun-Jang; Hwang, Lakkyong; Kim, Sang-Hoon; Kim, Chang-Ju] Kyung Hee Univ, Dept Physiol, Coll Med, Seoul, South Korea; [Jeon, Jung Won] Kyung Hee Univ, Dept Internal Med, Kyung Hee Univ Hosp Gangdong, Coll Med, Seoul, South Korea; [Chung, Jun-Young] Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Univ Hosp Gangdong, Coll Med, Seoul, South Korea; [Han, Jin Hee] Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Med Ctr, Coll Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital	Han, JH (corresponding author), Kyung Hee Univ, Dept Anesthesiol & Pain Med, Kyung Hee Med Ctr, Coll Med, Seoul, South Korea.	esthesi@khu.ac.kr	; Kim, Chang-Ju/M-4216-2017	HAN, JIN-HEE/0000-0003-0399-1148; Kim, Chang-Ju/0000-0003-4749-5795; Hwang, Lakkyong/0000-0001-5173-1258	National Research Foundation of Korea [NRF-2017R1D1A1B03032827]	National Research Foundation of Korea(National Research Foundation of Korea)	Jin Hee Han NRF-2017R1D1A1B03032827 National Research Foundation of Korea Research fund support	Aden U, 2003, STROKE, V34, P739, DOI 10.1161/01.STR.0000060204.67672.8B; Ahmad M, 2010, TRANSL STROKE RES, V1, P74, DOI 10.1007/s12975-010-0023-7; An J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091847; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Chen F, 2014, PROG NEUROBIOL, V115, P246, DOI 10.1016/j.pneurobio.2013.12.007; Chera S, 2011, DEV GROWTH DIFFER, V53, P186, DOI 10.1111/j.1440-169X.2011.01250.x; Cho CH, 2019, INT NEUROUROL J, V23, pS11, DOI 10.5213/inj.1938040.020; Cho JW, 2018, INT NEUROUROL J, V22, pS156, DOI 10.5213/inj.1836224.112; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Erfani S, 2015, NEUROPEPTIDES, V49, P63, DOI 10.1016/j.npep.2014.12.004; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Giambelluca MS, 2017, J LEUKOCYTE BIOL, V102, P829, DOI 10.1189/jlb.2VMA1216-517R; Hwang L, 2019, ANIM CELLS SYST, V23, P371, DOI 10.1080/19768354.2019.1688185; Jeon JW, 2014, ANIM CELLS SYST, V18, P399, DOI 10.1080/19768354.2014.983968; Jeon SJ, 2011, NEUROCHEM RES, V36, P2259, DOI 10.1007/s11064-011-0550-y; Jiang MJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0167-6; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Ko IG, 2019, J EXERC REHABIL, V15, P504, DOI 10.12965/jer.1938316.158; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Ko IG, 2018, LIFE SCI, V203, P12, DOI 10.1016/j.lfs.2018.04.009; Ko IG, 2009, PHARMACOL BIOCHEM BE, V91, P629, DOI 10.1016/j.pbb.2008.10.009; Kong LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-112; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lee JM, 2018, J EXERC REHABIL, V14, P713, DOI 10.12965/jer.36394.197; Lee SH, 2016, J EXERC REHABIL, V12, P69, DOI 10.12965/jer.1632586.293; Melani A, 2014, INT REV NEUROBIOL, V119, P309, DOI 10.1016/B978-0-12-801022-8.00013-1; Meng XB, 2018, MOLECULES, V23, DOI 10.3390/molecules23092401; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Naderi Y, 2017, BEHAV PHARMACOL, V28, P214, DOI 10.1097/FBP.0000000000000297; Park JH, 2016, INT NEUROUROL J, V20, P107, DOI 10.5213/inj.1632532.266; Pedata F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805198; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shin MS, 2019, INT NEUROUROL J, V23, P116, DOI 10.5213/inj.1938103.052; Tebano MT, 2008, J NEUROCHEM, V104, P279, DOI 10.1111/j.1471-4159.2007.05046.x; Wang T, 2019, AM J TRANSL RES, V11, P5967; Yang CH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081638; Yoon S, 2019, ANN REHABIL MED-ARM, V43, P204, DOI 10.5535/arm.2019.43.2.204; Zamani M, 2013, J Neurosci Rural Pract, V4, P164, DOI 10.4103/0976-3147.112753; Zhou YQ, 2019, BRIT J PHARMACOL, V176, P2250, DOI 10.1111/bph.14673	43	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248689	10.1371/journal.pone.0248689	http://dx.doi.org/10.1371/journal.pone.0248689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735236	gold, Green Published			2022-12-26	WOS:000631029700028
J	Tessema, ZT; Teshale, AB; Tesema, GA; Yeshaw, Y; Worku, MG				Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Yeshaw, Yigizie; Worku, Misganaw Gebrie			Pooled prevalence and determinants of modern contraceptive utilization in East Africa: A Multi-country Analysis of recent Demographic and Health Surveys	PLOS ONE			English	Article							TRENDS; WOMEN; ETHIOPIA; NIGERIA	Background According to the 2017 estimate, around 214 million reproductive-age women in developing regions who want to avoid pregnancy do not use a modern contraceptive method. Although there are studies done on factors associated with modern contraceptive utilization in individual East African countries, as to our search of the literature, there is limited evidence on the pooled prevalence and determinants of modern contraceptive utilization in the East African region. Therefore, this study aimed to estimate the pooled prevalence and determinants of modern contraceptive utilization in the East African region. Methods The pooled prevalence of modern contraceptive utilization and the strength of determinants were estimated using STATA version 14. Intra-class Correlation Coefficient (ICC), Median Odds Ratio (MOR), Proportional Change in Variance (PCV), and deviance were used for model fitness and comparison. The multilevel logistic regression model was fitted to identify determinants of modern contraceptive use in the region. Adjusted Odds Ratio with its 95% Confidence Interval was presented, and variables with a p-value <= of 0.05 were declared significant determinants of modern contraceptive utilization. Results Overall, about 20.68% (95%CI:-20.46.,20.91)of women used modern contraceptive, ranging from 9.08% in Mozambique to 61.49% in Comoros. In the multilevel logistic regression model; maternal age group 25-34 (AOR: 0.79, 95%CI:0.76,0.82) and 35-49 (AOR:0.49, 95%CI:0.46,0.51). Being married (AOR:0.85, 95%CI:0.82,0.88), mothers with primary education (AOR:1.48, 95%CI:1.43,1.54) and secondary and above education level (AOR:1.60, 95%CI:1.52,1.69), husbands with primary education (AOR:2.43, 95%CI:2.35,2.51) and secondary and above education level (AOR:2.92, 95%CI:2.76,3.05). The mothers who had occupation (AOR:2.11, 95%CI:1.23,1.33), mothers from households with middle wealth index (AOR:1.23, 95%CI:1.19,1.28) and rich wealth index (AOR:1.28, 95%CI:1.23,1.33) were found to be significant determinants of modern contraceptive use. Conclusion We found that modern contraceptive utilization in the 12 East Africa countries was low compared to SDG target 2030(75%). The governmental and non-governmental organizations should scale up their public health programs to the poor and marginalized communities to scale up modern contraceptive utilization uptake in the region. In addition, reforming the health system and reproductive health education through mass media to create awareness of modern contraceptive use benefits are effective strategies to improve modern contraceptive use among East Africa women.	[Tessema, Zemenu Tadesse; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Yeshaw, Yigizie] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Dept Human Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Tessema, ZT (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia.	zemenut1979@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Tadesse, Zemenu/ABG-1690-2021; Yeshaw, Yigizie/L-6336-2019	Yeshaw, Yigizie/0000-0003-4587-7925; Tadesse, Zemenu/0000-0003-3878-7956				Abate MG, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0371-z; Abraha TH, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017012; Alemayehu GA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0611-3; Ametepi P, 2012, DHS ANAL STUD; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Apanga PA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.10.5301; Aviisah PA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0634-9; Behrman JA, 2018, STUD FAMILY PLANN, V49, P319, DOI 10.1111/sifp.12075; Beson P, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0649-2; Beyene GA, 2019, AFR J REPROD HEALTH, V23, P101, DOI 10.29063/ajrh2019/v23i2.10; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Bongaarts J, 2019, AFR J REPROD HEALTH, V23, P96, DOI 10.29063/ajrh2019/v23i3.9; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Demographic T., GUIDE DHS STAT; Department of Economic and Social Affairs PDUN, 2019, FAMILY PLANNING 2030; Ejembi C. L., 2015, DHS Working Papers; Eliason S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-261; Endriyas M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-016-0036-z; FAUVEAU V, 1990, BRIT MED J, V301, P103, DOI 10.1136/bmj.301.6743.103; Gebeyehu A., 2014, TRENDS DETERMINANTS; Hounton S, 2015, GLOBAL HEALTH ACTION, V8, P53, DOI 10.3402/gha.v8.29737; Humera H, 2013, J OBSTET GYN INDIA, V63, P410, DOI 10.1007/s13224-013-0447-6; Izugbara CO., 2018, AFRICAN POPUL HEAL R; Jacobs J, 2017, EUR J CONTRACEP REPR, V22, P439, DOI 10.1080/13625187.2017.1409889; Katz M. H, 2011, MULTIVARIABLE ANAL P, VThird; Mohammed A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-13; Coll CDN, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0686-9; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Okigbo CC, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0664-3; Palamuleni Martin E, 2013, Afr J Reprod Health, V17, P91; Rebecca Winter., 2013, DHS ANALYTICAL STUDI; Tawiah EO, 1997, J BIOSOC SCI, V29, P141, DOI 10.1017/S0021932097001417; Tomkins A, 2001, BRIT J NUTR, V85, pS93, DOI 10.1079/BJN2001358; UNDESA, 2017, WORLD FAMILY PLANNIN, P43, DOI [10.1186/s12875-017-0618-0 28327096, DOI 10.1186/S12875-017-0618-028327096]; Wang CT, 2012, CONTRACEPTION, V85, P570, DOI 10.1016/j.contraception.2011.10.014; Wang W., 2017, ARXIV170500648; WHO. Organization WH, 2010, WORLD HLTH STAT 2010; Yaya S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0658-5	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247992	10.1371/journal.pone.0247992	http://dx.doi.org/10.1371/journal.pone.0247992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735305	Green Published, gold			2022-12-26	WOS:000631029700025
J	Teterycz, D; Sobota, A; Przygodzka, D; Lysakowska, P				Teterycz, Dorota; Sobota, Aldona; Przygodzka, Dominika; Lysakowska, Paulina			Hemp seed (Cannabis sativa L.) enriched pasta: Physicochemical properties and quality evaluation	PLOS ONE			English	Article							WHEAT; CAKE	Hemp seed (Cannabis sativa L.) contain large amounts of nutrients, e.g. protein, dietary fiber, minerals, and unsaturated fatty acids, which make them a good fortifying component in food production. The aim of the present study was to determine the effect of hemp addition on the physicochemical properties, cooking quality, texture parameters and sensory properties of durum wheat pasta. The samples were fortified with 5-40% of commercially available hemp flour or 2.5-10% of hemp cake obtained from hemp seed oil pressing. Our study showed that the addition of hemp seed raw materials led to an increase in the protein, total dietary fiber (TDF), ash and fat content in the pasta samples. Due to its lower granulation and higher nutritional value, hemp flour was found to be a better raw material for the fortification of pasta than hemp cake. Pasta enriched with hemp flour at the level of 30-40% contains 19.53-28.87% d.m. of protein and 17.02-21.49% d.m. of TDF and according to the EU, a definition can be described as a high-protein and high-fiber products. All enriched pasta samples were also characterized by safe Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) content, and their sensory properties were accepted by consumers.	[Teterycz, Dorota; Sobota, Aldona; Lysakowska, Paulina] Univ Life Sci Lublin, Dept Plant Food Technol & Gastron, Div Engn & Cereals Technol, Lublin, Poland; [Przygodzka, Dominika] Med Univ Lublin, Chair & Dept Forens Med, Lublin, Poland	University of Life Sciences in Lublin; Medical University of Lublin	Sobota, A (corresponding author), Univ Life Sci Lublin, Dept Plant Food Technol & Gastron, Div Engn & Cereals Technol, Lublin, Poland.	aldona.sobota@up.lublin.pl		Przygodzka, Dominika/0000-0001-7040-4754; Teterycz, Dorota/0000-0002-8714-9814; Sobota, Aldona/0000-0001-6526-6764				Aluko RE, 2017, SUSTAINABLE PROTEIN SOURCES, P121, DOI 10.1016/B978-0-12-802778-3.00007-X; [Anonymous], 2016, AOAC ASS OFFICIAL AN, V20; [Anonymous], 2016, PHE PUBLIC HLTH ENGL; [Anonymous], 2000, AACC AM ASS CEREAL C, V10th; Bruni N, 2018, MOLECULES, V23, DOI 10.3390/molecules23102478; Callaway JC, 2004, EUPHYTICA, V140, P65, DOI 10.1007/s10681-004-4811-6; EMCDDA-European Monitoring Centre for Drugs and Drug Addiction, 2017, CANN LEG EUR OV; Guerriero G, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00019, 10.3389/fpls.2016.00463]; Hadener M, 2019, FORENSIC SCI INT, V299, P142, DOI 10.1016/j.forsciint.2019.03.046; Harris J. M., 1997, Journal of Food Distribution Research, V28, P92; House JD, 2010, J AGR FOOD CHEM, V58, P11801, DOI 10.1021/jf102636b; Hruskova M, 2015, CZECH J FOOD SCI, V33, P545, DOI 10.17221/9/2015-CJFS; Kasprzak M, 2011, ZYWN-NAUK TECHNOL JA, V18, P124; Kiralan M, 2010, SPAN J AGRIC RES, V8, P385, DOI 10.5424/sjar/2010082-1220; Li H, 2020, EUR J MED CHEM, V192, DOI 10.1016/j.ejmech.2020.112163; Lukin A., 2017, Bulletin of the Transilvania University of Brasov, Series II - Forestry, Wood Industry, Agricultural Food Engineering, V10, P113; Makhlouf S, 2019, FOOD QUAL SAF-OXFORD, V3, P117, DOI 10.1093/fqsafe/fyz010; Michalak-Majewska M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227942; Monteiro MLG, 2019, LWT-FOOD SCI TECHNOL, V111, P751, DOI 10.1016/j.lwt.2019.05.075; Pojic M, 2015, J FOOD QUALITY, V38, P431, DOI 10.1111/jfq.12159; Radocaj O, 2014, J FOOD SCI, V79, pC318, DOI 10.1111/1750-3841.12370; Russo R., 2013, PLANT, V1, P25, DOI [10.11648/j.plant.20130102.13, DOI 10.11648/J.PLANT.20130102.13]; Sanchez Marc C, 2018, HEMP PROT POWD GRAS; Sfrija D., 2017, EUROPEAN IND HEMP AS; Sobota A, 2020, INT J FOOD SCI TECH, V55, P2677, DOI 10.1111/ijfs.14521; Sobota A, 2020, J SCI FOOD AGR, V100, P2035, DOI 10.1002/jsfa.10222; Sobota A, 2015, INT J FOOD SCI TECH, V50, P111, DOI 10.1111/ijfs.12641; Stephen AM, 2017, NUTR RES REV, V30, P149, DOI 10.1017/S095442241700004X; Sykut-Domanska E, 2020, J FOOD PROCESS PRES, V44, DOI 10.1111/jfpp.14490; Teterycz D, 2020, J FOOD SCI TECH MYS, V57, P301, DOI 10.1007/s13197-019-04061-5; Wang QL, 2019, COMPR REV FOOD SCI F, V18, P936, DOI 10.1111/1541-4337.12450; Wang YY, 2013, FOOD SCI BIOTECHNOL, V22, P89, DOI 10.1007/s10068-013-0053-5; Zarzycki P., 2017, ACTA AGROPHYS, V24, P625; Zarzycki P, 2020, FOODS, V9, DOI 10.3390/foods9040404	34	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248790	10.1371/journal.pone.0248790	http://dx.doi.org/10.1371/journal.pone.0248790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735229	gold, Green Published			2022-12-26	WOS:000631029700018
J	Tadesse, AW; Negussie, YM; Aychiluhm, SB				Woday Tadesse, Abay; Mekuria Negussie, Yohannes; Birara Aychiluhm, Setognal			Neonatal mortality and its associated factors among neonates admitted at public hospitals, pastoral region, Ethiopia: A health facility based study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PREDICTORS; UNIVERSITY	Background Neonatal mortality is a public health issue in, Ethiopia. Unfortunately, the issue is noticeably under-reported and underestimated, so the true gravity of the situation cannot be acknowledged in developing regions of the country. Regrettably, there is no single study to show the rates and predictors of neonatal mortality for Afar region. Thus, this study aims to assess neonatal mortality and associated factors in Afar region, Ethiopia. Methods A health facility-based cross-sectional study was conducted on 403 neonates admitted to the neonatal intensive care units (NICUs) from January 2015 to December 2019. Maternal and neonatal medical records were reviewed and audited using structured data extraction checklist. The data was collected by four trained nurses and midwives. The medical records were selected using a systematic random sampling technique. Bivariate and multivariable logistic regression analyses were done. Adjusted odds ratio with the corresponding 95% confidence interval were used to assess the association between neonatal mortality and the associated factors. Finally, the statistical significance level was declared at a p-value of less than 0.05. Results In this study, 391 medical records of newborns were included with the data complete rate of 97.02%. The prevalence of neonatal mortality was 57 (14.6%) [95% CI 11.0%-18.4%]. A multivariable logistic regression showed that lack of antenatal care (ANC) follow up [AOR = 4.69: 95%CI (1.77, 12.47)], giving birth through cesarean section [AOR 3.59, 95%CI (1.22, 10.55)], having admission temperature less than 36.5 degrees C [AOR 10.75, 95%CI (3.75, 30.80)], birth asphyxia [AOR 7.16, 95%CI (2.22, 23.10)], and having a length of stay greater than five days in the hospital [AOR 0.23, 95%CI (0.08, 0.66)] were significantly associated with neonatal mortality. Conclusion This study revealed that the rate of neonatal mortality is still high compared to the national data. Antenatal care, cesarean section delivery, length of stay in the hospital, low temperature at admission and birth asphyxia were factors associated with neonatal mortality. Thus, the health facilities should give due attention to improve antenatal care, intrapartum care and standardized care for admitted neonates. Furthermore, prospective studies are recommended.	[Woday Tadesse, Abay; Mekuria Negussie, Yohannes; Birara Aychiluhm, Setognal] Samara Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Samara, Afar Region, Ethiopia	Samara University	Tadesse, AW (corresponding author), Samara Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Samara, Afar Region, Ethiopia.	abaywoday@yahoo.com	Aychiluhm, Setognal Birara/GRX-4681-2022	Aychiluhm, Setognal Birara/0000-0001-7565-7515; Mekuria, Yohanness/0000-0002-1332-670X; woday, abay/0000-0003-0499-4690				[Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; [Anonymous], NATL NEWBORN CHILD S; [Anonymous], 2019, ETHIOPIA MINI DEMOGR; [Anonymous], NEONATAL MORTALITY R; [Anonymous], HLTH SECTOR DEV PROG; [Anonymous], 2006, NEONATAL PERINATAL M; [Anonymous], CHILD MORTALITY ESTI; [Anonymous], 2017, ETHIOPIA DEMOGRAPHIC; [Anonymous], 2018, 3 PLAZA; [Anonymous], WORLD HLTH STAT 2016; [Anonymous], 2015, HLTH SECTOR TRANSFOR; [Anonymous], TRANSF OUR WORLD 203; [Anonymous], 2001, ETHIOPIA DEMOGRAPHIC; Bekana K, 2012, ETHIOP J HEALTH DEV, V6; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P119, DOI 10.4314/ejhs.v24i0.11S; Debelew GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107184; Demisse AG, 2017, PEDIATR HEALTH MED T, V8, P57, DOI 10.2147/PHMT.S130309; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Doctor HV, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020406; Emmanuel T, 2011, PAN AFR MED J, V8; Farah AE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203314; FMoFED [Ethiopia], UCT ASSESSING PROGR; FMOH [Ethiopia, ADDIS ABABA ETHIOPIA; FMOH [Ethiopia], NEONATAL INTENSIVE C; Fottrell E, 2015, ARCH DIS CHILD-FETAL, V100, pF439, DOI 10.1136/archdischild-2014-307636; Gizaw M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-64; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Kidus F, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2243-5; Kokeb M, 2016, ETHIOP J HEALTH SCI, V26, P73, DOI 10.4314/ejhs.v26i1.12; Kolobo HA, 2019, J CLIN NEONATOL, V8, P232, DOI 10.4103/jcn.JCN_23_19; Kolola T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164472; Lee ACC, 2008, PEDIATRICS, V121, pE1381, DOI 10.1542/peds.2007-1966; Leta M., 2019, J PEDIAT NEONATAL CA; Mekonnen T., 2018, CLIN MOTHER CHILD HL, V15, DOI [10.4172/2090-7214.1000305, DOI 10.4172/2090-7214.1000305]; Nighat Aijaz, 2012, Journal of the Dow University of Health Sciences, V6, P32; Orsido TT, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2227-5; Seid SS, 2019, PEDIATR HEALTH MED T, V10, P39, DOI 10.2147/PHMT.S197280; Tewabe T, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0498-5	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0242481	10.1371/journal.pone.0242481	http://dx.doi.org/10.1371/journal.pone.0242481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730039	gold, Green Published			2022-12-26	WOS:000630345000066
J	Wongkaew, M; Sangta, J; Chansakaow, S; Jantanasakulwong, K; Rachtanapun, P; Sommano, SR				Wongkaew, Malaiporn; Sangta, Jiraporn; Chansakaow, Sunee; Jantanasakulwong, Kittisak; Rachtanapun, Pornchai; Sommano, Sarana Rose			Volatile profiles from over-ripe puree of Thai mango varieties and their physiochemical properties during heat processing	PLOS ONE			English	Article							BOUND AROMA COMPOUNDS; MANGIFERA-INDICA L.; SENSORY ATTRIBUTES; QUALITY; FRUIT; FRESH; PECTIN; CONSTITUENTS; TEMPERATURE; COMPONENTS	This research investigated volatile profiles of over-ripe Thai mango puree during thermal processing by solid-phase extraction, volatile quantification by XAD-2-solvent extraction, as well as descriptive sensory analysis. Overripe fruits of three varieties were analyzed for the ripening stage using specific gravity as well as firmness and the physiochemical properties were also reported. We found that aromatic profiles could be used as true representative to describe Thai mango identities of each varieties. A simple and straightforward heat treatment had differing effects on aroma characteristics and those effects were dependent with mango varieties. Indeed, the amount of terpene hydrocarbons and oxygenated sesquiterpenoids alternated after heat treatment. All descriptive attributes of heated 'sam-pee' puree were intensified while, heat treatment significantly improved only "mango identity" in 'maha-chanok' and "fermented" odour in 'keaw' puree. With or without heat treatment, the volatile profiles of 'maha-chanok' remained quite stable while heating played a significant role on chemical ingredients of 'keaw' and 'sam-pee'. Our study demonstrated that the manufacturing of the over-ripe mango into the products of high market value, selection of varieties is vitally important based upon their specific aroma characteristics before and after processing.	[Wongkaew, Malaiporn; Sangta, Jiraporn; Sommano, Sarana Rose] Chiang Mai Univ, Fac Agr, Dept Plant & Soil Sci, Plant Bioact Compound Lab, Chiang Mai, Thailand; [Wongkaew, Malaiporn] Rajamangala Univ Technol Lanna, Fac Integrated Sci & Technol, Programme Food Prod & Innovat, Chiang Mai, Thailand; [Wongkaew, Malaiporn; Sangta, Jiraporn] Chiang Mai Univ, Grad Sch, Major Biotechnol, Chiang Mai, Thailand; [Chansakaow, Sunee] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Sci, Chiang Mai, Thailand; [Jantanasakulwong, Kittisak; Rachtanapun, Pornchai; Sommano, Sarana Rose] Chiang Mai Univ, Cluster Agro Biocircular Green Ind Agro BCG, Chiang Mai, Thailand; [Jantanasakulwong, Kittisak; Rachtanapun, Pornchai] Chiang Mai Univ, Fac Agroind, Sch Agroind, Chiang Mai, Thailand	Chiang Mai University; Rajamangala University of Technology Lanna; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Sommano, SR (corresponding author), Chiang Mai Univ, Fac Agr, Dept Plant & Soil Sci, Plant Bioact Compound Lab, Chiang Mai, Thailand.; Sommano, SR (corresponding author), Chiang Mai Univ, Cluster Agro Biocircular Green Ind Agro BCG, Chiang Mai, Thailand.	sarana.s@cmu.ac.th		Jantanasakulwong, Kittisak/0000-0002-9070-9579; Sommano, Sarana/0000-0001-7356-2598	Chiang Mai University; TSRI	Chiang Mai University; TSRI	This research work was partially supported by Chiang Mai University. The research project is supported by TSRI.	Alvarez RQ, 2011, PROC FOOD SCI, V1, P1396, DOI 10.1016/j.profoo.2011.09.207; Pino JA, 2012, CIENCIA TECNOL ALIME, V32, P76, DOI 10.1590/S0101-20612012005000006; Beaulieu JC, 2003, POSTHARVEST BIOL TEC, V30, P15, DOI 10.1016/S0925-5214(03)00081-4; Bekele M, 2020, SCI AFR, V7, DOI 10.1016/j.sciaf.2020.e00277; Boonbumrung S., 2001, Food Science and Technology Research, V7, P200, DOI 10.3136/fstr.7.200; Boudhrioua N, 2003, LEBENSM-WISS TECHNOL, V36, P633, DOI 10.1016/S0023-6438(03)00083-5; Castro R, 2008, EUR FOOD RES TECHNOL, V228, P1, DOI 10.1007/s00217-008-0900-4; Castro-Vargas HI, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8020041; Chambers E, 2016, J SENS STUD, V31, P465, DOI 10.1111/joss.12237; Chen JY, 2005, FOOD SCI TECHNOL RES, V11, P26, DOI 10.3136/fstr.11.26; Das S. C., 2013, Asian Journal of Horticulture, V8, P336; Diez-Simon C, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1493-6; Maldonado-Celis ME, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01073; Garde-Cerdan T, 2007, FOOD CONTROL, V18, P473, DOI 10.1016/j.foodcont.2005.12.004; Islam M.K., 2013, MALAYS J ANAL SCI, V17, P499; Jarimopas B, 2007, INT J FOOD PROP, V10, P899, DOI 10.1080/10942910701221731; Kadam SS., 1995, HDB FRUIT SCI TECHNO; Kapilan R., 2015, BIOSCI BIOENG BIOTEC, V2, P12; Kasantikul D., 1984, KASETSART J NATURAL, V18, P55; Khalid NS, 2017, ASIA MODEL SYMP AMS, P113, DOI 10.1109/AMS.2017.26; KIMURA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1386, DOI 10.1271/bbb.58.1386; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V29, P205, DOI 10.1016/S0925-5214(02)00250-8; Lalel HJD, 2003, POSTHARVEST BIOL TEC, V27, P323, DOI 10.1016/S0925-5214(02)00117-5; Ledeker CN, 2014, LWT-FOOD SCI TECHNOL, V56, P138, DOI 10.1016/j.lwt.2013.11.011; Ledeker CN, 2012, J FOOD SCI, V77, pS348, DOI 10.1111/j.1750-3841.2012.02882.x; Leguizamon-Delgado María Alejandra, 2019, Dyna rev.fac.nac.minas, V86, P276, DOI 10.15446/dyna.v86n209.72950; Li L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187487; Liu HC, 2020, FOODS, V9, DOI 10.3390/foods9010075; Malundo TMM, 1997, J AGR FOOD CHEM, V45, P2187, DOI 10.1021/jf960569c; Marquez CJ, 2011, VITAE-COLUMBIA, V18, P245; Nassur RDMR, 2015, J FOOD SCI, V80, pS2055, DOI 10.1111/1750-3841.12989; Mwaurah PW, 2020, COMPR REV FOOD SCI F, V19, P2421, DOI 10.1111/1541-4337.12598; Narayana C. K., 1999, Journal of Applied Horticulture (Lucknow), V1, P41; Nikolic MV, 2007, FOOD CHEM, V101, P1, DOI 10.1016/j.foodchem.2005.12.053; Nordey T, 2016, J PLANT PHYSIOL, V196-197, P70, DOI 10.1016/j.jplph.2016.03.008; Occena-Po LG., 2007, HDB FRUITS FRUIT PRO, P635; Ounamornas P., 2019, ACTA HORT, V1244, P181; Pandit SS, 2009, FOOD CHEM, V114, P363, DOI 10.1016/j.foodchem.2008.09.107; Pino JA, 2006, FLAVOUR FRAG J, V21, P207, DOI 10.1002/ffj.1703; Quijano CE, 2007, FLAVOUR FRAG J, V22, P401, DOI 10.1002/ffj.1812; Rai M.K., 2016, RESOURCE EFFICIENT T, V2, pS63, DOI [10.1016/j.reffit.2016.11.011, DOI 10.1016/J.REFFIT.2016.11.011]; Robles-Sanchez RM, 2009, J FOOD SCI, V74, pS126, DOI 10.1111/j.1750-3841.2009.01104.x; Rooban R., 2016, J APPL ADV RES, V1, P53, DOI DOI 10.21839/JAAR.2016.V1I2.27; Sanchez-Palomo E, 2015, FOOD CHEM, V173, P1195, DOI 10.1016/j.foodchem.2014.10.148; Seymour GB., 2013, MOL BIOL BIOCH FRUIT, P1; Sirijariyawat A, 2012, J SCI FOOD AGR, V92, P2581, DOI 10.1002/jsfa.5791; Sommano SR, 2018, INT FOOD RES J, V25, P2657; Sriwichai T, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9040078; Sunanta P., 2018, THE J, V6, P35; Suwonsichon S, 2012, J SENS STUD, V27, P148, DOI 10.1111/j.1745-459X.2012.00377.x; Tongtao S., 2019, INT SOC HORT SCI, P209; Vasquez-Caicedo AL, 2007, FOOD CHEM, V102, P1172, DOI 10.1016/j.foodchem.2006.07.005; Verlent I, 2005, INNOV FOOD SCI EMERG, V6, P293, DOI 10.1016/j.ifset.2005.02.003; Wang Z, 2016, POSTHARVEST BIOL TEC, V114, P10, DOI 10.1016/j.postharvbio.2015.11.015; Wen YQ, 2014, FOOD CHEM, V152, P29, DOI 10.1016/j.foodchem.2013.11.092; White IR, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0973-1; Yashoda HM, 2007, FOOD CHEM, V102, P691, DOI 10.1016/j.foodchem.2006.06.001; Zhu JC, 2019, EUR FOOD RES TECHNOL, V245, P129, DOI 10.1007/s00217-018-3145-x	58	7	7	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248657	10.1371/journal.pone.0248657	http://dx.doi.org/10.1371/journal.pone.0248657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730082	Green Published, gold			2022-12-26	WOS:000630345000040
J	Xu, HY; Qing, XY; Wang, Q; Li, CM; Lai, LH				Xu, Hanyu; Qing, Xiaoyu; Wang, Qian; Li, Chunmei; Lai, Luhua			Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; L-SERINE BIOSYNTHESIS; PHOSPHOGLYCERATE DEHYDROGENASE; 3-PHOSPHOGLYCERATE DEHYDROGENASE; HOT-SPOTS; CRYSTAL-STRUCTURES; INHIBITOR; CANCER; METABOLISM; PATHWAY	Human D-3-phosphoglycerate dehydrogenase (PHGDH), a key enzyme in de novo serine biosynthesis, is amplified in various cancers and serves as a potential target for anticancer drug development. To facilitate this process, more information is needed on the basic biochemistry of this enzyme. For example, PHGDH was found to form tetramers in solution and the structure of its catalytic unit (sPHGDH) was solved as a dimer. However, how the oligomeric states affect PHGDH enzyme activity remains elusive. We studied the dependence of PHGDH enzymatic activity on its oligomeric states. We found that sPHGDH forms a mixture of monomers and dimers in solution with a dimer dissociation constant of similar to 0.58 mu M, with the enzyme activity depending on the dimer content. We computationally identified hotspot residues at the sPHGDH dimer interface. Single-point mutants at these sites disrupt dimer formation and abolish enzyme activity. Molecular dynamics simulations showed that dimer formation facilitates substrate binding and maintains the correct conformation required for enzyme catalysis. We further showed that the full-length PHGDH exists as a dynamic mixture of monomers, dimers, and tetramers in solution with enzyme concentrationdependent activity. Mutations that can completely disrupt the sPHGDH dimer show different abilities to interrupt the fulllength PHGDH tetramer. Among them, E108A and I121A can also disrupt the oligomeric structures of the full-length PHGDH and abolish its enzyme activity. Our study indicates that disrupting the oligomeric structure of PHGDH serves as a novel strategy for PHGDH drug design and the hotspot residues identified can guide the design process.	[Xu, Hanyu; Qing, Xiaoyu; Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, BNLMS, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Wang, Qian] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Li, Chunmei; Lai, Luhua] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing, Peoples R China	Peking University; Peking University; Peking University	Lai, LH (corresponding author), Peking Univ, Coll Chem & Mol Engn, BNLMS, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Lai, LH (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing, Peoples R China.	lhlai@pku.edu.cn			National Natural Science Foundation of China [21633001]; Ministry of Science and Technology of China [2016YFA0502303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported in part by the National Natural Science Foundation of China (21633001) and the Ministry of Science and Technology of China (2016YFA0502303).	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Buss O, 2018, COMPUT STRUCT BIOTEC, V16, P25, DOI 10.1016/j.csbj.2018.01.002; Delgado J, 2019, BIOINFORMATICS, V35, P4168, DOI 10.1093/bioinformatics/btz184; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dong JK, 2018, THERANOSTICS, V8, P1808, DOI 10.7150/thno.23177; Garton M, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0190; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Grant GA, 1999, J BIOL CHEM, V274, P5357, DOI 10.1074/jbc.274.9.5357; Grant GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P171, DOI 10.1006/abbi.1999.1652; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00110; Grant GA, 2018, BIOCHEMISTRY-US, V57, P1798, DOI 10.1021/acs.biochem.8b00074; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hancock RD, 1996, INORG CHEM, V35, P2165, DOI 10.1021/ic951422q; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Huang PS, 2020, ACS OMEGA, V5, P6487, DOI 10.1021/acsomega.9b04105; Ruiz-Pernia JJ, 2019, ACS CATAL, V9, P5902, DOI 10.1021/acscatal.9b01250; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Liu JL, 2013, J NEURO-ONCOL, V111, P245, DOI 10.1007/s11060-012-1018-x; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; London N, 2013, CURR OPIN CHEM BIOL, V17, P952, DOI 10.1016/j.cbpa.2013.10.011; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matelska D, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1309-8; Mattaini KR, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0131-7; Mishra V, 2012, MOL BIOCHEM PARASIT, V181, P117, DOI 10.1016/j.molbiopara.2011.10.008; Mullarky E, 2019, BIOORG MED CHEM LETT, V29, P2503, DOI 10.1016/j.bmcl.2019.07.011; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Ngo B, 2020, CANCER DISCOV, V10, P1352, DOI 10.1158/2159-8290.CD-19-1228; Nishi H, 2013, PROG MOL BIOL TRANSL, V117, P3, DOI 10.1016/B978-0-12-386931-9.00001-5; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rathore R, 2020, CANCER DRUG RESIST, V3, P762, DOI 10.20517/cdr.2020.46; Ravez S, 2017, J MED CHEM, V60, P1591, DOI 10.1021/acs.jmedchem.6b01166; Ravez S, 2017, J MED CHEM, V60, P1227, DOI 10.1021/acs.jmedchem.6b01167; Reid MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07868-6; Ross KC, 2017, MOL CANCER THER, V16, P1596, DOI 10.1158/1535-7163.MCT-16-0798; Shaheen R, 2014, AM J HUM GENET, V94, P898, DOI 10.1016/j.ajhg.2014.04.015; Singh RK, 2014, FEBS J, V281, P5498, DOI 10.1111/febs.13091; Song ZW, 2018, GENE, V642, P43, DOI 10.1016/j.gene.2017.11.014; Spillier Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41187-0; Tabatabaie L, 2009, HUM MUTAT, V30, P749, DOI 10.1002/humu.20934; Tanner JM, 2017, MOL CANCER RES, V15, P1517, DOI 10.1158/1541-7786.MCR-17-0182; Thompson JR, 2005, BIOCHEMISTRY-US, V44, P5763, DOI 10.1021/bi047944b; Unterlass Judith E, 2018, Oncotarget, V9, P13139, DOI 10.18632/oncotarget.11487; Unterlass JE, 2017, ONCOTARGET, V8, P104478, DOI 10.18632/oncotarget.22327; Wang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32511-1; Wang Q, 2017, CELL CHEM BIOL, V24, P55, DOI 10.1016/j.chembiol.2016.11.013; Wei L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12606-7; Weinstabl H, 2019, J MED CHEM, V62, P7976, DOI 10.1021/acs.jmedchem.9b00718; Xu XL, 2015, ARCH BIOCHEM BIOPHYS, V570, P32, DOI 10.1016/j.abb.2015.02.008; Yang JH, 2010, J BIOL CHEM, V285, P41380, DOI 10.1074/jbc.M110.187443; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yoshino H, 2017, CANCER RES, V77, P6321, DOI 10.1158/0008-5472.CAN-17-1589; Zhang X, 2016, CANCER CHEMOTH PHARM, V78, P655, DOI 10.1007/s00280-016-3117-4; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	60	3	3	3	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100572	10.1016/j.jbc.2021.100572	http://dx.doi.org/10.1016/j.jbc.2021.100572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753166	Green Published, gold			2022-12-26	WOS:000672866400545
J	Mayere, C; Neirijnck, Y; Sararols, P; Rands, CM; Stevant, I; Kuhne, F; Chassot, AA; Chaboissier, MC; Dermitzakis, ET; Nef, S				Mayere, Chloe; Neirijnck, Yasmine; Sararols, Pauline; Rands, Chris M.; Stevant, Isabelle; Kuhne, Francoise; Chassot, Anne-Amandine; Chaboissier, Marie-Christine; Dermitzakis, Emmanouil T.; Nef, Serge			Single-cell transcriptomics reveal temporal dynamics of critical regulators of germ cell fate during mouse sex determination	FASEB JOURNAL			English	Article						development; gene regulatory network; germ cells; gonocytes; meiosis; oocytes; ovary; prospermatogonia; RNA splicing; sex determination; single&#8208; cell RNA&#8208; sequencing (scRNA&#8208; seq); testis	BONE MORPHOGENETIC PROTEIN; INTRON RETENTION PROGRAM; GENE-EXPRESSION; MEIOTIC INITIATION; MESSENGER-RNA; DNA DEMETHYLATION; GENOMIC ANALYSIS; MITOTIC ARREST; ENTER MEIOSIS; DIFFERENTIATION	Despite the importance of germ cell (GC) differentiation for sexual reproduction, the gene networks underlying their fate remain unclear. Here, we comprehensively characterize the gene expression dynamics during sex determination based on single-cell RNA sequencing of 14 914 XX and XY mouse GCs between embryonic days (E) 9.0 and 16.5. We found that XX and XY GCs diverge transcriptionally as early as E11.5 with upregulation of genes downstream of the bone morphogenic protein (BMP) and nodal/Activin pathways in XY and XX GCs, respectively. We also identified a sex-specific upregulation of genes associated with negative regulation of mRNA processing and an increase in intron retention consistent with a reduction in mRNA splicing in XY testicular GCs by E13.5. Using computational gene regulation network inference analysis, we identified sex-specific, sequential waves of putative key regulator genes during GC differentiation and revealed that the meiotic genes are regulated by positive and negative master modules acting in an antagonistic fashion. Finally, we found that rare adrenal GCs enter meiosis similarly to ovarian GCs but display altered expression of master genes controlling the female and male genetic programs, indicating that the somatic environment is important for GC function. Our data are available on a web platform and provide a molecular roadmap of GC sex determination at single-cell resolution, which will serve as a valuable resource for future studies of gonad development, function, and disease.	[Mayere, Chloe; Neirijnck, Yasmine; Sararols, Pauline; Rands, Chris M.; Stevant, Isabelle; Kuhne, Francoise; Dermitzakis, Emmanouil T.; Nef, Serge] Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland; [Mayere, Chloe; Stevant, Isabelle; Dermitzakis, Emmanouil T.; Nef, Serge] Univ Geneva, Inst Genet & Genom Geneva, iGE3, Geneva, Switzerland; [Neirijnck, Yasmine; Chassot, Anne-Amandine; Chaboissier, Marie-Christine] Univ Cote Azur, CNRS, INSERM, IBV, Nice, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Nef, S (corresponding author), Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Serge.Nef@unige.ch	Chassot, Anne-Amandine/O-2102-2016; CHABOISSIER, Marie-Christine/F-6166-2019; CHABOISSIER, Marie-Christine/AAZ-5905-2021	Chassot, Anne-Amandine/0000-0003-1242-9456; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Nef, Serge/0000-0001-5462-0676; Neirijnck, Yasmine/0000-0001-7236-8451; Dermitzakis, Emmanouil/0000-0002-9302-6490; MAYERE, Chloe/0000-0002-9254-4886; Rands, Christopher/0000-0002-8222-9364; Stevant, Isabelle/0000-0002-0193-2526	Swiss National Science Foundation [31003A_173070]; Departement de l'Instruction Publique of the State of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Departement de l'Instruction Publique of the State of Geneva	This work was supported by grants from the Swiss National Science Foundation (grant 31003A_173070) and by the Departement de l'Instruction Publique of the State of Geneva (to SN)	Adams IR, 2002, DEVELOPMENT, V129, P1155; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Boehm E, 2017, NUCLEIC ACIDS RES, V45, P6135, DOI 10.1093/nar/gkx164; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1261; Chassot AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025641; CHEE L F, 1989, Journal of Forensic Sciences, V34, P708; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Darde TA, 2019, BIOINFORMATICS, V35, P3133, DOI 10.1093/bioinformatics/btz047; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; Edwards CR, 2016, BLOOD, V127, pE24, DOI 10.1182/blood-2016-01-692764; EVANS EP, 1977, NATURE, V267, P430, DOI 10.1038/267430a0; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Heeren AM, 2016, BIOL OPEN, V5, P185, DOI 10.1242/bio.013847; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishiguro K, 2020, DEV CELL, V52, P429, DOI 10.1016/j.devcel.2020.01.010; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Jourdain AA, 2017, NUCLEIC ACIDS RES, V45, P10941, DOI 10.1093/nar/gkx772; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lebrigand K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17800-6; Lee KL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002130; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Licatalosi DD, 2016, ADV EXP MED BIOL, V907, P123, DOI 10.1007/978-3-319-29073-7_6; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; MCLAREN A, 1983, DIFFERENTIATION, V23, pS93; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Miyauchi H, 2017, EMBO J, V36, P3100, DOI 10.15252/embj.201796875; Moerman T, 2019, BIOINFORMATICS, V35, P2159, DOI 10.1093/bioinformatics/bty916; Molyneaux KA, 2004, GENE EXPR PATTERNS, V4, P167, DOI 10.1016/j.modgep.2003.09.002; MOTOKURA T, 1992, J BIOL CHEM, V267, P20412; Myers M, 2011, BIOL REPROD, V85, P1175, DOI 10.1095/biolreprod.111.091728; Nagaoka SI, 2020, SCIENCE, V367, P1089, DOI 10.1126/science.aaw4115; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Naro C, 2017, DEV CELL, V41, P82, DOI 10.1016/j.devcel.2017.03.003; Nilsson EE, 2014, REPRODUCTION, V147, P865, DOI 10.1530/REP-14-0005; Niu WB, 2020, P NATL ACAD SCI USA, V117, P20015, DOI 10.1073/pnas.2005570117; Pentek J, 2009, GENESIS, V47, P261, DOI 10.1002/dvg.20486; Pimentel H, 2016, NUCLEIC ACIDS RES, V44, P838, DOI 10.1093/nar/gkv1168; Prados J., 2018, SINGLE CELL TRANSCRI; Pushpa Kumari, 2017, Results Probl Cell Differ, V59, P175, DOI 10.1007/978-3-319-44820-6_6; Rolland AD, 2008, ADV EXP MED BIOL, V636, P16, DOI 10.1007/978-0-387-09597-4_2; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soh YQS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005531; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller C, 2019, CURR TOP DEV BIOL, V134, P253, DOI 10.1016/bs.ctdb.2019.01.011; Spiller CM, 2012, INT J DEV BIOL, V56, P779, DOI 10.1387/ijdb.120142pk; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Stevant I, 2019, CELL REP, V26, P3272, DOI 10.1016/j.celrep.2019.02.069; Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Teichmann SA., 2018, FAST BATCH ALIGNMENT; Teo CH, 2010, J MACH LEARN RES, V11, P311; Thijssen R., 2020, COMPREHENSIVE CHARAC; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; UPADHYAY S, 1982, P NATL ACAD SCI-BIOL, V79, P6584, DOI 10.1073/pnas.79.21.6584; Vanhoutteghem A, 2014, DEVELOPMENT, V141, P4298, DOI 10.1242/dev.112888; Vernet N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1139; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang AHJ, 2017, MOL CELL, V68, P398, DOI 10.1016/j.molcel.2017.09.016; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Wu J, 2017, BRIT J CANCER, V117, P675, DOI 10.1038/bjc.2017.204; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; ZAMBONI L, 1983, J EXP ZOOL, V228, P173, DOI 10.1002/jez.1402280204; Zou C, 2021, CELL MOL LIFE SCI, V78, P117, DOI 10.1007/s00018-020-03593-w	99	15	15	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21452	10.1096/fj.202002420R	http://dx.doi.org/10.1096/fj.202002420R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749946	Green Published, Green Submitted			2022-12-26	WOS:000635216100080
J	Wang, XZ; Liu, ZY; Sun, JJ; Song, X; Bian, MX; Wang, FK; Yan, F; Yu, ZY				Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yan, Feng; Yu, Zhiyong			Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer	FASEB JOURNAL			English	Article						breast cancer; lymphangiogenesis; metastasis; Nox4	C-INDUCED LYMPHANGIOGENESIS; LYMPH-NODE METASTASIS; NOX4; CELLS; BEVACIZUMAB; EXPRESSION; GENERATION; INDUCTION; PROGNOSIS; DENSITY	Lymphangiogenesis is thought to contribute to promote tumor cells to enter lymphatic vessels and plant at a secondary site. Endothelial cells are the cornerstone of the generation of new lymphatic vessels. NADPH oxidase 4 (Nox4) is the most abundant one of NADPH oxidases in endothelial cells and the most studied one in relevance with cancer. Our purpose is to analyze the relationship between Nox4 and lymphangiogenesis and find out whether the newborn lymphatic vessels lead to cancer metastasis. We first explored the expression of Nox4 in lymphatic endothelial cells of primary invasive breast tumors and human normal mammary glands using GEO databases and found that Nox4 was upregulated in primary invasive breast tumors samples. In addition, its high expression correlated with lymph node metastasis in breast cancer patients. Nox4 could increase the tube formation and lymphatic vessel sprouting in a three-dimensional setting. In vivo, inhibition of Nox4 in 4T1 tumor-bearing mice could significantly decrease the tumor lymphangiogenesis and metastasis. Nox4 may increase tumor lymphangiogenesis via ROS/ERK/CCL21 pathway and attract CCR7-positive breast cancer cells to entry lymphatic vessels and distant organs. In conclusion, our results show that Nox4 is a factor that promotes lymphangiogenesis and is a potential target of antitumor metastasis.	[Wang, Xinzhao; Liu, Zhaoyun] Shandong Univ, Cheeloo Coll Med, Jinan, Peoples R China; [Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yu, Zhiyong] Shandong First Med Univ, Shandong Canc Hosp & Inst, Breast Canc Ctr, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China; [Wang, Xinzhao; Liu, Zhaoyun; Sun, Jujie; Song, Xiang; Bian, Mengxue; Wang, Fukai; Yu, Zhiyong] Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China; [Yan, Feng] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Emergency Med, Jinan 250012, Shandong, Peoples R China; [Yan, Feng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Jinan, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong University	Yu, ZY (corresponding author), Shandong First Med Univ, Shandong Canc Hosp & Inst, Breast Canc Ctr, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.; Yu, ZY (corresponding author), Shandong Acad Med Sci, 440 Jiyan Rd, Jinan 250117, Shandong, Peoples R China.; Yan, F (corresponding author), Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Emergency Med, Jinan 250012, Shandong, Peoples R China.	yanfeng@sdu.edu.cn; drzhiyongyu@aliyun.com		Yan, Feng/0000-0002-2756-3167	Natural Science Foundation of Shandong Province [ZR2017PH055, ZR2019MH109, ZR2016HB11]; National Natural Science Foundation of China [81601721]; Key Research and Development Program of Shandong Province [2018GSF118089]; Medical and Health Development Plan of Shandong Province [2016WS0556]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; Medical and Health Development Plan of Shandong Province	Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2017PH055, ZR2019MH109 and ZR2016HB11; National Natural Science Foundation of China, Grant/Award Number: 81601721; Key Research and Development Program of Shandong Province, Grant/Award Number: 2018GSF118089; Medical and Health Development Plan of Shandong Province, Grant/Award Number: 2016WS0556	Bonner MY, 2012, CELL MOL LIFE SCI, V69, P2435, DOI 10.1007/s00018-012-1017-2; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chen YH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120497; Du SC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0953-7; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gregg JL, 2014, CANCER RES, V74, P3501, DOI 10.1158/0008-5472.CAN-13-2979; Guo SH, 2015, J DRUG TARGET, V23, P888, DOI 10.3109/1061186X.2015.1036276; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lala PK, 2018, CANCER METAST REV, V37, P369, DOI 10.1007/s10555-018-9734-0; Lee E, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.2; Li XY, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101373; Lin HY, 2017, INT IMMUNOPHARMACOL, V51, P124, DOI 10.1016/j.intimp.2017.07.018; Lin XL, 2017, ONCOTARGET, V8, P33586, DOI 10.18632/oncotarget.16829; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Nathanson SD, 2000, ARCH SURG-CHICAGO, V135, P586, DOI 10.1001/archsurg.135.5.586; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-22; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Srour MK, 2020, BREAST J, V26, P904, DOI 10.1111/tbj.13684; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang CT, 2018, CELL SIGNAL, V46, P52, DOI 10.1016/j.cellsig.2018.02.007; Tutunea-Fatan E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0306-4; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; WEIDNER N, 1995, AM J PATHOL, V147, P9; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Zhang B, 2013, BIOCHEM PHARMACOL, V86, P253, DOI 10.1016/j.bcp.2013.05.011; Zhang CX, 2014, ONCOTARGET, V5, P4392, DOI 10.18632/oncotarget.2025	36	9	9	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21531	10.1096/fj.202002533R	http://dx.doi.org/10.1096/fj.202002533R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33769605				2022-12-26	WOS:000635216100034
J	Kesoju, SR; Kramer, M; Brunet, J; Greene, SL; Jordan, A; Martin, RC				Kesoju, Sandya R.; Kramer, Matthew; Brunet, Johanne; Greene, Stephanie L.; Jordan, Amelia; Martin, Ruth C.			Gene flow in commercial alfalfa (Medicago sativa subsp. sativa L.) seed production fields: Distance is the primary but not the sole influence on adventitious presence	PLOS ONE			English	Article							MEGACHILE-ROTUNDATA; FORAGING DISTANCES; POLLEN DISPERSAL; BEES HYMENOPTERA; LEAFCUTTING BEE; HONEY-BEES; POLLINATION; WILD; MANAGEMENT; COTTON	In insect-pollinated crops, gene flow is affected by numerous factors including crop characteristics, mating system, life history, pollinators, and planting management practices. Previous studies have concentrated on the impact of distance between genetically engineered (GE) and conventional fields on adventitious presence (AP) which represents the unwanted presence of a GE gene. Variables other than distance, however, may affect AP. In addition, some AP is often present in the parent seed lots used to establish conventional fields. To identify variables that influence the proportion of AP in conventional alfalfa fields, we performed variable selection regression analyses. Analyses based on a sample-level and a field-level analysis gave similar, though not identical results. For the sample-level model, distance from the GE field explained 66% of the variance in AP, confirming its importance in affecting AP. The area of GE fields within the pollinator foraging range explained an additional 30% of the variation in AP in the model. The density of alfalfa leafcutting bee domiciles influenced AP in both models. To minimize AP in conventional alfalfa seed fields, management practices should focus on optimizing isolation distances while also considering the size of the GE pollen pool within the pollinator foraging range, and the foraging behavior of pollinators.	[Kesoju, Sandya R.] Columbia Basin Coll, Dept Agr, Pasco, WA 99301 USA; [Kramer, Matthew] USDA ARS, Stat Grp, Beltsville Agr Res Ctr, Beltsville, MD USA; [Brunet, Johanne] ARS, Vegetable Crops Res Unit, USDA, Madison, WI USA; [Greene, Stephanie L.] ARS, Agr Genet Resources Preservat Res Unit, USDA, Ft Collins, CO USA; [Jordan, Amelia] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Martin, Ruth C.] ARS, Forage Seed & Cereal Res, USDA, Corvallis, OR USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA)	Kesoju, SR (corresponding author), Columbia Basin Coll, Dept Agr, Pasco, WA 99301 USA.	skesoju@columbiabasin.edu	Brunet, Johanne/ABB-6499-2021	Brunet, Johanne/0000-0003-4555-7411	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2013-33522-30733]	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture	This project was supported by a Biotechnology Risk Assessment Grant Program, competitive grant no. 2013-33522-30733 from the USDA National Institute of Food and Agriculture to SG. USDA is an equal opportunity provider and employer.	Amand PCS, 2000, THEOR APPL GENET, V101, P107, DOI 10.1007/s001220051457; [Anonymous], 2014, FED REG, V79, P66686; [Anonymous], 2005, FED, V70, P7; Baltazar BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131549; Bannert M, 2007, EUR J AGRON, V27, P44, DOI 10.1016/j.eja.2007.01.002; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; BOHART GE, 1972, ANNU REV ENTOMOL, V17, P287, DOI 10.1146/annurev.en.17.010172.001443; Boydston RA, 2016, PACIFIC NW EXTENSION, P1; Boyle NK, 2017, J ECON ENTOMOL, V110, P6, DOI 10.1093/jee/tow243; Brunet J, 2019, PLANT BIOLOGY, V21, P715, DOI 10.1111/plb.12959; Brunet J, 2019, INT J PLANT SCI, V180, P954, DOI 10.1086/705591; Brunet J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212561; Brunet Johanne, 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/201858; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; BURRILL RM, 1981, APIDOLOGIE, V12, P319, DOI 10.1051/apido:19810402; Cane JH, 2008, APIDOLOGIE, V39, P315, DOI 10.1051/apido:2008013; Cane JH, 2002, J ECON ENTOMOL, V95, P22, DOI 10.1603/0022-0493-95.1.22; Carpenter JE., 2001, AGR BIOTECHNOLOGY UP, V46; Conner AJ, 1996, THEOR APPL GENET, V92, P505, DOI 10.1007/BF00224551; Cornish R., 2015, BEST MANAGEMENT PRAC; Cornish R, BEST MANAGEMENT PRAC; Danner N, 2016, ECOL APPL, V26, P1920, DOI 10.1890/15-1840.1; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Fitzpatrick S, 2007, N CENTR WEED SCI SOC; Fitzpatrick S., 2003, CENTR ALF IMPR C VIR; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Gatford KT, 2006, EUPHYTICA, V151, P383, DOI 10.1007/s10681-006-9160-1; Goggi AS, 2006, FIELD CROP RES, V99, P147, DOI 10.1016/j.fcr.2006.04.005; Greene SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143296; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Hagler JR, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14401; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; Hokanson SC, 1997, ECOL APPL, V7, P1075, DOI 10.1890/1051-0761(1997)007[1075:EOBRAT]2.0.CO;2; Ishihama F, 2006, J ECOL, V94, P846, DOI 10.1111/j.1365-2745.2006.01122.x; JACKSON JF, 1991, THEOR APPL GENET, V82, P169, DOI 10.1007/BF00226208; Johannessen MM, 2006, HEREDITY, V96, P360, DOI 10.1038/sj.hdy.6800796; Kesoju SR, 2019, CROP SCI, V59, P1701, DOI 10.2135/cropsci2018.07.0414; Kesoju SR, 2017, CROP FORAGE TURF MAN, V3, DOI 10.2134/cftm2016.12.0080; Lander TA, 2011, CURR BIOL, V21, P1302, DOI 10.1016/j.cub.2011.06.045; Larsen AS, 2009, CONSERV GENET, V10, P1637, DOI 10.1007/s10592-008-9713-z; LEVIN DA, 1969, AM NAT, V103, P61, DOI 10.1086/282582; Llewellyn D, 2007, AGR ECOSYST ENVIRON, V121, P419, DOI 10.1016/j.agee.2006.11.019; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Millwood R, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0363-4; Moon HS, 2011, BIOTECHNOL J, V6, P118, DOI 10.1002/biot.201000258; Nelson B, 2018, NATL ALFALFA FORAGE; Osgood C.E, 1964, THESIS OREGON STATE; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Pinheiro J, 2020, **DATA OBJECT**; Pitts-Singer TL, 2013, J ECON ENTOMOL, V106, P576, DOI 10.1603/EC12416; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Pu DQ, 2014, J APPL ECOL, V51, P1357, DOI 10.1111/1365-2664.12299; R Core Team, 2020, R LANG ENV STAT COMP; Rankin EEW, 2020, J INSECT SCI, V20, DOI 10.1093/jisesa/ieaa114; Redhead JW, 2016, ECOL APPL, V26, P726, DOI 10.1890/15-0546; Riday H, 2015, CROP SCI, V55, P1087, DOI 10.2135/cropsci2014.04.0295; Rieben S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029730; Scorza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075291; Somerville D, 1999, NSW AGR; Stephen WP, 1959, THE B, V568; Stubbs CS, 1997, J KANSAS ENTOMOL SOC, V70, P81; Teuber LR, 2004, JOINT M 39 N AM ALF; Tian JP, 2004, ANN BOT-LONDON, V93, P167, DOI 10.1093/aob/mch013; Van Deynze A., 2007, P GEN FLOW S N CENTR; Van Deynze AE, 2005, CROP SCI, V45, P1565, DOI 10.2135/cropsci2004.0463; Van Deynze AE., 2008, CAST, V28; Wit E, 2012, STAT NEERL, V66, P217, DOI 10.1111/j.1467-9574.2012.00530.x; Zhang BH, 2005, MOL BIOTECHNOL, V31, P11, DOI 10.1385/MB:31:1:011	71	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248746	10.1371/journal.pone.0248746	http://dx.doi.org/10.1371/journal.pone.0248746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765070	gold, Green Published			2022-12-26	WOS:000634832800103
J	Lyng, GD; Sheils, NE; Kennedy, CJ; Griffin, DO; Berke, EM				Lyng, Gregory D.; Sheils, Natalie E.; Kennedy, Caleb J.; Griffin, Daniel O.; Berke, Ethan M.			Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost	PLOS ONE			English	Article								Background COVID-19 test sensitivity and specificity have been widely examined and discussed, yet optimal use of these tests will depend on the goals of testing, the population or setting, and the anticipated underlying disease prevalence. We model various combinations of key variables to identify and compare a range of effective and practical surveillance strategies for schools and businesses. Methods We coupled a simulated data set incorporating actual community prevalence and test performance characteristics to a susceptible, infectious, removed (SIR) compartmental model, modeling the impact of base and tunable variables including test sensitivity, testing frequency, results lag, sample pooling, disease prevalence, externally-acquired infections, symptom checking, and test cost on outcomes including case reduction and false positives. Findings Increasing testing frequency was associated with a non-linear positive effect on cases averted over 100 days. While precise reductions in cumulative number of infections depended on community disease prevalence, testing every 3 days versus every 14 days (even with a lower sensitivity test) reduces the disease burden substantially. Pooling provided cost savings and made a high-frequency approach practical; one high-performing strategy, testing every 3 days, yielded per person per day costs as low as $1.32. Interpretation A range of practically viable testing strategies emerged for schools and businesses. Key characteristics of these strategies include high frequency testing with a moderate or high sensitivity test and minimal results delay. Sample pooling allowed for operational efficiency and cost savings with minimal loss of model performance.	[Lyng, Gregory D.; Sheils, Natalie E.; Kennedy, Caleb J.; Berke, Ethan M.] UnitedHlth Grp, OptumLabs, Minnetonka, MN 55343 USA; [Griffin, Daniel O.] Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA; [Griffin, Daniel O.] Optum, ProHealth Care, Lake Success, NY USA	Columbia University	Berke, EM (corresponding author), UnitedHlth Grp, OptumLabs, Minnetonka, MN 55343 USA.	ethan.berke@uhg.com	Sheils, Natalie/J-2719-2013	Sheils, Natalie/0000-0002-0631-5834; Griffin, Daniel/0000-0001-5853-6906				Abdalhamid B, 2020, AM J CLIN PATHOL, V153, P715, DOI [10.1093/ajcp/aqaa064, 10.1093/AJCP/AQAA064, 10.1101/2020.04.03.20050195]; [Anonymous], NEW YORK TIMES; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bilder C.R., 2019, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat08227, DOI 10.1002/9781118445112.STAT08227, 10.1002/9781118445112.stat08231]; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; CDC, 2020, COVID 19 PAND PLANN; Chan CL, 2014, IEEE T INFORM THEORY, V60, P3019, DOI 10.1109/TIT.2014.2310477; Corman VM, 2020, TRANSFUSION, V60, P1119, DOI 10.1111/trf.15841; FDA, 2020, EM US AUTH; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; for D C. . and Health R, 2020, SARS COV 2 REFERENCE; Griffin J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040263; He DH, 2020, INT J INFECT DIS, V94, P145, DOI 10.1016/j.ijid.2020.04.034; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Huang CG, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01068-20; Kirkcaldy RD, 2020, JAMA-J AM MED ASSOC, V323, P2245, DOI 10.1001/jama.2020.7869; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; La Marca A, 2020, REPROD BIOMED ONLINE, V41, P483, DOI 10.1016/j.rbmo.2020.06.001; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Larremore DB., 2020, TEST SENSITIVITY IS, DOI [10.1101/2020.04.15.20064931, DOI 10.1101/2020.04.15.20064931]; Litvak E, 2020, AM J PUBLIC HEALTH, V110, P1772, DOI 10.2105/AJPH.2020.305945; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Perera RAPM, 2020, EMERG INFECT DIS, V26, P2701, DOI 10.3201/eid2611.203219; Savvides C., 2020, ASYMPTOMATIC PRESYMP, DOI [10.1101/2020.04.15.20064931, DOI 10.1101/2020.04.15.20064931]; Service RF., 2020, SCI AAAS; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Smith DRM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01866-6; Watkins Anne E, 2020, medRxiv, DOI 10.1101/2020.09.02.20183830; Wu JR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9759; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xiao AT, 2020, J MED VIROL, V92, P1755, DOI 10.1002/jmv.25855; Xing YY, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.10.2000191; Xue J, 2020, REINFECTION COULD NO, DOI [10.1101/2020.03.13.990226v2, DOI 10.1101/2020.03.13.990226V1, 10.1101/2020.03.13.990226]; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00743-20	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248783	10.1371/journal.pone.0248783	http://dx.doi.org/10.1371/journal.pone.0248783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33764982	Green Submitted, gold, Green Published			2022-12-26	WOS:000634832800044
J	Niyukuri, D; Nyasulu, P; Delva, W				Niyukuri, David; Nyasulu, Peter; Delva, Wim			Assessing the uncertainty around age-mixing patterns in HIV transmission inferred from phylogenetic trees	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIAL DESIRABILITY BIAS; SOUTH-AFRICA; DISPARATE RELATIONSHIPS; ANTIRETROVIRAL THERAPY; CAPE-TOWN; INFECTION; EPIDEMIC; RISK; PREVALENCE	Understanding age-mixing patterns in Human Immunodeficiency Virus (HIV) transmission networks can enhance the design and implementation of HIV prevention strategies in sub-Saharan Africa. Due to ethical consideration, it is less likely possible to conduct a benchmark study to assess which sampling strategy, and sub-optimal sampling coverage which can yield best estimates for these patterns. We conducted a simulation study, using phylogenetic trees to infer estimates of age-mixing patterns in HIV transmission, through the computation of proportions of pairings between men and women, who were phylogenetically linked across different age groups (15-24 years, 25-39 years, and 40-49 years); and the means, and standard deviations of their age difference. We investigated also the uncertainty around these estimates as a function of the sampling coverage in four sampling strategies: when missing sequence data were missing completely at random (MCAR), and missing at random (MAR) with at most 30%-50%-70% of women in different age groups being in the sample. The results suggested that age-mixing patterns in HIV transmission can be unveiled from proportions of phylogenetic pairings between men and women across age groups; and the mean, and standard deviation of their age difference. A 55% sampling coverage was sufficient to provide the best values of estimates of age-mixing patterns in HIV transmission with MCAR scenario. But we should be cautious in interpreting proportions of men phylogenetically linked to women because they may be overestimated or underestimated, even at higher sampling coverage. The findings showed that, MCAR was the best sampling strategy. This means, it is advisable not to use sequence data collected in settings where we can find a systematic imbalance of age and gender to investigate age-mixing in HIV transmission. If not possible, ensure to take into consideration the imbalance in interpreting the results.	[Niyukuri, David; Nyasulu, Peter; Delva, Wim] Stellenbosch Univ, Div Epidemiol & Biostat, Fac Med & Hlth Sci, Cape Town, South Africa; [Niyukuri, David; Delva, Wim] Stellenbosch Univ, South African Dept Sci & Technol, Natl Res Fdn DST NRF, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Cape Town, South Africa; [Nyasulu, Peter] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa; [Delva, Wim] Hasselt Univ, Ctr Stat, I BioStat, Diepenbeek, Belgium; [Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Delva, Wim] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium	Stellenbosch University; Stellenbosch University; University of Witwatersrand; Hasselt University; Ghent University; KU Leuven	Niyukuri, D (corresponding author), Stellenbosch Univ, Div Epidemiol & Biostat, Fac Med & Hlth Sci, Cape Town, South Africa.; Niyukuri, D (corresponding author), Stellenbosch Univ, South African Dept Sci & Technol, Natl Res Fdn DST NRF, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Cape Town, South Africa.	kuriniyu@gmail.com		Niyukuri, David/0000-0002-2112-4999; Nyasulu, Peter/0000-0003-2757-0663	NRF-TWAS [100014]	NRF-TWAS	This research was funded by NRF-TWAS grant number 100014 awarded to DN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; [Anonymous], 2016, GLOBAL UPDATE 2016; Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Beauclair R., 2018, AGE DIFFERENCES SEXU; Beauclair R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36121; Beauclair R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19372; Beauclair R, 2012, EUR J CONTRACEP REPR, V17, P30, DOI 10.3109/13625187.2011.644841; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Delva W, 2014, CURR HIV-AIDS REP, V11, P99, DOI 10.1007/s11904-014-0205-0; Delva W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-616; Evans M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21310; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Hosseinipour M, 2002, CLIN INFECT DIS, V34, P1391, DOI 10.1086/340403; Imam A., 2014, IOSR J MATH, V10, P1, DOI 10.9790/5728-10140106; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kusejko K, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey024; LANL, 2017, HIV 1 SUBT C; LANL, 2017, LANDM HIV 1 GEN; Leventhal MGE., 2013, PACKAGE EXPOTREE; Liesenborgs J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55689-4; Osborne J.W., 2013, BEST PRACTICES DATA; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Rao A, 2017, AIDS BEHAV, V21, P2207, DOI 10.1007/s10461-017-1792-8; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rose R, 2017, AIDS RES HUM RETROV, V33, P211, DOI [10.1089/aid.2016.0205, 10.1089/AID.2016.0205]; Street RA, 2016, INT J STD AIDS, V27, P746, DOI 10.1177/0956462415592325; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex025; Vu A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-162; West B. T., 2014, LINEAR MIXED MODELS; Williams BG, 2011, CURR HIV RES, V9, P367, DOI 10.2174/157016211798038533; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249013	10.1371/journal.pone.0249013	http://dx.doi.org/10.1371/journal.pone.0249013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765091	Green Published, gold			2022-12-26	WOS:000634832800026
J	Kuru, O; Stecula, D; Lu, H; Ophir, Y; Chan, MPS; Winneg, K; Jamieson, KH; Albarracin, D				Kuru, Ozan; Stecula, Dominik; Lu, Hang; Ophir, Yotam; Chan, Man-pui Sally; Winneg, Ken; Jamieson, Kathleen Hall; Albarracin, Dolores			The effects of scientific messages and narratives about vaccination	PLOS ONE			English	Article							FALSE BALANCE; RISK; BIAS; MISINFORMATION; INFORMATION; PERCEPTIONS; DECISIONS; FREQUENCY; ATTITUDES; CONSENSUS	A fundamental challenge complicates news decisions about covering vaccine side effects: although serious vaccine side effects are rare, less severe ones do occur occasionally. The study was designed to test whether a side effect message could induce vaccine hesitancy and whether that could be countered by pro-vaccine messages about vaccine safety. A large (N = 2,345), nationally representative experiment was conducted by randomly exposing participants to one of six videos about the measles, mumps, and rubella (MMR) vaccine edited from news programs produced during the 2019 measles outbreak in the United States. The design was a 2x3 factorial crossing the presence or absence of a hesitancy-inducing narrative message with a pro-vaccine science-supporting message (i.e., no message, science-supporting expert message, or pro-vaccine narrative message), leading to a total of six conditions. A general linear model was used to assess the effects of these videos on respondents' (1) vaccine risk perceptions, (2) policy views on vaccination, (3) willingness to encourage others to vaccinate their children, and (4) intention to send a pro-vaccine letter to their state representative. Findings indicated that the science-supporting expert message about vaccine safety led to higher pro-vaccine evaluations relative to other conditions [e.g., b = -0.17, p < .001, a reduction in vaccine risk perceptions of 0.17 as compared to the control]. There was also suggestive evidence that the hesitancy-inducing narrative may limit the effectiveness of a science-supporting expert message, although this finding was not consistent across different outcomes. When shown alone the hesitancy-inducing narrative did not shift views and intentions, but more research is needed to ascertain whether exposure to such messages can undercut the pro-vaccine influence of science-supporting (expert) ones. All in all, however, it is clear that science-supporting messages are effective and therefore worthwhile in combating vaccine misinformation.	[Kuru, Ozan] Natl Univ Singapore, Dept Commun & New Media, Singapore, Singapore; [Stecula, Dominik] Colorado State Univ, Dept Polit Sci, Ft Collins, CO USA; [Lu, Hang] Univ Michigan, Dept Commun & Media, Ann Arbor, MI 48109 USA; [Ophir, Yotam] Univ Buffalo State Univ New York, Dept Commun, Buffalo, NY USA; [Chan, Man-pui Sally; Albarracin, Dolores] Univ Illinois, Dept Psychol, Champaign, IL USA; [Winneg, Ken; Jamieson, Kathleen Hall; Albarracin, Dolores] Univ Penn, Annenberg Publ Policy Ctr, Philadelphia, PA USA	National University of Singapore; Colorado State University; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania	Kuru, O (corresponding author), Natl Univ Singapore, Dept Commun & New Media, Singapore, Singapore.	okuru@nus.edu.sg	Kuru, Ozan/AAU-3333-2021	Kuru, Ozan/0000-0002-0485-1705	Annenberg Public Policy Center; Annenberg Science Knowledge (ASK) surveys; NIH [R01 AI147487, DP1 DA048570, R01MH114847]	Annenberg Public Policy Center; Annenberg Science Knowledge (ASK) surveys; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the current study comes from the Annenberg Public Policy Center, Annenberg Science Knowledge (ASK) surveys to Kathleen Hall Jamieson, and NIH Grants R01 AI147487, DP1 DA048570, and R01MH114847 to Dolores Albarracin. Authors Ozan Kuru (20182020), Dominik Stecula (2018-2020), Hang Lu (2018-2019) and Yotam Ophir (2018-2019) were funded with postdoctoral fellowship positions at the Annenberg Public Policy Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluz J., 2019, VOX; Bennett WL, 2008, J COMMUN, V58, P707, DOI 10.1111/j.1460-2466.2008.00410.x; Betsch C, 2015, JUDGM DECIS MAK, V10, P241; Betsch C, 2013, MED DECIS MAKING, V33, P14, DOI 10.1177/0272989X12452342; Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387; Betsch C, 2011, MED DECIS MAKING, V31, P742, DOI 10.1177/0272989X11400419; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166; Braddock K, 2016, COMMUN MONOGR, V83, P446, DOI 10.1080/03637751.2015.1128555; Carpiano RM, 2017, SOC SCI MED, V185, P127, DOI 10.1016/j.socscimed.2017.05.014; Centers for Disease Control, MEASLES HIST MEASLES; Centers For Disease Control, 2019, MEASL CAS OUTBR; Centers for Disease Control. Vaccine Information Statement, 2019, MMR MEASLES MUMPS RU; Chan MPS, 2017, PSYCHOL SCI, V28, P1531, DOI 10.1177/0956797617714579; Cook J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175799; Dal Cin S, 2004, RESISTANCE AND PERSUASION, P175; Dixon G, 2013, HEALTH EDUC RES, V28, P352, DOI 10.1093/her/cys110; Dixon GN, 2013, SCI COMMUN, V35, P358, DOI 10.1177/1075547012458290; Dunwoody S, 2017, SCI COMMUN, V39, P338, DOI 10.1177/1075547017707765; Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931; Hanley SJB, 2015, LANCET, V385, P2571, DOI 10.1016/S0140-6736(15)61152-7; Horne Z, 2015, P NATL ACAD SCI USA, V112, P10321, DOI 10.1073/pnas.1504019112; Jamieson K.H, 2020, HARVARD KENNEDY SCH, V1; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Koehler DJ, 2016, J EXP PSYCHOL-APPL, V22, P24, DOI 10.1037/xap0000073; Kohl PA, 2016, PUBLIC UNDERST SCI, V25, P976, DOI 10.1177/0963662515615087; Kuru O, 2020, MASS COMMUN SOC, V23, P628, DOI 10.1080/15205436.2020.1774780; Liao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068019; Merkley E, 2020, PUBLIC OPIN QUART, V84, P24, DOI 10.1093/poq/nfz053; Mitchell Amy., 2018, AMERICANS STILL PREF; Nabi RL, 2015, MEDIA PSYCHOL, V18, P137, DOI 10.1080/15213269.2014.912585; Nan XL, 2015, HEALTH COMMUN, V30, P301, DOI 10.1080/10410236.2014.888629; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Obrecht NA, 2009, MEM COGNITION, V37, P632, DOI 10.3758/MC.37.5.632; Ophir Y, 2018, J PUBLIC HEALTH-UK, V40, pE531, DOI 10.1093/pubmed/fdy042; Pluviano S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181640; Redlawsk DP, 2002, J POLIT, V64, P1021, DOI 10.1111/1468-2508.00161; Reyna VF, 2008, LEARN INDIVID DIFFER, V18, P89, DOI 10.1016/j.lindif.2007.03.011; Sangalang A, 2019, J COMMUN, V69, P298, DOI 10.1093/joc/jqz014; Saulsberry L, 2019, VACCINE, V37, P5121, DOI 10.1016/j.vaccine.2019.05.062; Sstrom A., 2019, MEASLES OUTBREAK NEW; Stecula DA, 2020, AM J PUBLIC HEALTH, V110, P1561, DOI 10.2105/AJPH.2020.305828; Thorson E, 2016, POLIT COMMUN, V33, P460, DOI 10.1080/10584609.2015.1102187; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; van der Linden SL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2541-4; Vraga EK, 2017, SCI COMMUN, V39, P621, DOI 10.1177/1075547017731776; Walter N, 2018, COMMUN MONOGR, V85, P423, DOI 10.1080/03637751.2018.1467564; Wardle C, 2017, FAKE NEWS ITS COMPLI; Wenner Moyer, 2018, NEW YORK TIMES	51	10	10	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248328	10.1371/journal.pone.0248328	http://dx.doi.org/10.1371/journal.pone.0248328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760856	Green Published, gold			2022-12-26	WOS:000633030400020
J	Ward, ZJ; Bleich, SN; Long, MW; Gortmaker, SL				Ward, Zachary J.; Bleich, Sara N.; Long, Michael W.; Gortmaker, Steven L.			Association of body mass index with health care expenditures in the United States by age and sex	PLOS ONE			English	Article							CHILDHOOD OBESITY; COSTS; METAANALYSIS; REGRESSION	Background Estimates of health care costs associated with excess weight are needed to inform the development of cost-effective obesity prevention efforts. However, commonly used cost estimates are not sensitive to changes in weight across the entire body mass index (BMI) distribution as they are often based on discrete BMI categories. Methods We estimated continuous BMI-related health care expenditures using data from the Medical Expenditure Panel Survey (MEPS) 2011-2016 for 175,726 respondents. We adjusted BMI for self-report bias using data from the National Health and Nutrition Examination Survey (NHANES) 2011-2016, and controlled for potential confounding between BMI and medical expenditures using a two-part model. Costs are reported in $US 2019. Results We found a J-shaped curve of medical expenditures by BMI, with higher costs for females and the lowest expenditures occurring at a BMI of 20.5 for adult females and 23.5 for adult males. Over 30 units of BMI, each one-unit BMI increase was associated with an additional cost of $253 (95% CI $167-$347) per person. Among adults, obesity was associated with $1,861 (95% CI $1,656-$2,053) excess annual medical costs per person, accounting for $172.74 billion (95% CI $153.70-$190.61) of annual expenditures. Severe obesity was associated with excess costs of $3,097 (95% CI $2,777-$3,413) per adult. Among children, obesity was associated with $116 (95% CI $14-$201) excess costs per person and $1.32 billion (95% CI $0.16-$2.29) of medical spending, with severe obesity associated with $310 (95% CI $124-$474) excess costs per child. Conclusions Higher health care costs are associated with excess body weight across a broad range of ages and BMI levels, and are especially high for people with severe obesity. These findings highlight the importance of promoting a healthy weight for the entire population while also targeting efforts to prevent extreme weight gain over the life course.	[Ward, Zachary J.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Bleich, Sara N.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Long, Michael W.] George Washington Univ, Milken Inst, Dept Prevent & Community Hlth, Sch Publ Hlth, Washington, DC USA; [Gortmaker, Steven L.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; George Washington University; Harvard University; Harvard T.H. Chan School of Public Health	Ward, ZJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA.	zward@hsph.harvard.edu		Ward, Zachary/0000-0002-4007-2207	JPB Foundation [1085]; National Institutes of Health [R01HL146625]; Centers for Disease Control and Prevention (CDC) [U48DP006376]	JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All of the authors received support from The JPB Foundation (Grant No. 1085). ZJW, SNB, and SLG were supported by the National Institutes of Health (Grant No. R01HL146625). SNB and SLG were supported by the Centers for Disease Control and Prevention (CDC) (Grant No. U48DP006376). This work is solely the responsibility of the authors and does not represent official views of the CDC or other agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Cradock AL, 2017, PREV MED, V95, pS17, DOI 10.1016/j.ypmed.2016.10.017; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Finkelstein Eric A, 2006, N C Med J, V67, P310; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Fryar CD, 2016, PREVALENCE OVERWEIGH; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gortmaker SL, 2015, HEALTH AFFAIR, V34, P1932, DOI 10.1377/hlthaff.2015.0631; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kent S, 2017, OBES REV, V18, P869, DOI 10.1111/obr.12560; Kim DD, 2016, VALUE HEALTH, V19, P602, DOI 10.1016/j.jval.2016.02.008; Lassman D, 2014, HEALTH AFFAIR, V33, P815, DOI 10.1377/hlthaff.2013.1224; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Medical Expenditure Panel Survey, 2020, US APPR PRIC IND AN; Mitchell E., 2016, NONINSTITUTIONALIZED; Spieker EA, 2016, PRIMARY CARE, V43, P83, DOI 10.1016/j.pop.2015.08.013; Trasande L, 2009, HEALTH AFFAIR, V28, pW751, DOI 10.1377/hlthaff.28.4.w751; Trogdon JG, 2012, OBESITY, V20, P214, DOI 10.1038/oby.2011.169; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; U.S. Census Bureau, 2020, ANN EST RES POP SING, DOI 10-2019/national/asrh/nc-est2019-syasexn.xlsx; Wang YC, 2015, HEALTH AFFAIR, V34, P1923, DOI 10.1377/hlthaff.2015.0633; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Ward ZJ, 2017, NEW ENGL J MED, V377, P2145, DOI [10.1056/NEJMoa1703860, 10.1056/nejmoa1703860]; Ward ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150735; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x	27	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0247307	10.1371/journal.pone.0247307	http://dx.doi.org/10.1371/journal.pone.0247307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RC8FS	33760880	gold, Green Published			2022-12-26	WOS:000633030400002
J	Zenebe, MH; Mekonnen, Z; Loha, E; Padalko, E				Zenebe, Mengistu Hailemariam; Mekonnen, Zeleke; Loha, Eskindir; Padalko, Elizaveta			Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; NEISSERIA-GONORRHOEAE; MORTALITY; IMPACT	Introduction Curable sexually transmitted infections (STIs) such as infection with Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoeae), and Trichomonas vaginalis (T. vaginalis) can lead to adverse pregnancy and birth outcome. There are limited data on the prevalence and correlate of STI in Ethiopia, yet pregnant women are not screened for curable STI. Hence in this study, the prevalence of STIs and associated risk factors were assessed. Methodology A cross- sectional study was conducted on consecutive women attending the delivery ward at the Hawassa comprehensive and specialized hospital. Vaginal swabs collected at the time of labor and delivery were tested for C. trachomatis, N. gonorrhoeae and T. vaginalis using GeneXpert. Study participants responded to a questionnaire about their previous and current obstetric history and socio-demographic characteristics. Possible independent factors for curable STIs were assessed by chi-square, bivariable, and multivariable, logistic regression. Results Of the 350 vaginal swabs tested, 51 (14.6%, 95% CI: 10.9-18.3) were positive for one or more curable STIs. The prevalence of C. trachomatis, N. gonorrhoeae and T. vaginalis were 8.3%, 4.3%, and 3.1%, respectively. STIs was associated (p<0.005) with the delivery outcomes birth weight and gestational age. A 3-fold increase in odds of acquisition STIs was found in currently unmarried women (AOR, 3.5; 95% CI: 1.1-10.4; p = 0.028), in women <25 years (AOR, 2.7; 95% CI 1.1-6.6; p = 0.031). Women reporting presence of vaginal discharge (AOR, 7.7; 95% CI: 3.2-18.6; p < 0.001) and reporting pain during urination (AOR, 6.5; 95% CI: 2.6-16.2; p <0.001) found to associate with curable STIs. Conclusion The higher magnitude of STIs found in this population, and the absence of symptoms in many illustrate the need for systematic follow-up during routine antenatal care primarily history taking and asking for signs and symptoms to provide early management and avoid long term sequelae.	[Zenebe, Mengistu Hailemariam] Hawassa Univ, Sch Med Lab Sci, Coll Med & Hlth Sceinces, Hawassa, Ethiopia; [Zenebe, Mengistu Hailemariam; Mekonnen, Zeleke] Jimma Univ, Inst Hlth, Sch Med Lab Sci, Jimma, Ethiopia; [Zenebe, Mengistu Hailemariam; Padalko, Elizaveta] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium; [Loha, Eskindir] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Loha, Eskindir] Chr Michelsen Inst, Bergen, Norway; [Padalko, Elizaveta] Ghent Univ Hosp, Lab Med Microbiol, Ghent, Belgium	Hawassa University; Jimma University; Ghent University; University of Bergen; Ghent University; Ghent University Hospital	Zenebe, MH (corresponding author), Hawassa Univ, Sch Med Lab Sci, Coll Med & Hlth Sceinces, Hawassa, Ethiopia.; Zenebe, MH (corresponding author), Jimma Univ, Inst Hlth, Sch Med Lab Sci, Jimma, Ethiopia.; Zenebe, MH (corresponding author), Univ Ghent, Dept Diagnost Sci, Ghent, Belgium.	mengemariamzenebe@gmail.com	HAILEMARIAM, MENGISTU/AAL-4397-2021; zenebe, MENGISTU Hailemariam/GSE-3937-2022	Mekonnen, Zeleke/0000-0003-3418-7291; zenebe, MENGISTU HAILEMARIAM/0000-0002-7048-0594	Jimma University, Ethiopia; consortium of Flemish Universities, Belgium	Jimma University, Ethiopia; consortium of Flemish Universities, Belgium	This research has been supported by VLIR-UOS NETWORK Ethiopia -University Collaboration for Better Health in Ethiopia (UCBHE) scholarship as a part of the project between Jimma University, Ethiopia, and a consortium of Flemish Universities, Belgium.	Adachi K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9315757; Adachi K, 2016, PEDIATR INFECT DIS J, V35, P894, DOI 10.1097/INF.0000000000001199; [Anonymous], 2017, WHORHR1718; Center for Disease Control Prevention (CDC), 2019, SEX TRANSM DIS SURV; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Davey DLJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218349; Eshete A, 2013, ISRN INFECT DIS, V2013, DOI [10.5402/2013/485439, 10.5402/2013/478192]; FDRE. Federal Democratic Republic of Ethiopia, 2015, NATL GUIDELINES MANA; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Hailemariam M, 2013, ETHIOP J HEALTH SCI, V23, P10; Hailu K., 2020, DETERMINANTS GONORRH, V16, DOI [10.1177/1745506520940095, DOI 10.1177/1745506520940095]; Hussen S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3477-y; Ijasan O, 2018, NIGER POSTGRAD MED J, V25, P21, DOI 10.4103/npmj.npmj_7_18; Jena BH, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03089-2; Johnson HL, 2011, SEX TRANSM DIS, V38, P167, DOI 10.1097/OLQ.0b013e3181f2e85f; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Masha SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175166; Medina-Marino A, 2020, INT J STD AIDS, V31, P294, DOI 10.1177/0956462419898612; Moodley D, 2015, SEX TRANSM DIS, V42, P43, DOI 10.1097/OLQ.0000000000000219; Mudau M, 2018, INT J STD AIDS, V29, P324, DOI 10.1177/0956462417724908; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Organization WH, 2016, HLTH SOCIAL EFFECTS; Rouchou B, 2013, PERSPECT PUBLIC HEAL, V133, P174, DOI 10.1177/1757913912472415; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Schonfeld A, 2018, INT J STD AIDS, V29, P251, DOI 10.1177/0956462417723545; Schwebke JR, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01091-17; Tadesse E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168580; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wi TE., 2019, DIAGNOSING SEXUALLY, V22, DOI [10.1002/jia2.25343, DOI 10.1002/JIA2.25343]; Wi TEC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25343; Wolde HF, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4668-3; Wynn A, 2020, SEX TRANSM DIS, V47, P5, DOI 10.1097/OLQ.0000000000001075; Wynn A, 2018, SEX TRANSM INFECT, V94, P230, DOI 10.1136/sextrans-2017-053134	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248958	10.1371/journal.pone.0248958	http://dx.doi.org/10.1371/journal.pone.0248958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760867	Green Published, gold			2022-12-26	WOS:000633030400005
J	Zhu, QH; Cheng, WG; Song, YX; He, Q; Ju, JH; Li, QL				Zhu, Qinghua; Cheng, Weige; Song, Yongxiang; He, Qing; Ju, Jianhua; Li, Qinglian			Complete genome sequence of the deep South China Sea-derived Streptomyces niveus SCSIO 3406, the producer of cytotoxic and antibacterial marfuraquinocins	PLOS ONE			English	Article								Streptomyces niveus SCSIO 3406 was isolated from a sediment sample collected from South China Sea at a depth of 3536 m. Four new sesquiterpenoid naphthoquinones, marfuraquinocins A-D, and two new geranylated phenazines, i. e. phenaziterpenes A and B, were isolated from the fermentation broth of the strain. Here, we present its genome sequence, which contains 7,990,492 bp with a G+C content of 70.46% and harbors 7088 protein-encoding genes. The genome sequence analysis revealed the presence of a 28,787 bp gene cluster encoding for 24 open reading frames including 1,3,6,8-tetrahydroxynaphthalene synthase and monooxygenase, seven phenazine biosynthesis proteins, two prenyltransferases and a squalene-hopene cyclase. These genes are known to be necessary for the biosynthesis of both marfuraquinocins and phenaziterpenes. Outside the gene cluster (and scattered around the genome), there are seven genes belonging to the methylerythritol phosphate pathway for the biosynthesis of the essential primary metabolite, isopentenyl diphosphate, as well as six geranyl diphosphate/farnesyl diphosphate synthase genes. The strain S. niveus SCSIO 3406 showed type I PKS, type III PKS and nonribosomal peptide synthetase cluster. The sequence will provide the genetic basis for better understanding of biosynthesis mechanism of the above mentioned six compounds and for the construction of improved strain for the industrial production of antimicrobial agents.	[Zhu, Qinghua; He, Qing] Dezhou Univ, Coll Life Sci, Dezhou, Peoples R China; [Cheng, Weige; Song, Yongxiang; Ju, Jianhua; Li, Qinglian] Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol, Guangdong Key Lab Marine Mat Med, RNAM Ctr Marine Microbiol,South China Sea Inst Oc, Guangzhou, Peoples R China	Dezhou University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Ju, JH; Li, QL (corresponding author), Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol, Guangdong Key Lab Marine Mat Med, RNAM Ctr Marine Microbiol,South China Sea Inst Oc, Guangzhou, Peoples R China.	jju@scsio.ac.cn; liql@scsio.ac.cn			National Natural Science Foundation of China [41306140]; Pearl River S&T Nova Program of Guangzhou [201806010109]; Special Support Program for Training High-Level Talents in Guangdong [2016TQ03R288]; Guangzhou Science and Technology Plan [201707010454]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou; Special Support Program for Training High-Level Talents in Guangdong; Guangzhou Science and Technology Plan	This work was supported by the National Natural Science Foundation of China (41306140) received by QZ, the Pearl River S&T Nova Program of Guangzhou (201806010109), the Special Support Program for Training High-Level Talents in Guangdong (2016TQ03R288) received by QL and the Program of Guangzhou Science and Technology Plan (201707010454) received by YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BARTHELEMY P, 1984, J ANTIBIOT, V37, P1692, DOI 10.7164/antibiotics.37.1692; Buchholz K, 2016, APPL MICROBIOL BIOT, V100, P3825, DOI 10.1007/s00253-016-7399-6; Cho JY, 2006, ORG LETT, V8, P2471, DOI 10.1021/ol060630r; CORNFORTH JW, 1966, J BIOL CHEM, V241, P3970; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Flinspach K, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01146-13; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Leipoldt F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143237; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; MARTIN JF, 1989, ANNU REV MICROBIOL, V43, P173, DOI 10.1146/annurev.micro.43.1.173; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mukhtar TA, 2001, BIOCHEMISTRY-US, V40, P8877, DOI 10.1021/bi0106787; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; PATHIRANA C, 1992, TETRAHEDRON LETT, V33, P7663, DOI 10.1016/0040-4039(93)88010-G; Qin S, 2012, ENV MICROBIOL REP, V4, P522, DOI 10.1111/j.1758-2229.2012.00357.x; Sivalingam P, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/5283948; Song YX, 2013, J NAT PROD, V76, P2263, DOI 10.1021/np4006025; Soria-Mercado IE, 2005, J NAT PROD, V68, P904, DOI 10.1021/np058011z; Steinbuchel A, 2003, CURR OPIN MICROBIOL, V6, P261, DOI 10.1016/S1369-5274(03)00061-4; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Zhang Y, 2013, ORG LETT, V15, P3254, DOI 10.1021/ol401253p	30	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0248404	10.1371/journal.pone.0248404	http://dx.doi.org/10.1371/journal.pone.0248404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755698	gold, Green Published			2022-12-26	WOS:000632916600014
J	Hung, CT; Huang, HH; Wang, CK; Chung, CH; Tsao, CH; Chien, WC; Wang, WM				Hung, Chih-Tsung; Huang, Hsin-Hui; Wang, Chun-Kai; Chung, Chi-Hsiang; Tsao, Chang-Huei; Chien, Wu-Chien; Wang, Wei-Ming			Pregnancy outcomes in women with vitiligo: A Taiwanese nationwide cohort study	PLOS ONE			English	Article								Vitiligo is perceived as an autoimmune skin disease. Previous studies showed conflicting data about vitiligo and pregnancy outcomes. To delineate the associations between vitiligo and the pregnancy outcomes, we used the National Health Insurance Research Database of Taiwan to conduct a retrospective cohort study from January 1, 2000 to December 31, 2015. This study population was composed of 1,096 women with vitiligo and 4,384 women without vitiligo, who were all matched according to age, comorbidity, and index year. Compared with the non-vitiligo controls, women with vitiligo had a higher risk of abortion (aHR 1.158, 95% confidence interval (CI) 1.095-1.258, P < .001). Perinatal events, such as preterm delivery, pre-eclampsia/eclampsia, gestational diabetes mellitus, stillbirth, and intrauterine growth retardation, were not different between both groups (aHR 1.065, 95% CI 0.817-1.157, P = .413). To determine if systemic treatment before conception decreases the risk of abortion, we assessed the medical history of pregnant women with vitiligo 1 year before pregnancy. Patients who were treated with oral medications had a lower risk of abortion than those who were not (aHR: 0.675, 95% CI: 0.482-0.809, P < .001). Our study indicates that there is a higher risk of abortion in pregnant women with vitiligo and the control of disease activity with systemic treatment before conception could improve pregnancy outcomes.	[Hung, Chih-Tsung; Wang, Wei-Ming] Natl Def Med Ctr, Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Hung, Chih-Tsung; Wang, Wei-Ming] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Hsin-Hui] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wang, Chun-Kai] Kaohsiung Armed Forces Gen Hosp, Dept Obstet & Gynecol, Zuoying Branch, Kaohsiung, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Tsao, Chang-Huei; Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Wang, WM (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Dermatol, Taipei, Taiwan.; Wang, WM (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	chienwu@ndmctsgh.edu.tw; ades0431@ms38.hinet.net	Chung, Chi-Hsiang/AAY-3386-2021		Tri-Service Hospital Research Foundation [TSGH-B-109-010, TSGH-D-109-050, TSGH-E110219]	Tri-Service Hospital Research Foundation	This study was supported by grants from Tri-Service Hospital Research Foundation (TSGH-B-109-010, TSGH-D-109-050, and TSGH-E110219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti B, 2015, J RHEUMATOL, V42, P1376, DOI 10.3899/jrheum.140583; Chen YT, 2015, J EUR ACAD DERMATOL, V29, P1362, DOI 10.1111/jdv.12870; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Fischer-Betz R, 2017, BEST PRACT RES CL RH, V31, P397, DOI 10.1016/j.berh.2017.09.011; Garbelli S, 2005, PIGM CELL RES, V18, P234, DOI 10.1111/j.1600-0749.2005.00244.x; Gomes Vania, 2015, BMC Res Notes, V8, P216, DOI 10.1186/s13104-015-1177-x; Horev A, 2011, INT J DERMATOL, V50, P1083, DOI 10.1111/j.1365-4632.2010.04839.x; Jenkins C, 2000, FERTIL STERIL, V73, P1206, DOI 10.1016/S0015-0282(00)00517-3; Kolstad KD, 2020, BJOG-INT J OBSTET GY, V127, P70, DOI 10.1111/1471-0528.15970; Lee H, 2015, YONSEI MED J, V56, P719, DOI 10.3349/ymj.2015.56.3.719; LIN H, 1993, J IMMUNOL, V151, P4562; Lissauer D, 2014, CLIN SCI, V126, P347, DOI 10.1042/CS20130247; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Ongenae K, 2005, BRIT J DERMATOL, V152, P1165, DOI 10.1111/j.1365-2133.2005.06456.x; Ongenae K, 2005, DERMATOLOGY, V210, P279, DOI 10.1159/000084751; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Osinubi O, 2018, BRIT J DERMATOL, V178, P863, DOI 10.1111/bjd.16049; Park KY, 2018, J AM ACAD DERMATOL, V79, P836, DOI 10.1016/j.jaad.2018.02.036; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Rodrigues M, 2017, J AM ACAD DERMATOL, V77, P1, DOI 10.1016/j.jaad.2016.10.048; Sawicki J, 2012, J CUTAN MED SURG, V16, P261, DOI 10.1177/120347541201600408; Tanemura A, 2012, EUR J DERMATOL, V22, P279, DOI 10.1684/ejd.2012.1656; Vrijman C, 2012, BRIT J DERMATOL, V167, P1224, DOI 10.1111/j.1365-2133.2012.11198.x; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Yang LL, 2015, ACTA DERM-VENEREOL, V95, P664, DOI 10.2340/00015555-2080; Zhang BX, 2013, EUR J DERMATOL, V23, P331, DOI 10.1684/ejd.2013.2011; Zhen Y, 2016, ARCH DERMATOL RES, V308, P703, DOI 10.1007/s00403-016-1690-3	28	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248651	10.1371/journal.pone.0248651	http://dx.doi.org/10.1371/journal.pone.0248651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750961	Green Published, gold			2022-12-26	WOS:000631967100010
J	Chen, YY; Cheng, WY; Shi, HY; Huang, SS; Chen, HR; Liu, DB; Xu, WQ; Yu, J; Wang, JG				Chen, Yiyun; Cheng, Wing Yin; Shi, Hongyu; Huang, Shengshuo; Chen, Huarong; Liu, Dabin; Xu, Weiqi; Yu, Jun; Wang, Jiguang			Classifying gastric cancer using FLORA reveals clinically relevant molecular subtypes and highlights LINC01614 as a biomarker for patient prognosis	ONCOGENE			English	Article								Molecular-based classifications of gastric cancer (GC) were recently proposed, but few of them robustly predict clinical outcomes. While mutation and expression signature of protein-coding genes were used in previous molecular subtyping methods, the noncoding genome in GC remains largely unexplored. Here, we developed the fast long-noncoding RNA analysis (FLORA) method to study RNA sequencing data of GC cases, and prioritized tumor-specific long-noncoding RNAs (lncRNAs) by integrating clinical and multi-omic data. We uncovered 1235 tumor-specific lncRNAs, based on which three subtypes were identified. The lncRNA-based subtype 3 (L3) represented a subgroup of intestinal GC with worse survival, characterized by prevalent TP53 mutations, chromatin instability, hypomethylation, and over-expression of oncogenic lncRNAs. In contrast, the lncRNA-based subtype 1 (L1) has the best survival outcome, while LINC01614 expression further segregated a subgroup of L1 cases with worse survival and increased chance of developing distal metastasis. We demonstrated that LINC01614 over-expression is an independent prognostic factor in L1 and network-based functional prediction implicated its relevance to cell migration. Over-expression and CRISPR-Cas9-guided knockout experiments further validated the functions of LINC01614 in promoting GC cell growth and migration. Altogether, we proposed a lncRNA-based molecular subtype of GC that robustly predicts patient survival and validated LINC01614 as an oncogenic lncRNA that promotes GC proliferation and migration.	[Chen, Yiyun; Shi, Hongyu; Huang, Shengshuo; Wang, Jiguang] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Div Life Sci, Hong Kong, Peoples R China; [Chen, Yiyun; Shi, Hongyu; Huang, Shengshuo; Wang, Jiguang] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Dept Chem & Biol Engn, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Cheng, Wing Yin; Chen, Huarong; Liu, Dabin; Xu, Weiqi; Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, Inst Digest Dis, Hong Kong, Peoples R China; [Cheng, Wing Yin; Chen, Huarong; Liu, Dabin; Xu, Weiqi; Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,CUHK Shenzhen Res Inst, Hong Kong, Peoples R China; [Xu, Weiqi] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Oncol,Dept Hepat Surg, Shanghai, Peoples R China; [Wang, Jiguang] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong; Chinese University of Hong Kong; Fudan University	Wang, JG (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Div Life Sci, Hong Kong, Peoples R China.; Wang, JG (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Dept Chem & Biol Engn, State Key Lab Mol Neurosci, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, Inst Digest Dis, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,CUHK Shenzhen Res Inst, Hong Kong, Peoples R China.; Wang, JG (corresponding author), Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk; jgwang@ust.hk	Chen, Huarong/ABZ-5810-2022; Liu, Dabin/GNH-2648-2022; chen, huarong/ABH-8561-2020; Jun, Yu/D-8569-2015	chen, huarong/0000-0003-2192-1864; Liu, Dabin/0000-0002-3811-8317; Chen, Yiyun/0000-0003-3886-2100; Jun, Yu/0000-0001-5008-2153	NSFC Excellent Young Scientists Fund (Hong Kong and Macau) [31922088]; HK CRF [C4039-19GF, C7065-18GF]; Hong Kong Epigenomics Project [LKCCFL18SC01-E]; HK ITC grant [ITCPD/17-9]; Department of Science and Technology of Guangdong Province [2020A0505090007]; HK RGC-CRF Fund [C6021-19EF]	NSFC Excellent Young Scientists Fund (Hong Kong and Macau); HK CRF; Hong Kong Epigenomics Project; HK ITC grant; Department of Science and Technology of Guangdong Province; HK RGC-CRF Fund	The authors were supported by NSFC Excellent Young Scientists Fund (Hong Kong and Macau) (No. 31922088), HK CRF grants (Nos. C4039-19GF and C7065-18GF), the Hong Kong Epigenomics Project (LKCCFL18SC01-E), HK ITC grant (ITCPD/17-9), and grants from the Department of Science and Technology of Guangdong Province (No. 2020A0505090007). This research made use of the computing resources of the X-GPU cluster supported by the HK RGC-CRF Fund: C6021-19EF.	Arnes L, 2019, GUT, V68, P499, DOI 10.1136/gutjnl-2017-314353; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dugimont T, 1998, ONCOGENE, V16, P2395, DOI 10.1038/sj.onc.1201742; Gan L, 2019, INT J ONCOL, V54, P2157, DOI 10.3892/ijo.2019.4773; Hajjari M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0670-0; Hashad D, 2016, J CLIN LAB ANAL, V30, P1100, DOI 10.1002/jcla.21987; He CY, 2020, CLIN TRANSL MED, V10, P353, DOI 10.1002/ctm2.32; Hu WL, 2018, NAT CELL BIOL, V20, P492, DOI 10.1038/s41556-018-0066-7; Huang GW, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4058-6; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Khan MR, 2019, DATABASE-OXFORD, DOI 10.1093/database/bay136; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li XC, 2016, CANCER RES, V76, P1724, DOI 10.1158/0008-5472.CAN-15-2443; Liu AN, 2018, J CELL MOL MED, V22, P4034, DOI 10.1111/jcmm.13483; Liu G, 2016, ONCOL RES, V23, P99, DOI 10.3727/096504015X14496932933575; Liu Y, 2018, CANCER CELL, V33, P721, DOI 10.1016/j.ccell.2018.03.010; Ma HW, 2017, ONCOTARGET, V8, P52211, DOI 10.18632/oncotarget.11075; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oh SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04179-8; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Petrelli F, 2017, J GASTROINTEST ONCOL, V8, P148, DOI 10.21037/jgo.2017.01.10; Qiu M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.203; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Serra O, 2019, CANCER TREAT REV, V77, P29, DOI 10.1016/j.ctrv.2019.05.005; Sohn BH, 2017, CLIN CANCER RES, V23, P4441, DOI 10.1158/1078-0432.CCR-16-2211; Sun ZF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14595-3; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xavier-Magalhaes Ana, 2018, Oncotarget, V9, P15740, DOI 10.18632/oncotarget.24597; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yoon SJ, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06814-4; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang EB, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1523-0; Zhou JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10221; Zhou XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11516	39	18	18	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2021	40	16					2898	2909		10.1038/s41388-021-01743-3	http://dx.doi.org/10.1038/s41388-021-01743-3		MAR 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	RQ5XW	33742127	hybrid, Green Published			2022-12-26	WOS:000630675000005
J	Ngai, JTK; Yu, RWM; Chau, KKY; Wong, PWC				Ngai, Joe T. K.; Yu, Rose W. M.; Chau, Kathy K. Y.; Wong, Paul W. C.			Effectiveness of a school-based programme of animal-assisted humane education in Hong Kong for the promotion of social and emotional learning: A quasi-experimental pilot study	PLOS ONE			English	Article							CHILDREN; IMPLEMENTATION; INTERVENTIONS; METAANALYSIS; OUTCOMES; DOSAGE; DOG	Background Humane education, which focuses on the cultivation of kindness and empathy towards animals, the environment, and fellow humans, helps children to be less egocentric and more sensitive to the human-animal interaction in ecology. Aim This study aimed to evaluate an animal-assisted, school-based humane education programme that promotes a humane attitude and enhances social-emotional competence for children in Hong Kong. Method A sequential mixed-methods formative evaluation was adopted in the pilot year of the programme. A controlled trial and focus groups were conducted to evaluate the preliminary outcomes and process of the programme and to identify the implementation obstacles and effective strategies. One hundred and ten primary three students from two primary schools participated in the study (55 in the intervention group and 55 in the control group with ordinary formal school extra-curricular activities). Paired sample t tests and a mixed ANOVA were conducted to explore the changes in students' social-emotional competence in our programme and two typical extra-curricular school programmes. Thematic analysis was conducted to categorise the transcriptions from the focus groups. Results Quantitative findings indicated that class-based, animal-assisted humane education increased cognitive competence (t[24] = 2.42, p = .02), empathy (t[24] = 2.94, p < .01), and reduced hyperactivity (t[23] = -2.40, p = .02). Further analysis indicated that the participant recruitment strategies moderate the impact of interventions on the development of empathy (F[2,104] = 4.11, p = .02) and cognitive competence (F[2,104] = 2.96, p = .05). Qualitative analysis suggested three major themes: enhancement of self-control, promotion of humane attitude, and improvement of reading skills. Conclusion The preliminary results of this pilot study indicate positive effects of the programme. Vigorous systematic formative evaluation on the process and effective implementation should be included in future follow-up studies to ensure its sustainability and fidelity.	[Ngai, Joe T. K.; Yu, Rose W. M.; Chau, Kathy K. Y.; Wong, Paul W. C.] Univ Hong Kong, Dept Social Work & Social Adm, Faulty Social Sci, Hong Kong, Peoples R China	University of Hong Kong	Wong, PWC (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Faulty Social Sci, Hong Kong, Peoples R China.	paulw@hku.hk		Ngai, Tsz Kin/0000-0002-2821-919X; Chau, Kathy K Y/0000-0001-8121-8092	Keswick Foundation	Keswick Foundation	The Keswick Foundation (http://www.keswickfoundation.org.hk) supported the development and implementation of "CARing Kids" programme. The author PWWC received the fund on behave of the research team. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2019, ENVIRON URBAN, V31, P443, DOI 10.1177/0956247819866124; Almeida A, 2013, INT J SCI EDUC, V35, P312, DOI 10.1080/09500693.2011.608387; Amuasi JH, 2020, LANCET, V395, P1469, DOI 10.1016/S0140-6736(20)31027-8; Arbour R, 2009, SOC ANIM, V17, P136, DOI 10.1163/156853009X418073; Beetz A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00234, 10.3389/fpsyg.2012.00352]; Bocquier P, 2005, DEMOGR RES, V12, P197, DOI 10.4054/DemRes.2005.12.9; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.1111/j.1467-8624.1982.tb01331.x; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Destoumieux-Garzon D, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00014; Driscoll K., 2011, J EARLY CHILDHOOD IN, V7, P1; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Edelman MW., 1992, MEASURE OUR SUCCESS; Evans R, 2015, PREV SCI, V16, P754, DOI 10.1007/s11121-015-0552-0; Fine AH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203997; Fine AH, 2010, HANDBOOK ON ANIMAL-ASSISTED THERAPY: THEORETICAL FOUNDATIONS AND GUIDELINES FOR PRACTICE, 3RD EDITION, P169, DOI 10.1016/B978-0-12-381453-1.10010-8; Food and Agriculture Organization of the United Nations World Organisation for Animal Health World Health Organization, 2010, FAO OIE WHO COLL SHA; Gullone E., 2000, J HAPPINESS STUD, V1, P293; Handlin L, 2011, ANTHROZOOS, V24, P301, DOI 10.2752/175303711X13045914865385; Hawkins JD, 2008, ARCH PEDIAT ADOL MED, V162, P1133, DOI 10.1001/archpedi.162.12.1133; Hsiao CY, 2016, INT RES GEOGR ENVIRO, V25, P36, DOI 10.1080/10382046.2015.1106203; Itle-Clark S., 2015, MAGIC STORIES ENCOUR; Jones S. M., 2017, NAVIGATING SEL INSID; Jones S.M., 2012, SOCIAL POLICY REPORT, V26, P3, DOI DOI 10.1002/J.2379-3988.2012.TB00073.X; Keller U, 2019, EUR J PSYCHOL ASSESS, V35, P137, DOI 10.1027/1015-5759/a000370; Kotrschal K, 2003, ANTHROZOOS, V16, P147, DOI 10.2752/089279303786992170; Lendrum A, 2012, OXFORD REV EDUC, V38, P635, DOI 10.1080/03054985.2012.734800; Ng Z, 2019, J APPL ANIM WELF SCI, V22, P364, DOI 10.1080/10888705.2018.1524765; ozen-Uyar R., 2016, J HUMAN SCI, V13, P4579, DOI DOI 10.14687/JHS.V13I3.3989; Piek JP, 2015, HUM MOVEMENT SCI, V43, P155, DOI 10.1016/j.humov.2015.08.004; Preziosi R., 1997, LATHAM LETT; Research Office of Legislative Council Secretiart, 2018, OV STUD HOURS STUD W; Reyes MR, 2012, SCHOOL PSYCHOL REV, V41, P82; Ritchie H., 2018, MENTAL HLTH; Sandt DD, 2020, EARLY CHILD EDUC J, V48, P103, DOI 10.1007/s10643-019-01000-z; Scientific and Technical Advisory Panel, 2014, SUST URB POL BRIEF P; Srivastava Kalpana, 2009, Ind Psychiatry J, V18, P75, DOI 10.4103/0972-6748.64028; Swami V, 2010, SCAND J PSYCHOL, V51, P139, DOI 10.1111/j.1467-9450.2009.00760.x; Taylor RD, 2017, CHILD DEV, V88, P1156, DOI 10.1111/cdev.12864; Tse SK., 2016, PROGR INT READING LI; VORMBROCK JK, 1988, J BEHAV MED, V11, P509, DOI 10.1007/BF00844843; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Wu LQ, 2012, J ENVIRON EDUC, V43, P107, DOI 10.1080/00958964.2011.616554; Zhai FH, 2010, SOC SERV REV, V84, P615, DOI 10.1086/657988	43	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0249033	10.1371/journal.pone.0249033	http://dx.doi.org/10.1371/journal.pone.0249033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HS	33740015	gold, Green Published			2022-12-26	WOS:000631030200052
J	Cheon, JE; Kim, JY; Choi, YH; Kim, WS; Cho, TJ; Yoo, WJ				Cheon, Jung-Eun; Kim, Ji Young; Choi, Young Hun; Kim, Woo Sun; Cho, Tae-Joon; Yoo, Won Joon			MRI risk factors for development of avascular necrosis after closed reduction of developmental dysplasia of the hip: Predictive value of contrast-enhanced MRI	PLOS ONE			English	Article							CONGENITAL DISLOCATION; FEMORAL-HEAD; OSSIFIC NUCLEUS; SPICA; ABDUCTION; CHILDREN	Purpose The purpose of this study was to identify imaging risk factors on contrast-enhanced hip MRI after closed reduction of developmental dysplasia of the hip (DDH) that could predict future development of avascular necrosis (AVN) of the femoral head. Materials and methods Fifty-eight infants (F: M = 53: 5, aged 3-18 months) who underwent immediate postoperative contrast-enhanced hip MRI after closed reduction of DDH were included in this study. Quality of reduction (concentric vs eccentric reduction with or without obstacles), abduction angle of the hip, presence of ossific nucleus, and pattern of contrast enhancement of the femoral head were retrospectively evaluated on MRI. Interobserver agreement of contrast enhancement pattern on MRI were evaluated by two radiologists. Development of AVN was determined through radiographic findings at 1 year after reduction. Results AVN of the femoral head developed in 13 (22%) of 58 patients. Excessive abduction of the hip joint (OR 4.65, [95% CI 1.20, 18.06] and global decreased enhancement of the femoral head (OR 71.66, [95% CI 10.54, 487.31]) exhibited statistically significant differences between the AVN and non-AVN groups (P < 0.05). Eccentric reduction (P = 0.320) did not show statistically significant difference between two groups and invisible ossific nucleus (P = 0.05) showed borderline significance. Multi-variable logistic regression indicated that global decreased enhancement of the femoral head was a significant risk factor of AVN (OR 27.92, 95% CI [4.17, 350.18]) (P = 0.0031). Interobserver agreement of contrast enhancement pattern analysis and diagnosis of AVN were good (0.66, 95% CI [0.52, 0.80]). Conclusion Contrast-enhanced hip MRI provides accurate anatomical assessment of the hip after closed reduction of DDH. Global decreased enhancement of the femoral head could be used as a good predictor for future development of AVN after closed reduction of DDH.	[Cheon, Jung-Eun; Kim, Ji Young; Choi, Young Hun; Kim, Woo Sun] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Cheon, Jung-Eun; Kim, Ji Young; Choi, Young Hun; Kim, Woo Sun] SNUMRC Seoul Natl Univ Med Res Ctr, Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Cheon, Jung-Eun; Kim, Ji Young; Choi, Young Hun; Kim, Woo Sun] SNUMRC Seoul Natl Univ Med Res Ctr, Seoul Natl Univ Hosp, Inst Radiat Med, Seoul, South Korea; [Cheon, Jung-Eun; Kim, Ji Young; Choi, Young Hun; Kim, Woo Sun] Seoul Natl Univ, Div Pediat Radiol, Childrens Hosp, Seoul, South Korea; [Cho, Tae-Joon; Yoo, Won Joon] Seoul Natl Univ, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Cho, Tae-Joon; Yoo, Won Joon] Seoul Natl Univ, Div Pediat Orthoped, Childrens Hosp, Seoul, South Korea; [Kim, Ji Young] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoo, WJ (corresponding author), Seoul Natl Univ, Dept Orthoped Surg, Coll Med, Seoul, South Korea.; Yoo, WJ (corresponding author), Seoul Natl Univ, Div Pediat Orthoped, Childrens Hosp, Seoul, South Korea.	yoowj@snu.ac.kr		Cheon, Jung-Eun/0000-0003-1479-2064; Yoo, Won Joon/0000-0001-5225-1440				Barrera CA, 2019, PEDIATR RADIOL, V49, P1652, DOI 10.1007/s00247-019-04504-3; BROUGHAM DI, 1990, J BONE JOINT SURG BR, V72, P557, DOI 10.1302/0301-620X.72B4.2380203; Cha SM, 2018, INT ORTHOP, V42, P175, DOI 10.1007/s00264-017-3685-x; DeFrancesco CJ, 2017, J CHILD ORTHOP, V11, P277, DOI 10.1302/1863-2548.11.170038; Desai AA, 2011, PEDIATR RADIOL, V41, P525, DOI 10.1007/s00247-010-1965-3; Dibello D, 2019, J PEDIATR ORTHOPED, V39, P449, DOI 10.1097/BPO.0000000000001037; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gans I, 2014, J PEDIATR ORTHOPED, V34, P787, DOI 10.1097/BPO.0000000000000187; Ge YH, 2016, HIP INT, V26, P355, DOI 10.5301/hipint.5000348; Gornitzky AL, 2016, CLIN ORTHOP RELAT R, V474, P1153, DOI 10.1007/s11999-015-4387-6; Gould SW, 2012, J PEDIATR ORTHOPED, V32, P504, DOI 10.1097/BPO.0b013e31825a23e4; Haruno LS, 2019, J PEDIATR ORTHOP B, V28, P424, DOI 10.1097/BPB.0000000000000606; Jaimes C, 2014, RADIOGRAPHICS, V34, P449, DOI 10.1148/rg.342135070; Jaremko JL, 2014, HIP INT, V24, P405, DOI 10.5301/hipint.5000143; McNally EG, 1997, J BONE JOINT SURG BR, V79B, P724, DOI 10.1302/0301-620X.79B5.7772; Murray Trevor, 2007, Am J Orthop (Belle Mead NJ), V36, P82; Nguyen JC, 2021, SKELETAL RADIOL, V50, P389, DOI 10.1007/s00256-020-03572-z; RACE C, 1983, J PEDIATR ORTHOPED, V3, P166, DOI 10.1097/01241398-198305000-00004; Rivlin MJ, 2016, J CHILD ORTHOP, V10, P381, DOI 10.1007/s11832-016-0765-1; Roposch A, 2011, CLIN ORTHOP RELAT R, V469, P2838, DOI 10.1007/s11999-011-1801-6; Roposch A, 2009, J BONE JOINT SURG AM, V91A, P911, DOI 10.2106/JBJS.H.00096; Rosenbaum DG, 2016, RADIOGRAPHICS, V36, P840, DOI 10.1148/rg.2016150159; SALTER RB, 1969, CAN J SURG, V12, P44; SCHOENECKER PL, 1995, J PEDIATR ORTHOPED, V15, P763, DOI 10.1097/01241398-199511000-00008; Sllamniku S, 2013, J CHILD ORTHOP, V7, P501, DOI 10.1007/s11832-013-0538-z; Smith BG, 1997, J PEDIATR ORTHOPED, V17, P631, DOI 10.1097/00004694-199709000-00011; Studer K, 2017, J CHILD ORTHOP, V11, P358, DOI 10.1302/1863-2548.11.170031; SUZUKI S, 1990, J BONE JOINT SURG AM, V72A, P1048, DOI 10.2106/00004623-199072070-00014; Talathi NS, 2018, J PEDIATR ORTHOPED, V38, pE440, DOI 10.1097/BPO.0000000000001199; Tiderius C, 2009, J PEDIATR ORTHOPED, V29, P14, DOI 10.1097/BPO.0b013e3181926c40; Tsukagoshi Y, 2017, BONE JOINT J, V99B, P1115, DOI 10.1302/0301-620X.99B8.BJJ-2016-1070.R1; Wang YJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004276; Weinstein SL, 2018, J CHILD ORTHOP, V12, P331, DOI 10.1302/1863-2548.12.180070	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248701	10.1371/journal.pone.0248701	http://dx.doi.org/10.1371/journal.pone.0248701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735261	Green Published, gold			2022-12-26	WOS:000631029700053
J	Hardy, RS; Zadmajid, V; Butts, IAE; Litvak, MK				Hardy, Ryan S.; Zadmajid, Vahid; Butts, Ian A. E.; Litvak, Matthew K.			Growth, survivorship, and predator avoidance capability of larval shortnose sturgeon (Acipenser brevirostrum) in response to delayed feeding	PLOS ONE			English	Article							EARLY-LIFE STAGES; SAINT JOHN RIVER; COMPENSATORY GROWTH; STARVATION RESISTANCE; TEMPORAL VARIATION; MALLOTUS-VILLOSUS; ATLANTIC STURGEON; WHITE STURGEON; NEW-BRUNSWICK; STRIPED BASS	Larval shortnose sturgeon, reared at 17 degrees C, were subjected to delayed feeding treatments of 0, 5, 10, 15, 18, and 23 days post-yolk absorption to examine effects of food deprivation on growth, survival, swimming activity, and escape capabilities. Starvation affected growth and survival but despite degree of starvation, larvae were able to resume growth and experience high survivorship following feeding. Specific growth rate based on larval dry weight for the period directly following first feeding was highest for the day 15 and 18 delayed feeding treatments. There were no differences in survival between the 0 and 5 day treatments, however survival was reduced to 71.2%, 45.4%, and 28.8% for 10, 15, and 18 day delayed feeding treatments, respectively. Shortnose sturgeon had a point-of-no-return (PNR; 55.7% initiated feeding) at similar to 19 days (or 42 days post-fertilization) following the full absorption of yolk. Mean percent swimming activity and swimming speeds showed an interaction between delayed feeding treatment and larval age, such that no differences were detected at 1 and 6 days post-yolk absorption, while these swimming behaviors generally increased or spiked as feeding was delayed for 10, 15, and 18 days post-yolk absorption. At 23 days post-yolk absorption, only swimming speed increased for larvae that were denied food for 18 days. While there was an interaction between delayed feeding treatments and age for proportion of larvae exhibiting an escape response, generally, larvae from all feeding treatments exhibited a positive escape response. There were also interactions between delayed feeding treatments and age post-yolk absorption for mean and maximum escape speeds, such that less aggressive escape responses were typically detected the longer larvae were denied food. Our research suggests that larval shortnose sturgeon increase physical activity during periods of starvation to find a food patch while remaining vigilant but maybe not as capable to defend against a predatory attack as fed individuals.	[Hardy, Ryan S.] Univ New Brunswick, Dept Biol, St John, NB, Canada; [Hardy, Ryan S.] Univ New Brunswick, Ctr Coastal Studies & Aquaculture, St John, NB, Canada; [Hardy, Ryan S.] Idaho Dept Fish & Game, Coeur Dalene, ID USA; [Zadmajid, Vahid] Univ Kurdistan, Fac Nat Resources, Dept Fisheries Sci, Sanandaj, Iran; [Butts, Ian A. E.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL USA; [Litvak, Matthew K.] Mt Allison Univ, Dept Biol, Sackville, NB, Canada	University of New Brunswick; University of New Brunswick; University of Kurdistan; Auburn University System; Auburn University; Mount Allison University	Litvak, MK (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB, Canada.	mlitvak@mta.ca		Zadmajid, Vahid/0000-0002-8034-9557	Alabama Agriculture Experimental Station; USDA National Institute of Food and Agriculture, Hatch project [1013854]; Sir James Dunn Research Center Fund; World Wildlife Fund Canada; Canadian Wildlife Service Endangered Species Research Fund; NB Wildlife Trust Fund [F300-19]; NSERC	Alabama Agriculture Experimental Station; USDA National Institute of Food and Agriculture, Hatch project; Sir James Dunn Research Center Fund; World Wildlife Fund Canada; Canadian Wildlife Service Endangered Species Research Fund; NB Wildlife Trust Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was supported by: Ian A.E. Butts: I.A.E.B.'s contribution to this research was supported by the Alabama Agriculture Experimental Station and the USDA National Institute of Food and Agriculture, Hatch project (1013854) Matthew K. Litvak: Funding for this work was provided by grants from Sir James Dunn Research Center Fund, World Wildlife Fund Canada and Canadian Wildlife Service Endangered Species Research Fund, NB Wildlife Trust Fund (F300-19), and NSERC Discovery grants to M. K. L.	Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Ali M, 2000, J FISH BIOL, V56, P648, DOI 10.1111/j.1095-8649.2000.tb00762.x; ARUL V, 1991, Aquaculture and Fisheries Management, V22, P423, DOI 10.1111/j.1365-2109.1991.tb00755.x; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bain MB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000168; Bestgen KR, 1996, ENVIRON BIOL FISH, V46, P197, DOI 10.1007/BF00005222; BLAXTER J. H. S., 1963, JOUR CONS CONS PERM INTERNATL EXPLOR MER, V28, P211; BLAXTER JHS, 1985, J MAR BIOL ASSOC UK, V65, P737, DOI 10.1017/S0025315400052565; Canadian Council on Animal Care, 2005, CCAC GUIDELINES CARE; CECH JJ, 1984, ESTUARIES, V7, P12, DOI 10.2307/1351952; Chai Y, 2014, J APPL ICHTHYOL, V30, P1590, DOI 10.1111/jai.12626; Chai Y, 2011, J APPL ICHTHYOL, V27, P687, DOI 10.1111/j.1439-0426.2010.01631.x; CHAMBERS RC, 1989, FISH B-NOAA, V87, P515; Chick JH, 2000, CAN J FISH AQUAT SCI, V57, P106, DOI 10.1139/cjfas-57-1-106; China V, 2014, P NATL ACAD SCI USA, V111, P8083, DOI 10.1073/pnas.1323205111; COSEWIC, 2015, COSEWIC ASSESSMENT U; Cotter S., 1981, BARTLETT TEST BIOMET, P403; Cushing D.H., 1972, Symposia Zool Soc Lond, VNo. 29, P213; Disler NN., 1971, PUBLICATIONS, V70; DOROSHOV SI, 1983, AQUACULTURE, V32, P93, DOI 10.1016/0044-8486(83)90272-7; Downie AT, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox038; Du SNN, 2018, ENVIRON SCI TECHNOL, V52, P801, DOI 10.1021/acs.est.7b03745; ELDRIDGE MB, 1981, T AM FISH SOC, V110, P111, DOI 10.1577/1548-8659(1981)110<111:EOFAFF>2.0.CO;2; Eom J., 2016, THESIS U BRIT COLUMB, P71; Ferrari MCO, 2010, BEHAV ECOL, V21, P532, DOI 10.1093/beheco/arq023; Fisher R, 2007, MAR ECOL PROG SER, V344, P257, DOI 10.3354/meps06927; GAMBLE JC, 1987, J EXP MAR BIOL ECOL, V113, P91, DOI 10.1016/0022-0981(87)90157-2; Garcia LMB, 2020, AQUACULT REP, V16, DOI 10.1016/j.aqrep.2020.100288; GERSHANOVICH AD, 1992, J FISH BIOL, V41, P425, DOI 10.1111/j.1095-8649.1992.tb02671.x; Gisbert E, 1999, J APPL ICHTHYOL, V15, P237, DOI 10.1111/j.1439-0426.1999.tb00242.x; Gisbert E, 1997, AQUACULTURE, V156, P63, DOI 10.1016/S0044-8486(97)00086-0; Gisbert E., 2018, SIBERIAN STURGEON AC, V2; Gjosaeter H, 2016, ICES J MAR SCI, V73, P182, DOI 10.1093/icesjms/fsv177; Gotceitas V, 1996, MAR ECOL PROG SER, V130, P29, DOI 10.3354/meps130029; Gross MR, 2002, AM FISH S S, V28, P13; Hardy RS, 2004, ENVIRON BIOL FISH, V70, P145, DOI 10.1023/B:EBFI.0000029345.97187.5b; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Holt J., 2011, LARVAL FISH NUTR; Jobling M, 1996, J FISH BIOL, V49, P658, DOI 10.1111/j.1095-8649.1996.tb00062.x; Jonsson M, 2013, CAN J FISH AQUAT SCI, V70, P1685, DOI 10.1139/cjfas-2013-0150; Jorgensen C, 2014, ICES J MAR SCI, V71, P909, DOI 10.1093/icesjms/fst083; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Koch L, 2019, INTEGR ORGANISM BIOL, V1, DOI 10.1093/iob/oby003; Kynard B, 2007, J APPL ICHTHYOL, V23, P365, DOI 10.1111/j.1439-0426.2007.00908.x; Kynard B, 2016, J APPL ICHTHYOL, V32, P208, DOI 10.1111/jai.13244; Kynard B, 2002, ENVIRON BIOL FISH, V63, P137, DOI 10.1023/A:1014270129729; Kynard B, 1997, ENVIRON BIOL FISH, V48, P319, DOI 10.1023/A:1007372913578; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LITVAK MK, 1992, MAR ECOL PROG SER, V81, P13, DOI 10.3354/meps081013; Lugert V, 2016, REV AQUACULT, V8, P30, DOI 10.1111/raq.12071; McClenahan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032295; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; MCGURK MD, 1984, MAR BIOL, V84, P13, DOI 10.1007/BF00394522; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; Pfleger MO, 2016, GLOB ECOL CONSERV, V8, P99, DOI 10.1016/j.gecco.2016.08.008; Pinheiro J, 2001, MIXED EFFECTS MODELS; RICE JA, 1987, CAN J FISH AQUAT SCI, V44, P467, DOI 10.1139/f87-055; RICHMOND AM, 1995, COPEIA, P172; RICKER W E, 1975, P382; Robert D, 2014, ICES J MAR SCI, V71, P2042, DOI 10.1093/icesjms/fst198; SAS Institute, 2003, SAS SYSTEM V 9 1; Shan XJ, 2008, AQUACULTURE, V277, P14, DOI 10.1016/j.aquaculture.2008.01.044; Shan Xiujuan, 2008, Journal of Ocean University of China, V7, P319, DOI 10.1007/s11802-008-0319-3; Shepherd TD, 2000, MAR BIOL, V137, P737, DOI 10.1007/s002270000340; Skajaa K, 2003, BIG FISH BANG, P105; Skajaa K, 2007, J EXP MAR BIOL ECOL, V353, P135, DOI 10.1016/j.jembe.2007.01.014; Sommerfeld N, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.204834; Stige LC, 2019, FISH FISH, V20, P962, DOI 10.1111/faf.12391; Usvyatsov S, 2013, T AM FISH SOC, V142, P717, DOI 10.1080/00028487.2012.760484; Usvyatsov S, 2012, CAN J FISH AQUAT SCI, V69, P1316, DOI 10.1139/F2012-062; Voesenek CJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.149583; WIESER W, 1992, ENVIRON BIOL FISH, V33, P63, DOI 10.1007/BF00002554; YAMASHITA Y, 1986, B JPN SOC SCI FISH, V52, P635; Yandi I, 2015, HELGOLAND MAR RES, V69, P25, DOI 10.1007/s10152-014-0414-3; Yarmohammadi M., 2015, Caspian Journal of Environmental Sciences, V13, P129; Yengkokpam S, 2014, AQUACULT NUTR, V20, P101, DOI 10.1111/anu.12056; YIN MC, 1987, MAR BIOL, V96, P459, DOI 10.1007/BF00397963; Yokota T, 2016, FISHERIES SCI, V82, P73, DOI 10.1007/s12562-015-0948-6; Yufera M, 2007, AQUACULTURE, V268, P53, DOI 10.1016/j.aquaculture.2007.04.050; Zhu X, 2001, J FISH BIOL, V58, P1149, DOI 10.1111/j.1095-8649.2001.tb00562.x	81	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247768	10.1371/journal.pone.0247768	http://dx.doi.org/10.1371/journal.pone.0247768			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730098	Green Published, gold			2022-12-26	WOS:000630345000036
J	Nagasu, M; Muto, K; Yamamoto, I				Nagasu, Miwako; Muto, Kaori; Yamamoto, Isamu			Impacts of anxiety and socioeconomic factors on mental health in the early phases of the COVID-19 pandemic in the general population in Japan: A web-based survey	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; PHYSICAL-ACTIVITY; SLEEP DURATION; RISK-FACTORS; DEPRESSION; ASSOCIATION; EPIDEMIC; OUTBREAK; SUICIDES; ILLNESS	Owing to the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic worldwide, individuals experience considerable psychological distress daily. The present study aimed to clarify the prevalence of psychological distress and determine the population most affected by risk factors such as the pandemic, socioeconomic status (SES), and lifestyle-related factors causing psychological distress in the early phases of the pandemic in Japan. This study was conducted via a web-based survey using quota sampling to ensure representativeness of the Japanese population aged 20-64 years. A cross-sectional study of 11,342 participants (5,734 males and 5,608 females) was conducted using a self-administered questionnaire that included the Japanese version of the Kessler 6 Psychological Distress Scale (K6) and questions related to the pandemic, SES, and lifestyle. The prevalence of psychological distress, represented by a K6 score of 5 or more, was 50.3% among males and 52.6% among females. Both males and females with annual household incomes less than 2 million yen and males aged in their twenties had significantly higher K6 scores than those with annual household incomes above 2 million yen and males aged over 30 years. Binary logistic regression analyses found pandemic-related factors such as medical history, inability to undergo clinical tests immediately, having trouble in daily life, unavailability of groceries, new work style, and vague anxiety; SES-related factors such as lesser income; and lifestyle-related factors such as insufficient rest, sleep, and nutritious meals to be significantly related to psychological distress. Psychological distress was more prevalent among people with low income and in younger generations than among other groups. There is an urgent need to provide financial, medical, and social support to those affected by the coronavirus disease 2019 (COVID-19) pandemic.	[Nagasu, Miwako] Keio Univ, Fac Econ, Tokyo, Japan; [Muto, Kaori] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Yamamoto, Isamu] Keio Univ, Fac Business & Commerce, Tokyo, Japan	Keio University; University of Tokyo; Keio University	Nagasu, M (corresponding author), Keio Univ, Fac Econ, Tokyo, Japan.	mnagasu555@gmail.com		Nagasu, Miwako/0000-0001-5245-1653	Ministry of Education, Culture, Sports, Science and Technology, Japan [18K01659, 17H06086]; Ministry of Education, Culture, Sports, Science and Technology [18K01659, 17H06086]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by university grants allocated to the Department of Public Policy, Human Genome Centre, Institute of Medical Sciences, University of Tokyo, and by Grand-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant No. 18K01659 and No. 17H06086, Recipient: Isamu Yamamoto). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the participants in our online survey for their valuable data. This work was supported by university grants allocated to the Department of Public Policy, Human Genome Centre, Institute of Medical Sciences, University of Tokyo, and by Grand-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (No. 18K01659 and No. 17H06086).	ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; [Anonymous], COMPREHENSIVE SURVEY; Bureau of Social Welfare and Public Health TMG, 2020, DEATH CAS DUE NEW CO; Byles J, 2006, J AM GERIATR SOC, V54, P1341, DOI 10.1111/j.1532-5415.2006.00837.x; Champion KE, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00135; Chatterjee P, 2020, INDIAN J MED RES, V151, P147, DOI 10.4103/ijmr.IJMR_519_20; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Hisham IN, 2021, BJPSYCH BULL, V45, P332, DOI 10.1192/bjb.2020.60; Hollifield M, 2008, BRIT J PSYCHIAT, V192, P39, DOI 10.1192/bjp.bp.107.038422; Huang JH, 2013, NEURAL REGEN RES, V8, P1898, DOI 10.3969/j.issn.1673-5374.2013.20.009; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Laaksonen E, 2007, INT J EPIDEMIOL, V36, P776, DOI 10.1093/ije/dym074; Lau JTF, 2010, INFECTION, V38, P275, DOI 10.1007/s15010-010-0034-z; Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609; Li HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113933; Li L, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0341-2; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Liu X, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00678-3; Makela P, 2015, EUR J PUBLIC HEALTH, V25, P225, DOI 10.1093/eurpub/cku133; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Matsuzaki Ichiyo, 2007, Environmental Health and Preventive Medicine, V12, P71, DOI 10.1007/BF02898152; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Ministry of Health Labour and Welfare, 2020, CURR COND NEW COR CA; Muto K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234292; Nagasu M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8022-4; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Matud MP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193531; Prevention TCfDCa, CHRON DIS 2019; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rana U, 2020, INT PSYCHOGERIATR, V32, P1251, DOI 10.1017/S1041610220001052; Rodgers B, 2000, ADDICTION, V95, P1833, DOI 10.1046/j.1360-0443.2000.9512183312.x; Sagara Takiko, 2009, Environmental Health and Preventive Medicine, V14, P319, DOI 10.1007/s12199-009-0100-2; Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988; Sinyor M, 2017, CURR OPIN PSYCHIATR, V30, P1, DOI 10.1097/YCO.0000000000000296; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Ustun G, 2021, INT J SOC PSYCHIATR, V67, P54, DOI 10.1177/0020764020938807; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang HY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233410; World Health Organization, MENT HLTH PSYCH CONS; Yamada Y., 2016, J SCI LABOUR, V93, P80	46	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247705	10.1371/journal.pone.0247705	http://dx.doi.org/10.1371/journal.pone.0247705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY9GW	33730044	gold, Green Published			2022-12-26	WOS:000630345000002
J	Rahimzadeh, S; Burczynska, B; Ahmadvand, A; Sheidaei, A; Khademioureh, S; Pazhuheian, F; Moghaddam, SS; Bentham, J; Farzadfar, F; Di Cesare, M				Rahimzadeh, Shadi; Burczynska, Beata; Ahmadvand, Alireza; Sheidaei, Ali; Khademioureh, Sara; Pazhuheian, Forough; Moghaddam, Sahar Saeedi; Bentham, James; Farzadfar, Farshad; Di Cesare, Mariachiara			Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data	PLOS ONE			English	Article							TRENDS; POPULATION; PATTERNS; WOMEN; EPIDEMIOLOGY; SURVIVAL; DEATH	Background In Iran, trends in breast cancer incidence and mortality have generally been monitored at national level. The purpose of this study is to examine province-level disparities in age-standardised breast cancer incidence versus mortality from 2000 to 2010 and their association with socioeconomic status. Methods In this study, data from Iran's national cancer and death registry systems, and covariates from census and household expenditure surveys were used. We estimated the age-standardised incidence and mortality rates in women aged more than 30 years for all 31 provinces in the consecutive time intervals 2000-2003, 2004-2007 and 2008-2010 using a Bayesian spatial model. Results Mean age-standardised breast cancer incidence across provinces increased over time from 15.0 per 100,000 people (95% credible interval 12.0,18.3) in 2000-2003 to 39.6 (34.5,45.1) in 2008-2010. The mean breast cancer mortality rate declined from 10.9 (8.3,13.8) to 9.9 (7.5,12.5) deaths per 100,000 people in the same period. When grouped by wealth index quintiles, provinces in the highest quintile had higher levels of incidence and mortality. In the wealthiest quintile, reductions in mortality over time were larger than those observed among provinces in the poorest quintile. Relative breast cancer mortality decreased by 16.7% in the highest quintile compared to 10.8% in the lowest quintile. Conclusions Breast cancer incidence has increased over time, with lower incidence in the poorest provinces likely driven by underdiagnoses or late-stage diagnosis. Although the reported mortality rate is still higher in wealthier provinces, the larger decline over time in these provinces indicates a possible future reversal, with the most deprived provinces having higher mortality rates. Ongoing analysis of incidence and mortality at sub-national level is crucial in addressing inequalities in healthcare systems and public health both in Iran and elsewhere.	[Rahimzadeh, Shadi; Burczynska, Beata; Di Cesare, Mariachiara] Middlesex Univ, Sch Sci & Technol, Dept Nat Sci, London, England; [Ahmadvand, Alireza] Griffith Univ, Sch Med, Gold Coast, Qld, Australia; [Sheidaei, Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Khademioureh, Sara] Allameh Tabatabai Univ, ECO Coll Insurance, Tehran, Iran; [Pazhuheian, Forough; Moghaddam, Sahar Saeedi; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Bentham, James] Univ Kent, Sch Math Stat & Actuarial Sci, Canterbury, Kent, England; [Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran	Middlesex University; Griffith University; Tehran University of Medical Sciences; Allameh Tabataba'i University; Tehran University of Medical Sciences; University of Kent; Tehran University of Medical Sciences	Di Cesare, M (corresponding author), Middlesex Univ, Sch Sci & Technol, Dept Nat Sci, London, England.	C.Dicesare@mdx.ac.uk	Sheidaei, Ali/AAU-2165-2020; Saeedi Moghaddam, Sahar/AEO-8071-2022; Saeedi Moghaddam, Sahar/AGX-5835-2022; Bentham, James/ABF-5746-2020; Ahmadvand, Alireza/J-8932-2015	Sheidaei, Ali/0000-0002-0480-5768; Saeedi Moghaddam, Sahar/0000-0002-3112-9179; Saeedi Moghaddam, Sahar/0000-0002-3112-9179; Di Cesare, Mariachiara/0000-0002-3934-3364; Ahmadvand, Alireza/0000-0001-5568-8787				Akbari ME, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/2481021; Asaria P, 2012, INT J EPIDEMIOL, V41, P1737, DOI 10.1093/ije/dys151; Azamjah Nasrindokht, 2019, Asian Pac J Cancer Prev, V20, P2015, DOI 10.31557/APJCP.2019.20.7.2015; Bab Sattar, 2019, J Med Life, V12, P140, DOI 10.25122/jml-2018-0087; Bellanger M, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00207; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Bray F, 2014, WORLD CANC REPORT 20, P54, DOI DOI 10.1596/978-1-4648-0349-9_CH3; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chagpar AB, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.1566; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Coccia M, 2013, BREAST CANCER RES TR, V141, P225, DOI 10.1007/s10549-013-2683-y; Di Cesare M, 2015, LANCET GLOB HEALTH, V3, pE229, DOI 10.1016/S2214-109X(15)70001-X; Downing A, 2007, BRIT J CANCER, V96, P836, DOI 10.1038/sj.bjc.6603622; Duport N, 2008, EUR J CANCER PREV, V17, P218, DOI 10.1097/CEJ.0b013e3282b6fde5; Enayatrad M, 2015, IRAN J PUBLIC HEALTH, V44, P430; Engmann NJ, 2017, JAMA ONCOL, V3, P1228, DOI 10.1001/jamaoncol.2016.6326; Etemadi Arash, 2008, Arch Iran Med, V11, P577; Farzadfar F, 2014, ARCH IRAN MED, V17, P7, DOI 0141701/AIM.004; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Ghoncheh Mahshid, 2015, Asian Pac J Cancer Prev, V16, P8439; Ghoncheh Mahshid, 2015, Asian Pac J Cancer Prev, V16, P6081; Great Britain. National Audit Office, 2004, TACKLING CANC ENGLAN; HABIBI A, 1962, Rev Med Moyen Orient, V19, P302; HABIBI A, 1965, J NATL CANCER I, V34, P553; Harirchi Iraj, 2004, Asian Pac J Cancer Prev, V5, P24; Hatefnia E, 2010, HEALTH CARE WOMEN IN, V31, P499, DOI 10.1080/07399331003725507; Heidari Z., 2008, Acta Medica Iranica, V46, P321; IARC Working Group on the Evaluation of Cancer-Preventive Interventions, 2018, IARC HDB CANC PREVEN; Institute for Health Metrics and Evaluation (IHME), 2018, GBD COMP DATA VIS; Jafari-Koshki T, 2014, ASIAN PAC J CANCER P, V15, P1557, DOI 10.7314/APJCP.2014.15.4.1557; Kardan-Souraki Maryam, 2019, Open Access Maced J Med Sci, V7, P637, DOI 10.3889/oamjms.2019.045; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; Modirian M, 2014, ARCH IRAN MED, V17, P193, DOI 0141703/AIM.0010; Mohagheghi MA, 2010, ASIAN PAC J CANCER P, V11, P1155; Mohammadi Y, 2014, ARCH IRAN MED, V17, P176, DOI 0141703/AIM.007; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Mousavi SM, 2009, ANN ONCOL, V20, P556, DOI 10.1093/annonc/mdn642; Nasrollahzadeh M, 2020, CLIN EPIDEMIOL GLOB, V8, P1011, DOI 10.1016/j.cegh.2020.03.013; Percy CL, 2000, INT CLASSIFICATION D; Prager GW, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000285; Preston S., 2020, DEMOGRAPHY MEASURING; Raei M, 2018, GEOSPATIAL HEALTH, V13, P164, DOI 10.4081/gh.2018.645; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Saadat S, 2015, EMERGENCY, V3, P16; Schootman M, 2004, EPIDEMIOLOGY, V15, P300, DOI 10.1097/01.ede.0000121605.41388.7c; Shabani M, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01428; Sheidaei A, 2017, ARCH IRAN MED, V20, P2, DOI 0172001/AIM.003; Simmonds A, 2014, NUTR BULL, V39, P126, DOI 10.1111/nbu.12077; Somi MH, 2008, ASIAN PAC J CANCER P, V9, P327; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SUTTON S, 1994, J EPIDEMIOL COMMUN H, V48, P65, DOI 10.1136/jech.48.1.65; Taghavi A, 2012, ASIAN PAC J CANCER P, V13, P367, DOI 10.7314/APJCP.2012.13.1.367; Taheri NS, 2012, ASIAN PAC J CANCER P, V13, P4517, DOI 10.7314/APJCP.2012.13.9.4517; Tfayli A, 2010, J ONCOL, V2010, DOI 10.1155/2010/490631; Veismoradi Maryam, 2019, TEHRAN U MED J, V77, P152; Wakefield JC., 2000, SPAT EPIDEMIOL, DOI [10.1093/acprof:oso/9780198515326.003.0007, DOI 10.1093/ACPROF:OSO/9780198515326.003.0007]	59	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248723	10.1371/journal.pone.0248723	http://dx.doi.org/10.1371/journal.pone.0248723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730079	Green Accepted, gold, Green Published			2022-12-26	WOS:000630345000021
J	Tian, X; Ma, KP; Ji, GY; Cui, JZ; Liao, Y; Xiang, MZ				Tian, Xia; Ma, Kaipeng; Ji, Guangyu; Cui, Junzhi; Liao, Yi; Xiang, Meizhen			Anisotropic shock responses of nanoporous Al by molecular dynamics simulations	PLOS ONE			English	Article							WAVES; MODEL	Mechanical responses of nanoporous aluminum samples under shock in different crystallographic orientations (, , , and ) are investigated by molecular dynamics simulations. The shape evolution of void during collapse is found to have no relationship with the shock orientation. Void collapse rate and dislocation activities at the void surface are found to strongly dependent on the shock orientation. For a relatively weaker shock, void collapses fastest when shocked along the orientation; while for a relatively stronger shock, void collapses fastest in the orientation. The dislocation nucleation position is strongly depended on the impacting crystallographic orientation. A theory based on resolved shear stress is used to explain which slip planes the earliest-appearing dislocations prefer to nucleate on under different shock orientations.	[Tian, Xia; Ma, Kaipeng] HoHai Univ, Coll Mech & Mat, Nanjing, Peoples R China; [Ji, Guangyu] HoHai Univ, Coll Civil & Transportat Engn, Nanjing, Peoples R China; [Cui, Junzhi] Chinese Acad Sci, Acad Math & Syst Sci, ICMSEC, LSEC, Beijing, Peoples R China; [Cui, Junzhi] Univ Chinese Acad Sci, Sch Math Sci, Beijing, Peoples R China; [Liao, Yi] Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China; [Xiang, Meizhen] Inst Appl Phys & Computat Math, Lab Computat Phys, Beijing, Peoples R China	Hohai University; Hohai University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest Petroleum University; Chinese Academy of Sciences; Institute of Applied Physics & Computational Mathematics - China	Tian, X (corresponding author), HoHai Univ, Coll Mech & Mat, Nanjing, Peoples R China.; Xiang, MZ (corresponding author), Inst Appl Phys & Computat Math, Lab Computat Phys, Beijing, Peoples R China.	tianxia@lsec.cc.ac.cn; xiang_meizhen@iapcm.ac.cn			National Natural Science Foundation of China [11972147, 11772068, 51739007]; Fundamental Research Funds for the Central Universities [2018B57914]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded in the form of grants by the National Natural Science Foundation of China (Grant Nos. 11972147 and11932006) awarded to XT, (Grant No. 11772068) awarded to MX, and (Grant No. 51739007) awarded to JC. This study was also funded in the form of a grant by the Fundamental Research Funds for the Central Universities (Grant No. 2018B57914) awarded to all authors.	Biener J, 2009, NAT MATER, V8, P47, DOI 10.1038/NMAT2335; Bonnan S, 1998, J APPL PHYS, V83, P5741, DOI 10.1063/1.367430; Bruck HA, 2000, INT J SOLIDS STRUCT, V37, P6383, DOI 10.1016/S0020-7683(99)00236-X; Czarnota C, 2017, J MECH PHYS SOLIDS, V107, P204, DOI 10.1016/j.jmps.2017.06.005; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Feldgun VR, 2015, INT J IMPACT ENG, V82, P113, DOI 10.1016/j.ijimpeng.2015.03.012; Guan YL, 2020, INT J MECH SCI, V181, DOI 10.1016/j.ijmecsci.2020.105707; Hirth J. P., 1972, THEORY DISLOCATIONS; Kazemi-Kamyab V, 2011, J APPL PHYS, V109, DOI 10.1063/1.3517791; LEVY A, 1993, EXP FLUIDS, V15, P183, DOI 10.1007/BF00189885; Li GM, 2018, INT J MECH SCI, V141, P143, DOI 10.1016/j.ijmecsci.2018.04.008; Liao Y, 2018, MECH MATER, V126, P13, DOI 10.1016/j.mechmat.2018.07.006; Liao Y, 2015, MECH MATER, V84, P12, DOI 10.1016/j.mechmat.2015.01.007; Medvedev A.B., 2012, UFN, V182, P829; Molinari A, 2004, J APPL PHYS, V95, P1718, DOI 10.1063/1.1640452; P Miller, 2001, M APS SHOCK COMPR CO; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Shimizu F, 2007, MATER TRANS, V48, P2923, DOI 10.2320/matertrans.MJ200769; Stukowski A, 2012, MODEL SIMUL MATER SC, V20, DOI 10.1088/0965-0393/20/3/035012; Stukowski A, 2012, MODEL SIMUL MATER SC, V20, DOI 10.1088/0965-0393/20/4/045021; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/8/085001; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Winey JM, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/5/055004; Xiang MZ, 2017, INT J PLASTICITY, V97, P24, DOI 10.1016/j.ijplas.2017.05.008; Yasuhara M, 1996, JSME INT J B-FLUID T, V39, P287, DOI 10.1299/jsmeb.39.287; Zhu WJ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024104	26	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247172	10.1371/journal.pone.0247172	http://dx.doi.org/10.1371/journal.pone.0247172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730074	gold, Green Published			2022-12-26	WOS:000630345000079
J	Munier, CC; De Maria, L; Edman, K; Gunnarsson, A; Longo, M; MacKintosh, C; Patel, S; Snijder, A; Wissler, L; Brunsveld, L; Ottmann, C; Perry, MWD				Munier, Claire C.; De Maria, Leonardo; Edman, Karl; Gunnarsson, Anders; Longo, Marianna; MacKintosh, Carol; Patel, Saleha; Snijder, Arjan; Wissler, Lisa; Brunsveld, Luc; Ottmann, Christian; Perry, Matthew W. D.			Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14-3-3 protein regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE STABILIZATION; CRYSTAL-STRUCTURE; LIGAND-BINDING; DOMAIN; DIMERIZATION; INHIBITION; PLASTICITY; MECHANISM; REVEALS; INSULIN	The glucocorticoid receptor (GR) is a ligand-dependent transcription factor that plays a central role in inflammation. The GR activity is also modulated via protein-protein interactions, including binding of 14-3-3 proteins induced by GR phosphorylation. However, the specific phosphorylation sites on the GR that trigger these interactions and their functional consequences are less clear. Hence, we sought to examine this system in more detail. We used phosphorylated GR peptides, biophysical studies, and X-ray crystallography to identify key residues within the ligand-binding domain of the GR, T524 and S617, whose phosphorylation results in binding of the representative 14-3-3 protein 14-3-3 zeta. A kinase screen identified misshapen-like kinase 1 (MINK1) as responsible for phosphorylating T524 and Rho-associated protein kinase 1 for phosphorylating S617; cell-based approaches confirmed the importance of both GR phosphosites and MINK1 but not Rhoassociated protein kinase 1 alone in inducing GR-14-3-3 binding. Together our results provide molecular-level insight into 14-3-3-mediated regulation of the GR and highlight both MINK1 and the GR-14-3-3 axis as potential targets for future therapeutic intervention.	[Munier, Claire C.; De Maria, Leonardo; Perry, Matthew W. D.] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Res & Early Dev, Gothenburg, Sweden; [Munier, Claire C.; Brunsveld, Luc; Ottmann, Christian] Tech Univ Eindhoven, Lab Chem Biol, Dept Biomed Engn, Eindhoven, Netherlands; [Munier, Claire C.; Brunsveld, Luc; Ottmann, Christian] Tech Univ Eindhoven, Inst Complex Mol Syst, Eindhoven, Netherlands; [Edman, Karl; Gunnarsson, Anders; Snijder, Arjan; Wissler, Lisa] AstraZeneca, BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden; [Longo, Marianna; MacKintosh, Carol] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol CM, Dundee, Scotland; [Patel, Saleha] AstraZeneca, R&D, Discovery Sci, Discovery Biol, Cambridge, England	AstraZeneca; Eindhoven University of Technology; Eindhoven University of Technology; AstraZeneca; University of Dundee; AstraZeneca	Perry, MWD (corresponding author), AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Res & Early Dev, Gothenburg, Sweden.	Matthew.Perry@astrazeneca.com	; MacKintosh, Carol/B-8210-2011	Brunsveld, Luc/0000-0001-5675-511X; Edman, Karl/0000-0002-2560-2388; Wissler, Lisa/0000-0002-8152-8522; Snijder, Arjan/0000-0003-2829-3098; Munier, Claire/0000-0002-8517-8398; MacKintosh, Carol/0000-0001-9166-589X; Perry, Matthew/0000-0002-9799-0746	H2020 Marie Curie Actions of the European Commission [675179]	H2020 Marie Curie Actions of the European Commission	This work was supported by the Initial Training Network TASPPI, funded by the H2020 Marie Curie Actions of the European Commission under Grant Agreement 675179.	Aghazadeh Y, 2016, DRUG DISCOV TODAY, V21, P278, DOI 10.1016/j.drudis.2015.09.012; Bartel M, 2014, FUTURE MED CHEM, V6, P903, DOI [10.4155/FMC.14.47, 10.4155/fmc.14.47]; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bier D, 2016, CHEMMEDCHEM, V11, P911, DOI 10.1002/cmdc.201500484; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Edman K, 2015, STRUCTURE, V23, P2280, DOI 10.1016/j.str.2015.09.012; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Habib T, 2017, MOL CELL ENDOCRINOL, V439, P431, DOI 10.1016/j.mce.2016.10.002; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Hwang Y, 2018, BIOCHEM BIOPH RES CO, V501, P800, DOI 10.1016/j.bbrc.2018.05.077; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim DK, 2014, DIABETOLOGIA, V57, P2576, DOI 10.1007/s00125-014-3366-x; Kim SW, 2017, CELL SIGNAL, V31, P124, DOI 10.1016/j.cellsig.2017.01.001; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; Kino T, 2003, J BIOL CHEM, V278, P25651, DOI 10.1074/jbc.M302818200; Kino T, 2018, TRENDS ENDOCRIN MET, V29, P260, DOI 10.1016/j.tem.2018.01.010; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Kuna P, 2017, BASIC CLIN PHARMACOL, V121, P279, DOI 10.1111/bcpt.12768; De Vries-van Leeuwen IJ, 2013, P NATL ACAD SCI USA, V110, P8894, DOI 10.1073/pnas.1220809110; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Nixon M, 2013, STEROIDS, V78, P59, DOI 10.1016/j.steroids.2012.09.013; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Scheschowitsch K, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00016; Sluchanko NN, 2019, PROG MOL BIOL TRANSL, V166, P19, DOI 10.1016/bs.pmbts.2019.03.007; Souffriau J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31150-w; Stevers LM, 2018, J AM CHEM SOC, V140, P14498, DOI 10.1021/jacs.8b09618; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Widen C, 2000, J BIOL CHEM, V275, P39296, DOI 10.1074/jbc.M006943200; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200	44	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100551	10.1016/j.jbc.2021.100551	http://dx.doi.org/10.1016/j.jbc.2021.100551			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33744286	Green Published, gold			2022-12-26	WOS:000672866400524
J	Sorimachi, Y; Karigane, D; Ootomo, Y; Kobayashi, H; Morikawa, T; Otsu, K; Kubota, Y; Okamoto, S; Goda, N; Takubo, K				Sorimachi, Yuriko; Karigane, Daiki; Ootomo, Yukako; Kobayashi, Hiroshi; Morikawa, Takayuki; Otsu, Kinya; Kubota, Yoshiaki; Okamoto, Shinichiro; Goda, Nobuhito; Takubo, Keiyo			p38 alpha plays differential roles in hematopoietic stem cell activity dependent on aging contexts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; PROTEIN-KINASE; P38 MAPK; RECOMBINATION; QUIESCENCE; SENESCENCE	Hematopoietic stem cells (HSCs) and their progeny sustain lifetime hematopoiesis. Aging alters HSC function, number, and composition and increases risk of hematological malignancies, but how these changes occur in HSCs remains unclear. Signaling via p38 mitogen-activated kinase (p38MAPK) has been proposed as a candidate mechanism underlying induction of HSC aging. Here, using genetic models of both chronological and premature aging, we describe a multimodal role for p38 alpha, the major p38MAPK isozyme in hematopoiesis, in HSC aging. We report that p38 alpha regulates differentiation bias and sustains transplantation capacity of HSCs in the early phase of chronological aging. However, p38 alpha decreased HSC transplantation capacity in the late progression phase of chronological aging. Furthermore, codeletion of p38 alpha in mice deficient in ataxia-telangiectasia mutated, a model of premature aging, exacerbated aging-related HSC phenotypes seen in ataxia-telangiectasia mutated single-mutant mice. Overall, these studies provide new insight into multiple functions of p38MAPK, which both promotes and suppresses HSC aging context dependently.	[Sorimachi, Yuriko; Karigane, Daiki; Ootomo, Yukako; Kobayashi, Hiroshi; Morikawa, Takayuki; Takubo, Keiyo] Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo, Japan; [Sorimachi, Yuriko; Ootomo, Yukako; Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med BioSci, Sch Adv Sci & Engn, Tokyo, Japan; [Karigane, Daiki; Okamoto, Shinichiro] Keio Univ, Dept Med, Div Hematol, Sch Med, Tokyo, Japan; [Otsu, Kinya] Kings Coll London, Sch Cardiovasc Med & Sci, London, England; [Kubota, Yoshiaki] Keio Univ, Dept Anat, Sch Med, Tokyo, Japan; [Karigane, Daiki] Stanford Canc Inst, Stanford, CA 94305 USA	National Center for Global Health & Medicine - Japan; Waseda University; Keio University; University of London; King's College London; Keio University; Stanford Cancer Institute	Karigane, D; Takubo, K (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Stem Cell Biol, Tokyo, Japan.; Karigane, D (corresponding author), Keio Univ, Dept Med, Div Hematol, Sch Med, Tokyo, Japan.; Karigane, D (corresponding author), Stanford Canc Inst, Stanford, CA 94305 USA.	karigane@keio.jp; ktakubo@ri.ncgm.go.jp		Takubo, Keiyo/0000-0002-1736-7592; Karigane, Daiki/0000-0002-4017-5193	KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) [19K17877]; Takeda Science Foundation; KAKENHI grant from MEXT/JSPS [19K17847]; National Center for Global Health and Medicine [26-001, 19A2002]; KAKENHI grants from MEXT/JSPS [18H02845, 18K19570, 20K21621]; Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development [JP18ck0106444, JP18ae0201014, JP20bm0704042, JP20gm1210011]; Ono Medical Research Foundation; Kanzawa Medical Research Foundation; National Center for Global Health and Medicine	KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI grant from MEXT/JSPS; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); KAKENHI grants from MEXT/JSPS; Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development; Ono Medical Research Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	D. K. was supported in part by a KAKENHI grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) (19K17877), JB research grants, and the Takeda Science Foundation. H. K. was supported in part by a KAKENHI grant from MEXT/JSPS (19K17847) and a grant from the National Center for Global Health and Medicine. K. T. was supported in part by KAKENHI grants from MEXT/JSPS (18H02845, 18K19570, and 20K21621), grants from the National Center for Global Health and Medicine (26-001 and 19A2002), a grant from Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development grants (JP18ck0106444, JP18ae0201014, JP20bm0704042, and JP20gm1210011), and grants from the Ono Medical Research Foundation, the Kanzawa Medical Research Foundation, and the Takeda Science Foundation.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Baudet A, 2012, BLOOD, V119, P6255, DOI 10.1182/blood-2012-01-403949; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen ZY, 2019, J EXP MED, V216, P152, DOI 10.1084/jem.20181505; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Haan G, 2018, BLOOD, V131, P479, DOI 10.1182/blood-2017-06-746412; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Florian MC, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003389; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Gutierrez-Martinez P, 2018, NAT CELL BIOL, V20, P413, DOI 10.1038/s41556-018-0054-y; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ho YH, 2019, CELL STEM CELL, V25, P407, DOI 10.1016/j.stem.2019.06.007; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Ju ZY, 2011, INT J HEMATOL, V94, P33, DOI 10.1007/s12185-011-0882-z; Jung H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13674; Karigane D, 2016, CELL STEM CELL, V19, P192, DOI 10.1016/j.stem.2016.05.013; Kobayashi H, 2019, CELL REP, V28, P145, DOI 10.1016/j.celrep.2019.06.008; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Lee J., 2019, INT J MOL SCI, V20; Li TL, 2016, GENOM PROTEOM BIOINF, V14, P147, DOI 10.1016/j.gpb.2016.04.002; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Pietras EM, 2017, BLOOD, V130, P1693, DOI 10.1182/blood-2017-06-780882; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Wang Y, 2011, RADIAT RES, V176, P743, DOI 10.1667/RR2727.1; Yamashita M, 2021, HAEMATOLOGICA, V106, P320, DOI 10.3324/haematol.2020.272898; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108	39	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100563	10.1016/j.jbc.2021.100563	http://dx.doi.org/10.1016/j.jbc.2021.100563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33745970	gold, Green Published			2022-12-26	WOS:000672866400536
J	Yang, DZ; Jiang, CZ; Ning, B; Kong, W; Shi, YX				Yang, Dezhi; Jiang, Chizhou; Ning, Bo; Kong, Wei; Shi, Yixin			The PorX/PorY system is a virulence factor of Porphyromonas gingivalis and mediates the activation of the type IX secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RESPONSE REGULATORS; CYSTEINE PROTEINASE; ENCODING GENES; DNA-BINDING; GINGIPAINS; IDENTIFICATION; ARGININE; DOMAIN; INVOLVEMENT; CLONING	PorX/PorY is a two-component system (TCS) of Porphyromonas gingivalis that governs transcription of numerous genes including those encoding a type IX secretion system (T9SS) for gingipain secretion and heme accumulation. Here, an in vitro analysis showed that the response regulator PorX specifically bound to two regions in the promoter of porT, a known PorX-regulated T9SS gene, thus demonstrating that PorX/PorY can directly regulate specific target genes. A truncated PorX protein containing the N-terminal receiver and effector domains retained a wild-type ability in both transcription regulation and heme accumulation, ruling out the role of the C-terminal ALP domain in gene regulation. The PorX/PorY system was the only TCS essential for heme accumulation and concomitantly responded to hemin to stimulate transcription of several known PorX-dependent genes in a concentration-dependent manner. We found that PorX/PorY activated the sigH gene, which encodes a sigma factor known for P. gingivalis adaptation to hydrogen peroxide (H2O2). Consistently, both Delta porX and Delta sigH mutants were susceptible to H2O2, suggesting a PorX/PorY-sigma(H) regulatory cascade to confer resistance to oxidative stress. Furthermore, the.porX mutant became susceptible to high hemin levels that could induce oxidative stress. Therefore, a possible reason why hemin activates PorX/PorY is to confer resistance to hemin-induced oxidative stress. We also demonstrated that PorX/PorY was essential for P. gingivalis virulence because the Delta porX mutant was avirulent in a mouse model. Specifically, this TCS was required for the repression of proinflammatory cytokines secreted by dendritic cells and T cells in the P. gingivalis-infected mice.	[Yang, Dezhi; Jiang, Chizhou; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Yang, Dezhi; Jiang, Chizhou; Kong, Wei; Shi, Yixin] Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ 85281 USA; [Ning, Bo] Tulane Univ, Sch Med, Ctr Cellular & Mol Diagnost, 1430 Tulane Ave, New Orleans, LA 70112 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Tulane University	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.; Kong, W; Shi, YX (corresponding author), Arizona State Univ, Biodesign Ctr Immunotherapy Vaccines & Virotherap, Tempe, AZ 85281 USA.	wei.kong@asu.edu; yixin.shi@asu.edu	Yang, Dezhi/HGB-2668-2022	Yang, Dezhi/0000-0003-4653-9856	NIDCR [R01 DE024607]	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by Research Project Grant R01 DE024607 from NIDCR (Y. S. and W. K.).	Abdi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182164; [Anonymous], 2005, NAT METHODS, V2, P557; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fujise K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185027; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GROSS R, 1989, MOL MICROBIOL, V3, P1661, DOI 10.1111/j.1365-2958.1989.tb00152.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huffman LJ, 2000, EXP LUNG RES, V26, P203; Irfan U M, 2001, J Int Acad Periodontol, V3, P14; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Lasica AM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00215; Lou YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9838; Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mattos-Graner RO, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1400858; McKenzie RME, 2012, MICROBIOL-SGM, V158, P2465, DOI 10.1099/mic.0.056416-0; Mikolajczyk-Pawlinska J, 1998, BIOL CHEM, V379, P205, DOI 10.1515/bchm.1998.379.2.205; Naito M, 2019, MICROBIOL IMMUNOL, V63, P11, DOI 10.1111/1348-0421.12665; Nakayama K, 1997, MICROBIOL IMMUNOL, V41, P185, DOI 10.1111/j.1348-0421.1997.tb01189.x; Nakayama K, 1998, MOL MICROBIOL, V27, P51, DOI 10.1046/j.1365-2958.1998.00656.x; NEIDERS ME, 1989, J PERIODONTAL RES, V24, P192, DOI 10.1111/j.1600-0765.1989.tb02005.x; Nonaka M, 2014, FEMS MICROBIOL LETT, V354, P60, DOI 10.1111/1574-6968.12426; Okamoto K, 1996, J BIOCHEM-TOKYO, V120, P398; OKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V316, P917, DOI 10.1006/abbi.1995.1123; Page RC, 1997, PERIODONTOL 2000, V14, P216, DOI 10.1111/j.1600-0757.1997.tb00199.x; Palm E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-155; Papapanou P N, 1999, J Int Acad Periodontol, V1, P110; Pavloff N, 1997, J BIOL CHEM, V272, P1595, DOI 10.1074/jbc.272.3.1595; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2011, J ORAL BIOSCI, V53, P187, DOI 10.2330/joralbiosci.53.187; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Scott JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073351; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x	54	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100574	10.1016/j.jbc.2021.100574	http://dx.doi.org/10.1016/j.jbc.2021.100574			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33757767	Green Published, gold			2022-12-26	WOS:000672866400547
J	Lindsay, A; Holm, J; Razzoli, M; Bartolomucci, A; Ervasti, JM; Lowe, DA				Lindsay, Angus; Holm, John; Razzoli, Maria; Bartolomucci, Alessandro; Ervasti, James M.; Lowe, Dawn A.			Some dystrophy phenotypes of dystrophin-deficient mdx mice are exacerbated by mild, repetitive daily stress	FASEB JOURNAL			English	Article						Duchenne muscular dystrophy; Dystrophin; fibrosis; hypothalamic&#8208; pituitary&#8208; adrenal axis; skeletal muscle		Psychosocial stressors can cause physical inactivity, cardiac damage, and hypotension-induced death in the mdx mouse model of Duchenne muscular dystrophy (DMD). Because repeated exposure to mild stress can lead to habituation in wild-type mice, we investigated the response of mdx mice to a mild, daily stress to determine whether habituation occurred. Male mdx mice were exposed to a 30-sec scruff restraint daily for 12 weeks. Scruff restraint induced immediate physical inactivity that persisted for at least 60 minutes, and this inactivity response was just as robust after 12 weeks as it was after one day. Physical inactivity in the mdx mice was not associated with acute skeletal muscle contractile dysfunction. However, skeletal muscle of mdx mice that were repeatedly stressed had slow-twitch and tetanic relaxation times and trended toward high passive stiffness, possibly due to a small but significant increase in muscle fibrosis. Elevated urinary corticosterone secretion, adrenal hypertrophy, and a larger adrenal cortex indicating chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis were measured in 12-week stressed mdx mice relative to those unstressed. However, pharmacological inhibition of the HPA axis did not affect scruff-induced physical inactivity and acute corticosterone injection did not recapitulate the scruff-induced phenotype, suggesting the HPA axis is not the driver of physical inactivity. Our results indicate that the response of mdx mice to an acute mild stress is non-habituating and that when that stressor is repeated daily for weeks, it is sufficient to exacerbate some phenotypes associated with dystrophinopathy in mdx mice.	[Lindsay, Angus; Lowe, Dawn A.] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Lindsay, Angus; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Lindsay, Angus] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Holm, John] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN USA; [Razzoli, Maria; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Deakin University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lowe, DA (corresponding author), Univ Minnesota, Dept Rehabil Med, Div Rehabil Sci & Phys Therapy, Minneapolis, MN 55455 USA.	lowex017@umn.edu		Lowe, Dawn/0000-0002-5784-9289; Lindsay, Angus/0000-0002-5195-1901	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH) [R01 AR042423, R01 AR049899]; Muscular Dystrophy Association (MDA) [349549]; Summer's Wish Foundation; Greg Marzolf Jr. Foundation	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Summer's Wish Foundation; Greg Marzolf Jr. Foundation	UM | Lillehei Heart Institute, University of Minnesota (LHI, UM); HHS | National Institutes of Health (NIH), Grant/Award Number: R01 AR042423 and R01 AR049899; Muscular Dystrophy Association (MDA), Grant/Award Number: 349549; Summer's Wish Foundation; Greg Marzolf Jr. Foundation, Grant/Award Number: Research Grant	Aupy P, 2020, MOL THER-METH CLIN D, V17, P1037, DOI 10.1016/j.omtm.2020.04.025; Belanto JJ, 2016, HUM MOL GENET, V25, P4951, DOI 10.1093/hmg/ddw318; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bonnefont-Rousselot D, 2002, REDOX REP, V7, P145, DOI 10.1179/135100002125000389; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Johansen IB, 2011, J EXP BIOL, V214, P1313, DOI 10.1242/jeb.053058; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lindsay A, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-0221-2; Lindsay A, 2019, FEBS J, V286, P2562, DOI 10.1111/febs.14831; Lindsay A, 2014, PTERIDINES, V25, P53, DOI 10.1515/pteridines-2014-0003; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Moran AL, 2005, EXP GERONTOL, V40, P966, DOI 10.1016/j.exger.2005.09.005; Nelson DM, 2018, HUM MOL GENET, V27, P2090, DOI 10.1093/hmg/ddy113; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; Rorabaugh BR, 2020, STRESS, V23, P125, DOI 10.1080/10253890.2019.1641081; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Smith ELP, 2002, BRAIN BEHAV IMMUN, V16, P140, DOI 10.1006/brbi.2001.0629; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Strakova J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31753-3; Swiderski K, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-1; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Vaillend C, 2017, HUM MOL GENET, V26, P1041, DOI 10.1093/hmg/ddx013; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamamoto K, 2010, NEUROMUSCULAR DISORD, V20, P505, DOI 10.1016/j.nmd.2010.05.006	36	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21489	10.1096/fj.202002500R	http://dx.doi.org/10.1096/fj.202002500R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33734502				2022-12-26	WOS:000635216100020
J	Gili, T; Benelli, G; Buscarini, E; Canetta, C; La Piana, G; Merli, G; Scartabellati, A; Vigano, G; Sfogliarini, R; Melilli, G; Assandri, R; Cazzato, D; Rossi, DS; Usai, S; Caldarelli, G; Tramacere, I; Pellegata, G; Lauria, G				Gili, Tommaso; Benelli, Giampaolo; Buscarini, Elisabetta; Canetta, Ciro; La Piana, Giuseppe; Merli, Guido; Scartabellati, Alessandro; Vigano, Giovanni; Sfogliarini, Roberto; Melilli, Giovanni; Assandri, Roberto; Cazzato, Daniele; Rossi, Davide Sebastiano; Usai, Susanna; Caldarelli, Guido; Tramacere, Irene; Pellegata, Germano; Lauria, Giuseppe			SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy	PLOS ONE			English	Article								We report onset, course, correlations with comorbidities, and diagnostic accuracy of nasopharyngeal swab in 539 individuals suspected to carry SARS-COV-2 admitted to the hospital of Crema, Italy. All individuals underwent clinical and laboratory exams, SARS-COV-2 reverse transcriptase-polymerase chain reaction on nasopharyngeal swab, and chest X-ray and/or computed tomography (CT). Data on onset, course, comorbidities, number of drugs including angiotensin converting enzyme (ACE) inhibitors and angiotensin-II-receptor antagonists (sartans), follow-up swab, pharmacological treatments, non-invasive respiratory support, ICU admission, and deaths were recorded. Among 411 SARS-COV-2 patients (67.7% males) median age was 70.8 years (range 5-99). Chest CT was performed in 317 (77.2%) and showed interstitial pneumonia in 304 (96%). Fatality rate was 17.5% (74% males), with 6.6% in 60-69 years old, 21.1% in 70-79 years old, 38.8% in 80-89 years old, and 83.3% above 90 years. No death occurred below 60 years. Non-invasive respiratory support rate was 27.2% and ICU admission 6.8%. Charlson comorbidity index and high C-reactive protein at admission were significantly associated with death. Use of ACE inhibitors or sartans was not associated with outcomes. Among 128 swab negative patients at admission (63.3% males) median age was 67.7 years (range 1-98). Chest CT was performed in 87 (68%) and showed interstitial pneumonia in 76 (87.3%). Follow-up swab turned positive in 13 of 32 patients. Using chest CT at admission as gold standard on the entire study population of 539 patients, nasopharyngeal swab had 80% accuracy. Comorbidity network analysis revealed a more homogenous distribution 60-40 aged SARS-COV-2 patients across diseases and a crucial different interplay of diseases in the networks of deceased and survived patients. SARS-CoV-2 caused high mortality among patients older than 60 years and correlated with pre-existing multiorgan impairment.	[Gili, Tommaso] IMT Sch Adv Studies, Lucca, Italy; [Benelli, Giampaolo] Osped Maggiore Crema, Radiol Unit, Crema, Italy; [Buscarini, Elisabetta] Osped Maggiore Crema, Gastroenterol Unit, Crema, Italy; [Canetta, Ciro] Fdn IRCCS Ca Granda Osped Maggiore Policlin, High Care Med Unit, Milan, Italy; [Canetta, Ciro] Osped Maggiore Crema, Emergency Med Unit, Crema, Italy; [La Piana, Giuseppe] Osped Maggiore Crema, Pneumol Unit 2, Crema, Italy; [Merli, Guido] Osped Maggiore Crema, Intens Care Unit, Crema, Italy; [Scartabellati, Alessandro] Osped Maggiore Crema, Pneumol Unit 1, Crema, Italy; [Vigano, Giovanni] Osped Maggiore Crema, Emergency Unit, Crema, Italy; [Sfogliarini, Roberto; Melilli, Giovanni] Osped Maggiore Crema, Hlth Directorate, Crema, Italy; [Assandri, Roberto] Osped Maggiore Crema, Clin Invest Lab, Crema, Italy; [Cazzato, Daniele; Rossi, Davide Sebastiano] Osped Maggiore Crema, Dept Diagnost & Technol, Crema, Italy; [Usai, Susanna; Lauria, Giuseppe] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Milan, Italy; [Caldarelli, Guido] DSMN Ca Foscari Univ, Venice, Italy; [Caldarelli, Guido] ECLT, Venice, Italy; [Caldarelli, Guido] ISC CNR Uos Sapienza, Rome, Italy; [Tramacere, Irene] Osped Maggiore Crema, Sci Directorate, Crema, Italy; [Pellegata, Germano] Osped Maggiore Crema, Gen Directorate, Crema, Italy; [Lauria, Giuseppe] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy	IMT School for Advanced Studies Lucca; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); University of Milan; Luigi Sacco Hospital	Caldarelli, G (corresponding author), DSMN Ca Foscari Univ, Venice, Italy.; Caldarelli, G (corresponding author), ECLT, Venice, Italy.; Caldarelli, G (corresponding author), ISC CNR Uos Sapienza, Rome, Italy.	Guido.Caldarelli@unive.it	Cazzato, Daniele/AAA-1509-2019; Rossi Sebastiano, Davide/G-8541-2016; Caldarelli, Guido/AAB-8206-2022; Assandri, Roberto/CAJ-5649-2022; Usai, Susanna/AAR-3185-2021; lauria, giuseppe/AAN-5371-2020	Cazzato, Daniele/0000-0002-7580-1422; Rossi Sebastiano, Davide/0000-0003-3698-8615; Usai, Susanna/0000-0002-0606-0691; lauria, giuseppe/0000-0001-9773-020X	IMT project PAI (Progetto di Attivita Integrata) 2018 "Chain the Brain: The Endophenotype of Serotonin Dysfunction in Violent Offenders and Psychopaths; Horizon 2020 Framework Programme [952026 Humane-AI-Net]	IMT project PAI (Progetto di Attivita Integrata) 2018 "Chain the Brain: The Endophenotype of Serotonin Dysfunction in Violent Offenders and Psychopaths; Horizon 2020 Framework Programme	The Horizon 2020 Framework Programme, 952026 Humane-AI-Net, provided funding to GC. TG has been funded by the IMT project PAI (Progetto di Attivita Integrata) 2018 "Chain the Brain: The Endophenotype of Serotonin Dysfunction in Violent Offenders and Psychopaths.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Asratian AS., 1998, BIPARTITE GRAPHS THE, DOI [10.1017/cbo9780511984068, DOI 10.1017/CBO9780511984068, 10.1017/CBO9780511984068]; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Caldarelli G., 2007, SCALE FREE NETWORKS, DOI [DOI 10.1093/ACPROF:OSO/9780199211517.001.0001, 10.1093/acprof:oso/9780199211517.001.0001]; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung F, 2003, P NATL ACAD SCI USA, V100, P6313, DOI 10.1073/pnas.0937490100; COVID-19 RISK and Treatments (CORIST) Collaboration, 2020, Eur J Intern Med, V82, P38, DOI 10.1016/j.ejim.2020.08.019; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Di Castelnuovo A, 2020, VASC PHARMACOL, V135, DOI 10.1016/j.vph.2020.106805; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Flacco ME, 2020, HEART, V106, P1519, DOI 10.1136/heartjnl-2020-317336; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jamal AJ., 2020, CLIN INFECT DIS, DOI [10.1017/ice.2020.1326, DOI 10.1017/ICE.2020.1326]; Krause M, 2021, J INTENSIVE CARE MED, V36, P271, DOI 10.1177/0885066620954806; Lang S, 2002, ALGEBRA, VThird; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Matsumoto H, 2019, HEART VESSELS, V34, P1961, DOI 10.1007/s00380-019-01435-9; McDonald J.H., 2014, HDB BIOL STAT; Sharifpour M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242400; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang TB, 2020, LANCET, V395, pE52, DOI 10.1016/S0140-6736(20)30558-4; Warusevitane A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150269; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yu Y., 2020, LANCET RESP MED, V8, P481; Zhang TQ, 2020, J MED VIROL, V92, P909, DOI 10.1002/jmv.25795; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	36	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0248498	10.1371/journal.pone.0248498	http://dx.doi.org/10.1371/journal.pone.0248498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765013	Green Published, Green Submitted, gold			2022-12-26	WOS:000634832800035
J	Mehryan, SAM; Raahemifar, K; Ramezani, SR; Hajjar, A; Younis, O; Sardari, PT; Ghalambaz, M				Mehryan, S. A. M.; Raahemifar, Kaamran; Ramezani, Sayed Reza; Hajjar, Ahmad; Younis, Obai; Sardari, Pouyan Talebizadeh; Ghalambaz, Mohammad			Melting phase change heat transfer in a quasi-petal tube thermal energy storage unit	PLOS ONE			English	Article							NATURAL-CONVECTION; SQUARE ENCLOSURE; TRIPLEX TUBE; PCM; NANOPARTICLES; SOLIDIFICATION; ENHANCEMENT; PERFORMANCE; SIMULATION; PARAMETERS	In the present study, the thermal energy storage of a hot petal tube inside a shell-tube type Thermal Energy Storage (TES) unit was addressed. The shell is filled with the capric acid Phase Change Material (PCM) and absorbs the heat from a hot U-tube petal. The governing equations for the natural convection flow of molten PCM and phase change heat transfer were introduced by using the enthalpy-porosity approach. An automatic adaptive mesh scheme was used to track the melting interface. The accuracy and convergence of numerical computations were also controlled by a free step Backward Differentiation Formula. The modeling results were compared with previous experimental data. It was found that the present adaptive mesh approach can adequately the melting heat transfer, and an excellent agreement was found with available literature. The effect of geometrical designs of the petal tube was investigated on the melting response of the thermal energy storage unit. The phase change behavior was analyzed by using temperature distribution contours. The results showed that petal tubes could notably increase the melting rate in the TES unit compared to a typical circular tube. Besides, the more the petal numbers, the better the heat transfer. Using a petal tube could increase the charging power by 44% compared to a circular tube. The placement angle of the tubes is another important design factor which should be selected carefully. For instance, vertical placement of tubes could improve the charging power by 300% compared to a case with the tubes' horizontal placement.	[Mehryan, S. A. M.] Islamic Azad Univ, Yasooj Branch, Young Researchers & Elite Club, Yasuj, Iran; [Raahemifar, Kaamran] Penn State Univ, Coll Informat Sci & Technol IST, Data Sci & Artificial Intelligence Program, State Coll, PA USA; [Raahemifar, Kaamran] Univ Waterloo, Dept Chem Engn, Fac Engn, Sch Optometry & Vis Sci,Fac Sci, Waterloo, ON, Canada; [Raahemifar, Kaamran] Sultan Qaboos Univ, Elect & Comp Engn Dept, Muscat, Oman; [Ramezani, Sayed Reza] KN Toosi Univ Technol, Dept Mech Engn, Tehran, Iran; [Hajjar, Ahmad] Univ Lyon, LabECAM, ECAM Lyon, Lyon, France; [Younis, Obai] Prince Sattam Bin Abdulaziz Univ, Coll Engn Wadi Addwaser, Dept Mech Engn, Al Kharj, Saudi Arabia; [Younis, Obai] Univ Khartoum, Fac Engn, Dept Mech Engn, Khartoum, Sudan; [Sardari, Pouyan Talebizadeh] Univ Nottingham, Fac Engn, Univ Pk, Nottingham, England; [Ghalambaz, Mohammad] Ton Duc Thang Univ, Metamat Mech Biomech & Multiphys Applicat Res Grp, Ho Chi Minh City, Vietnam; [Ghalambaz, Mohammad] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam	Islamic Azad University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Waterloo; Sultan Qaboos University; K. N. Toosi University of Technology; Prince Sattam Bin Abdulaziz University; University of Khartoum; University of Nottingham; Ton Duc Thang University; Ton Duc Thang University	Ghalambaz, M (corresponding author), Ton Duc Thang Univ, Metamat Mech Biomech & Multiphys Applicat Res Grp, Ho Chi Minh City, Vietnam.; Ghalambaz, M (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.	mohammad.ghalambaz@tdtu.edu.vn	Sardari, Pouyan Talebizadeh/G-1053-2019; Ghalambaz, Mohammad/G-6006-2011; Younis Taha, Obai/AAB-9449-2022; Ramezani, Sayed reza/AAV-4226-2021; younis, obai/HHZ-8864-2022; Hajjar, Ahmad/AGE-9312-2022; Hajjar, Ahmad/ABF-6702-2020	Sardari, Pouyan Talebizadeh/0000-0001-5947-8701; Ghalambaz, Mohammad/0000-0003-0965-2358; Younis Taha, Obai/0000-0002-1701-9387; younis, obai/0000-0002-1701-9387; Hajjar, Ahmad/0000-0003-4258-9442				Al Siyabi I, 2019, J ENERGY STORAGE, V23, P57, DOI 10.1016/j.est.2019.03.010; Al-Abidi AA, 2013, INT J HEAT MASS TRAN, V61, P684, DOI 10.1016/j.ijheatmasstransfer.2013.02.030; Arshad A, 2020, THERM SCI ENG PROG, V18, DOI 10.1016/j.tsep.2020.100520; Bertrand O, 1999, INT J THERM SCI, V38, P5, DOI 10.1016/S0035-3159(99)80013-0; Bhowmick D, 2020, J THERM ANAL CALORIM, V141, P839, DOI 10.1007/s10973-019-09054-2; Cho HW, 2019, INT J HEAT MASS TRAN, V135, P962, DOI 10.1016/j.ijheatmasstransfer.2019.02.048; De Los Reyes JC., 2012, NUMER METH PART D E, V28, P834; Dogonchi AS, 2019, J THERM ANAL CALORIM, V135, P3485, DOI 10.1007/s10973-018-7520-4; Dutta S, 2019, INT J NUMER METHOD H, V29, P4826, DOI 10.1108/HFF-11-2018-0678; Ebadi S, 2020, APPL THERM ENG, V174, DOI 10.1016/j.applthermaleng.2020.115266; Esen M, 1998, SOL ENERGY, V62, P19, DOI 10.1016/S0038-092X(97)00104-7; Fang M, 2007, APPL THERM ENG, V27, P994, DOI 10.1016/j.applthermaleng.2006.08.001; Farsani RY, 2020, THERM SCI ENG PROG, V16, DOI 10.1016/j.tsep.2019.100453; Gao ZS, 2019, APPL THERM ENG, V155, P428, DOI 10.1016/j.applthermaleng.2019.03.160; Gortych M, 2019, APPL THERM ENG, V161, DOI 10.1016/j.applthermaleng.2019.114140; Guo CX, 2008, ENERG CONVERS MANAGE, V49, P919, DOI 10.1016/j.enconman.2007.10.025; Haddad Z, 2021, J MOL LIQ, V332, DOI [10.1016/j.molliq.2019.112132, DOI 10.1016/J.MOLLIQ.2019.112132]; Hosseini MJ, 2015, ENERG BUILDINGS, V99, P263, DOI 10.1016/j.enbuild.2015.04.045; Hosseini MJ, 2014, INT COMMUN HEAT MASS, V50, P128, DOI 10.1016/j.icheatmasstransfer.2013.11.008; Hussanan A, 2017, J MOL LIQ, V229, P482, DOI 10.1016/j.molliq.2016.12.040; Ishak MS, 2020, INT J NUMER METHOD H, V30, P1518, DOI 10.1108/HFF-06-2019-0505; Jaworski M, 2012, APPL THERM ENG, V35, P212, DOI 10.1016/j.applthermaleng.2011.10.036; Jebasingh BE, 2020, MATER TODAY ENERGY, V16, DOI 10.1016/j.mtener.2020.100408; Jebasingh BE., 2018, FRONTIERS MAT PROCES, P75; Jebasingh BE, 2020, J ENERGY STORAGE, V31, DOI 10.1016/j.est.2020.101708; Jebasingh BE, 2020, ENERGY STORAGE MATER, V24, P52, DOI 10.1016/j.ensm.2019.07.031; Kandasamy R, 2008, APPL THERM ENG, V28, P1047, DOI 10.1016/j.applthermaleng.2007.06.010; Kant K, 2017, SOL ENERGY, V146, P453, DOI 10.1016/j.solener.2017.03.013; KUEHN TH, 1976, J FLUID MECH, V74, P695, DOI 10.1017/S0022112076002012; Kumar L, 2012, INT J THERM SCI, V61, P15, DOI 10.1016/j.ijthermalsci.2012.06.014; Li YQ, 2013, RENEW ENERG, V59, P92, DOI 10.1016/j.renene.2013.03.022; Li ZX, 2019, PHYSICA A, V524, P540, DOI 10.1016/j.physa.2019.03.129; Mahmoodi M, 2012, SUPERLATTICE MICROST, V52, P261, DOI 10.1016/j.spmi.2012.05.007; Mat S, 2013, ENERG CONVERS MANAGE, V74, P223, DOI 10.1016/j.enconman.2013.05.003; Mettawee EBS, 2007, SOL ENERGY, V81, P839, DOI 10.1016/j.solener.2006.11.009; Moraveji MK, 2013, INT COMMUN HEAT MASS, V44, P135, DOI 10.1016/j.icheatmasstransfer.2013.03.011; Mostafavi A, 2020, INT J THERM SCI, V153, DOI 10.1016/j.ijthermalsci.2020.106352; Mousavi S, 2019, NUMER HEAT TR A-APPL, V75, P560, DOI 10.1080/10407782.2019.1606634; Nabavizadeh SA, 2012, INT J THERM SCI, V51, P112, DOI 10.1016/j.ijthermalsci.2011.08.021; Nada SA, 2019, INT J THERM SCI, V137, P121, DOI 10.1016/j.ijthermalsci.2018.11.026; Pakrouh R, 2015, ENERG CONVERS MANAGE, V103, P542, DOI 10.1016/j.enconman.2015.07.003; Pourakabar A, 2019, APPL THERM ENG, V150, P132, DOI 10.1016/j.applthermaleng.2019.01.009; Rahimi M, 2014, J ENG-NY, V2014, DOI 10.1155/2014/641954; Reddy J.N., 2010, FINITE ELEMENT METHO; Roslan R, 2014, INT J HEAT MASS TRAN, V70, P119, DOI 10.1016/j.ijheatmasstransfer.2013.10.011; Schenk O, 2004, FUTURE GENER COMP SY, V20, P475, DOI 10.1016/j.future.2003.07.011; Sheikholeslami M, 2019, PHYSICA A, V523, P544, DOI 10.1016/j.physa.2019.02.020; Sun H, 2011, APPL THERM ENG, V31, P1252, DOI 10.1016/j.applthermaleng.2010.12.028; Tauseef-ur-Rehman, 2018, INT COMMUN HEAT MASS, V98, P155, DOI 10.1016/j.icheatmasstransfer.2018.08.003; Tian LL, 2020, APPL THERM ENG, V167, DOI 10.1016/j.applthermaleng.2019.114764; Verbosio F, 2017, J COMPUT SCI-NETH, V22, P99, DOI 10.1016/j.jocs.2017.08.013; Wang L, 2019, APPL MATH MODEL, V71, P31, DOI 10.1016/j.apm.2019.02.012; Weng YC, 2011, APPL ENERG, V88, P1825, DOI 10.1016/j.apenergy.2010.12.004; Wriggers P., 2008, NONLINEAR FINITE ELE; Zayed ME., 2020, J ENERGY STORAGE, V30, P101341; Zienkiewicz OC., 2015, FINITE ELEMENT METHO	56	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0246972	10.1371/journal.pone.0246972	http://dx.doi.org/10.1371/journal.pone.0246972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760813	Green Published, gold			2022-12-26	WOS:000633030400015
J	Yang, L; Shou, YH; Yang, YS; Xu, JH				Yang, Lu; Shou, Yan-Hong; Yang, Yong-Sheng; Xu, Jin-Hua			Elucidating the immune infiltration in acne and its comparison with rosacea by integrated bioinformatics analysis	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; CELL SUBSETS; T-CELL; PATHOGENESIS; EXPRESSION; MIGRATION; RESPONSES; AXIS; TH17	Background Acne vulgaris and rosacea are common inflammatory complications of the skin, both characterized by abnormal infiltration of immune cells. The two diseases can be differentiated based on characteristic profile of the immune cell infiltrates at the periphery of disease lesions. In addition, dysregulated infiltration of immune cells not only occur in the acne lesions but also in non-lesional areas of patients with the disease, thus characterizing the immune infiltration in these sites can further enhance our understanding on the pathogenesis of acne. Methods Five microarray data-sets (GSE108110, GSE53795, GSE65914, GSE14905 and GSE78097) were downloaded from Gene Expression Omnibus. After removing the batch effects and normalizing the data, we applied the CIBERSORT algorithm combined with signature matrix LM22, to describe 22 types of immune cells' infiltration in acne less than 48 hour (H) old, in comparation with non-lesional skin of acne patients, healthy skin and rosacea (including erythematotelangiectatic rosacea, papulopustular rosacea and phymatous rosacea) and we compared gene expression of Th1 and Th17-related molecules in acne, rosacea and healthy control. Results Compared with the non-lesional skin of acne patients, healthy individuals and rosacea patients, there is a significant increase in infiltration of neutrophils, monocytes and activated mast cells around the acne lesions, less than 48 H after their development. Contrarily, few naive CD4+ T cells, plasma cells, memory B cells and resting mast cells infiltrate acne sites compared to the aforementioned groups of individuals. Moreover, the infiltration of Regulatory T cells (Tregs) in acne lesions is substantially lower, relative to non-lesional sites of acne patients and skin of healthy individuals. In addition, non-lesional sites of acne patients exhibit lower infiltration of activated memory CD4+ T cells, plasma cells, memory B cells, M0 macrophages, neutrophils, resting mast cells but higher infiltration of Tregs and resting dendritic cells relative to skin of healthy individuals. Intriguingly, we found that among the 3 rosacea subtypes, the immune infiltration profile of papulopustular rosacea is the closest to that of acne lesions. In addition, through gene expression analysis of acne, rosacea and skin tissues of healthy individuals, we found a higher infiltration of Th1 and Th17 cells in acne lesions, relative to non-lesional skin areas of acne patients. Conclusions Our study provides new insights into the inflammatory pathogenesis of acne, and the difference between acne and rosacea, which helps in differentiating the two diseases. Our findings also guide on appropriate target therapy of the immune cell infiltrates in the two disease conditions.	[Yang, Lu; Shou, Yan-Hong; Yang, Yong-Sheng; Xu, Jin-Hua] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China	Fudan University	Yang, YS; Xu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China.	yangyongsheng73512@126.com; jinhuaxu@fudan.edu.cn	Lang, Ming/HIK-0758-2022					Babar O, 2019, CUREUS, V11, DOI 10.7759/cureus.5722; Barrimi M, 2021, ENCEPHALE, V47, P26, DOI 10.1016/j.encep.2020.03.006; Blakney AK, 2019, ACS NANO, V13, P5920, DOI 10.1021/acsnano.9b01774; Buddenkotte J., 2018, F1000 RES, P7, DOI 10.12688/f1000research.13350.2; Buhl T, 2015, J INVEST DERMATOL, V135, P2198, DOI 10.1038/jid.2015.141; Cai WS, 2020, PEERJ, V8, DOI 10.7717/peerj.8390; Cao YL, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0316-x; Carlavan I, 2018, BRIT J DERMATOL, V179, P906, DOI 10.1111/bjd.16680; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cong TX, 2019, ARCH DERMATOL RES, V311, P337, DOI 10.1007/s00403-019-01908-x; Couture P, 2009, EXP CELL RES, V315, P2192, DOI 10.1016/j.yexcr.2009.04.013; Deng YJ, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030171; Dursun R, 2019, DERMATOL THER, V32, DOI 10.1111/dth.13020; Fasching P, 2017, MOLECULES, V22, DOI 10.3390/molecules22010134; Garza ZCF, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-019-0567-7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goodarzi A, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13279; Jadidi-Niaragh F, 2012, IMMUNOPHARM IMMUNOT, V34, P727, DOI 10.3109/08923973.2011.619987; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; Kabashima K, 2019, NAT REV IMMUNOL, V19, P19, DOI 10.1038/s41577-018-0084-5; Kelhala HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105238; Kistowska M, 2015, J INVEST DERMATOL, V135, P110, DOI 10.1038/jid.2014.290; Kistowska M, 2014, J INVEST DERMATOL, V134, P677, DOI 10.1038/jid.2013.438; Marson JW, 2020, INT J DERMATOL, V59, pE175, DOI 10.1111/ijd.14757; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Parker HS, 2014, BIOINFORMATICS, V30, P2757, DOI 10.1093/bioinformatics/btu375; Pondeljak N, 2020, CLIN THER, V42, P757, DOI 10.1016/j.clinthera.2020.03.008; Rosamilia LL, 2016, SEMIN CUTAN MED SURG, V35, P87, DOI 10.12788/j.sder.2016.026; Sardana K, 2017, INDIAN J DERMATOL, V62, P392, DOI 10.4103/ijd.IJD_483_16; Sutaria A.H., 2021, STATPEARLS; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; Tan J, 2013, J AM ACAD DERMATOL, V69, pS27, DOI 10.1016/j.jaad.2013.04.043; Toyoda M, 2003, DERMATOLOGY, V206, P17, DOI 10.1159/000067818; Two AM, 2015, J AM ACAD DERMATOL, V72, P749, DOI 10.1016/j.jaad.2014.08.028; van Zuuren EJ, 2017, NEW ENGL J MED, V377, P1754, DOI 10.1056/NEJMcp1506630; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wilkin J, 2002, J AM ACAD DERMATOL, V46, P584, DOI 10.1067/mjd.2002.120625; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Wolkenstein P, 2018, J EUR ACAD DERMATOL, V32, P298, DOI 10.1111/jdv.14475; Zeng R, 2019, J INVEST DERMATOL, V139, P2488, DOI 10.1016/j.jid.2019.03.1161; Zhang JH, 2020, INT IMMUNOPHARMACOL, V81, DOI 10.1016/j.intimp.2020.106246	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248650	10.1371/journal.pone.0248650	http://dx.doi.org/10.1371/journal.pone.0248650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760854	Green Published, gold			2022-12-26	WOS:000633030400045
J	Conradie, TA; Jacobs, K				Conradie, Tersia Andrea; Jacobs, Karin			Distribution patterns of Acidobacteriota in different fynbos soils	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; DINGHUENSIS SP NOV.; 16S RIBOSOMAL-RNA; PLANT DIVERSITY; GEN. NOV.; RESPONSES; GRASSLAND; LINEAGES; DOMINATE; CARBON	The Acidobacteriota is ubiquitous and is considered as one of the major bacterial phyla in soils. The current taxonomic classifications of this phylum are divided into 15 class-level subdivisions (SDs), with only 5 of these SDs containing cultured and fully described species. Within the fynbos biome, the Acidobacteriota has been reported as one of the dominant bacterial phyla, with relative abundances ranging between 4-26%. However, none of these studies reported on the specific distribution and diversity of the Acidobacteriota within these soils. Therefore, in this study we aimed to first determine the relative abundance and diversity of the Acidobacteriota in three pristine fynbos nature reserve soils, and secondly, whether differences in the acidobacterial composition can be attributed to environmental factors, such as soil abiotic properties. A total of 27 soil samples were collected at three nature reserves, namely Jonkershoek, Hottentots Holland, and Kogelberg. The variable V4-V5 region of the 16S rRNA gene was sequenced using the Ion Torrent S5 platform. The mean relative abundance of the Acidobacteriota were 9.02% for Jonkershoek, 14.91% for Kogelberg, and most significantly (p<0.05), 18.42% for Hottentots Holland. A total of 33 acidobacterial operational taxonomic units (OTUs) were identified. The dominant subdivisions identified in all samples included SDs 1, 2, and 3. Significant differences were observed in the distribution and composition of these OTUs between nature reserves. The SD1 were negatively correlated to soil pH, hydrogen (H+), potassium (K+) and carbon (C). In contrast, SD2, was positively correlated to soil pH, phosphorus (P), and K+, and unclassified members of SD3 was positively correlated to H+, K, and C. This study is the first to report on the specific acidobacterial distribution in pristine fynbos soils in South Africa.	[Conradie, Tersia Andrea; Jacobs, Karin] Stellenbosch Univ, Dept Microbiol, Stellenbosch, Western Cape, South Africa	Stellenbosch University	Jacobs, K (corresponding author), Stellenbosch Univ, Dept Microbiol, Stellenbosch, Western Cape, South Africa.	kj@sun.ac.za		Jacobs, Karin/0000-0003-3972-5343; Conradie, Tersia/0000-0002-8330-2869	National Research Foundation of South Africa [112070]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation of South Africa (www.nrf.ac.za), grant number 112070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard RL, 2015, ISME J, V9, P946, DOI 10.1038/ismej.2014.192; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Belova SE, 2018, INT J SYST EVOL MICR, V68, P1265, DOI 10.1099/ijsem.0.002663; Brink CJ, 2020, PEDOSPHERE, V30, P778, DOI 10.1016/S1002-0160(20)60038-8; Catao Elisa C P, 2014, Int J Microbiol, V2014, P156341, DOI 10.1155/2014/156341; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; COWLING RM, 1990, J VEG SCI, V1, P699, DOI 10.2307/3235578; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Danilova OV, 2016, MICROBIOLOGY+, V85, P583, DOI 10.1134/S0026261716050039; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Dedysh SN., 2018, ELS; Dedysh SN, 2018, INT J SYST EVOL MICR, V68, P3796, DOI 10.1099/ijsem.0.003062; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; Docherty KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135352; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eichorst SA, 2018, ENVIRON MICROBIOL, V20, P1041, DOI 10.1111/1462-2920.14043; Elliott GN, 2007, ANN BOT-LONDON, V100, P1403, DOI 10.1093/aob/mcm227; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Foesel BU, 2014, ENVIRON MICROBIOL, V16, P658, DOI 10.1111/1462-2920.12162; Foesel BU, 2016, INT J SYST EVOL MICR, V66, P219, DOI 10.1099/ijsem.0.000700; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Ivanova AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230157; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jiang YW, 2016, INT J SYST EVOL MICR, V66, P76, DOI 10.1099/ijsem.0.000676; Johns M., 2001, KOGELBERG BIOSPHERE; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Keet JH, 2019, SOIL BIOL BIOCHEM, V136, DOI 10.1016/j.soilbio.2019.107541; Kielak AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00744; Koch IH, 2008, INT J SYST EVOL MICR, V58, P1114, DOI 10.1099/ijs.0.65303-0; Kulichevskaya IS, 2010, INT J SYST EVOL MICR, V60, P301, DOI 10.1099/ijs.0.013250-0; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Ludwig W, 1997, FEMS MICROBIOL LETT, V153, P181, DOI 10.1016/S0378-1097(97)00256-5; Mannisto MK, 2013, FEMS MICROBIOL ECOL, V84, P47, DOI 10.1111/1574-6941.12035; Mikha MM, 2005, SOIL BIOL BIOCHEM, V37, P339, DOI 10.1016/j.soilbio.2004.08.003; Moroenyane I, 2016, MICROB ECOL, V72, P313, DOI 10.1007/s00248-016-0761-5; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Naether A, 2012, APPL ENVIRON MICROB, V78, P7398, DOI 10.1128/AEM.01325-12; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Niu JJ, 2017, J BASIC MICROB, V57, P3, DOI 10.1002/jobm.201600222; O'Connor-Sanchez A, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-67; Okamura K, 2011, FEMS MICROBIOL LETT, V317, P138, DOI 10.1111/j.1574-6968.2011.02224.x; Postma A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw016; Rebelo A. G., 2006, VEGETATION S AFRICA, P53, DOI DOI 10.1007/S; Richards MB, 1997, PLANT ECOL, V130, P143, DOI 10.1023/A:1009742225383; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Slabbert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086560; Slabbert E, 2010, MOL ECOL, V19, P1031, DOI 10.1111/j.1365-294X.2009.04517.x; Sui X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55063-4; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANGESTEL M, 1992, SOIL BIOL BIOCHEM, V24, P103, DOI 10.1016/0038-0717(92)90265-Y; Wang J, 2016, INT J SYST EVOL MICR, V66, P276, DOI 10.1099/ijsem.0.000710; Wegner CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01023; Xia F, 2018, INT J SYST EVOL MICR, V68, P2530, DOI 10.1099/ijsem.0.002871; Xia F, 2017, INT J SYST EVOL MICR, V67, P4260, DOI 10.1099/ijsem.0.002300; Youssef NH, 2009, ISME J, V3, P305, DOI 10.1038/ismej.2008.106	63	5	5	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248913	10.1371/journal.pone.0248913	http://dx.doi.org/10.1371/journal.pone.0248913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750980	Green Published, gold			2022-12-26	WOS:000631967100001
J	Astolfi, ACMN; Astolfi, G; Ferreira, MGA; Centuriao, TD; Clemente, LZ; de Oliveira, BLMC; Porto, JVD; Roche, KF; Matsubara, ET; Pistori, H; Soares, MP; da Silva, WM				Astolfi, Angelica Christina Melo Nunes; Astolfi, Gilberto; Ferreira, Maria Gabriela Alves; Centuriao, Thaynara D'avalo; Clemente, Leyzinara Zenteno; de Oliveira, Bruno Leonardo Marques Castro; Porto, Joao Vitor de Andrade; Roche, Kennedy Francis; Matsubara, Edson Takashi; Pistori, Hemerson; Soares, Mayara Pereira; da Silva, William Marcos			Recognizing and counting Dendrocephalus brasiliensis (Crustacea: Anostraca) cysts using deep learning	PLOS ONE			English	Article							NEURAL-NETWORKS; FISH DETECTION	The Dendrocephalus brasiliensis, a native species from South America, is a freshwater crustacean well explored in conservational and productive activities. Its main characteristics are its rusticity and resistance cysts production, in which the hatching requires a period of dehydration. Independent of the species utilization nature, it is essential to manipulate its cysts, such as the counting using microscopes. Manually counting is a difficult task, prone to errors, and that also very time-consuming. In this paper, we propose an automatized approach for the detection and counting of Dendrocephalus brasiliensis cysts from images captured by a digital microscope. For this purpose, we built the DBrasiliensis dataset, a repository with 246 images containing 5141 cysts of Dendrocephalus brasiliensis. Then, we trained two state-of-the-art object detection methods, YOLOv3 (You Only Look Once) and Faster R-CNN (Region-based Convolutional Neural Networks), on DBrasiliensis dataset in order to compare them under both cyst detection and counting tasks. Experiments showed evidence that YOLOv3 is superior to Faster R-CNN, achieving an accuracy rate of 83,74%, R-2 of 0.88, RMSE (Root Mean Square Error) of 3.49, and MAE (Mean Absolute Error) of 2.24 on cyst detection and counting. Moreover, we showed that is possible to infer the number of cysts of a substrate, with known weight, by performing the automated counting of some of its samples. In conclusion, the proposed approach using YOLOv3 is adequate to detect and count Dendrocephalus brasiliensis cysts. The DBrasiliensis dataset can be accessed at: .	[Astolfi, Angelica Christina Melo Nunes; Ferreira, Maria Gabriela Alves; Centuriao, Thaynara D'avalo; Clemente, Leyzinara Zenteno; de Oliveira, Bruno Leonardo Marques Castro; Roche, Kennedy Francis; Soares, Mayara Pereira; da Silva, William Marcos] Univ Fed Mato Grosso do Sul, Fac Engn Architecture & Urbanism & Geog, Campo Grande, MS, Brazil; [Astolfi, Gilberto; Matsubara, Edson Takashi; Pistori, Hemerson] Univ Fed Mato Grosso do Sul, Coll Comp, Campo Grande, MS, Brazil; [Astolfi, Gilberto] Fed Inst Educ Sci & Technol Mato Grosso Sul, Campo Grande, MS, Brazil; [Porto, Joao Vitor de Andrade; Pistori, Hemerson] Univ Catolica Dom Bosco, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Catolica Dom Bosco (UCDB)	Astolfi, ACMN (corresponding author), Univ Fed Mato Grosso do Sul, Fac Engn Architecture & Urbanism & Geog, Campo Grande, MS, Brazil.	angelchrismelo@gmail.com	Centurião, Thaynara Davalo/AAV-5343-2020	Centurião, Thaynara Davalo/0000-0001-6145-1567; Astolfi, Angelica Christina Melo Nunes/0000-0003-1849-7214; Matsubara, Edson/0000-0002-4471-0886	Universidade Catolica Dom Bosco (UCDB); Foundation for Support to the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT); Brazilian National Council for Scientific and Technological Development (CNPQ); Coordination for the Improvement of Higher Education Personnel (Capes) [88882.458510/2019-01, EDITAL070/2018-PROPI/IFMS]; FUNDECT [23/200.248/2014]	Universidade Catolica Dom Bosco (UCDB); Foundation for Support to the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Brazilian National Council for Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	This work has received financial support from the Universidade Catolica Dom Bosco (UCDB), Foundation for Support to the Development of Education, Science and Technology of the State of Mato Grosso do Sul (FUNDECT), and from the Brazilian National Council for Scientific and Technological Development (CNPQ). ACMNA and GA received scholarships from the Coordination for the Improvement of Higher Education Personnel (Capes), grant numbers 88882.458510/2019-01 and EDITAL070/2018-PROPI/IFMS, respectively. HP received financial support from the FUNDECT (Number: 23/200.248/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Goncalves JL., 2001, ALGAE REMOVAL VIA FE; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jalal A, 2020, ECOL INFORM, V57, DOI 10.1016/j.ecoinf.2020.101088; Jiao LC, 2019, IEEE ACCESS, V7, P128837, DOI 10.1109/ACCESS.2019.2939201; Kingma DP., 2014, ADAM METHOD STOCHAST; Li R, 2019, BIOSYST ENG, V187, P39, DOI 10.1016/j.biosystemseng.2019.08.013; Lin M, 2014, 2014 INTERNATIONAL CONFERENCE ON MEDICAL BIOMETRICS (ICMB 2014), P1, DOI 10.1109/ICMB.2014.8; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lopes JP., 1998, PANORAMA AQUICULTURA, V8, P31; Lopes JP., 2007, BIOTEMAS, V20, P33; Luschi C, ABS180407612 CORR; MacIsaac HJ, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P51; Milardi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54210-1; Mohamed HE, 2020, PROCEDIA COMPUT SCI, V170, P539, DOI 10.1016/j.procs.2020.03.123; Neupane B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223906; Quan LZ, 2019, BIOSYST ENG, V184, P1, DOI 10.1016/j.biosystemseng.2019.05.002; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Richardson DM, 2011, DIVERS DISTRIB, V17, P771, DOI 10.1111/j.1472-4642.2011.00824.x; Santos LLS, 2019, AQUACULTURE, V512, DOI 10.1016/j.aquaculture.2019.734350; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vasconez JP, 2020, COMPUT ELECTRON AGR, V173, DOI 10.1016/j.compag.2020.105348; Santos VSV, 2018, ECOTOXICOLOGY, V27, P635, DOI 10.1007/s10646-018-1951-3; Wang QJ, 2020, COMPUT ELECTRON AGR, V175, DOI 10.1016/j.compag.2020.105585; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	31	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248574	10.1371/journal.pone.0248574	http://dx.doi.org/10.1371/journal.pone.0248574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735277	gold, Green Published			2022-12-26	WOS:000631029700104
J	Bae, YJ; Kim, TE; Choi, BS; Jeong, WJ; Cho, SJ; Baik, SH; Sunwoo, L; Kim, JH				Bae, Yun Jung; Kim, Tae Eun; Choi, Byung Se; Jeong, Woo-Jin; Cho, Se Jin; Baik, Sung Hyun; Sunwoo, Leonard; Kim, Jae Hyoung			Comprehensive assessments of the open mouth dynamic maneuver and metal artifact reduction algorithm on computed tomography images of the oral cavity and oropharynx	PLOS ONE			English	Article							8TH EDITION; CT; HEAD	Objectives To determine the optimal utility of the open mouth maneuver and Metal Artifact Reduction for the Orthopedic Implants (O-MAR) technique for CT of the oral cavity and oropharynx. Methods Between July 2017 and May 2019, 59 subjects who underwent both conventional and open mouth head and neck CT scans were included in this retrospective study. All images were reconstructed using the O-MAR algorithm. With conventional CT with/without the O-MAR (CTc_O/CTc) and open mouth CT with/without O-MAR (CTo_O/CTo), one reader measured the noise level in multiple anatomic regions of the oral cavity and oropharynx. Visual scores for the streak artifact and overall subjective image quality were assessed by two independent readers. Results For the mobile tongue, retromolar trigone, and palatine tonsil, the mean noise was significantly lower, and the mean visual scores were significantly higher, with CTo than with CTc or CTc_O (all, P < 0.001). The mean visual scores were higher with CTo_O than with CTo for the mobile tongue and palatine tonsil (all, P < 0.001). Contrarily, for the mouth floor and tongue base, the mean noise was significantly higher with CTo_O than with CTc or CTc_O, and the mean visual scores were significantly higher with CTc than with CTo or CTo_O (all, P < 0.001). Conclusions The open mouth maneuver and O-MAR technique can have different influences on the CT image quality according to the anatomical subsites of the oral cavity and oropharynx.	[Bae, Yun Jung; Kim, Tae Eun; Choi, Byung Se; Cho, Se Jin; Baik, Sung Hyun; Sunwoo, Leonard; Kim, Jae Hyoung] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea; [Jeong, Woo-Jin] Seoul Natl Univ, Dept Otolaryngol Head & Neck Surg, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, BS (corresponding author), Seoul Natl Univ, Dept Radiol, Bundang Hosp, Seongnam, South Korea.	byungse.choi@gmail.com	; Choi, Byung Se/J-9022-2018	Sunwoo, Leonard/0000-0003-0374-8658; Choi, Byung Se/0000-0001-6310-1798; JEONG, Woo-Jin/0000-0001-8577-6964	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1F1A1063771, 09-2019-003]; SNUBH Research Fund	National Research Foundation of Korea (NRF) - Korea government (MSIT); SNUBH Research Fund	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1F1A1063771) and grant No. 09-2019-003 from the SNUBH Research Fund, all of which were received by YJB.	Aulino Joseph M, 2006, Oral Maxillofac Surg Clin North Am, V18, P445, DOI 10.1016/j.coms.2006.06.011; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Bron G, 2019, ORAL ONCOL, V94, P41, DOI 10.1016/j.oraloncology.2019.04.023; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Doescher J, 2017, HNO, V65, P956, DOI 10.1007/s00106-017-0391-3; Dong J, 2013, OR SURG OR MED OR PA, V115, pE63, DOI 10.1016/j.oooo.2012.07.436; Henrot P, 2003, RADIOGRAPHICS, V23, P1201, DOI 10.1148/rg.235025045; Kidoh M, 2014, CLIN RADIOL, V69, pE11, DOI 10.1016/j.crad.2013.08.008; Lemmens C, 2009, IEEE T MED IMAGING, V28, P250, DOI 10.1109/TMI.2008.929103; Mahnken AH, 2003, INVEST RADIOL, V38, P769, DOI 10.1097/01.rli.0000086495.96457.54; Tohnak S, 2011, DENTOMAXILLOFAC RAD, V40, P184, DOI 10.1259/dmfr/25260548; Weissman JL, 2001, AM J NEURORADIOL, V22, P741; Wuest W, 2015, AM J NEURORADIOL, V36, P1988, DOI 10.3174/ajnr.A4386; Zanoni DK, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0799-x	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248696	10.1371/journal.pone.0248696	http://dx.doi.org/10.1371/journal.pone.0248696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735270	gold, Green Published			2022-12-26	WOS:000631029700105
J	Das, MK; Arora, NK; Chellani, HK; Debata, PK; Meena, KR; Rasaily, R; Kaur, G; Malik, P; Joshi, S; Kumari, M				Das, Manoja Kumar; Arora, Narendra Kumar; Chellani, Harish Kumar; Debata, Pradeep Kumar; Meena, K. R.; Rasaily, Reeta; Kaur, Gurkirat; Malik, Prikanksha; Joshi, Shipra; Kumari, Manisha			Perceptions of the parents of deceased children and of healthcare providers about end-of-life communication and breaking bad news at a tertiary care public hospital in India: A qualitative exploratory study	PLOS ONE			English	Article							DEATH; PERSPECTIVES; EXPERIENCES; COMPETENCE; PROTOCOL; VIOLENCE; FAMILY; CANCER; DIES	Author summary The parents of terminally ill and dying children face unimaginably psychological stress and have strong need for compassionate professional support. To improve the parents and family experience, there is need for obtaining feedback and documenting the experiences of parents, family and healthcare providers with reference to the local contexts. There is limited information on parents experience on end-of-life communication related to their child death from Indian context. An exploratory qualitative study was conducted at a tertiary care hospital in India involved in-depth interviews with parents and family of deceased children and healthcare providers (HCPs: doctors, nurses and support staffs) involved in treating children. Parents remembered the communication by junior doctors as brief, inappropriate and insensitive, while the senior doctor's communication was positive and complete. The death declaration by resident doctors was remembered as non-empathetic, blunt and cold. No emotional support was received by them around and after child's death. The doctors were affected emotionally with death of the patients, but were constrained with high workload, infrastructural limitations and lack of training in communication. Preparation of context specific, sociocultural appropriate module and communication training for HCPs can improve their competence for providing end-of-life care, breaking bad news and also parents experience. Background Parents of dying children face unique challenge and expect compassionate support from health care providers (HCPs). This study explored the experiences of the parents and HCPs about the end-of-life care and breaking bad news and related positive and negative factors in Indian context. Methods This qualitative exploratory study was conducted at paediatrics department of a tertiary care hospital in Delhi. In-depth interviews with the parents (n = 49) and family members (n = 21) of the children died at the hospital and HCPs (6 doctors, 6 nurses and 4 support staffs) were conducted. Also events and communication around death of eight children were observed. Data were inductively analysed using thematic content analysis method to identify emerging themes and codes. Results Doctors were the lead communicators. Majority of parents perceived the attitude, communication and language used as by resident doctors as brief, insensitive and sometimes inappropriate or negative. They perceived that the attitude and communication by senior doctor's as empathetic, positive and complete. Parents recalled the death declaration by resident doctors as non-empathetic, blunt and cold. Most parents received no emotional support from HCPs during and after death of their child. All doctors expressed that death of their patients affected them and their emotions, which they coped through different activities. The overcrowded wards, high workload, infrastructural limitation and no formal communication training added to the emotional stress of the HCPs. Conclusions Majority of the communication by the HCPs during the hospitalisation and end-of-life period were perceived as suboptimal by the parents. The HCPs were emotionally affected and faced end-of-life communication challenges. The study highlights the communication by HCPs and support for parents during the end-of-life communication and breaking bad news. It suggests adoption of context specific communication protocol and materials and training of HCPs in communication to improve the quality of care.	[Das, Manoja Kumar; Arora, Narendra Kumar; Kaur, Gurkirat; Malik, Prikanksha; Joshi, Shipra; Kumari, Manisha] INCLEN Trust Int, New Delhi, India; [Chellani, Harish Kumar; Debata, Pradeep Kumar; Meena, K. R.] Safdarjang Hosp, Dept Pediat, New Delhi, India; [Chellani, Harish Kumar; Debata, Pradeep Kumar; Meena, K. R.] Vardhman Mahavir Med Coll, New Delhi, India; [Rasaily, Reeta] Indian Council Med Res, Div Reprod Biol Maternal & Child Hlth, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR)	Das, MK (corresponding author), INCLEN Trust Int, New Delhi, India.	manoj@inclentrust.org	Das, Manoja/I-2558-2017	Das, Manoja/0000-0002-8559-5837	INCLEN Trust International by Bill and Melinda Gates Foundation through Indian Council of Medical Research [OPP1184205, 5/7/1504/2016-CH]	INCLEN Trust International by Bill and Melinda Gates Foundation through Indian Council of Medical Research	This study is funded to The INCLEN Trust International by Bill and Melinda Gates Foundation (OPP1184205) through Indian Council of Medical Research (no 5/7/1504/2016-CH). The funders had no role in study planning, conduct, analysis and manuscript preparation.	[Anonymous], 2003, CHILDREN DIE IMPROVE; Arber Anne, 2003, Int J Palliat Nurs, V9, P166; Aschenbrenner AP, 2012, J PEDIATR NURS, V27, P514, DOI 10.1016/j.pedn.2011.07.008; Baig L, 2018, PAK J MED SCI, V34, P294, DOI 10.12669/pjms.342.14432; Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8; Berry P., 2001, BMJ-BRIT MED J, V323, P1373; Castillo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132057; Das MK, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0665-1; de Leo D., 2015, HUMANITIES, V4, P702, DOI [10.3390/h4040702, DOI 10.3390/H4040702]; Dean A, 2016, INT J PALLIAT NURS, V22, P265, DOI 10.12968/ijpn.2016.22.6.265; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Dighe MP, 2012, CONTEMPORARY AND INNOVATIVE PRACTICE IN PALLIATIVE CARE, P115; Eggly S, 1997, ACAD MED, V72, P397, DOI 10.1097/00001888-199705000-00023; FINLAY I, 1991, BRIT MED J, V302, P1524, DOI 10.1136/bmj.302.6791.1524; Geeta MG, 2017, INDIAN PEDIATR, V54, P685, DOI 10.1007/s13312-017-1135-x; Gillio-Meina C, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0490; GIRGIS A, 1995, J CLIN ONCOL, V13, P2449, DOI 10.1200/JCO.1995.13.9.2449; Gold KJ, 2007, J PERINATOL, V27, P230, DOI 10.1038/sj.jp.7211676; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; Kubler-Ross E., 2005, GRIEF GRIEVING FINDI; Kvale J, 1999, Fam Med, V31, P691; Lamiani G, 2013, MINERVA ANESTESIOL, V79, P1334; Mast MS, 2005, PATIENT EDUC COUNS, V58, P244, DOI 10.1016/j.pec.2005.05.005; Medical Council of India, 2018, ATT ETH COMM AETCOM; Melin-Johansson C, 2014, J PEDIATR NURS, V29, P660, DOI 10.1016/j.pedn.2014.06.009; Narayanan V, 2010, INDIAN J PALLIAT CAR, V16, P61, DOI 10.4103/0973-1075.68401; O'Malley P, 2014, J EMERG NURS, V40, pE83, DOI 10.1016/j.jen.2014.05.003; O'Malley PJ, 2008, PEDIATRICS, V122, pE511, DOI 10.1542/peds.2008-1569; Parker PA, 2001, J CLIN ONCOL, V19, P2049, DOI 10.1200/JCO.2001.19.7.2049; Price J, 2006, INT J PALLIAT NURS, V12, P115, DOI 10.12968/ijpn.2006.12.3.20695; Ptacek JT, 2001, J BEHAV MED, V24, P205, DOI 10.1023/A:1010766732373; Rabow MW, 1999, WESTERN J MED, V171, P260; Rahim AA, 2017, NATL MED J INDIA, V30, P332, DOI 10.4103/0970-258X.239076; ROBERTS CS, 1994, CANCER, V74, P336, DOI 10.1002/cncr.2820741319; Singh G, 2019, INDIAN J PUBLIC HLTH, V63, P143, DOI 10.4103/ijph.IJPH_70_18; Stevens M., 2004, OXFORD TXB PALLIATIV, V3rd ed., P807; TOLLE SW, 1984, ARCH INTERN MED, V144, P2389, DOI 10.1001/archinte.144.12.2389; Vail L, 2011, PATIENT EDUC COUNS, V83, P185, DOI 10.1016/j.pec.2010.05.016; Xafis V, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0024-0; Zimmermann K, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0098-3	40	2	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248661	10.1371/journal.pone.0248661	http://dx.doi.org/10.1371/journal.pone.0248661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735296	Green Published, gold			2022-12-26	WOS:000631029700057
J	Matthay, EC; Farkas, K; Goin, DE; Rudolph, KE; Pear, VA; Ahern, J				Matthay, Ellicott C.; Farkas, Kriszta; Goin, Dana E.; Rudolph, Kara E.; Pear, Veronica A.; Ahern, Jennifer			Associations of firearm dealer openings with firearm self-harm deaths and injuries: A differences-in-differences analysis	PLOS ONE			English	Article							SUICIDE; HOMICIDE; ALCOHOL; AVAILABILITY; HANDGUN; ACCESS; CRIME; STATE; RISK	Background Firearm dealer density is correlated with firearm interpersonal violence, but no quasi-experimental studies have assessed whether changes in dealer density lead to changes in firearm self-harm injuries and deaths. We assessed whether openings of firearm dealers are associated with short-term changes in local firearm self-harm injury rates. Methods We identified 718 openings of firearm dealers in California using licensing data, 2014-2016. We defined exposure regions based on aggregations of zip codes defined by proximity to firearm dealer openings and matched each opening to four control regions on time and determinants of firearm injury. We applied a differences-in-differences approach to compare rates of firearm self-harm, in the month before and after each opening, in places with and without openings. Results Firearm dealer openings were not associated with acute, local changes in firearm self-harm relative to places without openings (ratio of rate ratio: 0.90 [95% CI:0.68-1.19]). Results were robust to numerous sensitivity and secondary analyses. Conclusion We found no associations of firearm dealer openings with acute, localized firearm self-harm deaths and injuries. Our focus on acute, local effects; broad availability of dealers and firearms; durability of firearms; or strong confounding-control may explain these null findings.	[Matthay, Ellicott C.] Univ Calif San Francisco, Sch Med, Ctr Hlth & Commun, San Francisco, CA 94143 USA; [Farkas, Kriszta; Pear, Veronica A.; Ahern, Jennifer] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA; [Goin, Dana E.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, Program Reprod Hlth & Environm, San Francisco, CA USA; [Rudolph, Kara E.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Columbia University	Matthay, EC (corresponding author), Univ Calif San Francisco, Sch Med, Ctr Hlth & Commun, San Francisco, CA 94143 USA.	ellicott.matthay@ucsf.edu		Matthay, Ellicott/0000-0003-4535-8252; Farkas, Kriszta/0000-0003-1605-580X	Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of the Director at the National Institutes of Health [DP2 HD080350]; University of California, Berkeley Committee on Research; University of California Firearm Violence Research Center	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director at the National Institutes of Health; University of California, Berkeley Committee on Research(University of California System); University of California Firearm Violence Research Center	This work was supported by: the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Office of the Director at the National Institutes of Health (grant DP2 HD080350, awarded to JA); the University of California Firearm Violence Research Center (awarded to JA); and the University of California, Berkeley Committee on Research (awarded to JA).	Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Annest Joseph L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Ashe M, 2003, AM J PUBLIC HEALTH, V93, P1404, DOI 10.2105/AJPH.93.9.1404; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Centers for Disease Control and Prevention, 2018, CDC WEB BASED INJURY; Chao SD, 2019, J TRAUMA ACUTE CARE, V86, P123, DOI 10.1097/TA.0000000000002067; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Dzau VJ, 2018, ANN INTERN MED, V168, P876, DOI 10.7326/M18-0579; Galea S, 2018, AM J PUBLIC HEALTH, V108, P858, DOI 10.2105/AJPH.2018.304436; Gruenewald PJ, 2011, ALCOHOL RES HEALTH, V34, P248; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Ho DE, 2011, J STAT SOFTW, V42; Ibrahim JG, 2012, J CLIN ONCOL, V30, P3297, DOI 10.1200/JCO.2011.38.7589; Institute for Womens Policy Research (IWPR), 2021, BRIEF PAP; Mair C, 2021, AM J EPIDEMIOL, V190, P150, DOI 10.1093/aje/kwaa157; Matthay EC, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2019.100526; Matthay EC, 2018, EPIDEMIOLOGY, V29, P697, DOI [10.1097/EDE.0000000000000872, 10.1097/ede.0000000000000872]; Matthay EC, 2017, ANN INTERN MED, V167, P837, DOI 10.7326/M17-1792; Miller M, 2017, ANN INTERN MED, V166, P233, DOI 10.7326/M16-1590; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; Peterson RD, 2000, J RES CRIME DELINQ, V37, P31, DOI 10.1177/0022427800037001002; Price JH, 2004, J COMMUN HEALTH, V29, P271, DOI 10.1023/B:JOHE.0000025326.89365.5c; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Semenza DC, 2022, JUSTICE Q, V39, P134, DOI 10.1080/07418825.2019.1707858; Sorenson SB, 2003, INJ PREV, V9, P147, DOI 10.1136/ip.9.2.147; Stansfield R, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.05.027; Steidley T, 2017, SOC FORCES, V96, P265, DOI 10.1093/sf/sox039; Studdert DM, 2020, NEW ENGL J MED, V382, P2220, DOI 10.1056/NEJMsa1916744; USDA ERS, RURAL URBAN COMMUTIN; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Westefeld JS, 2016, PROF PSYCHOL-RES PR, V47, P271, DOI 10.1037/pro0000089; Wiebe DJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-199; Wintemute GJ, 2004, ANN EMERG MED, V43, P733, DOI 10.1016/j.annemergmed.2003.11.017; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; Xu Y, 2019, ICC 2019 2019 IEEE I, V5, P58, DOI 10.1080/23754931.2019.1619192	38	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248130	10.1371/journal.pone.0248130	http://dx.doi.org/10.1371/journal.pone.0248130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735181	gold, Green Published			2022-12-26	WOS:000631029700050
J	Ravvaz, K; Weissert, JA; Jahangir, A; Ruff, CT				Ravvaz, Kourosh; Weissert, John A.; Jahangir, Arshad; Ruff, Christian T.			Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation	PLOS ONE			English	Article							STRATIFICATION; DISADVANTAGE; INEQUALITIES; WARFARIN; METRICS; DISEASE	Background The risk of thromboembolism and bleeding before initiation of oral anticoagulant (OAC) in atrial fibrillation patients is estimated by CHA(2)DS(2)-VASc and HAS-BLED scoring system, respectively. Patients' socioeconomic status (SES) could influence these risks, but its impact on the two risk scores' predictive performance with respect to clinical events remains unknown. Our objective was to determine if patient SES defined by area deprivation index (ADI), in conjunction with CHA(2)DS(2)-VASc and HAS-BLED scores, could guide oral anticoagulation therapy. Methods and findings The study cohort included newly diagnosed patients with AF who were treated with warfarin. The cohort was stratified by the time in therapeutic range of INR (TTR), ADI, CHA(2)DS(2)-VASc, and HAS-BLED risk scores. TTR and ischemic and bleeding events during the first year of therapy were compared across subpopulations. Among 7274 patients, those living in the two most deprived quintiles (ADI >= 60%) had a significantly higher risk of ischemic events and those in the most deprived quintile (ADI >= 80%) had a significantly increased risk of bleeding events. ADI significantly improved the predictive performance of CHA(2)DS(2)-VASc but not HAS-BLED risk scores. Conclusion ADI can predict increased risk for ischemic and bleeding events in the first year of warfarin therapy in patients with incident AF.	[Ravvaz, Kourosh; Weissert, John A.] Advocate Aurora Hlth, Advocate Aurora Res Inst, Milwaukee, WI 53204 USA; [Jahangir, Arshad] Aurora Sinai Aurora St Lukes Med Ctr, Ctr Adv Atrial Fibrillat Therapies, Aurora Cardiovasc & Thorac Serv, Aurora, WI USA; [Ruff, Christian T.] Harvard Med Sch, TIMI Study Grp, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ravvaz, K (corresponding author), Advocate Aurora Hlth, Advocate Aurora Res Inst, Milwaukee, WI 53204 USA.	ravvaz@gmail.com			Advocate Aurora Health Cardiovascular Award	Advocate Aurora Health Cardiovascular Award	This work was funded through an Advocate Aurora Health Cardiovascular Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd AD, 2013, J AM MED INFORM ASSN, V20, P708, DOI 10.1136/amiajnl-2012-001358; Burn J, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000712; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Dzeshka MS, 2014, CLIN CARDIOL, V37, P634, DOI 10.1002/clc.22294; Fanola CL, 2017, EUR HEART J, V38, P888, DOI 10.1093/eurheartj/ehw565; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Jaakkola S, 2018, AM J CARDIOL, V121, P1182, DOI 10.1016/j.amjcard.2018.01.038; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Knighton Andrew J, 2016, EGEMS (Wash DC), V4, P1238, DOI 10.13063/2327-9214.1238; Lin KJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006814; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540; Miller JD, 2015, J AM COLL CARDIOL, V66, P2899, DOI 10.1016/j.jacc.2015.10.047; Mozaffarian, 2015, CIRCULATION, V131, pE535, DOI 10.1161/CIR.0000000000000219; Nelson WW, 2015, INT J CLIN PHARM-NET, V37, P53, DOI 10.1007/s11096-014-0038-3; Pugh D, 2011, AGE AGEING, V40, P675, DOI 10.1093/ageing/afr097; R Core Team, 2019, R LANG ENV STAT COMP; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sanghai S, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014108; Sherzai AZ, 2015, ANN NY ACAD SCI, V1338, P1, DOI 10.1111/nyas.12723; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Sjolander M, 2015, STROKE, V46, P2220, DOI 10.1161/STROKEAHA.115.009718; Wandell P, 2016, INT J CARDIOL, V202, P776, DOI 10.1016/j.ijcard.2015.09.027; Williams BA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006669	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248134	10.1371/journal.pone.0248134	http://dx.doi.org/10.1371/journal.pone.0248134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735259	gold, Green Published			2022-12-26	WOS:000631029700040
J	Than, MW; Zaw, NT; Minn, K; Saw, YM; Kiriya, J; Jimba, M; Win, HH; Shibanuma, A				Than, Myat Wint; Zaw, Nicholus Tint; Minn, Kyi; Saw, Yu Mon; Kiriya, Junko; Jimba, Masamine; Win, Hla Hla; Shibanuma, Akira			Assessing depressive symptoms among people living with HIV in Yangon city, Myanmar: Does being a member of self-help group matter?	PLOS ONE			English	Article							MENTAL-HEALTH; SOCIAL SUPPORT; ANTIRETROVIRAL THERAPY; TREATMENT PROGRAMS; INFECTED ADULTS; RISK BEHAVIOR; STIGMA; CARE; ADHERENCE; COUNTRIES	Background While self-help groups have been formed among people living with HIV, few studies have been conducted to assess the role of self-help groups in mitigating depressive symptoms. This study investigated the association between self-help group membership and depressive symptoms among people living with HIV in Yangon, Myanmar. Methods In this cross-sectional study, data were collected from people living with HIV at three antiretroviral therapy clinics in 2017. Multiple logistic regression analyses were carried out to examine the associations between having self-help group membership and depressive symptoms. Three ART clinics were purposively selected based on the recommendation from the National AIDS Program in Myanmar. At these clinics, people living with HIV were recruited by a convenience sampling method. Results Among people living with HIV recruited in this study (n = 464), 201 (43.3%) were members of a self-help group. The membership was not associated with having depressive symptoms (adjusted odds ratio [AOR] 1.59, 95% confidence interval [CI] 0.98-2.59). Factors associated with having depressive symptoms were female (AOR 3.70, 95% CI 1.54-8.88) and lack of social support (AOR 0.97, 95% CI 0.96-0.98) among self-help group members, and female (AOR 3.47, 95% CI 1.70-7.09), lack of social support (AOR 0.98, 95% CI 0.97-0.99), and internalized stigma (AOR 1.28, 95% 1.08-1.53) among non-members. Conclusions This study did not find evidence on the association between membership in self-help groups and depressive symptoms among people living with HIV. Social support was a protective factor against depressive symptoms both self-help group members and non-members, although the level of social support was lower among members than non-members. The activities of self-help groups and care provided by the ART clinics should be strengthened to address mental health problems among people living with HIV in the study site.	[Than, Myat Wint; Kiriya, Junko; Jimba, Masamine; Shibanuma, Akira] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Zaw, Nicholus Tint] Innovat Poverty Act Myanmar, Yangon, Myanmar; [Minn, Kyi] Myanmar Hlth & Dev Consortium, Yangon, Myanmar; [Saw, Yu Mon] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi, Japan; [Saw, Yu Mon] Nagoya Univ, Asian Satellite Campuses Inst, Nagoya, Aichi, Japan; [Win, Hla Hla] Univ Med 1, Dept Prevent & Social Med, Yangon, Myanmar	University of Tokyo; Nagoya University; Nagoya University	Shibanuma, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	shibanuma@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016	Shibanuma, Akira/0000-0003-2058-1722; Saw, Yu Mon/0000-0002-5038-0043; Minn, Kyi/0000-0002-7108-4956	Asian Development Bank-Japan Scholarship Program	Asian Development Bank-Japan Scholarship Program	This study was supported by the Asian Development Bank-Japan Scholarship Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen L, 2001, J ADV NURS, V35, P909, DOI 10.1046/j.1365-2648.2001.01928.x; Akiyama T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-337; Aye WL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4309-5; Barlow SH, 2000, INT J GROUP PSYCHOTH, V50, P53, DOI 10.1080/00207284.2000.11490981; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Biradavolu MR, 2012, J EPIDEMIOL COMMUN H, V66, pII95, DOI 10.1136/jech-2011-200508; Bolton P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001757; Bradley MV, 2008, PSYCHOSOM MED, V70, P186, DOI 10.1097/PSY.0b013e3181642a1c; Cardozo BL, 2004, SOC SCI MED, V58, P2637, DOI 10.1016/j.socscimed.2003.09.024; Chesney MA, 2003, PSYCHOSOM MED, V65, P1038, DOI 10.1097/01.PSY.0000097344.78697.ED; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Coursaris CK, 2009, COMPUT HUM BEHAV, V25, P911, DOI 10.1016/j.chb.2009.03.006; Cruess S, 2002, COGNITIVE THER RES, V26, P373, DOI 10.1023/A:1016081012073; Do HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-154; Thanh DC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-428; Gidron B., 2013, SELF HELP MUTUAL AID, V2nd, P45; Gordillo V, 2009, J BEHAV MED, V32, P523, DOI 10.1007/s10865-009-9222-7; Haroz Emily E, 2014, BMC Psychol, V2, P31, DOI 10.1186/s40359-014-0031-6; Heywood W, 2016, AIDS BEHAV, V20, P1632, DOI 10.1007/s10461-016-1324-y; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Joint United Nations Programme on HIV/AIDS, 2019, GLOB AIDS UPD 2019 C; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2018, COUNTR FACTSH MYANM; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV AS PAC; Khasnabis C., 2010, COMMUNITY BASED REHA; Knight C., 2016, GROUP WORK POPULATIO, V4 th, P3; Knight C., 2016, GROUP WORK POPULATIO, V4 th, P83; Kurtz L.F., 1997, SELF HELP SUPPORT GR; Lee K, 2009, GLOB INST, P1; Liamputtong P, 2009, SOC SCI MED, V69, P862, DOI 10.1016/j.socscimed.2009.05.040; Logie CH, 2020, AIDS BEHAV, V24, P3462, DOI 10.1007/s10461-020-02917-y; Lowther K, 2014, INT J NURS STUD, V51, P1171, DOI 10.1016/j.ijnurstu.2014.01.015; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Markowitz FE, 2015, HEALTH SOCIOL REV, V24, P199, DOI 10.1080/14461242.2015.1015149; Mcdowell TL, 2007, AIDS CARE, V19, P1223, DOI 10.1080/09540120701402830; National AIDS Programme (NAP), 2012, HIV SENT SER SURV SU; National AIDS Programme (NAP), 2015, GLOB AIDS RESP PROGR; National AIDS Programme (NAP), 2018, PROGR REP 2018; Nguyen AJ, 2018, GLOB MENT HEALTH, V5, DOI 10.1017/gmh.2017.30; Puspitasari HP, 2016, RES SOC ADMIN PHARM, V12, P104, DOI 10.1016/j.sapharm.2015.04.008; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Ryan K, 2008, AIDS CARE, V20, P331, DOI 10.1080/09540120701660338; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Serovich JM, 2001, AIDS CARE, V13, P335, DOI 10.1080/09540120120043982; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Shimizu M, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31999; Silver EJ, 2003, AIDS BEHAV, V7, P421, DOI 10.1023/B:AIBE.0000004734.21864.25; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Slaymaker E, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22789; Takada S, 2014, ANN BEHAV MED, V48, P26, DOI 10.1007/s12160-013-9576-5; Thandar M, 2017, ANN TROP MED PUBLIC, V10, P216, DOI 10.4103/1755-6783.205589; Thar M., 2016, INT J COMMUNITY MED, V3, P1318; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Williams Brian, 2008, Confl Health, V2, P3, DOI 10.1186/1752-1505-2-3; Wituk S, 2000, SOC WORK, V45, P157, DOI 10.1093/sw/45.2.157	56	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248807	10.1371/journal.pone.0248807	http://dx.doi.org/10.1371/journal.pone.0248807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QZ9HN	33735312	Green Published, gold			2022-12-26	WOS:000631029700086
J	Matsuo, T; Matsuyama, M				Matsuo, Takao; Matsuyama, Miwa			Detection of poststroke oropharyngeal dysphagia with swallowing screening by ultrasonography	PLOS ONE			English	Article								There are currently no standard evaluation tools for poststroke neurogenic oropharyngeal dysphagia. We previously suggested calculating the relative movements of the hyoid bone and larynx by ultrasonography to evaluate swallowing movement. Swallowing movement is altered in neurogenic oropharyngeal dysphagia. Therefore, the present study aimed to verify whether an ultrasonographic evaluation of swallowing movement facilitates the detection of neurogenic oropharyngeal dysphagia. Eighteen healthy male elderly participants (the healthy group) and 18 male stroke patients diagnosed with neurogenic oropharyngeal dysphagia (the dysphagia group) were enrolled. Participants swallowed 5 mL of liquid and water with an adjusted viscosity and the movements of the hyoid bone and larynx were visualized by ultrasonography. The results obtained revealed significant differences in laryngeal duration (static phase), laryngeal displacement (elevation phase), and the hyoid bone-laryngeal motion ratio (HL motion ratio) between the two groups. A multiple regression analysis was performed to adjust for confounding factors, and laryngeal duration (static phase) and the HL motion ratios were identified as factors affecting dysphagia. In the receiver operation characteristic curve of the two variations, the area under the curve for laryngeal duration (static phase) was 0.744 and the cut-off was 0.26 sec with 72.2% sensitivity and 88.9% specificity; the area under the curve for the HL motion ratio was 0.951 and the cut-off was 0.56 with 88.9% sensitivity and 88.9% specificity. Therefore, the objective evaluation of hyoid bone and larynx movements during swallowing by ultrasonography facilitated the detection of neurogenic oropharyngeal dysphagia.	[Matsuo, Takao] Kansai Univ Welf Sci, Fac Allied Hlth Sci, Dept Rehabil Sci, Div Speech Language Hearing Therapy, Kashiwara, Osaka, Japan; [Matsuyama, Miwa] Tokushima Univ, Inst Biomed Sci, Dept Oral Hlth Care & Rehabil, Grad Sch, Kuramoto Cho, Tokushima, Tokushima, Japan	Tokushima University	Matsuo, T (corresponding author), Kansai Univ Welf Sci, Fac Allied Hlth Sci, Dept Rehabil Sci, Div Speech Language Hearing Therapy, Kashiwara, Osaka, Japan.	mauto.takao@gmail.com		Matsuo, Takao/0000-0003-2915-9683				Al-Khaled M, 2016, CEREBROVASC DIS, V42, P81, DOI 10.1159/000445299; Aslan M, 2020, J CRANIOFAC SURG, V31, pE667, DOI 10.1097/SCS.0000000000006503; Baijens LWJ, 2016, CLIN INTERV AGING, V11, P1403, DOI 10.2147/CIA.S107750; BISCH EM, 1994, J SPEECH HEAR RES, V37, P1041, DOI 10.1044/jshr.3705.1041; Bolivar-Prados M, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13695; Bours GJ, 2009, J ADV NURS, V65, P477, DOI 10.1111/j.1365-2648.2008.04915.x; Brodsky MB, 2016, CHEST, V150, P148, DOI 10.1016/j.chest.2016.03.059; Carrion S, 2015, CLIN NUTR, V34, P436, DOI 10.1016/j.clnu.2014.04.014; D'Amico E, 2019, EXPERT REV GASTROENT, V13, P47, DOI 10.1080/17474124.2019.1544890; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953, DOI 10.2214/ajr.154.5.2108569; Eltringham SA, 2018, CEREBROVASC DIS, V46, P97, DOI 10.1159/000492730; Ertekin C, 2003, CLIN NEUROPHYSIOL, V114, P2226, DOI 10.1016/S1388-2457(03)00237-2; Falsetti P, 2009, J STROKE CEREBROVASC, V18, P329, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.009; Ferlito S., 2019, ACTA MED MEDITERR; Hendriks Thomas, 2018, BMJ Case Rep, V11, DOI 10.1136/bcr-2018-228162; Ickenstein GW, 2012, J STROKE CEREBROVASC, V21, P569, DOI 10.1016/j.jstrokecerebrovasdis.2011.01.004; Ishida R, 2002, DYSPHAGIA, V17, P262, DOI 10.1007/s00455-002-0064-5; Ito Y, 2020, J ORAL REHABIL, V47, P1287, DOI 10.1111/joor.13062; Kendall KA, 2001, ARCH OTOLARYNGOL, V127, P1224, DOI 10.1001/archotol.127.10.1224; Lee KD, 2016, ANN REHABIL MED-ARM, V40, P206, DOI 10.5535/arm.2016.40.2.206; Logemann JA, 2000, J SPEECH LANG HEAR R, V43, P1264, DOI 10.1044/jslhr.4305.1264; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2000, DYSPHAGIA, V15, P19, DOI 10.1007/s004559910006; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Matsuo T, 2020, RADIOL PHYS TECHNOL, V13, P62, DOI 10.1007/s12194-019-00547-1; Na YJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016349; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; Ogawa N, 2021, GERIATR GERONTOL INT, V21, P14, DOI 10.1111/ggi.14079; Ogawa N, 2018, J AM MED DIR ASSOC, V19, P516, DOI 10.1016/j.jamda.2017.11.007; Okada T, 2013, J APPL PHYSIOL, V115, P1138, DOI 10.1152/japplphysiol.00467.2013; Ortega O, 2017, J AM MED DIR ASSOC, V18, P576, DOI 10.1016/j.jamda.2017.02.015; Osawa A, 2013, CEREBROVASC DIS, V35, P276, DOI 10.1159/000348683; Patel DA, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dow028; Perkisas S., 2021, EUR GERIATR MED, V10; Picelli A, 2021, MINERVA MED, V112, P354, DOI 10.23736/S0026-4806.20.06571-4; Rofes L, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13338; Steele CM, 2011, CLIN OTOLARYNGOL, V36, P30, DOI 10.1111/j.1749-4486.2010.02219.x; Steele CM, 2019, J SPEECH LANG HEAR R, V62, P1338, DOI 10.1044/2019_JSLHR-S-18-0448; Steele CM, 2014, DYSPHAGIA, V29, P295, DOI 10.1007/s00455-014-9516-y; Terre R, 2006, NEUROGASTROENT MOTIL, V18, P200, DOI 10.1111/j.1365-2982.2005.00729.x; Yabunaka K, 2012, RADIOL PHYS TECHNOL, V5, P34, DOI 10.1007/s12194-011-0132-3; Yoshida M, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010050	42	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0248770	10.1371/journal.pone.0248770	http://dx.doi.org/10.1371/journal.pone.0248770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730038	gold, Green Published			2022-12-26	WOS:000630345000046
J	Castro, J; Maddern, J; Grundy, L; Manavis, J; Harrington, AM; Schober, G; Brierley, SM				Castro, Joel; Maddern, Jessica; Grundy, Luke; Manavis, Jim; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.			A mouse model of endometriosis that displays vaginal, colon, cutaneous, and bladder sensory comorbidities	FASEB JOURNAL			English	Article						bladder dysfunction; colonic hypersensitivity; cutaneous mechanical and thermal hypersensitivity; endometriotic lesions; vaginal hypersensitivity		Endometriosis is a painful inflammatory disorder affecting similar to 10% of women of reproductive age. Although chronic pelvic pain (CPP) remains the main symptom of endometriosis patients, adequate treatments for CPP are lacking. Animal models that recapitulate the features and symptoms experienced by women with endometriosis are essential for investigating the etiology of endometriosis, as well as developing new treatments. In this study, we used an autologous mouse model of endometriosis to examine a combination of disease features and symptoms including: a 10 week time course of endometriotic lesion development; the chronic inflammatory environment and development of neuroangiogenesis within lesions; sensory hypersensitivity and altered pain responses to vaginal, colon, bladder, and skin stimulation in conscious animals; and spontaneous animal behavior. We found significant increases in lesion size from week 6 post-transplant. Lesions displayed endometrial glands, stroma, and underwent neuroangiogenesis. Additionally, peritoneal fluid of mice with endometriosis contained known inflammatory mediators and angiogenic factors. Compared to Sham, mice with endometriosis displayed: enhanced sensitivity to pain evoked by (i) vaginal and (ii) colorectal distension, (iii) altered bladder function and increased sensitivity to cutaneous (iv) thermal and (v) mechanical stimuli. The development of endometriosis had no effect on spontaneous behavior. This study describes a comprehensive characterization of a mouse model of endometriosis, recapitulating the clinical features and symptoms experienced by women with endometriosis. Moreover, it delivers the groundwork to investigate the etiology of endometriosis and provides a platform for the development of therapeutical interventions to manage endometriosis-associated CPP.	[Castro, Joel; Maddern, Jessica; Grundy, Luke; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.] Flinders Univ S Australia, Flinders Hlth & Med Res Inst FHMRI, Coll Med & Publ Hlth, Visceral Pain Res Grp, Bedford Pk, SA, Australia; [Castro, Joel; Maddern, Jessica; Grundy, Luke; Harrington, Andrea M.; Schober, Gudrun; Brierley, Stuart M.] South Australian Hlth & Med Res Inst SAHMRI, Lifelong Hlth Theme, Hopwood Ctr Neurobiol, Adelaide, SA 5000, Australia; [Manavis, Jim] Univ Adelaide Adelaide, Fac Hlth & Med Sci, Sch Med, Adelaide, SA, Australia; [Brierley, Stuart M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide	Castro, J (corresponding author), South Australian Hlth & Med Res Inst SAHMRI, Lifelong Hlth Theme, Hopwood Ctr Neurobiol, Adelaide, SA 5000, Australia.	joel.castro@sahmri.com		Harrington, Andrea/0000-0002-1562-4137; Grundy, Luke/0000-0002-3900-7141; Castro, Joel/0000-0002-5781-2224; Brierley, Stuart/0000-0002-2527-2905	National Health and Medical Research Council (NHMRC) [APP1181448, APP1126378, 1139366, 1140297]; The Hospital Research Foundation (THRF) [SAPhD000242018]; Australian Research Council (ARC) Discovery Early Career Research [DE130100223, DP180101395]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); The Hospital Research Foundation (THRF); Australian Research Council (ARC) Discovery Early Career Research(Australian Research Council)	National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1181448, APP1126378, #1139366 and #1140297; The Hospital Research Foundation (THRF), Grant/Award Number: SAPhD000242018; Australian Research Council (ARC) Discovery Early Career Research, Grant/Award Number: DE130100223 and DP180101395	Abbott J, 2004, FERTIL STERIL, V82, P878, DOI 10.1016/j.fertnstert.2004.03.046; Adamson GD, 2010, J ENDOMETR PELVIC PA, V2, P3, DOI 10.1177/228402651000200102; Allen C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub3; Asante A, 2011, ANNU REV PHYSIOL, V73, P163, DOI 10.1146/annurev-physiol-012110-142158; Bajaj P, 2003, J PAIN, V4, P372, DOI 10.1016/S1526-5900(03)00720-X; Bakacak M, 2015, TURK J OBSTET GYNECO, V12, P125, DOI 10.4274/tjod.71601; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Barcz E, 2000, Med Sci Monit, V6, P1042; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426; Berkley KJ, 2007, PAIN, V132, pS150, DOI 10.1016/j.pain.2007.09.022; Berkley KJ, 2001, NEUROSCI LETT, V306, P185, DOI 10.1016/S0304-3940(01)01906-1; Braun KM, 2014, SEMIN PEDIATR SURG, V23, P336, DOI 10.1053/j.sempedsurg.2014.06.004; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub4; Bruner-Tran KL, 2018, CURR WOMENS HEALTH R, V14, P173, DOI 10.2174/1573404813666170921162041; Burns KA, 2018, ENDOCRINOLOGY, V159, P103, DOI 10.1210/en.2017-00562; Burns KA, 2012, ENDOCRINOLOGY, V153, P3960, DOI 10.1210/en.2012-1294; Busacca M, 2006, J MINIM INVAS GYN, V13, P49, DOI 10.1016/j.jmig.2005.10.002; Carstens BB, 2016, ANGEW CHEM INT EDIT, V55, P4692, DOI 10.1002/anie.201600297; Cason AM, 2003, HORM BEHAV, V44, P123, DOI 10.1016/S0018-506X(03)00121-1; Castro J, 2021, PAIN, V162, P227, DOI 10.1097/j.pain.0000000000002036; Castro J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131712; Castro J, 2018, BRIT J PHARMACOL, V175, P2384, DOI 10.1111/bph.14115; Castro J, 2017, GASTROENTEROLOGY, V152, pS204, DOI 10.1016/S0016-5085(17)30989-7; Chung Maurice K, 2005, JSLS, V9, P25; Chung Maurice K, 2002, JSLS, V6, P311; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Dmitrieva N, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00158; Exacoustos C, 2014, BEST PRACT RES CL OB, V28, P655, DOI 10.1016/j.bpobgyn.2014.04.010; Falcone T, 2018, OBSTET GYNECOL, V131, P557, DOI 10.1097/AOG.0000000000002469; Finnie GS, 2017, J COMP PATHOL, V156, P389, DOI 10.1016/j.jcpa.2017.03.001; Ge P, 2019, PAIN, V160, P2566, DOI 10.1097/j.pain.0000000000001657; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Grundy L, 2020, AM J PHYSIOL-RENAL, V318, pF298, DOI 10.1152/ajprenal.00435.2019; Grundy L, 2019, ANNU REV PHYSIOL, V81, P261, DOI 10.1146/annurev-physiol-020518-114525; Grundy L, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121841; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Harrington AM, 2012, J COMP NEUROL, V520, P2241, DOI 10.1002/cne.23042; Herington JL, 2011, FERTIL STERIL, V95, P1295, DOI 10.1016/j.fertnstert.2010.09.017; Hill WG, 2018, AM J PHYSIOL-RENAL, V315, pF1422, DOI 10.1152/ajprenal.00350.2018; Howard FM, 2000, J AM ASSOC GYN LAP, V7, P477, DOI 10.1016/S1074-3804(05)60360-X; Inserra MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42810; Jarrell J, 2015, J OBSTET GYNAECOL CA, V37, P628, DOI 10.1016/S1701-2163(15)30201-2; Jess T, 2012, GUT, V61, P1279, DOI 10.1136/gutjnl-2011-301095; Jimenez-Vargas NN, 2018, P NATL ACAD SCI USA, V115, pE7438, DOI 10.1073/pnas.1721891115; Kajitani T, 2013, ENDOCR J, V60, P1155; Kim NY, 2011, EUR J OBSTET GYN R B, V154, P85, DOI 10.1016/j.ejogrb.2010.08.008; Laux-Biehlmann A, 2015, TRENDS PHARMACOL SCI, V36, P270, DOI 10.1016/j.tips.2015.03.004; Li T, 2018, BIOL REPROD, V99, P349, DOI 10.1093/biolre/ioy035; Liang YC, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0441-z; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; McAllister SL, 2016, MOL CELL ENDOCRINOL, V437, P120, DOI 10.1016/j.mce.2016.08.017; McAllister SL, 2009, PAIN, V147, P255, DOI 10.1016/j.pain.2009.09.022; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; Mechsner S, 2009, FERTIL STERIL, V92, P1856, DOI 10.1016/j.fertnstert.2008.09.006; MOEN MH, 1992, ACTA OBSTET GYN SCAN, V71, P337, DOI 10.3109/00016349209021069; Morotti M, 2017, EUR J OBSTET GYN R B, V209, P8, DOI 10.1016/j.ejogrb.2016.07.497; Morotti M, 2014, HUM REPROD UPDATE, V20, P717, DOI 10.1093/humupd/dmu021; Morrison TC, 2006, FERTIL STERIL, V86, P1067, DOI 10.1016/j.fertnstert.2006.03.026; Nagabukuro H, 2007, PAIN, V132, pS96, DOI 10.1016/j.pain.2007.04.039; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Nijs J, 2011, MANUAL THER, V16, P413, DOI 10.1016/j.math.2011.04.005; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Pelch KE, 2012, JOVE-J VIS EXP, DOI 10.3791/3396; Prodromidou A, 2018, J INVEST SURG, V31, P275, DOI 10.1080/08941939.2017.1317374; Rogers PAW, 2017, REPROD SCI, V24, P202, DOI 10.1177/1933719116654991; RYAN IP, 1995, FERTIL STERIL, V63, P929, DOI 10.1016/S0015-0282(16)57506-2; Salvatierra J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121000; Scholl B, 2009, GYNECOL ENDOCRINOL, V25, P701, DOI 10.3109/09513590903159680; Schomacker ML, 2018, EUR J OBSTET GYN R B, V231, P65, DOI 10.1016/j.ejogrb.2018.10.023; Shakiba K, 2008, OBSTET GYNECOL, V111, P1285, DOI 10.1097/AOG.0b013e3181758ec6; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Slater H, 2015, PAIN, V156, P2468, DOI 10.1097/j.pain.0000000000000317; Somigliana E, 1999, HUM REPROD, V14, P2944, DOI 10.1093/humrep/14.12.2944; Stilley JAW, 2009, BIOL REPROD, V80, P649, DOI 10.1095/biolreprod.108.073411; Stocks MM, 2017, REPROD SCI, V24, P1121, DOI 10.1177/1933719117698584; Surrey ES, 2018, J WOMENS HEALTH, V27, P1114, DOI 10.1089/jwh.2017.6432; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Tirlapur SA, 2013, INT J SURG, V11, P233, DOI 10.1016/j.ijsu.2013.02.003; Tokushige N, 2006, HUM REPROD, V21, P3001, DOI 10.1093/humrep/del260; Vercellini P, 2007, HUM REPROD, V22, P266, DOI 10.1093/humrep/del339; VERNON MW, 1985, FERTIL STERIL, V44, P684; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; Wieser F, 2002, BJOG-INT J OBSTET GY, V109, P1298, DOI 10.1046/j.1471-0528.2002.01087.x; Yildirim G, 2009, J TURK-GER GYNECOL A, V10, P199; Zhang GH, 2008, AM J PHYSIOL-REG I, V294, pR162, DOI 10.1152/ajpregu.00649.2007	88	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21430	10.1096/fj.202002441R	http://dx.doi.org/10.1096/fj.202002441R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33749885				2022-12-26	WOS:000635216100057
J	Sanchez-Cardenas, C; Romarowski, A; Orta, G; De la Vega-Beltran, JL; Martin-Hidalgo, D; Hernandez-Cruz, A; Visconti, PE; Darszon, A				Sanchez-Cardenas, Claudia; Romarowski, Ana; Orta, Gerardo; De la Vega-Beltran, Jose Luis; Martin-Hidalgo, David; Hernandez-Cruz, Arturo; Visconti, Pablo E.; Darszon, Alberto			Starvation induces an increase in intracellular calcium and potentiates the progesterone-induced mouse sperm acrosome reaction	FASEB JOURNAL			English	Article						acrosome reaction; CatSper; intracellular calcium; mice sperm; progesterone; starving		We have recently reported two different methodologies that improve sperm functionality. The first method involved transient exposure to the Ca2+ ionophore A(23187), and the second required sperm incubation in the absence of energy nutrients (starvation). Both methods were associated with an initial loss of motility followed by a rescue step involving ionophore removal or addition of energy metabolites, respectively. In this work, we show that starvation is accompanied by an increase in intracellular Ca2+ ([Ca2+](i)). Additionally, the starved cells acquire a significantly enhanced capacity to undergo a progesterone-induced acrosome reaction. Electrophysiological measurements show that CatSper channel remains active in starvation conditions. However, the increase in [Ca2+](i) was also observed in sperm from CatSper null mice. Upon starvation, addition of energy nutrients reversed the effects on [Ca2+](i) and decreased the effect of progesterone on the acrosome reaction to control levels. These data indicate that both methods have common molecular features.	[Sanchez-Cardenas, Claudia; Orta, Gerardo; De la Vega-Beltran, Jose Luis; Darszon, Alberto] UNAM, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico; [Romarowski, Ana; Martin-Hidalgo, David; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Dept Neurociencia Cognit, Inst Fisiol Celular, Ciudad Univ, Mexico City, DF, Mexico; [Hernandez-Cruz, Arturo] Univ Nacl Autonoma Mexico, Lab Nacl Canalopatias, Inst Fisiol Celular, Ciudad Univ, Mexico City, DF, Mexico; [Martin-Hidalgo, David] Univ Extremadura, Res Grp Intracellular Signalling & Technol Reprod, Res Inst INBIO GC, Caceres, Spain	Universidad Nacional Autonoma de Mexico; University of Massachusetts System; University of Massachusetts Amherst; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad de Extremadura	Visconti, PE (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.; Darszon, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico.	pvisconti@vasci.umass.edu; darszon@ibt.unam.mx	; Martin Hidalgo, David/I-2840-2015	Darszon, Alberto/0000-0002-2502-0505; Martin Hidalgo, David/0000-0002-6787-0006	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD-038082, HD-088571]; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico) [314839, Fronteras 71]; UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [IN200919, IG200119]; Fondo Social Europeo [PO14005]	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: HD-038082, HD-088571; Consejo Nacional de Ciencia y Tecnologia (CONACYT Mexico), Grant/Award Number: 314839 and Fronteras 71; UNAM Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: IN200919 and IG200119; Fondo Social Europeo, Grant/Award Number: PO14005	BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Balbach M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572735; Balbach M, 2020, BIOL REPROD, V103, P791, DOI 10.1093/biolre/ioaa114; Beltran C, 2016, ADV ANAT EMBRYOL CEL, V220, P35, DOI 10.1007/978-3-319-30567-7_3; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chavez JC, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00366; Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Gervasi MG, 2016, MOL REPROD DEV, V83, P860, DOI 10.1002/mrd.22663; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; Hidalgo DM, 2020, MOL REPROD DEV, V87, P1037, DOI 10.1002/mrd.23421; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; MEIZEL S, 1991, MOL CELL ENDOCRINOL, V77, pR1, DOI 10.1016/0303-7207(91)90080-C; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Navarrete FA, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00262; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Orta G, 2018, J BIOL CHEM, V293, P16830, DOI 10.1074/jbc.RA117.001566; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rohatgi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098760; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Sakai H, 2013, J PHYSIOL-LONDON, V591, P5851, DOI 10.1113/jphysiol.2013.263558; Sanchez-Cardenas C, 2018, BIOL REPROD, V99, P1010, DOI 10.1093/biolre/ioy132; Sanchez-Cardenas C, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119768; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Tateno H, 2013, P NATL ACAD SCI USA, V110, P18543, DOI 10.1073/pnas.1317113110; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Yanagimachi R., 1994, PHYSL REPROD NEW YOR, P317	43	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2021	35	4							e21528	10.1096/fj.202100122R	http://dx.doi.org/10.1096/fj.202100122R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RG0GY	33742713	Green Accepted			2022-12-26	WOS:000635216100037
J	Atalay, AA; Abebe, RK; Dadhi, AE; Bededa, WK				Atalay, Adugnaw Atnafu; Abebe, Reta Kassa; Dadhi, Aberash Eifa; Bededa, Worku Ketema			Seroprevalence of hepatitis B virus among pregnant women attending Antenatal care in Dilla University Referral Hospital Gedio Zone, Ethiopia; health facility based cross-sectional study	PLOS ONE			English	Article							INFECTION; HIV-1	Introduction A pregnancy that has been complicated with Hepatitis B virus (HBV) infection results in typical management problems for both the mother and the newborn. One of the universal efforts in tackling the impact of chronic HBV is the prevention of mother-to-child transmission during Antenatal care via prompt screening as the majority of chronic infections globally harbored during this period. Rewarding result have been achieved in reducing this problem at this period of life through maternal screening programs and universal vaccination of infants. This study was aimed at assessing the seroprevalence and associated risk factor of HBV among pregnant women attending Antenatal Care (ANC) in Dilla University Referral Hospital (DURH), Southern Ethiopia. Method A facility- based cross- sectional study was conducted from December 01 to May 30, 2017 among pregnant women attending ANC. A total of 236 pregnant women were included in this study. All Pregnant women who were attending antenatal clinic and were volunteer during the study period were included, whereas those women who were unable to communicate due to any problem, and not volunteer to give informed consent were excluded. Volunteer participants were asked to complete a questionnaire and had offered to test for HBsAg infection. The data was analyzed using SPSS version 20 software. Logistic regression was used to determine the association between dependent and independent variables. Results From 215 pregnant women attending ANC, the prevalence of HBsAg by the rapid test was found to be 11 (5.1%). Among the study participants, 91.1% (215) were tested for HIV antibody during the ANC visit, with the positivity rate of 4.5%. The result showed 1.86% of the study participants who were tested for HIV were also positive for HBsAg. Among those factors affecting the transmission of HBV infection, multiple partners and HIV confection have significant association at P-value less than 0.05. Conclusion The Seropositivity of Hepatitis B Virus among Pregnant Women was found to be significant and hence, routine screening of pregnant mother at Antenatal care for this virus, and subsequent management according to the guideline for both the mother and child is recommended.	[Atalay, Adugnaw Atnafu] St Paul Millennium Coll, Coll Hlth Sci, Dept Internal Med, Addis Ababa, Ethiopia; [Abebe, Reta Kassa] Dilla Univ, Coll Hlth Sci, Sch Publ Hlth, Dilla, Ethiopia; [Dadhi, Aberash Eifa] Hawassa Univ, Coll Hlth Sci, Dept Midwifery, Hawassa, Ethiopia; [Bededa, Worku Ketema] Hawassa Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Hawassa, Ethiopia	Dilla University; Hawassa University; Hawassa University	Bededa, WK (corresponding author), Hawassa Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Hawassa, Ethiopia.	workuketema@gmail.com		Ketema, Worku/0000-0001-7056-6999	Ministry of Science and Higher Education and supervision of Dilla University College of Medicine and Health Sciences	Ministry of Science and Higher Education and supervision of Dilla University College of Medicine and Health Sciences	This study was funded by the Ministry of Science and Higher Education and supervision of Dilla University College of Medicine and Health Sciences. The funding organization has no role in the design of study and data collection, analysis, interpretation of the results and preparation of manuscript.	al TYe, 2015, SEROPREVALENCE PREDI, P1; [Anonymous], 2007, EPIDEMIOLOGY UPDATE, P3; [Anonymous], 2013, AFR HEALTH SCI, V13; Bayo P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005889; Bittaye M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3883-9; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Desta M, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/3916864; Dortey BA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232208; Dwivedi M, 2011, INDIAN J GASTROENTER, V30, P66, DOI 10.1007/s12664-011-0083-y; Eke AC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-12; Gary L, 2003, HEPATITIS B SURFACE; Gatanaga H, 2000, EUR J CLIN MICROBIOL, V19, P237, DOI 10.1007/s100960050468; Gitlin N, 1997, CLIN CHEM, V43, P1500; Health FMo, 2015, NATL EXPANDED PROGRA, V2 2, P2; Kolawole OM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-317; Lem EA., 2016, EUROPEAN J RES MEDIC, V4; Mahamat A, 2010, AM J TROP MED HYG, V83, P711, DOI 10.4269/ajtmh.2010.09-0727; Mohammed Seid B.G., 2014, ADV LIFE SCI HLTH, V1; Olokoba AB, 2011, NIGER J CLIN PRACT, V14, P10, DOI 10.4103/1119-3077.79232; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P349, DOI 10.1001/jama.2019.9365; Sathiyakala Rajendiran UG, KARTHIKA JAYAKUMAR S; Shukla S., 2011, J BIOSCIENCE TECHNOL, V2, P279; Sisay kibray, 2014, SEROPREVALENCE HBSAG, P38; Stewart RD, 2013, VACCINES, V1, P167, DOI 10.3390/vaccines1020167; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Umare A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166936; W.H.O, 2013, DEP COMMUNICABLE DIS; Walle F., 2008, ETHIOPIA JHEALTH SCI, V17, P13; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; WHO, 2020, COR DIS COVID 19 PAN; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Yohanes T., 2016, HINDAWI PUBLISHING C, V3	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249216	10.1371/journal.pone.0249216	http://dx.doi.org/10.1371/journal.pone.0249216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF4TN	33765065	Green Published, gold			2022-12-26	WOS:000634832800078
J	Youssef, L; Hallit, S; Sacre, H; Salameh, P; Cherfan, M; Akel, M; Hleyhel, M				Youssef, Lara; Hallit, Souheil; Sacre, Hala; Salameh, Pascale; Cherfan, Michelle; Akel, Marwan; Hleyhel, Mira			Knowledge, attitudes and practices towards people living with HIV/AIDS in Lebanon	PLOS ONE			English	Article							HIV-RELATED STIGMA; HUMAN-IMMUNODEFICIENCY-VIRUS; MIDDLE-EAST; HEALTH; WOMEN; TRENDS	Background Up till today, studies carried in Lebanon have focused more on the prevalence of HIV and behaviors and quality of life of infected individuals, however, none of these studies discussed the degree of stigma towards these populations. Therefore, the aim of this study is to measure the rate of stigma in terms of knowledge, attitude and practice towards patients living with Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) (PLWHA) and examine the factors associated with this stigma. Methods A cross-sectional survey, enrolling 862 participants, was carried across the five governorates in Lebanon: Beirut, Mount Lebanon, North, South and Bekaa. The survey was a self-administered questionnaire which covered information about participants' general demographics, their knowledge, attitudes, practices and awareness towards HIV/AIDS in Lebanon., attitudes towards PLWHA, practices related to HIV/AIDS and awareness regarding HIV/AIDS situation in Lebanon. Results The response rate to the survey was 78.36% (862 participants). Being Muslim (Beta = -2.56) or Druze (Beta = -2.64) compared to Christians were significantly associated with lower knowledge towards HIV/AIDS, whereas having a secondary (Beta = 2.71) and a university (Beta = 3.04) levels of education compared to illiteracy and higher age (Beta = 0.05) were significantly associated with higher knowledge. Higher knowledge (Beta = 0.66) was significantly associated with better attitude, whereas higher age (Beta = -0.14) and being Muslim compared to Christian (Beta = -3.44) were significantly associated with worse attitude. Better attitude (Beta = 0.02) was significantly associated with better practice, whereas females compared to males (Beta = -0.39), having a secondary level of education compared to illiteracy (Beta = -0.88) and being Muslim compared to Christian (Beta = -0.32) were significantly associated with worse practice. Conclusion Our results stress the need for educational programs, advocacy campaigns and policies to help reduce HIV stigma. This will then help start developing interventions and strategies for a possible reduction in the stigmatization level.	[Youssef, Lara] Univ Balamand UOB, Dept Med & Med Sci, Al Kurah, Lebanon; [Hallit, Souheil] Holy Spirit Univ Kaslik USEK, Fac Med & Med Sci, Jounieh, Lebanon; [Hallit, Souheil; Sacre, Hala; Salameh, Pascale; Cherfan, Michelle; Akel, Marwan; Hleyhel, Mira] INSPECT LB Natl Inst Publ Hlth Clin Epidemiol & T, Beirut, Lebanon; [Salameh, Pascale] Lebanese Univ, Fac Pharm, Beirut, Lebanon; [Salameh, Pascale] Univ Nicosia, Fac Med, Nicosia, Cyprus; [Cherfan, Michelle; Akel, Marwan] Lebanese Int Univ, Sch Pharm, Beirut, Lebanon; [Hleyhel, Mira] Lebanese Univ, Fac Publ Hlth, Fanar, Lebanon; [Hleyhel, Mira] Lebanese Univ, Pharmacoepidemiol Surveillance Unit, Ctr Res Publ Hlth, CERIPH,Fac Publ Hlth, Fanar, Lebanon	Lebanese University; University of Nicosia; Lebanese University; Lebanese University	Youssef, L (corresponding author), Univ Balamand UOB, Dept Med & Med Sci, Al Kurah, Lebanon.; Hallit, S (corresponding author), Holy Spirit Univ Kaslik USEK, Fac Med & Med Sci, Jounieh, Lebanon.; Hallit, S (corresponding author), INSPECT LB Natl Inst Publ Hlth Clin Epidemiol & T, Beirut, Lebanon.	lara.s.youssef@balamand.edu.lb; souheilhallit@hotmail.com	Salameh, Pascale/F-9676-2011; Sacre, Hala/O-7644-2019; Youssef, lara/HCH-6094-2022; Hallit, Souheil/R-6727-2018	Salameh, Pascale/0000-0002-4780-0772; Sacre, Hala/0000-0001-6547-6251; Youssef, Lara/0000-0003-3259-0706; Hallit, Souheil/0000-0001-6918-5689; Cherfane, Michelle/0000-0002-6438-0159				Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Azar M, 2016, SEX REPROD HEALTHC, V8, P13, DOI 10.1016/j.srhc.2016.01.001; Badahdah AM, 2010, J TRANSCULT NURS, V21, P386, DOI 10.1177/1043659609360873; Beer Linda, 2019, J Int Assoc Provid AIDS Care, V18, p2325958218823541, DOI 10.1177/2325958218823541; Bowen P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2756-z; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; Clark KA, 2017, CULT HEALTH SEX, V19, P996, DOI 10.1080/13691058.2017.1282045; Coleman JD, 2016, AM J PUBLIC HEALTH, V106, P492, DOI 10.2105/AJPH.2015.302985; DeJong Jocelyn, 2015, J Int AIDS Soc, V18, P20084, DOI 10.7448/IAS.18.1.20084; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; Farotimi Adekunbi A, 2015, Iran J Nurs Midwifery Res, V20, P705, DOI 10.4103/1735-9066.170011; Farouq A., 2016, EXPLORATORY CASE STU; Gallant JE, 2017, J INFECT DIS, V216, pS624, DOI 10.1093/infdis/jix238; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Gokengin D, 2016, INT J INFECT DIS, V44, P66, DOI 10.1016/j.ijid.2015.11.008; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Jain M., 2017, J COMM ACQ INFEC, V4, P6, DOI [10.4103/2225-6482.203265, DOI 10.4103/2225-6482.203265]; Jeelani S, 2015, J PHARM BIOALLIED SC, V7, P509, DOI 10.4103/0975-7406.163520; Kahhaleh J. G., 2009, Eastern Mediterranean Health Journal, V15, P920; Li ATW, 2018, AIDS CARE, V30, P739, DOI 10.1080/09540121.2017.1391982; Lohiniva AL, 2016, AIDS CARE, V28, P644, DOI 10.1080/09540121.2015.1124974; Maatouk I., 2019, AUTHOREA PREPRINTS; Melhem NM, 2015, WORLD J HEPATOL, V7, P2619, DOI 10.4254/wjh.v7.i25.2619; Nkawana P, 2014, J GLOBAL EC; Parker R, 2012, CAD SAUDE PUBLICA, V28, P164, DOI 10.1590/S0102-311X2012000100017; Sadeghi M, 2009, J DENT EDUC, V73, P740; Sayles JN, 2007, J URBAN HEALTH, V84, P814, DOI 10.1007/s11524-007-9220-4; Shokoohi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161849; Sohn Aeree, 2012, Osong Public Health Res Perspect, V3, P24, DOI 10.1016/j.phrp.2012.01.004; Statistics Solutions, 2013, NORMALITY; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Thomson C, 1999, HEALTH EDUC RES, V14, P357, DOI 10.1093/her/14.3.357; Tiittala P, 2018, J IMMIGR MINOR HEALT, V20, P1415, DOI 10.1007/s10903-018-0707-8; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UNAIDS, 2018, COUNTR FACTSH LEB 20; UNAIDS, GLOB HIV AIDS STAT 2; Yimer, 2014, SCI J PUBLIC HLTH, V2, P78; Zhang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151078	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2021	16	3							e0249025	10.1371/journal.pone.0249025	http://dx.doi.org/10.1371/journal.pone.0249025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF4TN	33765069	Green Published, gold			2022-12-26	WOS:000634832800093
J	Temesgen, MM; Alemu, T; Shiferaw, B; Legesse, S; Zeru, T; Haile, M; Gelanew, T				Temesgen, Minwuyelet Maru; Alemu, Tefera; Shiferaw, Birtukan; Legesse, Seid; Zeru, Taye; Haile, Mahteme; Gelanew, Tesfaye			Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; NEGATIVE WOMEN; CANCER; RISK; CYTOLOGY; BURDEN	Background Human papillomavirus (HPV) infection is considered as the major risk factor for the development of cervical cancer, second most frequent cancer in Ethiopia. However, the magnitude of the problem and the associated factors remain unrevealed in the Amhara region. This study aimed to determine the prevalence of HPV infection and factors contributing to the progression of HPV infection to cervical cancer. Methods Facility-based cross-sectional study design was employed among women aged 21 to 49 years of age who came for routine cervical cancer screening to 4 randomly selected hospitals (2 general and 2 referral) of Amhara region from May to October, 2019. The sample size was calculated by using the single population proportion formula, proportionated to hospitals, and women were recruited consecutively. Socio demographic and clinical data were collected using a pretested questionnaire and detection of HPV infection was done using HPV test (OncoE6(TM) Cervical Test) specific to HPV16/18 in cervical swabs. Visual inspection with acetic acid (VIA) was used to determine cervical lesions (precancerous and cancerous). Descriptive statistics and bivariate and multivariate logistic regression were used to describe HR-HPV and cervical lesions burden and association between HR-HPV, and cervical lesions and potential risk factors. Results Among 337 women 21 to 49 years (median age of 35 years +/- SD = 7.1 years) of age enrolled in the study, The overall prevalence of oncogenic HPVs (HPV16/18) and the VIA-positivity rate, possible an indicative of cervical lesions, were 7.1% and 13.1%, respectively. Logistic regression analysis showed a significant association between early age of first sexual intercourse (COR = 2.26; 95% CI: 1.0-5.05) and level of education (COR = 0.31; 95% CI: 0.12-0.78) with cervical lesions. Higher odds of HPV positivity (COR = 1.56; 95% CI: 0.59-4.11, p = 0.36) and VIA positivity (COR = 1.39; 95% CI: 0.64-3.00, p = 0.39) were observed among participants who had a history of sexually transmitted illnesses (STIs). Conclusions There was a relatively low prevalence of oncogenic HPV 16/18 and VIA-positivity in women attending four hospitals in the Amhara Region. Early age sexual contact, high parity, and being uneducated/low level of education were independently associated factors with HR-HPV infection and development of cervical lesions, highlighting the importance of prioritizing the limited HPV testing to those risk groups.	[Temesgen, Minwuyelet Maru; Alemu, Tefera; Shiferaw, Birtukan; Legesse, Seid] Amhara Publ Hlth Inst Dessie Branch, Dessie, Ethiopia; [Zeru, Taye; Haile, Mahteme] Amhara Publ Hlth Inst, Bahir Dar, Ethiopia; [Gelanew, Tesfaye] Armauer Hansen Res Inst, Addis Ababa, Ethiopia		Temesgen, MM (corresponding author), Amhara Publ Hlth Inst Dessie Branch, Dessie, Ethiopia.	minwuyelet@yahoo.com	Temesgen, Minwuyelet/GRJ-9375-2022	zeru, Taye/0000-0003-0736-2955; Temesgen, Minwuyelet Maru/0000-0002-0058-7548				Abate S.M., 2016, CERV CANC, V1; Adewuyi SA, 2008, EUR J GYNAECOL ONCOL, V29, P61; Ali KE, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5953-1; Ameya G, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0444-5; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Ardahan M, 2011, CANCER NURS, V34, P158, DOI 10.1097/NCC.0b013e3181efe69f; Aweke YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181415; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; Bekele A, 2010, TROP MED INT HEALTH, V15, P890, DOI 10.1111/j.1365-3156.2010.02552.x; Bobdey S, 2016, INDIAN J MED PAEDIAT, V37, P278, DOI 10.4103/0971-5851.195751; Branca M, 2004, EUR J GYNAECOL ONCOL, V25, P689; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; Chan CK, 2019, J ONCOL, V2019, DOI 10.1155/2019/3257939; ChangClaude J, 1996, GYNECOL ONCOL, V60, P355, DOI 10.1006/gyno.1996.0055; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; De Vuyst H, 2010, CANCER CAUSE CONTROL, V21, P2309, DOI 10.1007/s10552-010-9645-z; Deksissa Zewdie Mulissa, 2015, BMC Res Notes, V8, P618, DOI 10.1186/s13104-015-1594-x; Deng Dongrui, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P343; Denny L, 2015, INT J GYNECOL OBSTET, V131, pS28, DOI 10.1016/j.ijgo.2015.02.009; Denny L, 2012, CANCER EPIDEM BIOMAR, V21, P1434, DOI 10.1158/1055-9965.EPI-12-0334; Dinc B, 2010, BRAZ J INFECT DIS, V14, P19, DOI 10.1590/S1413-86702010000100005; Gebremariam T., 2016, INT J HLTH SCI QASSI, V10; Gedefaw A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084519; Getinet M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0016-2; Ghosh I, 2016, J CLIN DIAGN RES, V10, pXE1, DOI 10.7860/JCDR/2016/15305.7173; Gupta S., 2015, BIOMED PHARMACOL J, V3, P179; Hailemariam T., 2017, SO ETHIOPIA, V9; Health F.M., 2015, GUID CERV CANC PREV; Kang LN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-96; Kassa Roza Teshome, 2018, BMC Res Notes, V11, P145, DOI 10.1186/s13104-018-3244-6; Leyh-Bannurah SR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-33; Mukanyangezi MF, 2019, HIV MED, V20, P485, DOI 10.1111/hiv.12782; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Ruland R, 2006, EUR J EPIDEMIOL, V21, P727, DOI 10.1007/s10654-006-9055-4; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Salih Magdi M, 2010, Infect Agent Cancer, V5, P26, DOI 10.1186/1750-9378-5-26; Shader RI, 2016, CLIN THER, V38, P429, DOI 10.1016/j.clinthera.2016.02.017; Silva J, 2014, ARCH GYNECOL OBSTET, V289, P715, DOI 10.1007/s00404-013-3122-3; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wolday D, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0201-x; World Health Organization, 2012, PREVENTION CERVICAL	41	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2021	16	3							e0248949	10.1371/journal.pone.0248949	http://dx.doi.org/10.1371/journal.pone.0248949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC8FS	33760866	Green Published, gold			2022-12-26	WOS:000633030400059
J	Bertoldi, V; Rondoni, G; Peri, E; Conti, E; Brodeur, J				Bertoldi, Valeria; Rondoni, Gabriele; Peri, Ezio; Conti, Eric; Brodeur, Jacques			Learning can be detrimental for a parasitic wasp	PLOS ONE			English	Article							MARMORATED STINK BUG; EGG PARASITOIDS; HEMIPTERA-PENTATOMIDAE; VEGETABLE CROPS; HOST; SEMIOCHEMICALS; HETEROPTERA; HYMENOPTERA; PREDATION; LOCATION	Animals have evolved the capacity to learn, and the conventional view is that learning allows individuals to improve foraging decisions. The parasitoid Telenomus podisi has been shown to parasitize eggs of the exotic stink bug Halyomorpha halys at the same rate as eggs of its coevolved host, Podisus maculiventris, but the parasitoid cannot complete its development in the exotic species. We hypothesized that T. podisi learns to exploit cues from this non-coevolved species, thereby increasing unsuccessful parasitism rates. We conducted bioassays to compare the responses of naive vs. experienced parasitoids on chemical footprints left by one of the two host species. Both naive and experienced females showed a higher response to footprints of P. maculiventris than of H. halys. Furthermore, parasitoids that gained an experience on H. halys significantly increased their residence time within the arena and the frequency of re-encounter with the area contaminated by chemical cues. Hence, our study describes detrimental learning where a parasitoid learns to associate chemical cues from an unsuitable host, potentially re-enforcing a reproductive cul-de-sac (evolutionary trap). Maladaptive learning in the T. podisi-H. halys association could have consequences for population dynamics of sympatric native and exotic host species.	[Bertoldi, Valeria; Rondoni, Gabriele; Conti, Eric] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambientali, Perugia, Italy; [Peri, Ezio] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Brodeur, Jacques] Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ, Canada	University of Perugia; University of Palermo; Universite de Montreal	Brodeur, J (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Sci Biol, Montreal, PQ, Canada.	jacques.brodeur@umontreal.ca		Brodeur, Jacques/0000-0001-6148-7877; RONDONI, GABRIELE/0000-0002-1797-0842	Innovation Staff Exchange (RISE) H2020-MSCA-RISE-2015 of the European Union; project Impact of invasive alien true bug species in native trophic webs INVASION [GA 690952]	Innovation Staff Exchange (RISE) H2020-MSCA-RISE-2015 of the European Union; project Impact of invasive alien true bug species in native trophic webs INVASION	This work was supported by Innovation Staff Exchange (RISE) H2020-MSCA-RISE-2015 of the European Union with the project Impact of invasive alien true bug species in native trophic webs INVASION (GA 690952) awarded to E.P, E.C and J.B.	Abram PK, 2014, BIOL INVASIONS, V16, P1387, DOI 10.1007/s10530-013-0576-y; Abram PK, 2017, PEERJ, V5, DOI 10.7717/peerj.3097; Abram PK, 2016, BIOL J LINN SOC, V117, P620, DOI 10.1111/bij.12658; ARTHUR AP, 1971, CAN ENTOMOL, V103, P1137, DOI 10.4039/Ent1031137-8; Berthon K, 2015, BIOL INVASIONS, V17, P2199, DOI 10.1007/s10530-015-0874-7; Borges M, 2003, PHYSIOL ENTOMOL, V28, P349, DOI 10.1111/j.1365-3032.2003.00350.x; Botch PS, 2018, ENVIRON ENTOMOL, V47, P403, DOI 10.1093/ee/nvy014; Boyle SM, 2020, BIOL CONTROL, V149, DOI 10.1016/j.biocontrol.2020.104324; Bradley BA, 2019, P NATL ACAD SCI USA, V116, P9919, DOI 10.1073/pnas.1818081116; Cameron EK, 2016, GLOBAL ECOL BIOGEOGR, V25, P596, DOI 10.1111/geb.12436; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Conti E, 2004, BIOL CONTROL, V29, P435, DOI 10.1016/j.biocontrol.2003.08.009; Conti E, 2003, J CHEM ECOL, V29, P115, DOI 10.1023/A:1021980614512; Cornelius ML, 2016, ENVIRON ENTOMOL, V45, P1536, DOI 10.1093/ee/nvw134; Costi E, 2020, BIOL CONTROL, V151, DOI 10.1016/j.biocontrol.2020.104396; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Floyd R.B., 1995, NICHOLSON CENTENARY, P254; Gariepy TD, 2019, MOL ECOL, V28, P456, DOI 10.1111/mec.14868; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Guerra-Grenier E, 2020, BEHAV ECOL, V31, P1391, DOI 10.1093/beheco/araa096; Haverkamp A, 2020, CURR OPIN INSECT SCI, V42, P47, DOI 10.1016/j.cois.2020.09.003; Haye T, 2015, J PEST SCI, V88, P693, DOI 10.1007/s10340-015-0671-1; Heimpel GE, 2003, ECOL LETT, V6, P556, DOI 10.1046/j.1461-0248.2003.00466.x; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoogendoorn M, 2002, BIOL CONTROL, V25, P224, DOI 10.1016/S1049-9644(02)00101-9; Jones AL, 2014, BIOL CONTROL, V78, P61, DOI 10.1016/j.biocontrol.2014.07.011; Konig K, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1850; Konopka JK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33756-6; Koppel AL, 2009, ENVIRON ENTOMOL, V38, P375, DOI 10.1603/022.038.0209; Kruidhof HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039615; Leadbeater E, 2009, CONTEMP TOP ENTOMOL, P135; Leung K, 2020, BIOL REV, V95, P1838, DOI 10.1111/brv.12641; LEWIS WJ, 1988, NATURE, V331, P257, DOI 10.1038/331257a0; Martorana L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55396-0; Nieberding CM, 2018, CURR OPIN INSECT SCI, V27, P75, DOI 10.1016/j.cois.2018.03.008; Papaj D.R., 1993, INSECT LEARNING ECOL; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Peri E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27098; Prokopy Ronald J., 1993, P308; R Core Team, 2020, R LANG ENV STAT COMP; Rice AM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0542; Robertson BA, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.116; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Smid HM, 2016, CURR OPIN INSECT SCI, V15, P61, DOI 10.1016/j.cois.2016.03.008; Tognon R, 2019, ENVIRON ENTOMOL, V48, P211, DOI 10.1093/ee/nvy186; Turlings Ted C. J., 1993, P51; VET LEM, 1990, J CHEM ECOL, V16, P3119, DOI 10.1007/BF00979615; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; WARDLE AR, 1986, NATURWISSENSCHAFTEN, V73, P559, DOI 10.1007/BF00368168; YEARGAN KV, 1979, ENVIRON ENTOMOL, V8, P715, DOI 10.1093/ee/8.4.715; Zhou Y, 2014, ENTOMOL EXP APPL, V151, P106, DOI 10.1111/eea.12173; Zuur AF, 2007, STAT BIOL HEALTH, P1	56	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2021	16	3							e0238336	10.1371/journal.pone.0238336	http://dx.doi.org/10.1371/journal.pone.0238336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RC6NY	33755694	gold, Green Submitted, Green Published			2022-12-26	WOS:000632916600039
J	Bonin-Jacob, CM; Almeida-Lugo, LZ; Puga, MAM; Machado, AP; Padovani, CTJ; Noceti, MC; Ferreira, AMT; Fernandes, CED; Resende, JCP; Bovo, AC; Tozetti, IA				Bonin-Jacob, Camila Mareti; Almeida-Lugo, Larissa Zatorre; Moreira Puga, Marco Antonio; Machado, Ana Paula; Junqueira Padovani, Cacilda Tezelli; Noceti, Mariana Calarge; Teixeira Ferreira, Alda Maria; dos Santos Fernandes, Carlos Eurico; Possati Resende, Julio Cesar; Bovo, Adriane Cristina; Tozetti, Ines Aparecida			IL-6 and IL-10 in the serum and exfoliated cervical cells of patients infected with high-risk human papillomavirus	PLOS ONE			English	Article							LOCAL IMMUNOSUPPRESSION; IMMUNE-RESPONSE; HPV INFECTION; TH17 CELLS; CANCER; WOMEN; GROWTH; INTERLEUKIN-6; EXPRESSION; CYTOKINES	Persistent infection by high-risk human papillomavirus (HR-HPV) is the main cause of cervical cancer and its precursor lesions. While some cytokines help immune cells in virus clearance, others contribute to the persistence of infection and neoplastic progression. Here, the levels of interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, interleukin (IL)-10, IL-6, IL-4, and IL-2 were quantified in the serum and exfoliated cervical cells (ECCs) of patients with HR-HPV, and the presence of IL-6(+) cells was investigated in uterine cervix biopsies. Cytokine levels in the serum and ECCs of 26 HR-HPV DNA-positive patients and 18 HPV DNA-negative patients were measured using flow cytometry. Fifteen uterine cervix biopsy samples embedded in paraffin were subjected to immunohistochemical analysis for the detection of IL-6(+) cells. HR-HPV-positive patients showed increased IL-6 and IL-10 in the ECCs and serum, respectively. Compared with HPV DNA-positive patients, HPV DNA-negative patients had higher levels of IL-6 in ECCs. Patients with multiple infections of HPV had higher levels of IL-6 in their ECCs than those with a single infection. Immunostaining of uterine cervix biopsy samples revealed no differences in IL-6 expression between the different classes of histopathological lesions. However, differences were observed in the expression levels of IL-6 and IL-10 at the systemic and local levels in HR-HPV-positive patients without cervical lesions. Considering the functional characteristics of these cytokines, it can be inferred that such patients are prone to persistent HPV infection.	[Bonin-Jacob, Camila Mareti; Almeida-Lugo, Larissa Zatorre; Moreira Puga, Marco Antonio] Fed Univ Mato Grosso do Sul UFMS, Postgrad Program Infect & Parasitary Dis Med Sch, Campo Grande, MS, Brazil; [Bonin-Jacob, Camila Mareti; Junqueira Padovani, Cacilda Tezelli; Noceti, Mariana Calarge; Teixeira Ferreira, Alda Maria; dos Santos Fernandes, Carlos Eurico] Univ Fed Mato Grosso do Sul, Biosci Inst, Campo Grande, MS, Brazil; [Machado, Ana Paula; Tozetti, Ines Aparecida] Univ Fed Mato Grosso do Sul, Multicentr Program Postgrad Biochem & Mol Biol, Inst Biosci, Campo Grande, MS, Brazil; [Possati Resende, Julio Cesar] Barretos Canc Hosp, Dept Canc Prevent, Barretos, SP, Brazil; [Bovo, Adriane Cristina] Barretos Canc Hosp, Dept Canc Prevent, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos	Puga, MAM (corresponding author), Fed Univ Mato Grosso do Sul UFMS, Postgrad Program Infect & Parasitary Dis Med Sch, Campo Grande, MS, Brazil.	marco.m.puga@gmail.com	Puga, Marco Antonio/L-5560-2014	Puga, Marco Antonio/0000-0002-6514-537X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [406148/2016-3]; Fundacao Universidade Federal de Mato Grosso do Sul UFMS/MEC-Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Universidade Federal de Mato Grosso do Sul UFMS/MEC-Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant number: 406148/2016-3) and financed in part by Fundacao Universidade Federal de Mato Grosso do Sul UFMS/MEC-Brazil. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KS, 2012, J IMMUNOTOXICOL, V9, P168, DOI 10.3109/1547691X.2011.642419; Alshaker HA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-33; Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693; Bonin CM, 2019, J MED VIROL, V91, P317, DOI 10.1002/jmv.25312; Bonin CM, 2019, CYTOKINE, V120, P92, DOI 10.1016/j.cyto.2019.04.008; Bosch FX., 2012, VACCINE, V31, pG1; Brunni L., 2017, HUMAN PAPILLOMAVIRUS; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chopra V, 1998, CANCER INVEST, V16, P152, DOI 10.3109/07357909809050029; de Almeida FG, 2014, J MED VIROL, V86, P266, DOI 10.1002/jmv.23725; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; EUSTACE D, 1993, GYNECOL ONCOL, V50, P15, DOI 10.1006/gyno.1993.1156; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; Kim TJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6317; KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133, DOI 10.1146/annurev.iy.03.040185.001025; Kyrgiou M, 2017, TRANSL RES, V179, P168, DOI 10.1016/j.trsl.2016.07.004; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lieberman JA, 2008, CLIN VACCINE IMMUNOL, V15, P49, DOI 10.1128/CVI.00216-07; Liu CT, 2016, MOL MED REP, V13, P5068, DOI 10.3892/mmr.2016.5195; Prata TTM, 2015, IMMUNOLOGY, V146, P113, DOI 10.1111/imm.12487; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OKADA M, 1988, J IMMUNOL, V141, P1543; Paaso A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0498-9; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Salazar KL, 2015, ACTA CYTOL, V59, P391, DOI 10.1159/000442512; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Scott M, 2001, CLIN DIAGN LAB IMMUN, V8, P209, DOI 10.1128/CDLI.8.2.209-220.2001; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Song ZW, 2016, MED SCI MONITOR, V22, P4475, DOI 10.12659/MSM.898569; Takeshita S, 1996, J IMMUNOL, V156, P2591; Tjiong MY, 1999, GYNECOL ONCOL, V73, P285, DOI 10.1006/gyno.1999.5358; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Vidal AC, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0005-1; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wei LH, 2001, GYNECOL ONCOL, V82, P49, DOI 10.1006/gyno.2001.6235; Wentzensen N, 2009, INT J CANCER, V124, P964, DOI 10.1002/ijc.23969; Xue JS, 2018, CANCER MED-US, V7, P297, DOI 10.1002/cam4.1279; Zanotta N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151851	44	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2021	16	3							e0248639	10.1371/journal.pone.0248639	http://dx.doi.org/10.1371/journal.pone.0248639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB2TH	33750983	gold, Green Published			2022-12-26	WOS:000631967100005
J	Kim, SH; Jeong, JB; Kang, J; Ahn, DW; Kim, JW; Kim, BG; Lee, KL; Oh, S; Yoon, SH; Park, SJ; Lee, DH				Kim, Su Hwan; Jeong, Ji Bong; Kang, Jinwoo; Ahn, Dong-Won; Kim, Ji Won; Kim, Byeong Gwan; Lee, Kook Lae; Oh, Sohee; Yoon, Soon Ho; Park, Sang Joon; Lee, Doo Hee			Association between sarcopenia level and metabolic syndrome	PLOS ONE			English	Article								Aims Metabolic syndrome (MetS) increases the risk of diabetes mellitus (DM), cardiovascular disease (CVD), cancer, and mortality. Sarcopenia has been reported as a risk factor for MetS, non-alcoholic fatty liver disease, and CVD. To date, the association between sarcopenia and MetS has been investigated. However, there have been few studies on the dose-response relationship between sarcopenia and MetS. We investigated the association between sarcopenia and the prevalence of MetS. We also aimed to analyze the dose-response relationship between skeletal muscle mass and the prevalence of MetS. Methods We enrolled 13,620 participants from October 2014 to December 2019. Skeletal muscle mass was measured using bioelectrical impedance analysis (BIA). Appendicular skeletal muscle mass (ASM) was divided by body weight (kg) and was expressed as a percentage (ASM x 100/Weight, ASM%). The quartiles of ASM% were calculated for each gender, with Q1 and Q4 being the lowest and highest quartiles of ASM%, respectively. The quartiles of ASM% were calculated for each gender, with Q1 and Q4 being the lowest and highest quartiles of ASM%, respectively. Linear regression and logistic regression analyses were used to compare the clinical parameters according to ASM%, adjusted for age, sex, obesity, hypertension (HT), DM, dyslipidemia (DL), smoking, alcohol intake, and C-reactive protein (CRP). Multiple logistic regression analysis was performed to determine the risk of MetS in each group. Results A dose-response relationship was identified between ASM% and MetS. Sarcopenia was associated with an increased prevalence of MetS. After adjustment for age, sex, obesity, HT, DM, DL, smoking, alcohol intake, and CRP, sarcopenia remained significantly associated with MetS. For each 1 quartile increment in ASM%, the risk of MetS decreased by 56% (P< 0.001). After adjusting for age, sex, obesity, HT, DM, DL, smoking, alcohol intake, and CRP, the risk of MetS decreased by 25% per 1Q increment in ASM% (P < 0.001). Conclusions Sarcopenia by BIA is independently associated with the risk of MetS and has a dose-response relationship.	[Kim, Su Hwan; Jeong, Ji Bong; Kang, Jinwoo; Ahn, Dong-Won; Kim, Ji Won; Kim, Byeong Gwan; Lee, Kook Lae] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Boramae Med Ctr,Coll Med, Seoul, South Korea; [Kim, Su Hwan] Seoul Natl Univ, Hlth Care Ctr, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Oh, Sohee] Seoul Natl Univ, Med Res Collaborating Ctr, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Yoon, Soon Ho; Park, Sang Joon] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Lee, Doo Hee] MEDICALIP Co Ltd, Dept Res & Dev, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeong, JB (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Boramae Med Ctr,Coll Med, Seoul, South Korea.	jibjeong@gmail.com	Yoon, Soon Ho/AAL-1640-2020; KIM, SUHWAN/GSE-0120-2022	Yoon, Soon Ho/0000-0002-3700-0165; Kim, Su Hwan/0000-0001-6444-7969; Lee, Doohee/0000-0002-5838-6925; Jeong, Ji Bong/0000-0003-4553-1721				Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Butler J, 2008, AM J CARDIOL, V101, P1127, DOI 10.1016/j.amjcard.2007.12.012; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Ida S, 2015, ANN SURG ONCOL, V22, P4432, DOI 10.1245/s10434-015-4559-3; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jeon HH, 2021, KOREAN J INTERN MED, V36, P97, DOI 10.3904/kjim.2018.427; Kim DH, 2019, ANN GERIATR MED RES, V23, P141, DOI 10.4235/agmr.19.0030; Kim G, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0659-2; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee MJ, 2019, GUT LIVER, V13, P67, DOI 10.5009/gnl18070; Lee YH, 2014, J CLIN ENDOCR METAB, V99, P3879, DOI 10.1210/jc.2013-3764; Lim S, 2005, DIABETES RES CLIN PR, V70, P126, DOI 10.1016/j.diabres.2005.02.020; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Lu CW, 2013, OBES RES CLIN PRACT, V7, pE301, DOI 10.1016/j.orcp.2012.02.003; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Moon SS, 2014, ENDOCR J, V61, P61, DOI 10.1507/endoc; Ng AC, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.12; Ogawa H, 2011, HEPATO-GASTROENTEROL, V58, P42; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Park SJ, 2019, METAB SYNDR RELAT D, V17, P494, DOI 10.1089/met.2019.0059; Park SH, 2014, CLIN NUTR, V33, P668, DOI 10.1016/j.clnu.2013.08.008; Park YS, 2017, INT J COLORECTAL DIS, V32, P557, DOI 10.1007/s00384-016-2738-8; Prado CMM, 2012, CLIN NUTR, V31, P583, DOI 10.1016/j.clnu.2012.06.010; Ranasinghe C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-797; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Schneider SM, 2020, NUTRITION, V69, DOI 10.1016/j.nut.2019.110581; Schweitzer L, 2015, AM J CLIN NUTR, V102, P58, DOI 10.3945/ajcn.115.111203; Seo DH, 2020, ATHEROSCLEROSIS, V305, P19, DOI 10.1016/j.atherosclerosis.2020.05.021; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Steering Committee, 2000, ASIA PACIFIC PERSPEC; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Unno M, 2012, J ATHEROSCLER THROMB, V19, P462; Yamakage H, 2014, ENDOCR J, V61, P807, DOI 10.1507/endocrj.EJ14-0092; Younis A, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0466-6; Zajac-Gawlak I, 2017, BIOGERONTOLOGY, V18, P357, DOI 10.1007/s10522-017-9693-9; Zhang HQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030364; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	50	14	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2021	16	3							e0248856	10.1371/journal.pone.0248856	http://dx.doi.org/10.1371/journal.pone.0248856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HS	33739984	gold, Green Published			2022-12-26	WOS:000631030200036
J	Candadai, AA; Liu, F; Fouda, AY; Alfarhan, M; Palani, CD; Xu, ZM; Caldwell, RB; Narayanan, SP				Candadai, Amritha A.; Liu, Fang; Fouda, Abdelrahman Y.; Alfarhan, Moaddey; Palani, Chithra D.; Xu, Zhimin; Caldwell, Ruth B.; Narayanan, S. Priya			Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GANGLION-CELL LOSS; MULTIPLE-SCLEROSIS; T-CELLS; AXONAL DEGENERATION; UP-REGULATION; NERVE DAMAGE; MURINE MODEL; MOUSE MODEL; ACUTE-PHASE	Vision impairment due to optic neuritis (ON) is one of the major clinical presentations in Multiple Sclerosis (MS) and is characterized by inflammation and degeneration of the optic nerve and retina. Currently available treatments are only partially effective and have a limited impact on the neuroinflammatory pathology of the disease. A recent study from our laboratory highlighted the beneficial effect of arginase 2 (A2) deletion in suppressing retinal neurodegeneration and inflammation in an experimental model of MS. Utilizing the same model, the present study investigated the impact of A2 deficiency on MS-induced optic neuritis. Experimental autoimmune encephalomyelitis (EAE) was induced in wild-type (WT) and A2 knockout (A2(-/-)) mice. EAE-induced cellular infiltration, as well as activation of microglia and macrophages, were reduced in A2(-/-) optic nerves. Axonal degeneration and demyelination seen in EAE optic nerves were observed to be reduced with A2 deletion. Further, the lack of A2 significantly ameliorated astrogliosis induced by EAE. In conclusion, our findings demonstrate a critical involvement of arginase 2 in mediating neuroinflammation in optic neuritis and suggest the potential of A2 blockade as a targeted therapy for MS-induced optic neuritis.	[Candadai, Amritha A.; Liu, Fang; Alfarhan, Moaddey; Palani, Chithra D.; Narayanan, S. Priya] Univ Georgia, Coll Pharm, Clin & Expt Therapeut, Augusta, GA 30912 USA; [Candadai, Amritha A.; Liu, Fang; Fouda, Abdelrahman Y.; Alfarhan, Moaddey; Palani, Chithra D.; Xu, Zhimin; Caldwell, Ruth B.; Narayanan, S. Priya] Augusta Univ, Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Candadai, Amritha A.; Liu, Fang; Fouda, Abdelrahman Y.; Alfarhan, Moaddey; Narayanan, S. Priya] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA; [Liu, Fang; Fouda, Abdelrahman Y.; Palani, Chithra D.; Xu, Zhimin; Caldwell, Ruth B.; Narayanan, S. Priya] Augusta Univ, Vasc Biol Ctr, Augusta, GA 30912 USA; [Caldwell, Ruth B.; Narayanan, S. Priya] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Narayanan, SP (corresponding author), Univ Georgia, Coll Pharm, Clin & Expt Therapeut, Augusta, GA 30912 USA.; Narayanan, SP (corresponding author), Augusta Univ, Culver Vis Discovery Inst, Augusta, GA 30912 USA.; Narayanan, SP (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA.; Narayanan, SP (corresponding author), Augusta Univ, Vasc Biol Ctr, Augusta, GA 30912 USA.; Narayanan, SP (corresponding author), Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA.	pnarayanan@augusta.edu	Fouda, Abdel/GYI-9576-2022	Candadai, Amritha Anand/0000-0003-3661-8200	National Eye Institute [R01EY028569]; National Institute of Health K99 award [1K99EY029373-01A1]; NIH/NEI [P30EY031631]; University of Georgia	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Health K99 award; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Georgia	This study was supported in part by the National Eye Institute to SPN (R01EY028569), the National Institute of Health K99 award to AF (1K99EY029373-01A1), and a core grant from the NIH/NEI to the Augusta University Vision Discovery Institute (P30EY031631). The University of Georgia provided startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2007, INT REV NEUROBIOL, V79, P99, DOI 10.1016/S0074-7742(07)79005-0; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Alrashdi B, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1622-1; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Badawi AH, 2012, NEUROPHARMACOLOGY, V62, P1874, DOI 10.1016/j.neuropharm.2011.12.013; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Bennett JL, 2015, J NEUROL NEUROSUR PS, V86, P799, DOI 10.1136/jnnp-2014-308185; Bernardes D, 2016, J NEUROCHEM, V136, P63, DOI 10.1111/jnc.13354; BIGNAMI A, 1981, J NEUROPATH EXP NEUR, V40, P537, DOI 10.1097/00005072-198109000-00005; Brambilla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-213; Burman J, 2011, ACTA NEUROL SCAND, V123, P207, DOI 10.1111/j.1600-0404.2010.01388.x; Caldwell RW, 2018, PHYSIOL REV, V98, P641, DOI 10.1152/physrev.00037.2016; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Castegna A, 2011, NEUROSCIENCE, V185, P97, DOI 10.1016/j.neuroscience.2011.04.041; Chinnery HR, 2017, PFLUG ARCH EUR J PHY, V469, P501, DOI 10.1007/s00424-017-1947-5; Choudry M, 2018, IMMUNOLOGY, V155, P85, DOI 10.1111/imm.12926; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; Deng KW, 2009, J NEUROSCI, V29, P9545, DOI 10.1523/JNEUROSCI.1175-09.2009; Dong YF, 2019, NAT REV NEUROL, V15, P704, DOI 10.1038/s41582-019-0253-6; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fang M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02588; Farooqi N, 2010, J NEUROCHEM, V115, P829, DOI 10.1111/j.1471-4159.2010.06982.x; Feng L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0331-16.2016; Filippi M, 2013, LANCET NEUROL, V12, P12, DOI 10.1016/S1474-4422(12)70288-0; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Giannetti P, 2014, NEUROBIOL DIS, V65, P203, DOI 10.1016/j.nbd.2014.01.018; Gimsa U, 2004, J MOL MED-JMM, V82, P364, DOI 10.1007/s00109-004-0531-6; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Greenhalgh AD, 2016, BRAIN BEHAV IMMUN, V56, P61, DOI 10.1016/j.bbi.2016.04.013; Horstmann L, 2016, J NEUROIMMUNOL, V298, P32, DOI 10.1016/j.jneuroim.2016.06.008; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; Jin J, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0767-6; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Khan RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48087-3; Kingwell E, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-128; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Lin TH, 2014, NEUROIMAGE, V100, P244, DOI 10.1016/j.neuroimage.2014.06.009; Ljubisavljevic S, 2012, NEUROSCIENCE, V219, P175, DOI 10.1016/j.neuroscience.2012.05.062; Ljubisavljevic S, 2012, J NEUROL SCI, V318, P106, DOI 10.1016/j.jns.2012.03.015; Ljubisavljevic S, 2011, REDOX REP, V16, P166, DOI 10.1179/1351000211Y.0000000007; Locri F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101447; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Melero-Jerez C, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104869; Melero-Jerez C, 2019, NEUROBIOL DIS, V127, P13, DOI 10.1016/j.nbd.2019.02.014; Moline-Velazquez V, 2014, NEUROBIOL DIS, V67, P149, DOI 10.1016/j.nbd.2014.03.017; Moline-Velazquez V, 2011, BRAIN PATHOL, V21, P678, DOI 10.1111/j.1750-3639.2011.00495.x; Narayanan SP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.23; Nishioka C, 2019, MULT SCLER RELAT DIS, V27, P315, DOI 10.1016/j.msard.2018.11.010; Noristani R, 2016, J MOL NEUROSCI, V58, P470, DOI 10.1007/s12031-015-0707-2; Palani CD, 2019, MOL NEUROBIOL, V56, P8589, DOI 10.1007/s12035-019-01691-w; Parisi Vincenzo, 2003, Semin Ophthalmol, V18, P50; Pau D, 2011, EYE, V25, P832, DOI 10.1038/eye.2011.81; Ponath G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00217; Redondo J, 2015, BRAIN PATHOL, V25, P692, DOI 10.1111/bpa.12230; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Rossetti I, 2018, J NEUROIMMUNOL, V323, P94, DOI 10.1016/j.jneuroim.2018.07.005; Schmidt A, 2017, STROKE, V48, P1061, DOI 10.1161/STROKEAHA.116.015577; Shosha E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.295; Sorensen TL, 1999, NEUROLOGY, V53, P473, DOI 10.1212/WNL.53.3.473; Stojic A, 2018, J NEUROPATH EXP NEUR, V77, P361, DOI 10.1093/jnen/nly011; Su KG, 2012, EUR J NEUROSCI, V35, P562, DOI 10.1111/j.1460-9568.2011.07972.x; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Veremeyko T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00050; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wasser B, 2016, J NEUROIMMUNE PHARM, V11, P721, DOI 10.1007/s11481-016-9696-3; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Wilmes AT, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1208-3; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Xiong YQ, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0301-4; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x; Xu ZM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00970; Zhou YD, 2017, MOL MED REP, V15, P3949, DOI 10.3892/mmr.2017.6491; Zhu YJ, 2017, INT J MOL MED, V40, P281, DOI 10.3892/ijmm.2017.3022; Zwibel Howard L, 2011, Am J Manag Care, V17 Suppl 5 Improving, pS139	82	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247901	10.1371/journal.pone.0247901	http://dx.doi.org/10.1371/journal.pone.0247901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735314	Green Published, gold			2022-12-26	WOS:000631029700001
J	Cao, YP; Yang, R; Lee, I; Zhang, WW; Sun, JN; Meng, XF; Wang, W				Cao, Yipeng; Yang, Rui; Lee, Imshik; Zhang, Wenwen; Sun, Jiana; Meng, Xiangfei; Wang, Wei			Prediction of LncRNA-encoded small peptides in glioma and oligomer channel functional analysis using in silico approaches	PLOS ONE			English	Article							LONG NONCODING RNAS; ION CHANNELS; TUMOR-CELL; SARCOLIPIN; AQUAPORIN-4; PROGRESSION; EXPRESSION; VECTOR; SERCA	Glioma is a lethal malignant brain cancer, and many reports have shown that abnormalities in the behavior of water and ion channels play an important role in regulating tumor proliferation, migration, apoptosis, and differentiation. Recently, new studies have suggested that some long noncoding RNAs containing small open reading frames can encode small peptides and form oligomers for water or ion regulation. However, because the peptides are difficult to identify, their functional mechanisms are far from being clearly understood. In this study, we used bioinformatics methods to identify and evaluate lncRNAs, which may encode small transmembrane peptides in gliomas. Combining ab initio homology modeling, molecular dynamics simulations, and free energy calculations, we constructed a predictive model and predicted the oligomer channel activity of peptides by identifying the lncRNA ORFs. We found that one key hub lncRNA, namely, DLEU1, which contains two smORFs (ORF1 and ORF8), encodes small peptides that form pentameric channels. The mechanics of water and ion (Na+ and Cl-) transport through this pentameric channel were simulated. The potential mean force of the H2O molecules along the two ORF-encoded peptide channels indicated that the energy barrier was different between ORF1 and ORF8. The ORF1-encoded peptide pentamer acted as a self-assembled water channel but not as an ion channel, and the ORF8 permeated neither ions nor water. This work provides new methods and theoretical support for further elucidation of the function of lncRNA-encoded small peptides and their role in cancer. Additionally, this study provides a theoretical basis for drug development.	[Cao, Yipeng; Zhang, Wenwen; Sun, Jiana; Wang, Wei] Tianjin Med Univ, Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Cao, Yipeng; Meng, Xiangfei] TEDA Tianjin Econ Technol Dev Area, Natl Supercomp Ctr Tianjin, Tianjin, Peoples R China; [Yang, Rui] Nankai Univ, Affiliated Hosp, Tianjin Union Med Ctr, Dept Infect & Immun, Tianjin, Peoples R China; [Lee, Imshik] Nankai Univ, Coll Phys, Tianjin, Peoples R China	Tianjin Medical University; Nankai University; Nankai University	Wang, W (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.; Meng, XF (corresponding author), TEDA Tianjin Econ Technol Dev Area, Natl Supercomp Ctr Tianjin, Tianjin, Peoples R China.	mengxf@nscc-tj.cn; weiwang_2@126.com			Science & Technology Development Fund of Tianjin Education Commission for Higher Education [2018KJ067]	Science & Technology Development Fund of Tianjin Education Commission for Higher Education	The manuscript is supported by Science & Technology Development Fund of Tianjin Education Commission for Higher Education (2018KJ067).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Altieri R, 2014, TRANSL MED UNISA, V10, P29; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Cao YP, 2017, PROTEINS, V85, P1065, DOI 10.1002/prot.25273; Cao YP, 2016, ARCH BIOCHEM BIOPHYS, V604, P143, DOI 10.1016/j.abb.2016.06.016; Chen X, 2019, BRIEF FUNCT GENOMICS, V18, P58, DOI 10.1093/bfgp/ely031; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Choi SW, 2019, BRIEF BIOINFORM, V20, P1853, DOI 10.1093/bib/bby055; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Ding T, 2010, J CLIN NEUROSCI, V17, P1359, DOI 10.1016/j.jocn.2010.02.014; Gao FL, 2016, ONCOTARGET, V7, P71330, DOI 10.18632/oncotarget.11114; Griesdale DEG, 2004, SURG NEUROL, V61, P418, DOI 10.1016/j.surneu.2003.10.047; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Han W, 2020, SEP PURIF TECHNOL, V232, DOI 10.1016/j.seppur.2019.115965; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Horner A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400083; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Jing SY, 2016, EUR REV MED PHARMACO, V20, P3992; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu TY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0873-2; Luo YW, 2018, LIFE SCI, V193, P93, DOI 10.1016/j.lfs.2017.12.007; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Payre F, 2016, SCIENCE, V351, P226, DOI 10.1126/science.aad9873; Peng ZX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0812-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Thompson EG, 2016, EUR BIOPHYS J BIOPHY, V45, P635, DOI 10.1007/s00249-016-1154-x; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tunuguntla RH, 2017, SCIENCE, V357, P792, DOI 10.1126/science.aan2438; Umans RA, 2018, NEUROSCI RES, V126, P22, DOI 10.1016/j.neures.2017.09.010; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wu F, 2017, ONCOTARGET, V8, P53110, DOI 10.18632/oncotarget.18162; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang WX, 2016, PROTEINS, V84, P76, DOI 10.1002/prot.24930; Zhu FQ, 2012, BIOPHYS J, V103, P219, DOI 10.1016/j.bpj.2012.06.003; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	66	4	5	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248634	10.1371/journal.pone.0248634	http://dx.doi.org/10.1371/journal.pone.0248634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735310	Green Submitted, Green Published, gold			2022-12-26	WOS:000631029700072
J	Hu, B; Dehmer, M; Emmert-Streib, F; Zhang, B				Hu, Bo; Dehmer, Matthias; Emmert-Streib, Frank; Zhang, Bo			Analysis of the real number of infected people by COVID-19: A system dynamics approach	PLOS ONE			English	Article								At the beginning of 2020, the COVID-19 pandemic was able to spread quickly in Wuhan and in the province of Hubei due to a lack of experience with this novel virus. Additionally, authories had no proven experience with applying insufficient medical, communication and crisis management tools. For a considerable period of time, the actual number of people infected was unknown. There were great uncertainties regarding the dynamics and spread of the Covid-19 virus infection. In this paper, we develop a system dynamics model for the three connected regions (Wuhan, Hubei excl. Wuhan, China excl. Hubei) to understand the infection and spread dynamics of the virus and provide a more accurate estimate of the number of infected people in Wuhan and discuss the necessity and effectivity of protective measures against this epidemic, such as the quarantines imposed throughout China. We use the statistics of confirmed cases of China excl. Hubei. Also the daily data on travel activity within China was utilized, in order to determine the actual numerical development of the infected people in Wuhan City and Hubei Province. We used a multivariate Monte Carlo optimization to parameterize the model to match the official statistics. In particular, we used the model to calculate the infections, which had already broken out, but were not diagnosed for various reasons.	[Hu, Bo] Univ Bundeswehr Munchen, Dept Business Adm, Neubiberg, Germany; [Dehmer, Matthias] Swiss Distance Univ Appl Sci, Dept Comp Sci, Brig, Switzerland; [Dehmer, Matthias] Xian Technol Univ, Sch Sci, Xian, Shaanxi, Peoples R China; [Dehmer, Matthias] Nankai Univ, Coll Artificial Intelligence, Tianjin, Peoples R China; [Dehmer, Matthias] UMIT, Dept Biomed Comp Sci & Mechatron, Hlth & Life Sci Univ, Hall In Tirol, Austria; [Emmert-Streib, Frank] Tampere Univ, Dept Signal Proc, Predict Med & Data Analyt Lab, Tampere, Finland; [Emmert-Streib, Frank] Inst Biosci & Med Technol, Tampere, Finland; [Zhang, Bo] Minist Ecol & Environm, Informat Ctr, Beijing, Peoples R China	Bundeswehr University Munich; Xi'an Technological University; Nankai University; Tampere University	Dehmer, M (corresponding author), Swiss Distance Univ Appl Sci, Dept Comp Sci, Brig, Switzerland.; Dehmer, M (corresponding author), Xian Technol Univ, Sch Sci, Xian, Shaanxi, Peoples R China.; Dehmer, M (corresponding author), Nankai Univ, Coll Artificial Intelligence, Tianjin, Peoples R China.; Dehmer, M (corresponding author), UMIT, Dept Biomed Comp Sci & Mechatron, Hlth & Life Sci Univ, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641	Austrian Science Fund [P 30031]	Austrian Science Fund(Austrian Science Fund (FWF))	Matthias Dehmer received funding from the Austrian Science Fund (P 30031). The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessia Lai, 2020, J MED VIROL; [Anonymous], 2020, EPIDEMIC REPORT; [Anonymous], 2014, 2014 INT C SYST DYN; [Anonymous], 2020, BAIDU QIANXI BAIDU; [Anonymous], 2020, **DROPPED REF**; Chen L, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009226; FORRESTER JW, 1971, THEOR DECIS, V2, P109, DOI 10.1007/BF00148991; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Reisen WK, 2003, J MED ENTOMOL, V40, P206, DOI 10.1603/0022-2585-40.2.206; RUBINSTEIN RY, 1985, OPER RES, V33, P661, DOI 10.1287/opre.33.3.661; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	13	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0245728	10.1371/journal.pone.0245728	http://dx.doi.org/10.1371/journal.pone.0245728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735225	gold, Green Published			2022-12-26	WOS:000631029700034
J	Joudeh, A; Ghosh, R; Spindler, H; Handu, S; Sonthalia, S; Das, A; Gore, A; Mahapatra, T; Walker, D				Joudeh, Ammar; Ghosh, Rakesh; Spindler, Hilary; Handu, Seema; Sonthalia, Sunil; Das, Aritra; Gore, Aboli; Mahapatra, Tanmay; Walker, Dilys			Increases in diagnosis and management of obstetric and neonatal complications in district hospitals during a high intensity nurse-mentoring program in Bihar, India	PLOS ONE			English	Article							MATERNAL MORTALITY; NEWBORN MORTALITY; IMPACT; HEALTH; RESUSCITATION; METAANALYSIS; IMPROVEMENT; STILLBIRTH; QUALITY; DEATHS	Maternal and neonatal mortality in Bihar, India was far higher than the aspirational levels set out by the Sustainable Development Goals. Provider training programs have been implemented in many low-resource settings to improve obstetric and neonatal outcomes. This longitudinal investigation assessed diagnoses and management of postpartum hemorrhage (PPH), hypertensive disorders of pregnancy, birth asphyxia (BA), and low birth weight (LBW), as part of the CARE's AMANAT program in 22 District Hospitals in Bihar, between 2015 and 2017. Physicians and nurse mentors conducted clinical instruction, simulations and teamwork and communication activities, infrastructure and management support, and data collection for 6 consecutive months. Analysis of diagnosis included 11,259 non-referred and management included 11,800 total (non-referred and referred) admissions that were observed. Data were analyzed using the chi-square test for trend. PPH was diagnosed in 3.7% with no significant trend but diagnosis of hypertensive disorders increased from 1.0% to 1.7%, (p(trend) = 0.04), over the 6 months. BA was diagnosed in 5.8% with no significant trend but LBW diagnoses increased from 11% to 16% (p(trend)<0.01). Among PPH patients, 96% received fluids, 85% received uterotonics and 11% received Tranexamic Acid (TXA). There was a significant positive trend in the number of patients receiving TXA for PPH (6% to 13.8%, p(trend) = 0.03). Of all neonates with BA, there were statistically significant increases in the proportion who were initially warmed, dried, and stimulated (78% to 94%, p(trend) = 0.02), received airway suction (80% to 93%, p(trend) = 0.03), and supplemental oxygen without positive pressure ventilation (73% to 86%, p(trend) = 0.05). Diagnoses of hypertensive disorders and LBW as well as initial management of BA increased during the AMANAT program. However, underdiagnoses of PPH and hypertensive disorders relative to population levels remain critical barriers to improving maternal morbidity and mortality.	[Joudeh, Ammar] Univ Calif San Diego, Dept Obstet Gynecol & Reprod Sci, San Diego, CA 92103 USA; [Ghosh, Rakesh; Spindler, Hilary] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Handu, Seema] PRONTO Int, State RMNCH A, Patna, Bihar, India; [Sonthalia, Sunil; Das, Aritra; Gore, Aboli; Mahapatra, Tanmay] CARE India, Patna, Bihar, India; [Walker, Dilys] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Walker, Dilys] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ghosh, R (corresponding author), Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA.	Rakesh.Ghosh@ucsf.edu		Ghosh, Rakesh/0000-0002-7839-4148	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation. The funding body had no role in study design, data collection, analysis, interpretation, manuscript writing, or the decision to submit the manuscript for publication.	[Anonymous], 2017, WHO RECOMMENDATION T; [Anonymous], 2011, WHO RECOMMENDATIONS; [Anonymous], STATE STAT; Bergh AM, 2015, BEST PRACT RES CL OB, V29, P1028, DOI 10.1016/j.bpobgyn.2015.03.017; Bhilwar M, 2016, NATL MED J INDIA, V29, P73; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Das A, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1452-z; Das A, 2016, BIRTH-ISS PERINAT C, V43, P328, DOI 10.1111/birt.12239; Davidoff F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3152; Deneux-Tharaux C, 2014, J GYNECOL OBST BIO R, V43, P936, DOI 10.1016/j.jgyn.2014.09.023; Ghosh R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216654; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; NITI Aayog, 2019, HLTH STATES PROGRESS; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Siassakos D, 2009, BJOG-INT J OBSTET GY, V116, P1028, DOI 10.1111/j.1471-0528.2009.02178.x; Singh SK, 2012, INDIAN PEDIATR, V49, P136, DOI 10.1007/s13312-012-0022-8; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stead K, 2009, MED J AUSTRALIA, V190, pS128; UNICEF, BIHAR STATE INFO; United Nations, GOAL 3 SUSTAINABLE D; Vail B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1254-0; Walker DM, 2016, SIMUL HEALTHC, V11, P1, DOI 10.1097/SIH.0000000000000106; Walker DM, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0401-7; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Ying W, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009382	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0247260	10.1371/journal.pone.0247260	http://dx.doi.org/10.1371/journal.pone.0247260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735280	gold, Green Published			2022-12-26	WOS:000631029700078
J	McEllistrem, MC; Clancy, CJ; Buehrle, DJ; Singh, N; Lucas, A; Sirianni, V; Decker, BK				McEllistrem, M. Catherine; Clancy, Cornelius J.; Buehrle, Deanna J.; Singh, Nina; Lucas, Aaron; Sirianni, Valerie; Decker, Brooke K.			SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers	PLOS ONE			English	Article							TRANSMISSION; COVID-19	Background Healthcare workers (HCW) are at increased risk of SARS-CoV-2 infection from both patients and other HCW with coronavirus disease 2019 (COVID-19). RT-PCR cycle threshold (Ct) values of SARS-CoV-2 <= 34 and the first 7-9 days of symptoms are associated with enhanced infectivity. We determined Ct values and duration of symptoms of HCW with a positive SARS-CoV-2 test. As HCW often assume their greatest risk of acquiring SARS-CoV-2 is working on a COVID-19 unit, we also determined Ct values and symptom duration of inpatients with a positive SARS-CoV-2 test. Methods From 6/24/2020-8/23/2020, Ct values and duration of symptoms from 13 HCW, 12 outpatients, and 28 inpatients who had a positive nasopharyngeal swab for SARS-CoV-2 were analyzed. Results Among HCW with a positive SARS-CoV-2 test, 46.2% (6/13) were asymptomatic and requested testing due to an exposure to someone with COVID-19; 83.3% (5/6) of those exposures occurred in the community rather than in the hospital. The median Ct value of HCW was 23.2, and 84.6% (11/13) had a Ct value <= 34. The median Ct value of 29.0 among outpatients with COVID-19 did not significantly differ from HCW. In contrast, inpatients with a positive SARS-CoV-2 test had a median Ct value of 34.0 (p = 0.003), which translated into a median similar to 1,000-fold lower viral load than observed in HCW. Among those with symptoms related to COVID-19, no (0/6) HCW compared to 50% (6/12) of inpatients had symptoms for at least one week (p = 0.04). Conclusions At our institution, asymptomatic COVID-19 accounted for nearly half of the cases among HCW. Symptomatic HCW had high viral loads and short duration of symptoms, both of which are associated with peak infectivity. Infection prevention programs should educate HCW on these findings in an effort to increase adherence to the requirement to maintain six feet separation in workspaces and breakrooms, in addition to consistently wearing personal protection equipment.	[McEllistrem, M. Catherine; Clancy, Cornelius J.; Buehrle, Deanna J.; Singh, Nina; Lucas, Aaron; Sirianni, Valerie; Decker, Brooke K.] VA Pittsburgh Healthcare Syst, Infect Dis Sect, Dept Med, Pittsburgh, PA 15213 USA; [McEllistrem, M. Catherine; Clancy, Cornelius J.; Singh, Nina; Lucas, Aaron; Decker, Brooke K.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McEllistrem, MC (corresponding author), VA Pittsburgh Healthcare Syst, Infect Dis Sect, Dept Med, Pittsburgh, PA 15213 USA.; McEllistrem, MC (corresponding author), Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15213 USA.	Mary.mcellistrem@va.gov		McEllistrem, Mary Catherine/0000-0002-4079-0620				Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Buehrle DJ, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01011-20; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Celebi G, 2020, AM J INFECT CONTROL, V48, P1225, DOI 10.1016/j.ajic.2020.07.039; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Maltezou HC, 2021, J INFECT DIS, V223, P1132, DOI 10.1093/infdis/jiaa804; Park SY, 2020, EMERG INFECT DIS, V26, P1666, DOI 10.3201/eid2608.201274; Self WH, 2020, MMWR-MORBID MORTAL W, V69, P1221, DOI 10.15585/mmwr.mm6935e2; Xiao J, 2020, J INFECT PUBLIC HEAL, V13, P843, DOI 10.1016/j.jiph.2020.05.019; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00783-20	14	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248347	10.1371/journal.pone.0248347	http://dx.doi.org/10.1371/journal.pone.0248347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735264	gold, Green Published			2022-12-26	WOS:000631029700121
J	Steiger, T; Philipp, A; Hiller, KA; Muller, T; Lubnow, M; Lehle, K				Steiger, Tamara; Philipp, Alois; Hiller, Karl-Anton; Mueller, Thomas; Lubnow, Matthias; Lehle, Karla			Different mechanisms of oxygenator failure and high plasma von Willebrand factor antigen influence success and survival of venovenous extracorporeal membrane oxygenation	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; PLATELET-ADHESION; CLEAVING PROTEASE; DYSFUNCTION; PREDICTOR; ECMO	Objective Failure of membrane oxygenator (MO) function of venovenous extracorporeal membrane oxygenators (VV ECMO) remains problematic. The development of device-induced coagulation disorder (COD) or worsened gas transfer (WGT) necessitates a system exchange. The aim was to correlate von Willebrand factor antigen (vWF:Ag) with the predisposition to MO failure and mortality. Methods Laboratory parameters (inflammation, coagulation) and ECMO-related data from 31 VV ECMO patients were analyzed before and after the first MO exchange. Study groups were identified according to the exchange reasons (COD, WGT) and the extent of vWF:Ag (low, <= 425%; high, >425%). Results vWF:Ag remained unchanged after system exchange. High vWF:Ag was associated with systemic endothelial activation of older and obese patients with elevated SOFA score, increased norepinephrine and higher requirement of continuous renal replacement therapy without an effect on MO runtime and mortality. Including the mechanism of MO failure (COD, WGT), various patient group emerged. COD/low vWF:Ag summarized younger and less critically ill patients that benefit mainly from ECMO by a significant improvement of their inflammatory and coagulation status (CRP, D-dimers, fibrinogen) and highest survival rate (91%). Instead, WGT/high vWF:Ag presented older and more obese patients with a two-digit SOFA score, highest norepinephrine, and aggravated gas transfer. They benefited temporarily from system exchange but with worst survival (33%). Conclusions vWF:Ag levels alone cannot predict early MO failure and outcome in VV ECMO patients. Probably, the mechanism of clotting disorder in combination with the vWF:Ag level seems to be essential for clot formation within the MO. In addition, vWF:Ag levels allows the identification different patient populations In particular, WGT/high vWF:Ag represented a critically ill population with higher ECMO-associated mortality.	[Steiger, Tamara; Philipp, Alois; Lehle, Karla] Univ Hosp Regensburg, Dept Cardiothorac Surg, Regensburg, Germany; [Hiller, Karl-Anton] Univ Hosp Regensburg, Dept Conservat Dent & Periodontol, Regensburg, Germany; [Mueller, Thomas; Lubnow, Matthias] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Lehle, K (corresponding author), Univ Hosp Regensburg, Dept Cardiothorac Surg, Regensburg, Germany.	karla.lehle@ukr.de		Lubnow, Matthias/0000-0002-4402-1810; Hiller, Karl-Anton/0000-0002-4726-9555				Birkenmaier C, 2020, ASAIO J, V66, P922, DOI 10.1097/MAT.0000000000001089; Cheung PY, 2000, CRIT CARE MED, V28, P2584, DOI 10.1097/00003246-200007000-00067; Claus RA, 2009, THROMB HAEMOSTASIS, V101, P239, DOI 10.1160/TH08-03-0161; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Dornia C, 2015, ARTIF ORGANS, V39, P782, DOI 10.1111/aor.12460; Dornia C, 2014, ASAIO J, V60, P652, DOI 10.1097/MAT.0000000000000133; Epis F, 2018, J THORAC DIS, V10, pS596, DOI 10.21037/jtd.2017.10.05; Heilmann C, 2012, INTENS CARE MED, V38, P62, DOI 10.1007/s00134-011-2370-6; Huck V, 2014, THROMB HAEMOSTASIS, V111, P598, DOI 10.1160/TH13-09-0800; Kalbhenn J, 2015, J ATHEROSCLER THROMB, V22, P265, DOI 10.5551/jat.27268; Lubnow M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112316; Lubnow M, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.12.008; MacLaren G, 2012, INTENS CARE MED, V38, P210, DOI 10.1007/s00134-011-2439-2; Millar JE, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1570-4; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Park M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054954; Philipp A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198392; POTTINGER BE, 1989, THROMB RES, V53, P387, DOI 10.1016/0049-3848(89)90317-4; Rack K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14346-4; RUBIN DB, 1990, J CLIN INVEST, V86, P474, DOI 10.1172/JCI114733; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Sethi S, 2011, ANN CARD ANAESTH, V14, P156, DOI [10.4103/0971-9784.81576, 10.4103/0971-9784.84030]; Steiger T, 2019, ARTIF ORGANS, V43, P1065, DOI 10.1111/aor.13513; Tauber H, 2015, ANESTH ANALG, V120, P730, DOI 10.1213/ANE.0000000000000554; Tschaut RJ, 2005, EXTRAKORPORALE ZIRKU, V1, P648; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Zilberman-Rudenko J, 2017, CELL MOL BIOENG, V10, P16, DOI 10.1007/s12195-016-0470-7	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2021	16	3							e0248645	10.1371/journal.pone.0248645	http://dx.doi.org/10.1371/journal.pone.0248645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ9HN	33735282	gold, Green Published			2022-12-26	WOS:000631029700093
J	Omae, N; Sameshima-Yamashita, Y; Ushimaru, K; Koike, H; Kitamoto, H; Morita, T				Omae, Natsuki; Sameshima-Yamashita, Yuka; Ushimaru, Kazunori; Koike, Hideaki; Kitamoto, Hiroko; Morita, Tomotake			Disruption of protease A and B orthologous genes in the basidiomycetous yeast Pseudozyma antarctica GB-4(0) yields a stable extracellular biodegradable plastic-degrading enzyme	PLOS ONE			English	Article							CUTINASE-LIKE ENZYME; SACCHAROMYCES-CEREVISIAE; PROTEINASE; DEGRADATION; VACUOLE; FILMS	The yeast Pseudozyma antarctica (currently designated Moesziomyces antarcticus) secretes a xylose-induced biodegradable plastic-degrading enzyme (PaE). To suppress degradation of PaE during production and storage, we targeted the inhibition of proteolytic enzyme activity in P. antarctica. Proteases A and B act as upper regulators in the proteolytic network of the model yeast, Saccharomyces cerevisiae. We searched for orthologous genes encoding proteases A and B in the genome of P. antarctica GB-4(0) based on the predicted amino acid sequences. We found two gene candidates, PaPRO1 and PaPRO2, with conserved catalytically important domains and signal peptides indicative of vacuolar protease function. We then prepared gene-deletion mutants of strain GB-4(0), Delta PaPRO1 and Delta PaPRO2, and evaluated PaE stability in culture by immunoblotting analysis. Both mutants exhibited sufficient production of PaE without degradation fragments, while the parent strain exhibited the degradation fragments. Therefore, we concluded that the protease A and B orthologous genes are related to the degradation of PaE. To produce a large quantity of PaE, we made a PaPRO2 deletion mutant of a PaE-overexpression strain named XG8 by introducing a PaE high-production cassette into the strain GB-4(0). The Delta PaPRO2 mutant of XG8 was able to produce PaE without the degradation fragments during large-scale cultivation in a 3-L jar fermenter for 3 days at 30 degrees C. After terminating the agitation, the PaE activity in the XG8 Delta PaPRO2 mutant culture was maintained for the subsequent 48 h incubation at 25 degrees C regardless of remaining cells, while activity in the XG8 control was reduced to 55.1%. The gene-deleted mutants will be useful for the development of industrial processes of PaE production and storage.	[Omae, Natsuki; Ushimaru, Kazunori; Morita, Tomotake] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan; [Sameshima-Yamashita, Yuka; Kitamoto, Hiroko] Natl Agr & Food Res Org NARO, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan; [Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioproc Res Inst, Tsukuba, Ibaraki, Japan; [Omae, Natsuki] Univ Tokyo, Dept Complex Sci & Engn, Kashiwanoha, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Agriculture & Food Research Organization - Japan; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Morita, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan.	morita-tomotake@aist.go.jp	Morita, Tomotake/L-7073-2018	Morita, Tomotake/0000-0001-6956-3096	Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology) [25017AB, 01029C]	Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology)	This research was supported by grants from the Project of the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology) [25017AB, 01029C].	Aguilar CF, 1997, J MOL BIOL, V267, P899, DOI 10.1006/jmbi.1996.0880; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Emadian SM, 2017, WASTE MANAGE, V59, P526, DOI 10.1016/j.wasman.2016.10.006; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HANSPAL JS, 1983, ANAL BIOCHEM, V132, P288, DOI 10.1016/0003-2697(83)90010-6; Hecht Karen A, 2014, Cell Logist, V4, pe28023; Johnson EA, 2013, APPL MICROBIOL BIOT, V97, P7563, DOI 10.1007/s00253-013-5046-z; JONES EW, 1991, J BIOL CHEM, V266, P7963; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; MOEHLE CM, 1987, MOL CELL BIOL, V7, P4390, DOI 10.1128/MCB.7.12.4390; Parr CL, 2007, YEAST, V24, P467, DOI 10.1002/yea.1485; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pilla S., 2011, HDB BIOPLASTICS BIOC; RENDUELES PS, 1988, FEMS MICROBIOL LETT, V54, P17; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sameshima-Yamashita Y, 2019, BIOSCI BIOTECH BIOCH, V83, P1547, DOI 10.1080/09168451.2019.1571898; Sato S, 2017, POLYM DEGRAD STABIL, V141, P26, DOI 10.1016/j.polymdegradstab.2017.05.007; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P8591, DOI 10.1007/s00253-012-4673-0; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P2951, DOI 10.1007/s00253-012-4188-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soberanes-Gutierrez CV, 2015, MOL PLANT PATHOL, V16, P837, DOI 10.1111/mpp.12240; Song LL, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2361-z; Stecher G, 2020, MOL BIOL EVOL, V37, P1237, DOI 10.1093/molbev/msz312; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Watanabe T, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0121-8; Watanabe T, 2016, APPL MICROBIOL BIOT, V100, P3207, DOI 10.1007/s00253-015-7232-7; Watanabe T, 2014, J BIOSCI BIOENG, V117, P325, DOI 10.1016/j.jbiosc.2013.09.002; Yarimizu T, 2017, YEAST, V34, P483, DOI 10.1002/yea.3251; ZUCKERKANDL EMILE, 1965, P97	36	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2021	16	3							e0247462	10.1371/journal.pone.0247462	http://dx.doi.org/10.1371/journal.pone.0247462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY9GW	33730094	gold, Green Published			2022-12-26	WOS:000630345000006
J	Bailleul, G; Nicoll, CR; Mascotti, ML; Mattevi, A; Fraaije, MW				Bailleul, Gautier; Nicoll, Callum R.; Mascotti, Maria Laura; Mattevi, Andrea; Fraaije, Marco W.			Ancestral reconstruction of mammalian FMO1 enables structural determination, revealing unique features that explain its catalytic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; SUBSTRATE SPECIFICITIES; DRUG-METABOLISM; HALF-REACTION; VISUALIZATION; LOCALIZATION; EXPRESSION; TAMOXIFEN; OXIDATION	Mammals rely on the oxidative flavin-containing mono-oxygenases (FMOs) to detoxify numerous and potentially deleterious xenobiotics; this activity extends to many drugs, giving FMOs high pharmacological relevance. However, our knowledge regarding these membrane-bound enzymes has been greatly impeded by the lack of structural information. We anticipated that ancestral-sequence reconstruction could help us identify protein sequences that are more amenable to structural analysis. As such, we hereby reconstructed the mammalian ancestral protein sequences of both FMO1 and FMO4, denoted as ancestral flavin-containing monooxygenase (AncFMO)1 and AncFMO4, respectively. AncFMO1, sharing 89.5% sequence identity with human FMO1, was successfully expressed as a functional enzyme. It displayed typical FMO activities as demonstrated by oxygenating benzydamine, tamoxifen, and thioanisole, drug-related compounds known to be also accepted by human FMO1, and both NADH and NADPH cofactors could act as electron donors, a feature only described for the FMO1 paralogs. AncFMO1 crystallized as a dimer and was structurally resolved at 3.0 angstrom resolution. The structure harbors typical FMO aspects with the flavin adenine dinucleotide and NAD(P)H binding domains and a C-terminal transmembrane helix. Intriguingly, AncFMO1 also contains some unique features, including a significantly porous and exposed active site, and NADPH adopting a new conformation with the 2'-phosphate being pushed inside the NADP(+) binding domain instead of being stretched out in the solvent. Overall, the ancestrally reconstructed mammalian AncFMO1 serves as the first structural model to corroborate and rationalize the catalytic properties of FMO1.	[Bailleul, Gautier; Mascotti, Maria Laura; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands; [Nicoll, Callum R.; Mattevi, Andrea] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy; [Mascotti, Maria Laura] Univ Nacl San Luis, Fac Quim Bioquim & Farm, IMIBIO SL CONICET, San Luis, Argentina	University of Groningen; University of Pavia; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis	Fraaije, MW (corresponding author), Univ Groningen, Mol Enzymol Grp, Groningen, Netherlands.; Mattevi, A (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Pavia, Italy.	andrea.mattevi@unipv.it; m.w.fraaije@rug.nl	Mattevi, Andrea/K-5464-2012; Mascotti, Maria Laura/H-9501-2017	Mattevi, Andrea/0000-0002-9523-7128; Mascotti, Maria Laura/0000-0002-5817-4631; Bailleul, Gautier/0000-0001-5083-2727; Fraaije, Marco/0000-0001-6346-5014; Nicoll, Callum/0000-0002-2122-9387	European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [722390]; Italian Ministry of Education, University and Research (MIUR); ANPCyT (Argentina) [PICT 2016-2839]; European Union [847675]	European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); ANPCyT (Argentina)(ANPCyT); European Union(European Commission)	The research for this work has received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement no. 722390; the Italian Ministry of Education, University and Research (MIUR) under the "Dipartimenti di Eccellenza (2018-2022)" program; The European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 847675 and ANPCyT (Argentina) PICT 2016-2839 to M. L. M. M. L. M. is a member of the Research Career of CONICET, Argentina.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; [Anonymous], 2020, EXPR ATL QUER ENSG00; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Basarab T, 1999, BRIT J DERMATOL, V140, P164; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; Campbell AC, 2020, BIOCHEMISTRY-US, V59, P4609, DOI 10.1021/acs.biochem.0c00783; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Chitra M., 1993, DRUG METAB DISPOS, V21, P657; Cruciani G, 2014, J MED CHEM, V57, P6183, DOI 10.1021/jm5007098; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Dolphin CT, 1996, EUR J BIOCHEM, V235, P683, DOI 10.1111/j.1432-1033.1996.00683.x; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fabara AN, 2020, APPL MICROBIOL BIOT, V104, P925, DOI 10.1007/s00253-019-10292-5; Fiorentini F, 2017, ACS CHEM BIOL, V12, P2379, DOI 10.1021/acschembio.7b00470; Fiorentini F, 2016, ACS CHEM BIOL, V11, P1039, DOI 10.1021/acschembio.5b01016; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Hines RN, 2002, MOL PHARMACOL, V62, P320, DOI 10.1124/mol.62.2.320; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hochberg GKA, 2017, ANNU REV BIOPHYS, V46, P247, DOI 10.1146/annurev-biophys-070816-033631; Hu Steven X, 2018, Drug Metab Lett, V12, P125, DOI 10.2174/1872312812666180913145334; Itagaki K, 1996, J BIOL CHEM, V271, P20102, DOI 10.1074/jbc.271.33.20102; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAWAJI A, 1993, ANAL BIOCHEM, V214, P409, DOI 10.1006/abio.1993.1515; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; McCombie RR, 1996, GENOMICS, V34, P426, DOI 10.1006/geno.1996.0308; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA T, 1990, CHEM RES TOXICOL, V3, P372, DOI 10.1021/tx00016a016; Nicoll CR, 2020, NAT STRUCT MOL BIOL, V27, DOI 10.1038/s41594-019-0347-2; Parte P, 2005, DRUG METAB DISPOS, V33, P1446, DOI 10.1124/dmd.104.000802; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips IR, 2020, XENOBIOTICA, V50, P19, DOI 10.1080/00498254.2019.1643515; Phillips IR, 2017, EXPERT OPIN DRUG MET, V13, P167, DOI 10.1080/17425255.2017.1239718; Robinson R, 2013, BIOCHEMISTRY-US, V52, P9089, DOI 10.1021/bi4014903; Romero E., 2012, J VIS EXP, V10, P3791; Sambrook J., 2001, MOL CLONING LAB MANU; SHEPHARD EA, 1993, GENOMICS, V16, P85, DOI 10.1006/geno.1993.1144; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Siddiq MA, 2017, CURR OPIN STRUC BIOL, V47, P113, DOI 10.1016/j.sbi.2017.07.003; SOFER SS, 1978, DRUG METAB DISPOS, V6, P232; Uno Y, 2013, BIOCHEM PHARMACOL, V85, P1837, DOI 10.1016/j.bcp.2013.04.012; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Veeravalli S, 2020, DRUG METAB DISPOS, V48, P378, DOI 10.1124/dmd.119.089995; Vonrhein C, 2018, ACTA CRYSTALLOGR A, V74, pA360, DOI 10.1107/S010876731809640X; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; Ziegler D M, 1978, Methods Enzymol, V52, P142; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	53	5	5	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100221	10.1074/jbc.RA120.016297	http://dx.doi.org/10.1074/jbc.RA120.016297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33759784	Green Published, gold			2022-12-26	WOS:000672866400199
J	Dai, DL; Li, XY; Wang, L; Xie, C; Jin, YA; Zeng, MS; Zuo, ZX; Xia, TL				Dai, Dan-Ling; Li, Xingyang; Wang, Lin; Xie, Chu; Jin, Yanan; Zeng, Mu-Sheng; Zuo, Zhixiang; Xia, Tian-Liang			Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein-Barr virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZTA; MESSENGER-RNA METHYLATION; NASOPHARYNGEAL CARCINOMA; GENE; CYCLE; REACTIVATION; TRANSLATION; REPRESSION; REGION; EBV	N6-methyladenosine (m(6)A) is among the most abundant mRNA modifications, particularly in eukaryotes, and is found in mammals, plants, and even some viruses. Although essential for the regulation of many biological processes, the exact role of m(6)A modification in virus-host interaction remains largely unknown. Here, using m(6)A -immunoprecipitation and sequencing, we find that Epstein-Barr virus (EBV) infection decreases the m(6)A modification of transcriptional factor KLF4 mRNA and subsequently increases its protein level. Mechanistically, EBV immediate-early protein BZLF1 interacts with the promoter of m(6)A methyltransferase METTL3, inhibiting its expression. Subsequently, the decrease of METTL3 reduces the level of KLF4 mRNA m(6)A modification, preventing its decay by the m(6)A reader protein YTHDF2. As a result, KLF4 protein level is upregulated and, in turn, promotes EBV infection of nasopharyngeal epithelial cells. Thus, our results suggest the existence of a positive feedback loop formed between EBV and host molecules via cellular mRNA m(6)A levels, and this feedback loop acts to facilitate viral infection. This mechanism contains multiple potential targets for controlling viral infectious diseases.	[Dai, Dan-Ling; Wang, Lin; Xie, Chu; Jin, Yanan; Zeng, Mu-Sheng; Zuo, Zhixiang; Xia, Tian-Liang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Li, Xingyang] Guangzhou Med Univ, Dept Temporomandibular Joint Surg, Guangzhou Key Lab Basic & Appl Res Oral Regenerat, Affiliated Stomatol Hosp, Guangzhou, Peoples R China; [Wang, Lin] Sun Yat Sen Univ, Canc Ctr, Dept Nasopharyngeal Carcinoma, Guangzhou, Peoples R China; [Jin, Yanan] Sun Yat Sen Univ, Canc Ctr, Dept VIP Reg, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Zuo, ZX; Xia, TL (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.	zuozhx@sysucc.org.cn; xiatl@sysucc.org.cn	Zuo, Zhixiang/M-4441-2016	Zuo, Zhixiang/0000-0002-2492-2689	National Key R&D Program of China [2017YFA0505600, 2017YFC0908503, 2016YFA0502100]; National Natural Science Foundation of China [81830090, 81802775, 82003081]; Guangdong Province Key Research And Development Program [2019B020226002]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Key Research And Development Program	This study was supported by the National Key R&D Program of China (2017YFA0505600, 2017YFC0908503, and 2016YFA0502100), the National Natural Science Foundation of China (81830090, 81802775, and 82003081), and Guangdong Province Key Research And Development Program (2019B020226002).	Balan N, 2016, J GEN VIROL, V97, P725, DOI 10.1099/jgv.0.000369; Bristol JA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007179; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Courtney DG, 2019, MBIO, V10, DOI 10.1128/mBio.01209-19; Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Farrell PJ, 2019, ANNU REV PATHOL-MECH, V14, P29, DOI 10.1146/annurev-pathmechdis-012418-013023; Fiches GN, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008778; Gokhale NS, 2020, MOL CELL, V77, P542, DOI 10.1016/j.molcel.2019.11.007; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Hao HJ, 2019, NUCLEIC ACIDS RES, V47, P362, DOI 10.1093/nar/gky1007; Henle W, 1980, Ann N Y Acad Sci, V354, P326, DOI 10.1111/j.1749-6632.1980.tb27975.x; Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995; Hicks MR, 2003, J VIROL, V77, P8173, DOI 10.1128/JVI.77.14.8173-8177.2003; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Lang FC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007796; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HD, 2016, INT J BIOL SCI, V12, P1309, DOI 10.7150/ijbs.16564; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu SL, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0357-9; Liu X, 2020, CELL, V182, P24, DOI 10.1016/j.cell.2020.06.023; Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Luo WW, 2016, CELL MOL IMMUNOL, V13, P65, DOI 10.1038/cmi.2014.125; Martinez-Perez M, 2017, P NATL ACAD SCI USA, V114, P10755, DOI 10.1073/pnas.1703139114; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morrison TE, 2004, J VIROL, V78, P544, DOI 10.1128/JVI.78.1.544-549.2004; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977; Munz C, 2019, NAT REV MICROBIOL, V17, P691, DOI 10.1038/s41579-019-0249-7; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Nawandar DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005195; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ramasubramanyan S, 2015, NUCLEIC ACIDS RES, V43, P3563, DOI 10.1093/nar/gkv212; Rane MJ, 2019, EBIOMEDICINE, V40, P743, DOI 10.1016/j.ebiom.2019.01.021; Rubio RM, 2018, GENE DEV, V32, P1472, DOI 10.1101/gad.319475.118; Schaeffner M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800108; Schelcher C, 2005, J VIROL, V79, P13822, DOI 10.1128/JVI.79.21.13822-13828.2005; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shaverdashvili K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215746; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sun XS, 2020, CANCER COMMUN, V40, P32, DOI 10.1002/cac2.12004; Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8; Tirumuru N, 2019, J BIOL CHEM, V294, P3249, DOI 10.1074/jbc.RA118.005608; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wille CK, 2015, P NATL ACAD SCI USA, V112, pE7257, DOI 10.1073/pnas.1513432112; Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z; Wu CF, 2021, CANCER COMMUN, V41, P37, DOI 10.1002/cac2.12113; Xiong D, 2015, P NATL ACAD SCI USA, V112, P11036, DOI 10.1073/pnas.1513359112; Yan M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4661; Yang L, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12669; Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17; Young LS, 2020, CANCER COMMUN, V40, P60, DOI 10.1002/cac2.12006; Young LS, 2016, NAT REV CANCER, V16, P789, DOI 10.1038/nrc.2016.92; Zhang H, 2018, NAT MICROBIOL, V3, P164, DOI 10.1038/s41564-017-0080-8; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2020, CANCER COMMUN, V40, P721, DOI 10.1002/cac2.12104; ZURHAUSEN H, 1978, NATURE, V272, P373	72	9	9	6	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100547	10.1016/j.jbc.2021.100547	http://dx.doi.org/10.1016/j.jbc.2021.100547			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33741341	gold, Green Published			2022-12-26	WOS:000672866400520
J	Mangiapane, G; Parolini, I; Conte, K; Malfatti, MC; Corsi, J; Sanchez, M; Pietrantoni, A; D'Agostino, VG; Tell, G				Mangiapane, Giovanna; Parolini, Isabella; Conte, Kristel; Malfatti, Matilde Clarissa; Corsi, Jessica; Sanchez, Massimo; Pietrantoni, Agostina; D'Agostino, Vito G.; Tell, Gianluca			Enzymatically active apurinic/apyrimidinic endodeoxyribonuclease 1 is released by mammalian cells through exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; AP-ENDONUCLEASE APE1/REF-1; HUMAN ABASIC ENDONUCLEASE; DNA-REPAIR; BIOGENESIS; DAMAGE; ACETYLATION; EXPRESSION; VESICLES; RESIDUES	The apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1), the main AP-endonuclease of the DNA base excision repair pathway, is a key molecule of interest to researchers due to its unsuspected roles in different nonrepair activities, such as: i) adaptive cell response to genotoxic stress, ii) regulation of gene expression, and iii) processing of microRNAs, which make it an excellent drug target for cancer treatment. We and others recently demonstrated that APE1 can be secreted in the extracellular environment and that serum APE1 may represent a novel prognostic biomarker in hepatocellular and non-small-cell lung cancers. However, the mechanism by which APE1 is released extracellularly was not described before. Here, using three different approaches for exosomes isolation: commercial kit, nickel-based isolation, and ultracentrifugation methods and various mammalian cell lines, we elucidated the mechanisms responsible for APE1 secretion. We demonstrated that APE1 p37 and p33 forms are actively secreted through extra-cellular vesicles (EVs), including exosomes from different mammalian cell lines. We then observed that APE1 p33 form is generated by proteasomal-mediated degradation and is enzymatically active in EVs. Finally, we revealed that the p33 form of APE1 accumulates in EVs upon genotoxic treatment by cisplatin and doxorubicin, compounds commonly found in chemotherapy pharmacological treatments. Taken together, these findings provide for the first time evidence that a functional Base Excision Repair protein is delivered through exosomes in response to genotoxic stresses, shedding new light into the complex noncanonical biological functions of APE1 and opening new intriguing perspectives on its role in cancer biology.	[Mangiapane, Giovanna; Conte, Kristel; Malfatti, Matilde Clarissa; Tell, Gianluca] Univ Udine, Dept Med DAME, Lab Mol Biol & DNA Repair, Udine, Italy; [Parolini, Isabella] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [Corsi, Jessica; D'Agostino, Vito G.] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Trento, Italy; [Sanchez, Massimo; Pietrantoni, Agostina] Ist Super Sanita, Core Facil, Rome, Italy	University of Udine; Istituto Superiore di Sanita (ISS); University of Trento; Istituto Superiore di Sanita (ISS)	Tell, G (corresponding author), Univ Udine, Dept Med DAME, Lab Mol Biol & DNA Repair, Udine, Italy.	gianluca.tell@uniud.it	parolini, Isabella/J-9955-2016; Pietrantoni, Agostina/ABA-6900-2021; Sanchez, Massimo/K-4385-2018	parolini, Isabella/0000-0001-9863-1051; Pietrantoni, Agostina/0000-0002-1121-4464; Mangiapane, Giovanna/0000-0001-6633-0481; Tell, Gianluca/0000-0001-8845-6448; D'AGOSTINO, VITO/0000-0003-3379-2254; MALFATTI, MATILDE CLARISSA/0000-0002-8101-568X; Sanchez, Massimo/0000-0003-3696-7582	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG19862]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC) [grant number IG19862] to G. T.	Ageta H, 2019, CELL MOL LIFE SCI, V76, P4829, DOI 10.1007/s00018-019-03246-7; Antoniali G, 2021, CHEM BIO, V15, P24; Antoniali G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00842-8; Antoniali G, 2017, DNA REPAIR, V56, P65, DOI 10.1016/j.dnarep.2017.06.008; Antoniali G, 2014, MOL BIOL CELL, V25, P532, DOI 10.1091/mbc.E13-05-0286; Antoniali G, 2014, ANTIOXID REDOX SIGN, V20, P621, DOI 10.1089/ars.2013.5491; Ayyildiz D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56981-z; Bebelman MP, 2018, PHARMACOL THERAPEUT, V188, P1, DOI 10.1016/j.pharmthera.2018.02.013; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Bhakat KK, 2016, ONCOTARGET, V7, P22590, DOI 10.18632/oncotarget.8026; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Boussadia Z, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0915-z; Burra S, 2019, DNA REPAIR, V73, P129, DOI 10.1016/j.dnarep.2018.11.010; Choi S, 2013, BIOCHEM BIOPH RES CO, V435, P403, DOI 10.1016/j.bbrc.2013.04.101; Codrich M, 2019, DNA REPAIR, V82, DOI 10.1016/j.dnarep.2019.102675; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coscia C, 2016, METHODS MOL BIOL, V1448, P217, DOI 10.1007/978-1-4939-3753-0_16; Dai N, 2013, NEOPLASMA, V60, P384, DOI 10.4149/neo_2013_050; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Fantini D, 2010, NUCLEIC ACIDS RES, V38, P8239, DOI 10.1093/nar/gkq691; Friand V, 2015, BIOL CELL, V107, P331, DOI 10.1111/boc.201500010; Graham John M, 2002, ScientificWorldJournal, V2, P1356; Greening DW, 2018, EXPERT REV PROTEOMIC, V15, P887, DOI 10.1080/14789450.2018.1537788; Gurunathan S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040307; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Jin SA, 2015, KOREAN CIRC J, V45, P364, DOI 10.4070/kcj.2015.45.5.364; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Kalimuthu S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01116; Lee YR, 2015, ONCOTARGET, V6, P23383, DOI 10.18632/oncotarget.4345; Li B, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0126-2; Lirussi L, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040531; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Malfatti MC, 2020, MUTAGENESIS, V35, P129, DOI 10.1093/mutage/gez051; Malfatti MC, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1294-9; Malfatti MC, 2019, J BIOL CHEM, V294, P13061, DOI 10.1074/jbc.RA119.009493; Malfatti MC, 2017, NUCLEIC ACIDS RES, V45, P11193, DOI 10.1093/nar/gkx723; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Nath S, 2017, CELL SIGNAL, V39, P18, DOI 10.1016/j.cellsig.2017.07.019; Notarangelo M, 2019, EBIOMEDICINE, V43, P114, DOI 10.1016/j.ebiom.2019.04.039; Park MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23015; Park MS, 2013, BIOCHEM BIOPH RES CO, V435, P621, DOI 10.1016/j.bbrc.2013.05.030; Pascut Devis, 2019, Oncotarget, V10, P383, DOI 10.18632/oncotarget.26555; Poletto M, 2016, MOL CARCINOGEN, V55, P688, DOI 10.1002/mc.22313; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Rossi A, 2016, EXPERT REV ANTICANC, V16, P653, DOI 10.1586/14737140.2016.1170596; Sanderson RD, 2019, MATRIX BIOL, V75-76, P160, DOI 10.1016/j.matbio.2017.10.007; Scognamiglio PL, 2016, ONCOTARGET, V7, P59129, DOI 10.18632/oncotarget.10991; Scott TL, 2017, MOL CARCINOGEN, V56, P325, DOI 10.1002/mc.22495; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shimoda M, 2013, PROTEOMICS, V13, P1624, DOI 10.1002/pmic.201200458; Shin JH, 2015, CANCER RES TREAT, V47, P823, DOI 10.4143/crt.2014.074; Shu XT, 2016, ANGEW CHEM INT EDIT, V55, P14244, DOI 10.1002/anie.201607380; Simms CL, 2016, CELL MOL LIFE SCI, V73, P3639, DOI 10.1007/s00018-016-2261-7; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Sun FR, 2018, ONCOL RES, V26, P655, DOI 10.3727/096504017X15119525209765; Tell G, 2015, ONCOTARGET, V6, P584, DOI 10.18632/oncotarget.2705; Tell G, 2013, BIOTECHNIQUES, V55, P198, DOI 10.2144/000114088; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vascotto C, 2015, ONCOGENE, V34, P3482, DOI 10.1038/onc.2015.191; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Ye PJ, 2018, ARTIF CELL NANOMED B, V46, pS661, DOI 10.1080/21691401.2018.1505745; Yokoi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8849; Zhang SH, 2016, ONCOTARGET, V7, P77482, DOI 10.18632/oncotarget.13030	75	9	9	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100569	10.1016/j.jbc.2021.100569	http://dx.doi.org/10.1016/j.jbc.2021.100569			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33753167	gold, Green Published			2022-12-26	WOS:000672866400542
